PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Han, C; Wu, WH; Ale, A; Kim, MS; Cai, DS				Han, Cheng; Wu, Wenhe; Ale, Albert; Kim, Min Soo; Cai, Dongsheng			Central Leptin and Tumor Necrosis Factor-alpha (TNF alpha) in Diurnal Control of Blood Pressure and Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBESITY-RELATED HYPERTENSION; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; HYPOTHALAMIC INFLAMMATION; INTRACEREBROVENTRICULAR LEPTIN; MECHANISMS; RESISTANCE; MICE; RATS; PROLIFERATION	Leptin and TNF alpha can individually work in the brain to affect blood pressure; however, it remains unknown whether these two cytokines might have an interactive role in this process and, if so, how. In this work, we found that leptin stimulation led to TN-F alpha production under both in vitro and in vivo conditions, and diurnal fluctuation of leptin concentrations in the cerebrospinal fluid predicted the circadian changes of TN-F alpha gene expression in the hypothalamus. Signaling analysis showed that leptin stimulation led to a rapid and strong STAT3 activation followed by a second-phase moderate STAT3 activation, which was selectively abolished by anti-inflammatory chemical PS1145 or TNFa antagonist WP9QY. Physiological study in normal mice revealed that diurnal rise of blood pressure was abrogated following central administration of PS1145 or a leptin receptor antagonist. Central TNFa pretreatment was found to potentiate the effect of leptin in elevating blood pressure in normal mice. In pathophysiology, dietary obesity mimicked TNFa pretreatment in promoting leptin-induced blood pressure rise, and this effect was blocked by central treatment with either PS1145 or WP9QY. Hence, central leptin employs TNFa to mediate the diurnal blood pressure elevation in physiology while enhancement of this mechanism can contribute to hypertension development.	[Han, Cheng; Wu, Wenhe; Ale, Albert; Kim, Min Soo; Cai, Dongsheng] Albert Einstein Coll Med, Dept Mol Pharmacol, Diabet Res Ctr, Inst Aging, Bronx, NY 10461 USA; [Wu, Wenhe] Wenzhou Med Univ, Key Lab Lab Med, Zhejiang Prov Key Lab Med Genet, Wenzhou 325035, Zhejiang, Peoples R China	Yeshiva University; Albert Einstein College of Medicine; Wenzhou Medical University	Cai, DS (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	dongsheng.cai@einstein.yu.edu			National Institutes of Health [R01 DK078750, R01 AG031774, R01 HL113180, R01 DK099136]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078750, R01DK099136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health Grants R01 DK078750, R01 AG031774, R01 HL113180, and R01 DK099136 (all to D. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aizawa-Abe M, 2000, J CLIN INVEST, V105, P1243, DOI 10.1172/JCI8341; Aoki K, 2006, J CLIN INVEST, V116, P1525, DOI 10.1172/JCI22513; Bates SH, 2005, CELL METAB, V1, P169, DOI 10.1016/j.cmet.2005.02.001; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; Brown RJ, 2015, CELL, V162, P465, DOI 10.1016/j.cell.2015.07.007; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Buettner C, 2006, CELL METAB, V4, P49, DOI 10.1016/j.cmet.2006.04.014; Cai DS, 2013, VITAM HORM, V91, P195, DOI 10.1016/B978-0-12-407766-9.00008-0; Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x; da Silva AA, 2013, CURR OPIN NEPHROL HY, V22, P135, DOI 10.1097/MNH.0b013e32835d0c05; De Wardener HE, 2001, PHYSIOL REV, V81, P1599, DOI 10.1152/physrev.2001.81.4.1599; Dunbar JC, 1997, DIABETES, V46, P2040, DOI 10.2337/diabetes.46.12.2040; Gao JC, 2009, CANCER SCI, V100, P389, DOI 10.1111/j.1349-7006.2008.01053.x; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hall JE, 2010, J BIOL CHEM, V285, P17271, DOI 10.1074/jbc.R110.113175; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Iadecola C, 2008, CELL METAB, V7, P476, DOI 10.1016/j.cmet.2008.03.010; Kettner NM, 2015, CELL METAB, V22, P448, DOI 10.1016/j.cmet.2015.06.005; Kim MS, 2015, NAT IMMUNOL, V16, P525, DOI 10.1038/ni.3133; Lambert GW, 2010, PHARMACOL THERAPEUT, V126, P159, DOI 10.1016/j.pharmthera.2010.02.002; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Loraine YC, 2015, MOL METAB, V4, P287, DOI 10.1016/j.molmet.2015.01.011; Lu HQ, 1998, BRAIN RES BULL, V47, P331, DOI 10.1016/S0361-9230(98)00086-0; Maness LM, 1998, ENDOCRINOLOGY, V139, P4556, DOI 10.1210/en.139.11.4556; Mark AL, 2013, AM J PHYSIOL-REG I, V305, pR566, DOI 10.1152/ajpregu.00180.2013; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Purkayastha S, 2013, MOL METAB, V2, P356, DOI 10.1016/j.molmet.2013.09.005; Purkayastha S, 2011, NAT MED, V17, P883, DOI 10.1038/nm.2372; Rahmouni K, 2005, HYPERTENSION, V45, P9, DOI 10.1161/01.HYP.0000151325.83008.b4; Rahmouni K, 2003, HYPERTENSION, V41, P763, DOI 10.1161/01.HYP.0000048342.54392.40; Rahmouni K, 2005, DIABETES, V54, P2012, DOI 10.2337/diabetes.54.7.2012; Rahmouni K, 2002, HYPERTENSION, V39, P486, DOI 10.1161/hy0202.102836; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874; Santos-Alvarez J, 1999, CELL IMMUNOL, V194, P6, DOI 10.1006/cimm.1999.1490; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Shi P, 2010, CLIN EXP PHARMACOL P, V37, pE52, DOI 10.1111/j.1440-1681.2009.05234.x; Shin JI, 2014, NAT REV ENDOCRINOL, V10, DOI 10.1038/nrendo.2014.44-c1; Shiraishi T, 1999, NUTRITION, V15, P576, DOI 10.1016/S0899-9007(99)00088-X; Simonds SE, 2014, CELL, V159, P1404, DOI 10.1016/j.cell.2014.10.058; Tang YZ, 2013, CELL CYCLE, V12, P2711, DOI 10.4161/cc.26054; Tanida M, 2015, J NEUROSCI, V35, P474, DOI 10.1523/JNEUROSCI.1828-14.2015; Theiss AL, 2005, J BIOL CHEM, V280, P36099, DOI 10.1074/jbc.M505291200; Toffanin S, 2010, CANCER CELL, V17, P115, DOI 10.1016/j.ccr.2010.01.018; Tumer N, 2007, J HYPERTENS, V25, P2471, DOI 10.1097/HJH.0b013e3282e9a9fd; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Yan JQ, 2014, NAT MED, V20, P1001, DOI 10.1038/nm.3616; Yemelyanov A, 2006, ONCOGENE, V25, P387, DOI 10.1038/sj.onc.1209066; Zarkesh-Esfahani H, 2004, J IMMUNOL, V172, P1809, DOI 10.4049/jimmunol.172.3.1809; Zarkesh-Esfahani H, 2001, J IMMUNOL, V167, P4593, DOI 10.4049/jimmunol.167.8.4593; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhao T, 2005, CELL IMMUNOL, V238, P19, DOI 10.1016/j.cellimm.2005.12.002; Zimmerman MC, 2004, CIRC RES, V95, P210, DOI 10.1161/01.RES.0000135483.12297.e4	58	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15131	15142		10.1074/jbc.M116.730408	http://dx.doi.org/10.1074/jbc.M116.730408			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226618	hybrid, Green Published			2022-12-28	WOS:000380583200023
J	Lokhandwala, J; de la Vega, RISY; Hopkins, HC; Britton, CW; Rodriguez-Iglesias, A; Bogomolni, R; Schmoll, M; Zoltowski, BD				Lokhandwala, Jameela; Silverman y de la Vega, Rafael I.; Hopkins, Hilary C.; Britton, Collin W.; Rodriguez-Iglesias, Aroa; Bogomolni, Roberto; Schmoll, Monika; Zoltowski, Brian D.			A Native Threonine Coordinates Ordered Water to Tune Light-Oxygen-Voltage (LOV) Domain Photocycle Kinetics and Osmotic Stress Signaling in Trichoderma reesei ENVOY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kinetics; molecular dynamics; optogenetics; photobiology; structure-function; LOV domain; osmotic stress	BLUE-LIGHT; TRANSFORMATION SYSTEM; MOLECULAR SIMULATION; MUTATIONAL ANALYSIS; HYDRATION DYNAMICS; STRUCTURAL-CHANGES; INTEGRATING LIGHT; HIGH-THROUGHPUT; PROTEIN; MECHANISM	Light-oxygen-voltage (LOV) domain-containing proteins function as small light-activated modules capable of imparting blue light control of biological processes. Their small modular nature has made them model proteins for allosteric signal transduction and optogenetic devices. Despite intense research, key aspects of their signal transduction mechanisms and photochemistry remain poorly understood. In particular, ordered water has been identified as a possible key mediator of photocycle kinetics, despite the lack of ordered water in the LOV active site. Herein, we use recent crystal structures of a fungal LOV protein ENVOY to interrogate the role of Thr(101) in recruiting water to the flavin active site where it can function as an intrinsic base to accelerate photocycle kinetics. Kinetic and molecular dynamic simulations confirm a role in solvent recruitment to the active site and identify structural changes that correlate with solvent recruitment. In vivo analysis of T101I indicates a direct role of the Thr(101) position in mediating adaptation to osmotic stress, thereby verifying biological relevance of ordered water in LOV signaling. The combined studies identify position 101 as a mediator of both allostery and photocycle catalysis that can impact organism physiology.	[Lokhandwala, Jameela; Hopkins, Hilary C.; Britton, Collin W.; Zoltowski, Brian D.] Southern Methodist Univ, Dept Chem, Fondren Sci Bldg,Rm 321, Dallas, TX 75275 USA; [Silverman y de la Vega, Rafael I.; Bogomolni, Roberto] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Rodriguez-Iglesias, Aroa; Schmoll, Monika] Austrian Inst Technol, Dept Hlth & Environm, Bioresources, A-3430 Tulln, Austria	Southern Methodist University; University of California System; University of California Santa Cruz	Zoltowski, BD (corresponding author), Southern Methodist Univ, Dept Chem, Fondren Sci Bldg,Rm 321, Dallas, TX 75275 USA.	bzoltowski@smu.edu	Schmoll, Monika/I-6541-2016	Schmoll, Monika/0000-0003-3918-0574	Herman Frasch Foundation [739-HF12]; Austrian Science Fund Project [P24350-B20]; Austrian Science Fund (FWF) [P 24350] Funding Source: researchfish	Herman Frasch Foundation; Austrian Science Fund Project(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Grant 739-HF12 from the Herman Frasch Foundation (to B. D. Z.) and Austrian Science Fund Project Grant P24350-B20 (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexandre MTA, 2007, BIOCHEMISTRY-US, V46, P3129, DOI 10.1021/bi062074e; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Bazafkan H, 2015, MOL MICROBIOL, V96, P1103, DOI 10.1111/mmi.12993; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bocola M, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00055; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Carr D., 2015, HEXBIN HEXAGONAL BIN; Chan RH, 2012, J PHYS CHEM B, V116, P10609, DOI 10.1021/jp304934t; CHANDLER D, 1987, CHEM PHYS LETT, V140, P108, DOI 10.1016/0009-2614(87)80425-6; Christie JM, 2007, BIOCHEMISTRY-US, V46, P9310, DOI 10.1021/bi700852w; Corchnoy SB, 2003, J BIOL CHEM, V278, P724, DOI 10.1074/jbc.M209119200; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Dasgupta A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005215; Demarsy E, 2009, CURR OPIN PLANT BIOL, V12, P69, DOI 10.1016/j.pbi.2008.09.002; Diensthuber RP, 2014, ACS SYNTH BIOL, V3, P811, DOI 10.1021/sb400205x; El-Arab KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124874; Foreman R, 2012, J BACTERIOL, V194, P3038, DOI 10.1128/JB.00182-12; Freddolino PL, 2013, PHOTOCH PHOTOBIO SCI, V12, P1158, DOI 10.1039/c3pp25400c; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; GRUBER F, 1990, CURR GENET, V18, P71, DOI 10.1007/BF00321118; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Jones MA, 2007, J BIOL CHEM, V282, P6405, DOI 10.1074/jbc.M605969200; Kawano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082693; Krauss U, 2010, MICROB BIOTECHNOL, V3, P15, DOI 10.1111/j.1751-7915.2009.00140.x; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lokhandwala J, 2015, STRUCTURE, V23, P116, DOI 10.1016/j.str.2014.10.020; Losi A, 2015, PHOTOCHEM PHOTOBIOL, V91, P1021, DOI 10.1111/php.12489; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Moriconi V, 2013, PLANT J, V76, P322, DOI 10.1111/tpj.12289; Nash AI, 2008, BIOCHEMISTRY-US, V47, P13842, DOI 10.1021/bi801430e; Nozaki D, 2004, BIOCHEMISTRY-US, V43, P8373, DOI 10.1021/bi0494727; Nucci NV, 2011, J AM CHEM SOC, V133, P12326, DOI 10.1021/ja202033k; Nucci NV, 2011, NAT STRUCT MOL BIOL, V18, P245, DOI 10.1038/nsmb.1955; Ogura Y, 2008, J PLANT RES, V121, P97, DOI 10.1007/s10265-007-0118-8; Okajima K, 2012, J BIOL CHEM, V287, P40972, DOI 10.1074/jbc.M112.406512; PENTTILA M, 1987, GENE, V61, P155, DOI 10.1016/0378-1119(87)90110-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Pudasaini A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00018; Pudasaini A, 2013, BIOCHEMISTRY-US, V52, P7150, DOI 10.1021/bi401027n; Purcell EB, 2010, BIOCHEMISTRY-US, V49, P6761, DOI 10.1021/bi1006404; Querfurth C, 2011, MOL CELL, V43, P713, DOI 10.1016/j.molcel.2011.06.033; Raffelberg S, 2011, J AM CHEM SOC, V133, P5346, DOI 10.1021/ja1097379; Rani R, 2013, BIOCHEMISTRY-US, V52, P4460, DOI 10.1021/bi400311r; Schmoll M, 2016, MICROBIOL MOL BIOL R, V80, P205, DOI 10.1128/MMBR.00040-15; Schmoll M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-127; Schuster A, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-1; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Tisch D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-657; Vaidya AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001945; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Yee EF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10079; Zayner JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087074; Zayner JP, 2013, BIOPHYS J, V105, P1027, DOI 10.1016/j.bpj.2013.07.010; Zayner JP, 2012, J MOL BIOL, V419, P61, DOI 10.1016/j.jmb.2012.02.037; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128; Zoltowski BD, 2013, BIOCHEMISTRY-US, V52, P6653, DOI 10.1021/bi401040m; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P8771, DOI 10.1021/bi200976a; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P4, DOI 10.1021/bi101665s; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210	63	17	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14839	14850		10.1074/jbc.M116.731448	http://dx.doi.org/10.1074/jbc.M116.731448			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226624	Green Published, hybrid			2022-12-28	WOS:000380366700035
J	Schaarschmidt, J; Nagel, MBM; Huth, S; Jaeschke, H; Moretti, R; Hintze, V; von Bergen, M; Kalkhof, S; Meiler, J; Paschke, R				Schaarschmidt, Joerg; Nagel, Marcus B. M.; Huth, Sandra; Jaeschke, Holger; Moretti, Rocco; Hintze, Vera; von Bergen, Martin; Kalkhof, Stefan; Meiler, Jens; Paschke, Ralf			Rearrangement of the Extracellular Domain/Extracellular Loop 1 Interface Is Critical for Thyrotropin Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; computer modeling; G protein-coupled receptor (GPCR); mass spectrometry (MS); protein cross-linking; receptor structure-function; site-directed mutagenesis; structural biology; surface plasmon resonance (SPR)	STIMULATING HORMONE-RECEPTOR; HUMAN CHORIONIC-GONADOTROPIN; TSH RECEPTOR; CRYSTAL-STRUCTURE; HINGE REGION; GLYCOPROTEIN HORMONES; TYROSINE SULFATION; LIGAND-BINDING; AMINO-ACIDS; PROTEIN	The thyroid stimulating hormone receptor (TSHR) is a G protein-coupled receptor (GPCR) with a characteristic large extracellular domain (ECD). TSHR activation is initiated by binding of the hormone ligand TSH to the ECD. How the extracellular binding event triggers the conformational changes in the transmembrane domain (TMD) necessary for intracellular G protein activation is poorly understood. To gain insight in this process, the knowledge on the relative positioning of ECD and TMD and the conformation of the linker region at the interface of ECD and TMD are of particular importance. To generate a structural model for the TSHR we applied an integrated structural biology approach combining computational techniques with experimental data. Chemical cross-linking followed by mass spectrometry yielded 17 unique distance restraints within the ECD of the TSHR, its ligand TSH, and the hormone-receptor complex. These structural restraints generally confirm the expected binding mode of TSH to the ECD as well as the general fold of the domains and were used to guide homology modeling of the ECD. Functional characterization of TSHR mutants confirms the previously suggested close proximity of Ser-281 and Ile-486 within the TSHR. Rigidifying this contact permanently with a disulfide bridge disrupts ligand-induced receptor activation and indicates that rearrangement of the ECD/extracellular loop 1 (ECL1) interface is a critical step in receptor activation. The experimentally verified contact of Ser-281 (ECD) and Ile-486 (TMD) was subsequently utilized in docking homology models of the ECD and the TMD to create a full-length model of a glycoprotein hormone receptor.	[Schaarschmidt, Joerg; Nagel, Marcus B. M.; Huth, Sandra; Jaeschke, Holger] Univ Leipzig, Dept Internal Med, D-04103 Leipzig, Germany; [Nagel, Marcus B. M.; von Bergen, Martin; Kalkhof, Stefan] Helmholtz Ctr Environm Res, Dept Prote, D-04318 Leipzig, Germany; [Moretti, Rocco; Meiler, Jens] Vanderbilt Univ, Dept Chem, Box 1583, Nashville, TN 37235 USA; [Moretti, Rocco; Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37235 USA; [Hintze, Vera] Tech Univ Dresden, Inst Mat Sci, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany; [von Bergen, Martin] Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, D-04103 Leipzig, Germany; [von Bergen, Martin] Aalborg Univ, Dept Chem & Biosci, Fredrik Bajers Vej 7, DK-9220 Aalborg, Denmark; [Kalkhof, Stefan] Univ Appl Sci & Arts Coburg, Dept Bioanalyt, D-96450 Coburg, Germany; [Paschke, Ralf] Univ Calgary, Div Endocrinol & Metab, Calgary, AB T2N 1N4, Canada; [Paschke, Ralf] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB T2N 1N4, Canada	Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Vanderbilt University; Vanderbilt University; Technische Universitat Dresden; Leipzig University; Aalborg University; University of Calgary; University of Calgary	Paschke, R (corresponding author), Univ Calgary, RRDTC, 1820 Richmond Rd SW, Calgary, AB T2T 5C7, Canada.	ralf.paschke@ucalgary.ca	Schaarschmidt, Joerg/A-9449-2017; von Bergen, Martin/D-7960-2011; Kalkhof, Stefan/Z-2000-2019	Schaarschmidt, Joerg/0000-0002-4389-2366; von Bergen, Martin/0000-0003-2732-2977; Kalkhof, Stefan/0000-0001-6121-7105; Meiler, Jens/0000-0001-8945-193X	Deutsche Forschungsgemeinschaft (DFG) [Ja 1927/1-2]; ESF Investigator group GPCR; Else Kroner-Fresenius-Stiftung [2012_A244]; Office Of Internatl Science &Engineering [1157751] Funding Source: National Science Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); ESF Investigator group GPCR; Else Kroner-Fresenius-Stiftung; Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG, Ja 1927/1-2), ESF Investigator group GPCR 2, and a grant from the Else Kroner-Fresenius-Stiftung (2012_A244). The authors declare that they have no conflicts of interest with the contents of this article.	BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Chazenbalk GD, 1999, ENDOCRINOLOGY, V140, P4516, DOI 10.1210/en.140.10.4516; Cornelis S, 2001, BIOCHEMISTRY-US, V40, P9860, DOI 10.1021/bi0107389; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; De Marco G, 2009, CLIN ENDOCRINOL, V70, P335, DOI 10.1111/j.1365-2265.2008.03333.x; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Graves P, 1999, J CLIN ENDOCR METAB, V84, P2177, DOI 10.1210/jc.84.6.2177; Hamidi S, 2011, MOL ENDOCRINOL, V25, P184, DOI 10.1210/me.2010-0401; Hampf M, 2006, ANAL BIOCHEM, V356, P94, DOI 10.1016/j.ab.2006.04.046; Heitman LH, 2012, MOL CELL ENDOCRINOL, V351, P326, DOI 10.1016/j.mce.2012.01.010; Ho SC, 2008, THYROID, V18, P1313, DOI 10.1089/thy.2008.0240; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; Jaeschke H, 2006, ENDOCRINOLOGY, V147, P1753, DOI 10.1210/en.2005-1138; Jaeschke H, 2014, J CLIN ENDOCR METAB, V99, pE2051, DOI 10.1210/jc.2014-1436; Jaeschke H, 2011, ENDOCRINOLOGY, V152, P3986, DOI 10.1210/en.2011-1389; Jaschke H, 2006, J BIOL CHEM, V281, P9841, DOI 10.1074/jbc.C600014200; Jiang XL, 1995, STRUCTURE, V3, P1341, DOI 10.1016/S0969-2126(01)00272-6; Jiang XL, 2014, J BIOL CHEM, V289, P14273, DOI 10.1074/jbc.M114.549592; Jiang XL, 2014, MOL CELL ENDOCRINOL, V382, P424, DOI 10.1016/j.mce.2013.08.021; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Klco JM, 2006, J BIOL CHEM, V281, P12010, DOI 10.1074/jbc.M600548200; Kleinau G, 2008, FASEB J, V22, P2798, DOI 10.1096/fj.07-104711; Kleinau G, 2007, J BIOL CHEM, V282, P518, DOI 10.1074/jbc.M606176200; Kleinau G, 2013, ENDOCR REV, V34, P691, DOI 10.1210/er.2012-1072; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; Kursawe R, 2007, TRENDS ENDOCRIN MET, V18, P199, DOI 10.1016/j.tem.2007.05.002; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li SC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-25; Meiler J, 2001, J MOL MODEL, V7, P360, DOI 10.1007/s008940100038; Montanelli L, 2004, MOL ENDOCRINOL, V18, P2061, DOI 10.1210/me.2004-0036; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; Mueller S, 2010, TRENDS ENDOCRIN MET, V21, P111, DOI 10.1016/j.tem.2009.09.001; Mueller S, 2009, J BIOL CHEM, V284, P16317, DOI 10.1074/jbc.M109.005710; Muller SA, 2015, J PROTEOMICS, V126, P34, DOI 10.1016/j.jprot.2015.05.011; Nagayama Y, 2000, J PHARMACOL EXP THER, V295, P404; Nakabayashi K, 2003, MOL CELL ENDOCRINOL, V202, P139, DOI 10.1016/S0303-7207(03)00075-3; Neumann S, 2012, THYROID, V22, P839, DOI 10.1089/thy.2011.0520; Nicholas HB, 1999, ENDOCRINE, V11, P285, DOI 10.1385/ENDO:11:3:285; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Sanders P, 2011, J MOL ENDOCRINOL, V46, P81, DOI 10.1530/JME-10-0127; Schaarschmidt J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111570; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Stranges PB, 2013, PROTEIN SCI, V22, P74, DOI 10.1002/pro.2187; Tanaka K, 2000, ENDOCRINOLOGY, V141, P3573, DOI 10.1210/en.141.10.3573; Tegoni M, 1999, J MOL BIOL, V289, P1375, DOI 10.1006/jmbi.1999.2845; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; WADSWORTH HL, 1990, SCIENCE, V249, P1423, DOI 10.1126/science.2169649; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Zoenen M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1991	58	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14095	14108		10.1074/jbc.M115.709659	http://dx.doi.org/10.1074/jbc.M115.709659			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129207	Green Published, hybrid			2022-12-28	WOS:000379975100018
J	Recktenwald, CV; Hansson, GC				Recktenwald, Christian V.; Hansson, Gunnar C.			The Reduction-insensitive Bonds of the MUC2 Mucin Are Isopeptide Bonds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intestine; mass spectrometry (MS); mucin; mucus; transglutaminase	GAMMA-GLUTAMYL-TRANSPEPTIDASE; LS 174T CELLS; KERATINOCYTE TRANSGLUTAMINASE; INTESTINAL MUCUS; CROSS-LINKING; HUMAN COLON; C-TERMINUS; IDENTIFICATION; EXPRESSION; CLEAVAGE	The main structural component of the mucus in the gastrointestinal tract is the MUC2 mucin. It forms large networks that in colon build the loose outer mucous layer that provides the habitat for the commensal flora and the inner mucous layer that protects the epithelial cells by being impenetrable to bacteria. The epithelial cells in mice lacking MUC2 are not adequately protected from bacteria, resulting in inflammation and the development of colon cancer as found in human ulcerative colitis. Correct processing of the MUC2 mucin is the basis for the building of these protective networks. During the biosynthesis of the MUC2 mucin, post-translational modifications are formed resulting in reduction-insensitive bonds between MUC2 monomers. By the use of -glutamyltranspeptidase and isopeptidase activity in leech saliva, we could show that the molecular nature of these reduction-insensitive bonds is isopeptide bonds formed between side chains of lysine and glutamine. Transglutaminase 2 has an affinity to the MUC2 CysD2 domain in the nanomolar range and can catalyze its cross-linking. By using mass spectrometry, we identified MUC2 residues involved in this cross-linking. This shows for the first time that transamidation is not only stabilizing the skin and the fibrin clot, but is also important for the correct intracellular processing of MUC2 to generate protective mucus.	[Recktenwald, Christian V.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, Box 440, SE-40530 Gothenburg, Sweden	University of Gothenburg	Hansson, GC (corresponding author), Univ Gothenburg, Dept Med Biochem, Box 440, SE-40530 Gothenburg, Sweden.	gunnar.hansson@medkem.gu.se	Hansson, Gunnar C/A-1236-2009; Hansson, Gunnar C./AAF-7324-2019	Hansson, Gunnar C/0000-0002-1900-1869; Hansson, Gunnar C./0000-0002-1900-1869; Recktenwald, Christian Viktor/0000-0003-1710-1863	Swedish Research Council [746]; Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation; IngaBritt and Arne Lundberg Foundation; Sahlgren's University Hospital (ALF); Wilhelm and Martina Lundgren's Foundation; Torsten Soderbergs Stiftelse; The Sahlgrenska Academy; National Institutes of Health from NIAID [U01AI095473]; Swedish Foundation for Strategic Research-The Mucus-Bacteria-Colitis Center of the Innate Immunity Program; Swedish Cystic Fibrosis Foundation; Erica Lederhausen's Foundation; Lederhausen's Center for Cystic Fibrosis Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); IngaBritt and Arne Lundberg Foundation; Sahlgren's University Hospital (ALF); Wilhelm and Martina Lundgren's Foundation; Torsten Soderbergs Stiftelse; The Sahlgrenska Academy; National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swedish Foundation for Strategic Research-The Mucus-Bacteria-Colitis Center of the Innate Immunity Program; Swedish Cystic Fibrosis Foundation; Erica Lederhausen's Foundation; Lederhausen's Center for Cystic Fibrosis Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Swedish Research Council Grant 746, the Swedish Cancer Foundation, the Knut and Alice Wallenberg Foundation, the IngaBritt and Arne Lundberg Foundation, Sahlgren's University Hospital (ALF), the Wilhelm and Martina Lundgren's Foundation, Torsten Soderbergs Stiftelse, The Sahlgrenska Academy, National Institutes of Health Grant U01AI095473 from NIAID, the Swedish Foundation for Strategic Research-The Mucus-Bacteria-Colitis Center of the Innate Immunity Program, the Swedish Cystic Fibrosis Foundation, the Erica Lederhausen's Foundation, and the Lederhausen's Center for Cystic Fibrosis Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamczyk M, 2015, J CELL SCI, V128, P4615, DOI 10.1242/jcs.175968; ALLISON RD, 1981, J BIOL CHEM, V256, P2988; Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Ambort D, 2011, BIOCHEM J, V436, P61, DOI 10.1042/BJ20102066; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Axelsson MAB, 1998, J BIOL CHEM, V273, P18864, DOI 10.1074/jbc.273.30.18864; BASKOVA I P, 1985, Biokhimiya, V50, P424; Belkin AM, 2011, FEBS J, V278, P4704, DOI 10.1111/j.1742-4658.2011.08346.x; CARLSTEDT I, 1993, J BIOL CHEM, V268, P18771; D'Argenio G, 2005, GUT, V54, P496, DOI 10.1136/gut.2004.049411; DARBOUY M, 1991, AM J PHYSIOL, V261, pC1130, DOI 10.1152/ajpcell.1991.261.6.C1130; Eckert RL, 2014, PHYSIOL REV, V94, P383, DOI 10.1152/physrev.00019.2013; Eckert RL, 2005, J INVEST DERMATOL, V124, P481, DOI 10.1111/j.0022-202X.2005.23627.x; Eckhart L, 2013, BBA-MOL CELL RES, V1833, P3471, DOI 10.1016/j.bbamcr.2013.06.010; Feng JF, 1996, J BIOL CHEM, V271, P16451, DOI 10.1074/jbc.271.28.16451; Fleckenstein B, 2002, J BIOL CHEM, V277, P34109, DOI 10.1074/jbc.M204521200; Friedrich T, 1998, EUR J BIOCHEM, V256, P297, DOI 10.1046/j.1432-1327.1998.2560297.x; Godl K, 2002, J BIOL CHEM, V277, P47248, DOI 10.1074/jbc.M208483200; Gotze M, 2015, J AM SOC MASS SPECTR, V26, P83, DOI 10.1007/s13361-014-1001-1; GUM JR, 1994, J BIOL CHEM, V269, P2440; HAGEN TM, 1990, AM J PHYSIOL, V259, pG530, DOI 10.1152/ajpgi.1990.259.4.G530; Hardy E, 2004, ANAL BIOCHEM, V328, P1, DOI 10.1016/j.ab.2004.02.017; Herrmann A, 2003, BIOCHIMIE, V85, P381, DOI 10.1016/S0300-9084(03)00064-6; Herrmann A, 1999, J BIOL CHEM, V274, P15828, DOI 10.1074/jbc.274.22.15828; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Johansson MEV, 2015, CELL HOST MICROBE, V18, P582, DOI 10.1016/j.chom.2015.10.007; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kiraly R, 2016, AMINO ACIDS, V48, P31, DOI 10.1007/s00726-015-2063-5; LICHTI U, 1985, J BIOL CHEM, V260, P1422; Lidell ME, 2003, BIOCHEM J, V372, P335, DOI 10.1042/BJ20030003; Lidell ME, 2003, J BIOL CHEM, V278, P13944, DOI 10.1074/jbc.M210069200; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; Ozpolat B, 2007, AUTOPHAGY, V3, P480, DOI 10.4161/auto.4349; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rodriguez-Pineiro AM, 2013, AM J PHYSIOL-GASTR L, V305, pG348, DOI 10.1152/ajpgi.00047.2013; SANE DC, 1990, J BIOL CHEM, V265, P3543; Schulz BL, 2002, ANAL CHEM, V74, P6088, DOI 10.1021/ac025890a; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Stamnaes J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134922; Thomsson KA, 2011, METHODS MOL BIOL, V742, P127, DOI 10.1007/978-1-61779-120-8_8; Zaidi SMA, 2011, ALTERN MED REV, V16, P59	43	29	29	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13580	13590		10.1074/jbc.M116.726406	http://dx.doi.org/10.1074/jbc.M116.726406			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129250	Green Published, hybrid			2022-12-28	WOS:000379771100016
J	Gunn, JS; Bakaletz, LO; Wozniak, DJ				Gunn, John S.; Bakaletz, Lauren O.; Wozniak, Daniel J.			What's on the Outside Matters: The Role of the Extracellular Polymeric Substance of Gram-negative Biofilms in Evading Host Immunity and as a Target for Therapeutic Intervention	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NONTYPABLE HAEMOPHILUS-INFLUENZAE; ENTERICA SEROVAR TYPHIMURIUM; PSEUDOMONAS-AERUGINOSA BIOFILMS; OUTER-MEMBRANE VESICLES; COMMUNITIES IN-VITRO; CYSTIC-FIBROSIS LUNG; O-ANTIGEN CAPSULE; D-AMINO ACIDS; OTITIS-MEDIA; SALMONELLA-TYPHIMURIUM	Biofilms are organized multicellular communities encased in an extracellular polymeric substance (EPS). Biofilm-resident bacteria resist immunity and antimicrobials. The EPS provides structural stability and presents a barrier; however, a complete understanding of how EPS structure relates to biological function is lacking. This review focuses on the EPS of three Gram-negative pathogens: Pseudomonas aeruginosa, nontypeable Haemophilus influenzae, and Salmonella enterica serovar Typhi/Typhimurium. Although EPS proteins and polysaccharides are diverse, common constituents include extracellular DNA, DNABII (DNA binding and bending) proteins, pili, flagella, and outer membrane vesicles. The EPS biochemistry promotes recalcitrance and informs the design of therapies to reduce or eliminate biofilm burden.	[Gunn, John S.; Bakaletz, Lauren O.; Wozniak, Daniel J.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Wozniak, Daniel J.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Bakaletz, Lauren O.] Nationwide Childrens Hosp, Res Inst, Dept Pediat, Columbus, OH 43210 USA; [Bakaletz, Lauren O.] Nationwide Childrens Hosp, Res Inst, Dept Otolaryngol, Columbus, OH 43210 USA; [Bakaletz, Lauren O.] Ohio State Univ, Columbus, OH 43210 USA; [Gunn, John S.; Bakaletz, Lauren O.; Wozniak, Daniel J.] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Interface Biol, Columbus, OH 43205 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Wozniak, DJ (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Ctr Microbial Interface Biol, Microbiol, 1018 BRT,460 West 12th Ave, Columbus, OH 43210 USA.	daniel.wozniak@osumc.edu	Bakaletz, Lauren/GMW-8490-2022		Public Health Preparedness for Infectious Diseases (PHPID); Biofilms in Human Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097511, R01AI116917] Funding Source: NIH RePORTER	Public Health Preparedness for Infectious Diseases (PHPID); Biofilms in Human Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Public Health Preparedness for Infectious Diseases (PHPID) and Biofilms in Human Medicine. This is the second article in the Thematic Minireview series "Biofilms." The authors declare that they have no conflicts of interest with the contents of this article.	Alhede M., 2014, ADV APPL MICROBIOL, P1; Alhede M, 2009, MICROBIOL-SGM, V155, P3500, DOI 10.1099/mic.0.031443-0; Armbruster CE, 2010, EXPERT REV ANTI-INFE, V8, P1067, DOI [10.1586/eri.10.109, 10.1586/ERI.10.109]; Bakaletz LO, 2009, EXPERT REV VACCINES, V8, P1063, DOI 10.1586/ERV.09.63; Baker P, 2015, J BIOL CHEM, V290, P28374, DOI 10.1074/jbc.M115.674929; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Borlee BR, 2010, MOL MICROBIOL, V75, P827, DOI 10.1111/j.1365-2958.2009.06991.x; Brockson ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040088; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; CASH HA, 1979, AM REV RESPIR DIS, V119, P453; Cavaliere R, 2014, MICROBIOLOGYOPEN, V3, P557, DOI 10.1002/mbo3.187; Couto N, 2015, J PROTEOME RES, V14, P4207, DOI 10.1021/acs.jproteome.5b00312; Crawford RW, 2010, J BACTERIOL, V192, P2981, DOI 10.1128/JB.01620-09; Crawford RW, 2010, P NATL ACAD SCI USA, V107, P4353, DOI 10.1073/pnas.1000862107; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; de la Fuente-Nunez C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004152; Dongol S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047342; Ehrlich GD, 2002, JAMA-J AM MED ASSOC, V287, P1710, DOI 10.1001/jama.287.13.1710; Fleiszig Suzanne M J, 2002, Clin Exp Optom, V85, P271; Fong JNC, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0004-2014; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Gallo PM, 2015, IMMUNITY, V42, P1171, DOI 10.1016/j.immuni.2015.06.002; Gawande PV, 2014, CURR MICROBIOL, V68, P635, DOI 10.1007/s00284-014-0519-6; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; Gonzalez-Escobedo G, 2013, INFECT IMMUN, V81, P2920, DOI 10.1128/IAI.00258-13; Gonzalez-Escobedo G, 2011, NAT REV MICROBIOL, V9, P9, DOI 10.1038/nrmicro2490; Goodman SD, 2011, MUCOSAL IMMUNOL, V4, P625, DOI 10.1038/mi.2011.27; Gupta P, 2016, ARCH MICROBIOL, V198, P1, DOI 10.1007/s00203-015-1148-6; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Hong WZ, 2007, J BACTERIOL, V189, P8300, DOI 10.1128/JB.00532-07; Hong WZ, 2007, INFECT IMMUN, V75, P958, DOI 10.1128/IAI.01691-06; Hong WZ, 2009, J INNATE IMMUN, V1, P215, DOI 10.1159/000205937; Imberty A, 2004, MICROBES INFECT, V6, P221, DOI 10.1016/j.micinf.2003.10.016; Izano EA, 2009, MICROB PATHOGENESIS, V46, P207, DOI 10.1016/j.micpath.2009.01.004; Janssens JCA, 2008, APPL ENVIRON MICROB, V74, P6639, DOI 10.1128/AEM.01262-08; Jennings LK, 2015, P NATL ACAD SCI USA, V112, P11353, DOI 10.1073/pnas.1503058112; Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329; Johnson L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-115; Jones EA, 2013, J INNATE IMMUN, V5, P24, DOI 10.1159/000339961; Juneau RA, 2015, INFECT IMMUN, V83, P239, DOI 10.1128/IAI.02390-14; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kavanaugh JS, 2016, J BIOL CHEM, V291, P12556, DOI 10.1074/jbc.R116.722710; KOCHAROVA NA, 1989, J BIOL CHEM, V264, P15569; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Koopman JA, 2015, ANTIMICROB AGENTS CH, V59, P76, DOI 10.1128/AAC.03407-14; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; KRIEG DP, 1988, INFECT IMMUN, V56, P3173, DOI 10.1128/IAI.56.12.3173-3179.1988; Lamppa JW, 2013, ANTIMICROB AGENTS CH, V57, P137, DOI 10.1128/AAC.01789-12; Latasa C, 2005, MOL MICROBIOL, V58, P1322, DOI 10.1111/j.1365-2958.2005.04907.x; Lebeaux D, 2013, PATHOGENS, V2, P288, DOI 10.3390/pathogens2020288; Ledeboer NA, 2005, J BACTERIOL, V187, P3214, DOI 10.1128/JB.187.9.3214-3226.2005; Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512; Leid JG, 2002, INFECT IMMUN, V70, P6339, DOI 10.1128/IAI.70.11.6339-6345.2002; Leiman SA, 2015, J BACTERIOL, V197, P1632, DOI 10.1128/JB.00009-15; Limoli DH, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0011-2014; Limoli DH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004083; Lowery CA, 2009, J AM CHEM SOC, V131, P15584, DOI 10.1021/ja9066783; Marshall JM, 2015, INFECT IMMUN, V83, P3946, DOI 10.1128/IAI.00634-15; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; Menendez A, 2009, J INFECT DIS, V200, P1703, DOI 10.1086/646608; Mishra M, 2012, CELL MICROBIOL, V14, P95, DOI 10.1111/j.1462-5822.2011.01704.x; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Morey P, 2013, INFECT IMMUN, V81, P4100, DOI 10.1128/IAI.00492-13; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Mulcahy LR, 2014, MICROB ECOL, V68, P1, DOI 10.1007/s00248-013-0297-x; Murphy TF, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-7; Novotny LA, 2011, MUCOSAL IMMUNOL, V4, P456, DOI 10.1038/mi.2011.6; Novotny LA, 2015, MOL MICROBIOL, V96, P276, DOI 10.1111/mmi.12934; Novotny LA, 2013, VACCINE, V31, P3417, DOI 10.1016/j.vaccine.2012.10.033; O'Toole A, 2015, BIOFOULING, V31, P665, DOI 10.1080/08927014.2015.1083985; Pang B, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00058; Pastar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056846; Petrova OE, 2015, J BACTERIOL, V197, P174, DOI 10.1128/JB.02244-14; Puig C, 2014, INFECT IMMUN, V82, P1591, DOI 10.1128/IAI.01445-13; Rahmani-Badi A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00383; Rapsinski GJ, 2015, INFECT IMMUN, V83, P693, DOI 10.1128/IAI.02370-14; Rodriguez-Rojas A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005546; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Roier S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10515; Romling U, 2003, INT J MED MICROBIOL, V293, P273, DOI 10.1078/1438-4221-00268; Roy S, 2014, J PATHOL, V233, P331, DOI 10.1002/path.4360; Sanchez Z, 2013, APPL ENVIRON MICROB, V79, P1396, DOI 10.1128/AEM.02911-12; Sarkar S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117613; SCHIOLER H, 1983, SCAND J INFECT DIS, V15, P17, DOI 10.3109/inf.1983.15.issue-1.04; Schooling SR, 2006, J BACTERIOL, V188, P5945, DOI 10.1128/JB.00257-06; Seviour T, 2015, J BIOL CHEM, V290, P6457, DOI 10.1074/jbc.M114.613810; Sheppard DC, 2016, J BIOL CHEM, V291, P12529, DOI 10.1074/jbc.R116.720995; Simm R, 2014, FUTURE MICROBIOL, V9, P1261, DOI [10.2217/FMB.14.88, 10.2217/fmb.14.88]; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Steenackers HPL, 2011, BIOORGAN MED CHEM, V19, P3462, DOI 10.1016/j.bmc.2011.04.026; Sullivan SR, 2004, PLAST RECONSTR SURG, V113, P953, DOI 10.1097/01.PRS.0000105044.03230.F4; Toyofuku M, 2012, J PROTEOME RES, V11, P4906, DOI 10.1021/pr300395j; Tukel C, 2010, CELL MICROBIOL, V12, P1495, DOI 10.1111/j.1462-5822.2010.01485.x; Valentini M, 2016, J BIOL CHEM, V291, P12547, DOI 10.1074/jbc.R115.711507; Van Acker H, 2016, J BIOL CHEM, V291, P12565, DOI 10.1074/jbc.R115.707257; Watters C, 2013, MED MICROBIOL IMMUN, V202, P131, DOI 10.1007/s00430-012-0277-7; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wilson RP, 2011, INFECT IMMUN, V79, P830, DOI 10.1128/IAI.00961-10; Winter SE, 2008, CELL MICROBIOL, V10, P247, DOI 10.1111/j.1462-5822.2007.01037.x; Wu S, 2014, PATHOG DIS, V72, P143, DOI 10.1111/2049-632X.12195; Yang L, 2012, FEMS IMMUNOL MED MIC, V65, P366, DOI 10.1111/j.1574-695X.2012.00936.x; Yu S, 2015, CELL RES, V25, P1352, DOI 10.1038/cr.2015.129; Zhou Z, 2011, J CYST FIBROS, V10, pS172, DOI 10.1016/S1569-1993(11)60021-0	104	102	104	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12538	12546		10.1074/jbc.R115.707547	http://dx.doi.org/10.1074/jbc.R115.707547			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129225	Green Published, hybrid			2022-12-28	WOS:000378119900009
J	Kavanaugh, JS; Horswill, AR				Kavanaugh, Jeffrey S.; Horswill, Alexander R.			Impact of Environmental Cues on Staphylococcal Quorum Sensing and Biofilm Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACCESSORY GENE REGULATOR; VIRULENCE DETERMINANT PRODUCTION; SARA PROTEIN FAMILY; AUREUS INFECTION; IN-VIVO; ANTIBIOTIC-RESISTANCE; BACTERIAL VIRULENCE; GLOBAL REGULATORS; MASS-SPECTROMETRY; APOLIPOPROTEIN-B	Staphylococci are commensal bacteria that colonize the epithelial surfaces of humans and many other mammals. These bacteria can also attach to implanted medical devices and develop surface-associated biofilm communities that resist clearance by host defenses and available chemotherapies. These communities are often associated with persistent staphylococcal infections that place a tremendous burden on the healthcare system. Understanding the regulatory program that controls staphylococcal biofilm development, as well as the environmental conditions that modulate this program, has been a focal point of research in recent years. A central regulator controlling biofilm development is a peptide quorum-sensing system, also called the accessory gene regulator or agr system. In the opportunistic pathogen Staphylococcus aureus, the agr system controls production of exo-toxins and exo-enzymes essential for causing infections, and simultaneously, it modulates the ability of this pathogen to attach to surfaces and develop a biofilm, or to disperse from the biofilm state. In this review, we explore advances on the interconnections between the agr quorum-sensing system and biofilm mechanisms, and topics covered include recent findings on how different environmental conditions influence quorum sensing, the impact on biofilm development, and ongoing questions and challenges in the field. As our understanding of the quorum sensing and biofilm interconnection advances, there are growing opportunities to take advantage of this knowledge and develop therapeutic approaches to control staphylococcal infections.	[Kavanaugh, Jeffrey S.; Horswill, Alexander R.] Univ Iowa, Carver Coll Med, Dept Microbiol, 540F EMRB, Iowa City, IA 52242 USA	University of Iowa	Horswill, AR (corresponding author), Univ Iowa, Carver Coll Med, Dept Microbiol, 540F EMRB, Iowa City, IA 52242 USA.	alex-horswill@uiowa.edu			National Institutes of Health [AI083211]; U.S. Department of Veterans Affairs [I01 BX002711]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grant AI083211 (to A. R. H.) and U.S. Department of Veterans Affairs Grant I01 BX002711 (to A. R. H.). This is the fourth article in the Thematic Minireview series "Biofilms." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adkins JN, 2002, MOL CELL PROTEOMICS, V1, P947, DOI 10.1074/mcp.M200066-MCP200; Banat IM, 2014, APPL MICROBIOL BIOT, V98, P9915, DOI 10.1007/s00253-014-6169-6; Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Boles BR, 2011, TRENDS MICROBIOL, V19, P449, DOI 10.1016/j.tim.2011.06.004; Brinsmade SR, 2010, J BACTERIOL, V192, P6357, DOI 10.1128/JB.00937-10; Burian M, 2010, J INFECT DIS, V201, P1414, DOI 10.1086/651619; Cech NB, 2013, FUTURE MICROBIOL, V8, P1511, DOI 10.2217/fmb.13.134; Cheung AL, 2002, FRONT BIOSCI-LANDMRK, V7, pD1825, DOI 10.2741/cheung; CHEUNG AL, 1994, J CLIN INVEST, V94, P1815, DOI 10.1172/JCI117530; Cheung AL, 2008, INT J BIOCHEM CELL B, V40, P355, DOI 10.1016/j.biocel.2007.10.032; Chien YT, 1998, J BIOL CHEM, V273, P2645, DOI 10.1074/jbc.273.5.2645; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Elmore BO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125027; Geisinger E, 2006, MOL MICROBIOL, V61, P1038, DOI 10.1111/j.1365-2958.2006.05292.x; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Gordon CP, 2013, J MED CHEM, V56, P1389, DOI 10.1021/jm3014635; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Gray B, 2013, SENSORS-BASEL, V13, P5130, DOI 10.3390/s130405130; Hall PR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003166; Holtfreter S, 2009, CLIN VACCINE IMMUNOL, V16, P1607, DOI 10.1128/CVI.00263-09; James EH, 2013, FEMS MICROBIOL LETT, V349, P153, DOI 10.1111/1574-6968.12309; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Junio HA, 2013, J CHROMATOGR B, V930, P7, DOI 10.1016/j.jchromb.2013.04.019; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; Kavanaugh JS, 2007, MOL MICROBIOL, V65, P780, DOI 10.1111/j.1365-2958.2007.05830.x; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kiedrowski MR, 2016, CELL MICROBIOL, V18, P720, DOI 10.1111/cmi.12543; Kiedrowski MR, 2011, ANN NY ACAD SCI, V1241, P104, DOI 10.1111/j.1749-6632.2011.06281.x; Lauderdale KJ, 2010, J ORTHOP RES, V28, P55, DOI 10.1002/jor.20943; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; Le KY, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01174; Lister JL, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00178; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Manifold-Wheeler BC, 2016, J IMMUNOL, V196, P328, DOI 10.4049/jimmunol.1501835; Manna AC, 2006, MOL MICROBIOL, V60, P1289, DOI 10.1111/j.1365-2958.2006.05171.x; McGavin MJ, 1997, INFECT IMMUN, V65, P2621, DOI 10.1128/IAI.65.7.2621-2628.1997; Montgomery CP, 2012, INFECT IMMUN, V80, P2382, DOI 10.1128/IAI.06172-11; Mootz JM, 2015, MOL MICROBIOL, V96, P388, DOI 10.1111/mmi.12943; Mootz JM, 2013, INFECT IMMUN, V81, P3227, DOI 10.1128/IAI.00377-13; MORFELDT E, 1995, EMBO J, V14, P4569, DOI 10.1002/j.1460-2075.1995.tb00136.x; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Olson ME, 2014, J BACTERIOL, V196, P3482, DOI 10.1128/JB.01882-14; Oogai Y, 2011, APPL ENVIRON MICROB, V77, P8097, DOI 10.1128/AEM.05316-11; Otto M, 2004, FEMS MICROBIOL LETT, V241, P135, DOI 10.1016/j.femsle.2004.11.016; Otto M, 2001, INFECT IMMUN, V69, P1957, DOI 10.1128/IAI.69.3.1957-1960.2001; Pang YY, 2010, J INNATE IMMUN, V2, P546, DOI 10.1159/000319855; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Peschel A, 2013, NAT REV MICROBIOL, V11, P667, DOI 10.1038/nrmicro3110; Peterson MM, 2008, CELL HOST MICROBE, V4, P555, DOI 10.1016/j.chom.2008.10.001; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Poor CB, 2009, J BIOL CHEM, V284, P23517, DOI 10.1074/jbc.M109.015826; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Pynnonen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002104; Quave CL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00706; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; REGASSA LB, 1992, INFECT IMMUN, V60, P3381, DOI 10.1128/IAI.60.8.3381-3388.1992; Reyes D, 2011, J BACTERIOL, V193, P6020, DOI 10.1128/JB.05436-11; Rivera FE, 2012, PROTEOMICS, V12, P263, DOI 10.1002/pmic.201100298; Rothfork JM, 2004, P NATL ACAD SCI USA, V101, P13867, DOI 10.1073/pnas.0402996101; Rothfork JM, 2003, J IMMUNOL, V171, P5389, DOI 10.4049/jimmunol.171.10.5389; Roux A, 2014, J BACTERIOL, V196, P1184, DOI 10.1128/JB.00128-13; Schlievert PM, 2007, BIOCHEMISTRY-US, V46, P14349, DOI 10.1021/bi701202w; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Spellberg B, 2013, NEW ENGL J MED, V368, P299, DOI 10.1056/NEJMp1215093; Speziale P, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00171; Stenz L, 2011, FEMS IMMUNOL MED MIC, V62, P123, DOI 10.1111/j.1574-695X.2011.00812.x; Sun F, 2012, P NATL ACAD SCI USA, V109, P15461, DOI 10.1073/pnas.1205952109; Sun F, 2012, P NATL ACAD SCI USA, V109, P9095, DOI 10.1073/pnas.1200603109; Sun F, 2012, J AM CHEM SOC, V134, P305, DOI 10.1021/ja2071835; Surewaard BGJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002606; Thammavongsa V, 2015, NAT REV MICROBIOL, V13, P529, DOI 10.1038/nrmicro3521; Thoendel M, 2013, MOL MICROBIOL, V87, P318, DOI 10.1111/mmi.12100; Thoendel M, 2011, CHEM REV, V111, P117, DOI 10.1021/cr100370n; Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606; Vuong C, 2004, J INFECT DIS, V190, P1498, DOI 10.1086/424487; Walker JN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003819; WALSH MT, 1990, J LIPID RES, V31, P1051; Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520; Weinrick B, 2004, J BACTERIOL, V186, P8407, DOI 10.1128/JB.186.24.8407-8423.2004; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wilde AD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005341; Wollenberg MS, 2014, MBIO, V5, DOI 10.1128/mBio.01286-14; Wright JS, 2005, P NATL ACAD SCI USA, V102, P1691, DOI 10.1073/pnas.0407661102; Xiong YQ, 2002, J INFECT DIS, V186, P668, DOI 10.1086/342046; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004; Yarwood JM, 2003, J CLIN INVEST, V112, P1620, DOI 10.1172/JCI200320442; Yarwood JM, 2002, J BACTERIOL, V184, P1095, DOI 10.1128/jb.184.4.1095-1101.2002; Yarwood JM, 2001, J BACTERIOL, V183, P1113, DOI 10.1128/JB.183.4.1113-1123.2001; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181	98	57	62	3	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12556	12564		10.1074/jbc.R116.722710	http://dx.doi.org/10.1074/jbc.R116.722710			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129223	Green Published, hybrid			2022-12-28	WOS:000378119900011
J	Popa, IL; Milac, AL; Sima, LE; Alexandru, PR; Pastrama, F; Munteanu, CVA; Negroiu, G				Popa, Ioana L.; Milac, Adina L.; Sima, Livia E.; Alexandru, Petruta R.; Pastrama, Florin; Munteanu, Cristian V. A.; Negroiu, Gabriela			Cross-talk between Dopachrome Tautomerase and Caveolin-1 Is Melanoma Cell Phenotype-specific and Potentially Involved in Tumor Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINASE-RELATED PROTEIN-2; SCAFFOLDING DOMAIN; RADIATION-RESISTANCE; E-CADHERIN; CHOLESTEROL; EXPRESSION; BINDING; RAFTS; TRP-2; DIFFERENTIATION	L-Dopachrome tautomerase (L-DCT), also called tyrosinase-related protein-2 (TRP-2), is a melanoma antigen overexpressed in most chemo-/radiotherapeutic stress-resistant tumor clones, and caveolin-1 (CAV1) is a main regulator of numerous signaling processes. A structural and functional relationship between DCT and CAV1 is first presented here in two human amelanotic melanoma cell lines, derived from vertical growth phase (MelJuSo) and metastatic (SKMel28) melanomas. DCTco-localizes at the plasma membrane with CAV1 and Cavin-1, another molecular marker for caveolae in both cell phenotypes. Our novel structural model proposed for the DCT-CAV1 complex, in addition to co-immunoprecipitation and mass spectrometry data, indicates a possible direct interaction between DCT and CAV1. The CAV1 control on DCT gene expression, DCT post-translational processing, and subcellular distribution is cell phenotype-dependent. DCT is a modulator of CAV1 stability and supramolecular assembly in both cell phenotypes. During autocrine stimulation, the expressions of DCT and CAV1 are oppositely regulated; DCT increases while CAV1 decreases. Sub-confluent MelJuSo clones DCThigh/CAV1(low) are proliferating and acquire fibroblast-like morphology, forming massive, confluent clusters as demonstrated by immunofluorescent staining and TissueFAXS quantitative image cytometry analysis. CAV1 down-regulation directly contributes to the expansion of MelJuSo DCThigh subtype. CAV1 involved in the perpetuation of cell phenotype-overexpressing anti-stress DCT molecule supports the concept that CAV1 functions as a tumor suppressor in early stages of melanoma. DCT is a regulator of the CAV1-associated structures and is possibly a new molecular player in CAV1-mediated processes in melanoma.	[Popa, Ioana L.] Romanian Acad, Inst Biochem, Dept Prot Folding, Bucharest 060031, Romania; [Milac, Adina L.; Pastrama, Florin] Romanian Acad, Inst Biochem, Dept Bioinformat & Struct Biochem, Bucharest 060031, Romania; [Sima, Livia E.; Alexandru, Petruta R.; Munteanu, Cristian V. A.; Negroiu, Gabriela] Romanian Acad, Inst Biochem, Dept Mol Cell Biol, Splaiul Independentei 296, Bucharest 060031, Romania	Romanian Academy of Sciences; Institute of Biochemistry, Bucharest; Romanian Academy of Sciences; Institute of Biochemistry, Bucharest; Romanian Academy of Sciences; Institute of Biochemistry, Bucharest; Nicolae Simionescu Institute of Cellular Biology & Pathology	Negroiu, G (corresponding author), Romanian Acad, Inst Biochem, Dept Mol Cell Biol, Splaiul Independentei 296, Bucharest 060031, Romania.	gnegroiu@biochim.ro	Munteanu, Cristian V.A./I-9290-2016; Negroiu, Gabriela/AAO-3980-2020; Milac, Adina/C-1070-2011; Sima, Livia E/C-2882-2011; Sima, Livia/M-4389-2019	Munteanu, Cristian V.A./0000-0002-2998-0458; Milac, Adina/0000-0003-1845-4281; Sima, Livia E/0000-0002-3404-4162; Sima, Livia/0000-0002-3404-4162; Negroiu, Gabriela/0000-0003-3712-7681	Grant Application [156]; Exploratory Research Projects [PN-II-ID-PCE-2011-3-0492-1]; Ministerul Educatiei si Cercetarii Stiintifice; Academia Romana Project of the Institute of Biochemistry [1/2011]	Grant Application; Exploratory Research Projects; Ministerul Educatiei si Cercetarii Stiintifice(Ministry of Education and Research - Romania); Academia Romana Project of the Institute of Biochemistry	This work was supported by Grant Application 156, Exploratory Research Projects PN-II-ID-PCE-2011-3-0492-1, funded by Ministerul Educatiei si Cercetarii Stiintifice and in part by Academia Romana Project 1/2011 of the Institute of Biochemistry.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; [Anonymous], 2002, NCBI HDB; Aoki S, 2012, BBA-BIOMEMBRANES, V1818, P12, DOI 10.1016/j.bbamem.2011.09.009; Baruthio F, 2008, PROTEOMICS, V8, P4733, DOI 10.1002/pmic.200800169; Bastian BC, 2014, ANNU REV PATHOL-MECH, V9, P239, DOI 10.1146/annurev-pathol-012513-104658; BransburgZabary S, 1996, BBA-BIOMEMBRANES, V1285, P146, DOI 10.1016/S0005-2736(96)00148-4; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chen ST, 2004, INT J MOL MED, V14, P577; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Chu W, 2000, ONCOGENE, V19, P395, DOI 10.1038/sj.onc.1203315; Dalton LE, 2013, J INVEST DERMATOL, V133, P1572, DOI 10.1038/jid.2013.23; Epand RM, 2005, J MOL BIOL, V345, P339, DOI 10.1016/j.jmb.2004.10.064; Felicetti F, 2009, INT J CANCER, V125, P1514, DOI 10.1002/ijc.24451; Fielding PE, 2004, BIOCHEMISTRY-US, V43, P2578, DOI 10.1021/bi035442c; Filimon A, 2014, MELANOMA RES, V24, P219, DOI 10.1097/CMR.0000000000000066; Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Holt A, 2010, EUR BIOPHYS J BIOPHY, V39, P609, DOI 10.1007/s00249-009-0567-1; Hoop CL, 2012, BIOCHEMISTRY-US, V51, P90, DOI 10.1021/bi201356v; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang S, 2010, FREE RADICAL BIO MED, V48, P1144, DOI 10.1016/j.freeradbiomed.2010.01.033; Jiao ZX, 2006, DEV BIOL, V296, P396, DOI 10.1016/j.ydbio.2006.06.006; JIMENEZ M, 1991, J BIOL CHEM, V266, P1147; Jung AC, 2015, ONCOTARGET, V6, P41884, DOI 10.18632/oncotarget.6099; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614; Le Lan C, 2006, FEBS LETT, V580, P5301, DOI 10.1016/j.febslet.2006.08.075; Le Lan C, 2010, EUR BIOPHYS J BIOPHY, V39, P307, DOI 10.1007/s00249-009-0548-4; Lee JW, 2012, BBA-BIOMEMBRANES, V1818, P1158, DOI 10.1016/j.bbamem.2011.12.033; Levin AM, 2006, PROTEIN SCI, V15, P478, DOI 10.1110/ps.051911706; Li FZ, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00031; Liu GT, 2003, J IMMUNOTHER, V26, P301, DOI 10.1097/00002371-200307000-00002; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Lobos-Gonzales L., 2011, ADV MALIGNANT MELANO, P200, DOI [10.5772/21829, DOI 10.5772/21829]; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Makwana KM, 2015, PROTEIN SCI, V24, P1920, DOI 10.1002/pro.2814; Michard Q, 2008, FREE RADICAL BIO MED, V44, P1023, DOI 10.1016/j.freeradbiomed.2007.11.021; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; Nakashima H, 2007, CANCER SCI, V98, P512, DOI 10.1111/j.1349-7006.2007.00419.x; Negroiu G, 2005, BIOCHEM BIOPH RES CO, V328, P914, DOI 10.1016/j.bbrc.2005.01.040; Negroiu G, 2003, J BIOL CHEM, V278, P27035, DOI 10.1074/jbc.M303167200; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Orlow SJ, 1998, CANCER RES, V58, P1521; Pak BJ, 2000, MELANOMA RES, V10, P499, DOI 10.1097/00008390-200010000-00013; Pak BJ, 2004, ONCOGENE, V23, P30, DOI 10.1038/sj.onc.1207007; Pak BJ, 2001, CANCER METAST REV, V20, P27, DOI 10.1023/A:1013175516793; Popa I, 2014, BIOCHEM CELL BIOL, V92, P127, DOI 10.1139/bcb-2013-0064; Recamier KS, 2010, J MEMBRANE BIOL, V237, P31, DOI 10.1007/s00232-010-9304-z; RODECK U, 1991, J INVEST DERMATOL, V97, P20, DOI 10.1111/1523-1747.ep12477822; Salem AF, 2011, CELL CYCLE, V10, P3692, DOI 10.4161/cc.10.21.17895; Sanna E, 2007, EXP CELL RES, V313, P1307, DOI 10.1016/j.yexcr.2007.02.005; Savage K, 2007, CLIN CANCER RES, V13, P90, DOI 10.1158/1078-0432.CCR-06-1371; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schlegel A, 1999, J BIOL CHEM, V274, P22660, DOI 10.1074/jbc.274.32.22660; Sendoel A, 2010, NATURE, V465, P577, DOI 10.1038/nature09141; Setaluri V, 2000, PIGM CELL RES, V13, P128, DOI 10.1034/j.1600-0749.2000.130302.x; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Shan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097239; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Slominski A., 2004, PHYSIOL REV, V84, P1164; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Smedley RC, 2011, VET PATHOL, V48, P32, DOI 10.1177/0300985810387447; Sprong H, 2001, J CELL BIOL, V155, P369, DOI 10.1083/jcb.200106104; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Torres VA, 2007, MOL CELL BIOL, V27, P7703, DOI 10.1128/MCB.01991-06; Trane AE, 2015, EUR J PHARMACOL, V766, P46, DOI 10.1016/j.ejphar.2015.09.033; Trimmer C, 2010, CANCER RES, V70, P7489, DOI 10.1158/0008-5472.CAN-10-0900; Wang N, 2006, PIGM CELL RES, V19, P3, DOI 10.1111/j.1600-0749.2005.00288.x; Watabe H, 2004, J BIOL CHEM, V279, P7971, DOI 10.1074/jbc.M309714200; Watanabe R, 2004, CURR OPIN CELL BIOL, V16, P350, DOI 10.1016/j.ceb.2004.06.010; Zhuang GL, 2012, EMBO J, V31, P3513, DOI 10.1038/emboj.2012.183; ZIEGLERHEITBROCK HWL, 1985, CANCER RES, V45, P1344	76	7	8	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12481	12500		10.1074/jbc.M116.714733	http://dx.doi.org/10.1074/jbc.M116.714733			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27053106	Green Published, hybrid			2022-12-28	WOS:000378119900004
J	Rajkovic, A; Hummels, KR; Witzky, A; Erickson, S; Gafken, PR; Whitelegge, JP; Faull, KF; Kearns, DB; Ibba, M				Rajkovic, Andrei; Hummels, Katherine R.; Witzky, Anne; Erickson, Sarah; Gafken, Philip R.; Whitelegge, Julian P.; Faull, Kym F.; Kearns, Daniel B.; Ibba, Michael			Translation Control of Swarming Proficiency in Bacillus subtilis by 5-Amino-pentanolylated Elongation Factor P	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; cell motility; microbiology; posttranslational modification; protein synthesis; translation elongation factor	TRANSFER-RNA SYNTHETASE; RIBOSOME; PATHWAY; PROLINE; GENES; POXA	Elongation factor P (EF-P) accelerates diprolyl synthesis and requires a posttranslational modification to maintain proteostasis. Two phylogenetically distinct EF-P modification pathways have been described and are encoded in the majority of Gram-negative bacteria, but neither is present in Gram-positive bacteria. Prior work suggested that the EF-P-encoding gene (efp) primarily supports Bacillus subtilis swarming differentiation, whereas EF-P in Gram-negative bacteria has a more global housekeeping role, prompting our investigation to determine whether EF-P is modified and how it impacts gene expression in motile cells. We identified a 5-aminopentanol moiety attached to Lys(32) of B. subtilis EF-P that is required for swarming motility. A fluorescent in vivo B. subtilis reporter system identified peptide motifs whose efficient synthesis was most dependent on 5-aminopentanol EF-P. Examination of the B. subtilis genome sequence showed that these EF-P-dependent peptide motifs were represented in flagellar genes. Taken together, these data show that, in B. subtilis, a previously uncharacterized posttranslational modification of EF-P can modulate the synthesis of specific diprolyl motifs present in proteins required for swarming motility.	[Rajkovic, Andrei; Ibba, Michael] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Rajkovic, Andrei; Ibba, Michael] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Witzky, Anne] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Erickson, Sarah] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Ibba, Michael] Ohio State Univ, Dept Microbiol, 318 W 12th Ave, Columbus, OH 43210 USA; [Hummels, Katherine R.; Kearns, Daniel B.] Indiana Univ, Dept Biol, Bloomington, IN 47305 USA; [Gafken, Philip R.] Fred Hutchinson Canc Res Ctr, Prote Facil, Seattle, WA 98109 USA; [Whitelegge, Julian P.; Faull, Kym F.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA; [Whitelegge, Julian P.; Faull, Kym F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Indiana University System; Indiana University Bloomington; Fred Hutchinson Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ibba, M (corresponding author), Ohio State Univ, Dept Microbiol, 318 W 12th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu			National Institutes of Health [P30 CA015704]; M. J. Murdock Charitable Trust; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007757, R01GM065183, T32GM086252, R01GM093030] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. J. Murdock Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Yuko Ogata for assistance with collecting mass spectrometry data. We also thank Masaya Fujita, Rebecca Calvo, Eric Vanderpool, and Sampriti Mukherjee for strains and reagents. The Fred Hutchinson Cancer Research Center Proteomics Facility is funded by Cancer Center Support Grant P30 CA015704 from the National Institutes of Health, and the OrbiTrap Fusion used in this research was funded in part by the M. J. Murdock Charitable Trust.	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Balibar CJ, 2013, CURR MICROBIOL, V67, P293, DOI 10.1007/s00284-013-0363-0; Bullwinkle TJ, 2013, J BIOL CHEM, V288, P4416, DOI 10.1074/jbc.M112.438879; Calvo RA, 2015, J BACTERIOL, V197, P81, DOI 10.1128/JB.02324-14; CARPENTER PB, 1993, MOL MICROBIOL, V7, P735, DOI 10.1111/j.1365-2958.1993.tb01164.x; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; COOPER HL, 1983, P NATL ACAD SCI-BIOL, V80, P1854, DOI 10.1073/pnas.80.7.1854; Courtney CR, 2012, J BACTERIOL, V194, P4619, DOI 10.1128/JB.00444-12; Doerfel LK, 2015, J AM CHEM SOC, V137, P12997, DOI 10.1021/jacs.5b07427; Doherty Geoff P, 2010, BMC Res Notes, V3, P303, DOI 10.1186/1756-0500-3-303; Elgamal S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004553; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gomez SM, 2002, MOL CELL PROTEOMICS, V1, P46, DOI 10.1074/mcp.M100007-MCP200; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hersch SJ, 2014, J BIOL CHEM, V289, P28160, DOI 10.1074/jbc.M114.593277; Hersch SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00180-13; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; Lassak J, 2015, NAT CHEM BIOL, V11, P299, DOI 10.1038/nchembio0415-299d; Mukherjee S, 2014, ANNU REV GENET, V48, P319, DOI 10.1146/annurev-genet-120213-092406; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Ohashi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2245, DOI 10.1271/bbb.67.2245; Patrick JE, 2008, MOL MICROBIOL, V70, P1166, DOI 10.1111/j.1365-2958.2008.06469.x; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; Rajkovic A, 2015, MBIO, V6, DOI 10.1128/mBio.00823-15; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Sekowska A, 1998, MOL MICROBIOL, V29, P851, DOI 10.1046/j.1365-2958.1998.00979.x; Starosta AL, 2014, CELL REP, V9, P476, DOI 10.1016/j.celrep.2014.09.008; Whitelegge JP, 2007, INT J MASS SPECTROM, V268, P190, DOI 10.1016/j.ijms.2007.08.008; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Woolstenhulme CJ, 2015, CELL REP, V11, P13, DOI 10.1016/j.celrep.2015.03.014; YASBIN RE, 1974, J VIROL, V14, P1343, DOI 10.1128/JVI.14.6.1343-1348.1974; Zhang L, 2008, J AM SOC MASS SPECTR, V19, P1875, DOI 10.1016/j.jasms.2008.08.004; Zou SB, 2012, J BACTERIOL, V194, P413, DOI 10.1128/JB.05864-11; Zou SB, 2011, VIRULENCE, V2, P147, DOI 10.4161/viru.2.2.15039	36	34	35	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					10976	10985		10.1074/jbc.M115.712091	http://dx.doi.org/10.1074/jbc.M115.712091			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27002156	Green Published, hybrid			2022-12-28	WOS:000377042100003
J	Cui, HM; Li, XY; Han, CH; Wang, QE; Wang, HB; Ding, HF; Zhang, JR; Yan, CH				Cui, Hongmei; Li, Xingyao; Han, Chunhua; Wang, Qi-En; Wang, Hongbo; Ding, Han-Fei; Zhang, Junran; Yan, Chunhong			The Stress-responsive Gene ATF3 Mediates Dichotomous UV Responses by Regulating the Tip60 and p53 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; NUCLEOTIDE EXCISION-REPAIR; INDUCED APOPTOSIS; HISTONE ACETYLTRANSFERASE; DNA-REPAIR; ACETYLATION; DEGRADATION; BINDING; IRRADIATION; SUPPRESSES	The response to UV irradiation is important for a cell to maintain its genetic integrity when challenged by environmental genotoxins. An immediate early response to UV irradiation is the rapid induction of activating transcription factor 3 (ATF3) expression. Although emerging evidence has linked ATF3 to stress pathways regulated by the tumor suppressor p53 and the histone acetyltransferase Tip60, the role of ATF3 in the UV response remains largely unclear. Here, we report that ATF3 mediated dichotomous UV responses. Although UV irradiation enhanced the binding of ATF3 to Tip60, knockdown of ATF3 expression decreased Tip60 stability, thereby impairing Tip60 induction by UV irradiation. In line with the role of Tip60 in mediating UV-induced apoptosis, ATF3 promoted the death of p53-defective cells in response to UV irradiation. However, ATF3 could also activate p53 and promote p53-mediated DNA repair, mainly through altering histone modifications that could facilitate recruitment of DNA repair proteins (such as DDB2) to damaged DNA sites. As a result, ATF3 rather protected the p53 wild-type cells from UV-induced apoptosis. Our results thus indicate that ATF3 regulates cell fates upon UV irradiation in a p53-dependent manner.	[Cui, Hongmei; Li, Xingyao; Ding, Han-Fei; Yan, Chunhong] Augusta Univ, Med Coll Georgia, Georgia Canc Ctr, Augusta, GA 30912 USA; [Ding, Han-Fei] Augusta Univ, Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA; [Yan, Chunhong] Augusta Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Han, Chunhua; Wang, Qi-En] Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA; [Wang, Hongbo] Yantai Univ, Sch Pharm, Key Lab Mol Pharmacol & Drug Evaluat, Yantai 264005, Peoples R China; [Zhang, Junran] Case Western Reserve Univ, Sch Med, Dept Radiat Oncol, Cleveland, OH 44106 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Ohio; Ohio State University; Yantai University; Case Western Reserve University	Yan, CH (corresponding author), Georgia Canc Ctr, CN2134,1410 Laney Walker Blvd, Augusta, GA 30912 USA.	cyan@augusta.edu	王, 洪波/A-6767-2019; Wang, Hongbo/AHC-7831-2022	王, 洪波/0000-0001-8530-2339; Wang, Hongbo/0000-0001-8530-2339; Ding, Han-Fei/0000-0001-5702-3439; Yan, Chunhong/0000-0002-3974-7991	National Institute of Health [R01CA139107, R01CA164006]; Department of Defense [W81XWH-15-1-0049]; NATIONAL CANCER INSTITUTE [R01CA139107, R01CA164006] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institute of Health grants R01CA139107 and R01CA164006 and Department of Defense Award W81XWH-15-1-0049 (to C. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe T, 2003, BIOCHEM BIOPH RES CO, V310, P1168, DOI 10.1016/j.bbrc.2003.09.143; Adimoolam S, 2002, P NATL ACAD SCI USA, V99, P12985, DOI 10.1073/pnas.202485699; Amundson SA, 1999, ONCOGENE, V18, P3666, DOI 10.1038/sj.onc.1202676; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Cui HM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7752; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Hamdi M, 2008, DNA REPAIR, V7, P487, DOI 10.1016/j.dnarep.2007.12.004; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; Jassim OW, 2003, EMBO J, V22, P5622, DOI 10.1093/emboj/cdg543; Kaidi A, 2013, NATURE, V498, DOI 10.1038/nature12201; Kranz D, 2008, J CELL BIOL, V182, P197, DOI 10.1083/jcb.200712014; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; McKay BC, 2001, ONCOGENE, V20, P6805, DOI 10.1038/sj.onc.1204901; Mo PL, 2010, J BIOL CHEM, V285, P26908, DOI 10.1074/jbc.M110.132597; Niida H, 2010, GENE DEV, V24, P333, DOI 10.1101/gad.1863810; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Turchi L, 2008, CELL DEATH DIFFER, V15, P1472, DOI 10.1038/cdd.2008.74; Turchi L, 2009, CELL DEATH DIFFER, V16, P728, DOI 10.1038/cdd.2009.2; Tyteca S, 2006, EMBO J, V25, P1680, DOI 10.1038/sj.emboj.7601066; Wang HB, 2012, MOL CELL BIOL, V32, P3190, DOI 10.1128/MCB.00159-12; Wang HB, 2010, J BIOL CHEM, V285, P13201, DOI 10.1074/jbc.M109.058669; Wang QE, 2013, NUCLEIC ACIDS RES, V41, P1722, DOI 10.1093/nar/gks1312; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; Wang Z, 2015, ONCOGENE, V34, P4975, DOI 10.1038/onc.2014.426; Wei SS, 2014, J BIOL CHEM, V289, P8947, DOI 10.1074/jbc.M113.503755; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yan CH, 2006, CELL CYCLE, V5, P926, DOI 10.4161/cc.5.9.2714; Yuan XL, 2013, CANCER RES, V73, P3625, DOI 10.1158/0008-5472.CAN-12-3879	39	16	16	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10847	10857		10.1074/jbc.M115.713099	http://dx.doi.org/10.1074/jbc.M115.713099			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26994140	Green Published, hybrid			2022-12-28	WOS:000377042600034
J	Lenz, JD; Stohl, EA; Robertson, RM; Hackett, KT; Fisher, K; Xiong, K; Lee, M; Hesek, D; Mobashery, S; Seifert, HS; Davies, C; Dillard, JP				Lenz, Jonathan D.; Stohl, Elizabeth A.; Robertson, Rosanna M.; Hackett, Kathleen T.; Fisher, Kathryn; Xiong, Kalia; Lee, Mijoon; Hesek, Dusan; Mobashery, Shahriar; Seifert, H. Steven; Davies, Christopher; Dillard, Joseph P.			Amidase Activity of AmiC Controls Cell Separation and Stem Peptide Release and Is Enhanced by NlpD in Neisseria gonorrhoeae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-BINDING PROTEINS; L-ALANINE AMIDASE; FALLOPIAN-TUBE MUCOSA; ESCHERICHIA-COLI; SOLUBLE PEPTIDOGLYCAN; MYCOBACTERIUM-TUBERCULOSIS; BACTERIAL PEPTIDOGLYCAN; PSEUDOMONAS-AERUGINOSA; LYTIC TRANSGLYCOSYLASE; NOSTOC-PUNCTIFORME	The human-restricted pathogen Neisseria gonorrhoeae encodes a single N-acetylmuramyl-L-alanine amidase involved in cell separation (AmiC), as compared with three largely redundant cell separation amidases found in Escherichia coli (AmiA, AmiB, and AmiC). Deletion of amiC from N. gonorrhoeae results in severely impaired cell separation and altered peptidoglycan (PG) fragment release, but little else is known about how AmiC functions in gonococci. Here, we demonstrated that gonococcal AmiC can act on macromolecular PG to liberate cross-linked and non-cross-linked peptides indicative of amidase activity, and we provided the first evidence that a cell separation amidase can utilize a small synthetic PG fragment as substrate (GlcNAc-MurNAc(pentapeptide)-GlcNAc-MurNAc (pentapeptide)). An investigation of two residues in the active site of AmiC revealed that Glu-229 is critical for both normal cell separation and the release of PG fragments by gonococci during growth. In contrast, Gln-316 has an autoinhibitory role, and its mutation to lysine resulted in an AmiC with increased enzymatic activity on macromolecular PG and on the synthetic PG derivative. Curiously, the same Q316K mutation that increased AmiC activity also resulted in cell separation and PG fragment release defects, indicating that activation state is not the only factor determining normal AmiC activity. In addition to displaying high basal activity on PG, gonococcal AmiC can utilize metal ions other than the zinc cofactor typically used by cell separation amidases, potentially protecting its ability to function in zinc-limiting environments. Thus gonococcal AmiC has distinct differences from related enzymes, and these studies revealed parameters for how AmiC functions in cell separation and PG fragment release.	[Lenz, Jonathan D.; Hackett, Kathleen T.; Fisher, Kathryn; Xiong, Kalia; Dillard, Joseph P.] Univ Wisconsin, Dept Med Microbiol & Immunol, 1550 Linden Dr,4157 Microbial Sci Bldg, Madison, WI 53706 USA; [Stohl, Elizabeth A.; Seifert, H. Steven] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Robertson, Rosanna M.; Davies, Christopher] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Lee, Mijoon; Hesek, Dusan; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, South Bend, IN 46556 USA	University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Feinberg School of Medicine; Medical University of South Carolina; University of Notre Dame	Dillard, JP (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, 1550 Linden Dr,4157 Microbial Sci Bldg, Madison, WI 53706 USA.	jpdillard@wisc.edu	Lee, Mijoon/AFK-1543-2022	Lee, Mijoon/0000-0001-7432-0427; Fisher, Kathryn/0000-0003-2260-8634; Lenz, Jonathan/0000-0002-2637-9720	National Institutes of Health [R01 AI097157, R21 AI099539, T32 AI055397, F32 AI115911, R37 AI033493, R01 AI044239, R01 GM066861, R01 AI090348, R01 GM061629]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI114821, R37AI033493, R01AI090348, R01AI044239, F32AI115911, T32AI055397, R01AI097157, R21AI099539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066861, R01GM061629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 AI097157 and R21 AI099539 (to J.P. D.), T32 AI055397 and F32 AI115911 (to J. D. L.), R37 AI033493 and R01 AI044239 (to E. A. S. and H. S. S.), R01 GM066861 (to C. D.), and R01 AI090348 and R01 GM061629 (to S. M.). The authors declare that they have no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barbee LA, 2014, CURR OPIN INFECT DIS, V27, P282, DOI [10.1097/QCO.0000000000000058, 10.1097/QCO.0000000000000059]; BARBOUR AG, 1981, ANTIMICROB AGENTS CH, V19, P316, DOI 10.1128/AAC.19.2.316; Berendt S, 2012, J BACTERIOL, V194, P5218, DOI 10.1128/JB.00912-12; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Boneca IG, 2005, CURR OPIN MICROBIOL, V8, P46, DOI 10.1016/j.mib.2004.12.008; Buttner FM, 2016, FEBS J, V283, P1336, DOI 10.1111/febs.13673; Carrasco-Lopez C, 2011, J BIOL CHEM, V286, P31714, DOI 10.1074/jbc.M111.264366; CDC, 2013, ANTIBIOTIC RESISTANC; Cloud KA, 2004, J BACTERIOL, V186, P7811, DOI 10.1128/JB.186.22.7811-7814.2004; Cloud KA, 2002, INFECT IMMUN, V70, P2752, DOI 10.1128/IAI.70.6.2752-2757.2002; Cloud-Hansen KA, 2008, J BACTERIOL, V190, P5989, DOI 10.1128/JB.00506-08; Craig M, 2013, MOL MICROBIOL, V89, P887, DOI 10.1111/mmi.12318; den Blaauwen T, 2014, BIOORG CHEM, V55, P27, DOI 10.1016/j.bioorg.2014.03.007; Dillard J. P., 2011, CURR PROTOC MICROBIO, V23; Dillard JP, 2005, INFECT IMMUN, V73, P5697, DOI 10.1128/IAI.73.9.5697-5705.2005; Firczuk M, 2005, J MOL BIOL, V354, P578, DOI 10.1016/j.jmb.2005.09.082; Firczuk M, 2007, FEMS MICROBIOL REV, V31, P676, DOI 10.1111/j.1574-6976.2007.00084.x; Frirdich E, 2013, CURR OPIN MICROBIOL, V16, P767, DOI 10.1016/j.mib.2013.09.005; Garcia DL, 2006, J BACTERIOL, V188, P7211, DOI 10.1128/JB.00724-06; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; GOLDMAN W E, 1988, Tokai Journal of Experimental and Clinical Medicine, V13, P187; GOODELL EW, 1985, J BACTERIOL, V162, P391, DOI 10.1128/JB.162.1.391-397.1985; GREGG CR, 1981, J INFECT DIS, V143, P432, DOI 10.1093/infdis/143.3.432; Hamilton HL, 2001, J BACTERIOL, V183, P4718, DOI 10.1128/JB.183.16.4718-4726.2001; HEBELER BH, 1976, J BACTERIOL, V126, P1186, DOI 10.1128/JB.126.3.1186-1193.1976; HEBELER BH, 1976, J BACTERIOL, V126, P1180, DOI 10.1128/JB.126.3.1180-1185.1976; Heidrich C, 2001, MOL MICROBIOL, V41, P167, DOI 10.1046/j.1365-2958.2001.02499.x; JENSEN SE, 1976, J BACTERIOL, V127, P319, DOI 10.1128/JB.127.1.319-326.1976; Jimenez Garcia Daniel, 2007, THESIS; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kumar A, 2013, ACTA CRYSTALLOGR D, V69, P2543, DOI 10.1107/S0907444913026371; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Lee M, 2013, J AM CHEM SOC, V135, P12604, DOI 10.1021/ja407445x; Lee M, 2010, CHEMBIOCHEM, V11, P2525, DOI 10.1002/cbic.201000626; Lehner J, 2011, MOL MICROBIOL, V79, P1655, DOI 10.1111/j.1365-2958.2011.07554.x; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Martinez-Caballero S, 2013, J AM CHEM SOC, V135, P10318, DOI 10.1021/ja405464b; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; Mavrogiorgos N, 2014, INNATE IMMUN-LONDON, V20, P377, DOI 10.1177/1753425913493453; Mehr IJ, 2000, GENETICS, V154, P523; MELLY MA, 1984, J INFECT DIS, V149, P378, DOI 10.1093/infdis/149.3.378; Moll A, 2014, J BACTERIOL, V196, P3937, DOI 10.1128/JB.02094-14; MORSE SA, 1974, P SOC EXP BIOL MED, V145, P1418; Peters NT, 2013, MOL MICROBIOL, V89, P690, DOI 10.1111/mmi.12304; Peters NT, 2011, J BACTERIOL, V193, P4973, DOI 10.1128/JB.00316-11; Prigozhin DM, 2013, J BIOL CHEM, V288, P31549, DOI 10.1074/jbc.M113.510792; Priyadarshini R, 2006, J BACTERIOL, V188, P5345, DOI 10.1128/JB.00476-06; Ramsey ME, 2012, APPL ENVIRON MICROB, V78, P3068, DOI 10.1128/AEM.07871-11; Rocaboy M, 2013, MOL MICROBIOL, V90, P267, DOI 10.1111/mmi.12361; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; ROSENTHAL RS, 1994, METHOD ENZYMOL, V235, P253; ROSENTHAL RS, 1979, INFECT IMMUN, V24, P869, DOI 10.1128/IAI.24.3.869-878.1979; ROSENTHAL RS, 1980, INFECT IMMUN, V28, P867; Shida T, 2001, J BIOL CHEM, V276, P28140, DOI 10.1074/jbc.M103903200; SINHA RK, 1980, INFECT IMMUN, V29, P914; Stefanova ME, 2003, BIOCHEMISTRY-US, V42, P14614, DOI 10.1021/bi0350607; Stohl EA, 2016, J BACTERIOL, V198, P615, DOI 10.1128/JB.00540-15; Stohl EA, 2012, J BIOL CHEM, V287, P11222, DOI 10.1074/jbc.M111.338830; Uehara T, 2007, J BACTERIOL, V189, P5634, DOI 10.1128/JB.00446-07; Uehara T, 2010, EMBO J, V29, P1412, DOI 10.1038/emboj.2010.36; Veyrier FJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005338; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Woodhams KL, 2013, INFECT IMMUN, V81, P3490, DOI 10.1128/IAI.00279-13; Yang DC, 2012, MOL MICROBIOL, V85, P768, DOI 10.1111/j.1365-2958.2012.08138.x	66	18	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10916	10933		10.1074/jbc.M116.715573	http://dx.doi.org/10.1074/jbc.M116.715573			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26984407	hybrid, Green Published			2022-12-28	WOS:000377042600041
J	Flach, RJR; Danai, LV; DiStefano, MT; Kelly, M; Menendez, LG; Jurczyk, A; Sharma, RB; Jung, DY; Kim, JH; Kim, JK; Bortell, R; Alonso, LC; Czech, MP				Flach, Rachel J. Roth; Danai, Laura V.; DiStefano, Marina T.; Kelly, Mark; Menendez, Lorena Garcia; Jurczyk, Agata; Sharma, Rohit B.; Jung, Dae Young; Kim, Jong Hun; Kim, Jason K.; Bortell, Rita; Alonso, Laura C.; Czech, Michael P.			Protein Kinase Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Promotes Obesity-induced Hyperinsulinemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELL; INSULIN-SECRETION; PROLIFERATION; GLUCOSE; MASS; SENSITIVITY; DYSFUNCTION; RESISTANCE; CLEARANCE; REGULATOR	Previous studies revealed a paradox whereby mitogen-activated protein kinase kinase kinase kinase 4 (Map4k4) acted as a negative regulator of insulin sensitivity in chronically obese mice, yet systemic deletion of Map4k4 did not improve glucose tolerance. Here, we report markedly reduced glucose-responsive plasma insulin and C-peptide levels in whole body Map4k4-depleted mice (M4K4 iKO) as well as an impaired first phase of insulin secretion from islets derived from M4K4 iKO mice ex vivo. After long-term high fat diet (HFD), M4K4 iKO mice pancreata also displayed reduced beta cell mass, fewer proliferating beta cells and reduced islet-specific gene mRNA expression compared with controls, although insulin content was normal. Interestingly, the reduced plasma insulin in M4K4 iKO mice exposed to chronic (16 weeks) HFD was not observed in response to acute HFD challenge or short term treatment with the insulin receptor antagonist S961. Furthermore, the improved insulin sensitivity in obese M4K4iKO mice was abrogated by high exogenous insulin over the course of a euglycemic clamp study, indicating that hypoinsulinemia promotes insulin sensitivity in chronically obese M4K4 iKO mice. These results demonstrate that protein kinase Map4k4 drives obesity-induced hyperinsulinemia and insulin resistance in part by promoting insulin secretion from beta cells in mice.	[Flach, Rachel J. Roth; Danai, Laura V.; DiStefano, Marina T.; Menendez, Lorena Garcia; Jurczyk, Agata; Jung, Dae Young; Kim, Jong Hun; Kim, Jason K.; Bortell, Rita; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St,Ste 100, Worcester, MA 01605 USA; [Sharma, Rohit B.; Kim, Jason K.; Alonso, Laura C.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA 01605 USA; [Kelly, Mark] Univ Massachusetts, Sch Med, Div Cardiovasc Med, Worcester, MA 01605 USA; [Flach, Rachel J. Roth; Menendez, Lorena Garcia] Pfizer, Cambridge, MA 02139 USA; [Danai, Laura V.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Pfizer; Massachusetts Institute of Technology (MIT)	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St,Ste 100, Worcester, MA 01605 USA.	Michael.Czech@umassmed.edu	Sharma, Rohit/ABC-1785-2020	Sharma, Rohit/0000-0002-1435-7612; kelly, mark/0000-0001-9018-594X; Kim, Jason/0000-0002-7185-042X	National Institutes of Health [U24-DK093000, R01-DK080756, DK095140, DK030898]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030898, R01DK080756, U2CDK093000, U24DK093000, R01DK095140, R01DK030898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by Grants from the National Institutes of Health: U24-DK093000 and R01-DK080756 (to J. K. K.), DK095140 (to L. C. A.), and DK030898 (to M. P. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ardestani A, 2014, NAT MED, V20, P385, DOI 10.1038/nm.3482; Boucher J, 2014, COLD SPRING HARB PER, V6; Bouzakri K, 2009, J BIOL CHEM, V284, P27892, DOI 10.1074/jbc.M109.048058; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Byrne MM, 1996, DIABETES, V45, P1503, DOI 10.2337/diabetes.45.11.1503; Campbell JE, 2015, NAT REV ENDOCRINOL, V11, P329, DOI 10.1038/nrendo.2015.51; Corkey BE, 2012, DIABETES CARE, V35, P2432, DOI 10.2337/dc12-0825; CRYER PE, 1981, DIABETES, V30, P261, DOI 10.2337/diab.30.3.261; CURRY DL, 1968, ENDOCRINOLOGY, V83, P572, DOI 10.1210/endo-83-3-572; Danai LV, 2015, MOL CELL BIOL, V35, P2356, DOI 10.1128/MCB.00150-15; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El Ouaamari A, 2013, CELL REP, V3, P401, DOI 10.1016/j.celrep.2013.01.007; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Gerich JE, 2002, DIABETES, V51, pS117, DOI 10.2337/diabetes.51.2007.S117; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; Meneghini LF, 2013, AM J MED, V126, pS28, DOI 10.1016/j.amjmed.2013.06.011; Pascoe J, 2012, DIABETES, V61, P632, DOI 10.2337/db11-0991; Pedersen DJ, 2015, MOL METAB, V4, P507, DOI 10.1016/j.molmet.2015.04.003; POLONSKY KS, 1988, J CLIN INVEST, V81, P435, DOI 10.1172/JCI113338; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Sharma RB, 2015, J CLIN INVEST, V125, P3831, DOI 10.1172/JCI79264; Sharma RB, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0492-2; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tamarina NA, 2014, ISLETS, V6, DOI 10.4161/isl.27685; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Thorens B, 2014, DIABETES OBES METAB, V16, P87, DOI 10.1111/dom.12346; VANCAUTER E, 1992, DIABETES, V41, P368, DOI 10.2337/diabetes.41.3.368; Vikram A, 2010, BIOCHEM BIOPH RES CO, V398, P260, DOI 10.1016/j.bbrc.2010.06.070; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zhao XM, 2012, J BIOL CHEM, V287, P31155, DOI 10.1074/jbc.M112.362632	33	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16221	16230		10.1074/jbc.M116.718932	http://dx.doi.org/10.1074/jbc.M116.718932			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226575	Green Published, hybrid			2022-12-28	WOS:000380585400026
J	Colombo, SF; Cardani, S; Maroli, A; Vitiello, A; Soffientini, P; Crespi, A; Bram, RF; Benfante, R; Borgese, N				Colombo, Sara Francesca; Cardani, Silvia; Maroli, Annalisa; Vitiello, Adriana; Soffientini, Paolo; Crespi, Arianna; Bram, Richard F.; Benfante, Roberta; Borgese, Nica			Tail-anchored Protein Insertion in Mammals FUNCTION AND RECIPROCAL INTERACTIONS OF THE TWO SUBUNITS OF THE TRC40 RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATING CYCLOPHILIN LIGAND; ENDOPLASMIC-RETICULUM MEMBRANE; ACTIVATED T-CELLS; ER MEMBRANE; PHOSPHOLIPID-BILAYERS; TARGETING FACTOR; STRUCTURAL BASIS; TRANSLOCATION; COMPLEX; CAML	The GET (guided entry of tail-anchored proteins)/TRC (transmembrane recognition complex) pathway for tail-anchored protein targeting to the endoplasmic reticulum (ER) has been characterized in detail in yeast and is thought to function similarly in mammals, where the orthologue of the central ATPase, Get3, is known as TRC40 or Asnal. Get3/TRC40 function requires an ER receptor, which in yeast consists of the Get' / Get2 heterotetramer and in mammals of the WRB protein (tryptophan-rich bask protein), homologous to yeast Getl, in combination with CAME (calcium-modulating cyclophilin ligand), which is not homologous to Get2. To better characterize the mammalian receptor, we investigated the role of endogenous WRB and CAML in tail -anchored protein insertion as well as their association, concentration, and stoichiometry in rat liver microsomes and cultured cells. Functional proteoliposomes, reconstituted from a microsomal detergent extract, lost their activity when made with an extract depleted of TRC40-associated proteins or of CAML itself, whereas in vitro synthesized CAML and WRB together were sufficient to confer insertion competence to liposomes. CAML was found to be in 5 -fold excess over WRB, and alteration of this ratio did not inhibit insertion. Depletion of each subunit affected the levels of the other one; in the case of CAML silencing, this effect was attributable to destabilization of the WRB transcript and not of WRB protein itself. These results reveal unanticipated complexity in the mutual regulation of the TRC40 receptor subunits and raise the question as to the role of the excess CAM I, in the mammalian ER.	[Colombo, Sara Francesca; Cardani, Silvia; Maroli, Annalisa; Vitiello, Adriana; Crespi, Arianna; Benfante, Roberta; Borgese, Nica] Univ Milan, Inst Neurosci, CNR, I-20100 Milan, Italy; [Colombo, Sara Francesca; Cardani, Silvia; Maroli, Annalisa; Vitiello, Adriana; Crespi, Arianna; Benfante, Roberta; Borgese, Nica] Univ Milan, BIOMETRA Dept, I-20100 Milan, Italy; [Soffientini, Paolo] FIRC Inst Mol Oncol Fdn, IFOM, I-20100 Milan, Italy; [Bram, Richard F.] Mayo Clin, Rochester, MN 55905 USA	Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; IFOM - FIRC Institute of Molecular Oncology; Mayo Clinic	Colombo, SF; Borgese, N (corresponding author), Univ Milan, Inst Neurosci, CNR, I-20100 Milan, Italy.; Colombo, SF; Borgese, N (corresponding author), Univ Milan, BIOMETRA Dept, I-20100 Milan, Italy.	s.colombo@in.cnr.it; n.borgese@in.cnr.it	Benfante, Roberta/C-1513-2015; Borgese, Nica/GWZ-8895-2022	Benfante, Roberta/0000-0001-5396-5429; Borgese, Nica/0000-0002-7537-3974; Soffientini, Paolo/0000-0002-1730-5615; COLOMBO, SARA FRANCESCA/0000-0001-9714-3961	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme [607072]	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme	This work was supported by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under REA Grant 607072. See The Tampting Network for further details. This work reflects only the author's views; the union is not liable for any use that may he made of the information contained therein. The authors declare that they have no conflicts of interest with the contents of this article.	ADAMUS G, 1991, J NEUROIMMUNOL, V34, P89, DOI 10.1016/0165-5728(91)90118-Q; Borgese N., 2015, MEMBRANE INSERTION T, DOI [10.1002/9780470015902.a0021876.pub2, DOI 10.1002/9780470015902.A0021876.PUB2]; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Borgese N, 2010, TRAFFIC, V11, P877, DOI 10.1111/j.1600-0854.2010.01068.x; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; BRAM RJ, 1994, NATURE, V371, P355, DOI 10.1038/371355a0; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Brambillasca S, 2012, J BIOL CHEM, V287, P41808, DOI 10.1074/jbc.M112.376558; Chan SL, 2015, J IMMUNOL, V195, P5648, DOI 10.4049/jimmunol.1500308; Chartron JW, 2012, CURR OPIN STRUC BIOL, V22, P217, DOI 10.1016/j.sbi.2012.03.001; Colombo SF, 2009, J CELL SCI, V122, P2383, DOI 10.1242/jcs.049460; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Denic V, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013334; Denic V, 2012, TRENDS BIOCHEM SCI, V37, P411, DOI 10.1016/j.tibs.2012.07.004; Edgar CE, 2010, CELL DEATH DIFFER, V17, P1566, DOI 10.1038/cdd.2010.30; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Guo SD, 2005, J BIOL CHEM, V280, P12536, DOI 10.1074/jbc.M500296200; Guth S, 2004, EUR J BIOCHEM, V271, P3200, DOI 10.1111/j.1432-1033.2004.04252.x; HARLOW E, 1988, ANTIBODIES LAB MANUA, P522; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Holloway MP, 1998, J BIOL CHEM, V273, P16346, DOI 10.1074/jbc.273.26.16346; Johnson N, 2013, BBA-MOL CELL RES, V1833, P2403, DOI 10.1016/j.bbamcr.2012.12.008; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; Liu F, 2016, P NATL ACAD SCI USA, V113, P4859, DOI 10.1073/pnas.1521577113; Liu Y, 2009, CELL CYCLE, V8, P940, DOI 10.4161/cc.8.6.7948; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Mateja A, 2015, SCIENCE, V347, P1152, DOI 10.1126/science.1261671; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; NICCHITTA CV, 1991, CELL, V65, P587, DOI 10.1016/0092-8674(91)90091-C; Prandini P, 2007, AM J HUM GENET, V81, P252, DOI 10.1086/519248; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Tran DD, 2003, DEV CELL, V5, P245, DOI 10.1016/S1534-5807(03)00207-7; Vilardi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085033; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Yamamoto Y, 2012, MOL CELL, V48, P387, DOI 10.1016/j.molcel.2012.08.028; YU Y, 1990, J CELL BIOL, V111, P1335, DOI 10.1083/jcb.111.4.1335; Yuan X, 2008, MOL CELL NEUROSCI, V38, P277, DOI 10.1016/j.mcn.2008.03.002	47	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15292	15306		10.1074/jbc.M115.707752	http://dx.doi.org/10.1074/jbc.M115.707752			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226539	Green Published, hybrid			2022-12-28	WOS:000380583200035
J	Oh, J; Hwang, I; Rhee, S				Oh, Juntaek; Hwang, Ingyu; Rhee, Sangkee			Structural Insights into an Oxalate -producing Serine Hydrolase with an Unusual Oxyanion Hole and Additional Lyase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BURKHOLDERIA-GLUMAE; QUORUM; MODEL; METABOLISM; PREDICTION; EVOLUTION; PATHOGEN; FEATURES; SERVER	In Burkholderia species, the production of oxalate, an acidic molecule, is a key event for bacterial growth in the stationary phase. Oxalate plays a central role in maintaining environmental pH, which counteracts inevitable population-collapsing alkaline toxicity in amino acid-based culture medium. In the phytopathogen Burkholderia glurnae, two enzymes are responsible for oxalate production. First, the enzyme oxalate biosynthetic component A (ObcA) catalyzes the formation of a tetrahedral C6-CoA adduct from the substrates acetyl-CoA and oxaloacetate. Then the ObcB enzyme liberates three products from the C6-CoA adduct: oxalate, acetoacetate, and CoA. Interestingly, these two stepwise reactions are catalyzed by a single bifunctional enzyme, Obc1, from Burkholderia thailandensis and Burkholderia pseudornallei. Obc1 has an ObcA-like N-terminal domain and shows ObcB activity in its C-terminal domain despite no sequence homology with ObcB. We report the crystal structure of Obcl in its apo and glycerol-bound form at 2.5 A and 2.8 A resolution, respectively. The Obcl N-terminal domain is essentially identical both in structure and function to that of ObcA. Its C-terminal domain has an alpha/beta hydrolase fold that has a catalytic triad for oxalate production and a novel oxyanion hole distinct from the canonical HGGG motif in other a/0 hydrolases. Functional analyses through mutagenesis studies suggested that His -934 is an additional catalytic acid/base for its lyase activity and liberates two additional products, acetoacetate and CoA. These results provide structural and functional insights into bacterial oxalogenesis and an example of divergent evolution of the a/13 hydrolase fold, which has both hydrolase and lyase activity.	[Oh, Juntaek; Hwang, Ingyu; Rhee, Sangkee] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea	Seoul National University (SNU)	Rhee, S (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.	srheesnu@snu.ac.kr	Oh, Juntaek/AFM-0371-2022; Oh, Juntaek/AAH-2692-2022	Oh, Juntaek/0000-0002-7625-2779	Next-Generation BioGreen 21 Program of Rural Development Administration (Plant Molecular Breeding Center) of Republic of Korea [PJ01101901]	Next-Generation BioGreen 21 Program of Rural Development Administration (Plant Molecular Breeding Center) of Republic of Korea	This work was supported by Next-Generation BioGreen 21 Program of Rural Development Administration (Plant Molecular Breeding Center no. PJ01101901; to S. R.) of Republic of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Bradley P, 2001, P NATL ACAD SCI USA, V98, P14819, DOI 10.1073/pnas.251267298; Buller AR, 2013, P NATL ACAD SCI USA, V110, pE653, DOI 10.1073/pnas.1221050110; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dandekar AA, 2012, SCIENCE, V338, P264, DOI 10.1126/science.1227289; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Eydoux C, 2008, BIOCHEMISTRY-US, V47, P9553, DOI 10.1021/bi8005576; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Goo E, 2015, TRENDS MICROBIOL, V23, P567, DOI 10.1016/j.tim.2015.05.007; Goo E, 2012, P NATL ACAD SCI USA, V109, P19775, DOI 10.1073/pnas.1218092109; Ham JH, 2011, MOL PLANT PATHOL, V12, P329, DOI 10.1111/j.1364-3703.2010.00676.x; Heilmann S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00767; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jones AJY, 2013, ANAL BIOCHEM, V442, P19, DOI 10.1016/j.ab.2013.07.018; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kourist R, 2010, CHEMBIOCHEM, V11, P1635, DOI 10.1002/cbic.201000213; Lee SG, 2014, TRENDS PARASITOL, V30, P241, DOI 10.1016/j.pt.2014.03.001; Lee SG, 2013, STRUCTURE, V21, P1778, DOI 10.1016/j.str.2013.07.023; Leitao JH, 2010, APPL MICROBIOL BIOT, V87, P31, DOI 10.1007/s00253-010-2528-0; Li HQ, 1999, J BIOCHEM, V126, P243, DOI 10.1093/oxfordjournals.jbchem.a022429; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nakamura H, 2008, ANAL CHIM ACTA, V620, P127, DOI 10.1016/j.aca.2008.05.008; Nakata PA, 2011, MICROBIOL RES, V166, P531, DOI 10.1016/j.micres.2010.11.002; Nakata PA, 2010, FEMS MICROBIOL LETT, V304, P177, DOI 10.1111/j.1574-6968.2010.01895.x; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Oh J, 2014, J BIOL CHEM, V289, P11465, DOI 10.1074/jbc.M113.543462; Pai A, 2012, P NATL ACAD SCI USA, V109, P19810, DOI 10.1073/pnas.1211072109; Raychaudhuri A, 2005, BIOCHEMISTRY-US, V44, P2974, DOI 10.1021/bi048005m; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schuster M, 2013, ANNU REV MICROBIOL, V67, P43, DOI 10.1146/annurev-micro-092412-155635; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	38	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15185	15195		10.1074/jbc.M116.727180	http://dx.doi.org/10.1074/jbc.M116.727180			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226606	Green Published, hybrid			2022-12-28	WOS:000380583200027
J	Orlando, BJ; Malkowski, MG				Orlando, Benjamin J.; Malkowski, Michael G.			Substrate-selective Inhibition of Cyclooxygeanse-2 by Fenamic Acid Derivatives Is Dependent on Peroxide Tone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN H SYNTHASE; ENDOCANNABINOID OXYGENATION; ARACHIDONIC-ACID; HUMAN CYCLOOXYGENASE-2; STRUCTURAL BASIS; CROSS-TALK; PROTEIN; MECHANISM; PATHWAYS; MONOMERS	Cyclooxygenase-2 (COX-2) catalyzes the oxygenation of arachidonic acid (AA) and endocannabinoid substrates, placing the enzyme at a unique junction between the eicosanoid and endocannabinoid signaling pathways. COX-2 is a sequence homodimer, but the enzyme displays half-of-site reactivity, such that only one monomer of the dimer is active at a given time. Certain rapid reversible, competitive nonsteroidal anti-inflammatory drugs (NSAIlls) have been shown to inhibit COX-2 in a substrate-selective manner, with the binding of inhibitor to a single monomer sufficient to inhibit the oxygenation of endo-cannabinoids but not arachidonic acid. The underlying mechanism responsible for substrate-selective inhibition has remained elusive, We utilized structural and biophysical methods to evaluate flufenamic acid, meclofenamic acid, mefenamic acid, and tolfenamic acid for their ability to act as substrate selective inhibitors. Crystal structures of each drug in complex with human COX-2 revealed that the inhibitor binds within the cyclooxygenase channel in an inverted orientation, with the carboxylate group interacting with Tyr-385 and Ser-530 at the top of the channel. Tryptophan fluorescence quenching, continuous -wave electron spin resonance, and UV-visible spectroscopy demonstrate that flufenamic acid, mefenamic acid, and tolfenamic acid are substrate-selective inhibitors that bind rapidly to COX-2, quench tyrosyl radicals, and reduce higher oxidation states of the heme moiety. Substrate-selective inhibition was attenuated by the addition of the lipid peroxide 15-hydroperoxyeicosatertaenoic acid. Collectively, these studies implicate peroxide tone as an important mechanistic component of substrate -selective inhibition by flufenamic acid, mefenamic acid, and tolfenamic acid.	[Orlando, Benjamin J.; Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA; [Malkowski, Michael G.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Hauptman Woodward Medical Research Institute	Malkowski, MG (corresponding author), SUNY Buffalo, Dept Biol Struct, Hauptman Woodward Inst, 700 Ellicott St, Buffalo, NY 14203 USA.	mgm22@buffalo.edu		Malkowski, Michael/0000-0002-1203-7463	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115386, P41GM103521] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Elka R. Georgieva and Peter P. Borbat for assistance with ESR spectroscopic measurements. X-ray diffraction experiments were conducted at the Advanced Photon Source. Use of IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by companies of the Industrial Macromolecular Crystallography Association through a contract with the Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aronoff DM, 2006, CLIN PHARMACOL THER, V79, P9, DOI 10.1016/j.clpt.2005.09.009; Bambai B, 2000, J BIOL CHEM, V275, P27608; Bisogno T, 2008, J NEUROENDOCRINOL, V20, P1, DOI 10.1111/j.1365-2826.2008.01676.x; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Blobaum AL, 2015, J BIOL CHEM, V290, P12793, DOI 10.1074/jbc.M114.635987; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GRAFF G, 1990, ANAL BIOCHEM, V188, P38, DOI 10.1016/0003-2697(90)90525-E; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hermanson DJ, 2014, TRENDS PHARMACOL SCI, V35, P358, DOI 10.1016/j.tips.2014.04.006; Koszelak-Rosenblum M, 2009, PROTEIN SCI, V18, P1828, DOI 10.1002/pro.193; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2001, J BIOL CHEM, V276, P36993, DOI 10.1074/jbc.M105854200; Kozak KR, 2004, CURR PHARM DESIGN, V10, P659, DOI 10.2174/1381612043453081; Kudalkar SN, 2015, J BIOL CHEM, V290, P7897, DOI 10.1074/jbc.M114.634014; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lucido MJ, 2016, BIOCHEMISTRY-US, V55, P1226, DOI 10.1021/acs.biochem.5b01378; Luft JR, 2011, EXPERT OPIN DRUG DIS, V6, P465, DOI 10.1517/17460441.2011.566857; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muraoka S, 2003, LIFE SCI, V72, P1897, DOI 10.1016/S0024-3205(03)00012-2; Musee J, 2012, J BIOL CHEM, V287, P37383, DOI 10.1074/jbc.M112.381202; Orlando BJ, 2015, BIOCHEMISTRY-US, V54, P7309, DOI 10.1021/acs.biochem.5b00979; Orlando BJ, 2015, J STRUCT BIOL, V189, P62, DOI 10.1016/j.jsb.2014.11.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Rogge CE, 2004, BIOCHEMISTRY-US, V43, P1560, DOI 10.1021/bi035717o; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Rowlinson SW, 2003, J BIOL CHEM, V278, P45763, DOI 10.1074/jbc.M305481200; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Tsai AL, 2010, ARCH BIOCHEM BIOPHYS, V493, P103, DOI 10.1016/j.abb.2009.08.019; Vecchio AJ, 2012, J BIOL CHEM, V287, P24619, DOI 10.1074/jbc.M112.372243; Vecchio AJ, 2011, J STRUCT BIOL, V176, P254, DOI 10.1016/j.jsb.2011.07.019; Vecchio AJ, 2011, J BIOL CHEM, V286, P20736, DOI 10.1074/jbc.M111.230367; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; WEI CH, 1995, BIOCHEMISTRY-US, V34, P8499, DOI 10.1021/bi00026a034; Windsor MA, 2013, BIOORG MED CHEM LETT, V23, P5860, DOI 10.1016/j.bmcl.2013.08.097; Windsor MA, 2012, ACS MED CHEM LETT, V3, P759, DOI 10.1021/ml3001616; Wu G, 2009, BIOCHEMISTRY-US, V48, P11902, DOI 10.1021/bi901600f; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200	54	86	95	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15069	15081		10.1074/jbc.M116.725713	http://dx.doi.org/10.1074/jbc.M116.725713			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226593	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000380583200018
J	Chen, LQ; Song, YJ; He, L; Wan, XP; Lai, LH; Dai, F; Liu, Y; Wang, QQ				Chen, Luoquan; Song, Yinjing; He, Li; Wan, Xiaopeng; Lai, Lihua; Dai, Feng; Liu, Yang; Wang, Qingqing			MicroRNA-223 Promotes Type I Interferon Production in Antiviral Innate Immunity by Targeting Forkhead Box Protein O3 (FOXO3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antiviral agent; innate immunity; interferon; interferon regulatory factor (IRF); microRNA (miRNA); FOXO3; IRF7; type I interferon; microRNA-223	TRANSCRIPTION FACTORS; PROINFLAMMATORY CYTOKINE; POSITIVE FEEDBACK; VIRUS-REPLICATION; ACTIVATION; GENE; EXPRESSION; MIR-223; PHOSPHORYLATION; MACROPHAGES	Effective recognition of viral infection and subsequent triggering of antiviral innate immune responses are essential for the host antiviral defense, which is tightly regulated by multiple regulators, including microRNAs. Previous reports have shown that some microRNAs are induced during virus infection and participate in the regulation of the innate antiviral response. However, whether the type I IFN response is regulated by miR-223 is still unknown. Here, we reported that vesicular stomatitis virus (VSV) infection induced significant up-regulation of miR-223 in murine macrophages. We observed that miR-223 overexpression up-regulated type I IFN expression levels in VSV-infected macrophages. We also demonstrated that miR-223 directly targets FOXO3 to regulate the type I IFN production. Furthermore, type I IFN, which is triggered by VSV infection, is responsible for the up-regulation of miR-223, thus forming a positive regulatory loop for type I IFN production. Our results uncovered a novel mechanism of miR-223-mediated regulation of type I IFN production in the antiviral innate immunity for the first time.	[Chen, Luoquan; Song, Yinjing; He, Li; Wan, Xiaopeng; Lai, Lihua; Dai, Feng; Liu, Yang; Wang, Qingqing] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Liu, Y; Wang, QQ (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China.	liuyang0620@zju.edu.cn; wqq@zju.edu.cn	yang, liu/GVU-8760-2022; wei, jiang/GRX-7907-2022		National Natural Science Foundation of China [81230074, 81571524]; National Key Basic Research Program of China [2013CB530502]; Zhejiang Provincial Program for Cultivation of High Level Innovative Health Talents; Zhejiang Provincial Program for Innovative Research Team in Zhejiang Province [2010R50046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Zhejiang Provincial Program for Cultivation of High Level Innovative Health Talents; Zhejiang Provincial Program for Innovative Research Team in Zhejiang Province	This work was supported by National Natural Science Foundation of China Grants 81230074 and 81571524, National Key Basic Research Program of China Grant 2013CB530502, and Zhejiang Provincial Program for Cultivation of High Level Innovative Health Talents and for Innovative Research Team in Zhejiang Province Grant 2010R50046. The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Albulescu IC, 2015, ANTIVIR RES, V121, P39, DOI 10.1016/j.antiviral.2015.06.013; An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Beutler B, 2007, NAT REV IMMUNOL, V7, P753, DOI 10.1038/nri2174; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen WL, 2013, CELL, V152, P467, DOI 10.1016/j.cell.2013.01.011; Chiba S, 2012, NAT IMMUNOL, V13, P832, DOI 10.1038/ni.2376; Choi EJ, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0252-0; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Fernandez M, 2002, J VIROL, V76, P895, DOI 10.1128/JVI.76.2.895-904.2002; Fiorucci G, 2015, CYTOKINE GROWTH F R, V26, P183, DOI 10.1016/j.cytogfr.2014.11.002; Herdy B, 2012, NAT IMMUNOL, V13, P543, DOI 10.1038/ni.2291; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Jimenez VC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00763; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Killip MJ, 2015, VIRUS RES, V209, P11, DOI 10.1016/j.virusres.2015.02.003; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YK, 2012, CELL MOL IMMUNOL, V9, P497, DOI 10.1038/cmi.2012.35; Li Y, 2010, J VIROL, V84, P3023, DOI 10.1128/JVI.02203-09; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Litvak V, 2012, NATURE, V490, P421, DOI 10.1038/nature11428; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Liu Y, 2011, FEBS LETT, V585, P1963, DOI 10.1016/j.febslet.2011.05.029; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; Luron L, 2012, EUR J IMMUNOL, V42, P1030, DOI 10.1002/eji.201141969; Mallick B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007837; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Mastrangelo E, 2012, J MOL BIOL, V419, P198, DOI 10.1016/j.jmb.2012.03.008; Moran JM, 2005, J VIROL, V79, P10226, DOI 10.1128/JVI.79.16.10226-10236.2005; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Riou C, 2007, J EXP MED, V204, P79, DOI 10.1084/jem.20061681; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Stifter SA, 2015, J IMMUNOL, V194, P2455, DOI 10.4049/jimmunol.1402794; Taibi F, 2014, BBA-MOL BASIS DIS, V1842, P1001, DOI 10.1016/j.bbadis.2014.03.005; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Wang QQ, 2008, J IMMUNOL, V180, P2419, DOI 10.4049/jimmunol.180.4.2419; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Wu N, 2014, MICROBES INFECT, V16, P911, DOI 10.1016/j.micinf.2014.08.011; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712	52	38	40	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14706	14716		10.1074/jbc.M115.700252	http://dx.doi.org/10.1074/jbc.M115.700252			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226534	Green Published, hybrid			2022-12-28	WOS:000380366700024
J	Hollands, A; Corriden, R; Gysler, G; Dahesh, S; Olson, J; Ali, SR; Kunkel, MT; Lin, AE; Forli, S; Newton, AC; Kumar, GB; Nair, BG; Perry, JJP; Nizet, V				Hollands, Andrew; Corriden, Ross; Gysler, Gabriela; Dahesh, Samira; Olson, Joshua; Ali, Syed Raza; Kunkel, Maya T.; Lin, Ann E.; Forli, Stefano; Newton, Alexandra C.; Kumar, Geetha B.; Nair, Bipin G.; Perry, J. Jefferson P.; Nizet, Victor			Natural Product Anacardic Acid from Cashew Nut Shells Stimulates Neutrophil Extracellular Trap Production and Bactericidal Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; innate immunity; neutrophil; reactive oxygen species (ROS); sphingosine-1-phosphate (S1P); Anacardic Acid; Neutrophil extracellular traps; PI3 kinase	HISTONE ACETYLTRANSFERASE; ANTIBACTERIAL; INDUCTION; AUTOPHAGY; AUGMENTS; KINASE; CELLS	Emerging antibiotic resistance among pathogenic bacteria is an issue of great clinical importance, and new approaches to therapy are urgently needed. Anacardic acid, the primary active component of cashew nut shell extract, is a natural product used in the treatment of a variety of medical conditions, including infectious abscesses. Here, we investigate the effects of this natural product on the function of human neutrophils. We find that anacardic acid stimulates the production of reactive oxygen species and neutrophil extracellular traps, two mechanisms utilized by neutrophils to kill invading bacteria. Molecular modeling and pharmacological inhibitor studies suggest anacardic acid stimulation of neutrophils occurs in a PI3K-dependent manner through activation of surface-expressed G protein-coupled sphingosine-1-phosphate receptors. Neutrophil extracellular traps produced in response to anacardic acid are bactericidal and complement select direct antimicrobial activities of the compound.	[Hollands, Andrew; Gysler, Gabriela; Dahesh, Samira; Olson, Joshua; Ali, Syed Raza; Lin, Ann E.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Corriden, Ross; Kunkel, Maya T.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Forli, Stefano] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Kumar, Geetha B.; Nair, Bipin G.; Perry, J. Jefferson P.] Amrita Univ, Sch Biotechnol, Kollam 690525, Kerala, India; [Perry, J. Jefferson P.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Amritapuri; University of California System; University of California Riverside	Nizet, V (corresponding author), Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.	vnizet@ucsd.edu	Nizet, Victor/AAF-3190-2019; Forli, Stefano/AFR-7638-2022	Forli, Stefano/0000-0002-5964-7111; nair, bipin/0000-0002-4944-8805; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health [AI057153, HD71600, GM43154, AR059968, AI124316]; Amrita Vishwa Vidyapeetham University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD071600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI124316, U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR059968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043154, R37GM043154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amrita Vishwa Vidyapeetham University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AI057153, HD71600, GM43154, AR059968, and AI124316 and by funds from Amrita Vishwa Vidyapeetham University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cavalcante AAM, 2003, ENVIRON MOL MUTAGEN, V41, P360, DOI 10.1002/em.10158; Corriden R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9369; Graler MH, 2003, J CELL BIOCHEM, V89, P507, DOI 10.1002/jcb.10537; Guerrero M, 2011, BIOORG MED CHEM LETT, V21, P3632, DOI 10.1016/j.bmcl.2011.04.097; Hemshekhar M, 2012, BASIC CLIN PHARMACOL, V110, P122, DOI 10.1111/j.1742-7843.2011.00833.x; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kihara Y, 2015, EXP CELL RES, V333, P171, DOI 10.1016/j.yexcr.2014.11.020; Kubo J, 1999, J AGR FOOD CHEM, V47, P533, DOI 10.1021/jf9808980; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Mamidyala SK, 2013, BIOORG MED CHEM LETT, V23, P1667, DOI 10.1016/j.bmcl.2013.01.074; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Omanakuttan A, 2012, MOL PHARMACOL, V82, P614, DOI 10.1124/mol.112.079020; Pandey D, 2011, ARTERIOSCL THROM VAS, V31, P1634, DOI 10.1161/ATVBAHA.111.226621; Pietrocola F, 2015, CELL DEATH DIFFER, V22, P509, DOI 10.1038/cdd.2014.215; Rada B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054205; Raj MH, 2016, APOPTOSIS, V21, P578, DOI 10.1007/s10495-016-1223-8; Seong YA, 2014, CELL BIOCHEM BIOPHYS, V68, P369, DOI 10.1007/s12013-013-9717-2; Sharma R, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-292; Sung B, 2008, BLOOD, V111, P4880, DOI 10.1182/blood-2007-10-117994; Trevisan MTS, 2006, FOOD CHEM TOXICOL, V44, P188, DOI 10.1016/j.fct.2005.06.012; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; von Kockritz-Blickwede M, 2009, J MOL MED, V87, P775, DOI 10.1007/s00109-009-0481-0; Wartha F, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe25; World Health Organization, 2016, ANTIMICROBIAL RESIST	29	43	46	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					13964	13973		10.1074/jbc.M115.695866	http://dx.doi.org/10.1074/jbc.M115.695866			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226531	hybrid, Green Published			2022-12-28	WOS:000379975100006
J	DeSantis, MC; Kim, JH; Song, HN; Klasse, PJ; Cheng, W				DeSantis, Michael C.; Kim, Jin H.; Song, Hanna; Klasse, Per Johan; Cheng, Wei			Quantitative Correlation between Infectivity and Gp120 Density on HIV-1 Virions Revealed by Optical Trapping Virometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MEMBRANE-FUSION PROTEINS; ENVELOPE GLYCOPROTEIN; ENTRY; NEUTRALIZATION; ANTIBODY; SURFACE; FLUORESCENCE; CELLS; ENDOCYTOSIS	The envelope glycoprotein (Env) gp120/gp41 is required for HIV-1 infection of host cells. Although in general it has been perceived that more Env gives rise to higher infectivity, the precise quantitative dependence of HIV-1 virion infectivity on Env density has remained unknown. Here we have developed a method to examine this dependence. This method involves 1) production of a set of single-cycle HIV-1 virions with varied density of Env on their surface, 2) site-specific labeling of Env-specific antibody Fab with a fluorophore at high efficiency, and 3) optical trapping virometry to measure the number of gp120 molecules on individual HIV-1 virions. The resulting gp120 density per virion is then correlated with the infectivity of the virions measured in cell culture. In the presence of DEAE-dextran, the polycation known to enhance HIV-1 infectivity in cell culture, virion infectivity follows gp120 density as a sigmoidal dependence and reaches an apparent plateau. This quantitative dependence can be described by a Hill equation, with a Hill coefficient of 2.4 +/- 0.6. In contrast, in the absence of DEAE-dextran, virion infectivity increases monotonically with gp120 density and no saturation is observed under the experimental conditions. These results provide the first quantitative evidence that Env trimers cooperate on the virion surface to mediate productive infection by HIV-1. Moreover, as a result of the low number of Env trimers on individual virions, the number of additional Env trimers per virion that is required for the optimal infectivity will depend on the inclusion of facilitating agents during infection.	[DeSantis, Michael C.; Kim, Jin H.; Song, Hanna; Cheng, Wei] Univ Michigan, Sch Med, Dept Pharmaceut Sci, Coll Pharm, Ann Arbor, MI 48109 USA; [Cheng, Wei] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Klasse, Per Johan] Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med, New York, NY 10065 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cornell University	Cheng, W (corresponding author), 428 Church St, Ann Arbor, MI 48109 USA.	chengwe@umich.edu	Klasse, P.J./AEX-0142-2022	Klasse, P.J./0000-0001-8222-278X; DeSantis, Michael/0000-0002-7214-2740	National Institutes of Health Director's New Innovator Award [1DP2OD008693-01]; National Science Foundation CAREER Award [CHE1149670]; March of Dimes Foundation [5-FY10-490]; National Institutes of Health [F32-GM109771, R37 AI36082]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM109771] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008693] Funding Source: NIH RePORTER	National Institutes of Health Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation CAREER Award(National Science Foundation (NSF)); March of Dimes Foundation(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Director's New Innovator Award 1DP2OD008693-01 (to W. C.), National Science Foundation CAREER Award CHE1149670 (to W. C.), and Research Grant 5-FY10-490 from the March of Dimes Foundation (to W. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare no competing financial interests.r Supported by National Institutes of Health postdoctoral fellowship award F32-GM109771.r Supported by National Institutes of Health Grant R37 AI36082.	Arunajadai SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059279; Barouch DH, 2005, J VIROL, V79, P8828, DOI 10.1128/JVI.79.14.8828-8834.2005; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; Brandenberg OF, 2015, TRENDS MICROBIOL, V23, P763, DOI 10.1016/j.tim.2015.09.003; Brandenberg OF, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004595; Cheng W, 2010, OPT LETT, V35, P2988, DOI 10.1364/OL.35.002988; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Chojnacki J, 2012, SCIENCE, V338, P524, DOI 10.1126/science.1226359; Coffman VC, 2012, TRENDS BIOCHEM SCI, V37, P499, DOI 10.1016/j.tibs.2012.08.002; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Evans R. D., 1969, ATOMIC NUCL, P774; Galimidi RP, 2015, CELL, V160, P433, DOI 10.1016/j.cell.2015.01.016; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hill AV, 1913, BIOCHEM J, V7, P471, DOI 10.1042/bj0070471; Hou XM, 2011, OPT LETT, V36, P3185, DOI 10.1364/OL.36.003185; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Kim Joonseok, 2013, Case Rep Med, V2013, P131395, DOI 10.1155/2013/131395; Klasse PJ, 2007, VIROLOGY, V369, P245, DOI 10.1016/j.virol.2007.06.044; Klasse PJ, 2012, CELL MICROBIOL, V14, P1183, DOI 10.1111/j.1462-5822.2012.01812.x; Klasse PJ, 1996, J VIROL, V70, P3668, DOI 10.1128/JVI.70.6.3668-3677.1996; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Lawrimore J, 2011, J CELL BIOL, V195, P573, DOI 10.1083/jcb.201106036; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Magnus C, 2009, J VIROL, V83, P1523, DOI 10.1128/JVI.01764-08; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Pang YJ, 2014, NAT NANOTECHNOL, V9, P624, DOI [10.1038/NNANO.2014.140, 10.1038/nnano.2014.140]; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Platt EJ, 2010, J VIROL, V84, P3106, DOI 10.1128/JVI.01958-09; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyman J, 1990, BINDING LINKAGE FUNC; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Yuste E, 2005, J VIROL, V79, P12455, DOI 10.1128/JVI.79.19.12455-12463.2005; Zhang YJ, 2002, J VIROL, V76, P6332, DOI 10.1128/JVI.76.12.6332-6343.2002; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	42	24	26	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13088	13097		10.1074/jbc.M116.729210	http://dx.doi.org/10.1074/jbc.M116.729210			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129237	Green Published, hybrid			2022-12-28	WOS:000379770500017
J	Gandhirajan, RK; Jain, M; Walla, B; Johnsen, M; Bartram, MP; Anh, MH; Rinschen, MM; Benzing, T; Schermer, B				Gandhirajan, Rajesh Kumar; Jain, Manaswita; Walla, Benedikt; Johnsen, Marc; Bartram, Malte P.; Minh Huynh Anh; Rinschen, Markus M.; Benzing, Thomas; Schermer, Bernhard			Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; OXYGEN SPECIES GENERATION; REACTIVE OXYGEN; OXIDATIVE-STRESS; KIDNEY-DISEASE; CANCER CELLS; REPERFUSION INJURY; PATHWAY; PROTEIN; BETA	Transcriptional co-activator with PDZ-binding motif (TAZ) and Yes-associated protein (YAP) are critical transcriptional co-activators downstream of the Hippo pathway involved in the regulation of organ size, tissue regeneration, proliferation, and apoptosis. Recent studies suggested common and distinct functions of TAZ and YAP and their diverse impact under several pathological conditions. Here we report differential regulation of TAZ and YAP in response to oxidative stress. H2O2 exposure leads to increased stability and activation of TAZ but not of YAP. H2O2 induces reversible S-glutathionylation at conserved cysteine residues within TAZ. We further demonstrate that TAZ S-glutathionylation is critical for reactive oxygen species (ROS)-mediated, TAZ-dependent TEA domain transcription factor (TEAD) trans-activation. Lysophosphatidic acid, a physiological activator of YAP and TAZ, induces ROS elevation and, subsequently, TAZ S-glutathionylation, which promotes TAZ-mediated target gene expression. TAZ expression is essential for renal homeostasis in mice, and we identify basal TAZ S-glutathionylation in murine kidney lysates, which is elevated during ischemia/reperfusion injury in vivo. This induced nuclear localization of TAZ and increased expression of connective tissue growth factor. These results describe a novel mechanism by which ROS sustains total cellular levels of TAZ. This preferential regulation suggests TAZ to be a redox sensor of the Hippo pathway.	[Gandhirajan, Rajesh Kumar; Jain, Manaswita; Walla, Benedikt; Johnsen, Marc; Bartram, Malte P.; Minh Huynh Anh; Rinschen, Markus M.; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Dept Internal Med 2, Kerpener Str 62, D-50937 Cologne, Germany; [Gandhirajan, Rajesh Kumar; Jain, Manaswita; Walla, Benedikt; Johnsen, Marc; Bartram, Malte P.; Minh Huynh Anh; Rinschen, Markus M.; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Ctr Mol Med, D-50937 Cologne, Germany; [Gandhirajan, Rajesh Kumar; Jain, Manaswita; Walla, Benedikt; Johnsen, Marc; Bartram, Malte P.; Minh Huynh Anh; Rinschen, Markus M.; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50937 Cologne, Germany; [Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Syst Biol Ageing Cologne, D-50937 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne	Schermer, B (corresponding author), Univ Cologne, Dept Internal Med 2, Kerpener Str 62, D-50937 Cologne, Germany.	bernhard.schermer@uk-koeln.de	Benzing, Thomas/X-5476-2019; Schermer, Bernhard/E-9972-2014; Rinschen, Markus/N-7283-2019	Schermer, Bernhard/0000-0002-5194-9000; Rinschen, Markus/0000-0002-9252-1342; Gandhirajan, Rajesh/0000-0002-0039-771X; Jain, Manaswita/0000-0002-5107-7505	Deutsche Forschungsgemeinschaft [SFB829, SCHE1562/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft Grant SFB829.; Supported by Deutsche Forschungsgemeinschaft Grant SCHE1562/2.	Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Bao YJ, 2011, J BIOCHEM, V150, P199, DOI 10.1093/jb/mvr063; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Goetzl Edward J, 2002, ScientificWorldJournal, V2, P324; Granger DN, 2015, REDOX BIOL, V6, P524, DOI 10.1016/j.redox.2015.08.020; Grek CL, 2013, J BIOL CHEM, V288, P26497, DOI 10.1074/jbc.R113.461368; Habbig S, 2011, J CELL BIOL, V193, P633, DOI 10.1083/jcb.201009069; Hall AM, 2013, KIDNEY INT, V83, P72, DOI 10.1038/ki.2012.328; Hall AM, 2011, J AM SOC NEPHROL, V22, P1297, DOI 10.1681/ASN.2010101054; Happe H, 2011, BBA-MOL BASIS DIS, V1812, P1249, DOI 10.1016/j.bbadis.2011.05.005; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036; Jiang F, 2014, REDOX BIOL, V2, P267, DOI 10.1016/j.redox.2014.01.012; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kohli P, 2014, AM J PHYSIOL-CELL PH, V306, pC805, DOI 10.1152/ajpcell.00339.2013; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Lin CC, 2013, BIOCHEM BIOPH RES CO, V440, P564, DOI 10.1016/j.bbrc.2013.09.104; Miseta A, 2000, MOL BIOL EVOL, V17, P1232, DOI 10.1093/oxfordjournals.molbev.a026406; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Okusa MD, 2003, AM J PHYSIOL-RENAL, V285, pF565, DOI 10.1152/ajprenal.00023.2003; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Plouffe SW, 2015, TRENDS MOL MED, V21, P212, DOI 10.1016/j.molmed.2015.01.003; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Saunders JA, 2010, FREE RADICAL BIO MED, V49, P2058, DOI 10.1016/j.freeradbiomed.2010.10.663; Shao D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4315; Su D, 2014, FREE RADICAL BIO MED, V67, P460, DOI 10.1016/j.freeradbiomed.2013.12.004; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Velu CS, 2007, BIOCHEMISTRY-US, V46, P7765, DOI 10.1021/bi700425y; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	42	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11596	11607		10.1074/jbc.M115.712539	http://dx.doi.org/10.1074/jbc.M115.712539			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27048650	hybrid, Green Published			2022-12-28	WOS:000377264800012
J	Paci, A; Liu, PXH; Zhang, LJ; Zhao, RM				Paci, Alexandr; Liu, Peter X. H.; Zhang, Lingjie; Zhao, Rongmin			The Proteasome Subunit Rpn8 Interacts with the Small Nucleolar RNA Protein (snoRNP) Assembly Protein Pih1 and Mediates Its Ubiquitin-independent Degradation in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN THYMIDYLATE SYNTHASE; R2TP COMPLEX; 26S PROTEASOME; POLYMERASE-II; COCHAPERONE COMPLEX; REGULATORY PARTICLE; TERMINAL DOMAIN; HSP90 CHAPERONE; BUDDING YEAST; DEGRON	Pih1 is a scaffold protein of the Rvb1-Rvb2-Tah1-Pih1 (R2TP) protein complex, which is conserved in fungi and animals. The chaperone-like activity of the R2TP complex has been implicated in the assembly of multiple protein complexes, such as the small nucleolar RNA protein complex. However, the mechanism of the R2TP complex activity in vivo and the assembly of the complex itself are still largely unknown. Pih1 is an unstable protein and tends to aggregate when expressed alone. The C-terminal fragment of Pih1 contains multiple destabilization factors and acts as a degron when fused to other proteins. In this study, we investigated Pih1 interactors and identified a specific interaction between Pih1 and the proteasome subunit Rpn8 in yeast Saccharomyces cerevisiae when HSP90 co-chaperone Tah1 is depleted. By analyzing truncation mutants, we identified that the C-terminal 30 amino acids of Rpn8 are sufficient for the binding to Pih1 C terminus. With in vitro and in vivo degradation assays, we showed that the Pih1 C-terminal fragment Pih1(282-344) is able to induce a ubiquitin-independent degradation of GFP. Additionally, we demonstrated that truncation of the Rpn8 C-terminal disordered region does not affect proteasome assembly but specifically inhibits the degradation of the GFP-Pih1(282-344) fusion protein in vivo and Pih1 in vitro. We propose that Pih1 is a ubiquitin-independent proteasome substrate, and the direct interaction with Rpn8 C terminus mediates its proteasomal degradation.	[Paci, Alexandr; Liu, Peter X. H.; Zhang, Lingjie; Zhao, Rongmin] Univ Toronto, Dept Biol Sci, Toronto, ON M1C 1A4, Canada	University of Toronto	Zhao, RM (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada.	rzhao@utsc.utoronto.ca		Zhao, Rongmin/0000-0003-1300-5882	University of Toronto Connaught New Staff Matching Fund [487199]; NSERC [RGPIN-2014-05309]	University of Toronto Connaught New Staff Matching Fund; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by University of Toronto Connaught New Staff Matching Fund Grant 487199 and NSERC Discovery Grant RGPIN-2014-05309 (to R. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad Moaz, 2013, Communicative & Integrative Biology, V6, pe26005, DOI 10.4161/cib.26005; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Back R, 2013, STRUCTURE, V21, P1834, DOI 10.1016/j.str.2013.07.024; Ban Y, 2013, MOL CELL BIOL, V33, P4008, DOI 10.1128/MCB.00403-13; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Benbahouche NE, 2014, J BIOL CHEM, V289, P6236, DOI 10.1074/jbc.M113.499608; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Craxton A, 2012, CELL DEATH DIFFER, V19, P1424, DOI 10.1038/cdd.2012.16; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Dong FL, 2014, J CELL BIOL, V204, P203, DOI 10.1083/jcb.201304076; Eckert K, 2010, J BIOL CHEM, V285, P31304, DOI 10.1074/jbc.M110.138263; Enenkel C, 2014, BIOMOLECULES, V4, P940, DOI 10.3390/biom4040940; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Estrin E, 2013, STRUCTURE, V21, P1624, DOI 10.1016/j.str.2013.06.023; Forsthoefel AM, 2004, BIOCHEMISTRY-US, V43, P1972, DOI 10.1021/bi035894p; Ghaboosi N, 2007, MOL BIOL CELL, V18, P1953, DOI 10.1091/mbc.E06-10-0965; Godderz D, 2011, J MOL BIOL, V407, P354, DOI 10.1016/j.jmb.2011.01.051; Gu ZC, 2014, CELL MOL LIFE SCI, V71, P4729, DOI 10.1007/s00018-014-1699-8; Ha SW, 2012, BIOCHEM BIOPH RES CO, V419, P226, DOI 10.1016/j.bbrc.2012.01.152; Horejsi Z, 2014, CELL REP, V7, P19, DOI 10.1016/j.celrep.2014.03.013; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Hwang J, 2011, BBA-REV CANCER, V1816, P147, DOI 10.1016/j.bbcan.2011.05.005; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Jimenez B, 2012, J BIOL CHEM, V287, P5698, DOI 10.1074/jbc.M111.287458; Ju DH, 2004, J BIOL CHEM, V279, P23851, DOI 10.1074/jbc.C400111200; Kakihara Yoshito, 2014, BioMolecular Concepts, V5, P513, DOI 10.1515/bmc-2014-0028; Kakihara Y, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0404-4; Kakihara Y, 2012, BBA-MOL CELL RES, V1823, P101, DOI 10.1016/j.bbamcr.2011.08.016; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Melo SP, 2011, J BIOL CHEM, V286, P36559, DOI 10.1074/jbc.M111.274258; Melo SP, 2010, BIOCHEM J, V432, P217, DOI 10.1042/BJ20101027; Meszaros B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035003; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Paci A, 2012, J BIOL CHEM, V287, P43205, DOI 10.1074/jbc.M112.408849; Pakay JL, 2012, ONCOGENE, V31, P1817, DOI 10.1038/onc.2011.375; Pal M, 2014, STRUCTURE, V22, P805, DOI 10.1016/j.str.2014.04.001; Ponsuksili S, 2014, INT J BIOL SCI, V10, P327, DOI 10.7150/ijbs.8134; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Prieto MB, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0037-5; Quinternet M, 2015, J MOL BIOL, V427, P2816, DOI 10.1016/j.jmb.2015.07.012; Rinaldi T, 2004, BIOCHEM J, V381, P275, DOI 10.1042/BJ20040008; Rothe B, 2014, NUCLEIC ACIDS RES, V42, P10731, DOI 10.1093/nar/gku612; Rothe B, 2014, NUCLEIC ACIDS RES, V42, P2015, DOI 10.1093/nar/gkt1091; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Shen M, 2013, EXPERT OPIN THER TAR, V17, P1091, DOI 10.1517/14728222.2013.815728; Shen XT, 2004, METHOD ENZYMOL, V377, P401; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Stintzing S, 2014, CLIN CANCER RES, V20, P3064, DOI 10.1158/1078-0432.CCR-13-3175; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Winkler LL, 2013, J VIROL, V87, P4665, DOI 10.1128/JVI.03301-12; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Worden EJ, 2014, NAT STRUCT MOL BIOL, V21, P220, DOI 10.1038/nsmb.2771; Young MJ, 2008, YEAST, V25, P903, DOI 10.1002/yea.1644; Zhang MH, 2008, EMBO J, V27, P2789, DOI 10.1038/emboj.2008.190; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061	71	3	3	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11761	11775		10.1074/jbc.M115.702043	http://dx.doi.org/10.1074/jbc.M115.702043			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27053109	Green Published, hybrid			2022-12-28	WOS:000377264800026
J	Ugarte-Berzal, E; Vandooren, J; Bailon, E; Opdenakker, G; Garcia-Pardo, A				Ugarte-Berzal, Estefania; Vandooren, Jennifer; Bailon, Elvira; Opdenakker, Ghislain; Garcia-Pardo, Angeles			Inhibition of MMP-9-dependent Degradation of Gelatin, but Not Other MMP-9 Substrates, by the MMP-9 Hemopexin Domain Blades 1 and 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; MATRIX-METALLOPROTEINASE-9 MMP-9; CELL-SURFACE; ALPHA-4-BETA-1 INTEGRIN; B-CELLS; MIGRATION; CANCER; DEGRADOMICS; BIOCHEMISTRY; CONSTITUTE	Degradation and remodeling of the extracellular matrix by matrix metalloproteinases (MMPs) plays important roles in normal development, inflammation, and cancer. MMP-9 efficiently degrades the extracellular matrix component gelatin, and the hemopexin domain of MMP-9 (PEX9) inhibits this degradation. To study the molecular basis of this inhibition, we generated GST fusion proteins containing PEX9 or truncated forms corresponding to specific structural blades (B1-B4) of PEX9. GST-PEX9 inhibited MMP-9-driven gelatin proteolysis, measured by gelatin zymography, FITC-gelatin conversion, and DQ-gelatin degradation assays. However, GST-PEX9 did not prevent the degradation of other MMP-9 substrates, such as a fluorogenic peptide, alpha B crystalline, or nonmuscular actin. Therefore, PEX9 may inhibit gelatin degradation by shielding gelatin and specifically preventing its binding to MMP-9. Accordingly, GST-PEX9 also abolished the degradation of gelatin by MMP-2, confirming that PEX9 is not an MMP-9 antagonist. Moreover, GST-B4 and, to a lesser extent, GST-B1 also inhibited gelatin degradation by MMP-9, indicating that these regions are responsible for the inhibitory activity of PEX9. Accordingly, ELISAs demonstrated that GST-B4 and GST-B1 specifically bound to gelatin. Our results establish new functions of PEX9 attributed to blades B4 and B1 and should help in designing specific inhibitors of gelatin degradation.	[Ugarte-Berzal, Estefania; Bailon, Elvira; Garcia-Pardo, Angeles] CSIC, Ctr Invest Biol, Cellular & Mol Med Dept, Ramiro Maeztu 9, Madrid 28040, Spain; [Ugarte-Berzal, Estefania; Vandooren, Jennifer; Opdenakker, Ghislain] Univ Leuven, KULeuven, Rega Inst Med Res, Dept Microbiol & Immunol, B-3000 Leuven, Belgium	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); KU Leuven	Garcia-Pardo, A (corresponding author), CSIC, Ctr Invest Biol, Cellular & Mol Med Dept, Ramiro Maeztu 9, Madrid 28040, Spain.	agarciapardo@cib.csic.es	Opdenakker, Ghislain/Q-3130-2017; Vandooren, Jennifer/H-5318-2019; Opdenakker, Ghislain/V-8562-2019; Vandooren, Jennifer/O-6424-2018	Opdenakker, Ghislain/0000-0003-1714-2294; Opdenakker, Ghislain/0000-0003-1714-2294; Vandooren, Jennifer/0000-0002-7157-3370	Ministry of Economy and Competitivity (Spain) [SAF2012-31613, RD12/0036/0061]; Comunidad de Madrid/European Union [S2010/BMD-2314]; Concerted Research Actions Grant GOA; fund for Scientific Research of Flanders; Ministry of Economy and Competitivity [SAF 2009-07035]; Rega Institute of KU Leuven; European Union [263307]; Junta de Ampliacion de Estudios program; CSIC/European Union; Ministry of Economy and Competitivity	Ministry of Economy and Competitivity (Spain); Comunidad de Madrid/European Union; Concerted Research Actions Grant GOA; fund for Scientific Research of Flanders(FWO); Ministry of Economy and Competitivity; Rega Institute of KU Leuven; European Union(European Commission); Junta de Ampliacion de Estudios program; CSIC/European Union(European Commission); Ministry of Economy and Competitivity	This work was supported by Grant SAF2012-31613 and Red Tematica de Investigacion Cooperativa en Cancer Grant RD12/0036/0061 from the Ministry of Economy and Competitivity (Spain) (to A. G.-P.); by Grant S2010/BMD-2314 (to A. G.-P.) from the Comunidad de Madrid/European Union; and by the Concerted Research Actions Grant GOA 2013-2015 and the fund for Scientific Research of Flanders (to G. O.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Fellowship SAF 2009-07035 from Ministry of Economy and Competitivity. Currently supported as a postdoctoral fellow at the Rega Institute of KU Leuven.; Supported by European Union Seventh Framework Programme FP7/2007 2013, under Grant Agreement 263307.; Supported by the Junta de Ampliacion de Estudios program, CSIC/European Union, and by Ministry of Economy and Competitivity.	Bailon E, 2014, J LEUKOCYTE BIOL, V96, P185, DOI 10.1189/jlb.3HI0913-521R; BICKETT DM, 1993, ANAL BIOCHEM, V212, P58, DOI 10.1006/abio.1993.1291; Burg-Roderfeld M, 2007, INT J ONCOL, V30, P985; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; Cauwe B, 2010, CRIT REV BIOCHEM MOL, V45, P351, DOI 10.3109/10409238.2010.501783; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Garc~ia-Pardo A, 2015, METALLOPROTEINASES M, V2015, P19, DOI DOI 10.2147/MNM.S63629; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Huesgen PF, 2012, PHYSIOL PLANTARUM, V145, P5, DOI 10.1111/j.1399-3054.2011.01536.x; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Loffek S, 2011, EUR RESPIR J, V38, P191, DOI 10.1183/09031936.00146510; Marchant DJ, 2014, NAT MED, V20, P497, DOI 10.1038/nm.3508; Mira E, 2004, J CELL SCI, V117, P1847, DOI 10.1242/jcs.01035; Nabeshima K, 2002, PATHOL INT, V52, P255, DOI 10.1046/j.1440-1827.2002.01343.x; Overall CM, 2004, BIOL CHEM, V385, P493, DOI 10.1515/BC.2004.058; Overall CM, 2002, BIOL CHEM, V383, P1059, DOI 10.1515/BC.2002.114; Piccard H, 2007, J LEUKOCYTE BIOL, V81, P870, DOI 10.1189/jlb.1006629; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Redondo-Munoz J, 2010, CANCER CELL, V17, P160, DOI 10.1016/j.ccr.2009.12.044; Roeb E, 2002, J BIOL CHEM, V277, P50326, DOI 10.1074/jbc.M207446200; Sela-Passwell N, 2010, BBA-MOL CELL RES, V1803, P29, DOI 10.1016/j.bbamcr.2009.04.010; Starckx S, 2003, J NEUROIMMUNOL, V141, P47, DOI 10.1016/S0165-5728(03)00217-0; Ugarte-Berzal E, 2014, J BIOL CHEM, V289, P15340, DOI 10.1074/jbc.M114.559187; Ugarte-Berzal E, 2012, J BIOL CHEM, V287, P27601, DOI 10.1074/jbc.M112.354670; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; Vandooren J, 2015, BIOCHEM J, V465, P259, DOI 10.1042/BJ20140418; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vandooren Jennifer, 2011, World J Biol Chem, V2, P14, DOI 10.4331/wjbc.v2.i1.14; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Zarrabi K, 2011, J BIOL CHEM, V286, P33167, DOI 10.1074/jbc.M111.256644	35	18	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11751	11760		10.1074/jbc.M115.708438	http://dx.doi.org/10.1074/jbc.M115.708438			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27044750	Green Published, hybrid			2022-12-28	WOS:000377264800025
J	Katoh, Y; Terada, M; Nishijima, Y; Takei, R; Nozaki, S; Hamada, H; Nakayama, K				Katoh, Yohei; Terada, Masaya; Nishijima, Yuya; Takei, Ryota; Nozaki, Shohei; Hamada, Hiroshi; Nakayama, Kazuhisa			Overall Architecture of the Intraflagellar Transport (IFT)-B Complex Containing Cluap1/IFT38 as an Essential Component of the IFT-B Peripheral Subcomplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cilia; intracellular trafficking; primary cilium; protein assembly; Cluap1; IFT-B complex; VIP assay	KINESIN-II; CILIOGENESIS; PROTEINS; CILIA; CHLAMYDOMONAS; CORE; FLAGELLA; LINKS; MAINTENANCE; PARTICLE	Intraflagellar transport (IFT) is essential for assembly and maintenance of cilia and flagella as well as ciliary motility and signaling. IFT is mediated by multisubunit complexes, including IFT-A, IFT-B, and the BBSome, in concert with kinesin and dynein motors. Under high salt conditions, purified IFT-B complex dissociates into a core subcomplex composed of at least nine subunits and at least five peripherally associated proteins. Using the visible immunoprecipitation assay, which we recently developed as a convenient protein-protein interaction assay, we determined the overall architecture of the IFT-B complex, which can be divided into core and peripheral subcomplexes composed of 10 and 6 subunits, respectively. In particular, we identified TTC26/IFT56 and Cluap1/IFT38, neither of which was included with certainty in previous models of the IFT-B complex, as integral components of the core and peripheral subcomplexes, respectively. Consistent with this, a ciliogenesis defect of Cluap1-deficient mouse embryonic fibroblasts was rescued by exogenous expression of wild-type Cluap1 but not by mutant Cluap1 lacking the binding ability to other IFT-B components. The detailed interaction map as well as comparison of subcellular localization of IFT-B components between wild-type and Cluap1-deficient cells provides insights into the functional relevance of the architecture of the IFT-B complex.	[Katoh, Yohei; Terada, Masaya; Nishijima, Yuya; Takei, Ryota; Nozaki, Shohei; Nakayama, Kazuhisa] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Hamada, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Dev Genet Grp, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Hamada, Hiroshi] RIKEN, Ctr Dev Biol, Chuou Ku, Kobe, Hyogo 6500047, Japan	Kyoto University; Osaka University; RIKEN	Nakayama, K (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	kazunaka@pharm.kyoto-u.ac.jp	Hamada, Hiroshi/N-6374-2015; Nakayama, Kazuhisa/ABF-2924-2020; Katoh, Yohei/AAA-3378-2020	Hamada, Hiroshi/0000-0002-7196-5948; Katoh, Yohei/0000-0003-1649-4917; Nakayama, Kazuhisa/0000-0001-7701-7183	Ministry of Education, Culture, Sports, Science, and Technology, Japan [25113514, 15H01211]; Japan Society for Promotion of Science [22390013, 15H04370, 25860044, 15K07929]; Uehara Memorial Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [15H04370, 16J03865, 15K14456] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas "Cilia and Centrosome" from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (Grants 25113514 and 15H01211 to K. N.); Japan Society for Promotion of Science Grants 22390013 and 15H04370 (to K. N.) and 25860044 and 15K07929 (to Y. K.); and grants from the Uehara Memorial Foundation (to K. N.) and from the Takeda Science Foundation (to Y. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Baker SA, 2003, J BIOL CHEM, V278, P34211, DOI 10.1074/jbc.M300156200; Behal RH, 2012, J BIOL CHEM, V287, P11689, DOI 10.1074/jbc.M111.287102; Bhogaraju S, 2013, SCIENCE, V341, P1009, DOI 10.1126/science.1240985; Bhogaraju Sagar, 2013, Cilia, V2, P10, DOI 10.1186/2046-2530-2-10; Bhogaraju S, 2011, EMBO J, V30, P1907, DOI 10.1038/emboj.2011.110; Boldt K, 2011, J CLIN INVEST, V121, P2169, DOI 10.1172/JCI45627; Botilde Y, 2013, DEV BIOL, V381, P203, DOI 10.1016/j.ydbio.2013.05.024; Brazelton WJ, 2001, CURR BIOL, V11, P1591, DOI 10.1016/S0960-9822(01)00485-7; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Eguether T, 2014, DEV CELL, V31, P279, DOI 10.1016/j.devcel.2014.09.011; Fan ZC, 2010, MOL BIOL CELL, V21, P2696, DOI 10.1091/mbc.E10-03-0191; Follit JA, 2009, CELL MOTIL CYTOSKEL, V66, P457, DOI 10.1002/cm.20346; Fridy PC, 2014, NAT METHODS, V11, P1253, DOI [10.1038/NMETH.3170, 10.1038/nmeth.3170]; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Ishikawa H, 2014, ELIFE, V3, DOI 10.7554/eLife.01566; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Katoh Y, 2015, J CELL SCI, V128, P2351, DOI 10.1242/jcs.168740; Lee CJ, 2014, INVEST OPHTH VIS SCI, V55, P4585, DOI 10.1167/iovs.14-14888; Liew GM, 2014, DEV CELL, V31, P265, DOI 10.1016/j.devcel.2014.09.004; Lucker BF, 2010, J BIOL CHEM, V285, P21508, DOI 10.1074/jbc.M110.106997; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Nachury MV, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0465; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Pasek Raymond C, 2012, Cilia, V1, P20, DOI 10.1186/2046-2530-1-20; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Richey EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043118; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schou KB, 2014, BIOINFORMATICS, V30, P899, DOI 10.1093/bioinformatics/btt661; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; Swiderski RE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004689; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Taschner M, 2016, EMBO J, V35, P773, DOI 10.15252/embj.201593164; Taschner M, 2014, J CELL BIOL, V207, P269, DOI 10.1083/jcb.201408002; Taschner M, 2012, DIFFERENTIATION, V83, pS12, DOI 10.1016/j.diff.2011.11.001; Taschner M, 2011, J BIOL CHEM, V286, P26344, DOI 10.1074/jbc.M111.254920; Wang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005384; Yang N, 2015, DEVELOPMENT, V142, P2194, DOI 10.1242/dev.115261	39	75	79	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					10962	10975		10.1074/jbc.M116.713883	http://dx.doi.org/10.1074/jbc.M116.713883			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	26980730	Green Published, hybrid			2022-12-28	WOS:000377042100002
J	Vashchenko, G; Das, S; Moon, KM; Rogalski, JC; Taves, MD; Soma, KK; Van Petegem, F; Foster, LJ; Hammond, GL				Vashchenko, Ganna; Das, Samir; Moon, Kyung-Mee; Rogalski, Jason C.; Taves, Matthew D.; Soma, Kiran K.; Van Petegem, Filip; Foster, Leonard J.; Hammond, Geoffrey L.			Identification of Avian Corticosteroid-binding Globulin (SerpinA6) Reveals the Molecular Basis of Evolutionary Adaptations in SerpinA6 Structure and Function as a Steroid-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						androgen; glucocorticoid; N-linked glycosylation; progesterone; protein crystallization; stress; birds; serine proteinase inhibitor	APOLIPOPROTEIN-A-I; HORMONE-BINDING; CORTISOL; BIOSYNTHESIS; PLASMA; GENE; TETRAHYDROCORTISOL; TESTOSTERONE; RESPONSES; PITUITARY	Corticosteroid-binding globulin (CBG) was isolated from chicken serum and identified by mass spectrometry and genomic analysis. This revealed that the organization and synteny of avian and mammalian SerpinA6 genes are conserved. Recombinant zebra finch CBG steroid-binding properties reflect those of the natural protein in plasma and confirm its identity. Zebra finch and rat CBG crystal structures in complex with cortisol resemble each other, but their primary structures share only approximate to 40% identity, and their steroid-binding site topographies differ in several unexpected ways. Remarkably, a tryptophan that anchors ligands in mammalian CBG steroid-binding sites is replaced by an asparagine. Phylogenetic comparisons show that reptilian CBG orthologs share this unexpected property. Glycosylation of this asparagine in zebra finch CBG does not influence its steroid-binding affinity, but we present evidence that it may participate in protein folding and steroid-binding site formation. Substitutions of amino acids within zebra finch CBG that are conserved only in birds reveal how they contribute to their distinct steroid-binding properties, including their high (nanomolar) affinities for glucocorticoids, progesterone, and androgens. As in mammals, a protease secreted by Pseudomonas aeruginosa cleaves CBG in zebra finch plasma within its reactive center loop and disrupts steroid binding, suggesting an evolutionarily conserved property of CBGs. Measurements of CBG mRNA in zebra finch tissues indicate that liver is the main site of plasma CBG production, and anti-zebra finch CBG antibodies cross-react with CBGs in other birds, extending opportunities to study how CBG regulates the actions of glucocorticoids and sex steroids in these species.	[Vashchenko, Ganna; Hammond, Geoffrey L.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Das, Samir; Moon, Kyung-Mee; Rogalski, Jason C.; Van Petegem, Filip; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Taves, Matthew D.; Soma, Kiran K.] Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Hammond, GL (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada.	geoffrey.hammond@ubc.ca	Taves, Matthew Donald/AAW-3148-2020; Van Petegem, Filip/M-6061-2016; Soma, Kiran K/B-9772-2012	Taves, Matthew Donald/0000-0002-4841-059X; Van Petegem, Filip/0000-0003-2728-8537; Soma, Kiran K/0000-0003-2169-8092; Hammond, Geoffrey/0000-0002-4639-7336	Canadian Institutes of Health [MOP111102, MOP77688, MOP119404]; Natural Sciences and Engineering Research Council [RGPIN-2014-04884]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research Grants MOP111102 (to G. L. H.), MOP77688 (to L. J. F.), and MOP119404 (to F. V. P.) and Natural Sciences and Engineering Research Council Grant RGPIN-2014-04884 (to K. K. S). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AVVAKUMOV GV, 1993, J BIOL CHEM, V268, P862; Baker ME, 2013, J STEROID BIOCHEM, V137, P57, DOI 10.1016/j.jsbmb.2013.07.009; BERDUSCO ETM, 1993, ENDOCRINOLOGY, V132, P2001, DOI 10.1210/en.132.5.2001; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Charlier TD, 2009, HORM BEHAV, V56, P339, DOI 10.1016/j.yhbeh.2009.06.012; Colombo L, 2006, J ENDOCRINOL INVEST, V29, P373, DOI 10.1007/BF03344112; Deviche P, 2001, GEN COMP ENDOCR, V122, P67, DOI 10.1006/gcen.2001.7613; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forstmeier W, 2007, MOL ECOL, V16, P4039, DOI 10.1111/j.1365-294X.2007.03444.x; Forsyth S, 2003, GENOMICS, V81, P336, DOI 10.1016/S0888-7543(02)00041-1; Fredslund J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-315; Gardill BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052759; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Goodson JL, 2005, HORM BEHAV, V48, P461, DOI 10.1016/j.yhbeh.2005.04.005; HAMMOND GL, 1990, J CLIN ENDOCR METAB, V71, P34, DOI 10.1210/jcem-71-1-34; HAMMOND GL, 1983, CLIN CHIM ACTA, V132, P101, DOI 10.1016/0009-8981(83)90237-1; HAMMOND GL, 1986, J STEROID BIOCHEM, V24, P815, DOI 10.1016/0022-4731(86)90442-5; HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153; HAMMOND GL, 1990, ENDOCR REV, V11, P65, DOI 10.1210/edrv-11-1-65; Harms MJ, 2014, NATURE, V512, P203, DOI 10.1038/nature13410; Heit C, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-22; Hill LA, 2012, J CLIN ENDOCR METAB, V97, P4260, DOI 10.1210/jc.2012-2467; HILL RE, 1987, NATURE, V326, P96, DOI 10.1038/326096a0; Huntington JA, 2003, STRUCTURE, V11, P205, DOI 10.1016/S0969-2126(02)00944-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klieber MA, 2007, J BIOL CHEM, V282, P29594, DOI 10.1074/jbc.M705014200; KONISHI M, 1989, SCIENCE, V246, P465, DOI 10.1126/science.2683069; Lewis JG, 2014, MOL CELL ENDOCRINOL, V384, P96, DOI 10.1016/j.mce.2014.01.005; Li DM, 2012, HORM BEHAV, V61, P582, DOI 10.1016/j.yhbeh.2012.02.007; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lin HY, 2010, MOL CELL ENDOCRINOL, V316, P3, DOI 10.1016/j.mce.2009.06.015; Lin HY, 2009, J BIOL CHEM, V284, P884, DOI 10.1074/jbc.M807376200; Lobo PA, 2011, STRUCTURE, V19, P790, DOI 10.1016/j.str.2011.03.016; Lynn SE, 2010, HORM BEHAV, V58, P214, DOI 10.1016/j.yhbeh.2010.03.015; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Malisch JL, 2010, MOL CELL ENDOCRINOL, V316, P42, DOI 10.1016/j.mce.2009.09.019; Malisch JL, 2010, GEN COMP ENDOCR, V165, P345, DOI 10.1016/j.ygcen.2009.08.003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ousova O, 2004, MOL ENDOCRINOL, V18, P1687, DOI 10.1210/me.2004-0005; Panin LE, 2007, B EXP BIOL MED+, V144, P291, DOI 10.1007/s10517-007-0313-6; Panin LE, 2003, J STEROID BIOCHEM, V87, P309, DOI 10.1016/j.jsbmb.2003.09.004; Parker R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011096; ROBINSON PA, 1985, J ENDOCRINOL, V104, P259, DOI 10.1677/joe.0.1040259; Romero LM, 2006, GEN COMP ENDOCR, V149, P66, DOI 10.1016/j.ygcen.2006.05.011; Romero LM, 2006, GEN COMP ENDOCR, V149, P58, DOI 10.1016/j.ygcen.2006.05.004; Schmidt KL, 2010, BRAIN BEHAV IMMUN, V24, P908, DOI 10.1016/j.bbi.2010.02.008; SCROCCHI LA, 1993, ENDOCRINOLOGY, V132, P910, DOI 10.1210/en.132.2.910; SCROCCHI LA, 1993, ENDOCRINOLOGY, V132, P903, DOI 10.1210/en.132.2.903; SERALINI GE, 1990, MOL ENDOCRINOL, V4, P1166, DOI 10.1210/mend-4-8-1166; SERALINI GE, 1990, HUM GENET, V86, P73; Sievers Fabian, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0313s48; Simard M, 2015, J CLIN ENDOCR METAB, V100, pE129, DOI 10.1210/jc.2014-3130; Simard M, 2014, ENDOCRINOLOGY, V155, P2900, DOI 10.1210/en.2014-1055; Smith C L, 1988, Steroids, V52, P331, DOI 10.1016/0039-128X(88)90132-8; UNDERHILL DA, 1995, GENE, V162, P205, DOI 10.1016/0378-1119(95)00337-6; UNDERHILL DA, 1989, MOL ENDOCRINOL, V3, P1448, DOI 10.1210/mend-3-9-1448; Verhoog N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110702; Walker SE, 2002, AVIAN DIS, V46, P1045, DOI 10.1637/0005-2086(2002)046[1045:COPAIA]2.0.CO;2; Westphal U, 1986, Monogr Endocrinol, V27, P1; WINGFIELD JC, 1984, GEN COMP ENDOCR, V53, P281, DOI 10.1016/0016-6480(84)90254-5; Wingfield JC, 2005, HORM BEHAV, V48, P395, DOI 10.1016/j.yhbeh.2005.06.003; Zhang GJ, 2014, SCIENCE, V346, P1308, DOI 10.1126/science.346.6215.1308; Zhou AW, 2008, J MOL BIOL, V380, P244, DOI 10.1016/j.jmb.2008.05.012; Zinzow-Kramer WM, 2014, HORM BEHAV, V66, P267, DOI 10.1016/j.yhbeh.2014.04.011	66	10	10	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11300	11312		10.1074/jbc.M116.714378	http://dx.doi.org/10.1074/jbc.M116.714378			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27026706	Green Published, hybrid			2022-12-28	WOS:000377042100029
J	Mast, FD; Jamakhandi, A; Saleem, RA; Dilworth, DJ; Rogers, RS; Rachubinski, RA; Aitchison, JD				Mast, Fred D.; Jamakhandi, Arvind; Saleem, Ramsey A.; Dilworth, David J.; Rogers, Richard S.; Rachubinski, Richard A.; Aitchison, John D.			Peroxins Pex30 and Pex29 Dynamically Associate with Reticulons to Regulate Peroxisome Biogenesis from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; FLUORESCENT PROTEINS; ACTIN ORGANIZATION; SECRETORY PROTEINS; ZELLWEGER-SYNDROME; ROUGH MICROSOMES; GENE-EXPRESSION; GLOBAL ANALYSIS; MONOMERIC RED; PEX11 FAMILY	Peroxisome proliferation occurs by at least two routes, division of existing peroxisomes and de novo biogenesis from the endoplasmic reticulum (ER). The proteins and molecular mechanisms governing peroxisome emergence from the ER are poorly characterized. In this study, we report that two integral membrane peroxins (proteins required for peroxisome biogenesis) in Saccharomyces cerevisiae, Pex29 and Pex30, reside in distinct regions of the ER and associate with Rtn1 and Yop1, reticulon family members that contribute to ER morphology, to govern peroxisome emergence from the ER. In vivo and in vitro analyses reveal that peroxisome proliferation is therefore not restricted to the peroxisome but begins at the level of the ER.	[Mast, Fred D.; Jamakhandi, Arvind; Saleem, Ramsey A.; Dilworth, David J.; Rogers, Richard S.; Aitchison, John D.] Ctr Infect Dis Res, 307 Westlake Ave N, Seattle, WA 98109 USA; [Mast, Fred D.; Jamakhandi, Arvind; Saleem, Ramsey A.; Dilworth, David J.; Rogers, Richard S.; Aitchison, John D.] Inst Syst Biol, Seattle, WA 98109 USA; [Rachubinski, Richard A.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; [Mast, Fred D.] Canadian Inst Hlth Res, Ottawa, ON, Canada	Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); Institute for Systems Biology (ISB); University of Alberta; Institute for Work & Health	Aitchison, JD (corresponding author), Ctr Infect Dis Res, 307 Westlake Ave N, Seattle, WA 98109 USA.	john.aitchison@CIDResearch.org	Mast, Fred/AAM-2426-2021; Mast, Fred/A-6507-2011	Mast, Fred/0000-0002-2177-6647; Mast, Fred/0000-0002-2177-6647	National Institutes of Health [P50 GM076547, P41 GM109824]; Canadian Institutes for Health Research Foundation [143289]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM109824, P50GM076547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research Foundation(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P50 GM076547 and P41 GM109824 (to J. D. A.) and by Canadian Institutes for Health Research Foundation Grant 143289 (to R. A. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adames NR, 2001, J CELL BIOL, V153, P159, DOI 10.1083/jcb.153.1.159; ADAMS AEM, 1991, NATURE, V354, P404, DOI 10.1038/354404a0; Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Agrawal G, 2016, J CELL BIOL, V212, P335, DOI 10.1083/jcb.201506141; Agrawal G, 2011, P NATL ACAD SCI USA, V108, P9113, DOI 10.1073/pnas.1018749108; AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Brown TW, 2000, MOL BIOL CELL, V11, P141, DOI 10.1091/mbc.11.1.141; BRUL S, 1988, BIOCHEM BIOPH RES CO, V152, P1083, DOI 10.1016/S0006-291X(88)80395-4; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chadrin A, 2010, J CELL BIOL, V189, P795, DOI 10.1083/jcb.200910043; Chang JL, 2015, J CELL SCI, V128, P1327, DOI 10.1242/jcs.157743; Cook JG, 1997, NATURE, V390, P85, DOI 10.1038/36355; Cristea I. M., 2011, COLD SPRING HARB PRO, V2011; David C, 2013, MOL CELL PROTEOMICS, V12, P2408, DOI 10.1074/mcp.M112.017830; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; Dilworth DJ, 2005, J CELL BIOL, V171, P955, DOI 10.1083/jcb.200509061; Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; Dubois-Dalcq M, 1999, TRENDS NEUROSCI, V22, P4, DOI 10.1016/S0166-2236(98)01319-8; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; Fagarasanu A, 2009, J CELL BIOL, V186, P541, DOI 10.1083/jcb.200904050; Faulhammer F, 2005, J CELL BIOL, V168, P185, DOI 10.1083/jcb.200407118; Faulhammer F, 2007, TRAFFIC, V8, P1554, DOI 10.1111/j.1600-0854.2007.00632.x; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Graschopf A, 2001, J BIOL CHEM, V276, P16216, DOI 10.1074/jbc.M101504200; Hakhverdyan Z, 2015, NAT METHODS, V12, P553, DOI 10.1038/nmeth.3395; Hammond AT, 2000, TRAFFIC, V1, P935, DOI 10.1034/j.1600-0854.2000.011203.x; Hettema EH, 2014, CURR OPIN CELL BIOL, V29, P25, DOI 10.1016/j.ceb.2014.02.002; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Huber A, 2012, TRAFFIC, V13, P157, DOI 10.1111/j.1600-0854.2011.01290.x; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; JACKSON RC, 1977, P NATL ACAD SCI USA, V74, P5598, DOI 10.1073/pnas.74.12.5598; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Knoblach B, 2013, EMBO J, V32, P2439, DOI 10.1038/emboj.2013.170; Knoblach B, 2010, J BIOL CHEM, V285, P6670, DOI 10.1074/jbc.M109.094805; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; Konrad G, 2002, J BIOL CHEM, V277, P10547, DOI 10.1074/jbc.M200090200; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lam SK, 2010, P NATL ACAD SCI USA, V107, P21523, DOI 10.1073/pnas.1013397107; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lynes EM, 2011, BBA-MOL CELL RES, V1813, P1893, DOI 10.1016/j.bbamcr.2011.06.011; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; MANDERS EMM, 1992, J CELL SCI, V103, P857; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Marelli M, 2004, J CELL BIOL, V167, P1099, DOI 10.1083/jcb.200404119; Mast FD, 2015, CURR OPIN CELL BIOL, V35, P131, DOI 10.1016/j.ceb.2015.05.002; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; Motley AM, 2015, J CELL BIOL, V211, P1041, DOI 10.1083/jcb.201412066; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Opalinski L, 2011, EMBO J, V30, P5, DOI 10.1038/emboj.2010.299; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Passreiter M, 1998, J CELL BIOL, V141, P373, DOI 10.1083/jcb.141.2.373; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Perry RJ, 2009, EUKARYOT CELL, V8, P830, DOI 10.1128/EC.00024-09; PREUSS D, 1991, YEAST, V7, P891, DOI 10.1002/yea.320070902; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Raychaudhuri S, 2008, P NATL ACAD SCI USA, V105, P15785, DOI 10.1073/pnas.0808321105; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Rottensteiner H, 2003, MOL BIOL CELL, V14, P4316, DOI 10.1091/mbc.E03-03-0153; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Saleem RA, 2008, J CELL BIOL, V181, P281, DOI 10.1083/jcb.200710009; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Tackett AJ, 2005, J CELL BIOL, V169, P35, DOI 10.1083/jcb.200502104; Tam YYC, 2005, J BIOL CHEM, V280, P34933, DOI 10.1074/jbc.M506208200; Tam YYC, 2003, MOL BIOL CELL, V14, P4089, DOI 10.1091/mbc.E03-03-0150; Tam YYC, 2002, MOL BIOL CELL, V13, P2681, DOI 10.1091/mbc.E02-02-0117; Titorenko VI, 2000, J CELL BIOL, V148, P29, DOI 10.1083/jcb.148.1.29; Titorenko VI, 1997, MOL CELL BIOL, V17, P5210, DOI 10.1128/MCB.17.9.5210; Titorenko VI, 1998, MOL CELL BIOL, V18, P2789, DOI 10.1128/MCB.18.5.2789; Titorenko VI, 2001, NAT REV MOL CELL BIO, V2, P357, DOI 10.1038/35073063; Titorenko VI, 2000, J CELL BIOL, V150, P881, DOI 10.1083/jcb.150.4.881; Titorenko VI, 2009, INT REV CEL MOL BIO, V272, P191, DOI 10.1016/S1937-6448(08)01605-5; Tower RJ, 2011, MOL BIOL CELL, V22, P1727, DOI 10.1091/mbc.E11-01-0084; van der Zand A, 2012, CELL, V149, P397, DOI 10.1016/j.cell.2012.01.054; vanSteensel B, 1996, J CELL SCI, V109, P787; Vizeacoumar FJ, 2004, MOL BIOL CELL, V15, P665, DOI 10.1091/mbc.E03-09-0681; Vizeacoumar FJ, 2003, J CELL BIOL, V161, P321, DOI 10.1083/jcb.200210130; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voss C, 2012, J CELL SCI, V125, P4791, DOI 10.1242/jcs.105635; Wanders RJA, 2005, CLIN GENET, V67, P107, DOI 10.1111/j.1399-0004.2004.00329.x; Yan M, 2008, MOL BIOL CELL, V19, P885, DOI 10.1091/mbc.E07-10-1042	104	33	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15408	15427		10.1074/jbc.M116.728154	http://dx.doi.org/10.1074/jbc.M116.728154			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27129769	hybrid, Green Published			2022-12-28	WOS:000380584200001
J	Monte, E; Rosa-Garrido, M; Karbassi, E; Chen, HD; Lopez, R; Rau, CD; Wang, J; Nelson, SF; Wu, Y; Stefani, E; Lusis, AJ; Wang, YB; Kurdistani, SK; Franklin, S; Vondriska, TM				Monte, Emma; Rosa-Garrido, Manuel; Karbassi, Elaheh; Chen, Haodong; Lopez, Rachel; Rau, Christoph D.; Wang, Jessica; Nelson, Stanley F.; Wu, Yong; Stefani, Enrico; Lusis, Aldons J.; Wang, Yibin; Kurdistani, Siavash K.; Franklin, Sarah; Vondriska, Thomas M.			Reciprocal Regulation of the Cardiac Epigenome by Chromatin Structural Proteins Hmgb and Ctcf IMPLICATIONS FOR TRANSCRIPTIONAL REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR LAMINA INTERACTIONS; DNA METHYLATION; HUMAN GENOME; HISTONE H3; EPIGENETIC REGULATION; INCREASED EXPRESSION; GENE-EXPRESSION; HUMAN-CELLS; IN-VIVO; HYPERTROPHY	Transcriptome remodeling in heart disease occurs through the coordinated actions of transcription factors, histone modifications, and other chromatin features at pathology-associated genes. The extent to which genome-wide chromatin reorganization also contributes to the resultant changes in gene expression remains unknown. We examined the roles of two chromatin structural proteins, Ctcf (CCCTC-binding factor) and Hmgb2 (high mobility group protein B2), in regulating pathologic transcription and chromatin remodeling. Our data demonstrate a reciprocal relationship between Hmgb2 and Ctcf in controlling aspects of chromatin structure and gene expression. Both proteins regulate each others' expression as well as transcription in cardiac myocytes; however, only Hmgb2 does so in a manner that involves global reprogramming of chromatin accessibility. We demonstrate that the actions of Hmgb2 on local chromatin accessibility are conserved across genomic loci, whereas the effects on transcription are loci-dependent and emerge in concert with histone modification and other chromatin features. Finally, although both proteins share gene targets, Hmgb2 and Ctcf, neither binds these genes simultaneously nor do they physically colocalize in myocyte nuclei. Our study uncovers a previously unknown relationship between these two ubiquitous chromatin proteins and provides a mechanistic explanation for how Hmgb2 regulates gene expression and cellular phenotype. Furthermore, we provide direct evidence for structural remodeling of chromatin on a genome-wide scale in the setting of cardiac disease.	[Monte, Emma; Rosa-Garrido, Manuel; Karbassi, Elaheh; Chen, Haodong; Lopez, Rachel; Rau, Christoph D.; Wu, Yong; Stefani, Enrico; Wang, Yibin; Vondriska, Thomas M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, BH 557 CHS Bldg,650 Charles Young Dr, Los Angeles, CA 90095 USA; [Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Nelson, Stanley F.; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Wang, Jessica; Lusis, Aldons J.; Wang, Yibin; Vondriska, Thomas M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Franklin, Sarah] Univ Utah, Cardiovasc Res & Training Inst, Salt Lake City, UT 84112 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Utah System of Higher Education; University of Utah	Vondriska, TM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, BH 557 CHS Bldg,650 Charles Young Dr, Los Angeles, CA 90095 USA.; Vondriska, TM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med & Physiol, BH 557 CHS Bldg,650 Charles Young Dr, Los Angeles, CA 90095 USA.	tvondriska@mednet.ucla.edu	Chen, Haodong/G-2277-2012; Wang, Jessica/O-1805-2014; Rosa-Garrido, Manuel/AAE-4188-2019; Rau, Christoph/AAC-3943-2020; Nelson, Stanley F/D-4771-2009	Chen, Haodong/0000-0003-2798-0478; Wang, Jessica/0000-0001-7348-0509; Rosa-Garrido, Manuel/0000-0002-2169-3972; Rau, Christoph/0000-0002-0782-207X; Nelson, Stanley F/0000-0002-2082-3114; Wang, Yibin/0000-0003-0852-0767; Lopez, Rachel/0000-0003-1464-0108	National Institutes of Health [HL105699, HL115238, HL114437, HL129639]; American Heart Association [IRG18870056, PRE14430015, 16POST27780019, PRE22700005, PRE7290056, 14UFEL20130049]; Thermo Fisher Scientific; Department of Anesthesiology at UCLA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115238, R01HL105699, R01HL123295, R01HL129639, R01HL114437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM086262, T32GM065823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Thermo Fisher Scientific; Department of Anesthesiology at UCLA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants HL105699 (to T. M. V.), HL115238 (to T. M. V.), HL114437 (to A. J. L. and Y. Wang), and HL129639 (to T.M.V. and Y. Wang), American Heart Association Grant IRG18870056 (to T. M. V.), Thermo Fisher Scientific, and the Department of Anesthesiology at UCLA. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Recipient of American Heart Association Fellowship PRE14430015.r Recipient of American Heart Association Fellowship 16POST27780019.r Recipient of American Heart Association Fellowship PRE22700005.r Recipient of American Heart Association Fellowship PRE7290056.r Recipient of American Heart Association Fellowship 14UFEL20130049.	Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bartova E, 2010, J HISTOCHEM CYTOCHEM, V58, P391, DOI 10.1369/jhc.2009.955435; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BONNEANDREA C, 1984, EMBO J, V3, P1193, DOI 10.1002/j.1460-2075.1984.tb01950.x; Brandenburger Y, 2003, FEBS LETT, V548, P79, DOI 10.1016/S0014-5793(03)00744-0; Brandenburger Y, 2001, FASEB J, V15, P2051, DOI 10.1096/fj.00-0853fje; Bush E, 2004, P NATL ACAD SCI USA, V101, P2870, DOI 10.1073/pnas.0308723101; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cato L, 2008, J MOL BIOL, V384, P1262, DOI 10.1016/j.jmb.2008.10.001; Celona B, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001086; Chen HD, 2016, CIRC RES, V118, P786, DOI 10.1161/CIRCRESAHA.115.305298; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Cuddapah S, 2011, MOL CELL BIOL, V31, P700, DOI 10.1128/MCB.00740-10; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dorn GW, 2011, TRANSL RES, V157, P226, DOI 10.1016/j.trsl.2010.12.013; Farber CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002038; Farley KI, 2015, CHROMOSOMA, V124, P323, DOI 10.1007/s00412-015-0507-z; Fedele M, 2006, CANCER RES, V66, P2536, DOI 10.1158/0008-5472.CAN-05-1889; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Fiorentino FP, 2012, J CELL PHYSIOL, V227, P479, DOI 10.1002/jcp.22780; Franklin S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014258; Furusawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7138; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gaikwad AB, 2010, AM J PATHOL, V176, P1079, DOI 10.2353/ajpath.2010.090528; Gang HY, 2013, AM J PHYSIOL-HEART C, V304, pH1662, DOI 10.1152/ajpheart.00093.2013; Ghazalpour A, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20135004; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hannan RD, 2003, CLIN EXP PHARMACOL P, V30, P517, DOI 10.1046/j.1440-1681.2003.03873.x; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Hoppe G, 2007, J COMP NEUROL, V501, P219, DOI 10.1002/cne.21248; Jarboui MA, 2011, MOL IMMUNOL, V49, P441, DOI 10.1016/j.molimm.2011.09.005; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lehming N, 1998, P NATL ACAD SCI USA, V95, P7322, DOI 10.1073/pnas.95.13.7322; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lu JT, 2011, DIS MODEL MECH, V4, P562, DOI 10.1242/dmm.006346; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maurano MT, 2015, CELL REP, V12, P1184, DOI 10.1016/j.celrep.2015.07.024; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Mitchell-Jordan S, 2012, J MOL CELL CARDIOL, V53, P552, DOI 10.1016/j.yjmcc.2012.07.009; Moore JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034915; Movassagh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008564; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nazar RN, 2004, IUBMB LIFE, V56, P457, DOI 10.1080/15216540400010867; NER SS, 1994, EMBO J, V13, P1817, DOI 10.1002/j.1460-2075.1994.tb06450.x; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Pallier C, 2003, MOL BIOL CELL, V14, P3414, DOI 10.1091/mbc.E02-09-0581; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Papait R, 2013, P NATL ACAD SCI USA, V110, P20164, DOI 10.1073/pnas.1315155110; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Raska I, 2004, BIOL CELL, V96, P579, DOI 10.1016/j.biolcel.2004.04.015; Rau CD, 2015, CIRC-CARDIOVASC GENE, V8, P40, DOI 10.1161/CIRCGENETICS.113.000732; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Rosa-Garrido M, 2013, CIRC J, V77, P1389, DOI 10.1253/circj.CJ-13-0176; Rosa-Garrido M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039371; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Stros M, 2002, J BIOL CHEM, V277, P7157, DOI 10.1074/jbc.M110233200; Ubil E, 2014, NATURE, V514, P585, DOI 10.1038/nature13839; Ugrinova I, 2009, BIOCHEMISTRY-US, V48, P6502, DOI 10.1021/bi9004304; van de Nobelen S, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-19; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; YAMAZAKI F, 1995, BIOCHEM BIOPH RES CO, V210, P1045, DOI 10.1006/bbrc.1995.1762; YEAGER JC, 1981, P SOC EXP BIOL MED, V168, P137; Zhang JY, 2009, NUCLEIC ACIDS RES, V37, P1107, DOI 10.1093/nar/gkn1011; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111; ZWILLING S, 1995, EMBO J, V14, P1198, DOI 10.1002/j.1460-2075.1995.tb07103.x	81	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15428	15446		10.1074/jbc.M116.719633	http://dx.doi.org/10.1074/jbc.M116.719633			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226577	Green Published, hybrid			2022-12-28	WOS:000380584200002
J	Rastogi, R; Verma, JK; Kapoor, A; Langsley, G; Mukhopadhyay, A				Rastogi, Ruchir; Verma, Jitender Kumar; Kapoor, Anjali; Langsley, Gordon; Mukhopadhyay, Amitabha			Rab5 Isoforms Specifically Regulate Different Modes of Endocytosis in Leishmania	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocytosis; hemoglobin; Leishmania; membrane trafficking; Rab	EPIDERMAL-GROWTH-FACTOR; SMALL GTPASE RAB5; NUCLEOTIDE EXCHANGE FACTOR; TRYPANOSOMA-BRUCEI; HEMOGLOBIN ENDOCYTOSIS; MEDIATED ENDOCYTOSIS; FLAGELLAR POCKET; APPL ENDOSOMES; RECEPTOR; TRAFFICKING	Differential functions of Rab5 isoforms in endocytosis are not well characterized. Here, we cloned, expressed, and characterized Rab5a and Rab5b from Leishmania and found that both of them are localized in the early endosome. To understand the role of LdRab5 isoforms in different modes of endocytosis in Leishmania, we generated transgenic parasites overexpressing LdRab5a, LdRab5b, or their dominant-positive (LdRab5a:Q93L and LdRab5b:Q80L) or dominant-negative mutants (LdRab5a:N146I and LdRab5b:N133I). Using LdRab5a or its mutants overexpressing parasites, we found that LdRab5a specifically regulates the fluid-phase endocytosis of horseradish peroxidase and also specifically induced the transport of dextran-Texas Red to the lysosomes. In contrast, cells overexpressing LdRab5b or its mutants showed that LdRab5b explicitly controls receptor-mediated endocytosis of hemoglobin, and overexpression of LdRab5b:WT enhanced the transport of internalized Hb to the lysosomes in comparison with control cells. To unequivocally demonstrate the role of Rab5 isoforms in endocytosis in Leishmania, we tried to generate null-mutants of LdRab5a and LdRab5b parasites, but both were lethal indicating their essential functions in parasites. Therefore, we used heterozygous LdRab5a(+/-) and LdRab5b(+/-) cells. LdRab5a(+/-)Leishmania showed 50% inhibition of HRP uptake, but hemoglobin endocytosis was uninterrupted. In contrast, about 50% inhibition of Hb endocytosis was observed in LdRab5b(+/-) cells without any significant effect on HRP uptake. Finally, we tried to identify putative LdRab5a and LdRab5b effectors. We found that LdRab5b interacts with clathrin heavy chain and hemoglobin receptor. However, LdRab5a failed to interact with the clathrin heavy chain, and interaction with hemoglobin receptor was significantly less. Thus, our results showed that LdRab5a and LdRab5b differentially regulate fluid phase and receptor-mediated endocytosis in Leishmania.	[Rastogi, Ruchir; Verma, Jitender Kumar; Kapoor, Anjali; Mukhopadhyay, Amitabha] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India; [Langsley, Gordon] CNRS, Cochin Inst, INSERM, U1016,UMR8104, F-75014 Paris, France	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mukhopadhyay, A (corresponding author), Natl Inst Immunol, Cell Biol Lab, New Delhi 110067, India.	amitabha@nii.res.in			CEFIPRA Grant [3303-3]; Department of Biotechnology; Department of Science and Technology, Government of India; Council of Scientific and Industrial Research, Government of India; University Grant Commission, Government of India	CEFIPRA Grant; Department of Biotechnology; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission, Government of India(University Grants Commission, India)	This work was supported in part by CEFIPRA Grant 3303-3, the Department of Biotechnology, and a J. C. Bose Fellowship from the Department of Science and Technology, Government of India (to A. M). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by fellowships from Council of Scientific and Industrial Research and University Grant Commission, Government of India.	Agarwal S, 2013, BBA-MOL CELL RES, V1833, P1065, DOI 10.1016/j.bbamcr.2013.01.006; Alvarez-Dominguez C, 1998, J BIOL CHEM, V273, P33901, DOI 10.1074/jbc.273.51.33901; Alvarez-Dominguez C, 1999, J BIOL CHEM, V274, P11459, DOI 10.1074/jbc.274.17.11459; Bahl S, 2015, J BIOL CHEM, V290, P29993, DOI 10.1074/jbc.M115.670018; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Ben Rached F, 2012, BIOL CELL, V104, P34, DOI 10.1111/boc.201100081; Bhattacharya M, 2006, EMBO J, V25, P2878, DOI 10.1038/sj.emboj.7601170; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Callaghan L, 1999, EUR J BIOCHEM, V265, P361; Chen PI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090384; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; Chen YG, 2007, J BIOL CHEM, V282, P9688, DOI 10.1074/jbc.M611704200; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; Ezougou CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087695; Field H, 1998, J BIOL CHEM, V273, P32102, DOI 10.1074/jbc.273.48.32102; Field MC, 2007, TRAFFIC, V8, P629, DOI 10.1111/j.1600-0854.2007.00558.x; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; Grab DJ, 1998, ELECTROPHORESIS, V19, P1162, DOI 10.1002/elps.1150190717; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; GRUENBERG J, 1989, ANNU REV CELL BIOL, V5, P453; Guha R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006406; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Hall B, 2004, MOL BIOCHEM PARASIT, V138, P67, DOI 10.1016/j.molbiopara.2004.07.007; Hirota Y, 2007, BIOCHEM BIOPH RES CO, V364, P40, DOI 10.1016/j.bbrc.2007.09.089; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; Kalaidzidis I, 2015, J CELL BIOL, V211, P123, DOI 10.1083/jcb.201311117; Kimura T, 2006, J BIOL CHEM, V281, P10598, DOI 10.1074/jbc.M510531200; Krishnamurthy G, 2005, J BIOL CHEM, V280, P5884, DOI 10.1074/jbc.M411845200; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; LI GP, 1993, J BIOL CHEM, V268, P24475; Li YJ, 2013, AUTOPHAGY, V9, P150, DOI 10.4161/auto.22742; Li YJ, 2014, TRAFFIC, V15, P749, DOI 10.1111/tra.12175; Liu GJ, 2015, GENETICS, V201, P631, DOI 10.1534/genetics.115.180018; Luo L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5407; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Menard L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4907; Modun B, 2000, TRENDS MICROBIOL, V8, P231, DOI 10.1016/S0966-842X(00)01728-5; Mukhopadhyay A, 1997, J CELL BIOL, V136, P1227, DOI 10.1083/jcb.136.6.1227; Murungi E, 2014, PARASITOL INT, V63, P341, DOI 10.1016/j.parint.2013.11.002; Onodera Y, 2012, J CELL BIOL, V197, P983, DOI 10.1083/jcb.201201065; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Pal A, 2002, J BIOL CHEM, V277, P9529, DOI 10.1074/jbc.M110055200; Patel N, 2008, P NATL ACAD SCI USA, V105, P3980, DOI 10.1073/pnas.0800404105; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Perini ED, 2014, TRAFFIC, V15, P1366, DOI 10.1111/tra.12232; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Reider A, 2011, J CELL SCI, V124, P1613, DOI 10.1242/jcs.073395; Rosenfeld JL, 2001, J CELL SCI, V114, P4499; Sengupta S, 1999, J BIOL CHEM, V274, P2758, DOI 10.1074/jbc.274.5.2758; Singh SB, 2003, EMBO J, V22, P5712, DOI 10.1093/emboj/cdg557; Skjeldal FM, 2012, J CELL SCI, V125, P1910, DOI 10.1242/jcs.092569; Su X, 2007, J BIOL CHEM, V282, P21278, DOI 10.1074/jbc.M703725200; Su X, 2006, J BIOL CHEM, V281, P27982, DOI 10.1074/jbc.M602873200; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Williams RAM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002695; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zheng ZF, 2004, J BIOL CHEM, V279, P42106, DOI 10.1074/jbc.M403780200; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	64	19	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14732	14746		10.1074/jbc.M116.716514	http://dx.doi.org/10.1074/jbc.M116.716514			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226564	Green Published, hybrid			2022-12-28	WOS:000380366700026
J	Sendler, M; Maertin, S; John, D; Persike, M; Weiss, FU; Kruger, B; Wartmann, T; Wagh, P; Halangk, W; Schaschke, N; Mayerle, J; Lerch, MM				Sendler, Matthias; Maertin, Sandrina; John, Daniel; Persike, Maria; Weiss, F. Ulrich; Krueger, Burkhard; Wartmann, Thomas; Wagh, Preshit; Halangk, Walter; Schaschke, Norbert; Mayerle, Julia; Lerch, Markus M.			Cathepsin B Activity Initiates Apoptosis via Digestive Protease Activation in Pancreatic Acinar Cells and Experimental Pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; autophagy; cathepsin B (CTSB); cell death; chymotrypsin; pancreas; pancreatitis; trypsin activation	HUMAN CATIONIC TRYPSINOGEN; HEREDITARY PANCREATITIS; MORPHOLOGICAL-CHANGES; IN-VITRO; MODELS; SECRETION; SEVERITY; NECROSIS; EXPRESSION; PREMATURE	Pancreatitis is associated with premature activation of digestive proteases in the pancreas. The lysosomal hydrolase cathepsin B (CTSB) is a known activator of trypsinogen, and its deletion reduces disease severity in experimental pancreatitis. Here we studied the activation mechanism and subcellular compartment in which CTSB regulates protease activation and cellular injury. Cholecystokinin (CCK) increased the activity of CTSB, cathepsin L, trypsin, chymotrypsin, and caspase 3 in vivo and in vitro and induced redistribution of CTSB to a secretory vesicle-enriched fraction. Neither CTSB protein nor activity redistributed to the cytosol, where the CTSB inhibitors cystatin-B/C were abundantly present. Deletion of CTSB reduced and deletion of cathepsin L increased intracellular trypsin activation. CTSB deletion also abolished CCK-induced caspase 3 activation, apoptosis-inducing factor, as well as X-linked inhibitor of apoptosis protein degradation, but these depended on trypsinogen activation via CTSB. Raising the vesicular pH, but not trypsin inhibition, reduced CTSB activity. Trypsin inhibition did not affect apoptosis in hepatocytes. Deletion of CTSB affected apoptotic but not necrotic acinar cell death. In summary, CTSB in pancreatitis undergoes activation in a secretory, vesicular, and acidic compartment where it activates trypsinogen. Its deletion or inhibition regulates acinar cell apoptosis but not necrosis in two models of pancreatitis. Caspase 3-mediated apoptosis depends on intravesicular trypsinogen activation induced by CTSB, not CTSB activity directly, and this mechanism is pancreas-specific.	[Sendler, Matthias; Maertin, Sandrina; John, Daniel; Persike, Maria; Weiss, F. Ulrich; Wagh, Preshit; Mayerle, Julia; Lerch, Markus M.] Univ Med Greifswald, Dept Med A, D-17489 Greifswald, Germany; [Krueger, Burkhard] Univ Rostock, Div Med Biol, D-18057 Rostock, Germany; [Wartmann, Thomas; Halangk, Walter] Otto Von Guericke Univ, Dept Surg, Div Expt Surg, D-39120 Magdeburg, Germany; [Schaschke, Norbert] Hsch Aalen, Fak Chem, D-73430 Aalen, Germany	Greifswald Medical School; University of Rostock; Otto von Guericke University; Hochschule Aalen	Lerch, MM (corresponding author), Univ Med Greifswald, Dept Med A, D-17489 Greifswald, Germany.	lerch@uni-greifswald.de	Mayerle, Julia/W-7907-2019; Lerch, Markus M./E-2206-2016; Sendler, Matthias/V-9341-2017	Lerch, Markus M./0000-0002-9643-8263; Sendler, Matthias/0000-0001-6494-4105; Mayerle, Julia/0000-0002-3666-6459; Sendler, Matthias/0000-0003-3554-9426	Deutsche Krebshilfe/Dr. Mildred-Scheel-Stiftung Grant [109102]; Deutsche Forschungsgemeinschaft [GRK1947, A3, MA 4115/1-2/3, WA 2430/2-1]; Federal Ministry of Education and Research (BMBF) [GANI-MED 03IS2061A, BMBF 0314107, 01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012]; European Union [EU-FP-7 EPC-TM, EU-FP7-REGPOT-2010-1]	Deutsche Krebshilfe/Dr. Mildred-Scheel-Stiftung Grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This work was supported by Deutsche Krebshilfe/Dr. Mildred-Scheel-Stiftung Grant 109102; Deutsche Forschungsgemeinschaft Grants GRK1947, A3, MA 4115/1-2/3, and WA 2430/2-1; Federal Ministry of Education and Research (BMBF) Grants GANI-MED 03IS2061A and BMBF 0314107, 01ZZ9603, 01ZZ0103, 01ZZ0403, and 03ZIK012; and European Union Grants EU-FP-7 EPC-TM and EU-FP7-REGPOT-2010-1. The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055959; Aghdassi AA, 2015, PANCREATOLOGY, V15, pS23, DOI 10.1016/j.pan.2015.05.476; Athwal T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.120; Balaji KN, 2002, J EXP MED, V196, P493, DOI 10.1084/jem.20011836; Cheriyath V, 2011, BRIT J CANCER, V104, P957, DOI 10.1038/bjc.2011.42; Chiari H., 1896, ZEITSCHRIFTFURHEILKU, V17, P69; Ekiel I, 1996, J BIOL CHEM, V271, P1314, DOI 10.1074/jbc.271.3.1314; Fortunato F, 2009, GASTROENTEROLOGY, V137, P350, DOI 10.1053/j.gastro.2009.04.003; Gaiser S, 2011, GUT, V60, P1379, DOI 10.1136/gut.2010.226175; Gonzalez A, 1997, BIOCHEM BIOPH RES CO, V230, P652, DOI 10.1006/bbrc.1996.6026; Grady T, 1998, AM J PHYSIOL-GASTR L, V275, pG1010, DOI 10.1152/ajpgi.1998.275.5.G1010; Grasso D, 2011, J BIOL CHEM, V286, P8308, DOI 10.1074/jbc.M110.197301; GREENBAUM LM, 1959, J BIOL CHEM, V234, P2885; GRESS TM, 1994, Z GASTROENTEROL, V32, P221; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Halangk W, 2002, AM J PHYSIOL-GASTR L, V282, pG367, DOI 10.1152/ajpgi.00315.2001; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; HERNANDEZ CA, 1993, LANCET, V341, P1371, DOI 10.1016/0140-6736(93)90942-A; HIRANO T, 1991, J CLIN INVEST, V87, P865, DOI 10.1172/JCI115091; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; KAISER AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1295, DOI 10.1152/ajpcell.1995.269.5.C1295; Keim V, 2001, AM J MED, V111, P622, DOI 10.1016/S0002-9343(01)00958-5; Kereszturi E, 2009, HUM MUTAT, V30, P575, DOI 10.1002/humu.20853; Kim YI, 2011, MOL NUTR FOOD RES, V55, P585, DOI 10.1002/mnfr.201000264; KOIKE H, 1982, AM J PHYSIOL, V242, pG297, DOI 10.1152/ajpgi.1982.242.4.G297; Kruger B, 1998, LAB INVEST, V78, P763; Kukor Z, 2002, J BIOL CHEM, V277, P21389, DOI 10.1074/jbc.M200878200; Lerch MM, 2013, GASTROENTEROLOGY, V144, P1180, DOI 10.1053/j.gastro.2012.12.043; Lerch MM, 1997, GASTROENTEROLOGY, V113, P1355, DOI 10.1053/gast.1997.v113.pm9322531; Lerch MM, 2000, MED CLIN N AM, V84, P549, DOI 10.1016/S0025-7125(05)70239-X; LERCH MM, 1992, GASTROENTEROLOGY, V103, P205, DOI 10.1016/0016-5085(92)91114-J; LERCH MM, 1993, GASTROENTEROLOGY, V104, P1768, DOI 10.1016/0016-5085(93)90658-Y; LERCH MM, 1995, J CLIN INVEST, V95, P2222, DOI 10.1172/JCI117912; MACH L, 1994, J BIOL CHEM, V269, P13030; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Mareninova OA, 2015, CELL MOL GASTROENTER, V1, P678, DOI 10.1016/j.jcmgh.2015.07.006; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; Mayerle J, 2005, GASTROENTEROLOGY, V129, P1251, DOI 10.1053/j.gastro.2005.08.002; Meister T, 2010, J PHYSIOL PHARMACOL, V61, P565; Mooren FC, 2001, FASEB J, V15, P659, DOI 10.1096/fj.00-0172com; Mooren FC, 2003, J BIOL CHEM, V278, P9361, DOI 10.1074/jbc.M207454200; Neoptolemos JP, 2000, LANCET, V355, P1955, DOI 10.1016/S0140-6736(00)02327-8; Otani T, 1998, AM J PHYSIOL-GASTR L, V275, pG999, DOI 10.1152/ajpgi.1998.275.5.G999; Pallagi P, 2011, GASTROENTEROLOGY, V141, P2228, DOI 10.1053/j.gastro.2011.08.039; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Sah RP, 2013, GASTROENTEROLOGY, V144, P1076, DOI 10.1053/j.gastro.2013.01.041; SAITO I, 1987, AM J PHYSIOL, V253, pG517, DOI 10.1152/ajpgi.1987.253.4.G517; Saluja AK, 1997, GASTROENTEROLOGY, V113, P304, DOI 10.1016/S0016-5085(97)70108-2; Schick V, 2014, GUT, V63, P1469, DOI 10.1136/gutjnl-2012-304274; Sendler M, 2015, GASTROENTEROLOGY, V149, P765, DOI 10.1053/j.gastro.2015.05.012; Sendler M, 2013, GUT, V62, P430, DOI 10.1136/gutjnl-2011-300771; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; Taniguchi M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.82; Wartmann T, 2010, GASTROENTEROLOGY, V138, P726, DOI 10.1053/j.gastro.2009.10.048; WATANABE O, 1984, AM J PHYSIOL, V246, pG457, DOI 10.1152/ajpgi.1984.246.4.G457; Waterford SD, 2005, J BIOL CHEM, V280, P5430, DOI 10.1074/jbc.M413513200; Weiss FU, 2007, GUT, V56, P1322, DOI 10.1136/gut.2007.122507; Whitcomb DC, 2012, NAT GENET, V44, P1349, DOI 10.1038/ng.2466; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141	59	57	59	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14717	14731		10.1074/jbc.M116.718999	http://dx.doi.org/10.1074/jbc.M116.718999			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226576	hybrid, Green Published			2022-12-28	WOS:000380366700025
J	Gautam, S; Fatehchand, K; Elavazhagan, S; Reader, BF; Ren, L; Mo, XK; Byrd, JC; Tridandapani, S; Butchar, JP				Gautam, Shalini; Fatehchand, Kavin; Elavazhagan, Saranya; Reader, Brenda F.; Ren, Li; Mo, Xiaokui; Byrd, John C.; Tridandapani, Susheela; Butchar, Jonathan P.			Reprogramming Nurse-like Cells with Interferon to Interrupt Chronic Lymphocytic Leukemia Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell-cell interaction; Fc receptor; interferon; signal transduction; tumor immunology	FC-GAMMA-RI; IMMUNE INTERFERON; MYELOID CELLS; TUMOR-CELLS; MACROPHAGES; RECEPTOR; DIFFERENTIATE; GROWTH; MONOCYTES; ANTIBODY	Nurse-like cells (NLCs) play a central role in chronic lymphocytic leukemia (CLL) because they promote the survival and proliferation of CLL cells. NLCs are derived from the monocyte lineage and are driven toward their phenotype via contact-dependent and -independent signals from CLL cells. Because of the central role of NLCs in promoting disease, new strategies to eliminate or reprogram them are needed. Successful reprogramming may be of extra benefit because NLCs express Fc receptors (FcRs) and thus could act as effector cells within the context of antibody therapy. IFN is known to promote the polarization of macrophages toward an M1-like state that is no longer tumor-supportive. In an effort to reprogram the phenotype of NLCs, we found that IFN up-regulated the M1-related markers CD86 and HLA-DR as well as FcRIa. This corresponded to enhanced FcR-mediated cytokine production as well as rituximab-mediated phagocytosis of CLL cells. In addition, IFN down-regulated the expression of CD31, resulting in withdrawal of the survival advantage on CLL cells. These results suggest that IFN can re-educate NLCs and shift them toward an effector-like state and that therapies promoting local IFN production may be effective adjuvants for antibody therapy in CLL.	[Gautam, Shalini; Fatehchand, Kavin; Elavazhagan, Saranya; Reader, Brenda F.; Ren, Li; Byrd, John C.; Tridandapani, Susheela; Butchar, Jonathan P.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Ren, Li] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130000, Jilin, Peoples R China	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Jilin University	Tridandapani, S; Butchar, JP (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	tridandapani.2@osu.edu; butchar.2@osu.edu			National Institutes of Health [P01-CA095426, R01 CA162411, T32 HL007946]; Ohio State University College of Medicine McWhinney Bridge Fund [244749]; NATIONAL CANCER INSTITUTE [P01CA095426, R01CA162411, R35CA197734] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University College of Medicine McWhinney Bridge Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants P01-CA095426 and R01 CA162411 (to S. T. and J. C. B.) and T32 HL007946 (to B. F. R.) and by Ohio State University College of Medicine McWhinney Bridge Fund 244749 (to J. P. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BERGSAGEL DE, 1990, J CLIN ONCOL, V8, P1444, DOI 10.1200/JCO.1990.8.8.1444; Boissard F, 2015, LEUKEMIA LYMPHOMA, V56, P1570, DOI 10.3109/10428194.2014.991731; Burger JA, 2000, BLOOD, V96, P2655; Deaglio S, 2005, BLOOD, V105, P3042, DOI 10.1182/blood-2004-10-3873; Duluc D, 2009, INT J CANCER, V125, P367, DOI 10.1002/ijc.24401; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Giannoni P, 2014, HAEMATOLOGICA, V99, P1078, DOI 10.3324/haematol.2013.091405; GRAZIANO RF, 1987, J IMMUNOL, V139, P3536; GUYRE PM, 1983, J CLIN INVEST, V72, P393, DOI 10.1172/JCI110980; Kane A, 2010, NEUROSURG CLIN N AM, V21, P77, DOI 10.1016/j.nec.2009.08.011; Marchesi F, 2015, HEMATOL ONCOL, V33, P110, DOI 10.1002/hon.2142; Miller CHT, 2009, ANN NY ACAD SCI, V1182, P69, DOI 10.1111/j.1749-6632.2009.05069.x; Morande PE, 2012, INVEST NEW DRUG, V30, P1830, DOI 10.1007/s10637-011-9740-3; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; NOTTER M, 1993, BLOOD, V82, P3113; Parihar R, 2004, CLIN CANCER RES, V10, P5027, DOI 10.1158/1078-0432.CCR-04-0265; PERUSSIA B, 1983, J EXP MED, V158, P1092, DOI 10.1084/jem.158.4.1092; PERUSSIA B, 1983, J EXP MED, V158, P2058, DOI 10.1084/jem.158.6.2058; Prasse A, 2007, J ALLERGY CLIN IMMUN, V119, P464, DOI 10.1016/j.jaci.2006.09.030; Roda JM, 2005, J IMMUNOL, V175, P1619, DOI 10.4049/jimmunol.175.3.1619; Schulz A, 2013, BLOOD, V121, P2503, DOI 10.1182/blood-2012-08-447664; Shah P, 2013, J BIOL CHEM, V288, P12345, DOI 10.1074/jbc.M113.449983; Stephenson RM, 2013, CANCER IMMUNOL IMMUN, V62, P1347, DOI 10.1007/s00262-013-1437-3; Tsukada N, 2002, BLOOD, V99, P1030, DOI 10.1182/blood.V99.3.1030; Ysebaert L, 2011, LEUKEMIA LYMPHOMA, V52, P1404, DOI 10.3109/10428194.2011.568078	25	15	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14356	14362		10.1074/jbc.M116.723551	http://dx.doi.org/10.1074/jbc.M116.723551			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226587	Green Published, hybrid			2022-12-28	WOS:000379975100037
J	Huang, YK; Chou, RH; Yu, C				Huang, Yen-Kai; Chou, Ruey-Hwang; Yu, Chin			Tranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; nuclear magnetic resonance (NMR); protein complex; protein purification; receptor for advanced glycation end products (RAGE); S100 proteins; tranilast	NEURITE OUTGROWTH; ANTIALLERGIC DRUG; ANTHRANILIC ACID; BINDING-PROTEINS; SMOOTH-MUSCLE; INFLAMMATION; EXPRESSION; CANCER; ACTIVATION; INSIGHTS	The human S100 calcium-binding protein A11 (S100A11) is a member of the S100 protein family. Once S100A11 proteins bind to calcium ions at EF-hand motifs, S100A11 changes its conformation, promoting interaction with target proteins. The receptor for advanced glycation end products (RAGE) consists of three extracellular domains, including the V domain, C1 domain, and C2 domain. In this case, the V domain is the target for mutant S100A11 (mS100A11) binding. RAGE binds to the ligands, resulting in cell proliferation, cell growth, and several signal transduction cascades. We used NMR and fluorescence spectroscopy to demonstrate the interactions between mS100A11and RAGE V domain. The tranilast molecule is a drug used for treating allergic disorders. We discovered that the RAGE V domain and tranilast would interact with mS100A11 by using H-1-N-15 HSQC NMR titrations. According to the results, we obtained two binary complex models from the HADDOCK program, S100A11-RAGE V domain and S100A11-tranilast, respectively. We overlapped two binary complex models with the same orientation of S100A11 homodimer and demonstrated that tranilast would block the binding site between S100A11 and the RAGE V domain. We further utilized a water-soluble tetrazolium-1 assay to confirm this result. We think that the results will be potentially useful in the development of new anti-cancer drugs.	[Huang, Yen-Kai; Yu, Chin] Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Grad Inst Canc Biol, Taichung 40454, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Ctr Mol Med, Taichung 40454, Taiwan	National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan	Yu, C (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan.	cyu.nthu@gmail.com	Chou, Ruey-Hwang/K-8541-2013	Chou, Ruey-Hwang/0000-0002-2297-2180	Ministry of Science and Technology (MOST) Taiwan [103-2113-M-007-017-MY3, 104-2320-B-039-031]; China Medical University Hospital, Taiwan [CMU104-S-02]	Ministry of Science and Technology (MOST) Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital, Taiwan	This work was supported by Ministry of Science and Technology (MOST) Taiwan Grants 103-2113-M-007-017-MY3 (to C. Y.) and 104-2320-B-039-031 (to R.-H. C.) and China Medical University Hospital, Taiwan, Grant CMU104-S-02 (to R.-H. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen BG, 1996, BIOCHEM CELL BIOL, V74, P687, DOI 10.1139/o96-075; Anania MC, 2013, J CLIN ENDOCR METAB, V98, pE1591, DOI 10.1210/jc.2013-1652; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Cecil DL, 2005, J IMMUNOL, V175, P8296, DOI 10.4049/jimmunol.175.12.8296; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dempsey AC, 2003, STRUCTURE, V11, P887, DOI 10.1016/S0969-2126(03)00126-6; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Gospodarska E, 2011, BBA-PROTEINS PROTEOM, V1814, P592, DOI 10.1016/j.bbapap.2011.02.011; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Hung KW, 2012, J BIOMOL NMR, V54, P211, DOI 10.1007/s10858-012-9661-2; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; KOMATSU H, 1988, JPN J PHARMACOL, V46, P43, DOI 10.1254/jjp.46.43; KONDO N, 1992, CLIN EXP ALLERGY, V22, P447, DOI 10.1111/j.1365-2222.1992.tb00146.x; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Lakowicz J. R., 2013, PRINCIPLES FLUORESCE, P533, DOI [DOI 10.1016/J.CANLET.2011.08.028, 10.1016/j.canlet.2011.08.028]; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu XG, 2010, ONCOL REP, V23, P1301, DOI 10.3892/or_00000764; Liu YQ, 2015, EXP THER MED, V9, P1460, DOI 10.3892/etm.2015.2257; Logsdon CD, 2007, CURR MOL MED, V7, P777, DOI 10.2174/156652407783220697; Meding S, 2012, J PATHOL, V228, P459, DOI 10.1002/path.4021; Memon AA, 2005, CLIN CANCER RES, V11, P606; Mohan SK, 2013, BIOCHEM BIOPH RES CO, V434, P328, DOI 10.1016/j.bbrc.2013.03.049; Murakami Y, 2006, BIOINFORMATICS, V22, P1794, DOI 10.1093/bioinformatics/btl171; Murzik U, 2008, MOL BIOL CELL, V19, P2926, DOI 10.1091/mbc.E07-11-1167; Nakamura K, 2005, MICROVASC RES, V70, P137, DOI 10.1016/j.mvr.2005.10.002; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; OKUDA M, 1984, ANN ALLERGY, V53, P178; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Penumutchu SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103947; Rintala-Dempsey AC, 2006, BIOCHEMISTRY-US, V45, P14695, DOI 10.1021/bi061754e; Rouhiainen Ari, 2013, Methods Mol Biol, V963, P239, DOI 10.1007/978-1-62703-230-8_15; Sakaguchi M, 2008, MOL BIOL CELL, V19, P78, DOI 10.1091/mbc.E07-07-0682; Saleh A, 2013, EXP NEUROL, V249, P149, DOI 10.1016/j.expneurol.2013.08.018; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Schonekess BO, 1997, BIOCHEM CELL BIOL, V75, P771, DOI 10.1139/bcb-75-6-771; SHIODA H, 1979, ALLERGY, V34, P213; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Srikrishna G, 2010, J CELL BIOCHEM, V110, P645, DOI 10.1002/jcb.22575; Stern DM, 2002, AGEING RES REV, V1, P1, DOI 10.1016/S0047-6374(01)00366-9; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Walters KJ, 1999, P NATL ACAD SCI USA, V96, P7877, DOI 10.1073/pnas.96.14.7877; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Xiao MB, 2012, MED ONCOL, V29, P1886, DOI 10.1007/s12032-011-0058-y; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Yamamoto M, 2009, TOHOKU J EXP MED, V217, P193, DOI 10.1620/tjem.217.193; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0	65	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14300	14310		10.1074/jbc.M116.722215	http://dx.doi.org/10.1074/jbc.M116.722215			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226584	Green Published, hybrid			2022-12-28	WOS:000379975100033
J	Khan, I; Crouch, JD; Bharti, SK; Sommers, JA; Carney, SM; Yakubovskaya, E; Garcia-Diaz, M; Trakselis, MA; Brosh, RM				Khan, Irfan; Crouch, Jack D.; Bharti, Sanjay Kumar; Sommers, Joshua A.; Carney, Sean M.; Yakubovskaya, Elena; Garcia-Diaz, Miguel; Trakselis, Michael A.; Brosh, Robert M., Jr.			Biochemical Characterization of the Human Mitochondrial Replicative Twinkle Helicase: SUBSTRATE SPECIFICITY, DNA BRANCH MIGRATION, AND ABILITY TO OVERCOME BLOCKADES TO DNA UNWINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA helicase; DNA repair; DNA replication; genetic disease; mitochondria; Twinkle; branch migration; helicase	SINGLE-MOLECULE FRET; DUPLEX DNA; TRANSCRIPTION INITIATION; DELETION BREAKPOINTS; HUMAN-DISEASE; PROTEIN-A; COMPLEX; BINDING; STRAND; MTDNA	Mutations in the c10orf2 gene encoding the human mitochondrial DNA replicative helicase Twinkle are linked to several rare genetic diseases characterized by mitochondrial defects. In this study, we have examined the catalytic activity of Twinkle helicase on model replication fork and DNA repair structures. Although Twinkle behaves as a traditional 5 to 3 helicase on conventional forked duplex substrates, the enzyme efficiently dissociates D-loop DNA substrates irrespective of whether it possesses a 5 or 3 single-stranded tailed invading strand. In contrast, we report for the first time that Twinkle branch-migrates an open-ended mobile three-stranded DNA structure with a strong 5 to 3 directionality preference. To determine how well Twinkle handles potential roadblocks to mtDNA replication, we tested the ability of the helicase to unwind substrates with site-specific oxidative DNA lesions or bound by the mitochondrial transcription factor A. Twinkle helicase is inhibited by DNA damage in a unique manner that is dependent on the type of oxidative lesion and the strand in which it resides. Novel single molecule FRET binding and unwinding assays show an interaction of the excluded strand with Twinkle as well as events corresponding to stepwise unwinding and annealing. TFAM inhibits Twinkle unwinding, suggesting other replisome proteins may be required for efficient removal. These studies shed new insight on the catalytic functions of Twinkle on the key DNA structures it would encounter during replication or possibly repair of the mitochondrial genome and how well it tolerates potential roadblocks to DNA unwinding.	[Khan, Irfan; Crouch, Jack D.; Bharti, Sanjay Kumar; Sommers, Joshua A.; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Carney, Sean M.; Trakselis, Michael A.] Univ Pittsburgh, Mol Biophys & Struct Biol Program, Pittsburgh, PA 15260 USA; [Yakubovskaya, Elena; Garcia-Diaz, Miguel] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Trakselis, Michael A.] Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Baylor University	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, 251 Bayview Blvd, Baltimore, MD 21224 USA.	broshr@mail.nih.gov	Brosh, Robert/AAR-6124-2020; Trakselis, Michael/V-3806-2019	Trakselis, Michael/0000-0001-7054-8475	National Institutes of Health; NIA; University of Pittsburgh; Baylor University from American Cancer Society [RSG-11-049-01-DMC]; National Institutes of Health [GM100021]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Pittsburgh(University of Pittsburgh); Baylor University from American Cancer Society; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health, NIA, University of Pittsburgh, Baylor University, Research Scholar Grant RSG-11-049-01-DMC (to M. A. T.) from the American Cancer Society, and National Institutes of Health Grant GM100021 (to M. G.-D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berquist BR, 2012, CANCER LETT, V327, P61, DOI 10.1016/j.canlet.2012.02.001; Bharti SK, 2014, J BIOL CHEM, V289, P29975, DOI 10.1074/jbc.M114.567073; Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005; Bronson JE, 2009, BIOPHYS J, V97, P3196, DOI 10.1016/j.bpj.2009.09.031; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Bugreev DV, 2008, J BIOL CHEM, V283, P20231, DOI 10.1074/jbc.M801582200; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763; Ding L, 2015, INT J MOL SCI, V16, P10870, DOI 10.3390/ijms160510870; Dong DW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-677; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; Fagerburg MV, 2011, METHODS MOL BIOL, V749, P273, DOI 10.1007/978-1-61779-142-0_19; Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025; Fernandez-Millan P, 2015, NUCLEIC ACIDS RES, V43, P4284, DOI 10.1093/nar/gkv189; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Huang H, 2011, J AM CHEM SOC, V133, P20357, DOI 10.1021/ja207407n; Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804; Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653; Khan I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113293; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; Kung HC, 1997, J BIOL CHEM, V272, P9227; Lee W, 2013, BIOCHEMISTRY-US, V52, P3157, DOI 10.1021/bi400231s; Manhart CM, 2015, J BIOL CHEM, V290, P10828, DOI 10.1074/jbc.M115.642066; McKinney EA, 2013, GENET MOL BIOL, V36, P308, DOI [10.1590/S1415-47572013000300002, 10.1590/s1415-47572013000300002]; Muftuoglu M, 2014, MITOCHONDRION, V17, P164, DOI 10.1016/j.mito.2014.03.007; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Ngo HB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4077; Pohjoismaki JLO, 2013, P NATL ACAD SCI USA, V110, P19408, DOI 10.1073/pnas.1303046110; Pohjoismaki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600; Rajala N, 2014, NUCLEIC ACIDS RES, V42, P952, DOI 10.1093/nar/gkt988; Rasband W, 2009, IMAGEJ; Rothenberg E, 2007, J BIOL CHEM, V282, P34229, DOI 10.1074/jbc.M706300200; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sage JM, 2013, MITOCHONDRION, V13, P350, DOI 10.1016/j.mito.2013.04.004; Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846; San Martin C, 1998, STRUCTURE, V6, P501; Satapathy AK, 2011, J BIOL CHEM, V286, P34468, DOI 10.1074/jbc.M111.283796; Sen D, 2016, NUCLEIC ACIDS RES, V44, P4200, DOI 10.1093/nar/gkw098; Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468; Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sommers JA, 2014, J BIOL CHEM, V289, P19928, DOI 10.1074/jbc.M113.542456; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; Stein A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005664; Suhasini AN, 2009, J BIOL CHEM, V284, P18458, DOI 10.1074/jbc.M109.012229; Wang KZQ, 2014, MITOCHONDRION, V17, P132, DOI 10.1016/j.mito.2014.04.008; Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015; Yakubovskaya E, 2014, NUCLEIC ACIDS RES, V42, P4100, DOI 10.1093/nar/gkt1360; Yang SX, 2002, J MOL BIOL, V321, P839, DOI 10.1016/S0022-2836(02)00711-8; Zaliznyak T, 2012, CHEM RES TOXICOL, V25, P2103, DOI 10.1021/tx300193k; Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079; Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	57	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14324	14339		10.1074/jbc.M115.712026	http://dx.doi.org/10.1074/jbc.M115.712026			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226550	Green Published, hybrid			2022-12-28	WOS:000379975100035
J	Kumar, R; Hazan, A; Basu, A; Zalcman, N; Matzner, H; Priel, A				Kumar, Rakesh; Hazan, Adina; Basu, Arijit; Zalcman, Nomi; Matzner, Henry; Priel, Avi			Tyrosine Residue in the TRPV1 Vanilloid Binding Pocket Regulates Deactivation Kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; gating; site-directed mutagenesis; structure-function; transient receptor potential channels (TRP channels)	CAPSAICIN RECEPTOR; ION-CHANNEL; PAIN PATHWAY; ACTIVATION; RESINIFERATOXIN; PHOSPHORYLATION; DESENSITIZATION; SENSITIVITY; MECHANISMS; LIGANDS	Vanilloids are pain evoking molecules that serve as ligands of the heat and capsaicin receptor TRPV1. Binding of either endogenous or exogenous vanilloids evokes channel and subsequent neuronal activation, leading to pain sensation. Despite its pivotal physiological role, the molecular basis of TRPV1 activation and deactivation is not fully understood. The highly conserved tyrosine in position 511 (Tyr(511)) of the rat TRPV1 (rTRPV1) was the first residue to be identified as a necessary participant in the vanilloid-mediated response. rTRPV1 cryo-EM structures implicated rotation of this residue in the vanilloids bound state. Therefore, we hypothesize that the rTRPV1 Tyr(511) residue entraps vanilloids in their binding site, prolonging channel activity. To test our hypothesis, we generated an array of rTRPV1 mutants, containing the whole spectrum of Tyr(511) substitutions, and tested their response to both exo- and endovanilloids. Our data show that only substitutions of Tyr(511) to aromatic amino acids were able to mimic, albeit partially, the vanilloid-evoked activation pattern of the wt receptor. Although these substitutions reduced the channel sensitivity to vanilloids, a maximal open-channel lifetime could be achieved. Moreover, whereas their current activation rate remains intact, receptors with Tyr(511) substitutions exhibited a faster current deactivation. Our findings therefore suggest that the duration of channel activity evoked by vanilloids is regulated by the interaction between Tyr(511) and the agonist. To conclude, we suggest that Tyr(511)-mediated anchoring of vanilloids in their binding pocket is pivotal for TRPV1 activation and subsequent pain sensation.	[Kumar, Rakesh; Hazan, Adina; Basu, Arijit; Zalcman, Nomi; Matzner, Henry; Priel, Avi] Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, Fac Med, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Priel, A (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, Fac Med, IL-91120 Jerusalem, Israel.	avip@ekmd.huji.ac.il	kumar, rakesh/ABE-8708-2020; Priel, Avi/ABB-1721-2020	kumar, rakesh/0000-0001-9693-4374; Priel, Avi/0000-0002-6105-5035	Israel Science Foundation [1721/12, 1368/12]; Marie-Curie Career Integration Grant [FP7-CIG-321899]; Jerusalem Brain Committee (JBC) Postdoctoral Fellowship; Kaete Klausner fellowship; Fellowship Program for Outstanding Post-Doctoral Researchers of the Planning and Budget Commission of Israel	Israel Science Foundation(Israel Science Foundation); Marie-Curie Career Integration Grant; Jerusalem Brain Committee (JBC) Postdoctoral Fellowship; Kaete Klausner fellowship; Fellowship Program for Outstanding Post-Doctoral Researchers of the Planning and Budget Commission of Israel	This work was supported in part by the Israel Science Foundation Grants 1721/12 and 1368/12 (to A. P.), Marie-Curie Career Integration Grant FP7-CIG-321899 (to A. P.), a Jerusalem Brain Committee (JBC) Postdoctoral Fellowship (to R. K.), the Kaete Klausner fellowship (to A. H), and the Fellowship Program for Outstanding Post-Doctoral Researchers of the Planning and Budget Commission of Israel (to A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bevan S, 2014, HANDB EXP PHARMACOL, V222, P207, DOI 10.1007/978-3-642-54215-2_9; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Boukalova S, 2010, J BIOL CHEM, V285, P41455, DOI 10.1074/jbc.M110.145466; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chou MZ, 2004, BIOCHEMISTRY-US, V43, P2501, DOI 10.1021/bi035981h; Colton C. K., 2007, V179, P173; Darre L, 2015, MOL PHARMACEUT, V12, P4454, DOI 10.1021/acs.molpharmaceut.5b00641; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Elokely K, 2016, P NATL ACAD SCI USA, V113, pE137, DOI 10.1073/pnas.1517288113; Galzi JL, 1996, P NATL ACAD SCI USA, V93, P1853, DOI 10.1073/pnas.93.5.1853; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Hanson SM, 2015, BIOPHYS J, V108, P1425, DOI 10.1016/j.bpj.2015.02.013; Hazan A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12278; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; O'Neill J, 2012, PHARMACOL REV, V64, P939, DOI 10.1124/pr.112.006163; Piomelli D, 2014, NAT NEUROSCI, V17, P164, DOI 10.1038/nn.3612; Premkumar LS, 2004, J NEUROPHYSIOL, V91, P1442, DOI 10.1152/jn.00745.2003; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Ryu SJ, 2003, J GEN PHYSIOL, V122, P45, DOI 10.1085/jgp.200308847; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Studer M, 2010, J PHYSIOL-LONDON, V588, P3743, DOI 10.1113/jphysiol.2010.190611; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Touska F, 2011, CURR PHARM BIOTECHNO, V12, P122, DOI 10.2174/138920111793937826; Trapani JG, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-15; van der Stelt M, 2004, EUR J BIOCHEM, V271, P1827, DOI 10.1111/j.1432-1033.2004.04081.x; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Winter Z, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-30; Yang F, 2015, NAT CHEM BIOL, V11, P518, DOI [10.1038/NCHEMBIO.1835, 10.1038/nchembio.1835]; Zagotta WN, 2015, HDB ION CHANNELS, P41, DOI [10.1201/b18027, DOI 10.1201/B18027]; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	42	12	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13855	13863		10.1074/jbc.M116.726372	http://dx.doi.org/10.1074/jbc.M116.726372			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27143360	hybrid, Green Published			2022-12-28	WOS:000379771100039
J	Young, SK; Shao, Y; Bidwell, JP; Wek, RC				Young, Sara K.; Shao, Yu; Bidwell, Joseph P.; Wek, Ronald C.			Nuclear Matrix Protein 4 Is a Novel Regulator of Ribosome Biogenesis and Controls the Unfolded Protein Response via Repression of Gadd34 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); eukaryotic initiation factor 2 (eIF2); protein synthesis; translation control; unfolded protein response (UPR); protein homeostasis	ENDOPLASMIC-RETICULUM STRESS; TRANSLATIONAL CONTROL; TRANSCRIPTION FACTORS; OSTEOBLAST DIFFERENTIATION; MAMMALIAN-CELLS; ER-STRESS; GENE; KINASE; BONE; DEPHOSPHORYLATION	The unfolded protein response (UPR) maintains protein homeostasis by governing the processing capacity of the endoplasmic reticulum (ER) to manage ER client loads; however, key regulators within the UPR remain to be identified. Activation of the UPR sensor PERK (EIFAK3/PEK) results in the phosphorylation of the subunit of eIF2 (eIF2-P), which represses translation initiation and reduces influx of newly synthesized proteins into the overloaded ER. As part of this adaptive response, eIF2-P also induces a feedback mechanism through enhanced transcriptional and translational expression of Gadd34 (Ppp1r15A),which targets type 1 protein phosphatase for dephosphorylation of eIF2-P to restore protein synthesis. Here we describe a novel mechanism by which Gadd34 expression is regulated through the activity of the zinc finger transcription factor NMP4 (ZNF384, CIZ). NMP4 functions to suppress bone anabolism, and we suggest that this occurs due to decreased protein synthesis of factors involved in bone formation through NMP4-mediated dampening of Gadd34 and c-Myc expression. Loss of Nmp4 resulted in an increase in c-Myc and Gadd34 expression that facilitated enhanced ribosome biogenesis and global protein synthesis. Importantly, protein synthesis was sustained during pharmacological induction of the UPR through a mechanism suggested to involve GADD34-mediated dephosphorylation of eIF2-P. Sustained protein synthesis sensitized cells to pharmacological induction of the UPR, and the observed decrease in cell viability was restored upon inhibition of GADD34 activity. We conclude that NMP4 is a key regulator of ribosome biogenesis and the UPR, which together play a central role in determining cell viability during endoplasmic reticulum stress.	[Young, Sara K.; Wek, Ronald C.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA; [Bidwell, Joseph P.] Indiana Univ Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA; [Shao, Yu] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Wek, RC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.; Bidwell, JP (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	jbidwell@iu.edu; rwek@iu.edu		Young-Baird, Sara/0000-0002-8915-3139	National Institutes of Health [GM049164]; Ralph W. and Grace M. Showalter Research Trust Fund; Department of Defense [PR120563]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph W. and Grace M. Showalter Research Trust Fund; Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM049164 (to R. C. W.). This work was also supported by the Ralph W. and Grace M. Showalter Research Trust Fund (to R. C. W.) and Department of Defense Grant PR120563 (to J. P. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare no conflicts of interest with the contents of this manuscript.	Alvarez M, 2005, GENE, V347, P43, DOI 10.1016/j.gene.2004.10.025; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Childress P, 2015, MOL ENDOCRINOL, V29, P1269, DOI 10.1210/me.2014-1406; Childress P, 2011, CALCIFIED TISSUE INT, V89, P74, DOI 10.1007/s00223-011-9496-y; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; Feister HA, 2000, J CELL BIOCHEM, V79, P506, DOI 10.1002/1097-4644(20001201)79:3<506::AID-JCB150>3.3.CO;2-1; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Iadevaia V, 2014, SEMIN CELL DEV BIOL, V36, P113, DOI 10.1016/j.semcdb.2014.08.004; Jang WG, 2012, J BIOL CHEM, V287, P905, DOI 10.1074/jbc.M111.253187; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Kondo S, 2011, IUBMB LIFE, V63, P233, DOI 10.1002/iub.433; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nakamoto T, 2000, MOL CELL BIOL, V20, P1649, DOI 10.1128/MCB.20.5.1649-1658.2000; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Preston AM, 2013, J CELL SCI, V126, P4253, DOI 10.1242/jcs.130336; Robling AG, 2009, J CELL PHYSIOL, V219, P734, DOI 10.1002/jcp.21717; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Thunyakitpisal P, 2001, J BONE MINER RES, V16, P10, DOI 10.1359/jbmr.2001.16.1.10; Tohmonda T, 2011, EMBO REP, V12, P451, DOI 10.1038/embor.2011.34; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Wu XH, 2006, HUM MOL GENET, V15, P2837, DOI 10.1093/hmg/ddl208; Young SK, 2015, J BIOL CHEM, V290, P28257, DOI 10.1074/jbc.M115.693184	40	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13780	13788		10.1074/jbc.M116.729830	http://dx.doi.org/10.1074/jbc.M116.729830			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129771	Green Published, hybrid			2022-12-28	WOS:000379771100032
J	Broer, A; Rahimi, F; Broer, S				Broer, Angelika; Rahimi, Farid; Broer, Stefan			Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEPATOMA-CELLS; GENE-EXPRESSION; SYSTEM-N; COPY-NUMBER; METABOLISM; CARCINOMA; GROWTH; PATHWAYS; PHOSPHORYLATION; INHIBITORS	Many cancer cells depend on glutamine as they use the glutaminolysis pathway to generate building blocks and energy for anabolic purposes. As a result, glutamine transporters are essential for cancer growth and are potential targets for cancer chemotherapy with ASCT2 (SLC1A5) being investigated most intensively. Here we show that HeLa epithelial cervical cancer cells and 143B osteosarcoma cells express a set of glutamine transporters including SNAT1 (SLC38A1), SNAT2 (SLC38A2), SNAT4 (SLC38A4), LAT1 (SLC7A5), and ASCT2 (SLC1A5). Net glutamine uptake did not depend on ASCT2 but required expression of SNAT1 and SNAT2. Deletion of ASCT2 did not reduce cell growth but caused an amino acid starvation response and up-regulation of SNAT1 to replace ASCT2 functionally. Silencing of GCN2 in the ASCT2(-/-) background reduced cell growth, showing that a combined targeted approach would inhibit growth of glutamine-dependent cancer cells.	[Broer, Angelika; Rahimi, Farid; Broer, Stefan] Australian Natl Univ, Res Sch Biol, Linnaeus Way 134, Canberra, ACT 2601, Australia	Australian National University	Broer, S (corresponding author), Australian Natl Univ, Res Sch Biol, Linnaeus Way 134, Canberra, ACT 2601, Australia.	Stefan.broeer@anu.edu.au	Broer, Stefan/A-1286-2008; Rahimi, Farid/E-6522-2018	Broer, Stefan/0000-0002-8040-1634; Rahimi, Farid/0000-0002-0920-8188				Baird FE, 2004, J PHYSIOL-LONDON, V559, P367, DOI 10.1113/jphysiol.2003.060293; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bode BP, 2002, AM J PHYSIOL-GASTR L, V283, pG1062, DOI 10.1152/ajpgi.00031.2002; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Broer A, 2000, BIOCHEM J, V346, P705, DOI 10.1042/0264-6021:3460705; Broer A, 1999, J NEUROCHEM, V73, P2184; Broer Stefan, 2003, Methods Mol Biol, V227, P245, DOI 10.1385/1-59259-387-9:245; Bror S, 2014, PFLUG ARCH EUR J PHY, V466, P155, DOI 10.1007/s00424-013-1393-y; Chandel NS., 2015, NAVIGATING METABOLIS; D'Aniello C, 2015, CELL DEATH DIFFER, V22, P1234, DOI 10.1038/cdd.2015.64; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Deitmer JW, 2003, J NEUROCHEM, V87, P127, DOI 10.1046/j.1471-4159.2003.01981.x; Esslinger CS, 2005, BIOORGAN MED CHEM, V13, P1111, DOI 10.1016/j.bmc.2004.11.028; Frew IJ, 2015, ANNU REV PATHOL-MECH, V10, P263, DOI 10.1146/annurev-pathol-012414-040306; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Fuchs BC, 2004, AM J PHYSIOL-GASTR L, V286, pG467, DOI 10.1152/ajpgi.00344.2003; Fuchs BC, 2007, AM J PHYSIOL-CELL PH, V293, pC55, DOI 10.1152/ajpcell.00330.2006; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Gazzola RF, 2001, FEBS LETT, V490, P11; Grewer C, 2004, J PHYSIOL-LONDON, V557, P747, DOI 10.1113/jphysiol.2004.062521; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hellman NE, 2008, J BIOL CHEM, V283, P4272, DOI 10.1074/jbc.M708027200; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Hyde R, 2003, BIOCHEM J, V373, P1, DOI 10.1042/BJ20030405; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Jeon YJ, 2015, CANCER CELL, V27, P354, DOI 10.1016/j.ccell.2015.02.006; Kaira K, 2008, CANCER SCI, V99, P2380, DOI 10.1111/j.1349-7006.2008.00969.x; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kim D, 2002, BBA-BIOMEMBRANES, V1565, P112, DOI 10.1016/S0005-2736(02)00516-3; Kung HN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002229; Lenburg ME, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-31; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P1343, DOI 10.1006/bbrc.2001.4504; NEWSHOLME EA, 1985, Q J EXP PHYSIOL CMS, V70, P473, DOI 10.1113/expphysiol.1985.sp002935; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Oda K, 2010, CANCER SCI, V101, P173, DOI 10.1111/j.1349-7006.2009.01386.x; Phang JM, 2015, CURR OPIN CLIN NUTR, V18, P71, DOI 10.1097/MCO.0000000000000121; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; TAMARAPPOO BK, 1992, J BIOL CHEM, V267, P2370; Wang Q, 2015, AM J CANCER RES, V5, P1281; Wang Q, 2015, J PATHOL, V236, P278, DOI 10.1002/path.4518; Wang Q, 2014, INT J CANCER, V135, P1060, DOI 10.1002/ijc.28749; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Yusenko MV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-152; Zhang J, 2014, METHOD ENZYMOL, V542, P369, DOI 10.1016/B978-0-12-416618-9.00019-4	51	136	140	4	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13194	13205		10.1074/jbc.M115.700534	http://dx.doi.org/10.1074/jbc.M115.700534			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129276	Green Published, hybrid			2022-12-28	WOS:000379770500025
J	Di Lascio, S; Belperio, D; Benfante, R; Fornasari, D				Di Lascio, Simona; Belperio, Debora; Benfante, Roberta; Fornasari, Diego			Alanine Expansions Associated with Congenital Central Hypoventilation Syndrome Impair PHOX2B Homeodomain-mediated Dimerization and Nuclear Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC RECEPTOR SUBUNIT; BETA-HYDROXYLASE GENE; AUTO-REGULATORY MECHANISM; TRANSCRIPTION FACTOR; POLYALANINE EXPANSIONS; FUNCTIONAL-CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; TRINUCLEOTIDE REPEATS; FRAMESHIFT MUTATIONS; LOCUS-COERULEUS	Heterozygous mutations of the human PHOX2B gene, a key regulator of autonomic nervous system development, lead to congenital central hypoventilation syndrome (CCHS), a neuro-developmental disorder characterized by a failure in the autonomic control of breathing. Polyalanine expansions in the 20-residues region of the C terminus of PHOX2B are the major mutations responsible for CCHS. Elongation of the alanine stretch in PHOX2B leads to a protein with altered DNA binding, transcriptional activity, and nuclear localization and the possible formation of cytoplasmic aggregates; furthermore, the findings of various studies support the idea that CCHS is not due to a pure loss of function mechanism but also involves a dominant negative effect and/or toxic gain of function for PHOX2B mutations. Because PHOX2B forms homodimers and heterodimers with its paralogue PHOX2A in vitro, we tested the hypothesis that the dominant negative effects of the mutated proteins are due to non-functional interactions with the wild-type protein or PHOX2A using a co-immunoprecipitation assay and the mammalian two-hybrid system. Our findings show that PHOX2B forms homodimers and heterodimerizes weakly with mutated proteins, exclude the direct involvement of the polyalanine tract in dimer formation, and indicate that mutated proteins retain partial ability to form heterodimers with PHOX2A. Moreover, in this study, we investigated the effects of the longest polyalanine expansions on the homeodomain-mediated nuclear import, and our data clearly show that the expanded C terminus interferes with this process. These results provide novel insights into the effects of the alanine tract expansion on PHOX2B folding and activity.	[Di Lascio, Simona; Belperio, Debora; Benfante, Roberta; Fornasari, Diego] Univ Milan, Dept Med Biotechnol & Translat Med, Via Vanvitelli 32, I-20129 Milan, Italy; [Benfante, Roberta; Fornasari, Diego] Natl Res Council CNR, Neurosci Inst, I-20129 Milan, Italy	University of Milan	Fornasari, D (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, Via Vanvitelli 32, I-20129 Milan, Italy.	diego.fornasari@unimi.it	Benfante, Roberta/C-1513-2015	Benfante, Roberta/0000-0001-5396-5429; Fornasari, Diego/0000-0002-9668-3103; DI LASCIO, SIMONA/0000-0002-5971-1515	Telethon Foundation [GGP13055]; Associazione Italiana per la Sindrome da Ipoventilazione Centrale Congenita (A.I.S.I.C.C.)	Telethon Foundation(Fondazione Telethon); Associazione Italiana per la Sindrome da Ipoventilazione Centrale Congenita (A.I.S.I.C.C.)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Telethon Foundation Grant GGP13055 (to D. F.) and the Associazione Italiana per la Sindrome da Ipoventilazione Centrale Congenita (A.I.S.I.C.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Shaar M, 1999, GENE DEV, V13, P935, DOI 10.1101/gad.13.8.935; Adachi M, 2000, DNA CELL BIOL, V19, P539, DOI 10.1089/104454900439773; Amiel J, 2004, HUM MOL GENET, V13, pR235, DOI 10.1093/hmg/ddh251; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Bachetti T, 2005, HUM MOL GENET, V14, P1815, DOI 10.1093/hmg/ddi188; Battaglioli E, 1998, J NEUROCHEM, V71, P1261; Benfante R, 2007, J BIOL CHEM, V282, P13290, DOI 10.1074/jbc.M608616200; Berthelsen J, 1999, GENE DEV, V13, P946, DOI 10.1101/gad.13.8.946; Brown LY, 2004, TRENDS GENET, V20, P51, DOI 10.1016/j.tig.2003.11.002; Bruun JA, 2005, NUCLEIC ACIDS RES, V33, P2661, DOI 10.1093/nar/gki562; Bryan JT, 2000, J CELL SCI, V113, P4013; Cargnin F, 2005, J BIOL CHEM, V280, P37439, DOI 10.1074/jbc.M508368200; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P12745, DOI 10.1073/pnas.91.26.12745; COLEMAN M, 1980, ARCH DIS CHILD, V55, P901, DOI 10.1136/adc.55.11.901; D'Elia AV, 2001, HUM MUTAT, V18, P361, DOI 10.1002/humu.1207; Di Lascio S, 2013, NEUROBIOL DIS, V50, P187, DOI 10.1016/j.nbd.2012.10.019; Di Zanni E, 2012, NEUROBIOL DIS, V45, P508, DOI 10.1016/j.nbd.2011.09.007; Fan XP, 2001, HUM MOL GENET, V10, P2341, DOI 10.1093/hmg/10.21.2341; Fei YJ, 2000, INVEST OPHTH VIS SCI, V41, P2849; Flora A, 2001, J NEUROSCI, V21, P7037, DOI 10.1523/JNEUROSCI.21-18-07037.2001; Furukawa K, 2002, GENES CELLS, V7, P1135, DOI 10.1046/j.1365-2443.2002.00587.x; Ge LM, 1997, BIOTECHNIQUES, V22, P28, DOI 10.2144/97221bm03; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; GREEN H, 1994, P NATL ACAD SCI USA, V91, P4298, DOI 10.1073/pnas.91.10.4298; Hong SJ, 2001, J NEUROCHEM, V79, P1225, DOI 10.1046/j.1471-4159.2001.00672.x; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Karlin S, 1996, P NATL ACAD SCI USA, V93, P1560, DOI 10.1073/pnas.93.4.1560; Kim HS, 1998, J NEUROSCI, V18, P8247; Lavoie H, 2003, HUM MOL GENET, V12, P2967, DOI 10.1093/hmg/ddg329; Matera I, 2004, J MED GENET, V41, P373, DOI 10.1136/jmg.2003.015412; Messaed C, 2009, NEUROBIOL DIS, V34, P397, DOI 10.1016/j.nbd.2009.02.013; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Nobuta H, 2015, ACTA NEUROPATHOL, V130, P171, DOI 10.1007/s00401-015-1441-0; Oma Y, 2007, PROTEIN SCI, V16, P2195, DOI 10.1110/ps.072955307; Parker GE, 2000, J BIOL CHEM, V275, P23891, DOI 10.1074/jbc.M000377200; Parodi S, 2012, J MOL MED, V90, P1025, DOI 10.1007/s00109-012-0868-1; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Raabe EH, 2008, ONCOGENE, V27, P469, DOI 10.1038/sj.onc.1210659; Rychlik JL, 2003, J BIOL CHEM, V278, P49652, DOI 10.1074/jbc.M308577200; Seo H, 2002, J NEUROCHEM, V80, P905, DOI 10.1046/j.0022-3042.2002.00782.x; Shinchuk LM, 2005, PROTEINS, V61, P579, DOI 10.1002/prot.20536; Shoubridge Cheryl, 2010, Pathogenetics, V3, P1, DOI 10.1186/1755-8417-3-1; Stevens KE, 2007, GENETICS, V175, P1625, DOI 10.1534/genetics.106.066449; Tang HK, 1998, J BIOL CHEM, V273, P7210, DOI 10.1074/jbc.273.13.7210; Terzano S, 2000, J BIOL CHEM, V275, P41495, DOI 10.1074/jbc.M006197200; Trochet D, 2005, HUM MOL GENET, V14, P3697, DOI 10.1093/hmg/ddi401; Trochet D, 2005, AM J HUM GENET, V76, P421, DOI 10.1086/428366; Trochet D, 2009, HUM MUTAT, V30, pE421, DOI 10.1002/humu.20923; Vanderlaan M, 2004, PEDIATR PULM, V37, P217, DOI 10.1002/ppul.10438; Weese-Mayer DE, 2003, AM J MED GENET A, V123A, P267, DOI 10.1002/ajmg.a.20527; Wu HT, 2009, HUM MUTAT, V30, P655, DOI 10.1002/humu.20929; Yang CY, 1998, J NEUROCHEM, V71, P1813	53	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13375	13393		10.1074/jbc.M115.679027	http://dx.doi.org/10.1074/jbc.M115.679027			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129232	Green Published, hybrid			2022-12-28	WOS:000379770500038
J	Jancso, Z; Sahin-Toth, M				Jancso, Zsanett; Sahin-Toth, Miklos			Tighter Control by Chymotrypsin C (CTRC) Explains Lack of Association between Human Anionic Trypsinogen and Hereditary Pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CATIONIC TRYPSINOGEN; ZYMOGEN ACTIVATION; BOVINE TRYPSIN; DEGRADATION; AUTOACTIVATION; VARIANTS; PROTEINS; PRSS2; PURIFICATION; EXPRESSION	The human pancreas expresses two major trypsinogen isoforms, cationic trypsinogen (PRSS1) and anionic trypsinogen (PRSS2). Mutations in PRSS1 cause hereditary pancreatitis by altering cleavage of regulatory nick sites by chymotrypsin C (CTRC) resulting in reduced trypsinogen degradation and increased autoactivation. Despite 90% identity with PRSS1 and a strong propensity for autoactivation, mutations in PRSS2 are not found in hereditary pancreatitis suggesting that activation of this isoform is more tightly regulated. Here, we demonstrated that CTRC promoted degradation and thereby markedly suppressed autoactivation of human anionic trypsinogen more effectively than previously observed with cationic trypsinogen. Increased sensitivity of anionic trypsinogen to CTRC-mediated degradation was due to an additional cleavage site at Leu-148 in the autolysis loop and the lack of the conserved Cys-139-Cys-206 disulfide bond. Significant stabilization of anionic trypsinogen against degradation was achieved by simultaneous mutations of CTRC cleavage sites Leu-81 and Leu-148, autolytic cleavage site Arg-122, and restoration of the missing disulfide bridge. This stands in stark contrast to cationic trypsinogen where single mutations of either Leu-81 or Arg-122 resulted in almost complete resistance to CTRC-mediated degradation. Finally, processing of the trypsinogen activation peptide at Phe-18 by CTRC inhibited autoactivation of anionic trypsinogen, although cationic trypsinogen was strongly stimulated. Taken together, the observations indicate that human anionic trypsinogen is controlled by CTRC in a manner that individual natural mutations are unlikely to increase stability enough to promote intra-pancreatic activation. This unique biochemical property of anionic trypsinogen explains the lack of association of PRSS2 mutations with hereditary pancreatitis.	[Jancso, Zsanett; Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Ctr Exocrine Disorders, Boston, MA 02118 USA	Boston University	Sahin-Toth, M (corresponding author), 72 East Concord St,Evans 433, Boston, MA 02118 USA.	miklos@bu.edu		Sahin-Toth, Miklos/0000-0003-4513-9922	National Institutes of Health [R01 DK058088, R01 DK082412, R01 DK095753]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082412, R01DK095753, R01DK058088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK058088, R01 DK082412, and R01 DK095753. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Borgstrom A, 1995, INT J PANCREATOL, V18, P221; Chen JM, 2000, PANCREAS, V21, P57, DOI 10.1097/00006676-200007000-00052; COLOMB E, 1979, BIOCHIM BIOPHYS ACTA, V570, P397, DOI 10.1016/0005-2744(79)90159-1; COLOMB E, 1979, BIOCHIM BIOPHYS ACTA, V571, P343, DOI 10.1016/0005-2744(79)90104-9; GUY O, 1978, BIOCHEMISTRY-US, V17, P1669, DOI 10.1021/bi00602a014; Kiraly O, 2006, PROTEIN EXPRES PURIF, V48, P104, DOI 10.1016/j.pep.2006.01.023; Kiraly O, 2011, METHODS MOL BIOL, V705, P175, DOI 10.1007/978-1-61737-967-3_10; KOSSIAKOFF AA, 1977, BIOCHEMISTRY-US, V16, P654, DOI 10.1021/bi00623a016; Kukor Z, 2003, EUR J BIOCHEM, V270, P2047, DOI 10.1046/j.1432-1033.2003.03581.x; Kukor Z, 2002, J BIOL CHEM, V277, P6111, DOI 10.1074/jbc.M110959200; Kume K, 2009, GUT, V58, P820, DOI 10.1136/gut.2008.151688; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; MAROUX S, 1969, BIOCHIM BIOPHYS ACTA, V181, P59, DOI 10.1016/0005-2795(69)90227-X; Nemeth BC, 2014, AM J PHYSIOL-GASTR L, V306, pG466, DOI 10.1152/ajpgi.00419.2013; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; Nemoda Z, 2005, J BIOL CHEM, V280, P29645, DOI 10.1074/jbc.M505661200; RINDERKNECHT H, 1979, GUT, V20, P886, DOI 10.1136/gut.20.10.886; RINDERKNECHT H, 1985, DIGEST DIS SCI, V30, P65, DOI 10.1007/BF01318373; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; Ronai Z, 2009, BIOCHEM J, V418, P155, DOI 10.1042/BJ20081848; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; RU BG, 1980, SCI SINICA, V23, P1453; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Sahin-Toth M, 1999, J BIOL CHEM, V274, P29699, DOI 10.1074/jbc.274.42.29699; Sahin-Toth M, 2006, FEBS J, V273, P5044, DOI 10.1111/j.1742-4658.2006.05501.x; Santhosh S, 2008, PANCREAS, V36, P317, DOI 10.1097/MPA.0b013e31815db4b3; SCHEELE G, 1981, GASTROENTEROLOGY, V80, P461; SMITH RL, 1969, J BIOL CHEM, V244, P4704; Szabo A, 2014, J BIOL CHEM, V289, P4753, DOI 10.1074/jbc.M113.538884; Szabo A, 2012, J BIOL CHEM, V287, P20701, DOI 10.1074/jbc.M112.360065; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2006, NAT GENET, V38, P668, DOI 10.1038/ng1797	35	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					12897	12905		10.1074/jbc.M116.725374	http://dx.doi.org/10.1074/jbc.M116.725374			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129265	Green Published, hybrid			2022-12-28	WOS:000379770500001
J	Kim, K; Heo, DH; Kim, I; Suh, JY; Kim, M				Kim, Kyumin; Heo, Dong-hyuk; Kim, Iktae; Suh, Jeong-Yong; Kim, Minkyu			Exosome Cofactors Connect Transcription Termination to RNA Processing by Guiding Terminated Transcripts to the Appropriate Exonuclease within the Nuclear Exosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYPTIC UNSTABLE TRANSCRIPTS; POLYMERASE-II TRANSCRIPTS; SMALL NUCLEOLAR RNAS; BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; POLY(A) POLYMERASE; QUALITY-CONTROL; YEAST; DEGRADATION; NRD1	The yeast Nrd1 interacts with the C-terminal domain (CTD) of RNA polymerase II (RNApII) through its CTD-interacting domain (CID) and also associates with the nuclear exosome, thereby acting as both a transcription termination and RNA processing factor. Previously, we found that the Nrd1 CID is required to recruit the nuclear exosome to the Nrd1 complex, but it was not clear which exosome subunits were contacted. Here, we show that two nuclear exosome cofactors, Mpp6 and Trf4, directly and competitively interact with the Nrd1 CID and differentially regulate the association of Nrd1 with two catalytic subunits of the exosome. Importantly, Mpp6 promotes the processing of Nrd1-terminated transcripts preferentially by Dis3, whereas Trf4 leads to Rrp6-dependent processing. This suggests that Mpp6 and Trf4 may play a role in choosing a particular RNA processing route for Nrd1-terminated transcripts within the exosome by guiding the transcripts to the appropriate exonuclease.	[Kim, Kyumin; Kim, Minkyu] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 1650 Owens St, San Francisco, CA 94158 USA; [Kim, Kyumin; Kim, Minkyu] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Heo, Dong-hyuk] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Kim, Iktae; Suh, Jeong-Yong] Seoul Natl Univ, Dept Agr Biotechnol, 1 Gwanak Ro, Seoul 08826, South Korea; [Suh, Jeong-Yong] Shinshu Univ, Interdisciplinary Cluster Cutting Edge Res, Inst Biomed Sci, Matsumoto, Nagano 3908621, Japan	University of California System; University of California San Francisco; University of Oxford; Seoul National University (SNU); Shinshu University	Kim, M (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 1650 Owens St, San Francisco, CA 94158 USA.	minkyu.kim@ucsf.edu	Kim, Minkyu/AAZ-8535-2021	Kim, Minkyu/0000-0001-9317-1658; Kim, Kyu-Min/0000-0002-1880-7801	Cancer Cell Map Initiative; California Institute for Quantitative Biosciences at UCSF; National Research Foundation of Korea [2013R1A1A2A10013757, 2013R1A1A2010856]	Cancer Cell Map Initiative; California Institute for Quantitative Biosciences at UCSF; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Cancer Cell Map Initiative and the California Institute for Quantitative Biosciences at UCSF (to M. K.) and by the National Research Foundation of Korea (Basic Science Research Program Grants 2013R1A1A2A10013757 (to M. K.) and 2013R1A1A2010856 (to J.-Y. S.)). The authors declare that they have no conflict of interest with the contents of this article.	Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gudipati RK, 2012, MOL CELL, V48, P409, DOI 10.1016/j.molcel.2012.08.018; Heo DH, 2013, J BIOL CHEM, V288, P36676, DOI 10.1074/jbc.M113.508267; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; James P, 1996, GENETICS, V144, P1425; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kubicek K, 2012, GENE DEV, V26, P1891, DOI 10.1101/gad.192781.112; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Makino DL, 2015, NATURE, V524, P54, DOI 10.1038/nature14865; Milligan L, 2008, MOL CELL BIOL, V28, P5446, DOI 10.1128/MCB.00463-08; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Porrua O, 2013, NAT STRUCT MOL BIOL, V20, P884, DOI 10.1038/nsmb.2592; Rasmussen TP, 1998, MOL CELL BIOL, V18, P6885, DOI 10.1128/MCB.18.12.6885; Schilders G, 2005, NUCLEIC ACIDS RES, V33, P6795, DOI 10.1093/nar/gki982; Schilders G, 2007, NUCLEIC ACIDS RES, V35, P2564, DOI 10.1093/nar/gkm082; Schneider C, 2013, TRENDS BIOCHEM SCI, V38, P485, DOI 10.1016/j.tibs.2013.06.013; Schuch B, 2014, EMBO J, V33, P2829, DOI 10.15252/embj.201488757; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Sung MK, 2008, YEAST, V25, P301, DOI 10.1002/yea.1588; Thiebaut M, 2006, MOL CELL, V23, P853, DOI 10.1016/j.molcel.2006.07.029; Tudek A, 2014, MOL CELL, V55, P467, DOI 10.1016/j.molcel.2014.05.031; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Wasmuth EV, 2014, NATURE, V511, P435, DOI 10.1038/nature13406; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	38	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13229	13242		10.1074/jbc.M116.715771	http://dx.doi.org/10.1074/jbc.M116.715771			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27076633	hybrid, Green Published			2022-12-28	WOS:000379770500028
J	Pediani, JD; Ward, RJ; Godin, AG; Marsango, S; Milligan, G				Pediani, John D.; Ward, Richard J.; Godin, Antoine G.; Marsango, Sara; Milligan, Graeme			Dynamic Regulation of Quaternary Organization of the M-1 Muscarinic Receptor by Subtype-selective Antagonist Drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTENSITY DISTRIBUTION ANALYSIS; PROTEIN-COUPLED RECEPTORS; FLUORESCENCE CORRELATION SPECTROSCOPY; HIGHER-ORDER OLIGOMERS; ACETYLCHOLINE-RECEPTOR; LIVE CELLS; INTERFACE; SEROTONIN; DIMERIZATION; ACTIVATION	Although rhodopsin-like G protein-coupled receptors can exist as both monomers and non-covalently associated dimers/oligomers, the steady-state proportion of each form and whether this is regulated by receptor ligands are unknown. Herein we address these topics for the M-1 muscarinic acetylcholine receptor, a key molecular target for novel cognition enhancers, by using spatial intensity distribution analysis. This method can measure fluorescent particle concentration and assess oligomerization states of proteins within defined regions of living cells. Imaging and analysis of the basolateral surface of cells expressing some 50 molecules.mu m(-2) human muscarinic M-1 receptor identified a similar to 75:25 mixture of receptor monomers and dimers/oligomers. Both sustained and shorter term treatment with the selective M-1 antagonist pirenzepine resulted in a large shift in the distribution of receptor species to favor the dimeric/oligomeric state. Although sustained treatment with pirenzepine also resulted in marked up-regulation of the receptor, simple mass action effects were not the basis for ligand-induced stabilization of receptor dimers/oligomers. The related antagonist telenzepine also produced stabilization and enrichment of the M-1 receptor dimer population, but the receptor subtype non-selective antagonists atropine and N-methylscopolamine did not. In contrast, neither pirenzepine nor telenzepine altered the quaternary organization of the related M-3 muscarinic receptor. These data provide unique insights into the selective capacity of receptor ligands to promote and/or stabilize receptor dimers/oligomers and demonstrate that the dynamics of ligand regulation of the quaternary organization of G protein-coupled receptors is markedly more complex than previously appreciated. This may have major implications for receptor function and behavior.	[Pediani, John D.; Ward, Richard J.; Marsango, Sara; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Godin, Antoine G.] Inst Opt, F-33405 Talence, France; [Godin, Antoine G.] CNRS, LP2N, F-33405 Talence, France; [Godin, Antoine G.] Univ Bordeaux, LP2N, UMR 5298, F-33405 Talence, France	University of Glasgow; UDICE-French Research Universities; Universite de Bordeaux; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite de Bordeaux; Universite Paris Saclay	Milligan, G (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk	Pediani, John/F-2708-2019	Pediani, John/0000-0001-6615-537X; Godin, Antoine/0000-0003-2417-2563; Milligan, Graeme/0000-0002-6946-3519	Medical Research Council [MR/L023806/1, G0900050]; MRC [MR/L023806/1, G0900050] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grants MR/L023806/1 and G0900050. The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez-Curto E, 2010, ANAL BIOANAL CHEM, V398, P167, DOI 10.1007/s00216-010-3823-4; Alvarez-Curto E, 2010, J BIOL CHEM, V285, P23316, DOI 10.1074/jbc.M110.122184; Aslanoglou D, 2015, J BIOL CHEM, V290, P14785, DOI 10.1074/jbc.M115.649079; Barbeau A, 2013, METHOD ENZYMOL, V522, P109, DOI 10.1016/B978-0-12-407865-9.00007-8; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Ganguly S, 2011, BIOPHYS J, V100, P361, DOI 10.1016/j.bpj.2010.12.3692; Godin AG, 2015, BIOPHYS J, V109, P710, DOI 10.1016/j.bpj.2015.06.068; Godin AG, 2011, P NATL ACAD SCI USA, V108, P7010, DOI 10.1073/pnas.1018658108; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; HAMMER R, 1980, NATURE, V283, P90, DOI 10.1038/283090a0; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Herrick-Davis K, 2015, MOL PHARMACOL, V87, P660, DOI 10.1124/mol.114.096636; Herrick-Davis K, 2013, MOL PHARMACOL, V84, P630, DOI 10.1124/mol.113.087072; Herrick-Davis K, 2012, J BIOL CHEM, V287, P23604, DOI 10.1074/jbc.M112.350249; Hu JX, 2012, FASEB J, V26, P604, DOI 10.1096/fj.11-191510; Ilien B, 2009, J BIOL CHEM, V284, P19533, DOI 10.1074/jbc.M109.017145; Jastrzebska B, 2015, J BIOL CHEM, V290, P25728, DOI 10.1074/jbc.M115.662684; Johnston JM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002649; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Liste MJV, 2015, MOL PHARMACOL, V87, P936, DOI 10.1124/mol.114.096925; Marsango Sara, 2015, Methods Mol Biol, V1335, P95, DOI 10.1007/978-1-4939-2914-6_7; Marsango S, 2015, J BIOL CHEM, V290, P15146, DOI 10.1074/jbc.M114.630681; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Milligan G, 2013, MOL PHARMACOL, V84, P158, DOI 10.1124/mol.113.084780; Nenasheva TA, 2013, J MOL CELL CARDIOL, V57, P129, DOI 10.1016/j.yjmcc.2013.01.009; Patowary S, 2013, BIOCHEM J, V452, P303, DOI 10.1042/BJ20121902; Redka DS, 2014, J BIOL CHEM, V289, P24347, DOI 10.1074/jbc.M114.559294; von Stetten D, 2012, ACTA CRYSTALLOGR F, V68, P878, DOI 10.1107/S1744309112028667; Ward RJ, 2015, J BIOL CHEM, V290, P12844, DOI 10.1074/jbc.M115.644724; Ward RJ, 2011, METHODS MOL BIOL, V746, P21, DOI 10.1007/978-1-61779-126-0_2; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zakrys L, 2014, BIOCHEM J, V461, P61, DOI 10.1042/BJ20140190	38	33	33	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13132	13146		10.1074/jbc.M115.712562	http://dx.doi.org/10.1074/jbc.M115.712562			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27080256	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000379770500021
J	Bagdonaite, I; Norden, R; Joshi, HJ; King, SL; Vakhrushev, SY; Olofsson, S; Wandall, HH				Bagdonaite, Ieva; Norden, Rickard; Joshi, Hiren J.; King, Sarah L.; Vakhrushev, Sergey Y.; Olofsson, Sigvard; Wandall, Hans H.			Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; INSULIN-DEGRADING ENZYME; CELL-CELL FUSION; N-LINKED GLYCANS; GLYCOPROTEIN B; ENVELOPE PROTEIN; VIRAL REPLICATION; CRYSTAL-STRUCTURE; TERMINAL REGION; MEMBRANE-FUSION	Herpesviruses are among the most complex and widespread viruses, infection and propagation of which depend on envelope proteins. These proteins serve as mediators of cell entry as well as modulators of the immune response and are attractive vaccine targets. Although envelope proteins are known to carry glycans, little is known about the distribution, nature, and functions of these modifications. This is particularly true for O-glycans; thus we have recently developed a "bottom up" mass spectrometry-based technique for mapping O-glycosylation sites on herpes simplex virus type 1. We found wide distribution of O-glycans on herpes simplex virus type 1 glycoproteins and demonstrated that elongated O-glycans were essential for the propagation of the virus. Here, we applied our proteome-wide discovery platform for mapping O-glycosites on representative and clinically significant members of the herpesvirus family: varicella zoster virus, human cytomegalovirus, and Epstein-Barr virus. We identified a large number of O-glycosites distributed on most envelope proteins in all viruses and further demonstrated conserved patterns of O-glycans on distinct homologous proteins. Because glycosylation is highly dependent on the host cell, we tested varicella zoster virus-infected cell lysates and clinically isolated virus and found evidence of consistent O-glycosites. These results present a comprehensive view of herpesvirus O-glycosylation and point to the widespread occurrence of O-glycans in regions of envelope proteins important for virus entry, formation, and recognition by the host immune system. This knowledge enables dissection of specific functional roles of individual glycosites and, moreover, provides a framework for design of glycoprotein vaccines with representative glycosylation.	[Bagdonaite, Ieva; Joshi, Hiren J.; King, Sarah L.; Vakhrushev, Sergey Y.; Wandall, Hans H.] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Norden, Rickard; Olofsson, Sigvard] Univ Gothenburg, Inst Biomed, Dept Infect Dis, S-41345 Gothenburg, Sweden	University of Copenhagen; University of Gothenburg	Wandall, HH (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	hhw@sund.ku.dk	Nordén, Rickard/AAQ-8843-2020; Vakhrushev, Sergey Y/A-7638-2014; Bagdonaite, Ieva/GLT-8773-2022; Joshi, Hiren/B-5739-2016	Vakhrushev, Sergey Y/0000-0002-0418-5765; Bagdonaite, Ieva/0000-0002-9383-8448; Norden, Rickard/0000-0002-3866-7228; Wandall, Hans H./0000-0003-0240-9232; Joshi, Hiren/0000-0002-8192-2829	Danish Research Council [1331-00133B]; University of Copenhagen [2016CDO04210, CDO2016]; Danish National Research Foundation [DNRF107]; Carl Emil Friis og hustru Olga Doris Friis Foundation; Lundbeck Foundation; A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; Kirsten og Freddy Johansen Fonden; Mizutani Foundation; Novo Nordisk Foundation	Danish Research Council(Det Frie Forskningsrad (DFF)); University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond); Carl Emil Friis og hustru Olga Doris Friis Foundation; Lundbeck Foundation(Lundbeckfonden); A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; Kirsten og Freddy Johansen Fonden; Mizutani Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported in part by Danish Research Council Grant 1331-00133B; Program of Excellence 2016 Grant 2016CDO04210 ( Copenhagen as the next leader in precise genetic engineering, Program CDO2016) from the University of Copenhagen; Danish National Research Foundation Grant DNRF107; and by funds from the Carl Emil Friis og hustru Olga Doris Friis Foundation, the Lundbeck Foundation, the A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal, the Kirsten og Freddy Johansen Fonden, the Mizutani Foundation, and the Novo Nordisk Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Abaitua F, 2013, J VIROL, V87, P7921, DOI 10.1128/JVI.01172-13; Altgarde N, 2015, J BIOL CHEM, V290, P21473, DOI 10.1074/jbc.M115.637363; Astuto M, 2014, J CLIN VIROL, V59, P59, DOI 10.1016/j.jcv.2013.11.006; Backovic M, 2009, P NATL ACAD SCI USA, V106, P2880, DOI 10.1073/pnas.0810530106; Bagdonaite I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004784; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Berarducci B, 2010, P NATL ACAD SCI USA, V107, P282, DOI 10.1073/pnas.0912373107; Berarducci B, 2009, J VIROL, V83, P228, DOI 10.1128/JVI.00913-08; Bergstrom T, 1996, SCAND J INFECT DIS, P41; Borza CM, 1998, J VIROL, V72, P7577, DOI 10.1128/JVI.72.9.7577-7582.1998; Borza CM, 2002, NAT MED, V8, P594, DOI 10.1038/nm0602-594; Bradel-Tretheway BG, 2015, J VIROL, V89, P7235, DOI 10.1128/JVI.00773-15; Brautigam J, 2013, GLYCOBIOLOGY, V23, P453, DOI 10.1093/glycob/cws171; Breuza L, 2002, EXP CELL RES, V273, P178, DOI 10.1006/excr.2001.5442; Bronzini M, 2012, J VIROL, V86, P6875, DOI 10.1128/JVI.06310-11; Casarosa P, 2005, J BIOL CHEM, V280, P3275, DOI 10.1074/jbc.M407536200; Cavaletto N, 2015, J VIROL, V89, P11092, DOI 10.1128/JVI.01141-15; CHIBA S, 1972, APPL MICROBIOL, V23, P780, DOI 10.1128/AEM.23.4.780-783.1972; Christensen J, 2013, J VIROL, V87, P13719, DOI 10.1128/JVI.02293-13; Chu FL, 2013, VIRUS RES, V174, P137, DOI 10.1016/j.virusres.2013.03.012; Ciferri C, 2015, P NATL ACAD SCI USA, V112, P1767, DOI 10.1073/pnas.1424818112; Clo E, 2012, J VIROL, V86, P6268, DOI 10.1128/JVI.00392-12; Corrales-Aguilar E, 2014, SEMIN IMMUNOPATHOL, V36, P627, DOI 10.1007/s00281-014-0448-2; Corrales-Aguilar E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004131; Cortese M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050166; D'Arrigo I, 2013, GLYCOCONJUGATE J, V30, P633, DOI 10.1007/s10719-012-9465-3; Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200; Davison AJ, 2002, VET MICROBIOL, V86, P69, DOI 10.1016/S0378-1135(01)00492-8; Davison AJ, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P3; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Engel P, 2011, IMMUNOL CELL BIOL, V89, P753, DOI 10.1038/icb.2011.55; Favoreel HW, 2006, VET MICROBIOL, V113, P257, DOI 10.1016/j.vetmic.2005.11.003; Fielding CA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004058; Fishman JA, 2013, AM J TRANSPLANT, V13, P1, DOI 10.1111/ajt.12002; Fournillier A, 2001, J VIROL, V75, P12088, DOI 10.1128/JVI.75.24.12088-12097.2001; Fowler J, 1995, VIROLOGY, V214, P531; Gabaev I, 2014, J VIROL, V88, P14326, DOI 10.1128/JVI.01691-14; GarciaValcarcel M, 1997, VACCINE, V15, P709, DOI 10.1016/S0264-410X(96)00228-9; Geyer H, 2014, J VIROL, V88, P292, DOI 10.1128/JVI.02330-13; Go EP, 2014, J PROTEOME RES, V13, P4012, DOI 10.1021/pr5003643; Goth CK, 2015, P NATL ACAD SCI USA, V112, P14623, DOI 10.1073/pnas.1511175112; Gramolelli S, 2015, J PATHOL, V235, P368, DOI 10.1002/path.4441; Grinde B, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.22766; Grose C, 2010, CURR TOP MICROBIOL, V342, P113, DOI 10.1007/82_2009_4; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Hakalahti AE, 2010, J BIOL CHEM, V285, P28850, DOI 10.1074/jbc.M110.149989; Halim A, 2014, J PROTEOME RES, V13, P6024, DOI 10.1021/pr500898r; Hannah BP, 2009, J VIROL, V83, P6825, DOI 10.1128/JVI.00301-09; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Helle F, 2010, J VIROL, V84, P11905, DOI 10.1128/JVI.01548-10; Hobman T C, 1993, Trends Microbiol, V1, P124, DOI 10.1016/0966-842X(93)90126-C; Iversen MB, 2016, NAT IMMUNOL, V17, P150, DOI 10.1038/ni.3319; Janz A, 2000, J VIROL, V74, P10142, DOI 10.1128/JVI.74.21.10142-10152.2000; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Kropff B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002999; Krummenacher C, 2013, ADV EXP MED BIOL, V790, P178, DOI 10.1007/978-1-4614-7651-1_10; Lake CM, 2000, J VIROL, V74, P11162, DOI 10.1128/JVI.74.23.11162-11172.2000; Lennemann NJ, 2014, MBIO, V5, DOI 10.1128/mBio.00862-13; Lesniewski M, 2006, VIROLOGY, V354, P286, DOI 10.1016/j.virol.2006.06.035; Leuenberger B, 2003, BIOCHEM J, V369, P659, DOI 10.1042/BJ20021398; Levery SB, 2015, BBA-GEN SUBJECTS, V1850, P33, DOI 10.1016/j.bbagen.2014.09.026; Li G, 2015, P NATL ACAD SCI USA, V112, P4471, DOI 10.1073/pnas.1419875112; Li QX, 2007, J VIROL, V81, P8525, DOI 10.1128/JVI.00286-07; Li QX, 2006, CELL, V127, P305, DOI 10.1016/j.cell.2006.08.046; Liu FL, 2010, J VIROL, V84, P10375, DOI 10.1128/JVI.00381-10; LUNDSTROM M, 1987, VIROLOGY, V161, P395, DOI 10.1016/0042-6822(87)90132-2; Luo SK, 2015, VIROLOGY, V483, P72, DOI 10.1016/j.virol.2015.04.005; Luttichau HR, 2010, J BIOL CHEM, V285, P9137, DOI 10.1074/jbc.M109.002774; Mach M, 2005, J VIROL, V79, P2160, DOI 10.1128/JVI.79.4.2160-2170.2005; Machiels B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002387; MacManiman JD, 2014, MBIO, V5, DOI 10.1128/mBio.02035-14; Madsen CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050139; Magrane J, 1999, FEBS LETT, V451, P56, DOI 10.1016/S0014-5793(99)00494-9; Mallory S, 1997, J VIROL, V71, P8279, DOI 10.1128/JVI.71.11.8279-8288.1997; Maryon EB, 2009, J BIOL CHEM, V284, P28104, DOI 10.1074/jbc.M109.044925; Matsuura H, 2010, P NATL ACAD SCI USA, V107, P22641, DOI 10.1073/pnas.1011806108; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; Mocarski ES, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P204; Moffat J, 2002, J VIROL, V76, P8468, DOI 10.1128/JVI.76.16.8468-8471.2002; Moffat JF, 1998, J VIROL, V72, P965, DOI 10.1128/JVI.72.2.965-974.1998; Muller S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000723; Mullberg J, 1999, J GEN VIROL, V80, P437, DOI 10.1099/0022-1317-80-2-437; Nakamura S, 2016, J VIROL, V90, P1788, DOI 10.1128/JVI.02246-15; Nejatollahi F, 2002, FEMS IMMUNOL MED MIC, V34, P237, DOI 10.1016/S0928-8244(02)00400-5; NEMEROW GR, 1989, CELL, V56, P369, DOI 10.1016/0092-8674(89)90240-7; Norberg P, 2007, J GEN VIROL, V88, P1683, DOI 10.1099/vir.0.82500-0; Norberg P, 2010, INFECT GENET EVOL, V10, P14, DOI 10.1016/j.meegid.2009.09.004; Norden R, 2015, J BIOL CHEM, V290, P5078, DOI 10.1074/jbc.M114.616409; Noriega VM, 2014, VIRUSES-BASEL, V6, P1202, DOI 10.3390/v6031202; Noriega VM, 2012, MOL IMMUNOL, V51, P245, DOI 10.1016/j.molimm.2012.03.024; Oliver SL, 2013, P NATL ACAD SCI USA, V110, P1911, DOI 10.1073/pnas.1216985110; Oliver SL, 2011, J VIROL, V85, P4095, DOI 10.1128/JVI.02596-10; Oliver SL, 2009, J VIROL, V83, P7495, DOI 10.1128/JVI.00400-09; Olofsson S, 1998, SCAND J INFECT DIS, V30, P435, DOI 10.1080/00365549850161386; OLOFSSON S, 1983, J GEN VIROL, V64, P2735, DOI 10.1099/0022-1317-64-12-2735; Olofsson S, 2016, REV MED VIROL, V26, P34, DOI 10.1002/rmv.1859; Pedersen JW, 2011, J BIOL CHEM, V286, P32684, DOI 10.1074/jbc.M111.273722; Reimer JJ, 2009, J VIROL, V83, P734, DOI 10.1128/JVI.01817-08; Remacle AG, 2006, J BIOL CHEM, V281, P16897, DOI 10.1074/jbc.M600295200; Roizman B, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P70; Rowe AM, 2013, PROG RETIN EYE RES, V32, P88, DOI 10.1016/j.preteyeres.2012.08.002; Rowe CL, 2015, MBIO, V6, DOI 10.1128/mBio.02285-14; Sabugo F, 2014, JCR-J CLIN RHEUMATOL, V20, P42, DOI 10.1097/RHU.0000000000000060; Sadaoka T, 2010, J VIROL, V84, P3488, DOI 10.1128/JVI.01838-09; Sathiyamoorthy K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004309; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schuman J, 2000, GLYCOCONJUGATE J, V17, P835, DOI 10.1023/A:1010909011496; Sekulin K, 2007, VIRUS GENES, V35, P577, DOI 10.1007/s11262-007-0158-0; SERAFINICESSI F, 1983, VIROLOGY, V131, P59, DOI 10.1016/0042-6822(83)90533-0; SERAFINICESSI F, 1989, VIROLOGY, V170, P1, DOI 10.1016/0042-6822(89)90345-0; Sharma S, 2013, VIROLOGY, V435, P239, DOI 10.1016/j.virol.2012.09.024; Shiley K, 2010, INFECT DIS CLIN N AM, V24, P373, DOI 10.1016/j.idc.2010.01.003; Sili U, 2014, J CLIN VIROL, V60, P112, DOI 10.1016/j.jcv.2014.03.010; Sorem J, 2009, J VIROL, V83, P6664, DOI 10.1128/JVI.00195-09; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Suenaga T, 2015, J BIOL CHEM, V290, P19833, DOI 10.1074/jbc.M114.635508; Suenaga T, 2010, P NATL ACAD SCI USA, V107, P866, DOI 10.1073/pnas.0913351107; Szakonyi G, 2006, NAT STRUCT MOL BIOL, V13, P996, DOI 10.1038/nsmb1161; Tadagaki K, 2012, BLOOD, V119, P4908, DOI 10.1182/blood-2011-08-372516; THORLEYLAWSON DA, 1982, J VIROL, V43, P730, DOI 10.1128/JVI.43.2.730-736.1982; Tirabassi RS, 2002, J VIROL, V76, P6832, DOI 10.1128/JVI.76.13.6832-6835.2002; Tsao SW, 2015, J PATHOL, V235, P323, DOI 10.1002/path.4448; Vanarsdall AL, 2008, J VIROL, V82, P11837, DOI 10.1128/JVI.01623-08; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Vleck SE, 2011, P NATL ACAD SCI USA, V108, P18412, DOI 10.1073/pnas.1111333108; Vomaske Jennifer, 2009, Infectious Disorders - Drug Targets, V9, P548; Wandall HH, 2012, BLOOD, V120, P626, DOI 10.1182/blood-2012-02-409235; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Wang J, 2009, J VIROL, V83, P13042, DOI 10.1128/JVI.00792-09; Wang WB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-14; Wang X, 1998, J VIROL, V72, P5552, DOI 10.1128/JVI.72.7.5552-5558.1998; Wille PT, 2013, MBIO, V4, DOI 10.1128/mBio.00332-13; Xing Y, 2015, P NATL ACAD SCI USA, V112, P6056, DOI 10.1073/pnas.1501176112; Yang Z, 2015, NAT BIOTECHNOL, V33, P842, DOI 10.1038/nbt.3280; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654; Zerboni L, 2014, NAT REV MICROBIOL, V12, P197, DOI 10.1038/nrmicro3215; Zhou MM, 2015, J VIROL, V89, P8999, DOI 10.1128/JVI.01325-15	139	38	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12014	12028		10.1074/jbc.M116.721746	http://dx.doi.org/10.1074/jbc.M116.721746			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27129252	hybrid, Green Published			2022-12-28	WOS:000378092800006
J	Ma, HX; Lin, Y; Zhao, ZA; Lu, XK; Yu, Y; Zhang, XX; Wang, Q; Li, L				Ma, Haixia; Lin, Yu; Zhao, Zhen-Ao; Lu, Xukun; Yu, Yang; Zhang, Xiaoxin; Wang, Qiang; Li, Lei			MicroRNA-127 Promotes Mesendoderm Differentiation of Mouse Embryonic Stem Cells by Targeting Left-Right Determination Factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE GASTRULATION; PRIMITIVE STREAK; BIOGENESIS; DICER; GENE; PLURIPOTENCY; EXPRESSION; PATTERNS; REVEALS; ROLES	Specification of the three germ layers is a fundamental process and is essential for the establishment of organ rudiments. Multiple genetic and epigenetic factors regulate this dynamic process; however, the function of specific microRNAs in germ layer differentiation remains unknown. In this study, we established that microRNA-127 (miR-127) is related to germ layer specification via microRNA array analysis of isolated three germ layers of E7.5 mouse embryos and was verified through differentiation of mouse embryonic stem cells. miR-127 is highly expressed in endoderm and primitive streak. Overexpression of miR-127 increases and inhibition of miR-127 decreases the expression of mesendoderm markers. We further show that miR-127 promotes mesendoderm differentiation through the nodal pathway, a determinative signaling pathway in early embryogenesis. Using luciferase reporter assay, left-right determination factor 2 (Lefty2), an antagonist of nodal, is identified to be a novel target of miR-127. Furthermore, the role of miR-127 in mesendoderm differentiation is attenuated by Lefty2 overexpression. Altogether, our results indicate that miR-127 accelerates mesendoderm differentiation of mouse embryonic stem cells through nodal signaling by targeting Lefty2.	[Ma, Haixia; Zhao, Zhen-Ao; Lu, Xukun; Yu, Yang; Zhang, Xiaoxin; Li, Lei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Lin, Yu; Wang, Qiang] Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing 100101, Peoples R China; [Ma, Haixia; Li, Lei] Univ Chinese Acad Sci, Inst Zool, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Chinese Academy of Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Wang, Q (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing 100101, Peoples R China.; Li, L (corresponding author), Univ Chinese Acad Sci, Inst Zool, Beijing 100049, Peoples R China.	qiangwang@ioz.ac.cn; lil@ioz.ac.cn	Ma, Haixia/ABC-4707-2021	Ma, Haixia/0000-0001-9080-2004; Wang, Qiang/0000-0002-8735-8771; Li, Lei/0000-0001-5478-5681	National Natural Science Foundation of China [31590832, 31471353]; National Basic Research Program of China [2012CB944401]; Chinese Academy of Sciences [XDA01010103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 31590832 and 31471353, National Basic Research Program of China Grant 2012CB944401, and Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA01010103. The authors declare that they have no conflicts of interest with the contents of this article.	Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Betschinger J, 2013, CELL, V153, P335, DOI 10.1016/j.cell.2013.03.012; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Colas AR, 2012, GENE DEV, V26, P2567, DOI 10.1101/gad.200758.112; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Constam DB, 2000, GENE DEV, V14, P1146; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heisenberg CP, 2008, CURR OPIN GENET DEV, V18, P311, DOI 10.1016/j.gde.2008.07.011; Hoodless PA, 2001, GENE DEV, V15, P1257, DOI 10.1101/gad.881501; Ito M, 2015, DEVELOPMENT, V142, P2425, DOI 10.1242/dev.121996; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kim VN, 2005, MOL CELLS, V19, P1; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu ZT, 2011, J BIOL CHEM, V286, P28520, DOI 10.1074/jbc.M111.236307; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; Meno C, 2001, DEV CELL, V1, P127, DOI 10.1016/S1534-5807(01)00006-5; Mukherjee A, 2007, P NATL ACAD SCI USA, V104, P1348, DOI 10.1073/pnas.0607966104; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sevignani C, 2006, MAMM GENOME, V17, P189, DOI 10.1007/s00335-005-0066-3; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wong SSY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036121; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Ying SY, 2004, GENE, V342, P25, DOI 10.1016/j.gene.2004.07.025; Zhao ZA, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150092	40	16	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12126	12135		10.1074/jbc.M116.723247	http://dx.doi.org/10.1074/jbc.M116.723247			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27072135	hybrid, Green Published			2022-12-28	WOS:000378092800015
J	Tsukamoto, T; Mizutani, K; Hasegawa, T; Takahashi, M; Honda, N; Hashimoto, N; Shimono, K; Yamashita, K; Yamamoto, M; Miyauchi, S; Takagi, S; Hayashi, S; Murata, T; Sudo, Y				Tsukamoto, Takashi; Mizutani, Kenji; Hasegawa, Taisuke; Takahashi, Megumi; Honda, Naoya; Hashimoto, Naoki; Shimono, Kazumi; Yamashita, Keitaro; Yamamoto, Masaki; Miyauchi, Seiji; Takagi, Shin; Hayashi, Shigehiko; Murata, Takeshi; Sudo, Yuki			X-ray Crystallographic Structure of Thermophilic Rhodopsin IMPLICATIONS FOR HIGH THERMAL STABILITY AND OPTOGENETIC FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-PUMPING RHODOPSIN; MOLECULAR-DYNAMICS; BACTERIORHODOPSIN; PROTEORHODOPSIN; XANTHORHODOPSIN; TRIMER	Thermophilic rhodopsin (TR) is a photoreceptor protein with an extremely high thermal stability and the first characterized light-driven electrogenic proton pump derived from the extreme thermophile Thermus thermophilus JL-18. In this study, we confirmed its high thermal stability compared with other microbial rhodopsins and also report the potential availability of TR for optogenetics as a light-induced neural silencer. The x-ray crystal structure of TR revealed that its overall structure is quite similar to that of xanthorhodopsin, including the presence of a putative binding site for a carotenoid antenna; but several distinct structural characteristics of TR, including a decreased surface charge and a larger number of hydrophobic residues and aromatic-aromatic interactions, were also clarified. Based on the crystal structure, the structural changes of TR upon thermal stimulation were investigated by molecular dynamics simulations. The simulations revealed the presence of a thermally induced structural substate in which an increase of hydrophobic interactions in the extracellular domain, the movement of extracellular domains, the formation of a hydrogen bond, and the tilting of transmembrane helices were observed. From the computational and mutational analysis, we propose that an extracellular LPGG motif between helices F and G plays an important role in the thermal stability, acting as a "thermal sensor." These findings will be valuable for understanding retinal proteins with regard to high protein stability and high optogenetic performance.	[Tsukamoto, Takashi; Honda, Naoya; Sudo, Yuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Div Pharmaceut Sci, Okayama 7008530, Japan; [Mizutani, Kenji; Hashimoto, Naoki; Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba 2638522, Japan; [Mizutani, Kenji; Murata, Takeshi] Chiba Univ, Mol Chiral Res Ctr, Chiba 2638522, Japan; [Hasegawa, Taisuke; Hayashi, Shigehiko] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan; [Takahashi, Megumi; Takagi, Shin] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; [Shimono, Kazumi; Miyauchi, Seiji] Toho Univ, Fac Pharmaceut Sci, Funabashi, Chiba 2748510, Japan; [Yamashita, Keitaro; Yamamoto, Masaki] RIKEN SPring 8 Ctr, Mikazuki, Hyogo 6795148, Japan	Okayama University; Chiba University; Chiba University; Kyoto University; Nagoya University; Toho University; RIKEN	Sudo, Y (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Div Pharmaceut Sci, Okayama 7008530, Japan.; Murata, T (corresponding author), Chiba Univ, Grad Sch Sci, Dept Chem, Chiba 2638522, Japan.; Murata, T (corresponding author), Chiba Univ, Mol Chiral Res Ctr, Chiba 2638522, Japan.	t.murata@faculty.chiba-u.jp; sudo@pharm.okayama-u.ac.jp	Hasegawa, Taisuke/I-6102-2012; Yamamoto, Masaki/B-7844-2015; Tsukamoto, Takashi/F-3993-2017; Murata, Takeshi/J-6181-2017; Miyauchi, Seiji/AAA-4036-2021; Sudo, Yuki/AGY-0493-2022	Yamamoto, Masaki/0000-0002-1311-1768; Tsukamoto, Takashi/0000-0002-6348-6664; Murata, Takeshi/0000-0002-5748-4670; Sudo, Yuki/0000-0001-8155-9356; Shimono, Kazumi/0000-0001-9752-5329; Mizutani, Kenji/0000-0002-7337-2134; Yamashita, Keitaro/0000-0002-5442-7582	Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [15K18519, 25104004, 25291034, 15H04363, 15H00878]; Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT; Japan Agency for Medical Research and Development (AMED)	Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Grants 15K18519 ( to T. T.), 25104004 and 25291034 ( to S. H.), and 15H04363 and 15H00878 ( to Y. S.) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT). This work also was supported by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT and the Japan Agency for Medical Research and Development (AMED) ( to T. M.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by Grant-in-for Scientific Research on Innovative Areas 15H00878 (All Nippon Artificial Photosynthesis Project for Living Earth). To whom correspondence may be addressed. E-mail: sudo@pharm.okayamau.ac.jp.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Bergo VB, 2009, J BIOL CHEM, V284, P2836, DOI 10.1074/jbc.M803792200; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bricogne G., 2011, BUSTER VERSION 2 10; Cao PX, 2012, FASEB J, V26, P480, DOI 10.1096/fj.11-197798; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Grote M, 2014, BBA-BIOENERGETICS, V1837, P533, DOI 10.1016/j.bbabio.2013.08.006; Hayashi S, 2002, BIOPHYS J, V83, P1281, DOI 10.1016/S0006-3495(02)73900-3; Hempelmann F, 2011, J AM CHEM SOC, V133, P4645, DOI 10.1021/ja111116a; Hirata K, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/1/012002; Hohenfeld IP, 1999, FEBS LETT, V442, P198, DOI 10.1016/S0014-5793(98)01659-7; Imasheva ES, 2009, BIOCHEMISTRY-US, V48, P10948, DOI 10.1021/bi901552x; Inoue K, 2014, BBA-BIOENERGETICS, V1837, P562, DOI 10.1016/j.bbabio.2013.05.005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Martinez A, 2007, P NATL ACAD SCI USA, V104, P5590, DOI 10.1073/pnas.0611470104; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murugapiran SK, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00106-12; Okazaki A, 2014, METHODS, V68, P425, DOI 10.1016/j.ymeth.2014.02.030; Okazaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035370; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sudo Y, 2003, PHOTOCHEM PHOTOBIOL, V78, P511, DOI 10.1562/0031-8655(2003)078<0511:IONPPS>2.0.CO;2; Sudo Y, 2013, J BIOL CHEM, V288, P20624, DOI 10.1074/jbc.M113.475533; Tian B, 2010, TRENDS MICROBIOL, V18, P512, DOI 10.1016/j.tim.2010.07.007; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tsukamoto T, 2014, J PHYS CHEM B, V118, P12383, DOI 10.1021/jp507374q; Tsukamoto T, 2013, J BIOL CHEM, V288, P21581, DOI 10.1074/jbc.M113.479394; Tsukamoto T, 2013, FEBS LETT, V587, P322, DOI 10.1016/j.febslet.2012.12.022; Wada T, 2011, J MOL BIOL, V411, P986, DOI 10.1016/j.jmb.2011.06.028; Yoshizawa S, 2012, ENVIRON MICROBIOL, V14, P1240, DOI 10.1111/j.1462-2920.2012.02702.x; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F	42	31	31	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12223	12232		10.1074/jbc.M116.719815	http://dx.doi.org/10.1074/jbc.M116.719815			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27129243	Green Published, hybrid			2022-12-28	WOS:000378092800023
J	Vieweg, S; Ansaloni, A; Wang, ZM; Warner, JB; Lashuel, HA				Vieweg, Sophie; Ansaloni, Annalisa; Wang, Zhe-Ming; Warner, John B.; Lashuel, Hilal A.			An Intein-based Strategy for the Production of Tag-free Huntingtin Exon 1 Proteins Enables New Insights into the Polyglutamine Dependence of Httex1 Aggregation and Fibril Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-LIKE FIBRILS; IN-VITRO; GLUTAMINE REPEATS; FUSION PROTEINS; DISEASE; LENGTH; NUCLEAR; CYTOTOXICITY; OLIGOMERS; MECHANISM	The first exon of the Huntingtin protein (Httex1) is one of the most actively studied Htt fragments because its overexpression in R6/2 transgenic mice has been shown to recapitulate several key features of Huntington disease. However, the majority of biophysical studies of Httex1 are based on assessing the structure and aggregation of fusion constructs where Httex1 is fused to large proteins, such as glutathione S-transferase, maltosebinding protein, or thioredoxin, or released in solution upon in situ cleavage of these proteins. Herein, we report an inteinbased strategy that allows, for the first time, the rapid and efficient production of native tag-free Httex1 with polyQ repeats ranging from 7Q to 49Q. Aggregation studies on these proteins enabled us to identify interesting polyQ-length-dependent effects on Httex1 oligomer and fibril formation that were previously not observed using Httex1 fusion proteins or Httex1 proteins produced by in situ cleavage of fusion proteins. Our studies revealed the inability of Httex1-7Q/15Q to undergo amyloid fibril formation and an inverse correlation between fibril length and polyQ repeat length, suggesting possible polyQ length-dependent differences in the structural properties of the Httex1 aggregates. Altogether, our findings underscore the importance of working with tag-free Httex1 proteins and indicate that model systems based on non-native Httex1 sequences may not accurately reproduce the effect of polyQ repeat length and solution conditions on Httex1 aggregation kinetics and structural properties.	[Vieweg, Sophie; Ansaloni, Annalisa; Wang, Zhe-Ming; Warner, John B.; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol & Chem Biol Neurodegenerat, CH-1015 Lausanne, Switzerland; [Lashuel, Hilal A.] HBKU, QBRI, Doha 5825, Qatar	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol & Chem Biol Neurodegenerat, CH-1015 Lausanne, Switzerland.; Lashuel, HA (corresponding author), HBKU, QBRI, Doha 5825, Qatar.	hilal.lashuel@epfl.ch	Lashuel, Hilal/M-3500-2017		CHDI foundation [A_7627]; Swiss National Science Foundation [31003A-146680]	CHDI foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported primarily by grants from the CHDI foundation (A_7627) and the Swiss National Science Foundation (31003A-146680). The authors declare that they have no conflicts of interest with the contents of this article.	Ansaloni A, 2014, ANGEW CHEM INT EDIT, V53, P1928, DOI 10.1002/anie.201307510; Arnesen T, 2010, MOL CELL BIOL, V30, P1898, DOI 10.1128/MCB.01199-09; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Bounab Y., 2010, THESIS; Bugg CW, 2012, J BIOL CHEM, V287, P31739, DOI 10.1074/jbc.M112.353839; Bulone D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000111; Busch A, 2003, J BIOL CHEM, V278, P41452, DOI 10.1074/jbc.M303354200; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Chen SM, 2001, PROTEIN SCI, V10, P887, DOI 10.1110/ps.42301; Crick SL, 2013, P NATL ACAD SCI USA, V110, P20075, DOI 10.1073/pnas.1320626110; Dahlgren PR, 2005, NANOMED-NANOTECHNOL, V1, P52, DOI 10.1016/j.nano.2004.11.004; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Dehay B, 2006, J BIOL CHEM, V281, P35608, DOI 10.1074/jbc.M605558200; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duim WC, 2011, CHEMPHYSCHEM, V12, P2386, DOI 10.1002/cphc.201100392; Fodale V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112262; Georgalis Y, 1998, P NATL ACAD SCI USA, V95, P6118, DOI 10.1073/pnas.95.11.6118; Halliday GM, 1998, EXP NEUROL, V154, P663, DOI 10.1006/exnr.1998.6919; Heiser V, 2000, P NATL ACAD SCI USA, V97, P6739, DOI 10.1073/pnas.110138997; Hollenbach B, 1999, PHILOS T ROY SOC B, V354, P991, DOI 10.1098/rstb.1999.0450; Huntington G, 2003, J NEUROPSYCH CLIN N, V15, P109, DOI 10.1176/appi.neuropsych.15.1.109; Isas JM, 2015, BIOCHEMISTRY-US, V54, P3942, DOI 10.1021/acs.biochem.5b00281; Kar K, 2011, NAT STRUCT MOL BIOL, V18, P328, DOI 10.1038/nsmb.1992; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Landrum E, 2014, J BIOL CHEM, V289, P10254, DOI 10.1074/jbc.C114.552943; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MacDonald ME, 2003, NEUROMOL MED, V4, P7, DOI 10.1385/NMM:4:1-2:7; Masino L, 2002, FEBS LETT, V513, P267, DOI 10.1016/S0014-5793(02)02335-9; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Mishra R, 2012, J MOL BIOL, V424, P1, DOI 10.1016/j.jmb.2012.09.011; Monsellier E, 2015, J BIOL CHEM, V290, P2560, DOI 10.1074/jbc.M114.603332; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Nucifora LG, 2012, J BIOL CHEM, V287, P16017, DOI 10.1074/jbc.M111.252577; O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Sahoo B, 2014, BIOCHEMISTRY-US, V53, P3897, DOI 10.1021/bi500300c; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Singer D, 2010, J PEPT SCI, V16, P358, DOI 10.1002/psc.1252; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tartari M, 2008, MOL BIOL EVOL, V25, P330, DOI 10.1093/molbev/msm258; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Walters RH, 2009, J MOL BIOL, V393, P978, DOI 10.1016/j.jmb.2009.08.034	60	20	20	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12074	12086		10.1074/jbc.M116.713982	http://dx.doi.org/10.1074/jbc.M116.713982			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27002149	Green Published, hybrid			2022-12-28	WOS:000378092800011
J	Sun, T; Fu, JJ; Shen, T; Lin, X; Liao, L; Feng, XH; Xu, JM				Sun, Tong; Fu, Junjiang; Shen, Tao; Lin, Xia; Liao, Lan; Feng, Xin-Hua; Xu, Jianming			The Small C-terminal Domain Phosphatase 1 Inhibits Cancer Cell Migration and Invasion by Dephosphorylating Ser(P)(68)-Twist1 to Accelerate Twist1 Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; TUMOR-METASTASIS; PROMOTES INVASION; POOR SURVIVAL; EXPRESSION; PHOSPHORYLATION; FAMILY; CARCINOMA; APOPTOSIS; COMPLEX	Twist1 is a basic helix-loop-helix transcription factor that strongly promotes epithelial-to-mesenchymal transition, migration, invasion, and metastasis of cancer cells. The MAPK-phosphorylated Twist1 on its serine 68 (Ser(P)(68)-Twist1) has a significantly enhanced stability and function to drive cancer cell invasion and metastasis. However, the phosphatase that dephosphorylates Ser(P)(68)-Twist1 and destabilizes Twist1 has not been identified and characterized. In this study, we screened a serine/threonine phosphatase cDNA expression library in HEK293T cells with ectopically coexpressed Twist1. We found that the small C-terminal domain phosphatase 1 (SCP1) specifically dephosphorylates Ser(P)(68)-Twist1 in both cell-free reactions and living cells. SCP1 uses its amino acid residues 43-63 to interact with the N terminus of Twist1. Increased SCP1 expression in cells decreased Ser(P)(68)-Twist1 and total Twist1 proteins, whereas knockdown of SCP1 increased Ser(P)(68)-Twist1 and total Twist1 proteins. Furthermore, the levels of SCP1 are negatively correlated with Twist1 protein levels in several cancer cell lines. SCP1-dephosphorylated Twist1 undergoes fast degradation via the ubiquitin-proteasome pathway. Importantly, an increase in SCP1 expression in breast cancer cells with either endogenous or ectopically expressed Twist1 largely inhibits the Twist1-induced epithelial-to-mesenchymal transition phenotype and the migration and invasion capabilities of these cells. These results indicate that SCP1 is the phosphatase that counterregulates the MAPK-mediated phosphorylation of Ser(68)-Twist1. Thus, an increase in SCP1 expression and activity may be a useful strategy for eliminating the detrimental roles of Twist1 in cancer cells.	[Sun, Tong; Fu, Junjiang; Shen, Tao; Liao, Lan; Feng, Xin-Hua; Xu, Jianming] Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA; [Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Michael E DeBakey Dept Surg, 1 Baylor Plaza, Houston, TX 77030 USA; [Fu, Junjiang; Xu, Jianming] Southwest Med Univ, Res Ctr Preclin Med, Inst Canc Med, Luzhou 646000, Sichuan, Peoples R China; [Fu, Junjiang; Xu, Jianming] Southwest Med Univ, Coll Basic Med Sci, Luzhou 646000, Sichuan, Peoples R China; [Feng, Xin-Hua] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Feng, Xin-Hua] Zhejiang Univ, Innovat Ctr Cell Signaling Networks, Hangzhou 310058, Zhejiang, Peoples R China; [Sun, Tong] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing 210029, Jiangsu, Peoples R China	Baylor College of Medicine; Baylor College of Medicine; Southwest Medical University; Southwest Medical University; Zhejiang University; Zhejiang University; Nanjing Medical University	Xu, JM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	jxu@bcm.edu	Sun, Tong/E-8493-2017		National Institutes of Health [CA112403, CA193455, DK073932, AR053591]; Cancer Prevention and Research Institute of Texas [RP120732-P5, RP150197]; Department of Defense Breast Cancer Research Program [1W81XWH-15-1-0650]; NATIONAL CANCER INSTITUTE [R01CA112403, R01CA193455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants CA112403 and CA193455 (to J. X.), DK073932 (to X. L.), and AR053591 (to X. H. F.); Cancer Prevention and Research Institute of Texas Grants RP120732-P5 and RP150197 (to J. X.), and Department of Defense Breast Cancer Research Program Grant 1W81XWH-15-1-0650 (to X. H. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3054; Chandrasekaran S, 2014, INT J MOL SCI, V15, P20209, DOI 10.3390/ijms151120209; Chen HF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5697; Cheng GZ, 2008, CANCER RES, V68, P957, DOI 10.1158/0008-5472.CAN-07-5067; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; Fu JJ, 2012, INT J BIOL SCI, V8, P522, DOI 10.7150/ijbs.4164; Fu JJ, 2011, CELL RES, V21, P275, DOI 10.1038/cr.2010.118; Hong J, 2011, CANCER RES, V71, P3980, DOI 10.1158/0008-5472.CAN-10-2914; Hosono S, 2007, BRIT J CANCER, V96, P314, DOI 10.1038/sj.bjc.6603533; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kim YJ, 2014, BIOCHEM BIOPH RES CO, V448, P189, DOI 10.1016/j.bbrc.2014.04.089; Lander R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2543; Li S, 2014, INT J ONCOL, V44, P1806, DOI 10.3892/ijo.2014.2362; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Ma G, 2015, INT J BIOL SCI, V11, P618, DOI 10.7150/ijbs.11380; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Mikheeva SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-194; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Sacco F, 2012, FEBS LETT, V586, P2732, DOI 10.1016/j.febslet.2012.05.008; Sapkota G, 2006, J BIOL CHEM, V281, P40412, DOI 10.1074/jbc.M610172200; Scherbakov AM, 2012, J CELL BIOCHEM, V113, P2147, DOI 10.1002/jcb.24087; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Shibata K, 2008, ANN ONCOL, V19, P81, DOI 10.1093/annonc/mdm344; Su YW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019412; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Vichalkovski A, 2010, ONCOGENE, V29, P3554, DOI 10.1038/onc.2010.115; Wang Yifan, 2013, Cancer Hallm, V1, P38; Weinberg RA, 2007, BIOL CANC; Weiss MB, 2012, CANCER RES, V72, P6382, DOI 10.1158/0008-5472.CAN-12-1033; Wrighton KH, 2006, J BIOL CHEM, V281, P38365, DOI 10.1074/jbc.M607246200; Wu YD, 2009, J BIOL CHEM, V284, P640, DOI 10.1074/jbc.M806916200; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Yeo M, 2005, SCIENCE, V307, P596, DOI 10.1126/science.1100801; Zhang Y, 2006, MOL CELL, V24, P759, DOI 10.1016/j.molcel.2006.10.027; Zhong JT, 2013, DISCOV MED, V15, P7	41	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11518	11528		10.1074/jbc.M116.721795	http://dx.doi.org/10.1074/jbc.M116.721795			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	26975371	Green Published, hybrid			2022-12-28	WOS:000377264800005
J	Dickey, DM; Edmund, AB; Otto, NM; Chaffee, TS; Robinson, JW; Potter, LR				Dickey, Deborah M.; Edmund, Aaron B.; Otto, Neil M.; Chaffee, Thomas S.; Robinson, Jerid W.; Potter, Lincoln R.			Catalytically Active Guanylyl Cyclase B Requires Endoplasmic Reticulum-mediated Glycosylation, and Mutations That Inhibit This Process Cause Dwarfism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cGMP; glycosylation; glycosylation inhibitor; guanylate cyclase (guanylyl cyclase); N-linked glycosylation; natriuretic peptide	NATRIURETIC-PEPTIDE RECEPTOR; KINASE HOMOLOGY DOMAIN; NPR-B/GC-B; SHORT STATURE; ACROMESOMELIC DYSPLASIA; HETEROZYGOUS MUTATIONS; PHOSPHORYLATION SITES; DEPENDENT INHIBITION; GENE; MAROTEAUX	C-type natriuretic peptide activation of guanylyl cyclase B (GC-B), also known as natriuretic peptide receptor B or NPR2, stimulates long bone growth, and missense mutations in GC-B cause dwarfism. Four such mutants (L658F, Y708C, R776W, and G959A) bound I-125-C-type natriuretic peptide on the surface of cells but failed to synthesize cGMP in membrane GC assays. Immunofluorescence microscopy also indicated that the mutant receptors were on the cell surface. All mutant proteins were dephosphorylated and incompletely glycosylated, but dephosphorylation did not explain the inactivation because the mutations inactivated a constitutively phosphorylated enzyme. Tunicamycin inhibition of glycosylation in the endoplasmic reticulum or mutation of the Asn-24 glycosylation site decreased GC activity, but neither inhibition of glycosylation in the Golgi by N-acetylglucosaminyltransferase I gene inactivation nor PNGase F deglycosylation of fully processed GC-B reduced GC activity. We conclude that endoplasmic reticulum-mediated glycosylation is required for the formation of an active catalytic, but not ligand-binding domain, and that mutations that inhibit this process cause dwarfism.	[Dickey, Deborah M.; Edmund, Aaron B.; Otto, Neil M.; Chaffee, Thomas S.; Robinson, Jerid W.; Potter, Lincoln R.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Potter, Lincoln R.] Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Potter, LR (corresponding author), Univ Minnesota, 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	potter@umn.edu		Edmund, Aaron/0000-0001-5042-6518	National Institutes of Health [R01GM098309, T32AR050938]; Fund for Science; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fund for Science; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM098309 (to L. R. P.) and T32AR050938 (to A. B. E.) and the Fund for Science. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbey SE, 2002, J BIOL CHEM, V277, P42423, DOI 10.1074/jbc.M206686200; Abbey-Hosch SE, 2005, BIOCHEM PHARMACOL, V70, P686, DOI 10.1016/j.bcp.2005.04.034; Amano N, 2014, J CLIN ENDOCR METAB, V99, pE713, DOI 10.1210/jc.2013-3525; Bartels CF, 2004, AM J HUM GENET, V75, P27, DOI 10.1086/422013; Bryan PM, 2006, BIOCHEMISTRY-US, V45, P1295, DOI 10.1021/bi051253d; Fan DH, 2005, MOL PHARMACOL, V67, P174, DOI 10.1124/mol.104.002436; Fenrick R, 1997, MOL CELL BIOCHEM, V173, P25, DOI 10.1023/A:1006855522272; Flora DR, 2010, ENDOCRINOLOGY, V151, P2769, DOI 10.1210/en.2009-1239; Hachiya R, 2007, J CLIN ENDOCR METAB, V92, P4009, DOI 10.1210/jc.2007-1101; Hannema SE, 2013, J CLIN ENDOCR METAB, V98, pE1988, DOI 10.1210/jc.2013-2358; Hisado-Oliva A, 2015, J CLIN ENDOCR METAB, V100, pE1133, DOI 10.1210/jc.2015-1612; Hume AN, 2009, HUM MOL GENET, V18, P267, DOI 10.1093/hmg/ddn354; Khan S, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-44; KOLLER KJ, 1993, J BIOL CHEM, V268, P5997; LOWE DG, 1992, J BIOL CHEM, V267, P21691; Miura K, 2014, AM J MED GENET A, V164, P156, DOI 10.1002/ajmg.a.36218; Miura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042180; Miyagi M, 2000, EUR J BIOCHEM, V267, P5758, DOI 10.1046/j.1432-1327.2000.01647.x; Olney RC, 2006, J CLIN ENDOCR METAB, V91, P1229, DOI 10.1210/jc.2005-1949; PATTERSON SI, 1994, J CELL BIOL, V124, P521, DOI 10.1083/jcb.124.4.521; Potter LR, 2011, CELL SIGNAL, V23, P1921, DOI 10.1016/j.cellsig.2011.09.001; Potter LR, 2011, FEBS J, V278, P1808, DOI 10.1111/j.1742-4658.2011.08082.x; Potter LR, 2011, PHARMACOL THERAPEUT, V130, P71, DOI 10.1016/j.pharmthera.2010.12.005; Potter LR, 1998, J BIOL CHEM, V273, P15533, DOI 10.1074/jbc.273.25.15533; Potter LR, 1998, BIOCHEMISTRY-US, V37, P2422, DOI 10.1021/bi972303k; Potter LR, 2001, J BIOL CHEM, V276, P6057, DOI 10.1074/jbc.R000033200; Potter LR, 1998, MOL CELL BIOL, V18, P2164, DOI 10.1128/MCB.18.4.2164; Potthast R, 2004, J BIOL CHEM, V279, P48513, DOI 10.1074/jbc.M408247200; Prescher JA, 2006, CELL, V126, P851, DOI 10.1016/j.cell.2006.08.017; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Robinson JW, 2013, BONE, V56, P375, DOI 10.1016/j.bone.2013.06.024; Robinson JW, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003253; Robinson JW, 2011, J BIOL CHEM, V286, P33841, DOI 10.1074/jbc.M111.273565; Schmidt H, 2007, J CELL BIOL, V179, P331, DOI 10.1083/jcb.200707176; Shuhaibar LC, 2016, DEV BIOL, V409, P194, DOI 10.1016/j.ydbio.2015.10.025; Tamura N, 2004, P NATL ACAD SCI USA, V101, P17300, DOI 10.1073/pnas.0407894101; Tannous A, 2015, SEMIN CELL DEV BIOL, V41, P79, DOI 10.1016/j.semcdb.2014.12.001; Vasques GA, 2013, J CLIN ENDOCR METAB, V98, pE1636, DOI 10.1210/jc.2013-2142; Wang SR, 2015, HUM MUTAT, V36, P474, DOI 10.1002/humu.22773; Wang W, 2016, AM J MED GENET A, V170, P426, DOI 10.1002/ajmg.a.37463; Yoder AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036747; Yoder AR, 2010, BIOCHEMISTRY-US, V49, P10137, DOI 10.1021/bi101700e; Zhang MJ, 2010, SCIENCE, V330, P366, DOI 10.1126/science.1193573	43	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11385	11393		10.1074/jbc.M115.704015	http://dx.doi.org/10.1074/jbc.M115.704015			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	26980729	Green Published, hybrid			2022-12-28	WOS:000377042100036
J	Li, Q; Huang, Y; Liu, XC; Gan, JH; Chen, H; Yang, CG				Li, Qi; Huang, Yue; Liu, Xichun; Gan, Jianhua; Chen, Hao; Yang, Cai-Guang			Rhein Inhibits AlkB Repair Enzymes and Sensitizes Cells to Methylated DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; cancer therapy; chemical biology; DNA repair; DNA-protein interaction; enzyme inhibitor; enzyme structure	ESCHERICHIA-COLI; OXIDATIVE DEMETHYLATION; ALKYLATION DAMAGE; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; PROSTATE-CANCER; STRANDED-DNA; IN-VIVO; PROTEIN; RNA	The AlkB repair enzymes, including Escherichia coli AlkB and two human homologues, ALKBH2 and ALKBH3, are iron(II)- and 2-oxoglutarate-dependent dioxygenases that efficiently repair N-1-methyladenine and N-3-methylcytosine methylated DNA damages. The development of small molecule inhibitors of these enzymes has seen less success. Here we have characterized a previously discovered natural product rhein and tested its ability to inhibit AlkB repair enzymes in vitro and to sensitize cells to methyl methane sulfonate that mainly produces N-1-methyladenine and N-3-methylcytosine lesions. Our investigation of the mechanism of rhein inhibition reveals that rhein binds to AlkB repair enzymes in vitro and promotes thermal stability in vivo. In addition, we have determined a new structural complex of rhein bound to AlkB, which shows that rhein binds to a different part of the active site in AlkB than it binds to in fat mass and obesity-associated protein (FTO). With the support of these observations, we put forth the hypothesis that AlkB repair enzymes would be effective pharmacological targets for cancer treatment.	[Li, Qi; Huang, Yue; Yang, Cai-Guang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Biol Chem Lab, Shanghai 201203, Peoples R China; [Liu, Xichun; Chen, Hao] Nanjing Univ, Inst Coordinat Chem, Nanjing 210093, Jiangsu, Peoples R China; [Liu, Xichun; Chen, Hao] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210093, Jiangsu, Peoples R China; [Gan, Jianhua] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Nanjing University; Nanjing University; Fudan University	Yang, CG (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Biol Chem Lab, Shanghai 201203, Peoples R China.	yangcg@simm.ac.cn			National Natural Science Foundation of China [21372237, 91313303]; National Basic Research Program [2015CB910603]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" Grant [2014ZX09507009-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" Grant	This work was supported by National Natural Science Foundation of China Grants 21372237 and 91313303, National Basic Research Program Grant 2015CB910603, and National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" Grant 2014ZX09507009-01. The authors declare that they have no conflicts of interest with the contents of this article.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Aik W, 2013, J MED CHEM, V56, P3680, DOI 10.1021/jm400193d; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bleijlevens B, 2008, EMBO REP, V9, P872, DOI 10.1038/embor.2008.120; Bunnage ME, 2013, NAT CHEM BIOL, V9, P195, DOI 10.1038/nchembio.1197; Cetica V, 2009, J NEURO-ONCOL, V94, P195, DOI 10.1007/s11060-009-9837-0; Chen BE, 2014, SCI CHINA CHEM, V57, P307, DOI 10.1007/s11426-013-5029-z; Chen BE, 2012, J AM CHEM SOC, V134, P17963, DOI 10.1021/ja3064149; Chen BE, 2010, MOL BIOSYST, V6, P2143, DOI 10.1039/c005148a; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; DAY RS, 1987, J CELL SCI, P333; Dietlein F, 2014, TRENDS GENET, V30, P326, DOI 10.1016/j.tig.2014.06.003; Dinglay S, 2000, GENE DEV, V14, P2097; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Hopkinson RJ, 2013, CHEM SCI, V4, P3110, DOI [10.1039/c3sc51122g, 10.1039/C3SC51122G]; Huang Y, 2015, NUCLEIC ACIDS RES, V43, P373, DOI 10.1093/nar/gku1276; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Johannessen TCA, 2013, NEURO-ONCOLOGY, V15, P269, DOI 10.1093/neuonc/nos301; Konishi N, 2005, CLIN CANCER RES, V11, P5090, DOI 10.1158/1078-0432.CCR-05-0195; Labahn J, 1996, CELL, V86, P321, DOI 10.1016/S0092-8674(00)80103-8; Li DY, 2013, CHEM RES TOXICOL, V26, P1182, DOI 10.1021/tx400096m; Li PS, 2013, CELL REP, V4, P817, DOI 10.1016/j.celrep.2013.07.027; Liefke R, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0180-0; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; Mielecki D, 2016, DNA REPAIR, V39, P34, DOI 10.1016/j.dnarep.2015.12.010; Mishina Y, 2006, CHEM REV, V106, P215, DOI 10.1021/cr0404702; Mitra S, 2007, DNA REPAIR, V6, P1064, DOI 10.1016/j.dnarep.2007.03.007; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakao S, 2014, BIOORG MED CHEM LETT, V24, P1071, DOI 10.1016/j.bmcl.2014.01.008; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; O'Brien PJ, 2004, J BIOL CHEM, V279, P26876, DOI 10.1074/jbc.M403860200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Shah D, 2003, BIOCHEMISTRY-US, V42, P12610, DOI 10.1021/bi035315g; Shimada K, 2008, CANCER SCI, V99, P39, DOI 10.1111/j.1349-7006.2007.00655.x; Sikora A, 2010, MUTAGENESIS, V25, P139, DOI 10.1093/mutage/gep052; Srinivasan A, 2012, FUTURE MED CHEM, V4, P1093, DOI [10.4155/FMC.12.58, 10.4155/fmc.12.58]; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Vagbo CB, 2013, DNA REPAIR, V12, P188, DOI 10.1016/j.dnarep.2012.11.010; van den Born E, 2009, NUCLEIC ACIDS RES, V37, P7124, DOI 10.1093/nar/gkp774; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Verdemato PE, 2000, NUCLEIC ACIDS RES, V28, P3710, DOI 10.1093/nar/28.19.3710; Wang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3035; Wang P, 2015, CELL REP, V13, P2353, DOI 10.1016/j.celrep.2015.11.029; Wang TL, 2015, J AM CHEM SOC, V137, P13736, DOI 10.1021/jacs.5b06690; Welford RWD, 2003, J BIOL CHEM, V278, P10157, DOI 10.1074/jbc.M211058200; Woon ECY, 2012, J MED CHEM, V55, P2173, DOI 10.1021/jm201417e; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yi CQ, 2012, NAT STRUCT MOL BIOL, V19, P671, DOI 10.1038/nsmb.2320; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; ZHANG Y, 1993, BIOCHEMISTRY-US, V32, P7954, DOI 10.1021/bi00082a017; Zhao Y, 2015, EMBO J, V34, P1687, DOI 10.15252/embj.201490497; Zhou YX, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/578107; Zhu CX, 2014, ANGEW CHEM INT EDIT, V53, P3659, DOI 10.1002/anie.201310050	62	52	55	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11083	11093		10.1074/jbc.M115.711895	http://dx.doi.org/10.1074/jbc.M115.711895			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27015802	Green Published, hybrid			2022-12-28	WOS:000377042100012
J	Rhoden, JJ; Dyas, GL; Wroblewski, VJ				Rhoden, John J.; Dyas, Gregory L.; Wroblewski, Victor J.			A Modeling and Experimental Investigation of the Effects of Antigen Density, Binding Affinity, and Antigen Expression Ratio on Bispecific Antibody Binding to Cell Surface Targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; antibody engineering; cooperativity; kinetics; mathematical modeling; multifunctional protein; avidity; bispecific antibody	FRAGMENTS; DOMAINS; DESIGN; CANCER; SPECIFICITY; SCATTERING; RECEPTOR; THERAPY; DISPLAY; GROWTH	Despite the increasing number of multivalent antibodies, bispecific antibodies, fusion proteins, and targeted nanoparticles that have been generated and studied, the mechanism of multivalent binding to cell surface targets is not well understood. Here, we describe a conceptual and mathematical model of multivalent antibody binding to cell surface antigens. Our model predicts that properties beyond 1:1 antibody:antigen affinity to target antigens have a strong influence on multivalent binding. Predicted crucial properties include the structure and flexibility of the antibody construct, the target antigen(s) and binding epitope(s), and the density of antigens on the cell surface. For bispecific antibodies, the ratio of the expression levels of the two target antigens is predicted to be critical to target binding, particularly for the lower expressed of the antigens. Using bispecific antibodies of different valencies to cell surface antigens including MET and EGF receptor, we have experimentally validated our modeling approach and its predictions and observed several nonintuitive effects of avidity related to antigen density, target ratio, and antibody affinity. In some biological circumstances, the effect we have predicted and measured varied from the monovalent binding interaction by several orders of magnitude. Moreover, our mathematical framework affords us a mechanistic interpretation of our observations and suggests strategies to achieve the desired antibody-antigen binding goals. These mechanistic insights have implications in antibody engineering and structure/activity relationship determination in a variety of biological contexts.	[Rhoden, John J.; Dyas, Gregory L.; Wroblewski, Victor J.] Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA	Eli Lilly	Rhoden, JJ (corresponding author), Eli Lilly & Co, Lilly Res Labs, Lilly Corp Ctr, S Delaware St, Indianapolis, IN 46285 USA.	rhoden_john_j@lilly.com						Angelini A, 2015, METHODS MOL BIOL, V1319, P3, DOI 10.1007/978-1-4939-2748-7_1; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Casadevall A, 2012, P NATL ACAD SCI USA, V109, P12272, DOI 10.1073/pnas.1209750109; Castoldi R, 2012, PROTEIN ENG DES SEL, V25, P551, DOI 10.1093/protein/gzs048; Chames P, 2009, MABS-AUSTIN, V1, P539, DOI 10.4161/mabs.1.6.10015; Chen C, 2014, MOL CANCER THER, V13, P90, DOI 10.1158/1535-7163.MCT-13-0558; Coloma MJ, 1997, NAT BIOTECHNOL, V15, P159, DOI 10.1038/nbt0297-159; Diaz-Rohrer B, 2014, BBA-BIOMEMBRANES, V1838, P3003, DOI 10.1016/j.bbamem.2014.07.029; Garber K, 2014, NAT REV DRUG DISCOV, V13, P799, DOI 10.1038/nrd4478; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Harms BD, 2014, METHODS, V65, P95, DOI 10.1016/j.ymeth.2013.07.017; Nguyen HH, 2015, SENSORS-BASEL, V15, P10481, DOI 10.3390/s150510481; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hosokawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067466; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; Kang JC, 2014, MABS-AUSTIN, V6, P340, DOI 10.4161/mabs.27658; KAUFMAN EN, 1992, CANCER RES, V52, P4157; Kearns JD, 2015, MOL CANCER THER, V14, P1625, DOI 10.1158/1535-7163.MCT-14-0772; Kontermann RE, 2012, ARCH BIOCHEM BIOPHYS, V526, P194, DOI 10.1016/j.abb.2012.03.001; Kontermann RE, 2011, BISPECIFIC ANTIBODIES, P1, DOI 10.1007/978-3-642-20910-9_1; Lewis SM, 2014, NAT BIOTECHNOL, V32, P191, DOI 10.1038/nbt.2797; Mazor Y, 2015, MABS-AUSTIN, V7, P377, DOI 10.1080/19420862.2015.1007816; MURPHY RM, 1988, BIOPHYS J, V54, P45, DOI 10.1016/S0006-3495(88)82929-1; Nelson AL, 2010, MABS-AUSTIN, V2, P77, DOI 10.4161/mabs.2.1.10786; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Nielsen UB, 2000, CANCER RES, V60, P6434; Olafsen T, 2010, SEMIN NUCL MED, V40, P167, DOI 10.1053/j.semnuclmed.2009.12.005; Omidfar K, 2015, EXPERT OPIN DRUG DIS, V10, P651, DOI 10.1517/17460441.2015.1037738; Reichert JM, 2015, MABS-AUSTIN, V7, P1, DOI 10.4161/19420862.2015.988944; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Shen Y, 2015, MABS-AUSTIN, V7, P931, DOI 10.1080/19420862.2015.1055442; SOSNICK TR, 1992, BIOCHEMISTRY-US, V31, P1779, DOI 10.1021/bi00121a028; Spangler JB, 2012, J MOL BIOL, V422, P532, DOI 10.1016/j.jmb.2012.06.014; Zhang K, 2015, MABS-AUSTIN, V7, P42, DOI 10.4161/19420862.2014.985933; Zhou Y, 2012, MOL CANCER THER, V11, P1467, DOI 10.1158/1535-7163.MCT-11-1038	37	30	31	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11337	11347		10.1074/jbc.M116.714287	http://dx.doi.org/10.1074/jbc.M116.714287			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27022022	hybrid, Green Published			2022-12-28	WOS:000377042100032
J	Ansari, SA; Paul, E; Sommer, S; Lieleg, C; He, QY; Daly, AZ; Rode, KA; Barber, WT; Ellis, LC; LaPorta, E; Orzechowski, AM; Taylor, E; Reeb, T; Wong, J; Korber, P; Morse, RH				Ansari, Suraiya A.; Paul, Emily; Sommer, Sebastian; Lieleg, Corinna; He, Qiye; Daly, Alexandre Z.; Rode, Kara A.; Barber, Wesley T.; Ellis, Laura C.; LaPorta, Erika; Orzechowski, Amanda M.; Taylor, Emily; Reeb, Tanner; Wong, Jason; Korber, Philipp; Morse, Randall H.			Mediator, TATA-binding protein, and RNA polymerase II contribute to low histone occupancy at active gene promoters in yeast (vol 289, pg 14981, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Korber, Philipp/AAN-7633-2021	Korber, Philipp/0000-0001-7526-6549				Ansari SA, 2014, J BIOL CHEM, V289, P14981, DOI 10.1074/jbc.M113.529354	1	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9938	9938		10.1074/jbc.A113.529354	http://dx.doi.org/10.1074/jbc.A113.529354			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	27197204	Green Published, hybrid			2022-12-28	WOS:000375602800008
J	Chacon-Fernandez, P; Sauberli, K; Colzani, M; Moreau, T; Ghevaert, C; Barde, YA				Chacon-Fernandez, Pedro; Saeuberli, Katharina; Colzani, Maria; Moreau, Thomas; Ghevaert, Cedric; Barde, Yves-Alain			Brain-derived Neurotrophic Factor in Megakaryocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTORS; FACTOR BDNF; EXPRESSION; RAT; BIOSYNTHESIS; VESICLES; EXERCISE; RELEASE; PEPTIDE; MEMORY	The biosynthesis of endogenous brain-derived neurotrophic factor (BDNF) has thus far been examined in neurons where it is expressed at very low levels, in an activity-dependent fashion. In humans, BDNF has long been known to accumulate in circulating platelets, at levels far higher than in the brain. During the process of blood coagulation, BDNF is released from platelets, which has led to its extensive use as a readily accessible biomarker, under the assumption that serum levels may somehow reflect brain levels. To identify the cellular origin of BDNF in platelets, we established primary cultures of megakaryocytes, the progenitors of platelets, and we found that human and rat megakaryocytes express the BDNF gene. Surprisingly, the pattern of mRNA transcripts is similar to neurons. In the presence of thapsigargin and external calcium, the levels of the mRNA species leading to efficient BDNF translation rapidly increase. Under these conditions, pro-BDNF, the obligatory precursor of biologically active BDNF, becomes readily detectable. Megakaryocytes store BDNF in alpha-granules, with more than 80% of them also containing platelet factor 4. By contrast, BDNF is undetectable in mouse megakaryocytes, in line with the absence of BDNF in mouse serum. These findings suggest that alterations of BDNF levels in human serum as reported in studies dealing with depression or physical exercise may primarily reflect changes occurring in megakaryocytes and platelets, including the ability of the latter to retain and release BDNF.	[Barde, Yves-Alain] Cardiff Univ, Sch Biosci, Sir Martin Evans Bldg, Cardiff CF10 3AX, S Glam, Wales; [Colzani, Maria; Moreau, Thomas; Ghevaert, Cedric] Univ Cambridge, Dept Haematol, Cambridge CB2 0PT, England	Cardiff University; University of Cambridge	Barde, YA (corresponding author), Cardiff Univ, Sch Biosci, Sir Martin Evans Bldg, Cardiff CF10 3AX, S Glam, Wales.	bardey@cardiff.ac.uk		Ghevaert, Cedric/0000-0002-9251-0934; Barde, Yves/0000-0002-7627-461X; Moreau, Thomas/0000-0003-1090-6685; Chacon Fernandez, Pedro Jose/0000-0003-0925-814X	Life Science Research Network Wales through the Welsh Government's Ser Cymru program; National Institute for Health Research [RP-PG-0310-1002]; MRC [MR/L022982/1] Funding Source: UKRI; British Heart Foundation [FS/09/039/27788] Funding Source: researchfish; Medical Research Council [MR/L022982/1, MC_PC_12009] Funding Source: researchfish	Life Science Research Network Wales through the Welsh Government's Ser Cymru program; National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Life Science Research Network Wales, an initiative funded through the Welsh Government's Ser Cymru program, and National Institute for Health Research Grant RP-PG-0310-1002 (to C.G.).	Aatonen MT, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24692; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Burnouf T, 2012, TRANSFUSION, V52, P1721, DOI 10.1111/j.1537-2995.2011.03494.x; Cheng KT, 2011, ADV EXP MED BIOL, V704, P435, DOI 10.1007/978-94-007-0265-3_24; Cohen S, 2008, J BIOL CHEM, V283, P33793, DOI 10.1074/jbc.X800008200; Day RB, 2014, NAT MED, V20, P1233, DOI 10.1038/nm.3745; Dieni S, 2012, J CELL BIOL, V196, P775, DOI 10.1083/jcb.201201038; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Hillman EMC, 2014, ANNU REV NEUROSCI, V37, P161, DOI 10.1146/annurev-neuro-071013-014111; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; KESTIN AS, 1993, CIRCULATION, V88, P1502, DOI 10.1161/01.CIR.88.4.1502; Kolbeck R, 1999, J NEUROCHEM, V72, P1930, DOI 10.1046/j.1471-4159.1999.0721930.x; KOLBECK R, 1994, EUR J BIOCHEM, V225, P995, DOI 10.1111/j.1432-1033.1994.0995b.x; Koppel I, 2015, J NEUROCHEM, V134, P1015, DOI 10.1111/jnc.13124; Kwok SCM, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-91; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Maynard DM, 2007, J THROMB HAEMOST, V5, P1945, DOI 10.1111/j.1538-7836.2007.02690.x; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Munkholm K, 2016, MOL PSYCHIATR, V21, P216, DOI 10.1038/mp.2015.54; PARDRIDGE WM, 1994, PHARMACEUT RES, V11, P738, DOI 10.1023/A:1018940732550; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Polyakova M, 2015, J AFFECT DISORDERS, V174, P432, DOI 10.1016/j.jad.2014.11.044; Radka SF, 1996, BRAIN RES, V709, P122, DOI 10.1016/0006-8993(95)01321-0; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; SUTER U, 1991, EMBO J, V10, P2395, DOI 10.1002/j.1460-2075.1991.tb07778.x; Szuhany KL, 2015, J PSYCHIATR RES, V60, P56, DOI 10.1016/j.jpsychires.2014.10.003; West A E, 2014, Handb Exp Pharmacol, V220, P67, DOI 10.1007/978-3-642-45106-5_4; Wetsel WC, 2013, P NATL ACAD SCI USA, V110, P17362, DOI 10.1073/pnas.1314698110; YAMAMOTO H, 1990, J NEUROSCI, V10, P3469; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Zagrebelsky M, 2014, NEUROPHARMACOLOGY, V76, P628, DOI 10.1016/j.neuropharm.2013.05.029; Zeiler M, 2014, MOL CELL PROTEOMICS, V13, P3435, DOI 10.1074/mcp.M114.038513	36	104	108	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9872	9881		10.1074/jbc.M116.720029	http://dx.doi.org/10.1074/jbc.M116.720029			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	27006395	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000375602800002
J	Swedberg, JE; Schroeder, CI; Mitchell, JM; Fairlie, DP; Edmonds, DJ; Griffith, DA; Ruggeri, RB; Derksen, DR; Loria, PM; Price, DA; Liras, S; Craik, DJ				Swedberg, Joakim E.; Schroeder, Christina I.; Mitchell, Justin M.; Fairlie, David P.; Edmonds, David J.; Griffith, David A.; Ruggeri, Roger B.; Derksen, David R.; Loria, Paula M.; Price, David A.; Liras, Spiros; Craik, David J.			Truncated Glucagon-like Peptide-1 and Exendin-4 alpha-Conotoxin p114a Peptide Chimeras Maintain Potency and alpha-Helicity and Reveal Interactions Vital for cAMP Signaling in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; RECEPTOR EXTRACELLULAR DOMAIN; NMR CHEMICAL-SHIFTS; GLP-1 RECEPTOR; DIABETES-MELLITUS; AMINO-ACIDS; AGONISTS; INCRETIN; INSULIN; BINDING	Glucagon-like peptide-1 (GE P-1) signaling through the glucagon-like peptide 1 receptor (GLP-1R) is a key regulator of normal glucose metabolism, and exogenous GLP-1R agonist therapy is a promising avenue for the treatment of type 2 diabetes mellitus. To date, the development of therapeutic GLP-1R agonists has focused on producing drugs with an extended serum half-life. This has been achieved by engineering synthetic analogs of GLP-1 or the more stable exogenous GLP-1R agonist exendin-4 (Ex-4). These synthetic peptide hormones share the overall structure of GLP-1 and Ex-4, with a C-terminal helical segment and a flexible N-terminal tail. Although numerous studies have investigated the molecular determinants underpinning GLP-1 and Ex-4 binding and signaling through the GLP1R, these have primarily focused on the length and composition of the N-terminal tail or on how to modulate the helicity of the full-length peptides. Here, we investigate the effect of C-terminal truncation in GLP-1 and Ex-4 on the cAMP pathway. To ensure helical C-terminal regions in the truncated peptides, we produced a series of chimeric peptides combining the N-terminal portion of GLP-1 or Ex-4 and the C-terminal segment of the helix-promoting peptide alpha-conotoxin p114a. The helicity and structures of the chimeric peptides were confirmed using circular dichroism and NMR, respectively. We found no direct correlation between the fractional helicity and potency in signaling via the cAMP pathway. Rather, the most important feature for efficient receptor binding and signaling was the C-terminal helical segment (residues 22-27) directing the binding of Phe' into a hydrophobic pocket on the GLP-1R.	[Swedberg, Joakim E.; Schroeder, Christina I.; Mitchell, Justin M.; Fairlie, David P.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Edmonds, David J.; Griffith, David A.; Ruggeri, Roger B.; Price, David A.; Liras, Spiros] Pfizer Inc, Cardiovasc & Metab Dis Res Unit, Worldwide Med Chem, Cambridge, MA 02139 USA; [Derksen, David R.; Loria, Paula M.] Pfizer Inc, Pharmacokinet Dynam & Metab, Worldwide Res & Dev, Groton, CT 06340 USA	University of Queensland; Pfizer; Pfizer	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Bldg 80,Serv Rd, St Lucia, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Mitchell, justin M/D-2061-2017; Fairlie, David P/F-8865-2014; Schroeder, Cristina I./K-2042-2014; Craik, David/B-1695-2010; swedberg, Joakim/K-1501-2014	Mitchell, justin M/0000-0001-8391-5959; Fairlie, David P/0000-0002-7856-8566; Schroeder, Cristina I./0000-0002-6737-6374; Craik, David/0000-0003-0007-6796; swedberg, Joakim/0000-0003-4243-8660; Griffith, David/0000-0002-7592-2478	Australian Research Council (ARC) [LP110200213]; Queensland Government Department of Science, Information Technology, Innovation, and the Arts Co-investment Fund; National Health and Medical Research Council ECR [APP1069819]; Australian Research Council Center of Excellence in Advanced Molecular Imaging [CE140100011]	Australian Research Council (ARC)(Australian Research Council); Queensland Government Department of Science, Information Technology, Innovation, and the Arts Co-investment Fund; National Health and Medical Research Council ECR; Australian Research Council Center of Excellence in Advanced Molecular Imaging(Australian Research Council)	This work was supported in part by Australian Research Council (ARC) Linkage Grant LP110200213 and a Queensland Government Department of Science, Information Technology, Innovation, and the Arts Co-investment Fund grant. The authors declare that they have no conflicts of interest with the contents of this article.r A National Health and Medical Research Council ECR (Early Career Fellowships) Fellow (APP1069819).r A National Health and Medical Research Council Senior Principal Research Fellow (APP1027369) and funded by the Australian Research Council Center of Excellence in Advanced Molecular Imaging (CE140100011).	ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Al-Sabah S, 2004, PROTEIN PEPTIDE LETT, V11, P9, DOI 10.2174/0929866043478365; Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Andersen NH, 2002, BIOORGAN MED CHEM, V10, P79, DOI 10.1016/S0968-0896(01)00263-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bulheller BM, 2007, PHYS CHEM CHEM PHYS, V9, P2020, DOI 10.1039/b615870f; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conibear AC, 2012, BIOCHEMISTRY-US, V51, P9718, DOI 10.1021/bi301363a; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donnelly D, 2012, BRIT J PHARMACOL, V166, P27, DOI 10.1111/j.1476-5381.2011.01687.x; DUPRE J, 1973, J CLIN ENDOCR METAB, V37, P826, DOI 10.1210/jcem-37-5-826; ENG J, 1992, J BIOL CHEM, V267, P7402; GALLWITZ B, 1994, EUR J BIOCHEM, V225, P1151, DOI 10.1111/j.1432-1033.1994.1151b.x; GALLWITZ B, 1990, J MOL ENDOCRINOL, V5, P33, DOI 10.1677/jme.0.0050033; Garber AJ, 2011, DIABETES CARE, V34, pS279, DOI 10.2337/dc11-s231; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haque TS, 2010, PEPTIDES, V31, P950, DOI 10.1016/j.peptides.2010.01.008; Henchey LK, 2008, CURR OPIN CHEM BIOL, V12, P692, DOI 10.1016/j.cbpa.2008.08.019; Hjorth SA, 1996, ACTA PHYSIOL SCAND, V157, P343, DOI 10.1046/j.1365-201X.1996.37259000.x; Hoang HN, 2015, J MED CHEM, V58, P4080, DOI 10.1021/acs.jmedchem.5b00166; Imperial JS, 2006, BIOCHEMISTRY-US, V45, P8331, DOI 10.1021/bi060263r; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; KREYMANN B, 1987, LANCET, V2, P1300; Mapelli C, 2009, J MED CHEM, V52, P7788, DOI 10.1021/jm900752a; MCINTYRE N, 1964, LANCET, V2, P20, DOI 10.1016/s0140-6736(64)90011-x; Miranda LP, 2008, J MED CHEM, V51, P2758, DOI 10.1021/jm701522b; MOJSOV S, 1992, INT J PEPT PROT RES, V40, P333; Murage EN, 2008, BIOORGAN MED CHEM, V16, P10106, DOI 10.1016/j.bmc.2008.10.006; Murage EN, 2010, J MED CHEM, V53, P6412, DOI 10.1021/jm100602m; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Neidigh JW, 2001, BIOCHEMISTRY-US, V40, P13188, DOI 10.1021/bi010902s; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Patgiri A, 2010, NAT PROTOC, V5, P1857, DOI 10.1038/nprot.2010.146; Patterson JT, 2013, MOL METAB, V2, P86, DOI 10.1016/j.molmet.2013.01.003; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Schroeder CI, 2014, CHEM BIOL, V21, P284, DOI 10.1016/j.chembiol.2013.11.014; SEGRE GV, 1993, TRENDS ENDOCRIN MET, V4, P309, DOI 10.1016/1043-2760(93)90071-L; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; SUZUKI S, 1989, ENDOCRINOLOGY, V125, P3109, DOI 10.1210/endo-125-6-3109; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471	48	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15778	15787		10.1074/jbc.M116.724542	http://dx.doi.org/10.1074/jbc.M116.724542			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226591	Green Published, hybrid			2022-12-28	WOS:000380584200030
J	Zhang, Y; Bode, A; Nguyen, B; Keramidas, A; Lynch, JW				Zhang, Yan; Bode, Anna; Nguyen, Bindi; Keramidas, Angelo; Lynch, Joseph W.			Investigating the Mechanism by Which Gain-of-function Mutations to the alpha 1 Glycine Receptor Cause Hyperekplexia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5-HYDROXYTRYPTAMINE(3) RECEPTOR; SYNAPTIC-TRANSMISSION; MOLECULAR-CLONING; NEURONAL FUNCTION; TIME-COURSE; POTENTIATION; SUBUNIT; TARGET; GLRA1; MOTONEURONS	Hyperekplexia is a rare human neuromotor disorder caused by mutations that impair the efficacy of glycinergic inhibitory neurotransmission. Loss-of-function mutations in the GLRA1 or GLRB genes, which encode the al and glycine receptor (GIyR) subunits, are the major cause. Paradoxically, gain -of function GLRAI mutations also cause hyperekplexia, although the mechanism is unknown. Here we identify two new gain -of function mutations (I43F and W170S) and characterize these along with known gain -of -function mutations (Q226E, V280M, and R414H) to identify how they cause hyperekplexia. Using artificial synapses, we show that all mutations prolong the decay of inhibitory postsynaptic currents (IPSCs) and induce spontaneous G1yR activation. As these effects may deplete the chloride electrochemical gradient, hyperekplexia could potentially result from reduced glycinergic inhibitory efficacy. However, we consider this unlikely as the depleted chloride gradient should also lead to pain sensitization and to a hyperekplexia phenotype that correlates with mutation severity, neither of which is observed in patients with GLRA1 hyperekplexia mutations. We also rule out small increases in IPSC decay times (as caused by W170S and R414H) as a possible mechanism given that the clinically important drug, tropisetron, significantly increases glycinergic IPSC decay times without causing motor side effects. A recent study on cultured spinal neurons concluded that an elevated intracellular chloride concentration late during development ablates a.113 glycinergic synapses but spares GABAergic synapses. As this mechanism satisfies all our considerations, we propose it is primarily responsible for the hyperekplexia phenotype.	[Zhang, Yan; Bode, Anna; Nguyen, Bindi; Keramidas, Angelo; Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Lynch, JW (corresponding author), Univ Queensland, Queensland Brain Inst, Bldg 79, St Lucia, Qld 4072, Australia.	j.lynch@uq.edu.au	; Keramidas, Angelo/I-1704-2013	Zhang, Yan/0000-0002-4159-2044; Keramidas, Angelo/0000-0003-2846-052X; Lynch, Joseph/0000-0002-1227-2252; Nguyen, Bindi/0000-0003-0898-7439	Australian Research Council [DP150102428]; National Health and Medical Research Council [1058542, 1080976]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Research Grant DP150102428 and National Health and Medical Research Council Grants 1058542 and 1080976. The authors declare that they have no conflict of interest with the contents of this article.	Ahmadi S, 2002, NAT NEUROSCI, V5, P34, DOI 10.1038/nn778; Al-Futaisi AM, 2012, PEDIATR NEUROL, V46, P89, DOI 10.1016/j.pediatrneurol.2011.11.008; Bakker MJ, 2006, LANCET NEUROL, V5, P513, DOI 10.1016/S1474-4422(06)70470-7; Balansa W, 2013, ORG BIOMOL CHEM, V11, P4695, DOI 10.1039/c3ob40861b; Beato M, 2008, J NEUROSCI, V28, P7412, DOI 10.1523/JNEUROSCI.0581-08.2008; Bhumbra GS, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00008; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Bode A, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-2; Bode A, 2013, J BIOL CHEM, V288, P33745, DOI 10.1074/jbc.M113.509240; Bode A, 2013, J BIOL CHEM, V288, P33760, DOI 10.1074/jbc.M113.513804; Brune W, 1996, AM J HUM GENET, V58, P989; Carlisle JB, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004125.pub2; Choii G, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.5; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; De Koninck Y, 2007, CURR OPIN PHARMACOL, V7, P93, DOI 10.1016/j.coph.2006.11.005; Dixon C, 2014, J BIOL CHEM, V289, P5399, DOI 10.1074/jbc.M113.514695; Dixon CL, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00080; Dixon CL, 2015, BRIT J PHARMACOL, V172, P3522, DOI 10.1111/bph.13142; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Durisic N, 2012, J NEUROSCI, V32, P12915, DOI 10.1523/JNEUROSCI.2050-12.2012; Dutertre S, 2012, J BIOL CHEM, V287, P40216, DOI 10.1074/jbc.R112.408229; Elenes S, 2006, J GEN PHYSIOL, V128, P615, DOI 10.1085/jgp.200609570; Gao BX, 2001, J NEUROPHYSIOL, V86, P492, DOI 10.1152/jn.2001.86.1.492; Graham BA, 2006, J NEUROSCI, V26, P4880, DOI 10.1523/JNEUROSCI.3991-05.2006; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Haus U, 2004, SCAND J RHEUMATOL, V33, P12, DOI 10.1080/03009740410006961; Hirzel K, 2006, NEURON, V52, P679, DOI 10.1016/j.neuron.2006.09.035; Horvath Emese, 2014, J Med Case Rep, V8, P233, DOI 10.1186/1752-1947-8-233; Jiang J, 2015, J NEUROSCI, V35, P1991, DOI 10.1523/JNEUROSCI.1627-14.2015; Lankiewicz S, 1998, MOL PHARMACOL, V53, P202, DOI 10.1124/mol.53.2.202; LAUBE B, 1995, J PHYSIOL-LONDON, V483, P613, DOI 10.1113/jphysiol.1995.sp020610; Legendre P, 1998, J NEUROSCI, V18, P2856; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Lewis TM, 1998, J PHYSIOL-LONDON, V507, P25, DOI 10.1111/j.1469-7793.1998.025bu.x; Lynch JW, 2006, CURR OPIN INVEST DR, V7, P48; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Martin LJ, 2012, MOL NEUROBIOL, V45, P30, DOI 10.1007/s12035-011-8217-x; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Miller PS, 2005, J BIOL CHEM, V280, P37877, DOI 10.1074/jbc.M508303200; MIYAKE A, 1995, MOL PHARMACOL, V48, P407; Schaefer N, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00098; Schwale C, 2016, HISTOCHEM CELL BIOL, V145, P637, DOI 10.1007/s00418-015-1397-0; Scott S, 2015, J BIOL CHEM, V290, P5621, DOI 10.1074/jbc.M114.616573; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Supplisson S, 2000, MOL PHARMACOL, V58, P763, DOI 10.1124/mol.58.4.763; Thomas RH, 2013, BRAIN, V136, P3085, DOI 10.1093/brain/awt207; Tyagarajan SK, 2014, NAT REV NEUROSCI, V15, P141, DOI 10.1038/nrn3670; Wyllie DJA, 1998, J PHYSIOL-LONDON, V510, P1, DOI 10.1111/j.1469-7793.1998.001bz.x; Yang Z, 2007, J NEUROCHEM, V100, P758, DOI 10.1111/j.1471-4159.2006.04242.x; Zeilhofer HU, 2005, CELL MOL LIFE SCI, V62, P2027, DOI 10.1007/s00018-005-5107-2; Zhang Y, 2015, NEUROPHARMACOLOGY, V89, P391, DOI 10.1016/j.neuropharm.2014.10.026; Zhou N, 2013, J NEUROSCI, V33, P17675, DOI 10.1523/JNEUROSCI.3240-13.2013	53	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15332	15341		10.1074/jbc.M116.728592	http://dx.doi.org/10.1074/jbc.M116.728592			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226610	Green Published, hybrid			2022-12-28	WOS:000380583200038
J	Salzer, R; D'Imprima, E; Gold, VAM; Rose, I; Drechsler, M; Vonck, J; Averhoff, B				Salzer, Ralf; D'Imprima, Edoardo; Gold, Vicki A. M.; Rose, Ilona; Drechsler, Moritz; Vonck, Janet; Averhoff, Beate			Topology and Structure/Function Correlation of Ring- and Gate-forming Domains in the Dynamic Secretin Complex of Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						EM; protein domain; protein folding; structure; function; type IV pili; Thermus thermophilus; electron cryotomography; natural transformation; ring and gate forming domains; secretin	IV PILUS BIOGENESIS; GRAM-NEGATIVE BACTERIA; NATURAL-TRANSFORMATION; TWITCHING-MOTILITY; DNA UPTAKE; ATPASE PILF; COMPETENCE; PROTEIN; HB27; IDENTIFICATION	Secretins are versatile outer membrane pores used by many bacteria to secrete proteins, toxins, or filamentous phages; extrude type IV pili (T4P); or take up DNA. Extrusion of T4P and natural transformation of DNA in the thermophilic bacterium Thermus thermophilus requires a unique secretin complex comprising six stacked rings, a membrane-embedded cone structure, and two gates that open and close a central channel. To investigate the role of distinct domains in ring and gate formation, we examined a set of deletion derivatives by cryomicroscopy techniques. Here we report that maintaining the N0 ring in the deletion derivatives led to stable PilQ complexes. Analyses of the variants unraveled that an N-terminal domain comprising a unique fold is essential for the formation of gate 2. Furthermore, we identified four domains essential for the formation of the N2 to N5 rings. Mutant studies revealed that deletion of individual ring domains significantly reduces piliation. The N1, N2, N4, and N5 deletion mutants were significantly impaired in T4P-mediated twitching motility, whereas the motility of the N3 mutant was comparable with that of wild-type cells. This indicates that the deletion of the N3 ring leads to increased pilus dynamics, thereby compensating for the reduced number of pili of the N3 mutant. All mutants exhibit a wild-type natural transformation phenotype, leading to the conclusion that DNA uptake is independent of functional T4P.	[Salzer, Ralf; Rose, Ilona; Drechsler, Moritz; Averhoff, Beate] Goethe Univ Frankfurt, Inst Mol Biosci, Mol Microbiol & Bioenerget, Max von Laue Str 9, D-60438 Frankfurt, Germany; [D'Imprima, Edoardo; Gold, Vicki A. M.; Vonck, Janet] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Max Planck Society	Averhoff, B (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Mol Microbiol & Bioenerget, Max von Laue Str 9, D-60438 Frankfurt, Germany.	averhoff@bio.uni-frankfurt.de		Vonck, Janet/0000-0001-5659-8863; D'Imprima, Edoardo/0000-0002-9830-7929; Averhoff, Beate/0000-0003-1460-3649; Gold, Vicki/0000-0002-6908-0745	Deutsche Forschungsgemeinschaft [AV 9/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant AV 9/6-1. The authors declare that they have no conflicts of interest with the contents of this article.	Berry JL, 2015, FEMS MICROBIOL REV, V39, P134, DOI 10.1093/femsre/fuu001; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Burkhardt J, 2012, J BIOL CHEM, V287, P8484, DOI 10.1074/jbc.M111.334912; Burkhardt J, 2011, J BIOL CHEM, V286, P9977, DOI 10.1074/jbc.M110.212688; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; Friedrich A, 2001, APPL ENVIRON MICROB, V67, P3140, DOI 10.1128/AEM.67.7.3140-3148.2001; Friedrich A, 2003, APPL ENVIRON MICROB, V69, P3695, DOI 10.1128/AEM.69.7.3695-3700.2003; Friedrich A, 2002, APPL ENVIRON MICROB, V68, P745, DOI 10.1128/AEM.68.2.745-755.2002; Gold VAM, 2015, ELIFE, V4, DOI 10.7554/eLife.07380; Guilvout I, 1999, J BACTERIOL, V181, P7212, DOI 10.1128/JB.181.23.7212-7220.1999; Karuppiah V, 2013, P NATL ACAD SCI USA, V110, pE4638, DOI 10.1073/pnas.1312313110; Karuppiah V, 2011, TRENDS MICROBIOL, V19, P40, DOI 10.1016/j.tim.2010.10.006; Karuppiah V, 2010, PROTEINS, V78, P2049, DOI 10.1002/prot.22720; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Koster M, 2000, INT J MED MICROBIOL, V290, P325; Kowal J, 2013, STRUCTURE, V21, P2152, DOI 10.1016/j.str.2013.09.012; Kruger NJ, 2011, MOL MICROBIOL, V80, P860, DOI 10.1111/j.1365-2958.2011.07647.x; Kudryashev M, 2013, ELIFE, V2, DOI 10.7554/eLife.00792; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nudleman E, 2004, J MOL MICROB BIOTECH, V7, P52, DOI 10.1159/000077869; OSHIMA T, 1971, J GEN APPL MICROBIOL, V17, P513, DOI 10.2323/jgam.17.513; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Roca I., 2015, New Microbes and New Infections, V6, P22, DOI 10.1016/j.nmni.2015.02.007; Rose I, 2011, EXTREMOPHILES, V15, P191, DOI 10.1007/s00792-010-0343-2; Rumszauer J, 2006, FEBS J, V273, P3261, DOI 10.1111/j.1742-4658.2006.05335.x; Salzer R, 2016, ENVIRON MICROBIOL, V18, P65, DOI 10.1111/1462-2920.12820; Salzer R, 2015, EXTREMOPHILES, V19, P261, DOI 10.1007/s00792-014-0711-4; Salzer R, 2014, J BIOL CHEM, V289, P30343, DOI 10.1074/jbc.M114.598656; Salzer R, 2014, APPL ENVIRON MICROB, V80, P644, DOI 10.1128/AEM.03218-13; Salzer R, 2013, EXTREMOPHILES, V17, P697, DOI 10.1007/s00792-013-0544-6; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schwarzenlander C, 2009, ENVIRON MICROBIOL, V11, P801, DOI 10.1111/j.1462-2920.2008.01801.x; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Tarry M, 2011, J MOL BIOL, V409, P642, DOI 10.1016/j.jmb.2011.04.034; Teplova M, 2011, STRUCTURE, V19, P930, DOI 10.1016/j.str.2011.05.002; Tosi T, 2014, STRUCTURE, V22, P1348, DOI 10.1016/j.str.2014.07.005; Zechner EL, 2012, PHILOS T R SOC B, V367, P1073, DOI 10.1098/rstb.2011.0207	43	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14448	14456		10.1074/jbc.M116.724153	http://dx.doi.org/10.1074/jbc.M116.724153			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226590	Green Published, hybrid			2022-12-28	WOS:000380366700004
J	Ohrvik, H; Logeman, B; Turk, B; Reinheckel, T; Thiele, DJ				Ohrvik, Helena; Logeman, Brandon; Turk, Boris; Reinheckel, Thomas; Thiele, Dennis J.			Cathepsin Protease Controls Copper and Cisplatin Accumulation via Cleavage of the Ctr1 Metal-binding Ectodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper transport; cysteine protease; intracellular processing; metal homeostasis; protein processing; anti-cancer drug; cathepsin; cisplatin	METHIONINE-RICH CLUSTERS; TRANSPORTER CTR1; CELLULAR ACCUMULATION; SACCHAROMYCES-CEREVISIAE; STIMULATED ENDOCYTOSIS; PROTEOLYTIC CLEAVAGE; CYSTEINE CATHEPSINS; LYSOSOMAL MEMBRANE; HCTR1; CANCER	Copper is an essential metal ion for embryonic development, iron acquisition, cardiac function, neuropeptide biogenesis, and other critical physiological processes. Ctr1 is a high affinity Cu+ transporter on the plasma membrane and endosomes that exists as a full-length protein and a truncated form of Ctr1 lacking the methionine- and histidine-rich metal-binding ectodomain, and it exhibits reduced Cu+ transport activity. Here, we identify the cathepsin L/B endolysosomal proteases functioning in a direct and rate-limiting step in the Ctr1 ectodomain cleavage. Cells and mice lacking cathepsin L accumulate full-length Ctr1 and hyper-accumulate copper. As Ctr1 also transports the chemotherapeutic drug cisplatin via direct binding to the ectodomain, we demonstrate that the combination of cisplatin with a cathepsin L/B inhibitor enhances cisplatin uptake and cell killing. These studies identify a new processing event and the key protease that cleaves the Ctr1 metal-binding ectodomain, which functions to regulate cellular Cu+ and cisplatin acquisition.	[Ohrvik, Helena; Logeman, Brandon; Thiele, Dennis J.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Box 3813,Res Dr,LSRC C134, Durham, NC 27710 USA; [Thiele, Dennis J.] Duke Univ, Sch Med, Dept Biochem, Box 3813,Res Dr,LSRC C134, Durham, NC 27710 USA; [Thiele, Dennis J.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Box 3813,Res Dr,LSRC C134, Durham, NC 27710 USA; [Turk, Boris] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, SI-1000 Ljubljana, Slovenia; [Turk, Boris] Univ Ljubljana, Fac Chem & Chem Technol, SI-1000 Ljubljana, Slovenia; [Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, Fac Med, D-79104 Freiburg, Germany; [Reinheckel, Thomas] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	Duke University; Duke University; Duke University; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; University of Freiburg; University of Freiburg	Thiele, DJ (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Box 3813,Res Dr,LSRC C134, Durham, NC 27710 USA.; Thiele, DJ (corresponding author), Duke Univ, Sch Med, Dept Biochem, Box 3813,Res Dr,LSRC C134, Durham, NC 27710 USA.; Thiele, DJ (corresponding author), Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Box 3813,Res Dr,LSRC C134, Durham, NC 27710 USA.; Ohrvik, H (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden.	helena.ohrvik@imbim.uu.se; dennis.thiele@duke.edu	Reinheckel, Thomas/AAL-9761-2021	Reinheckel, Thomas/0000-0001-9866-9105; Logeman, Brandon/0000-0002-9975-3541; Turk, Boris/0000-0002-9007-5764	National Institutes of Health [DK074192]; Alexander and Margaret Stewart Trust from Duke University Cancer Institute; Swedish Research Council [524-2014-1]; Ake Wiberg Foundation [M14-0080]; Magnus Bergvall Foundation [2014-00058]; Deutsche Forschungsgemeinschaft [Re1584/6-1, SFB850]; Excellence Initiative of the German Federal and State Governments [EXC 294]; Slovene Research Agency [P1-0140]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander and Margaret Stewart Trust from Duke University Cancer Institute; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ake Wiberg Foundation; Magnus Bergvall Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; Slovene Research Agency(Slovenian Research Agency - Slovenia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK074192 (to D. J. T.), the Alexander and Margaret Stewart Trust from Duke University Cancer Institute (to D. J. T.), Swedish Research Council Grant 524-2014-1 (to H. O.), Ake Wiberg Foundation Grant M14-0080 (to H. O.), Magnus Bergvall Foundation Grant 2014-00058 (to H. O.), Deutsche Forschungsgemeinschaft Grant Re1584/6-1 (to T. R.), SFB850 Project B7 (to T. R.), Excellence Initiative of the German Federal and State Governments Grant EXC 294, BIOSS, Project B10 (to T. R.). and by Grant P1-0140 from Slovene Research Agency (to B. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blair BG, 2010, MOL PHARMACOL, V77, P912, DOI 10.1124/mol.109.062836; Blair BG, 2009, CLIN CANCER RES, V15, P4312, DOI 10.1158/1078-0432.CCR-09-0311; Collins JF, 2010, NUTR REV, V68, P133, DOI 10.1111/j.1753-4887.2010.00271.x; Crider SE, 2010, METALLOMICS, V2, P74, DOI 10.1039/b916899k; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Du XB, 2013, CHEM COMMUN, V49, P9134, DOI 10.1039/c3cc45360j; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Eisses JF, 2005, J BIOL CHEM, V280, P9635, DOI 10.1074/jbc.M500116200; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Funkelstein L, 2008, J BIOL CHEM, V283, P35652, DOI 10.1074/jbc.M709010200; Garcia-Cattaneo A, 2012, P NATL ACAD SCI USA, V109, P9053, DOI 10.1073/pnas.1115091109; Guo Y, 2004, J BIOL CHEM, V279, P46393, DOI 10.1074/jbc.M407777200; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Haas KL, 2011, J AM CHEM SOC, V133, P4427, DOI 10.1021/ja108890c; Hardman B, 2006, PLACENTA, V27, P968, DOI 10.1016/j.placenta.2005.10.011; Holzer AK, 2006, MOL PHARMACOL, V70, P1390, DOI 10.1124/mol.106.022624; Ishida S, 2002, P NATL ACAD SCI USA, V99, P14298, DOI 10.1073/pnas.162491399; Jiang JF, 2005, INORG CHEM, V44, P9787, DOI 10.1021/ic051180m; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Kuo MT, 2012, CANCER RES, V72, P4616, DOI 10.1158/0008-5472.CAN-12-0888; Kuo YM, 2006, J NUTR, V136, P21, DOI 10.1093/jn/136.1.21; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Larson CA, 2010, MOL PHARMACOL, V78, P333, DOI 10.1124/mol.110.064766; Larson CA, 2010, BIOCHEM PHARMACOL, V80, P448, DOI 10.1016/j.bcp.2010.04.030; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; Lee YY, 2011, GYNECOL ONCOL, V122, P361, DOI 10.1016/j.ygyno.2011.04.025; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; LUKASEWYCZ OA, 1990, ANN NY ACAD SCI, V587, P147, DOI 10.1111/j.1749-6632.1990.tb00142.x; Madsen E, 2007, ANNU REV NEUROSCI, V30, P317, DOI 10.1146/annurev.neuro.30.051606.094232; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Maryon EB, 2009, J BIOL CHEM, V284, P28104, DOI 10.1074/jbc.M109.044925; MCGOWAN EB, 1989, BIOCHEM BIOPH RES CO, V158, P432, DOI 10.1016/S0006-291X(89)80065-8; MEDEIROS DM, 1993, P SOC EXP BIOL MED, V203, P262, DOI 10.3181/00379727-203-43599; Mihelic M, 2008, J BIOL CHEM, V283, P14453, DOI 10.1074/jbc.M801283200; Molloy SA, 2009, J BIOL CHEM, V284, P29704, DOI 10.1074/jbc.M109.000166; Muller S, 2012, BBA-PROTEINS PROTEOM, V1824, P34, DOI 10.1016/j.bbapap.2011.07.003; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Nose Y, 2010, J BIOL CHEM, V285, P32385, DOI 10.1074/jbc.M110.143826; Ohrvika H, 2013, P NATL ACAD SCI USA, V110, pE4279, DOI 10.1073/pnas.1311749110; Olson OC, 2015, NAT REV CANCER, V15, P712, DOI 10.1038/nrc4027; Pena MMO, 2000, J BIOL CHEM, V275, P33244, DOI 10.1074/jbc.M005392200; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Puzer L, 2004, ARCH BIOCHEM BIOPHYS, V430, P274, DOI 10.1016/j.abb.2004.07.006; Ralle M, 2010, J BIOL CHEM, V285, P30875, DOI 10.1074/jbc.M110.114447; Reddy VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8864; Riggio M, 2002, BBA-GENE STRUCT EXPR, V1576, P127, DOI 10.1016/S0167-4781(02)00337-8; Sancenon V, 2003, PLANT MOL BIOL, V51, P577, DOI 10.1023/A:1022345507112; Savalas LRT, 2011, BIOCHEM J, V439, P113, DOI 10.1042/BJ20110166; Sevenich L, 2006, BIOL CHEM, V387, P885, DOI 10.1515/BC.2006.112; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Sinani D, 2007, J BIOL CHEM, V282, P26775, DOI 10.1074/jbc.M703973200; Sobotic B, 2015, MOL CELL PROTEOMICS, V14, P2213, DOI 10.1074/mcp.M114.044628; Song IS, 2004, MOL CANCER THER, V3, P1543; Steenhuis P, 2012, BBA-MOL BASIS DIS, V1822, P1617, DOI 10.1016/j.bbadis.2012.05.015; TOWATARI T, 1983, J BIOCHEM-TOKYO, V93, P1119, DOI 10.1093/oxfordjournals.jbchem.a134237; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Turski ML, 2007, J BIOL CHEM, V282, P24017, DOI 10.1074/jbc.M703792200; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Vizovisek M, 2015, PROTEOMICS, V15, P2479, DOI 10.1002/pmic.201400460; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Xu XJ, 2012, LUNG CANCER, V77, P438, DOI 10.1016/j.lungcan.2012.03.023; Yasothornsrikul S, 2003, P NATL ACAD SCI USA, V100, P9590, DOI 10.1073/pnas.1531542100; Yoshida H, 2013, ANTICANCER RES, V33, P1409	68	27	30	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					13905	13916		10.1074/jbc.M116.731281	http://dx.doi.org/10.1074/jbc.M116.731281			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27143361	Green Published, hybrid			2022-12-28	WOS:000379975100001
J	Blazer, LL; Lima-Fernandes, E; Gibson, E; Eram, MS; Loppnau, P; Arrowsmith, CH; Schapira, M; Vedadi, M				Blazer, Levi L.; Lima-Fernandes, Evelyne; Gibson, Elisa; Eram, Mohammad S.; Loppnau, Peter; Arrowsmith, Cheryl H.; Schapira, Matthieu; Vedadi, Masoud			PR Domain-containing Protein 7 (PRDM7) Is a Histone 3 Lysine 4 Trimethyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; histone methylation; histone modification; substrate specificity; zinc finger	SINGLE-NUCLEOTIDE POLYMORPHISMS; MEIOTIC RECOMBINATION HOTSPOTS; ZINC-FINGER PROTEIN; MEISETZ GENE; METHYLTRANSFERASE; VARIANTS; LOCI; RIZ1; SET; DNA	PR domain-containing protein 7 (PRDM7) is a primate-specific histone methyltransferase that is the result of a recent gene duplication of PRDM9. The two proteins are highly homologous, especially in the catalytic PR/SET domain, where they differ by only three amino acid residues. Here we report that PRDM7 is an efficient methyltransferase that selectively catalyzes the trimethylation of H3 lysine 4 (H3K4) both in vitro and in cells. Through selective mutagenesis we have dissected the functional roles of each of the three divergent residues between the PR domains of PRDM7 and PRDM9. These studies indicate that after a single serine to tyrosine mutation at residue 357 (S357Y), PRDM7 regains the substrate specificities and catalytic activities similar to its evolutionary predecessor, including the ability to efficiently methylate H3K36.	[Blazer, Levi L.; Lima-Fernandes, Evelyne; Gibson, Elisa; Eram, Mohammad S.; Loppnau, Peter; Arrowsmith, Cheryl H.; Schapira, Matthieu; Vedadi, Masoud] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Schapira, Matthieu; Vedadi, Masoud] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto	Vedadi, M (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.; Vedadi, M (corresponding author), Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada.	m.vedadi@utoronto.ca	Blazer, Levi/T-6267-2019	Blazer, Levi/0000-0001-9594-4642; Lima Fernandes, Evelyne/0000-0002-3628-9745; Arrowsmith, Cheryl/0000-0002-4971-3250; Gibson, Elisa/0000-0002-7112-337X	Structural Genomics Consortium [1097737]; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada; Innovative Medicines Initiative (EU/EFPIA); Janssen; Merck Co.; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust; National Research Fund Luxembourg; Marie Curie Actions of the European Commission (FP7-COFUND); Banting Postdoctoral Fellowship	Structural Genomics Consortium(University of Toronto); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada(Genome Canada); Innovative Medicines Initiative (EU/EFPIA); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Co.(Merck & Company); Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); National Research Fund Luxembourg(Luxembourg National Research Fund); Marie Curie Actions of the European Commission (FP7-COFUND); Banting Postdoctoral Fellowship	This work was supported in part by the Structural Genomics Consortium, a registered charity (number 1097737), that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA), Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a postdoctoral fellowship by the National Research Fund Luxembourg and the Marie Curie Actions of the European Commission (FP7-COFUND) and subsequently of a Banting Postdoctoral Fellowship.	Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baudat F, 2010, M S-MED SCI, V26, P468, DOI 10.1051/medsci/2010265468; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Bhattacharyya T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004088; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Buard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085021; BUYSE IM, 1995, P NATL ACAD SCI USA, V92, P4467, DOI 10.1073/pnas.92.10.4467; CARDOZO T, 1995, PROTEINS, V23, P403, DOI 10.1002/prot.340230314; Caudill MA, 2001, J NUTR, V131, P2811, DOI 10.1093/jn/131.11.2811; Chasman DI, 2011, NAT GENET, V43, P695, DOI 10.1038/ng.856; Derunes C, 2005, BIOCHEM BIOPH RES CO, V333, P925, DOI 10.1016/j.bbrc.2005.05.190; Eom GH, 2009, BIOCHEM BIOPH RES CO, V388, P131, DOI 10.1016/j.bbrc.2009.07.134; Eram MS, 2015, BBA-GEN SUBJECTS, V1850, P1842, DOI 10.1016/j.bbagen.2015.05.013; Eram MS, 2014, J BIOL CHEM, V289, P12177, DOI 10.1074/jbc.M113.523183; Flachs P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095806; Fog CK, 2012, BIOESSAYS, V34, P50, DOI 10.1002/bies.201100107; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Groeneveld LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039064; Gyory I, 2003, J IMMUNOL, V170, P3125, DOI 10.4049/jimmunol.170.6.3125; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hayashi K, 2006, CELL CYCLE, V5, P615, DOI 10.4161/cc.5.6.2572; Hohenauer T, 2012, DEVELOPMENT, V139, P2267, DOI 10.1242/dev.070110; Horowitz S, 2013, J AM CHEM SOC, V135, P15536, DOI 10.1021/ja407140k; Huang S, 1998, J BIOL CHEM, V273, P15933, DOI 10.1074/jbc.273.26.15933; Huang S, 2002, NAT REV CANCER, V2, P469, DOI 10.1038/nrc819; Irie S, 2009, J ANDROL, V30, P426, DOI 10.2164/jandrol.108.006262; Kaniskan HU, 2015, ANGEW CHEM INT EDIT, V54, P5166, DOI 10.1002/anie.201412154; Kim KC, 2003, CANCER RES, V63, P7619; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Miyamoto T, 2008, J ASSIST REPROD GEN, V25, P553, DOI 10.1007/s10815-008-9270-x; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nowick K, 2013, TRENDS GENET, V29, P130, DOI 10.1016/j.tig.2012.11.007; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Ponting CP, 2011, TRENDS GENET, V27, P165, DOI 10.1016/j.tig.2011.02.001; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Sandovici I, 2010, F1000 BIOL REP, V2, P37; Schapira Matthieu, 2011, Curr Chem Genomics, V5, P85, DOI 10.2174/1875397301005010085; Segurel L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001211; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Wu H, 2013, CELL REP, V5, P13, DOI 10.1016/j.celrep.2013.08.035; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Wu YX, 2008, J MOL CELL CARDIOL, V44, P47, DOI 10.1016/j.yjmcc.2007.06.008	43	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13509	13519		10.1074/jbc.M116.721472	http://dx.doi.org/10.1074/jbc.M116.721472			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129774	hybrid, Green Published			2022-12-28	WOS:000379771100009
J	Lengyel, M; Czirjak, G; Enyedi, P				Lengyel, Miklos; Czirjak, Gabor; Enyedi, Peter			Formation of Functional Heterodimers by TREK-1 and TREK-2 Two-pore Domain Potassium Channel Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; patch clamp; pharmacology; plasma membrane; potassium channel; Ion channel heteromerization; KCNK10; KCNK2; ruthenium red; spadin	BACKGROUND K+ CHANNEL; CONE DYSTROPHY; CONDUCTANCE; CELLS; TRAAK; ACID; TASK-1/TASK-3; K(2P)10.1; TASK-1; COMMON	Two-pore domain (K-2P) potassium channels are the major molecular correlates of the background (leak) K+ current in a wide variety of cell types. They generally play a key role in setting the resting membrane potential and regulate the response of excitable cells to various stimuli. K-2P channels usually function as homodimers, and only a few examples of heteromerization have been previously reported. Expression of the TREK (TWIK-related K+ channel) subfamily members of K-2P channels often overlaps in neurons and in other excitable cells. Here, we demonstrate that heterologous coexpression of TREK-1 and TREK-2 subunits results in the formation of functional heterodimers. Taking advantage of a tandem construct (in which the two different subunits were linked together to enforce heterodimerization), we characterized the biophysical and pharmacological properties of the TREK-1/TREK-2 current. The heteromer was inhibited by extracellular acidification and by spadin similarly to TREK-1, and its ruthenium red sensitivity was intermediate between TREK-1 and TREK-2 homodimers. The heterodimer has also been distinguished from the homodimers by its unique single channel conductance. Assembly of the two different subunits was confirmed by coimmunoprecipitation of epitope-tagged TREK-1 and TREK-2 subunits, coexpressed in Xenopus oocytes. Formation of TREK-1/TREK-2 channels was also demonstrated in native dorsal root ganglion neurons indicating that heterodimerization may provide greater diversity of leak K+ conductances also in native tissues.	[Lengyel, Miklos; Czirjak, Gabor; Enyedi, Peter] Semmelweis Univ, Dept Physiol, POB 2, H-1428 Budapest, Hungary	Semmelweis University	Enyedi, P (corresponding author), Semmelweis Univ, Dept Physiol, POB 2, H-1428 Budapest, Hungary.	enyedi.peter@med.semmelweis-univ.hu	Lengyel, Miklos/E-6697-2016	Lengyel, Miklos/0000-0001-6382-6369	Hungarian National Research Fund OTKA [K108496]	Hungarian National Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by Hungarian National Research Fund OTKA K108496. The authors declare that they have no conflicts of interest with the contents of this article.	Bagriantsev SN, 2011, EMBO J, V30, P3594, DOI 10.1038/emboj.2011.230; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; Blin S, 2016, P NATL ACAD SCI USA, V113, P4200, DOI 10.1073/pnas.1522748113; Blin S, 2014, J BIOL CHEM, V289, P28202, DOI 10.1074/jbc.M114.600437; Braun G, 2015, BRIT J PHARMACOL, V172, P1728, DOI 10.1111/bph.13019; Cadaveira-Mosquera A, 2012, J MOL NEUROSCI, V48, P86, DOI 10.1007/s12031-012-9780-y; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Czirjak B, 2004, J BIOL CHEM, V279, P18550, DOI 10.1074/jbc.M312229200; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; Czirjak G, 2006, MOL PHARMACOL, V69, P1024, DOI 10.1124/mol.105.018556; Enyeart JJ, 2002, J BIOL CHEM, V277, P49186, DOI 10.1074/jbc.M207233200; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Gilling Mette, 2013, Frontiers in Genetics, V4, P54, DOI 10.3389/fgene.2013.00054; Han J, 2003, J PHYSIOL-LONDON, V546, P625, DOI 10.1113/jphysiol.2002.032094; Heurteaux C, 2006, NEUROSCIENCE, V137, P241, DOI 10.1016/j.neuroscience.2005.08.083; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Hwang EM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4227; Kang D, 2006, AM J PHYSIOL-CELL PH, V291, pC138, DOI 10.1152/ajpcell.00629.2005; Kang DW, 2004, J PHYSIOL-LONDON, V554, P64, DOI 10.1113/jphysiol.2003.054387; Kim D, 2009, J PHYSIOL-LONDON, V587, P2963, DOI 10.1113/jphysiol.2009.171181; Koh SD, 2001, J BIOL CHEM, V276, P44338, DOI 10.1074/jbc.M108125200; Larkman PM, 2005, EUR J NEUROSCI, V21, P679, DOI 10.1111/j.1460-9568.2005.03898.x; Levitz J, 2016, P NATL ACAD SCI USA, V113, P4194, DOI 10.1073/pnas.1522459113; Maati HMO, 2012, NEUROPHARMACOLOGY, V62, P278, DOI 10.1016/j.neuropharm.2011.07.019; Mazella J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000355; Meuth SG, 2006, MOL PHARMACOL, V69, P1468, DOI 10.1124/mol.105.020594; Noel J, 2011, CHANNELS, V5, P400, DOI 10.4161/chan.5.5.16469; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Plant LD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003431; Sandoz G, 2009, P NATL ACAD SCI USA, V106, P14628, DOI 10.1073/pnas.0906267106; Simkin D, 2008, J PHYSIOL-LONDON, V586, P5651, DOI 10.1113/jphysiol.2008.161927; Smith KE, 2012, J BIOL CHEM, V287, P43972, DOI 10.1074/jbc.M112.388033; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Thomas D, 2008, NEURON, V58, P859, DOI 10.1016/j.neuron.2008.04.016; Torborg CL, 2006, J NEUROSCI, V26, P7362, DOI 10.1523/JNEUROSCI.1257-06.2006; Toth JT, 2016, BBA-MOL CELL BIOL L, V1861, P177, DOI 10.1016/j.bbalip.2015.12.005; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Wissinger B, 2011, HUM MUTAT, V32, P1398, DOI 10.1002/humu.21580	39	32	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13649	13661		10.1074/jbc.M116.719039	http://dx.doi.org/10.1074/jbc.M116.719039			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129242	hybrid, Green Published			2022-12-28	WOS:000379771100021
J	Navarro, G; Aguinaga, D; Angelats, E; Medrano, M; Moreno, E; Mallol, J; Cortes, A; Canela, EI; Casado, V; McCormick, PJ; Lluis, C; Ferre, S				Navarro, Gemma; Aguinaga, David; Angelats, Edgar; Medrano, Mireia; Moreno, Estefania; Mallol, Josefa; Cortes, Antonio; Canela, Enric I.; Casado, Vicent; McCormick, Peter J.; Lluis, Carme; Ferre, Sergi			A Significant Role of the Truncated Ghrelin Receptor GHS-R1b in Ghrelin-induced Signaling in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CELL-SURFACE EXPRESSION; ALLOSTERIC INTERACTIONS; POLYPEPTIDE GHS-R1B; INSULIN-RELEASE; HETEROTETRAMER; HETERODIMERS; ACTIVATION; ATTENUATE; PATHWAYS	The truncated non-signaling ghrelin receptor growth hormone secretagogue R1b (GHS-R1b) has been suggested to simply exert a dominant negative role in the trafficking and signaling of the full and functional ghrelin receptor GHS-R1a. Here we reveal a more complex modulatory role of GHS-R1b. Differential co-expression of GHS-R1a and GHS-R1b, both in HEK-293T cells and in striatal and hippocampal neurons in culture, demonstrates that GHS-R1b acts as a dual modulator of GHS-R1a function: low relative GHS-R1b expression potentiates and high relative GHS-R1b expression inhibits GHS-R1a function by facilitating GHS-R1a trafficking to the plasma membrane and by exerting a negative allosteric effect on GHS-R1a signaling, respectively. We found a preferential G(i/o) coupling of the GHS-R1a-GHS-R1b complex in HEK-293T cells and, unexpectedly, a preferential G(s/olf) coupling in both striatal and hippocampal neurons in culture. A dopamine D-1 receptor (D1R) antagonist blocked ghrelin-induced cAMP accumulation in striatal but not hippocampal neurons, indicating the involvement of D1R in the striatal GHS-R1a-G(s/olf) coupling. Experiments in HEK-293T cells demonstrated that D1R co-expression promotes a switch in GHS-R1a-G protein coupling from G(i/o) to G(s/olf), but only upon co-expression of GHS-R1b. Furthermore, resonance energy transfer experiments showed that D1R interacts with GHS-R1a, but only in the presence of GHS-R1b. Therefore, GHS-R1b not only determines the efficacy of ghrelin-induced GHS-R1a-mediated signaling but also determines the ability of GHS-R1a to form oligomeric complexes with other receptors, promoting profound qualitative changes in ghrelin-induced signaling.	[Navarro, Gemma; Aguinaga, David; Angelats, Edgar; Medrano, Mireia; Moreno, Estefania; Mallol, Josefa; Cortes, Antonio; Canela, Enric I.; Casado, Vicent; Lluis, Carme] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Diagonal 645, E-08028 Barcelona, Spain; [Navarro, Gemma; Aguinaga, David; Angelats, Edgar; Medrano, Mireia; Moreno, Estefania; Mallol, Josefa; Cortes, Antonio; Canela, Enric I.; Casado, Vicent; Lluis, Carme] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona 08028, Spain; [McCormick, Peter J.] Univ East Anglia, Sch Pharm, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Ferre, Sergi] NIDA, Integrat Neurobiol Sect, Intramural Res Program, Baltimore, MD 21224 USA	University of Barcelona; CIBERNED; University of East Anglia; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Navarro, G (corresponding author), Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Diagonal 645, E-08028 Barcelona, Spain.; Ferre, S (corresponding author), NIDA, Integrat Neurobiol Sect, Intramural Res Program, NIH, Triad Technol Bldg,333 Cassell Dr, Baltimore, MD 21224 USA.	dimartts@hotmail.com; sferre@intra.nida.nih.gov	Ferre, Sergi/K-6115-2014; Mallol, Josefa/I-4194-2015; Casadó, Vicent/K-1660-2014; Medrano, Mireia/GVS-3226-2022; Canela, Enric I./M-8726-2013; Guillén, Estefanía Moreno/ABE-4371-2020; Navarro, Gemma/AAO-7866-2021; Medrano, Mireia/AFP-3427-2022	Ferre, Sergi/0000-0002-1747-1779; Mallol, Josefa/0000-0002-2479-4162; Casadó, Vicent/0000-0002-1764-3825; Canela, Enric I./0000-0003-4992-7440; Navarro, Gemma/0000-0003-4654-0873; Medrano, Mireia/0000-0002-8707-5501; Moreno, Estefania/0000-0002-2491-5753; Aguinaga Andres, David/0000-0003-2506-7204; Angelats Canals, Edgar/0000-0001-5405-7086	Spanish Ministerio de Ciencia y Tecnologia [SAF2011-23813]; government of Catalonia [2014-SGR-1236]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas Grant [CB06/05/0064]; National Institute on Drug Abuse; Ramon y Cajal fellowship; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000493] Funding Source: NIH RePORTER	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); government of Catalonia(Generalitat de Catalunya); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas Grant; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Ramon y Cajal fellowship(Spanish Government); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Spanish Ministerio de Ciencia y Tecnologia Grant SAF2011-23813, government of Catalonia Grant 2014-SGR-1236, Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas Grant CB06/05/0064, and intramural funds of the National Institute on Drug Abuse. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Ramon y Cajal fellowship.	Andrews ZB, 2011, TRENDS NEUROSCI, V34, P31, DOI 10.1016/j.tins.2010.10.001; Bennett KA, 2009, MOL PHARMACOL, V76, P802, DOI 10.1124/mol.109.056101; Bonaventura J, 2015, P NATL ACAD SCI USA, V112, pE3609, DOI 10.1073/pnas.1507704112; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chow KBS, 2012, MOL CELL ENDOCRINOL, V348, P247, DOI 10.1016/j.mce.2011.08.034; Ciruela F, 1999, FEBS LETT, V448, P91, DOI 10.1016/S0014-5793(99)00341-5; Cuellar JN, 2011, NEUROPHARMACOLOGY, V60, P842, DOI 10.1016/j.neuropharm.2010.12.024; Damian M, 2015, P NATL ACAD SCI USA, V112, P1601, DOI 10.1073/pnas.1414618112; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; Dezaki K, 2007, DIABETES, V56, P2319, DOI 10.2337/db07-0345; Dezaki K, 2013, ENDOCR DEV, V25, P135, DOI 10.1159/000346064; Dorn GW, 1997, BIOCHEMISTRY-US, V36, P6415, DOI 10.1021/bi970080s; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Guitart X, 2014, MOL PHARMACOL, V86, P417, DOI 10.1124/mol.114.093096; Holst B, 2005, MOL ENDOCRINOL, V19, P2400, DOI 10.1210/me.2005-0059; Hradsky Johannes, 2013, Methods Mol Biol, V963, P147, DOI 10.1007/978-1-62703-230-8_10; Jang JK, 2013, BEHAV BRAIN RES, V248, P7, DOI 10.1016/j.bbr.2013.03.049; Jiang H, 2006, MOL ENDOCRINOL, V20, P1772, DOI 10.1210/me.2005-0084; Kern A, 2015, CELL, V163, P1176, DOI 10.1016/j.cell.2015.10.062; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Leung PK, 2007, CELL SIGNAL, V19, P1011, DOI 10.1016/j.cellsig.2006.11.011; Malagon MM, 2003, ENDOCRINOLOGY, V144, P5372, DOI 10.1210/en.2003-0723; Mary S, 2013, J BIOL CHEM, V288, P24656, DOI 10.1074/jbc.M113.453423; Mason BL, 2014, ANNU REV PHYSIOL, V76, P519, DOI 10.1146/annurev-physiol-021113-170310; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Silver R, 2010, SLEEP BIOL RHYTHMS, V8, P120, DOI 10.1111/j.1479-8425.2010.00438.x; Sun YM, 2014, CELL SIGNAL, V26, P2530, DOI 10.1016/j.cellsig.2014.07.014; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1	29	30	32	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13048	13062		10.1074/jbc.M116.715144	http://dx.doi.org/10.1074/jbc.M116.715144			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129257	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000379770500014
J	Horber, S; Hildebrand, DG; Lieb, WS; Lorscheid, S; Hailfinger, S; Schulze-Osthoff, K; Essmann, F				Hoerber, Sebastian; Hildebrand, Dominic G.; Lieb, Wolfgang S.; Lorscheid, Sebastian; Hailfinger, Stephan; Schulze-Osthoff, Klaus; Essmann, Frank			The Atypical Inhibitor of NF-kappa B, I kappa B zeta, Controls Macrophage Interleukin-10 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-10 GENE; INFLAMMATORY GENES; P50 HOMODIMERS; PROTEIN; TRANSCRIPTION; POLARIZATION; ACTIVATION; PROMOTER; RECEPTOR; BCL-3	Macrophages constitute a first line of pathogen defense by triggering a number of inflammatory responses and the secretion of various pro-inflammatory cytokines. Recently, we and others found that I kappa B zeta, an atypical I kappa B family member and transcriptional coactivator of selected NF-kappa B target genes, is essential for macrophage expression of a subset of pro-inflammatory cytokines, such as IL-6, IL-12, and CCL2. Despite defective pro-inflammatory cytokine expression, however, I kappa B zeta-deficient mice develop symptoms of chronic inflammation. To elucidate this discrepancy, we analyzed a regulatory role of I kappa B zeta for the expression of anti-inflammatory cytokines and identified I kappa B zeta as an essential activator of IL-10 expression. LPS-challenged peritoneal and bone marrow-derived macrophages from I kappa B zeta-deficient mice revealed strongly decreased transcription and secretion of IL-10 compared with wild-type mice. Moreover, ectopic expression of I kappa B zeta was sufficient to stimulate Il10 transcription. On the molecular level, I kappa B zeta directly activated the Il10 promoter at a proximal kappa B site and was required for the transcription-enhancing trimethylation of histone 3 at lysine 4. Together, our findings show for the first time the I kappa B zeta-dependent expression of an anti-inflammatory cytokine that is crucial in controlling immune responses.	[Hoerber, Sebastian; Hildebrand, Dominic G.; Lieb, Wolfgang S.; Lorscheid, Sebastian; Hailfinger, Stephan; Schulze-Osthoff, Klaus; Essmann, Frank] Univ Tubingen, Dept Mol Med, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Schulze-Osthoff, Klaus] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Schulze-Osthoff, Klaus] German Canc Res Ctr, D-69120 Heidelberg, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Schulze-Osthoff, K; Essmann, F (corresponding author), Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany.	kso@uni-tuebingen.de; frank.essmann@uni-tuebingen.de	Schulze-Osthoff, Klaus/N-9025-2013; Hörber, Sebastian/AAO-2379-2021; Essmann, Frank/ABG-7409-2020	Schulze-Osthoff, Klaus/0000-0003-1443-2720; Essmann, Frank/0000-0003-4369-8456	Deutsche Forschungsgemeinschaft [SFB685, GRK1302]; Bundesminsterium fur Bildung und Forschung Grant AID-NET	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesminsterium fur Bildung und Forschung Grant AID-NET	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB685 and GRK1302 and Bundesminsterium fur Bildung und Forschung Grant AID-NET. The authors declare that they have no conflicts of interest with the contents of this article.	Alexander E, 2013, J CELL SCI, V126, P3738, DOI 10.1242/jcs.128835; Beguelin W, 2015, LEUKEMIA, V29, P1684, DOI 10.1038/leu.2015.57; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Brenner S, 2003, J BIOL CHEM, V278, P5597, DOI 10.1074/jbc.M207448200; Brightbill HD, 2000, J IMMUNOL, V164, P1940, DOI 10.4049/jimmunol.164.4.1940; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Graupner V, 2011, CELL DEATH DIFFER, V18, P1130, DOI 10.1038/cdd.2010.179; Hildebrand DG, 2013, J IMMUNOL, V190, P4812, DOI 10.4049/jimmunol.1300089; Hinz M, 2012, IMMUNOL REV, V246, P59, DOI 10.1111/j.1600-065X.2012.01102.x; Hirotani T, 2005, J IMMUNOL, V174, P3650, DOI 10.4049/jimmunol.174.6.3650; Johansen C, 2015, P NATL ACAD SCI USA, V112, pE5825, DOI 10.1073/pnas.1509971112; Kannan Y, 2011, BLOOD, V117, P2855, DOI 10.1182/blood-2010-07-294702; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Kuwata H, 2003, BLOOD, V102, P4123, DOI 10.1182/blood-2003-04-1228; Lang R, 2002, J IMMUNOL, V168, P3402, DOI 10.4049/jimmunol.168.7.3402; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Makita N, 2015, INT IMMUNOL, V27, P131, DOI 10.1093/intimm/dxu090; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Okuma A, 2013, IMMUNITY, V38, P450, DOI 10.1016/j.immuni.2012.11.016; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Prasse A, 2007, J ALLERGY CLIN IMMUN, V119, P464, DOI 10.1016/j.jaci.2006.09.030; Riemann M, 2005, J IMMUNOL, V175, P3560, DOI 10.4049/jimmunol.175.6.3560; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schuster M, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-23; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Shiina T, 2004, J BIOL CHEM, V279, P55493, DOI 10.1074/jbc.M409770200; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Tartey S, 2014, EMBO J, V33, P2332, DOI 10.15252/embj.201488447; Tone M, 2000, J IMMUNOL, V165, P286, DOI 10.4049/jimmunol.165.1.286; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Trinh DV, 2008, J MOL BIOL, V379, P122, DOI 10.1016/j.jmb.2008.03.060; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Wessells J, 2004, J BIOL CHEM, V279, P49995, DOI 10.1074/jbc.M404246200; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252; Ziegler-Heitbrock L, 2003, J IMMUNOL, V171, P285, DOI 10.4049/jimmunol.171.1.285	50	25	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12851	12861		10.1074/jbc.M116.718825	http://dx.doi.org/10.1074/jbc.M116.718825			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129283	Green Published, hybrid			2022-12-28	WOS:000378119900035
J	Tiwari, S; Siddiqi, S; Zhelyabovska, O; Siddiqi, SA				Tiwari, Samata; Siddiqi, Shaila; Zhelyabovska, Olga; Siddiqi, Shadab A.			Silencing of Small Valosin-containing Protein-interacting Protein (SVIP) Reduces Very Low Density Lipoprotein (VLDL) Secretion from Rat Hepatocytes by Disrupting Its Endoplasmic Reticulum (ER)-to-Golgi Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BINDING PROTEIN; APOLIPOPROTEIN B100; TRANSPORT VESICLE; MULTIPROTEIN COMPLEX; HEPATIC STEATOSIS; COPII; ER; EXPORT; IDENTIFICATION; BIOGENESIS	The transport of nascent very low density lipoprotein (VLDL) particles from the endoplasmic reticulum (ER) to the Golgi determines their secretion by the liver and is mediated by a specialized ER-derived vesicle, the VLDL transport vesicle (VTV). Our previous studies have shown that the formation of ER-derived VTV requires proteins in addition to coat complex II proteins. The VTV proteome revealed that a 9-kDa protein, small valosin-containing protein-interacting protein (SVIP), is uniquely present in these specialized vesicles. Our biochemical and morphological data indicate that the VTV contains SVIP. Using confocal microscopy and co-immunoprecipitation assays, we show that SVIP co-localizes with apolipoprotein B-100 (apoB100) and specifically interacts with VLDL apoB100 and coat complex II proteins. Treatment of ER membranes with myristic acid in the presence of cytosol increases SVIP recruitment to the ER in a concentration-dependent manner. Furthermore, we show that myristic acid treatment of hepatocytes increases both VTV budding and VLDL secretion. To determine the role of SVIP in VTV formation, we either blocked the SVIP protein using specific antibodies or silenced SVIP by siRNA in hepatocytes. Our results show that both blocking and silencing of SVIP lead to significant reduction in VTV formation. Additionally, we show that silencing of SVIP reduces VLDL secretion, suggesting a physiological role of SVIP in intracellular VLDL trafficking and secretion. We conclude that SVIP acts as a novel regulator of VTV formation by interacting with its cargo and coat proteins and has significant implications in VLDL secretion by hepatocytes.	[Tiwari, Samata; Siddiqi, Shaila; Zhelyabovska, Olga; Siddiqi, Shadab A.] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 6900 Lake Nona Blvd,Rm 349, Orlando, FL 32827 USA	State University System of Florida; University of Central Florida	Siddiqi, SA (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 6900 Lake Nona Blvd,Rm 349, Orlando, FL 32827 USA.	shadab.siddiqi@ucf.edu			NIDDK, National Institutes of Health [RO1 DK-81413]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081413] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grant RO1 DK-81413 (to S. A. S.). The authors have no conflict of interest to report. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barlowe C, 1998, BBA-MOL CELL RES, V1404, P67, DOI 10.1016/S0167-4889(98)00047-0; Butkinaree C, 2014, ARTERIOSCL THROM VAS, V34, P251, DOI 10.1161/ATVBAHA.113.302728; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; Gusarova V, 2003, J BIOL CHEM, V278, P48051, DOI 10.1074/jbc.M306898200; Gusarova V, 2007, J BIOL CHEM, V282, P19453, DOI 10.1074/jbc.M700475200; Hossain T, 2014, BIOCHEM J, V459, P47, DOI 10.1042/BJ20131215; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kummrow E, 2002, J LIPID RES, V43, P2155, DOI 10.1194/jlr.M200249-JLR200; Liang JS, 2003, J BIOL CHEM, V278, P23984, DOI 10.1074/jbc.M302683200; Mansbach CM, 2010, ANNU REV PHYSIOL, V72, P315, DOI 10.1146/annurev-physiol-021909-135801; Miller EA, 2013, CURR OPIN CELL BIOL, V25, P420, DOI 10.1016/j.ceb.2013.04.005; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; Mirandola S, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-13; Nagahama M, 2003, MOL BIOL CELL, V14, P262, DOI 10.1091/mbc.02-07-0115; Neeli I, 2007, J BIOL CHEM, V282, P17974, DOI 10.1074/jbc.M610765200; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Pahuja KB, 2015, P NATL ACAD SCI USA, V112, pE3199, DOI 10.1073/pnas.1509119112; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Powers J, 2002, MOL BIOL CELL, V13, P880, DOI 10.1091/mbc.01-10-0499; Rahim A, 2012, J PROTEOMICS, V75, P2225, DOI 10.1016/j.jprot.2012.01.026; Shrivastav A, 2003, CANCER RES, V63, P7975; Siddiqi SA, 2003, J CELL SCI, V116, P415, DOI 10.1242/jcs.00215; Siddiqi SA, 2008, BIOCHEM J, V413, P333, DOI 10.1042/BJ20071469; Siddiqi SA, 2006, J BIOL CHEM, V281, P20974, DOI 10.1074/jbc.M601401200; Siddiqi Shadab A, 2015, Curr Protoc Cell Biol, V67, DOI 10.1002/0471143030.cb1121s67; Siddiqi S, 2012, J BIOL CHEM, V287, P10178, DOI 10.1074/jbc.M111.327247; Siddiqi S, 2010, J LIPID RES, V51, P1918, DOI 10.1194/jlr.M005611; Siddiqi S, 2010, BIOCHEM J, V429, P391, DOI 10.1042/BJ20100336; Sparks JD, 2012, ARTERIOSCL THROM VAS, V32, P2104, DOI 10.1161/ATVBAHA.111.241463; Sundaram M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-35; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Tiwari S, 2013, J BIOL CHEM, V288, P5157, DOI 10.1074/jbc.M112.434258; Tiwari S, 2012, ARTERIOSCL THROM VAS, V32, P1079, DOI 10.1161/ATVBAHA.111.241471; Tran K, 2002, J BIOL CHEM, V277, P31187, DOI 10.1074/jbc.M200249200; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013	40	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12514	12526		10.1074/jbc.M115.705269	http://dx.doi.org/10.1074/jbc.M115.705269			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129256	hybrid, Green Published			2022-12-28	WOS:000378119900006
J	Pfeiffer, A; Stephanowitz, H; Krause, E; Volkwein, C; Hirsch, C; Jarosch, E; Sommer, T				Pfeiffer, Anett; Stephanowitz, Heike; Krause, Eberhard; Volkwein, Corinna; Hirsch, Christian; Jarosch, Ernst; Sommer, Thomas			A Complex of Htm1 and the Oxidoreductase Pdi1 Accelerates Degradation of Misfolded Glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; ER-ASSOCIATED DEGRADATION; RETICULUM-ASSOCIATED DEGRADATION; MANNOSIDASE-LIKE PROTEIN; CHAPERONE-LIKE ACTIVITY; N-LINKED GLYCANS; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; MASS-SPECTROMETRY	A quality control system in the endoplasmic reticulum (ER) efficiently discriminates polypeptides that are in the process of productive folding from conformers that are trapped in an aberrant state. Only the latter are transported into the cytoplasm and degraded in a process termed ER-associated protein degradation (ERAD). In the ER, an enzymatic cascade generates a specific-N-glycan structure of seven mannosyl and twoN-acetylglucosamine residues (Man(7)GlcNAc(2)) on misfolded glycoproteins to facilitate their disposal. We show that a complex encompassing the yeast lectin-like protein Htm1 and the oxidoreductase Pdi1 converts Man(8)GlcNAc(2) on glycoproteins into the Man(7)GlcNAc(2) signal. In vitro the Htm1-Pdi1 complex processes both unfolded and native proteins albeit with a preference for the former. In vivo, elevated expression ofHTM1causes glycan trimming on misfolded and folded proteins, but only degradation of the non-native species is accelerated. Thus, modification with a Man(7)GlcNAc(2) structure does not inevitably commit a protein for ER-associated protein degradation. The function of Htm1 in ERAD relies on its association with Pdi1, which appears to regulate the access to substrates. Our data support a model in which the balanced activities of Pdi1 and Htm1 are crucial determinants for the efficient removal of misfolded secretory glycoproteins.	[Pfeiffer, Anett; Volkwein, Corinna; Hirsch, Christian; Jarosch, Ernst; Sommer, Thomas] Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany; [Stephanowitz, Heike; Krause, Eberhard] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Sommer, Thomas] Humboldt Univ, Inst Biol, Fac Life Sci, D-10099 Berlin, Germany; [Pfeiffer, Anett] Berlin Inst Hlth, Kapelle Ufer 2, D-10117 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Humboldt University of Berlin; Berlin Institute of Health	Hirsch, C; Jarosch, E; Sommer, T (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	christian.hirsch@bihealth.de; ejarosch@mdc-berlin.de; tsommer@mdc-berlin.de		Jarosch, Ernst/0000-0002-5897-3492	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) ( to T. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Ausubel F. M., 1993, CURR PROTOC MOL BIOL; Bagola K, 2013, MOL CELL, V50, P528, DOI 10.1016/j.molcel.2013.04.005; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; BYRD JC, 1982, J BIOL CHEM, V257, P4657; CAI H, 1994, J BIOL CHEM, V269, P24550; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; FARQUHAR R, 1991, GENE, V108, P81, DOI 10.1016/0378-1119(91)90490-3; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; FU DT, 1994, CARBOHYD RES, V261, P173, DOI 10.1016/0008-6215(94)84015-6; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Gauss R, 2011, MOL CELL, V42, P782, DOI 10.1016/j.molcel.2011.04.027; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; GUNTHER R, 1991, J BIOL CHEM, V266, P24557; Harvey DJ, 2008, ANAL BIOCHEM, V376, P44, DOI 10.1016/j.ab.2008.01.025; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Hebert DN, 2012, TRENDS BIOCHEM SCI, V37, P404, DOI 10.1016/j.tibs.2012.07.005; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Jaenicke LA, 2011, MOL BIOL CELL, V22, P2937, DOI 10.1091/mbc.E10-10-0832; Jakob CA, 2001, EMBO REP, V2, P423; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Mehnert M, 2014, NAT CELL BIOL, V16, P77, DOI 10.1038/ncb2882; MIZUNAGA T, 1990, J BIOCHEM, V108, P846, DOI 10.1093/oxfordjournals.jbchem.a123291; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Morelle W, 2007, NAT PROTOC, V2, P1585, DOI 10.1038/nprot.2007.227; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Ninagawa S, 2014, J CELL BIOL, V206, P347, DOI 10.1083/jcb.201404075; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Sakoh-Nakatogawa M, 2009, J BIOL CHEM, V284, P11815, DOI 10.1074/jbc.M900813200; Satoh T, 2010, MOL CELL, V40, P905, DOI 10.1016/j.molcel.2010.11.017; SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x; TACHIKAWA H, 1991, J BIOCHEM, V110, P306, DOI 10.1093/oxfordjournals.jbchem.a123576; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0	59	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12195	12207		10.1074/jbc.M115.703256	http://dx.doi.org/10.1074/jbc.M115.703256			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27053108	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000378092800021
J	Taguchi, Y; Allende, ML; Mizukami, H; Cook, EK; Gavrilova, O; Tuymetova, G; Clarke, BA; Chen, WP; Olivera, A; Proia, RL				Taguchi, Yoshimitsu; Allende, Maria L.; Mizukami, Hiroki; Cook, Emily K.; Gavrilova, Oksana; Tuymetova, Galina; Clarke, Benjamin A.; Chen, Weiping; Olivera, Ana; Proia, Richard L.			Sphingosine-1-phosphate Phosphatase 2 Regulates Pancreatic Islet beta-Cell Endoplasmic Reticulum Stress and Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; TYPE-2 DIABETIC-PATIENTS; INSULIN-RESISTANCE; PHOSPHOHYDROLASE; SPHINGOLIPIDS; SPHINGOSINE; MASS; IDENTIFICATION; HOMEOSTASIS; METABOLISM	Sphingosine-1-phosphate (S1P) is a sphingolipid metabolite that regulates basic cell functions through metabolic and signaling pathways. Intracellular metabolism of S1P is controlled, in part, by two homologous S1P phosphatases (SPPases), 1 and 2, which are encoded by the Sgpp1 and Sgpp2 genes, respectively. SPPase activity is needed for efficient recycling of sphingosine into the sphingolipid synthesis pathway. SPPase 1 is important for skin homeostasis, but little is known about the functional role of SPPase 2. To identify the functions of SPPase 2 in vivo, we studied mice with the Sgpp2 gene deleted. In contrast to Sgpp1(-/)-mice, Sgpp2(-/)-mice had normal skin and were viable into adulthood. Unexpectedly, WT mice expressed Sgpp2 mRNA at high levels in pancreatic islets when compared with other tissues. Sgpp2(-/)-mice had normal pancreatic islet size; however, they exhibited defective adaptive beta-cell proliferation that was demonstrated after treatment with either a high-fat diet or the beta-cell-specific toxin, streptozotocin. Importantly, beta-cells from untreated Sgpp2(-/)-mice showed significantly increased expression of proteins characteristic of the endoplasmic reticulum stress response compared with beta-cells from WT mice, indicating a basal islet defect. Our results show that Sgpp2 deletion causes beta-cell endoplasmic reticulum stress, which is a known cause of beta-cell dysfunction, and reveal a juncture in the sphingolipid recycling pathway that could impact the development of diabetes.	[Taguchi, Yoshimitsu; Allende, Maria L.; Cook, Emily K.; Tuymetova, Galina; Clarke, Benjamin A.; Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, Bldg 10,Rm 9D-06,10 Ctr Dr MSC 1821, Bethesda, MD 20892 USA; [Gavrilova, Oksana] NIDDK, Mouse Metab Core Lab, Bethesda, MD 20892 USA; [Chen, Weiping] NIDDK, Genom Core, Bethesda, MD 20892 USA; [Olivera, Ana] NIAID, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Mizukami, Hiroki] Hirosaki Univ, Grad Sch Med, Dept Pathol & Mol Med, Hirosaki, Aomori 0368562, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Hirosaki University	Proia, RL (corresponding author), NIDDK, Genet Dev & Dis Branch, Bldg 10,Rm 9D-06,10 Ctr Dr MSC 1821, Bethesda, MD 20892 USA.	proia@nih.gov	Chen, Wei/GZK-7348-2022; Proia, Richard L/A-7908-2012; Mizukami, Hiroki/ABE-7877-2021	Mizukami, Hiroki/0000-0003-2920-582X; Proia, Richard/0000-0003-0456-1270	Intramural Research Program of NIDDK, National Institutes of Health; Intramural Research Program of NIAID, National Institutes of Health; Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina [P30 CA138313]; Lipidomics Core in the SC Lipidomics and Pathobiology COBRE [P20 RR017677]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001206, ZIAAI000965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056018, ZIADK056014, ZICDK070002, ZIADK056015] Funding Source: NIH RePORTER	Intramural Research Program of NIDDK, National Institutes of Health; Intramural Research Program of NIAID, National Institutes of Health; Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina; Lipidomics Core in the SC Lipidomics and Pathobiology COBRE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Programs of NIDDK and NIAID, National Institutes of Health; the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina ( Grant P30 CA138313); and the Lipidomics Core in the SC Lipidomics and Pathobiology COBRE ( Grant P20 RR017677). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allende ML, 2013, J BIOL CHEM, V288, P18381, DOI 10.1074/jbc.M113.478420; Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Biden TJ, 2014, TRENDS ENDOCRIN MET, V25, P389, DOI 10.1016/j.tem.2014.02.003; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Engin F, 2014, SCI REP-UK, V4, DOI 10.1038/srep04054; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Kamata K, 2014, AMYLOID, V21, P191, DOI 10.3109/13506129.2014.937857; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Le Stunff H, 2002, J BIOL CHEM, V277, P8920, DOI 10.1074/jbc.M109968200; Le Stunff H, 2002, J CELL BIOL, V158, P1039, DOI 10.1083/jcb.200203123; Le Stunff H, 2007, J BIOL CHEM, V282, P34372, DOI 10.1074/jbc.M703329200; Lepine S, 2011, CELL DEATH DIFFER, V18, P350, DOI 10.1038/cdd.2010.104; Maceyka M, 2007, METHOD ENZYMOL, V434, P243, DOI 10.1016/S0076-6879(07)34013-5; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Mandala SM, 2001, PROSTAG OTH LIPID M, V64, P143, DOI 10.1016/S0090-6980(01)00111-3; Mechtcheriakova D, 2007, FEBS LETT, V581, P3063, DOI 10.1016/j.febslet.2007.05.069; Mechtcheriakova D, 2007, CELL SIGNAL, V19, P748, DOI 10.1016/j.cellsig.2006.09.004; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Mizukami H, 2014, DIABETES CARE, V37, P1966, DOI 10.2337/dc13-2018; Ogawa C, 2003, J BIOL CHEM, V278, P1268, DOI 10.1074/jbc.M209514200; Papa FR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007666; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Sachdeva MM, 2009, MOL ENDOCRINOL, V23, P747, DOI 10.1210/me.2008-0400; Schulze H, 2014, BBA-MOL CELL BIOL L, V1841, P799, DOI 10.1016/j.bbalip.2013.10.015; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993	35	26	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12029	12038		10.1074/jbc.M116.728170	http://dx.doi.org/10.1074/jbc.M116.728170			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27059959	Green Published, hybrid			2022-12-28	WOS:000378092800007
J	Kadamur, G; Ross, EM				Kadamur, Ganesh; Ross, Elliott M.			Intrinsic Pleckstrin Homology (PH) Domain Motion in Phospholipase C- Exposes a G Protein Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; heterotrimeric G protein; phosphatidylinositol signaling; phospholipase C; protein conformation; G; PH domain	BETA-GAMMA-SUBUNITS; CRYSTAL-STRUCTURE; RHO GTPASES; ACTIVATION; C-BETA(2); STIMULATION; G-ALPHA(Q); RECEPTOR; COMPLEX; IDENTIFICATION	Mammalian phospholipase C- (PLC-) isoforms are stimulated by heterotrimeric G protein subunits and members of the Rho GTPase family of small G proteins. Although recent structural studies showed how G(q) and Rac1 bind PLC-, there is a lack of consensus regarding the G binding site in PLC-. Using FRET between cerulean fluorescent protein-labeled G and the Alexa Fluor 594-labeled PLC- pleckstrin homology (PH) domain, we demonstrate that the PH domain is the minimal G binding region in PLC-3. We show that the isolated PH domain can compete with full-length PLC-3 for binding G but not G(q), Using sequence conservation, structural analyses, and mutagenesis, we identify a hydrophobic face of the PLC- PH domain as the G binding interface. This PH domain surface is not solvent-exposed in crystal structures of PLC-, necessitating conformational rearrangement to allow G binding. Blocking PH domain motion in PLC- by cross-linking it to the EF hand domain inhibits stimulation by G without altering basal activity or G(q) response. The fraction of PLC- cross-linked is proportional to the fractional loss of G response. Cross-linked PLC- does not bind G in a FRET-based G-PLC- binding assay. We propose that unliganded PLC- exists in equilibrium between a closed conformation observed in crystal structures and an open conformation where the PH domain moves away from the EF hands. Therefore, intrinsic movement of the PH domain in PLC- modulates G access to its binding site.	Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Mol Biophys Grad Program, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ross, EM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Elliott.Ross@UTSouthwestern.edu		Ross, Elliott M./0000-0002-0252-8197; Kadamur, Ganesh/0000-0002-7019-1485	National Institutes of Health [R01MG030355]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01MG030355. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barr AJ, 2000, BIOCHEMISTRY-US, V39, P1800, DOI 10.1021/bi992021f; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Bonacci TM, 2005, J BIOL CHEM, V280, P10174, DOI 10.1074/jbc.M412514200; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Chan P, 2011, J BIOL CHEM, V286, P2625, DOI 10.1074/jbc.M110.178897; Chidiac P, 1999, J BIOL CHEM, V274, P19639, DOI 10.1074/jbc.274.28.19639; DIETRICH A, 1994, EUR J BIOCHEM, V219, P171, DOI 10.1111/j.1432-1033.1994.tb19927.x; Drin G, 2006, BIOCHEMISTRY-US, V45, P5712, DOI 10.1021/bi052317n; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Essen LO, 1997, BIOCHEMISTRY-US, V36, P1704, DOI 10.1021/bi962512p; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gao JM, 2009, NAT STRUCT MOL BIOL, V16, P684, DOI 10.1038/nsmb.1610; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Guo YJ, 2003, J BIOL CHEM, V278, P29995, DOI 10.1074/jbc.M301438200; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Huang ZW, 2009, NAT STRUCT MOL BIOL, V16, P853, DOI 10.1038/nsmb.1647; Ilkaeva O, 2002, J BIOL CHEM, V277, P4294, DOI 10.1074/jbc.M109612200; Illenberger D, 2003, J BIOL CHEM, V278, P3006, DOI 10.1074/jbc.M208282200; Illenberger D, 1998, EMBO J, V17, P6241, DOI 10.1093/emboj/17.21.6241; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; LEE E, 1994, METHOD ENZYMOL, V237, P146; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Lyon AM, 2011, NAT STRUCT MOL BIOL, V18, P999, DOI 10.1038/nsmb.2095; MAHADEVAN D, 1995, BIOCHEMISTRY-US, V34, P9111, DOI 10.1021/bi00028a021; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Panchenko MP, 1998, J BIOL CHEM, V273, P28298, DOI 10.1074/jbc.273.43.28298; Philip F, 2010, CURR BIOL, V20, P1327, DOI 10.1016/j.cub.2010.06.013; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; Savage JR, 2000, J BIOL CHEM, V275, P30399, DOI 10.1074/jbc.M005120200; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schnabel P, 1998, BIOCHEM J, V330, P461, DOI 10.1042/bj3300461; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Tang W, 2006, J BIOL CHEM, V281, P4746, DOI 10.1074/jbc.M510573200; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wang TL, 2000, J BIOL CHEM, V275, P7466, DOI 10.1074/jbc.275.11.7466; WU DQ, 1993, J BIOL CHEM, V268, P3704; Zhang W, 2001, J BIOL CHEM, V276, P2503, DOI 10.1074/jbc.M003562200	43	10	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11394	11406		10.1074/jbc.M116.723940	http://dx.doi.org/10.1074/jbc.M116.723940			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27002154	Green Published, hybrid			2022-12-28	WOS:000377042100037
J	Bonetti, D; Camilloni, C; Visconti, L; Longhi, S; Brunori, M; Vendruscolo, M; Gianni, S				Bonetti, Daniela; Camilloni, Carlo; Visconti, Lorenzo; Longhi, Sonia; Brunori, Maurizio; Vendruscolo, Michele; Gianni, Stefano			Identification and Structural Characterization of an Intermediate in the Folding of the Measles Virus X Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ON-PATHWAY INTERMEDIATE; REPLICA-AVERAGED METADYNAMICS; C-TERMINAL DOMAIN; PROTEIN-STRUCTURE; KINETIC-ANALYSIS; DENATURED STATE; 3-STATE MODEL; PDZ DOMAIN; MECHANISM; BINDING	Although most proteins fold by populating intermediates, the transient nature of such states makes it difficult to characterize their structures. In this work we identified and characterized the structure of an intermediate of the X domain of phosphoprotein (P) of measles virus. We obtained this result by a combination of equilibrium and kinetic measurements and NMR chemical shifts used as structural restraints in replica-averaged metadynamics simulations. The structure of the intermediate was then validated by rationally designing four mutational variants predicted to affect the stability of this state. These results provide a detailed view of an intermediate state and illustrate the opportunities offered by a synergistic use of experimental and computational methods to describe non-native states at atomic resolution.	[Bonetti, Daniela; Visconti, Lorenzo; Brunori, Maurizio; Gianni, Stefano] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Bonetti, Daniela; Visconti, Lorenzo; Brunori, Maurizio; Gianni, Stefano] Univ Roma La Sapienza, Ist Biol & Patol Mol, CNR, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy; [Camilloni, Carlo; Vendruscolo, Michele; Gianni, Stefano] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England; [Camilloni, Carlo] Tech Univ Munich, Dept Chem, Lichtenbergstr 4, D-85747 Garching, Germany; [Camilloni, Carlo] Tech Univ Munich, Inst Adv Study, Lichtenbergstr 4, D-85747 Garching, Germany; [Longhi, Sonia] Aix Marseille Univ, CNRS, UMR 7257, AFMB, F-13288 Marseille, France; [Longhi, Sonia] CNRS, AFMB UMR 7257, F-13288 Marseille, France	Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; University of Cambridge; Technical University of Munich; Technical University of Munich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Gianni, S (corresponding author), Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy.; Gianni, S (corresponding author), Univ Roma La Sapienza, Ist Biol & Patol Mol, CNR, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy.; Gianni, S (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	gianni@uniroma1.it	Vendruscolo, Michele/F-5901-2012; Camilloni, Carlo/A-4395-2009; Longhi, Sonia/M-5305-2014	Vendruscolo, Michele/0000-0002-3616-1610; Camilloni, Carlo/0000-0002-9923-8590; Longhi, Sonia/0000-0002-6829-6771	Italian Ministero dell'Istruzione dell'Universita e della Ricerca; Sapienza Universita di Roma [C26A155548]	Italian Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Sapienza Universita di Roma	This work was supported by the Italian Ministero dell'Istruzione dell'Universita e della Ricerca (Progetto di Interesse "Invecchiamento"; to S. G.) and by Sapienza Universita di Roma (C26A155548; to S. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Abascal JLF, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121687; Bernard C, 2009, FEBS LETT, V583, P1084, DOI 10.1016/j.febslet.2009.03.004; Best RB, 2010, J PHYS CHEM B, V114, P14916, DOI 10.1021/jp108618d; Bourhis JM, 2004, VIRUS RES, V99, P157, DOI 10.1016/j.virusres.2003.11.007; Bourhis JM, 2006, VIROLOGY, V344, P94, DOI 10.1016/j.virol.2005.09.025; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Camilloni C, 2014, J AM CHEM SOC, V136, P8982, DOI 10.1021/ja5027584; Camilloni C, 2013, J CHEM THEORY COMPUT, V9, P5610, DOI 10.1021/ct4006272; Camilloni C, 2012, J AM CHEM SOC, V134, P3968, DOI 10.1021/ja210951z; Capaldi AP, 2001, NAT STRUCT BIOL, V8, P68; Capaldi AP, 2002, NAT STRUCT BIOL, V9, P209, DOI 10.1038/nsb757; Cavalli A, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4793625; D'Urzo A, 2015, J AM SOC MASS SPECTR, V26, P472, DOI 10.1007/s13361-014-1048-z; Dosnon M, 2015, ACS CHEM BIOL, V10, P795, DOI 10.1021/cb5008579; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fu B, 2014, J COMPUT CHEM, V35, P1101, DOI 10.1002/jcc.23588; Gianni S, 2007, BIOPHYS CHEM, V128, P105, DOI 10.1016/j.bpc.2007.04.008; Gianni S, 2010, NAT STRUCT MOL BIOL, V17, P1431, DOI 10.1038/nsmb.1956; Gruebele M, 2002, NAT STRUCT BIOL, V9, P154, DOI 10.1038/nsb0302-154; Ivarsson Y, 2007, J BIOL CHEM, V282, P8568, DOI 10.1074/jbc.M611026200; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; Jemth P, 2004, P NATL ACAD SCI USA, V101, P6450, DOI 10.1073/pnas.0401732101; Johansson K, 2003, J BIOL CHEM, V278, P44567, DOI 10.1074/jbc.M308745200; Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193; Kingston RL, 2008, J MOL BIOL, V379, P719, DOI 10.1016/j.jmb.2007.12.080; Kohlhoff KJ, 2009, J AM CHEM SOC, V131, P13894, DOI 10.1021/ja903772t; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; MATOUSCHEK A, 1990, NATURE, V346, P440, DOI 10.1038/346440a0; Pace CN, 2000, PROTEINS, P1; PARKER MJ, 1995, J MOL BIOL, V253, P771, DOI 10.1006/jmbi.1995.0590; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054; Sedlmeier R, 1998, ADV VIRUS RES, V50, P101, DOI 10.1016/S0065-3527(08)60807-6; Travaglini-Allocatelli C, 2005, J BIOL CHEM, V280, P25729, DOI 10.1074/jbc.M502628200; Travaglini-Allocatelli C, 2003, J BIOL CHEM, V278, P41136, DOI 10.1074/jbc.M303990200; Wildegger G, 1997, J MOL BIOL, V270, P294, DOI 10.1006/jmbi.1997.1030; Yegambaram K, 2013, PROTEIN SCI, V22, P1502, DOI 10.1002/pro.2336	38	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10886	10892		10.1074/jbc.M116.721126	http://dx.doi.org/10.1074/jbc.M116.721126			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27002146	hybrid, Green Published			2022-12-28	WOS:000377042600038
J	Bueno, AB; Showalter, AD; Wainscott, DB; Stutsman, C; Marin, A; Ficorilli, J; Cabrera, O; Willard, FS; Sloop, KW				Bueno, Ana B.; Showalter, Aaron D.; Wainscott, David B.; Stutsman, Cynthia; Marin, Aranzazu; Ficorilli, James; Cabrera, Over; Willard, Francis S.; Sloop, Kyle W.			Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; EVOLUTIONARILY CONSERVED RESIDUES; STIMULATED INSULIN-SECRETION; CLASS-B GPCRS; DRUG DISCOVERY; GLP-1 RECEPTOR; IRREVERSIBLE INHIBITORS; ASSAY INTERFERENCE; DISULFIDE PATTERN; LIGAND-BINDING	Therapeutic intervention to activate the glucagon-like peptide-1 receptor (GLP-1R) enhances glucose-dependent insulin secretion and improves energy balance in patients with type 2 diabetes mellitus. Studies investigating mechanisms whereby peptide ligands activate GLP-1R have utilized mutagenesis, receptor chimeras, photo-affinity labeling, hydrogen-deuterium exchange, and crystallography of the ligand-binding ectodomain to establish receptor homology models. However, this has not enabled the design or discovery of drug-like non-peptide GLP-1R activators. Recently, studies investigating 4-(3-benzyloxyphenyl)-2-ethylsulfinyl-6-(trifluoromethyl) pyrimidine (BETP), a GLP-1R-positive allosteric modulator, determined that Cys-347 in the GLP-1R is required for positive allosteric modulator activity via covalent modification. To advance small molecule activation of the GLP-1R, we characterized the insulinotropic mechanism of BETP. In guanosine 5'-3-O-(thio) triphosphate binding and INS1 832-3 insulinoma cell cAMP assays, BETP enhanced GLP-1(9-36)-NH2-stimulated cAMP signaling. Using isolated pancreatic islets, BETP potentiated insulin secretion in a glucose-dependent manner that requires both the peptide ligand and GLP-1R. In studies of the covalent mechanism, PAGE fluorography showed labeling of GLP-1R in immunoprecipitation experiments from GLP-1R-expressing cells incubated with [H-3] BETP. Furthermore, we investigated whether other reported GLP-1R activators and compounds identified from screening campaigns modulate GLP-1R by covalent modification. Similar to BETP, several molecules were found to enhance GLP-1R signaling in a Cys-347-dependent manner. These chemotypes are electrophiles that react with GSH, and LC/MS determined the cysteine adducts formed upon conjugation. Together, our results suggest covalent modification may be used to stabilize the GLP-1R in an active conformation. Moreover, the findings provide pharmacological guidance for the discovery and characterization of small molecule GLP-1R ligands as possible therapeutics.	[Bueno, Ana B.; Marin, Aranzazu] Eli Lilly & Co, Ctr Invest Lilly, Alcobendas 28108, Spain; [Showalter, Aaron D.; Stutsman, Cynthia; Ficorilli, James; Cabrera, Over; Sloop, Kyle W.] Eli Lilly & Co, Lilly Res Labs, Endocrine Discovery, Indianapolis, IN 46285 USA; [Wainscott, David B.; Willard, Francis S.] Eli Lilly & Co, Lilly Res Labs, Quantitat Biol, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Eli Lilly	Sloop, KW (corresponding author), Eli Lilly & Co, Lilly Res Labs, Endocrine Discovery, Indianapolis, IN 46285 USA.	sloop_kyle_w@lilly.com		Bueno, Ana Belen/0000-0002-4190-6891				Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Bauer RA, 2015, DRUG DISCOV TODAY, V20, P1061, DOI 10.1016/j.drudis.2015.05.005; Bazarsuren A, 2002, BIOPHYS CHEM, V96, P305, DOI 10.1016/S0301-4622(02)00023-6; Bhumralkar D., 2000, U. S. Patent, Patent No. [WO2000/42026, 200042026]; Bruns RF, 2012, J MED CHEM, V55, P9763, DOI 10.1021/jm301008n; Campbell R. M., 2004, ASSAY GUIDANCE MANUA; Chein R.-J., 2015, U. S. Patent, Patent No. [9,193,665, 9193665]; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; Copeland Robert A, 2005, Methods Biochem Anal, V46, P1; Dahlin JL, 2015, J MED CHEM, V58, P2091, DOI 10.1021/jm5019093; De Amici M, 2010, MED RES REV, V30, P463, DOI 10.1002/med.20166; Deacon CF, 2012, DIABETES OBES METAB, V14, P762, DOI 10.1111/j.1463-1326.2012.01603.x; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Eng H, 2013, DRUG METAB DISPOS, V41, P1470, DOI 10.1124/dmd.113.052183; Epps DE, 2001, ANAL BIOCHEM, V295, P101, DOI 10.1006/abio.2001.5173; Erlanson DA, 2015, J MED CHEM, V58, P2088, DOI 10.1021/acs.jmedchem.5b00294; Flanagan ME, 2014, J MED CHEM, V57, P10072, DOI 10.1021/jm501412a; Gelbert LM, 2014, INVEST NEW DRUG, V32, P825, DOI 10.1007/s10637-014-0120-7; GOERDELER J, 1964, CHEM BER-RECL, V97, P225, DOI 10.1002/cber.19640970133; Gong YD, 2010, B KOREAN CHEM SOC, V31, P3760, DOI 10.5012/bkcs.2010.31.12.3760; Grauschopf U, 2000, BIOCHEMISTRY-US, V39, P8878, DOI 10.1021/bi0001426; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hofmann BA, 2001, PROTEIN SCI, V10, P2050, DOI 10.1110/ps.12101; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Irwin JJ, 2015, J MED CHEM, V58, P7076, DOI 10.1021/acs.jmedchem.5b01105; Jun LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093746; Kirkpatrick A, 2012, P NATL ACAD SCI USA, V109, P19988, DOI [10.1073/pnas.1218051109, 10.1073/pnas.12180511091]; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Knudsen S. M., 2006, U. S. Patent, Patent No. [WO2006/003096, 2006003096]; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Kopin A. S., 2004, U. S. Patent, Patent No. [WO2004/203310, 2004203310]; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lebakken CS, 2009, J BIOMOL SCREEN, V14, P924, DOI 10.1177/1087057109339207; Li NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047936; Liao J., 2014, U. S. Patent, Patent No. [8,748,412, 8748412]; Liu QS, 2013, CHEM BIOL, V20, P146, DOI 10.1016/j.chembiol.2012.12.006; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Moon H. S., 2011, U. S. Patent, Patent No. [WO2011/122815, 2011122815]; Moon HS, 2011, ARCH PHARM RES, V34, P1041, DOI 10.1007/s12272-011-0721-z; Moon MJ, 2015, J BIOL CHEM, V290, P5696, DOI 10.1074/jbc.M114.612606; Moon MJ, 2012, J BIOL CHEM, V287, P3873, DOI 10.1074/jbc.M111.276808; Morris LC, 2014, J MED CHEM, V57, P10192, DOI 10.1021/jm501375c; Nakane A, 2015, ANAL BIOCHEM, V491, P23, DOI 10.1016/j.ab.2015.08.026; NOGUCHI T, 1968, Yakugaku Zasshi, V88, P1437; Nolte WM, 2014, NAT CHEM BIOL, V10, P629, DOI 10.1038/nchembio.1581; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; PLAPP BV, 1982, METHOD ENZYMOL, V87, P469; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Singh J, 1997, J MED CHEM, V40, P1130, DOI 10.1021/jm960380s; Siu FY, 2010, STRUCTURE, V18, P1067, DOI 10.1016/j.str.2010.08.004; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; Takahashi K, 2009, BIOL PHARM BULL, V32, P475, DOI 10.1248/bpb.32.475; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Wessel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6897; Willard FS, 2012, MOL PHARMACOL, V82, P1066, DOI 10.1124/mol.112.080432; Willard FS, 2012, EXP DIABETES RES, DOI 10.1155/2012/709893; Wootten D, 2013, MOL PHARMACOL, V83, P822, DOI 10.1124/mol.112.084525; Wootten D, 2012, MOL PHARMACOL, V82, P281, DOI 10.1124/mol.112.079319; Wu R.-Y., 2015, U. S. Patent, Patent No. [9,150,482, 9150482]; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859	65	40	42	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10700	10715		10.1074/jbc.M115.696039	http://dx.doi.org/10.1074/jbc.M115.696039			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26975372	hybrid, Green Published			2022-12-28	WOS:000377042600022
J	Shimizu, T; Tomita, T; Kuzuyama, T; Nishiyama, M				Shimizu, Tetsu; Tomita, Takeo; Kuzuyama, Tomohisa; Nishiyama, Makoto			Crystal Structure of the LysY.LysW Complex from Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1ST 2 STEPS; LYSINE BIOSYNTHESIS; GLUTAMATE KINASE; CARRIER PROTEIN; ENZYME; DEHYDROGENASE; PHOSPHATE; BACTERIUM; PROLINE; BINDING	Several bacteria and archaea utilize the amino group-carrier protein, LysW, for lysine biosynthesis, in which an isopeptide bond is formed between the C-terminal Glu of LysW and an amino group of a-aminoadipate (AAA), The resulting LysW-gamma-AAA is phosphorylated by LysZ to form LysW-gamma-AAA phosphate, which is subsequently reduced to LysW-gamma-aminoadipic semialdehyde (LysW-gamma-AASA) through a reaction catalyzed by LysY. In this study, we determined the crystal structures of LysY from Thermus thermophilus HB27 (TtLysY) complexed with TtLysW-gamma-AASA and TtLysW-gamma-AAA, respectively. In both structures, the globular domain of TtLysW was recognized by positively charged residues on helix alpha 9 and the beta 11-alpha 10 loop of TtLysY through conformational changes. A mutational analysis confirmed that the interactions observed between TtLysY and LysW are important for the function of TtLysY. The extended LysW recognition loop and conserved arginine residue were identified as signatures to discriminate LysY from ArgC, which is involved in arginine biosynthesis. Combined with the previously determined TtLysZ.TtLysW complex structure, TtLysW may simultaneously bind TtLysZ and TtLysY. These structural insights suggest the formation of a TtLysWZY ternary complex, in which the flexible C-terminal extension of TtLysW promotes the efficient transfer of the labile intermediate from the active site of TtLysZ to that of TtLysY during the sequential reactions catalyzed by TtLysZY.	[Shimizu, Tetsu; Tomita, Takeo; Kuzuyama, Tomohisa; Nishiyama, Makoto] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan	University of Tokyo	Nishiyama, M (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	umanis@mail.ecc.u-tokyo.ac.jp		Kuzuyama, Tomohisa/0000-0002-7221-5858	Japan Society for the Promotion of Science [24228001]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grant 24228001 (to M. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Abadjieva A, 2001, J BIOL CHEM, V276, P42869, DOI 10.1074/jbc.M103732200; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aral B, 1996, CR ACAD SCI III-VIE, V319, P171; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLACK S, 1955, J BIOL CHEM, V213, P27; Bulaj G, 1998, BIOCHEMISTRY-US, V37, P8965, DOI 10.1021/bi973101r; Cherney LT, 2007, J MOL BIOL, V367, P1357, DOI 10.1016/j.jmb.2007.01.033; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Demmer U, 2013, J BIOL CHEM, V288, P6363, DOI 10.1074/jbc.M112.421263; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faehnle CR, 2006, J BIOL CHEM, V281, P31031, DOI 10.1074/jbc.M605926200; GILSON MK, 1988, PROTEINS, V4, P7, DOI 10.1002/prot.340040104; Hadfield A, 2001, BIOCHEMISTRY-US, V40, P14475, DOI 10.1021/bi015713o; Horie A, 2009, NAT CHEM BIOL, V5, P673, DOI 10.1038/nchembio.198; HU CAA, 1992, P NATL ACAD SCI USA, V89, P9354, DOI 10.1073/pnas.89.19.9354; James CL, 2002, BIOCHEMISTRY-US, V41, P3726, DOI 10.1021/bi0159074; Jia YH, 2006, BIOCHEM J, V396, P479, DOI 10.1042/BJ20051711; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KATCHALSKY A, 1954, J AM CHEM SOC, V76, P6042, DOI 10.1021/ja01652a053; Kobashi N, 1999, J BACTERIOL, V181, P1713, DOI 10.1128/JB.181.6.1713-1718.1999; KOSHLAND DE, 1952, J AM CHEM SOC, V74, P2286, DOI 10.1021/ja01129a035; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLoughlin SY, 2008, P NATL ACAD SCI USA, V105, P13497, DOI 10.1073/pnas.0804804105; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; Miyazaki J, 2003, J BIOL CHEM, V278, P1864, DOI 10.1074/jbc.M205133200; Miyazaki T, 2004, MICROBIOL-SGM, V150, P2327, DOI 10.1099/mic.0.27037-0; Mukherjee S, 2010, J MOL BIOL, V401, P949, DOI 10.1016/j.jmb.2010.07.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouchi T, 2013, NAT CHEM BIOL, V9, P277, DOI [10.1038/NCHEMBIO.1200, 10.1038/nchembio.1200]; Pavlovsky AG, 2014, ACTA CRYSTALLOGR D, V70, P3244, DOI 10.1107/S1399004714023979; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SEDDON AP, 1989, J BIOL CHEM, V264, P11326; STRASSMAN M, 1953, J AM CHEM SOC, V75, P1680, DOI 10.1021/ja01103a049; Udaka S., 1958, J GEN APPL MICROBIOL, V4, P272; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; VOGEL HJ, 1964, AM NAT, V98, P435, DOI 10.1086/282338; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wulandari AP, 2002, FEBS LETT, V522, P35, DOI 10.1016/S0014-5793(02)02877-6; Yoshida A, 2015, J BIOL CHEM, V290, P435, DOI 10.1074/jbc.M114.595983; YOSHINAGA F, 1967, BIOCHEM BIOPH RES CO, V27, P143, DOI 10.1016/S0006-291X(67)80053-6	42	3	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9948	9959		10.1074/jbc.M115.707034	http://dx.doi.org/10.1074/jbc.M115.707034			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26966182	Green Published, hybrid			2022-12-28	WOS:000375602800010
J	Smith, JS; Rajagopal, S				Smith, Jeffrey S.; Rajagopal, Sudarshan			The beta-Arrestins: Multifunctional Regulators of G Protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MUSCARINIC ACETYLCHOLINE-RECEPTOR; AGONIST-PROMOTED DESENSITIZATION; 3RD INTRACELLULAR LOOP; ADRENERGIC-RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; VISUAL ARRESTIN; BETA-2-ADRENERGIC RECEPTOR; 7-TRANSMEMBRANE RECEPTORS; INDEPENDENT INTERNALIZATION	The beta-arrestins (beta arrs) are versatile, multifunctional adapter proteins that are best known for their ability to desensitize G protein-coupled receptors (GPCRs), but also regulate a diverse array of cellular functions. To signal in such a complex fashion, beta arrs adopt multiple conformations and are regulated at multiple levels to differentially activate downstream pathways. Recent structural studies have demonstrated that beta arrs have a conserved structure and activation mechanism, with plasticity of their structural fold, allowing them to adopt a wide array of conformations. Novel roles for beta arrs continue to be identified, demonstrating the importance of these dynamic regulators of cellular signaling.	[Smith, Jeffrey S.; Rajagopal, Sudarshan] Duke Univ, Med Ctr, Dept Biochem, Box 3126, Durham, NC 27710 USA; [Rajagopal, Sudarshan] Duke Univ, Med Ctr, Dept Med, Box 3126, Durham, NC 27710 USA	Duke University; Duke University	Rajagopal, S (corresponding author), Duke Univ, Med Ctr, Box 3126, Durham, NC 27710 USA.	sudarshan.rajagopal@dm.duke.edu	Rajagopal, Sudarshan/G-8975-2013	Rajagopal, Sudarshan/0000-0002-3443-5040; Smith, Jeffrey/0000-0003-2840-2899	National Institutes of Health [HL114643, 5T32GM007171]; Burroughs Wellcome Career Award for Medical Scientists; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL114643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants HL114643 (to S. R.) and 5T32GM007171 (to J. S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Burroughs Wellcome Career Award for Medical Scientists.	Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Bhatnagar A, 2001, J BIOL CHEM, V276, P8269, DOI 10.1074/jbc.M006968200; Boerrigter G, 2012, CIRC-HEART FAIL, V5, P627, DOI 10.1161/CIRCHEARTFAILURE.112.969220; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; Brame AL, 2015, HYPERTENSION, V65, P834, DOI 10.1161/HYPERTENSIONAHA.114.05099; Breitman M, 2012, J BIOL CHEM, V287, P19653, DOI 10.1074/jbc.M112.358192; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Brust TF, 2015, J PHARMACOL EXP THER, V352, P480, DOI 10.1124/jpet.114.220293; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Butcher AJ, 2011, J BIOL CHEM, V286, P11506, DOI 10.1074/jbc.M110.154526; Bychkov E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048912; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Conner DA, 1997, CIRC RES, V81, P1021; CRAFT CM, 1994, J BIOL CHEM, V269, P4613; DeGraff JL, 2002, J BIOL CHEM, V277, P43247, DOI 10.1074/jbc.M207495200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Feinstein TN, 2013, J BIOL CHEM, V288, P27849, DOI 10.1074/jbc.M112.445098; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Feuerstein SE, 2009, BIOCHEMISTRY-US, V48, P10733, DOI 10.1021/bi900544p; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gimenez LE, 2012, J BIOL CHEM, V287, P29495, DOI 10.1074/jbc.M112.366674; Granzin J, 2015, SCI REP-UK, V5, DOI 10.1038/srep15808; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; Kang DS, 2013, METHOD ENZYMOL, V521, P91, DOI 10.1016/B978-0-12-391862-8.00005-3; Kang DS, 2009, J BIOL CHEM, V284, P29860, DOI 10.1074/jbc.M109.023366; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; KENAKIN TP, 1985, J PHARMACOL METHOD, V13, P281, DOI 10.1016/0160-5402(85)90011-7; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; KONG GH, 1994, J BIOL CHEM, V269, P13084; Kook S, 2013, J BIOL CHEM, V288, P37332, DOI 10.1074/jbc.M113.510412; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lee KB, 1998, J BIOL CHEM, V273, P12967, DOI 10.1074/jbc.273.21.12967; LIGGETT SB, 1992, J BIOL CHEM, V267, P4740; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; McDonald PH, 1999, J BIOL CHEM, V274, P10677, DOI 10.1074/jbc.274.16.10677; Milano SK, 2006, J BIOL CHEM, V281, P9812, DOI 10.1074/jbc.M512703200; Nobles KN, 2007, J BIOL CHEM, V282, P21370, DOI 10.1074/jbc.M611483200; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Onaran HO, 2014, TRENDS PHARMACOL SCI, V35, P639, DOI 10.1016/j.tips.2014.09.010; Ozawa K, 2008, MOL CELL, V31, P395, DOI 10.1016/j.molcel.2008.05.024; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P14152, DOI 10.1074/jbc.272.22.14152; Patwari P, 2012, TRENDS ENDOCRIN MET, V23, P216, DOI 10.1016/j.tem.2012.03.003; PITCHER J, 1992, BIOCHEMISTRY-US, V31, P3193, DOI 10.1021/bi00127a021; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Snyder JC, 2013, J BIOL CHEM, V288, P10286, DOI 10.1074/jbc.M112.447540; Soergel DG, 2014, PAIN, V155, P1829, DOI 10.1016/j.pain.2014.06.011; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Tarigopula M, 2015, CARDIOVASC RES, V107, P226, DOI 10.1093/cvr/cvv162; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Tran JA, 2009, MOL PHARMACOL, V75, P381, DOI 10.1124/mol.108.051276; Vines CM, 2003, J BIOL CHEM, V278, P41581, DOI 10.1074/jbc.C300291200; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Wehbi VL, 2013, P NATL ACAD SCI USA, V110, P1530, DOI 10.1073/pnas.1205756110; WILDEN U, 1986, FEBS LETT, V207, P292, DOI 10.1016/0014-5793(86)81507-1; Wyatt D, 2011, J BIOL CHEM, V286, P3884, DOI 10.1074/jbc.M110.152116; Yang F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9202; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	98	189	195	3	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8969	8977		10.1074/jbc.R115.713313	http://dx.doi.org/10.1074/jbc.R115.713313			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26984408	Green Published, hybrid			2022-12-28	WOS:000374849000010
J	Zhang, LY; Xiang, WP; Wang, GL; Yan, ZZ; Zhu, ZW; Guo, Z; Sengupta, R; Chen, AF; Loughran, PA; Lu, B; Wang, QD; Billiar, TR				Zhang, Liyong; Xiang, Wenpei; Wang, Guoliang; Yan, Zhengzheng; Zhu, Zhaowei; Guo, Zhong; Sengupta, Rajib; Chen, Alex F.; Loughran, Patricia A.; Lu, Ben; Wang, Qingde; Billiar, Timothy R.			Interferon beta (IFN-beta) Production during the Double-stranded RNA (dsRNA) Response in Hepatocytes Involves Coordinated and Feedforward Signaling through Toll-like Receptor 3 (TLR3), RNA-dependent Protein Kinase (PKR), Inducible Nitric Oxide Synthase (iNOS), and Src Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HEPATITIS-C VIRUS; ISCHEMIA-REPERFUSION INJURY; LIVER-INJURY; TYROSINE RESIDUES; INNATE IMMUNITY; TNF RECEPTOR; MACROPHAGES; ACTIVATION; EXPRESSION	The sensing of double-stranded RNA (dsRNA) in the liver important for antiviral defenses but can also contribute to sterile inflammation during liver injury. Hepatocytes are often the target of viral infection and are easily injured by inflammatory insults. Here we sought to establish the pathways involved in the production of type I interferons (IFN-I) in response to extracellular poly(I:C), a dsRNA mimetic, in hepatocytes. This was of interest because hepatocytes are long-lived and, unlike most immune cells that readily die after activation with dsRNA, are not viewed as cells with robust antimicrobial capacity. We found that poly(LC) leads to rapid up-regulation of inducible nitric oxide synthase (iNOS), double-stranded RNA-dependent protein kinase (PKR), and Src. The production of IFN-I3 was dependent on iNOS, PKR, and Src and partially dependent on TLR3/Trif. iNOS and Src up-regulation was partially dependent on TLR3/Trif but entirely dependent on PKR. The phosphorylation of TLR3 on tyrosine 759 was shown to increase in parallel to IFN-fl production in an iNOS- and Src-dependent manner, and Src was found to directly interact with TLR3 in the endosomal compartment of poly(I:C)-treated cells. Furthermore, we identified a robust NO/cGMP/PKG-dependent feedforward pathway for the amplification of iNOS expression. These data identify iNOS/NO as an integral component of IFN-beta production in response to dsRNA in hepatocytes in a pathway that involves the coordinated activities of TLR3/Trif and PKR.	[Zhang, Liyong; Xiang, Wenpei; Wang, Guoliang; Yan, Zhengzheng; Zhu, Zhaowei; Guo, Zhong; Sengupta, Rajib; Chen, Alex F.; Loughran, Patricia A.; Wang, Qingde; Billiar, Timothy R.] Univ Pittsburgh, Sch Med, Dept Surg, 200 Lothrop St, Pittsburgh, PA 15213 USA; [Xiang, Wenpei] Huazhong Univ Sci & Technol, Family Planning Res Inst, Tongji Med Coll, Wuhan, Peoples R China; [Loughran, Patricia A.] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15213 USA; [Lu, Ben] Xiangya Third Hosp, Changsha, Hunan, Peoples R China; [Lu, Ben] Cent S Univ, Sch Med, Changsha, Hunan, Peoples R China; [Sengupta, Rajib] Sardar Bhagwan Singh PG Inst, Dept Biochem & Biotechnol, Dehra Dun, Uttarakhand, India	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Huazhong University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; Central South University	Billiar, TR (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, 200 Lothrop St, Pittsburgh, PA 15213 USA.	billiartr@upmc.edu	Lu, Ben/AAN-1068-2021; SENGUPTA, RAJIB/AGY-3587-2022; Loughran, Patricia/AAB-1184-2021	Lu, Ben/0000-0002-8597-0406; SENGUPTA, RAJIB/0000-0002-9665-8784; Zhang, Liyong/0000-0002-6952-7463; Yan, Zheng-Zheng/0000-0003-3082-6762	National Institutes of Health [R37-GM-044100, R01-GM-050441]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050441, R01GM044100, R37GM044100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R37-GM-044100 and R01-GM-050441. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BILLIAR TR, 1992, AM J PHYSIOL, V262, pC1077, DOI 10.1152/ajpcell.1992.262.4.C1077; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Broering R, 2014, J VIRAL HEPATITIS, V21, P480, DOI 10.1111/jvh.12174; Cavassani KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065899; Chanthaphavong RS, 2012, J BIOL CHEM, V287, P35887, DOI 10.1074/jbc.M112.365171; CURRAN RD, 1989, J EXP MED, V170, P1769, DOI 10.1084/jem.170.5.1769; delaTorre A, 1999, J IMMUNOL, V162, P4101; Deng M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005548; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Eum HA, 2011, AM J PATHOL, V179, P1221, DOI 10.1016/j.ajpath.2011.05.046; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; GELLER DA, 1993, P NATL ACAD SCI USA, V90, P3491, DOI 10.1073/pnas.90.8.3491; GELLER DA, 1995, J IMMUNOL, V155, P4890; Guidotti LG, 2000, J EXP MED, V191, P1247, DOI 10.1084/jem.191.7.1247; Hato T, 2015, CLIN J AM SOC NEPHRO, V10, P1459, DOI 10.2215/CJN.04680514; He Y, 2013, EUR J IMMUNOL, V43, P1147, DOI 10.1002/eji.201243187; Heydtmann M, 2009, J VIROL, V83, P2796, DOI 10.1128/JVI.00996-08; Hsieh MY, 2014, J BIOL CHEM, V289, P9208, DOI 10.1074/jbc.M113.508663; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Jiang W, 2005, P NATL ACAD SCI USA, V102, P17077, DOI 10.1073/pnas.0504570102; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Kanda T, 2007, J VIROL, V81, P12375, DOI 10.1128/JVI.01695-07; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim YM, 1997, J BIOL CHEM, V272, P1402, DOI 10.1074/jbc.272.2.1402; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Lee KG, 2012, P NATL ACAD SCI USA, V109, P5791, DOI 10.1073/pnas.1119238109; Lee VG, 2001, SHOCK, V16, P355, DOI 10.1097/00024382-200116050-00006; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Liu SB, 2002, INFECT IMMUN, V70, P3433, DOI 10.1128/IAI.70.7.3433-3442.2002; Loi P, 2013, HEPATOLOGY, V57, P351, DOI 10.1002/hep.26022; Ma ZY, 2015, CELL MOL IMMUNOL, V12, P273, DOI 10.1038/cmi.2014.112; Maa MC, 2011, BBA-MOL CELL RES, V1813, P136, DOI 10.1016/j.bbamcr.2010.09.004; McAllister CS, 2013, J IMMUNOL, V190, P418, DOI 10.4049/jimmunol.1202756; Mehta DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031688; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mihm S, 1997, HEPATOLOGY, V26, P451, DOI 10.1002/hep.510260228; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Moore TC, 2013, FEBS LETT, V587, P3014, DOI 10.1016/j.febslet.2013.07.025; Newton K., 2012, COLD SPRING HARB PER, V4; NUSSLER AK, 1992, J EXP MED, V176, P261, DOI 10.1084/jem.176.1.261; PENG HB, 1995, J BIOL CHEM, V270, P14214, DOI 10.1074/jbc.270.23.14214; Sarkar SN, 2007, J BIOL CHEM, V282, P3423, DOI 10.1074/jbc.C600226200; Sarkar SN, 2003, J BIOL CHEM, V278, P4393, DOI 10.1074/jbc.C200655200; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Shears LL, 1997, J CLIN INVEST, V100, P2035, DOI 10.1172/JCI119736; Shen XD, 2012, AM J TRANSPLANT, V12, P1730, DOI 10.1111/j.1600-6143.2012.04021.x; Solis M, 2006, BIOCHEM PHARMACOL, V72, P1469, DOI 10.1016/j.bcp.2006.06.002; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Vercammen E, 2008, CLIN MICROBIOL REV, V21, P13, DOI 10.1128/CMR.00022-07; Wang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep20248; Wang K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.499; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Xiao XY, 2009, J IMMUNOL, V183, P3712, DOI 10.4049/jimmunol.0901221; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamashita M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002581; Yang SY, 2014, J IMMUNOL, V193, P3436, DOI 10.4049/jimmunol.1401136; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000; Zhai YA, 2008, HEPATOLOGY, V47, P199, DOI 10.1002/hep.21970; Zhang LY, 2010, EMBO J, V29, P1726, DOI 10.1038/emboj.2010.55; Zhang LM, 2013, VIROLOGY, V438, P28, DOI 10.1016/j.virol.2013.01.015; Zorde-Khvalevsky E, 2009, HEPATOLOGY, V50, P198, DOI 10.1002/hep.22973	63	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15093	15107		10.1074/jbc.M116.717942	http://dx.doi.org/10.1074/jbc.M116.717942			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226571	Green Published, hybrid			2022-12-28	WOS:000380583200020
J	McDonald, S; Block, A; Beaucourt, S; Moratorio, G; Vignuzzi, M; Peersen, OB				McDonald, Seth; Block, Andrew; Beaucourt, Stephanie; Moratorio, Gonzalo; Vignuzzi, Marco; Peersen, Olve B.			Design of a Genetically Stable High Fidelity Coxsackievirus B3 Polymerase That Attenuates Virus Growth in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plus-stranded RNA virus; protein engineering; vaccine development; viral polymerase; virology; polymerase fidelity	DEPENDENT RNA-POLYMERASES; REPLICATION FIDELITY; MECHANISM; DYNAMICS; MUTATION; MODEL	Positive strand RNA viruses replicate via a virally encoded RNA-dependent RNA polymerase (RdRP) that uses a unique palm domain active site closure mechanism to establish the canonical two-metal geometry needed for catalysis. This mechanism allows these viruses to evolutionarily fine-tune their replication fidelity to create an appropriate distribution of genetic variants known as a quasispecies. Prior work has shown that mutations in conserved motif A drastically alter RdRP fidelity, which can be either increased or decreased depending on the viral polymerase background. In the work presented here, we extend these studies to motif D, a region that forms the outer edge of the NTP entry channel where it may act as a nucleotide sensor to trigger active site closure. Crystallography, stopped-flow kinetics, quench-flow reactions, and infectious virus studies were used to characterize 15 engineered mutations in coxsackievirus B3 polymerase. Mutations that interfere with the transport of the metal A Mg2+ ion into the active site had only minor effects on RdRP function, but the stacking interaction between Phe(364) and Pro(357), which is absolutely conserved in enteroviral polymerases, was found to be critical for processive elongation and virus growth. Mutating Phe(364) to tryptophan resulted in a genetically stable high fidelity virus variant with significantly reduced pathogenesis in mice. The data further illustrate the importance of the palm domain movement for RdRP active site closure and demonstrate that protein engineering can be used to alter viral polymerase function and attenuate virus growth and pathogenesis.	[McDonald, Seth; Block, Andrew; Peersen, Olve B.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Beaucourt, Stephanie; Moratorio, Gonzalo; Vignuzzi, Marco] Inst Pasteur, CNRS, UMR 3569, 28 Rue Dr Roux, F-75724 Paris 15, France	Colorado State University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Peersen, OB (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	Olve.Peersen@ColoState.edu	Peersen, Olve/P-5587-2016	Beaucourt, Stephanie/0000-0001-9394-6425; Vignuzzi, Marco/0000-0002-4400-771X	National Institutes of Health [R01 AI059130]; LabEx Integrative Biology of Emerging Infectious Diseases program grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LabEx Integrative Biology of Emerging Infectious Diseases program grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 AI059130 (to O. B. P.) and a LabEx Integrative Biology of Emerging Infectious Diseases program grant (to M. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andino R, 2015, VIROLOGY, V479, P46, DOI 10.1016/j.virol.2015.03.022; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Beaucourt S, 2011, JOVE-J VIS EXP, DOI 10.3791/2953; Campagnola G, 2015, J VIROL, V89, P275, DOI 10.1128/JVI.01574-14; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer-Orta C, 2015, VIRUSES-BASEL, V7, P4438, DOI 10.3390/v7082829; Gnadig NF, 2012, P NATL ACAD SCI USA, V109, pE2294, DOI 10.1073/pnas.1204022109; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Gong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060272; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Gong P, 2009, ANAL BIOCHEM, V391, P45, DOI 10.1016/j.ab.2009.04.035; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Korboukh VK, 2014, J BIOL CHEM, V289, P29531, DOI 10.1074/jbc.M114.592303; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Moustafa IM, 2014, J BIOL CHEM, V289, P36229, DOI 10.1074/jbc.M114.616193; Moustafa IM, 2011, J MOL BIOL, V410, P159, DOI 10.1016/j.jmb.2011.04.078; Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shen HJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002851; Stapleford KA, 2015, J VIROL, V89, P11233, DOI 10.1128/JVI.01553-15; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Steitz TA, 2009, CURR OPIN STRUC BIOL, V19, P683, DOI 10.1016/j.sbi.2009.09.001; Theobald DL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040043; Theobald DL, 2006, BIOINFORMATICS, V22, P2171, DOI 10.1093/bioinformatics/btl332; Thompson AA, 2007, J MOL BIOL, V366, P1459, DOI 10.1016/j.jmb.2006.11.070; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Weeks SA, 2012, J BIOL CHEM, V287, P31618, DOI 10.1074/jbc.C112.401471; Yang XR, 2012, STRUCTURE, V20, P1519, DOI 10.1016/j.str.2012.06.012	37	37	37	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					13999	14011		10.1074/jbc.M116.726596	http://dx.doi.org/10.1074/jbc.M116.726596			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27137934	Green Published, hybrid			2022-12-28	WOS:000379975100009
J	Sautrey, G; El Khoury, M; dos Santos, AG; Zimmermann, L; Deleu, M; Lins, L; Decout, JL; Mingeot-Leclercq, MP				Sautrey, Guillaume; El Khoury, Micheline; dos Santos, Andreia Giro; Zimmermann, Louis; Deleu, Magali; Lins, Laurence; Decout, Jean-Luc; Mingeot-Leclercq, Marie-Paule			Negatively Charged Lipids as a Potential Target for New Amphiphilic Aminoglycoside Antibiotics: A BIOPHYSICAL STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotics; bacteria; cardiolipin; lipid bilayer; membrane lipid	MEMBRANE-FUSION; BACTERIAL-MEMBRANES; ESCHERICHIA-COLI; ANIONIC PHOSPHOLIPIDS; NEAMINE DERIVATIVES; OUTER-MEMBRANE; PSEUDOMONAS-AERUGINOSA; PHASE-TRANSITIONS; INNER MEMBRANE; PORE FORMATION	Bacterial membranes are highly organized, containing specific microdomains that facilitate distinct protein and lipid assemblies. Evidence suggests that cardiolipin molecules segregate into such microdomains, probably conferring a negative curvature to the inner plasma membrane during membrane fission upon cell division. 3,6-Dinonyl neamine is an amphiphilic aminoglycoside derivative active against Pseudomonas aeruginosa, including strains resistant to colistin. The mechanisms involved at the molecular level were identified using lipid models (large unilamellar vesicles, giant unilamelllar vesicles, and lipid monolayers) that mimic the inner membrane of P. aeruginosa. The study demonstrated the interaction of 3,6-dinonyl neamine with cardiolipin and phosphatidylglycerol, two negatively charged lipids from inner bacterial membranes. This interaction induced membrane permeabilization and depolarization. Lateral segregation of cardiolipin and membrane hemifusion would be critical for explaining the effects induced on lipid membranes by amphiphilic aminoglycoside antibiotics. The findings contribute to an improved understanding of how amphiphilic aminoglycoside antibiotics that bind to negatively charged lipids like cardiolipin could be promising antibacterial compounds.	[Mingeot-Leclercq, Marie-Paule] Catholic Univ Louvain, Louvain Drug Res Inst, Pharmacol Cellulaire & Mol, Ave E Mounier 73,UCL B1-73-05, Brussels, Belgium; [Zimmermann, Louis; Decout, Jean-Luc] Univ Grenoble Alpes, Dept Pharmacochim Mol, CNRS, UMR 5063,ICMG FR 2607, 470 Rue Chim,BP 53, F-38041 Grenoble, France; [Deleu, Magali; Lins, Laurence] Univ Liege, Lab Biophys Mol Interfaces, Gembloux Agrobio Tech, Passage Deportes 2, B-5030 Gembloux, Belgium; [Sautrey, Guillaume] Univ Lorraine, UMR 7565, CNRS, 1 Blvd Aiguillettes,BP 70239, F-54506 Vandoeuvre Les Nancy, France	Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Liege; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lorraine	Mingeot-Leclercq, MP (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Pharmacol Cellulaire & Mol, Ave E Mounier 73,UCL B1-73-05, Brussels, Belgium.	marie-paule.mingeot@uclouvain.be	Sautrey, Guillaume/AAC-3142-2019; LINS, LAURENCE/Y-1661-2019	LINS, LAURENCE/0000-0001-7772-6748; Deleu, Magali/0000-0001-8255-2965	Belgian Funds for Scientific Research (Fonds National de la Recherche Scientifique) [3.4578.12, PDR.T.1003.14]; Agence Nationale de la Recherche "Programme Labex" (ARCANE) [ANR-11-LABX-003, 11-LABX-008]; Region Rhone Alpes (ARC1) Grant [12 00887201]	Belgian Funds for Scientific Research (Fonds National de la Recherche Scientifique)(Fonds de la Recherche Scientifique - FNRS); Agence Nationale de la Recherche "Programme Labex" (ARCANE)(French National Research Agency (ANR)); Region Rhone Alpes (ARC1) Grant(Region Auvergne-Rhone-Alpes)	This work was supported by the Belgian Funds for Scientific Research (Fonds National de la Recherche Scientifique Grants 3.4578.12 and PDR.T.1003.14), the Agence Nationale de la Recherche "Programme Labex" (ARCANE) Grant IDs ANR-11-LABX-003 and 11-LABX-008, and Region Rhone Alpes (ARC1) Grant ID 12 00887201 (postdoctoral fellowship to L. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Alam JM, 2012, BIOCHEMISTRY-US, V51, P5160, DOI 10.1021/bi300448g; ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Apellaniz B, 2010, BIOPHYS J, V99, P3619, DOI 10.1016/j.bpj.2010.09.027; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Basanez G, 2002, CELL MOL LIFE SCI, V59, P1478, DOI 10.1007/s00018-002-8523-6; Baussanne I, 2010, J MED CHEM, V53, P119, DOI 10.1021/jm900615h; Beales PA, 2011, LANGMUIR, V27, P6107, DOI 10.1021/la104924c; Ben Ghorbal SK, 2013, CURR MICROBIOL, V67, P112, DOI 10.1007/s00284-013-0342-5; Bernal P, 2007, ENVIRON MICROBIOL, V9, P1658, DOI 10.1111/j.1462-2920.2007.01283.x; Boeris PS, 2007, J APPL MICROBIOL, V103, P1048, DOI 10.1111/j.1365-2672.2007.03346.x; Bramkamp M, 2009, CURR OPIN MICROBIOL, V12, P683, DOI 10.1016/j.mib.2009.10.002; Broniatowski M, 2015, BBA-BIOMEMBRANES, V1848, P469, DOI 10.1016/j.bbamem.2014.10.024; Chanturiya A, 2000, J MEMBRANE BIOL, V176, P67, DOI 10.1007/s002320001076; Cheng JTJ, 2011, BBA-BIOMEMBRANES, V1808, P622, DOI 10.1016/j.bbamem.2010.11.025; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; CHOPRA I, 1988, PARASITOLOGY, V96, pS25, DOI 10.1017/S0031182000085966; Dalebroux ZD, 2015, CELL HOST MICROBE, V17, P441, DOI 10.1016/j.chom.2015.03.003; Dalebroux ZD, 2014, P NATL ACAD SCI USA, V111, P1963, DOI 10.1073/pnas.1316901111; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; Di Pasquale E, 2010, CHEM PHYS LIPIDS, V163, P131, DOI 10.1016/j.chemphyslip.2009.10.006; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Duzgunes N, 2010, METHODS MOL BIOL, V606, P209, DOI 10.1007/978-1-60761-447-0_16; Epand RF, 2002, J BIOL CHEM, V277, P32632, DOI 10.1074/jbc.M202396200; Epand RM, 2008, J AM CHEM SOC, V130, P14346, DOI 10.1021/ja8062327; Epand RM, 2011, J PEPT SCI, V17, P298, DOI 10.1002/psc.1319; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; EVANS EA, 1977, BIOPHYS J, V20, P307, DOI 10.1016/S0006-3495(77)85551-3; Fauci AS, 2014, JAMA-J AM MED ASSOC, V311, P1853, DOI 10.1001/jama.2014.2465; Favini-Stabile S, 2013, ENVIRON MICROBIOL, V15, P3218, DOI 10.1111/1462-2920.12171; FEIGENSON GW, 1986, BIOCHEMISTRY-US, V25, P5819, DOI 10.1021/bi00367a071; Fishov I, 2012, CURR OPIN MICROBIOL, V15, P724, DOI 10.1016/j.mib.2012.11.001; Gessmann D, 2014, P NATL ACAD SCI USA, V111, P5878, DOI 10.1073/pnas.1322473111; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; Ibarguren M, 2013, BBA-BIOMEMBRANES, V1828, P2553, DOI 10.1016/j.bbamem.2013.06.014; Kaneko H, 2000, BIOSCI BIOTECH BIOCH, V64, P72, DOI 10.1271/bbb.64.72; Katsov K, 2004, BIOPHYS J, V87, P3277, DOI 10.1529/biophysj.103.038943; Kozlovsky Y, 2002, BIOPHYS J, V83, P2634, DOI 10.1016/S0006-3495(02)75274-0; KRASNE S, 1980, BIOPHYS J, V30, P441, DOI 10.1016/S0006-3495(80)85106-X; Laan EVDD, 2003, J BACTERIOL, V185, P3773, DOI 10.1128/JB.185.3773.3779.2003; Lelkes P. I., 1984, LIPOSOME TECHNOLOGY, P225; Lobasso S, 2009, CHEM PHYS LIPIDS, V157, P12, DOI 10.1016/j.chemphyslip.2008.09.002; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; Lopes SC, 2012, MOL MEMBR BIOL, V29, P207, DOI 10.3109/09687688.2012.700491; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; MATTAI J, 1989, BIOCHEMISTRY-US, V28, P2322, DOI 10.1021/bi00431a051; Meers P, 2000, BBA-BIOMEMBRANES, V1467, P227, DOI 10.1016/S0005-2736(00)00224-8; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Mileykovskaya E, 2009, J BIOL CHEM, V284, P2990, DOI 10.1074/jbc.M805189200; Minkler PE, 2010, J LIPID RES, V51, P856, DOI 10.1194/jlr.D002857; Mohammadi T, 2007, MOL MICROBIOL, V65, P1106, DOI 10.1111/j.1365-2958.2007.05851.x; Murzyn K, 2005, BIOPHYS J, V88, P1091, DOI 10.1529/biophysj.104.048835; Nikolaus J, 2011, CURR TOP MEMBR, V68, P1, DOI 10.1016/B978-0-12-385891-7.00001-5; Niven GW, 1998, J APPL MICROBIOL, V84, P90, DOI 10.1046/j.1365-2672.1997.00316.x; OHKI S, 1982, BIOCHIM BIOPHYS ACTA, V689, P1, DOI 10.1016/0005-2736(82)90182-1; Oliver PM, 2014, J BACTERIOL, V196, P3386, DOI 10.1128/JB.01877-14; Olofsson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073040; Ortiz A, 1999, BIOPHYS J, V77, P2003, DOI 10.1016/S0006-3495(99)77041-4; Ouberai M, 2011, BBA-BIOMEMBRANES, V1808, P1716, DOI 10.1016/j.bbamem.2011.01.014; Payne DJ, 2008, SCIENCE, V321, P1644, DOI 10.1126/science.1164586; Renner LD, 2012, J BIOL CHEM, V287, P38835, DOI 10.1074/jbc.M112.407817; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Rogasevskaia Tatiana P, 2011, J Chem Biol, V4, P117, DOI 10.1007/s12154-011-0056-8; Sadeghi S, 2014, BIOPHYS J, V107, P1591, DOI 10.1016/j.bpj.2014.07.072; Salay LC, 2012, COLLOID SURFACE B, V100, P95, DOI 10.1016/j.colsurfb.2012.05.002; Sautrey G, 2014, ANTIMICROB AGENTS CH, V58, P4420, DOI 10.1128/AAC.02536-13; Saxena R, 2013, INT J MOL SCI, V14, P8517, DOI 10.3390/ijms14048517; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Siegel DP, 1999, BIOPHYS J, V76, P291, DOI 10.1016/S0006-3495(99)77197-3; Siegel DP, 1997, BIOPHYS J, V73, P3089, DOI 10.1016/S0006-3495(97)78336-X; SMITH JC, 1990, BIOCHIM BIOPHYS ACTA, V1016, P1, DOI 10.1016/0005-2728(90)90002-L; Stockl M, 2008, J MOL BIOL, V375, P1394, DOI 10.1016/j.jmb.2007.11.051; Tiriveedhi V, 2007, BIOCHEMISTRY-US, V46, P3888, DOI 10.1021/bi602527t; VANBAMBEKE F, 1993, EUR J PHARM-MOLEC PH, V247, P155, DOI 10.1016/0922-4106(93)90073-I; Vanounou S, 2003, MOL MICROBIOL, V49, P1067, DOI 10.1046/j.1365-2958.2003.03614.x; Wadhwani P, 2012, BIOPHYS J, V103, P265, DOI 10.1016/j.bpj.2012.06.004; WEINSTEIN JN, 1977, SCIENCE, V195, P489, DOI 10.1126/science.835007; Wesolowska O, 2009, ACTA BIOCHIM POL, V56, P33; Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29; Wydro P, 2013, COLLOID SURFACE B, V106, P217, DOI 10.1016/j.colsurfb.2013.01.053; Zimmermann L, 2013, J MED CHEM, V56, P7691, DOI 10.1021/jm401148j	83	28	30	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13864	13874		10.1074/jbc.M115.665364	http://dx.doi.org/10.1074/jbc.M115.665364			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27189936	hybrid, Green Published			2022-12-28	WOS:000379771100040
J	Groeme, R; Airouche, S; Kopecny, D; Jaekel, J; Savko, M; Berjont, N; Bussieres, L; Le Mignon, M; Jagic, F; Zieglmayer, P; Baron-Bodo, V; Bordas-Le Floch, V; Mascarell, L; Briozzo, P; Moingeon, P				Groeme, Rachel; Airouche, Sabi; Kopecny, David; Jaekel, Judith; Savko, Martin; Berjont, Nathalie; Bussieres, Laetitia; Le Mignon, Maxime; Jagic, Franck; Zieglmayer, Petra; Baron-Bodo, Veronique; Bordas-Le Floch, Veronique; Mascarell, Laurent; Briozzo, Pierre; Moingeon, Philippe			Structural and Functional Characterization of the Major Allergen Amb a 11 from Short Ragweed Pollen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUST-MITE ALLERGEN; DICHROISM SPECTROSCOPIC DATA; PROTEIN SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; CYSTEINE PROTEASE; DERMATOPHAGOIDES-PTERONYSSINUS; ACTIVATION MECHANISM; PROTEOLYTIC ACTIVITY; PRO-SEQUENCE; DER-P-1	Allergy to the short ragweed (Ambrosia artemisiifolia) pollen is a major health problem. The ragweed allergen repertoire has been recently expanded with the identification of Amb a 11, a new major allergen belonging to the cysteine protease family. To better characterize Amb a 11, a recombinant proform of the molecule with a preserved active site was produced in Escherichia coli, refolded, and processed in vitro into a mature enzyme. The enzymatic activity is revealed by maturation following an autocatalytic processing resulting in the cleavage of both N- and C-terminal propeptides. The 2.05-angstrom resolution crystal structure of pro-Amb a 11 shows an overall typical C1A cysteine protease fold with a network of molecular interactions between the N-terminal propeptide and the catalytic triad of the enzyme. The allergenicity of Amb a 11 was confirmed in a murine sensitization model, resulting in airway inflammation, production of serum IgEs, and induction of Th2 immune responses. Of note, inflammatory responses were higher with the mature form, demonstrating that the cysteine protease activity critically contributes to the allergenicity of the molecule. Collectively, our results clearly demonstrate that Amb a 11 is a bona fide cysteine protease exhibiting a strong allergenicity. As such, it should be considered as an important molecule for diagnosis and immunotherapy of ragweed pollen allergy.	[Groeme, Rachel; Airouche, Sabi; Jaekel, Judith; Berjont, Nathalie; Bussieres, Laetitia; Le Mignon, Maxime; Baron-Bodo, Veronique; Bordas-Le Floch, Veronique; Mascarell, Laurent; Moingeon, Philippe] Stallergenes Greer, Res & Dev, F-92160 Antony, France; [Kopecny, David] Palacky Univ, Fac Sci, Dept Prot Biochem & Prote, Ctr Reg Hana Biotechnol & Agr Res, Slechtitelu 27, CZ-78371 Olomouc, Czech Republic; [Savko, Martin] SOLEIL Synchrotron, PROXIMA 2A, St Aubin BP 48, F-91192 Gif Sur Yvette, France; [Jagic, Franck; Briozzo, Pierre] AgroParisTech, INRA, Inst Jean Pierre Bourgin, F-78026 Versailles, France; [Zieglmayer, Petra] Allergy Ctr Vienna West, Vienna Challenge Chamber, A-1150 Vienna, Austria	Stallergenes Greer; Palacky University Olomouc; SOLEIL Synchrotron; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Moingeon, P (corresponding author), Stallergenes Greer, Res & Dev, 6 Rue Alexis de Tocqueville, F-92183 Antony, France.	pmoingeon@stallergenes.com	Kopecny, David/ABH-4250-2020; Zieglmayer, Petra/AAG-1006-2020	Kopecny, David/0000-0002-4309-4284; 	Stallergenes; Convention Industrielles de Formation par la Recherche (CIFRE) fellowship from the Association Nationale de la Recherche et de la Technologie; National Program of Sustainability I Grant from the Czech Ministry of Education, Youth and Sports [LO1204]	Stallergenes; Convention Industrielles de Formation par la Recherche (CIFRE) fellowship from the Association Nationale de la Recherche et de la Technologie; National Program of Sustainability I Grant from the Czech Ministry of Education, Youth and Sports	This work was supported in part by Stallergenes. R. G., S. A., J. J., N. B., L. B., M. L. M., V. B.-B., V. B.-L. F., L. M., and P. M. are employees at Stallergenes SAS.r Supported by a Convention Industrielles de Formation par la Recherche (CIFRE) fellowship from the Association Nationale de la Recherche et de la Technologie.r Supported by National Program of Sustainability I Grant LO1204 from the Czech Ministry of Education, Youth and Sports.	Arbes SJ, 2005, J ALLERGY CLIN IMMUN, V116, P377, DOI 10.1016/j.jaci.2005.05.017; Asero R, 2006, CLIN EXP ALLERGY, V36, P658, DOI 10.1111/j.1365-2222.2006.02477.x; Bordas-Le Floch V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136258; Bouley J, 2015, J ALLERGY CLIN IMMUN, V136, P1055, DOI 10.1016/j.jaci.2015.03.001; Bricogne G., 2011, BUSTER VERSION 2 1 0; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Burbach GJ, 2009, ALLERGY, V64, P664, DOI 10.1111/j.1398-9995.2009.01975.x; Burtin D, 2009, CLIN EXP ALLERGY, V39, P760, DOI 10.1111/j.1365-2222.2009.03201.x; Bussieres L, 2010, INT ARCH ALLERGY IMM, V153, P141, DOI 10.1159/000312631; Chapman MD, 2007, CURR ALLERGY ASTHM R, V7, P363, DOI 10.1007/s11882-007-0055-6; Chevigne A, 2007, J MOL BIOL, V374, P170, DOI 10.1016/j.jmb.2007.08.025; Choudhury D, 2009, PHYTOCHEMISTRY, V70, P465, DOI 10.1016/j.phytochem.2009.02.001; Comoy EE, 1998, J IMMUNOL, V160, P2456; Cunningham PT, 2012, INT ARCH ALLERGY IMM, V158, P347, DOI 10.1159/000334280; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; de Halleux S, 2006, J ALLERGY CLIN IMMUN, V117, P571, DOI 10.1016/j.jaci.2005.11.032; Deb R, 2007, J BIOL CHEM, V282, P36808, DOI 10.1074/jbc.M702336200; Demidyuk Ilya V, 2010, Biomol Concepts, V1, P305, DOI 10.1515/bmc.2010.025; Dutta S, 2011, FEBS J, V278, P3012, DOI 10.1111/j.1742-4658.2011.08221.x; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Floch VBL, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0565-6; Gadermaier G, 2008, ALLERGY, V63, P1543, DOI 10.1111/j.1398-9995.2008.01780.x; Gadermaier G, 2014, METHODS, V66, P55, DOI 10.1016/j.ymeth.2013.06.014; Gough L, 2001, CLIN EXP ALLERGY, V31, P1594, DOI 10.1046/j.1365-2222.2001.01207.x; Groves MR, 1996, STRUCTURE, V4, P1193, DOI 10.1016/S0969-2126(96)00127-X; Gunawan Hendra, 2008, Allergol Int, V57, P83, DOI 10.2332/allergolint.O-07-507; Gunawan H, 2008, INT ARCH ALLERGY IMM, V147, P276, DOI 10.1159/000144035; Henriquez OA, 2013, INT FORUM ALLERGY RH, V3, P630, DOI 10.1002/alr.21168; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAMPHUIS IG, 1984, J MOL BIOL, V179, P233, DOI 10.1016/0022-2836(84)90467-4; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kaulmann G, 2006, PROTEIN SCI, V15, P2619, DOI 10.1110/ps.062401806; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Meno K, 2005, J IMMUNOL, V175, P3835, DOI 10.4049/jimmunol.175.6.3835; Nandana V, 2014, PROTEIN EXPRES PURIF, V103, P16, DOI 10.1016/j.pep.2014.08.003; Novinec Marko, 2013, Biomol Concepts, V4, P287, DOI 10.1515/bmc-2012-0054; Okomoto T, 1999, J BIOL CHEM, V274, P11390, DOI 10.1074/jbc.274.16.11390; Oswalt Matthew L, 2008, Allergy Asthma Clin Immunol, V4, P130, DOI 10.1186/1710-1492-4-3-130; PAUL W, 1995, PLANT PHYSIOL, V108, P261, DOI 10.1104/pp.108.1.261; Razafindratsita A, 2007, J ALLERGY CLIN IMMUN, V120, P278, DOI 10.1016/j.jaci.2007.04.009; Reubsaet L, 2013, J ALLERGY CLIN IMMUN, V132, P1440, DOI 10.1016/j.jaci.2013.06.028; Roy S, 2012, ACTA CRYSTALLOGR D, V68, P1591, DOI 10.1107/S0907444912038607; Schmid M, 1998, PLANTA, V206, P466, DOI 10.1007/s004250050423; Sivaraman J, 1999, PROTEIN SCI, V8, P283; Smith M, 2013, ENVIRON INT, V61, P115, DOI 10.1016/j.envint.2013.08.005; Stack CM, 2008, J BIOL CHEM, V283, P9896, DOI 10.1074/jbc.M708521200; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Than ME, 2004, J MOL BIOL, V336, P1103, DOI 10.1016/j.jmb.2003.12.075; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wiederanders B, 2003, ACTA BIOCHIM POL, V50, P691; Wiederanders B, 2003, CURR PROTEIN PEPT SC, V4, P309, DOI 10.2174/1389203033487081; Yi MH, 2015, CYTOKINE, V75, P356, DOI 10.1016/j.cyto.2015.07.011	55	15	16	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13076	13087		10.1074/jbc.M115.702001	http://dx.doi.org/10.1074/jbc.M115.702001			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129273	hybrid, Green Published			2022-12-28	WOS:000379770500016
J	Klein, RH; Stephens, DN; Ho, H; Chen, JK; Salmans, ML; Wang, WN; Yu, ZQ; Andersen, B				Klein, Rachel Herndon; Stephens, Denise N.; Ho, Hsiang; Chen, Jefferson K.; Salmans, Michael L.; Wang, Winnie; Yu, Zhengquan; Andersen, Bogi			Cofactors of LIM Domains Associate with Estrogen Receptor alpha to Regulate the Expression of Noncoding RNA H19 and Corneal Epithelial Progenitor Cell Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE STEM-CELLS; ERYTHROID-DIFFERENTIATION; HOMEODOMAIN PROTEINS; GENOME BROWSER; BREAST-CANCER; LDB1; BINDING; GENE; TRANSCRIPTION; LOCUS	Cofactors of LIM domain proteins, CLIM1 and CLIM2, are widely expressed transcriptional cofactors that are recruited to gene regulatory regions by DNA-binding proteins, including LIM domain transcription factors. In the cornea, epithelium-specific expression of a dominant negative (DN) CLIM under the keratin 14 (K14) promoter causes blistering, wounding, inflammation, epithelial hyperplasia, and neovascularization followed by epithelial thinning and subsequent epidermal-like differentiation of the corneal epithelium. The defects in corneal epithelial differentiation and cell fate determination suggest that CLIM may regulate corneal progenitor cells and the transition to differentiation. Consistent with this notion, the K14-DN-Clim corneal epithelium first exhibits increased proliferation followed by fewer progenitor cells with decreased proliferative potential. In vivo ChIP-sequencing experiments with corneal epithelium show that CLIM binds to and regulates numerous genes involved in cell adhesion and proliferation, including limbally enriched genes. Intriguingly, CLIM associates primarily with non-LIM homeodomain motifs in corneal epithelial cells, including that of estrogen receptor alpha. Among CLIM targets is the noncoding RNA H19 whose deregulation is associated with Silver-Russell and Beckwith-Wiedemann syndromes. We demonstrate here that H19 negatively regulates corneal epithelial proliferation. In addition to cell cycle regulators, H19 affects the expression of multiple cell adhesion genes. CLIM interacts with estrogen receptor alpha at the H19 locus, potentially explaining the higher expression of H19 in female than male corneas. Together, our results demonstrate an important role for CLIM in regulating the proliferative potential of corneal epithelial progenitors and identify CLIM downstream target H19 as a regulator of corneal epithelial proliferation and adhesion.	[Klein, Rachel Herndon; Stephens, Denise N.; Salmans, Michael L.; Wang, Winnie; Yu, Zhengquan; Andersen, Bogi] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Ho, Hsiang; Chen, Jefferson K.; Andersen, Bogi] Univ Calif Irvine, Dept Med, 839 Hlth Sci Dr, Irvine, CA 92697 USA; [Klein, Rachel Herndon; Salmans, Michael L.; Andersen, Bogi] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA; [Yu, Zhengquan] China Agr Univ, State Key Labs AgroBiotechnol, Coll Biol Sci, Beijing 100193, Peoples R China	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; China Agricultural University	Andersen, B (corresponding author), Univ Calif Irvine, Dept Med, 839 Hlth Sci Dr, Irvine, CA 92697 USA.	bogi@uci.edu	Wang, Winnie/GXN-4222-2022; tian, yuhua/AAK-1312-2020		National Institutes of Health [R01EY019413, R01AR44882, T15LM00744, F32AR065356, T32GM08620]; California Institute for Regenerative Medicine [TG2-01152]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044882, F32AR065356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008620] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01EY019413 and R01AR44882 (to B. A.), T15LM00744 (to R. H. K. and M. L. S.), F32AR065356 (to H. H.), and T32GM08620 (to J. K. C.) and by California Institute for Regenerative Medicine Grant TG2-01152 (to D. S. and M. L. S.). The authors have no conflicts of interest to declare. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Azzi S, 2014, CURR OPIN ENDOCRINOL, V21, P30, DOI 10.1097/MED.0000000000000037; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dey-Guha I, 2009, INT J BIOL SCI, V5, P686; Drewell RA, 2002, DEVELOPMENT, V129, P1205; Folgueras AR, 2013, CELL STEM CELL, V13, P314, DOI 10.1016/j.stem.2013.06.018; Gabory A, 2010, BIOESSAYS, V32, P473, DOI 10.1002/bies.200900170; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gordon WM, 2014, J CLIN INVEST, V124, P5205, DOI 10.1172/JCI77138; Gronlund MA, 2011, BRIT J OPHTHALMOL, V95, P637, DOI 10.1136/bjo.2010.184457; Hopkin AS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002829; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Johnsen SA, 2009, CANCER RES, V69, P128, DOI 10.1158/0008-5472.CAN-08-1630; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; Kaffer CR, 2001, MOL CELL BIOL, V21, P8189, DOI 10.1128/MCB.21.23.8189-8196.2001; Kawakita T, 2004, INVEST OPHTH VIS SCI, V45, P3507, DOI 10.1167/iovs.04-0266; Kayala MA, 2012, NUCLEIC ACIDS RES, V40, pW553, DOI 10.1093/nar/gks420; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lasek AW, 2011, J NEUROSCI, V31, P14134, DOI 10.1523/JNEUROSCI.3415-11.2011; Li LQ, 2011, NAT IMMUNOL, V12, P129, DOI 10.1038/ni.1978; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Mardaryev AN, 2011, DEVELOPMENT, V138, P4843, DOI 10.1242/dev.070284; Meier N, 2006, DEVELOPMENT, V133, P4913, DOI 10.1242/dev.02656; Mukhopadhyay M, 2003, DEVELOPMENT, V130, P495, DOI 10.1242/dev.00225; Povinelli BJ, 2014, STEM CELLS, V32, P105, DOI 10.1002/stem.1513; Reinius B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056611; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Salmans ML, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004520; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Singh Purnima, 2012, Frontiers in Genetics, V3, P214, DOI 10.3389/fgene.2012.00214; Singh RR, 2005, CANCER RES, V65, P10594, DOI 10.1158/0008-5472.CAN-05-2268; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Stephens DN, 2013, J BIOL CHEM, V288, P34304, DOI 10.1074/jbc.M113.504399; Storbeck CJ, 2009, MOL BIOL CELL, V20, P4174, DOI 10.1091/mbc.E08-07-0707; Visvader JE, 1997, P NATL ACAD SCI USA, V94, P13707, DOI 10.1073/pnas.94.25.13707; Wang SB, 2012, FASEB J, V26, P1506, DOI 10.1096/fj.11-198036; Xu XM, 2007, DEV BIOL, V312, P484, DOI 10.1016/j.ydbio.2007.09.052; Yu ZQ, 2009, EMBO J, V28, P1890, DOI 10.1038/emboj.2009.142; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou MY, 2006, J BIOL CHEM, V281, P19600, DOI 10.1074/jbc.M600777200	49	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13271	13285		10.1074/jbc.M115.709386	http://dx.doi.org/10.1074/jbc.M115.709386			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129775	hybrid, Green Published			2022-12-28	WOS:000379770500031
J	Cheng, MZ; Xue, H; Cao, WP; Li, WX; Chen, H; Liu, BF; Ma, BY; Yan, XH; Chen, YG				Cheng, Minzhang; Xue, Hua; Cao, Weipeng; Li, Wenxia; Chen, Hua; Liu, Bofeng; Ma, Benyu; Yan, Xiaohua; Chen, Ye-Guang			Receptor for Activated C Kinase 1 (RACK1) Promotes Dishevelled Protein Degradation via Autophagy and Antagonizes Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR CELL POLARITY; HEPATOCELLULAR-CARCINOMA; SELECTIVE AUTOPHAGY; COMPLEX-FORMATION; SRC ACTIVITY; PATHWAY; LIGASE; GROWTH; APOPTOSIS	Wnt signaling plays a critical role in embryonic development, tissue homeostasis, and cancer development. Dishevelled (Dvl) is an essential and central component in Wnt signaling, and its stability and activity is tightly regulated. It has been shown that Dvl can be degraded via both the proteasome and autophagy-lysosome pathways. Here we report that receptor for activated C kinase 1 (RACK1) negatively regulates Dishevelled stability and Wnt signaling. RACK1 interacts with Dvl proteins and promotes their lysosomal degradation, and this effect is enhanced by autophagy induction. RACK1 also interacts with LC3 and enhances the association of LC3 with Dvl2, thereby leading to degradation of Dvl proteins through autophagy. These findings reveal a novel regulatory function of RACK1 in Wnt signaling by modulating Dvl stability.	[Cheng, Minzhang; Xue, Hua; Cao, Weipeng; Li, Wenxia; Chen, Hua; Liu, Bofeng; Ma, Benyu; Yan, Xiaohua; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Xue, Hua] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing 100083, Peoples R China	Tsinghua University; Beijing Forestry University	Chen, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Yan, Xiaohua/J-4922-2015	Yan, Xiaohua/0000-0002-7528-5771	973 Program [2013CB933700]; National Natural Science Foundation of China [31330049, 31501144]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 973 Program Grant 2013CB933700 and National Natural Science Foundation of China Grants 31330049 (to Y. G. C.) and 31501144 (to H. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Deng YZ, 2012, GASTROENTEROLOGY, V142, P812, DOI 10.1053/j.gastro.2011.12.046; Devenport D, 2014, J CELL BIOL, V207, P171, DOI 10.1083/jcb.201408039; Ding Y, 2013, J BIOL CHEM, V288, P8289, DOI 10.1074/jbc.M112.433185; Erdi B, 2012, AUTOPHAGY, V8, P1124, DOI 10.4161/auto.20069; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Guo YY, 2013, HEPATOLOGY, V57, P140, DOI 10.1002/hep.25978; Harada M, 2008, EXP CELL RES, V314, P1753, DOI 10.1016/j.yexcr.2008.01.035; He X, 2011, ONCOGENE, V30, P535, DOI 10.1038/onc.2010.427; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li JJ, 2015, ONCOGENE, V34, P1890, DOI 10.1038/onc.2014.127; Li SD, 2011, P NATL ACAD SCI USA, V108, P2264, DOI 10.1073/pnas.1013170108; Ma BY, 2015, J BIOL CHEM, V290, P12346, DOI 10.1074/jbc.M115.654590; Ma BY, 2014, CELL RES, V24, P912, DOI 10.1038/cr.2014.84; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mamidipudi V, 2007, ONCOGENE, V26, P2914, DOI 10.1038/sj.onc.1210091; Mamidipudi V, 2004, MOL CELL BIOL, V24, P6788, DOI 10.1128/MCB.24.15.6788-6798.2004; Mamidipudi V, 2009, ONCOGENE, V28, P4421, DOI 10.1038/onc.2009.293; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Peng RJ, 2013, ONCOL REP, V30, P2195, DOI 10.3892/or.2013.2723; Ruan YY, 2012, J CLIN INVEST, V122, P2554, DOI 10.1172/JCI58488; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma J, 2012, J BIOL CHEM, V287, P6830, DOI 10.1074/jbc.M111.315135; Shi S, 2012, J BIOL CHEM, V287, P7845, DOI 10.1074/jbc.M111.315416; Subauste MC, 2010, MOL CARCINOGEN, V49, P105, DOI 10.1002/mc.20594; Tumbarello DA, 2012, NAT CELL BIOL, V14, P1024, DOI 10.1038/ncb2589; Wehner P, 2011, DEVELOPMENT, V138, P1321, DOI 10.1242/dev.056291; Wei W, 2012, MOL CELL BIOL, V32, P3903, DOI 10.1128/MCB.00251-12; Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhao YW, 2015, CELL REP, V13, P1407, DOI 10.1016/j.celrep.2015.10.011	42	19	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12871	12879		10.1074/jbc.M115.708818	http://dx.doi.org/10.1074/jbc.M115.708818			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129200	hybrid, Green Published			2022-12-28	WOS:000378119900037
J	Dyer, DP; Salanga, CL; Johns, SC; Valdambrini, E; Fuster, MM; Milner, CM; Day, AJ; Handel, TM				Dyer, Douglas P.; Salanga, Catherina L.; Johns, Scott C.; Valdambrini, Elena; Fuster, Mark M.; Milner, Caroline M.; Day, Anthony J.; Handel, Tracy M.			The Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC-CELL TRAFFICKING; HYALURONAN-BINDING PROTEIN; COLLAGEN-INDUCED ARTHRITIS; MONOMER-DIMER EQUILIBRIUM; ALPHA-STIMULATED GENE-6; GLYCOSAMINOGLYCAN-BINDING; LINK MODULE; NEUTROPHIL MIGRATION; IFN-GAMMA; IN-VIVO	TNF-stimulated gene-6 (TSG-6) is a multifunctional protein secreted in response to pro-inflammatory stimuli by a wide range of cells, including neutrophils, monocytes, and endothelial cells. It has been shown to mediate anti-inflammatory and protective effects when administered in disease models, in part, by reducing neutrophil infiltration. Human TSG-6 inhibits neutrophil migration by binding CXCL8 through its Link module (Link_TSG6) and interfering with the presentation of CXCL8 on cell-surface glycosaminoglycans (GAGs), an interaction that is vital for the function of many chemokines. TSG-6 was also found to interact with chemokines CXCL11 and CCL5, suggesting the possibility that it may function as a broad specificity chemokine-binding protein, functionally similar to those encoded by viruses. This study was therefore undertaken to explore the ability of TSG-6 to regulate the function of other chemokines. Herein, we demonstrate that Link_TSG6 binds chemokines from both the CXC and CC families, including CXCL4, CXCL12, CCL2, CCL5, CCL7, CCL19, CCL21, and CCL27. We also show that the Link_TSG6-binding sites on chemokines overlap with chemokine GAG-binding sites, and that the affinities of Link_TSG6 for these chemokines (K-D values 1-85 nM) broadly correlate with chemokine-GAG affinities. Link_TSG6 also inhibits chemokine presentation on endothelial cells not only through a direct interaction with chemokines but also by binding and therefore masking the availability of GAGs. Along with previous work, these findings suggest that TSG-6 functions as a pluripotent regulator of chemokines by modulating chemokine/GAG interactions, which may be a major mechanism by which TSG-6 produces its anti-inflammatory effects in vivo.	[Dyer, Douglas P.; Salanga, Catherina L.; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Dyer, Douglas P.] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow G12 8TA, Lanark, Scotland; [Johns, Scott C.; Fuster, Mark M.] Vet Affairs San Diego Healthcare Syst, Med Sect, La Jolla, CA 92093 USA; [Johns, Scott C.; Fuster, Mark M.] Vet Affairs San Diego Healthcare Syst, Res Sect, La Jolla, CA 92093 USA; [Johns, Scott C.; Fuster, Mark M.] Univ Calif San Diego, Dept Med, Div Pulm & Crit Care, La Jolla, CA 92093 USA; [Valdambrini, Elena; Milner, Caroline M.; Day, Anthony J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Valdambrini, Elena; Day, Anthony J.] Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England	University of California System; University of California San Diego; University of Glasgow; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of Manchester; University of Manchester	Handel, TM (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.; Milner, CM; Day, AJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	caroline.milner@manchester.ac.uk; anthony.day@manchester.ac.uk; thandel@ucsd.edu	Dyer, Douglas/J-2675-2015; Dyer, Douglas/L-9679-2019; Day, Anthony/O-1658-2015	Dyer, Douglas/0000-0001-5567-6241; Dyer, Douglas/0000-0001-5567-6241; Day, Anthony/0000-0002-1415-3134	Arthritis Research UK [18472, 20347]; Medical Research Council [J014621]; National Institutes of Health [R01AI37113, R01AI118985, R01HL107652]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113, R01AI118985] Funding Source: NIH RePORTER; Medical Research Council [MR/J014621/1] Funding Source: researchfish; Versus Arthritis [20347, 18472] Funding Source: researchfish; MRC [MR/J014621/1] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Arthritis Research UK Grants 18472 and 20347, Medical Research Council Grant J014621 (to C. M. M. and A. J. D.), National Institutes of Health Grants R01AI37113 and R01AI118985 (to T. M. H.) and Grant R01HL107652 (to M. M. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Alexander-Brett JM, 2007, J EXP MED, V204, P3157, DOI 10.1084/jem.20071677; Ali S, 2005, J IMMUNOL, V175, P1257, DOI 10.4049/jimmunol.175.2.1257; Allen SJ, 2011, CYTOKINE, V55, P168, DOI 10.1016/j.cyto.2011.05.002; Asquith DL, 2015, CURR OPIN RHEUMATOL, V27, P204, DOI 10.1097/BOR.0000000000000150; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; Briggs DC, 2015, J BIOL CHEM, V290, P28708, DOI 10.1074/jbc.M115.669838; Cao TV, 2004, MICROCIRCULATION, V11, P615, DOI 10.1080/10739680490503438; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200; Coombes BK, 2001, INFECT IMMUN, V69, P1420, DOI 10.1128/IAI.69.3.1420-1427.2001; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; Dougherty DA, 2007, J NUTR, V137, p1504S, DOI 10.1093/jn/137.6.1504S; Dougherty DA, 2013, ACCOUNTS CHEM RES, V46, P885, DOI 10.1021/ar300265y; Dyer DP, 2016, GLYCOBIOLOGY, V26, P312, DOI 10.1093/glycob/cwv100; Dyer DP, 2014, J IMMUNOL, V192, P2177, DOI 10.4049/jimmunol.1300194; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Fessler MB, 2002, J BIOL CHEM, V277, P31291, DOI 10.1074/jbc.M200755200; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Foskett AM, 2014, AM J PHYSIOL-LUNG C, V306, pL120, DOI 10.1152/ajplung.00240.2013; Gangavarapu P, 2012, J LEUKOCYTE BIOL, V91, P259, DOI 10.1189/jlb.0511239; Gasperini S, 1999, J IMMUNOL, V162, P4928; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Glant TT, 2002, ARTHRITIS RHEUM-US, V46, P2207, DOI 10.1002/art.10555; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Heidarieh H, 2015, VIRUS RES, V209, P67, DOI 10.1016/j.virusres.2015.02.028; Higman VA, 2007, J MOL BIOL, V371, P669, DOI 10.1016/j.jmb.2007.05.073; Higman VA, 2014, J BIOL CHEM, V289, P5619, DOI 10.1074/jbc.M113.542357; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hirose J, 2002, BBA-GEN SUBJECTS, V1571, P219, DOI 10.1016/S0304-4165(02)00232-5; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Jansma AL, 2010, J BIOL CHEM, V285, P14424, DOI 10.1074/jbc.M109.091108; Johnson LA, 2014, ANGIOGENESIS, V17, P335, DOI 10.1007/s10456-013-9407-0; Kahmann JD, 1997, PROTEIN EXPRES PURIF, V9, P315, DOI 10.1006/prep.1996.0694; Kato T, 2014, TRANSPLANTATION, V98, P277, DOI 10.1097/TP.0000000000000230; Kolarova H, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/694312; Kota DJ, 2013, DIABETES, V62, P2048, DOI 10.2337/db12-0931; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Lawrance W, 2016, J BIOL CHEM, V291, P8014, DOI 10.1074/jbc.M115.708305; Lee HY, 2011, J IMMUNOL, V186, P4347, DOI 10.4049/jimmunol.1002068; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; LEE TH, 1993, J BIOL CHEM, V268, P6154; LEE TH, 1990, MOL CELL BIOL, V10, P1982, DOI 10.1128/MCB.10.5.1982; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Maina V, 2009, J LEUKOCYTE BIOL, V86, P123, DOI 10.1189/jlb.0608345; Marson A, 2009, GLYCOBIOLOGY, V19, P1537, DOI 10.1093/glycob/cwp132; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mindrescu C, 2002, ARTHRITIS RHEUM, V46, P2453, DOI 10.1002/art.10503; Mindrescu C, 2000, ARTHRITIS RHEUM, V43, P2668, DOI 10.1002/1529-0131(200012)43:12<2668::AID-ANR6>3.0.CO;2-E; Nagakubo D, 2003, J IMMUNOL, V171, P553, DOI 10.4049/jimmunol.171.2.553; Nagyeri G, 2011, J BIOL CHEM, V286, P23559, DOI 10.1074/jbc.M111.222026; O'Boyle G, 2009, FASEB J, V23, P3906, DOI 10.1096/fj.09-134643; O'Hayre M, 2009, METHOD ENZYMOL, V460, P331, DOI 10.1016/S0076-6879(09)05216-1; Oh JY, 2012, MOL THER, V20, P2143, DOI 10.1038/mt.2012.165; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Park Y, 2016, BIOCHEMISTRY-US, V55, P262, DOI 10.1021/acs.biochem.5b01148; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; Proudfoot AEI, 2015, CYTOKINE, V74, P259, DOI 10.1016/j.cyto.2015.02.011; Qi Y, 2014, J INVEST DERMATOL, V134, P526, DOI 10.1038/jid.2013.328; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Ruiz-Arguello MB, 2008, J VIROL, V82, P917, DOI 10.1128/JVI.02111-07; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Salanga CL, 2014, J BIOL CHEM, V289, P14896, DOI 10.1074/jbc.M114.547737; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Scapini P, 2002, EUR J IMMUNOL, V32, P3515, DOI 10.1002/1521-4141(200212)32:12<3515::AID-IMMU3515>3.0.CO;2-3; Schmidt EP, 2011, PHYSIOLOGY, V26, P334, DOI 10.1152/physiol.00011.2011; Smith P, 2005, J EXP MED, V202, P1319, DOI 10.1084/jem.20050955; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Tanino Y, 2010, J IMMUNOL, V184, P2677, DOI 10.4049/jimmunol.0903274; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wang X, 2011, STRUCTURE, V19, P1138, DOI 10.1016/j.str.2011.06.001; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yang BG, 2007, J IMMUNOL, V179, P4376, DOI 10.4049/jimmunol.179.7.4376; Yoshimura T, 2007, J IMMUNOL, V179, P1942, DOI 10.4049/jimmunol.179.3.1942; Yu YH, 2005, J BIOL CHEM, V280, P32200, DOI 10.1074/jbc.M505738200; Ziarek JJ, 2013, J BIOL CHEM, V288, P737, DOI 10.1074/jbc.M112.394064; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	97	60	61	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12627	12640		10.1074/jbc.M116.720953	http://dx.doi.org/10.1074/jbc.M116.720953			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27044744	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000378119900019
J	Meckler, X; Checler, F				Meckler, Xavier; Checler, Frederic			Presenilin 1 and Presenilin 2 Target gamma-Secretase Complexes to Distinct Cellular Compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; BETA-APP; INTRACELLULAR DOMAIN; C-TERMINUS; IN-VIVO; TRANSMEMBRANE DOMAIN; RECEPTOR ACTIVATION; MISSENSE MUTATIONS; PLASMA-MEMBRANE	gamma-Secretase complexes achieve the production of amyloid peptides playing a key role in Alzheimer disease. These proteases have many substrates involved in important physiological functions. They are composed of two constant subunits, nicastrin and PEN2, and two variable ones, presenilin (PS1 or PS2) and APH1 (APH1aL, APH1aS, or APH1b). Whether the composition of a given gamma-secretase complex determines a specific cellular targeting remains unsolved. Here we combined a bidirectional inducible promoter and 2A peptide technology to generate constructs for the temporary, stoichiometric co-expression of six different combinations of the four gamma-secretase subunits including EGFP-tagged nicastrin. These plasmids allow for the formation of functional gamma-secretase complexes displaying specific activities and maturations. We show that PS1-containing gamma-secretase complexes were targeted to the plasma membrane, whereas PS2-containing ones were addressed to the trans-Golgi network, to recycling endosomes, and, depending on the APH1-variant, to late endocytic compartments. Overall, these novel constructs unravel a presenilin-dependent subcellular targeting of gamma-secretase complexes. These tools should prove useful to determine whether the cellular distribution of gamma-secretase complexes contributes to substrate selectivity and to delineate regulations of their trafficking.	[Meckler, Xavier; Checler, Frederic] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS UMR7275, Lab Excellence Distalz, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur	Checler, F (corresponding author), CNRS UMR7275, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	checler@ipmc.cnrs.fr	Checler, Frederic/C-1241-2009	Checler, Frederic/0000-0003-2098-1750	French National Foundation for Alzheimer Disease and Related Disorders; European League against Alzheimer disease (LECMA); Hospital-University Federation (FHU Onco-Age); LABEX "Excellence Laboratory Program Investment for the Future" Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer disease (DISTALZ)	French National Foundation for Alzheimer Disease and Related Disorders; European League against Alzheimer disease (LECMA); Hospital-University Federation (FHU Onco-Age); LABEX "Excellence Laboratory Program Investment for the Future" Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer disease (DISTALZ)	This work was supported by the French National Foundation for Alzheimer Disease and Related Disorders (to X. M.) and by the European League against Alzheimer disease (LECMA) (to F. C.). This work has been developed and supported through the Hospital-University Federation (FHU Onco-Age) and the LABEX "Excellence Laboratory Program Investment for the Future" Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer disease (DISTALZ). The authors declare that they have no conflicts of interest with the contents of this article.	Acx H, 2014, J BIOL CHEM, V289, P4346, DOI 10.1074/jbc.M113.530907; Andrau D, 2003, J BIOL CHEM, V278, P25859, DOI 10.1074/jbc.M302622200; Bergman A, 2004, J BIOL CHEM, V279, P45564, DOI 10.1074/jbc.M407717200; Bohm C, 2015, MOL CELL NEUROSCI, V66, P3, DOI 10.1016/j.mcn.2015.02.016; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Capell A, 2003, J BIOL CHEM, V278, P52519, DOI 10.1074/jbc.C300435200; Chen FS, 2003, J BIOL CHEM, V278, P19974, DOI 10.1074/jbc.M210049200; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Chyung JH, 2003, J BIOL CHEM, V278, P51035, DOI 10.1074/jbc.M304989200; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; CLARK RF, 1995, NAT GENET, V11, P219, DOI 10.1038/ng1095-219; Dauch P, 1997, NEUROSCI LETT, V221, P85; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Dumanchin C, 1999, HUM MOL GENET, V8, P1263, DOI 10.1093/hmg/8.7.1263; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fassler M, 2010, TRAFFIC, V11, P250, DOI 10.1111/j.1600-0854.2009.01014.x; Flammang B, 2012, J ALZHEIMERS DIS, V30, P145, DOI 10.3233/JAD-2012-112186; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Gu YJ, 2004, J BIOL CHEM, V279, P31329, DOI 10.1074/jbc.M401548200; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hansson EM, 2005, J NEUROCHEM, V92, P1010, DOI 10.1111/j.1471-4159.2004.02926.x; Hasegawa H, 2004, J BIOL CHEM, V279, P46455, DOI 10.1074/jbc.M406289200; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Iwata H, 2001, J BIOL CHEM, V276, P21678, DOI 10.1074/jbc.M007989200; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Laboratory C.S.H., 2007, COLD SPRING HARB PRO, V291, DOI [10.1101/pdb.rec10913, DOI 10.1101/PDB.REC10913]; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Lee J, 2011, BIOCHEMISTRY-US, V50, P4973, DOI 10.1021/bi200026m; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Marambaud P, 1998, BIOCHEM BIOPH RES CO, V252, P134, DOI 10.1006/bbrc.1998.9619; Marcello E, 2008, EUR J PHARMACOL, V585, P109, DOI 10.1016/j.ejphar.2007.11.083; McCarthy JV, 2009, CELL MOL LIFE SCI, V66, P1534, DOI 10.1007/s00018-009-8435-9; Meckler X, 2014, J ALZHEIMERS DIS, V40, P161, DOI 10.3233/JAD-131268; Mikulca JA, 2014, J CLIN PHARM THER, V39, P25, DOI 10.1111/jcpt.12112; Morais VA, 2003, J BIOL CHEM, V278, P43284, DOI 10.1074/jbc.M305685200; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Petit A, 2001, NAT CELL BIOL, V3, P507, DOI 10.1038/35074581; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarzman AL, 1999, P NATL ACAD SCI USA, V96, P7932, DOI 10.1073/pnas.96.14.7932; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Takeda K, 2004, EUR J NEUROSCI, V19, P258, DOI 10.1111/j.0953-816X.2003.03135.x; Tam JHK, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0054-1; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Urra S, 2007, J BIOL CHEM, V282, P7606, DOI 10.1074/jbc.M610458200; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Wakabayashi T, 2009, NAT CELL BIOL, V11, P1340, DOI 10.1038/ncb1978; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yang DS, 2002, J BIOL CHEM, V277, P28135, DOI 10.1074/jbc.M110871200; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zeitelhofer Manuel, 2009, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0432s47; Zhang M, 2006, FASEB J, V20, P1176, DOI 10.1096/fj.05-5531fje	85	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12821	12837		10.1074/jbc.M115.708297	http://dx.doi.org/10.1074/jbc.M115.708297			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27059953	Green Published, hybrid			2022-12-28	WOS:000378119900033
J	Wohl, AP; Troilo, H; Collins, RF; Baldock, C; Sengle, G				Wohl, Alexander P.; Troilo, Helen; Collins, Richard F.; Baldock, Clair; Sengle, Gerhard			Extracellular Regulation of Bone Morphogenetic Protein Activity by the Microfibril Component Fibrillin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTROSCOPY; TGF-BETA; SECONDARY STRUCTURE; MARFAN-SYNDROME; GROWTH; ACTIVATION; PRODOMAIN; RECEPTORS; SPECTRA; COMPETE	Since the discovery of bone morphogenetic proteins (BMPs) as pluripotent cytokines extractable from bone matrix, it has been speculated how targeting of BMPs to the extracellular matrix (ECM) modulates their bioavailability. Understanding these processes is crucial for elucidating pathomechanisms of connective tissue disorders characterized by ECM deficiency and growth factor dysregulation. Here, we provide evidence for a new BMP targeting and sequestration mechanism that is controlled by the ECM molecule fibrillin-1. We present the nanoscale structure of the BMP-7 prodomain-growth factor complex using electron microscopy, small angle x-ray scattering, and circular dichroism spectroscopy, showing that it assumes an open V-like structure when it is bioactive. However, upon binding to fibrillin-1, the BMP-7 complex is rendered into a closed ring shape, which also confers latency to the growth factor, as demonstrated by bioactivity measurements. BMP-7 prodomain variants were used to map the critical epitopes for prodomain-growth factor and prodomain-prodomain binding. Together, these data show that upon prodomain binding to fibrillin-1, the BMP-7 complex undergoes a conformational change, which denies access of BMP receptors to the growth factor.	[Wohl, Alexander P.; Sengle, Gerhard] Univ Cologne, Fac Med, Ctr Biochem, Joseph Stelzmann St 52, D-50931 Cologne, Germany; [Troilo, Helen; Baldock, Clair] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg, Manchester M13 9PT, Lancs, England; [Troilo, Helen; Collins, Richard F.; Baldock, Clair] Univ Manchester, Fac Life Sci, Michael Smith Bldg, Manchester M13 9PT, Lancs, England; [Sengle, Gerhard] Univ Cologne, CMMC, Robert Koch St 21, D-50931 Cologne, Germany	University of Cologne; University of Manchester; University of Manchester; University of Cologne	Sengle, G (corresponding author), Univ Cologne, Fac Med, Ctr Biochem, Joseph Stelzmann St 52, D-50931 Cologne, Germany.	gsengle@uni-koeln.de		Baldock, Clair/0000-0003-3497-1959; Troilo, Helen/0000-0003-0537-1786	NIGMS, National Institutes of Health [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/L00612X/1] Funding Source: researchfish; BBSRC [BB/L00612X/1] Funding Source: UKRI	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to Dr. Lynn Sakai for providing the BMP-7 complex-expressing cell line, the rF11 expression plasmid, and anti-fibrillin-1 polyclonal antibody 9543 and to Karolin Scharnetzki, Tobias Zbik, and Christian Meissner for excellent technical assistance. We thank the ESRF for access to beamline BM29 (Midland BAG Proposal MX-1483) and DESY for access to PetraIII beamline P12, and we thank Dr. Benoit Maillot (ESRF) and Dr. Cy Jefferies (DESY) for assistance during data collection. Molecular graphics and analyses were performed with the UCSF Chimera package. Chimera was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California (San Francisco, CA) (supported by NIGMS, National Institutes of Health, Grant P41-GM103311).	Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Berry R, 2009, P NATL ACAD SCI USA, V106, P8561, DOI 10.1073/pnas.0812178106; Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843; Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000; Chen H, 2013, P NATL ACAD SCI USA, V110, P11887, DOI 10.1073/pnas.1306074110; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jiang H, 2016, J BIOL CHEM, V291, P2954, DOI 10.1074/jbc.M115.683292; Kienast Y, 2016, J BIOL CHEM, V291, P3395, DOI 10.1074/jbc.M115.680009; Koch M, 2006, J BIOL CHEM, V281, P21546, DOI 10.1074/jbc.M604131200; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; Le Goff C, 2011, AM J HUM GENET, V89, P7, DOI 10.1016/j.ajhg.2011.05.012; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Loeys BL, 2013, PEDIATR ENDOCR REV P, V10, P417; Loeys BL, 2003, ACTA CLIN BELG, V58, P3, DOI 10.1179/acb.2003.58.1.001; Massague J, 2000, GENE DEV, V14, P627; Mi LZ, 2015, P NATL ACAD SCI USA, V112, P3710, DOI 10.1073/pnas.1501303112; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Nistala H, 2010, J CELL BIOL, V190, P1107, DOI 10.1083/jcb.201003089; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Sengle G, 2015, MATRIX BIOL, V47, P3, DOI 10.1016/j.matbio.2015.05.002; Sengle G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005340; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534; Wakefield LM, 1989, GROWTH FACTORS, V1, P203, DOI 10.3109/08977198908997997; Walton KL, 2010, J BIOL CHEM, V285, P17029, DOI 10.1074/jbc.M110.110288; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012	47	50	50	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12732	12746		10.1074/jbc.M115.704734	http://dx.doi.org/10.1074/jbc.M115.704734			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27059954	Green Published, hybrid			2022-12-28	WOS:000378119900026
J	Zhang, XJ; Zhao, D; Xiong, XZ; He, ZM; Li, HT				Zhang, Xiaojie; Zhao, Dan; Xiong, Xiaozhe; He, Zhimin; Li, Haitao			Multifaceted Histone H3 Methylation and Phosphorylation Readout by the Plant Homeodomain Finger of Human Nuclear Antigen Sp100C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHD FINGER; OXIDATIVE STRESS; INNER CENTROMERE; INFECTION; BODIES; RECOGNITION; LYSINE-4; PROTEINS; ISOFORMS; FEATURES	The decoding of histone post-translational modifications by chromatin-binding modules ("readers") constitutes one major mechanism of epigenetic regulation. Nuclear antigen Sp100 (SPECKLED, 100 kDa), a constitutive component of the promyelocytic leukemia nuclear bodies, plays key roles in intrinsic immunity and transcriptional repression. Sp100C, a splicing isoform specifically up-regulated upon interferon stimulation, harbors a unique tandem plant homeodomain (PHD) finger and bromodomain at its C terminus. Combining structural, quantitative binding, and cellular co-localization studies, we characterized Sp100C PHD finger as an unmethylated histone H3 Lys(4) (H3K4me0) reader that tolerates histone H3 Thr(3) phosphorylation (H3T3ph), histone H3 Lys(9) trimethylation (H3K9me3), and histone H3 Ser(10) phosphorylation (H3S10ph), hallmarks associated with the mitotic chromosome. In contrast, whereas H3K4me0 reader activity is conserved in Sp140, an Sp100C paralog, the multivalent tolerance of H3T3ph, H3K9me3, and H3S10ph was lost for Sp140. The complex structure determined at 2.1 angstrom revealed a highly coordinated lysine epsilon-amine recognition sphere formed by an extended N-terminal motif for H3K4me0 readout. Interestingly, reader pocket rigidification by disulfide bond formation enhanced H3K4me0 binding by Sp100C. An additional complex structure solved at 2.7 angstrom revealed that H3T3ph is recognized by the arginine residue, Arg(713), that is unique to the PHD finger of Sp100C. Consistent with a restrictive cellular role of Sp100C, these results establish a direct chromatin targeting function of Sp100C that may regulate transcriptional gene silencing and promyelocytic leukemia nuclear body-mediated intrinsic immunity in response to interferon stimulation.	[Zhang, Xiaojie; Zhao, Dan; Xiong, Xiaozhe; He, Zhimin; Li, Haitao] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Minist Educ,Key Lab Prot Sci, Dept Basic Med,Sci Sch Med, Beijing 100084, Peoples R China; [Li, Haitao] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China	Tsinghua University; Sichuan University	Li, HT (corresponding author), Tsinghua Univ, Med Sci Bldg C228, Beijing 100084, Peoples R China.	lht@tsinghua.edu.cn	Li, Haitao/B-2668-2012	Li, Haitao/0000-0001-6741-293X	Major State Basic Research Development Program in China [2015CB910503]; Tsinghua University Initiative Scientific Research Program; National Natural Science Foundation of China [91519304]	Major State Basic Research Development Program in China(National Basic Research Program of China); Tsinghua University Initiative Scientific Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Major State Basic Research Development Program in China Grant 2015CB910503, a grant from the Tsinghua University Initiative Scientific Research Program, and National Natural Science Foundation of China Grant 91519304 (to H. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berscheminski J, 2014, J VIROL, V88, P6076, DOI 10.1128/JVI.00469-14; Bloch DB, 1996, J BIOL CHEM, V271, P29198, DOI 10.1074/jbc.271.46.29198; Casas-Mollano JA, 2008, P NATL ACAD SCI USA, V105, P6486, DOI 10.1073/pnas.0711310105; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Dent AL, 1996, BLOOD, V88, P1423, DOI 10.1182/blood.V88.4.1423.bloodjournal8841423; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Filippakopoulos P., 2015, HISTONE RECOGNITION, P173; Flynn EM, 2015, STRUCTURE, V23, P1801, DOI 10.1016/j.str.2015.08.004; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kavouras JH, 2007, J NEUROVIROL, V13, P416, DOI 10.1080/13550280701460573; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Li H., 2015, HISTONE RECOGNITION, P149; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li YY, 2012, ACTA BIOCH BIOPH SIN, V44, P28, DOI 10.1093/abbs/gmr117; Maul GG, 1995, J CELL BIOCHEM, V59, P498, DOI 10.1002/jcb.240590410; Negorev DG, 2006, J VIROL, V80, P8019, DOI 10.1128/JVI.02164-05; Negorev DG, 2009, J VIROL, V83, P5168, DOI 10.1128/JVI.02083-08; Noh KM, 2015, MOL CELL, V59, P89, DOI 10.1016/j.molcel.2015.05.017; Noh KM, 2015, P NATL ACAD SCI USA, V112, P6820, DOI 10.1073/pnas.1411258112; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Saare M, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/526518; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1; Seeler JS, 1998, P NATL ACAD SCI USA, V95, P7316, DOI 10.1073/pnas.95.13.7316; Sille FCM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029632; SZOSTECKI C, 1990, J IMMUNOL, V145, P4338; Tanno Y, 2015, SCIENCE, V349, P1237, DOI 10.1126/science.aaa2655; Tavalai N, 2009, VIRUSES-BASEL, V1, P1240, DOI 10.3390/v1031240; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VOLKIN DB, 1993, ARCH BIOCHEM BIOPHYS, V300, P30, DOI 10.1006/abbi.1993.1005; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032; Xie J, 2015, CELL, V163, P920, DOI 10.1016/j.cell.2015.10.002; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Zucchelli C, 2014, FEBS J, V281, P216, DOI 10.1111/febs.12588	42	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12786	12798		10.1074/jbc.M116.721159	http://dx.doi.org/10.1074/jbc.M116.721159			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129259	hybrid, Green Published			2022-12-28	WOS:000378119900030
J	Heinrich, G; Russo, L; Castaneda, TR; Pfeiffer, V; Ghadieh, HE; Ghanem, SS; Wu, JS; Faulkner, LD; Ergun, S; McInerney, MF; Hill, JW; Najjar, SM				Heinrich, Garrett; Russo, Lucia; Castaneda, Tamara R.; Pfeiffer, Verena; Ghadieh, Hilda E.; Ghanem, Simona S.; Wu, Jieshen; Faulkner, Latrice D.; Erguen, Sueleyman; McInerney, Marcia F.; Hill, Jennifer W.; Najjar, Sonia M.			Leptin Resistance Contributes to Obesity in Mice with Null Mutation of Carcinoembryonic Antigen-related Cell Adhesion Molecule 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid oxidation; fatty-acid synthase (FAS); insulin resistance; leptin; nuclear magnetic resonance (NMR); CEACAM1; Energy homeostasis; hyperleptinemia; hyperphagia; leptin resistance NIH [; and (to S; M; Najjar); (to J; W; Hill) and	ACTIVATED PROTEIN-KINASE; ACID SYNTHASE INHIBITOR; LOW AEROBIC CAPACITY; INSULIN ACTION; ENERGY-BALANCE; SKELETAL-MUSCLE; POMC NEURONS; FOOD-INTAKE; GLUCOSE-HOMEOSTASIS; HEPATIC STEATOSIS	Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) promotes hepatic insulin clearance. Consistently, mice with null mutation of Ceacam1 (Cc1(-/-)) exhibit impaired insulin clearance with increased lipid production in liver and redistribution to white adipose tissue, leading to visceral obesity at 2 months of age. When the mutation is propagated on the C57/BL6J genetic background, total fat mass rises significantly with age, and glucose intolerance and systemic insulin resistance develop at 6 months of age. This study was carried out to determine the mechanisms underlying the marked increase in total fat mass in 6-month-old mutants. Indirect calorimetry analysis showed that Cc1(-/-) mice develop hyperphagia and a significant reduction in physical activity, in particular in the early hours of the dark cycle, during which energy expenditure is only slightly lower than in wild-type mice. They also exhibit increased triglyceride accumulation in skeletal muscle, due in part to incomplete fatty acid -oxidation. Mechanistically, hypothalamic leptin signaling is reduced, as demonstrated by blunted STAT3 phosphorylation in coronal sections in response to an intracerebral ventricular injection of leptin. Hypothalamic fatty-acid synthase activity is also elevated in the mutants. Together, the data show that the increase in total fat mass in Cc1(-/-) mice is mainly attributed to hyperphagia and reduced spontaneous physical activity. Although the contribution of the loss of CEACAM1 from anorexigenic proopiomelanocortin neurons in the arcuate nucleus is unclear, leptin resistance and elevated hypothalamic fatty-acid synthase activity could underlie altered energy balance in these mice.	[Heinrich, Garrett; Russo, Lucia; Castaneda, Tamara R.; Ghadieh, Hilda E.; Ghanem, Simona S.; Wu, Jieshen; Faulkner, Latrice D.; McInerney, Marcia F.; Hill, Jennifer W.; Najjar, Sonia M.] Coll Pharm & Pharmaceut Sci, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA; [Castaneda, Tamara R.; McInerney, Marcia F.] Coll Pharm & Pharmaceut Sci, Dept Med & Biol Chem, Toledo, OH 43614 USA; [Pfeiffer, Verena; Erguen, Sueleyman] Univ Wurzburg, Inst Anat & Zellbiol, D-97070 Wurzburg, Germany; [Najjar, Sonia M.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University of Wurzburg; University System of Ohio; Ohio University	Najjar, SM (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Off Grants & Res, Irvine Hall,Rm 220B,1 Ohio Univ, Athens, OH 45701 USA.	najjar@ohio.edu	Najjar, Sonia M/GXW-2217-2022; Hill, Jennifer/AAD-8415-2019	Hill, Jennifer/0000-0001-7482-9215	National Institutes of Health [R01 DK054254, R01 DK083850, R01 HL112248, R01 HD081792, R15 DK103196]; Wolfe Innovation Fund (University of Toledo Foundation); Deutsche Forschungsgemeinschaft [ER 276/9-1 TI 690/3-1, SFB 688/3 A19]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD081792] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083850, R01DK054254, P30DK020572, R15DK103196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wolfe Innovation Fund (University of Toledo Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK054254, R01 DK083850, and R01 HL112248 (to S.M.N.), R01 HD081792 (to J.W.H.), and R15 DK103196 (to M.F.M.) and in part by the Wolfe Innovation Fund (University of Toledo Foundation) and Deutsche Forschungsgemeinschaft Grants ER 276/9-1 TI 690/3-1 and SFB 688/3 A19 (to S.E). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Share QY, 2015, DIABETES, V64, P2780, DOI 10.2337/db14-1772; Allison MB, 2014, J ENDOCRINOL, V223, pT25, DOI 10.1530/JOE-14-0404; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; Cha SH, 2005, P NATL ACAD SCI USA, V102, P14557, DOI 10.1073/pnas.0507300102; Cha SH, 2004, BIOCHEM BIOPH RES CO, V317, P301, DOI 10.1016/j.bbrc.2004.03.026; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Chen AS, 2000, TRANSGENIC RES, V9, P145, DOI 10.1023/A:1008983615045; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; DeAngelis AM, 2008, DIABETES, V57, P2296, DOI 10.2337/db08-0379; Draper S, 2010, BRAIN RES, V1350, P139, DOI 10.1016/j.brainres.2010.03.082; Gao S, 2003, P NATL ACAD SCI USA, V100, P5628, DOI 10.1073/pnas.1031698100; Ghosh Sumona, 2010, Hepat Med, V2010, P69; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Han E, 2001, BIOCHEM J, V355, P417, DOI 10.1042/0264-6021:3550417; Heinrich G, 2010, GASTROENTEROLOGY, V139, P644, DOI 10.1053/j.gastro.2010.03.056; Kim JD, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00480; Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021; Lam DD, 2015, ENDOCRINOLOGY, V156, P1292, DOI 10.1210/en.2014-1373; Lee SJ, 2008, GASTROENTEROLOGY, V135, P2084, DOI 10.1053/j.gastro.2008.08.007; Lester SG, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00116; Luo N, 2011, ENDOCRINOLOGY, V152, P883, DOI 10.1210/en.2010-1135; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mul JD, 2012, OBESITY, V20, P612, DOI 10.1038/oby.2011.81; Muoio DM, 1997, DIABETES, V46, P1360, DOI 10.2337/diabetes.46.8.1360; Najjar SM, 2005, CELL METAB, V2, P43, DOI 10.1016/j.cmet.2005.06.001; Najjar SM, 2002, TRENDS ENDOCRIN MET, V13, P240, DOI 10.1016/S1043-2760(02)00608-2; Obici S, 2003, ENDOCRINOLOGY, V144, P5172, DOI 10.1210/en.2003-0999; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Patel PR, 2012, DIABETOLOGIA, V55, P763, DOI 10.1007/s00125-011-2388-x; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Plum L, 2006, J CLIN INVEST, V116, P1761, DOI 10.1172/JCI29063; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; Ren HX, 2015, DIABETES, V64, P405, DOI 10.2337/db14-0752; SMITH AL, 1991, J INFECT DIS, V163, P879, DOI 10.1093/infdis/163.4.879; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Tanaka T, 2007, CELL METAB, V5, P395, DOI 10.1016/j.cmet.2007.04.004; Thyfault JP, 2009, J PHYSIOL-LONDON, V587, P1805, DOI 10.1113/jphysiol.2009.169060; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Xu E, 2009, ENDOCRINOLOGY, V150, P3503, DOI 10.1210/en.2008-1439; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008	46	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11124	11132		10.1074/jbc.M116.716431	http://dx.doi.org/10.1074/jbc.M116.716431			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27002145	Green Published, hybrid			2022-12-28	WOS:000377042100016
J	Lubarski-Gotliv, I; Asher, C; Dada, LA; Garty, H				Lubarski-Gotliv, Irina; Asher, Carol; Dada, Laura A.; Garty, Haim			FXYD5 Protein Has a Pro-inflammatory Role in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine induction; inflammation; lipopolysaccharide (LPS); plasma membrane; translocation	TUMOR-NECROSIS-FACTOR; ALVEOLAR FLUID CLEARANCE; KAPPA-B; K-ATPASE; DYSADHERIN; EXPRESSION; RECEPTOR; NA,K-ATPASE; ACTIVATION; TNF	The FXYD proteins are a family of small membrane proteins that share an invariant four amino acid signature motif F-X-Y-D and act as tissue-specific regulatory subunits of the Na,K-ATPase. FXYD5 (also termed dysadherin or RIC) is a structurally and functionally unique member of the FXYD family. As other FXYD proteins, FXYD5 specifically interacts with the Na,K-ATPase and alters its kinetics by increasing V-max. However, unlike other family members FXYD5 appears to have additional functions, which cannot be readily explained by modulation of transport kinetics. Knockdown of FXYD5 in MDA-MB-231 breast cancer cells largely decreases expression and secretion of the chemokine CCL2 (MCP-1). A related effect has also been observed in renal cell carcinoma cells. The current study aims to further characterize the relationship between the expression of FXYD5 and CCL2 secretion. We demonstrate that transfection of M1 epithelial cell line with FXYD5 largely increases lipopolysaccharide (LPS) stimulated CCL2 mRNA and secretion of the translated protein. We have completed a detailed analysis of the molecular events leading to the above response. Our key findings indicate that FXYD5 generates a late response by increasing the surface expression of the TNF receptor, without affecting its total protein level, or mRNA transcription. LPS administration to mice demonstrates induced secretion of CCL2 and TNF in FXYD5-expressing lung peripheral tissue, which suggests a possible role for FXYD5 in normal epithelia during inflammation.	[Lubarski-Gotliv, Irina; Asher, Carol; Garty, Haim] Weizmann Inst Sci, Dept Biol Chem, IL-7610001 Rehovot, Israel; [Dada, Laura A.] Northwestern Univ, Div Pulm & Crit Care Med, Chicago, IL 60611 USA	Weizmann Institute of Science; Northwestern University	Lubarski-Gotliv, I (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	irina.lubarski@weizmann.ac.il			U.S.-Israel Binational Science Foundation; National Institutes of Health [HL113350]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113350] Funding Source: NIH RePORTER	U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the U.S.-Israel Binational Science Foundation (to L. A. D. and H. G.) and National Institutes of Health Grant HL113350. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramowitz J, 2003, CIRCULATION, V108, P3048, DOI 10.1161/01.CIR.0000101919.00548.86; Amiot F, 1997, MOL MED, V3, P864, DOI 10.1007/BF03401722; Anand AR, 2009, MOL IMMUNOL, V46, P962, DOI 10.1016/j.molimm.2008.09.022; Azzam ZS, 2002, CIRCULATION, V105, P497, DOI 10.1161/hc0402.102848; Baay M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/565187; Barwe SP, 2005, MOL BIOL CELL, V16, P1082, DOI 10.1091/mbc.E04-05-0427; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Dmitrieva RI, 2003, J BIOL CHEM, V278, P28160, DOI 10.1074/jbc.M303768200; Dumasius V, 2001, CIRC RES, V89, P907, DOI 10.1161/hh2201.100204; Gaeta ML, 2000, LAB INVEST, V80, P1185, DOI 10.1038/labinvest.3780126; Garty H, 2002, AM J PHYSIOL-RENAL, V283, pF607, DOI 10.1152/ajprenal.00112.2002; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Ino Y, 2002, P NATL ACAD SCI USA, V99, P365, DOI 10.1073/pnas.012425299; Jones SJ, 1999, J IMMUNOL, V162, P1042; Lee HW, 2013, BBA-REV CANCER, V1835, P170, DOI 10.1016/j.bbcan.2012.12.007; Lee YK, 2012, CANCER SCI, V103, P1280, DOI 10.1111/j.1349-7006.2012.02302.x; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lubarski I, 2005, J BIOL CHEM, V280, P37717, DOI 10.1074/jbc.M506397200; Lubarski I, 2007, AM J PHYSIOL-RENAL, V293, pF1818, DOI 10.1152/ajprenal.00367.2007; Lubarski I, 2014, AM J PHYSIOL-CELL PH, V306, pC1080, DOI 10.1152/ajpcell.00042.2014; Lubarski I, 2011, AM J PHYSIOL-RENAL, V301, pF1270, DOI 10.1152/ajprenal.00142.2011; McConkey DJ, 2000, CANCER RES, V60, P3807; McFarlane SM, 2002, FEBS LETT, V515, P119, DOI 10.1016/S0014-5793(02)02450-X; Mendes SD, 2009, CELL SIGNAL, V21, P1109, DOI 10.1016/j.cellsig.2009.02.025; Miller TJ, 2008, AM J PHYSIOL-LUNG C, V294, pL654, DOI 10.1152/ajplung.00430.2007; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; Nam JS, 2007, CANCER LETT, V255, P161, DOI 10.1016/j.canlet.2007.02.018; Nam JS, 2006, CANCER RES, V66, P7176, DOI 10.1158/0008-5472.CAN-06-0825; Nikas JB, 2013, SCI REP-UK, V3, DOI 10.1038/srep03254; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Rowlands DJ, 2011, J CLIN INVEST, V121, P1986, DOI 10.1172/JCI43839; Schaer DA, 2011, J EXP MED, V208, P1937, DOI 10.1084/jem.20111856; Schuler Y, 2012, INT J CANCER, V130, P288, DOI 10.1002/ijc.25981; Shimamura T, 2004, CANCER RES, V64, P6989, DOI 10.1158/0008-5472.CAN-04-1166; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; Tsuiji H, 2003, GLYCOBIOLOGY, V13, P521, DOI 10.1093/glycob/cwg065; Vagin O, 2006, J BIOL CHEM, V281, P39573, DOI 10.1074/jbc.M606507200; Wang HL, 2007, J IMMUNOL, V179, P1834, DOI 10.4049/jimmunol.179.3.1834; Xaus J, 2000, BLOOD, V95, P3823; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006	41	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11072	11082		10.1074/jbc.M115.699041	http://dx.doi.org/10.1074/jbc.M115.699041			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27006401	Green Published, hybrid			2022-12-28	WOS:000377042100011
J	Shrestha, E; Hussein, MA; Savas, JN; Ouimet, M; Barrett, TJ; Leone, S; Yates, JR; Moore, KJ; Fisher, EA; Garabedian, MJ				Shrestha, Elina; Hussein, Maryem A.; Savas, Jeffery N.; Ouimet, Mireille; Barrett, Tessa J.; Leone, Sarah; Yates, John R., III; Moore, Kathryn J.; Fisher, Edward A.; Garabedian, Michael J.			Poly(ADP-ribose) Polymerase 1 Represses Liver X Receptor-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; atherosclerosis; cholesterol regulation; gene expression; nuclear receptor; transcription corepressor; ABCA1; ADP-ribosylation; LXR; PARP-1	SIGNALING PATHWAY; GENE-EXPRESSION; LXR; PARP-1; INHIBITION; PROTEIN; MICE; ATHEROSCLEROSIS; METABOLISM; ALPHA	Liver X receptors (LXR) are oxysterol-activated nuclear receptors that play a central role in reverse cholesterol transport through up-regulation of ATP-binding cassette transporters (ABCA1 and ABCG1) that mediate cellular cholesterol efflux. Mouse models of atherosclerosis exhibit reduced atherosclerosis and enhanced regression of established plaques upon LXR activation. However, the coregulatory factors that affect LXR-dependent gene activation in macrophages remain to be elucidated. To identify novel regulators of LXR that modulate its activity, we used affinity purification and mass spectrometry to analyze nuclear LXR complexes and identified poly(ADP-ribose) polymerase-1 (PARP-1) as an LXR-associated factor. In fact, PARP-1 interacted with both LXR and LXR. Both depletion of PARP-1 and inhibition of PARP-1 activity augmented LXR ligand-induced ABCA1 expression in the RAW 264.7 macrophage line and primary bone marrow-derived macrophages but did not affect LXR-dependent expression of other target genes, ABCG1 and SREBP-1c. Chromatin immunoprecipitation experiments confirmed PARP-1 recruitment at the LXR response element in the promoter of the ABCA1 gene. Further, we demonstrated that LXR is poly(ADP-ribosyl)ated by PARP-1, a potential mechanism by which PARP-1 influences LXR function. Importantly, the PARP inhibitor 3-aminobenzamide enhanced macrophage ABCA1-mediated cholesterol efflux to the lipid-poor apolipoprotein AI. These findings shed light on the important role of PARP-1 on LXR-regulated lipid homeostasis. Understanding the interplay between PARP-1 and LXR may provide insights into developing novel therapeutics for treating atherosclerosis.	[Shrestha, Elina; Hussein, Maryem A.; Leone, Sarah; Garabedian, Michael J.] NYU, Sch Med, Dept Microbiol, 550 1st Ave, New York, NY 10016 USA; [Savas, Jeffery N.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Ouimet, Mireille; Barrett, Tessa J.; Moore, Kathryn J.; Fisher, Edward A.] NYU, Sch Med, Dept Med, Div Cardiol,Marc & Ruti Bell Program Vasc Biol, New York, NY 10016 USA; [Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	New York University; Northwestern University; Feinberg School of Medicine; New York University; Scripps Research Institute	Garabedian, MJ (corresponding author), NYU, Sch Med, Dept Microbiol, 550 1st Ave, New York, NY 10016 USA.	michael.garabedian@nyumc.org	Fisher, Edward/ABE-7469-2020; Moore, Kathryn/ABE-6416-2020	Moore, Kathryn/0000-0003-2505-2547; Barrett, Tessa/0000-0003-0751-1578; Fisher, Edward/0000-0001-9802-143X	National Institutes of Health from the National Center for the Advancement of Translational Science [T32GM007238, UL1TR000038]; Vilcek Foundation; American Heart Association [15POST25090199];  [P41GM103533];  [R01MH067880];  [F32AG039127];  [R00DC013805];  [T32AI07180];  [T32GM007308];  [R01HL117226];  [R01HL117334]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038, UL1TR001445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117334, R01HL117226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533, T32GM007308, T32GM007238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG039127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R00DC013805] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for the Advancement of Translational Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vilcek Foundation; American Heart Association(American Heart Association); ; ; ; ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported in part by National Institutes of Health Grants T32GM007238 and UL1TR000038 from the National Center for the Advancement of Translational Science (to E. S.) and Grants P41GM103533 and R01MH067880 (to J. R. Y.), F32AG039127 and R00DC013805 (to J. N. S.), T32AI07180 and T32GM007308 (to M. A. H.), R01HL117226 (to M. J. G. and E. A. F.), and R01HL117334 (to K. J. M.); by a fellowship from the Vilcek Foundation (to E. S.); and by American Heart Association Fellowship 15POST25090199 (to M. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aiello RJ, 2003, ARTERIOSCL THROM VAS, V23, P972, DOI 10.1161/01.ATV.0000054661.21499.FB; Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Anthonisen EH, 2010, J BIOL CHEM, V285, P1607, DOI 10.1074/jbc.M109.082685; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Calkin AC, 2010, ARTERIOSCL THROM VAS, V30, P1513, DOI 10.1161/ATVBAHA.109.191197; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chi YH, 2007, J BIOL CHEM, V282, P27447, DOI 10.1074/jbc.M703098200; Collingwood TN, 1999, J MOL ENDOCRINOL, V23, P255, DOI 10.1677/jme.0.0230255; Costet P, 2000, J BIOL CHEM, V275, P28240; Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Hans CP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007430; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Huuskonen J, 2004, ARTERIOSCL THROM VAS, V24, P703, DOI 10.1161/01.ATV.0000121202.72593.da; Ito A, 2015, ELIFE, V4, DOI 10.7554/eLife.08009; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kong RR, 2011, J BIOL CHEM, V286, P7139, DOI 10.1074/jbc.M110.173393; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; Lee JH, 2009, MOL CELL, V35, P806, DOI 10.1016/j.molcel.2009.07.021; Lee S, 2008, MOL ENDOCRINOL, V22, P1312, DOI 10.1210/me.2008-0012; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Levin N, 2005, ARTERIOSCL THROM VAS, V25, P135, DOI 10.1161/01.ATV.0000150044.84012.68; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; Mita P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063879; Miyamoto T, 1999, MOL CELL BIOL, V19, P2644; Modena P, 2005, CANCER RES, V65, P4012, DOI 10.1158/0008-5472.CAN-04-3050; Muthurajan UM, 2014, P NATL ACAD SCI USA, V111, P12752, DOI 10.1073/pnas.1405005111; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Oumouna-Benachour K, 2007, CIRCULATION, V115, P2442, DOI 10.1161/CIRCULATIONAHA.106.668756; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Peng XN, 2012, ACTA BIOCH BIOPH SIN, V44, P911, DOI 10.1093/abbs/gms080; Petrilli V, 2004, J CLIN INVEST, V114, P1072, DOI 10.1172/JCI200421854; Radovits T, 2007, EUR J PHARMACOL, V564, P158, DOI 10.1016/j.ejphar.2007.02.060; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Savas JN, 2008, P NATL ACAD SCI USA, V105, P10820, DOI 10.1073/pnas.0800658105; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; Soriano FG, 2001, NAT MED, V7, P108, DOI 10.1038/83241; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Torra IP, 2008, MOL CELL BIOL, V28, P2626, DOI 10.1128/MCB.01575-07; Ulven SM, 2005, PROSTAG LEUKOTR ESS, V73, P59, DOI 10.1016/j.plefa.2005.04.009; Vainio S, 2003, ANN MED, V35, P146, DOI 10.1080/07853890310008198; van Tilborg MAA, 2000, J MOL BIOL, V301, P947, DOI 10.1006/jmbi.2000.4001; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; Wang C, 2013, MOL CELL BIOL, V33, P4492, DOI 10.1128/MCB.00160-13; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wei SJ, 2013, BBA-MOL CELL RES, V1833, P479, DOI 10.1016/j.bbamcr.2012.11.007; Xu SW, 2014, MED RES REV, V34, P644, DOI 10.1002/med.21300; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zhang FX, 2013, J BIOL CHEM, V288, P11348, DOI 10.1074/jbc.M112.429134	63	33	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11172	11184		10.1074/jbc.M116.726729	http://dx.doi.org/10.1074/jbc.M116.726729			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27026705	Green Published, hybrid			2022-12-28	WOS:000377042100020
J	Pham, DD; Do, HT; Bruelle, C; Kukkonen, JP; Eriksson, O; Mogollon, I; Korhonen, LT; Arumae, U; Lindholm, D				Dan Duc Pham; Hai Thi Do; Bruelle, Celine; Kukkonen, Jyrki P.; Eriksson, Ove; Mogollon, Isabel; Korhonen, Laura T.; Arumae, Urmas; Lindholm, Dan			p75 Neurotrophin Receptor Signaling Activates Sterol Regulatory Element-binding Protein-2 in Hepatocyte Cells via p38 Mitogen-activated Protein Kinase and Caspase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; NF-KAPPA-B; DEGENERATION INVOLVEMENT; SELECTIVE ACTIVATION; HIPPOCAMPAL-NEURONS; LINKED INHIBITOR; P75(NTR); CLEAVAGE; PATHWAY; STRESS	Nerve growth factor (NGF) influences the survival and differentiation of a specific population of neurons during development, but its role in non-neuronal cells has been less studied. We observed here that NGF and its pro-form, pro-NGF, are elevated in fatty livers from leptin-deficient mice compared with controls, concomitant with an increase in low density lipoprotein receptors (LDLRs). Stimulation of mouse primary hepatocytes withNGFor pro-NGF increased LDLR expression through the p75 neurotrophin receptor (p75NTR). Studies using Huh7 human hepatocyte cells showed that the neurotrophins activate the sterol regulatory element-binding protein-2 (SREBP2) that regulates genes involved in lipid metabolism. The mechanisms for this were related to stimulation of p38 mitogen-activated protein kinase (p38 MAPK) and activation of caspase-3 and SREBP2 cleavage following NGF and pro-NGF stimulations. Cell fractionation experiments showed that caspase-3 activity was increased particularly in the membrane fraction that harbors SREBP2 and caspase-2. Experiments showed further that caspase-2 interacts with pro-caspase-3 and that p38 MAPK reduced this interaction and caused caspase-3 activation. Because of the increased caspase-3 activity, the cells did not undergo cell death following p75NTR stimulation, possibly due to concomitant activation of nuclear factor-kappa B (NF-kappa B) pathway by the neurotrophins. These results identify a novel signaling pathway triggered by ligand-activated p75NTR that via p38MAPK and caspase-3 mediate the activation of SREBP2. This pathway may regulate LDLRs and lipid uptake particularly after injury or during tissue inflammation accompanied by an increased production of growth factors, including NGF and pro-NGF.	[Dan Duc Pham; Hai Thi Do; Bruelle, Celine; Eriksson, Ove; Mogollon, Isabel; Korhonen, Laura T.; Lindholm, Dan] Univ Helsinki, Fac Med, Dept Biochem & Dev Biol, Med, POB 63, FIN-00014 Helsinki, Finland; [Dan Duc Pham; Hai Thi Do; Bruelle, Celine; Mogollon, Isabel; Korhonen, Laura T.; Lindholm, Dan] Minerva Fdn, Biomed 2,Tukholmankatu 8, FIN-00290 Helsinki, Finland; [Kukkonen, Jyrki P.] Univ Helsinki, Dept Vet Biosci, Biochem & Cell Biol, POB 66, FIN-00014 Helsinki, Finland; [Arumae, Urmas] Univ Helsinki, Inst Biotechnol, Res Program Dev Biol, POB 65, FIN-00014 Helsinki, Finland; [Arumae, Urmas] Tallinn Univ Technol, Dept Gene Technol, Akad Tee 15, EE-12618 Tallinn, Estonia	University of Helsinki; University of Helsinki; University of Helsinki; Tallinn University of Technology	Lindholm, D (corresponding author), Univ Helsinki, Fac Med, Dept Biochem & Dev Biol, Med, POB 63, FIN-00014 Helsinki, Finland.; Lindholm, D (corresponding author), Minerva Fdn, Biomed 2,Tukholmankatu 8, FIN-00290 Helsinki, Finland.	dan.lindholm@helsinki.fi	Eriksson-Rosenberg, Ove/GVU-6692-2022; Pham, dan/F-5009-2019; Arumäe, Urmas/E-8290-2016; Korhonen, Laura/AAW-3256-2020	Pham, dan/0000-0003-1956-2794; Arumäe, Urmas/0000-0003-3658-6464; Kukkonen, Jyrki/0000-0002-6989-1564; Korhonen, Laura/0000-0002-1837-5930	Academy of Finland; Novo Nordisk Fonden; Magnus Ehrnrooth Foundation; Liv och Halsa Foundation; Finska Lakaresallskapet; Parkinson Foundation; Minerva Foundation; Novo Nordisk Fonden [NNF16OC0021492, NNF15OC0016558] Funding Source: researchfish	Academy of Finland(Academy of Finland); Novo Nordisk Fonden(Novo Nordisk Foundation); Magnus Ehrnrooth Foundation; Liv och Halsa Foundation; Finska Lakaresallskapet; Parkinson Foundation; Minerva Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported in part by grants from Academy of Finland (to D. L., L. T. K., and U. A.), the Novo Nordisk Fonden (to D. L.), the Magnus Ehrnrooth Foundation (to J. P. K. and D. L.), the Liv och Halsa Foundation (to J. P. K., D. L., O. E., and L. T. K), Finska Lakaresallskapet (to D. L., L T. K., and O. E.), the Parkinson Foundation (to C. B. and D. L.), and the Minerva Foundation (to D. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Aalto K, 2002, CYTOKINE, V20, P136, DOI 10.1006/cyto.2002.1991; Allen SJ, 2006, CLIN SCI, V110, P175, DOI 10.1042/CS20050161; ALOE L, 1993, GROWTH FACTORS, V9, P149, DOI 10.3109/08977199309010830; ALOE L, 1994, AUTOIMMUNITY, V19, P141, DOI 10.3109/08916939409009542; Ammoun S, 2006, J BIOL CHEM, V281, P834, DOI 10.1074/jbc.M508603200; Baeza-Raja B, 2016, CELL REP, V14, P255, DOI 10.1016/j.celrep.2015.12.028; Baeza-Raja B, 2012, P NATL ACAD SCI USA, V109, P5838, DOI 10.1073/pnas.1103638109; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Bouchier-Hayes L, 2010, CELL CYCLE, V9, P12, DOI 10.4161/cc.9.1.10477; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Deponti D, 2009, MOL BIOL CELL, V20, P3620, DOI 10.1091/mbc.E09-01-0012; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Eriksson O, 1999, AM J PHYSIOL-CELL PH, V276, pC1297, DOI 10.1152/ajpcell.1999.276.6.C1297; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Do HT, 2016, J NEUROCHEM, V136, P306, DOI 10.1111/jnc.13397; Do HT, 2013, J BIOL CHEM, V288, P29613, DOI 10.1074/jbc.M113.500967; Do HT, 2012, J BIOL CHEM, V287, P12602, DOI 10.1074/jbc.M112.341248; Hempstead B L, 2014, Handb Exp Pharmacol, V220, P17, DOI 10.1007/978-3-642-45106-5_2; HEUMANN R, 1987, P NATL ACAD SCI USA, V84, P8735, DOI 10.1073/pnas.84.23.8735; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Hyrskyluoto A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.170; Hyrskyluoto A, 2014, HUM MOL GENET, V23, P5928, DOI 10.1093/hmg/ddu317; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Kairisalo M, 2009, EUR J NEUROSCI, V30, P958, DOI 10.1111/j.1460-9568.2009.06898.x; Knopp RH, 1999, NEW ENGL J MED, V341, P498, DOI 10.1056/NEJM199908123410707; Korhonen L, 2004, EXP CELL RES, V295, P290, DOI 10.1016/j.yexcr.2003.12.026; LINDHOLM D, 1987, NATURE, V330, P658, DOI 10.1038/330658a0; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; Peeraully MR, 2004, AM J PHYSIOL-ENDOC M, V287, pE331, DOI 10.1152/ajpendo.00076.2004; Riikonen RS, 1998, PEDIATR NEUROL, V18, P231, DOI 10.1016/S0887-8994(97)00204-X; Shulga A, 2012, J NEUROSCI, V32, P1757, DOI 10.1523/JNEUROSCI.3282-11.2012; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Vakifahmetoglu-Norberg H, 2010, TRENDS CELL BIOL, V20, P150, DOI 10.1016/j.tcb.2009.12.006; Wang XD, 1996, EMBO J, V15, P1012, DOI 10.1002/j.1460-2075.1996.tb00438.x; Wootz H, 2004, BIOCHEM BIOPH RES CO, V322, P281, DOI 10.1016/j.bbrc.2004.07.118; Yu LY, 2003, J CELL BIOL, V163, P987, DOI 10.1083/jcb.200305083; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	45	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10747	10758		10.1074/jbc.M116.722272	http://dx.doi.org/10.1074/jbc.M116.722272			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26984409	Green Published, hybrid			2022-12-28	WOS:000377042600026
J	Duan, DZ; Zhang, JM; Yao, J; Liu, YP; Fang, JG				Duan, Dongzhu; Zhang, Junmin; Yao, Juan; Liu, Yaping; Fang, Jianguo			Targeting Thioredoxin Reductase by Parthenolide Contributes to Inducing Apoptosis of HeLa Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-MEDIATED APOPTOSIS; OXIDATIVE STRESS; MAMMALIAN THIOREDOXIN; REACTIVE OXYGEN; KAPPA-B; CANCER; EXPRESSION; GLUTATHIONE; INHIBITION; CURCUMIN	Parthenolide (PTL), a major active sesquiterpene lactone from the herbal plant Tanacetum parthenium, has been applied in traditional Chinese medicine for centuries. Although PTL demonstrates potent anticancer efficacy in numerous types of malignant cells, the cellular targets of PTL have not been well defined. We reported here that PTL interacts with both cytosolic thioredoxin reductase (TrxR1) and mitochondrial thioredoxin reductase (TrxR2), two ubiquitous selenocysteine-containing antioxidant enzymes, to elicit reactive oxygen species-mediated apoptosis in HeLa cells. PTL selectively targets the selenocysteine residue in TrxR1 to inhibit the enzyme function, and further shifts the enzyme to an NADPH oxidase to generate superoxide anions, leading to reactive oxygen species accumulation and oxidized thioredoxin. Under the conditions of inhibition of TrxRs in cells, PTL does not cause significant alteration of cellular thiol homeostasis, supporting selective target of TrxRs by PTL. Importantly, overexpression of functional TrxR1 or Trx1 confers protection, whereas knockdown of the enzymes sensitizes cells to PTL treatment. Targeting TrxRs by PTL thus discloses an unprecedented mechanism underlying the biological activity of PTL, and provides deep insights to understand the action of PTL in treatment of cancer.	[Duan, Dongzhu; Zhang, Junmin; Yao, Juan; Liu, Yaping; Fang, Jianguo] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China; [Duan, Dongzhu; Zhang, Junmin; Yao, Juan; Liu, Yaping; Fang, Jianguo] Lanzhou Univ, Coll Chem & Chem Engn, Lanzhou 730000, Peoples R China; [Duan, Dongzhu] Baoji Univ Arts & Sci, Shannxi Key Lab Phytochem, Baoji 721013, Peoples R China	Lanzhou University; Lanzhou University; Baoji University of Arts & Sciences	Fang, JG (corresponding author), Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.; Fang, JG (corresponding author), Lanzhou Univ, Coll Chem & Chem Engn, Lanzhou 730000, Peoples R China.	fangjg@lzu.edu.cn	Zhang, Junmin/AAI-5069-2020; Fang, Jianguo/K-8058-2016; Duan, Dongzhu/AAD-1479-2022; Zhang, Junmin/AAI-5133-2020	Zhang, Junmin/0000-0001-5036-5559; Duan, Dongzhu/0000-0001-5635-819X	Natural Science Foundation of China [21572093]; Natural Science Foundation of Gansu Province [145RJZA225]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Gansu Province	This work was supported by Natural Science Foundation of China Grant 21572093 and Natural Science Foundation of Gansu Province Grant 145RJZA225. The authors declare they have no conflicts of interest with the contents of this article.	Anestal K, 2003, J BIOL CHEM, V278, P15966, DOI 10.1074/jbc.M210733200; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; ARNER ESJ, 1995, J BIOL CHEM, V270, P3479, DOI 10.1074/jbc.270.8.3479; Berggren M, 1996, ANTICANCER RES, V16, P3459; Bindoli A, 2013, ANTIOXID REDOX SIGN, V18, P1557, DOI 10.1089/ars.2012.4655; Cai WQ, 2012, TOXICOL APPL PHARM, V262, P341, DOI 10.1016/j.taap.2012.05.012; Chew EH, 2010, FREE RADICAL BIO MED, V48, P98, DOI 10.1016/j.freeradbiomed.2009.10.028; Citta A, 2014, J MED CHEM, V57, P8849, DOI 10.1021/jm5013165; Citta A, 2013, METALLOMICS, V5, P1006, DOI 10.1039/c3mt20260g; D'Anneo A, 2013, INT J ONCOL, V43, P1895, DOI 10.3892/ijo.2013.2137; Du YT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.392225; Duan DZ, 2014, FREE RADICAL BIO MED, V70, P182, DOI 10.1016/j.freeradbiomed.2014.02.016; Duan DZ, 2014, FREE RADICAL BIO MED, V69, P15, DOI 10.1016/j.freeradbiomed.2013.12.027; Eriksson SE, 2009, FREE RADICAL BIO MED, V47, P1661, DOI 10.1016/j.freeradbiomed.2009.09.016; Fang JG, 2005, J BIOL CHEM, V280, P25284, DOI 10.1074/jbc.M414645200; Fonrose X, 2007, CANCER RES, V67, P3371, DOI 10.1158/0008-5472.CAN-06-3732; Gallegos A, 1996, CANCER RES, V56, P5765; Gan FF, 2013, ANTIOXID REDOX SIGN, V19, P1149, DOI 10.1089/ars.2012.4909; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Ghantous A, 2013, DRUG DISCOV TODAY, V18, P894, DOI 10.1016/j.drudis.2013.05.005; Gopal YNV, 2009, MOL CANCER THER, V8, P552, DOI 10.1158/1535-7163.MCT-08-0661; Gopal YV, 2007, CHEM BIOL, V14, P813, DOI 10.1016/j.chembiol.2007.06.007; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Hehner SP, 1999, J IMMUNOL, V163, P5617; Hellfritsch J, 2015, ANTIOXID REDOX SIGN, V22, P938, DOI 10.1089/ars.2014.5889; Javvadi P, 2010, CANCER RES, V70, P1941, DOI 10.1158/0008-5472.CAN-09-3025; Johansson L, 2004, NAT METHODS, V1, P61, DOI 10.1038/NMETH707; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kim JH, 2005, CANCER RES, V65, P6312, DOI 10.1158/0008-5472.CAN-04-4193; Kim SJ, 2005, CLIN CANCER RES, V11, P8425, DOI 10.1158/1078-0432.CCR-05-0449; Kurdi M, 2007, J CELL PHYSIOL, V212, P424, DOI 10.1002/jcp.21033; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Lan B, 2015, BIOCHEM BIOPH RES CO, V456, P434, DOI 10.1016/j.bbrc.2014.11.102; Lincoln DT, 2003, ANTICANCER RES, V23, P2425; Liu YP, 2016, CHEM COMMUN, V52, P2296, DOI 10.1039/c5cc09998f; Liu YP, 2014, J MED CHEM, V57, P5203, DOI 10.1021/jm500221p; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Mitchell DA, 2007, P NATL ACAD SCI USA, V104, P11609, DOI 10.1073/pnas.0704898104; Nalvarte I, 2004, J BIOL CHEM, V279, P54510, DOI 10.1074/jbc.M408494200; Nogueira V, 2013, CLIN CANCER RES, V19, P4309, DOI 10.1158/1078-0432.CCR-12-1424; Kreuger MRO, 2012, ANTI-CANCER DRUG, V23, P883, DOI 10.1097/CAD.0b013e328356cad9; Peng SJ, 2015, FOOD FUNCT, V6, P2813, DOI [10.1039/c5fo00214a, 10.1039/C5FO00214A]; Peng SJ, 2015, J MED CHEM, V58, P5242, DOI 10.1021/acs.jmedchem.5b00410; Qiu X, 2008, BIOORGAN MED CHEM, V16, P8035, DOI 10.1016/j.bmc.2008.07.054; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Shelar SB, 2015, FREE RADICAL BIO MED, V87, P125, DOI 10.1016/j.freeradbiomed.2015.06.029; Soethoudt M, 2014, FREE RADICAL BIO MED, V77, P331, DOI 10.1016/j.freeradbiomed.2014.09.025; Steele AJ, 2006, LEUKEMIA, V20, P1073, DOI 10.1038/sj.leu.2404230; Sun YL, 2010, CANCER RES, V70, P2880, DOI 10.1158/0008-5472.CAN-09-4572; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Welsh SJ, 2002, CANCER RES, V62, P5089; Wen J, 2002, J BIOL CHEM, V277, P38954, DOI 10.1074/jbc.M203842200; Won YK, 2005, CARCINOGENESIS, V26, P2149, DOI 10.1093/carcin/bgi194; Won YK, 2004, CARCINOGENESIS, V25, P1449, DOI 10.1093/carcin/bgh151; Xu Y, 2013, CANCER RES, V73, P4406, DOI 10.1158/0008-5472.CAN-12-4297; Yao J, 2015, J AGR FOOD CHEM, V63, P1521, DOI 10.1021/jf505075n; Yoo MH, 2006, J BIOL CHEM, V281, P13005, DOI 10.1074/jbc.C600012200; Zhang BX, 2015, J MED CHEM, V58, P1795, DOI 10.1021/jm5016507; Zhang JM, 2016, BIOCHEM PHARMACOL, V102, P34, DOI 10.1016/j.bcp.2015.12.004; Zhang LW, 2014, J AM CHEM SOC, V136, P226, DOI 10.1021/ja408792k; Zhang SY, 2004, CANCER LETT, V211, P175, DOI 10.1016/j.canlet.2004.03.033; Zhao L, 2015, FREE RADICAL BIO MED, V82, P29, DOI 10.1016/j.freeradbiomed.2015.01.014; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	69	85	87	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10021	10031		10.1074/jbc.M115.700591	http://dx.doi.org/10.1074/jbc.M115.700591			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	27002142	Green Published, hybrid			2022-12-28	WOS:000375602800015
J	Zhao, HL; Wang, HB; Bauzon, F; Lu, ZL; Fu, H; Cui, JH; Zhu, L				Zhao, Hongling; Wang, Hongbo; Bauzon, Frederick; Lu, Zhonglei; Fu, Hao; Cui, Jinhua; Zhu, Liang			Deletions of Retinoblastoma 1 (Rb1) and Its Repressing Target S Phase Kinase-associated protein 2 (Skp2) Are Synthetic Lethal in Mouse Embryogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; SUPPRESSES APOPTOSIS; NERVOUS-SYSTEM; MUTANT MICE; MUTATION; DEFICIENT; DEFECTS; PROLIFERATION; TUMORIGENESIS; EXTENDS	Tumor suppressor pith represses Skp2, a substrate-recruiting subunit of the SCFSkp2 ubiquitin ligase. Rb1(+/-) mice incur "two hit" pituitary tumorigenesis; Skp2(-/-);Rb1(+/-) mice do not Rb1(-/-) embryos die on embryonic day (E) 14.5-15.5. Here, we report that Skp2(-/-);Rb1(-/-) embryos died on F11.5, establishing an organismal level synthetic lethal relationship between Rbi and Skp2. On E10.5, Rb1(-/-) placentas showed similarly active proliferation and similarly inactive apoptosis as WT placenta, whereas Rb1(-/-) embryos showed ectopic proliferation without increased apoptosis in the brain. Combining Skp2-1did not reduce proliferation or increase apoptosis in the placentas but induced extensive apoptosis in the brain. We conditionally deleted Rb1 in neuronal lineage with Nes-Cre and reproduced the brain apoptosis in E13.5 Nes-Cre; Rb1(-/-);Skp2(-/-) embryos, demonstrating their synthetic lethal relationship at a cell autonomous level. Nes-Cre-mediated.Rbl deletion increased expression of proliferative E2F target genes in the brains of Skp2(+/+) embryos; the increases rose higher with activation of expression of apoptotic E2F target genes in Skp2(-/-) embryos. The brain apoptosis was independent of p53 but coincident with proliferation. The highly activated expression of proliferative and apoptotic E2F target genes subsided with gradually reduced roles of Skp2 in preventing p27 protein accumulation in the brain in late gestation, allowing the embryos to reach full term with normally sized brains. These findings establish that Rbi and Skp2 deletions are synthetic lethal and suggest how this lethal relationship might be circumvented, which could help design better therapies for pRb-deficient cancer.	Albert Einstein Coll Med, Dept Dev & Mol Biol & Ophthalmol & Visual Sci Med, Albert Einstein Comprehens Canc Ctr, Bronx, NY 10461 USA; Albert Einstein Coll Med, Liver Res Ctr, Bronx, NY 10461 USA; [Wang, Hongbo] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Texas System; University of Texas Health San Antonio	Zhu, L (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave,Rm U-521, Bronx, NY 10461 USA.	liang.zhu@einstein.yu.edu		Lu, Zhonglei/0000-0002-8915-4828	National Institutes of Health [RO1CA127901, RO1CA131421]; Albert Einstein Comprehensive Cancer Research Center [5P30CA13330]; Liver Research Center [5P30DK061153]; Department of Defense Prostate Cancer Research Program (PCRP) Postdoctoral Fellowship [PC121837]; NATIONAL CANCER INSTITUTE [R01CA127901, R01CA131421, P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296, R01DK061153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein Comprehensive Cancer Research Center; Liver Research Center; Department of Defense Prostate Cancer Research Program (PCRP) Postdoctoral Fellowship(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants RO1CA127901and RO1CA131421 (to L. Z.), Albert Einstein Comprehensive Cancer Research Center Grant 5P30CA13330, and Liver Research Center Grant 5P30DK061153. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Department of Defense Prostate Cancer Research Program (PCRP) Postdoctoral Fellowship PC121837.	Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Dirlam A, 2007, MOL CELL BIOL, V27, P8713, DOI 10.1128/MCB.01118-07; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Ji P, 2004, MOL CELL, V16, P47, DOI 10.1016/j.molcel.2004.09.029; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Lu ZL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4463; Macleod KF, 1996, EMBO J, V15, P6178, DOI 10.1002/j.1460-2075.1996.tb01006.x; MacPherson D, 2003, MOL CELL BIOL, V23, P1044, DOI 10.1128/MCB.23.3.1044-1053.2003; Marino S, 2000, GENE DEV, V14, P994; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; Wenzel PL, 2007, GENE DEV, V21, P85, DOI 10.1101/gad.1485307; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; Yamasaki L, 1998, NAT GENET, V18, P360, DOI 10.1038/ng0498-360; Yung Y, 2007, J CELL BIOL, V178, P741, DOI 10.1083/jcb.200703034; Zhang L, 2006, ONCOGENE, V25, P2615, DOI 10.1038/sj.onc.1209286; Zhao HL, 2013, CANCER CELL, V24, P645, DOI 10.1016/j.ccr.2013.09.021; Ziebold U, 2003, MOL CELL BIOL, V23, P6542, DOI 10.1128/MCB.23.18.6542-6552.2003; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	25	5	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10201	10209		10.1074/jbc.M116.718049	http://dx.doi.org/10.1074/jbc.M116.718049			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26966181	hybrid, Green Published			2022-12-28	WOS:000375602800029
J	Gabreski, NA; Vaghasia, JK; Novakova, SS; McDonald, NQ; Pierchala, BA				Gabreski, Nicole A.; Vaghasia, Janki K.; Novakova, Silvia S.; McDonald, Neil Q.; Pierchala, Brian A.			Exon Skipping in the RET Gene Encodes Novel Isoforms That Differentially Regulate RET Protein Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; MICE LACKING GDNF; DEVELOPING SYMPATHETIC NEURONS; ENTERIC NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; CELL-LINE; C-RET; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSFORMING ACTIVITY; SELF-ASSOCIATION	Rearranged during transfection (RET), a receptor tyrosine kinase that is activated by the glial cell line-derived neurotrophic factor family ligands (GFLs), plays a crucial role in the development and function of the nervous system and additionally is required for kidney development and spermatogenesis. RET encodes a transmembrane receptor that is 20 exons long and produces two known protein isoforms differing in C-terminal amino acid composition, referred to as RET9 and RET51. Studies of human pheochromocytomas identified two additional novel transcripts involving the skipping of exon 3 or exons 3, 4, and 5 and are referred to as RET Delta E3 and RET Delta E345, respectively. Here we report the presence of Ret(Delta E3) and Ret(Delta E345) in zebrafish, mice, and rats and show that these transcripts are dynamically expressed throughout development of the CNS, peripheral nervous system, and kidneys. We further explore the biochemical properties of these isoforms, demonstrating that, like full-length RET, RET Delta E3 and RET Delta E345 are trafficked to the cell surface, interact with all four GFR alpha co-receptors, and have the ability to heterodimerize with full-length RET. Signaling experiments indicate that RET Delta E3 is phosphorylated in a similar manner to full-length RET. RET Delta E345, in contrast, displays higher baseline autophosphorylation, specifically on the catalytic tyrosine, Tyr(905), and also on one of the most important signaling residues, Tyr(1062). These data provide the first evidence for a physiologic role of these isoforms in RET pathway function.	[Gabreski, Nicole A.; Vaghasia, Janki K.; Novakova, Silvia S.; Pierchala, Brian A.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, 1011 N Univ Ave, Ann Arbor, MI 48109 USA; [Gabreski, Nicole A.; Pierchala, Brian A.] Univ Michigan, Sch Med, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [McDonald, Neil Q.] Francis Crick Inst, Struct Biol Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England; [McDonald, Neil Q.] Birkbeck Coll, Dept Biol Sci, Inst Struct & Mol Biol, Malet St, London WC1E 7HX, England	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Francis Crick Institute; University of London; Birkbeck University London	Pierchala, BA (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.	pierchal@umich.edu		Gabreski, Nicole/0000-0002-1688-6059	National Institutes of Health [R01 NS089585]; University of Michigan Cellular and Molecular Biology Predoctoral Fellowship [T32-GM007315]; Cancer Research UK [19344, 10747] Funding Source: researchfish; The Francis Crick Institute [10115] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Cellular and Molecular Biology Predoctoral Fellowship; Cancer Research UK(Cancer Research UK); The Francis Crick Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01 NS089585 (to B. A. P.). Additional funding support came from the University of Michigan Cellular and Molecular Biology Predoctoral Fellowship T32-GM007315 (to N. A. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Amoresano A, 2005, CELL SIGNAL, V17, P717, DOI 10.1016/j.cellsig.2004.10.012; Anders J, 2001, J BIOL CHEM, V276, P35808, DOI 10.1074/jbc.M104968200; Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; Arighi E, 1997, ONCOGENE, V14, P773, DOI 10.1038/sj.onc.1200896; Asai N, 1996, J BIOL CHEM, V271, P17644, DOI 10.1074/jbc.271.30.17644; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Besset V, 2000, J BIOL CHEM, V275, P39159, DOI 10.1074/jbc.M006908200; Bonanomi D, 2012, CELL, V148, P568, DOI 10.1016/j.cell.2012.01.024; Bourane S, 2009, NEURON, V64, P857, DOI 10.1016/j.neuron.2009.12.004; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Carter MT, 2001, CYTOGENET CELL GENET, V95, P169, DOI 10.1159/000059341; de Graaff E, 2001, GENE DEV, V15, P2433, DOI 10.1101/gad.205001; Durick K, 1996, J BIOL CHEM, V271, P12691, DOI 10.1074/jbc.271.22.12691; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Franck MCM, 2011, EUR J NEUROSCI, V33, P1385, DOI 10.1111/j.1460-9568.2011.07634.x; Goodman KM, 2014, CELL REP, V8, P1894, DOI 10.1016/j.celrep.2014.08.040; Gould TW, 2008, J NEUROSCI, V28, P2131, DOI 10.1523/JNEUROSCI.5185-07.2008; Grimm J, 2001, J CELL BIOL, V154, P345, DOI 10.1083/jcb.200102032; Hayashi H, 2000, ONCOGENE, V19, P4469, DOI 10.1038/sj.onc.1203799; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; Horger BA, 1998, J NEUROSCI, V18, P4929; Iwashita T, 1996, ONCOGENE, V12, P481; Kjaer S, 2006, ONCOGENE, V25, P7086, DOI 10.1038/sj.onc.1209698; Kjaer S, 2003, J BIOL CHEM, V278, P47898, DOI 10.1074/jbc.M309772200; Kjaer S, 2010, NAT STRUCT MOL BIOL, V17, P726, DOI 10.1038/nsmb.1808; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Kurokawa K, 2001, ONCOGENE, V20, P1929, DOI 10.1038/sj.onc.1204290; LORENZO MJ, 1995, ONCOGENE, V10, P1377; Lorenzo MJ, 1997, ONCOGENE, V14, P763, DOI 10.1038/sj.onc.1200894; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Melillo RM, 2001, MOL CELL BIOL, V21, P4177, DOI 10.1128/MCB.21.13.4177-4187.2001; Melillo RM, 2001, ONCOGENE, V20, P209, DOI 10.1038/sj.onc.1204049; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Mulligan LM, 2014, NAT REV CANCER, V14, P173, DOI 10.1038/nrc3680; MYERS SM, 1995, ONCOGENE, V11, P2039; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Nishino J, 1999, NEURON, V23, P725, DOI 10.1016/S0896-6273(01)80031-3; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pandey A, 1996, J BIOL CHEM, V271, P10607, DOI 10.1074/jbc.271.18.10607; PANDEY A, 1995, J BIOL CHEM, V270, P21461, DOI 10.1074/jbc.270.37.21461; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pierchala BA, 2006, J NEUROSCI, V26, P2777, DOI 10.1523/JNEUROSCI.3420-05.2006; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Shneider NA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-42; TAHIRA T, 1990, ONCOGENE, V5, P97; Tsui CC, 2010, J NEUROSCI, V30, P5149, DOI 10.1523/JNEUROSCI.5246-09.2010; Tsui-Pierchala B, 2002, NEURON, V33, P261, DOI 10.1016/S0896-6273(01)00585-2; Tsui-Pierchala BA, 2002, J BIOL CHEM, V277, P34618, DOI 10.1074/jbc.M203580200; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wells SA, 2009, CLIN CANCER RES, V15, P7119, DOI 10.1158/1078-0432.CCR-08-2742	58	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16249	16262		10.1074/jbc.M115.709675	http://dx.doi.org/10.1074/jbc.M115.709675			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226544	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000380585400029
J	Rajasekaran, D; Groning, S; Schmitz, C; Zierow, S; Drucker, N; Bakou, M; Kohl, K; Mertens, A; Lue, HQ; Weber, C; Xiao, AN; Luker, G; Kapurniotu, A; Lolis, E; Bernhagen, J				Rajasekaran, Deepa; Groening, Sabine; Schmitz, Corinna; Zierow, Swen; Drucker, Natalie; Bakou, Maria; Kohl, Kristian; Mertens, Andre; Lue, Hongqi; Weber, Christian; Xiao, Annie; Luker, Gary; Kapurniotu, Aphrodite; Lolis, Elias; Bernhagen, Juergen			Macrophage Migration Inhibitory Factor-CXCR4 Receptor Interactions EVIDENCE FOR PARTIAL ALLOSTERIC AGONISM IN COMPARISON WITH CXCL12 CHEMOKINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; TRANSFER-RNA SYNTHETASE; N-TERMINAL PEPTIDES; CRYSTAL-STRUCTURE; FACTOR MIF; CHEMOKINE RECEPTORS; STRUCTURAL BASIS; FACTOR-I; PHENYLPYRUVATE TAUTOMERASE; INTERNATIONAL UNION	An emerging number of non-chemokine mediators are found to bind to classical chemokine receptors and to elicit critical biological responses. Macrophage migration inhibitory factor (MIF) is an inflammatory cytokine that exhibits chemokine-like activities through non-cognate interactions with the chemokine receptors CXCR2 and CXCR4, in addition to activating the type II receptor CD74. Activation of the MIF-CXCR2 and -CXCR4 axes promotes leukocyte recruitment, mediating the exacerbating role of MIF in atherosclerosis and contributing to the wealth of other MIF biological activities. Although the structural basis of the MIF-CXCR2 interaction has been well studied and was found to engage a pseudo-ELR and an N-like loop motif, nothing is known about the regions of CXCR4 and MIF that are involved in binding to each other. Using a genetic strain of Saccharomyces cerevisiae that expresses a functional CXCR4 receptor, site-specific mutagenesis, hybrid CXCR3/CXCR4 receptors, pharmacological reagents, peptide array analysis, chemotaxis, fluorescence spectroscopy, and circular dichroism, we provide novel molecular information about the structural elements that govern the interaction between MIF and CXCR4. The data identify similarities with classical chemokine-receptor interactions but also provide evidence for a partial allosteric agonist compared with CXCL12 that is possible due to the two binding sites of CXCR4.	[Rajasekaran, Deepa; Zierow, Swen; Drucker, Natalie; Lolis, Elias] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Groening, Sabine; Schmitz, Corinna; Mertens, Andre; Lue, Hongqi; Bernhagen, Juergen] Univ Aachen, RWTH, Inst Biochem & Mol Cell Biol, Pauwelsstr 30, D-52074 Aachen, Germany; [Bakou, Maria; Kohl, Kristian; Kapurniotu, Aphrodite] Tech Univ Munich, Div Peptide Biochem, D-85354 Freising Weihenstephan, Germany; [Weber, Christian] Univ Munich, Klinikum Univ Munchen, Inst Cardiovasc Prevent, Pettenkofer Str 8, D-80336 Munich, Germany; [Xiao, Annie; Luker, Gary] Univ Michigan, Ctr Mol Imaging, Dept Radiol, Ann Arbor, MI 48109 USA; [Xiao, Annie; Luker, Gary] Univ Michigan, Ctr Mol Imaging, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Xiao, Annie; Luker, Gary] Univ Michigan, Ctr Mol Imaging, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Schmitz, Corinna; Bernhagen, Juergen] Univ Munich, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Vasc Biol, Feodor Lynen Str 17, D-81377 Munich, Germany; [Bernhagen, Juergen] Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany; [Zierow, Swen] Kundl Inc, A-6520 Sandoz, Austria	Yale University; RWTH Aachen University; Technical University of Munich; University of Munich; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Munich; University of Munich	Lolis, E (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA.; Bernhagen, J (corresponding author), Univ Aachen, RWTH, Inst Biochem & Mol Cell Biol, Pauwelsstr 30, D-52074 Aachen, Germany.; Kapurniotu, A (corresponding author), Tech Univ Munich, Div Peptide Biochem, D-85354 Freising Weihenstephan, Germany.; Bernhagen, J (corresponding author), Univ Munich, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Vasc Biol, Feodor Lynen Str 17, D-81377 Munich, Germany.; Bernhagen, J (corresponding author), Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany.	akapurniotu@wzw.tum.de; elias.lolis@yale.edu; juergen.bernhagen@med.uni-muenchen.de	Weber, Christian/AAW-2153-2020	Weber, Christian/0000-0003-4610-8714; luker, gary/0000-0001-6832-2581; Lolis, Elias/0000-0002-7902-7868	Deutsche Forschungsgemeinschaft [SFB1123/A03, SFB1123/A01, DFG-IRTG1508]; National Institutes of Health [R01CA170198, R01CA196018, AI065029]; Yale Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016359, R01CA170198, R01CA196018] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065029, R01AI082295] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB1123/A03 (to J. B. and A. K.), SFB1123/A01 (to C. W.), and DFG-IRTG1508 (to M. B. and J. B.) and National Institutes of Health Grants R01CA170198 and R01CA196018 (to G. L.) and AI065029 and a Pilot Grant from the Yale Cancer Center (to E. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreeva A, 2014, NUCLEIC ACIDS RES, V42, pD310, DOI 10.1093/nar/gkt1242; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bifulco C, 2008, CURR PHARM DESIGN, V14, P3790, DOI 10.2174/138161208786898608; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Burger-Kentischer A, 2002, CIRCULATION, V105, P1561, DOI 10.1161/01.CIR.0000012942.49244.82; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CHO Y, 2012, THE MIF HDB, P101; Cho Y, 2011, CHEM BIOL, V18, P1089, DOI 10.1016/j.chembiol.2011.07.011; Coggins NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098328; Cournia Z, 2009, J MED CHEM, V52, P416, DOI 10.1021/jm801100v; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Crump MP, 2001, FEBS LETT, V489, P171, DOI 10.1016/S0014-5793(00)02393-0; Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941; DeLano W.L, PYMOL MOL GRAPHICS S; DENOBEL JG, 1991, YEAST, V7, P313, DOI 10.1002/yea.320070402; Elisseeva EL, 2000, J BIOL CHEM, V275, P26799; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Farzan M, 2002, J BIOL CHEM, V277, P29484, DOI 10.1074/jbc.M203361200; Feng Z, 2006, J IMMUNOL, V177, P782, DOI 10.4049/jimmunol.177.2.782; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Harrison JE, 2008, J VIROL, V82, P11695, DOI 10.1128/JVI.01303-08; Heveker N, 2001, MOL PHARMACOL, V59, P1418, DOI 10.1124/mol.59.6.1418; Heveker N, 1998, CURR BIOL, V8, P369, DOI 10.1016/S0960-9822(98)70155-1; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kamir D, 2008, J IMMUNOL, V180, P8250, DOI 10.4049/jimmunol.180.12.8250; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kleemann R, 1999, EUR J BIOCHEM, V261, P753, DOI 10.1046/j.1432-1327.1999.00327.x; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Kraemer S, 2011, FASEB J, V25, P894, DOI 10.1096/fj.10-168559; Lapham CK, 1996, SCIENCE, V274, P602, DOI 10.1126/science.274.5287.602; Leech M, 1998, ARTHRITIS RHEUM-US, V41, P910, DOI 10.1002/1529-0131(199805)41:5<910::AID-ART19>3.0.CO;2-E; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Loetscher P, 1998, J BIOL CHEM, V273, P22279, DOI 10.1074/jbc.273.35.22279; Lolis Elias, 2001, Current Opinion in Pharmacology, V1, P662, DOI 10.1016/S1471-4892(01)00112-6; Lubetsky JB, 1999, BIOCHEMISTRY-US, V38, P7346, DOI 10.1021/bi990306m; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Luker KE, 2008, ANAL CHEM, V80, P5565, DOI 10.1021/ac8005457; McDevitt MA, 2006, J EXP MED, V203, P1185, DOI 10.1084/jem.20052398; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Murphy JW, 2010, PROTEINS, V78, P1331, DOI 10.1002/prot.22666; Murphy PM, 2000, PHARMACOL REV, V52, P145; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Ouertatani-Sakouhi H, 2010, J BIOL CHEM, V285, P26581, DOI 10.1074/jbc.M110.113951; Pan JH, 2004, CIRCULATION, V109, P3149, DOI 10.1161/01.CIR.0000134704.84454.D2; Panstruga R, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0337-x; Pantouris G, 2015, CHEM BIOL, V22, P1197, DOI 10.1016/j.chembiol.2015.08.006; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rankovic Z, 2016, BIOORG MED CHEM LETT, V26, P241, DOI 10.1016/j.bmcl.2015.12.024; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Rosengren E, 1997, FEBS LETT, V417, P85, DOI 10.1016/S0014-5793(97)01261-1; Sachpatzidis A, 2003, J BIOL CHEM, V278, P896, DOI 10.1074/jbc.M204667200; Saini V, 2010, J BIOL CHEM, V285, P15566, DOI 10.1074/jbc.M110.103408; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Schober A, 2004, CIRCULATION, V109, P380, DOI 10.1161/01.CIR.0000109201.72441.09; Schwartz V, 2012, EUR J CELL BIOL, V91, P435, DOI 10.1016/j.ejcb.2011.08.006; Schwartz V, 2009, FEBS LETT, V583, P2749, DOI 10.1016/j.febslet.2009.07.058; Seibert C, 2008, BIOCHEMISTRY-US, V47, P11251, DOI 10.1021/bi800965m; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Swope MD, 1999, REV PHYSIOL BIOCH P, V139, P1, DOI 10.1007/BFb0033647; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Tchernychev B, 2010, P NATL ACAD SCI USA, V107, P22255, DOI 10.1073/pnas.1009633108; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Tillmann S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00115; Toso C, 2008, DIABETOLOGIA, V51, P1937, DOI 10.1007/s00125-008-1063-3; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Weiser JN, 2015, J INFECT DIS, V212, P1677, DOI 10.1093/infdis/jiv262; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu L, 2015, PHYS CHEM CHEM PHYS, V17, P3370, DOI 10.1039/c4cp05095a; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zernecke A, 2008, CIRCULATION, V117, P1594, DOI 10.1161/CIRCULATIONAHA.107.729125; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200	89	49	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15881	15895		10.1074/jbc.M116.717751	http://dx.doi.org/10.1074/jbc.M116.717751			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226569	Green Published, hybrid			2022-12-28	WOS:000380584200039
J	Chiba, T; Thomas, CP; Calcutt, MW; Boeglin, WE; O'Donnell, VB; Brash, AR				Chiba, Takahito; Thomas, Christopher P.; Calcutt, M. Wade; Boeglin, William E.; O'Donnell, Valerie B.; Brash, Alan R.			The Precise Structures and Stereochemistry of Trihydroxy-linoleates Esterified in Human and Porcine Epidermis and Their Significance in Skin Barrier Function: IMPLICATION OF AN EPOXIDE HYDROLASE IN THE TRANSFORMATIONS OF LINOLEATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ceramide; epidermis; lipid oxidation; lipoxygenase pathway; mass spectrometry (MS); essential fatty acid; linoleic acid	ESSENTIAL FATTY-ACID; PERMEABILITY BARRIER; TRIHYDROXYOCTADECENOIC ACIDS; TARGETED DISRUPTION; STRATUM-CORNEUM; RABBIT AORTA; METABOLISM; DEFICIENCY; LIPOXYGENASES; CERAMIDES	Creation of an intact skin water barrier, a prerequisite for life on dry land, requires the lipoxygenase-catalyzed oxidation of the essential fatty acid linoleate, which is esterified to the -hydroxyl of an epidermis-specific ceramide. Oxidation of the linoleate moiety by lipoxygenases is proposed to facilitate enzymatic cleavage of the ester bond, releasing free -hydroxyceramide for covalent binding to protein, thus forming the corneocyte lipid envelope, a key component of the epidermal barrier. Herein, we report the transformations of esterified linoleate proceed beyond the initial steps of oxidation and epoxyalcohol synthesis catalyzed by the consecutive actions of 12R-LOX and epidermal LOX3. The major end product in human and porcine epidermis is a trihydroxy derivative, formed with a specificity that implicates participation of an epoxide hydrolase in converting epoxyalcohol to triol. Of the 16 possible triols arising from hydrolysis of 9,10-epoxy-13-hydroxy-octadecenoates, using LC-MS and chiral analyses, we identify and quantify specifically 9R,10S,13R-trihydroxy-11E-octadecenoate as the single major triol esterified in porcine epidermis and the same isomer with lesser amounts of its 10R diastereomer in human epidermis. The 9R,10S,13R-triol is formed by S(N)2 hydrolysis of the 9R,10R-epoxy-13R-hydroxy-octadecenoate product of the LOX enzymes, a reaction specificity characteristic of epoxide hydrolase. The high polarity of triol over the primary linoleate products enhances the concept that the oxidations disrupt corneocyte membrane lipids, promoting release of free -hydroxyceramide for covalent binding to protein and sealing of the waterproof barrier.	[Chiba, Takahito; Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Sch Med, Dept Pharmacol, 23rd Ave & Pierce, Nashville, TN 37232 USA; [Calcutt, M. Wade] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Calcutt, M. Wade] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37212 USA; [Thomas, Christopher P.; O'Donnell, Valerie B.] Cardiff Univ, Sch Med, Syst Immun Res Inst, Cardiff CF14 4XN, S Glam, Wales	Vanderbilt University; Vanderbilt University; Vanderbilt University; Cardiff University	Brash, AR (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, 23rd Ave & Pierce, Nashville, TN 37232 USA.	alan.brash@vanderbilt.edu	Thomas, Christopher P/R-5243-2016	Thomas, Christopher P/0000-0001-5840-8613; /0000-0003-4089-8460	National Institutes of Health [AR51968]; Medical Research Council [MR/M011445/1]; National Institutes of Health Shared Resource Grant [P30 CA068485]; Department of Dermatology of Kyushu University; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051968] Funding Source: NIH RePORTER; MRC [MR/M011445/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health Shared Resource Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Dermatology of Kyushu University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by National Institutes of Health Grant AR51968 (to A. R. B.), by Medical Research Council Research Grant MR/M011445/1 (to V. B. O.), by National Institutes of Health Shared Resource Grant P30 CA068485, and by an award from the Department of Dermatology of Kyushu University (to T. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABIAN J, 1991, PLANT PHYSIOL, V95, P1277, DOI 10.1104/pp.95.4.1277; Al-Amoudi A, 2005, J INVEST DERMATOL, V124, P764, DOI 10.1111/j.0022-202X.2005.23630.x; Ala U, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000043; Arand M, 2005, METHOD ENZYMOL, V400, P569, DOI 10.1016/S0076-6879(05)00032-7; BAER AN, 1991, BIOCHEM BIOPH RES CO, V180, P98, DOI 10.1016/S0006-291X(05)81260-4; Belkner J, 2000, BIOCHEM J, V352, P125, DOI 10.1042/0264-6021:3520125; BOWSER PA, 1986, INT J COSMETIC SCI, V8, P125, DOI 10.1111/j.1467-2494.1986.tb00440.x; BOWSER PA, 1985, BIOCHIM BIOPHYS ACTA, V834, P419, DOI 10.1016/0005-2760(85)90016-5; Burr GO, 1930, J BIOL CHEM, V86, P0587; Burr GO, 1929, J BIOL CHEM, V82, P345; Campbell WB, 2013, J CARDIOVASC PHARM, V61, P176, DOI 10.1097/FJC.0b013e31828165db; Chawengsub Y, 2008, AM J PHYSIOL-HEART C, V294, pH1348, DOI 10.1152/ajpheart.01326.2007; Cronin A, 2011, J LIPID RES, V52, P712, DOI 10.1194/jlr.M009639; Decker M, 2012, J LIPID RES, V53, P2038, DOI 10.1194/jlr.M024448; Decker M, 2009, ARCH TOXICOL, V83, P297, DOI 10.1007/s00204-009-0416-0; Eckl KM, 2009, J INVEST DERMATOL, V129, P1421, DOI 10.1038/jid.2008.409; Elias PM, 2008, J LIPID RES, V49, P697, DOI 10.1194/jlr.R800002-JLR200; Elias PM, 2000, J INVEST DERMATOL, V115, P765, DOI 10.1046/j.1523-1747.2000.00124-5.x; ELIAS PM, 1980, J INVEST DERMATOL, V74, P230, DOI 10.1111/1523-1747.ep12541775; Enayetallah AE, 2004, J HISTOCHEM CYTOCHEM, V52, P447, DOI 10.1177/002215540405200403; Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116; FEUSSNER I, 1995, FEBS LETT, V367, P12, DOI 10.1016/0014-5793(95)00531-D; GALLIARD T, 1971, BIOCHEM J, V124, P431, DOI 10.1042/bj1240431; Garbe LA, 2005, J AM SOC BREW CHEM, V63, P157, DOI 10.1094/ASBCJ-63-0157; HAMBERG M, 1991, J AGR FOOD CHEM, V39, P1568, DOI 10.1021/jf00009a006; HAMBERG M, 1991, LIPIDS, V26, P407, DOI 10.1007/BF02536065; Hamberg M, 2011, LIPIDS, V46, P873, DOI 10.1007/s11745-011-3592-7; HANSEN HS, 1985, BIOCHIM BIOPHYS ACTA, V834, P357, DOI 10.1016/0005-2760(85)90009-8; HANSEN HS, 1986, TRENDS BIOCHEM SCI, V11, P263, DOI 10.1016/0968-0004(86)90191-X; Hoopes S. L., 2016, 16 INT WINT EIC C BA; HOUTSMULLER U M T, 1981, Progress in Lipid Research, V20, P219, DOI 10.1016/0163-7827(81)90041-2; Jobard F, 2002, HUM MOL GENET, V11, P107, DOI 10.1093/hmg/11.1.107; KATO T, 1991, AGR BIOL CHEM TOKYO, V55, P1349, DOI 10.1080/00021369.1991.10870750; Krieg P, 2014, BBA-MOL CELL BIOL L, V1841, P390, DOI 10.1016/j.bbalip.2013.08.005; Krieg P, 2013, J INVEST DERMATOL, V133, P172, DOI 10.1038/jid.2012.250; Lee SH, 2003, RAPID COMMUN MASS SP, V17, P2168, DOI 10.1002/rcm.1170; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Lord CC, 2013, BBA-MOL CELL BIOL L, V1831, P792, DOI 10.1016/j.bbalip.2013.01.002; Marekov LN, 1998, J BIOL CHEM, V273, P17763, DOI 10.1074/jbc.273.28.17763; MASUI H, 1989, PHYTOCHEMISTRY, V28, P2613, DOI 10.1016/S0031-9422(00)98051-8; Meguro S, 2000, ARCH DERMATOL RES, V292, P463, DOI 10.1007/s004030000160; Miyata M, 1999, J BIOL CHEM, V274, P23963, DOI 10.1074/jbc.274.34.23963; MOLL C, 1979, J AGR FOOD CHEM, V27, P239, DOI 10.1021/jf60222a050; Moran JL, 2007, J INVEST DERMATOL, V127, P1893, DOI 10.1038/sj.jid.5700825; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; NUGTEREN DH, 1987, BIOCHIM BIOPHYS ACTA, V921, P135, DOI 10.1016/0005-2760(87)90179-2; NUGTEREN DH, 1985, BIOCHIM BIOPHYS ACTA, V834, P429, DOI 10.1016/0005-2760(85)90017-7; Pfister SL, 2003, BBA-GEN SUBJECTS, V1622, P6, DOI 10.1016/S0304-4165(03)00097-7; SEVANIAN A, 1985, Journal of Free Radicals in Biology and Medicine, V1, P263, DOI 10.1016/0748-5514(85)90130-8; Simsek S, 2014, INT J FOOD SCI NUTR, V65, P803, DOI 10.3109/09637486.2014.925427; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; Thomas CP, 2013, CHEM PHYS LIPIDS, V167, P21, DOI 10.1016/j.chemphyslip.2013.01.002; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; WERTZ PW, 1989, J INVEST DERMATOL, V92, P109, DOI 10.1111/1523-1747.ep13071317; WERTZ PW, 1987, BIOCHIM BIOPHYS ACTA, V917, P108, DOI 10.1016/0005-2760(87)90290-6; WERTZ PW, 1983, J LIPID RES, V24, P759; WERTZ PW, 1983, BIOCHIM BIOPHYS ACTA, V753, P350, DOI 10.1016/0005-2760(83)90058-9; WERTZ PW, 1990, J LIPID RES, V31, P1839; Zheng YX, 2008, J BIOL CHEM, V283, P5138, DOI 10.1074/jbc.M705780200; Zheng YX, 2011, J BIOL CHEM, V286, P24046, DOI 10.1074/jbc.M111.251496	61	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14540	14554		10.1074/jbc.M115.711267	http://dx.doi.org/10.1074/jbc.M115.711267			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27151221	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000380366700011
J	Tang, SJ; Luo, SF; Ho, JXJ; Ly, PT; Goh, E; Roca, X				Tang, Sze Jing; Luo, Shufang; Ho, Jia Xin Jessie; Phuong Thao Ly; Goh, Eling; Roca, Xavier			Characterization of the Regulation of CD46 RNA Alternative Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; complement system; exonic splicing enhancer; lymphocyte; molecular genetics; exonic splicing silencer	MEMBRANE COFACTOR PROTEIN; TRACT BINDING-PROTEIN; CELLULAR PILUS RECEPTOR; MEASLES-VIRUS RECEPTOR; T-CELLS; COMPLEMENT REGULATOR; EXON DEFINITION; 5'-SPLICE SITES; U1 SNRNA; NEURONAL DIFFERENTIATION	Here we present a detailed analysis of the alternative splicing regulation of human CD46, which generates different isoforms with distinct functions. CD46 is a ubiquitous membrane protein that protects host cells from complement and plays other roles in immunity, autophagy, and cell adhesion. CD46 deficiency causes an autoimmune disorder, and this protein is also involved in pathogen infection and cancer. Before this study, the mechanisms of CD46 alternative splicing remained unexplored even though dysregulation of this process has been associated with autoimmune diseases. We proved that the 5 splice sites of CD46 cassette exons 7 and 8 encoding extracellular domains are defined by noncanonical mechanisms of base pairing to U1 small nuclear RNA. Next we characterized the regulation of CD46 cassette exon 13, whose inclusion or skipping generates different cytoplasmic tails with distinct functions. Using splicing minigenes, we identified multiple exonic and intronic splicing enhancers and silencers that regulate exon 13 inclusion via trans-acting splicing factors like PTBP1 and TIAL1. Interestingly, a common splicing activator such as SRSF1 appears to repress CD46 exon 13 inclusion. We also report that expression of CD46 mRNA isoforms is further regulated by non-sense-mediated mRNA decay and transcription speed. Finally, we successfully manipulated CD46 exon 13 inclusion using antisense oligonucleotides, opening up opportunities for functional studies of the isoforms as well as for therapeutics for autoimmune diseases. This study provides insight into CD46 alternative splicing regulation with implications for its function in the immune system and for genetic disease.	[Tang, Sze Jing; Luo, Shufang; Ho, Jia Xin Jessie; Phuong Thao Ly; Goh, Eling; Roca, Xavier] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Roca, X (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	xroca@ntu.edu.sg	Roca, Xavier/C-5838-2011	Roca, Xavier/0000-0003-3853-5273; Ly, Phuong Thao/0000-0002-5986-2735	School of Biological Sciences, Nanyang Technological University; Singapore's Ministry of Education Academic Research Fund [RG 20/11]	School of Biological Sciences, Nanyang Technological University(Nanyang Technological University); Singapore's Ministry of Education Academic Research Fund	This work was supported by School of Biological Sciences, Nanyang Technological University Startup Grant 2011 and Singapore's Ministry of Education Academic Research Fund Tier 1 RG 20/11 (2011). The authors declare that they have no conflicts of interest with the contents of this article.	Akerman M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r30; Anczukow O, 2015, MOL CELL, V60, P105, DOI 10.1016/j.molcel.2015.09.005; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Astier A, 2000, J IMMUNOL, V164, P6091, DOI 10.4049/jimmunol.164.12.6091; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Aznarez I, 2008, GENOME RES, V18, P1247, DOI 10.1101/gr.073155.107; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bonomi S, 2013, NUCLEIC ACIDS RES, V41, P8665, DOI 10.1093/nar/gkt579; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Cardone J, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00028; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Chiou NT, 2013, MOL CELL, V49, P972, DOI 10.1016/j.molcel.2012.12.025; Choileain SN, 2011, ARCH IMMUNOL THER EX, V59, P49, DOI 10.1007/s00005-010-0109-7; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; Coutinho-Mansfield GC, 2007, GENE DEV, V21, P1573, DOI 10.1101/gad.1575607; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Cui W, 2010, CANCER BIOL THER, V10, P232; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dujardin G, 2014, MOL CELL, V54, P683, DOI 10.1016/j.molcel.2014.03.044; Ebrahimi KB, 2013, J PATHOL, V229, P729, DOI 10.1002/path.4128; Erkelenz S, 2013, RNA, V19, P96, DOI 10.1261/rna.037044.112; Fishelson Z, 2003, MOL IMMUNOL, V40, P109, DOI 10.1016/S0161-5890(03)00112-3; Forch P, 2002, EMBO J, V21, P6882, DOI 10.1093/emboj/cdf668; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Fuchs A, 2009, EUR J IMMUNOL, V39, P3097, DOI 10.1002/eji.200939392; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Izquierdo JM, 2007, J BIOL CHEM, V282, P1539, DOI 10.1074/jbc.C600198200; Jabara HH, 2011, INT IMMUNOL, V23, P215, DOI 10.1093/intimm/dxq474; JOHNSTONE RW, 1993, MOL IMMUNOL, V30, P1231, DOI 10.1016/0161-5890(93)90038-D; Joubert PE, 2009, CELL HOST MICROBE, V6, P354, DOI 10.1016/j.chom.2009.09.006; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kallstrom H, 2001, CELL MICROBIOL, V3, P133, DOI 10.1046/j.1462-5822.2001.00095.x; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kurita-Taniguchi M, 2000, J IMMUNOL, V165, P5143, DOI 10.4049/jimmunol.165.9.5143; Le Friec G, 2011, ANN RHEUM DIS, V70, pA48, DOI 10.1136/ard.2010.148981.15; Le Guienr C, 2001, J BIOL CHEM, V276, P40638, DOI 10.1074/jbc.M105642200; LISZEWSKI MK, 1994, J BIOL CHEM, V269, P10776; Liszewski MK, 1996, J IMMUNOL, V156, P4415; Ludford-Menting MJ, 2002, J BIOL CHEM, V277, P4477, DOI 10.1074/jbc.M108479200; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Maisner A, 1996, J VIROL, V70, P4973, DOI 10.1128/JVI.70.8.4973-4977.1996; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; McLaughlin BJ, 2003, INVEST OPHTH VIS SCI, V44, P3669, DOI 10.1167/iovs.02-0813; Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428; Naftelberg S, 2015, ANNU REV BIOCHEM, V84, P165, DOI 10.1146/annurev-biochem-060614-034242; Ni Choileain S., 2011, PLOS ONE, V6; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Okunola HL, 2009, MOL CELL BIOL, V29, P5620, DOI 10.1128/MCB.01678-08; Paz I, 2010, NUCLEIC ACIDS RES, V38, pW281, DOI 10.1093/nar/gkq444; POST TW, 1991, J EXP MED, V174, P93, DOI 10.1084/jem.174.1.93; Price JD, 2005, J IMMUNOL, V175, P677, DOI 10.4049/jimmunol.175.2.677; PURCELL DFJ, 1991, IMMUNOGENETICS, V33, P335, DOI 10.1007/BF00216692; Richards A, 2003, P NATL ACAD SCI USA, V100, P12966, DOI 10.1073/pnas.2135497100; Riley RC, 2002, MOL REPROD DEV, V62, P534, DOI 10.1002/mrd.10144; Roca X, 2013, GENE DEV, V27, P129, DOI 10.1101/gad.209759.112; Roca X, 2012, GENE DEV, V26, P1098, DOI 10.1101/gad.190173.112; Roca X, 2009, NAT STRUCT MOL BIOL, V16, P176, DOI 10.1038/nsmb.1546; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; RUSSELL SM, 1992, EUR J IMMUNOL, V22, P1513, DOI 10.1002/eji.1830220625; Sanford JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003369; SEYA T, 1986, J EXP MED, V163, P837, DOI 10.1084/jem.163.4.837; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Smith A, 2003, BLOOD, V102, P2877, DOI 10.1182/blood-2002-10-3152; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Sun SY, 2010, NAT STRUCT MOL BIOL, V17, P306, DOI 10.1038/nsmb.1750; Tan JZ, 2016, NUCLEIC ACIDS RES, V44, P3908, DOI 10.1093/nar/gkw163; Tan JZ, 2016, METHODS MOL BIOL, V1421, P243, DOI 10.1007/978-1-4939-3591-8_19; Tsai YG, 2012, LAB INVEST, V92, P1260, DOI 10.1038/labinvest.2012.86; Venables JP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3480; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wang GX, 2000, J IMMUNOL, V164, P1839, DOI 10.4049/jimmunol.164.4.1839; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Zhu J, 2000, GENE DEV, V14, P3166, DOI 10.1101/gad.189500	87	19	20	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14311	14323		10.1074/jbc.M115.710350	http://dx.doi.org/10.1074/jbc.M115.710350			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226545	Green Published, hybrid			2022-12-28	WOS:000379975100034
J	Brinkmann, EM; Mattes, B; Kumar, R; Hagemann, AIH; Gradl, D; Scholpp, S; Steinbeisser, H; Kaufmann, LT; Ozbek, S				Brinkmann, Eva-Maria; Mattes, Benjamin; Kumar, Rahul; Hagemann, Anja I. H.; Gradl, Dietmar; Scholpp, Steffen; Steinbeisser, Herbert; Kaufmann, Lilian T.; Oezbek, Suat			Secreted Frizzled-related Protein 2 (sFRP2) Redirects Non-canonical Wnt Signaling from Fz7 to Ror2 during Vertebrate Gastrulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						development; embryo; Wnt signaling; Xenopus; zebrafish; Fz7; Ror2; papc; sFRP2	CONVERGENT EXTENSION MOVEMENTS; MORPHOGENETIC MOVEMENTS; PARAXIAL PROTOCADHERIN; WNT/BETA-CATENIN; XENOPUS; ENDOCYTOSIS; ANTAGONIST; EXPRESSION; COMPLEX; BINDS	Convergent extension movements during vertebrate gastrulation require a balanced activity of non-canonical Wnt signaling pathways, but the factors regulating this interplay on the molecular level are poorly characterized. Here we show that sFRP2, a member of the secreted frizzled-related protein (sFRP) family, is required for morphogenesis and papc expression during Xenopus gastrulation. We further provide evidence that sFRP2 redirects non-canonical Wnt signaling from Frizzled 7 (Fz7) to the receptor tyrosine kinase-like orphan receptor 2 (Ror2). During this process, sFRP2 promotes Ror2 signal transduction by stabilizing Wnt5a-Ror2 complexes at the membrane, whereas it inhibits Fz7 signaling, probably by blocking Fz7 receptor endocytosis. The cysteine-rich domain of sFRP2 is sufficient for Ror2 activation, and related sFRPs can substitute for this function. Notably, direct interaction of the two receptors via their cysteine-rich domains also promotes Ror2-mediated papc expression but inhibits Fz7 signaling. We propose that sFRPs can act as a molecular switch, channeling the signal input for different non-canonical Wnt pathways during vertebrate gastrulation.	[Brinkmann, Eva-Maria; Kumar, Rahul; Steinbeisser, Herbert; Kaufmann, Lilian T.] Univ Heidelberg Hosp, Dept Dev Genet, Inst Human Genet, D-69120 Heidelberg, Germany; [Mattes, Benjamin; Hagemann, Anja I. H.; Scholpp, Steffen] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76344 Karlsruhe, Germany; [Gradl, Dietmar] Karlsruhe Inst Technol, Dept Cell & Dev Biol, Inst Zool, D-76131 Karlsruhe, Germany; [Oezbek, Suat] Heidelberg Univ, Dept Mol Evolut & Genom, Ctr Organismal Studies, Neuenheimer Feld 329, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg	Ozbek, S (corresponding author), Heidelberg Univ, Dept Mol Evolut & Genom, Ctr Organismal Studies, Neuenheimer Feld 329, D-69120 Heidelberg, Germany.; Kaufmann, LT (corresponding author), Univ Heidelberg Hosp, Inst Human Genet, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	lilian.kaufmann@med.uni-heidelberg.de; suat.oezbek@cos.uni-heidelberg.de	Scholpp, Steffen/E-4472-2018; Özbek, Suat/D-3701-2014; Heeren-Hagemann, Anja/AAC-8192-2020	Scholpp, Steffen/0000-0002-4903-9657; Heeren-Hagemann, Anja/0000-0001-5491-4607; Kumar, Rahul/0000-0002-0934-0859; Ozbek, Suat/0000-0003-2569-3942	Deutsche Forschungsgemeinschaft [STE 613/8-2, FOR1036, Oe 416/5-1, SCHO847/5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft research grants STE 613/8-2 and FOR1036 (to H. S., L. T. K., and E. M. B.), Oe 416/5-1 and FOR1036 (to S. O.), and SCHO847/5 (to S. S., B. M., and A. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Bhat RA, 2007, J CELL BIOCHEM, V102, P1519, DOI 10.1002/jcb.21372; Brand Michael, 2002, P7; Chong JM, 2002, J BIOL CHEM, V277, P5134, DOI 10.1074/jbc.M108533200; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Djiane A, 2000, DEVELOPMENT, V127, P3091; DU SJ, 1995, MOL CELL BIOL, V15, P2625; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Gibb N, 2013, DEVELOPMENT, V140, P1537, DOI 10.1242/dev.088047; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Hagemann AIH, 2014, J CELL SCI, V127, P3970, DOI 10.1242/jcs.148767; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; ISAACS HV, 1994, EMBO J, V13, P4469, DOI 10.1002/j.1460-2075.1994.tb06769.x; Itoh K, 1998, MECH DEVELOP, V74, P145, DOI 10.1016/S0925-4773(98)00076-8; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Kim SH, 1998, DEVELOPMENT, V125, P4681; Kim SH, 2000, CURR BIOL, V10, P821, DOI 10.1016/S0960-9822(00)00580-7; Kumar S, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-44; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Lin KM, 1997, P NATL ACAD SCI USA, V94, P11196, DOI 10.1073/pnas.94.21.11196; Lopez-Rios J, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-19; Malinauskas T, 2014, CURR OPIN STRUC BIOL, V29, P77, DOI 10.1016/j.sbi.2014.10.003; Medina A, 2000, DEV DYNAM, V218, P671, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1017>3.0.CO;2-9; Medina A, 2004, EMBO J, V23, P3249, DOI 10.1038/sj.emboj.7600329; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; MOON RT, 1993, DEVELOPMENT, V119, P97; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nishita M, 2010, MOL CELL BIOL, V30, P3610, DOI 10.1128/MCB.00177-10; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Ohkawara B, 2011, DEV DYNAM, V240, P188, DOI 10.1002/dvdy.22500; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Pera EM, 2000, MECH DEVELOP, V96, P183, DOI 10.1016/S0925-4773(00)00394-4; Perry SW, 1997, BIOTECHNIQUES, V22, P1020, DOI 10.2144/97226bm01; Rengarajan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086373; Satoh W, 2006, DEVELOPMENT, V133, P989, DOI 10.1242/dev.02274; Satoh W, 2008, GENESIS, V46, P92, DOI 10.1002/dvg.20369; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Shibata M, 2005, MECH DEVELOP, V122, P1322, DOI 10.1016/j.mod.2005.06.002; Stanganello E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6846; Sugiyama Y, 2010, DEV BIOL, V338, P193, DOI 10.1016/j.ydbio.2009.11.033; Sumanas S, 2001, GENESIS, V30, P119, DOI 10.1002/gene.1044; Swain RK, 2001, INT J DEV BIOL, V45, P259; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; Wallkamm V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109428; Wang YQ, 2009, CELL MOL LIFE SCI, V66, P2263, DOI 10.1007/s00018-009-0018-2; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Winklbauer R, 2001, NATURE, V413, P856, DOI 10.1038/35101621; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017; Yu AA, 2010, STRUCTURE, V18, P1311, DOI 10.1016/j.str.2010.07.010; Yuan YA, 2011, INT J MOL MED, V27, P63, DOI 10.3892/ijmm.2010.560	55	18	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13730	13742		10.1074/jbc.M116.733766	http://dx.doi.org/10.1074/jbc.M116.733766			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129770	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000379771100027
J	Higa, M; Zhang, X; Tanaka, K; Saijo, M				Higa, Mitsuru; Zhang, Xue; Tanaka, Kiyoji; Saijo, Masafumi			Stabilization of Ultraviolet (UV)-stimulated Scaffold Protein A by Interaction with Ubiquitin-specific Peptidase 7 Is Essential for Transcription-coupled Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deubiquitylation (deubiquitination); genetic disease; nucleotide excision repair; protein degradation; protein stability; protein-protein interaction	UV-SENSITIVE SYNDROME; RNA-POLYMERASE-II; COCKAYNE-SYNDROME; COMPLEMENTATION GROUPS; XERODERMA-PIGMENTOSUM; DNA-DAMAGE; DEFECT; P53; CSA; DEUBIQUITINATION	UV-sensitive syndrome is an autosomal recessive disorder characterized by hypersensitivity to UV light and deficiency in transcription-coupled nucleotide excision repair (TC-NER), a subpathway of nucleotide excision repair that rapidly removes transcription-blocking DNA damage. UV-sensitive syndrome consists of three genetic complementation groups caused by mutations in the CSA, CSB, and UVSSA genes. UV-stimulated scaffold protein A (UVSSA), the product of UVSSA, which is required for stabilization of Cockayne syndrome group B (CSB) protein and reappearance of the hypophosphorylated form of RNA polymerase II after UV irradiation, forms a complex with ubiquitin-specific peptidase 7 (USP7). In this study, we demonstrated that the deubiquitination activity of USP7 is suppressed by its interaction with UVSSA. The interaction required the tumor necrosis factor receptor-associated factor domain of USP7 and the central region of UVSSA and was disrupted by an amino acid substitution in the tumor necrosis factor receptor-associated factor-binding motif of UVSSA. Cells expressing mutant UVSSA were highly sensitive to UV irradiation and defective in recovery of RNA synthesis after UV irradiation. These results indicate that the interaction between UVSSA and USP7 is important for TC-NER. Furthermore, the mutant UVSSA was rapidly degraded by the proteasome, and CSB was also degraded after UV irradiation as observed in UVSSA-deficient cells. Thus, stabilization of UVSSA by interaction with USP7 is essential for TC-NER.	[Higa, Mitsuru; Zhang, Xue; Tanaka, Kiyoji; Saijo, Masafumi] Osaka Univ, Grad Sch Frontier Biosci, Yamadaoka 1-3, Suita, Osaka 5650871, Japan	Osaka University	Tanaka, K; Saijo, M (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Yamadaoka 1-3, Suita, Osaka 5650871, Japan.	ktanaka@fbs.osaka-u.ac.jp; saijom@fbs.osaka-u.ac.jp			Japan Society for the Promotion of Science [22131009, 15H02820]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas 22131009 (to K. T.) and Grant-in-aid for Scientific Research (B) 15H02820 (to M. S.) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest related to the contents of this article.	Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Fei J, 2012, J BIOL CHEM, V287, P35118, DOI 10.1074/jbc.M112.398131; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Friedberg E. C., 2005, DNA REPAIR MUTAGENES, P267; FUJIWARA Y, 1981, J INVEST DERMATOL, V77, P256, DOI 10.1111/1523-1747.ep12482447; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hassiepen U, 2007, ANAL BIOCHEM, V371, P201, DOI 10.1016/j.ab.2007.07.034; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; Holowaty MN, 2003, J BIOL CHEM, V278, P47753, DOI 10.1074/jbc.M307200200; Horibata K, 2004, P NATL ACAD SCI USA, V101, P15410, DOI 10.1073/pnas.0404587101; Horibata K, 2011, GENES CELLS, V16, P101, DOI 10.1111/j.1365-2443.2010.01467.x; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; ITOH T, 1995, AM J HUM GENET, V56, P1267; ITOH T, 1994, MUTAT RES, V314, P233, DOI 10.1016/0921-8777(94)90068-X; LEHMANN AR, 1985, LANCET, V1, P486; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; MAYNE LV, 1982, CANCER RES, V42, P1473; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Nakazawa Y, 2012, NAT GENET, V44, P586, DOI 10.1038/ng.2229; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Nardo T, 2009, P NATL ACAD SCI USA, V106, P6209, DOI 10.1073/pnas.0902113106; Sarkari F, 2010, J MOL BIOL, V402, P825, DOI 10.1016/j.jmb.2010.08.017; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Spivak G, 2005, MUTAT RES-FUND MOL M, V577, P162, DOI 10.1016/j.mrfmmm.2005.03.017; TANAKA K, 1981, SOMAT CELL GENET, V7, P445, DOI 10.1007/BF01542989; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228	33	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13771	13779		10.1074/jbc.M116.724658	http://dx.doi.org/10.1074/jbc.M116.724658			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129218	hybrid, Green Published			2022-12-28	WOS:000379771100031
J	Martin, J; Midgley, A; Meran, S; Woods, E; Bowen, T; Phillips, AO; Steadman, R				Martin, John; Midgley, Adam; Meran, Soma; Woods, Emma; Bowen, Timothy; Phillips, Aled O.; Steadman, Robert			Tumor Necrosis Factor-stimulated Gene 6 (TSG-6)-mediated Interactions with the Inter-alpha-inhibitor Heavy Chain 5 Facilitate Tumor Growth Factor beta 1 (TGF beta 1)-dependent Fibroblast to Myofibroblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast; fibrosis; hyaluronan; myofibroblast; transforming growth factor beta (TGF-B); fibroblast; tumor necrosis factor gene 6	HYALURONAN; PROGRESSION; PROTEIN; ITIH5; TSG-6; INACTIVATION; INFLAMMATION; PREDICTORS; EXPRESSION; PROMOTES	Fibroblasts are central to wound healing and fibrosis through TGF1-triggered differentiation into contractile, -smooth muscle actin (-SMA)-positive myofibroblasts. This is mediated by accumulation of a pericellular matrix of hyaluronan (HA) and the HA-dependent co-localization of CD44 with the epidermal growth factor receptor (EGFR). Interactions of HA with hyaladherins, such as inter--inhibitor (II) and tumor necrosis factor-stimulated gene-6 (TSG-6), are also essential for differentiation. This study investigated the mechanisms involved. TSG-6 and -SMA had different kinetics of induction by TGF1, with TSG-6 peaking before -SMA. Si CD44 or EGFR inhibition prevented differentiation but had no effect on TSG-6 expression. TSG-6 was essential for differentiation, and mAb A38 (preventing II heavy chain (HC) transfer), HA-oligosaccharides, cobalt, or Si bikunin prevented TSG-6 activity, preventing differentiation. A38 also prevented the EGFR/CD44 association. This suggested that TSG-6/II HC interaction was necessary for the effect of TSG-6 and that HC stabilization of HA initiated the CD44/EGFR association. The newly described HC5 was shown to be the principal HC expressed, and its cell surface expression was prevented by siRNA inhibition of TSG-6 or bikunin. HC5 was released by hyaluronidase treatment, confirming its association with cell surface HA. Finally, HC5 knockdown by siRNA confirmed its role in myofibroblast differentiation. The current study describes a novel mechanism linking the TSG-6 transfer of the newly described HC5 to the HA-dependent control of cell phenotype. The interaction of HC5 with cell surface HA was essential for TGF1-dependent differentiation of fibroblasts to myofibroblasts, highlighting its importance as a novel potential therapeutic target.	[Steadman, Robert] Cardiff Univ, Sch Med, Inst Mol & Expt Med, Dept Nephrol, Heath Pk, Cardiff CF14 4XN, S Glam, Wales; [Steadman, Robert] Cardiff Inst Tissue Engn & Repair, Heath Pk, Cardiff CF14 4XN, S Glam, Wales	Cardiff University; Cardiff University	Steadman, R (corresponding author), Cardiff Univ, Sch Med, Inst Mol & Expt Med, Dept Nephrol, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.; Steadman, R (corresponding author), Cardiff Inst Tissue Engn & Repair, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	steadmanr@cf.ac.uk	Midgley, Adam C./P-8108-2019; Steadman, Robert/O-1614-2016	Midgley, Adam C./0000-0002-7622-0275; Steadman, Robert/0000-0002-1303-2496; Phillips, Aled/0000-0001-9744-7113	Kidney Wales Foundation; Medical Research Council [MR/K010328/1] Funding Source: researchfish; MRC [MR/K010328/1] Funding Source: UKRI	Kidney Wales Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Kidney Wales Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Blom AM, 1999, J BIOL CHEM, V274, P298, DOI 10.1074/jbc.274.1.298; Bommaya G, 2011, INT J BIOCHEM CELL B, V43, P1739, DOI 10.1016/j.biocel.2011.08.009; Choi-Miura NH, 2000, INFLAMM RES, V49, P305, DOI 10.1007/PL00000211; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Essawy M, 1997, NEPHROL DIAL TRANSPL, V12, P43, DOI 10.1093/ndt/12.1.43; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Goumenos D, 1998, NEPHROL DIAL TRANSPL, V13, P1652, DOI 10.1093/ndt/13.7.1652; GOUMENOS DS, 1994, NEPHROL DIAL TRANSPL, V9, P1418; Hamm A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-25; Himmelfarb M, 2004, CANCER LETT, V204, P69, DOI 10.1016/j.canlet.2003.09.011; Huth S, 2015, EXP DERMATOL, V24, P663, DOI 10.1111/exd.12704; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Knudson W, 1996, EXP CELL RES, V228, P216, DOI 10.1006/excr.1996.0320; KUHN C, 1991, AM J PATHOL, V138, P1257; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; Lewis A, 2008, HISTOL HISTOPATHOL, V23, P731, DOI 10.14670/HH-23.731; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P4376, DOI 10.1210/en.2003-0487; Roberts ISD, 1997, J CLIN PATHOL, V50, P123, DOI 10.1136/jcp.50.2.123; Rose M, 2014, CARCINOGENESIS, V35, P727, DOI 10.1093/carcin/bgt375; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sato H, 2001, BIOCHEM BIOPH RES CO, V281, P1154, DOI 10.1006/bbrc.2001.4475; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selbi W, 2004, J AM SOC NEPHROL, V15, P1199, DOI 10.1097/01.ASN.0000125619.27422.8E; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Veeck J, 2008, ONCOGENE, V27, P865, DOI 10.1038/sj.onc.1210669; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	43	27	27	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13789	13801		10.1074/jbc.M115.670521	http://dx.doi.org/10.1074/jbc.M115.670521			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27143355	Green Published, hybrid			2022-12-28	WOS:000379771100033
J	White, CL; Kessler, PM; Dickerman, BK; Ozato, K; Sen, GC				White, Christine L.; Kessler, Patricia M.; Dickerman, Benjamin K.; Ozato, Keiko; Sen, Ganes C.			Interferon Regulatory Factor 8 (IRF8) Impairs Induction of Interferon Induced with Tetratricopeptide Repeat Motif (IFIT) Gene Family Members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; interferon; interferon regulatory factor (IRF); promoter; transcription regulation	SEQUENCE-BINDING-PROTEIN; INDUCIBLE HUMAN GENES; RIG-I; TRANSCRIPTION FACTOR; ALPHA; MOUSE; ACTIVATION; EXPRESSION; COMPLEX; RNA	The chromosomally clustered interferon-induced with tetratricopeptide repeat motif (IFIT) gene family members share structural features at the gene and protein levels. Despite these similarities, different IFIT genes have distinct inducer- and cell type-specific induction patterns. Here, we investigated the mechanism for the observed differential induction of the mouse Ifit1, Ifit2, and Ifit3 genes in B cells and demonstrated that the repressive effect of the transcription factor interferon regulatory factor 8 (IRF8), which is highly expressed in B cells, played an essential role in this regulation. Although IRF8 could impair induction of all three IFIT genes following stimulation of retinoic acid-inducible gene I (RIG-I), it could selectively impair the induction of the Ifit1 gene following IFN stimulation. The above properties could be imparted to IRF8-non-expressing cells by ectopic expression of the protein. Induction of reporter genes, driven by truncated Ifit1 promoters, identified the regions that mediate the repression, and a chromatin immunoprecipitation assay revealed that more IRF8 bound to the IFN-stimulated response element of the Ifit1 gene than to those of the Ifit2 and the Ifit3 genes. Mutational analyses of IRF8 showed that its ability to bind DNA, interact with other proteins, and undergo sumoylation were all necessary to selectively repress Ifit1 gene induction in response to IFN. Our study revealed a new role for IRFs in differentially regulating the induction patterns of closely related IFN-stimulated genes that are located adjacent to one another in the mouse genome.	[White, Christine L.; Kessler, Patricia M.; Dickerman, Benjamin K.; Sen, Ganes C.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA; [Dickerman, Benjamin K.; Sen, Ganes C.] Case Western Reserve Univ, Grad Program Mol Virol, Cleveland, OH 44106 USA; [Ozato, Keiko] NICHD, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA; [Dickerman, Benjamin K.] Burnet Inst Med Res, Melbourne, Vic 3004, Australia	Cleveland Clinic Foundation; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Burnet Institute	White, CL (corresponding author), Hudson Inst Med Res, Ctr Canc Res, 27-31 Wright St, Clayton, Vic 3168, Australia.; Sen, GC (corresponding author), Cleveland Clin, Dept Immunol NE20, 9500 Euclid Ave, Cleveland, OH 44195 USA.	christine.white@hudson.org.au; seng@ccf.org	White, Christine/AAQ-4546-2021	White, Christine/0000-0002-5920-0029	National Institutes of Health [CA068782, CA062220, AI073303]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310, ZIHHD001310] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA062220, R01CA068782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI073303, R01AI073303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants CA068782, CA062220, and AI073303 (to G. C. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BLUYSSEN HAR, 1994, EUR J BIOCHEM, V220, P395, DOI 10.1111/j.1432-1033.1994.tb18636.x; BLUYSSEN HAR, 1994, GENOMICS, V24, P137, DOI 10.1006/geno.1994.1591; BOVOLENTA C, 1994, P NATL ACAD SCI USA, V91, P5046, DOI 10.1073/pnas.91.11.5046; Carey Michael F, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5277; Chang TH, 2012, J IMMUNOL, V189, P3548, DOI 10.4049/jimmunol.1201104; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fensterl V, 2008, J VIROL, V82, P11045, DOI 10.1128/JVI.01593-08; Fensterl V, 2015, J VIROL, V89, P2462, DOI 10.1128/JVI.02744-14; Fensterl V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002712; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; Huang WQ, 2007, J BIOL CHEM, V282, P6629, DOI 10.1074/jbc.M607760200; Hui DJ, 2005, J BIOL CHEM, V280, P3433, DOI 10.1074/jbc.M406700200; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Lai KC, 2008, MOL CANCER RES, V6, P1431, DOI 10.1158/1541-7786.MCR-08-0141; LEVY DE, 1989, GENE DEV, V3, P1362, DOI 10.1101/gad.3.9.1362; Li P, 2011, BLOOD, V117, P2847, DOI 10.1182/blood-2010-07-294272; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Maniatis T., 1982, MOL CLONING; Marecki S, 1999, J IMMUNOL, V163, P2713; Meraro D, 1999, J IMMUNOL, V163, P6468; NELSON N, 1993, MOL CELL BIOL, V13, P588, DOI 10.1128/MCB.13.1.588; Ortiz MA, 1999, P NATL ACAD SCI USA, V96, P2740, DOI 10.1073/pnas.96.6.2740; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; SHARF R, 1995, J BIOL CHEM, V270, P13063, DOI 10.1074/jbc.270.22.13063; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Terenzi F, 2007, J VIROL, V81, P8656, DOI 10.1128/JVI.00322-07; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Tsujimura H, 2003, BLOOD, V101, P961, DOI 10.1182/blood-2002-05-1327; Unlu S, 2007, MOL IMMUNOL, V44, P3364, DOI 10.1016/j.molimm.2007.02.016; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; WATHELET MG, 1988, EUR J BIOCHEM, V174, P323, DOI 10.1111/j.1432-1033.1988.tb14101.x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	40	8	8	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13535	13545		10.1074/jbc.M115.705467	http://dx.doi.org/10.1074/jbc.M115.705467			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27137933	hybrid, Green Published			2022-12-28	WOS:000379771100012
J	Guo, JL; Buist, A; Soares, A; Callaerts, K; Calafate, S; Stevenaert, F; Daniels, JP; Zoll, BE; Crowe, A; Brunden, KR; Moechars, D; Lee, VMY				Guo, Jing L.; Buist, Arjan; Soares, Alberto; Callaerts, Kathleen; Calafate, Sara; Stevenaert, Frederik; Daniels, Joshua P.; Zoll, Bryan E.; Crowe, Alex; Brunden, Kurt R.; Moechars, Diederik; Lee, Virginia M. Y.			The Dynamics and Turnover of Tau Aggregates in Cultured Cells INSIGHTS INTO THERAPIES FOR TAUOPATHIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; ALPHA-SYNUCLEIN FIBRILS; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; NEURODEGENERATIVE DISEASES; MAMMALIAN AUTOPHAGY; DEGRADATION; PROTEASOME; PHOSPHORYLATION	Filamentous tau aggregates, the hallmark lesions of Alzheimer disease (AD), play key roles in neurodegeneration. Activation of protein degradation systems has been proposed to be a potential strategy for removing pathological tau, but it remains unclear how effectively tau aggregates can be degraded by these systems. By applying our previously established cellular model system of AD-like tau aggregate induction using preformed tau fibrils, we demonstrate that tau aggregates induced in cells with regulated expression of full-length mutant tau can be gradually cleared when soluble tau expression is suppressed. This clearance is at least partially mediated by the autophagy-lysosome pathway, although both the ubiquitin-proteasome system and the autophagy-lysosome pathway are deficient in handling large tau aggregates. Importantly, residual tau aggregates left after the clearance phase leads to a rapid reinstatement of robust tau pathology once soluble tau expression is turned on again. Moreover, we succeeded in generating monoclonal cells persistently carrying tau aggregates without obvious cytotoxicity. Live imaging of GFP-tagged tau aggregates showed that tau inclusions are dynamic structures constantly undergoing "fission" and "fusion," which facilitate stable propagation of tau pathology in dividing cells. These findings provide a greater understanding of cell-to-cell transmission of tau aggregates in dividing cells and possibly neurons.	[Daniels, Joshua P.; Zoll, Bryan E.; Crowe, Alex; Brunden, Kurt R.; Lee, Virginia M. Y.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Inst Aging, Philadelphia, PA 19104 USA; [Daniels, Joshua P.; Zoll, Bryan E.; Crowe, Alex; Brunden, Kurt R.; Lee, Virginia M. Y.] Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Buist, Arjan; Soares, Alberto; Callaerts, Kathleen; Calafate, Sara; Stevenaert, Frederik; Moechars, Diederik] Janssen Res & Dev, Neurosci Dept, B-2340 Beerse, Belgium	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Johnson & Johnson; Janssen Pharmaceuticals	Guo, JL; Lee, VMY (corresponding author), Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, 3rd Floor Maloney Bldg,3600 Spruce St, Philadelphia, PA 19104 USA.	guojing@mail.med.upenn.edu; vmylee@upenn.edu		calafate, sara/0000-0002-1276-3211	National Institutes of Health NIA [AG17586]; CurePSP Foundation; BrightFocus Foundation; NATIONAL INSTITUTE ON AGING [P01AG017586] Funding Source: NIH RePORTER	National Institutes of Health NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); CurePSP Foundation; BrightFocus Foundation(BrightFocus Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health NIA Grant AG17586, the CurePSP Foundation, and a postdoctoral fellowship award (to J. L. G.) from Sophie M. Moyer and other donors of the Alzheimer's disease research program of the BrightFocus Foundation. Some coauthors work for Janssen, Pharmaceutical Companies of Johnson & Johnson. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Belitzky A, 2011, PHYS CHEM CHEM PHYS, V13, P13809, DOI 10.1039/c1cp20832b; Bi XN, 2000, J NEUROCHEM, V74, P1469, DOI 10.1046/j.1471-4159.2000.0741469.x; BRION JP, 1989, NEUROCHEM INT, V14, P121, DOI 10.1016/0197-0186(89)90111-3; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; Caccamo A, 2013, AGING CELL, V12, P370, DOI 10.1111/acel.12057; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chesser AS, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00122; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; COLE GM, 1987, NEUROSCI LETT, V79, P207, DOI 10.1016/0304-3940(87)90698-7; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hamano T, 2008, EUR J NEUROSCI, V27, P1119, DOI 10.1111/j.1460-9568.2008.06084.x; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Ii K, 1997, J NEUROPATH EXP NEUR, V56, P125, DOI 10.1097/00005072-199702000-00002; Inoue K, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-48; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Keck S, 2003, J NEUROCHEM, V85, P115, DOI 10.1046/j.1471-4159.2003.01642.x; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kouri N, 2011, BRAIN, V134, P3264, DOI 10.1093/brain/awr234; Kruger U, 2012, NEUROBIOL AGING, V33, P2291, DOI 10.1016/j.neurobiolaging.2011.11.009; KWAK S, 1991, NEUROSCI LETT, V128, P21, DOI 10.1016/0304-3940(91)90751-E; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Ling H, 2014, NEUROPATH APPL NEURO, V40, P149, DOI 10.1111/nan.12037; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Meyer V, 2014, BIOCHEMISTRY-US, V53, P5804, DOI 10.1021/bi501050g; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Polydoro M, 2013, J NEUROSCI, V33, P13300, DOI 10.1523/JNEUROSCI.0881-13.2013; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sampathu DM, 2006, AM J PATHOL, V169, P1343, DOI 10.2353/ajpath.2006.060438; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143; Shammas SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8025; Sydow A, 2010, NEURODEGENER DIS, V7, P28, DOI 10.1159/000283479; Tang L, 2006, MICRON, V37, P675, DOI 10.1016/j.micron.2006.02.004; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	52	46	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13175	13193		10.1074/jbc.M115.712083	http://dx.doi.org/10.1074/jbc.M115.712083			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129267	Green Published, hybrid			2022-12-28	WOS:000379770500024
J	Vetterli, L; Carobbio, S; Frigerio, F; Karaca, M; Maechler, P				Vetterli, Laurene; Carobbio, Stefania; Frigerio, Francesca; Karaca, Melis; Maechler, Pierre			The Amplifying Pathway of the beta-Cell Contributes to Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED INSULIN-SECRETION; GLUTAMATE-DEHYDROGENASE; WEIGHT-LOSS; GLUCOSE; DIAZOXIDE; HYPERINSULINEMIA; PROTECTS; MICE; EXPRESSION; CHANNELS	Efficient energy storage in adipose tissues requires optimal function of the insulin-producing beta-cell, whereas its dysfunction promotes diabetes. The associated paradox related to beta-cell efficiency is that excessive accumulation of fat in adipose tissue predisposes for type 2 diabetes. Insulin exocytosis is regulated by intracellular metabolic signal transduction, with glutamate dehydrogenase playing a key role in the amplification of the secretory response. Here, we used mice with beta-cell-selective glutamate dehydrogenase deletion (beta Glud1(-/-)), lacking an amplifying pathway of insulin secretion. As opposed to control mice, beta Glud1(-/-) animals fed a high calorie diet maintained glucose tolerance and did not develop diet-induced obesity. Islets of beta Glud1(-/-) mice did not increase their secretory response upon high calorie feeding, as did islets of control mice. Inhibited adipose tissue expansion observed in knock-out mice correlated with lower expression of genes responsible for adipogenesis. Rather than being efficiently stored, lipids were consumed at a higher rate in beta Glud1(-/-) mice compared with controls, in particular during food intake periods. These results show that reduced beta-cell function prior to high calorie feeding prevented diet-induced obesity.	Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland; Univ Geneva, Med Ctr, Fac Diabet Ctr, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva	Maechler, P (corresponding author), Univ Med Ctr, Dept Cell Physiol & Metab, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Pierre.Maechler@unige.ch	carobbio, stefania/E-7095-2018	Karaca, Melis/0000-0001-6951-3507; Maechler, Pierre/0000-0002-2005-1433	State of Geneva; Swiss National Science Foundation	State of Geneva; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the State of Geneva and the Swiss National Science Foundation (to P. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Alemzadeh R, 1998, J CLIN ENDOCR METAB, V83, P1911, DOI 10.1210/jc.83.6.1911; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Ashcroft FM, 2006, BIOCHEM SOC T, V34, P243, DOI 10.1042/BST0340243; Bluher M, 2004, J BIOL CHEM, V279, P31902, DOI 10.1074/jbc.M404570200; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Carobbio S, 2004, DIABETOLOGIA, V47, P266, DOI 10.1007/s00125-003-1306-2; Carobbio S, 2009, J BIOL CHEM, V284, P921, DOI 10.1074/jbc.M806295200; Casimir M, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-2; Casimir M, 2009, J BIOL CHEM, V284, P25004, DOI 10.1074/jbc.M109.015495; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Due A, 2007, DIABETES OBES METAB, V9, P566, DOI 10.1111/j.1463-1326.2006.00645.x; Ferdaoussi M, 2015, J CLIN INVEST, V125, P3847, DOI 10.1172/JCI82498; FOLCH J, 1957, J BIOL CHEM, V226, P497; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; Gheni G, 2014, CELL REP, V9, P661, DOI 10.1016/j.celrep.2014.09.030; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; Hoy M, 2002, FEBS LETT, V531, P199, DOI 10.1016/S0014-5793(02)03500-7; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Karaca M, 2014, NEUROCHEM RES, V39, P456, DOI 10.1007/s11064-013-1041-0; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Lamberts SWJ, 1996, NEW ENGL J MED, V334, P246, DOI 10.1056/NEJM199601253340408; Li N, 2012, DIABETES, V61, P2842, DOI 10.2337/db12-0009; Lustig RH, 2006, INT J OBESITY, V30, P331, DOI 10.1038/sj.ijo.0803074; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 2013, MOL CELL ENDOCRINOL, V379, P12, DOI 10.1016/j.mce.2013.06.019; Matsumoto S, 2005, LANCET, V365, P1642, DOI 10.1016/S0140-6736(05)66383-0; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; MICHAELIDIS TM, 1993, GENOMICS, V16, P150, DOI 10.1006/geno.1993.1152; Movassat J, 2008, AM J PHYSIOL-ENDOC M, V294, pE168, DOI 10.1152/ajpendo.00501.2007; POLONSKY KS, 1988, J CLIN INVEST, V81, P435, DOI 10.1172/JCI113338; PORTHA B, 1991, DIABETES, V40, P486, DOI 10.2337/diabetes.40.4.486; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Robertson RP, 2002, TRANSPLANTATION, V73, P736; Rubi B, 2001, J BIOL CHEM, V276, P36391, DOI 10.1074/jbc.M104999200; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Supale S, 2013, DIABETES, V62, P3488, DOI 10.2337/db13-0152; Templeman NM, 2015, DIABETOLOGIA, V58, P2392, DOI 10.1007/s00125-015-3676-7; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; van Boekel G, 2008, DIABETES OBES METAB, V10, P1195, DOI 10.1111/j.1463-1326.2008.00878.x; Vetterli L, 2012, MOL BIOL CELL, V23, P3851, DOI 10.1091/mbc.E11-08-0676; Virtue S, 2012, CELL METAB, V16, P665, DOI 10.1016/j.cmet.2012.10.008; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Wu YJ, 2011, J CLIN INVEST, V121, P2422, DOI 10.1172/JCI45027; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	46	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13063	13075		10.1074/jbc.M115.707448	http://dx.doi.org/10.1074/jbc.M115.707448			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27137930	hybrid, Green Published			2022-12-28	WOS:000379770500015
J	Chahi, AK; Martin, CE; Jones, N				Chahi, Ava Keyvani; Martin, Claire E.; Jones, Nina			Nephrin Suppresses Hippo Signaling through the Adaptor Proteins Nck and WTIP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; PODOCYTE PHENOTYPE; CELL; YAP; REORGANIZATION; RECRUITMENT; PATHWAY; COMPLEX; YAP/TAZ; GROWTH	Podocytes are key components of the kidney blood filtration barrier, and their ability to withstand hemodynamic strain is proposed to be closely tied to their unique and flexible cytoarchitecture. However, the mechanisms that control such mechanotransduction are poorly understood. We have previously established that tyrosine phosphorylation of the transmembrane protein nephrin promotes recruitment of the Nck1/2 cytoskeletal adaptor proteins and downstream actin remodeling. We now reveal that Nck integrates nephrin with the Hippo kinase cascade through association with the adaptor protein WTIP. Using mutational analysis, we show that Nck sequesters WTIP and its binding partner Lats1 to phosphorylated nephrin, resulting in decreased phospho-activation of Lats1. We further demonstrate that, coincident with nephrin dephosphorylation in a transient model of podocyte injury in mice, Lats1 is rapidly activated, and this precedes significant down-regulation of the transcription regulator Yap. Moreover, we show reduced levels of Yap protein in mice with chronic disruption of nephrin phospho-signaling. Together, these findings support the existence of a dynamic molecular link between nephrin signaling and the canonical Hippo pathway in podocytes, which may facilitate the conversion of mechanical cues to biochemical signals promoting podocyte viability.	[Chahi, Ava Keyvani; Martin, Claire E.; Jones, Nina] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E,Rm 3461,Summerlee Sci Complex, Guelph, ON N1G 2W1, Canada	University of Guelph	Jones, N (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E,Rm 3461,Summerlee Sci Complex, Guelph, ON N1G 2W1, Canada.	jonesmcb@uoguelph.ca			Kidney Foundation of Canada; Ontario Graduate Scholarships; NSERC Alexander Graham Bell Canada Graduate Doctoral Scholarship; KRESCENT program	Kidney Foundation of Canada; Ontario Graduate Scholarships(Ontario Graduate Scholarship); NSERC Alexander Graham Bell Canada Graduate Doctoral Scholarship; KRESCENT program(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Kidney Foundation of Canada (to N. J.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by Ontario Graduate Scholarships.r Supported by an NSERC Alexander Graham Bell Canada Graduate Doctoral Scholarship.r Holder of a Tier II Canada Research Chair in Eukaryotic Cellular Signaling and recipient of a New Investigator Award from the KRESCENT program.	Abe Y, 2006, FEBS LETT, V580, P782, DOI 10.1016/j.febslet.2005.12.096; Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Blasutig IM, 2008, MOL CELL BIOL, V28, P2035, DOI 10.1128/MCB.01770-07; Campbell KN, 2013, J BIOL CHEM, V288, P17057, DOI 10.1074/jbc.C113.457390; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Endlich N, 2012, SEMIN NEPHROL, V32, P327, DOI 10.1016/j.semnephrol.2012.06.004; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Hoppe John M, 2014, Methods Mol Biol, V1169, P159, DOI 10.1007/978-1-4939-0882-0_15; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Jones N, 2009, J AM SOC NEPHROL, V20, P1533, DOI 10.1681/ASN.2009010056; Kann M, 2015, J AM SOC NEPHROL, V26, P2097, DOI 10.1681/ASN.2014090940; Kim JH, 2012, AM J PHYSIOL-RENAL, V302, pF103, DOI 10.1152/ajprenal.00419.2011; Kim JH, 2010, J BIOL CHEM, V285, P9995, DOI 10.1074/jbc.M109.061671; Kriz W, 2015, J AM SOC NEPHROL, V26, P258, DOI 10.1681/ASN.2014030278; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Li HP, 2006, BIOCHEM BIOPH RES CO, V349, P310, DOI 10.1016/j.bbrc.2006.08.053; Low BC, 2014, FEBS LETT, V588, P2663, DOI 10.1016/j.febslet.2014.04.012; New LA, 2016, J AM SOC NEPHROL, V27, P2422, DOI 10.1681/ASN.2015091048; New LA, 2014, CURR OPIN NEPHROL HY, V23, P420, DOI 10.1097/01.mnh.0000447018.28852.b6; New LA, 2013, J BIOL CHEM, V288, P1500, DOI 10.1074/jbc.M112.439463; Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Schwartzman M, 2016, J AM SOC NEPHROL, V27, P216, DOI 10.1681/ASN.2014090916; Simons M, 2008, KIDNEY INT, V73, P671, DOI 10.1038/sj.ki.5002798; Srichai MB, 2004, J BIOL CHEM, V279, P14398, DOI 10.1074/jbc.M314155200; Uchida K, 2008, KIDNEY INT, V73, P926, DOI [10.1038/ki.2008.19, 10.1038/KI.2008.19]; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Wennmann DO, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.476	31	15	15	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12799	12808		10.1074/jbc.M116.724245	http://dx.doi.org/10.1074/jbc.M116.724245			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27033705	Green Published, hybrid			2022-12-28	WOS:000378119900031
J	Tando, T; Hirayama, A; Furukawa, M; Sato, Y; Kobayashi, T; Funayama, A; Kanaji, A; Hao, W; Watanabe, R; Morita, M; Oike, T; Miyamoto, K; Soga, T; Nomura, M; Yoshimura, A; Tomita, M; Matsumoto, M; Nakamura, M; Toyama, Y; Miyamoto, T				Tando, Toshimi; Hirayama, Akiyoshi; Furukawa, Mitsuru; Sato, Yuiko; Kobayashi, Tami; Funayama, Atsushi; Kanaji, Arihiko; Hao, Wu; Watanabe, Ryuichi; Morita, Mayu; Oike, Takatsugu; Miyamoto, Kana; Soga, Tomoyoshi; Nomura, Masatoshi; Yoshimura, Akihiko; Tomita, Masaru; Matsumoto, Morio; Nakamura, Masaya; Toyama, Yoshiaki; Miyamoto, Takeshi			Smad2/3 Proteins Are Required for Immobilization-induced Skeletal Muscle Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; FOXO TRANSCRIPTION FACTORS; SCF UBIQUITIN LIGASE; F-BOX PROTEIN; CAPILLARY-ELECTROPHORESIS; MYOSTATIN GENE; MASS-SPECTROMETRY; HYPERTROPHY; MICE; RECEPTOR	Skeletal muscle atrophy promotes muscle weakness, limiting activities of daily living. However, mechanisms underlying atrophy remain unclear. Here, we show that skeletal muscle immobilization elevates Smad2/3 protein but not mRNA levels in muscle, promoting atrophy. Furthermore, we demonstrate that myostatin, which negatively regulates muscle hypertrophy, is dispensable for denervation-induced muscle atrophy and Smad2/3 protein accumulation. Moreover, muscle-specific Smad2/3-deficient mice exhibited significant resistance to denervation-induced muscle atrophy. In addition, expression of the atrogenes Atrogin-1 and MuRF1, which underlie muscle atrophy, did not increase in muscles of Smad2/3-deficient mice following denervation. We also demonstrate that serum starvation promotes Smad2/3 protein accumulation in C2C12 myogenic cells, an in vitro muscle atrophy model, an effect inhibited by IGF1 treatment. In vivo, we observed IGF1 receptor deactivation in immobilized muscle, even in the presence of normal levels of circulating IGF1. Denervation-induced muscle atrophy was accompanied by reduced glucose intake and elevated levels of branched-chain amino acids, effects that were Smad2/3-dependent. Thus, muscle immobilization attenuates IGF1 signals at the receptor rather than the ligand level, leading to Smad2/3 protein accumulation, muscle atrophy, and accompanying metabolic changes.	[Tando, Toshimi; Furukawa, Mitsuru; Sato, Yuiko; Kobayashi, Tami; Funayama, Atsushi; Kanaji, Arihiko; Hao, Wu; Watanabe, Ryuichi; Oike, Takatsugu; Miyamoto, Kana; Matsumoto, Morio; Nakamura, Masaya; Toyama, Yoshiaki; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan; [Sato, Yuiko; Kobayashi, Tami] Keio Univ, Sch Med, Dept Musculoskeletal Reconstruct & Regenerat Surg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Immunol, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan; [Morita, Mayu] Keio Univ, Sch Med, Dept Dent & Oral Surg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan; [Hirayama, Akiyoshi; Soga, Tomoyoshi; Tomita, Masaru] Keio Univ, Inst Adv Biosci, 246-2 Mizukami, Tsuruoka, Yamagata 9970052, Japan; [Nomura, Masatoshi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Maidashi 3-1-1,Higashi Ward, Fukuoka 8128582, Japan	Keio University; Keio University; Keio University; Keio University; Keio University; Kyushu University	Miyamoto, T (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	miyamoto@z5.keio.jp	hao, wu/HDM-1705-2022; Soga, Tomoyoshi/B-8105-2014; Nakamura, Masaya/K-4111-2013; Yoshimura, Akihiko/K-5515-2013	Soga, Tomoyoshi/0000-0001-9502-2509; 	Translational Research Network Program; Grants-in-Aid for Scientific Research [16K10917] Funding Source: KAKEN	Translational Research Network Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research and in part by a grant from the Translational Research Network Program. The authors declare that they have no conflicts of interest with the contents of this article.	Alzghoul MB, 2004, FASEB J, V18, P221, DOI 10.1096/fj.03-0293fje; BILAN PJ, 1992, FEBS LETT, V298, P285, DOI 10.1016/0014-5793(92)80078-U; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Criswell DS, 1998, AM J PHYSIOL-ENDOC M, V275, pE373; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; DIMITRIADIS G, 1992, BIOCHEM J, V285, P269, DOI 10.1042/bj2850269; DIMITRIADIS G, 1992, J ENDOCRINOL, V133, P37, DOI 10.1677/joe.0.1330037; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Gallot YS, 2014, CANCER RES, V74, P7344, DOI 10.1158/0008-5472.CAN-14-0057; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jogo M, 2009, FEBS LETT, V583, P2715, DOI 10.1016/j.febslet.2009.07.033; Katsuyama E, 2015, J BIOL CHEM, V290, P716, DOI 10.1074/jbc.M114.568360; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Klampfl CW, 2001, ELECTROPHORESIS, V22, P2737, DOI 10.1002/1522-2683(200108)22:13&lt;2737::AID-ELPS2737&gt;3.0.CO;2-Z; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Mavalli MD, 2010, J CLIN INVEST, V120, P4007, DOI 10.1172/JCI42447; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Miyamoto H, 2012, J BIOL CHEM, V287, P32479, DOI 10.1074/jbc.M112.358226; Miyauchi Y, 2013, P NATL ACAD SCI USA, V110, P16568, DOI 10.1073/pnas.1308755110; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Pistilli EE, 2011, AM J PATHOL, V178, P1287, DOI 10.1016/j.ajpath.2010.11.071; Powers SK, 2005, AM J PHYSIOL-REG I, V288, pR337, DOI 10.1152/ajpregu.00469.2004; Reid MB, 2001, RESP RES, V2, P269, DOI 10.1186/rr67; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shi J, 2011, DEV CELL, V21, P835, DOI 10.1016/j.devcel.2011.09.011; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Smith RC, 2013, CURR OPIN SUPPORT PA, V7, P352, DOI 10.1097/SPC.0000000000000013; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de; Stevenson EJ, 2005, J APPL PHYSIOL, V98, P1396, DOI 10.1152/japplphysiol.01055.2004; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Winbanks CE, 2013, J CELL BIOL, V203, P345, DOI 10.1083/jcb.201211134	54	38	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12184	12194		10.1074/jbc.M115.680579	http://dx.doi.org/10.1074/jbc.M115.680579			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27129272	Green Published, hybrid			2022-12-28	WOS:000378092800020
J	Ozawa, A; Sato, Y; Imabayashi, T; Uemura, T; Takagi, J; Sekiguchi, K				Ozawa, Akio; Sato, Yuya; Imabayashi, Tsukasa; Uemura, Toshihiko; Takagi, Junichi; Sekiguchi, Kiyotoshi			Molecular Basis of the Ligand Binding Specificity of alpha v beta 8 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE; STRUCTURAL BASIS; CELL-ADHESION; MICE LACKING; MOUSE; ALPHA(V)BETA(3); FIBRONECTIN; RECOGNITION; ACTIVATION; SUBUNIT	alpha v beta 8 is an integrin that recognizes an Arg-Gly-Asp (RGD) motif and interacts with fibronectin, vitronectin, and latent TGF-beta 1. We comprehensively determined the binding activity of the alpha v beta 8 integrin toward 25 secreted proteins having an RGD motif. The alpha v beta 8 integrin strongly bound to latent TGF-beta 1 but showed marginal activity for other RGD-containing proteins, including fibronectin and vitronectin. Site-directed mutagenesis of latent TGF-beta 1 demonstrated that the high affinity binding of alpha v beta 8 integrin to latent TGF-beta 1 was defined by Leu-218 immediately following the RGD motif within the latency-associated peptide of TGF-beta 1. Consistent with the critical role of Leu-218 in latent TGF-beta 1 recognition by alpha v beta 8 integrin, a 9-mer synthetic peptide containing an RGDL sequence strongly inhibited interactions of latent TGF-beta 1 with alpha v beta 8 integrin, whereas a 9-mer peptide with an RGDA sequence was similar to 60-fold less inhibitory. Because alpha v beta 3 integrin did not exhibit strong binding to latent TGF-beta 1 or distinguish between RGDL- and RGDA-containing peptides, we explored the mechanism by which the integrin beta 8 subunit defines the high affinity binding of latent TGF-beta 1 by alpha v beta 8 integrin. Production of a series of swap mutants of integrin beta 8 and beta 3 subunits indicated that the high affinity binding of alpha v beta 8 integrin with latent TGF-beta 1 was ensured by interactions between the Leu-218 residue and the beta 8 I-like domain, with the former serving as an auxiliary recognition residue defining the restricted ligand specificity of alpha v beta 8 integrin toward latent TGF-beta 1. In support of this conclusion, high affinity binding toward the alpha v beta 8 integrin was conferred on fibronectin by substitution of its RGDS motif with an RGDL sequence.	[Ozawa, Akio; Sato, Yuya; Imabayashi, Tsukasa; Uemura, Toshihiko; Takagi, Junichi; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University	Sekiguchi, K (corresponding author), Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sekiguch@protein.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research on innovative areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	AOTA S, 1994, J BIOL CHEM, V269, P24756; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arnold TD, 2014, DEVELOPMENT, V141, P4489, DOI 10.1242/dev.107193; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Cambier S, 2000, CANCER RES, V60, P7084; Chen CM, 2013, BIOINFORMATICS, V29, P2808, DOI 10.1093/bioinformatics/btt484; Cheng M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081609; DAMSKY C, 1993, FASEB J, V7, P1320, DOI 10.1096/fasebj.7.14.8224605; DELANNET M, 1994, DEVELOPMENT, V120, P2687; DiCara D, 2007, J BIOL CHEM, V282, P9657, DOI 10.1074/jbc.M610461200; Dong XC, 2014, NAT STRUCT MOL BIOL, V21, P1091, DOI 10.1038/nsmb.2905; Dong XC, 2012, BIOCHEMISTRY-US, V51, P8814, DOI 10.1021/bi300734n; DRAKE CJ, 1995, J CELL SCI, V108, P2655; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; Friedlander M, 1996, P NATL ACAD SCI USA, V93, P9764, DOI 10.1073/pnas.93.18.9764; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HIRSCH E, 1994, DEV DYNAM, V201, P108, DOI 10.1002/aja.1002010203; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ido H, 2004, J BIOL CHEM, V279, P10946, DOI 10.1074/jbc.M313626200; Ido H, 2007, J BIOL CHEM, V282, P11144, DOI 10.1074/jbc.M609402200; Jovanovic J, 2008, BIOCHEM SOC T, V36, P257, DOI 10.1042/BST0360257; Kiyozumi D, 2005, EXP CELL RES, V306, P9, DOI 10.1016/j.yexcr.2005.01.020; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Manabe R, 1997, J CELL BIOL, V139, P295, DOI 10.1083/jcb.139.1.295; MOYLE M, 1991, J BIOL CHEM, V266, P19650; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Mu ZY, 2008, MECH DEVELOP, V125, P508, DOI 10.1016/j.mod.2008.01.003; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NISHIMURA SL, 1994, J BIOL CHEM, V269, P28708; Nishimura SL, 1998, BRAIN RES, V791, P271, DOI 10.1016/S0006-8993(98)00118-8; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Osada A, 2005, EXP CELL RES, V303, P148, DOI 10.1016/j.yexcr.2004.04.053; PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766; Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sato Y, 2009, J BIOL CHEM, V284, P14524, DOI 10.1074/jbc.M900200200; SEKIGUCHI K, 1983, J BIOL CHEM, V258, P3967; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; VENSTROM K, 1995, MOL BIOL CELL, V6, P419, DOI 10.1091/mbc.6.4.419; Weis SM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006478; Worthington JJ, 2011, TRENDS BIOCHEM SCI, V36, P47, DOI 10.1016/j.tibs.2010.08.002; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zhu JW, 2002, DEVELOPMENT, V129, P2891	54	31	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11551	11565		10.1074/jbc.M116.719138	http://dx.doi.org/10.1074/jbc.M116.719138			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27033701	Green Published, hybrid			2022-12-28	WOS:000377264800008
J	Harprecht, C; Okifo, O; Robbins, KJ; Motwani, T; Alexandrescu, AT; Teschke, CM				Harprecht, Christina; Okifo, Oghenefejiro; Robbins, Kevin J.; Motwani, Tina; Alexandrescu, Andrei T.; Teschke, Carolyn M.			Contextual Role of a Salt Bridge in the Phage P22 Coat Protein I-Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteriophage; nuclear magnetic resonance (NMR); protein folding; protein stability; virus; ionization constant; nanoparticle; procapsid	AMINO-ACID SUBSTITUTIONS; P22 SCAFFOLDING PROTEIN; BACTERIOPHAGE P22; HYDROGEN-EXCHANGE; ASSEMBLY IDENTIFICATION; STAPHYLOCOCCAL NUCLEASE; CAPSID MATURATION; NMR ASSIGNMENTS; VIRAL CAPSIDS; STABILITY	The I-domain is a genetic insertion in the phage P22 coat protein that chaperones its folding and stability. Of 11 acidic residues in the I-domain, seven participate in stabilizing electrostatic interactions with basic residues across elements of secondary structure, fastening the -barrel fold. A hydrogen-bonded salt bridge between Asp-302 and His-305 is particularly interesting as Asp-302 is the site of a temperature-sensitive-folding mutation. The pK(a) of His-305 is raised to 9.0, indicating the salt bridge stabilizes the I-domain by approximate to 4 kcal/mol. Consistently, urea denaturation experiments indicate the stability of the WT I-domain decreases by 4 kcal/mol between neutral and basic pH. The mutants D302A and H305A remove the pH dependence of stability. The D302A substitution destabilizes the I-domain by 4 kcal/mol, whereas H305A had smaller effects, on the order of 1-2 kcal/mol. The destabilizing effects of D302A are perpetuated in the full-length coat protein as shown by a higher sensitivity to protease digestion, decreased procapsid assembly rates, and impaired phage production in vivo. By contrast, the mutants have only minor effects on capsid expansion or stability in vitro. The effects of the Asp-302-His-305 salt bridge are thus complex and context-dependent. Substitutions that abolish the salt bridge destabilize coat protein monomers and impair capsid self-assembly, but once capsids are formed the effects of the substitutions are overcome by new quaternary interactions between subunits.	[Alexandrescu, Andrei T.; Teschke, Carolyn M.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; Univ Connecticut, Dept Chem, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Alexandrescu, AT; Teschke, CM (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	andrei.alexandrescu@uconn.edu; carolyn.teschke@uconn.edu			National Institutes of Health [R01 GM076661]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM076661 (to C. M. T. and A. T. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALEXANDRESCU AT, 1994, J MOL BIOL, V242, P527, DOI 10.1006/jmbi.1994.1598; Alexandrescu AT, 1999, J MOL BIOL, V289, P1041, DOI 10.1006/jmbi.1999.2813; Anderson E, 2003, VIROLOGY, V313, P184, DOI 10.1016/S0042-6822(03)00240-X; BAI YW, 1994, PROTEINS, V20, P4, DOI 10.1002/prot.340200103; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Capen CM, 2000, BIOCHEMISTRY-US, V39, P1142, DOI 10.1021/bi991956t; CASJENS S, 1988, J MOL BIOL, V199, P467, DOI 10.1016/0022-2836(88)90618-3; CASJENS S, 1992, J MOL BIOL, V224, P1055, DOI 10.1016/0022-2836(92)90469-Z; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Cortines JR, 2014, J VIROL, V88, P5287, DOI 10.1128/JVI.00036-14; Cortines JR, 2011, VIROLOGY, V421, P1, DOI 10.1016/j.virol.2011.09.005; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P225; Croke RL, 2008, PROTEIN SCI, V17, P1434, DOI 10.1110/ps.033803.107; Croke RL, 2011, PROTEIN SCI, V20, P256, DOI 10.1002/pro.556; D'Lima NG, 2015, J VIROL, V89, P10569, DOI 10.1128/JVI.01629-15; Flenniken ML, 2009, CURR TOP MICROBIOL, V327, P71; FOGUEL D, 1995, BIOCHEMISTRY-US, V34, P1120, DOI 10.1021/bi00004a003; GALISTEO ML, 1993, BIOPHYS J, V65, P227, DOI 10.1016/S0006-3495(93)81073-7; GORDON CL, 1994, J BIOL CHEM, V269, P27941; GORDON CL, 1994, GENETICS, V136, P427; Kang S, 2010, BIOMACROMOLECULES, V11, P2804, DOI 10.1021/bm100877q; KING J, 1978, CELL, V15, P551, DOI 10.1016/0092-8674(78)90023-5; KING J, 1976, PHILOS T ROY SOC B, V276, P37, DOI 10.1098/rstb.1976.0096; KING J, 1973, J MOL BIOL, V80, P697, DOI 10.1016/0022-2836(73)90205-2; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; Li YY, 2005, J MOL BIOL, V348, P167, DOI 10.1016/j.jmb.2005.02.045; Liu Z, 2012, CHEM SOC REV, V41, P6178, DOI 10.1039/c2cs35108k; LUMB KJ, 1995, SCIENCE, V268, P436, DOI 10.1126/science.7716550; Newcomer RL, 2015, BIOPHYS J, V109, P2666, DOI 10.1016/j.bpj.2015.11.010; O'Neil A, 2012, BIOMACROMOLECULES, V13, P3902, DOI 10.1021/bm301347x; Pace C N, 1986, Methods Enzymol, V131, P266; Padilla-Meier GP, 2012, J BIOL CHEM, V287, P33766, DOI 10.1074/jbc.M112.393132; Padilla-Meier GP, 2011, J MOL BIOL, V410, P226, DOI 10.1016/j.jmb.2011.05.006; Parent KN, 2004, MOL MICROBIOL, V54, P1036, DOI 10.1111/j.1365-2958.2004.04326.x; Parent KN, 2007, MOL MICROBIOL, V65, P1300, DOI 10.1111/j.1365-2958.2007.05868.x; Parent KN, 2007, J MOL BIOL, V365, P513, DOI 10.1016/j.jmb.2006.09.088; Parent KN, 2006, J MOL BIOL, V359, P1097, DOI 10.1016/j.jmb.2006.03.068; Parent KN, 2012, BIOMATERIALS, V33, P5628, DOI 10.1016/j.biomaterials.2012.04.026; Parent KN, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/045004; Parent KN, 2010, STRUCTURE, V18, P390, DOI 10.1016/j.str.2009.12.014; Patterson DP, 2012, ACS NANO, V6, P5000, DOI 10.1021/nn300545z; PREVELIGE PE, 1988, J MOL BIOL, V202, P743, DOI 10.1016/0022-2836(88)90555-4; PREVELIGE PE, 1993, PROG MED VIROL, V40, P206; Rizzo AA, 2014, STRUCTURE, V22, P830, DOI 10.1016/j.str.2014.04.003; Rizzo AA, 2013, BIOMOL NMR ASSIGN, V7, P257, DOI 10.1007/s12104-012-9422-x; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sheftic SR, 2009, METHOD ENZYMOL, V466, P233, DOI 10.1016/S0076-6879(09)66010-9; Shortle D, 1996, FASEB J, V10, P27, DOI 10.1096/fasebj.10.1.8566543; Suhanovsky MM, 2015, VIROLOGY, V479, P487, DOI 10.1016/j.virol.2015.02.055; Suhanovsky MM, 2013, J BIOL CHEM, V288, P33772, DOI 10.1074/jbc.M113.515312; Teschke CM, 2010, VIROLOGY, V401, P119, DOI 10.1016/j.virol.2010.02.017; Teschke CM, 2003, BIOPHYS J, V84, P2585, DOI 10.1016/S0006-3495(03)75063-2; TESCHKE CM, 1993, BIOCHEMISTRY-US, V32, P10839, DOI 10.1021/bi00091a040; Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806; Tripler TN, 2015, BIOMOL NMR ASSIGN, V9, P333, DOI 10.1007/s12104-015-9604-4; Watson E, 2007, BIOCHEMISTRY-US, V46, P9484, DOI 10.1021/bi700532j; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; WINSTON F, 1979, J BACTERIOL, V137, P433, DOI 10.1128/JB.137.1.433-439.1979; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Zhang Y.Z., 1995, THESIS U PENNSYLVANI; Zhang ZX, 2000, J MOL BIOL, V297, P615, DOI 10.1006/jmbi.2000.3601; Zlotnick A, 2012, VIROLOGY, V428, P64, DOI 10.1016/j.virol.2012.03.017	64	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11359	11372		10.1074/jbc.M116.716910	http://dx.doi.org/10.1074/jbc.M116.716910			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27006399	Green Published, hybrid			2022-12-28	WOS:000377042100034
J	Kumar, A; Gupta, C; Nair, DT; Salunke, DM				Kumar, Ashish; Gupta, Chitra; Nair, Deepak T.; Salunke, Dinakar M.			MP-4 Contributes to Snake Venom Neutralization by Mucuna pruriens Seeds through an Indirect Antibody-mediated Mechanism (Publication with Expression of Concern. See vol. 293, pg. 11253, 2018) (Publication with Expression of Concern. See vol. 293, pg. 11253, 2018) (Publication with Expression of Concern. See vol. 293, pg. 11253, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Publication with Expression of Concern						antibody; crystal structure; humoral response; protease inhibitor; snake venom	ECHIS-CARINATUS VENOM; EXTRACT; GLYCOPROTEIN; BITES	Mortality due to snakebite is a serious public health problem, and available therapeutics are known to induce debilitating side effects. Traditional medicine suggests that seeds of Mucuna pruriens can provide protection against the effects of snakebite. Our aim is to identify the protein(s) that may be important for snake venom neutralization and elucidate its mechanism of action. To this end, we have identified and purified a protein from M. pruriens, which we have named MP-4. The full-length polypeptide sequence of MP-4 was obtained through N-terminal sequencing of peptide fragments. Sequence analysis suggested that the protein may belong to the Kunitz-type protease inhibitor family and therefore may potentially neutralize the proteases present in snake venom. Using various structural and biochemical tools coupled with in vivo assays, we are able to show that MP-4 does not afford direct protection against snake venom because it is actually a poor inhibitor of serine proteases. Further experiments showed that antibodies generated against MP-4 cross-react with the whole venom and provide protection to mice against Echis carinatus snake venom. This study shows that the MP-4 contributes significantly to the snake venom neutralization activity of M. pruriens seeds through an indirect antibody-mediated mechanism.	[Kumar, Ashish; Gupta, Chitra; Salunke, Dinakar M.] Natl Inst Immunol, Struct Biol Unit, Aruna Asaf Ali Rd, New Delhi 110067, India; [Kumar, Ashish; Nair, Deepak T.; Salunke, Dinakar M.] NCR Biotech Sci Cluster, Reg Ctr Biotechnol, 3rd Milestone,POB 3, Faridabad 121001, India; [Salunke, Dinakar M.] Int Ctr Genet Engn & Biotechnol, Aruna Asaf Ali Marg, Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Nair, DT (corresponding author), NCR Biotech Sci Cluster, Reg Ctr Biotechnol, 3rd Milestone,POB 3, Faridabad 121001, India.; Salunke, DM (corresponding author), Int Ctr Genet Engn & Biotechnol, Aruna Asaf Ali Marg, Delhi 110067, India.	deepak@rcb.res.in; dinakar.salunke@gmail.com	Nair, Deepak T/AAR-5234-2020	Nair, Deepak/0000-0002-0677-9444	Department of Biotechnology (Government of India); National Institute of Immunology (New Delhi, India)	Department of Biotechnology (Government of India)(Department of Biotechnology (DBT) India); National Institute of Immunology (New Delhi, India)	This work was supported by funds provided by the Department of Biotechnology (Government of India) to the Regional Centre for Biotechnology (Faridabad, India) and the National Institute of Immunology (New Delhi, India). The authors declare that they have no conflicts of interest with the contents of this article.	Adepoju GKA, 2009, J MED PLANTS RES, V3, P73; Aguiyi JC, 1999, FITOTERAPIA, V70, P21, DOI 10.1016/S0367-326X(98)00004-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amin MR, 2008, J VENOM ANIM TOXINS, V14, P660, DOI 10.1590/S1678-91992008000400009; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; CROWTHER RA, 1967, ACTA CRYSTALLOGR, V23, P544, DOI 10.1107/S0365110X67003172; Dey A, 2012, AFR J TRADIT COMPLEM, V9, P153, DOI 10.4314/ajtcam.v9i1.20; Dhananjaya BL, 2011, INDIAN J BIOCHEM BIO, V48, P175; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; Fung SY, 2009, TROP BIOMED, V26, P80; Grover JK, 2002, J ETHNOPHARMACOL, V81, P81, DOI 10.1016/S0378-8741(02)00059-4; Guerranti R, 2004, BIOCHEM BIOPH RES CO, V323, P484, DOI 10.1016/j.bbrc.2004.08.122; Guerranti R, 2002, J BIOL CHEM, V277, P17072, DOI 10.1074/jbc.M201387200; Guerranti R, 2001, J ETHNOPHARMACOL, V75, P175, DOI 10.1016/S0378-8741(00)00401-3; Guerranti R., 1999, J PREV MED HYG, V40, P25; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hope-Onyekwere NS, 2012, PHYTOTHER RES, V26, P1913, DOI 10.1002/ptr.4663; Horigome D, 2007, J BIOL CHEM, V282, P6525, DOI 10.1074/jbc.M609458200; Hsu J, 2015, SCI AM, V313, P14, DOI 10.1038/scientificamerican1215-14; JOHNSON EK, 1987, TOXICON, V25, P1347, DOI 10.1016/0041-0101(87)90013-4; Kastritis PL, 2011, PROTEIN SCI, V20, P482, DOI 10.1002/pro.580; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kavitha C., 2014, Journal of Medicinal Plants Research, V8, P138; Koh DCI, 2006, CELL MOL LIFE SCI, V63, P3030, DOI 10.1007/s00018-006-6315-0; Lake S., 2004, NC HERPS NEWSLETTER, V27; Lauk L., 1993, INT J PHARMACOL, V31, P213, DOI DOI 10.3109/13880209309082944; LESLIE AG, 1992, JOINT CCP4 ESF EAMCB, V26; Makhija I. K., 2010, Der Pharmacia Lettre, V2, P399; Manyam BV, 2004, PHYTOTHER RES, V18, P706, DOI 10.1002/ptr.1514; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; Otlewski J, 2001, ACTA BIOCHIM POL, V48, P419; Reimers AR, 2000, CLIN EXP ALLERGY, V30, P276; Rita Paul, 2011, International Journal of Research in Ayurveda and Pharmacy (IJRAP), V2, P1060; Salau AO, 2007, AFR J BIOTECHNOL, V6, P2091; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Scire A, 2011, PHYTOMEDICINE, V18, P887, DOI 10.1016/j.phymed.2011.02.004; Siddhuraju P, 2003, J SCI FOOD AGR, V83, P1517, DOI 10.1002/jsfa.1587; Tan NH, 2009, J ETHNOPHARMACOL, V123, P356, DOI 10.1016/j.jep.2009.03.025; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2	41	10	11	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11373	11384		10.1074/jbc.M115.699173	http://dx.doi.org/10.1074/jbc.M115.699173			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	26987900	Green Published, hybrid			2022-12-28	WOS:000377042100035
J	Togi, S; Muromoto, R; Hirashima, K; Kitai, Y; Okayama, T; Ikeda, O; Matsumoto, N; Kon, S; Sekine, Y; Oritani, K; Matsuda, T				Togi, Sumihito; Muromoto, Ryuta; Hirashima, Koki; Kitai, Yuichi; Okayama, Taichiro; Ikeda, Osamu; Matsumoto, Naoki; Kon, Shigeyuki; Sekine, Yuichi; Oritani, Kenji; Matsuda, Tadashi			A New STAT3-binding Partner, ARL3, Enhances the Phosphorylation and Nuclear Accumulation of STAT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene transcription; nuclear translocation; protein phosphorylation; signal transduction; STAT3	NF-KAPPA-B; GUANINE-NUCLEOTIDE EXCHANGE; FUNCTIONAL INTERACTIONS; TRANSCRIPTIONAL CONTROL; CELL-GROWTH; ARF FAMILY; ACTIVATION; PROTEINS; BINDING; STAP-2	Signal transducer and activator of transcription 3 (STAT3) is involved in cell proliferation, differentiation, and cell survival during immune responses, hematopoiesis, neurogenesis, and other biological processes. STAT3 activity is regulated by a variety of mechanisms, including phosphorylation and nuclear translocation. To clarify the molecular mechanisms underlying the regulation of STAT3 activity, we performed yeast two-hybrid screening. We identified ARL3 (ADP-ribosylation factor-like 3) as a novel STAT3-binding partner. ARL3 recognizes the DNA-binding domain as well as the C-terminal region of STAT3 in vivo, and their binding was the strongest when both proteins were activated. Importantly, small interfering RNA-mediated reduction of endogenous ARL3 expression decreased IL-6-induced tyrosine phosphorylation, nuclear accumulation, and transcriptional activity of STAT3. These results indicate that ARL3 interacts with STAT3 and regulates the transcriptional activation of STAT3 by influencing its nuclear accumulation of STAT3.	[Togi, Sumihito; Muromoto, Ryuta; Hirashima, Koki; Kitai, Yuichi; Okayama, Taichiro; Ikeda, Osamu; Matsumoto, Naoki; Kon, Shigeyuki; Sekine, Yuichi; Matsuda, Tadashi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan; [Oritani, Kenji] Grad Sch Med, Dept Hematol & Oncol, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan	Hokkaido University	Matsuda, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	tmatsuda@pharm.hokudai.ac.jp	Matsuda, Tadashi/A-3835-2012; Sekine, Yuichi/S-8813-2019; Muromoto, Ryuta/E-4203-2012; Togi, Sumihito/ABH-6734-2020	Matsuda, Tadashi/0000-0002-3089-3757; Sekine, Yuichi/0000-0002-2861-603X; Muromoto, Ryuta/0000-0002-7474-493X; Togi, Sumihito/0000-0002-3189-8111	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [26461444] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; CAVENAGH MM, 1994, J BIOL CHEM, V269, P18937; Cimica V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020188; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; FEIG LA, 1988, MOL CELL BIOL, V8, P2472, DOI 10.1128/MCB.8.6.2472; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Ikeda O, 2008, MOL CELL BIOL, V28, P5027, DOI 10.1128/MCB.00194-08; Ikeda O, 2010, J BIOL CHEM, V285, P38093, DOI 10.1074/jbc.M110.162388; Jove R, 2000, ONCOGENE, V19, P2466, DOI 10.1038/sj.onc.1203549; Kahn RA, 2005, BIOCHEM SOC T, V33, P1269, DOI 10.1042/BST0331269; Kamitani S, 2011, J IMMUNOL, V187, P2476, DOI 10.4049/jimmunol.1003243; Katanaev VL, 1998, J CELL SCI, V111, P1583; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Minoguchi M, 2003, J BIOL CHEM, V278, P11182, DOI 10.1074/jbc.M211230200; Muromoto R, 2006, ONCOGENE, V25, P2131, DOI 10.1038/sj.onc.1209235; Muromoto R, 2008, INT IMMUNOL, V20, P395, DOI 10.1093/intimm/dxm154; Muromoto R, 2006, J IMMUNOL, V177, P1160, DOI 10.4049/jimmunol.177.2.1160; Muromoto R, 2010, EUR J IMMUNOL, V40, P3570, DOI 10.1002/eji.201040688; Muromoto R, 2009, BIOCHEM BIOPH RES CO, V382, P63, DOI 10.1016/j.bbrc.2009.02.127; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Ohbayashi N, 2008, BIOCHEM BIOPH RES CO, V372, P475, DOI 10.1016/j.bbrc.2008.05.073; Okita Keisuke, 2006, Curr Stem Cell Res Ther, V1, P103, DOI 10.2174/157488806775269061; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sato N, 2005, INT IMMUNOL, V17, P1543, DOI 10.1093/intimm/dxh331; Schrick JJ, 2006, AM J PATHOL, V168, P1288, DOI 10.2353/ajpath.2006.050941; Sekine Y, 2015, J BIOL CHEM, V290, P17462, DOI 10.1074/jbc.M115.658575; Sekine Y, 2009, J IMMUNOL, V183, P7966, DOI 10.4049/jimmunol.0902096; Sharer JD, 1999, J BIOL CHEM, V274, P27553, DOI 10.1074/jbc.274.39.27553; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Simon AR, 2000, SCIENCE, V290, P144, DOI 10.1126/science.290.5489.144; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tanaka T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001637; Tsuruma R, 2008, ONCOGENE, V27, P3054, DOI 10.1038/sj.onc.1210952; Walker SR, 2010, MOL PHARMACOL, V78, P903, DOI 10.1124/mol.110.066316; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; ZHONG Z, 1994, P NATL ACAD SCI USA, V91, P4806, DOI 10.1073/pnas.91.11.4806; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	45	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11161	11171		10.1074/jbc.M116.724849	http://dx.doi.org/10.1074/jbc.M116.724849			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27048653	Green Published, hybrid			2022-12-28	WOS:000377042100019
J	Cirillo, F; Ghiroldi, A; Fania, C; Piccoli, M; Torretta, E; Tettamanti, G; Gelfi, C; Anastasia, L				Cirillo, Federica; Ghiroldi, Andrea; Fania, Chiara; Piccoli, Marco; Torretta, Enrica; Tettamanti, Guido; Gelfi, Cecilia; Anastasia, Luigi			NEU3 Sialidase Protein Interactors in the Plasma Membrane and in the Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT ENDOCYTIC PATHWAY; GLUCOSE-REGULATED PROTEINS; APOPTOSIS SUPPRESSION; CELL-SURFACE; ENDOPLASMIC-RETICULUM; STRESS; DIFFERENTIATION; GROWTH; MICRODOMAINS; EXPRESSION	NEU3 sialidase has been shown to be a key player in many physio- and pathological processes, including cell differentiation, cellular response to hypoxic stress, and carcinogenesis. The enzyme, peculiarly localized on the outer leaflet of the plasma membrane, has been shown to be able to remove sialic acid residues from the gangliosides present on adjacent cells, thus creating cell to cell interactions. Nonetheless, herein we report that the enzyme localization is dynamically regulated between the plasma membrane and the endosomes, where a substantial amount of NEU3 is stored with low enzymatic activity. However, under opportune stimuli, NEU3 is shifted from the endosomes to the plasma membrane, where it greatly increases the sialidase activity. Finally, we found that NEU3 possesses also the ability to interact with specific proteins, many of which are different in each cell compartment. They were identified by mass spectrometry, and some selected ones were also confirmed by cross-immunoprecipitation with the enzyme, supporting NEU3 involvement in the cell stress response, protein folding, and intracellular trafficking.	[Cirillo, Federica; Ghiroldi, Andrea; Fania, Chiara; Piccoli, Marco; Tettamanti, Guido; Gelfi, Cecilia; Anastasia, Luigi] Ist Ricovero Cura Carattere Sci Policlin San Dona, I-20097 Milan, Italy; [Torretta, Enrica; Gelfi, Cecilia; Anastasia, Luigi] Univ Milan, Dept Biomed Sci Hlth, I-20122 Milan, Italy	University of Milan	Anastasia, L (corresponding author), Univ Milan, Dept Biomed Sci Hlth, I-20122 Milan, Italy.	luigi.anastasia@unimi.it	torretta, enrica/I-8793-2012; Piccoli, Marco/S-3731-2019; Gelfi, Cecilia/L-1490-2016; Anastasia, Luigi/AAN-1964-2020; Cirillo, Federica/ABE-3480-2020; Ghiroldi, Andrea/AAO-4409-2020	torretta, enrica/0000-0002-6374-3325; Piccoli, Marco/0000-0002-9461-2715; Gelfi, Cecilia/0000-0002-2996-6912; Anastasia, Luigi/0000-0002-0712-2161; Cirillo, Federica/0000-0002-0196-5977; Ghiroldi, Andrea/0000-0002-2896-7390; Fania, Chiara/0000-0003-3949-8769				Anastasia L, 2008, J BIOL CHEM, V283, P36265, DOI 10.1074/jbc.M805755200; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Aureli M, 2011, J NEUROCHEM, V116, P891, DOI 10.1111/j.1471-4159.2010.07019.x; Bonardi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099405; Costa M, 1999, NUCLEIC ACIDS RES, V27, P817, DOI 10.1093/nar/27.3.817; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Girard M, 2005, J BIOL CHEM, V280, P40135, DOI 10.1074/jbc.M505036200; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; HAAS IG, 1994, EXPERIENTIA, V50, P1012, DOI 10.1007/BF01923455; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Kato K, 2006, BIOCHEM J, V394, P647, DOI 10.1042/BJ20050737; Kawamura S, 2012, CELL DEATH DIFFER, V19, P170, DOI 10.1038/cdd.2011.83; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Li RL, 2012, PLANT CELL, V24, P2105, DOI 10.1105/tpc.112.095695; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundmark R, 2009, J CELL SCI, V122, P5, DOI 10.1242/jcs.037135; Mandal C, 2010, INT J CANCER, V126, P337, DOI 10.1002/ijc.24733; Meister M, 2014, FEBS J, V281, P2956, DOI 10.1111/febs.12834; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Miyata M, 2011, CANCER SCI, V102, P2139, DOI 10.1111/j.1349-7006.2011.02086.x; Monti E, 2002, NEUROCHEM RES, V27, P649, DOI 10.1023/A:1020276000901; Nomura H, 2006, ONCOL RES, V16, P289, DOI 10.3727/000000006783981035; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Papini N, 2012, J CELL BIOCHEM, V113, P2967, DOI 10.1002/jcb.24174; Rodriguez JA, 2001, J NEUROSCI, V21, P8387, DOI 10.1523/JNEUROSCI.21-21-08387.2001; Saito M, 1995, BIOL SIALIC ACIDS, P261, DOI [10.1007/978-1-4757-9504-2_8, DOI 10.1007/978-1-4757-9504-2_8]; Sasaki A, 2003, J BIOL CHEM, V278, P27896, DOI 10.1074/jbc.M212200200; Scaringi R, 2013, J BIOL CHEM, V288, P3153, DOI 10.1074/jbc.M112.404327; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Tocque B, 1997, CELL SIGNAL, V9, P153, DOI 10.1016/S0898-6568(96)00135-0; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; Tringali C, 2012, J BIOL CHEM, V287, P42835, DOI 10.1074/jbc.M112.407718; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Tsai YL, 2015, J BIOL CHEM, V290, P8049, DOI 10.1074/jbc.M114.618736; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang Y, 2002, J BIOL CHEM, V277, P26252, DOI 10.1074/jbc.M110515200; Yamaguchi K, 2006, BIOCHEM BIOPH RES CO, V346, P484, DOI 10.1016/j.bbrc.2006.05.136; Yamamoto K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120578; Zanchetti G, 2007, BIOCHEM J, V408, P211, DOI 10.1042/BJ20070503; Zhao F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-479	51	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10615	10624		10.1074/jbc.M116.719518	http://dx.doi.org/10.1074/jbc.M116.719518			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26987901	hybrid, Green Published			2022-12-28	WOS:000377042600015
J	Dolino, DM; Adariani, SR; Shaikh, SA; Jayaraman, V; Sanabria, H				Dolino, Drew M.; Adariani, Soheila Rezaei; Shaikh, Sana A.; Jayaraman, Vasanthi; Sanabria, Hugo			Conformational Selection and Submillisecond Dynamics of the Ligand-binding Domain of the N-methyl-D-aspartate Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; PROBABILITY-DISTRIBUTION ANALYSIS; FLUORESCENCE LIFETIME ANALYSIS; SINGLE-MOLECULE FRET; NMDA RECEPTORS; PARTIAL AGONISM; AMPA RECEPTOR; STRUCTURAL DYNAMICS; PHOTON DISTRIBUTION; GLUTAMATE-RECEPTOR	The N-methyl-D-aspartate (NMDA) receptors are heteromeric non-selective cation channels that require the binding of glycine and glutamate for gating. Based on crystal structures, the mechanism of partial agonism at the glycine-binding site is thought to be mediated by a shift in the conformational equilibrium between an open clamshell and a closed clamshell-like structure of the bilobed ligand-binding domain (LBD). Using single-molecule Forster resonance energy transfer (smFRET) and multiparameter fluorescence detection, which allows us to study the conformational states and dynamics in the submillisecond time scale, we show that there are atleast three conformational states explored by the LBD: the low FRET, medium FRET, and high FRET states. The distance of the medium and low FRET states corresponds to what has been observed in crystallography structures. We show that the high FRET state, which would represent a more closed clamshell conformation than that observed in the crystal structure, is most likely the state initiating activation, as evidenced by the fact that the fraction of the protein in this state correlates well with the extent of activation. Furthermore, full agonist bound LBDs show faster dynamic motions between the medium and high FRET states, whereas they show slower dynamics when bound to weaker agonists or to antagonists.	[Dolino, Drew M.; Shaikh, Sana A.; Jayaraman, Vasanthi] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA; [Adariani, Soheila Rezaei; Sanabria, Hugo] Clemson Univ, Dept Phys & Astron, Clemson, SC 29634 USA	University of Texas System; University of Texas Health Science Center Houston; Clemson University	Jayaraman, V (corresponding author), MSB 6-528,6431 Fannin St, Houston, TX 77030 USA.; Sanabria, H (corresponding author), 214 Kinard Lab, Clemson, SC 29634 USA.	vasanthi.jayaraman@uth.tmc.edu; hsanabr@clemson.edu	Sanabria, Hugo/A-1231-2013	Sanabria, Hugo/0000-0001-7068-6827; Dolino, Drew/0000-0002-2690-7140	National Institutes of Health [R01 GM094246]; NIGMS [GM089657]; Clemson University; Schissler Foundation Fellowship for Translational Studies of Common Human Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM089657, R01GM094246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Clemson University; Schissler Foundation Fellowship for Translational Studies of Common Human Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM094246 (to V. J.) and NIGMS Grant GM089657 (to D. M. D.), start-up funds from Clemson University (to H. S.), and a Schissler Foundation Fellowship for Translational Studies of Common Human Diseases (to D. M. D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed AH, 2013, J BIOL CHEM, V288, P27658, DOI 10.1074/jbc.M113.495564; Antonik M, 2006, J PHYS CHEM B, V110, P6970, DOI 10.1021/jp057257+; Cai Q, 2007, BIOPHYS J, V93, P2110, DOI 10.1529/biophysj.107.109439; Cooper DR, 2015, BIOPHYS J, V109, P66, DOI 10.1016/j.bpj.2015.05.025; Dai J, 2015, STRUCTURE, V23, P228, DOI 10.1016/j.str.2014.11.012; DALE RE, 1979, BIOPHYS J, V26, P161, DOI 10.1016/S0006-3495(79)85243-1; Dolino DM, 2015, J BIOL CHEM, V290, P797, DOI 10.1074/jbc.M114.605436; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gonzalez J, 2008, BIOCHEMISTRY-US, V47, P10027, DOI 10.1021/bi800690b; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jespersen A, 2014, NEURON, V81, P366, DOI 10.1016/j.neuron.2013.11.033; Kalinin S, 2008, J PHYS CHEM B, V112, P8361, DOI 10.1021/jp711942q; Kalinin S, 2007, J PHYS CHEM B, V111, P10253, DOI 10.1021/jp072293p; Kalinin S, 2012, NAT METHODS, V9, P1218, DOI [10.1038/nmeth.2222, 10.1038/NMETH.2222]; Kalinin S, 2010, J PHYS CHEM B, V114, P7983, DOI 10.1021/jp102156t; Kalinin S, 2010, J PHYS CHEM B, V114, P6197, DOI 10.1021/jp100025v; Kudryavtsev V, 2012, CHEMPHYSCHEM, V13, P1060, DOI 10.1002/cphc.201100822; Kuhnemuth R, 2001, SINGLE MOL, V2, P251, DOI 10.1002/1438-5171(200112)2:4<251::AID-SIMO251>3.0.CO;2-T; Kumar J, 2013, ANNU REV PHYSIOL, V75, P313, DOI 10.1146/annurev-physiol-030212-183711; Kussius CL, 2009, NAT NEUROSCI, V12, P1114, DOI 10.1038/nn.2361; Lau AY, 2011, NAT STRUCT MOL BIOL, V18, P283, DOI 10.1038/nsmb.2010; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Maus M, 2001, ANAL CHEM, V73, P2078, DOI 10.1021/ac000877g; Muschielok A, 2008, NAT METHODS, V5, P965, DOI 10.1038/nmeth.1259; Ramaswamy S, 2012, J BIOL CHEM, V287, P43557, DOI 10.1074/jbc.M112.371815; Rambhadran A, 2011, J BIOL CHEM, V286, P16953, DOI 10.1074/jbc.M111.224576; Sasmal DK, 2014, J AM CHEM SOC, V136, P12998, DOI 10.1021/ja506231j; Schaffer J, 1999, J PHYS CHEM A, V103, P331, DOI 10.1021/jp9833597; Sindbert S, 2011, J AM CHEM SOC, V133, P2463, DOI 10.1021/ja105725e; Sisamakis E, 2010, METHOD ENZYMOL, V475, P455, DOI 10.1016/S0076-6879(10)75018-7; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Wozniak AK, 2008, P NATL ACAD SCI USA, V105, P18337, DOI 10.1073/pnas.0800977105; Yao YN, 2013, STRUCTURE, V21, P1788, DOI 10.1016/j.str.2013.07.011	34	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16175	16185		10.1074/jbc.M116.721274	http://dx.doi.org/10.1074/jbc.M116.721274			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226581	Green Published, hybrid			2022-12-28	WOS:000380585400022
J	Zhao, LH; Yin, YT; Yang, DH; Liu, B; Hou, L; Wang, XX; Pal, K; Jiang, Y; Feng, Y; Cai, XQ; Dai, AT; Liu, MY; Wang, MW; Melcher, K; Xu, HE				Zhao, Li-Hua; Yin, Yanting; Yang, Dehua; Liu, Bo; Hou, Li; Wang, Xiaoxi; Pal, Kuntal; Jiang, Yi; Feng, Yang; Cai, Xiaoqing; Dai, Antao; Liu, Mingyao; Wang, Ming-Wei; Melcher, Karsten; Xu, H. Eric			Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICOTROPIN-RELEASING-FACTOR; SMALL-MOLECULE AGONISTS; PEPTIDE-1 RECEPTOR; GLUCAGON RECEPTOR; PARATHYROID-HORMONE; DRUG DISCOVERY; GLP-1 RECEPTOR; RECOGNITION; LIGANDS; BINDING	G protein-coupled receptors (GPCRs) from the secretin-like (class B) family are key players in hormonal homeostasis and are important drug targets for the treatment of metabolic disorders and neuronal diseases. They consist of a large N-terminal extra cellular domain (ECD) and a transmembrane domain (TMD) with the GPCR signature of seven transmembrane helices. Class GPCRs are activated by peptide hormones with their C termini bound to the receptor ECD and their N termini bound to the TMD. It is thought that the ECD functions as an affinity trap to bind and localize the hormone to the receptor. This in turn would allow the hormone N terminus to insert into the TMD and induce conformational changes of the TMD to activate downstream signaling. In contrast to this prevailing model, we demonstrate that human class B GPCRs vary widely in their requirement of the ECD for activation. In one group, represented by corticotrophin-releasing factor receptor 1 (CRF1R), parathyroid hormone receptor (PTH1R), and pituitary adenylate cyclase activating polypeptide type 1 receptor (PAC1R), the ECD requirement for high affinity hormone binding can be bypassed by induced proximity and mass action effects, whereas in the other group, represented by glucagon receptor (GCGR) and glucagon-like peptide-1 receptor (GLP-1R), the LCD is required for signaling even when the hormone is covalently linked to the TMD. Furthermore, the activation of GLP-1R by small molecules that interact with the intracellular side of the receptor is dependent on the presence of its LCD, suggesting a direct role of the ECD in GLP-1R activation.	[Zhao, Li-Hua; Liu, Mingyao] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Zhao, Li-Hua; Liu, Mingyao] East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Zhao, Li-Hua; Yin, Yanting; Liu, Bo; Hou, Li; Wang, Xiaoxi; Jiang, Yi; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, VARI SIMM Ctr Struct & Funct Drug Targets, Shanghai 201203, Peoples R China; [Zhao, Li-Hua; Yin, Yanting; Liu, Bo; Hou, Li; Wang, Xiaoxi; Jiang, Yi; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Yin, Yanting; Pal, Kuntal; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Ctr Struct Biol & Drug Discovery, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Yang, Dehua; Feng, Yang; Cai, Xiaoqing; Dai, Antao; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China; [Yang, Dehua; Feng, Yang; Cai, Xiaoqing; Dai, Antao; Wang, Ming-Wei] Chinese Acad Sci, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Wang, Ming-Wei] Fudan Univ, Sch Pharm, 826 Zhangheng Rd, Shanghai 201203, Peoples R China	East China Normal University; East China Normal University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Van Andel Institute; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Fudan University	Melcher, K; Xu, HE (corresponding author), Van Andel Res Inst, Ctr Canc & Cell Biol, Lab Struct Sci, Grand Rapids, MI 49503 USA.	Karsten.Melcher@vai.org; Eric.Xu@vai.org	Yang, Dehua/M-5789-2019; Yang, Dehua/S-6156-2017; sarkar, sabyasachi/A-9896-2010; Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021; Pal, Kuntal/W-6348-2019	sarkar, sabyasachi/0000-0002-8954-4375; Melcher, Karsten/0000-0002-9125-4027; PAL, KUNTAL/0000-0001-7094-2456; Liu, Mingyao/0000-0001-7339-5048; Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [DK071662, GM102545, GM104212]; National Natural Science Foundation of China [31300245, 31300607]; Van Andel Research Institute, Ministry of Science and Technology of China [2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, 2013ZX09507001]; Amway (China); National Health and Family Planning Commission [2012ZX09304-011, 2013ZX09401003-005, 2013ZX 09507001, 2013ZX09507-002]; Shanghai Science and Technology Development Fund [15DZ2291600]; Shanghai Science and Technology Committee [13ZR1447600]; Shanghai Rising-Star Program [14QA1404300]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104212, R01GM102545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Van Andel Research Institute, Ministry of Science and Technology of China; Amway (China); National Health and Family Planning Commission; Shanghai Science and Technology Development Fund; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Shanghai Rising-Star Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071662 (to H. E. X.) and GM102545 and GM104212 (to K. M.) This work was also supported by grants from the National Natural Science Foundation of China (31300245; to L.-H. Z.) and in part by the Van Andel Research Institute, Ministry of Science and Technology of China (2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, and 2013ZX09507001), Amway (China), the National Health and Family Planning Commission (2012ZX09304-011, 2013ZX09401003-005, 2013ZX 09507001, and 2013ZX09507-002; to M.-W. W.), Shanghai Science and Technology Development Fund (15DZ2291600; to M.-W. W.), National Natural Science Foundation of China (31300607; to Y. J.), Shanghai Science and Technology Committee (13ZR1447600; to Y. J.), Shanghai Rising-Star Program (14QA1404300; to Y. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Archbold JK, 2011, TRENDS PHARMACOL SCI, V32, P591, DOI 10.1016/j.tips.2011.05.007; Bortolato A, 2014, BRIT J PHARMACOL, V171, P3132, DOI 10.1111/bph.12689; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Chen DS, 2007, P NATL ACAD SCI USA, V104, P943, DOI 10.1073/pnas.0610173104; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Eng H, 2013, DRUG METAB DISPOS, V41, P1470, DOI 10.1124/dmd.113.052183; Fan H, 2015, BRIT J PHARMACOL, V172, P64, DOI 10.1111/bph.12895; Fortin JP, 2009, P NATL ACAD SCI USA, V106, P8049, DOI 10.1073/pnas.0900149106; Grace CRR, 2010, J BIOL CHEM, V285, P38580, DOI 10.1074/jbc.M110.121897; Gravholt CH, 2001, J CLIN ENDOCR METAB, V86, P2085, DOI 10.1210/jc.86.5.2085; He M, 2012, ACTA PHARMACOL SIN, V33, P148, DOI 10.1038/aps.2011.169; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019682; Liu Q, 2012, J MED CHEM, V55, P250, DOI 10.1021/jm201150j; Nielsen SM, 2000, P NATL ACAD SCI USA, V97, P10277, DOI 10.1073/pnas.97.18.10277; Nolte WM, 2014, NAT CHEM BIOL, V10, P629, DOI 10.1038/nchembio.1581; Pal K, 2012, ACTA PHARMACOL SIN, V33, P300, DOI 10.1038/aps.2011.170; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Ruiter M, 2003, DIABETES, V52, P1709, DOI 10.2337/diabetes.52.7.1709; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Wang MW, 2010, ACTA PHARMACOL SIN, V31, P1026, DOI 10.1038/aps.2010.107; Willard FS, 2012, EXP DIABETES RES, DOI 10.1155/2012/709893; Wootten D, 2013, MOL PHARMACOL, V83, P822, DOI 10.1124/mol.112.084525; Wootten D, 2012, MOL PHARMACOL, V82, P281, DOI 10.1124/mol.112.079319; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859; Zhou CQ, 2009, PANCREAS, V38, P941, DOI 10.1097/MPA.0b013e3181b2bb03	38	41	41	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15119	15130		10.1074/jbc.M116.726620	http://dx.doi.org/10.1074/jbc.M116.726620			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226600	Green Published, hybrid			2022-12-28	WOS:000380583200022
J	Yu, HQ; Gautam, AKS; Wilmington, SR; Wylie, D; Martinez-Fonts, K; Kago, G; Warburton, M; Chavali, S; Inobe, T; Finkelstein, IJ; Babu, MM; Matouschek, A				Yu, Houqing; Gautam, Amit K. Singh; Wilmington, Shameika R.; Wylie, Dennis; Martinez-Fonts, Kirby; Kago, Grace; Warburton, Marie; Chavali, Sreenivas; Inobe, Tomonao; Finkelstein, Ilya J.; Babu, M. Madan; Matouschek, Andreas			Conserved Sequence Preferences Contribute to Substrate Recognition by the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-dependent protease; intrinsically disordered protein; proteasome; protein degradation; protein stability; protein targeting; protein turnover; ubiquitylation (ubiquitination); cellular protein abundance	PROTEIN HALF-LIFE; 26S PROTEASOME; ORNITHINE-DECARBOXYLASE; UBIQUITIN CHAINS; SACCHAROMYCES-CEREVISIAE; FLUORESCENT PROTEIN; PROTEOLYTIC MACHINE; DISORDERED SEGMENTS; REGULATORY PARTICLE; DEGRADATION SIGNAL	The proteasome has pronounced preferences for the amino acid sequence of its substrates at the site where it initiates degradation. Here, we report that modulating these sequences can tune the steady-state abundance of proteins over 2 orders of magnitude in cells. This is the same dynamic range as seen for inducing ubiquitination through a classic N-end rule degron. The stability and abundance of His3 constructs dictated by the initiation site affect survival of yeast cells and show that variation in proteasomal initiation can affect fitness. The proteasome's sequence preferences are linked directly to the affinity of the initiation sites to their receptor on the proteasome and are conserved between Saccharomyces cerevisiae, Schizosaccharomyces pombe, and human cells. These findings establish that the sequence composition of unstructured initiation sites influences protein abundance in vivo in an evolutionarily conserved manner and can affect phenotype and fitness.	[Yu, Houqing; Gautam, Amit K. Singh; Wilmington, Shameika R.; Martinez-Fonts, Kirby; Kago, Grace; Warburton, Marie; Finkelstein, Ilya J.; Matouschek, Andreas] Univ Texas Austin, Dept Mol Biosci, 2506 Speedway Stop A5000, Austin, TX 78712 USA; [Wylie, Dennis] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Yu, Houqing; Wilmington, Shameika R.; Martinez-Fonts, Kirby; Matouschek, Andreas] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Chavali, Sreenivas; Babu, M. Madan] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Inobe, Tomonao] Toyama Univ, Frontier Res Core Life Sci, 3190 Gofuku, Toyama, Toyama 9308555, Japan	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Northwestern University; MRC Laboratory Molecular Biology; University of Toyama	Matouschek, A (corresponding author), Univ Texas Austin, Dept Mol Biosci, 2506 Speedway Stop A5000, Austin, TX 78712 USA.	matouschek@austin.utexas.edu	Mohan, Babu P./I-7362-2019; GAUTAM, AMIT KUMAR SINGH/AAN-6296-2020; Matouschek, Andreas/L-9379-2013	GAUTAM, AMIT KUMAR SINGH/0000-0001-9846-1945; Matouschek, Andreas/0000-0001-6016-2341	National Institutes of Health [U54GM105816, R21CA196456, R21CA191664]; Welch Foundation [F-1817, F-1808]; Cancer Prevention and Research Institute of Texas [RP140328]; Program to Disseminate Tenure Track System from the Ministry of Education, Culture, Sports, Science and Technology, Japan; United Kingdom Medical Research Council [MC_U105185859]; European Molecular Biology Organization; MRC [MC_U105185859] Funding Source: UKRI; Grants-in-Aid for Scientific Research [15H01531] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R21CA196456, T32CA080621, R21CA191664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063004, U54GM105816] Funding Source: NIH RePORTER; Medical Research Council [MC_U105185859] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Cancer Prevention and Research Institute of Texas; Program to Disseminate Tenure Track System from the Ministry of Education, Culture, Sports, Science and Technology, Japan; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by National Institutes of Health Grants U54GM105816, R21CA196456, and R21CA191664 (to A. M.), Welch Foundation Grants F-1817 (to A. M.) and F-1808 (to I. J. F.), Cancer Prevention and Research Institute of Texas Grant RP140328 (to A. M.), the Program to Disseminate Tenure Track System from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to T. I.), the United Kingdom Medical Research Council Grant MC_U105185859 (to M. M. B.), and the European Molecular Biology Organization Long-Term Fellowship (to S. C.) and Young Investigator Program (to M. M. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alifano P, 1996, MICROBIOL REV, V60, P44, DOI 10.1128/MMBR.60.1.44-69.1996; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Barthelme D, 2012, SCIENCE, V337, P843, DOI 10.1126/science.1224352; Beckwith R, 2013, NAT STRUCT MOL BIOL, V20, P1164, DOI 10.1038/nsmb.2659; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERCOVICH Z, 1989, J BIOL CHEM, V264, P15949; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; Chen H, 2002, J BIOL CHEM, V277, P45957, DOI 10.1074/jbc.M206799200; Cilia E, 2014, NUCLEIC ACIDS RES, V42, pW264, DOI 10.1093/nar/gku270; Cilia E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3741; Collins GA, 2010, YEAST, V27, P965, DOI 10.1002/yea.1805; Crawford LJA, 2006, CANCER RES, V66, P6379, DOI 10.1158/0008-5472.CAN-06-0605; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Finley D, 2016, TRENDS BIOCHEM SCI, V41, P77, DOI 10.1016/j.tibs.2015.10.009; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fishbain S, 2015, NAT STRUCT MOL BIOL, V22, P214, DOI 10.1038/nsmb.2958; Fishbain S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1194; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Fort P, 2015, GENOME BIOL EVOL, V7, P1363, DOI 10.1093/gbe/evv068; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Ghaboosi N, 2007, MOL BIOL CELL, V18, P1953, DOI 10.1091/mbc.E06-10-0965; Guharoy M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10239; HAWKES TR, 1995, BIOCHEM J, V306, P385, DOI 10.1042/bj3060385; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Iosefson O, 2015, CELL REP, V12, P1032, DOI 10.1016/j.celrep.2015.07.007; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jacobson AD, 2009, J BIOL CHEM, V284, P35485, DOI 10.1074/jbc.M109.052928; Juenemann K, 2013, J BIOL CHEM, V288, P27068, DOI 10.1074/jbc.M113.486076; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Koga N, 2009, P NATL ACAD SCI USA, V106, P18237, DOI 10.1073/pnas.0904756106; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kraut DA, 2012, ACS CHEM BIOL, V7, P1444, DOI 10.1021/cb3001155; Kraut DA, 2011, ACS CHEM BIOL, V6, P1087, DOI 10.1021/cb2002285; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; Lu Y., 2015, SCIENCE, V348; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1248737; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Martinez-Fonts K, 2016, BIOCHEMISTRY-US, V55, P1898, DOI 10.1021/acs.biochem.5b01310; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Partow S, 2010, YEAST, V27, P955, DOI 10.1002/yea.1806; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Raman M, 2011, MOL CELL, V44, P72, DOI 10.1016/j.molcel.2011.06.036; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Shabek N, 2009, P NATL ACAD SCI USA, V106, P11907, DOI 10.1073/pnas.0905746106; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Shi Y, 2016, SCIENCE, V351, DOI 10.1126/science.aad9421; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Strack RL, 2011, METHODS MOL BIOL, V699, P355, DOI 10.1007/978-1-61737-950-5_17; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Unverdorben P, 2014, P NATL ACAD SCI USA, V111, P5544, DOI 10.1073/pnas.1403409111; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; VIHINEN M, 1994, PROTEINS, V19, P141, DOI 10.1002/prot.340190207; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Weatheritt RJ, 2012, NUCLEIC ACIDS RES, V40, P7123, DOI 10.1093/nar/gks442; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Williamson A, 2011, MOL CELL, V42, P744, DOI 10.1016/j.molcel.2011.04.022; Wilmington SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152679; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Wu HY, 2015, P NATL ACAD SCI USA, V112, P11229, DOI 10.1073/pnas.1508187112; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022; Zhao ML, 2010, J BIOL CHEM, V285, P4771, DOI 10.1074/jbc.M109.060095	104	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14526	14539		10.1074/jbc.M116.727578	http://dx.doi.org/10.1074/jbc.M116.727578			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226608	hybrid, Green Published			2022-12-28	WOS:000380366700010
J	Matsumoto, K; Ayukawa, T; Ishio, A; Sasamura, T; Yamakawa, T; Matsuno, K				Matsumoto, Kenjiroo; Ayukawa, Tomonori; Ishio, Akira; Sasamura, Takeshi; Yamakawa, Tomoko; Matsuno, Kenji			Dual Roles of O-Glucose Glycans Redundant with Monosaccharide O-Fucose on Notch in Notch Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; Drosophila; fucosyltransferase; intracellular trafficking; Notch pathway; O-fucosetransferase; O-glucose; O-glycan; UDP-xylose synthase; xylosyltransferase	HEPARAN-SULFATE PROTEOGLYCANS; PROTEIN O-FUCOSYL-TRANSFERASE-1; LIGAND BINDING; MODIFIES NOTCH; DROSOPHILA; GLYCOSYLATION; RECEPTOR; GLYCOSYLTRANSFERASE; GENE; XYLOSYLTRANSFERASE	Notch is a transmembrane receptor that mediates cell-cell interactions and controls various cell-fate specifications in metazoans. The extracellular domain of Notch contains multiple epidermal growth factor (EGF)-like repeats. At least five different glycans are found in distinct sites within these EGF-like repeats. The function of these individual glycans in Notch signaling has been investigated, primarily by disrupting their individual glycosyltransferases. However, we are just beginning to understand the potential functional interactions between these glycans. Monosaccharide O-fucose and O-glucose trisaccharide (O-glucose-xylose-xylose) are added to many of the Notch EGF-like repeats. In Drosophila, Shams adds a xylose specifically to the monosaccharide O-glucose. We found that loss of the terminal dixylose of O-glucose-linked saccharides had little effect on Notch signaling. However, our analyses of double mutants of shams and other genes required for glycan modifications revealed that both the monosaccharide O-glucose and the terminal dixylose of O-glucose-linked saccharides function redundantly with the monosaccharide O-fucose in Notch activation and trafficking. The terminal dixylose of O-glucose-linked saccharides and the monosaccharide O-glucose were required in distinct Notch trafficking processes: Notch transport from the apical plasma membrane to adherens junctions, and Notch export from the endoplasmic reticulum, respectively. Therefore, the monosaccharide O-glucose and terminal dixylose of O-glucose-linked saccharides have distinct activities in Notch trafficking, although a loss of these activities is compensated for by the presence of monosaccharide O-fucose. Given that various glycans attached to a protein motif may have redundant functions, our results suggest that these potential redundancies may lead to a serious underestimation of glycan functions.	[Matsumoto, Kenjiroo; Sasamura, Takeshi; Yamakawa, Tomoko; Matsuno, Kenji] Osaka Univ, Dept Biol Sci, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan; [Ayukawa, Tomonori; Ishio, Akira] Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1251500, Japan	Osaka University; Tokyo University of Science	Matsuno, K (corresponding author), Osaka Univ, Dept Biol Sci, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	kmatsuno@bio.sci.osaka-u.ac.jp	Tomoko, Yamakawa/GXG-9619-2022	Tomoko, Yamakawa/0000-0002-6590-6183	Japanese Ministry of Education, Culture, Sports, and Science; PRESTO, the Japan Science and Technology Agency; Japan Society for the Promotion of Science; Naito Foundation; Mizutani Foundation for Glycoscience	Japanese Ministry of Education, Culture, Sports, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO, the Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Mizutani Foundation for Glycoscience	This work was supported by grants-in-aid from the Japanese Ministry of Education, Culture, Sports, and Science (to K. Matsuno), grants from PRESTO, the Japan Science and Technology Agency (to K. Matsuno), the Japan Society for the Promotion of Science (to K. Matsumoto), the Naito Foundation (to K. Matsumoto), and a research grant (2015) from the Mizutani Foundation for Glycoscience (to K. Matsuno). The authors declare no that they have no conflict of interest with the contents of this article.	Abad-Rodriguez J, 2015, TRENDS BIOCHEM SCI, V40, P385, DOI 10.1016/j.tibs.2015.03.015; Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Ayukawa T, 2012, P NATL ACAD SCI USA, V109, P15318, DOI 10.1073/pnas.1202369109; Bakker H, 2009, J BIOL CHEM, V284, P2576, DOI 10.1074/jbc.M804394200; Bar-Peled M, 2001, P NATL ACAD SCI USA, V98, P12003, DOI 10.1073/pnas.211229198; Boskovski MT, 2013, NATURE, V504, P456, DOI 10.1038/nature12723; Chillakuri CR, 2012, SEMIN CELL DEV BIOL, V23, P421, DOI 10.1016/j.semcdb.2012.01.009; COUSO JP, 1994, CELL, V79, P259, DOI 10.1016/0092-8674(94)90195-3; DANG DT, 1992, DEV GENET, V13, P367, DOI 10.1002/dvg.1020130507; Eames BF, 2010, DEV BIOL, V341, P400, DOI 10.1016/j.ydbio.2010.02.035; Eixelsberger T, 2012, J BIOL CHEM, V287, P31349, DOI 10.1074/jbc.M112.386706; Forsten-Williams K, 2005, J THEOR BIOL, V233, P483, DOI 10.1016/j.jtbi.2004.10.020; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Hummel Thomas, 2008, V420, P97, DOI 10.1007/978-1-59745-583-1_6; Ishikawa HO, 2010, J BIOL CHEM, V285, P4122, DOI 10.1074/jbc.M109.016964; Ishio A, 2015, J BIOL CHEM, V290, P505, DOI 10.1074/jbc.M114.616847; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kuroda J, 2012, MECH DEVELOP, V128, P625, DOI 10.1016/j.mod.2011.12.002; Lacroix C, 2011, NAT PROTOC, V6, P1412, DOI 10.1038/nprot.2011.363; Lee TV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003547; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Micchelli CA, 2002, DEVELOPMENT, V129, P843; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Pan Y, 2006, DEVELOPMENT, V133, P4933, DOI 10.1242/dev.02679; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Ray M, 2015, J GENET, V94, P407, DOI 10.1007/s12041-015-0535-8; Rincon-Limas DE, 1999, P NATL ACAD SCI USA, V96, P2165, DOI 10.1073/pnas.96.5.2165; Ryder E, 2007, GENETICS, V177, P615, DOI 10.1534/genetics.107.076216; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Sasaki N, 2007, GENES CELLS, V12, P89, DOI 10.1111/j.1365-2443.2007.01037.x; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Stanley P, 2010, CURR TOP DEV BIOL, V92, P131, DOI 10.1016/S0070-2153(10)92004-8; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Takeuchi H, 2011, P NATL ACAD SCI USA, V108, P16600, DOI 10.1073/pnas.1109696108; The I, 2000, NAT CELL BIOL, V2, pE79, DOI 10.1038/35010511; Ueyama M, 2008, J BIOL CHEM, V283, P6076, DOI 10.1074/jbc.M709189200; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Yamamoto S, 2012, SCIENCE, V338, P1229, DOI 10.1126/science.1228745	53	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13743	13752		10.1074/jbc.M115.710483	http://dx.doi.org/10.1074/jbc.M115.710483			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129198	hybrid, Green Published			2022-12-28	WOS:000379771100028
J	Vakili, H; Jin, Y; Cattini, PA				Vakili, Hana; Jin, Yan; Cattini, Peter A.			Evidence for a Circadian Effect on the Reduction of Human Growth Hormone Gene Expression in Response to Excess Caloric Intake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circadian rhythm; gene transcription; growth hormone; pituitary gland; transgenic mice; Chromosomal conformation; excess caloric intake	LOCUS-CONTROL REGION; UPSTREAM STIMULATORY FACTOR; HYPERSENSITIVE SITES I; 24-HOUR PROFILES; CLOCK; TRANSCRIPTION; PITUITARY; BINDING; SEQUENCES; PROMOTER	Rhythmicity of biological functions is fundamental for optimal adaptations to environmental cues. Growth hormone (GH) is a major metabolic homeostatic factor that is secreted with a circadian pattern, but whether it is synthesized rhythmically is unknown. We used transgenic mice containing the human (h) GH gene (hGH1) locus to investigate the rhythmicity of hGH synthesis and secretion and to show that RNA and secreted protein levels oscillate over a 24-h cycle. Analysis of hGH1 promoter sequences revealed an enhancer motif (E-box) element that binds the circadian transcriptional machinery (Bmal1 and Clock). Furthermore, Bmal1/Clock were able to transactivate the hGH1 promoter, and mutation of this E-box element adversely affected basal activity after gene transfer. The ability of Bmal1 to bind the hGH1 promoter region containing the E-box element was confirmed in the hGH1 transgenic mouse pituitary in situ. Occupancy was reduced in mice fed a high fat diet during the light (inactive) stage of the daily cycle in mice and corresponded to a decrease in hGH1 RNA levels. The decreases in occupancy and RNA levels were not seen, however, during the dark (active) stage. A chromatin loop required for efficient postnatal hGH1 expression was negatively affected by the high fat diet in the light but not dark stage similar to the pattern observed with Bmal1 association with the promoter region. This is the first evidence that hGH synthesis follows a diurnal rhythm and of dynamic associations of the circadian machinery with a component of a chromosomal structure of the hGH1 locus that is essential for efficient expression.	[Vakili, Hana] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Internal Med, Winnipeg, MB R3E 0J9, Canada; [Jin, Yan; Cattini, Peter A.] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Physiol & Pathophysiol, Winnipeg, MB R3E 0J9, Canada	University of Manitoba; University of Manitoba	Cattini, PA (corresponding author), Univ Manitoba, Dept Physiol & Pathophysiol, Div Endocrinol & Metab Dis, 745 Bannatyne Ave, Winnipeg, MB R3E 0J9, Canada.	peter.cattini@umanitoba.ca			Canadian Institutes of Health Research [MT-10853]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research MT-10853. The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar-Arnal L, 2013, NAT STRUCT MOL BIOL, V20, P1206, DOI 10.1038/nsmb.2667; ANDREWS RV, 1964, COMP BIOCHEM PHYSIOL, V11, P393, DOI 10.1016/0010-406X(64)90006-4; Arpiainen S, 2007, J MOL BIOL, V369, P640, DOI 10.1016/j.jmb.2007.03.075; Avram AM, 2005, J CLIN ENDOCR METAB, V90, P2982, DOI 10.1210/jc.2004-1785; Aza-Carmona M, 2011, HUM MOL GENET, V20, P1547, DOI 10.1093/hmg/ddr032; Bennani-Baiti IM, 1998, P NATL ACAD SCI USA, V95, P10655, DOI 10.1073/pnas.95.18.10655; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004882; Brandenberger G, 2004, J SLEEP RES, V13, P251, DOI 10.1111/j.1365-2869.2004.00415.x; Cornford AS, 2011, J CLIN ENDOCR METAB, V96, P824, DOI 10.1210/jc.2010-1895; COURTOIS SJ, 1992, J BIOL CHEM, V267, P19736; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deng WL, 2010, CURR OPIN GENET DEV, V20, P548, DOI 10.1016/j.gde.2010.06.007; Duez H, 2010, ARTERIOSCL THROM VAS, V30, P1529, DOI 10.1161/ATVBAHA.110.209098; Duivenvoorde LPM, 2011, J MOL ENDOCRINOL, V47, P81, DOI 10.1530/JME-11-0001; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Elefant F, 2000, J BIOL CHEM, V275, P13827, DOI 10.1074/jbc.275.18.13827; Fleetwood MR, 2012, J BIOL CHEM, V287, P25454, DOI 10.1074/jbc.M112.365825; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gamble KL, 2014, NAT REV ENDOCRINOL, V10, P466, DOI 10.1038/nrendo.2014.78; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Girotti M, 2007, ENDOCRINOLOGY, V148, P2542, DOI 10.1210/en.2006-1304; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Ho YG, 2002, MOL CELL, V9, P291, DOI 10.1016/S1097-2765(02)00447-1; Ho YG, 2008, EMBO REP, V9, P891, DOI 10.1038/embor.2008.126; Ho YG, 2006, MOL CELL, V23, P365, DOI 10.1016/j.molcel.2006.05.041; Ho Y, 2013, MOL CELL BIOL, V33, P1723, DOI 10.1128/MCB.01166-12; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Jin Y, 1999, MOL ENDOCRINOL, V13, P1249, DOI 10.1210/me.13.8.1249; Jin Y, 2009, PLACENTA, V30, P226, DOI 10.1016/j.placenta.2008.12.011; Jin Y, 2011, DNA CELL BIOL, V30, P995, DOI 10.1089/dna.2011.1268; JONES BK, 1995, MOL CELL BIOL, V15, P7010; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Langmesser S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-41; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; LEMAIGRE FP, 1989, EUR J BIOCHEM, V181, P555, DOI 10.1111/j.1432-1033.1989.tb14760.x; LINKOWSKI P, 1987, J CLIN ENDOCR METAB, V65, P141, DOI 10.1210/jcem-65-1-141; LINKOWSKI P, 1994, ARCH GEN PSYCHIAT, V51, P616; LIRA SA, 1993, MOL ENDOCRINOL, V7, P694, DOI 10.1210/me.7.5.694; Mendoza J, 2008, J PHYSIOL-LONDON, V586, P5901, DOI 10.1113/jphysiol.2008.159566; Miele Adriana, 2008, V464, P105; NICKEL BE, 1990, ENDOCRINOLOGY, V126, P971, DOI 10.1210/endo-126-2-971; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Norquay LD, 2006, MOL ENDOCRINOL, V20, P598, DOI 10.1210/me.2005-0221; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Shewchuk BM, 1999, J BIOL CHEM, V274, P35725, DOI 10.1074/jbc.274.50.35725; STRASBURGER CJ, 1990, ACTA PAEDIATR SCAND, P82; Su YH, 2000, J BIOL CHEM, V275, P7902, DOI 10.1074/jbc.275.11.7902; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Uchiyama M, 1998, PSYCHIAT CLIN NEUROS, V52, P241, DOI 10.1111/j.1440-1819.1998.tb01053.x; Vakili H, 2014, J CLIN INVEST, V124, P5002, DOI 10.1172/JCI77126; Vakili H, 2012, J BIOL CHEM, V287, P33282, DOI 10.1074/jbc.M112.380949; Vakili N, 2011, MOL CELL ENDOCRINOL, V345, P48, DOI 10.1016/j.mce.2011.07.010; Weibel L, 1997, CHRONOBIOL INT, V14, P49, DOI 10.3109/07420529709040541; WELLS JA, 1993, RECENT PROG HORM RES, V48, P253; WELLS JA, 1993, ANNU REV BIOPH BIOM, V22, P329, DOI 10.1146/annurev.bb.22.060193.001553; Xu HY, 2015, NAT STRUCT MOL BIOL, V22, P476, DOI 10.1038/nsmb.3018; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yi SJ, 2002, MOL BIOL EVOL, V19, P1083, DOI 10.1093/oxfordjournals.molbev.a004166; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104	60	15	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13823	13833		10.1074/jbc.M116.722744	http://dx.doi.org/10.1074/jbc.M116.722744			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27151213	hybrid, Green Published			2022-12-28	WOS:000379771100036
J	Fishburn, J; Galburt, E; Hahn, S				Fishburn, James; Galburt, Eric; Hahn, Steven			Transcription Start Site Scanning and the Requirement for ATP during Transcription Initiation by RNA Polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN COMPLEX-FORMATION; SACCHAROMYCES-CEREVISIAE; PREINITIATION COMPLEX; PROMOTER CLEARANCE; FACTOR TFIIH; IN-VITRO; MECHANISM; DNA; ARCHITECTURE; ACTIVATION	Saccharomyces cerevisiae RNA polymerase (Pol) II locates transcription start sites (TSS) at TATA-containing promoters by scanning sequences downstream from the site of preinitiation complex formation, a process that involves the translocation of downstream promoter DNA toward Pol II. To investigate a potential role of yeast Pol II transcription in TSS scanning, HIS4 promoter derivatives were generated that limited transcripts in the 30-bp scanned region to two nucleotides in length. Although we found that TSS scanning does not require RNA synthesis, our results revealed that transcription in the purified yeast basal system is largely ATP-independent despite a requirement for the TFIIH DNA translocase subunit Ssl2. This result is rationalized by our finding that, although they are poorer substrates, UTP and GTP can also be utilized by Ssl2. ATP gamma S is a strong inhibitor of rNTP-fueled translocation, and high concentrations of ATP gamma S make transcription completely dependent on added dATP. Limiting Pol II function with low ATP concentrations shifted the TSS position downstream. Combined with prior work, our results show that Pol II transcription plays an important role in TSS selection but is not required for the scanning reaction.	[Fishburn, James; Hahn, Steven] Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,Mailstop A1-162, Seattle, WA 98109 USA; [Galburt, Eric] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Fred Hutchinson Cancer Center; Washington University (WUSTL)	Hahn, S (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,Mailstop A1-162, Seattle, WA 98109 USA.	shahn@fredhutch.org		Galburt, Eric/0000-0003-4314-3215; Hahn, Steven/0000-0001-7240-2533	National Institute of General Medical Sciences, National Institutes of Health [2RO1GM053451]; National Science Foundation Molecular and Cellular Biosciences Grant [1243918]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053451] Funding Source: NIH RePORTER; Direct For Biological Sciences [1243918] Funding Source: National Science Foundation	National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation Molecular and Cellular Biosciences Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institute of General Medical Sciences, National Institutes of Health Grant 2RO1GM053451 (to S. H.) and National Science Foundation Molecular and Cellular Biosciences Grant 1243918 (to E. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BUNICK D, 1982, CELL, V29, P877, DOI 10.1016/0092-8674(82)90449-4; CHEN W, 1985, EMBO J, V4, P3273, DOI 10.1002/j.1460-2075.1985.tb04077.x; Coin F, 1998, COLD SPRING HARB SYM, V63, P105, DOI 10.1101/sqb.1998.63.105; Dvir A, 1997, P NATL ACAD SCI USA, V94, P9006, DOI 10.1073/pnas.94.17.9006; Dvir A, 1996, J BIOL CHEM, V271, P7245, DOI 10.1074/jbc.271.13.7245; Fazal FM, 2015, NATURE, V525, P274, DOI 10.1038/nature14882; Fishburn J, 2015, P NATL ACAD SCI USA, V112, P3961, DOI 10.1073/pnas.1417709112; Fishburn J, 2012, MOL CELL BIOL, V32, P12, DOI 10.1128/MCB.06242-11; Goel S, 2012, J BIOL CHEM, V287, P557, DOI 10.1074/jbc.M111.281576; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Grunberg S, 2013, TRENDS BIOCHEM SCI, V38, P603, DOI 10.1016/j.tibs.2013.09.002; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; HAHN S, 1985, P NATL ACAD SCI USA, V82, P8562, DOI 10.1073/pnas.82.24.8562; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Jeronimo C, 2014, NAT STRUCT MOL BIOL, V21, P449, DOI 10.1038/nsmb.2810; JIANG Y, 1995, J BIOL CHEM, V270, P1277, DOI 10.1074/jbc.270.3.1277; Jiang Y, 1996, MOL CELL BIOL, V16, P1614; Kaplan CD, 2012, PLOS GENET, V8, P172, DOI 10.1371/journal.pgen.1002627; Khaperskyy DA, 2008, MOL CELL BIOL, V28, P3757, DOI 10.1128/MCB.02272-07; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kuehner JN, 2006, J BIOL CHEM, V281, P14119, DOI 10.1074/jbc.M601937200; Kugel JF, 1998, P NATL ACAD SCI USA, V95, P9232, DOI 10.1073/pnas.95.16.9232; Luse DS, 2013, BBA-GENE REGUL MECH, V1829, P63, DOI 10.1016/j.bbagrm.2012.08.010; LUSE DS, 1987, J BIOL CHEM, V262, P14990; Murakami K, 2015, MOL CELL, V59, P133, DOI 10.1016/j.molcel.2015.05.021; NAGAWA F, 1985, P NATL ACAD SCI USA, V82, P8557, DOI 10.1073/pnas.82.24.8557; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Sainsbury S, 2015, NAT REV MOL CELL BIO, V16, P129, DOI 10.1038/nrm3952; SAWADOGO M, 1984, J BIOL CHEM, V259, P5321; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; Tuteja N, 2004, EUR J BIOCHEM, V271, P1835, DOI 10.1111/j.1432-1033.2004.04093.x; WANG WD, 1992, SCIENCE, V255, P450, DOI 10.1126/science.1310361; Wong KH, 2014, MOL CELL, V54, P601, DOI 10.1016/j.molcel.2014.03.024; Yan M, 1997, EMBO J, V16, P7457, DOI 10.1093/emboj/16.24.7457; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583; Zhou XH, 1999, J VIROL, V73, P1580, DOI 10.1128/JVI.73.2.1580-1590.1999	40	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13040	13047		10.1074/jbc.M116.724583	http://dx.doi.org/10.1074/jbc.M116.724583			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129284	Green Published, hybrid			2022-12-28	WOS:000379770500013
J	Han, XZ; Tang, JS; Wang, JN; Ren, F; Zheng, JH; Gragg, M; Kiser, P; Park, PSH; Palczewski, K; Yao, XS; Zhang, YW				Han, Xiangzi; Tang, Jinshan; Wang, Jingna; Ren, Feng; Zheng, Jinhua; Gragg, Megan; Kiser, Philip; Park, Paul S. H.; Palczewski, Krzysztof; Yao, Xinsheng; Zhang, Youwei			Conformational Change of Human Checkpoint Kinase 1 (Chk1) Induced by DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION-INDEPENDENT ACTIVATION; CELL-CYCLE; REPLICATION CHECKPOINT; PROTEIN INTERACTIONS; FISSION YEAST; IN-VIVO; ATR; GENE; CANCER; DOMAIN	Phosphorylation of Chk1 by ataxia telangiectasia-mutated and Rad3-related (ATR) is critical for checkpoint activation upon DNA damage. However, how phosphorylation activates Chk1 remains unclear. Many studies suggest a conformational change model of Chk1 activation in which phosphorylation shifts Chk1 from a closed inactive conformation to an open active conformation during the DNA damage response. However, no structural study has been reported to support this Chk1 activation model. Here we used FRET and bimolecular fluorescence complementary techniques to show that Chk1 indeed maintains a closed conformation in the absence of DNA damage through an intramolecular interaction between a region (residues 31-87) at the N-terminal kinase domain and the distal C terminus. A highly conserved Leu-449 at the C terminus is important for this intramolecular interaction. We further showed that abolishing the intramolecular interaction by a Leu-449 to Arg mutation or inducing ATR-dependent Chk1 phosphorylation by DNA damage disrupts the closed conformation, leading to an open and activated conformation of Chk1. These data provide significant insight into the mechanisms of Chk1 activation during the DNA damage response.	[Han, Xiangzi; Wang, Jingna; Ren, Feng; Zheng, Jinhua; Kiser, Philip; Palczewski, Krzysztof; Zhang, Youwei] Case Western Reserve Univ, Dept Pharmacol, Case Comprehens Canc Ctr, 2109 Adelbert Rd,Wood Bldg W343A, Cleveland, OH 44106 USA; [Gragg, Megan; Park, Paul S. H.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Tang, Jinshan; Yao, Xinsheng] Jinan Univ, Coll Pharm, Inst Tradit Chinese Med & Nat Prod, Guangzhou 510632, Guangdong, Peoples R China	Case Western Reserve University; Case Western Reserve University; Jinan University	Zhang, YW (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Case Comprehens Canc Ctr, 2109 Adelbert Rd,Wood Bldg W343A, Cleveland, OH 44106 USA.	yxz169@case.edu	金华, 郑/GWM-7529-2022	, Megan/0000-0003-3722-9493	National Institutes of Health [R01EY021731]; Arnold and Mabel Beckman Foundation; NCI, National Institutes of Health [R01 163214]; American Cancer Society [ACS RSG-15-042 DMC]; NATIONAL EYE INSTITUTE [T32EY024236, R01EY021731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institutes of Health Grant R01EY021731.r John H. Hord Professor of Pharmacology and supported by the Arnold and Mabel Beckman Foundation.r Supported by NCI, National Institutes of Health Grant R01 163214 and American Cancer Society Grant ACS RSG-15-042 DMC.	Capasso H, 2002, J CELL SCI, V115, P4555, DOI 10.1242/jcs.00133; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Chen YH, 2009, J BIOL CHEM, V284, P182, DOI 10.1074/jbc.M806530200; Cho SH, 2005, CELL CYCLE, V4, P131, DOI 10.4161/cc.4.1.1299; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Goedhart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027321; Gong EY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10856; Guo C, 2015, MOL CELL, V57, P492, DOI 10.1016/j.molcel.2014.12.003; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Han XZ, 2015, J BIOL CHEM, V290, P12370, DOI 10.1074/jbc.M114.621532; Han XZ, 2014, P NATL ACAD SCI USA, V111, P17456, DOI 10.1073/pnas.1408538111; Han XZ, 2014, J BIOL CHEM, V289, P24716, DOI 10.1074/jbc.M114.575035; Hong J, 2012, J CLIN INVEST, V122, P2165, DOI 10.1172/JCI61380; Hovan SC, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3505023; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kosoy A, 2008, MOL BIOL CELL, V19, P4546, DOI 10.1091/mbc.E08-04-0444; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Liu QH, 2000, GENE DEV, V14, P1448; Lundgren K, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2150; Madoz-Gurpide J, 2007, MOL CELL PROTEOMICS, V6, P2150, DOI 10.1074/mcp.M700006-MCP200; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Ng CP, 2004, J BIOL CHEM, V279, P8808, DOI 10.1074/jbc.M312215200; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; Oe T, 2001, DEV BIOL, V229, P250, DOI 10.1006/dbio.2000.9968; Pabla N, 2012, P NATL ACAD SCI USA, V109, P197, DOI 10.1073/pnas.1104767109; Pereira E, 2009, CELL CYCLE, V8, P1788, DOI 10.4161/cc.8.11.8737; Shann YJ, 2001, J BIOL CHEM, V276, P48863, DOI 10.1074/jbc.M108253200; Sriuranpong V, 2004, CLIN CANCER RES, V10, P4944, DOI 10.1158/1078-0432.CCR-03-0757; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; Verlinden L, 2007, CANCER RES, V67, P6574, DOI 10.1158/0008-5472.CAN-06-3545; Walker M, 2009, ONCOGENE, V28, P2314, DOI 10.1038/onc.2009.102; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wan SH, 1999, YEAST, V15, P821, DOI 10.1002/(SICI)1097-0061(199907)15:10A<821::AID-YEA422>3.3.CO;2-R; Wang JN, 2012, CANCER RES, V72, P3786, DOI 10.1158/0008-5472.CAN-12-0523; Wang JN, 2012, J BIOL CHEM, V287, P25501, DOI 10.1074/jbc.M112.350397; Wang SX, 2000, FEBS LETT, V487, P277, DOI 10.1016/S0014-5793(00)02370-X; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Xu J, 2012, INT J PHOTOENERGY, V2012, DOI 10.1155/2012/425735; Yao Hongliang, 2010, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V35, P1080, DOI 10.3969/j.issn.1672-7347.2010.10.008; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2014, INT J CANCER, V134, P1013, DOI 10.1002/ijc.28226; Zhang YW, 2006, CELL CYCLE, V5, P125, DOI 10.4161/cc.5.2.2308; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	46	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					12951	12959		10.1074/jbc.M115.713248	http://dx.doi.org/10.1074/jbc.M115.713248			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129240	Green Published, hybrid			2022-12-28	WOS:000379770500006
J	Park, J; Yu, YP; Zhou, CY; Li, KW; Wang, DQ; Chang, E; Kim, DS; Vo, B; Zhang, X; Gong, NA; Sharp, K; Steward, O; Vitko, I; Perez-Reyes, E; Eroglu, C; Barres, B; Zaucke, F; Feng, GP; Luo, ZD				Park, John; Yu, Yanhui Peter; Zhou, Chun-Yi; Li, Kang-Wu; Wang, Dongqing; Chang, Eric; Kim, Doo-Sik; Vo, Benjamin; Zhang, Xia; Gong, Nian; Sharp, Kelli; Steward, Oswald; Vitko, Iuliia; Perez-Reyes, Edward; Eroglu, Cagla; Barres, Ben; Zaucke, Frank; Feng, Guoping; Luo, Z. David			Central Mechanisms Mediating Thrombospondin-4-induced Pain States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSPECIFIC INTERACTION ANALYSIS; CHANNEL ALPHA(2)DELTA SUBUNITS; SURFACE-PLASMON RESONANCE; GATED CALCIUM-CHANNELS; NEUROPATHIC PAIN; SPINAL-CORD; UP-REGULATION; PERIPHERAL NEUROPATHY; GABAPENTIN NEURONTIN; DOUBLE-BLIND	Peripheral nerve injury induces increased expression of thrombospondin-4 (TSP4) in spinal cord and dorsal root ganglia that contributes to neuropathic pain states through unknown mechanisms. Here, we test the hypothesis that TSP4 activates its receptor, the voltage-gated calcium channel Ca-v alpha(2)delta(1) subunit (Ca-v alpha(2)delta(1)), on sensory afferent terminals in dorsal spinal cord to promote excitatory synaptogenesis and central sensitization that contribute to neuropathic pain states. We show that there is a direct molecular interaction between TSP4 and Ca-v alpha(2)delta(1) in the spinal cord in vivo and that TSP4/Ca-v alpha(2)delta(1)-dependent processes lead to increased behavioral sensitivities to stimuli. In dorsal spinal cord, TSP4/Ca-v alpha(2)delta(1)-dependent processes lead to increased frequency of miniature and amplitude of evoked excitatory post-synaptic currents in second-order neurons as well as increased VGlut(2)- and PSD95-positive puncta, indicative of increased excitatory synapses. Blockade of TSP4/Ca-v alpha(2)delta(1)-dependent processes with Ca-v alpha(2)delta(1) ligand gabapentin or genetic Ca-v alpha(2)delta(1) knockdown blocks TSP4 induced nociception and its pathological correlates. Conversely, TSP4 antibodies or genetic ablation blocks nociception and changes in synaptic transmission in mice overexpressing Ca-v alpha(2)delta(1). Importantly, TSP4/Ca-v alpha(2)delta(1)-dependent processes also lead to similar behavioral and pathological changes in a neuropathic pain model of peripheral nerve injury. Thus, a TSP4/Ca-v alpha(2)delta(1)-dependent pathway activated by TSP4 or peripheral nerve injury promotes exaggerated presynaptic excitatory input and evoked sensory neuron hyperexcitability and excitatory synaptogenesis, which together lead to central sensitization and pain state development.	[Park, John; Yu, Yanhui Peter; Zhou, Chun-Yi; Luo, Z. David] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; [Li, Kang-Wu; Chang, Eric; Kim, Doo-Sik; Vo, Benjamin; Zhang, Xia; Gong, Nian; Luo, Z. David] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Gillespie Bldg,Rm 3113,837 Hlth Sci Rd, Irvine, CA 92697 USA; [Wang, Dongqing; Feng, Guoping] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Sharp, Kelli; Steward, Oswald; Luo, Z. David] Univ Calif Irvine, Sch Med, Reeve Irvine Res Ctr, Irvine, CA 92697 USA; [Vitko, Iuliia; Perez-Reyes, Edward] Univ Virginia, Dept Pharmacol, Sch Med, Charlottesville, VA 22908 USA; [Eroglu, Cagla] Duke Univ, Med Ctr, Cell Biol, Durham, NC 27710 USA; [Barres, Ben] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Zaucke, Frank] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Zaucke, Frank] Univ Cologne, Fac Med, Cologne Ctr Musculoskeletal Biomech, D-50931 Cologne, Germany	University of California System; University of California Irvine; University of California System; University of California Irvine; Massachusetts Institute of Technology (MIT); University of California System; University of California Irvine; University of Virginia; Duke University; Stanford University; University of Cologne; University of Cologne	Luo, ZD (corresponding author), Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Gillespie Bldg,Rm 3113,837 Hlth Sci Rd, Irvine, CA 92697 USA.	zluo@uci.edu	Core, Vector/CAF-4832-2022; Feng, Guoping/Y-2827-2019; Zaucke, Frank/E-2077-2012; Zaucke, Frank/AAT-2688-2021; Eroglu, Cagla/P-5315-2014	Eroglu, Cagla/0000-0002-7204-0218	University of California Irvine [CA-62203]; National Institutes of Health [NS069524, NS40135, DE014545, NS064341, DE021847]; Pharmaceutical Research and Manufacturers of America Foundation [PRMAF-52427]; National Institutes of Health Rehabilitation Medicine Scientist Training Program fellowship [K-12]; Institute for Clinical and Translational Science; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE014545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040135, R01NS064341, R01NS096352, R21NS069524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031833] Funding Source: NIH RePORTER	University of California Irvine(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmaceutical Research and Manufacturers of America Foundation; National Institutes of Health Rehabilitation Medicine Scientist Training Program fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Clinical and Translational Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in part, through access to the confocal facility of the Optical Biology Shared Resource of the Cancer Center, Support Grant CA-62203, at the University of California Irvine and by National Institutes of Health Grants NS069524 (to E. P.-R.), NS40135, DE014545, and NS064341 (to Z. D. L.), and DE021847 (to O. S. and Z. D. L). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Recipient of a Pre-Doctoral Fellowship in Pharmacology/Toxicology from the Pharmaceutical Research and Manufacturers of America Foundation (PRMAF-52427).r Recipient of National Institutes of Health Rehabilitation Medicine Scientist Training Program fellowship (K-12) and faculty career development (KL-2) fellowship from the Institute for Clinical and Translational Science.	Abdi S, 1998, ANESTH ANALG, V87, P1360, DOI 10.1097/00000539-199812000-00027; Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Ahn SH, 2003, SPINE, V28, P341, DOI 10.1097/00007632-200302150-00005; ARBER S, 1995, J CELL BIOL, V131, P1083, DOI 10.1083/jcb.131.4.1083; Backonja M, 1998, JAMA-J AM MED ASSOC, V280, P1831, DOI 10.1001/jama.280.21.1831; Backonja M, 2003, CLIN THER, V25, P81, DOI 10.1016/S0149-2918(03)90011-7; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bauer CS, 2009, J NEUROSCI, V29, P4076, DOI 10.1523/JNEUROSCI.0356-09.2009; BENMENACHEM E, 1995, EPILEPSY RES, V21, P231; Bernstein GM, 2007, CELL CALCIUM, V41, P27, DOI 10.1016/j.ceca.2006.04.010; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Boroujerdi A, 2011, PAIN, V152, P649, DOI 10.1016/j.pain.2010.12.014; Braz J, 2014, NEURON, V82, P522, DOI 10.1016/j.neuron.2014.01.018; Chang EY, 2013, EUR J PAIN, V17, P505, DOI 10.1002/j.1532-2149.2012.00221.x; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Dunkle ET, 2007, EXP EYE RES, V84, P707, DOI 10.1016/j.exer.2006.12.014; Dworkin RH, 2005, NAT REV DRUG DISCOV, V4, P455, DOI 10.1038/nrd1756; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Faralli A, 2016, BRAIN STRUCT FUNCT, V221, P3193, DOI 10.1007/s00429-015-1095-7; Field MJ, 2006, P NATL ACAD SCI USA, V103, P17537, DOI 10.1073/pnas.0409066103; Field MJ, 1997, BRIT J PHARMACOL, V121, P1513, DOI 10.1038/sj.bjp.0701320; Gee NS, 1996, J BIOL CHEM, V271, P5768, DOI 10.1074/jbc.271.10.5768; Gordh TE, 2008, PAIN, V138, P255, DOI 10.1016/j.pain.2007.12.011; Graham BA, 2007, J NEUROPHYSIOL, V98, P1057, DOI 10.1152/jn.00581.2007; Guay David R P, 2005, Am J Geriatr Pharmacother, V3, P274, DOI 10.1016/j.amjopharm.2005.12.008; Gustorff G, 2004, ANESTH ANALG, V98, P401, DOI [10.1213/01/ANE.0000095150.76735.5D, 10.1213/01.ANE.0000095150.76735.5D]; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Hioki H, 2007, GENE THER, V14, P872, DOI 10.1038/sj.gt.3302924; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Hunter JC, 1997, EUR J PHARMACOL, V324, P153, DOI 10.1016/S0014-2999(97)00070-8; Hwang JH, 1997, REGION ANESTH, V22, P249, DOI 10.1016/S1098-7339(06)80010-6; JAY SD, 1991, J BIOL CHEM, V266, P3287; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Kim DS, 2012, J NEUROSCI, V32, P8977, DOI 10.1523/JNEUROSCI.6494-11.2012; Kim DS, 2009, PAIN, V143, P114, DOI 10.1016/j.pain.2009.02.006; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Klugbauer N, 1999, J NEUROSCI, V19, P684; Klugbauer N, 2003, J BIOENERG BIOMEMBR, V35, P639, DOI 10.1023/B:JOBB.0000008028.41056.58; Levendoglu F, 2004, SPINE, V29, P743, DOI 10.1097/01.BRS.0000112068.16108.3A; Li CY, 2006, PAIN, V125, P20, DOI 10.1016/j.pain.2006.04.022; Li CY, 2004, J NEUROSCI, V24, P8494, DOI 10.1523/JNEUROSCI.2982-04.2004; Li KW, 2014, J BIOL CHEM, V289, P7025, DOI 10.1074/jbc.M114.548990; Lin YX, 2004, J NEUROPHYSIOL, V92, P2820, DOI 10.1152/jn.00048.2004; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Marais E, 2001, MOL PHARMACOL, V59, P1243, DOI 10.1124/mol.59.5.1243; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Michalski D, 2013, NEUROSCIENCE, V231, P328, DOI 10.1016/j.neuroscience.2012.11.046; Newton RA, 2001, MOL BRAIN RES, V95, P1, DOI 10.1016/S0169-328X(01)00188-7; Nguyen D, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-6; Nikitczuk JS, 2014, HIPPOCAMPUS, V24, P943, DOI 10.1002/hipo.22282; Pan B, 2015, J NEUROSCI RES, V93, P443, DOI 10.1002/jnr.23498; Pan JQ, 2000, J NEUROSCI, V20, P4769; Park J, 2016, J COMP NEUROL, V524, P309, DOI 10.1002/cne.23844; Patel MK, 2000, BRIT J PHARMACOL, V130, P1731, DOI 10.1038/sj.bjp.0703530; Perederiy JV, 2013, J NEUROSCI, V33, P4754, DOI 10.1523/JNEUROSCI.4785-12.2013; Qin N, 2002, MOL PHARMACOL, V62, P485, DOI 10.1124/mol.62.3.485; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Rigaud M, 2008, PAIN, V136, P188, DOI 10.1016/j.pain.2008.01.016; Rose MA, 2002, ANAESTHESIA, V57, P451, DOI 10.1046/j.0003-2409.2001.02399.x; Rosenberg JM, 1997, CLIN J PAIN, V13, P251, DOI 10.1097/00002508-199709000-00011; Rosner H, 1996, CLIN J PAIN, V12, P56, DOI 10.1097/00002508-199603000-00010; Shepard AR, 2005, ANAL BIOCHEM, V344, P287, DOI 10.1016/j.ab.2005.06.005; Shimoyama M, 2000, PAIN, V85, P405, DOI 10.1016/S0304-3959(99)00283-3; Sodersten F, 2006, CONNECT TISSUE RES, V47, P85, DOI 10.1080/03008200600584124; Stacey BR, 2008, PAIN MED, V9, P1202, DOI 10.1111/j.1526-4637.2008.00423.x; Stanfa LC, 1997, NEUROREPORT, V8, P587, DOI 10.1097/00001756-199702100-00002; To TP, 2002, SPINAL CORD, V40, P282, DOI 10.1038/sj.sc.3101300; Underhill SM, 2015, J NEUROSCI, V35, P5260, DOI 10.1523/JNEUROSCI.4365-14.2015; Werner MU, 2001, REGION ANESTH PAIN M, V26, P322, DOI 10.1053/rapm.2001.25070; Xiao W, 2007, NEUROSCIENCE, V144, P714, DOI 10.1016/j.neuroscience.2006.09.044; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459; Zareba G, 2005, DRUG TODAY, V41, P509, DOI 10.1358/dot.2005.41.8.910482; Zhou C, 2015, EUR J PAIN, V19, P1267, DOI 10.1002/ejp.656; Zhou C, 2014, EUR J PAIN, V18, P649, DOI 10.1002/j.1532-2149.2013.00416.x	85	34	34	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13335	13348		10.1074/jbc.M116.723478	http://dx.doi.org/10.1074/jbc.M116.723478			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129212	Green Published, hybrid			2022-12-28	WOS:000379770500035
J	Schnicker, NJ; Dey, M				Schnicker, Nicholas J.; Dey, Mishtu			Bacillus anthracis Prolyl 4-Hydroxylase Modifies Collagen-like Substrates in Asymmetric Patterns	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAURINE/ALPHA-KETOGLUTARATE DIOXYGENASE; 2-HIS-1-CARBOXYLATE FACIAL TRIAD; SPIN FE(IV) COMPLEX; BINDING DOMAIN; NITRIC-OXIDE; ACTIVE-SITE; ZALERION-ARBORICOLA; STRUCTURAL MOTIFS; CRYSTAL-STRUCTURE; IRON ENZYMES	Proline hydroxylation is the most prevalent post-translational modification in collagen. The resulting product trans-4-hydroxyproline (Hyp) is of critical importance for the stability and thus function of collagen, with defects leading to several diseases. Prolyl 4-hydroxylases (P4Hs) are mononuclear non-heme iron alpha-ketoglutarate (alpha KG)-dependent dioxygenases that catalyze Hyp formation. Although animal and plant P4Hs target peptidyl proline, prokaryotes have been known to use free L-proline as a precursor to form Hyp. The P4H from Bacillus anthracis (BaP4H) has been postulated to act on peptidyl proline in collagen peptides, making it unusual within the bacterial clade, but its true physiological substrate remains enigmatic. Here we use mass spectrometry, fluorescence binding, x-ray crystallography, and docking experiments to confirm that BaP4H recognizes and acts on peptidyl substrates but not free L-proline, using elements characteristic of an Fe(II)/alpha KG-dependent dioxygenases. We further show that BaP4H can hydroxylate unique peptidyl proline sites in collagen-derived peptides with asymmetric hydroxylation patterns. The cofactor-bound crystal structures of BaP4H reveal active site conformational changes that define open and closed forms and mimic "ready" and "product-released" states of the enzyme in the catalytic cycle. These results help to clarify the role of BaP4H as well as provide broader insights into human collagen P4H and proteins with poly-L-proline type II helices.	[Schnicker, Nicholas J.; Dey, Mishtu] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA	University of Iowa	Dey, M (corresponding author), Univ Iowa, Dept Chem, Iowa City, IA 52242 USA.	mishtu-dey@uiowa.edu		Schnicker, Nicholas/0000-0002-5189-4943	University of Iowa College of Liberal Arts and Sciences	University of Iowa College of Liberal Arts and Sciences	This work was supported by the University of Iowa College of Liberal Arts and Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	ADEFARATI AA, 1992, J ANTIBIOT, V45, P1953, DOI 10.7164/antibiotics.45.1953; ADEFARATI AA, 1991, J AM CHEM SOC, V113, P3542, DOI 10.1021/ja00009a048; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Anantharajan J, 2013, STRUCTURE, V21, P2107, DOI 10.1016/j.str.2013.09.005; Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; BERG RA, 1973, BIOCHEMISTRY-US, V12, P3395, DOI 10.1021/bi00742a005; BERG RA, 1977, BIOCHEMISTRY-US, V16, P1615, DOI 10.1021/bi00627a014; Berisio R, 2012, CURR PROTEIN PEPT SC, V13, P855, DOI 10.2174/138920312804871157; Bollinger JM, 2009, CURR OPIN CHEM BIOL, V13, P51, DOI 10.1016/j.cbpa.2009.03.018; Bollinger JM, 2006, J INORG BIOCHEM, V100, P586, DOI 10.1016/j.jinorgbio.2006.01.022; Bruijnincx PCA, 2008, CHEM SOC REV, V37, P2716, DOI 10.1039/b707179p; Brummett AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127288; Cerveny L, 2013, INFECT IMMUN, V81, P629, DOI 10.1128/IAI.01035-12; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Coufal DE, 1999, BIOCHEMISTRY-US, V38, P4504, DOI 10.1021/bi9823378; Culpepper MA, 2010, BIOCHEMISTRY-US, V49, P124, DOI 10.1021/bi901771z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eriksson M, 1999, J BIOL CHEM, V274, P22131, DOI 10.1074/jbc.274.32.22131; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gaffney BJ, 2009, BIOL MAGN RESON, V28, P233, DOI 10.1007/978-0-387-84856-3_6; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Grzyska PK, 2005, BIOCHEMISTRY-US, V44, P3845, DOI 10.1021/bi048746n; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hieta R, 2003, J BIOL CHEM, V278, P34966, DOI 10.1074/jbc.M303624200; Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Horita S, 2015, STRUCTURE, V23, P639, DOI 10.1016/j.str.2015.01.014; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; HUTTON JJ, 1967, ARCH BIOCHEM BIOPHYS, V121, P384, DOI 10.1016/0003-9861(67)90091-4; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Keskiaho K, 2007, PLANT CELL, V19, P256, DOI 10.1105/tpc.106.042739; KIVIRIKKO KI, 1971, BIOCHEM BIOPH RES CO, V45, P1591, DOI 10.1016/0006-291X(71)90203-8; Knauer SH, 2012, FEBS J, V279, P816, DOI 10.1111/j.1742-4658.2012.08473.x; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; Koski MK, 2007, J BIOL CHEM, V282, P37112, DOI 10.1074/jbc.M706554200; Koski MK, 2009, J BIOL CHEM, V284, P25290, DOI 10.1074/jbc.M109.014050; Kukkola L, 2004, J BIOL CHEM, V279, P18656, DOI 10.1074/jbc.M401514200; LANCASTER JR, 1992, J BIOL CHEM, V267, P10994; Lange SJ, 1998, CURR OPIN CHEM BIOL, V2, P159, DOI 10.1016/S1367-5931(98)80057-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Longbotham JE, 2015, BIOCHEMISTRY-US, V54, P6093, DOI 10.1021/acs.biochem.5b00789; MAJAMAA K, 1984, EUR J BIOCHEM, V138, P239, DOI 10.1111/j.1432-1033.1984.tb07907.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; McNeill LA, 2005, MOL BIOSYST, V1, P321, DOI 10.1039/b511249b; Miller MA, 2008, ACTA CRYSTALLOGR F, V64, P788, DOI 10.1107/S1744309108023439; Myllyharju J, 1999, EMBO J, V18, P306, DOI 10.1093/emboj/18.2.306; Myllyharju J, 2013, ACTA PHYSIOL, V208, P148, DOI 10.1111/apha.12096; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; ORVILLE AM, 1993, J BIOL CHEM, V268, P8596; Pappalardi MB, 2011, BIOCHEM J, V436, P363, DOI 10.1042/BJ20101201; Pekkala M, 2004, J BIOL CHEM, V279, P52255, DOI 10.1074/jbc.M410007200; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Ploumakis A, 2015, MOL CELL, V58, P729, DOI 10.1016/j.molcel.2015.05.026; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ryle MJ, 2003, P NATL ACAD SCI USA, V100, P3790, DOI 10.1073/pnas.0636740100; Ryle MJ, 2003, BIOCHEMISTRY-US, V42, P1854, DOI 10.1021/bi026832m; Schnicker NJ, 2016, ACTA CRYSTALLOGR D, V72, P675, DOI 10.1107/S2059798316004198; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Scotti JS, 2014, P NATL ACAD SCI USA, V111, P13331, DOI 10.1073/pnas.1409916111; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yuan HX, 2013, MOL CELL, V49, P379, DOI 10.1016/j.molcel.2013.01.019; Zarrinpar A, 2000, NAT STRUCT BIOL, V7, P611, DOI 10.1038/77891	74	11	11	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13360	13374		10.1074/jbc.M116.725432	http://dx.doi.org/10.1074/jbc.M116.725432			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129244	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000379770500037
J	Graham, BW; Tao, YQ; Dodge, KL; Thaxton, CT; Olaso, D; Young, NL; Marshall, AG; Trakselis, MA				Graham, Brian W.; Tao, Yeqing; Dodge, Katie L.; Thaxton, Carly T.; Olaso, Danae; Young, Nicolas L.; Marshall, Alan G.; Trakselis, Michael A.			DNA Interactions Probed by Hydrogen-Deuterium Exchang (HDX) Fourier Transform Ion Cyclotron Resonance Mass Spectrometry Confirm External Binding Sites on the Minichromosomal Maintenance (MCM) Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARCHAEAL MCM; HEXAMERIC HELICASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; COMPLEX; STRAND; TRANSLOCATION; REPLICATION; MECHANISM; DOMAIN	The archaeal minichromosomal maintenance (MCM) helicase from Sulfolobus solfataricus (SsoMCM) is a model for understanding structural and mechanistic aspects of DNA unwinding. Although interactions of the encircled DNA strand within the central channel provide an accepted mode for translocation, interactions with the excluded strand on the exterior surface have mostly been ignored with regard to DNA unwinding. We have previously proposed an extension of the traditional steric exclusion model of unwinding to also include significant contributions with the excluded strand during unwinding, termed steric exclusion and wrapping (SEW). The SEW model hypothesizes that the displaced single strand tracks along paths on the exterior surface of hexameric helicases to protect single-stranded DNA (ssDNA) and stabilize the complex in a forward unwinding mode. Using hydrogen/deuterium exchange monitored by Fourier transform ion cyclotron resonance MS, we have probed the binding sites for ssDNA, using multiple substrates targeting both the encircled and excluded strand interactions. In each experiment, we have obtained >98.7% sequence coverage of SsoMCM from >650 peptides (5-30 residues in length) and are able to identify interacting residues on both the interior and exterior of SsoMCM. Based on identified contacts, positively charged residues within the external waist region were mutated and shown to generally lower DNA unwinding without negatively affecting the ATP hydrolysis. The combined data globally identify binding sites for ssDNA during SsoMCM unwinding as well as validating the importance of the SEW model for hexameric helicase unwinding.	[Graham, Brian W.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Tao, Yeqing; Marshall, Alan G.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Dodge, Katie L.; Thaxton, Carly T.; Olaso, Danae; Trakselis, Michael A.] Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA; [Young, Nicolas L.; Marshall, Alan G.] Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Graham, Brian W.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA; [Young, Nicolas L.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, One Baylor Plaza, Houston, TX 77030 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; Florida State University; Baylor University; State University System of Florida; Florida State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Baylor College of Medicine	Trakselis, MA (corresponding author), One Bear Pl 97348, Waco, TX 76798 USA.	michael_trakselis@baylor.edu	Trakselis, Michael/V-3806-2019; Young, Nicolas/AAI-5242-2020	Young, Nicolas/0000-0002-3323-2815; Trakselis, Michael/0000-0001-7054-8475; Thaxton, Carly/0000-0001-9270-8708; Olaso, Danae/0000-0002-2070-6022	American Cancer Society Research Scholar Grant [RSG-11-049-01-DMC]; National Science Foundation Division of Materials Research Grant [DMR-11-57490]	American Cancer Society Research Scholar Grant(American Cancer Society); National Science Foundation Division of Materials Research Grant(National Science Foundation (NSF))	This work was supported by American Cancer Society Research Scholar Grant RSG-11-049-01-DMC (to M. A. T.) and National Science Foundation Division of Materials Research Grant DMR-11-57490 (to A. G. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Aarattuthodiyil S, 2014, NUCLEIC ACIDS RES, V42, P11707, DOI 10.1093/nar/gku845; Arias-Palomo E, 2013, CELL, V153, P438, DOI 10.1016/j.cell.2013.03.006; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Bauer RJ, 2013, J MOL BIOL, V425, P1259, DOI 10.1016/j.jmb.2013.01.025; Berger JM, 2008, CELL, V134, DOI 10.1016/j.cell.2008.08.027; Blakney GT, 2011, INT J MASS SPECTROM, V306, P246, DOI 10.1016/j.ijms.2011.03.009; Brewster AS, 2008, P NATL ACAD SCI USA, V105, P20191, DOI 10.1073/pnas.0808037105; Costa A, 2008, EMBO J, V27, P2250, DOI 10.1038/emboj.2008.135; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; Costa A, 2014, ELIFE, V3, DOI 10.7554/eLife.03273; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Duderstadt KE, 2013, CURR OPIN STRUC BIOL, V23, P144, DOI 10.1016/j.sbi.2012.11.012; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fletcher RJ, 2006, BIOCHEMISTRY-US, V45, P462, DOI 10.1021/bi051754z; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Froelich CA, 2014, ELIFE, V3, DOI 10.7554/eLife.01993; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kazazic S, 2010, J AM SOC MASS SPECTR, V21, P550, DOI 10.1016/j.jasms.2009.12.016; Krajewski WW, 2014, NATURE, V508, P416, DOI 10.1038/nature13037; Li NN, 2015, NATURE, V524, P186, DOI 10.1038/nature14685; Liew LP, 2011, BIOCHEM J, V436, P409, DOI 10.1042/BJ20110084; Lisal J, 2006, VIROLOGY, V351, P73, DOI 10.1016/j.virol.2006.03.025; Liu W, 2008, NUCLEIC ACIDS RES, V36, P3235, DOI 10.1093/nar/gkn183; Manhart CM, 2015, J BIOL CHEM, V290, P10828, DOI 10.1074/jbc.M115.642066; Marshall AG, 1998, MASS SPECTROM REV, V17, P1, DOI 10.1002/(SICI)1098-2787(1998)17:1<1::AID-MAS1>3.0.CO;2-K; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Miller JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03433; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nevin P, 2015, DNA REPAIR, V29, P65, DOI 10.1016/j.dnarep.2015.01.012; Petojevic T, 2015, P NATL ACAD SCI USA, V112, pE249, DOI 10.1073/pnas.1422003112; Pirrone GF, 2015, ANAL CHEM, V87, P99, DOI 10.1021/ac5040242; Reynolds KA, 2015, BIOCHEMISTRY-US, V54, P4248, DOI 10.1021/acs.biochem.5b00214; Riera A, 2014, SEMIN CELL DEV BIOL, V30, P104, DOI 10.1016/j.semcdb.2014.03.008; Rothenberg E, 2007, J BIOL CHEM, V282, P34229, DOI 10.1074/jbc.M706300200; Sakakibara N, 2009, MOL MICROBIOL, V72, P286, DOI 10.1111/j.1365-2958.2009.06663.x; Satapathy AK, 2011, J BIOL CHEM, V286, P34468, DOI 10.1074/jbc.M111.283796; Schaub TM, 2008, ANAL CHEM, V80, P3985, DOI 10.1021/ac800386h; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Slaymaker IM, 2013, NUCLEIC ACIDS RES, V41, P3446, DOI 10.1093/nar/gkt022; Smith DL, 1997, J MASS SPECTROM, V32, P135, DOI 10.1002/(SICI)1096-9888(199702)32:2<135::AID-JMS486>3.0.CO;2-M; Spies M, 2007, CELL, V131, P694, DOI 10.1016/j.cell.2007.09.023; Wiedemann C, 2015, NUCLEIC ACIDS RES, V43, P2958, DOI 10.1093/nar/gkv120; Yuan ZN, 2016, NAT STRUCT MOL BIOL, V23, P217, DOI 10.1038/nsmb.3170; Zhang HM, 2009, J AM SOC MASS SPECTR, V20, P520, DOI 10.1016/j.jasms.2008.11.010; Zhang HM, 2008, ANAL CHEM, V80, P9034, DOI 10.1021/ac801417d; Zhang Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep01247; Zhang Q, 2011, ANAL CHEM, V83, P7129, DOI 10.1021/ac201501z; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhang ZQ, 1997, PROTEIN SCI, V6, P2203; Zhang ZQ, 1997, TECH PROT CHEM, V8, P703, DOI 10.1016/S1080-8914(97)80069-5	53	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12467	12480		10.1074/jbc.M116.719591	http://dx.doi.org/10.1074/jbc.M116.719591			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27044751	Green Published, hybrid			2022-12-28	WOS:000378119900003
J	Burr, R; Stewart, EV; Shao, W; Zhao, S; Hannibal-Bach, HK; Ejsing, CS; Espenshade, PJ				Burr, Risa; Stewart, Emerson V.; Shao, Wei; Zhao, Shan; Hannibal-Bach, Hans Kristian; Ejsing, Christer S.; Espenshade, Peter J.			Mga2 Transcription Factor Regulates an Oxygen-responsive Lipid Homeostasis Pathway in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEAVAGE-ACTIVATING PROTEIN; ELEMENT-BINDING PROTEINS; SACCHAROMYCES-CEREVISIAE; SREBP CLEAVAGE; SCHIZOSACCHAROMYCES-POMBE; GENE-EXPRESSION; MITOCHONDRIAL THIOREDOXIN; ENDOPLASMIC-RETICULUM; PH HOMEOSTASIS; FATTY-ACIDS	Eukaryotic lipid synthesis is oxygen-dependent with cholesterol synthesis requiring 11 oxygen molecules and fatty acid desaturation requiring 1 oxygen molecule per double bond. Accordingly, organisms evaluate oxygen availability to control lipid homeostasis. The sterol regulatory element-binding protein (SREBP) transcription factors regulate lipid homeostasis. In mammals, SREBP-2 controls cholesterol biosynthesis, whereas SREBP-1 controls triacylglycerol and glycerophospholipid biosynthesis. In the fission yeast Schizosaccharomyces pombe, the SREBP-2 homolog Sre1 regulates sterol homeostasis in response to changing sterol and oxygen levels. However, notably missing is an SREBP-1 analog that regulates triacylglycerol and glycerophospholipid homeostasis in response to low oxygen. Consistent with this, studies have shown that the Sre1 transcription factor regulates only a fraction of all genes up-regulated under low oxygen. To identify new regulators of low oxygen adaptation, we screened the S. pombe nonessential haploid deletion collection and identified 27 gene deletions sensitive to both low oxygen and cobalt chloride, a hypoxia mimetic. One of these genes, mga2, is a putative transcriptional activator. In the absence of mga2, fission yeast exhibited growth defects under both normoxia and low oxygen conditions. Mga2 transcriptional targets were enriched for lipid metabolism genes, and mga2 Delta cells showed disrupted triacylglycerol and glycerophospholipid homeostasis, most notably with an increase in fatty acid saturation. Indeed, addition of exogenous oleic acid to mga2 Delta cells rescued the observed growth defects. Together, these results establish Mga2 as a transcriptional regulator of triacylglycerol and glycerophospholipid homeostasis in S. pombe, analogous to mammalian SREBP-1.	[Burr, Risa; Stewart, Emerson V.; Shao, Wei; Zhao, Shan; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Hannibal-Bach, Hans Kristian; Ejsing, Christer S.] Univ Southern Denmark, VILLUM Ctr Bioanalyt Sci, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark	Johns Hopkins University; University of Southern Denmark	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Physiol 107B, 725 N Wolfe St, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu	Burr, Risa/AGK-7711-2022; Ejsing, Christer S/R-5922-2016	Ejsing, Christer S./0000-0003-4963-0276; Shao, Wei/0000-0002-5966-4376; Burr, Risa/0000-0001-6851-2932	National Institutes of Health [HL077588]; VILLUM FONDEN Grant [VKR023439]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER; Villum Fonden [00007363] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VILLUM FONDEN Grant(Villum Fonden); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Villum Fonden(Villum Fonden)	This work was supported by National Institutes of Health Grant HL077588 ( to P. J. E.) and VILLUM FONDEN Grant VKR023439 ( to C. S. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Bien CM, 2009, MOL MICROBIOL, V74, P672, DOI 10.1111/j.1365-2958.2009.06895.x; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; BLOOMFIELD DK, 1960, J BIOL CHEM, V235, P337; Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Casanovas A, 2015, CHEM BIOL, V22, P412, DOI 10.1016/j.chembiol.2015.02.007; Conaway RC, 2011, SEMIN CELL DEV BIOL, V22, P729, DOI 10.1016/j.semcdb.2011.07.021; DuBois JC, 2016, MED MYCOL, V54, P40, DOI 10.1093/mmy/myv073; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Ferreira T, 2004, BIOCHEM J, V378, P899, DOI 10.1042/BJ20031064; Grahl N, 2012, EUKARYOT CELL, V11, P560, DOI 10.1128/EC.00031-12; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Ho JJD, 2012, J BIOL CHEM, V287, P29003, DOI 10.1074/jbc.M112.373365; Holic R, 2012, APPL MICROBIOL BIOT, V95, P179, DOI 10.1007/s00253-012-3959-6; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Husen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079736; JAHNKE L, 1983, J BACTERIOL, V155, P488, DOI 10.1128/JB.155.2.488-492.1983; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jiang YD, 2001, MOL CELL BIOL, V21, P6161, DOI 10.1128/MCB.21.18.6161-6169.2001; JOHNSON B, 1972, ANTON VAN LEE J M S, V38, P137, DOI 10.1007/BF02328085; Kandasamy P, 2004, J BIOL CHEM, V279, P36586, DOI 10.1074/jbc.M401557200; Kelley R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000488; Kim J, 2015, BIOCHEM BIOPH RES CO, V468, P606, DOI 10.1016/j.bbrc.2015.10.165; KLEIN HP, 1954, BIOCHIM BIOPHYS ACTA, V13, P591, DOI 10.1016/0006-3002(54)90382-0; Kuhl I, 2011, NUCLEIC ACIDS RES, V39, P8029, DOI 10.1093/nar/gkr511; Kwast KE, 1998, J EXP BIOL, V201, P1177; Dang K, 2015, INT J MOL SCI, V16, P6353, DOI 10.3390/ijms16036353; Lane S, 2015, EUKARYOT CELL, V14, P1114, DOI 10.1128/EC.00102-15; Lee H, 2007, MOL MICROBIOL, V65, P1018, DOI 10.1111/j.1365-2958.2007.05844.x; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Nohturfft A, 1999, P NATL ACAD SCI USA, V96, P11235, DOI 10.1073/pnas.96.20.11235; Pancaldi V, 2012, G3-GENES GENOM GENET, V2, P453, DOI 10.1534/g3.111.001560; Prevorovsky M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137820; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Rupaimoole R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6202; Ryuko S, 2012, MOL GENET GENOMICS, V287, P651, DOI 10.1007/s00438-012-0705-9; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Solaini G, 2010, BBA-BIOENERGETICS, V1797, P1171, DOI 10.1016/j.bbabio.2010.02.011; Song JY, 2006, EUKARYOT CELL, V5, P1857, DOI 10.1128/EC.00244-06; Song JY, 2008, EUKARYOT CELL, V7, P2160, DOI 10.1128/EC.00106-08; Spahr H, 2001, P NATL ACAD SCI USA, V98, P11985, DOI 10.1073/pnas.211253898; Stewart EV, 2011, MOL CELL, V42, P160, DOI 10.1016/j.molcel.2011.02.035; Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837; Tarsio M, 2011, J BIOL CHEM, V286, P28089, DOI 10.1074/jbc.M111.251363; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; van den Beucken T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6203; Willger SD, 2012, EUKARYOT CELL, V11, P1557, DOI 10.1128/EC.00252-12; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yang WL, 2000, J BIOL CHEM, V275, P429, DOI 10.1074/jbc.275.1.429; Zhang SR, 1999, GENETICS, V151, P473	67	25	26	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12171	12183		10.1074/jbc.M116.723650	http://dx.doi.org/10.1074/jbc.M116.723650			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27053105	hybrid, Green Published			2022-12-28	WOS:000378092800019
J	Tian, J; Geng, QZ; Ding, YH; Liao, J; Dong, MQ; Xu, XZ; Li, J				Tian, Jie; Geng, Qizhi; Ding, Yuehe; Liao, Ji; Dong, Meng-Qiu; Xu, Xingzhi; Li, Jing			O-GlcNAcylation Antagonizes Phosphorylation of CDH1 (CDC20 Homologue 1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINE; ANAPHASE-PROMOTING COMPLEX; GLCNAC; PROTEINS; IDENTIFICATION; APC/C-CDH1; ACTIVATION; DEGRADATION; INHIBITION; SITE	The anaphase promoting complex/ cyclosome (APC/C) orchestrates various aspects of the eukaryotic cell cycle. One of its co-activators, Cdh1, is subject to myriad post-translational modifications, such as phosphorylation and ubiquitination. Herein we identify the O-linkedN-acetylglucosamine (O-GlcNAc) modification that occurs on Cdh1. Cdh1 is O-GlcNAcylated in cultured cells and mouse brain extracts. Mass spectrometry identifies an O-GlcNAcylated peptide that neighbors a known phosphorylation site. Cell synchronization and mutation studies reveal that O-GlcNAcylation of Cdh1 may antagonize its phosphorylation. Our results thus reveal a pivotal role of O-GlcNAcylation in regulating APC/ C activity.	[Tian, Jie; Geng, Qizhi; Liao, Ji; Xu, Xingzhi; Li, Jing] Capital Normal Univ, Beijing Key Lab DNA Damage Response, Beijing 100048, Peoples R China; [Tian, Jie; Geng, Qizhi; Liao, Ji; Xu, Xingzhi; Li, Jing] Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China; [Ding, Yuehe; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Capital Normal University; Capital Normal University; National Institute of Biological Sciences, Beijing	Xu, XZ; Li, J (corresponding author), Capital Normal Univ, Beijing Key Lab DNA Damage Response, Beijing 100048, Peoples R China.; Xu, XZ; Li, J (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China.	xingzhi_xu@cnu.edu.cn; jing_li@cnu.edu.cn	Tian, Jie/AAN-7225-2021; ding, yuehe/AAZ-6994-2021; Li, Jing/C-2031-2013; Xu, Xingzhi/E-8158-2012	Tian, Jie/0000-0003-3926-820X; Li, Jing/0000-0002-3977-1641; Xu, Xingzhi/0000-0002-4459-2082	NSFC (National Science Foundation of China) [31271446]; NSFC [31461143012, 31130017]; 973 projects [2013CB911002, 2015CB910601]; Young Talent Development Plan in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality [CITTCD201404158]; Beijing Nova Program Interdisciplinary Cooperation Project [XXJC201614]	NSFC (National Science Foundation of China)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); 973 projects(National Basic Research Program of China); Young Talent Development Plan in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality; Beijing Nova Program Interdisciplinary Cooperation Project	This work was supported by NSFC (National Science Foundation of China) fund (31271446; to J. Liao). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by NSFC funds (31461143012 and 31130017), the 973 projects 2013CB911002 and 2015CB910601. To whom correspondence may be addressed: Beijing Key Laboratory of DNA Damage Response and College of Life Sciences, Capital Normal University, Beijing 100048, China. Tel.: 86-10-68901692; Fax: 86-10-68906307; E-mail: xingzhi_xu@cnu.edu.cn.r Supported by Young Talent Development Plan in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality (CIT&TCD201404158) and Beijing Nova Program Interdisciplinary Cooperation Project (XXJC201614). To whom correspondence may be addressed: Beijing Key Laboratory of DNA Damage Response and College of Life Sciences, Capital Normal University, Beijing 100048, China. Tel.: 86-10-68901692; Fax: 86-10-68906307; E-mail: jing_li@cnu.edu.cn	Almeida A, 2005, J NEUROSCI, V25, P8115, DOI 10.1523/JNEUROSCI.1143-05.2005; Almeida A, 2012, MOL NEUROBIOL, V46, P547, DOI 10.1007/s12035-012-8309-2; Benmaamar R, 2005, CELL CYCLE, V4, P1230, DOI 10.4161/cc.4.9.2048; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Dehennaut V, 2007, J BIOL CHEM, V282, P12527, DOI 10.1074/jbc.M700444200; Delgado-Esteban M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3879; Drougat L, 2012, BBA-GEN SUBJECTS, V1820, P1839, DOI 10.1016/j.bbagen.2012.08.024; Fardini Y, 2015, BIOCHEM BIOPH RES CO, V462, P151, DOI 10.1016/j.bbrc.2015.04.114; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Fukushima H, 2013, CELL REP, V4, P803, DOI 10.1016/j.celrep.2013.07.031; Hahne H, 2012, MOL CELL PROTEOMICS, V11, P843, DOI 10.1074/mcp.M112.019463; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; HOLT GD, 1986, J BIOL CHEM, V261, P8049; Janetzko J, 2014, J BIOL CHEM, V289, P34424, DOI 10.1074/jbc.R114.604405; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Pathak S, 2015, NAT STRUCT MOL BIOL, V22, P744, DOI 10.1038/nsmb.3063; Puram SV, 2011, SEMIN CELL DEV BIOL, V22, P586, DOI 10.1016/j.semcdb.2011.03.006; Ramakrishnan P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004097; Sivakumar S, 2015, NAT REV MOL CELL BIO, V16, P82, DOI 10.1038/nrm3934; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tan EP, 2013, J BIOL CHEM, V288, P27085, DOI 10.1074/jbc.M113.470187; Tang Zhanyun, 2004, Methods Mol Biol, V281, P227; TORRES CR, 1984, J BIOL CHEM, V259, P3308; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; de Tudela MVP, 2015, SCI REP-UK, V5, DOI 10.1038/srep18180; Wan Y, 2001, P NATL ACAD SCI USA, V98, P13066, DOI 10.1073/pnas.231487598; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Zhao P, 2011, J PROTEOME RES, V10, P4088, DOI 10.1021/pr2002726; Zhu YP, 2014, J BIOL CHEM, V289, P34472, DOI 10.1074/jbc.R114.601351	41	8	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12136	12144		10.1074/jbc.M116.717850	http://dx.doi.org/10.1074/jbc.M116.717850			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27080259	Green Published, hybrid			2022-12-28	WOS:000378092800016
J	Iwanowycz, S; Wang, JF; Altomare, D; Hui, Y; Fan, DP				Iwanowycz, Stephen; Wang, Junfeng; Altomare, Diego; Hui, Yvonne; Fan, Daping			Emodin Bidirectionally Modulates Macrophage Polarization and Epigenetically Regulates Macrophage Memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INFLAMMATORY RESPONSE; MOLECULAR-MECHANISM; TRAINED IMMUNITY; RAT MODEL; ACTIVATION; GAMMA; MONOCYTE; EXPRESSION; PROTEIN	Macrophages are pleiotropic cells capable of performing a broad spectrum of functions. Macrophage phenotypes are classified along a continuum between the extremes of proinflammatory M1 macrophages and anti-inflammatory M2 macrophages. The seemingly opposing functions of M1 and M2 macrophages must be tightly regulated for an effective and proper response to foreign molecules or damaged tissue. Excessive activation of either M1 or M2 macrophages contributes to the pathology of many diseases. Emodin is a Chinese herb-derived compound and has shown potential to inhibit inflammation in various settings. In this study, we tested the ability of emodin to modulate the macrophage response to both M1 and M2 stimuli. Primary mouse macrophages were stimulated with LPS/IFN gamma or IL4 with or without emodin, and the effects of emodin on gene transcription, cell signaling pathways, and histone modifications were examined by a variety of approaches, including microarray, quantitative real-time PCR, Western blotting, chromatin immunoprecipitation, and functional assays. We found that emodin bidirectionally tunes the induction of LPS/IFN gamma- and IL4-responsive genes through inhibiting NF kappa B/IRF5/STAT1 signaling and IRF4/STAT6 signaling, respectively. Thereby, emodin modulates macrophage phagocytosis, migration, and NO production. Furthermore, emodin inhibited the removal of H3K27 trimethylation (H3K27m3) marks and the addition of H3K27 acetylation (H3K27ac) marks on genes required for M1 or M2 polarization of macrophages. In conclusion, our data suggest that emodin is uniquely able to suppress the excessive response of macrophages to both M1 and M2 stimuli and therefore has the potential to restore macrophage homeostasis in various pathologies.	[Iwanowycz, Stephen; Wang, Junfeng; Hui, Yvonne; Fan, Daping] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, 6439 Garners Ferry Rd,Bldg 1,C36, Columbia, SC 29209 USA; [Altomare, Diego] Univ S Carolina, South Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Fan, DP (corresponding author), Univ S Carolina, Sch Med, Dept Cell Biol & Anat, 6439 Garners Ferry Rd,Bldg 1,C36, Columbia, SC 29209 USA.	daping.fan@uscmed.sc.edu	Wang, Junfeng/AAJ-3248-2020		National Institutes of Health [HL116626, AT003961-8455]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL116626 and AT003961-8455. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chang Y-C, 2011, EVID-BASED COMPL ALT, V2011; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chu X, 2012, FOOD CHEM TOXICOL, V50, P2368, DOI 10.1016/j.fct.2012.03.076; Deng H, 2013, J BIOL CHEM, V288, P3897, DOI 10.1074/jbc.M112.424390; El Chartouni C, 2010, IMMUNOBIOLOGY, V215, P821, DOI 10.1016/j.imbio.2010.05.031; Fu X, 2014, CLIN EXP PHARMACOL P, V41, P679, DOI 10.1111/1440-1681.12262; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gupta SC, 2014, ARCH BIOCHEM BIOPHYS, V559, P91, DOI 10.1016/j.abb.2014.06.006; Hermansson C, 2014, INT IMMUNOPHARMACOL, V22, P318, DOI 10.1016/j.intimp.2014.07.009; Ifrim DC, 2014, CLIN VACCINE IMMUNOL, V21, P534, DOI 10.1128/CVI.00688-13; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Jia XM, 2014, BREAST CANCER RES TR, V148, P291, DOI 10.1007/s10549-014-3164-7; Jia XM, 2014, EXP BIOL MED, V239, P1025, DOI 10.1177/1535370214530247; Karsdal MA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3280; Komohara Y, 2014, CANCER SCI, V105, P1, DOI 10.1111/cas.12314; Kundu JK, 2008, MUTAT RES-REV MUTAT, V659, P15, DOI 10.1016/j.mrrev.2008.03.002; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Le KA, 2011, DIABETES, V60, P2802, DOI 10.2337/db10-1263; Li Y, 2015, IRAN J KIDNEY DIS, V9, P202; Liang QL, 2011, J BIOL CHEM, V286, P26470, DOI 10.1074/jbc.M111.227934; Lin SZ, 2010, CLIN EXP PHARMACOL P, V37, P790, DOI 10.1111/j.1440-1681.2010.05378.x; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Moberas J, 2009, EUR J IMMUNOL, V39, P691, DOI 10.1002/eji.200939262; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Muto A, 2007, MOL CANCER THER, V6, P987, DOI 10.1158/1535-7163.MCT-06-0605; Nahrendorf M, 2013, CIRC RES, V112, P1624, DOI 10.1161/CIRCRESAHA.113.300890; National Toxicology Program, 2001, Natl Toxicol Program Tech Rep Ser, V493, P1; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Ni QQ, 2014, BIOMED REP, V2, P63, DOI 10.3892/br.2013.178; Ni QQ, 2014, MOL MED REP, V9, P355, DOI 10.3892/mmr.2013.1771; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Sandholt IS, 2009, ANTI-CANCER DRUG, V20, P238, DOI 10.1097/CAD.0b013e328326472e; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Shechter R, 2013, J PATHOL, V229, P332, DOI 10.1002/path.4106; Shehzad A, 2013, BIOFACTORS, V39, P69, DOI 10.1002/biof.1066; Shia CS, 2011, J ETHNOPHARMACOL, V137, P1388, DOI 10.1016/j.jep.2011.08.003; Shrimali D, 2013, CANCER LETT, V341, P139, DOI 10.1016/j.canlet.2013.08.023; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Srinivas G, 2007, MED RES REV, V27, P591, DOI 10.1002/med.20095; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tomar S, 2016, HEAD NECK-J SCI SPEC, V38, pE694, DOI 10.1002/hed.24072; Tong HF, 2011, ANAT REC, V294, P445, DOI 10.1002/ar.21352; Wang B, 2015, J MATER CHEM B, V3, P3840, DOI 10.1039/c5tb00065c; Wang QX, 2011, INT IMMUNOPHARMACOL, V11, P373, DOI 10.1016/j.intimp.2010.11.018; Wang T, 2015, CHIN J INTEGR MED, V21, P431, DOI 10.1007/s11655-014-1898-z; Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644; Wicks K, 2014, SEMIN IMMUNOL, V26, P341, DOI 10.1016/j.smim.2014.04.006; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xaus J, 1999, IMMUNITY, V11, P103, DOI 10.1016/S1074-7613(00)80085-0; Xiao M, 2014, INT J MOL SCI, V15, P19355, DOI 10.3390/ijms151119355; Xue JH, 2015, CELL PHYSIOL BIOCHEM, V35, P1557, DOI 10.1159/000373971; Xue J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8158; Yang ZT, 2014, INT IMMUNOPHARMACOL, V21, P354, DOI 10.1016/j.intimp.2014.05.019; Zheng Y, 2011, BLOOD, V118, P156, DOI 10.1182/blood-2010-01-266320; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	62	42	48	6	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11491	11503		10.1074/jbc.M115.702092	http://dx.doi.org/10.1074/jbc.M115.702092			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27008857	Green Published, hybrid			2022-12-28	WOS:000377264800003
J	Tanui, R; Tao, Z; Silverstein, N; Kanner, B; Grewer, C				Tanui, Rose; Tao, Zhen; Silverstein, Nechama; Kanner, Baruch; Grewer, Christof			Electrogenic Steps Associated with Substrate Binding to the Neuronal Glutamate Transporter EAAC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR GATE; NA+ BINDING; KINETICS; MECHANISM; AFFINITY; DYNAMICS; GLT-1; ELECTROSTATICS; TRANSLOCATION; DIRECTION	Glutamate transporters actively take up glutamate into the cell, driven by the co-transport of sodium ions down their transmembrane concentration gradient. It was proposed that glutamate binds to its binding site and is subsequently transported across the membrane in the negatively charged form. With the glutamate binding site being located partially within the membrane domain, the possibility has to be considered that glutamate binding is dependent on the transmembrane potential and, thus, is electrogenic. Experiments presented in this report test this possibility. Rapid application of glutamate to the wildtype glutamate transporter subtype EAAC1 (excitatory amino acid carrier 1) through photo-release from caged glutamate generated a transient inward current, as expected for the electrogenic inward movement of co-transported Na+. In contrast, glutamate application to a transporter with the mutation A334E induced transient outward current, consistent with movement of negatively charged glutamate into its binding site within the dielectric of the membrane. These results are in agreement with electrostatic calculations, predicting a valence for glutamate binding of -0.27. Control experiments further validate and rule out other possible explanations for the transient outward current. Electrogenic glutamate binding can be isolated in the mutant glutamate transporter because reactions, such as glutamate translocation and/or Na+ binding to the glutamate-bound state, are inhibited by the A334E substitution. Electrogenic glutamate binding has to be considered together with other voltage-dependent partial reactions to cooperatively determine the voltage dependence of steady-state glutamate uptake and glutamate buffering at the synapse.	[Tanui, Rose; Tao, Zhen; Grewer, Christof] SUNY Binghamton, Dept Chem, 4400 Vestal Pkwy E, Binghamton, NY 13902 USA; [Silverstein, Nechama; Kanner, Baruch] Hebrew Univ Jerusalem, Canada Fac Med, Inst Med Res Israel, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel; [Tao, Zhen] 14323 Woodcrest Dr, Rockville, MD 29853 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Hebrew University of Jerusalem	Grewer, C (corresponding author), SUNY Binghamton, Dept Chem, 4400 Vestal Pkwy E, Binghamton, NY 13902 USA.	cgrewer@binghamton.edu		TANUI, ROSE/0000-0001-6594-1854	National Science Foundation [1515028]; Binational Science Foundation (BSF) [2007051]	National Science Foundation(National Science Foundation (NSF)); Binational Science Foundation (BSF)(US-Israel Binational Science Foundation)	This work was supported by National Science Foundation Grant 1515028 (to C. G.) and Binational Science Foundation (BSF) Grant 2007051 (to C. G. and B. I. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bastug T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033058; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Bergles DE, 2002, J NEUROSCI, V22, P10153; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Callenberg KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012722; Cater RJ, 2014, BIOPHYS J, V107, P621, DOI 10.1016/j.bpj.2014.05.046; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Diamond JS, 1997, J NEUROSCI, V17, P4672; Forster IC, 2002, PROG BIOPHYS MOL BIO, V80, P69, DOI 10.1016/S0079-6107(02)00015-9; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Grewer C, 2000, BIOCHEMISTRY-US, V39, P2063, DOI 10.1021/bi9919652; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 1999, BIOPHYS J, V77, P727, DOI 10.1016/S0006-3495(99)76927-4; Grewer C, 2008, IUBMB LIFE, V60, P609, DOI 10.1002/iub.98; Grewer C, 2014, BIOPHYS J, V107, P546, DOI 10.1016/j.bpj.2014.06.027; Grewer C, 2012, J BIOL CHEM, V287, P26921, DOI 10.1074/jbc.M112.364059; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Holmes WR, 1995, BIOPHYS J, V69, P1734, DOI 10.1016/S0006-3495(95)80043-3; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Li Y, 2015, J BIOL CHEM, V290, P31069, DOI 10.1074/jbc.M115.688275; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Lu CC, 1999, J GEN PHYSIOL, V114, P445, DOI 10.1085/jgp.114.3.445; Machtens JP, 2015, CELL, V160, P542, DOI 10.1016/j.cell.2014.12.035; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maier W, 2005, J NEUROSCI METH, V142, P1, DOI 10.1016/j.jneumeth.2004.07.006; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Mim C, 2007, BIOCHEMISTRY-US, V46, P9007, DOI 10.1021/bi7005465; Mwaura J, 2012, ACS CHEM NEUROSCI, V3, P1073, DOI 10.1021/cn300163p; Otis TS, 2000, J NEUROSCI, V20, P2749; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2010, J NEUROCHEM, V114, P565, DOI 10.1111/j.1471-4159.2010.06796.x; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; Shabaneh M, 2014, J BIOL CHEM, V289, P11175, DOI 10.1074/jbc.M114.550277; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Silva JR, 2009, P NATL ACAD SCI USA, V106, P11102, DOI 10.1073/pnas.0904505106; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2000, J GEN PHYSIOL, V116, P609, DOI 10.1085/jgp.116.5.609; Watzke N, 2001, FEBS LETT, V503, P121, DOI 10.1016/S0014-5793(01)02715-6; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zerangue N, 1996, J PHYSIOL-LONDON, V493, P419, DOI 10.1113/jphysiol.1996.sp021393; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104; Zhang Z, 2007, BIOCHEMISTRY-US, V46, P3872, DOI 10.1021/bi0620860	60	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11852	11864		10.1074/jbc.M116.722470	http://dx.doi.org/10.1074/jbc.M116.722470			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27044739	Green Published, hybrid			2022-12-28	WOS:000377264800034
J	Murata, K; Ishida, J; Ishimaru, T; Mizukami, H; Hamada, J; Saito, C; Fukamizu, A				Murata, Kazuya; Ishida, Junji; Ishimaru, Tomohiro; Mizukami, Hayase; Hamada, Juri; Saito, Chiaki; Fukamizu, Akiyoshi			Lactation Is a Risk Factor of Postpartum Heart Failure in Mice with Cardiomyocyte-specific Apelin Receptor (APJ) Overexpression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiac hypertrophy; cardiomyopathy; G protein-coupled receptor (GPCR); heart; heart failure; pregnancy; APJ; lactation	PERIPARTUM CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; TRANSGENIC MICE; PREGNANCY; SYSTEM; GENE; CONTRACTILITY; HOMEOSTASIS; MUTATIONS	The G protein-coupled receptor APJ and its ligand apelin are highly expressed in cardiovascular tissues and are associated with the regulation of blood pressure and cardiac function. Although accumulating evidence suggests that APJ plays a crucial role in the heart, it remains unclear whether up-regulation of APJ affects cardiac function. Here we generated cardiomyocyte-specific APJ-overexpressing (APJ-TG) mice and investigated the cardiac phenotype in APJ-TG mice. Male and non-pregnant APJ-TG mice showed cardiac hypertrophy, contractile dysfunction, and elevation of B-type natriuretic peptide gene expression in the heart but not cardiac fibrosis and symptoms of heart failure, including breathing abnormality and pleural effusion. We further examined the influence of APJ overexpression in response to physiological stress induced by pregnancy and lactation in the heart. Interestingly, repeating pregnancy and lactation (pregnancy-lactation cycle) exacerbated cardiac hypertrophy and systolic dysfunction and induced cardiac fibrosis, lung congestion, pleural effusion, and abnormal breathing in APJ-TG mice. These data indicate that female APJ-TG mice develop postpartum cardiomyopathy. We showed that lactation, but not parturition, was critical for the onset of postpartum cardiomyopathy in APJ-TG mice. Furthermore, we found that lactating APJ-TG mice showed impaired myocardial angiogenesis and imbalance of pro- and antiangiogenic gene expression in the heart. These results demonstrate that overexpression of APJ in cardiomyocytes has adverse effects on cardiac function in male and non-pregnant mice and that lactation contributes to the development of postpartum cardiomyopathy in the heart with APJ overexpression.	[Murata, Kazuya; Ishida, Junji; Hamada, Juri; Fukamizu, Akiyoshi] Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, 1-1-1 Ten-noudai, Tsukuba, Ibaraki 3058577, Japan; [Ishida, Junji; Ishimaru, Tomohiro; Mizukami, Hayase; Saito, Chiaki; Fukamizu, Akiyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Ten-noudai, Tsukuba, Ibaraki 3058577, Japan	University of Tsukuba; University of Tsukuba	Fukamizu, A (corresponding author), Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, 1-1-1 Ten-noudai, Tsukuba, Ibaraki 3058577, Japan.	akif@tara.tsukuba.ac.jp	Murata, Kazuya/GLR-2334-2022	Murata, Kazuya/0000-0002-3328-069X	Japan Society for the Promotion of Science KAKENHI [23300152]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science KAKENHI Grant 23300152. The authors declare that they have no conflicts of interest with the contents of this article.	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Charo DN, 2009, AM J PHYSIOL-HEART C, V297, pH1904, DOI 10.1152/ajpheart.00686.2009; Chung E, 2014, CARDIOVASC RES, V101, P561, DOI 10.1093/cvr/cvu013; DEMAKIS JG, 1971, CIRCULATION, V44, P964, DOI 10.1161/01.CIR.44.5.964; Diwan A, 2008, CIRCULATION, V117, P396, DOI 10.1161/CIRCULATIONAHA.107.727073; Elkayam U, 2005, CIRCULATION, V111, P2050, DOI 10.1161/01.CIR.0000162478.36652.7E; Eyries M, 2008, CIRC RES, V103, P432, DOI 10.1161/CIRCRESAHA.108.179333; Hamada J, 2008, INT J MOL MED, V22, P547, DOI 10.3892/ijmm_00000054; Hamada J, 2015, AM J PHYSIOL-HEART C, V308, pH931, DOI 10.1152/ajpheart.00703.2013; HANWELL A, 1973, J PHYSIOL-LONDON, V233, P93, DOI 10.1113/jphysiol.1973.sp010299; Hata J, 2007, HUM MOL GENET, V16, P630, DOI 10.1093/hmg/ddm005; Hayakawa Y, 2003, CIRCULATION, V108, P3036, DOI 10.1161/01.CIR.0000101920.72665.58; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; Hilfiker-Kleiner D, 2015, EUR HEART J, V36, P1090, DOI 10.1093/eurheartj/ehv009; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; Japp AG, 2008, BIOCHEM PHARMACOL, V75, P1882, DOI 10.1016/j.bcp.2007.12.015; Kamiya CA, 2011, CIRC J, V75, P1975, DOI 10.1253/circj.CJ-10-1214; Kaptein A, 1996, J BIOL CHEM, V271, P5961, DOI 10.1074/jbc.271.11.5961; Kishimoto I, 2009, CURR CARDIOL REV, V5, P45, DOI 10.2174/157340309787048068; Kleinz MJ, 2008, REGUL PEPTIDES, V146, P271, DOI 10.1016/j.regpep.2007.10.002; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Kunduzova O, 2008, FASEB J, V22, P4146, DOI 10.1096/fj.07-104018; Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627; Li JY, 2012, AM J CARDIOVASC DIS, V2, P192; Malek MH, 2009, EXP PHYSIOL, V94, P749, DOI 10.1113/expphysiol.2008.045989; Mesa A, 1999, CIRCULATION, V99, P511, DOI 10.1161/01.CIR.99.4.511; Morales A, 2010, CIRCULATION, V121, P2176, DOI 10.1161/CIRCULATIONAHA.109.931220; Murata K, 2013, ENDOCRINOLOGY, V154, P597, DOI 10.1210/en.2012-1789; Ntusi NBA, 2009, INT J CARDIOL, V131, P168, DOI 10.1016/j.ijcard.2008.06.054; O'Carroll AM, 2013, J ENDOCRINOL, V219, pR13, DOI 10.1530/JOE-13-0227; Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040; Poole AT, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.004; Ricke-Hoch M, 2014, CARDIOVASC RES, V101, P587, DOI 10.1093/cvr/cvu010; Roos KP, 2007, J CARD FAIL, V13, P318, DOI 10.1016/j.cardfail.2007.01.004; Safirstein JG, 2012, INT J CARDIOL, V154, P27, DOI 10.1016/j.ijcard.2010.08.065; SAKANASHI TM, 1987, J NUTR, V117, P1469, DOI 10.1093/jn/117.8.1469; Schwarz EB, 2009, OBSTET GYNECOL, V113, P974, DOI 10.1097/01.AOG.0000346884.67796.ca; Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263; Sliwa K, 2006, LANCET, V368, P687, DOI 10.1016/S0140-6736(06)69253-2; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; van Spaendonck-Zwarts KY, 2014, EUR HEART J, V35, P2165, DOI 10.1093/eurheartj/ehu050; van Spaendonck-Zwarts KY, 2010, CIRCULATION, V121, P2169, DOI 10.1161/CIRCULATIONAHA.109.929646; Wang X, 1998, AM J PHYSIOL-ENDOC M, V275, pE265, DOI 10.1152/ajpendo.1998.275.2.E265; Xu L, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-13; Yue P, 2011, ENDOCRINOLOGY, V152, P59, DOI 10.1210/en.2010-0576	48	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11241	11251		10.1074/jbc.M115.699009	http://dx.doi.org/10.1074/jbc.M115.699009			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27033703	hybrid, Green Published			2022-12-28	WOS:000377042100025
J	Zhang, M; Hu, C; Tong, D; Xiang, SY; Williams, K; Bai, WL; Li, GM; Bepler, G; Zhang, XH				Zhang, Mu; Hu, Chen; Tong, Dan; Xiang, Shengyan; Williams, Kendra; Bai, Wenlong; Li, Guo-Min; Bepler, Gerold; Zhang, Xiaohong			Ubiquitin-specific Peptidase 10 (USP10) Deubiquitinates and Stabilizes MutS Homolog 2 (MSH2) to Regulate Cellular Sensitivity to DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY EPITHELIAL-CELLS; HUMAN MISMATCH REPAIR; EXPRESSION; ALPHA; P53; ENDOCYTOSIS; MECHANISMS; ENZYMES; CANCER; HMSH2	MSH2 is a key DNA mismatch repair protein, which plays an important role in genomic stability. In addition to its DNA repair function, MSH2 serves as a sensor for DNA base analogs-provoked DNA replication errors and binds to various DNA damage-induced adducts to trigger cell cycle arrest or apoptosis. Loss or depletion of MSH2 from cells renders resistance to certain DNA-damaging agents. Therefore, the level of MSH2 determines DNA damage response. Previous studies showed that the level of MSH2 protein is modulated by the ubiquitin-proteasome pathway, and histone deacetylase 6 (HDAC6) serves as an ubiquitin E3 ligase. However, the deubiquitinating enzymes, which regulate MSH2 remain unknown. Here we report that ubiquitin-specific peptidase 10 (USP10) interacts with and stabilizes MSH2. USP10 deubiquitinates MSH2 in vitro and in vivo. Moreover, the protein level of MSH2 is positively correlated with the USP10 protein level in a panel of lung cancer cell lines. Knockdown of USP10 in lung cancer cells exhibits increased cell survival and decreased apoptosis upon the treatment of DNA-methylating agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and antimetabolite 6-thioguanine (6-TG). The above phenotypes can be rescued by ectopic expression of MSH2. In addition, knockdown of MSH2 decreases the cellular mismatch repair activity. Overall, our results suggest a novel USP10-MSH2 pathway regulating DNA damage response and DNA mismatch repair.	[Zhang, Mu; Hu, Chen; Xiang, Shengyan; Williams, Kendra; Bai, Wenlong; Zhang, Xiaohong] Morsani Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Tong, Dan; Li, Guo-Min] Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA; [Bai, Wenlong; Zhang, Xiaohong] H Lee Moffitt Canc Ctr & Res Inst, Canc Biol & Evolut Program, Tampa, FL 33612 USA; [Bepler, Gerold] Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48201 USA; [Li, Guo-Min] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA	University of Kentucky; H Lee Moffitt Cancer Center & Research Institute; Barbara Ann Karmanos Cancer Institute; University of Southern California	Zhang, XH (corresponding author), Karmanos Canc Inst, 4100 John R St, Detroit, MI 48201 USA.	zhangx@karmanos.org	Bai, Wenlong/A-8977-2013; XIANG, SHENGYAN/C-3176-2013	Bai, Wenlong/0000-0002-9536-0556; XIANG, SHENGYAN/0000-0002-6940-3559; Li, Guo-Min/0000-0002-9842-4578	National Institutes of Health [R01CA164147]; Florida James and Esther King Biomedical Program [09KN-17]; Liz Tilberis award from Ovarian Cancer Research Fund; Karmanos Cancer Institute start-up funds; NATIONAL CANCER INSTITUTE [R01CA164147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida James and Esther King Biomedical Program; Liz Tilberis award from Ovarian Cancer Research Fund; Karmanos Cancer Institute start-up funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant R01CA164147, a New Investigator Grant 09KN-17 from Florida James and Esther King Biomedical Program, a Liz Tilberis award from Ovarian Cancer Research Fund, and the Karmanos Cancer Institute start-up funds (to X. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bepler G, 2013, J CLIN ONCOL, V31, P2404, DOI 10.1200/JCO.2012.46.9783; Bomberger JM, 2010, CHANNELS, V4, P150, DOI 10.4161/chan.4.3.11223; Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Draker R, 2011, NUCLEIC ACIDS RES, V39, P3529, DOI 10.1093/nar/gkq1352; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Fink D, 1998, CLIN CANCER RES, V4, P1; Fu W, 2009, J BIOL CHEM, V284, P13987, DOI 10.1074/jbc.M901758200; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Humbert O, 2003, NUCLEIC ACIDS RES, V31, P5627, DOI 10.1093/nar/gkg781; Humbert O, 2002, J BIOL CHEM, V277, P18061, DOI 10.1074/jbc.M103451200; Jochemsen AG, 2010, CELL, V140, P308, DOI 10.1016/j.cell.2010.01.034; KOLODNER RD, 1995, TRENDS BIOCHEM SCI, V20, P397, DOI 10.1016/S0968-0004(00)89087-8; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Scherer SJ, 2000, J BIOL CHEM, V275, P37469, DOI 10.1074/jbc.M006990200; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Tong D, 2015, J BIOL CHEM, V290, P14536, DOI 10.1074/jbc.M115.641399; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zhang M, 2014, MOL CELL, V55, P31, DOI 10.1016/j.molcel.2014.04.028; Zhang Y, 2009, ONCOGENE, V28, P445, DOI 10.1038/onc.2008.388; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	28	30	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10783	10791		10.1074/jbc.M115.700047	http://dx.doi.org/10.1074/jbc.M115.700047			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26975374	hybrid, Green Published			2022-12-28	WOS:000377042600029
J	Tabrizi, ST; Sawicki, A; Zhou, SX; Luo, MZ; Willows, RD				Tabrizi, Shabnam Tarahi; Sawicki, Artur; Zhou, Shuaixiang; Luo, Meizhong; Willows, Robert D.			GUN4-Protoporphyrin IX Is a Singlet Oxygen Generator with Consequences for Plastid Retrograde Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MG-PROTOPORPHYRIN IX; BIOCHEMICAL-CHARACTERIZATION; CHLOROPHYLL BIOSYNTHESIS; MAGNESIUM CHELATASE; GENE-EXPRESSION; PHOTOSYSTEM-II; QUANTUM YIELD; GUN4 PROTEIN; CHLOROPLAST; NUCLEUS	The genomes uncoupled 4 (GUN4) protein is a nuclear-encoded, chloroplast-localized, porphyrin-binding protein implicated in retrograde signaling between the chloroplast and nucleus, although its exact role in this process is still unclear. Functionally, it enhances Mg-chelatase activity in the chlorophyll biosynthesis pathway. Because GUN4 is present only in organisms that carry out oxygenic photosynthesis and because it binds protoporphyrin IX (PPIX) and Mg-PPIX, it has been suggested that it prevents production of light-and PPIX-or Mg-PPIX-dependent reactive oxygen species. A chld-1/GUN4 mutant with elevated PPIX has a light-dependent up-regulation of GUN4, implicating this protein in light-dependent sensing of PPIX, with the suggestion that GUN4 reduces PPIX-generated singlet oxygen, O-2(a(1)Delta(g)), and subsequent oxidative damage (Brzezowski, P., Schlicke, H., Richter, A., Dent, R. M., Niyogi, K. K., and Grimm, B. (2014) Plant J. 79, 285-298). In direct contrast, our results show that purified GUN4 and oxidatively damaged ChlH increase the rate of PPIX-generated singlet oxygen production in the light, by a factor of 5 and 10, respectively, when compared with PPIX alone. Additionally, the functional GUN4-PPIX-ChlH complex and ChlH-PPIX complexes generate O-2(a(1)Delta(g)) at a reduced rate when compared with GUN4-PPIX. As O-2(a(1)Delta(g)) is a potential plastid-to-nucleus signal, possibly through second messengers, light-dependent O-2(a(1)Delta(g)) generation by GUN4-PPIX is proposed to be part of a signal transduction pathway from the chloroplast to the nucleus. GUN4 thus senses the availability and flux of PPIX through the chlorophyll biosynthetic pathway and also modulates Mg-chelatase activity. The light-dependent O-2(a(1)Delta(g)) generation from GUN4-PPIX is thus proposed as the first step in retrograde signaling from the chloroplast to the nucleus.	[Tabrizi, Shabnam Tarahi; Willows, Robert D.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Sawicki, Artur] Jagiellonian Univ, Dept Biophys, Gronostajowa 7, PL-30387 Krakow, Poland; [Zhou, Shuaixiang; Luo, Meizhong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China	Macquarie University; Jagiellonian University; Huazhong Agricultural University	Willows, RD (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	robert.willows@mq.edu.au	Willows, Robert/C-1537-2010; Sawicki, Artur/G-7984-2016	Willows, Robert/0000-0002-0731-2950; Sawicki, Artur/0000-0001-6187-042X; Sawicki, Artur/0000-0002-1469-0845	National Natural Science Foundation of China [30971748]; Macquarie University Safety Net Scheme grant; MQRES scholarship from Macquarie University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Macquarie University Safety Net Scheme grant; MQRES scholarship from Macquarie University	This work was supported by the National Natural Science Foundation of China (Grant No. 30971748) and by a Macquarie University Safety Net Scheme 2014 grant. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an MQRES scholarship from Macquarie University.	Adhikari ND, 2011, PLANT CELL, V23, P1449, DOI 10.1105/tpc.110.082503; Adhikari ND, 2009, J BIOL CHEM, V284, P24783, DOI 10.1074/jbc.M109.025205; Agon VV, 2006, FREE RADICAL BIO MED, V40, P698, DOI 10.1016/j.freeradbiomed.2005.09.039; Bosio GN, 2013, J AM CHEM SOC, V135, P272, DOI 10.1021/ja308930a; Brancaleon L, 2002, BIOPHYS CHEM, V96, P77, DOI 10.1016/S0301-4622(02)00035-2; Brzezowski P, 2014, PLANT J, V79, P285, DOI 10.1111/tpj.12560; Chen XM, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.125, 10.1038/NPLANTS.2015.125]; Chen XM, 2015, MOL PLANT, V8, P1125, DOI 10.1016/j.molp.2015.04.013; Davison PA, 2005, BIOCHEMISTRY-US, V44, P7603, DOI 10.1021/bi050240x; Dawson R.M.C., 1986, DATA BIOCH RES, P128; DAY DA, 1985, AUST J PLANT PHYSIOL, V12, P219, DOI 10.1071/PP9850219; DeRosa MC, 2002, COORDIN CHEM REV, V233, P351, DOI 10.1016/S0010-8545(02)00034-6; Duanmu D, 2013, P NATL ACAD SCI USA, V110, P3621, DOI 10.1073/pnas.1222375110; Flors C, 2006, J EXP BOT, V57, P1725, DOI 10.1093/jxb/erj181; Formighieri C, 2012, MOL PLANT, V5, P1242, DOI 10.1093/mp/sss051; Fuhrhop J., 1971, BIOCH PREPARATIONS, V13, P55; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Kuimova MK, 2009, J AM CHEM SOC, V131, P332, DOI 10.1021/ja807484b; Laloi C, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00039; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Lee KP, 2007, P NATL ACAD SCI USA, V104, P10270, DOI 10.1073/pnas.0702061104; Mendez-Hurtado J, 2012, CHEM-EUR J, V18, P8437, DOI 10.1002/chem.201103680; Meskauskiene R, 2001, P NATL ACAD SCI USA, V98, P12826, DOI 10.1073/pnas.221252798; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Moulin M, 2008, P NATL ACAD SCI USA, V105, P15178, DOI 10.1073/pnas.0803054105; Muller AH, 2014, PROTEIN EXPRES PURIF, V101, P61, DOI 10.1016/j.pep.2014.06.004; Ogilby PR, 2010, CHEM SOC REV, V39, P3181, DOI 10.1039/b926014p; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Peter E, 2009, MOL PLANT, V2, P1198, DOI 10.1093/mp/ssp072; Rehman AU, 2013, BBA-BIOENERGETICS, V1827, P689, DOI 10.1016/j.bbabio.2013.02.016; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Shapiguzov A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00292; Singh R, 2015, J PLANT PHYSIOL, V181, P55, DOI 10.1016/j.jplph.2015.04.001; Sobotka R, 2008, J BIOL CHEM, V283, P25794, DOI 10.1074/jbc.M803787200; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Szechynska-Hebda M, 2013, J PLANT PHYSIOL, V170, P1501, DOI 10.1016/j.jplph.2013.06.005; Tabrizi ST, 2015, ACTA CRYSTALLOGR F, V71, P1094, DOI 10.1107/S2053230X15012248; TELFER A, 1994, J BIOL CHEM, V269, P13244; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; Tripathy BC, 2007, BBA-BIOENERGETICS, V1767, P860, DOI 10.1016/j.bbabio.2007.03.008; Verdecia MA, 2005, PLOS BIOL, V3, P777, DOI 10.1371/journal.pbio.0030151; VERLHAC JB, 1984, NOUV J CHIM, V8, P401; Wagner D, 2004, SCIENCE, V306, P1183, DOI 10.1126/science.1103178; Woodson JD, 2011, CURR BIOL, V21, P897, DOI 10.1016/j.cub.2011.04.004; Zhou SX, 2012, FEBS LETT, V586, P205, DOI 10.1016/j.febslet.2011.12.026	46	28	28	5	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8978	8984		10.1074/jbc.C116.719989	http://dx.doi.org/10.1074/jbc.C116.719989			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26969164	hybrid, Green Published			2022-12-28	WOS:000374849000011
J	Rajan, MR; Nyman, E; Kjolhede, P; Cedersund, G; Stralfors, P				Rajan, Meenu Rohini; Nyman, Elin; Kjolhede, Preben; Cedersund, Gunnar; Stralfors, Peter			Systems-wide Experimental and Modeling Analysis of Insulin Signaling through Forkhead Box Protein O1 (FOXO1) in Human Adipocytes, Normally and in Type 2 Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; TRANSCRIPTION FACTOR; FAT-CELLS; DEPENDENT REGULATION; AKT PHOSPHORYLATION; ADIPOSE-TISSUE; OBESE-PATIENTS; RESISTANCE; RICTOR; DOWNSTREAM	Insulin resistance is a major aspect of type 2 diabetes (T2D), which results from impaired insulin signaling in target cells. Signaling to regulate forkhead box protein O1 (FOXO1) may be the most important mechanism for insulin to control transcription. Despite this, little is known about how insulin regulates FOXO1 and how FOXO1 may contribute to insulin resistance in adipocytes, which are the most critical cell type in the development of insulin resistance. We report a detailed mechanistic analysis of insulin control of FOXO1 in human adipocytes obtained from non-diabetic subjects and from patients with T2D. We show that FOXO1 is mainly phosphorylated through mTORC2-mediated phosphorylation of protein kinase B at Ser(473) and that this mechanism is unperturbed in T2D. We also demonstrate a cross-talk from the MAPK branch of insulin signaling to stimulate phosphorylation of FOXO1. The cellular abundance and consequently activity of FOXO1 are halved in T2D. Interestingly, inhibition of mTORC1 with rapamycin reduces the abundance of FOXO1 to the levels in T2D. This suggests that the reduction of the concentration of FOXO1 is a consequence of attenuation of mTORC1, which defines much of the diabetic state in human adipocytes. We integrate insulin control of FOXO1 in a network-wide mathematical model of insulin signaling dynamics based on compatible data from human adipocytes. The diabetic state is network-wide explained by attenuation of an mTORC1-to-insulin receptor substrate-1 (IRS1) feedback and reduced abundances of insulin receptor, GLUT4, AS160, ribosomal protein S6, and FOXO1. The model demonstrates that attenuation of the mTORC1-toIRS1 feedback is a major mechanism of insulin resistance in the diabetic state.	[Rajan, Meenu Rohini; Kjolhede, Preben; Cedersund, Gunnar; Stralfors, Peter] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden; [Nyman, Elin; Cedersund, Gunnar] Linkoping Univ, Dept Biomed Engn, SE-58185 Linkoping, Sweden; [Nyman, Elin] AstraZeneca Res & Dev, Cardiovasc & Metab Dis Innovat Med & Drug Metab &, S-43150 Gothenburg, Sweden	Linkoping University; Linkoping University; AstraZeneca	Stralfors, P (corresponding author), Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden.	peter.stralfors@liu.se	Nyman, Elin/I-3363-2019	Nyman, Elin/0000-0002-4261-0291; Stralfors, Peter/0000-0002-1196-1806	Swedish Diabetes Fund, University of Linkoping; Swedish Research Council; AstraZeneca	Swedish Diabetes Fund, University of Linkoping; Swedish Research Council(Swedish Research CouncilEuropean Commission); AstraZeneca(AstraZeneca)	This work was supported by a 3-year program at the Swedish Diabetes Fund, University of Linkoping, and a 5-year program at the Swedish Research Council. The salary for E. N. was paid through a grant from AstraZeneca.	Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Barbato DL, 2014, BBA-MOL CELL BIOL L, V1841, P1555, DOI 10.1016/j.bbalip.2014.08.004; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Brannmark C, 2010, J BIOL CHEM, V285, P20171, DOI 10.1074/jbc.M110.106849; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Danielsson A, 2005, J BIOL CHEM, V280, P34389, DOI 10.1074/jbc.C500230200; Danielsson A, 2005, FEBS J, V272, P141, DOI 10.1111/j.1432-1033.2004.04396.x; Danielsson A, 2009, MOL MED, V15, P228, DOI 10.2119/molmed.2009.00037; de Vries GJ, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0032-z; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Filteau M, 2015, P NATL ACAD SCI USA, V112, P4501, DOI 10.1073/pnas.1409938112; Franck N, 2007, DIABETOLOGIA, V50, P1716, DOI 10.1007/s00125-007-0713-1; Fu W, 2009, J BIOL CHEM, V284, P13987, DOI 10.1074/jbc.M901758200; Gonzalez E, 2011, P NATL ACAD SCI USA, V108, P10162, DOI 10.1073/pnas.1019268108; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kantidakis T, 2010, P NATL ACAD SCI USA, V107, P11823, DOI 10.1073/pnas.1005188107; Kim JJ, 2009, DIABETES, V58, P1275, DOI 10.2337/db08-1001; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Kondapaka SB, 2004, CLIN CANCER RES, V10, P7192, DOI 10.1158/1078-0432.CCR-04-0772; Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034; Laurencikiene J, 2011, J CLIN ENDOCR METAB, V96, pE2045, DOI 10.1210/jc.2011-1702; Lonn M, 2010, FASEB J, V24, P326, DOI 10.1096/fj.09-133058; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Nyman E, 2014, J BIOL CHEM, V289, P33215, DOI 10.1074/jbc.M114.608927; Nyman E, 2011, J BIOL CHEM, V286, P26028, DOI 10.1074/jbc.M110.188987; Ost A, 2010, MOL MED, V16, P235, DOI 10.2119/molmed.2010.00023; Pereira MJ, 2012, MOL CELL ENDOCRINOL, V355, P96, DOI 10.1016/j.mce.2012.01.024; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; SALANS LB, 1971, J CLIN INVEST, V50, P1399, DOI 10.1172/JCI106623; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Schmidt H, 2007, BIOINFORMATICS, V23, P646, DOI 10.1093/bioinformatics/btl668; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; STRALFORS P, 1989, EUR J BIOCHEM, V182, P379, DOI 10.1111/j.1432-1033.1989.tb14842.x; Tonks KT, 2013, DIABETOLOGIA, V56, P875, DOI 10.1007/s00125-012-2811-y; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Xu Y, 2014, EXP CLIN ENDOCR DIAB, V122, P287, DOI 10.1055/s-0034-1371830; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013	52	18	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15806	15819		10.1074/jbc.M116.715763	http://dx.doi.org/10.1074/jbc.M116.715763			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226562	Green Published, hybrid			2022-12-28	WOS:000380584200033
J	Chandra, G; Rangasamy, SB; Roy, A; Kordower, JH; Pahan, K				Chandra, Goutam; Rangasamy, Suresh B.; Roy, Avik; Kordower, Jeffrey H.; Pahan, Kalipada			Neutralization of RANTES and Eotaxin Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; PRIMED T-CELLS; NF-KAPPA-B; ACTIVATED RECEPTOR-ALPHA; MICROGLIAL CELLS; MULTIPLE-SCLEROSIS; UP-REGULATION; PROINFLAMMATORY CYTOKINES; CHRONIC NEURODEGENERATION; GENDER BIAS	Parkinson disease (PD) is second only to Alzheimer disease as the most common human neurodegenerative disorder, Despite intense investigation, no interdictive therapy is available for PD. Recent studies indicate that both innate and adaptive immune processes are active in PD. Accordingly, we found a rapid increase in RANTES (regulated on activation normal T cell expressed and secreted) and eotaxin, chemokines that are involved in T cell trafficking, in vivo in the substantia nigra pars compacta and the serum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated mice. RANTES and eotaxin were also up-regulated in the substantia nigra pars compacta of post-mortem PD brains as compared with age -matched controls. Therefore, we investigated whether neutralization of RANTES and eotaxin could protect against nigrostriatal degeneration in MPTP -intoxicated mice, Interestingly, after peripheral administration, functional blocking antibodies against RANTES and eotaxin reduced the infiltration of CD4+ and CDS+ T cells into the nigra, attenuated nigral expression of proinflammatory molecules, and suppressed nigral activation of glial cells. These findings paralleled dopaminergic neuronal protection, normalized striatal neurotransmitters, and improved motor functions in MPTP -intoxicated mice. Therefore, we conclude that attenuation of the chemokine-dependent adaptive immune response may be of therapeutic benefit for P1) patients.	[Chandra, Goutam; Rangasamy, Suresh B.; Roy, Avik; Kordower, Jeffrey H.; Pahan, Kalipada] Rush Univ, Dept Neurol Sci, Med Ctr, 1735 West Harrison St,Suite Cohn 320, Chicago, IL 60612 USA	Rush University	Pahan, K (corresponding author), Rush Univ, Dept Neurol Sci, Med Ctr, 1735 West Harrison St,Suite Cohn 320, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu			National Institutes of Health [NS083054, NS064564]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064564, R01NS083054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS083054 and NS064564. The authors do not have any conflict of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Benner EJ, 2004, P NATL ACAD SCI USA, V101, P9435, DOI 10.1073/pnas.0400569101; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; Brahmachari S, 2010, J IMMUNOL, V184, P6103, DOI 10.4049/jimmunol.0804356; Brahmachari S, 2009, J IMMUNOL, V183, P5917, DOI 10.4049/jimmunol.0803336; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Chabot S, 2001, J NEUROSCI METH, V105, P111, DOI 10.1016/S0165-0270(00)00346-0; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Dasgupta S, 2005, J BIOL CHEM, V280, P32609, DOI 10.1074/jbc.M500299200; Dasgupta S, 2003, J BIOL CHEM, V278, P22424, DOI 10.1074/jbc.M301789200; Dasgupta S, 2002, J BIOL CHEM, V277, P39327, DOI 10.1074/jbc.M111841200; Dasgupta S, 2007, MOL PHARMACOL, V72, P934, DOI 10.1124/mol.106.033787; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Field R, 2010, BRAIN BEHAV IMMUN, V24, P996, DOI 10.1016/j.bbi.2010.04.004; Gendelman HE, 2015, J NEUROIMMUNE PHARM, V10, P645, DOI 10.1007/s11481-015-9639-4; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; Hu SX, 1999, J LEUKOCYTE BIOL, V65, P815, DOI 10.1002/jlb.65.6.815; Jana M, 2002, J NEUROCHEM, V80, P197, DOI 10.1046/j.0022-3042.2001.00691.x; Jana M, 2001, J BIOL CHEM, V276, P44527, DOI 10.1074/jbc.M106771200; Jana M, 2007, J IMMUNOL, V179, P4142, DOI 10.4049/jimmunol.179.6.4142; Khasnavis S, 2014, J NEUROIMMUNE PHARM, V9, P569, DOI 10.1007/s11481-014-9552-2; Khasnavis S, 2014, J NEUROIMMUNE PHARM, V9, P218, DOI 10.1007/s11481-013-9503-3; Khasnavis S, 2012, J NEUROIMMUNE PHARM, V7, P424, DOI 10.1007/s11481-011-9286-3; Lee JK, 2011, J NEUROSCI, V31, P11879, DOI 10.1523/JNEUROSCI.1002-11.2011; Martin HL, 2016, GLIA, V64, P386, DOI 10.1002/glia.22935; Mondal S, 2012, J NEUROIMMUNE PHARM, V7, P544, DOI 10.1007/s11481-012-9377-9; Nitsch R, 2004, J NEUROSCI, V24, P2458, DOI 10.1523/JNEUROSCI.4703-03.2004; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Pahan P, 2015, NEURAL REGEN RES, V10, P30, DOI 10.4103/1673-5374.150647; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Reynolds AD, 2010, J IMMUNOL, V184, P2261, DOI 10.4049/jimmunol.0901852; Roy A, 2015, NEUROSCIENCE, V302, P36, DOI 10.1016/j.neuroscience.2015.03.011; Roy A, 2008, FREE RADICAL BIO MED, V45, P686, DOI 10.1016/j.freeradbiomed.2008.05.026; Roy A, 2006, J BIOL CHEM, V281, P14971, DOI 10.1074/jbc.M600236200; Roy A, 2015, CELL METAB, V22, P253, DOI 10.1016/j.cmet.2015.05.022; Roy A, 2013, CELL REP, V4, P724, DOI 10.1016/j.celrep.2013.07.028; Roy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038113; Roy A, 2011, NEUROSCIENTIST, V17, P244, DOI 10.1177/1073858410385006; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Wada T, 1999, NEPHROL DIAL TRANSPL, V14, P76, DOI 10.1093/ndt/14.1.76; Wei J, 2013, PARASITOL RES, V112, P207, DOI 10.1007/s00436-012-3127-z; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002	44	49	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15267	15281		10.1074/jbc.M116.714824	http://dx.doi.org/10.1074/jbc.M116.714824			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226559	Green Published, hybrid			2022-12-28	WOS:000380583200033
J	Rodrigo-Unzueta, A; Martinez, MA; Comino, N; Alzari, PM; Chenal, A; Guerin, ME				Rodrigo-Unzueta, Ane; Martinez, Mariano A.; Comino, Natalia; Alzari, Pedro M.; Chenal, Alexandre; Guerin, Marcelo E.			Molecular Basis of Membrane Association by the Phosphatidylinositol Mannosyltransferase PimA Enzyme from Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; glycolipid; glycosyltransferase; membrane enzyme; structure-function	PERTUSSIS CYAA TOXIN; DIPHTHERIA-TOXIN; ACHOLEPLASMA-LAIDLAWII; AMPHITROPIC PROTEINS; LIPID-MEMBRANE; CYTOCHROME-C; T-DOMAIN; TRANSLOCATION; INSERTION; BINDING	Phosphatidyl-myo-inositol mannosyltransferase A (PimA) is an essential glycosyltransferase that initiates the biosynthetic pathway of phosphatidyl-myo-inositol mannoside, lipomannan, and lipoarabinomannan, which are key glycolipids/lipoglycans of the mycobacterial cell envelope. PimA belongs to a large family of membrane-associated glycosyltransferases for which the understanding of the molecular mechanism and conformational changes that govern substrate/membrane recognition and catalysis remains a major challenge. Here, we determined that PimA preferentially binds to negatively charged phosphatidyl-myo-inositol substrate and non-substrate membrane model systems (small unilamellar vesicle) through its N-terminal domain, inducing an important structural reorganization of anionic phospholipids. By using a combination of single-point mutagenesis, circular dichroism, and a variety of fluorescence spectroscopy techniques, we determined that this interaction is mainly mediated by an amphipathic -helix (2), which undergoes a substantial conformational change and localizes in the vicinity of the negatively charged lipid headgroups and the very first carbon atoms of the acyl chains, at the PimA-phospholipid interface. Interestingly, a flexible region within the N-terminal domain, which undergoes -strand-to--helix and -helix-to--strand transitions during catalysis, interacts with anionic phospholipids; however, the effect is markedly less pronounced to that observed for the amphipathic 2, likely reflecting structural plasticity/variability. Altogether, we propose a model in which conformational transitions observed in PimA might reflect a molten globule state that confers to PimA, a higher affinity toward the dynamic and highly fluctuating lipid bilayer.	[Rodrigo-Unzueta, Ane; Comino, Natalia; Guerin, Marcelo E.] Univ Basque Country, CSIC, Unidad Biofis, Ctr Mixto, Barrio Sarriena S-N, Leioa 48940, Bizkaia, Spain; [Rodrigo-Unzueta, Ane; Comino, Natalia; Guerin, Marcelo E.] Univ Basque Country, Dept Bioquim, Leioa 48940, Vizcaya, Spain; [Martinez, Mariano A.; Alzari, Pedro M.] Inst Pasteur, CNRS, UMR 3528, Unite Microbiol Struct, 25 Rue Dr Roux, F-75724 Paris 15, France; [Martinez, Mariano A.; Alzari, Pedro M.] Univ Paris Diderot, Sorbonne Paris Cite, 25 Rue Dr Roux, F-75724 Paris 15, France; [Comino, Natalia; Guerin, Marcelo E.] Ctr Cooperat Res Biosci CIC BioGUNE, Struct Biol Unit, Bizkaia Technol Pk, Derio 48160, Spain; [Chenal, Alexandre] Unite Biochim Interact Macromol, 28 Rue Dr Roux, F-75724 Paris 15, France; [Chenal, Alexandre] CNRS, UMR 3528, 28 Rue Dr Roux, F-75724 Paris 15, France; [Guerin, Marcelo E.] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; CIC bioGUNE; Centre National de la Recherche Scientifique (CNRS); Basque Foundation for Science	Chenal, A (corresponding author), Unite Biochim Interact Macromol, 28 Rue Dr Roux, F-75724 Paris 15, France.; Chenal, A (corresponding author), CNRS, UMR 3528, 28 Rue Dr Roux, F-75724 Paris 15, France.; Guerin, ME (corresponding author), CIC BioGUNE, Struct Biol Unit, Bizkaia Technol Pk, Derio 48160, Spain.	alexandre.chenal@pasteur.fr; mrcguerin@cicbiogune.es	Guerin, Marcelo M/N-7245-2016; Chenal, Alexandre/C-2240-2009	Guerin, Marcelo M/0000-0001-9524-3184; Chenal, Alexandre/0000-0002-4959-1003; Comino, Natalia/0000-0001-8924-8819; Alzari, Pedro/0000-0002-4233-1903; Martinez, Mariano/0000-0003-4460-8045	European Commission [HEALTH-F3-2011-260872]; Spanish Ministry of Economy and Competitiveness [BIO2013-49022-C2-2-R]; Basque Government; Institut Pasteur	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Economy and Competitiveness(Spanish Government); Basque Government(Basque Government); Institut Pasteur(European Commission)	This work was supported by the European Commission Contract HEALTH-F3-2011-260872, the Spanish Ministry of Economy and Competitiveness Contract BIO2013-49022-C2-2-R, the Basque Government (to M. E. G.), and Institut Pasteur (to A. C. and P. M. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Albesa-Jove D, 2014, GLYCOBIOLOGY, V24, P108, DOI 10.1093/glycob/cwt101; Angala SK, 2014, CRIT REV BIOCHEM MOL, V49, P361, DOI 10.3109/10409238.2014.925420; Boldrin F, 2014, J BACTERIOL, V196, P3441, DOI 10.1128/JB.01346-13; Brodhun F, 2015, NAT CHEM BIOL, V11, P102, DOI 10.1038/nchembio.1738; BURN P, 1988, TRENDS BIOCHEM SCI, V13, P79, DOI 10.1016/0968-0004(88)90043-6; BYCHKOVA VE, 1988, FEBS LETT, V238, P231, DOI 10.1016/0014-5793(88)80485-X; Chenal A, 2002, J BIOL CHEM, V277, P43425, DOI 10.1074/jbc.M204148200; Chenal A, 2005, J MOL BIOL, V349, P890, DOI 10.1016/j.jmb.2005.04.036; Chenal A, 2009, J MOL BIOL, V391, P872, DOI 10.1016/j.jmb.2009.06.061; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; Ge CR, 2011, J BIOL CHEM, V286, P6669, DOI 10.1074/jbc.M110.138495; Giganti D, 2015, NAT CHEM BIOL, V11, P16, DOI 10.1038/nchembio.1694; Giganti D, 2013, J BIOL CHEM, V288, P29797, DOI 10.1074/jbc.M113.462705; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Guerin ME, 2010, J BIOL CHEM, V285, P33577, DOI 10.1074/jbc.R110.168328; Guerin ME, 2009, J BIOL CHEM, V284, P25687, DOI 10.1074/jbc.M109.030593; Guerin ME, 2009, J BIOL CHEM, V284, P21613, DOI 10.1074/jbc.M109.003947; Guerin ME, 2005, ACTA CRYSTALLOGR F, V61, P518, DOI 10.1107/S1744309105012364; Halskau O, 2009, CURR PROTEIN PEPT SC, V10, P339, DOI 10.2174/138920309788922199; HEIMBURG T, 1993, BIOPHYS J, V65, P2408, DOI 10.1016/S0006-3495(93)81299-2; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; Karst JC, 2012, J BIOL CHEM, V287, P9200, DOI 10.1074/jbc.M111.316166; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Li L, 2003, BIOCHEMISTRY-US, V42, P9677, DOI 10.1021/bi034360l; Lindeberg M, 2000, J MOL BIOL, V295, P679, DOI 10.1006/jmbi.1999.3396; Man P, 2007, J MOL BIOL, V368, P464, DOI 10.1016/j.jmb.2007.02.014; Montagner C, 2007, BIOCHEMISTRY-US, V46, P1878, DOI 10.1021/bi602381z; Morita YS, 2011, BBA-GEN SUBJECTS, V1810, P630, DOI 10.1016/j.bbagen.2011.03.017; Mosbahi K, 2004, J BIOL CHEM, V279, P22145, DOI 10.1074/jbc.M400402200; MUGA A, 1991, BIOCHEMISTRY-US, V30, P7219, DOI 10.1021/bi00243a025; REBECCHI MJ, 1993, J BIOL CHEM, V268, P1735; Rocha J, 2016, PLANT J, V85, P622, DOI 10.1111/tpj.13129; Schwartz R, 2001, GENOME RES, V11, P703, DOI 10.1101/gr.GR-1587R; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Subrini O, 2013, J BIOL CHEM, V288, P32585, DOI 10.1074/jbc.M113.508838; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319	39	14	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					13955	13963		10.1074/jbc.M116.723676	http://dx.doi.org/10.1074/jbc.M116.723676			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27189944	Green Published, hybrid			2022-12-28	WOS:000379975100005
J	Lu, JX; Bayro, MJ; Tycko, R				Lu, Jun-Xia; Bayro, Marvin J.; Tycko, Robert			Major Variations in HIV-1 Capsid Assembly Morphologies Involve Minor Variations in Molecular Structures of Structurally Ordered Protein Segments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SOLID-STATE NMR; NUCLEAR-MAGNETIC-RESONANCE; ANGLE-SPINNING NMR; CHEMICAL-SHIFTS; GAG POLYPROTEIN; TERMINAL DOMAIN; DIMERIZATION DOMAIN; CRYSTAL-STRUCTURE; LATTICE FORMATION	We present the results of solid state nuclear magnetic resonance (NMR) experiments on HIV-1 capsid protein (CA) assemblies with three different morphologies, namely wild-type CA (WT-CA) tubes with 35-60 nm diameters, planar sheets formed by the Arg(18)-Leu mutant (R18L-CA), and R18L-CA spheres with 20-100 nm diameters. The experiments are intended to elucidate molecular structural variations that underlie these variations in CA assembly morphology. We find that multidimensional solid state NMR spectra of N-15, C-13-labeled CA assemblies are remarkably similar for the three morphologies, with only small differences in N-15 and C-13 chemical shifts, no significant differences in NMR line widths, and few differences in the number of detectable NMR cross-peaks. Thus, the pronounced differences in morphology do not involve major differences in the conformations and identities of structurally ordered protein segments. Instead, morphological variations are attributable to variations in conformational distributions within disordered segments, which do not contribute to the solid state NMR spectra. Variations in solid state NMR signals from certain amino acid side chains are also observed, suggesting differences in the intermolecular dimerization interface between curved and planar CA lattices, as well as possible differences in intramolecular helix-helix packing.	[Lu, Jun-Xia; Bayro, Marvin J.; Tycko, Robert] NIDKK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Lu, Jun-Xia] ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); ShanghaiTech University	Tycko, R (corresponding author), Bldg 5,Rm 112, Bethesda, MD 20892 USA.	robertty@mail.nih.gov	Bayro, Marvin/Q-4643-2016	Bayro, Marvin/0000-0003-1482-9381	NIDDK, National Institutes of Health [DK075032]; National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075032, R01DK075032] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the NIDDK, National Institutes of Health, under project DK075032, and by the Intramural AIDS Targeted Antiviral Program of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Alcaraz LA, 2007, BIOPHYS J, V93, P1264, DOI 10.1529/biophysj.106.101089; Bailey GD, 2012, J MOL BIOL, V417, P212, DOI 10.1016/j.jmb.2012.01.014; Bayro MJ, 2014, J MOL BIOL, V426, P1109, DOI 10.1016/j.jmb.2013.12.021; Bayro MJ, 2012, J BIOL CHEM, V287, P3479, DOI 10.1074/jbc.M111.313049; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Byeon IJL, 2012, J AM CHEM SOC, V134, P6455, DOI 10.1021/ja300937v; Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010; Campos-Olivas R, 1999, BIOCHEMISTRY-US, V38, P10262, DOI 10.1021/bi990991x; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Chen B, 2011, BIOPHYS J, V100, P3035, DOI 10.1016/j.bpj.2011.05.025; Chen B, 2010, PROTEIN SCI, V19, P716, DOI 10.1002/pro.348; Deshmukh L, 2015, P NATL ACAD SCI USA, V112, P3374, DOI 10.1073/pnas.1501985112; Deshmukh L, 2014, ANGEW CHEM INT EDIT, V53, P1025, DOI 10.1002/anie.201309127; Deshmukh L, 2013, J AM CHEM SOC, V135, P16133, DOI 10.1021/ja406246z; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; Frank GA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6854; Franks WT, 2005, J AM CHEM SOC, V127, P12291, DOI 10.1021/ja044497e; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2012, ADV EXP MED BIOL, V726, P441, DOI 10.1007/978-1-4614-0980-9_20; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Gres AT, 2015, SCIENCE, V349, P99, DOI 10.1126/science.aaa5936; Grime JMA, 2012, BIOPHYS J, V103, P1774, DOI 10.1016/j.bpj.2012.09.007; Han Y, 2013, J AM CHEM SOC, V135, P17793, DOI 10.1021/ja406907h; Han Y, 2010, J AM CHEM SOC, V132, P1976, DOI 10.1021/ja908687k; Hardy EH, 2001, J MAGN RESON, V148, P459, DOI 10.1006/jmre.2000.2258; Higman VA, 2009, J BIOMOL NMR, V44, P245, DOI 10.1007/s10858-009-9338-7; Hong M, 1999, J MAGN RESON, V139, P389, DOI 10.1006/jmre.1999.1805; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Lu MM, 2015, P NATL ACAD SCI USA, V112, P14617, DOI 10.1073/pnas.1516920112; Meng X, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002886; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Morcombe CR, 2004, J AM CHEM SOC, V126, P7196, DOI 10.1021/ja047919t; MORRIS GA, 1979, J AM CHEM SOC, V101, P760, DOI 10.1021/ja00497a058; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2010, J MOL BIOL, V401, P985, DOI 10.1016/j.jmb.2010.06.042; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Qiao X, 2015, BBA-GEN SUBJECTS, V1850, P2353, DOI 10.1016/j.bbagen.2015.08.017; Schmidt HLF, 2007, J PHYS CHEM B, V111, P14362, DOI 10.1021/jp075531p; Schur FKM, 2015, NATURE, V517, P505, DOI 10.1038/nature13838; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shin R, 2011, BIOCHEMISTRY-US, V50, P9457, DOI 10.1021/bi2011493; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wong HC, 2008, BIOCHEMISTRY-US, V47, P2289, DOI 10.1021/bi7022128; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Xu XP, 2001, J BIOMOL NMR, V21, P321, DOI 10.1023/A:1013324104681; Yu ZH, 2013, J MOL BIOL, V425, P112, DOI 10.1016/j.jmb.2012.10.006; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	58	12	12	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13098	13112		10.1074/jbc.M116.720557	http://dx.doi.org/10.1074/jbc.M116.720557			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129282	Green Published, hybrid			2022-12-28	WOS:000379770500018
J	Adase, CA; Borkowski, AW; Zhang, LJ; Williams, MR; Sato, E; Sanford, JA; Gallo, RL				Adase, Christopher A.; Borkowski, Andrew W.; Zhang, Ling-juan; Williams, Michael R.; Sato, Emi; Sanford, James A.; Gallo, Richard L.			Non-coding Double-stranded RNA and Antimicrobial Peptide LL-37 Induce Growth Factor Expression from Keratinocytes and Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-3; HUMAN CATHELICIDIN LL-37; NF-KAPPA-B; HUMAN SKIN; DENDRITIC CELLS; IMMUNE-RESPONSES; EPITHELIAL-CELLS; INNATE IMMUNITY; MESSENGER-RNA; ACTIVATION	A critical function for skin is that when damaged it must simultaneously identify the nature of the injury, repair barrier function, and limit the intrusion of pathogenic organisms. These needs are carried out through the detection of damage-associated molecular patterns (DAMPs) and a response that includes secretion of cytokines, chemokines, growth factors, and antimicrobial peptides (AMPs). In this study, we analyzed how non-coding double-stranded RNA (dsRNAs) act as a DAMP in the skin and how the human cathelicidin AMP LL-37 might influence growth factor production in response to this DAMP. dsRNA alone significantly increased the expression of multiple growth factors in keratinocytes, endothelial cells, and fibroblasts. Furthermore, RNA sequencing transcriptome analysis found that multiple growth factors increase when cells are exposed to both LL-37 and dsRNA, a condition that mimics normal wounding. Quantitative PCR and/or ELISA validated that growth factors expressed by keratinocytes in these conditions included, but were not limited to, basic fibroblast growth factor (FGF2), heparin-binding EGF-like growth factor (HBEGF), vascular endothelial growth factor C (VEGFC), betacellulin (BTC), EGF, epiregulin (EREG), and other members of the transforming growth factor beta superfamily. These results identify a novel role for DAMPs and AMPs in the stimulation of repair and highlight the complex interactions involved in the wound environment.	[Adase, Christopher A.; Borkowski, Andrew W.; Zhang, Ling-juan; Williams, Michael R.; Sato, Emi; Sanford, James A.; Gallo, Richard L.] Univ Calif San Diego, Dept Dermatol, San Diego, CA 92093 USA	University of California System; University of California San Diego	Gallo, RL (corresponding author), Univ Calif San Diego, Dept Dermatol, San Diego, CA 92093 USA.	rgallo@ucsd.edu	Zhang, Ling-juan/V-6141-2019; Zhang, Lingjuan/K-3080-2017; Gallo, Richard L/A-8931-2009	Zhang, Ling-juan/0000-0001-6937-4578; Zhang, Lingjuan/0000-0001-6937-4578; Gallo, Richard L/0000-0002-1401-7861; Sanford, James/0000-0001-7901-5579; Sato, Emi/0000-0001-9394-653X	National Institutes of Health [R01 AR052728, R01 AR064781, R01 AI116576, R01 AI052453, T32 AR062496]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052453, R01AI116576, R37AI052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064781, T32AR062496, R01AR052728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants R01 AR052728, R01 AR064781, R01 AI116576, R01 AI052453 (to R. L. G.) and T32 AR062496 (to C. A. A. and M. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Borkowski AW, 2015, J INVEST DERMATOL, V135, P569, DOI 10.1038/jid.2014.354; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Filewod NCJ, 2009, FEMS IMMUNOL MED MIC, V56, P233, DOI 10.1111/j.1574-695X.2009.00571.x; Fischer S, 2011, THROMB HAEMOSTASIS, V105, P345, DOI 10.1160/TH10-06-0345; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Fulton C, 1997, LANCET, V350, P1750, DOI 10.1016/S0140-6736(05)63574-X; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Gronberg A, 2014, WOUND REPAIR REGEN, V22, P613, DOI 10.1111/wrr.12211; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hasan M, 2011, J IMMUNOL, V187, P5653, DOI 10.4049/jimmunol.1102144; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Hong SP, 2008, J INVEST DERMATOL, V128, P2880, DOI 10.1038/jid.2008.169; Kandler K, 2006, INT IMMUNOL, V18, P1729, DOI 10.1093/intimm/dxl107; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kim JE, 2005, J KOREAN MED SCI, V20, P649, DOI 10.3346/jkms.2005.20.4.649; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026632; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lin Q, 2012, J INVEST DERMATOL, V132, P2085, DOI 10.1038/jid.2012.120; Lin Q, 2011, J IMMUNOL, V186, P3710, DOI 10.4049/jimmunol.1003007; Maerki C, 2009, J IMMUNOL, V182, P507, DOI 10.4049/jimmunol.182.1.507; Mallbris L, 2005, J INVEST DERMATOL, V125, P1072, DOI 10.1111/j.0022-202X.2005.23872.x; Matsukura S, 2006, CLIN EXP ALLERGY, V36, P1049, DOI 10.1111/j.1365-2222.2006.02530.x; Nakagawa Y, 2015, J IMMUNOL, V194, P1274, DOI 10.4049/jimmunol.1402388; Schmid P, 2001, J INVEST DERMATOL, V116, P471, DOI 10.1046/j.1523-1747.2001.01279.x; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Seo SJ, 2001, J DERMATOL SCI, V27, P183, DOI 10.1016/S0923-1811(01)00135-9; Seya T, 2012, ONCOIMMUNOLOGY, V1, P917, DOI 10.4161/onci.21244; Singh D, 2014, J BIOL CHEM, V289, P27614, DOI 10.1074/jbc.M114.582973; Sorensen OE, 2003, J IMMUNOL, V170, P5583, DOI 10.4049/jimmunol.170.11.5583; Sorensen OE, 2006, J CLIN INVEST, V116, P1878, DOI 10.1172/JCI28422; Takiguchi T, 2014, BRIT J DERMATOL, V171, P492, DOI 10.1111/bjd.12942; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009; Yoshioka M, 2008, BIOL PHARM BULL, V31, P212, DOI 10.1248/bpb.31.212; Zhang LJ, 2012, J CELL SCI, V125, P5733, DOI 10.1242/jcs.108969; Zughaier SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013627	47	13	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11635	11646		10.1074/jbc.M116.725317	http://dx.doi.org/10.1074/jbc.M116.725317			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27048655	Green Published, hybrid			2022-12-28	WOS:000377264800015
J	Bradford, HN; Krishnaswamy, S				Bradford, Harlan N.; Krishnaswamy, Sriram			The Fragment 1 Region of Prothrombin Facilitates the Favored Binding of Fragment 12 to Zymogen and Enforces Zymogen-like Character in the Proteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; prothrombin; serine protease; thermodynamics; thrombin	ACTIVE-SITE; CRYSTAL-STRUCTURE; ENZYME COMPLEXES; FACTOR-VA; ACTIVATION; THROMBIN; MEIZOTHROMBIN; SUBSTRATE; SPECIFICITY; PRODUCTS	Thrombin is produced from the C-terminal half of prothrombin following its proteolytic activation. The N-terminal half, released as the propiece Fragment 12 (F12), is composed of an N-terminal -carboxyglutamate domain (Gla) followed by two kringles (K1 and K2). The propiece plays essential roles in regulating prothrombin activation and proteinase function. The latter results from the ability of F12 to reversibly bind to the (pro)catalytic domain through K2 with high affinity and highly favorable thermodynamic constants when it is a zymogen in comparison to proteinase. Such discrimination is lost for K2 binding after proteolytic removal of the N-terminal Gla-K1 region of F12. The Ca2+-stabilized structure of the Gla domain is not required for F12 to bind the zymogen form more favorably. Enhanced binding to zymogen versus proteinase correlates with the ability of the propiece to enforce zymogen-like character in the proteinase. This is evident in variants of meizothrombin, an intermediate of prothrombin activation that contains the propiece covalently attached. This phenomenon is also independent of the Gla domain. Thus, the presence of K1 in covalent linkage with K2 in the propiece governs the ability of K2 to bind the (pro)catalytic domain in favor of zymogen, thereby enforcing zymogen-like character in the proteinase.	[Bradford, Harlan N.; Krishnaswamy, Sriram] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Krishnaswamy, Sriram] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	Krishnaswamy, S (corresponding author), Childrens Hosp Philadelphia, 310 Abramson,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	skrishna@mail.med.upenn.edu	Krishnaswamy, Sriram/Z-4380-2019	Bradford, Harlan/0000-0001-5582-278X	National Institutes of Health [HL-074124, HL-108933];  [HL-12722]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074124, R01HL108933, R01HL125422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-074124 and HL-108933 (to S. K.) and by Project 1 of HL-12722. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams TE, 2016, BIOCHIMIE, V122, P235, DOI 10.1016/j.biochi.2015.09.013; ARMSTRONG SA, 1990, J BIOL CHEM, V265, P6210; ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Bevington P. R., 1992, DATA REDUCTION ERROR, P161; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; BLOOM JW, 1979, BIOCHEMISTRY-US, V18, P1957, DOI 10.1021/bi00577a017; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bradford HN, 2013, J BIOL CHEM, V288, P27789, DOI 10.1074/jbc.M113.502005; Bradford HN, 2012, J BIOL CHEM, V287, P30414, DOI 10.1074/jbc.M112.394809; Chen ZW, 2010, P NATL ACAD SCI USA, V107, P19278, DOI 10.1073/pnas.1010262107; COTE HCF, 1994, J BIOL CHEM, V269, P11374; DOYLE MF, 1993, METHOD ENZYMOL, V222, P299; DOYLE MF, 1990, J BIOL CHEM, V265, P10693; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; JENNY NS, 2006, HEMOSTASIS THROMBOSI, P193; Kamath P, 2008, J BIOL CHEM, V283, P30164, DOI 10.1074/jbc.M806158200; Kamath P, 2010, J BIOL CHEM, V285, P28651, DOI 10.1074/jbc.M110.154914; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Krishnaswamy S, 2013, J THROMB HAEMOST, V11, P265, DOI 10.1111/jth.12217; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; Lechtenberg BC, 2013, BLOOD, V122, P2777, DOI 10.1182/blood-2013-06-511733; Lu GM, 2005, J BIOL CHEM, V280, P15471, DOI 10.1074/jbc.M500881200; Lundblad R L, 1976, Methods Enzymol, V45, P156; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; Mann KG, 2003, CHEST, V124, p4S, DOI 10.1378/chest.124.3_suppl.4S; MANN KG, 1990, BLOOD, V76, P1; Matafonov A, 2011, BLOOD, V118, P437, DOI 10.1182/blood-2010-10-312983; NESHEIM ME, 1979, BIOCHEMISTRY-US, V18, P996, DOI 10.1021/bi00573a010; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; Orfeo T, 2004, J BIOL CHEM, V279, P19580, DOI 10.1074/jbc.M400727200; POLLOCK JS, 1988, J BIOL CHEM, V263, P14216; Pozzi N, 2016, J BIOL CHEM, V291, P6071, DOI 10.1074/jbc.M115.700401; Pozzi N, 2014, P NATL ACAD SCI USA, V111, P7630, DOI 10.1073/pnas.1403779111; PRICE PA, 1983, METHOD ENZYMOL, V91, P13; TANS G, 1994, J BIOL CHEM, V269, P15969	40	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11114	11123		10.1074/jbc.M116.723072	http://dx.doi.org/10.1074/jbc.M116.723072			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27013660	Green Published, hybrid			2022-12-28	WOS:000377042100015
J	Jager, J; Wang, FF; Fang, B; Lim, HW; Peed, LC; Steger, DJ; Won, KJ; Kharitonenkov, A; Adams, AC; Lazar, MA				Jager, Jennifer; Wang, Fenfen; Fang, Bin; Lim, Hee-Woon; Peed, Lindsey C.; Steger, David J.; Won, Kyoung-Jae; Kharitonenkov, Alexei; Adams, Andrew C.; Lazar, Mitchell A.			The Nuclear Receptor Rev-erb alpha Regulates Adipose Tissue-specific FGF21 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR 21; BETA-KLOTHO; INSULIN-RESISTANCE; TRANSCRIPTION; EXPRESSION; OBESITY; INFLAMMATION; PGC-1-ALPHA; METABOLISM; ACTIVATION	FGF21 is an atypical member of the FGF family that functions as a hormone to regulate carbohydrate and lipid metabolism. Here we demonstrate that the actions of FGF21 in mouse adipose tissue, but not in liver, are modulated by the nuclear receptor Rev-erb alpha, a potent transcriptional repressor. Interrogation of genes induced in the absence of Rev-erba for Rev-erb alpha-binding sites identified beta kappa lotho, an essential coreceptor for FGF21, as a direct target gene of Rev-erba in white adipose tissue but not liver. Rev-erba ablation led to the robust elevated expression of beta kappa lotho. Consequently, the effects of FGF21 were markedly enhanced in the white adipose tissue of mice lacking Rev-erb alpha. A major Rev-erb alpha-controlled enhancer at the Klb locus was also bound by the adipocytic transcription factor peroxisome proliferator-activated receptor (PPAR) gamma, which regulates its activity in the opposite direction. These findings establish Rev-erb alpha as a specific modulator of FGF21 signaling in adipose tissue.	[Jager, Jennifer; Wang, Fenfen; Fang, Bin; Lim, Hee-Woon; Peed, Lindsey C.; Steger, David J.; Won, Kyoung-Jae; Lazar, Mitchell A.] Univ Penn, Div Endocrinol Diabet & Metab, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Jager, Jennifer; Wang, Fenfen; Fang, Bin; Lim, Hee-Woon; Peed, Lindsey C.; Steger, David J.; Won, Kyoung-Jae; Lazar, Mitchell A.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Jager, Jennifer; Wang, Fenfen; Fang, Bin; Lim, Hee-Woon; Peed, Lindsey C.; Steger, David J.; Won, Kyoung-Jae; Lazar, Mitchell A.] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kharitonenkov, Alexei] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Adams, Andrew C.] Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Indiana University System; Indiana University Bloomington; Eli Lilly	Lazar, MA (corresponding author), Univ Penn, Div Endocrinol Diabet & Metab, Perelman Sch Med, Dept Med,Smilow Ctr Translat Res 12102, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.; Lazar, MA (corresponding author), Univ Penn, Dept Genet, Perelman Sch Med, Smilow Ctr Translat Res 12102, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.; Lazar, MA (corresponding author), Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Smilow Ctr Translat Res 12102, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019; Lim, Hee Woong/AAX-6835-2021; Lim, HW/GRY-3517-2022	Lim, Hee Woong/0000-0001-8599-1808; Jager, Jennifer/0000-0003-3740-9742; Won, Kyoung Jae/0000-0002-2924-9630	National Institutes of Health [R01 DK45586, DK49780]; JPB Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049780, P30DK019525, R01DK045586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK45586 and DK49780, and the JPB Foundation. M. A. L. is a consultant to Lilly, A. K. is a former employee of Lilly, and A. C. A. is a current employee of Lilly. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams AC, 2013, MOL METAB, V2, P205, DOI 10.1016/j.molmet.2013.05.005; Adams AC, 2013, MOL METAB, V2, P31, DOI 10.1016/j.molmet.2012.08.007; Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049977; Anghel SI, 2007, CELL RES, V17, P486, DOI 10.1038/cr.2007.48; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Delezie J, 2012, FASEB J, V26, P3321, DOI 10.1096/fj.12-208751; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Duez H, 2010, ARTERIOSCL THROM VAS, V30, P1529, DOI 10.1161/ATVBAHA.110.209098; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Harms MJ, 2015, GENE DEV, V29, P298, DOI 10.1101/gad.252734.114; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Jager J, 2014, MOL ENDOCRINOL, V28, P490, DOI 10.1210/me.2013-1351; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2014, MOL METAB, V3, P221, DOI 10.1016/j.molmet.2013.12.003; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Lee JM, 2014, NATURE, V516, P112, DOI 10.1038/nature13961; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mathieu P, 2010, CLIN PHARMACOL THER, V87, P407, DOI 10.1038/clpt.2009.311; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schmidt SF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-152; Schupp M, 2009, J BIOL CHEM, V284, P9458, DOI 10.1074/jbc.M809498200; Soccio RE, 2015, CELL, V162, P33, DOI 10.1016/j.cell.2015.06.025; Step SE, 2014, GENE DEV, V28, P1018, DOI 10.1101/gad.237628.114; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Veniant MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040164; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Yang X, 2007, COLD SPRING HARB SYM, V72, P387, DOI 10.1101/sqb.2007.72.058; Zamir I, 1996, MOL CELL BIOL, V16, P5458; Zhang YX, 2015, SCIENCE, V348, P1488, DOI 10.1126/science.aab3021	63	26	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10867	10875		10.1074/jbc.M116.719120	http://dx.doi.org/10.1074/jbc.M116.719120			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27002153	Green Published, hybrid			2022-12-28	WOS:000377042600036
J	Motta, P; Molla, G; Pollegioni, L; Nardini, M				Motta, Paolo; Molla, Gianluca; Pollegioni, Loredano; Nardini, Marco			Structure-Function Relationships in L-Amino Acid Deaminase, a Flavoprotein Belonging to a Novel Class of Biotechnologically Relevant Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOTORULA-GRACILIS; ACTIVE-SITE; CRYSTAL-STRUCTURE; WEB SERVER; OXIDASE; PROTEUS; MECHANISM; COMPLEX; PURIFICATION; CYTOCHROMES	L-Amino acid deaminase from Proteus myxofaciens (PmaLAAD) is a membrane flavoenzyme that catalyzes the deamination of neutral and aromatic L-amino acids into alpha-keto acids and ammonia. PmaLAAD does not use dioxygen to re-oxidize reduced FADH(2) and thus does not produce hydrogen peroxide; instead, it uses a cytochrome b-like protein as an electron acceptor. Although the overall fold of this enzyme resembles that of known amine or amino acid oxidases, it shows the following specific structural features: an additional novel alpha+beta subdomain placed close to the putative transmembrane alpha-helix and to the active-site entrance; an FAD isoalloxazine ring exposed to solvent; and a large and accessible active site suitable to bind large hydrophobic substrates. In addition, PmaLAAD requires substrate-induced conformational changes of part of the active site, particularly in Arg-316 and Phe-318, to achieve the correct geometry for catalysis. These studies are expected to pave the way for rationally improving the versatility of this flavoenzyme, which is critical for biocatalysis of enantiomerically pure amino acids.	[Motta, Paolo; Molla, Gianluca; Pollegioni, Loredano] Univ Insubria, Dipartimento Biotecnol & Sci Vita, Via JH Dunant 3, I-21100 Varese, Italy; [Molla, Gianluca; Pollegioni, Loredano] Politecn Milan, Prot Factory, I-21100 Varese, Italy; [Molla, Gianluca; Pollegioni, Loredano] Univ Insubria, I-21100 Varese, Italy; [Nardini, Marco] Univ Milan, Dipartimento Biosci, Via Celoria 26, I-20133 Milan, Italy	University of Insubria; Polytechnic University of Milan; University of Insubria; University of Milan	Molla, G (corresponding author), Univ Insubria, Dipartimento Biotecnol & Sci Vita, Via JH Dunant 3, I-21100 Varese, Italy.; Nardini, M (corresponding author), Univ Milan, Dipartimento Biosci, Via Celoria 26, I-20133 Milan, Italy.	gianluca.molla@uninsubria.it; marco.nardini@unimi.it	Nardini, Marco/B-7842-2017	Nardini, Marco/0000-0002-3718-2165; POLLEGIONI, LOREDANO/0000-0003-1733-7243	Fondo di Ateneo per la Ricerca	Fondo di Ateneo per la Ricerca	This work was supported by a grant from Fondo di Ateneo per la Ricerca (to G. M. and L. P.). The authors declare that they have no conflicts of interest with the content of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baek JO, 2011, J BASIC MICROB, V51, P129, DOI 10.1002/jobm.201000086; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Busto E, 2014, CHEM-EUR J, V20, P11225, DOI 10.1002/chem.201403195; Caldinelli L, 2005, J BIOL CHEM, V280, P22572, DOI 10.1074/jbc.M500549200; Caldinelli L, 2013, BBA-MOL BASIS DIS, V1832, P400, DOI 10.1016/j.bbadis.2012.11.019; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018910; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen ZW, 2006, J MOL BIOL, V360, P1000, DOI 10.1016/j.jmb.2006.05.067; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; FONDA ML, 1968, J BIOL CHEM, V243, P1931; Giammanco GM, 2011, INT J SYST EVOL MICR, V61, P1638, DOI 10.1099/ijs.0.021964-0; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harris CM, 1999, J BIOL CHEM, V274, P36233, DOI 10.1074/jbc.274.51.36233; Harris CM, 2001, EUR J BIOCHEM, V268, P5504, DOI 10.1046/j.1432-1033.2001.02462.x; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hou Y, 2015, APPL MICROBIOL BIOT, V99, P8391, DOI 10.1007/s00253-015-6757-0; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Massey V, 1980, BIOCHEM SOC T, V8, P246, DOI 10.1042/bst0080246; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Molla G, 2000, J BIOL CHEM, V275, P24715, DOI 10.1074/jbc.M908193199; Molla G, 2012, METHODS MOL BIOL, V794, P273, DOI 10.1007/978-1-61779-331-8_18; Moriguchi T, 2010, J BIOCHEM, V148, P491, DOI 10.1093/jb/mvq083; Mortl M, 2004, J BIOL CHEM, V279, P29718, DOI 10.1074/jbc.M401224200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pantaleone DP, 2001, J MOL CATAL B-ENZYM, V11, P795, DOI 10.1016/S1381-1177(00)00155-7; Pawelek PD, 2000, EMBO J, V19, P4204, DOI 10.1093/emboj/19.16.4204; POLLEGIONI L, 1993, J BIOL CHEM, V268, P13850; Pollegioni L, 2007, CURR PROTEIN PEPT SC, V8, P600, DOI 10.2174/138920307783018677; Pollegioni L, 2013, APPL MICROBIOL BIOT, V97, P9323, DOI 10.1007/s00253-013-5230-1; Pollegioni L, 2011, TRENDS BIOTECHNOL, V29, P276, DOI 10.1016/j.tibtech.2011.01.010; Saam J, 2010, J BIOL CHEM, V285, P24439, DOI 10.1074/jbc.M110.131193; Sacchi S, 2012, AMINO ACIDS, V43, P1833, DOI 10.1007/s00726-012-1345-4; Shabbiri K, 2010, BRAZ J MICROBIOL, V41, P796, DOI 10.1590/S1517-83822010005000032; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tessaro D, 2015, ACS CATAL, V5, P1604, DOI 10.1021/cs502064s; Tsuge H, 2005, J BIOL CHEM, V280, P31045, DOI 10.1074/jbc.C500234200; Turner NJ, 2004, CURR OPIN CHEM BIOL, V8, P114, DOI 10.1016/j.cbpa.2004.02.001; Umhau S, 2000, P NATL ACAD SCI USA, V97, P12463, DOI 10.1073/pnas.97.23.12463; VANWIELINK JE, 1983, ARCH MICROBIOL, V136, P152, DOI 10.1007/BF00404791; VANWIELINK JE, 1983, ARCH MICROBIOL, V134, P118, DOI 10.1007/BF00407943; Volbeda A, 2013, STRUCTURE, V21, P184, DOI 10.1016/j.str.2012.11.010; Volonte F, 2008, PROTEIN EXPRES PURIF, V61, P131, DOI 10.1016/j.pep.2008.05.010	51	40	43	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10457	10475		10.1074/jbc.M115.703819	http://dx.doi.org/10.1074/jbc.M115.703819			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27022028	hybrid, Green Published			2022-12-28	WOS:000377042600003
J	Tran, QK; Firkins, R; Giles, J; Francis, S; Matnishian, V; Tran, P; VerMeer, M; Jasurda, J; Burgard, MA; Gebert-Oberle, B				Tran, Quang-Kim; Firkins, Rachel; Giles, Jennifer; Francis, Sarah; Matnishian, Vahe; Phuong Tran; VerMeer, Mark; Jasurda, Jake; Burgard, Michelle Ann; Gebert-Oberle, Briana			Estrogen Enhances Linkage in the Vascular Endothelial Calmodulin Network via a Feedforward Mechanism at the G Protein-coupled Estrogen Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; GROWTH-FACTOR RECEPTOR; CANCER-ASSOCIATED FIBROBLASTS; PLASMA-MEMBRANE CA2+-ATPASE; TRANSCRIPTIONAL ACTIVITY; CELLS; GPR30; PHOSPHORYLATION; CA2+; ACTIVATION	Estrogen exerts many effects on the vascular endothelium. Calmodulin (CaM) is the transducer of Ca2+ signals and is a limiting factor in cardiovascular tissues. It is unknown whether and how estrogen modifies endothelial functions via the network of CaM-dependent proteins. Here we show that 17 beta-estradiol (E-2) up-regulates total CaM level in endothelial cells. Concurrent measurement of Ca2+ and Ca2+-CaM indicated that E2 also increases free Ca2+-CaM. Pharmacological studies, gene silencing, and receptor expression-specific cell studies indicated that the G protein-coupled estrogen receptor 1 (GPER/GPR30) mediates these effects via transactivation of EGFR and subsequent MAPK activation. The outcomes were then examined on four distinct members of the intracellular CaM target network, including GPER/GPR30 itself and estrogen receptor a, the plasma membrane Ca2+-ATPase (PMCA), and endothelial nitric-oxide synthase (eNOS). E2 substantially increases CaM binding to estrogen receptor a and GPER/GPR30. Mutations that reduced CaM binding to GPER/GPR30 in separate binding domains do not affect GPER/GPR30-G(beta gamma) preassociation but decrease GPER/GPR30-mediated ERK1/2 phosphorylation. E2 increases CaM-PMCA association, but the expected stimulation of Ca2+ efflux is reversed by E-2-stimulated tyrosine phosphorylation of PMCA. These effects sustain Ca2+ signals and promote Ca2+-dependent CaM interactions with other CaM targets. Consequently, E-2 doubles CaM-eNOS interaction and also promotes dual phosphorylation of eNOS at Ser-617 and Ser-1179. Calculations using in-cell and in vitro data revealed substantial individual and combined contribution of these effects to total eNOS activity. Taken together, E-2 generates a feedforward loop via GPER/GPR30, which enhances Ca2+/CaM signals and functional linkage in the endothelial CaM target network.	[Tran, Quang-Kim; Firkins, Rachel; Giles, Jennifer; Francis, Sarah; Matnishian, Vahe; Phuong Tran; VerMeer, Mark; Jasurda, Jake; Burgard, Michelle Ann; Gebert-Oberle, Briana] Des Moines Univ, Coll Osteopath Med, Dept Physiol & Pharmacol, Ryan Hall 258,3200 Grand Ave, Des Moines, IA 50312 USA		Tran, QK (corresponding author), Des Moines Univ, Coll Osteopath Med, Dept Physiol & Pharmacol, Ryan Hall 258,3200 Grand Ave, Des Moines, IA 50312 USA.	kim.tran@dmu.edu		Tran, Kim/0000-0003-1881-1357	National Institutes of Health [HL112184]; Iowa Osteopathic and Educational Research Funds; Des Moines University's Mentored Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL112184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iowa Osteopathic and Educational Research Funds; Des Moines University's Mentored Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health Grant HL112184 (to Q.-K.T.) and Iowa Osteopathic and Educational Research Funds (to Q.-K.T). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by Des Moines University's Mentored Research Program.	Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Albanito L, 2015, ENVIRON HEALTH PERSP, V123, P493, DOI 10.1289/ehp.1408586; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Caride AJ, 1999, J BIOL CHEM, V274, P35227, DOI 10.1074/jbc.274.49.35227; CASTORIA G, 1988, MOL ENDOCRINOL, V2, P167, DOI 10.1210/mend-2-2-167; Chakrabarti S, 2014, CAN J CARDIOL, V30, P705, DOI 10.1016/j.cjca.2013.08.006; Das SK, 2000, J BIOL CHEM, V275, P28834, DOI 10.1074/jbc.M003827200; Dean WL, 1997, J BIOL CHEM, V272, P15113, DOI 10.1074/jbc.272.24.15113; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Ding Q, 2009, AM J PHYSIOL-CELL PH, V297, pC1178; El-Beialy W, 2010, ENDOCR J, V57, P93, DOI 10.1507/endocrj.K09E-247; Filardo EJ, 2008, STEROIDS, V73, P870, DOI 10.1016/j.steroids.2007.12.025; Filardo EJ, 2012, ENDOCRINOLOGY, V153, P2953, DOI 10.1210/en.2012-1061; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Haynes MP, 2000, CIRC RES, V87, P677, DOI 10.1161/01.RES.87.8.677; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; KAKIUCHI S, 1982, J BIOCHEM-TOKYO, V92, P1041, DOI 10.1093/oxfordjournals.jbchem.a134019; Kim SA, 2004, P NATL ACAD SCI USA, V101, P105, DOI 10.1073/pnas.2436461100; KUHNE W, 1993, AM J PHYSIOL, V264, pH1599, DOI 10.1152/ajpheart.1993.264.5.H1599; Levitan IB, 1999, NEURON, V22, P645, DOI 10.1016/S0896-6273(00)80722-9; Li L, 2005, J BIOL CHEM, V280, P13097, DOI 10.1074/jbc.M410642200; Li L, 2003, J BIOL CHEM, V278, P1195, DOI 10.1074/jbc.M210708200; Li L, 2007, CELL SIGNAL, V19, P439, DOI 10.1016/j.cellsig.2006.08.018; Li ZG, 2001, J BIOL CHEM, V276, P17354, DOI 10.1074/jbc.M010238200; Lin BC, 2009, CANCER RES, V69, P5415, DOI 10.1158/0008-5472.CAN-08-1622; LUBYPHELPS K, 1995, J BIOL CHEM, V270, P21532, DOI 10.1074/jbc.270.37.21532; McConnell EJ, 2000, CIRC RES, V86, P191, DOI 10.1161/01.RES.86.2.191; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Persechini A, 2002, TRENDS CARDIOVAS MED, V12, P32, DOI 10.1016/S1050-1738(01)00144-X; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Prossnitz ER, 2015, PHARMACOL REV, V67, P505, DOI 10.1124/pr.114.009712; Tran QK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089669; Rakhilin SV, 2004, SCIENCE, V306, P698, DOI 10.1126/science.1099961; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Romoser VA, 1997, J BIOL CHEM, V272, P13270, DOI 10.1074/jbc.272.20.13270; Santolla MF, 2012, J BIOL CHEM, V287, P43234, DOI 10.1074/jbc.M112.417303; Shen XC, 2005, P NATL ACAD SCI USA, V102, P5969, DOI 10.1073/pnas.0407928102; Song QJ, 2008, J BIOL CHEM, V283, P31531, DOI 10.1074/jbc.M804902200; Spahr R., 1990, CELL CULTURE TECHNIQ, P220; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Tran QK, 2005, CELL CALCIUM, V37, P541, DOI 10.1016/j.ceca.2005.02.001; Tran QK, 2003, J BIOL CHEM, V278, P24247, DOI 10.1074/jbc.C300165200; Tran QK, 2008, BIOCHEMISTRY-US, V47, P7557, DOI 10.1021/bi8003186; Tran QK, 2015, J BIOL CHEM, V290, P13293, DOI 10.1074/jbc.M114.628743; Tran QK, 2009, J BIOL CHEM, V284, P11892, DOI 10.1074/jbc.M806205200; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Vivacqua A, 2006, MOL PHARMACOL, V70, P1414, DOI 10.1124/mol.106.026344; Vladusic EA, 2000, ONCOL REP, V7, P157; Wang X, 2002, CELL CALCIUM, V31, P265, DOI 10.1016/S0143-4160(02)00075-1; Watanabe H, 1996, BIOCHEM BIOPH RES CO, V225, P777, DOI 10.1006/bbrc.1996.1250; WATANABE H, 1991, AM J PHYSIOL, V260, pH1344, DOI 10.1152/ajpheart.1991.260.4.H1344; Watanabe H, 2001, FASEB J, V15, P282, DOI 10.1096/fj.00-0587fje; Wu X, 2007, CELL CALCIUM, V41, P353, DOI 10.1016/j.ceca.2006.07.011; Zhang RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065266; Zhang YH, 2012, J BIOL CHEM, V287, P9336, DOI 10.1074/jbc.M111.334797	64	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10805	10823		10.1074/jbc.M115.697334	http://dx.doi.org/10.1074/jbc.M115.697334			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26987903	Green Published, hybrid			2022-12-28	WOS:000377042600031
J	Fang, ZH; Marshall, CB; Yin, JNC; Mazhab-Jafari, MT; Gasmi-Seabrook, GMC; Smith, MJ; Nishikawa, T; Xu, Y; Neel, BG; Ikura, M				Fang, Zhenhao; Marshall, Christopher B.; Yin, Jiani C.; Mazhab-Jafari, Mohammad T.; Gasmi-Seabrook, Genevieve M. C.; Smith, Matthew J.; Nishikawa, Tadateru; Xu, Yang; Neel, Benjamin G.; Ikura, Mitsuhiko			Biochemical Classification of Disease-associated Mutants of RAS-like Protein Expressed in Many Tissues (RIT1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAUSE NOONAN SYNDROME; REAL-TIME NMR; NEURONAL DIFFERENTIATION; KRAS MUTATIONS; SMALL GTPASES; DEVELOPMENTAL DISORDERS; SIGNALING PATHWAY; CANCER; ACTIVATION; GTP	RAS-like protein expressed in many tissues 1 (RIT1) is a disease-associated RAS subfamily small guanosine triphosphatase (GTPase). Recent studies revealed that germ-line and somatic RIT1 mutations can cause Noonan syndrome (NS), and drive proliferation of lung adenocarcinomas, respectively, akin to RAS mutations in these diseases. However, the locations of these RIT1 mutations differ significantly from those found in RAS, and do not affect the three mutational "hot spots" of RAS. Moreover, few studies have characterized the GTPase cycle of RIT1 and its disease-associated mutants. Here we developed a real-time NMR-based GTPase assay for RIT1 and investigated the effect of disease-associated mutations on GTPase cycle. RIT1 exhibits an intrinsic GTP hydrolysis rate similar to that of H-RAS, but its intrinsic nucleotide exchange rate is similar to 4-fold faster, likely as a result of divergent residues near the nucleotide binding site. All of the disease-associated mutations investigated increased the GTP-loaded, activated state of RIT1 in vitro, but they could be classified into two groups with different intrinsic GTPase properties. The S35T, A57G, and Y89H mutants exhibited more rapid nucleotide exchange, whereas F82V and T83P impaired GTP hydrolysis. A RAS-binding domain pulldown assay indicated that RIT1 A57G and Y89H were highly activated in HEK293T cells, whereas T83P and F82V exhibited more modest activation. All five mutations are associated with NS, whereas two (A57G and F82V) have also been identified in urinary tract cancers and myeloid malignancies. Characterization of the effects on the GTPase cycle of RIT1 disease-associated mutations should enable better understanding of their role in disease processes.	[Fang, Zhenhao; Marshall, Christopher B.; Yin, Jiani C.; Mazhab-Jafari, Mohammad T.; Gasmi-Seabrook, Genevieve M. C.; Smith, Matthew J.; Nishikawa, Tadateru; Xu, Yang; Neel, Benjamin G.; Ikura, Mitsuhiko] Univ Toronto, Campbell Family Inst Canc Res, Dept Med Biophys, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Yin, Jiani C.; Xu, Yang; Neel, Benjamin G.] NYU, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA; [Mazhab-Jafari, Mohammad T.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Smith, Matthew J.] Univ Montreal, IRIC, 2900 Blvd Edouard Montpetit, Montreal, PQ H3T 1J4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; New York University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Universite de Montreal	Ikura, M (corresponding author), Univ Toronto, Campbell Family Inst Canc Res, Dept Med Biophys, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.; Marshall, CB (corresponding author), 101 Coll St, Toronto, ON M5G 2M9, Canada.	cmarshal@uhnres.utoronto.ca; mikura@uhnres.utoronto.ca	Marshall, Christopher/K-8943-2019; Xu, Yang/CAG-8877-2022; Smith, Matthew J/AAI-8060-2020	Marshall, Christopher/0000-0002-7571-5700; Xu, Yang/0000-0003-1670-6131; Smith, Matthew J/0000-0003-2896-9350; Fang, Zhenhao/0000-0002-1246-3665; Mazhab-Jafari, Mohammad T./0000-0003-0207-5877; Yin, Jiani/0000-0002-9523-1930	Canada Foundation for Innovation	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	NMR spectrometers were funded by the Canada Foundation for Innovation.	Addissie YA, 2015, AM J MED GENET A, V167, P2657, DOI 10.1002/ajmg.a.37259; Aoki Y, 2013, AM J HUM GENET, V93, P173, DOI 10.1016/j.ajhg.2013.05.021; Berger AH, 2014, ONCOGENE, V33, P4418, DOI 10.1038/onc.2013.581; Bertola DR, 2014, AM J MED GENET A, V164, P2952, DOI 10.1002/ajmg.a.36722; BOS JL, 1989, CANCER RES, V49, P4682; Buhrman G, 2011, J BIOL CHEM, V286, P3323, DOI 10.1074/jbc.M110.193854; Calvert RJ, 2005, ANAL BIOCHEM, V343, P283, DOI 10.1016/j.ab.2005.06.008; Cave H, 2016, EUR J HUM GENET, V24, P1124, DOI 10.1038/ejhg.2015.273; Chen J, 2013, CANCER CHEMOTH PHARM, V71, P265, DOI 10.1007/s00280-012-2005-9; Chen PC, 2014, P NATL ACAD SCI USA, V111, P11473, DOI 10.1073/pnas.1324128111; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cirstea IC, 2013, HUM MOL GENET, V22, P262, DOI 10.1093/hmg/dds426; Cordeddu V, 2015, HUM MUTAT, V36, P1080, DOI 10.1002/humu.22834; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Ford B, 2009, BIOCHEMISTRY-US, V48, P11449, DOI 10.1021/bi901479b; FRECH M, 1994, BIOCHEMISTRY-US, V33, P3237, DOI 10.1021/bi00177a014; Gasper R, 2008, J MOL BIOL, V379, P51, DOI 10.1016/j.jmb.2008.03.011; Goddard D., 2008, SPARKY 3; Gomez-Segui I, 2013, LEUKEMIA, V27, P1943, DOI 10.1038/leu.2013.179; Gos M, 2014, AM J MED GENET A, V164, P2310, DOI 10.1002/ajmg.a.36646; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Huang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123918; Huang L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6410; Hunter JC, 2015, MOL CANCER RES, V13, P1325, DOI 10.1158/1541-7786.MCR-15-0203; Janne PA, 2015, BRIT J CANCER, V113, P199, DOI 10.1038/bjc.2015.215; Kapoor A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108846; Koenighofer M, 2016, CLIN GENET, V89, P359, DOI 10.1111/cge.12608; Kouz K, 2016, GENET MED, V18, P1226, DOI 10.1038/gim.2016.32; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li Jin-tian, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P43; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Marshall CB, 2012, METHODS, V57, P473, DOI 10.1016/j.ymeth.2012.06.014; Marshall CB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000029; Mazhab-Jafari MT, 2010, J BIOL CHEM, V285, P5132, DOI 10.1074/jbc.C109.064766; Mott HR, 1997, BIOCHEMISTRY-US, V36, P3640, DOI 10.1021/bi962790o; Nassar N, 2010, BIOCHEMISTRY-US, V49, P1970, DOI 10.1021/bi9020742; NUREKAMAL MSA, 1992, J BIOL CHEM, V267, P1415; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; REINSTEIN J, 1991, J BIOL CHEM, V266, P17700; Roberts AE, 2013, LANCET, V381, P333, DOI 10.1016/S0140-6736(12)61023-X; Romano AA, 2010, PEDIATRICS, V126, P746, DOI 10.1542/peds.2009-3207; Rusyn EV, 2000, ONCOGENE, V19, P4685, DOI 10.1038/sj.onc.1203836; Sakabe K, 2002, FEBS LETT, V511, P15, DOI 10.1016/S0014-5793(01)03264-1; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shao HP, 1999, ARCH BIOCHEM BIOPHYS, V371, P207, DOI 10.1006/abbi.1999.1448; Shi GX, 2006, MOL CELL BIOL, V26, P9136, DOI 10.1128/MCB.00332-06; Shi GX, 2013, CELL SIGNAL, V25, P2060, DOI 10.1016/j.cellsig.2013.06.002; Shi GX, 2010, MOL BIOL CELL, V21, P1597, DOI 10.1091/mbc.E09-12-1033; Shi GX, 2005, MOL CELL BIOL, V25, P830, DOI 10.1128/MCB.25.2.830-846.2005; Smith MJ, 2014, NAT CHEM BIOL, V10, P223, DOI [10.1038/NCHEMBIO.1435, 10.1038/nchembio.1435]; Smith MJ, 2013, P NATL ACAD SCI USA, V110, P4574, DOI 10.1073/pnas.1218173110; Stolze B, 2015, SCI REP-UK, V5, DOI 10.1038/srep08535; STOUTEN PFW, 1993, FEBS LETT, V320, P1, DOI 10.1016/0014-5793(93)81644-F; Tabancay AP, 2003, J BIOL CHEM, V278, P39921, DOI 10.1074/jbc.M306553200; Tejpar S, 2012, J CLIN ONCOL, V30, P3570, DOI 10.1200/JCO.2012.42.2592; Yaoita M, 2016, HUM GENET, V135, P209, DOI 10.1007/s00439-015-1627-5; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	63	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15641	15652		10.1074/jbc.M116.714196	http://dx.doi.org/10.1074/jbc.M116.714196			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226556	Green Published, hybrid			2022-12-28	WOS:000380584200019
J	Qin, L; Guimaraes, DSPSF; Melesse, M; Hall, MC				Qin, Liang; Guimaraes, Dimitrius Santiago P. S. F.; Melesse, Michael; Hall, Mark C.			Substrate Recognition by the Cdh1 Destruction Box Receptor Is a General Requirement for APC/C-Cdh1-mediated Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING-COMPLEX; CYCLE-DEPENDENT DEGRADATION; MITOTIC CHECKPOINT COMPLEX; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; KEN-BOX; PSEUDOSUBSTRATE INHIBITION; SPINDLE CHECKPOINT; UBIQUITIN LIGASE; MEDIATED PROTEOLYSIS	The anaphase-promoting complex, or cyclosome (APC/C), is a ubiquitin ligase that selectively targets proteins for degradation in mitosis and the G(1) phase and is an important component of the eukaryotic cell cycle control system. How the APC/C specifically recognizes its substrates is not fully understood. Although well characterized degron motifs such as the destruction box (D-box) and KEN-box are commonly found in APC/C substrates, many substrates apparently lack these motifs. A variety of alternative APC/C degrons have been reported, suggesting either that multiple modes of substrate recognition are possible or that our definitions of degron structure are incomplete. We used an in vivo yeast assay to compare the G1 degradation rate of 15 known substrates of the APC/C co-activator Cdh1 under normal conditions and conditions that impair binding of D-box, KEN-box, and the recently identified ABBA motif degrons to Cdh1. The D-box receptor was required for efficient proteolysis of all Cdh1 substrates, despite the absence of canonical D-boxes in many. In contrast, the KEN-box receptor was only required for normal proteolysis of a subset of substrates and the ABBA motif receptor for a single substrate in our system. Our results suggest that binding to the D-box receptor may be a shared requirement for recognition and processing of all Cdh1 substrates.	[Hall, Mark C.] Purdue Univ, Dept Biochem, 1203 West State St, W Lafayette, IN 47907 USA; Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hall, MC (corresponding author), Purdue Univ, Dept Biochem, 1203 West State St, W Lafayette, IN 47907 USA.	mchall@purdue.edu	Melesse, Michael/AAA-9425-2019; Hall, Mark C./D-1698-2011	Melesse Vergara, Michael/0000-0002-3474-6981; Hall, Mark/0000-0001-6429-2506	National Institutes of Health [P30 CA02316]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to the Purdue Center for Cancer Research shared resources, supported by National Institutes of Health Grant P30 CA02316, for DNA sequencing analysis. We thank Dr. Adam Rudner (University of Ottawa) for providing antibodies to APC subunits.	Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Araki M, 2005, GENE DEV, V19, P2458, DOI 10.1101/gad.1361905; Arnold L, 2015, MOL BIOL CELL, V26, P843, DOI 10.1091/mbc.E14-09-1342; Barford D, 2011, Q REV BIOPHYS, V44, P153, DOI 10.1017/S0033583510000259; Benanti JA, 2009, MOL CELL, V33, P581, DOI 10.1016/j.molcel.2009.01.032; Burton JL, 2011, EMBO J, V30, P1818, DOI 10.1038/emboj.2011.90; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Buschhorn BA, 2011, NAT STRUCT MOL BIOL, V18, P6, DOI 10.1038/nsmb.1979; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Castro A, 2003, MOL CELL BIOL, V23, P4126, DOI 10.1128/MCB.23.12.4126-4138.2003; Castro A, 2002, EMBO REP, V3, P1209, DOI 10.1093/embo-reports/kvf241; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Chang LF, 2014, NATURE, V513, P388, DOI 10.1038/nature13543; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Choi E, 2008, J BIOL CHEM, V283, P23701, DOI 10.1074/jbc.M803695200; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cotto-Rios XM, 2011, J CELL BIOL, V194, P177, DOI 10.1083/jcb.201101062; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Di Fiore B, 2015, DEV CELL, V32, P358, DOI 10.1016/j.devcel.2015.01.003; Diaz-Martinez LA, 2015, J BIOL CHEM, V290, P2431, DOI 10.1074/jbc.M114.616490; Engelbert D, 2008, ONCOGENE, V27, P907, DOI 10.1038/sj.onc.1210703; Enquist-Newman M, 2008, MOL CELL, V30, P437, DOI 10.1016/j.molcel.2008.04.004; Eshleman HD, 2014, J CELL SCI, V127, P4974, DOI 10.1242/jcs.161273; Gao DM, 2009, MOL BIOL CELL, V20, P3305, DOI 10.1091/mbc.E09-01-0092; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gordon DM, 2001, P NATL ACAD SCI USA, V98, P12515, DOI 10.1073/pnas.231212498; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; Hendrickson C, 2001, CURR BIOL, V11, P1781, DOI 10.1016/S0960-9822(01)00564-4; Hildebrandt ER, 2001, MOL BIOL CELL, V12, P3402, DOI 10.1091/mbc.12.11.3402; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Ko N, 2007, MOL BIOL CELL, V18, P5139, DOI 10.1091/mbc.E07-05-0509; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Lindon C, 2008, BIOCHEM SOC T, V36, P405, DOI 10.1042/BST0360405; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Lu D, 2014, J CELL BIOL, V207, P23, DOI 10.1083/jcb.201402041; Martinez JS, 2006, MOL CELL BIOL, V26, P9162, DOI 10.1128/MCB.00603-06; Martinez JS, 2012, CELL CYCLE, V11, P384, DOI 10.4161/cc.11.2.18944; McLean JR, 2011, CRIT REV BIOCHEM MOL, V46, P118, DOI 10.3109/10409238.2010.541420; Melesse M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103517; Ostapenko D, 2008, MOL CELL BIOL, V28, P4653, DOI 10.1128/MCB.00055-08; Ostapenko D, 2011, MOL BIOL CELL, V22, P2175, DOI 10.1091/mbc.E11-01-0031; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Pfleger CM, 2000, GENE DEV, V14, P655; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Reis A, 2006, EMBO REP, V7, P1040, DOI 10.1038/sj.embor.7400772; Robbins JA, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-23; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Shah R, 2001, GENETICS, V159, P965; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Sullivan M, 2007, J BIOL CHEM, V282, P19710, DOI 10.1074/jbc.M701507200; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Tian W, 2012, P NATL ACAD SCI USA, V109, P18419, DOI 10.1073/pnas.1213438109; Van Voorhis VA, 2014, CURR BIOL, V24, P1556, DOI 10.1016/j.cub.2014.05.052; Wasch R, 2010, ONCOGENE, V29, P1, DOI 10.1038/onc.2009.325; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Zur A, 2002, EMBO J, V21, P4500, DOI 10.1093/emboj/cdf452	66	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15564	15574		10.1074/jbc.M116.731190	http://dx.doi.org/10.1074/jbc.M116.731190			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226622	Green Published, hybrid			2022-12-28	WOS:000380584200013
J	Lossow, K; Hubner, S; Roudnitzky, N; Slack, JP; Pollastro, F; Behrens, M; Meyerhof, W				Lossow, Kristina; Huebner, Sandra; Roudnitzky, Natacha; Slack, Jay P.; Pollastro, Federica; Behrens, Maik; Meyerhof, Wolfgang			Comprehensive Analysis of Mouse Bitter Taste Receptors Reveals Different Molecular Receptive Ranges for Orthologous Receptors in Mice and Humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; SESQUITERPENE LACTONES; SUCROSE OCTAACETATE; CHEMOSENSORY CELLS; GENE REPERTOIRE; FUNCTIONAL-CHARACTERIZATION; OLFACTORY RECEPTORS; SIGNALING PATHWAYS; SEQUENCE ALIGNMENT; PEPTIDES ACTIVATE	One key to animal survival is the detection and avoidance of potentially harmful compounds by their bitter taste. Variable numbers of taste 2 receptor genes expressed in the gustatory end organs enable bony vertebrates (Euteleostomi) to recognize numerous bitter chemicals. It is believed that the receptive ranges of bitter taste receptor repertoires match the profiles of bitter chemicals that the species encounter in their diets. Human and mouse genomes contain pairs of orthologous bitter receptor genes that have been conserved throughout evolution. Moreover, expansions in both lineages generated species -specific sets of bitter taste receptor genes. It is assumed that the orthologous bitter taste receptor genes mediate the recognition of bitter toxins relevant for both species, whereas the lineage specific receptors enable the detection of substances differently encountered by mice and humans. By challenging 34 mouse bitter taste receptors with 128 prototypical bitter substances in a heterologous expression system, we identified cognate compounds for 21 receptors, 19 of which were previously orphan receptors. We have demonstrated that mouse taste 2 receptors, like their human counterparts, vary greatly in their breadth of tuning, ranging from very broadly to extremely narrowly tuned receptors. However, when compared with humans, mice possess fewer broadly tuned receptors and an elevated number of narrowly tuned receptors, supporting the idea that a large receptor repertoire is the basis for the evolution of specialized receptors. Moreover, we have demonstrated that sequence-orthologous bitter taste receptors have distinct agonist profiles. Species -specific gene expansions have enabled further diversification of bitter substance recognition spectra.	[Lossow, Kristina; Huebner, Sandra; Roudnitzky, Natacha; Behrens, Maik; Meyerhof, Wolfgang] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Genet, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany; [Slack, Jay P.] Givaudan Flavors Corp, Cincinnati, OH 45216 USA; [Pollastro, Federica] Univ Eastern Piemonte, Dept Drug Sci, I-28100 Novara, Italy	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Givaudan SA; University of Eastern Piedmont Amedeo Avogadro	Behrens, M (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Genet, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.	behrens@dife.de	Behrens, Maik/B-6753-2016	Behrens, Maik/0000-0003-2082-8860; Pollastro, Federica/0000-0002-0949-2799	Federal Ministry for Education and Research; Ministry for Science, Research, and Culture of the state of Brandenburg, Germany; European Union [613879]	Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry for Science, Research, and Culture of the state of Brandenburg, Germany; European Union(European Commission)	This study was supported by the Federal Ministry for Education and Research and the Ministry for Science, Research, and Culture of the state of Brandenburg, Germany, as well as the European Union's Seventh Framework Programme for research, technological development, and demonstration (SynSignal Grant 613879). J. P. S. is an employee of Givaudan Flavors Corp.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Ammon C., 2002, Archives of Physiology and Biochemistry, V110, P137, DOI 10.1076/apab.110.1.137.908; Ansoleaga B, 2013, NEUROSCIENCE, V248, P369, DOI 10.1016/j.neuroscience.2013.06.034; APPENDINO G, 1991, Fitoterapia, V62, P275; APPENDINO G, 1986, GAZZ CHIM ITAL, V116, P57; APPENDINO G, 1982, J AGR FOOD CHEM, V30, P518, DOI 10.1021/jf00111a027; Bachmanov AA, 2001, MAMM GENOME, V12, P695, DOI 10.1007/s00335-001-2061-7; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barratt-Fornell Anne, 2002, Nutr Today, V37, P144, DOI 10.1097/00017285-200207000-00003; BEAUHAIRE J, 1980, TETRAHEDRON LETT, V21, P3191, DOI 10.1016/S0040-4039(00)77442-9; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Behrens M, 2014, MOL BIOL EVOL, V31, P3216, DOI 10.1093/molbev/msu254; Behrens M, 2013, SEMIN CELL DEV BIOL, V24, P215, DOI 10.1016/j.semcdb.2012.08.006; Behrens M, 2011, PHYSIOL BEHAV, V105, P4, DOI 10.1016/j.physbeh.2011.02.010; Behrens M, 2009, J AGR FOOD CHEM, V57, P9860, DOI 10.1021/jf9014334; BELITZ H-D, 1985, Food Reviews International, V1, P271, DOI 10.1080/87559128509540773; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Born S, 2013, J NEUROSCI, V33, P201, DOI 10.1523/JNEUROSCI.3248-12.2013; Boughter JD, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-36; Boughter JD, 2002, CHEM SENSES, V27, P133, DOI 10.1093/chemse/27.2.133; BOUGHTER JD, 1992, CHEM SENSES, V17, P427, DOI 10.1093/chemse/17.4.427; Boughter JD, 1997, PHYSIOL BEHAV, V63, P101, DOI 10.1016/S0031-9384(97)00398-3; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Caicedo A, 2001, SCIENCE, V291, P1557, DOI 10.1126/science.1056670; CAPELESS CG, 1992, BEHAV GENET, V22, P655, DOI 10.1007/BF01066636; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chen MC, 2006, AM J PHYSIOL-CELL PH, V291, pC726, DOI 10.1152/ajpcell.00003.2006; Clark AA, 2015, FASEB J, V29, P164, DOI 10.1096/fj.14-262246; Conte C, 2003, PHYSIOL GENOMICS, V14, P73, DOI 10.1152/physiolgenomics.00060.2003; Correia JN, 2007, SEMIN REPROD MED, V25, P208, DOI 10.1055/s-2007-973433; Deckmann K, 2014, P NATL ACAD SCI USA, V111, P8287, DOI 10.1073/pnas.1402436111; Dehkordi O, 2012, BRAIN RES, V1475, P1, DOI 10.1016/j.brainres.2012.07.038; Dong D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-12; Dotson CD, 2004, CHEM SENSES, V29, P489, DOI 10.1093/chemse/bjh051; Dotson CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003974; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; Fattorusso E, 2002, J AGR FOOD CHEM, V50, P5131, DOI 10.1021/jf0203693; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; Feng P, 2014, GENOME BIOL EVOL, V6, P1254, DOI 10.1093/gbe/evu095; Foster SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064579; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Garcia-Esparcia P, 2013, J NEUROPATH EXP NEUR, V72, P524, DOI 10.1097/NEN.0b013e318294fd76; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Go Y, 2005, GENETICS, V170, P313, DOI 10.1534/genetics.104.037523; Grus WE, 2009, MOL BIOL EVOL, V26, P407, DOI 10.1093/molbev/msn262; Harder DB, 1998, CHEM SENSES, V23, P327, DOI 10.1093/chemse/23.3.327; Hayakawa T, 2014, MOL BIOL EVOL, V31, P2018, DOI 10.1093/molbev/msu144; He W, 2004, J NEUROSCI, V24, P7674, DOI 10.1523/JNEUROSCI.2441-04.2004; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Imai H, 2012, BIOL LETTERS, V8, P652, DOI 10.1098/rsbl.2011.1251; Intelmann D, 2009, CHEMOSENS PERCEPT, V2, P118, DOI 10.1007/s12078-009-9049-1; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Jiang PH, 2012, P NATL ACAD SCI USA, V109, P4956, DOI 10.1073/pnas.1118360109; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kohl S, 2013, J AGR FOOD CHEM, V61, P53, DOI 10.1021/jf303146h; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Lei WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139670; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li DY, 2014, MOL BIOL EVOL, V31, P303, DOI 10.1093/molbev/mst219; Li F, 2012, MOL HUM REPROD, V18, P289, DOI 10.1093/molehr/gas005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUSH IE, 1988, GENET RES, V52, P207, DOI 10.1017/S0016672300027671; LUSH IE, 1986, GENET RES, V47, P117, DOI 10.1017/S0016672300022941; LUSH IE, 1984, GENET RES, V44, P151, DOI 10.1017/S0016672300026355; LUSH IE, 1995, GENET RES, V66, P167, DOI 10.1017/S0016672300034510; LUSH IE, 1982, CHEM SENSES, V7, P93, DOI 10.1093/chemse/7.1.93; Maehashi K, 2008, BIOCHEM BIOPH RES CO, V365, P851, DOI 10.1016/j.bbrc.2007.11.070; Maga J. A., 1990, BITTERNESS FOODS BEV, P35; Marchiori A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064675; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Matsuo R, 2000, CRIT REV ORAL BIOL M, V11, P216, DOI 10.1177/10454411000110020501; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Ming D, 1998, P NATL ACAD SCI USA, V95, P8933, DOI 10.1073/pnas.95.15.8933; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson TM, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-32; Nelson TM, 2003, CHEM SENSES, V28, P695, DOI 10.1093/chemse/bjg062; Oike H, 2007, J NEUROSCI, V27, P5584, DOI 10.1523/JNEUROSCI.0651-07.2007; Ozeck M, 2004, EUR J PHARMACOL, V489, P139, DOI 10.1016/j.ejphar.2004.03.004; Prandi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082820; Pronin AN, 2004, CHEM SENSES, V29, P583, DOI 10.1093/chemse/bjh064; Roland WSU, 2011, J AGR FOOD CHEM, V59, P11764, DOI 10.1021/jf202816u; ROUSEFF RL, 1990, DEV FOOD SCI, V25, P1; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; Sainz E, 2007, BIOCHEM J, V403, P537, DOI 10.1042/BJ20061744; Sandau MM, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0170-6; Sbarbati A, 2009, ANAT REC, V292, P439, DOI 10.1002/ar.20866; Shi P, 2006, MOL BIOL EVOL, V23, P292, DOI 10.1093/molbev/msj028; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; SHINGAI T, 1985, BRAIN RES, V335, P245, DOI 10.1016/0006-8993(85)90476-7; Singh N, 2011, BIOCHEM BIOPH RES CO, V406, P146, DOI 10.1016/j.bbrc.2011.02.016; Slack JP, 2010, CURR BIOL, V20, P1104, DOI 10.1016/j.cub.2010.04.043; Soares S, 2013, J AGR FOOD CHEM, V61, P1525, DOI 10.1021/jf304198k; Syed AS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-650; Thalmann S, 2013, BIOCHEM BIOPH RES CO, V435, P267, DOI 10.1016/j.bbrc.2013.04.066; Tizzano M, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-3; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Ueda T, 2003, J NEUROSCI, V23, P7376; Voigt A, 2012, CHEM SENSES, V37, P897, DOI 10.1093/chemse/bjs082; WARREN RP, 1970, NATURE, V227, P77, DOI 10.1038/227077a0; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WHITNEY G, 1994, PHYSIOL BEHAV, V56, P1141, DOI 10.1016/0031-9384(94)90358-1; WHITNEY G, 1986, BEHAV GENET, V16, P559, DOI 10.1007/BF01066342; Wiener A, 2012, NUCLEIC ACIDS RES, V40, pD413, DOI 10.1093/nar/gkr755; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Wooding S, 2006, NATURE, V440, P930, DOI 10.1038/nature04655; Wu SV, 2005, PHYSIOL GENOMICS, V22, P139, DOI 10.1152/physiolgenomics.00030.2005; Wyrembek P, 2012, J NAT PROD, V75, P610, DOI 10.1021/np2008522; Xu J, 2013, MOL HUM REPROD, V19, P17, DOI 10.1093/molehr/gas040; Yu YQ, 2015, P NATL ACAD SCI USA, V112, P14966, DOI 10.1073/pnas.1517510112; Zhang LH, 2004, MOL MICROBIOL, V53, P1563, DOI 10.1111/j.1365-2958.2004.04234.x; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao HB, 2015, CURR BIOL, V25, pR141, DOI 10.1016/j.cub.2015.01.026; Zhu KL, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0218-8	124	118	123	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15358	15377		10.1074/jbc.M116.718544	http://dx.doi.org/10.1074/jbc.M116.718544			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226572	Green Published, hybrid			2022-12-28	WOS:000380583200040
J	Wakabayashi, T; Hidaka, R; Fujimaki, S; Asashima, M; Kuwabara, T				Wakabayashi, Tamami; Hidaka, Ryo; Fujimaki, Shin; Asashima, Makoto; Kuwabara, Tomoko			Diabetes Impairs Wnt3 Protein-induced Neurogenesis in Olfactory Bulbs via Glutamate Transporter 1 Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL STEM-CELLS; ADULT HIPPOCAMPAL NEUROGENESIS; POSTNATAL SUBVENTRICULAR ZONE; FIBROBLAST GROWTH FACTOR-2; PROGENITOR CELLS; IN-VITRO; NEUROTROPHIC FACTOR; DENTATE GYRUS; NEURONAL DIFFERENTIATION; ALZHEIMERS-DISEASE	Diabetes is associated with impaired cognitive function. Streptozotocin (STZ)-induced diabetic rats exhibit a loss of neurogenesis and deficits in behavioral tasks involving spatial learning and memory; thus, impaired adult hippocampal neurogenesis may contribute to diabetes-associated cognitive deficits. Recent studies have demonstrated that adult neurogenesis generally occurs in the dentate gyrus of the hippocampus, the sub ventricular zone, and the olfactory bulbs (OB) and is defective in patients with diabetes. We hypothesized that OB neurogenesis and associated behaviors would be affected in diabetes. In this study, we show that inhibition of Wnt3-induced neurogenesis in the OB causes several behavioral deficits in STZ-induced diabetic rats, including impaired odor discrimination, cognitive dysfunction, and increased anxiety. Notably, the sodium- and chloride-dependent GABA transporters and excitatory amino acid transporters that localize to GABAergic and glutamatergic terminals decreased in the OB of diabetic rats. Moreover, GAT1 inhibitor administration also hindered Wnt3-induced neurogenesis in vitro. Collectively, these data suggest that STZ-induced diabetes adversely affects OB neurogenesis via GABA and glutamate transporter systems, leading to functional impairments in olfactory performance.	[Wakabayashi, Tamami; Hidaka, Ryo; Fujimaki, Shin; Asashima, Makoto; Kuwabara, Tomoko] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Dept Life Sci & Biotechnol, Stem Cell Engn Res Grp, Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan; [Fujimaki, Shin] Univ Tsukuba, Grad Sch Comprehens Human Sci, Phys Educ Hlth & Sport Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3038577, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Wakabayashi, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Dept Life Sci & Biotechnol, Stem Cell Engn Res Grp, Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	t.warashina@aist.go.jp	Kuwabara, Tomoko/M-1639-2018	Kuwabara, Tomoko/0000-0002-7668-0896	National Institute of Advanced Industrial Science and Technology; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation; Mitsubishi Foundation	National Institute of Advanced Industrial Science and Technology; Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation	Supported by the National Institute of Advanced Industrial Science and Technology.r Supported by a grant-in-aid for scientific research on innovative areas, a grant-in-aid for scientific research (B), the Naito Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Takeda Science Foundation, and the Mitsubishi Foundation. To whom correspondence should be addressed. Tel.: 81-29-861-2529; Fax: 81-29-861-2897; E-mail: t.warashina@aist.go.jp.	Anarkooli IJ, 2008, EXP DIABETES RES, DOI 10.1155/2008/638467; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Arsenijevic Y, 2001, J NEUROSCI, V21, P7194, DOI 10.1523/JNEUROSCI.21-18-07194.2001; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bhutada P, 2012, PROG NEURO-PSYCHOPH, V37, P96, DOI 10.1016/j.pnpbp.2012.01.009; Biessels GJ, 2002, EUR J PHARMACOL, V441, P1, DOI 10.1016/S0014-2999(02)01486-3; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Boutin C, 2010, P NATL ACAD SCI USA, V107, P1201, DOI 10.1073/pnas.0909015107; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Carter BS, 2012, PHYSIOL GENOMICS, V44, P1188, DOI 10.1152/physiolgenomics.00097.2012; Coleman E, 2004, GLIA, V48, P166, DOI 10.1002/glia.20068; Coleman ES, 2010, BRAIN RES, V1306, P131, DOI 10.1016/j.brainres.2009.10.005; Dennis JC, 2005, J NEUROCYTOL, V34, P3, DOI 10.1007/s11068-005-5044-x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fujimaki S, 2014, J BIOL CHEM, V289, P7399, DOI 10.1074/jbc.M113.539247; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gandhi GK, 2010, ASN NEURO, V2, DOI 10.1042/AN20090048; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Giachino C, 2009, EUR J NEUROSCI, V30, P9, DOI 10.1111/j.1460-9568.2009.06798.x; Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gouveri E, 2014, ANGIOLOGY, V65, P869, DOI 10.1177/0003319714520956; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Hidaka R, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt201; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Jabbarpour Z, 2014, BRAIN RES BULL, V101, P51, DOI 10.1016/j.brainresbull.2013.12.013; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jin XT, 2012, EUR J NEUROSCI, V36, P2482, DOI 10.1111/j.1460-9568.2012.08147.x; Jolivalt CG, 2012, NEUROSCIENCE, V202, P405, DOI 10.1016/j.neuroscience.2011.11.032; Jurdak N, 2009, PHYSIOL BEHAV, V96, P1, DOI 10.1016/j.physbeh.2008.07.023; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kim JB, 2004, BRAIN RES, V1027, P1, DOI 10.1016/j.brainres.2004.070.93; Krause S, 2005, MOL PHARMACOL, V68, P1728, DOI 10.1124/mol.105.013870; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Kumagai AK, 1999, DIABETES-METAB RES, V15, P261, DOI 10.1002/(SICI)1520-7560(199907/08)15:4<261::AID-DMRR43>3.0.CO;2-Z; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Kuwabara T, 2011, EMBO MOL MED, V3, P742, DOI 10.1002/emmm.201100177; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lau WM, 2007, RESTOR NEUROL NEUROS, V25, P17; LEFLOCH JP, 1993, DIABETES CARE, V16, P934, DOI 10.2337/diacare.16.6.934; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Liu ZP, 2003, J COMP NEUROL, V459, P368, DOI 10.1002/cne.10664; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Machida M, 2012, J CELL PHYSIOL, V227, P1569, DOI 10.1002/jcp.22871; Milanese M, 2010, J NEUROCHEM, V113, P489, DOI 10.1111/j.1471-4159.2010.06628.x; Moreno-Estelles M, 2012, STEM CELLS, V30, P2796, DOI 10.1002/stem.1243; Mu JS, 1999, BRAIN RES, V835, P259, DOI 10.1016/S0006-8993(99)01592-9; Muranyi M, 2006, DIABETES, V55, P349, DOI 10.2337/diabetes.55.02.06.db05-0654; Nguyen L, 2003, J NEUROSCI, V23, P3278; Nishimura M, 1997, MOL BRAIN RES, V45, P268, DOI 10.1016/S0169-328X(96)00259-8; Nitta A, 2002, NEUROTOXICOL TERATOL, V24, P695, DOI 10.1016/S0892-0362(02)00220-9; Noble EE, 2011, AM J PHYSIOL-REG I, V300, pR1053, DOI 10.1152/ajpregu.00776.2010; Okamoto M, 2011, FASEB J, V25, P3570, DOI 10.1096/fj.11-184697; Pagano SF, 2000, STEM CELLS, V18, P295, DOI 10.1634/stemcells.18-4-295; Pallotto M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00166; Palmer TD, 1999, J NEUROSCI, V19, P8487; Piazza FV, 2011, BEHAV BRAIN RES, V217, P16, DOI 10.1016/j.bbr.2010.09.017; Platel JC, 2008, J PHYSIOL-LONDON, V586, P3739, DOI 10.1113/jphysiol.2008.155325; Ramanathan M, 1998, PSYCHOPHARMACOLOGY, V135, P361, DOI 10.1007/s002130050523; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; RERUP C, 1969, EUR J PHARMACOL, V7, P89, DOI 10.1016/0014-2999(69)90169-1; Revsin Y, 2009, NEUROPSYCHOPHARMACOL, V34, P747, DOI 10.1038/npp.2008.136; Schaaf MJM, 1997, J NEUROSCI RES, V48, P334, DOI 10.1002/(SICI)1097-4547(19970515)48:4<334::AID-JNR5>3.0.CO;2-C; Seib DRM, 2013, CELL STEM CELL, V12, P204, DOI 10.1016/j.stem.2012.11.010; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Stewart RR, 2002, J NEUROBIOL, V50, P305, DOI 10.1002/neu.10038; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Taliaz D, 2010, MOL PSYCHIATR, V15, P80, DOI 10.1038/mp.2009.67; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Unemura K, 2012, J PHARMACOL SCI, V119, P30, DOI 10.1254/jphs.12047FP; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Varela-Nallar L, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00100; Verdile G, 2015, NEUROBIOL DIS, V84, P22, DOI 10.1016/j.nbd.2015.04.008; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; WEINSTOCK RS, 1993, PHYSIOL BEHAV, V53, P17, DOI 10.1016/0031-9384(93)90005-Z; Wu YM, 2007, NEURON, V56, P851, DOI 10.1016/j.neuron.2007.10.021; Zhou Yun, 2013, Front Endocrinol (Lausanne), V4, P165, DOI 10.3389/fendo.2013.00165	86	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15196	15211		10.1074/jbc.M115.672857	http://dx.doi.org/10.1074/jbc.M115.672857			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226528	Green Published, hybrid			2022-12-28	WOS:000380583200028
J	Wuttke, A; Yu, Q; Tengholm, A				Wuttke, Anne; Yu, Qian; Tengholm, Anders			Autocrine Signaling Underlies Fast Repetitive Plasma Membrane Translocation of Conventional and Novel Protein Kinase C Isoforms in beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED INSULIN-SECRETION; P2Y(1) RECEPTORS; TUMOR PROMOTER; CA2+ INFLUX; PKC-ALPHA; GLUCOSE; DYNAMICS; INVOLVEMENT; DELTA; ACTIVATION	PKC signaling has been implicated in the regulation of many cell functions, including metabolism, cell death, proliferation, and secretion. Activation of conventional and novel PKC isoforms is associated with their Ca2+- and/or diacylglycerol (DAG)-dependent translocation to the plasma membrane. In 13 cells, exocytosis of insulin granules evokes brief (<10 s) local DAG elevations ("spiking") at the plasma membrane because of autocrine activation of P2Y(1), purinoceptors by ATP co-released with insulin. Using total internal reflection microscopy, fluorescent protein -tagged PKCs, and signaling biosensors, we investigated whether DAG spiking causes membrane recruitment of PKCs and whether different classes of PKCs show characteristic responses. Glucose stimulation of MINE cells triggered DAG spiking with concomitant repetitive translocation of the novel isoforms PKCI, PKCE, and PKCirp The conventional PKCa, PKCI3I, and PKC beta II isoforms showed a more complex pattern with both rapid and slow translocation. K+ depolarization-induced PKCE translocation entirely mirrored DAG spiking, whereas PKC beta 1 translocation showed a sustained component, reflecting the subplasma membrane Ca2+ concentration ([Ca2+)pm), with additional effect during DAG spikes. Interference with DAG spiking by purinoceptor inhibition prevented intermittent translocation of PKCs and reduced insulin secretion but did not affect [Ca2+]{,1 elevation or sustained PKCAI translocation. The muscarinic agonist carbachol induced pronounced transient PKCi3I translocation and sustained recruitment of PKCE. When rise of [Ca2+](p), was prevented, the carbachol-induced DAG and PKCE responses were somewhat reduced, but PKCI3I translocation was completely abolished. We conclude that exocytosis-induced DAG spikes efficiently recruit both conventional and novel PKCs to the beta cell plasma membrane. PKC signaling is thus implicated in autocrine regulation of beta cell function.	[Wuttke, Anne; Yu, Qian; Tengholm, Anders] Uppsala Univ, Dept Med Cell Biol, Biomed Ctr, Box 571, S-75123 Uppsala, Sweden	Uppsala University	Tengholm, A (corresponding author), Uppsala Univ, Dept Med Cell Biol, Biomed Ctr, Box 571, S-75123 Uppsala, Sweden.	anders.tengholm@mcb.uu.se		YU, QIAN/0000-0003-4888-9446	Swedish Research Council; Novo Nordisk Foundation; Swedish Diabetes Foundation; European Foundation for the Study of Diabetes (EFSD)-MSD; Diabetes Research AMP; Wellness Foundation; Family Ernfors Foundation; Novo Nordisk Fonden [NNF14OC0010363] Funding Source: researchfish; European Foundation for the Study of Diabetes [MSD 2014_2] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Foundation; European Foundation for the Study of Diabetes (EFSD)-MSD; Diabetes Research AMP; Wellness Foundation; Family Ernfors Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation); European Foundation for the Study of Diabetes	This work was supported by grants from the Swedish Research Council, the Novo Nordisk Foundation, the Swedish Diabetes Foundation, the European Foundation for the Study of Diabetes (EFSD)-MSD, the Diabetes Research & Wellness Foundation, and the Family Ernfors Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	ARKHAMMAR P, 1989, BIOCHEM J, V264, P207, DOI 10.1042/bj2640207; ARKHAMMAR P, 1994, J BIOL CHEM, V269, P2743; BIDEN TJ, 1987, J BIOL CHEM, V262, P3567; Biden TJ, 2008, BIOCHEM SOC T, V36, P916, DOI 10.1042/BST0360916; Carpenter L, 2004, DIABETES, V53, P53, DOI 10.2337/diabetes.53.1.53; Corbalan-Garcia S, 2006, BBA-MOL CELL BIOL L, V1761, P633, DOI 10.1016/j.bbalip.2006.04.015; Duquesnes N, 2011, J MOL CELL CARDIOL, V51, P665, DOI 10.1016/j.yjmcc.2011.07.013; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Harris TE, 1996, BIOCHEM BIOPH RES CO, V227, P672, DOI 10.1006/bbrc.1996.1567; Hashimoto N, 2005, J CLIN INVEST, V115, P138, DOI 10.1172/JCI200522232; HII CST, 1987, BIOCHEM J, V246, P489, DOI 10.1042/bj2460489; Hui X, 2014, MOL CELL BIOL, V34, P2370, DOI 10.1128/MCB.00040-14; Ishikawa T, 2005, LIFE SCI, V77, P462, DOI 10.1016/j.lfs.2005.01.008; Johnson JE, 2000, BIOCHEMISTRY-US, V39, P11360, DOI 10.1021/bi000902c; JONES PM, 1985, FEBS LETT, V191, P102, DOI 10.1016/0014-5793(85)81002-4; Kaneto H, 2002, J BIOL CHEM, V277, P3680, DOI 10.1074/jbc.M109647200; Khan S, 2014, DIABETOLOGIA, V57, P2535, DOI 10.1007/s00125-014-3368-8; KNUTSON KL, 1994, ENDOCRINOLOGY, V135, P881, DOI 10.1210/en.135.3.881; Knutson KL, 1996, J CELL BIOCHEM, V60, P130, DOI 10.1002/(SICI)1097-4644(19960101)60:1<130::AID-JCB15>3.0.CO;2-T; MALAISSE WJ, 1980, CANCER RES, V40, P3827; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Marin-Vicente C, 2008, J MOL BIOL, V377, P1038, DOI 10.1016/j.jmb.2007.12.011; Mendez CF, 2003, J BIOL CHEM, V278, P44753, DOI 10.1074/jbc.M308664200; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Petit P, 2009, EUR J PHARM SCI, V37, P67, DOI 10.1016/j.ejps.2009.01.007; Pinton P, 2002, J BIOL CHEM, V277, P37702, DOI 10.1074/jbc.M204478200; Salehi A, 2005, DIABETES, V54, P2126, DOI 10.2337/diabetes.54.7.2126; Schmitz-Peiffer C, 2007, CELL METAB, V6, P320, DOI 10.1016/j.cmet.2007.08.012; TAMAGAWA T, 1985, FEBS LETT, V183, P433, DOI 10.1016/0014-5793(85)80825-5; Tamarina NA, 2005, DIABETES, V54, P3073, DOI 10.2337/diabetes.54.11.3073; Tang SH, 1998, DIABETES, V47, P905, DOI 10.2337/diabetes.47.6.905; Tengholm A, 2014, DIABETOLOGIA, V57, P2436, DOI 10.1007/s00125-014-3392-8; Tewson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042791; Thore S, 2004, J BIOL CHEM, V279, P19396, DOI 10.1074/jbc.C400088200; Tian YM, 1996, MOL CELL ENDOCRINOL, V119, P185, DOI 10.1016/0303-7207(96)03811-7; Uchida T, 2007, J BIOL CHEM, V282, P2707, DOI 10.1074/jbc.M610482200; VIRJI MAG, 1978, ENDOCRINOLOGY, V102, P706, DOI 10.1210/endo-102-3-706; Warwar N, 2006, DIABETES, V55, P590, DOI 10.2337/diabetes.55.03.06.db05-0001; Wuttke A, 2013, FASEB J, V27, P1610, DOI 10.1096/fj.12-221499; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417; Zawalich WS, 2001, MOL CELL ENDOCRINOL, V177, P95, DOI 10.1016/S0303-7207(01)00422-1; Zeng LL, 2012, ADV EXP MED BIOL, V740, P639, DOI 10.1007/978-94-007-2888-2_28; Zhang H, 2004, J PHYSIOL-LONDON, V561, P133, DOI 10.1113/jphysiol.2004.071241; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	48	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14986	14995		10.1074/jbc.M115.698456	http://dx.doi.org/10.1074/jbc.M115.698456			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226533	hybrid, Green Published			2022-12-28	WOS:000380583200011
J	Codding, SJ; Marty, N; Abdullah, N; Johnson, CP				Codding, Sara J.; Marty, Naomi; Abdullah, Nazish; Johnson, Colin P.			Dysferlin Binds SNAREs (Soluble N-Ethylmaleimide-sensitive Factor (NSF) Attachment Protein Receptors) and Stimulates Membrane Fusion in a Calcium-sensitive Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium-binding protein; exocytosis; membrane fusion; muscular dystrophy; SNARE proteins; dysferlin	GIRDLE MUSCULAR-DYSTROPHY; C2 DOMAINS REVEALS; VESICLE FUSION; CELL-MEMBRANE; MIYOSHI MYOPATHY; SKELETAL-MUSCLE; REPAIR; OTOFERLIN; SYNAPTOTAGMIN; COMPLEX	Resealing of tears in the sarcolemma of myofibers is a necessary step in the repair of muscle tissue. Recent work suggests a critical role for dysferlin in the membrane repair process and that mutations in dysferlin are responsible for limb girdle muscular dystrophy 2B and Miyoshi myopathy. Beyond membrane repair, dysferlin has been linked to SNARE-mediated exocytotic events including cytokine release and acid sphingomyelinase secretion. However, it is unclear whether dysferlin regulates SNARE-mediated membrane fusion. In this study we demonstrate a direct interaction between dysferlin and the SNARE proteins syntaxin 4 and SNAP-23. In addition, analysis of FRET and in vitro reconstituted lipid mixing assays indicate that dysferlin accelerates syntaxin 4/SNAP-23 heterodimer formation and SNARE-mediated lipid mixing in a calcium-sensitive manner. These results support a function for dysferlin as a calcium-sensing SNARE effector for membrane fusion events.	[Codding, Sara J.; Marty, Naomi; Abdullah, Nazish; Johnson, Colin P.] Oregon State Univ, Dept Biochem & Biophys, 2011 ALS, Corvallis, OR 97331 USA	Oregon State University	Johnson, CP (corresponding author), Oregon State Univ, Dept Biochem & Biophys, 2011 ALS, Corvallis, OR 97331 USA.	colin.johnson@oregonstate.edu	abdullah, nazish/M-9541-2016	abdullah, nazish/0000-0002-4776-7300; Codding, Sara/0000-0002-2519-0299; Johnson, Colin/0000-0002-6783-2835				Abdullah N, 2014, BIOPHYS J, V106, P382, DOI 10.1016/j.bpj.2013.11.4492; Achanzar WE, 1997, J CELL SCI, V110, P1073; Ampong Beryl N, 2005, Acta Myol, V24, P134; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Azakir BA, 2012, J BIOL CHEM, V287, P27629, DOI 10.1074/jbc.M112.391722; Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; Bushby KMD, 2000, ACTA NEUROL BELG, V100, P142; Chen XC, 2008, J BIOMOL NMR, V41, P43, DOI 10.1007/s10858-008-9239-1; Chiu YH, 2009, HUM MOL GENET, V18, P1976, DOI 10.1093/hmg/ddp121; Defour A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.272; Evesson FJ, 2010, J BIOL CHEM, V285, P28529, DOI 10.1074/jbc.M110.111120; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Han WQ, 2012, J CELL SCI, V125, P1225, DOI 10.1242/jcs.094565; Hui EF, 2011, NAT STRUCT MOL BIOL, V18, P813, DOI 10.1038/nsmb.2075; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Humphrey GW, 2012, EXP CELL RES, V318, P127, DOI 10.1016/j.yexcr.2011.10.004; Johnson CP, 2010, J CELL BIOL, V191, P187, DOI 10.1083/jcb.201002089; Kerr JP, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00089; Kerr JP, 2013, P NATL ACAD SCI USA, V110, P20831, DOI 10.1073/pnas.1307960110; Kubista H, 2004, J CELL SCI, V117, P955, DOI 10.1242/jcs.00941; Lek A, 2012, TRAFFIC, V13, P185, DOI 10.1111/j.1600-0854.2011.01267.x; Lek A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-231; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Lostal W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038036; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Marty NJ, 2013, BIOCHEMISTRY-US, V52, P5585, DOI 10.1021/bi400432f; Matsuda C, 1999, NEUROLOGY, V53, P1119, DOI 10.1212/WNL.53.5.1119; Matsuda C., 2012, PLOS CURR, V4, DOI DOI 10.1371/5035ADD8CAFF4; McDade JR, 2014, HUM MOL GENET, V23, P1677, DOI 10.1093/hmg/ddt557; Nagaraju K, 2008, AM J PATHOL, V172, P774, DOI 10.2353/ajpath.2008.070327; Padmanarayana M, 2014, BIOCHEMISTRY-US, V53, P5023, DOI 10.1021/bi5004469; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P1364, DOI 10.1074/jbc.M803605200; Redpath GMI, 2014, MOL BIOL CELL, V25, P3037, DOI 10.1091/mbc.E14-04-0947; Roostalu U, 2012, DEV CELL, V22, P515, DOI 10.1016/j.devcel.2011.12.008; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Therrien C, 2009, BIOCHEMISTRY-US, V48, P2377, DOI 10.1021/bi802242r; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Waddell LB, 2011, J NEUROPATH EXP NEUR, V70, P302, DOI 10.1097/NEN.0b013e31821350b0; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	51	15	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14575	14584		10.1074/jbc.M116.727016	http://dx.doi.org/10.1074/jbc.M116.727016			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226605	Green Published, hybrid			2022-12-28	WOS:000380366700014
J	Brown, LE; Nicholson, MW; Arama, JE; Mercer, A; Thomson, AM; Jovanovic, JN				Brown, Laura E.; Nicholson, Martin W.; Arama, Jessica E.; Mercer, Audrey; Thomson, Alex M.; Jovanovic, Jasmina N.			gamma-Aminobutyric Acid Type A (GABA(A)) Receptor Subunits Play a Direct Structural Role in Synaptic Contact Formation via Their N-terminal Extracellular Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell culture; -aminobutyric acid (GABA); inhibition mechanism; protein domain; synapse	INFECTED INSECT CELLS; BASAL GANGLIA; GLOBUS-PALLIDUS; PYRAMIDAL CELLS; RAT-BRAIN; SYNAPSES; EXPRESSION; SUBTYPES; BETA; GLYCOSYLATION	The establishment of cell-cell contacts between presynaptic GABAergic neurons and their postsynaptic targets initiates the process of GABAergic synapse formation. GABA(A) receptors (GABA(A)Rs), the main postsynaptic receptors for GABA, have been recently demonstrated to act as synaptogenic proteins that can single-handedly induce the formation and functional maturation of inhibitory synapses. To establish how the subunit composition of GABA(A)Rs influences their ability to induce synaptogenesis, a co-culture model system incorporating GABAergic medium spiny neurons and the HEK293 cells, stably expressing different combinations of receptor subunits, was developed. Analyses of HEK293 cell innervation by medium spiny neuron axons using immunocytochemistry, activity-dependent labeling, and electrophysiology have indicated that the 2 subunit is required for the formation of active synapses and that its effects are influenced by the type of / subunits incorporated into the functional receptor. To further characterize this process, the large N-terminal extracellular domains (ECDs) of 1, 2, 2, and 2 subunits were purified using the baculovirus/Sf9 cell system. When these proteins were applied to the co-cultures of MSNs and 1/2/2-expressing HEK293 cells, the 1, 2, or 2 ECD each caused a significant reduction in contact formation, in contrast to the 2 ECD, which had no effect. Together, our experiments indicate that the structural role of GABA(A)Rs in synaptic contact formation is determined by their subunit composition, with the N-terminal ECDs of each of the subunits directly participating in interactions between the presynaptic and postsynaptic elements, suggesting the these interactions are multivalent and specific.	[Brown, Laura E.; Nicholson, Martin W.; Arama, Jessica E.; Mercer, Audrey; Thomson, Alex M.; Jovanovic, Jasmina N.] UCL, UCL Sch Pharm, Res Dept Pharmacol, London WC1N 1AX, England	University of London; University College London	Jovanovic, JN (corresponding author), UCL, UCL Sch Pharm, 29-39 Brunswick Sq, London WC1N 1AX, England.	j.jovanovic@ucl.ac.uk		Mercer, Audrey/0000-0002-5086-2560	Medical Research Council United Kingdom Project Grant [G0800498]; Wellcome Trust; Medical Research Council; Medical Research Council [G0800498] Funding Source: researchfish; MRC [G0800498] Funding Source: UKRI	Medical Research Council United Kingdom Project Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Medical Research Council United Kingdom Project Grant G0800498 and The Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Medical Research Council studentship.	Ali AB, 2008, CEREB CORTEX, V18, P1260, DOI 10.1093/cercor/bhm160; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Braat S, 2015, NEURON, V86, P1119, DOI 10.1016/j.neuron.2015.03.042; Brown LE, 2014, JOVE-J VIS EXP, DOI 10.3791/52115; CHAI H, 1993, BIOTECHNOL APPL BIOC, V18, P259; Chiou TT, 2011, J BIOL CHEM, V286, P22456, DOI 10.1074/jbc.M111.236190; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1996, P NATL ACAD SCI USA, V93, P9899, DOI 10.1073/pnas.93.18.9899; Crestani F, 2015, ADV PHARMACOL, V72, P37, DOI 10.1016/bs.apha.2014.10.001; Deidda G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00119; Dong N, 2007, MOL CELL NEUROSCI, V35, P14, DOI 10.1016/j.mcn.2007.01.013; DUGGAN MJ, 1990, J BIOL CHEM, V265, P3831; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Fritschy JM, 2012, CELL MOL LIFE SCI, V69, P2485, DOI 10.1007/s00018-012-0926-4; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Fu ZY, 2009, MOL CELL NEUROSCI, V42, P45, DOI 10.1016/j.mcn.2009.05.004; Fuchs Celine, 2013, Eur J Neurosci, V38, P3146, DOI 10.1111/ejn.12331; Fujiyama F, 2000, J COMP NEUROL, V416, P158; Goffin D, 2010, J NEUROSCI, V30, P2935, DOI 10.1523/JNEUROSCI.4411-09.2010; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Gross A, 2011, EUR J NEUROSCI, V33, P868, DOI 10.1111/j.1460-9568.2010.07552.x; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; JARVIS DL, 1989, MOL CELL BIOL, V9, P214, DOI 10.1128/MCB.9.1.214; JARVIS DL, 1990, J CELL BIOCHEM, V42, P181, DOI 10.1002/jcb.240420402; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; Klausberger T, 2002, J NEUROSCI, V22, P2513, DOI 10.1523/JNEUROSCI.22-07-02513.2002; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Kubota Y, 2014, CURR OPIN NEUROBIOL, V26, P7, DOI 10.1016/j.conb.2013.10.003; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; Mallet N, 2005, J NEUROSCI, V25, P3857, DOI 10.1523/JNEUROSCI.5027-04.2005; MHATRE MC, 1993, J NEUROCHEM, V61, P1620, DOI 10.1111/j.1471-4159.1993.tb09795.x; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mohler H, 2006, CELL TISSUE RES, V326, P505, DOI 10.1007/s00441-006-0284-3; Nelson AB, 2014, ANNU REV NEUROSCI, V37, P117, DOI 10.1146/annurev-neuro-071013-013916; Nuss P, 2015, NEUROPSYCH DIS TREAT, V11, P165, DOI 10.2147/NDT.S58841; Nyiri G, 2001, EUR J NEUROSCI, V13, P428, DOI 10.1046/j.1460-9568.2001.01407.x; Obeso JA, 2014, LANCET, V384, P523, DOI 10.1016/S0140-6736(13)62418-6; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Porcher C, 2011, J BIOL CHEM, V286, P21667, DOI 10.1074/jbc.M110.201582; Possee RD, 1997, CURR OPIN BIOTECH, V8, P569, DOI 10.1016/S0958-1669(97)80030-4; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Sieghart W, 2006, ADV PHARMACOL, V54, P231, DOI 10.1016/S1054-3589(06)54010-4; Silberberg G, 2015, CURR OPIN NEUROBIOL, V33, P182, DOI 10.1016/j.conb.2015.05.002; Sims RE, 2008, EUR J NEUROSCI, V28, P2401, DOI 10.1111/j.1460-9568.2008.06546.x; Somogyi P, 1996, NEUROPHARMACOLOGY, V35, P1425, DOI 10.1016/S0028-3908(96)00086-X; Tanaka H, 2012, CELL REPORTS, V2, P101, DOI 10.1016/j.celrep.2012.06.009; Tepper JM, 2007, PROG BRAIN RES, V160, P3, DOI 10.1016/S0079-6123(06)60001-0; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Thomson AM, 2010, EUR J NEUROSCI, V31, P2193, DOI 10.1111/j.1460-9568.2010.07252.x; Thomson AM, 2000, EUR J NEUROSCI, V12, P425, DOI 10.1046/j.1460-9568.2000.00915.x; Tretter V, 1997, J NEUROSCI, V17, P2728; UNWIN N, 1993, CELL, V72, P31, DOI 10.1016/S0092-8674(05)80026-1; Zhang B, 2015, NEURON, V87, P781, DOI 10.1016/j.neuron.2015.07.020; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008	62	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					13926	13942		10.1074/jbc.M116.714790	http://dx.doi.org/10.1074/jbc.M116.714790			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129275	Green Published, hybrid			2022-12-28	WOS:000379975100003
J	Zhang, WB; Yao, LL; Li, XD				Zhang, Wen-Bo; Yao, Lin-Lin; Li, Xiang-dong			The Globular Tail Domain of Myosin-5a Functions as a Dimer in Regulating the Motor Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; cytoskeleton; intracellular trafficking; molecular motor; myosin; myosin-5a	CLASS-V MYOSIN; UNCONVENTIONAL MYOSIN; STRUCTURAL BASIS; IDENTIFICATION; BINDING; SLAC2-A/MELANOPHILIN; MELANOPHILIN; CALMODULIN; ACTIVATION; SEQUENCES	Myosin-5a contains two heavy chains, which are dimerized via the coiled-coil regions. Thus, myosin-5a comprises two heads and two globular tail domains (GTDs). The GTD is the inhibitory domain that binds to the head and inhibits its motor function. Although the two-headed structure is essential for the processive movement of myosin-5a along actin filaments, little is known about the role of GTD dimerization. Here, we investigated the effect of GTD dimerization on its inhibitory activity. We found that the potent inhibitory activity of the GTD is dependent on its dimerization by the preceding coiled-coil regions, indicating synergistic interactions between the two GTDs and the two heads of myosin-5a. Moreover, we found that alanine mutations of the two conserved basic residues at N-terminal extension of the GTD not only weaken the inhibitory activity of the GTD but also enhance the activation of myosin-5a by its cargo-binding protein melanophilin (Mlph). These results are consistent with the GTD forming a head to head dimer, in which the N-terminal extension of the GTD interacts with the Mlph-binding site in the counterpart GTD. The Mlph-binding site at the GTD-GTD interface must be exposed prior to the binding of Mlph. We therefore propose that the inhibited Myo5a is equilibrated between the folded state, in which the Mlph-binding site is buried, and the preactivated state, in which the Mlph-binding site is exposed, and that Mlph is able to bind to the Myo5a in preactivated state and activates its motor function.	[Zhang, Wen-Bo; Yao, Lin-Lin; Li, Xiang-dong] Chinese Acad Sci, Inst Zool, Grp Cell Motil & Muscle Contract, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China; [Zhang, Wen-Bo] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, XD (corresponding author), Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China.	lixd@ioz.ac.cn			National Basic Research Program of China [2013CB932802, 2012CB114102]; National Natural Science Foundation of China [31171367, 31470791]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2013CB932802 and 2012CB114102 and the National Natural Science Foundation of China Grants 31171367 and 31470791. The authors declare that they have no conflicts of interest with the contents of this article.	CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Donovan KW, 2015, J CELL BIOL, V209, P359, DOI 10.1083/jcb.201411010; Fukuda M, 2004, J BIOL CHEM, V279, P22314, DOI 10.1074/jbc.401791200; Fukuda M, 2004, J CELL SCI, V117, P583, DOI 10.1242/jcs.00891; Geething NC, 2007, J BIOL CHEM, V282, P21518, DOI 10.1074/jbc.M701932200; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Lu ZK, 2012, J BIOL CHEM, V287, P16530, DOI 10.1074/jbc.M112.343079; Nascimento AFZ, 2013, J BIOL CHEM, V288, P34131, DOI 10.1074/jbc.M113.507202; Pylypenko O, 2013, P NATL ACAD SCI USA, V110, P20443, DOI 10.1073/pnas.1314329110; Rodriguez OC, 2002, J CELL SCI, V115, P991; SEPERACK PK, 1995, EMBO J, V14, P2326, DOI 10.1002/j.1460-2075.1995.tb07227.x; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Velvarska H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082065; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Wei ZY, 2013, P NATL ACAD SCI USA, V110, P11314, DOI 10.1073/pnas.1306768110; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yao LL, 2016, J BIOL CHEM, V291, P8241, DOI 10.1074/jbc.M115.693762; Yao LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10874; Zhao LP, 1996, P NATL ACAD SCI USA, V93, P10826, DOI 10.1073/pnas.93.20.10826	26	9	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13571	13579		10.1074/jbc.M116.724328	http://dx.doi.org/10.1074/jbc.M116.724328			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129208	hybrid, Green Published			2022-12-28	WOS:000379771100015
J	Polanco, JC; Scicluna, BJ; Hill, AF; Gotz, J				Polanco, Juan Carlos; Scicluna, Benjamin James; Hill, Andrew Francis; Gotz, Jurgen			Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL FRAGMENTS; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; ABNORMAL PHOSPHORYLATION; PATHOGENIC PROTEINS; MOUSE MODEL; IN-VITRO; PROPAGATION; EXOSOMES; TAUOPATHY	The microtubule-associated protein tau has a critical role in Alzheimer disease and related tauopathies. There is accumulating evidence that tau aggregates spread and replicate in a prion-like manner, with the uptake of pathological tau seeds causing misfolding and aggregation of monomeric tau in recipient cells. Here we focused on small extracellular vesicles enriched for exosomes that were isolated from the brains of tau transgenic rTg4510 and control mice. We found that these extracellular vesicles contained tau, although the levels were significantly higher in transgenic mice that have a pronounced tau pathology. Tau in the vesicles was differentially phosphorylated, although to a lower degree than in the brain cells from which they were derived. Several phospho-epitopes (AT8, AT100, and AT180) thought to be critical for tau pathology were undetected in extracellular vesicles. Despite this, when assayed with FRET tau biosensor cells, extracellular vesicles derived from transgenic mice were capable of seeding tau aggregation in a threshold-dependent manner. We also observed that the dye used to label extracellular vesicle membranes was still present during nucleation and formation of tau inclusions, suggesting either a role for membranes in the seeding or in the process of degradation. Together, we clearly demonstrate that extracellular vesicles can transmit tau pathology. This indicates a role for extracellular vesicles in the transmission and spreading of tau pathology. The characteristics of tau in extracellular vesicles and the seeding threshold we identified may explain why tau pathology develops very slowly in neurodegenerative diseases such as Alzheimer disease.	[Polanco, Juan Carlos; Gotz, Jurgen] Univ Queensland, Clem Jones Ctr Ageing Dementia Res, Queensland Brain Inst, St. Lucia Campus, Brisbane, Qld 4072, Australia; [Scicluna, Benjamin James; Hill, Andrew Francis] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Scicluna, Benjamin James; Hill, Andrew Francis] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Bundoora, Vic 3086, Australia	University of Queensland; University of Melbourne; La Trobe University	Gotz, J (corresponding author), Univ Queensland, Clem Jones Ctr Ageing Dementia Res, Queensland Brain Inst, St. Lucia Campus, Brisbane, Qld 4072, Australia.	j.goetz@uq.edu.au	Hill, Andrew F./GZL-4124-2022; Polanco, Juan Carlos/J-4272-2013; Hill, Andrew F./AAH-2854-2020; Götz, Jürgen/C-2448-2014; Polanco, Juan Carlos/AAE-1529-2019	Hill, Andrew F./0000-0001-5581-2354; Polanco, Juan Carlos/0000-0002-3335-6332; Götz, Jürgen/0000-0001-8501-7896; Polanco, Juan Carlos/0000-0002-3335-6332	Estate of Dr. Clem Jones; Australian Research Council [DP130101932]; National Health and Medical Research Council of Australia [APP1037746, APP1003150]	Estate of Dr. Clem Jones; Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Estate of Dr. Clem Jones, Australian Research Council Grant DP130101932, and National Health and Medical Research Council of Australia Grants APP1037746 and APP1003150. The authors declare that they have no conflicts of interest with the contents of this article.	Alonso AD, 2001, J BIOL CHEM, V276, P37967; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Ambegaokar SS, 2012, AUTOPHAGY, V8, P1144, DOI 10.4161/auto.20515; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Attems J, 2012, BIOCHEM SOC T, V40, P711, DOI 10.1042/BST20120034; Bellingham SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00124; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Calafate S, 2015, CELL REP, V11, P1176, DOI 10.1016/j.celrep.2015.04.043; Chai XY, 2012, NEUROBIOL DIS, V48, P356, DOI 10.1016/j.nbd.2012.05.021; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Deters N, 2008, EUR J NEUROSCI, V28, P137, DOI 10.1111/j.1460-9568.2008.06318.x; Dinkins MB, 2014, NEUROBIOL AGING, V35, P1792, DOI 10.1016/j.neurobiolaging.2014.02.012; Dujardin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100760; Dujardin S, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-14; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Frost B, 2015, TRENDS CELL BIOL, V25, P46, DOI 10.1016/j.tcb.2014.07.005; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Henkins KM, 2012, BRAIN PATHOL, V22, P826, DOI 10.1111/j.1750-3639.2012.00598.x; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Holmes BB, 2014, J BIOL CHEM, V289, P19855, DOI 10.1074/jbc.R114.549295; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kanmert D, 2015, J NEUROSCI, V35, P10851, DOI 10.1523/JNEUROSCI.0387-15.2015; Karch CM, 2012, J BIOL CHEM, V287, P42751, DOI 10.1074/jbc.M112.380642; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kohler C, 2014, NEUROBIOL DIS, V71, P169, DOI 10.1016/j.nbd.2014.07.006; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Marimpietri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075054; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mirbaha H, 2015, J BIOL CHEM, V290, P14893, DOI 10.1074/jbc.M115.652693; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Soto C, 2012, CELL, V149, P968, DOI 10.1016/j.cell.2012.05.007; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Walker LC, 2015, ANNU REV NEUROSCI, V38, P87, DOI 10.1146/annurev-neuro-071714-033828; Wang Z, 2012, PROTEOMICS, V12, P329, DOI 10.1002/pmic.201100477; Webber J, 2015, SEMIN CELL DEV BIOL, V40, P27, DOI 10.1016/j.semcdb.2015.01.013; Wren MC, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0042-7	59	151	151	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12445	12466		10.1074/jbc.M115.709485	http://dx.doi.org/10.1074/jbc.M115.709485			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27030011	Green Published, hybrid			2022-12-28	WOS:000378119900002
J	Fong, KP; Zhu, H; Span, LM; Moore, DT; Yoon, K; Tamura, R; Yin, H; DeGrado, WF; Bennett, JS				Fong, Karen P.; Zhu, Hua; Span, Lisa M.; Moore, David T.; Yoon, Kyungchul; Tamura, Ryo; Yin, Hang; DeGrado, William F.; Bennett, Joel S.			Directly Activating the Integrin alpha IIb beta 3 Initiates Outside-In Signaling by Causing alpha IIb beta 3 Clustering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; CALCIUM-BINDING DOMAIN; TALIN HEAD DOMAIN; GLANZMANN THROMBASTHENIA; TRANSMEMBRANE DOMAIN; SRC; FIBRINOGEN; ADHESION; PHOSPHORYLATION; ADHESIVENESS	alpha IIb beta 3 activation in platelets is followed by activation of the tyrosine kinase c-Src associated with the carboxyl terminus of the beta 3 cytosolic tail. Exogenous peptides designed to interact with the alpha IIb transmembrane (TM) domain activate single alpha IIb beta 3 molecules in platelets by binding to the alpha IIb TM domain and causing separation of the alpha IIb beta 3 TM domain heterodimer. Here we asked whether directly activating single alpha IIb beta 3 molecules in platelets using the designed peptide anti-alpha IIb TM also initiates alpha IIb beta 3-mediated outside-in signaling by causing activation of beta 3-associated c-Src. Anti-alpha IIb TM caused activation of beta 3-associated c-Src and the kinase Syk, but not the kinase FAK, under conditions that precluded extracellular ligand binding to alpha IIb beta 3. c-Src and Syk are activated by trans-autophosphorylation, suggesting that activation of individual alpha IIb beta 3 molecules can initiate alpha IIb beta 3 clustering in the absence of ligand binding. Consistent with this possibility, incubating platelets with anti-alpha IIb TM resulted in the redistribution of alpha IIb beta 3 from a homogenous ring located at the periphery of discoid platelets into nodular densities consistent with clustered alpha IIb beta 3. Thus, these studies indicate that not only is resting alpha IIb beta 3 poised to undergo a conformational change that exposes its ligand-binding site, but it is poised to rapidly assemble into intracellular signal-generating complexes as well.	[Fong, Karen P.; Zhu, Hua; Span, Lisa M.; Yoon, Kyungchul; Bennett, Joel S.] Univ Penn, Perelman Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Moore, David T.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Tamura, Ryo; Yin, Hang] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80030 USA; [Tamura, Ryo; Yin, Hang] Univ Colorado, BioFrontiers Inst, Boulder, CO 80030 USA; [DeGrado, William F.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of California System; University of California San Francisco	Bennett, JS (corresponding author), Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA.	bennetts@mail.med.upenn.edu			National Institutes of Health [HL40387, HL120846, GM54616, GM103843]; National Science Foundation [CHEM0954819]; American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL040387, P01HL120846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103843, R01GM054616, R37GM054616] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Institutes of Health Grants HL40387, HL120846, GM54616, and GM103843; National Science Foundation Grant CHEM0954819; and bridge funding from the American Society of Hematology. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Basani RB, 1996, BLOOD, V88, P167; Basani RB, 2001, J BIOL CHEM, V276, P13975, DOI 10.1074/jbc.M011511200; Bennett JS, 2001, ANNU REV MED, V52, P161, DOI 10.1146/annurev.med.52.1.161; BENNETT JS, 1979, J CLIN INVEST, V64, P1393, DOI 10.1172/JCI109597; Bledzka K, 2012, J BIOL CHEM, V287, P24585, DOI 10.1074/jbc.M111.336743; Bottcher RT, 2009, CURR OPIN CELL BIOL, V21, P670, DOI 10.1016/j.ceb.2009.05.008; Boylan B, 2008, BLOOD, V112, P2780, DOI 10.1182/blood-2008-02-142125; Brahme NN, 2013, J BIOL CHEM, V288, P35604, DOI 10.1074/jbc.M113.483016; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Caputo GA, 2008, BIOCHEMISTRY-US, V47, P8600, DOI 10.1021/bi800687h; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Choma C, 2000, NAT STRUCT BIOL, V7, P161; CLARK EA, 1994, J BIOL CHEM, V269, P28859; Cristian L, 2005, J MOL BIOL, V348, P1225, DOI 10.1016/j.jmb.2005.03.053; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Fox JEB, 1996, J BIOL CHEM, V271, P7004, DOI 10.1074/jbc.271.12.7004; Gao J, 1997, EMBO J, V16, P6414, DOI 10.1093/emboj/16.21.6414; GOLDEN A, 1989, P NATL ACAD SCI USA, V86, P901, DOI 10.1073/pnas.86.3.901; Goult BT, 2013, J STRUCT BIOL, V184, P21, DOI 10.1016/j.jsb.2013.05.014; Gradler U, 2013, J MOL BIOL, V425, P309, DOI 10.1016/j.jmb.2012.11.007; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Jones CI, 2014, J THROMB HAEMOST, V12, P1342, DOI 10.1111/jth.12620; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Lam WA, 2011, NAT MATER, V10, P61, DOI 10.1038/NMAT2903; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; Liu J, 2008, J THROMB HAEMOST, V6, P1035, DOI 10.1111/j.1538-7836.2008.02958.x; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; PONCZ M, 1994, J CLIN INVEST, V93, P172, DOI 10.1172/JCI116942; Senis YA, 2014, BLOOD, V124, P2013, DOI 10.1182/blood-2014-01-453134; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Tang J, 2009, J AM CHEM SOC, V131, P3816, DOI 10.1021/ja809007f; TANIGUCHI T, 1993, J BIOL CHEM, V268, P2277; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wang W, 2011, J BIOL CHEM, V286, P1860, DOI 10.1074/jbc.M110.193797; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; Woodside DG, 2001, CURR BIOL, V11, P1799, DOI 10.1016/S0960-9822(01)00565-6; Wu YB, 2015, J BIOL CHEM, V290, P15825, DOI 10.1074/jbc.M115.648428; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Ye F, 2013, CURR BIOL, V23, P2288, DOI 10.1016/j.cub.2013.09.050; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Yin H, 2006, J BIOL CHEM, V281, P36732, DOI 10.1074/jbc.M605877200; Zhu JQ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003576	53	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11706	11716		10.1074/jbc.M116.716613	http://dx.doi.org/10.1074/jbc.M116.716613			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27056329	Green Published, hybrid			2022-12-28	WOS:000377264800021
J	Greene, EC				Greene, Eric C.			DNA Sequence Alignment during Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							COLI RECA PROTEIN; DOUBLE-STRAND BREAKS; RAD54 PROTEIN; BASE-PAIRS; SEARCH; RECOGNITION; MECHANISM; REPAIR; EXCHANGE; PHAGE	Homologous recombination allows for the regulated exchange of genetic information between two different DNA molecules of identical or nearly identical sequence composition, and is a major pathway for the repair of double-stranded DNA breaks. A key facet of homologous recombination is the ability of recombination proteins to perfectly align the damaged DNA with homologous sequence located elsewhere in the genome. This reaction is referred to as the homology search and is akin to the target searches conducted by many different DNA-binding proteins. Here I briefly highlight early investigations into the homology search mechanism, and then describe more recent research. Based on these studies, I summarize a model that includes a combination of intersegmental transfer, short-distance one-dimensional sliding, and length-specific microhomology recognition to efficiently align DNA sequences during the homology search. I also suggest some future directions to help further our understanding of the homology search. Where appropriate, I direct the reader to other recent reviews describing various issues related to homologous recombination.	[Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, Black Bldg,Rm 536,650 W 168th St, New York, NY 10032 USA	Columbia University	Greene, EC (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Black Bldg,Rm 536,650 W 168th St, New York, NY 10032 USA.	ecg2108@cumc.columbia.edu			National Institutes of Health [GM074739]; National Science Foundation (NSF) [MCB-1154511]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118026, R01GM074739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM074739 and National Science Foundation (NSF) Grant MCB-1154511 (to E. C. G.) The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adzuma K, 1998, J BIOL CHEM, V273, P31565, DOI 10.1074/jbc.273.47.31565; Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; Aparicio OM, 2013, GENE DEV, V27, P117, DOI 10.1101/gad.209999.112; Bai XC, 2015, TRENDS BIOCHEM SCI, V40, P49, DOI 10.1016/j.tibs.2014.10.005; Barzel A, 2008, NAT REV GENET, V9, P27, DOI 10.1038/nrg2224; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Bianco P R, 1998, Front Biosci, V3, pD570; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Brown MS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016659; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chintapalli SV, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-240; Cho NW, 2014, CELL, V159, P108, DOI 10.1016/j.cell.2014.08.030; CHOW SA, 1985, P NATL ACAD SCI USA, V82, P5646, DOI 10.1073/pnas.82.17.5646; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; Collins BE, 2014, METHOD CELL BIOL, V123, P217, DOI 10.1016/B978-0-12-420138-5.00012-4; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2001, P NATL ACAD SCI USA, V98, P8173, DOI 10.1073/pnas.131004998; CRAIG NL, 1980, NATURE, V283, P26, DOI 10.1038/283026a0; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; CUNNINGHAM RP, 1979, NATURE, V281, P191, DOI 10.1038/281191a0; Danilowicz C, 2012, NUCLEIC ACIDS RES, V40, P1717, DOI 10.1093/nar/gkr855; De Vlaminck I, 2012, MOL CELL, V46, P616, DOI 10.1016/j.molcel.2012.03.029; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Dekker J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019356; Dion V, 2013, CELL, V152, P1355, DOI 10.1016/j.cell.2013.02.010; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; EGELMAN EH, 1986, J MOL BIOL, V191, P677, DOI 10.1016/0022-2836(86)90453-5; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Folta-Stogniew E, 2004, MOL CELL, V15, P965, DOI 10.1016/j.molcel.2004.08.017; Forget AL, 2013, NAT PROTOC, V8, P525, DOI 10.1038/nprot.2013.016; Forget AL, 2012, NATURE, V482, P423, DOI 10.1038/nature10782; GONDA DK, 1986, J BIOL CHEM, V261, P3087; GONDA DK, 1983, CELL, V34, P647, DOI 10.1016/0092-8674(83)90397-5; Gupta RC, 1999, MOL CELL, V4, P705, DOI 10.1016/S1097-2765(00)80381-0; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; HOWARDFLANDERS P, 1984, NATURE, V309, P215, DOI 10.1038/309215a0; HSIEH P, 1992, P NATL ACAD SCI USA, V89, P6492, DOI 10.1073/pnas.89.14.6492; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; Jiang LL, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.022704; Kates-Harbeck J, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012702; King GA, 2013, P NATL ACAD SCI USA, V110, P3859, DOI 10.1073/pnas.1213676110; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; Lee CS, 2016, P NATL ACAD SCI USA, V113, pE146, DOI 10.1073/pnas.1523660113; Lee JY, 2015, SCIENCE, V349, P977, DOI 10.1126/science.aab2666; Lesterlin C, 2014, NATURE, V506, P249, DOI 10.1038/nature12868; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; Mazin AV, 2003, J BIOL CHEM, V278, P14029, DOI 10.1074/jbc.M212779200; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; Mine-Hattab J, 2013, TRENDS CELL BIOL, V23, P529, DOI 10.1016/j.tcb.2013.05.006; Mine-Hattab J, 2012, NAT CELL BIOL, V14, P510, DOI 10.1038/ncb2472; Morrical SW, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016444; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petukhova G, 1999, J BIOL CHEM, V274, P29453, DOI 10.1074/jbc.274.41.29453; Petukhova G, 2000, GENE DEV, V14, P2206, DOI 10.1101/gad.826100; Prentiss M, 2015, CRIT REV BIOCHEM MOL, V50, P453, DOI 10.3109/10409238.2015.1092943; Qi Z, 2015, CELL, V160, P856, DOI 10.1016/j.cell.2015.01.029; Ragunathan K, 2012, ELIFE, V1, DOI 10.7554/eLife.00067; Rajendram M, 2015, MOL CELL, V60, P374, DOI 10.1016/j.molcel.2015.09.009; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Renkawitz J, 2013, CELL CYCLE, V12, P2526, DOI 10.4161/cc.25836; Renkawitz J, 2013, MOL CELL, V50, P261, DOI 10.1016/j.molcel.2013.02.020; Renkawitz J, 2014, NAT REV MOL CELL BIO, V15, P369, DOI 10.1038/nrm3805; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; ROBERTS JW, 1978, P NATL ACAD SCI USA, V75, P4714, DOI 10.1073/pnas.75.10.4714; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Savir Y, 2010, MOL CELL, V40, P388, DOI 10.1016/j.molcel.2010.10.020; Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P5100, DOI 10.1073/pnas.76.10.5100; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Strecker J, 2016, NAT CELL BIOL, V18, P281, DOI 10.1038/ncb3308; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Symington LS, 2014, GENETICS, V198, P795, DOI 10.1534/genetics.114.166140; Tan TLR, 2003, DNA REPAIR, V2, P787, DOI 10.1016/S1568-7864(03)00070-3; Tan TLR, 2003, DNA REPAIR, V2, P1293, DOI 10.1016/j.dnarep.2003.04.001; Thomas C A Jr, 1966, Prog Nucleic Acid Res Mol Biol, V5, P315, DOI 10.1016/S0079-6603(08)60237-8; TSANG SS, 1985, BIOCHEMISTRY-US, V24, P3226, DOI 10.1021/bi00334a023; Uphoff S, 2014, DNA REPAIR, V20, P32, DOI 10.1016/j.dnarep.2014.02.015; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Vlassakis J, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032702; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Weiner A, 2009, NAT REV MICROBIOL, V7, P748, DOI 10.1038/nrmicro2206; WEST SC, 1981, NATURE, V294, P659, DOI 10.1038/294659a0; Wolner B, 2005, J BIOL CHEM, V280, P10855, DOI 10.1074/jbc.M414388200; Yang DR, 2015, NUCLEIC ACIDS RES, V43, P10251, DOI 10.1093/nar/gkv883; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398; Zhang ZQ, 2007, NAT STRUCT MOL BIOL, V14, P397, DOI 10.1038/nsmb1223	98	42	42	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11572	11580		10.1074/jbc.R116.724807	http://dx.doi.org/10.1074/jbc.R116.724807			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27129270	hybrid, Green Published			2022-12-28	WOS:000377264800010
J	Yamashita, D; Moriuchi, T; Osumi, T; Hirose, F				Yamashita, Daisuke; Moriuchi, Takanobu; Osumi, Takashi; Hirose, Fumiko			Transcription Factor hDREF Is a Novel SUMO E3 Ligase of Mi2 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE; CELL-PROLIFERATION; CHROMATIN; COMPLEX; PROTEIN; SUMOYLATION; NURD; PROMOTERS; POLYCOMB; DREF	The human transcription factor DNA replication-related element-binding factor (hDREF) is essential for the transcription of a number of housekeeping genes. The mechanisms underlying constitutively active transcription by hDREF were unclear. Here, we provide evidence that hDREF possesses small ubiquitin-like modifier (SUMO) ligase activity and can specifically SUMOylate Mi2 alpha, an ATP-dependent DNA helicase in the nucleosome remodeling and deacetylation complex. Moreover, immunofluorescent staining and biochemical analyses showed that coexpression of hDREF and SUMO-1 resulted in dissociation of Mi2 alpha from chromatin, whereas a SUMOylation-defective Mi2 alpha mutant remained tightly bound to chromatin. Chromatin immunoprecipitation and quantitative RT-PCR analysis demonstrated that Mi2 alpha expression diminished transcription of the ribosomal protein genes, which are positively regulated by hDREF. In contrast, coexpression of hDREF and SUMO-1 suppressed the transcriptional repression by Mi2 alpha. These data indicate that hDREF might incite transcriptional activation by SUMOylating Mi2 alpha, resulting in the dissociation of Mi2 alpha from the gene loci. We propose a novel mechanism for maintaining constitutively active states of a number of hDREF target genes through SUMOylation.	[Yamashita, Daisuke; Moriuchi, Takanobu; Osumi, Takashi; Hirose, Fumiko] Univ Hyogo, Grad Sch Life Sci, 3-2-1 Koto, Kamigori, Hyogo 6781297, Japan	University of Hyogo	Hirose, F (corresponding author), Univ Hyogo, Grad Sch Life Sci, 3-2-1 Koto, Kamigori, Hyogo 6781297, Japan.	fhirose@sci.u-hyogo.ac.jp		Yamashita, Daisuke/0000-0001-6054-5617; Hirose, Fumiko/0000-0003-4586-4892	Japan Society for the Promotion of Science (JSPS) [KAKENHI 20570188]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (JSPS) Grant KAKENHI 20570188 (to F. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen HF, 2013, CELL MOL LIFE SCI, V70, P3513, DOI 10.1007/s00018-012-1256-2; Aubry F, 1998, EUR J BIOCHEM, V254, P558, DOI 10.1046/j.1432-1327.1998.2540558.x; Basta J, 2015, TRANSL RES, V165, P36, DOI 10.1016/j.trsl.2014.05.003; Becker PB, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017905; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bottardi S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004827; Dundr M, 2012, CURR OPIN CELL BIOL, V24, P415, DOI 10.1016/j.ceb.2012.03.010; Duprez E, 1999, J CELL SCI, V112, P381; Fidalgo M, 2012, P NATL ACAD SCI USA, V109, P16202, DOI 10.1073/pnas.1208533109; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gunther K, 2013, NUCLEIC ACIDS RES, V41, P3010, DOI 10.1093/nar/gkt035; Hart CM, 1999, CHROMOSOMA, V108, P375, DOI 10.1007/s004120050389; Hirose F, 1996, J BIOL CHEM, V271, P3930; Hirose F, 2002, MOL CELL BIOL, V22, P5182, DOI 10.1128/MCB.22.14.5182-5193.2002; Hirose F, 2001, MOL CELL BIOL, V21, P7231, DOI 10.1128/MCB.21.21.7231-7242.2001; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Jasper H, 2002, DEV CELL, V3, P511, DOI 10.1016/S1534-5807(02)00297-6; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kamitani T, 1997, J BIOL CHEM, V272, P14001, DOI 10.1074/jbc.272.22.14001; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Le Drean Y, 2002, ENDOCRINOLOGY, V143, P3482, DOI 10.1210/en.2002-220135; Lhoumaud P, 2014, EMBO J, V33, P1599, DOI 10.15252/embj.201385965; Liu HW, 2012, NUCLEIC ACIDS RES, V40, P10172, DOI 10.1093/nar/gks819; Luse DS, 2012, TRANSCR-AUSTIN, V3, P156, DOI 10.4161/trns.20725; Matsukage A, 2008, BBA-GENE REGUL MECH, V1779, P81, DOI 10.1016/j.bbagrm.2007.11.011; Meier K, 2014, EPIGENETICS-US, V9, P1485, DOI 10.4161/15592294.2014.971580; Ohshima N, 2003, J BIOL CHEM, V278, P22928, DOI 10.1074/jbc.M303109200; Ookawa K, 1997, ONCOGENE, V14, P1389, DOI 10.1038/sj.onc.1200976; Pirrotta V, 2012, CURR OPIN GENET DEV, V22, P101, DOI 10.1016/j.gde.2011.11.004; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Saether T, 2007, J BIOL CHEM, V282, P13994, DOI 10.1074/jbc.M700755200; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Schweikhard V, 2014, P NATL ACAD SCI USA, V111, P6642, DOI 10.1073/pnas.1405181111; Shimbo T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004028; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Torchy MP, 2015, CELL MOL LIFE SCI, V72, P2491, DOI 10.1007/s00018-015-1880-8; Trung N. T., 2014, J PROTEOM BIOINFORM, DOI [10.4172/jpb.1000306, DOI 10.4172/JPB.1000306]; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Vethantham Vasupradha, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5121; Wang J, 2004, J BIOL CHEM, V279, P49091, DOI 10.1074/jbc.M407494200; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Yamashita D, 2007, MOL CELL BIOL, V27, P2003, DOI 10.1128/MCB.01462-06; Yamashita D, 2007, J BIOL CHEM, V282, P7563, DOI 10.1074/jbc.M607180200; Yan Q, 2010, P NATL ACAD SCI USA, V107, P21034, DOI 10.1073/pnas.1007866107; Yang Y, 2011, ONCOGENE, V30, P2207, DOI 10.1038/onc.2010.600; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhao Q, 2014, NUCLEIC ACIDS RES, V42, pW325, DOI 10.1093/nar/gku383	55	18	18	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11619	11634		10.1074/jbc.M115.713370	http://dx.doi.org/10.1074/jbc.M115.713370			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27068747	hybrid, Green Published			2022-12-28	WOS:000377264800014
J	Yu, SY; Li, FY; Xing, SJ; Zhao, TY; Peng, WQ; Xue, HH				Yu, Shuyang; Li, Fengyin; Xing, Shaojun; Zhao, Tianyan; Peng, Weiqun; Xue, Hai-Hui			Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta-catenin (-catenin); gene regulation; hematopoietic stem cells; transcription factor; Wnt pathway; leukemic stem cells; self-renewal	CHRONIC MYELOID-LEUKEMIA; BETA-CATENIN; SELF-RENEWAL; BONE-MARROW; IN-VIVO; WNT/BETA-CATENIN; OXIDATIVE STRESS; LONG-TERM; T-CELLS; WNT	Hematopoietic and leukemic stem cells (HSCs and LSCs) have self-renewal ability to maintain normal hematopoiesis and leukemia propagation, respectively. Tcf1 and Lef1 transcription factors are expressed in HSCs, and targeting both factors modestly expanded the size of the HSC pool due to diminished HSC quiescence. Functional defects of Tcf1/Lef1-deficient HSCs in multi-lineage blood reconstitution was only evident under competitive conditions or when subjected to repeated regenerative stress. These are mechanistically due to direct positive regulation of Egr and Tcf3 by Tcf1 and Lef1, and significantly, forced expression of Egr1 in Tcf1/Lef1-deficient HSCs restored HSC quiescence. In a preclinical CML model, loss of Tcf1/Lef1 did not show strong impact on leukemia initiation and progression. However, when transplanted into secondary recipients, Tcf1/Lef1-deficient LSCs failed to propagate CML. By induced deletion of Tcf1 and Lef1 in pre-established CML, we further demonstrated an intrinsic requirement for these factors in LSC self-renewal. When combined with imatinib therapy, genetic targeting of Tcf1 and Lef1 potently diminished LSCs and conferred better protection to the CML recipients. LSCs are therefore more sensitive to loss of Tcf1 and Lef1 than HSCs in their self-renewal capacity. The differential requirements in HSCs and LSCs thus identify Tcf1 and Lef1 transcription factors as novel therapeutic targets in treating hematological malignancies, and inhibition of Tcf1/Lef1-regulated transcriptional programs may thus provide a therapeutic window to eliminate LSCs with minimal side effect on normal HSC functions.	[Yu, Shuyang; Zhao, Tianyan] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Li, Fengyin; Xing, Shaojun; Xue, Hai-Hui] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	China Agricultural University; George Washington University; University of Iowa	Yu, SY (corresponding author), 51 Newton Rd BSB 3-772, Iowa City, IA 52246 USA.	ysy@cau.edu.cn	/AAI-2516-2019; Li, Fengyin/AAG-9476-2019	Xing, Shaojun/0000-0003-0777-2196; Peng, Weiqun/0000-0001-5521-9091; Xue, Hai-Hui/0000-0002-9163-7669	American Cancer Society [RSG-11-161-01-MPC]; National Institutes of Health [AI105351, AI112579, AI115149, AI119160, AI113806]; U. S. Department of Veteran Affairs [I01 BX002903]; Chinese Universities Scientific Fund [2014RC004]; National Natural Science Foundation of China [31422037, 31571522]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112579, R21AI119160, R21AI105351, R21AI115149] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002903] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Veteran Affairs(US Department of Veterans Affairs); Chinese Universities Scientific Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This study is supported in-part by grants from the American Cancer Society (RSG-11-161-01-MPC, to H.-H. X.), the National Institutes of Health (AI105351, AI112579, AI115149, and AI119160, to H.-H. X.), and the U. S. Department of Veteran Affairs (Merit Review Award I01 BX002903 to H.-H. X., Biomedical laboratory Research and Development Program). H.-H. X. is the founder of Cure-it LifeSciences, and this capacity has no roles in experimental design and data interpretation in this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Veteran Affairs.; Supported by the Chinese Universities Scientific Fund (2014RC004) and National Natural Science Foundation of China (31422037 and 31571522). To whom correspondence may be addressed: 2 Yuanmingyuan West Rd., Haidian District, Beijing 100193, China. E-mail: ysy@cau.edu.cn.; Supported by a National Institutes of Health Grant AI113806.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Ashton JM, 2012, CELL STEM CELL, V11, P359, DOI 10.1016/j.stem.2012.05.024; Bunting KD, 2002, BLOOD, V99, P479, DOI 10.1182/blood.V99.2.479; Carleton M, 2002, J IMMUNOL, V168, P1649, DOI 10.4049/jimmunol.168.4.1649; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Edmaier KE, 2014, LEUKEMIA, V28, P227, DOI 10.1038/leu.2013.238; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Guo J, 2010, CELL METAB, V11, P161, DOI 10.1016/j.cmet.2009.12.007; Guo KY, 2007, ENDOCRINOLOGY, V148, P3987, DOI 10.1210/en.2007-0261; Heidel FH, 2012, CELL STEM CELL, V10, P412, DOI 10.1016/j.stem.2012.02.017; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hu Y, 2009, LEUKEMIA, V23, P109, DOI 10.1038/leu.2008.262; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Lento W, 2014, GENE DEV, V28, P995, DOI 10.1101/gad.231944.113; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Luis TC, 2010, BLOOD, V116, P496, DOI 10.1182/blood-2010-04-282624; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Nemeth MJ, 2009, STEM CELLS, V27, P1109, DOI 10.1002/stem.32; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Petropoulos K, 2008, J EXP MED, V205, P515, DOI 10.1084/jem.20071875; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Ross DM, 2010, LEUKEMIA, V24, P1719, DOI 10.1038/leu.2010.185; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Ruiz-Herguido C, 2012, J EXP MED, V209, P1457, DOI 10.1084/jem.20120225; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schaniel C, 2011, BLOOD, V118, P2420, DOI 10.1182/blood-2010-09-305664; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Steinke FC, 2014, IMMUNOL RES, V59, P45, DOI 10.1007/s12026-014-8545-9; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Tesio M, 2011, CELL STEM CELL, V9, P187, DOI 10.1016/j.stem.2011.08.005; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wu JQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002565; Xu M, 2009, J IMMUNOL, V182, P751, DOI 10.4049/jimmunol.182.2.751; Yang Q, 2011, BLOOD, V117, P3529, DOI 10.1182/blood-2010-07-297689; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Yu SY, 2012, CELL STEM CELL, V11, P207, DOI 10.1016/j.stem.2012.05.021; Yu SY, 2011, BLOOD, V117, P2166, DOI 10.1182/blood-2010-09-306563; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	57	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11148	11160		10.1074/jbc.M116.717801	http://dx.doi.org/10.1074/jbc.M116.717801			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27044748	hybrid, Green Published			2022-12-28	WOS:000377042100018
J	Meng, XY; Guo, J; Fang, WW; Dou, L; Li, M; Huang, XQ; Zhou, ST; Man, Y; Tang, WQ; Yu, LQ; Li, J				Meng, Xiangyu; Guo, Jun; Fang, Weiwei; Dou, Lin; Li, Meng; Huang, Xiuqing; Zhou, Shutong; Man, Yong; Tang, Weiqing; Yu, Liqing; Li, Jian			Liver MicroRNA-291b-3p Promotes Hepatic Lipogenesis through Negative Regulation of Adenosine 5'-Monophosphate (AMP)-activated Protein Kinase alpha 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; EMBRYONIC STEM-CELLS; INSULIN SENSITIVITY; LIPID-ACCUMULATION; NATURAL-HISTORY; CANCER CELLS; MICE; METABOLISM; EXPRESSION; DISEASE	In a microarray study, we found that hepatic miR-291b-3p was significantly increased in leptin-receptor-deficient type 2 mice (db/db), a mouse model of diabetes. The function of miR-291b-3p is unknown. The potential role of miR-291b-3p in regulating hepatic lipid metabolism was explored in this study. High-fat diet (HFD)- and chow-fed mice were injected with an adenovirus expressing a miR-2916-3p inhibitor and a miR-291b-3p mimic through the tail vein. Hepatic lipids and lipogenic gene expression were analyzed. Additionally, gain- and loss-of-function studies were performed in vitro to identify direct targets of miR-291b-3p. MiR-291b-3p expression and the protein levels of sterol regulatory element-binding protein 1 (SREBP1) and fatty acid synthase (FAS) were increased in the steatotic liver of db/db mice and HFD-fed mice versus their respective controls. Inhibition of hepatic miR-291b-3p expression prevented increases in hepatic lipogenesis and steatosis in HFD-fed mice. The opposite was observed when miR-291b-3p was overexpressed in the livers of chow-fed C57BL/6J wild-type mice. In vitro studies revealed that silencing of miR-291b-3p in NCTC1469 hepatic cells ameliorated oleic acid/palmitic acid mixture-induced elevation of cellular triglycerides. Importantly, we identified AMP-activated protein kinase (AMPK)-alpha 1 as a direct target of miR-291b-3p. Using metformin, an activator of AMPK, we showed that AMPK activation-induced inhibition of hepatic lipid accumulation was accompanied by reduced expression of miR-2916-3p in the liver. Liver miR-291b-3p promoted hepatic lipogenesis and lipid accumulation in mice. AMPK alpha 1 is a direct target of miR-291b-3p. In conclusion, our findings indicate that miR-291b-3p promotes hepatic lipogenesis by suppressing AMPK alpha 1 expression and activity, indicating the therapeutic potential of miR-291b-3p inhibitors in fatty liver disease.	[Meng, Xiangyu; Guo, Jun; Fang, Weiwei; Dou, Lin; Li, Meng; Huang, Xiuqing; Zhou, Shutong; Man, Yong; Tang, Weiqing; Li, Jian] Beijing Hosp, Key Lab Geriatr, Beijing 100730, Peoples R China; [Meng, Xiangyu; Guo, Jun; Fang, Weiwei; Dou, Lin; Li, Meng; Huang, Xiuqing; Zhou, Shutong; Man, Yong; Tang, Weiqing; Li, Jian] Beijing Inst Geriatr, Minist Hlth, Beijing 100730, Peoples R China; [Meng, Xiangyu; Guo, Jun] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Tang, Weiqing; Yu, Liqing] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	Beijing Hospital; Chinese Academy of Sciences; Institute of Biophysics, CAS; University System of Maryland; University of Maryland College Park	Li, J (corresponding author), Beijing Hosp, Key Lab Geriatr, Beijing 100730, Peoples R China.; Li, J (corresponding author), Beijing Inst Geriatr, Minist Hlth, Beijing 100730, Peoples R China.; Yu, LQ (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	lyu123@umd.edu; lijian@bjhmoh.cn		Meng, Xiangyu/0000-0003-3382-587X	973 program from the National Basic Research Program of China [2012CB517502, 2014CB910503]; National Natural Science Foundation of China [81270887, 81270495, 81170381]; Chinese Medical Association [13060970482]; NIDDK, National Institutes of Health [R01DK085176]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085176] Funding Source: NIH RePORTER	973 program from the National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Medical Association; NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by 973 program grants from the National Basic Research Program of China (2012CB517502, 2014CB910503, to J. L.), the National Natural Science Foundation of China (81270887, 81270495, 81170381, to J. L.), the Specific Fund of Clinical Medical Research of the Chinese Medical Association (13060970482, to M. S.), and the NIDDK, National Institutes of Health (R01DK085176, to L. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Ajmal Masihur Rehman, 2014, Indian Heart J, V66, P574, DOI 10.1016/j.ihj.2014.08.006; Aljada A, 2012, PHARMACOL THERAPEUT, V133, P108, DOI 10.1016/j.pharmthera.2011.09.004; An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Bao B, 2012, CANCER PREV RES, V5, P355, DOI 10.1158/1940-6207.CAPR-11-0299; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cao Y, 2015, EMBO J, V34, P609, DOI 10.15252/embj.201490441; Chen ZP, 1999, FEBS LETT, V460, P343, DOI 10.1016/S0014-5793(99)01371-X; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Cho K, 2009, J MED FOOD, V12, P1293, DOI 10.1089/jmf.2009.0085; Chu B, 2015, SCI REP-UK, V5, DOI 10.1038/srep08801; Ford RJ, 2015, BIOCHEM J, V468, P125, DOI 10.1042/BJ20150125; Foretz M, 1998, J BIOL CHEM, V273, P14767, DOI 10.1074/jbc.273.24.14767; Guo J, 2014, CELL PHYSIOL BIOCHEM, V33, P810, DOI 10.1159/000358654; HA J, 1994, J BIOL CHEM, V269, P22162; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2042, DOI 10.1016/S0002-9270(03)00622-1; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Hu M, 2012, HEPATOLOGY, V55, P437, DOI 10.1002/hep.24708; Kaspi H, 2013, STEM CELLS, V31, P2266, DOI 10.1002/stem.1465; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kong Yong, 2005, GeoActa, V3, P62; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee Kyung-Hee, 2015, Prev Nutr Food Sci, V20, P298, DOI 10.3746/pnf.2015.20.4.298; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lichner Z, 2011, DIFFERENTIATION, V81, P11, DOI 10.1016/j.diff.2010.08.002; Luningschror P, 2012, STEM CELLS, V30, P655, DOI 10.1002/stem.1033; Medeiros LA, 2011, P NATL ACAD SCI USA, V108, P14163, DOI 10.1073/pnas.1111241108; Nangia-Makker P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084369; Ng R, 2014, HEPATOLOGY, V60, P554, DOI 10.1002/hep.27153; Ramirez CM, 2013, MOL CELL BIOL, V33, P2891, DOI 10.1128/MCB.00016-13; Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x; Rottiers V, 2011, COLD SH Q B, V76, P225, DOI 10.1101/sqb.2011.76.011049; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Soh J, 2013, NAT MED, V19, P892, DOI 10.1038/nm.3200; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Tangeman Larissa, 2012, J RNAi Gene Silencing, V8, P470; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wen J, 2012, J CLIN INVEST, V122, P2773, DOI 10.1172/JCI63966; Xiao F, 2014, DIABETES, V63, P2631, DOI 10.2337/db13-1689; Yang J, 2009, J CELL BIOCHEM, V106, P414, DOI 10.1002/jcb.22024; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020; Zaiss AK, 2002, J VIROL, V76, P4580, DOI 10.1128/JVI.76.9.4580-4590.2002; Zheng GXY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002054; Zhou WB, 2007, CANCER RES, V67, P2964, DOI 10.1158/0008-5472.CAN-06-3439; Zovoilis A, 2009, DIFFERENTIATION, V78, P69, DOI 10.1016/j.diff.2009.06.003	50	31	32	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10625	10634		10.1074/jbc.M116.713768	http://dx.doi.org/10.1074/jbc.M116.713768			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27013659	Green Published, hybrid			2022-12-28	WOS:000377042600016
J	Cheng, HL; Bao, X; Rao, H				Cheng, Haili; Bao, Xin; Rao, Hai			The F-box Protein Rcy1 Is Involved in the Degradation of Histone H3 Variant Cse4 and Genome Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; GTPASE-ACTIVATING PROTEIN; SACCHAROMYCES-CEREVISIAE; ECTOPIC LOCALIZATION; MEDIATED PROTEOLYSIS; CENTROMERE PROTEINS; CENP-A; YEAST; PSH1; PROTEASOME	Cse4, a histone H3-like centromeric protein, plays critical functions in chromosome segregation. Cse4 level is tightly regulated, but the underlying mechanism remains poorly understood. We employed a toxicity-based screen to look for the degradation components involved in Cse4 regulation. Here, we show that the F-box containing protein Rcy1 is required for efficient Cse4 turnover as Cse4 degradation is compromised in yeast cells lacking RCY1. Excessive Cse4 accumulation in rcy1 Delta cells leads to growth retardation. Furthermore, the deletion of RCY1 is tied to enhanced chromosome instability and temperature-sensitive cell growth. Our results reveal the involvement of Rcy1 in chromosome regulation and another regulatory pathway controlling the Cse4 level and activity.	[Cheng, Haili; Bao, Xin; Rao, Hai] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Rao, H (corresponding author), 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	raoh@uthscsa.edu	Cheng, Haili/AGG-8193-2022	Cheng, Haili/0000-0002-1860-3585; RAO, HAI/0000-0002-4235-2210	Welch Foundation [AQ 1747]; William AMP; Ella Owens Medical Research Foundation; Helen F. Kerr Foundation; Department of Defense [W911NF-11-10466]; National Institutes of Health [GM 078085]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078085] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); William AMP; Ella Owens Medical Research Foundation; Helen F. Kerr Foundation; Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Welch Foundation Grant AQ 1747, the William & Ella Owens Medical Research Foundation, the Helen F. Kerr Foundation, Department of Defense Grant W911NF-11-10466, and National Institutes of Health Grant GM 078085 (to H. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that there is no conflict of interest for this study.	Amato A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-119; Athane A, 2015, INT J BIOCHEM CELL B, V64, P167, DOI 10.1016/j.biocel.2015.04.002; Au WC, 2013, GENETICS, V194, P513, DOI 10.1534/genetics.113.149898; Au WC, 2008, GENETICS, V179, P263, DOI 10.1534/genetics.108.088518; Bohm S, 2011, MOL CELL BIOL, V31, P1528, DOI 10.1128/MCB.00962-10; Chen SH, 2005, MOL BIOL CELL, V16, P178, DOI 10.1091/mbc.E04-03-0258; Chen Shu H, 2011, Cell Logist, V1, P21, DOI 10.4161/cl.1.1.14695; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; da Rosa JL, 2011, GENETICS, V187, P9, DOI 10.1534/genetics.110.123117; Deyter GMR, 2014, GENE DEV, V28, P1815, DOI 10.1101/gad.243113.114; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Earnshaw WC, 2015, NAT REV MOL CELL BIO, V16, P443, DOI 10.1038/nrm4001; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Gkikopoulos T, 2011, EMBO J, V30, P1919, DOI 10.1038/emboj.2011.112; Herrero S, 2014, EUKARYOT CELL, V13, P1085, DOI 10.1128/EC.00042-14; Hewawasam G, 2010, MOL CELL, V40, P444, DOI 10.1016/j.molcel.2010.10.014; Hewawasam GS, 2014, J BIOL CHEM, V289, P29297, DOI 10.1074/jbc.M114.580589; Hewawasam GS, 2011, CELL CYCLE, V10, P566, DOI 10.4161/cc.10.4.14770; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kus BM, 2004, PROTEINS, V54, P455, DOI 10.1002/prot.10620; Lafourcade C, 2003, GENETICS, V164, P469; Liu C, 2011, J BIOL CHEM, V286, P43660, DOI 10.1074/jbc.M111.286229; Liu C, 2010, TRENDS BIOTECHNOL, V28, P461, DOI 10.1016/j.tibtech.2010.06.003; Liu C, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-75; Lomonte P, 2001, J BIOL CHEM, V276, P5829, DOI 10.1074/jbc.M008547200; Love Ian M, 2012, Genes Cancer, V3, P249, DOI 10.1177/1947601912455198; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Mukherjee D, 2013, J CELL SCI, V126, P4560, DOI 10.1242/jcs.117663; Mullally JE, 2006, MOL CELL BIOL, V26, P822, DOI 10.1128/MCB.26.3.822-830.2006; Ohkuni K, 2014, GENETICS, V196, P1041, DOI 10.1534/genetics.114.161224; Ranjitkar P, 2010, MOL CELL, V40, P455, DOI 10.1016/j.molcel.2010.09.025; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Russell NS, 2004, BIOCHEMISTRY-US, V43, P4844, DOI 10.1021/bi035626r; Singh RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036295; Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903; Westhorpe FG, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015818; Wiederkehr A, 2000, J CELL BIOL, V149, P397, DOI 10.1083/jcb.149.2.397	39	21	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10372	10377		10.1074/jbc.M115.701813	http://dx.doi.org/10.1074/jbc.M115.701813			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26975376	Green Published, hybrid			2022-12-28	WOS:000375602800042
J	Um, JW; Choii, G; Park, D; Kim, D; Jeon, S; Kang, H; Mori, T; Papadopoulos, T; Yoo, T; Lee, Y; Kim, E; Tabuchi, K; Ko, J				Um, Ji Won; Choii, Gayoung; Park, Dongseok; Kim, Dongwook; Jeon, Sangmin; Kang, Hyeyeon; Mori, Takuma; Papadopoulos, Theofilos; Yoo, Taesun; Lee, Yeunkum; Kim, Eunjoon; Tabuchi, Katsuhiko; Ko, Jaewon			IQ Motif and SEC7 Domain-containing Protein 3 (IQSEC3) Interacts with Gephyrin to Promote Inhibitory Synapse Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; NEUROLIGIN 2; COLLYBISTIN; ARF6; TRANSMISSION; MAINTENANCE; MOLECULES; BRAG2	Gephyrin is a central scaffold protein that mediates development, function, and plasticity of mammalian inhibitory synapses by interacting with various inhibitory synaptic proteins. Here, we show that IQSLC3, a guanine nucleotide exchange factor for ARE6, directly interacts with gephyrin, an interaction that is critical for the inhibitory synapse localization of IQSEC3. Overexpression of IQSEC3 increases inhibitory, but not excitatory, synapse density in a guanine nucleotide exchange factor activity-dependent manner. Conversely, knockdown of IQSEC3 decreases size of gephyrin cluster without altering gephyrin puncta density. Collectively, these data reveal that IQSEC3 acts together with gephyrin to regulate inhibitory synapse development.	[Um, Ji Won; Choii, Gayoung; Jeon, Sangmin; Ko, Jaewon] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea; [Um, Ji Won; Park, Dongseok; Kim, Dongwook; Kang, Hyeyeon] Yonsei Univ, Coll Med, Dept Physiol, Seoul 120752, South Korea; [Um, Ji Won; Park, Dongseok; Kim, Dongwook; Kang, Hyeyeon] Yonsei Univ, Coll Med, PLUS Project Med Sci BK21, Seoul 120752, South Korea; [Mori, Takuma; Tabuchi, Katsuhiko] Shinshu Univ, Sch Med, Matsumoto, Nagano 3908621, Japan; [Papadopoulos, Theofilos] Univ Med Gottingen, Dept Mol Biol, D-37075 Gottingen, Germany; [Yoo, Taesun; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 305701, South Korea; [Lee, Yeunkum; Kim, Eunjoon] Ctr Synapt Brain Dysfunct, Inst Basic Sci, Daejeon 305701, South Korea; [Ko, Jaewon] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Shinshu University; University of Gottingen; Korea Advanced Institute of Science & Technology (KAIST); Institute for Basic Science - Korea (IBS); Japan Science & Technology Agency (JST)	Ko, J (corresponding author), Yonsei Univ, Ctr Sci Res, Coll Life Sci & Biotechnol, Dept Biochem, 134 Shinchon Dong,S421, Seoul 120749, South Korea.	jaewonko@yonsei.ac.kr	Mori, Takuma/AFS-0267-2022; Mori, Takuma/GMX-3581-2022; Kim, Eunjoon/C-1566-2011	Mori, Takuma/0000-0002-4195-2804; Mori, Takuma/0000-0002-4195-2804; Papadopoulos, Theofilos/0000-0002-0684-2407; Park, Dongseok/0000-0003-0065-7945	National Research Foundation of Korea - Ministry of Science and Future Planning [2014051826, NRF-2015R1C1A2A01052176]; Yonsei University Future-leading Research Initiative; National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2013R1A6A3A04061338]; Deutsche Forschungsgemeinschaft [PA2087/1-3]; Institute for Basic Science [IBS-R002-D1]; Japan Science and Technology Agency PRESTO; Brain Korea 21 PLUS Program	National Research Foundation of Korea - Ministry of Science and Future Planning; Yonsei University Future-leading Research Initiative; National Research Foundation of Korea - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Institute for Basic Science; Japan Science and Technology Agency PRESTO(Japan Science & Technology Agency (JST)); Brain Korea 21 PLUS Program	This work was supported in part by the National Research Foundation of Korea funded by the Ministry of Science and Future Planning Grants 2014051826 (to J. K.) and NRF-2015R1C1A2A01052176 (to J. W. U.), Yonsei University Future-leading Research Initiative of 2014 (to J. K.), Yonsei University Future-leading Research Initiative of 2015 (to J. W. U.), National Research Foundation of Korea funded by the Ministry of Education, Science and Technology Grant NRF-2013R1A6A3A04061338 (to J. W. U.), Deutsche Forschungsgemeinschaft Grant PA2087/1-3 (to T. P.), the Institute for Basic Science Grant IBS-R002-D1 (to E. K.), Japan Science and Technology Agency PRESTO (to K. T.), and in part by the Brain Korea 21 PLUS Program. The authors declare that they have no conflicts of interest with the contents of this article.	Arancibia-Carcamo I. Lorena, 2006, V43, P25, DOI 10.1007/017; Choi S, 2006, J NEUROSCI, V26, P4811, DOI 10.1523/JNEUROSCI.4182-05.2006; Choii G, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.5; Fritschy JM, 2012, CELL MOL LIFE SCI, V69, P2485, DOI 10.1007/s00018-012-0926-4; Fukaya M, 2011, J NEUROCHEM, V116, P1122, DOI 10.1111/j.1471-4159.2010.07167.x; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Hiester KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082084; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; Ko J, 2003, J NEUROSCI, V23, P1667; Ko J, 2015, TRENDS MOL MED, V21, P256, DOI 10.1016/j.molmed.2015.01.004; Ko J, 2011, J CELL BIOL, V194, P323, DOI 10.1083/jcb.201101072; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Mok H, 2002, J NEUROSCI, V22, P5253; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Myers KR, 2012, J NEUROSCI, V32, P11716, DOI 10.1523/JNEUROSCI.1942-12.2012; Papadopoulos T, 2008, MOL CELL NEUROSCI, V39, P161, DOI 10.1016/j.mcn.2008.06.006; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Papadopoulos Theofilos, 2011, Front Cell Neurosci, V5, P11, DOI 10.3389/fncel.2011.00011; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Saiyed T, 2007, J BIOL CHEM, V282, P5625, DOI 10.1074/jbc.M610290200; Sakagami H, 2013, J COMP NEUROL, V521, P860, DOI 10.1002/cne.23206; Scholz R, 2010, NEURON, V66, P768, DOI 10.1016/j.neuron.2010.05.003; Shoubridge C, 2010, NAT GENET, V42, P486, DOI 10.1038/ng.588; Specht CG, 2013, NEURON, V79, P308, DOI 10.1016/j.neuron.2013.05.013; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Tyagarajan SK, 2014, NAT REV NEUROSCI, V15, P141, DOI 10.1038/nrn3670; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Woo J, 2013, J CELL BIOL, V201, P929, DOI 10.1083/jcb.201209132	29	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10119	10130		10.1074/jbc.M115.712893	http://dx.doi.org/10.1074/jbc.M115.712893			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	27002143	Green Published, hybrid			2022-12-28	WOS:000375602800023
J	Xu, X; Han, KK; Tang, XW; Zeng, YY; Lin, X; Zhao, Y; Zhang, ZB; Cao, BY; Wu, DP; Mao, XL				Xu, Xin; Han, Kunkun; Tang, Xiaowen; Zeng, Yuanying; Lin, Xu; Zhao, Yun; Zhang, Zubin; Cao, Biyin; Wu, Depei; Mao, Xinliang			The Ring Finger Protein RNF6 Induces Leukemia Cell Proliferation as a Direct Target of Pre-B-cell Leukemia Homeobox 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; PRECLINICAL ACTIVITY; LUNG ADENOCARCINOMA; MULTIPLE-MYELOMA; TRANSCRIPTION; E2A-PBX1; GENE; PBX1; DIFFERENTIATION; UBIQUITINATION	RNF6 is a little-studied ring finger protein. In the present study, we found that RNF6 was overexpressed in various leukemia cells and that it accelerated leukemia cell proliferation, whereas knockdown of RNF6 delayed tumor growth in xeno-grafts. To find out the mechanism of RNF6 overexpression in leukemia, we designed a series of truncated constructs of RNF6 regulatory regions in the luciferase reporter system. The results revealed that the region between -144 and -99 upstream of the RNF6 transcription start site was critical and that this region contained a PBX1 recognition element (PRE). PBX1 modulated RNF6 expression by binding to the specific PRE. When PRE was mutated, RNF6 transcription was completely abolished. Further studies showed that PBX1 collaborated with PREP1 but not MEIS1 to modulate RNF6 expression. Moreover, RNF6 expression could be suppressed by doxorubicin, a major anti-leukemia agent, via down-regulating PBX1. This study thus suggests that RNF6 overexpression in leukemia is under the direction of PBX1 and that the PBX1/RNF6 axis can be developed as a novel therapeutic target of leukemia.	[Xu, Xin; Han, Kunkun; Zeng, Yuanying; Lin, Xu; Zhang, Zubin; Cao, Biyin; Mao, Xinliang] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Jiangsu Key Lab Translat Res & Therapeut Neuropsy, Suzhou 215123, Jiangsu, Peoples R China; [Tang, Xiaowen; Wu, Depei] Soochow Univ, Affiliated Hosp 1, Dept Hematol, Suzhou 215006, Jiangsu, Peoples R China; [Zhao, Yun] Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou 215123, Jiangsu, Peoples R China; [Mao, Xinliang] Soochow Univ, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou 215123, Jiangsu, Peoples R China; [Han, Kunkun] Asclepius Technol Co Grp, Suzhou 215123, Jiangsu, Peoples R China; [Han, Kunkun] Asclepius Canc Res Ctr, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Mao, XL (corresponding author), Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, 199 Ren Rd,Suzhou Ind Pk, Suzhou 215123, Peoples R China.	xinliangmao@suda.edu.cn	xu, xu/GQP-5096-2022	Lin, Xu/0000-0002-6382-7414	National Natural Science Foundation of China [81320108023, 81272632, 81270645]; Natural Science Foundation of Jiangsu Province [BE2014630]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Key Laboratory for Translational Research and Therapeutics of Neuro-Psycho-Diseases [BK2013003]; Suzhou City Science and Technology Programs [SYS201457]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Key Laboratory for Translational Research and Therapeutics of Neuro-Psycho-Diseases; Suzhou City Science and Technology Programs	This work was partly supported by National Natural Science Foundation of China Grants 81320108023 (to X. M.), 81272632 (to X. M.), 81270645 (to X. T.), by Natural Science Foundation of Jiangsu Province Grant BE2014630 (to X. M.), by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), by Jiangsu Key Laboratory for Translational Research and Therapeutics of Neuro-Psycho-Diseases Grant BK2013003 (to X. M.), and by Suzhou City Science and Technology Programs Grant SYS201457 (to X. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Aspland SE, 2001, ONCOGENE, V20, P5708, DOI 10.1038/sj.onc.1204592; Bruserud O, 2015, EXPERT REV HEMATOL, V8, P29, DOI 10.1586/17474086.2015.971005; Calvo KR, 1999, ONCOGENE, V18, P8033, DOI 10.1038/sj.onc.1203377; Cao BY, 2013, J BIOL CHEM, V288, P34181, DOI 10.1074/jbc.M113.472563; Chao SH, 2003, MOL CELL BIOL, V23, P831, DOI 10.1128/MCB.23.3.831-841.2003; Chen G, 2014, BRIT J CANCER, V110, P63, DOI 10.1038/bjc.2013.711; Collins CT, 2016, ONCOGENE, V35, P1090, DOI 10.1038/onc.2015.174; Dardaei L, 2014, P NATL ACAD SCI USA, V111, pE896, DOI 10.1073/pnas.1321200111; Duque-Afonso J, 2015, J CLIN INVEST, V125, P3667, DOI 10.1172/JCI81158; Imperato MR, 2015, INT J HEMATOL, V101, P319, DOI 10.1007/s12185-015-1762-8; Kikuchi J, 2010, BLOOD, V116, P406, DOI 10.1182/blood-2009-07-235663; Li XM, 2010, JNCI-J NATL CANCER I, V102, P1069, DOI 10.1093/jnci/djq198; Lo HS, 2002, CANCER RES, V62, P4191; Lopez P, 2002, MOL CELL BIOL, V22, P3488, DOI 10.1128/MCB.22.10.3488-3496.2002; Macdonald DHC, 1999, GENOMICS, V58, P94, DOI 10.1006/geno.1999.5802; Mao XL, 2008, BLOOD, V112, P760, DOI 10.1182/blood-2008-02-142687; Mao XL, 2011, MOL PHARMACOL, V79, P672, DOI 10.1124/mol.110.068122; Mao XL, 2011, BLOOD, V117, P1986, DOI 10.1182/blood-2010-05-284810; Qin X, 2012, INT J MOL MED, V29, P791, DOI 10.3892/ijmm.2012.912; Risolino M, 2014, P NATL ACAD SCI USA, V111, pE3775, DOI 10.1073/pnas.1407074111; Shi M, 2014, TOXICOL LETT, V228, P133, DOI 10.1016/j.toxlet.2014.05.003; Somasundaram R, 2015, BLOOD, V126, P144, DOI 10.1182/blood-2014-12-575688; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021	24	44	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9617	9628		10.1074/jbc.M115.701979	http://dx.doi.org/10.1074/jbc.M115.701979			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26971355	Green Published, hybrid			2022-12-28	WOS:000375602300020
J	Cao, H; Schroeder, B; Chen, J; Schott, MB; McNiven, MA				Cao, Hong; Schroeder, Barbara; Chen, Jing; Schott, Micah B.; McNiven, Mark A.			The Endocytic Fate of the Transferrin Receptor Is Regulated by c-Abl Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; TYROSINE KINASE; MAMMALIAN-CELLS; RETICULOCYTE MATURATION; CLATHRIN TRISKELIA; IRON-METABOLISM; DYNAMIN; DEGRADATION; CORTACTIN; BINDING	Clathrin-mediated endocytosis of transferrin (Tf) and its cognate receptor (TfR1) is a central pathway supporting the uptake of trophic iron. It has generally been assumed that this is a constitutive process. However, we have reported that the non-receptor tyrosine kinase, Src, is activated by Tf to facilitate the internalization of the Tf-TfR1 ligand-receptor complex. As an extension of these findings, we have tested whether subsequent trafficking steps might be regulated by additional kinase-dependent cascades, and we observed a significant endocytic block by inhibiting c-Abl kinase by a variety of methods. Importantly, Tf internalization was reduced significantly in all of these cell models and could be restored by re-expression of WTc-Abl. Surprisingly, this attenuated Tf-TfR1 endocytosis was due to a substantial drop in both the surface and total cellular receptor levels. Additional studies with the LDL receptor showed a similar effect. Surprisingly, immunofluorescence microscopy of imatinib-treated cells revealed a marked colocalization of internalized TfR1 with late endosomes/lysosomes, whereas attenuating the lysosome function with several inhibitors reduced this receptor loss. Importantly, inhibition of c-Abl resulted in a striking redistribution of the chaperone Hsc70 from a diffuse cytosolic localization to an association with the TfR1 at the late endosome-lysosome. Pharmacological inhibition of Hsc70 ATPase activity in cultured cells by the drug VER155008 prevents this chaperone-receptor interaction, resulting in an accumulation of the TfR1 in the early endosome. Thus, inhibition of c-Abl minimizes receptor recycling pathways and results in chaperone-dependent trafficking of the TfR1 to the lysosome for degradation. These findings implicate a novel role for c-Abl and Hsc70 as an unexpected regulator of Hsc70-mediated transport of trophic receptor cargo between the early and late endosomal compartments.	[Cao, Hong; Chen, Jing; Schott, Micah B.; McNiven, Mark A.] Mayo Clin, Ctr Basic Res Digest Dis, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Schroeder, Barbara] Mayo Clin, Dept Expt Pathol & Lab Med, Rochester, MN 55905 USA; [Schroeder, Barbara] Tech Munich, Chair Biol Imaging, Ismaninger Str 22, D-81675 Munich, Germany	Mayo Clinic; Mayo Clinic	McNiven, MA (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW,Guggenheim 1642D, Rochester, MN 55905 USA.	mmcniven@mayo.edu			National Institutes of Health [DK44650, T32DK007352, DK84567]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044650, P30DK084567, T32DK007352, R01DK044650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK44650 (to M. A. M.), T32DK007352 (to M. B. S.), and DK84567 (to the Optical Microscopy Core of the Mayo Center for Cell Signaling in Gastroenterology). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barisani D, 2002, BLOOD CELL MOL DIS, V29, P498, DOI 10.1006/bcmd.2002.0588; Beau I, 2010, MOL CELL, V39, P485, DOI 10.1016/j.molcel.2010.08.005; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Buchdunger E, 2002, EUR J CANCER, V38, pS28, DOI 10.1016/S0959-8049(02)80600-1; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Cao H, 2007, J CELL SCI, V120, P4167, DOI 10.1242/jcs.010686; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Chen JX, 2009, TRAFFIC, V10, P1488, DOI 10.1111/j.1600-0854.2009.00961.x; Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153; Dai J, 2004, DEV CELL, V7, P771, DOI 10.1016/j.devcel.2004.10.002; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Dores MR, 2012, MOL BIOL CELL, V23, P3612, DOI 10.1091/mbc.E12-03-0251; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; Fujita H, 2003, J CELL SCI, V116, P401, DOI 10.1242/jcs.00213; Fujita H, 2013, J CELL SCI, V126, P2798, DOI 10.1242/jcs.119909; Geminard C, 2004, TRAFFIC, V5, P181, DOI 10.1111/j.1600-0854.2004.0167.x; Geminard C, 2001, J BIOL CHEM, V276, P9910, DOI 10.1074/jbc.M009641200; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Henley JR, 1996, J CELL BIOL, V133, P761, DOI 10.1083/jcb.133.4.761; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; HEUSER J, 1989, J CELL BIOL, V109, P1457, DOI 10.1083/jcb.109.4.1457; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; Hsu VW, 2012, NAT REV MOL CELL BIO, V13, P1, DOI 10.1038/nrm3332; Jacob M, 2009, CELL SIGNAL, V21, P1308, DOI 10.1016/j.cellsig.2009.03.016; Johnson MB, 2007, MOL BIOL CELL, V18, P743, DOI 10.1091/mbc.E06-09-0798; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Lagace TA, 2014, CURR OPIN LIPIDOL, V25, P387, DOI 10.1097/MOL.0000000000000114; Leu JIJ, 2011, MOL CANCER RES, V9, P936, DOI 10.1158/1541-7786.MCR-11-0019; Lin YL, 2013, P NATL ACAD SCI USA, V110, P1664, DOI 10.1073/pnas.1214330110; Manley PW, 2002, EUR J CANCER, V38, pS19, DOI 10.1016/S0959-8049(02)80599-8; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; MATHEW A, 1995, BIOCHEM J, V308, P823, DOI 10.1042/bj3080823; Matsui T, 2011, TRAFFIC, V12, P1432, DOI 10.1111/j.1600-0854.2011.01240.x; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; McNiven MA, 1998, CELL, V94, P151, DOI 10.1016/S0092-8674(00)81414-2; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; O'Dwyer ME, 2000, CURR OPIN ONCOL, V12, P594, DOI 10.1097/00001622-200011000-00013; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Schlecht R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078443; Sharma SK, 2009, CURR PROTEIN PEPT SC, V10, P432, DOI 10.2174/138920309789351930; Shen SS, 2009, J CELL BIOL, V185, P629, DOI 10.1083/jcb.200810183; Srinivasan D, 2009, CELL SIGNAL, V21, P1143, DOI 10.1016/j.cellsig.2009.03.003; Tachiyama R, 2011, GENES CELLS, V16, P448, DOI 10.1111/j.1365-2443.2011.01499.x; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; Theis S, 1998, ONCOGENE, V17, P557, DOI 10.1038/sj.onc.1201973; Trinder D, 2003, INT J BIOCHEM CELL B, V35, P292, DOI 10.1016/S1357-2725(02)00258-3; UNGEWICKELL E, 1985, EMBO J, V4, P3385, DOI 10.1002/j.1460-2075.1985.tb04094.x; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Yogalingam G, 2008, J BIOL CHEM, V283, P35941, DOI 10.1074/jbc.M804543200; Zhu JW, 2007, J BIOL CHEM, V282, P16086, DOI 10.1074/jbc.M701997200	58	20	20	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16424	16437		10.1074/jbc.M116.724997	http://dx.doi.org/10.1074/jbc.M116.724997			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27226592	Green Published, hybrid			2022-12-28	WOS:000380826700002
J	Burger, D; Stihle, M; Sharma, A; Di Lello, P; Benz, J; D'Arcy, B; Debulpaep, M; Fry, D; Huber, W; Kremer, T; Laeremans, T; Matile, H; Ross, A; Rufer, AC; Schoch, G; Steinmetz, MO; Steyaert, J; Rudolph, MG; Thoma, R; Ruf, A				Burger, Dominique; Stihle, Martine; Sharma, Ashwani; Di Lello, Paola; Benz, Jorg; D'Arcy, Brigitte; Debulpaep, Maja; Fry, David; Huber, Walter; Kremer, Thomas; Laeremans, Toon; Matile, Hugues; Ross, Alfred; Rufer, Arne C.; Schoch, Guillaume; Steinmetz, Michel O.; Steyaert, Jan; Rudolph, Markus G.; Thoma, Ralf; Ruf, Armin			Crystal Structures of the Human Doublecortin C- and N-terminal Domains in Complex with Specific Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODEL; ULTRACENTRIFUGATION; CRYSTALLOGRAPHY; STABILIZATION; RECOGNIZES; REFINEMENT; GENERATION; FRAGMENTS; TUBULIN; SYSTEM	Doublecortin is a microtubule-associated protein produced during neurogenesis. The protein stabilizes microtubules and stimulates their polymerization, which allows migration of immature neurons to their designated location in the brain. Mutations in the gene that impair doublecortin function and cause severe brain formation disorders are located on a tandem repeat of two doublecortin domains. The molecular mechanism of action of doublecortin is only incompletely understood. Anti-doublecortin antibodies, such as the rabbit polyclonal Abcam 18732, are widely used as neurogenesis markers. Here, we report the generation and characterization of antibodies that bind to single doublecortin domains. The antibodies were used as tools to obtain structures of both domains. Four independent crystal structures of the N-terminal domain reveal several distinct open and closed conformations of the peptide linking N- and C-terminal domains, which can be related to doublecortin function. An NMR assignment and a crystal structure in complex with a camelid antibody fragment show that the doublecortin C-terminal domain adopts the same well defined ubiquitin-like fold as the N-terminal domain, despite its reported aggregation and molten globule-like properties. The antibodies' unique domain specificity also renders them ideal research tools to better understand the role of individual domains in doublecortin function. A single chain camelid antibody fragment specific for the C-terminal doublecortin domain affected microtubule binding, whereas a monoclonal mouse antibody specific for the N-terminal domain did not. Together with steric considerations, this suggests that the microtubule-interacting doublecortin domain observed in cryoelectron micrographs is the C-terminal domain rather than the N-terminal one.	[Burger, Dominique; Stihle, Martine; Benz, Jorg; D'Arcy, Brigitte; Huber, Walter; Matile, Hugues; Ross, Alfred; Rufer, Arne C.; Rudolph, Markus G.; Thoma, Ralf; Ruf, Armin] F Hoffmann La Roche Ltd, Therapeut Modal, pRED Pharma Res & Early Dev, Grenzacherstr 124, CH-4070 Basel, Switzerland; [Kremer, Thomas; Schoch, Guillaume] F Hoffmann La Roche Ltd, Roche Pharmaceut Res & Early Dev, NORD Discovery & Translat Area, Roche Innovat Ctr Basel, Grenzacherstr 124, CH-4070 Basel, Switzerland; [Sharma, Ashwani] Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Di Lello, Paola; Fry, David] Roche, Discovery Technol, Small Mol Res, pRED Pharma Res & Early Dev, Nutley, NJ 07110 USA; [Debulpaep, Maja; Laeremans, Toon; Steyaert, Jan] Vrije Univ Brussel, Struct Biol Brussels, Pl Laan 2, B-1050 Brussels, Belgium; [Debulpaep, Maja; Laeremans, Toon; Steyaert, Jan] VIB, Struct Biol Res Ctr, Pl Laan 2, B-1050 Brussels, Belgium; [Di Lello, Paola] Genentech Inc, Dept Biol Struct, 1 DNA Way, San Francisco, CA 94080 USA; [Schoch, Guillaume] Fishawack Archimed AG, Elisabethenanlage 11, CH-4051 Basel, Switzerland	Roche Holding; Roche Holding; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Roche Holding; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Roche Holding; Genentech	Ruf, A (corresponding author), F Hoffmann La Roche Ltd, pRED Pharma Res & Early Dev, Therapeut Modal, Chem Biol, CH-4070 Basel, Switzerland.	armin.ruf@roche.com	Steinmetz, Michel O/AAA-3349-2022; steyaert, jan/GQP-7811-2022; Steyaert, Jan/H-4662-2011	Steinmetz, Michel O/0000-0001-6157-3687; Steyaert, Jan/0000-0002-3825-874X; Rudolph, Markus/0000-0003-0447-1101	EMBO Long Term Fellowship; Swiss National Science Foundation [310030B_138659]	EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by an EMBO Long Term Fellowship (to A. S.) as well as Swiss National Science Foundation Grant 310030B_138659 (to M. O. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bahi-Buisson N, 2013, BRAIN, V136, P223, DOI 10.1093/brain/aws323; Banner DW, 2013, ACTA CRYSTALLOGR D, V69, P1124, DOI 10.1107/S0907444913006574; Bechstedt S, 2014, CURR BIOL, V24, P2366, DOI 10.1016/j.cub.2014.08.039; Bechstedt S, 2012, DEV CELL, V23, P181, DOI 10.1016/j.devcel.2012.05.006; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Campbell JN, 2011, METHODS MOL BIOL, V777, P87, DOI 10.1007/978-1-61779-252-6_6; Cierpicki T, 2006, PROTEINS, V64, P874, DOI 10.1002/prot.21068; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fourniol FJ, 2010, J CELL BIOL, V191, P463, DOI 10.1083/jcb.201007081; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hausammann GJ, 2013, BIOCHEM BIOPH RES CO, V431, P70, DOI 10.1016/j.bbrc.2012.12.089; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Kovari LC, 1995, STRUCTURE, V3, P1291, DOI 10.1016/S0969-2126(01)00266-0; Kremer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059269; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Liu JS, 2012, MOL CELL, V47, P707, DOI 10.1016/j.molcel.2012.06.025; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Tereshko V, 2008, PROTEIN SCI, V17, P1175, DOI 10.1110/ps.034892.108; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WISHART DS, 1994, J BIOMOL NMR, V4, P171	40	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16292	16306		10.1074/jbc.M116.726547	http://dx.doi.org/10.1074/jbc.M116.726547			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226599	Green Published, hybrid			2022-12-28	WOS:000380585400033
J	Bajaj, S; Alam, SK; Roy, KS; Datta, A; Nath, S; Roychoudhury, S				Bajaj, Swati; Alam, Sk. Kayum; Roy, Kumar Singha; Datta, Arindam; Nath, Somsubhra; Roychoudhury, Susanta			E2 Ubiquitin-conjugating Enzyme, UBE2C Gene, Is Reciprocally Regulated by Wild-type and Gain-of-Function Mutant p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E2F transcription factor; mitosis; mitotic spindle; p53; ubiquitin-conjugating enzyme (E2 enzyme)	SPINDLE ASSEMBLY CHECKPOINT; CELL-CYCLE GENES; SUPPRESSOR PROTEIN P53; TRANSCRIPTIONAL REPRESSION; DNA-DAMAGE; PROMOTER ELEMENTS; CANCER; EXPRESSION; UBCH10; COMPLEX	Spindle assembly checkpoint governs proper chromosomal segregation during mitosis to ensure genomic stability. At the cellular level, this event is tightly regulated by UBE2C, an E2 ubiquitin-conjugating enzyme that donates ubiquitin to the anaphase-promoting complex/cyclosome. This, in turn, facilitates anaphase-onset by ubiquitin-mediated degradation of mitotic substrates. UBE2C is an important marker of chromosomal instability and has been associated with malignant growth. However, the mechanism of its regulation is largely unexplored. In this study, we report that UBE2C is transcriptionally activated by the gain-of-function (GOF) mutant p53, although it is transcriptionally repressed by wild-type p53. We showed that wild-type p53-mediated inhibition of UBE2C is p21-E2F4-dependent and GOF mutant p53-mediated transactivation of UBE2C is NF-Y-dependent. We further explored that DNA damage-induced wild-type p53 leads to spindle assembly checkpoint arrest by repressing UBE2C, whereas mutant p53 causes premature anaphase exit by increasing UBE2C expression in the presence of 5-fluorouracil. Identification of UBE2C as a target of wild-type and GOF mutant p53 further highlights the contribution of p53 in regulation of spindle assembly checkpoint.	[Bajaj, Swati; Alam, Sk. Kayum; Roy, Kumar Singha; Datta, Arindam; Nath, Somsubhra; Roychoudhury, Susanta] CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, 4 Raja SC Mullick Rd, Kolkata 700032, India; [Bajaj, Swati] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Pathol, Adv Mol Diagnost Lab, Toronto, ON M5G 2M9, Canada; [Nath, Somsubhra] Saroj Gupta Canc Ctr & Res Inst, Mol Biol Res & Diagnost Lab, Mahatma Gandhi Rd, Kolkata 700063, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Roychoudhury, S (corresponding author), CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	susantarc@gmail.com	Nath, Somsubhra/AAL-6377-2020; Datta, Arindam/ADR-8763-2022; ALAM, SK KAYUM/ABA-3659-2020; Roychoudhury, Susanta/AAD-7946-2021	Datta, Arindam/0000-0002-0617-9908; ALAM, SK KAYUM/0000-0001-5342-4542; Nath, Somsubhra/0000-0001-8214-1218	Department of Biotechnology [BT/PR/5524/Med/14/649/2004, BT/01/COE/05/04]; Council of Scientific and Industrial Research [IAP-001]; CSIR-Mayo Clinic Collaboration for Innovation and Translational Research Grant [CMPP-08]; Council of Scientific and Industrial Research (New Delhi, India); University Grants Commission (New Delhi, India)	Department of Biotechnology; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); CSIR-Mayo Clinic Collaboration for Innovation and Translational Research Grant; Council of Scientific and Industrial Research (New Delhi, India)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (New Delhi, India)(University Grants Commission, India)	This work was supported in part by Department of Biotechnology Grants BT/PR/5524/Med/14/649/2004 and BT/01/COE/05/04, Council of Scientific and Industrial Research Grant IAP-001, and CSIR-Mayo Clinic Collaboration for Innovation and Translational Research Grant CMPP-08 (to S.R.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipients of predoctoral fellowships from Council of Scientific and Industrial Research (New Delhi, India).; Supported by a predoctoral fellowship from University Grants Commission (New Delhi, India).	Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; Alam SK, 2016, CELL DEATH DIFFER, V23, P707, DOI 10.1038/cdd.2015.133; Arvand A, 1998, ONCOGENE, V17, P2039, DOI 10.1038/sj.onc.1202129; Banerjee T, 2009, NUCLEIC ACIDS RES, V37, P2688, DOI 10.1093/nar/gkp110; Berlingieri MT, 2007, ONCOGENE, V26, P2136, DOI 10.1038/sj.onc.1210010; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chae HD, 2004, ONCOGENE, V23, P4084, DOI 10.1038/sj.onc.1207482; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chun ACS, 2003, J BIOL CHEM, V278, P37439, DOI 10.1074/jbc.M307185200; Ciliberto A, 2009, EMBO J, V28, P2162, DOI 10.1038/emboj.2009.186; Collins K, 1997, P NATL ACAD SCI USA, V94, P2776, DOI 10.1073/pnas.94.7.2776; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Dohna CLZ, 2000, FEBS LETT, V484, P77, DOI 10.1016/S0014-5793(00)02133-5; Fajas L, 2000, FEBS LETT, V471, P29, DOI 10.1016/S0014-5793(00)01363-6; Fujita T, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-87; Haugwitz U, 2002, NUCLEIC ACIDS RES, V30, P1967, DOI 10.1093/nar/30.9.1967; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Incassati A, 2006, ONCOGENE, V25, P2444, DOI 10.1038/sj.onc.1209276; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Krause K, 2001, BIOCHEM BIOPH RES CO, V284, P743, DOI 10.1006/bbrc.2001.5040; Krause K, 2000, NUCLEIC ACIDS RES, V28, P4410, DOI 10.1093/nar/28.22.4410; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Mannefeld M, 2009, CANCER RES, V69, P4073, DOI 10.1158/0008-5472.CAN-08-4156; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Mondal G, 2007, CARCINOGENESIS, V28, P81, DOI 10.1093/carcin/bgl100; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; Nath S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.160671; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Okamoto Y, 2003, CANCER RES, V63, P4167; Pallante P, 2005, BRIT J CANCER, V93, P464, DOI 10.1038/sj.bjc.6602721; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Quaas M, 2012, CELL CYCLE, V11, P4661, DOI 10.4161/cc.22917; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Tabach Y, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100030; Taylor WR, 2001, J BIOL CHEM, V276, P1998, DOI 10.1074/jbc.M005101200; Vogel C, 2004, ONCOGENE, V23, P6845, DOI 10.1038/sj.onc.1207860; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Weisz L, 2007, ONCOGENE, V26, P2202, DOI 10.1038/sj.onc.1210294; Yu HT, 1996, CURR BIOL, V6, P455, DOI 10.1016/S0960-9822(02)00513-4; Zwicker J, 1997, NUCLEIC ACIDS RES, V25, P4926, DOI 10.1093/nar/25.24.4926	52	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14231	14247		10.1074/jbc.M116.731398	http://dx.doi.org/10.1074/jbc.M116.731398			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129209	hybrid, Green Published			2022-12-28	WOS:000379975100028
J	Jadhav, S; Ajay, AK; Trivedi, P; Seematti, J; Pellegrini, K; Craciun, F; Vaidya, VS				Jadhav, Shreyas; Ajay, Amrendra K.; Trivedi, Priyanka; Seematti, Jenifer; Pellegrini, Kathryn; Craciun, Florin; Vaidya, Vishal S.			RNA-binding Protein Musashi Homologue 1 Regulates Kidney Fibrosis by Translational Inhibition of p21 and Numb mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cell cycle; fatty acid; fibrosis; kidney; RNA binding protein	CELL-CYCLE ARREST; TRANSITION; INJURY; NOTCH; EXPRESSION; PATHWAY; SCREEN; MICE	RNA-binding proteins (RBPs) are recognized as key posttranscriptional regulators that not only modulate the spatiotemporal expression of genes during organism development but also regulate disease pathogenesis. Very limited information exists on the potential role of RBPs in modulating kidney fibrosis, which is a major hallmark of chronic kidney disease. Here, we report a novel mechanism in kidney fibrosis involving a RBP, Musashi homologue 1 (Msi1), which is expressed in tubular epithelial cells. Using two mechanistically distinct mouse models of kidney fibrosis, we show that Msi1 protein levels are significantly down-regulated in the kidneys following fibrosis. We found that Msi1 functions by negatively regulating the translation of its target mRNAs, p21 and Numb, whose protein levels are markedly increased in kidney fibrosis. Also, Msi1 overexpression and knockdown in kidney epithelial cells cause p21- and Numb-mediated cell cycle arrest. Furthermore, we observed that Numb looses its characteristic membrane localization in fibrotic kidneys and therefore is likely unable to inhibit Notch resulting in tubular cell death. Oleic acid is a known inhibitor of Msi1 and injecting oleic acid followed by unilateral ureteral obstruction surgery in mice resulted in enhanced fibrosis compared with the control group, indicating that inhibiting Msi1 activity renders the mice more susceptible to fibrosis. Given that deregulated fatty acid metabolism plays a key role in kidney fibrosis, these results demonstrate a novel connection between fatty acid and Msi1, an RNA-binding protein, in kidney fibrosis.	[Jadhav, Shreyas; Ajay, Amrendra K.; Trivedi, Priyanka; Seematti, Jenifer; Pellegrini, Kathryn; Craciun, Florin; Vaidya, Vishal S.] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [Vaidya, Vishal S.] Harvard Med Sch, Harvard Program Therapeut Sci, Boston, MA 02115 USA; [Vaidya, Vishal S.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Vaidya, VS (corresponding author), Harvard Inst Med, Rm 562,77 Ave Louis Pasteur, Boston, MA 02115 USA.	vvaidya@bwh.harvard.edu	Ajay, Amrendra K/D-7431-2016	Ajay, Amrendra K/0000-0003-2790-5726; Pellegrini, Kathryn/0000-0002-5089-5477	National Institutes of Health NIEHS Outstanding New Environmental Sciences (ONES) Award [ES017543]; Innovation in Regulatory Science Award from Burroughs Wellcome Fund [BWF-1012518]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES017543, R01ES017543] Funding Source: NIH RePORTER	National Institutes of Health NIEHS Outstanding New Environmental Sciences (ONES) Award; Innovation in Regulatory Science Award from Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health NIEHS Outstanding New Environmental Sciences (ONES) Award ES017543 (to V. S. V.) and Innovation in Regulatory Science Award from Burroughs Wellcome Fund Grant BWF-1012518 (to V. S. V.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; Adler M, 2016, J AM SOC NEPHROL, V27, P1015, DOI 10.1681/ASN.2015010060; Ajay AK, 2014, J AM SOC NEPHROL, V25, P105, DOI 10.1681/ASN.2013020161; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bonventre JV, 2014, KIDNEY INT SUPPL, V4, P39, DOI 10.1038/kisup.2014.8; Busa R, 2007, ONCOGENE, V26, P4372, DOI 10.1038/sj.onc.1210224; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cheng HT, 2003, DEVELOPMENT, V130, P5031, DOI 10.1242/dev.00697; Clingman CC, 2014, ELIFE, V3, DOI 10.7554/eLife.02848; Craciun F. L., 2015, J AM SOC NEPHROL; Craciun FL, 2014, AM J PHYSIOL-RENAL, V307, pF471, DOI 10.1152/ajprenal.00189.2014; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Heraud-Farlow JE, 2013, CELL REP, V5, P1511, DOI 10.1016/j.celrep.2013.11.039; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Jadhav S, 2008, DEVELOPMENT, V135, P1803, DOI 10.1242/dev.013656; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; Lasko P, 2000, J CELL BIOL, V150, pF51, DOI 10.1083/jcb.150.2.F51; Lee Min-Ho, 2006, WormBook, P1; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Martinez-Gimeno M, 2003, INVEST OPHTH VIS SCI, V44, P2171, DOI 10.1167/iovs.02-0871; Megyesi J, 2015, AM J PHYSIOL-RENAL, V308, pF122, DOI 10.1152/ajprenal.00489.2014; Minuesa G, 2014, COMB CHEM HIGH T SCR, V17, P596, DOI 10.2174/1386207317666140609122714; Nakagawa Naoki, 2013, Curr Pathobiol Rep, V1, DOI 10.1007/s40139-013-0025-8; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Nikpour P, 2011, J CELL MOL MED, V15, P1210, DOI 10.1111/j.1582-4934.2010.01090.x; Riggi N, 2007, J PATHOL, V213, P4, DOI 10.1002/path.2209; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Saunders PTK, 2002, BIOL REPROD, V66, P500, DOI 10.1095/biolreprod66.2.500; Sirin Y, 2012, J PATHOL, V226, P394, DOI 10.1002/path.2967; Song Y, 2012, J BIOL CHEM, V287, P17716, DOI 10.1074/jbc.M112.360719; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053540; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Wang ZZ, 2009, EMBO J, V28, P2360, DOI 10.1038/emboj.2009.190; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zeisberg M, 2015, CLIN J AM SOC NEPHRO, V10, P1831, DOI 10.2215/CJN.00640114	41	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14085	14094		10.1074/jbc.M115.713289	http://dx.doi.org/10.1074/jbc.M115.713289			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129280	hybrid, Green Published			2022-12-28	WOS:000379975100017
J	Jhingan, GD; Kumari, S; Jamwal, SV; Kalam, H; Arora, D; Jain, N; Kumaar, LK; Samal, A; Rao, KVS; Kumar, D; Nandicoori, VK				Jhingan, Gagan Deep; Kumari, Sangeeta; Jamwal, Shilpa V.; Kalam, Haroon; Arora, Divya; Jain, Neharika; Kumaar, Lakshmi Krishna; Samal, Areejit; Rao, Kanury V. S.; Kumar, Dhiraj; Nandicoori, Vinay Kumar			Comparative Proteomic Analyses of Avirulent, Virulent, and Clinical Strains of Mycobacterium tuberculosis Identify Strain-specific Patterns	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mycobacteria; Mycobacterium tuberculosis; protein expression; proteomics; virulence factor	CULTURE SUPERNATANT PROTEINS; DRUG-RESISTANT TUBERCULOSIS; STREPTOMYCIN RESISTANT; 2-COMPONENT SYSTEM; EFFLUX PUMP; H37RV; IDENTIFICATION; DELETION; SURVIVAL; BOVIS	Mycobacterium tuberculosis is an adaptable intracellular pathogen, existing in both dormant as well as active disease-causing states. Here, we report systematic proteomic analyses of four strains, H37Ra, H37Rv, and clinical isolates BND and JAL, to determine the differences in protein expression patterns that contribute to their virulence and drug resistance. Resolution of lysates of the four strains by liquid chromatography, coupled to mass spectrometry analysis, identified a total of 2161 protein groups covering approximate to 54% of the predicted M. tuberculosis proteome. Label-free quantification analysis of the data revealed 257 differentially expressed protein groups. The differentially expressed protein groups could be classified into seven K-means cluster bins, which broadly delineated strain-specific variations. Analysis of the data for possible mechanisms responsible for drug resistance phenotype of JAL suggested that it could be due to a combination of overexpression of proteins implicated in drug resistance and the other factors. Expression pattern analyses of transcription factors and their downstream targets demonstrated substantial differential modulation in JAL, suggesting a complex regulatory mechanism. Results showed distinct variations in the protein expression patterns of Esx and mce1 operon proteins in JAL and BND strains, respectively. Abrogating higher levels of ESAT6, an important Esx protein known to be critical for virulence, in the JAL strain diminished its virulence, although it had marginal impact on the other strains. Taken together, this study reveals that strain-specific variations in protein expression patterns have a meaningful impact on the biology of the pathogen.	[Jhingan, Gagan Deep; Kumari, Sangeeta; Arora, Divya; Nandicoori, Vinay Kumar] Int Ctr Genet Engn & Biotechnol, Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India; [Kalam, Haroon; Jain, Neharika; Rao, Kanury V. S.; Kumar, Dhiraj] Int Ctr Genet Engn & Biotechnol, Cellular Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India; [Jamwal, Shilpa V.] Translat Hlth Sci & Technol Inst, Drug Discovery Res Ctr, Faridabad 121004, Haryana, India; [Kumaar, Lakshmi Krishna; Samal, Areejit] Inst Math Sci, Madras 600113, Tamil Nadu, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Institute of Mathematical Sciences (IMSc) India	Nandicoori, VK (corresponding author), Int Ctr Genet Engn & Biotechnol, Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.ac.in	Kumari, Sangeeta/AAB-7154-2022; Samal, Areejit/E-5422-2011; Samal, Areejit/AAC-2485-2020	Samal, Areejit/0000-0002-6796-9604; Kalam, Haroon/0000-0002-8964-3816; Kumari, Sangeeta/0000-0002-0692-0452; Nandicoori, Vinay/0000-0002-5682-4178	Department of Biotechnology, Government of India [BT/PR3260/BRB/10/967/2011]; Wellcome Trust/DBT India Alliance Early Career Fellowship [500080-Z-09-Z]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Wellcome Trust/DBT India Alliance Early Career Fellowship	This work was supported by Department of Biotechnology, Government of India, Grant BT/PR3260/BRB/10/967/2011 (to V. K. N.) and Wellcome Trust/DBT India Alliance Early Career Fellowship Ref. No. 500080-Z-09-Z (to G. D. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Albrethsen J, 2013, MOL CELL PROTEOMICS, V12, P1180, DOI 10.1074/mcp.M112.018846; ANDERSEN AB, 1992, INFECT IMMUN, V60, P2317, DOI 10.1128/IAI.60.6.2317-2323.1992; Forrellad MA, 2014, TUBERCULOSIS, V94, P170, DOI 10.1016/j.tube.2013.12.005; Ang KC, 2014, BIOTECHNOL APPL BIOC, V61, P153, DOI 10.1002/bab.1137; Bahk YY, 2004, PROTEOMICS, V4, P3299, DOI 10.1002/pmic.200400980; Bartek IL, 2014, MBIO, V5, DOI 10.1128/mBio.01106-14; Beatty WL, 2000, INFECT IMMUN, V68, P6997, DOI 10.1128/IAI.68.12.6997-7002.2000; Betts JC, 2000, MICROBIOL-SGM, V146, P3205, DOI 10.1099/00221287-146-12-3205; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Bisson GP, 2012, J BACTERIOL, V194, P6441, DOI 10.1128/JB.01013-12; Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007; Chatterjee A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054717; Chopra T, 2014, MOL CELL PROTEOMICS, V13, P3014, DOI 10.1074/mcp.M113.034082; Cohen KA, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0036-2013; Colangeli R, 2005, MOL MICROBIOL, V55, P1829, DOI 10.1111/j.1365-2958.2005.04510.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cubillos-Ruiz Andres, 2008, BMC Res Notes, V1, P110, DOI 10.1186/1756-0500-1-110; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; de Stoppelaar SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080062; Dutta NK, 2014, MBIO, V5, DOI 10.1128/mBio.01066-13; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Fu Li M, 2009, Int J Microbiol, V2009, P879621, DOI 10.1155/2009/879621; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Galagan JE, 2010, TUBERCULOSIS, V90, P225, DOI 10.1016/j.tube.2010.03.010; Gao LY, 2003, MOL MICROBIOL, V49, P1547, DOI 10.1046/j.1365-2958.2003.03667.x; Geiger T, 2013, MOL CELL PROTEOMICS, V12, P1709, DOI 10.1074/mcp.M112.024919; Gioffre A, 2005, MICROBES INFECT, V7, P325, DOI 10.1016/j.micinf.2004.11.007; Gordon BRG, 2010, P NATL ACAD SCI USA, V107, P5154, DOI 10.1073/pnas.0913551107; Gupta S, 2002, PROTEIN ENG, V15, P503, DOI 10.1093/protein/15.6.503; He XY, 2003, MICROBES INFECT, V5, P851, DOI 10.1016/S1286-4579(03)00179-5; Hebert AS, 2014, MOL CELL PROTEOMICS, V13, P339, DOI 10.1074/mcp.M113.034769; Ibrahim YM, 2004, INFECT IMMUN, V72, P3584, DOI 10.1128/IAI.72.6.3584-3591.2004; Ilina EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056577; Jiang X, 2006, MICROB DRUG RESIST, V12, P231, DOI 10.1089/mdr.2006.12.231; Jungblut PR, 1999, MOL MICROBIOL, V33, P1103, DOI 10.1046/j.1365-2958.1999.01549.x; Kaczmarczyk A, 2014, P NATL ACAD SCI USA, V111, pE5196, DOI 10.1073/pnas.1410095111; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kelkar DS, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011627, 10.1074/mcp.M111.011445]; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Kumar D, 2011, MICROBES INFECT, V13, P121, DOI 10.1016/j.micinf.2010.10.009; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Likic Vladimir A., 2010, Advances in Bioinformatics, V2010, P268925, DOI 10.1155/2010/268925; Liu J, 2012, EXPERT REV ANTI-INFE, V10, P1049, DOI [10.1586/ERI.12.86, 10.1586/eri.12.86]; Malen H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-18; Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Mattow J, 2003, ELECTROPHORESIS, V24, P3405, DOI 10.1002/elps.200305601; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Mehaffy C, 2010, PROTEOMICS, V10, P1966, DOI 10.1002/pmic.200900836; Mukherjee P, 2009, MOL MICROBIOL, V73, P103, DOI 10.1111/j.1365-2958.2009.06750.x; Nagaraj N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013722; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nagaraj N, 2010, J PROTEOME RES, V9, P6786, DOI 10.1021/pr100637q; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Prasad Rajendra, 2010, Indian J Tuberc, V57, P180; Qu Y, 2013, NUCLEIC ACIDS RES, V41, P5263, DOI 10.1093/nar/gkt249; Rao Prahlad K, 2009, J Proteomics Bioinform, V2, P19; Rustad TR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0502-3; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schmidt F, 2004, MOL CELL PROTEOMICS, V3, P24, DOI 10.1074/mcp.M300074-MCP200; Schubert OT, 2013, CELL HOST MICROBE, V13, P602, DOI 10.1016/j.chom.2013.04.008; Sebert ME, 2002, INFECT IMMUN, V70, P4059, DOI 10.1128/IAI.70.8.4059-4067.2002; Shah NS, 2008, JAMA-J AM MED ASSOC, V300, P2153, DOI 10.1001/jama.300.18.2153; Sharma P, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-59; Silva PEA, 2001, ANTIMICROB AGENTS CH, V45, P800, DOI 10.1128/AAC.45.3.800-804.2001; Stephenson K, 2002, CURR OPIN PHARMACOL, V2, P507, DOI 10.1016/S1471-4892(02)00194-7; ten Bokum AMC, 2008, TRENDS MICROBIOL, V16, P436, DOI 10.1016/j.tim.2008.06.003; Vashisht R, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0263-5; Vilcheze C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004115; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Waddell SJ, 2010, METHODS MOL BIOL, V642, P75, DOI 10.1007/978-1-60327-279-7_6; Warner DF, 2013, NAT GENET, V45, P1107, DOI 10.1038/ng.2769; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833; Zhang YY, 2011, J BACTERIOL, V193, P5591, DOI 10.1128/JB.05452-11; Zhu Chuanzhi, 2013, Weishengwu Xuebao, V53, P154	77	31	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14257	14273		10.1074/jbc.M115.666123	http://dx.doi.org/10.1074/jbc.M115.666123			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27151218	hybrid, Green Published			2022-12-28	WOS:000379975100030
J	Lahiri, N; Shah, RR; Layre, E; Young, D; Ford, C; Murray, MB; Fortune, SM; Moody, DB				Lahiri, Nivedita; Shah, Rupal R.; Layre, Emilie; Young, David; Ford, Chris; Murray, Megan B.; Fortune, Sarah M.; Moody, D. Branch			Rifampin Resistance Mutations Are Associated with Broad Chemical Remodeling of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; MS; Mycobacterium tuberculosis; siderophore; tuberculosis; lipidomics; multidrug resistance; rifampin	BACTERIAL RNA-POLYMERASE; SULFOLIPID-1 BIOSYNTHESIS; COMPENSATORY MUTATIONS; VIRULENCE; MACROPHAGES; DISCOVERY; IDENTIFICATION; ANTIGENS; REVEALS; PATHWAY	Global control of tuberculosis has become increasingly complicated with the emergence of multidrug-resistant strains of Mycobacterium tuberculosis. First-line treatments are anchored by two antibiotics, rifampin and isoniazid. Most rifampin resistance occurs through the acquisition of missense mutations in the rifampin resistance-determining region, an 81-base pair region encoding the rifampin binding site on the subunit of RNA polymerase (rpoB). Although these mutations confer a survival advantage in the presence of rifampin, they may alter the normal process of transcription, thereby imposing significant fitness costs. Because the downstream biochemical consequences of the rpoB mutations are unknown, we used an organism-wide screen to identify the number and types of lipids changed after rpoB mutation. A new mass spectrometry-based profiling platform systematically compared approximate to 10,000 cell wall lipids in a panel of rifampin-resistant mutants within two genetically distinct strains, CDC1551and W-Beijing. This unbiased lipidomic survey detected quantitative alterations (>2-fold, p < 0.05) in more than 100 lipids in each mutant. By focusing on molecular events that change among most mutants and in both genetic backgrounds, we found that rifampin resistance mutations lead to altered concentrations of mycobactin siderophores and acylated sulfoglycolipids. These findings validate a new organism-wide lipidomic analysis platform for drug-resistant mycobacteria and provide direct evidence for characteristic remodeling of cell wall lipids in rifampin-resistant strains of M. tuberculosis. The specific links between rifampin resistance and named lipid factors provide diagnostic and therapeutic targets that may be exploited to address the problem of drug resistance.	[Lahiri, Nivedita; Layre, Emilie; Young, David; Moody, D. Branch] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Smith Bldg,Rm 514,1 Jimmy Fund Way, Boston, MA 02115 USA; [Lahiri, Nivedita; Layre, Emilie; Young, David; Moody, D. Branch] Harvard Med Sch, Smith Bldg,Rm 514,1 Jimmy Fund Way, Boston, MA 02115 USA; [Shah, Rupal R.; Ford, Chris; Fortune, Sarah M.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Murray, Megan B.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Moody, DB (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Smith Bldg,Rm 514,1 Jimmy Fund Way, Boston, MA 02115 USA.; Moody, DB (corresponding author), Harvard Med Sch, Smith Bldg,Rm 514,1 Jimmy Fund Way, Boston, MA 02115 USA.	bmoody@rics.bwh.harvard.edu		Fortune, Sarah/0000-0001-7565-9975; Layre, Emilie/0000-0003-3044-1299	National Institutes of Health [U19 AI076217, U19 AI111224, R01 AI049313, P30 AI060354]; Burroughs Wellcome Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049313, P30AI060354, U19AI111224, U19AI076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants U19 AI076217, U19 AI111224, R01 AI049313, and P30 AI060354 and the Burroughs Wellcome Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bisson GP, 2012, J BACTERIOL, V194, P6441, DOI 10.1128/JB.01013-12; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brandis G, 2012, MOL MICROBIOL, V85, P142, DOI 10.1111/j.1365-2958.2012.08099.x; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Coovadia YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077712; Cummings MP, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-137; de Knegt GJ, 2013, TUBERCULOSIS, V93, P96, DOI 10.1016/j.tube.2012.10.013; de Vos M, 2013, ANTIMICROB AGENTS CH, V57, P827, DOI 10.1128/AAC.01541-12; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; EZEKIEL DH, 1968, NATURE, V220, P276, DOI 10.1038/220276a0; Favrot L, 2012, EXPERT REV ANTI-INFE, V10, P1023, DOI [10.1586/eri.12.91, 10.1586/ERI.12.91]; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Franke MF, 2013, CLIN INFECT DIS, V56, P770, DOI 10.1093/cid/cis1008; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Gilmore SA, 2012, ACS CHEM BIOL, V7, P863, DOI 10.1021/cb200311s; Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x; Goldstein BP, 2014, J ANTIBIOT, V67, P625, DOI 10.1038/ja.2014.107; Jain M, 2007, P NATL ACAD SCI USA, V104, P5133, DOI 10.1073/pnas.0610634104; Keshavjee S, 2012, NEW ENGL J MED, V367, P931, DOI 10.1056/NEJMra1205429; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Layre E, 2013, BIOCHIMIE, V95, P109, DOI 10.1016/j.biochi.2012.08.012; Layre E, 2011, CHEM BIOL, V18, P1537, DOI 10.1016/j.chembiol.2011.10.013; Madigan CA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004792; Madigan CA, 2012, P NATL ACAD SCI USA, V109, P1257, DOI 10.1073/pnas.1109958109; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Moody DB, 2004, SCIENCE, V303, P527, DOI 10.1126/science.1089353; Pang JM, 2012, J BACTERIOL, V194, P715, DOI 10.1128/JB.06304-11; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Sartain MJ, 2011, J LIPID RES, V52, P861, DOI 10.1194/jlr.M010363; Seeliger JC, 2012, J BIOL CHEM, V287, P7990, DOI 10.1074/jbc.M111.315473; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Strauss OJ, 2008, J CLIN MICROBIOL, V46, P1514, DOI 10.1128/JCM.01938-07; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; TOCCHINI.GP, 1968, NATURE, V220, P275, DOI 10.1038/220275a0; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Velayati AA, 2014, AM J TROP MED HYG, V90, P99, DOI 10.4269/ajtmh.13-0057	46	35	35	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14248	14256		10.1074/jbc.M116.716704	http://dx.doi.org/10.1074/jbc.M116.716704			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226566	hybrid, Green Published			2022-12-28	WOS:000379975100029
J	Fujiwara, Y; Kawaguchi, Y; Fujimoto, T; Kanayama, N; Magari, M; Tokumitsu, H				Fujiwara, Yuya; Kawaguchi, Yoshinori; Fujimoto, Tomohito; Kanayama, Naoki; Magari, Masaki; Tokumitsu, Hiroshi			Differential AMP-activated Protein Kinase (AMPK) Recognition Mechanism of Ca2+/Calmodulin-dependent Protein Kinase Kinase Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); Ca2+; calmodulin-dependent protein kinase (CaMK); calmodulin (CaM); phosphorylation; substrate specificity; CaMKI; CaMKK; substrate recognition	MOLECULAR-CLONING; SIGNALING COMPLEX; ESCHERICHIA-COLI; CAMKK-BETA; CALMODULIN; CASCADE; EXPRESSION; TRANSCRIPTION; INHIBITOR; UPSTREAM	Ca2+/calmodulin-dependent protein kinase kinase (CaMKK) is a known activating kinase for AMP-activated protein kinase (AMPK). In vitro, CaMKK phosphorylates Thr(172) in the AMPK subunit more efficiently than CaMKK, with a lower K-m (approximate to 2 m) for AMPK, whereas the CaMKI phosphorylation efficiencies by both CaMKKs are indistinguishable. Here we found that subdomain VIII of CaMKK is involved in the discrimination of AMPK as a native substrate by measuring the activities of various CaMKK/CaMKK chimera mutants. Site-directed mutagenesis analysis revealed that Leu(358) in CaMKK/Ile(322) in CaMKK confer, at least in part, a distinct recognition of AMPK but not of CaMKI.	[Fujiwara, Yuya; Kawaguchi, Yoshinori; Kanayama, Naoki; Magari, Masaki; Tokumitsu, Hiroshi] Okayama Univ, Grad Sch Nat Sci & Technol, Div Med Bioengn, Okayama 7008530, Japan; [Fujimoto, Tomohito] Carna Biosci Inc, Kobe, Hyogo 6500047, Japan	Okayama University	Tokumitsu, H (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Div Med Bioengn, Kita Ku, Okayama 7008530, Japan.	tokumit@okayama-u.ac.jp	MAGARI, Masaki/B-2555-2011; Kanayama, Naoki/G-1518-2010; Tokumitsu, Hiroshi/M-3978-2015	Kanayama, Naoki/0000-0003-1778-2005; Magari, Masaki/0000-0002-4624-0160; Tokumitsu, Hiroshi/0000-0002-2193-6794	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26440056]; Grants-in-Aid for Scientific Research [26440056, 15H04196] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research 26440056 (to H. T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Dhar M, 2014, J NEUROSCI, V34, P10022, DOI 10.1523/JNEUROSCI.2868-13.2014; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372; Fujiwara Y, 2015, BIOCHEMISTRY-US, V54, P3969, DOI 10.1021/acs.biochem.5b00149; Ghislat G, 2012, J BIOL CHEM, V287, P38625, DOI 10.1074/jbc.M112.365767; Green MF, 2011, CELL SIGNAL, V23, P2005, DOI 10.1016/j.cellsig.2011.07.014; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Horigane S, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0189-3; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kimura Y, 2002, EMBO REP, V3, P962, DOI 10.1093/embo-reports/kvf191; Kitani T, 1997, J BIOCHEM-TOKYO, V122, P243; Matsushita M, 1999, J BIOL CHEM, V274, P10086, DOI 10.1074/jbc.274.15.10086; Means AR, 2008, MOL ENDOCRINOL, V22, P2759, DOI 10.1210/me.2008-0312; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Tokumitsu H, 2000, J BIOL CHEM, V275, P20090, DOI 10.1074/jbc.M002193200; Tokumitsu H, 2003, J BIOL CHEM, V278, P10908, DOI 10.1074/jbc.M213183200; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Tokumitsu H, 2010, BIOCHEM J, V431, P81, DOI 10.1042/BJ20100637; Tu Z, 2003, J BIOL CHEM, V278, P48498, DOI 10.1074/jbc.M304234200; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yamauchi M, 2008, MOL ENDOCRINOL, V22, P893, DOI 10.1210/me.2007-0249	31	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13802	13808		10.1074/jbc.M116.727867	http://dx.doi.org/10.1074/jbc.M116.727867			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27151216	Green Published, hybrid			2022-12-28	WOS:000379771100034
J	Shin, JY; Wey, M; Umutesi, HG; Sun, XL; Simecka, J; Heo, J				Shin, Jin-Young; Wey, Michael; Umutesi, Hope G.; Sun, Xiangle; Simecka, Jerry; Heo, Jongyun			Thiopurine Prodrugs Mediate Immunosuppressive Effects by Interfering with Rac1 Protein Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						disulfide; immunosuppression; Ras-related C3 botulinum toxin substrate 1 (Rac1); redox regulation; T-cell; 6-TGNP-Rac1 adduct; CD4+cells; Rac1 inactivation; redox-sensitive GXXXXGK(ST)C motif; thiopurine prodrugs	GUANINE-NUCLEOTIDE EXCHANGE; INFLAMMATORY-BOWEL-DISEASE; THERAPY-RELATED CANCER; CARDIOVASCULAR-DISEASE; CELL-DIFFERENTIATION; MOLECULAR-MECHANISMS; BREAST-CANCER; RHO-GTPASES; RAS; ACTIVATION	6-Thiopurine (6-TP) prodrugs include 6-thioguanine and azathioprine. Both are widely used to treat autoimmune disorders and certain cancers. This study showed that a 6-thioguanosine triphosphate (6-TGTP), converted in T-cells from 6-TP, targets Rac1 to form a disulfide adduct between 6-TGTP and the redox-sensitive GXXXXGK(S/T)C motif of Rac1. This study also showed that, despite the conservation of the catalytic activity of RhoGAP (Rho-specific GAP) on the 6-TGTP-Rac1 adduct to produce the biologically inactive 6-thioguanosine diphosphate (6-TGDP)-Rac1 adduct, RhoGEF (Rho-specific GEF) cannot exchange the 6-TGDP adducted on Rac1 with free guanine nucleotide. The biologically inactive 6-TGDP-Rac1 adduct accumulates in cells because of the ongoing combined actions of RhoGEF and RhoGAP. Because other Rho GTPases, such as RhoA and Cdc42, also possess the GXXXXGK(S/T)C motif, the proposed mechanism for the inactivation of Rac1 also applies to RhoA and Cdc42. However, previous studies have shown that CD3/CD28-stimulated T-cells contain more activated Rac1 than other Rho GTPases such as RhoA and Cdc42. Accordingly, Rac1 is the main target of 6-TP in activated T-cells. This explains the T-cell-specific Rac1-targeting therapeutic action of 6-TP that suppresses the immune response. This proposed mechanism for the action of 6-TP on Rac1 performs a critical role in demonstrating the capability to design a Rac1-targeting chemotherapeutic agent(s) for autoimmune disorders. Nevertheless, the results also suggest that the targeting action of other Rho GTPases in other organ cells, such as RhoA in vascular cells, may be linked to cytotoxicities because RhoA plays a key role in vasculature functions.	[Shin, Jin-Young; Wey, Michael; Umutesi, Hope G.; Heo, Jongyun] Univ Texas Arlington, Dept Chem & Biochem, 700 Planetarium Pl, Arlington, TX 76019 USA; [Sun, Xiangle; Simecka, Jerry] Univ North Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA; [Simecka, Jerry] Univ North Texas, Hlth Sci Ctr, UNT Syst Coll Pharm, Dept Pharmaceut Sci, Ft Worth, TX 76107 USA; [Shin, Jin-Young] Natl Inst Food & Drug Safety Evaluat, Biol Res Div, Osong Hlth Technol Adm Complex, Cheongwon Gun 363700, Chungcheongbuk, South Korea	University of Texas System; University of Texas Arlington; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; Ministry of Food & Drug Safety (MFDS), Republic of Korea; National Institute of Food & Drug Safety Evaluation	Heo, J (corresponding author), Univ Texas Arlington, Dept Chem & Biochem, 700 Planetarium Pl, Arlington, TX 76019 USA.	jheo@uta.edu			National Institutes of Health [1R15AI096146-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI096146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant 1R15AI096146-01A1 (to J. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health..	Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Augusto O, 2002, FREE RADICAL BIO MED, V32, P841, DOI 10.1016/S0891-5849(02)00786-4; Azim AC, 2000, METHOD ENZYMOL, V325, P257; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Budzyn K, 2006, TRENDS PHARMACOL SCI, V27, P97, DOI 10.1016/j.tips.2005.12.002; Cernuda-Morollon E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012393; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; de Boer NKH, 2007, NAT CLIN PRACT GASTR, V4, P686, DOI 10.1038/ncpgasthep1000; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Dumont C, 2009, BLOOD, V113, P3990, DOI 10.1182/blood-2008-09-181180; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Gearry RB, 2005, J GASTROEN HEPATOL, V20, P1149, DOI 10.1111/j.1440-1746.2005.03832.x; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Guo F, 2008, J ELECTRON MATER, V37, P1, DOI 10.1007/s11664-007-0302-6; Heo J, 2006, BIOCHEMISTRY-US, V45, P2200, DOI 10.1021/bi051872m; Heo J, 2005, BIOCHEMISTRY-US, V44, P6573, DOI 10.1021/bi047443q; Heo J, 2005, J MOL BIOL, V346, P1423, DOI 10.1016/j.jmb.2004.12.050; Heo J, 2005, J BIOL CHEM, V280, P31003, DOI 10.1074/jbc.M504768200; Heo JY, 2006, BIOCHEMISTRY-US, V45, P14481, DOI 10.1021/bi0610101; Heo J, 2011, BIOCHEMISTRY-US, V50, P5731, DOI 10.1021/bi200347y; Heo JY, 2011, ANTIOXID REDOX SIGN, V14, P689, DOI 10.1089/ars.2009.2984; Heo J, 2010, BIOCHEMISTRY-US, V49, P3965, DOI 10.1021/bi902090q; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Hofbauer SW, 2014, BLOOD, V123, P2181, DOI 10.1182/blood-2013-08-523563; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; Karran P, 2006, BRIT MED BULL, V79-80, P153, DOI 10.1093/bmb/ldl020; Lage H, 1999, J CANCER RES CLIN, V125, P156, DOI 10.1007/s004320050258; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Langmuir PB, 2001, BEST PRACT RES CL HA, V14, P77, DOI 10.1053/beha.2000.0117; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Li BY, 2000, SCIENCE, V288, P2219, DOI 10.1126/science.288.5474.2219; Loirand G, 2010, NAT REV CARDIOL, V7, P637, DOI 10.1038/nrcardio.2010.136; Lopez-Martin C, 2011, GASTROENT HEPAT-BARC, V34, P385, DOI 10.1016/j.gastrohep.2011.03.023; McDonald E, 1996, CANCER RES, V56, P2250; Michel F, 1998, J BIOL CHEM, V273, P31932, DOI 10.1074/jbc.273.48.31932; Nakamoto M, 2001, INT J ONCOL, V19, P971; Niedbala W, 2002, P NATL ACAD SCI USA, V99, P16186, DOI 10.1073/pnas.252464599; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Poppe D, 2006, J IMMUNOL, V176, P640, DOI 10.4049/jimmunol.176.1.640; Sato M, 1997, CANCER LETT, V112, P181, DOI 10.1016/S0304-3835(96)04581-8; Shimokawa H, 2007, TRENDS PHARMACOL SCI, V28, P296, DOI 10.1016/j.tips.2007.04.006; Skelton TS, 2010, TRANSPL IMMUNOL, V23, P185, DOI 10.1016/j.trim.2010.06.009; Smits K, 2010, HAEMATOL-HEMATOL J, V95, P367, DOI 10.3324/haematol.2009.006890; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Thapa SD, 2015, AM J MED SCI, V350, P175, DOI 10.1097/MAJ.0000000000000535; Tiede I, 2003, J CLIN INVEST, V111, P1133, DOI 10.1172/JCI200316432; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; VISTICA DT, 1991, CANCER RES, V51, P2515; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wey M, 2014, BIOCHEMISTRY-US, V53, P518, DOI 10.1021/bi401528n; Yan T, 2003, CLIN CANCER RES, V9, P2327; Zalcman G, 1999, Prog Mol Subcell Biol, V22, P85	54	25	26	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13699	13714		10.1074/jbc.M115.694422	http://dx.doi.org/10.1074/jbc.M115.694422			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27189938	Green Published, hybrid			2022-12-28	WOS:000379771100025
J	Tobias, IS; Newton, AC				Tobias, Irene S.; Newton, Alexandra C.			Protein Scaffolds Control Localized Protein Kinase C Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin; insulin receptor substrate 1 (IRS-1); p62 (sequestosome 1(SQSTM1)); protein kinase C (PKC); scaffold protein; MARK2; Par6; autoinhibition	INSULIN-RECEPTOR SUBSTRATE-1; STIMULATED GLUCOSE-TRANSPORT; ENCODED FLUORESCENT REPORTER; PKC-ZETA; CELL-POLARITY; PHOSPHATASE TYPE-1; ACTIVATION LOOP; IN-VIVO; PHOSPHORYLATION; APKC	Atypical protein kinase C (aPKC) isozymes modulate insulin signaling and cell polarity, but how their activity is controlled in cells is not well understood. These enzymes are constitutively phosphorylated, insensitive to second messengers, and have relatively low activity. Here we show that protein scaffolds not only localize but also differentially control the catalytic activity of the aPKC PKC, thus promoting activity toward localized substrates and restricting activity toward global substrates. Using cellular substrate readouts and scaffolded activity reporters in live cell imaging, we show that PKC has highly localized and differentially controlled activity on the scaffolds p62 and Par6. Both scaffolds tether aPKC in an active conformation as assessed through pharmacological inhibition of basal activity, monitored using a genetically encoded reporter for PKC activity. However, binding to Par6 is of higher affinity and is more effective in locking PKC in an active conformation. FRET-based translocation assays reveal that insulin promotes the association of both p62 and aPKC with the insulin-regulated scaffold IRS-1. Using the aPKC substrate MARK2 as another readout for activity, we show that overexpression of IRS-1 reduces the phosphorylation of MARK2 and enhances its plasma membrane localization, indicating sequestration of aPKC by IRS-1 away from MARK2. These results are consistent with scaffolds serving as allosteric activators of aPKCs, tethering them in an active conformation near specific substrates. Thus, signaling of these intrinsically low activity kinases is kept at a minimum in the absence of scaffolding interactions, which position the enzymes for stoichiometric phosphorylation of substrates co-localized on the same protein scaffold.	[Tobias, Irene S.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Tobias, Irene S.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Newton, AC (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	anewton@ucsd.edu			National Institutes of Health [P01DK054441]; University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology through National Institutes of Health Institutional Training Grant from NIGMS [T32 GM007752]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology through National Institutes of Health Institutional Training Grant from NIGMS	This work was supported in part by National Institutes of Health Grants P01DK054441 (to A. C. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by the University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology through National Institutes of Health Institutional Training Grant T32 GM007752 from the NIGMS.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Allen PB, 1998, J BIOL CHEM, V273, P4089, DOI 10.1074/jbc.273.7.4089; Antal CE, 2014, CHEM BIOL, V21, P459, DOI 10.1016/j.chembiol.2014.02.008; Armstrong CG, 1997, FEBS LETT, V418, P210, DOI 10.1016/S0014-5793(97)01385-9; Bandyopadhyay G, 2000, ENDOCRINOLOGY, V141, P4120, DOI 10.1210/en.141.11.4120; Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Bandyopadhyay G, 1999, MOL ENDOCRINOL, V13, P1766, DOI 10.1210/me.13.10.1766; Bandyopadhyay G, 2002, J CLIN ENDOCR METAB, V87, P716, DOI 10.1210/jc.87.2.716; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Christian F, 2014, BBA-MOL CELL RES, V1843, P2765, DOI 10.1016/j.bbamcr.2014.07.021; Cohen PTW, 2002, J CELL SCI, V115, P241; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; DUTIL EM, 1994, J BIOL CHEM, V269, P29359; Farese RV, 2007, J CLIN INVEST, V117, P2289, DOI 10.1172/JCI31408; Geetha T, 2012, J BIOL CHEM, V287, P29672, DOI 10.1074/jbc.M111.322404; Graybill C, 2012, J BIOL CHEM, V287, P21003, DOI 10.1074/jbc.M112.360495; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Hirano K, 1996, FEBS LETT, V389, P191, DOI 10.1016/0014-5793(96)00577-7; Hirose T, 2002, J CELL SCI, V115, P2485; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Hurov J, 2007, CELL CYCLE, V6, P1966, DOI 10.4161/cc.6.16.4576; Hurov JB, 2007, P NATL ACAD SCI USA, V104, P5680, DOI 10.1073/pnas.0701179104; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johnson JE, 1997, J BIOL CHEM, V272, P30787, DOI 10.1074/jbc.272.49.30787; KAZANIETZ MG, 1994, J BIOL CHEM, V269, P11590; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Kusne Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005196; Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966; Lee S, 2008, ENDOCRINOLOGY, V149, P2451, DOI 10.1210/en.2007-1595; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Moeschel K, 2004, J BIOL CHEM, V279, P25157, DOI 10.1074/jbc.M402477200; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Okada K, 2009, HEPATOL RES, V39, P490, DOI 10.1111/j.1872-034X.2008.00478.x; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Pu YM, 2006, J BIOL CHEM, V281, P33773, DOI 10.1074/jbc.M606560200; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Sajan MP, 2006, J BIOL CHEM, V281, P17466, DOI 10.1074/jbc.M510803200; Schillace RV, 1999, CURR BIOL, V9, P321, DOI 10.1016/S0960-9822(99)80141-9; Scott JD, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-61; Sommerfeld MR, 2004, BIOCHEMISTRY-US, V43, P5888, DOI 10.1021/bi049640v; Standaert ML, 2001, BIOCHEMISTRY-US, V40, P249, DOI 10.1021/bi0018234; Sumimoto Hideki, 2007, Sci STKE, V2007, pre6, DOI 10.1126/stke.4012007re6; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Tobias IS, 2016, BIOCHEM J, V473, P509, DOI 10.1042/BJ20151013; Trujillo JI, 2009, BIOORG MED CHEM LETT, V19, P908, DOI 10.1016/j.bmcl.2008.11.105; Tsai LCL, 2015, J BIOL CHEM, V290, P21845, DOI 10.1074/jbc.M115.676221; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wu J, 1996, BIOCHEMISTRY-US, V35, P13858, DOI 10.1021/bi961669e; Wu-Zhang AX, 2013, BIOCHEM J, V452, P195, DOI 10.1042/BJ20130220; Wu-Zhang AX, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412635; Wu-Zhang AX, 2012, J BIOL CHEM, V287, P12879, DOI 10.1074/jbc.M112.357244; Xi G, 2016, J BONE MINER RES, V31, P1300, DOI 10.1002/jbmr.2791; Xi G, 2015, FASEB J, V29, P4772, DOI 10.1096/fj.15-275453; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6	68	24	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13809	13822		10.1074/jbc.M116.729483	http://dx.doi.org/10.1074/jbc.M116.729483			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27143478	Green Published, hybrid			2022-12-28	WOS:000379771100035
J	Fancy, RM; Wang, LY; Zeng, QH; Wang, H; Zhou, T; Buchsbaum, DJ; Song, YH				Fancy, Romone M.; Wang, Lingyun; Zeng, Qinghua; Wang, Hong; Zhou, Tong; Buchsbaum, Donald J.; Song, Yuhua			Characterization of the Interactions between Calmodulin and Death Receptor 5 in Triple-negative and Estrogen Receptor-positive Breast Cancer Cells AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING LIGAND; FADD-DEPENDENT APOPTOSIS; NF-KAPPA-B; TAMOXIFEN RESISTANCE; TUMORICIDAL ACTIVITY; MONOCLONAL-ANTIBODY; MOLECULAR-DYNAMICS; SIGNALING COMPLEX; EF-HANDS; PROTEIN	Activation of death receptor-5 (DR5) leads to the formation of death inducing signaling complex (DISC) for apoptotic signaling. Targeting DR5 to induce breast cancer apoptosis is a promising strategy to circumvent drug resistance and present a target for breast cancer treatment. Calmodulin (CaM) has been shown to regulate DR5-mediated apoptotic signaling, however, its mechanism remains unknown. In this study, we characterized CaM and DR5 interactions in breast cancer cells with integrated experimental and computational approaches. Results show that CaM directly binds to DR5 in a calcium dependent manner in breast cancer cells. The direct interaction of CaM with DR5 is localized at DR5 death domain. We have predicted and verified the CaM-binding site in DR5 being (354)WEPLMRKLGL(363) that is located at the alpha 2 helix and the loop between alpha 2 helix and alpha 3 helix of DR5 DD. The residues of Trp-354, Arg-359, Glu-355, Leu-363, and Glu-367 in DR5 death domain that are important for DR5 recruitment of FADD and caspase-8 for DISC formation to signal apoptosis also play an important role for CaM-DR5 binding. The changed electrostatic potential distribution in the CaM-binding site in DR5 DD by the point mutations of W354A, E355K, R359A, L363N, or E367K in DR5 DD could directly contribute to the experimentally observed decreased CaM-DR5 binding by the point mutations of the key residues in DR5 DD. Results from this study provide a key step for the further investigation of the role of CaM-DR5 binding in DR5-mediated DISC formation for apoptosis in breast cancer cells.	[Fancy, Romone M.; Wang, Lingyun; Zeng, Qinghua; Song, Yuhua] Univ Alabama Birmingham, Dept Biomed Engn, 803 Shelby Interdisciplinary Biomed Res Bldg, Birmingham, AL 35294 USA; [Wang, Hong; Zhou, Tong] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Buchsbaum, Donald J.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Song, YH (corresponding author), Univ Alabama Birmingham, Dept Biomed Engn, 803 Shelby Interdisciplinary Biomed Res Bldg, Birmingham, AL 35294 USA.	yhsong@uab.edu		Buchsbaum, Donald/0000-0003-2797-5847	National Institutes of Health [5K25 CA140791]; Comprehensive Minority Faculty and Student Development Program fellowship from the University of Alabama VP Office for Equity and Diversity; NATIONAL CANCER INSTITUTE [K25CA140791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive Minority Faculty and Student Development Program fellowship from the University of Alabama VP Office for Equity and Diversity; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by an National Institutes of Health K25 award (5K25 CA140791) (to Y. S.). The authors declare that they have no conflicts of interest with the contents of this article except that Dr. Tong Zhou and Dr. Donald J. Buchsbaum have intellectual property right in TRA-8. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by Comprehensive Minority Faculty and Student Development Program fellowship from the University of Alabama VP Office for Equity and Diversity.	Ahn EY, 2004, J BIOL CHEM, V279, P5661, DOI 10.1074/jbc.M311040200; Amm HM, 2011, MOL CANCER RES, V9, P403, DOI 10.1158/1541-7786.MCR-10-0133; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bin L, 2007, J BIOL CHEM, V282, P28189, DOI 10.1074/jbc.M704210200; BLALOCK JE, 1995, NAT MED, V1, P876, DOI 10.1038/nm0995-876; Buchsbaum DJ, 2003, CLIN CANCER RES, V9, P3731; Chang JM, 2014, MOL BIOL EVOL, V31, P1625, DOI 10.1093/molbev/msu117; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chen YB, 2008, J CELL BIOCHEM, V103, P788, DOI 10.1002/jcb.21447; Chinnaiyan AM, 2000, P NATL ACAD SCI USA, V97, P1754, DOI 10.1073/pnas.030545097; Cohen P, 1988, CALMODULIN; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Daniel PT, 2001, LEUKEMIA, V15, P1022, DOI 10.1038/sj.leu.2402169; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; DILLON J, 1991, P NATL ACAD SCI USA, V88, P9726, DOI 10.1073/pnas.88.21.9726; Dong HP, 2008, CANCER-AM CANCER SOC, V112, P84, DOI 10.1002/cncr.23140; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eldik L., 1998, CALMODULIN CALCIUM S; Eldik L. V., 1988, CALMODULIN SIGNAL TR; Fancy RM, 2014, BIOCHEMISTRY-US, V53, P2680, DOI 10.1021/bi500228h; Friedl J. E. F., 1997, MASTERING REGULAR EX; Ganoth A, 2006, BIOPHYS J, V91, P2436, DOI 10.1529/biophysj.106.085399; Goicoechea S, 2002, J BIOL CHEM, V277, P37219, DOI 10.1074/jbc.M202200200; Guarneri V, 2004, EUR J NUCL MED MOL I, V31, pS149, DOI 10.1007/s00259-004-1538-5; HAIT WN, 1986, J CLIN ONCOL, V4, P994, DOI 10.1200/JCO.1986.4.6.994; Houtman R, 2001, J IMMUNOL, V166, P861, DOI 10.4049/jimmunol.166.2.861; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang MK, 2009, BIOCHEM CELL BIOL, V87, P919, DOI [10.1139/O09-058, 10.1139/o09-058]; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000; Jacchieri SG, 2003, J BACTERIOL, V185, P4243, DOI 10.1128/JB.185.14.4243-4247.2003; Jo M, 2000, NAT MED, V6, P564, DOI 10.1038/75045; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SH, 1999, CANCER RES, V59, P5683; Maier C C, 1994, Immunomethods, V5, P107, DOI 10.1006/immu.1994.1044; Manion MK, 2000, BIOCHEM BIOPH RES CO, V277, P462, DOI 10.1006/bbrc.2000.3691; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; McCarthy MM, 2005, CLIN CANCER RES, V11, P5188, DOI 10.1158/1078-0432.CCR-05-0158; McDonald ER, 2001, J BIOL CHEM, V276, P14939, DOI 10.1074/jbc.M100399200; MOSER MJ, 1995, J BIOL CHEM, V270, P20643, DOI 10.1074/jbc.270.35.20643; Oliver PG, 2012, BREAST CANCER RES TR, V133, P417, DOI 10.1007/s10549-011-1755-0; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Ozoren N, 2003, SEMIN CANCER BIOL, V13, P135, DOI 10.1016/S1044-579X(02)00131-1; Park WS, 2001, GASTROENTEROLOGY, V121, P1219, DOI 10.1053/gast.2001.28663; Patterson RE, 2011, BREAST CANCER RES TR, V127, P541, DOI 10.1007/s10549-010-1236-x; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Plasschaert SLA, 2004, LEUKEMIA LYMPHOMA, V45, P649, DOI 10.1080/10428190310001597928; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Shin MS, 2001, CANCER RES, V61, P4942; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sorlie T, 2009, J CLIN ONCOL, V27, P1153, DOI 10.1200/JCO.2008.20.6276; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Suever JD, 2008, BIOPHYS J, V95, P5913, DOI 10.1529/biophysj.108.130542; Sukits SF, 2001, J MOL BIOL, V310, P895, DOI 10.1006/jmbi.2001.4790; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; Villain M, 2000, J BIOL CHEM, V275, P2676, DOI 10.1074/jbc.275.4.2676; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang C, 2009, J BIOL CHEM, V284, P3804, DOI 10.1074/jbc.M807191200; WEI JW, 1982, CANCER RES, V42, P2571; Weigent D A, 1994, Immunomethods, V5, P91, DOI 10.1006/immu.1994.1042; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wu XJ, 2005, J BIOL CHEM, V280, P29964, DOI 10.1074/jbc.M500710200	71	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12862	12870		10.1074/jbc.M116.727727	http://dx.doi.org/10.1074/jbc.M116.727727			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129269	Green Published, hybrid			2022-12-28	WOS:000378119900036
J	Griffiths, K; Dolezal, O; Cao, B; Nilsson, SK; See, HB; Pfleger, KDG; Roche, M; Gorry, PR; Pow, A; Viduka, K; Lim, K; Lu, BGC; Chang, DHC; Murray-Rust, T; Kvansakul, M; Perugini, MA; Dogovski, C; Doerflinger, M; Zhang, Y; Parisi, K; Casey, JL; Nuttall, SD; Foley, M				Griffiths, Katherine; Dolezal, Olan; Cao, Benjamin; Nilsson, Susan K.; See, Heng B.; Pfleger, Kevin D. G.; Roche, Michael; Gorry, Paul R.; Pow, Andrew; Viduka, Katerina; Lim, Kevin; Lu, Bernadine G. C.; Chang, Denison H. C.; Murray-Rust, Thomas; Kvansakul, Marc; Perugini, Matthew A.; Dogovski, Con; Doerflinger, Marcel; Zhang, Yuan; Parisi, Kathy; Casey, Joanne L.; Nuttall, Stewart D.; Foley, Michael			i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEMATOPOIETIC STEM; MONOCLONAL-ANTIBODIES; RAPID MOBILIZATION; CRYSTAL-STRUCTURE; ANTIGEN RECEPTOR; PROGENITOR CELLS; AMD3100; HIV-1; FRAGMENTS	CXCR4 is a G protein-coupled receptor with excellent potential as a therapeutic target for a range of clinical conditions, including stem cell mobilization, cancer prognosis and treatment, fibrosis therapy, and HIV infection. We report here the development of a fully human single-domain antibody-like scaffold termed an "i-body," the engineering of which produces an i-body library possessing a long complementarity determining region binding loop, and the isolation and characterization of a panel of i-bodies with activity against human CXCR4. The CXCR4-specific i-bodies show antagonistic activity in a range of in vitro and in vivo assays, including inhibition of HIV infection, cell migration, and leukocyte recruitment but, importantly, not the mobilization of hematopoietic stem cells. Epitope mapping of the three CXCR4 i-bodies AM3-114, AM4-272, and AM3-523 revealed binding deep in the binding pocket of the receptor.	[Griffiths, Katherine; Pow, Andrew; Viduka, Katerina; Lim, Kevin; Lu, Bernadine G. C.; Chang, Denison H. C.; Murray-Rust, Thomas; Doerflinger, Marcel; Parisi, Kathy; Casey, Joanne L.; Foley, Michael] AdAlta Pty Ltd, 15-2 Pk Dr, Bundoora, Vic 3083, Australia; [Dolezal, Olan; Nuttall, Stewart D.] CSIRO Mfg, Biomed Mfg, 343 Royal Parade, Parkville, Vic 3052, Australia; [Cao, Benjamin; Nilsson, Susan K.] Monash Univ, Australian Regenerat Med Inst, Wellington Rd, Clayton, Vic 3800, Australia; [Cao, Benjamin; Nilsson, Susan K.] CSIRO Mfg, Biomed Mfg, Bayview Ave, Clayton, Vic 3168, Australia; [See, Heng B.; Pfleger, Kevin D. G.] Harry Perkins Inst Med Res, Nedlands, WA 6009, Australia; [See, Heng B.; Pfleger, Kevin D. G.] Univ Western Australia, Ctr Med Res, Crawley, WA 6009, Australia; [Pfleger, Kevin D. G.] Dimerix Biosci Ltd, Nedlands, WA 6009, Australia; [Roche, Michael] Univ Melbourne, Doherty Inst Infect & Immun, 792 Elizabeth St, Melbourne, Vic 3000, Australia; [Roche, Michael] Burnet Inst, 85 Commercial Rd, Melbourne, Vic 3004, Australia; [Gorry, Paul R.] RMIT Univ, Coll Sci Engn & Hlth, Sch Hlth & Biomed Sci, Melbourne, Vic 3001, Australia; [Kvansakul, Marc; Perugini, Matthew A.; Dogovski, Con; Parisi, Kathy; Foley, Michael] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia; [Zhang, Yuan] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Pow, Andrew] Compugen Ltd, 260 East Grand Ave, San Francisco, CA 94080 USA; [Viduka, Katerina] AgriBio Ctr, Dept Econ Dev Jobs Transport & Resources, 5 Ring Rd, Bundoora, Vic 3083, Australia; [Lim, Kevin] Imunexus, 343 Royal Parade, Parkville, Vic 3052, Australia; [Lu, Bernadine G. C.] CSL Ltd, 45 Poplar Rd, Parkville, Vic 3052, Australia; [Chang, Denison H. C.] Virbac, Milperra, NSW 2214, Australia; [Dogovski, Con] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Doerflinger, Marcel; Casey, Joanne L.] Nexvet, 21-31 Wright St, Clayton, Vic 3168, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian Regenerative Medicine Institute; Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Harry Perkins Institute of Medical Research; University of Western Australia; University of Melbourne; Burnet Institute; Royal Melbourne Institute of Technology (RMIT); La Trobe University; St Vincent's Hospital Melbourne; University of Melbourne; CSL; University of Melbourne	Foley, M (corresponding author), La Trobe Univ, Dept Biochem, Plenty Rd, Bundoora, Vic 3086, Australia.	m.foley@latrobe.edu.au	Kvansakul, Marc/AAF-2453-2019; Dolezal, Olan/E-1691-2015; Cao, Benjamin/AAI-1626-2021; Nuttall, Stewart D/C-2016-2013; Nilsson, Susie K/C-5563-2015	Kvansakul, Marc/0000-0003-2639-2498; Cao, Benjamin/0000-0002-3024-3893; Nilsson, Susie K/0000-0002-7926-7335; Foley, Michael/0000-0003-1349-4698; DOLEZAL, OLAN/0000-0002-5823-6978; Perugini, Matthew/0000-0001-8052-5584; Roche, Michael/0000-0001-8819-0096; Pfleger, Kevin/0000-0001-8261-9189; Griffiths, Katherine/0000-0003-0580-1125; Doerflinger, Marcel/0000-0001-9159-3021	CSIRO OCE Science Leader Fellowship; State Government of Victoria; Australian Government	CSIRO OCE Science Leader Fellowship; State Government of Victoria; Australian Government(Australian GovernmentCGIAR)	This work was supported by a CSIRO OCE Science Leader Fellowship (to S. K. N.). The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government. K. Lim, J. L. Casey, K. Parisi, and M. Foley are shareholders in Adalta. K. Griffiths, T. Murray-Rust, and M. Foley are currently employed by Adalta. A. Pow, K. Viduka, K. Lim, B. G. C. Lu, D. H. C. Chang, K. Parisi, and J. Casey are former employees of Adalta. All authors or institutions received payment or services from a third party to conduct the research reported here. Some authors have non-financial relationships with entities in the biomedical arena that could be perceived to influence, or that give the appearance of potentially influencing, what is written in this work. K. G. and S. D. N. have an issued patent relating to the reported work, and K. G., A. P., K. V., and M. F. have a pending patent relating to the reported work.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Avniel S, 2006, J INVEST DERMATOL, V126, P468, DOI 10.1038/sj.jid.5700069; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Burger JA, 2009, LEUKEMIA, V23, P43, DOI 10.1038/leu.2008.299; Cao B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11007; Carnec X, 2005, J VIROL, V79, P1930, DOI 10.1128/JVI.79.3.1930-1933.2005; Cashen AF, 2009, DRUG TODAY, V45, P497, DOI 10.1358/dot.2009.45.7.1395292; Castaldo C, 2014, J BIOMOL SCREEN, V19, P859, DOI 10.1177/1087057114526283; Chatterjee S, 2014, ADV CANCER RES, V124, P31, DOI 10.1016/B978-0-12-411638-2.00002-1; Coia G, 1996, J IMMUNOL METHODS, V192, P13, DOI 10.1016/0022-1759(95)00264-2; Coley AM, 2001, PROTEIN ENG, V14, P691, DOI 10.1093/protein/14.9.691; Dar A, 2011, LEUKEMIA, V25, P1286, DOI 10.1038/leu.2011.62; DE CLERCQ E, 1994, ANTIMICROB AGENTS CH, V38, P668, DOI 10.1128/AAC.38.4.668; Duarte Djane B, 2012, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0506s56; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Goodchild SA, 2011, MOL IMMUNOL, V48, P2027, DOI 10.1016/j.molimm.2011.06.437; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Griffiths K, 2013, ANTIBODIES, V2, P66, DOI 10.3390/antib2010066; Haylock DN, 2007, STEM CELLS, V25, P1062, DOI 10.1634/stemcells.2006-0528; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Herr DR, 2012, INT REV CEL MOL BIO, V297, P45, DOI 10.1016/B978-0-12-394308-8.00002-9; Heym RG, 2015, BBA-PROTEINS PROTEOM, V1854, P979, DOI 10.1016/j.bbapap.2015.04.003; Hor L, 2013, BIOCHIMIE, V95, P1949, DOI 10.1016/j.biochi.2013.06.026; Hosse RJ, 2009, ANAL BIOCHEM, V385, P346, DOI 10.1016/j.ab.2008.11.026; Hummel S, 2014, CURR OPIN HEMATOL, V21, P29, DOI 10.1097/MOH.0000000000000002; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; Jahnichen S, 2010, P NATL ACAD SCI USA, V107, P20565, DOI 10.1073/pnas.1012865107; Jakobsen MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065950; Jost C, 2014, CURR OPIN STRUC BIOL, V27, P102, DOI 10.1016/j.sbi.2014.05.011; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Kuhne MR, 2013, CLIN CANCER RES, V19, P357, DOI 10.1158/1078-0432.CCR-12-2333; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liang ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034038; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; Liu JL, 2014, MOL IMMUNOL, V59, P194, DOI 10.1016/j.molimm.2014.02.014; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; MINSKY A, 1986, P NATL ACAD SCI USA, V83, P4180, DOI 10.1073/pnas.83.12.4180; Moll NM, 2010, EXPERT REV HEMATOL, V3, P315, DOI 10.1586/EHM.10.16; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nuttall Stewart D, 2012, Methods Mol Biol, V911, P27, DOI 10.1007/978-1-61779-968-6_3; Peng L, 2016, MABS-AUSTIN, V8, P163, DOI 10.1080/19420862.2015.1113359; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Pfleger KDG, 2008, ENDOCRINOLOGY, V149, P3118, DOI 10.1210/en.2008-0002; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Roche M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-43; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Roumen L, 2012, Drug Discov Today Technol, V9, pe281, DOI 10.1016/j.ddtec.2012.05.002; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; See HB, 2011, ASSAY DRUG DEV TECHN, V9, P21, DOI 10.1089/adt.2010.0336; Shu HKG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079768; Shukra AM, 2014, EUR J MICROBIOL IMMU, V4, P91, DOI 10.1556/EuJMI.4.2014.2.1; Simmons DP, 2008, PROTEINS, V71, P119, DOI 10.1002/prot.21663; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Steen A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00277; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Streltsov VA, 2004, P NATL ACAD SCI USA, V101, P12444, DOI 10.1073/pnas.0403509101; Strieter Robert M, 2009, Trans Am Clin Climatol Assoc, V120, P49; Tamamura H, 2003, FEBS LETT, V550, P79, DOI 10.1016/S0014-5793(03)00824-X; Walsh R, 2011, VIROLOGY, V411, P132, DOI 10.1016/j.virol.2010.12.034; Weidle UH, 2013, CANCER GENOM PROTEOM, V10, P155; Weitzenfeld P, 2014, CANCER LETT, V352, P36, DOI 10.1016/j.canlet.2013.10.006; Wurch T, 2012, TRENDS BIOTECHNOL, V30, P575, DOI 10.1016/j.tibtech.2012.07.006; Xu JG, 2007, AM J RESP CELL MOL, V37, P291, DOI 10.1165/rcmb.2006-0187OC	75	40	45	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12641	12657		10.1074/jbc.M116.721050	http://dx.doi.org/10.1074/jbc.M116.721050			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27036939	hybrid, Green Published			2022-12-28	WOS:000378119900020
J	Nadezhdin, KD; Garcia-Carpio, I; Goncharuk, SA; Mineev, KS; Arseniev, AS; Vilar, M				Nadezhdin, Kirill D.; Garcia-Carpio, Irmina; Goncharuk, Sergey A.; Mineev, Konstantin S.; Arseniev, Alexander S.; Vilar, Marcal			Structural Basis of p75 Transmembrane Domain Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; HELIX-HELIX INTERACTIONS; NEUROTROPHIN RECEPTOR; SYMPATHETIC NEURONS; MEMBRANE-PROTEINS; DIMERIC STRUCTURE; GAMMA-SECRETASE; DEATH RECEPTOR; GLYCOPHORIN-A; NGF RECEPTOR	Dimerization of single span transmembrane receptors underlies their mechanism of activation. p75 neurotrophin receptor plays an important role in the nervous system, but the understanding of p75 activation mechanism is still incomplete. The transmembrane (TM) domain of p75 stabilizes the receptor dimers through a disulfide bond, essential for the NGF signaling. Here we solved by NMR the three-dimensional structure of the p75-TM-WT and the functionally inactive p75-TM-C257A dimers. Upon reconstitution in lipid micelles, p75-TM-WT forms the disulfide-linked dimers spontaneously. Under reducing conditions, p75-TM-WT is in a monomer-dimer equilibrium with the Cys(257) residue located on the dimer interface. In contrast, p75-TM-C257A forms dimers through the AXXXG motif on the opposite face of the alpha-helix. Biochemical and cross-linking experiments indicate that AXXXG motif is not on the dimer interface of p75-TM-WT, suggesting that the conformation of p75-TM-C257A may be not functionally relevant. However, rather than mediating p75 homodimerization, mutagenesis of the AXXXG motif reveals its functional role in the regulated intramembrane proteolysis of p75 catalyzed by the gamma-secretase complex. Our structural data provide an insight into the key role of the Cys(257) in stabilization of the weak transmembrane dimer in a conformation required for the NGF signaling.	[Nadezhdin, Kirill D.; Goncharuk, Sergey A.; Mineev, Konstantin S.; Arseniev, Alexander S.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Garcia-Carpio, Irmina; Vilar, Marcal] Inst Salud Carlos III, Neurodegenerat Unit, Unidad Func Invest Enfermedades Cron, Madrid 28220, Spain	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Instituto de Salud Carlos III; Unidad Funcional de Investigacion de Enfermedades Cronicas (UFIEC)	Arseniev, AS (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia.; Vilar, M (corresponding author), CSIC, Inst Biomed Valencia, C Jaume Roig 11, Valencia 46010, Spain.	aars@nmr.ru; mvilar@ibv.csic.es	Mineev, Konstantin/E-4151-2010; Mineev, Konstantin S/Q-3948-2018; Goncharuk, Sergey/Q-4481-2016; Nadezhdin, Kirill D/R-6757-2016; Vilar, Marçal/B-4581-2016; Mineev, Konstantin/AAC-6662-2019	Mineev, Konstantin/0000-0002-2418-9421; Mineev, Konstantin S/0000-0002-2418-9421; Vilar, Marçal/0000-0002-9376-6544; Mineev, Konstantin/0000-0002-2418-9421; Nadezhdin, Kirill/0000-0002-7140-0779; Garcia Carpio, Irmina/0000-0003-1054-1655; Goncharuk, Sergey/0000-0002-0263-6462	Russian Science Foundation [14-50-00131]; Spanish Ministry of Economy and Competitiveness (MINECO) Project [BFU2013-42746-P]; MINECO Formacion de Personal Investigador (FPI) Predoctoral Fellowship [BFU2010-15276]	Russian Science Foundation(Russian Science Foundation (RSF)); Spanish Ministry of Economy and Competitiveness (MINECO) Project; MINECO Formacion de Personal Investigador (FPI) Predoctoral Fellowship(German Research Foundation (DFG))	This work was supported in part by Russian Science Foundation Project 14-50-00131 ( to A. S. A.) (NMR structural studies) and Spanish Ministry of Economy and Competitiveness (MINECO) Project BFU2013-42746-P ( to M. V.). The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.r Supported by MINECO Formacion de Personal Investigador (FPI) Predoctoral Fellowship BFU2010-15276.	Anastasia A, 2015, J NEUROSCI, V35, P11911, DOI 10.1523/JNEUROSCI.0591-15.2015; Aoki M, 2009, PROTEIN EXPRES PURIF, V68, P128, DOI 10.1016/j.pep.2009.07.017; Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Bhakar AL, 2003, J NEUROSCI, V23, P11373; Bocharov EV, 2007, J BIOL CHEM, V282, P16256, DOI 10.1074/jbc.M701745200; Bocharov EV, 2013, STRUCTURE, V21, P2087, DOI 10.1016/j.str.2013.08.026; Bocharov EV, 2012, BBA-BIOMEMBRANES, V1818, P2158, DOI 10.1016/j.bbamem.2012.05.001; Bothwell M, 2006, BRAIN BEHAV EVOLUT, V68, P124, DOI 10.1159/000094082; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chen LR, 2010, J AM CHEM SOC, V132, P3628, DOI 10.1021/ja910692u; Feng D, 2010, J MOL BIOL, V396, P967, DOI 10.1016/j.jmb.2009.12.030; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Fisher LE, 2003, BIOPHYS J, V85, P3097, DOI 10.1016/S0006-3495(03)74728-6; Fleming KG, 2002, J MOL BIOL, V323, P563, DOI 10.1016/S0022-2836(02)00920-8; Friedman WJ, 1999, EXP CELL RES, V253, P131, DOI 10.1006/excr.1999.4705; Fu QS, 2016, MOL CELL, V61, P602, DOI 10.1016/j.molcel.2016.01.009; Goncharuk SA, 2011, ACTA NATURAE, V3, P77, DOI 10.32607/20758251-2011-3-3-77-84; Gong Y, 2008, NATURE, V454, P789, DOI 10.1038/nature07089; GROB PM, 1983, P NATL ACAD SCI-BIOL, V80, P6819, DOI 10.1073/pnas.80.22.6819; Guntert Peter, 2004, Methods Mol Biol, V278, P353; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Jiang GQ, 1999, CURR BIOL, V9, pR568, DOI 10.1016/S0960-9822(99)80357-1; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kai L, 2012, METHODS MOL BIOL, V800, P201, DOI 10.1007/978-1-61779-349-3_14; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Keller R., 2004, COMPUTER AIDED RESON, V1; Kenchappa RS, 2010, J BIOL CHEM, V285, P20358, DOI 10.1074/jbc.M109.082834; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Lin Z, 2015, ELIFE, V4, DOI 10.7554/eLife.11692; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Mao GZ, 2009, J ALZHEIMERS DIS, V18, P167, DOI 10.3233/JAD-2009-1132; Mineev KS, 2011, ACTA NATURAE, V3, P90, DOI 10.32607/20758251-2011-3-2-90-98; Mineev KS, 2015, BIOCHEMISTRY-US, V54, P6295, DOI 10.1021/acs.biochem.5b00851; Mineev KS, 2015, BIOPHYS J, V109, P772, DOI 10.1016/j.bpj.2015.07.009; Mineev KS, 2014, BBA-BIOMEMBRANES, V1838, P164, DOI 10.1016/j.bbamem.2013.08.021; Nakano M, 2009, J AM CHEM SOC, V131, P8308, DOI 10.1021/ja9017013; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Polyansky AA, 2014, BIOINFORMATICS, V30, P889, DOI 10.1093/bioinformatics/btt645; Polyansky AA, 2012, J AM CHEM SOC, V134, P14390, DOI 10.1021/ja303483k; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Skeldal S, 2011, BIOESSAYS, V33, P614, DOI 10.1002/bies.201100036; Sulistijo ES, 2009, BIOCHEMISTRY-US, V48, P5106, DOI 10.1021/bi802245u; Sykes AM, 2012, J BIOL CHEM, V287, P43810, DOI 10.1074/jbc.M112.382903; Teese MG, 2015, BIOCHEMISTRY-US, V54, P5125, DOI 10.1021/acs.biochem.5b00495; Vicario A, 2015, J CELL SCI, V128, P1507, DOI 10.1242/jcs.161745; Vilar M, 2009, J CELL SCI, V122, P3351, DOI 10.1242/jcs.055061; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiesmann C, 2001, CELL MOL LIFE SCI, V58, P748, DOI 10.1007/PL00000898; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yamashita Toshihide, 2005, Anatomical Science International, V80, P37, DOI 10.1111/j.1447-073x.2005.00095.x; Zhou P, 2009, PROTEINS, V76, P151, DOI 10.1002/prot.22327	65	21	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12346	12357		10.1074/jbc.M116.723585	http://dx.doi.org/10.1074/jbc.M116.723585			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27056327	Green Published, hybrid			2022-12-28	WOS:000378092800033
J	Wei, DH; Li, NL; Zeng, YL; Liu, BM; Kumthip, K; Wang, TT; Huo, DZ; Ingels, JF; Lu, L; Shang, J; Li, K				Wei, Dahai; Li, Nan L.; Zeng, Yanli; Liu, Baoming; Kumthip, Kattareeya; Wang, Tony T.; Huo, Dezheng; Ingels, Jesse F.; Lu, Lu; Shang, Jia; Li, Kui			The Molecular Chaperone GRP78 Contributes to Toll-like Receptor 3-mediated Innate Immune Response to Hepatitis C Virus in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; SIGNALING PATHWAY; GENETIC-VARIATION; HEPATOMA-CELLS; ER STRESS; INFECTION; ACTIVATION; IL28B; REPLICATION	Toll-like receptor-3 (TLR3) senses double-stranded RNA intermediates produced during hepatitis C virus (HCV) replication, leading to activation of interferon regulatory factor-3 (IRF3) and NF-kappa B and subsequent antiviral and proinflammatory responses. Yet, how this TLR3-dependent pathway operates in hepatocytes is unclear. Upon fractionating cultured hepatocytes into various cellular organelles, we observed that TLR3 predominantly resides in endolysosomes of hepatocytes. To determine the critical regulators of TLR3 signaling in response to HCV infection in human hepatocytes, we isolated endolysosome fractions from mock-infected and HCV-infected hepatoma Huh7.5 cells that had been reconstituted for TLR3 expression, separated these fractions on two-dimensional gels, and identified up-regulated/down-regulated proteins by mass spectrometry. Approximately a dozen of cellular proteins were found to be differentially expressed in endolysosome fractions following HCV infection. Of these, expression of several molecular chaperone proteins was elevated. Knock down of one of these chaperones, glucose-regulated protein 78 kDa (GRP78), compromised TLR3-dependent induction of interferon-stimulated genes and chemokines following HCV infection or poly(I: C) stimulation in cultured hepatocytes. Consistent with this finding, GRP78 depletion impaired TLR3-mediated establishment of an antiviral state. Mechanistically, although TLR3 trafficking to endolysosomes was not affected, phosphorylated IRF3 diminished faster following GRP78 knockdown. Remarkably, GRP78 transcript was significantly up-regulated in liver biopsies of chronic hepatitis C patients as compared with normal liver tissues. Moreover, the GRP78 expression level correlated with that of RANTES (regulated upon activation, normal T-cell expressed and secreted) and CXCL10, two inflammatory chemokines most frequently elevated in HCV-infected liver. Altogether, our data suggest that GRP78 contributes to TLR3-mediated, IRF3-dependent innate immune response to HCV in hepatocytes.	[Wei, Dahai; Li, Nan L.; Liu, Baoming; Kumthip, Kattareeya; Li, Kui] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, 858 Madison Ave, Memphis, TN 38163 USA; [Ingels, Jesse F.; Lu, Lu] Univ Tennessee, Hlth Sci Ctr, Dept Genet Genom & Informat, Memphis, TN 38163 USA; [Zeng, Yanli; Shang, Jia] Henan Prov Peoples Hosp, Dept Infect Dis, Zhengzhou 450003, Henan, Peoples R China; [Wang, Tony T.] SRI Int, Harrisonburg, VA 22802 USA; [Huo, Dezheng] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Zhengzhou University; SRI International; University of Chicago	Li, K (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, 858 Madison Ave, Memphis, TN 38163 USA.	kli1@uthsc.edu		Kumthip, Kattareeya/0000-0001-7028-7607	National Institutes of Health [AI069285, DK088787]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI069285, R01AI069285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088787, R56DK088787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was support by National Institutes of Health Grants AI069285 ( to K. L.) and DK088787 ( to T. T. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bigger CB, 2001, J VIROL, V75, P7059, DOI 10.1128/JVI.75.15.7059-7066.2001; Chan SW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00233; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; Chang CH, 2011, J BIOL CHEM, V286, P7043, DOI 10.1074/jbc.M110.164632; Chen LM, 2010, GASTROENTEROLOGY, V138, P1123, DOI 10.1053/j.gastro.2009.10.046; Ciccaglione AR, 2005, ARCH VIROL, V150, P1339, DOI 10.1007/s00705-004-0487-4; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Joyce MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000291; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Lee SH, 2008, HEPATOLOGY, V47, P854, DOI 10.1002/hep.22107; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Li K, 2013, SEMIN IMMUNOPATHOL, V35, P53, DOI 10.1007/s00281-012-0332-x; Li K, 2012, HEPATOLOGY, V55, P666, DOI 10.1002/hep.24763; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Lin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114874; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; MACEJAK DG, 1990, ENZYME, V44, P310, DOI 10.1159/000468767; McGilvray I, 2012, GASTROENTEROLOGY, V142, P1122, DOI 10.1053/j.gastro.2012.01.028; McPherson S, 2011, J GASTROEN HEPATOL, V26, P319, DOI 10.1111/j.1440-1746.2010.06368.x; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Park SH, 2014, IMMUNITY, V40, P13, DOI 10.1016/j.immuni.2013.12.010; Pfeffer LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104202; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Sekine-Osajima Y, 2008, VIROLOGY, V371, P71, DOI 10.1016/j.virol.2007.09.019; Shen Y, 2012, J BIOL CHEM, V287, P36404, DOI 10.1074/jbc.M112.397075; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Chau TL, 2015, J IMMUNOL, V194, P3970, DOI 10.4049/jimmunol.1401614; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Ueno T, 1999, J BIOL CHEM, V274, P15222, DOI 10.1074/jbc.274.21.15222; von dem Bussche A, 2010, J HEPATOL, V53, P797, DOI 10.1016/j.jhep.2010.05.022; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang N, 2010, J BIOL CHEM, V285, P6080, DOI 10.1074/jbc.M109.054486; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Zheng Y, 2005, J MICROBIOL, V43, P529	50	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12294	12309		10.1074/jbc.M115.711598	http://dx.doi.org/10.1074/jbc.M115.711598			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27129228	Green Published, hybrid			2022-12-28	WOS:000378092800029
J	Zattas, D; Berk, JM; Kreft, SG; Hochstrasser, M				Zattas, Dimitrios; Berk, Jason M.; Kreft, Stefan G.; Hochstrasser, Mark			A Conserved C-terminal Element in the Yeast Doa10 and Human MARCH6 Ubiquitin Ligases Required for Selective Substrate Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; INNER NUCLEAR-MEMBRANE; IN-VIVO DEGRADATION; ER QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; PROTEIN-DEGRADATION; TRANSCRIPTIONAL REGULATOR; MAT-ALPHA-2 REPRESSOR; MISFOLDED PROTEINS	Specific proteins are modified by ubiquitin at the endoplasmic reticulum (ER) and are degraded by the proteasome, a process referred to as ER-associated protein degradation. In Saccharomyces cerevisiae, two principal ER-associated protein degradation ubiquitin ligases (E3s) reside in the ER membrane, Doa10 and Hrd1. The membrane-embedded Doa10 functions in the degradation of substrates in the ER membrane, nuclear envelope, cytoplasm, and nucleoplasm. How most E3 ligases, including Doa10, recognize their protein substrates remains poorly understood. Here we describe a previously unappreciated but highly conserved C-terminal element (CTE) in Doa10; this cytosolically disposed 16-residue motif follows the final transmembrane helix. A conserved CTE asparagine residue is required for ubiquitylation and degradation of a subset of Doa10 substrates. Such selectivity suggests that the Doa10 CTE is involved in substrate discrimination and not general ligase function. Functional conservation of the CTE was investigated in the human ortholog of Doa10, MARCH6 (TEB4), by analyzing MARCH6 autoregulation of its own degradation. Mutation of the conserved Asn residue (N890A) in the MARCH6 CTE stabilized the normally short lived enzyme to the same degree as a catalytically inactivating mutation (C9A). We also report the localization of endogenous MARCH6 to the ER using epitope tagging of the genomic MARCH6 locus by clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-mediated genome editing. These localization and CTE analyses support the inference that MARCH6 and Doa10 are functionally similar. Moreover, our results with the yeast enzyme suggest that the CTE is involved in the recognition and/or ubiquitylation of specific protein substrates.	[Zattas, Dimitrios; Berk, Jason M.; Kreft, Stefan G.; Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA; [Kreft, Stefan G.] Univ Konstanz, Dept Biol, Univ Str 10, D-78457 Constance, Germany; [Zattas, Dimitrios] Sloan Kettering Inst, Program Struct Biol, 1275 York Ave, New York, NY 10065 USA	Yale University; University of Konstanz; Memorial Sloan Kettering Cancer Center	Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	mark.hochstrasser@yale.edu		Hochstrasser, Mark/0000-0002-1131-5484	National Institutes of Health [R01 GM046904, F32 GM113456, T32 GM7223]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM113456, R37GM046904, R01GM046904, T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM046904 ( to M. H.). Additional training support was provided by National Institutes of Health Grants F32 GM113456 ( to J. M. B.) and T32 GM7223 ( to D. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfassy OS, 2013, J BIOL CHEM, V288, P12645, DOI 10.1074/jbc.M113.453027; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Burr ML, 2011, P NATL ACAD SCI USA, V108, P2034, DOI 10.1073/pnas.1016229108; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Foresti O, 2014, SCIENCE, V346, P751, DOI 10.1126/science.1255638; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Furth N, 2011, MOL BIOL CELL, V22, P4726, DOI 10.1091/mbc.E11-05-0463; Gilon T, 2000, MOL CELL BIOL, V20, P7214, DOI 10.1128/MCB.20.19.7214-7219.2000; Guthrie C, 1991, GUIDE YEAST GENETICS; Habeck G, 2015, J CELL BIOL, V209, P261, DOI 10.1083/jcb.201408088; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hickey CM, 2015, MOL BIOL CELL, V26, P3401, DOI 10.1091/mbc.E15-06-0436; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Khmelinskii A, 2014, NATURE, V516, P410, DOI 10.1038/nature14096; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Kreft SG, 2011, J BIOL CHEM, V286, P20163, DOI 10.1074/jbc.M110.196360; Laney Jeffrey D, 2002, Curr Protoc Protein Sci, VChapter 14, DOI 10.1002/0471140864.ps1405s29; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Mruk Dolores D, 2011, Spermatogenesis, V1, P121; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Pickart CM, 2000, NAT CELL BIOL, V2, pE139, DOI 10.1038/35019610; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rubenstein EM, 2012, J CELL BIOL, V197, P761, DOI 10.1083/jcb.201203061; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Sahi C, 2013, MOL BIOL EVOL, V30, P985, DOI 10.1093/molbev/mst008; Sato T, 2012, MOL CELL, V47, P99, DOI 10.1016/j.molcel.2012.04.015; Shiber A, 2013, MOL BIOL CELL, V24, P2076, DOI 10.1091/mbc.E13-01-0010; SIKORSKI RS, 1989, GENETICS, V122, P19; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; van de Weijer ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4832; van den Boomen DJH, 2014, P NATL ACAD SCI USA, V111, P11425, DOI 10.1073/pnas.1409099111; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Zattas D, 2015, CRIT REV BIOCHEM MOL, V50, P1, DOI 10.3109/10409238.2014.959889; Zattas D, 2013, MOL BIOL CELL, V24, P890, DOI 10.1091/mbc.E12-11-0838; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	56	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12105	12118		10.1074/jbc.M116.726877	http://dx.doi.org/10.1074/jbc.M116.726877			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27068744	hybrid, Green Published			2022-12-28	WOS:000378092800013
J	Rajasekaran, D; Jariwala, N; Mendoza, RG; Robertson, CL; Akiel, MA; Dozmorov, M; Fisher, PB; Sarkar, D				Rajasekaran, Devaraja; Jariwala, Nidhi; Mendoza, Rachel G.; Robertson, Chadia L.; Akiel, Maaged A.; Dozmorov, Mikhail; Fisher, Paul B.; Sarkar, Devanand			Staphylococcal Nuclease and Tudor Domain Containing 1 (SND1 Protein) Promotes Hepatocarcinogenesis by Inhibiting Monoglyceride Lipase (MGLL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; MONOACYLGLYCEROL LIPASE; COMPONENT; INSIGHTS; CANCER; IDENTIFICATION; ANGIOGENESIS; ABERRATIONS; METASTASIS; DOWNSTREAM	Staphylococcal nuclease and tudor domain containing 1 (SND1) is overexpressed in multiple cancers, including hepatocellular carcinoma (HCC), and functions as an oncogene. This study was carried out to identify novel SND1-interacting proteins to better understand its molecular mechanism of action. SND1-interacting proteins were identified by a modified yeast two-hybrid assay. Protein-protein interaction was confirmed by co-immunoprecipitation analysis. Monoglyceride lipase (MGLL) expression was analyzed by quantitative RT-PCR, Western blot, and immunohistochemistry. MGLL-overexpressing clones were analyzed for cell proliferation and cell cycle analysis and in vivo tumorigenesis in nude mice. MGLL was identified as an SND1-interacting protein. Interaction of SND1 with MGLL resulted in ubiquitination and proteosomal degradation of MGLL. MGLL expression was detected in normal human hepatocytes and mouse liver, although it was undetected in human HCC cell lines. An inverse correlation between SND1 and MGLL levels was identified in a human HCC tissue microarray as well as in the TCGA database. Forced overexpression of MGLL in human HCC cells resulted in marked inhibition in cell proliferation with a significant delay in cell cycle progression and a marked decrease in tumor growth in nude mouse xenograft assays. MGLL overexpression inhibited Akt activation that is independent of enzymatic activity of MGLL and overexpression of a constitutively active Akt rescued cells from inhibition of proliferation and restored normal cell cycle progression. This study unravels a novel mechanism of SND1 function and identifies MGLL as a unique tumor suppressor for HCC. MGLL might function as a homeostatic regulator of Akt restraining its activation.	[Rajasekaran, Devaraja; Jariwala, Nidhi; Mendoza, Rachel G.; Robertson, Chadia L.; Akiel, Maaged A.; Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, Dept Human & Mol Genet, 1220 East Broad St,POB 980035, Richmond, VA 23298 USA; [Dozmorov, Mikhail] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, VCU Inst Mol Med, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Sarkar, D (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, 1220 East Broad St,POB 980035, Richmond, VA 23298 USA.	devanand.sarkar@vcuhealth.org	Dozmorov, Mikhail/B-1374-2009; Akiel, Maaged/B-5109-2014	Dozmorov, Mikhail/0000-0002-0086-8358; Akiel, Maaged/0000-0002-0211-2837	James S. McDonnell Foundation; NCI from National Institutes of Health [R01 CA138540, R21 CA183954, R01 CA134721]; National Foundation for Cancer Research; NIDDK from National Institutes of Health [T32DK007150]; NATIONAL CANCER INSTITUTE [R21CA183954, R01CA138540, R01CA134721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007150] Funding Source: NIH RePORTER	James S. McDonnell Foundation; NCI from National Institutes of Health; National Foundation for Cancer Research; NIDDK from National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by The James S. McDonnell Foundation, NCI Grants R01 CA138540 and R21 CA183954 (to D. S.) and R01 CA134721 (to P. B. F.) from National Institutes of Health, and the National Foundation for Cancer Research (to P. B. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by NIDDK Grant T32DK007150 from National Institutes of Health.	Blanco MA, 2011, J BIOL CHEM, V286, P19982, DOI 10.1074/jbc.M111.240077; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Guo F, 2014, CELL REP, V8, P1704, DOI 10.1016/j.celrep.2014.08.033; Hashimoto K, 2004, MODERN PATHOL, V17, P617, DOI 10.1038/modpathol.3800107; Jariwala N, 2015, INT J ONCOL, V46, P465, DOI 10.3892/ijo.2014.2766; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Kuruma H, 2009, AM J PATHOL, V174, P2044, DOI 10.2353/ajpath.2009.080776; Labar G, 2010, CHEMBIOCHEM, V11, P218, DOI 10.1002/cbic.200900621; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CL, 2008, NUCLEIC ACIDS RES, V36, P3579, DOI 10.1093/nar/gkn236; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Patil MA, 2005, CARCINOGENESIS, V26, P2050, DOI 10.1093/carcin/bgi178; Paukku K, 2003, MOL ENDOCRINOL, V17, P1805, DOI 10.1210/me.2002-0256; Pek JW, 2012, DEVELOPMENT, V139, P2255, DOI 10.1242/dev.073304; Petrenko AB, 2014, BEHAV BRAIN RES, V271, P51, DOI 10.1016/j.bbr.2014.05.063; Quiroga AD, 2012, BBA-MOL CELL BIOL L, V1821, P762, DOI 10.1016/j.bbalip.2011.09.007; Rajasekaran D, 2015, ONCOTARGET, V6, P26266, DOI 10.18632/oncotarget.4656; Santhekadur PK, 2014, FEBS OPEN BIO, V4, P353, DOI 10.1016/j.fob.2014.03.012; Santhekadur PK, 2012, J BIOL CHEM, V287, P13952, DOI 10.1074/jbc.M111.321646; Srivastava J, 2014, CANCER RES, V74, P4364, DOI 10.1158/0008-5472.CAN-14-0421; Srivastava J, 2012, HEPATOLOGY, V56, P1782, DOI 10.1002/hep.25868; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Sun H, 2013, ONCOGENE, V32, P234, DOI 10.1038/onc.2012.34; Sundstrom JF, 2009, NAT CELL BIOL, V11, P1347, DOI 10.1038/ncb1979; Tsuchiya N, 2007, CANCER RES, V67, P9568, DOI 10.1158/0008-5472.CAN-06-2707; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Wan LL, 2014, CANCER CELL, V26, P92, DOI 10.1016/j.ccr.2014.04.027; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Yu L, 2015, CANCER RES, V75, P1275, DOI 10.1158/0008-5472.CAN-14-2387; Zhu YT, 2014, NAT METHODS, V11, P599, DOI 10.1038/nmeth.2956	33	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10736	10746		10.1074/jbc.M116.715359	http://dx.doi.org/10.1074/jbc.M116.715359			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26997225	hybrid, Green Published			2022-12-28	WOS:000377042600025
J	Ioannou, MS; McPherson, PS				Ioannou, Maria S.; McPherson, Peter S.			Regulation of Cancer Cell Behavior by the Small GTPase Rab13*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							VASODILATOR-STIMULATED PHOSPHOPROTEIN; ENDOTHELIAL GROWTH-FACTOR; MUTANT P53; NEURITE OUTGROWTH; TIGHT JUNCTION; GLUT4 TRANSLOCATION; THERAPEUTIC OPPORTUNITIES; HEPATOCELLULAR-CARCINOMA; LYMPHOCYTE TRAFFICKING; MEMBRANE TRAFFICKING	The members of the Rab family of GTPases are master regulators of cellular membrane trafficking. With similar to 70 members in humans, Rabs have been implicated in all steps of membrane trafficking ranging from vesicle formation and transport to vesicle docking/tethering and fusion. Vesicle trafficking controls the localization and levels of a myriad of proteins, thus regulating cellular functions including proliferation, metabolism, cell-cell adhesion, and cell migration. It is therefore not surprising that impairment of Rab pathways is associated with diseases including cancer. In this review, we highlight evidence supporting the role of Rab13 as a potent driver of cancer progression.	[Ioannou, Maria S.; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Univ St, Montreal, PQ H3A 2B4, Canada	McGill University	McPherson, PS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	peter.mcpherson@mcgill.ca						Abou-Zeid N, 2011, MOL BIOL CELL, V22, P3431, DOI 10.1091/mbc.E11-01-0030; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Artemenko Y, 2012, P NATL ACAD SCI USA, V109, P13632, DOI 10.1073/pnas.1211304109; Attarha S, 2014, INT J ONCOL, V45, P853, DOI 10.3892/ijo.2014.2447; Baldassarre M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007830; Bar J, 2005, CELL DEATH DIFFER, V12, P1578, DOI 10.1038/sj.cdd.4401677; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Calmon MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053260; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Cheng JC, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-14; D'Angelo G, 1999, MOL ENDOCRINOL, V13, P692, DOI 10.1210/me.13.5.692; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Doppler HR, 2013, J BIOL CHEM, V288, P24382, DOI 10.1074/jbc.M113.474676; Doyle B, 2010, J PATHOL, V222, P129, DOI 10.1002/path.2748; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Eom HS, 2015, INT J RADIAT BIOL, V91, P585, DOI 10.3109/09553002.2015.1029595; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Frasca F, 2013, J CLIN ENDOCR METAB, V98, P2502, DOI 10.1210/jc.2012-3623; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; GLUCK U, 1994, J CELL SCI, V107, P1773; Gupton SL, 2010, DEV CELL, V18, P725, DOI [10.1016/j.devcel.2010.02.017, 10.1016/j.devce1.2010.02.017]; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Hsu JH, 2001, BLOOD, V98, P2853, DOI 10.1182/blood.V98.9.2853; Hubbs AE, 1999, ONCOGENE, V18, P2519, DOI 10.1038/sj.onc.1202554; Ioannou MS, 2016, J BIOL CHEM, V291, P10726, DOI 10.1074/jbc.M116.722298; Ioannou MS, 2015, J CELL BIOL, V208, P629, DOI 10.1083/jcb.201407068; Jakobsen Kristine Raaby, 2013, J Mol Signal, V8, P9, DOI 10.1186/1750-2187-8-9; Jiang XH, 2010, CANCER BIOL THER, V10, P362, DOI 10.4161/cbt.10.4.12426; Kanda I, 2008, ONCOGENE, V27, P1687, DOI 10.1038/sj.onc.1210812; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Kim HS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-348; Klopper TH, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-71; Kobayashi H, 2014, BIOL OPEN, V3, P803, DOI 10.1242/bio.20148771; Kohler K, 2004, J CELL BIOL, V165, P175, DOI 10.1083/jcb.200312118; Kohler K, 2005, BIOL CELL, V97, P659; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lawrence DW, 2002, AM J PHYSIOL-CELL PH, V282, pC1235, DOI 10.1152/ajpcell.00288.2001; Lenferink AEG, 1998, EMBO J, V17, P3385, DOI 10.1093/emboj/17.12.3385; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; Li WS, 2014, GENE, V547, P346, DOI 10.1016/j.gene.2014.06.042; LICHY JH, 1992, CELL GROWTH DIFFER, V3, P541; Liu KY, 1999, MOL CELL BIOL, V19, P3696; Ma X, 2011, MOL PSYCHIATR, V16, P1105, DOI 10.1038/mp.2011.43; Mahadevan D, 2005, MOL CANCER THER, V4, P1867, DOI 10.1158/1535-7163.MCT-05-0146; Majidi M, 1998, J BIOL CHEM, V273, P16608, DOI 10.1074/jbc.273.26.16608; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marat AL, 2012, MOL BIOL CELL, V23, P163, DOI 10.1091/mbc.E11-05-0474; Marat AL, 2010, J BIOL CHEM, V285, P10627, DOI 10.1074/jbc.M109.050930; Marzesco AM, 1998, J BIOL CHEM, V273, P22340, DOI 10.1074/jbc.273.35.22340; McBrayer SK, 2012, BLOOD, V119, P4686, DOI 10.1182/blood-2011-09-377846; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Nakatsuji H, 2008, MOL CELL BIOL, V28, P3324, DOI 10.1128/MCB.00144-08; Neary CL, 2004, ONCOGENE, V23, P8847, DOI 10.1038/sj.onc.1208165; Nishikimi A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005199; Nishimura N, 2008, J MED INVESTIG, V55, P9, DOI 10.2152/jmi.55.9; Nokes RL, 2008, J CELL BIOL, V182, P845, DOI 10.1083/jcb.200802176; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; OSHIMURA M, 1990, J CELL BIOCHEM, V42, P135, DOI 10.1002/jcb.240420304; Parangi S, 1996, P NATL ACAD SCI USA, V93, P2002, DOI 10.1073/pnas.93.5.2002; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; Prates J, 2015, GENE, V570, P248, DOI 10.1016/j.gene.2015.06.021; Proux-Gillardeaux V, 2007, BIOL CELL, V99, P261, DOI 10.1042/BC20060097; Rainero E, 2012, J CELL BIOL, V196, P277, DOI 10.1083/jcb.201109112; Rawat SJ, 2015, TRENDS BIOCHEM SCI, V40, P149, DOI 10.1016/j.tibs.2015.01.001; REN J, 1990, CANCER RES, V50, P358; Sakane A, 2013, GENES CELLS, V18, P810, DOI 10.1111/gtc.12078; Sakane A, 2012, J BIOL CHEM, V287, P42455, DOI 10.1074/jbc.M112.383653; Sakane A, 2010, MOL CELL BIOL, V30, P1077, DOI 10.1128/MCB.01067-09; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Satoh H, 1996, EXP CELL RES, V222, P269, DOI 10.1006/excr.1996.0034; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sun Y, 2016, MOL BIOL CELL, V27, P75, DOI 10.1091/mbc.E15-05-0319; Sun Y, 2010, P NATL ACAD SCI USA, V107, P19909, DOI 10.1073/pnas.1009523107; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Weisz L, 2007, ONCOGENE, V26, P2202, DOI 10.1038/sj.onc.1210294; Wu CS, 2011, J BIOL CHEM, V286, P23511, DOI 10.1074/jbc.M111.245209; Yamamoto Y, 2003, BIOCHEM BIOPH RES CO, V308, P270, DOI 10.1016/S0006-291X(03)01358-5; Yamamura R, 2008, MOL BIOL CELL, V19, P971, DOI 10.1091/mbc.E07-06-0551; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang K, 2014, J CANCER RES CLIN, V140, P1913, DOI 10.1007/s00432-014-1722-3; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhou G, 2014, MOL CELL, V54, P960, DOI 10.1016/j.molcel.2014.04.024; Zhu LY, 2015, CANCER LETT, V363, P71, DOI 10.1016/j.canlet.2015.04.002	100	27	27	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9929	9937		10.1074/jbc.R116.715193	http://dx.doi.org/10.1074/jbc.R116.715193			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	27044746	Green Published, hybrid			2022-12-28	WOS:000375602800007
J	Sanvisens, N; Romero, AM; Zhang, CG; Wu, XR; An, XX; Huang, MX; Puig, S				Sanvisens, Nerea; Romero, Antonia M.; Zhang, Caiguo; Wu, Xiaorong; An, Xiuxiang; Huang, Mingxia; Puig, Sergi			Yeast Dun1 Kinase Regulates Ribonucleotide Reductase Small Subunit Localization in Response to Iron Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE CHECKPOINT PATHWAYS; SULFUR PROTEIN BIOGENESIS; RNA-BINDING-PROTEINS; SACCHAROMYCES-CEREVISIAE; DNA-DAMAGE; MESSENGER-RNA; INHIBITOR SML1; SUBCELLULAR-LOCALIZATION; NUCLEAR IMPORT; CLUSTER	Ribonucleotide reductase (RNR) is an essential iron-dependent enzyme that catalyzes deoxyribonucleotide synthesis in eukaryotes. Living organisms have developed multiple strategies to tightly modulate RNR function to avoid inadequate or unbalanced deoxyribonucleotide pools that cause DNA damage and genome instability. Yeast cells activate RNR in response to genotoxic stress and iron deficiency by facilitating redistribution of its small heterodimeric subunit Rnr2-Rnr4 from the nucleus to the cytoplasm, where it forms an active holoenzyme with large Rnr1 subunit. Dif1 protein inhibits RNR by promoting nuclear import of Rnr2-Rnr4. Upon DNA damage, Dif1 phosphorylation by the Dun1 checkpoint kinase and its subsequent degradation enhances RNR function. In this report, we demonstrate that Dun1 kinase triggers Rnr2-Rnr4 redistribution to the cytoplasm in response to iron deficiency. We show that Rnr2-Rnr4 relocalization by low iron requires Dun1 kinase activity and phosphorylation site Thr-380 in the Dun1 activation loop, but not the Dun1 forkhead-associated domain. By using different Dif1 mutant proteins, we uncover that Dun1 phosphorylates Dif1 Ser-104 and Thr-105 residues upon iron scarcity. We observe that the Dif1 phosphorylation pattern differs depending on the stimuli, which suggests different Dun1 activating pathways. Importantly, the Dif1-S104A/T105A mutant exhibits defects in nucleus-to-cytoplasm redistribution of Rnr2-Rnr4 by iron limitation. Taken together, these results reveal that, in response to iron starvation, Dun1 kinase phosphorylates Dif1 to stimulate Rnr2-Rnr4 relocalization to the cytoplasm and promote RNR function.	[Sanvisens, Nerea; Romero, Antonia M.; Puig, Sergi] CSIC, IATA, Dept Biotecnol, Valencia 46980, Spain; [Zhang, Caiguo; Wu, Xiaorong; An, Xiuxiang; Huang, Mingxia] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Sanvisens, Nerea] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California San Francisco	Huang, MX (corresponding author), 12801 E 17th Ave, Aurora, CO 80045 USA.; Puig, S (corresponding author), Catedrat Agustin Escardino 7, E-46980 Valencia, Spain.	mingxia.huang@ucdenver.edu; spuig@iata.csic.es	Puig, Sergi/E-4788-2010; Romero, Antonia Maria/AAG-8260-2019; Zhang, Caiguo/J-1421-2016	Puig, Sergi/0000-0002-1856-490X; Romero, Antonia Maria/0000-0002-2727-279X; Zhang, Caiguo/0000-0002-9055-3279	Conselleria d'Educacio de la Generalitat Valenciana; Spanish Ministry of Economy and Competitiveness; Spanish Ministry of Economy and Competitiveness [AGL2011-29099, BIO2014-56298-P]; National Institutes of Health [CA125574]; NATIONAL CANCER INSTITUTE [R01CA125574] Funding Source: NIH RePORTER	Conselleria d'Educacio de la Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)); Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported by a predoctoral fellowship from "Conselleria d'Educacio de la Generalitat Valenciana" (to N. S.), a predoctoral fellowship from the Spanish Ministry of Economy and Competitiveness (to A. M. R.), Spanish Ministry of Economy and Competitiveness Grants AGL2011-29099 and BIO2014-56298-P (to S. P.), and National Institutes of Health Grant CA125574 (to M. H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	An XX, 2006, GENETICS, V173, P63, DOI 10.1534/genetics.105.055236; Andreson BL, 2010, NUCLEIC ACIDS RES, V38, P6490, DOI 10.1093/nar/gkq552; Bashkirov VI, 2003, MOL CELL BIOL, V23, P1441, DOI 10.1128/MCB.23.4.1441-1452.2003; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chabes A, 2000, P NATL ACAD SCI USA, V97, P2474, DOI 10.1073/pnas.97.6.2474; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chen SH, 2007, J BIOL CHEM, V282, P986, DOI 10.1074/jbc.M609322200; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Craven RJ, 2000, MOL CELL BIOL, V20, P2378, DOI 10.1128/MCB.20.7.2378-2384.2000; de la Loza MDD, 2011, NUCLEIC ACIDS RES, V39, P6002, DOI 10.1093/nar/gkr193; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; Ge H, 2001, P NATL ACAD SCI USA, V98, P10067, DOI 10.1073/pnas.181336498; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Hausmann A, 2008, J BIOL CHEM, V283, P8318, DOI 10.1074/jbc.M705570200; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Lee H, 2008, MOL CELL, V30, P767, DOI 10.1016/j.molcel.2008.05.013; Lee YD, 2008, MOL CELL, V32, P70, DOI 10.1016/j.molcel.2008.08.018; Lee YD, 2006, GENE DEV, V20, P334, DOI 10.1101/gad.1380506; Martinez-Pastor M, 2013, MOL CELL BIOL, V33, P2178, DOI 10.1128/MCB.01458-12; Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Nguyen HHT, 1999, P NATL ACAD SCI USA, V96, P12339, DOI 10.1073/pnas.96.22.12339; Niida H, 2010, CANCER SCI, V101, P2505, DOI 10.1111/j.1349-7006.2010.01719.x; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pedro-Segura E, 2008, J BIOL CHEM, V283, P28527, DOI 10.1074/jbc.M804910200; Pijuan J, 2015, J CELL SCI, V128, P4653, DOI 10.1242/jcs.178046; Pike BL, 2003, J BIOL CHEM, V278, P30421, DOI 10.1074/jbc.C300227200; Prouteau M, 2008, EMBO J, V27, P2966, DOI 10.1038/emboj.2008.212; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Richardson DR, 2009, BBA-GEN SUBJECTS, V1790, P702, DOI 10.1016/j.bbagen.2008.04.003; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Sanvisens N, 2014, MOL CELL BIOL, V34, P3259, DOI 10.1128/MCB.00472-14; Sanvisens Nerea, 2013, Biomed J, V36, P51, DOI 10.4103/2319-4170.110398; Sanvisens N, 2011, MOL CELL, V44, P759, DOI 10.1016/j.molcel.2011.09.021; Shao JM, 2013, EXPERT OPIN THER TAR, V17, P1423, DOI 10.1517/14728222.2013.840293; SIKORSKI RS, 1989, GENETICS, V122, P19; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tsaponina O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002061; Uchiki T, 2004, J BIOL CHEM, V279, P11293, DOI 10.1074/jbc.M309751200; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Vergara SV, 2011, MOL CELL BIOL, V31, P417, DOI 10.1128/MCB.00754-10; Wanrooij PH, 2015, DNA REPAIR, V32, P17, DOI 10.1016/j.dnarep.2015.04.009; White MF, 2012, CURR OPIN STRUC BIOL, V22, P94, DOI 10.1016/j.sbi.2011.11.004; Wolter R, 1996, MOL GEN GENET, V250, P162, DOI 10.1007/s004380050063; Wu XR, 2008, MOL CELL BIOL, V28, P7156, DOI 10.1128/MCB.01388-08; Yao RJ, 2003, P NATL ACAD SCI USA, V100, P6628, DOI 10.1073/pnas.1131932100; Zhang CG, 2014, PROTEIN CELL, V5, P750, DOI 10.1007/s13238-014-0083-7; Zhang Z, 2006, P NATL ACAD SCI USA, V103, P1422, DOI 10.1073/pnas.0510516103; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299; Zhao XL, 2000, MOL CELL BIOL, V20, P9076, DOI 10.1128/MCB.20.23.9076-9083.2000; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G	60	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9807	9817		10.1074/jbc.M116.720862	http://dx.doi.org/10.1074/jbc.M116.720862			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26970775	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000375602300037
J	Yang, LW; Li, YT; Wang, XH; Mu, XJ; Qin, DZ; Huang, W; Alshahrani, S; Nieman, M; Peng, JT; Essandoh, K; Peng, TQ; Wang, YG; Lorenz, J; Soleimani, M; Zhao, ZQ; Fan, GC				Yang, Liwang; Li, Yutian; Wang, Xiaohong; Mu, Xingjiang; Qin, Dongze; Huang, Wei; Alshahrani, Saeed; Nieman, Michelle; Peng, Jiangtong; Essandoh, Kobina; Peng, Tianqing; Wang, Yigang; Lorenz, John; Soleimani, Manoocher; Zhao, Zhi-Qing; Fan, Guo-Chang			Overexpression of miR-223 Tips the Balance of Pro-and Anti-hypertrophic Signaling Cascades toward Physiologic Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CARDIOMYOCYTE HYPERTROPHY; PATHOLOGICAL HYPERTROPHY; C/EBP-BETA; GROWTH; MICRORNAS; PATHWAY; AKT; ACTIVATION; CELLS	MicroRNAs (miRNAs) have been extensively examined in pathological cardiac hypertrophy. However, few studies focused on profiling the miRNA alterations in physiological hypertrophic hearts. In this study we generated a transgenic mouse model with cardiac-specific overexpression of miR-223. Our results showed that elevation of miR-223 caused physiological cardiac hypertrophy with enhanced cardiac function but no fibrosis. Using the next generation RNA sequencing, we observed that most of dys-regulated genes (e.g. Atf3/5, Egr1/3, Sfrp2, Itgb1, Ndrg4, Akip1, Postn, Rxfp1, and Egln3) in miR-223-transgenic hearts were associated with cell growth, but they were not directly targeted by miR-223. Interestingly, these dys-regulated genes are known to regulate the Akt signaling pathway. Wefurther identified that miR-223 directly interacted with 3'-UTRs of FBXW7 and Acvr2a, two negative regulators of the Akt signaling. However, we also validated that miR-223 directly inhibited the expression of IGF-1R and beta 1-integrin, two positive regulators of the Akt signaling. Lastly, Western blotting did reveal that Akt was activated in miR-223-overexpressing hearts. Adenovirus-mediated overexpression of miR-223 in neonatal rat cardiomyocytes induced cell hypertrophy, which was blocked by the addition of MK2206, a specific inhibitor of Akt. Taken together, these data represent the first piece of work showing that miR-223 tips the balance of promotion and inactivation of Akt signaling cascades toward activation of Akt, a key regulator of physiological cardiac hypertrophy. Thus, our study suggests that the ultimate phenotype outcome of a miRNA may be decided by the secondary net effects of the whole target network rather than by several primary direct targets in an organ/tissue.	[Yang, Liwang; Qin, Dongze; Zhao, Zhi-Qing] Shanxi Med Univ, Taiyuan 030001, Peoples R China; [Yang, Liwang; Li, Yutian; Wang, Xiaohong; Mu, Xingjiang; Qin, Dongze; Alshahrani, Saeed; Peng, Jiangtong; Essandoh, Kobina; Fan, Guo-Chang] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, 231 Albert Sabin Way, Cincinnati, OH 45267 USA; [Huang, Wei; Wang, Yigang] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; [Alshahrani, Saeed; Soleimani, Manoocher] Univ Cincinnati, Coll Med, Res Serv, Vet Affairs Hosp, Cincinnati, OH 45267 USA; [Alshahrani, Saeed; Soleimani, Manoocher] Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH 45267 USA; [Nieman, Michelle; Lorenz, John] Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [Peng, Jiangtong] Huazhong Univ Sci & Technol, Dept Cardiol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China; [Peng, Tianqing] Lawson Hlth Res Inst, Crit Illness Res, London, ON N6A 4G5, Canada	Shanxi Medical University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Huazhong University of Science & Technology; Western University (University of Western Ontario)	Fan, GC (corresponding author), Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	fangg@ucmail.uc.edu	Fan, Guo-Chang/E-1153-2012; Alshahrani, Saeed/AAY-8319-2021; Peng, Tianqing/G-3340-2011	Fan, Guo-Chang/0000-0002-0439-8277; Huang, Wei/0000-0003-3046-4220; Li, Yutian/0000-0002-5118-0916	National Institutes of Health [R01 HL-087861, R01 GM-112930]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL-087861 and R01 GM-112930 (to G.-C. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad N, 2012, MOL CELL ENDOCRINOL, V363, P46, DOI 10.1016/j.mce.2012.07.006; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Cassavaugh JM, 2011, J CELL BIOCHEM, V112, P3882, DOI 10.1002/jcb.23321; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheong MW, 2015, J MOL MED, V93, P807, DOI 10.1007/s00109-015-1272-4; Chu WF, 2012, J CELL MOL MED, V16, P2022, DOI 10.1111/j.1582-4934.2011.01497.x; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Ellison GM, 2012, HEART, V98, P5, DOI 10.1136/heartjnl-2011-300639; Escribese MM, 2012, J IMMUNOL, V189, P1946, DOI 10.4049/jimmunol.1201064; Fan GC, 2004, AM J PHYSIOL-HEART C, V287, pH1705, DOI 10.1152/ajpheart.01211.2003; Fernandes T, 2015, AM J PHYSIOL-HEART C, V309, pH543, DOI 10.1152/ajpheart.00899.2014; Flugel D, 2012, BLOOD, V119, P1292, DOI 10.1182/blood-2011-08-375014; Haneklaus M, 2013, J INTERN MED, V274, P215, DOI 10.1111/joim.12099; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Kemi OJ, 2008, J CELL PHYSIOL, V214, P316, DOI 10.1002/jcp.21197; Ma ZC, 2013, EUR J APPL PHYSIOL, V113, P2473, DOI 10.1007/s00421-013-2685-9; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Martinelli NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093271; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; Moc C, 2015, CARDIOVASC RES, V105, P160, DOI 10.1093/cvr/cvu243; Montano MM, 2013, CARDIOVASC RES, V99, P74, DOI 10.1093/cvr/cvt086; Nakagomi S, 2003, J NEUROSCI, V23, P5187; Orenes-Pinero E, 2013, INT J CARDIOL, V167, P1651, DOI 10.1016/j.ijcard.2012.09.120; Ramasamy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121401; Ren J, 2015, BIOCHEM PHARMACOL, V93, P409, DOI 10.1016/j.bcp.2014.12.006; Riddle RC, 2011, J BIOL CHEM, V286, P44449, DOI 10.1074/jbc.M111.276683; Shettigar V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10794; Shi L, 2013, CIRC RES, V113, P1320, DOI 10.1161/CIRCRESAHA.113.301824; Taibi F, 2014, BBA-MOL BASIS DIS, V1842, P1001, DOI 10.1016/j.bbadis.2014.03.005; Taniguchi CM, 2013, NAT MED, V19, P1325, DOI 10.1038/nm.3294; Thackaberry E A, 2002, Cardiovasc Toxicol, V2, P263, DOI 10.1385/CT:2:4:263; Utispan K, 2012, INT J ONCOL, V41, P1110, DOI 10.3892/ijo.2012.1530; Velling T, 2004, EMBO REP, V5, P901, DOI 10.1038/sj.embor.7400234; Wang XH, 2014, BBA-MOL BASIS DIS, V1842, P701, DOI 10.1016/j.bbadis.2014.01.012; Wang XH, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/585709; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Wang YS, 2015, CELL PHYSIOL BIOCHEM, V35, P1546, DOI 10.1159/000373970; Watanabe T, 2014, ARCH ORAL BIOL, V59, P595, DOI 10.1016/j.archoralbio.2014.03.003; Yang JJ, 2016, INT J BIOCHEM CELL B, V71, P62, DOI 10.1016/j.biocel.2015.12.004; Yeves AM, 2014, J MOL CELL CARDIOL, V76, P186, DOI 10.1016/j.yjmcc.2014.09.004; Yu HJ, 2013, INT J MOL SCI, V14, P21378, DOI 10.3390/ijms141121378; Zhou HB, 2015, CELL REP, V13, P1149, DOI 10.1016/j.celrep.2015.09.073; Zhu HY, 2012, CARDIOVASC RES, V94, P284, DOI 10.1093/cvr/cvr291; Zolk O, 2008, BIOCHEM BIOPH RES CO, V376, P315, DOI 10.1016/j.bbrc.2008.08.152	47	32	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15700	15713		10.1074/jbc.M116.715805	http://dx.doi.org/10.1074/jbc.M116.715805			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226563	Green Published, hybrid			2022-12-28	WOS:000380584200024
J	Godoi, PHC; Wilkie-Grantham, RP; Hishiki, A; Sano, R; Matsuzawa, Y; Yanagi, H; Munte, CE; Chen, Y; Yao, Y; Marassi, FM; Kalbitzer, HR; Matsuzawa, SI; Reed, JC				Godoi, Paulo H. C.; Wilkie-Grantham, Rachel P.; Hishiki, Asami; Sano, Renata; Matsuzawa, Yasuko; Yanagi, Hiroko; Munte, Claudia E.; Chen, Ya; Yao, Yong; Marassi, Francesca M.; Kalbitzer, Hans R.; Matsuzawa, Shu-ichi; Reed, John C.			Orphan Nuclear Receptor NR4A1 Binds a Novel Protein Interaction Site on Anti-apoptotic B Cell Lymphoma Gene 2 Family Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; autophagy; B cell lymphoma 2 (Bcl-2) family; NMR; protein-protein interaction; Bcl-b; Bfl-1; NR4A1; Nur77	BH3 MIMETIC ABT-737; BCL-B; NMR-SPECTROSCOPY; RESISTANCE; AUTOPHAGY; NUR77; BFL-1; CONFORMATION; INHIBITORS; CONVERSION	B cell lymphoma gene 2 (Bcl-2) family proteins are key regulators of programmed cell death and important targets for drug discovery. Pro-apoptotic and anti-apoptotic Bcl-2 family proteins reciprocally modulate their activities in large part through protein interactions involving a motif known as BH3 (Bcl-2 homology 3). Nur77 is an orphan member of the nuclear receptor family that lacks a BH3 domain but nevertheless binds certain anti-apoptotic Bcl-2 family proteins (Bcl-2, Bfl-1, and Bcl-B), modulating their effects on apoptosis and autophagy. We used a combination of NMR spectroscopy-based methods, mutagenesis, and functional studies to define the interaction site of a Nur77 peptide on anti-apoptotic Bcl-2 family proteins and reveal a novel interaction surface. Nur77 binds adjacent to the BH3 peptide-binding crevice, suggesting the possibility of cross-talk between these discrete binding sites. Mutagenesis of residues lining the identified interaction site on Bcl-B negated the interaction with Nur77 protein in cells and prevented Nur77-mediated modulation of apoptosis and autophagy. The findings establish a new protein interaction site with the potential to modulate the apoptosis and autophagy mechanisms governed by Bcl-2 family proteins.	[Godoi, Paulo H. C.; Wilkie-Grantham, Rachel P.; Hishiki, Asami; Sano, Renata; Matsuzawa, Yasuko; Yanagi, Hiroko; Chen, Ya; Yao, Yong; Marassi, Francesca M.; Matsuzawa, Shu-ichi; Reed, John C.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Munte, Claudia E.; Kalbitzer, Hans R.] Univ Regensburg, Inst Biophys & Phys Biochem, Univ Str 31, D-93040 Regensburg, Germany; [Reed, John C.] Roche, Pharma Res & Early Dev, CH-4070 Basel, Switzerland	Sanford Burnham Prebys Medical Discovery Institute; University of Regensburg; Roche Holding	Matsuzawa, SI (corresponding author), Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.; Reed, JC (corresponding author), Roche, Pharma Res & Early Dev, CH-4070 Basel, Switzerland.	smatsuzawa@sbpdiscovery.org; John_C.Reed@roche.com	Godoi, Paulo HC/B-9847-2012	Godoi, Paulo HC/0000-0003-1859-3513; Kalbitzer, Hans Robert/0000-0002-6514-2355	California Tobacco-related Disease Research Program Fellowship [16FT-0056]; National Institutes of Health [AI-091967, CA-179087, CA-55164, CA-81543]; NATIONAL CANCER INSTITUTE [R01CA179087, P01CA055164, P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091967] Funding Source: NIH RePORTER	California Tobacco-related Disease Research Program Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by California Tobacco-related Disease Research Program Fellowship 16FT-0056 (to P. H. C. G.) and National Institutes of Health Grants AI-091967 (to S. M.), CA-179087 (to F. M. M.), CA-55164 (to J. C. R.), and CA-81543 (to J. C. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bouzas-Rodriguez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046422; Brien G, 2007, ONCOGENE, V26, P5828, DOI 10.1038/sj.onc.1210363; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Ferlini C, 2009, CANCER RES, V69, P6906, DOI 10.1158/0008-5472.CAN-09-0540; Goddard T. D., SPARKY 3; Gronwald W, 2004, PROG NUCL MAG RES SP, V44, P33, DOI 10.1016/j.pnmrs.2003.12.002; Hagn F, 2010, J BIOL CHEM, V285, P3439, DOI 10.1074/jbc.M109.065391; Herman MD, 2008, FEBS LETT, V582, P3590, DOI 10.1016/j.febslet.2008.09.028; Huang J, 2015, EXPERT REV HEMATOL, V8, P283, DOI 10.1586/17474086.2015.1026321; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Khaw SL, 2014, LEUKEMIA, V28, P1207, DOI 10.1038/leu.2014.1; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Kumar M, 2014, CANCER RES, V74, P3271, DOI 10.1158/0008-5472.CAN-13-2015; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Luciano F, 2007, BLOOD, V109, P3849, DOI 10.1182/blood-2006-11-056879; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Moldoveanu T, 2014, TRENDS BIOCHEM SCI, V39, P101, DOI 10.1016/j.tibs.2013.12.006; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Rautureau GJP, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.178; Robert G, 2012, AUTOPHAGY, V8, P637, DOI 10.4161/auto.19084; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Tamir S, 2014, P NATL ACAD SCI USA, V111, P5177, DOI 10.1073/pnas.1403770111; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Volkmann N, 2014, CELL DEATH DIFFER, V21, P206, DOI 10.1038/cdd.2013.153; Wang WJ, 2014, NAT CHEM BIOL, V10, P133, DOI [10.1038/nchembio.1406, 10.1038/NCHEMBIO.1406]; Wendt MD, 2008, EXPERT OPIN DRUG DIS, V3, P1123, DOI 10.1517/17460441.3.9.1123; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Yao Y, 2015, J MOL BIOL, V427, P2262, DOI 10.1016/j.jmb.2015.02.019; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Yip KW, 2008, J BIOMOL SCREEN, V13, P665, DOI 10.1177/1087057108320918; Ziarek JJ, 2011, METHOD ENZYMOL, V493, P241, DOI 10.1016/B978-0-12-381274-2.00010-8	41	14	14	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14072	14084		10.1074/jbc.M116.715235	http://dx.doi.org/10.1074/jbc.M116.715235			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129202	hybrid, Green Published			2022-12-28	WOS:000379975100016
J	Lee, SG; Nwumeh, R; Jez, JM				Lee, Soon Goo; Nwumeh, Ronald; Jez, Joseph M.			Structure and Mechanism of Isopropylmalate Dehydrogenase from Arabidopsis thaliana: INSIGHTS ON LEUCINE AND ALIPHATIC GLUCOSINOLATE BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; plant biochemistry; protein evolution; protein structure; x-ray crystallography; reaction mechanism	THERMOPHILUS 3-ISOPROPYLMALATE DEHYDROGENASE; ACID-BASE CHEMISTRY; THERMUS-THERMOPHILUS; CLONING; EXPRESSION; COMPLEX; ENZYME	Isopropylmalate dehydrogenase (IPMDH) and 3-(2-methylthio)ethylmalate dehydrogenase catalyze the oxidative decarboxylation of different -hydroxyacids in the leucine- and methionine-derived glucosinolate biosynthesis pathways, respectively, in plants. Evolution of the glucosinolate biosynthetic enzyme from IPMDH results from a single amino acid substitution that alters substrate specificity. Here, we present the x-ray crystal structures of Arabidopsis thaliana IPMDH2 (AtIPMDH2) in complex with either isopropylmalate and Mg2+ or NAD(+). These structures reveal conformational changes that occur upon ligand binding and provide insight on the active site of the enzyme. The x-ray structures and kinetic analysis of site-directed mutants are consistent with a chemical mechanism in which Lys-232 activates a water molecule for catalysis. Structural analysis of the AtIPMDH2 K232M mutant and isothermal titration calorimetry supports a key role of Lys-232 in the reaction mechanism. This study suggests that IPMDH-like enzymes in both leucine and glucosinolate biosynthesis pathways use a common mechanism and that members of the -hydroxyacid reductive decarboxylase family employ different active site features for similar reactions.	[Lee, Soon Goo; Nwumeh, Ronald; Jez, Joseph M.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA	Washington University (WUSTL)	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@wustl.edu		Lee, Soon Goo/0000-0002-1541-8587	National Science Foundation [MCB-0904215]; Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]; Washington University Summer Scholars Program in Biology and Biomedicine; Washington University uSTAR Summer Scholars Program	National Science Foundation(National Science Foundation (NSF)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); Washington University Summer Scholars Program in Biology and Biomedicine; Washington University uSTAR Summer Scholars Program	This work was supported in part by National Science Foundation Grant MCB-0904215. Portions of this research were carried out at the Argonne National Laboratory Structural Biology Center of the Advanced Photon Source, a national user facility operated by the University of Chicago for the Department of Energy Office of Biological and Environmental Research Grant DE-AC02-06CH11357. The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by the Washington University Summer Scholars Program in Biology and Biomedicine and the Washington University uSTAR Summer Scholars Program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agerbirk N, 2012, PHYTOCHEMISTRY, V77, P16, DOI 10.1016/j.phytochem.2012.02.005; Aktas DF, 2009, BIOCHEMISTRY-US, V48, P3565, DOI 10.1021/bi8022976; ELLERSTROM M, 1992, PLANT MOL BIOL, V18, P557, DOI 10.1007/BF00040671; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Graczer E, 2016, BIOCHEMISTRY-US, V55, P560, DOI 10.1021/acs.biochem.5b00839; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; He Y, 2011, J BIOL CHEM, V286, P28794, DOI 10.1074/jbc.M111.262519; He Y, 2011, NEW PHYTOL, V189, P160, DOI 10.1111/j.1469-8137.2010.03460.x; He Y, 2009, PLANT J, V60, P679, DOI 10.1111/j.1365-313X.2009.03990.x; HURLEY JH, 1994, STRUCTURE, V2, P1007, DOI 10.1016/S0969-2126(94)00104-9; IMADA K, 1991, J MOL BIOL, V222, P725, DOI 10.1016/0022-2836(91)90508-4; Imada K, 1998, STRUCTURE, V6, P971, DOI 10.1016/S0969-2126(98)00099-9; JACKSON SD, 1993, MOL GEN GENET, V236, P309, DOI 10.1007/BF00277127; KADONO S, 1995, J BIOCHEM-TOKYO, V118, P745, DOI 10.1093/oxfordjournals.jbchem.a124975; Karsten WE, 2005, BIOCHEMISTRY-US, V44, P3626, DOI 10.1021/bi047826o; Karsten WE, 1998, BIOCHEMISTRY-US, V37, P15691, DOI 10.1021/bi9812827; Knill T, 2008, PLANT PHYSIOL, V146, P1028, DOI 10.1104/pp.107.111609; Kroymann J, 2011, CURR OPIN PLANT BIOL, V14, P246, DOI 10.1016/j.pbi.2011.03.021; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyazaki J, 2005, J BACTERIOL, V187, P6779, DOI 10.1128/JB.187.19.6779-6788.2005; MIYAZAKI K, 1993, FEBS LETT, V332, P37, DOI 10.1016/0014-5793(93)80478-D; Nozawa A, 2005, BIOSCI BIOTECH BIOCH, V69, P806, DOI 10.1271/bbb.69.806; Ober D, 2005, TRENDS PLANT SCI, V10, P444, DOI 10.1016/j.tplants.2005.07.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schuster J, 2006, PLANT CELL, V18, P2664, DOI 10.1105/tpc.105.039339; Taylor AB, 2008, J BIOL CHEM, V283, P10872, DOI 10.1074/jbc.M708719200; Textor S, 2004, PLANTA, V218, P1026, DOI 10.1007/s00425-003-1184-3; Textor S, 2007, PLANT PHYSIOL, V144, P60, DOI 10.1104/pp.106.091579; Wallon G, 1997, J MOL BIOL, V266, P1016, DOI 10.1006/jmbi.1996.0797	30	10	10	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13421	13430		10.1074/jbc.M116.730358	http://dx.doi.org/10.1074/jbc.M116.730358			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27137927	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000379771100002
J	Chen, SM; Feng, T; Spasic, MV; Altamura, S; Breitkopf-Heinlein, K; Altenoder, J; Weiss, TS; Dooley, S; Muckenthaler, MU				Chen, Simeng; Feng, Teng; Spasic, Maja Vujic; Altamura, Sandro; Breitkopf-Heinlein, Katja; Altenoeder, Jutta; Weiss, Thomas S.; Dooley, Steven; Muckenthaler, Martina U.			Transforming Growth Factor beta 1 (TGF-beta 1) Activates Hepcidin mRNA Expression in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HEMOCHROMATOSIS PROTEIN; TRANSFERRIN RECEPTOR; IRON OVERLOAD; SMAD1/5 PHOSPHORYLATION; HUMAN CHONDROCYTES; I RECEPTORS; HFE; CELLS; LIVER; GENE	The hepatic hormone hepcidin is the master regulator of systemic iron homeostasis. Its expression level is adjusted to alterations in iron levels, inflammatory cues, and iron requirements for erythropoiesis. Bone morphogenetic protein 6 (BMP6) contributes to the iron-dependent control of hepcidin. In addition, TGF-beta 1 may stimulate hepcidin mRNA expression in murine hepatocytes and human leukocytes. However, receptors and downstream signaling proteins involved in TGF-beta 1-induced hepcidin expression are still unclear. Here we show that TGF-beta 1 treatment of mouse and human hepatocytes, as well as ectopic expression of TGF-beta 1 in mice, increases hepcidin mRNA levels. The hepcidin response to TGF-beta 1 depends on functional TGF-beta 1 type I receptor (ALK5) and TGF-beta 1 type II receptor (T beta RII) and is mediated by a noncanonical mechanism that involves Smad1/5/8 phosphorylation. Interestingly, increasing availability of canonical Smad2/3 decreases TGF-beta 1-induced hepcidin regulation, whereas the BMP6-hepcidin signal was enhanced, indicating a signaling component stoichiometry-dependent cross-talk between the two pathways. Although ALK2/3-dependent hepcidin activation by BMP6 can be modulated by each of the three hemochromatosis-associated proteins: HJV (hemojuvelin), HFE (hemochromatosis protein), and TfR2 (transferrin receptor 2), these proteins do not control the ALK5-mediated hepcidin response to TGF-beta 1. TGF-beta 1 mRNA levels are increased in mouse models of iron overload, indicating that TGF-beta 1 may contribute to hepcidin synthesis under these conditions. In conclusion, these data demonstrate that a complex regulatory network involving TGF-beta 1 and BMP6 may control the sensing of systemic and/or hepatic iron levels.	[Chen, Simeng; Spasic, Maja Vujic; Altamura, Sandro; Muckenthaler, Martina U.] Heidelberg Univ, Dept Pediat Hematol Oncol & Immunol, D-69117 Heidelberg, Germany; [Chen, Simeng; Feng, Teng; Breitkopf-Heinlein, Katja; Altenoeder, Jutta; Dooley, Steven] Heidelberg Univ, Med Fac Mannheim, Mol Hepatol, Dept Med 2, D-68167 Mannheim, Germany; [Chen, Simeng; Spasic, Maja Vujic; Altamura, Sandro; Muckenthaler, Martina U.] Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Weiss, Thomas S.] Univ Regensburg Hosp, Dept Pediat & Juvenile Med, Ctr Liver Cell Res, D-93053 Regensburg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Regensburg	Muckenthaler, MU (corresponding author), Heidelberg Univ, Dept Pediat Hematol Oncol & Immunol, D-69117 Heidelberg, Germany.; Dooley, S (corresponding author), Heidelberg Univ, Med Fac Mannheim, Mol Hepatol, Dept Med 2, D-68167 Mannheim, Germany.; Muckenthaler, MU (corresponding author), Mol Med Partnership Unit, D-69120 Heidelberg, Germany.	Steven.Dooley@medma.uni-heidelberg.de; Martina.Muckenthaler@med.uni-heidelberg.de	Dooley, Steven/T-6491-2018; Weiss, Thomas S./G-3989-2012; Altamura, Sandro/R-1195-2016	Dooley, Steven/0000-0002-4840-6240; Weiss, Thomas S./0000-0003-0336-0581; Muckenthaler, Martina/0000-0002-3778-510X; Altamura, Sandro/0000-0002-6781-1073	Federal Ministry of Education and Research (Germany) in Virtual Liver Network Projects [0315755, 0315761]; European Union; CellNetworks of Heidelberg University; Deutsche Forschungsgemeinschaft [SFB 1036]	Federal Ministry of Education and Research (Germany) in Virtual Liver Network Projects; European Union(European Commission); CellNetworks of Heidelberg University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Federal Ministry of Education and Research (Germany) in Virtual Liver Network Projects 0315755 and 0315761. This work was also supported by a grant from the European Union FP7 Marie Curie International Training Network IT-Liver (to T. F.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the Postdoc Program of CellNetworks of Heidelberg University.r Supported by Deutsche Forschungsgemeinschaft Grant SFB 1036.	Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Altamura S, 2014, CELL METAB, V20, P359, DOI 10.1016/j.cmet.2014.07.007; Armitage AE, 2011, BLOOD, V118, P4129, DOI 10.1182/blood-2011-04-351957; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bennett MJ, 2000, NATURE, V403, P46, DOI 10.1038/47417; Bharathy S, 2008, CANCER RES, V68, P1656, DOI 10.1158/0008-5472.CAN-07-5089; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Butz H, 2012, TRENDS PHARMACOL SCI, V33, P382, DOI 10.1016/j.tips.2012.04.003; Casanovas G, 2009, J MOL MED, V87, P471, DOI 10.1007/s00109-009-0447-2; Castoldi M, 2011, J CLIN INVEST, V121, P1386, DOI 10.1172/JCI44883; Chen JX, 2007, J BIOL CHEM, V282, P36862, DOI 10.1074/jbc.M706720200; Corradini E, 2011, GASTROENTEROLOGY, V141, P1907, DOI 10.1053/j.gastro.2011.06.077; Corradini E, 2009, GASTROENTEROLOGY, V137, P1489, DOI 10.1053/j.gastro.2009.06.057; D'Alessio F, 2012, J HEPATOL, V57, P1052, DOI 10.1016/j.jhep.2012.06.015; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Dong J, 2005, ARTERIOSCL THROM VAS, V25, P1078, DOI 10.1161/01.ATV.0000159701.24372.49; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Falzacappa MVV, 2008, J MOL MED, V86, P531, DOI 10.1007/s00109-008-0313-7; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Fechner H, 1999, GENE THER, V6, P1520, DOI 10.1038/sj.gt.3301030; Finnson KW, 2010, OSTEOARTHR CARTILAGE, V18, P1518, DOI 10.1016/j.joca.2010.09.002; Finnson KW, 2008, J BONE MINER RES, V23, P896, DOI 10.1359/JBMR.080209; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Gronroos E, 2012, MOL CELL BIOL, V32, P2904, DOI 10.1128/MCB.00231-12; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Houglum K, 1997, HEPATOLOGY, V26, P605, DOI 10.1002/hep.510260311; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Lee PL, 2004, BLOOD, V103, P4669, DOI 10.1182/blood-2004-01-0072; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Muckenthaler M, 2003, NAT GENET, V34, P102, DOI 10.1038/ng1152; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nurgazieva D, 2015, J IMMUNOL, V194, P709, DOI 10.4049/jimmunol.1300272; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Ryan JD, 2010, HEPATOLOGY, V52, P1266, DOI 10.1002/hep.23814; Sanvitale CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062721; Shayakhmetov DM, 2004, J VIROL, V78, P5368, DOI 10.1128/JVI.78.10.5368-5381.2004; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Spasic MV, 2013, BBA-MOL BASIS DIS, V1832, P76, DOI 10.1016/j.bbadis.2012.08.013; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Thompson MD, 2011, HEPATOLOGY, V54, P1333, DOI 10.1002/hep.24506; Wallace DF, 2007, GASTROENTEROLOGY, V132, P301, DOI 10.1053/j.gastro.2006.11.028; Warburton D, 2013, AM J PHYSIOL-LUNG C, V304, pL83, DOI 10.1152/ajplung.00258.2012; Weng HL, 2007, HEPATOLOGY, V46, P1257, DOI 10.1002/hep.21806; Wiercinska E, 2006, HEPATOLOGY, V43, P1032, DOI 10.1002/hep.21135; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Wu XG, 2014, BLOOD, V124, P1335, DOI 10.1182/blood-2014-01-552281; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200	57	22	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13160	13174		10.1074/jbc.M115.691543	http://dx.doi.org/10.1074/jbc.M115.691543			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129231	hybrid, Green Published			2022-12-28	WOS:000379770500023
J	Ren, YJ; Zhao, Y; Lin, DD; Xu, XM; Zhu, QY; Yao, J; Shu, HB; Zhong, B				Ren, Yujie; Zhao, Yin; Lin, Dandan; Xu, Ximing; Zhu, Qiyun; Yao, Jing; Shu, Hong-Bing; Zhong, Bo			The Type I Interferon-IRF7 Axis Mediates Transcriptional Expression of Usp25 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; VIRAL-INFECTION; POSITIVE FEEDBACK; IMMUNE-RESPONSES; IKK-EPSILON; ACTIVATION; INDUCTION; PATHWAY; BINDING; ROLES	Viral infection or lipopolysaccharide (LPS) treatment induces expression of a large array of genes, the products of which play a critical role in host antipathogen immunity and inflammation. We have previously reported that the expression of ubiquitin-specific protease 25 (USP25) is significantly up-regulated after viral infection or LPS treatment, and this is essential for innate immune signaling. However, the mechanism behind this phenomenon is unclear. In this study, we found that viral infection-induced up-regulation of Usp25 is diminished in cells lacking interferon regulatory factor 7 (IRF7) or interferon alpha receptor 1 (IFNAR1) but not p65. Sendai virus- or type I interferon-induced up-regulation of Usp25 requires de novo protein synthesis of IRF7. Furthermore, IRF7 directly binds to the two conserved IRF binding sites on the USP25 promoter to drive transcription of Usp25, and mutation of these two sites abolished Sendai virus-induced IRF7-mediated activation of the USP25 promoter. Our study has uncovered a previously unknown mechanism by which viral infection or LPS induces up-regulation of USP25.	[Ren, Yujie; Zhao, Yin; Yao, Jing; Zhong, Bo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Shu, Hong-Bing; Zhong, Bo] Wuhan Univ, Sch Med, Med Res Inst, Wuhan 430071, Peoples R China; [Lin, Dandan; Xu, Ximing] Wuhan Univ, Renmin Hosp, Ctr Canc, Wuhan 430060, Peoples R China; [Zhu, Qiyun] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou 730046, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Zhong, B (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.; Zhong, B (corresponding author), Wuhan Univ, Sch Med, Med Res Inst, Wuhan 430071, Peoples R China.	zhongbo@whu.edu.cn	Lin, Dandan/GRJ-2233-2022	Zhao, Yin/0000-0001-7007-2999; Yao, Jing/0000-0003-1844-3988	Ministry of Science and Technology of China [2014CB542601, 2012CB910201]; National Natural Science Foundation of China [31371427, 31271209]; Ministry of Education of China [201427]; State Key Laboratory of Veterinary Etiological Biology [SKLVEB2015KFKT001]; Natural Science Foundation of Hubei Province [2015CFA095]; Large-scale Instrument and Equipment Sharing Foundation of Wuhan University	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); State Key Laboratory of Veterinary Etiological Biology; Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Large-scale Instrument and Equipment Sharing Foundation of Wuhan University	This work was supported by Ministry of Science and Technology of China Grants 2014CB542601 and 2012CB910201, National Natural Science Foundation of China Grants 31371427 and 31271209, Ministry of Education of China Grant 201427, State Key Laboratory of Veterinary Etiological Biology Grant SKLVEB2015KFKT001, Natural Science Foundation of Hubei Province Grant 2015CFA095, and the Large-scale Instrument and Equipment Sharing Foundation of Wuhan University. The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Bosch-Comas A, 2006, CELL MOL LIFE SCI, V63, P723, DOI 10.1007/s00018-005-5533-1; Crouse J, 2015, NAT REV IMMUNOL, V15, P231, DOI 10.1038/nri3806; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gajewski TF, 2015, CYTOKINE GROWTH F R, V26, P175, DOI 10.1016/j.cytogfr.2015.01.001; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Levy DE, 2012, IMMUNITY, V36, P553, DOI 10.1016/j.immuni.2012.04.003; Lin DD, 2015, P NATL ACAD SCI USA, V112, P11324, DOI 10.1073/pnas.1509968112; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Lochte S, 2014, J CELL BIOL, V207, P407, DOI 10.1083/jcb.201406032; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Nguyen VP, 2002, J BIOL CHEM, V277, P9713, DOI 10.1074/jbc.m111161200; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Prakash A, 2006, BIOCHEM BIOPH RES CO, V342, P50, DOI 10.1016/j.bbrc.2006.01.122; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Schreiber G, 2015, TRENDS IMMUNOL, V36, P139, DOI 10.1016/j.it.2015.01.002; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stifter SA, 2015, J IMMUNOL, V194, P2455, DOI 10.4049/jimmunol.1402794; Takeda Kiyoshi, 2015, Curr Protoc Immunol, V109, DOI 10.1002/0471142735.im1412s109; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003708	36	21	22	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13206	13215		10.1074/jbc.M116.718080	http://dx.doi.org/10.1074/jbc.M116.718080			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129230	hybrid, Green Published			2022-12-28	WOS:000379770500026
J	Velasquez, SY; Killian, D; Schulte, J; Sticht, C; Thiel, M; Lindner, HA				Velasquez, Sonia Y.; Killian, Doreen; Schulte, Jutta; Sticht, Carsten; Thiel, Manfred; Lindner, Holger A.			Short Term Hypoxia Synergizes with Interleukin 15 Priming in Driving Glycolytic Gene Transcription and Supports Human Natural Killer Cell Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION INHIBITORY FACTOR; TUMOR MICROENVIRONMENT; INDUCIBLE FACTOR-1; IMMUNE CELLS; GRANZYME-B; EXPRESSION; CANCER; ACTIVATION; CYTOTOXICITY; METABOLISM	Natural killer (NK) cells induce apoptosis in infected and transformed cells and are important producers of immunoregulatory cytokines. Therefore, they operate under low oxygen conditions (hypoxia) in inflammatory and tumor environments. In vitro studies of NK cells are, however, commonly performed in ambient air (normoxia). We used global gene expression profiling to evaluate changes in transcriptional pathways in primary human NK cells following short term culture under hypoxia compared with normoxia and in response to interleukin 15 (IL-15) priming using a 2 x 2 factorial design. The largest contrasts observed were priming dependences for associations between hypoxia and the hypoxia-inducible factor (Hif) 1 signaling and glycolysis pathways. RT-PCR confirmed positive synergistic hypoxia/IL-15 interactions for genes of key regulatory and metabolic enzymes. IL-15 primes NK cells for effector functions, which were recently demonstrated to depend on glycolytic switching. We did not, however, observe important increases in glycolytic flux through hypoxia and priming alone. Chemical Hif-1 alpha inhibition suggested equal importance of this transcription factor for glycolysis and energy production under normoxia and hypoxia. Hypoxia promoted secretion of CC chemokines Ccl3/4/5 and macrophage migration inhibitory factor. Unexpectedly, hypoxia also stimulated migration of NK cells through the extracellular matrix and shifted amounts of susceptible leukemia target cells toward late apoptosis in a cell killing assay. We conclude that short term hypoxia supports these activities by positively interacting with NK cell priming at the level of glycolytic gene transcription. Hypoxic conditioning of NK cells may thus benefit their use in cell-based immunotherapy of cancer.	[Velasquez, Sonia Y.; Killian, Doreen; Schulte, Jutta; Thiel, Manfred; Lindner, Holger A.] Heidelberg Univ, Dept Anesthesiol & Surg Intens Care Med, Med Fac Mannheim, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany; [Sticht, Carsten] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Med Res Ctr, D-68167 Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Lindner, HA (corresponding author), Heidelberg Univ, Dept Anesthesiol & Surg Intens Care Med, Med Fac Mannheim, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	holger.lindner@medma.uni-heidelberg.de	Lindner, Holger A/C-5106-2014	Lindner, Holger A/0000-0002-6679-4355				Allavena P, 1997, J LEUKOCYTE BIOL, V61, P729, DOI 10.1002/jlb.61.6.729; Arnaud C, 2011, AM J RESP CRIT CARE, V184, P724, DOI 10.1164/rccm.201012-2033OC; Bacher M, 2003, AM J PATHOL, V162, P11, DOI 10.1016/S0002-9440(10)63793-5; Baginska J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00490; Balsamo M, 2013, EUR J IMMUNOL, V43, P2756, DOI 10.1002/eji.201343448; Bentz S, 2013, DIGESTION, V88, P182, DOI 10.1159/000355015; Berthou C, 2000, BLOOD, V95, P2329, DOI 10.1182/blood.V95.7.2329.007k34_2329_2336; Bezu L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00187; Bosco MC, 2008, IMMUNOBIOLOGY, V213, P733, DOI 10.1016/j.imbio.2008.07.031; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Casazza A, 2014, ONCOGENE, V33, P1743, DOI 10.1038/onc.2013.121; Childs RW, 2015, NAT REV DRUG DISCOV, V14, P487, DOI 10.1038/nrd4506; Cowell RM, 2002, STROKE, V33, P795, DOI 10.1161/hs0302.103740; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Domogala A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00264; Donnelly RP, 2014, J IMMUNOL, V193, P4477, DOI 10.4049/jimmunol.1401558; Edsparr K, 2011, CANCER MICROENVIRON, V4, P351, DOI 10.1007/s12307-010-0057-0; Edsparr K, 2009, IMMUNOL CELL BIOL, V87, P489, DOI 10.1038/icb.2009.35; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fink T, 2003, SCAND J IMMUNOL, V58, P607, DOI 10.1111/j.1365-3083.2003.01347.x; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Gonsalves C, 2010, J IMMUNOL, V185, P6253, DOI 10.4049/jimmunol.1000660; Grayson MH, 2006, AM J RESP CELL MOL, V35, P143, DOI 10.1165/rcmb.f318; Grieb G, 2010, DRUG NEWS PERSPECT, V23, P257, DOI 10.1358/dnp.2010.23.4.1453629; Grimm M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-569; Hatfield SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1260; Hira E, 2005, CANCER, V103, P588, DOI 10.1002/cncr.20818; Horng T, 2015, TRENDS IMMUNOL, V36, P1, DOI [10.1016/Lit.2014.11.004, 10.1016/j.it.2014.11.004]; Kepp O, 2011, CANCER METAST REV, V30, P61, DOI 10.1007/s10555-011-9273-4; Keppel MP, 2015, J IMMUNOL, V194, P1954, DOI 10.4049/jimmunol.1402099; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim TD, 2011, BLOOD, V118, P5476, DOI 10.1182/blood-2011-04-347526; Knorr DA, 2014, SEMIN IMMUNOL, V26, P161, DOI 10.1016/j.smim.2014.02.002; Krockenberger M, 2008, J IMMUNOL, V180, P7338, DOI 10.4049/jimmunol.180.11.7338; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Kurschus FC, 2005, BLOOD, V105, P2049, DOI 10.1182/blood-2004-06-2180; Lin SS, 2012, CANCER SCI, V103, P904, DOI 10.1111/j.1349-7006.2012.02259.x; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Maghazachi AA, 2010, CURR TOP MICROBIOL, V341, P37, DOI 10.1007/82_2010_20; Marais A, 2014, NAT IMMUNOL, V15, P749, DOI 10.1038/ni.2936; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Mishra A, 2014, CLIN CANCER RES, V20, P2044, DOI 10.1158/1078-0432.CCR-12-3603; Nandagopal N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00187; Ohta A, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00027; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pearce EJ, 2015, NAT REV IMMUNOL, V15, P18, DOI 10.1038/nri3771; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Peter C, 2010, APOPTOSIS, V15, P1007, DOI 10.1007/s10495-010-0472-1; Prakash MD, 2014, IMMUNITY, V41, P960, DOI 10.1016/j.immuni.2014.11.012; Roiniotis J, 2009, J IMMUNOL, V182, P7974, DOI 10.4049/jimmunol.0804216; Sarkar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064835; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Simons D, 2011, J CELL MOL MED, V15, P668, DOI 10.1111/j.1582-4934.2010.01041.x; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Skurk T, 2009, HORM METAB RES, V41, P183, DOI 10.1055/s-0028-1093345; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TAUB DD, 1995, J IMMUNOL, V155, P3877; Telang S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-95; Van den Bergh JMJ, 2015, CYTOKINE GROWTH F R, V26, P15, DOI 10.1016/j.cytogfr.2014.09.001; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Yeligar SM, 2009, J IMMUNOL, V183, P5964, DOI 10.4049/jimmunol.0901564; Yoon SR, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.114; Yoshida S, 2003, J LEUKOCYTE BIOL, V73, P137, DOI 10.1189/jlb.0302117	72	52	54	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					12960	12977		10.1074/jbc.M116.721753	http://dx.doi.org/10.1074/jbc.M116.721753			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129235	Green Published, hybrid			2022-12-28	WOS:000379770500007
J	Tomilov, A; Tomilova, N; Shan, YX; Hagopian, K; Bettaieb, A; Kim, K; Pelicci, PG; Haj, F; Ramsey, J; Cortopassi, G				Tomilov, Alexey; Tomilova, Natalia; Shan, Yuxi; Hagopian, Kevork; Bettaieb, Ahmed; Kim, Kyoungmi; Pelicci, Pier Giuseppe; Haj, Fawaz; Ramsey, Jon; Cortopassi, Gino			p46Shc Inhibits Thiolase and Lipid Oxidation in Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; LIFE-SPAN; PROTEIN COMPLEXES; BETA-OXIDATION; SHC PROTEINS; RAT-LIVER; 2-BROMOOCTANOATE; KETOGENESIS; MAMMALS; MUSCLE	Although the p46Shc isoform has been known to be mitochondrially localized for 11 years, its function in mitochondria has been a mystery. We confirmed p46Shc to be mitochondrially localized and showed that the major mitochondrial partner of p46Shc is the lipid oxidation enzyme 3-ketoacylCoA thiolase ACAA2, to which p46Shc binds directly and with a strong affinity. Increasing p46Shc expression inhibits, and decreasing p46Shc stimulates enzymatic activity of thiolase in vitro. Thus, we suggest p46Shc to be a negative mitochondrial thiolase activity regulator, and reduction of p46Shc expression activates thiolase. This is the first demonstration of a protein that directly binds and controls thiolase activity. Thiolase was thought previously only to be regulated by metabolite balance and steady-state flux control. Thiolase is the last enzyme of the mitochondrial fatty acid beta-oxidation spiral, and thus is important for energy metabolism. Mice with reduction of p46Shc are lean, resist obesity, have higher lipid oxidation capacity, and increased thiolase activity. The thiolase-p46Shc connection shown here in vitro and in organello may be an important underlying mechanism explaining the metabolic phenotype of Shc-depleted mice in vivo.	[Tomilov, Alexey; Tomilova, Natalia; Shan, Yuxi; Hagopian, Kevork; Bettaieb, Ahmed; Kim, Kyoungmi; Ramsey, Jon; Cortopassi, Gino] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA; [Kim, Kyoungmi] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Hagopian, Kevork; Haj, Fawaz; Ramsey, Jon] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Pelicci, Pier Giuseppe] IFOM IEO, European Inst Oncol, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO)	Cortopassi, G (corresponding author), Dept Mol Biosci, 1089 Vet Dr,3007 VM3B, Davis, CA 95616 USA.	gcortopassi@ucdavis.edu	Pelicci, Pier Giuseppe/AAL-6572-2020		National Institutes of Health [AG23311]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG023311, P01AG025532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant AG23311 (to G. A. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdiche YN, 2009, ANAL BIOCHEM, V386, P172, DOI 10.1016/j.ab.2008.11.038; Abdiche YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092451; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Berniakovich I, 2008, J BIOL CHEM, V283, P34283, DOI 10.1074/jbc.M804362200; BRUNENGRABER H, 1973, J BIOL CHEM, V248, P2656; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Hagopian K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124204; Hagopian K, 2012, METABOLISM, V61, P1703, DOI 10.1016/j.metabol.2012.05.007; Kiema TR, 2014, ACTA CRYSTALLOGR D, V70, P3212, DOI 10.1107/S1399004714023827; Kisielow M, 2002, BIOCHEM J, V363, P1, DOI 10.1042/0264-6021:3630001; KUNZ WS, 1991, BIOMED BIOCHIM ACTA, V50, P1143; LATIPAA PM, 1986, BIOCHIM BIOPHYS ACTA, V875, P293, DOI 10.1016/0005-2760(86)90179-7; Ljubicic V, 2010, MECH AGEING DEV, V131, P79, DOI 10.1016/j.mad.2009.12.004; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; RAAKA BM, 1979, J BIOL CHEM, V254, P6755; RAAKA BM, 1979, J BIOL CHEM, V254, P3303; Ramsey JJ, 2014, J GERONTOL A-BIOL, V69, P1177, DOI 10.1093/gerona/glt198; Ranieri SC, 2010, P NATL ACAD SCI USA, V107, P13420, DOI 10.1073/pnas.1008647107; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHULZ H, 1994, J NUTR, V124, P165, DOI 10.1093/jn/124.2.165; Smet J, 2011, J INHERIT METAB DIS, V34, P741, DOI 10.1007/s10545-011-9315-7; Tomilov A., 2014, AGING CELL, V26, P12267; Tomilov AA, 2011, AGING CELL, V10, P55, DOI 10.1111/j.1474-9726.2010.00641.x; Ventura A, 2004, J BIOL CHEM, V279, P2299, DOI 10.1074/jbc.M307655200; WANG HY, 1991, ARCH BIOCHEM BIOPHYS, V289, P274, DOI 10.1016/0003-9861(91)90472-U; Wilson JL, 2010, BIOCHEM MOL BIOL EDU, V38, P400, DOI 10.1002/bmb.20442; Wittig I, 2007, METHOD CELL BIOL, V80, P723, DOI 10.1016/S0091-679X(06)80033-6	29	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12575	12585		10.1074/jbc.M115.695577	http://dx.doi.org/10.1074/jbc.M115.695577			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27059956	Green Published, hybrid			2022-12-28	WOS:000378119900015
J	Van Acker, H; Coenye, T				Van Acker, Heleen; Coenye, Tom			The Role of Efflux and Physiological Adaptation in Biofilm Tolerance and Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PSEUDOMONAS-AERUGINOSA BIOFILMS; TOXIN-ANTITOXIN SYSTEMS; CEPACIA COMPLEX BACTERIA; PERSISTER CELL-FORMATION; ESCHERICHIA-COLI; BURKHOLDERIA-CENOCEPACIA; ANTIBIOTIC-RESISTANCE; MULTIDRUG EFFLUX; DRUG-RESISTANCE; MULTIPLE ANTIBIOTICS	Microbial biofilms demonstrate a decreased susceptibility to antimicrobial agents. Various mechanisms have been proposed to be involved in this recalcitrance. We focus on two of these factors. Firstly, the ability of sessile cells to actively mediate efflux of antimicrobial compounds has a profound impact on resistance and tolerance, and several studies point to the existence of biofilm-specific efflux systems. Secondly, biofilm-specific stress responses have a marked influence on cellular physiology, and contribute to the occurrence of persister cells. We provide an overview of the data that demonstrate that both processes are important for survival following exposure to antimicrobial agents.	[Van Acker, Heleen; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, Ottergemsesteenweg 460, B-9000 Ghent, Belgium	Ghent University	Coenye, T (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, Ottergemsesteenweg 460, B-9000 Ghent, Belgium.	Tom.Coenye@UGent.be	Coenye, Tom/A-6291-2014; Coenye, Tom/Z-1928-2019	Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601	FWO-Vlaanderen; Interuniversity Attraction Poles Programme; Belgian Science Policy Office	FWO-Vlaanderen(FWO); Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian Science Policy Office(Belgian Federal Science Policy Office)	This work was supported by FWO-Vlaanderen and the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office. This is the fifth article in the Thematic Minireview series "Biofilms." The authors declare that they have no conflicts of interest with the contents of this article.	Amato SM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00070; [Anonymous], 2007, BIOFILM PRIMER; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Baugh S, 2014, J ANTIMICROB CHEMOTH, V69, P673, DOI 10.1093/jac/dkt420; Baugh S, 2012, J ANTIMICROB CHEMOTH, V67, P2409, DOI 10.1093/jac/dks228; Bazzini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018902; Bernier SP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003144; Bjarnsholt T, 2013, APMIS, V121, P1, DOI 10.1111/apm.12099; Buroni S, 2014, ANTIMICROB AGENTS CH, V58, P7424, DOI 10.1128/AAC.03800-14; Buroni S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-200; Chambers JR, 2014, MOL MICROBIOL, V92, P471, DOI 10.1111/mmi.12562; Coenye T, 2011, ANTIMICROB AGENTS CH, V55, P1912, DOI 10.1128/AAC.01571-10; Coenye T, 2010, FEMS IMMUNOL MED MIC, V59, P239, DOI 10.1111/j.1574-695X.2010.00682.x; Cohen NR, 2013, CELL HOST MICROBE, V13, P632, DOI 10.1016/j.chom.2013.05.009; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; De Groote VN, 2009, FEMS MICROBIOL LETT, V297, P73, DOI 10.1111/j.1574-6968.2009.01657.x; De Kievit TR, 2001, ANTIMICROB AGENTS CH, V45, P1761, DOI 10.1128/AAC.45.6.1761-1770.2001; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Dwyer DJ, 2015, ANNU REV PHARMACOL, V55, P313, DOI 10.1146/annurev-pharmtox-010814-124712; Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0; Fernandez L, 2012, CLIN MICROBIOL REV, V25, P661, DOI 10.1128/CMR.00043-12; Folsom JP, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-294; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Germain E, 2013, MOL CELL, V52, P248, DOI 10.1016/j.molcel.2013.08.045; Gillis RJ, 2005, ANTIMICROB AGENTS CH, V49, P3858, DOI 10.1128/AAC.49.9.3858-3867.2005; Goeders N, 2014, TOXINS, V6, P304, DOI 10.3390/toxins6010304; Guglierame P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-66; Gunn JS, 2016, J BIOL CHEM, V291, P12538, DOI 10.1074/jbc.R115.707547; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; Imuta N, 2008, INFECT IMMUN, V76, P1247, DOI 10.1128/IAI.00758-07; Jayaraman R, 2008, J BIOSCIENCES, V33, P795, DOI 10.1007/s12038-008-0099-3; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kim YH, 2009, J BACTERIOL, V191, P1258, DOI 10.1128/JB.01465-08; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Kumar A, 2005, ADV DRUG DELIVER REV, V57, P1486, DOI 10.1016/j.addr.2005.04.004; Kvist M, 2008, APPL ENVIRON MICROB, V74, P7376, DOI 10.1128/AEM.01310-08; Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Li YF, 2007, ANTIMICROB AGENTS CH, V51, P2092, DOI 10.1128/AAC.00052-07; Liao J, 2013, J BACTERIOL, V195, P3352, DOI 10.1128/JB.00318-13; Liao JL, 2012, J BACTERIOL, V194, P4823, DOI 10.1128/JB.00765-12; Ma C, 2010, FEMS MICROBIOL LETT, V303, P33, DOI 10.1111/j.1574-6968.2009.01857.x; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Michel B, 2005, PLOS BIOL, V3, P1174, DOI 10.1371/journal.pbio.0030255; Mok WWK, 2015, MBIO, V6, DOI 10.1128/mBio.01588-15; Nikaido Hiroshi, 2011, Adv Enzymol Relat Areas Mol Biol, V77, P1; Orman MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8983; Orman MA, 2013, ANTIMICROB AGENTS CH, V57, P3230, DOI 10.1128/AAC.00243-13; Pamp SJ, 2008, MOL MICROBIOL, V68, P223, DOI 10.1111/j.1365-2958.2008.06152.x; Peeters E, 2009, J ANTIMICROB CHEMOTH, V64, P801, DOI 10.1093/jac/dkp253; Prax M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00148; Ramisetty BCM, 2015, CRIT REV MICROBIOL, V41, P89, DOI 10.3109/1040841X.2013.804030; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Routh Mathew D, 2011, Adv Enzymol Relat Areas Mol Biol, V77, P109; Rushton L, 2013, ANTIMICROB AGENTS CH, V57, P2972, DOI 10.1128/AAC.00140-13; Schaible B, 2012, ANTIMICROB AGENTS CH, V56, P2114, DOI 10.1128/AAC.05574-11; Schuster CF, 2013, FEMS MICROBIOL LETT, V340, P73, DOI 10.1111/1574-6968.12074; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Sheppard DC, 2016, J BIOL CHEM, V291, P12529, DOI 10.1074/jbc.R116.720995; Soto SM, 2013, VIRULENCE, V4, P223, DOI 10.4161/viru.23724; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stewart PS, 2015, ANTIMICROB AGENTS CH, V59, P3838, DOI 10.1128/AAC.00433-15; Tseng SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104986; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Valentini M, 2016, J BIOL CHEM, V291, P12547, DOI 10.1074/jbc.R115.711507; Van Acker H, 2014, PATHOG DIS, V71, P326, DOI 10.1111/2049-632X.12177; Van Acker H, 2014, TRENDS MICROBIOL, V22, P326, DOI 10.1016/j.tim.2014.02.001; Van Acker H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058943; Verstraeten N, 2015, MOL CELL, V59, P9, DOI 10.1016/j.molcel.2015.05.011; Viducic D, 2006, MICROBIOL IMMUNOL, V50, P349, DOI 10.1111/j.1348-0421.2006.tb03793.x; Vikram A, 2015, ANTIMICROB AGENTS CH, V59, P3433, DOI 10.1128/AAC.05152-14; Volzing KG, 2015, MBIO, V6, DOI 10.1128/mBio.00731-15; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Wolcott RD, 2010, J WOUND CARE, V19, P45, DOI 10.12968/jowc.2010.19.2.46966; Wood TK, 2013, APPL ENVIRON MICROB, V79, P7116, DOI 10.1128/AEM.02636-13; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Zhang L, 2008, J BACTERIOL, V190, P4447, DOI 10.1128/JB.01655-07	85	54	55	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12565	12572		10.1074/jbc.R115.707257	http://dx.doi.org/10.1074/jbc.R115.707257			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129224	hybrid, Green Published			2022-12-28	WOS:000378119900012
J	Wong, MK; Guan, DG; Ng, KHC; Ho, VWS; An, XM; Li, RS; Ren, XL; Zhao, ZY				Wong, Ming-Kin; Guan, Daogang; Ng, Kaoru Hon Chun; Ho, Vincy Wing Sze; An, Xiaomeng; Li, Runsheng; Ren, Xiaoliang; Zhao, Zhongying			Timing of Tissue-specific Cell Division Requires a Differential Onset of Zygotic Transcription during Metazoan Embryogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS EMBRYOS; MAJOR DEVELOPMENTAL TRANSITION; EARLY DROSOPHILA DEVELOPMENT; EARLY XENOPUS-EMBRYOS; C.-ELEGANS; GENE-EXPRESSION; GATA-FACTOR; MIDBLASTULA TRANSITION; FATE SPECIFICATION; GERM-CELLS	Metazoan development demands not only precise cell fate differentiation but also accurate timing of cell division to ensure proper development. How cell divisions are temporally coordinated during development is poorly understood. Caenorhabditis elegans embryogenesis provides an excellent opportunity to study this coordination due to its invariant development and widespread division asynchronies. One of the most pronounced asynchronies is a significant delay of cell division in two endoderm progenitor cells, Ea and Ep, hereafter referred to as E2, relative to its cousins that mainly develop into mesoderm organs and tissues. To unravel the genetic control over the endoderm-specific E2 division timing, a total of 822 essential and conserved genes were knocked down using RNAi followed by quantification of cell cycle lengths using in toto imaging of C. elegans embryogenesis and automated lineage. Intriguingly, knockdown of numerous genes encoding the components of general transcription pathway or its regulatory factors leads to a significant reduction in the E2 cell cycle length but an increase in cell cycle length of the remaining cells, indicating a differential requirement of transcription for division timing between the two. Analysis of lineage-specific RNA-seq data demonstrates an earlier onset of transcription in endoderm than in other germ layers, the timing of which coincides with the birth of E2, supporting the notion that the endoderm-specific delay in E2 division timing demands robust zygotic transcription. The reduction in E2 cell cycle length is frequently associated with cell migration defect and gastrulation failure. The results suggest that a tissue-specific transcriptional activation is required to coordinate fate differentiation, division timing, and cell migration to ensure proper development.	[Wong, Ming-Kin; Guan, Daogang; Ng, Kaoru Hon Chun; Ho, Vincy Wing Sze; An, Xiaomeng; Li, Runsheng; Ren, Xiaoliang; Zhao, Zhongying] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Zhao, Zhongying] Hong Kong Baptist Univ, State Key Lab Environm & Biol Anal, Hong Kong, Hong Kong, Peoples R China	Hong Kong Baptist University; Hong Kong Baptist University	Zhao, ZY (corresponding author), Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China.	zyzhao@hkbu.edu.hk	Zhao, Zhongying/C-3261-2015; LI, Runsheng/AFR-9519-2022; Zhao, Zhongying/ABF-9458-2021	LI, Runsheng/0000-0003-1563-1844; Zhao, Zhongying/0000-0003-2743-9008; Guan, Daogang/0000-0002-3289-1448; Guan, Daogang/0000-0003-1414-0189	National Institutes of Health, Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health, Office of Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Chung Wai Shing for logistic support and the members of the Zhao lab for helpful discussion and comments, in particular Khandker Khaldun Islam for critical reading of the manuscript. Some strains were provided by the CGC, which is funded by National Institutes of Health, Office of Research Infrastructure Programs, Grant P40 OD010440.	Arata Y, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00529; Bao ZR, 2008, DEV BIOL, V318, P65, DOI 10.1016/j.ydbio.2008.02.054; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Boeck ME, 2011, DEV BIOL, V358, P345, DOI 10.1016/j.ydbio.2011.08.002; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Bowerman B, 1997, DEVELOPMENT, V124, P3815; Brauchle M, 2003, CURR BIOL, V13, P819, DOI 10.1016/S0960-9822(03)00295-1; Broitman-Maduro G, 2005, DEV CELL, V8, P427, DOI 10.1016/j.devcel.2005.01.014; Dong P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5750; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; EDGAR LG, 1994, DEVELOPMENT, V120, P443; EDGAR LG, 1988, CELL, V53, P589, DOI 10.1016/0092-8674(88)90575-2; Gonczy Pierre, 2005, WormBook, P1; Hashimshony T, 2015, NATURE, V519, P219, DOI 10.1038/nature13996; Hebeisen M, 2008, DEVELOPMENT, V135, P1259, DOI 10.1242/dev.014969; Ho Vincy Wing Sze, 2015, Mol Syst Biol, V11, P814, DOI 10.15252/msb.20145857; KIMELMAN D, 1987, CELL, V48, P399, DOI 10.1016/0092-8674(87)90191-7; Knight JK, 1998, DEV BIOL, V198, P253, DOI 10.1006/dbio.1998.8894; Kruger AV, 2015, DEV BIOL, V398, P153, DOI 10.1016/j.ydbio.2014.10.014; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Li J, 2007, EMBO J, V26, P2284, DOI 10.1038/sj.emboj.7601667; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Maduro MF, 2001, MOL CELL, V7, P475, DOI 10.1016/S1097-2765(01)00195-2; Maduro MF, 2007, DEV BIOL, V301, P590, DOI 10.1016/j.ydbio.2006.08.029; Maduro MF, 2015, DEV BIOL, V404, P66, DOI 10.1016/j.ydbio.2015.04.025; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; McGhee JD, 2009, DEV BIOL, V327, P551, DOI 10.1016/j.ydbio.2008.11.034; Murray JI, 2008, NAT METHODS, V5, P703, DOI 10.1038/nmeth.1228; Nair G, 2013, DEVELOPMENT, V140, P3385, DOI 10.1242/dev.098012; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Nogare DED, 2009, DEV BIOL, V326, P131, DOI 10.1016/j.ydbio.2008.11.002; PowellCoffman JA, 1996, DEV BIOL, V178, P472, DOI 10.1006/dbio.1996.0232; Robertson SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106309; Rose Lesilee, 2014, WormBook, P1, DOI 10.1895/wormbook.1.30.2; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Seydoux G, 1999, DEVELOPMENT, V126, P3275; Shao JF, 2013, J BIOL CHEM, V288, P33411, DOI 10.1074/jbc.M113.487975; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tavernier N, 2015, EXP CELL RES, V337, P243, DOI 10.1016/j.yexcr.2015.07.022; Wilson MA, 1999, BBA-GENE STRUCT EXPR, V1445, P99, DOI 10.1016/S0167-4781(99)00027-5; Yang Q, 2013, NAT CELL BIOL, V15, P519, DOI 10.1038/ncb2737; Yook K, 2012, NUCLEIC ACIDS RES, V40, pD735, DOI 10.1093/nar/gkr954; Zhao ZY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001089; Zhao ZY, 2010, GENETICS, V184, P853, DOI 10.1534/genetics.109.110270; Zhu JW, 1997, GENE DEV, V11, P2883, DOI 10.1101/gad.11.21.2883	47	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12501	12513		10.1074/jbc.M115.705426	http://dx.doi.org/10.1074/jbc.M115.705426			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27056332	hybrid, Green Published			2022-12-28	WOS:000378119900005
J	Pang, YL; Li, Y; Lv, Y; Sun, LL; Zhang, SY; Li, Y; Wang, YH; Liu, G; Xu, MJ; Wang, X; Jiang, CT				Pang, Yanli; Li, Yang; Lv, Ying; Sun, Lulu; Zhang, Songyang; Li, Yin; Wang, Yuhui; Liu, George; Xu, Ming-Jiang; Wang, Xian; Jiang, Changtao			Intermedin Restores Hyperhomocysteinemia-induced Macrophage Polarization and Improves Insulin Resistance in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; ACTIVATED PROTEIN-KINASE; ADIPOSE-TISSUE; OXIDATIVE STRESS; APOLIPOPROTEIN-E; FAMILY PEPTIDE; DEFICIENT MICE; BONE-MARROW; OBESITY; INFLAMMATION	Hyperhomocysteinemia (HHcy) is a condition characterized by an abnormally high level of homocysteine, an inflammatory factor. This condition has been suggested to promote insulin resistance. To date, the underlying molecular mechanism remains largely unknown, and identifying novel therapeutic targets for HHcy-induced insulin resistance is of high priority. It is well known that intermedin (IMD), a calcitonin family peptide, exerts potent anti-inflammatory effects. In this study, the effects of IMD on HHcy-induced insulin resistance were investigated. Glucose tolerance and insulin tolerance tests were performed on mice treated with IMD by minipump implantation (318 ng/kg/h for 4 weeks) or adipocyte-specific IMD overexpression mice (Adipo-IMD transgenic mice). The expression of genes and proteins related to M1/M2 macrophages and endoplasmic reticulum stress (ERS) was evaluated in adipose tissues or cells. The expression of IMD was identified to be lower in the plasma and adipose tissues of HHcy mice. In both IMD treatment by minipump implantation and Adipo-IMD transgenic mice, IMD reversed HHcy-induced insulin resistance, as revealed by glucose tolerance and insulin tolerance tests. Further mechanistic study revealed that IMD reversed the Hcy-elevated ratio of M1/M2 macrophages by inhibiting AMP-activated protein kinase activity. Adipo-IMD transgenic mice displayed reduced ERS and lower inflammation in adipose tissues with HHcy. Soluble factors from Hcy-treated macrophages induced adipocyte ERS, which was reversed by IMD treatment. These findings revealed that IMD treatment restores the M1/M2 balance, inhibits chronic inflammation in adipose tissues, and improves systemic insulin sensitivity of HHcy mice.	[Pang, Yanli; Li, Yang; Lv, Ying; Sun, Lulu; Zhang, Songyang; Li, Yin; Wang, Yuhui; Liu, George; Xu, Ming-Jiang; Wang, Xian; Jiang, Changtao] Peking Univ, Minist Educ, Key Lab Mol Cardiovasc Sci, Dept Physiol & Pathophysiol,Basic Med Coll, Beijing 100191, Peoples R China; [Pang, Yanli] Peking Univ, Hosp 3, Ctr Reprod Med, Beijing 100191, Peoples R China	Peking University; Peking University	Wang, X; Jiang, CT (corresponding author), Peking Univ, Basic Med Coll, Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China.	xwang@bjmu.edu.cn; jiangchangtao@bjmu.edu.cn	Li, Yin/P-9296-2016; 王, 宇慧/GXZ-7548-2022	Li, Yin/0000-0002-4019-3391; Jiang, Changtao/0000-0002-5206-2372; Song-Yang, Zhang/0000-0002-4356-897X; Sun, Lulu/0000-0001-8876-5099	National Natural Science Foundation of China [31230035, 81470554, 81401168]; National Basic Research Program (973 Program) of China [2012CB518002]; Chinese Ministry of Education [B07001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program) of China(National Basic Research Program of China); Chinese Ministry of Education(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China Grants 31230035 ( to X. W.), 81470554 ( to C. J.), and 81401168 ( to Y. P.); National Basic Research Program (973 Program) of China Grant 2012CB518002 ( to M. X.); and 111 Project of the Chinese Ministry of Education Grant B07001. The authors declare that they have no conflicts of interest with the contents of this article.	Bell D, 2008, BRIT J PHARMACOL, V153, pS247, DOI 10.1038/sj.bjp.0707494; Chang CL, 2004, PEPTIDES, V25, P1633, DOI 10.1016/j.peptides.2004.05.021; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Dai J, 2006, FREE RADICAL BIO MED, V41, P1566, DOI 10.1016/j.freeradbiomed.2006.08.020; Dai XY, 2014, CARDIOVASC RES, V101, P297, DOI 10.1093/cvr/cvt254; Dai XY, 2012, J MOL CELL CARDIOL, V53, P509, DOI 10.1016/j.yjmcc.2012.07.006; Fadini GP, 2013, DIABETOLOGIA, V56, P1856, DOI 10.1007/s00125-013-2918-9; Fernandez-Real JM, 2012, DIABETOLOGIA, V55, P273, DOI 10.1007/s00125-011-2387-y; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Gao SS, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-13; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Hong YG, 2012, BRIT J PHARMACOL, V166, P110, DOI 10.1111/j.1476-5381.2011.01530.x; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-867; Kindt F, 2007, J INVEST DERMATOL, V127, P605, DOI 10.1038/sj.jid.5700576; Kraakman MJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00470; Lee CH, 2014, INT J MOL SCI, V15, P10334, DOI 10.3390/ijms150610334; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; Li H, 2013, CARDIOVASC DIABETOL, V12, DOI [10.1186/1475-2840-12-133, 10.1186/1475-2840-12-91]; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065278; Li Y, 2013, J BIOL CHEM, V288, P9583, DOI 10.1074/jbc.M112.431627; Li Y, 2008, DIABETES, V57, P817, DOI 10.2337/db07-0617; Li Y, 2007, PEPTIDES, V28, P1129, DOI 10.1016/j.peptides.2007.03.005; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Nomura I, 2009, REGUL PEPTIDES, V158, P127, DOI 10.1016/j.regpep.2009.08.003; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Omar B, 2009, CELL SIGNAL, V21, P760, DOI 10.1016/j.cellsig.2009.01.015; Pilon G, 2004, J BIOL CHEM, V279, P20767, DOI 10.1074/jbc.M401390200; Qiao X, 2013, AM J PHYSIOL-RENAL, V304, pF112, DOI 10.1152/ajprenal.00054.2012; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Shimosawa T, 2003, HYPERTENSION, V41, P1080, DOI 10.1161/01.HYP.0000066846.46422.2C; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Takei Y, 2004, PEPTIDES, V25, P1643, DOI 10.1016/j.peptides.2004.06.026; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zeng XK, 2003, CIRC RES, V93, P311, DOI 10.1161/01.RES.0000087642.01082.E4; Zhang DQ, 2012, CIRC RES, V111, P37, DOI [10.1161/CIRCRESAHA.112.269472, 10.1161/circresaha.112.269472]; Zhang DQ, 2009, CIRCULATION, V120, P1893, DOI 10.1161/CIRCULATIONAHA.109.866889; Zhang H, 2016, INT J OBESITY, V40, P852, DOI 10.1038/ijo.2016.2; Zhao L, 2012, PEPTIDES, V33, P329, DOI 10.1016/j.peptides.2011.12.016	46	19	21	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12336	12345		10.1074/jbc.M115.702654	http://dx.doi.org/10.1074/jbc.M115.702654			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27080257	Green Published, hybrid			2022-12-28	WOS:000378092800032
J	Patel, SJ; Lewis, BE; Long, JE; Nambi, S; Sassetti, CM; Stemmler, TL; Arguello, JM				Patel, Sarju J.; Lewis, Brianne E.; Long, Jarukit E.; Nambi, Subhalaxmi; Sassetti, Christopher M.; Stemmler, Timothy L.; Argueello, Jose M.			Fine-tuning of Substrate Affinity Leads to Alternative Roles of Mycobacterium tuberculosis Fe2+-ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-BINDING DOMAIN; HYDROGEN-PEROXIDE DISRUPTS; CHLOROPLAST-ENVELOPE; FERROUS IRON; TRANSPORT; PROTEIN; ZINC; ATPASE; SYSTEM; IDENTIFICATION	Little is known about iron efflux transporters within bacterial systems. Recently, the participation of Bacillus subtilis PfeT, a P-1B4-ATPase, in cytoplasmic Fe2+ efflux has been proposed. We report here the distinct roles of mycobacterial P-1B4-ATPases in the homeostasis of Co2+ and Fe2+. Mutation of Mycobacterium smegmatis ctpJ affects the homeostasis of both ions. Alternatively, an M. tuberculosis ctpJ mutant is more sensitive to Co2+ than Fe2+, whereas mutation of the homologous M. tuberculosis ctpD leads to Fe2+ sensitivity but no alterations in Co2+ homeostasis. In vitro, the three enzymes are activated by both Fe2+ and Co2+ and bind 1 eq of either ion at their transport site. However, equilibrium binding affinities and activity kinetics show that M. tuberculosis CtpD has higher affinity for Fe2+ and twice the Fe2+-stimulated activity than the CtpJs. These parameters are paralleled by a lower activation and affinity for Co2+. Analysis of Fe2+ and Co2+ binding to CtpD by x-ray absorption spectroscopy shows that both ions are five-to six-coordinate, constrained within oxygen/nitrogen environments with similar geometries. Mutagenesis studies suggest the involvement of invariant Ser, His, and Glu residues in metal coordination. Interestingly, replacement of the conserved Cys at the metal binding pocket leads to a large reduction in Fe2+ but not Co2+ binding affinity. We propose that CtpJ ATPases participate in the control of steady state Fe2+ levels. CtpD, required for M. tuberculosis virulence, is a high affinity Fe2+ transporter involved in the rapid response to iron dyshomeostasis generated upon redox stress.	[Patel, Sarju J.; Argueello, Jose M.] Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA; [Lewis, Brianne E.; Stemmler, Timothy L.] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48201 USA; [Long, Jarukit E.; Nambi, Subhalaxmi; Sassetti, Christopher M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Sassetti, Christopher M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Worcester Polytechnic Institute; Wayne State University; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Arguello, JM (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	arguello@wpi.edu	Lewis, Brianne/AAU-5344-2021; Arguello, Jose/D-1997-2012	Lewis, Brianne/0000-0003-1584-6407; Nambi, Subhalaxmi/0000-0001-7104-659X; Arguello, Jose/0000-0003-3940-6297	Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL120822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064282, R21AI082484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114949] Funding Source: NIH RePORTER	Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Andrew Baez (Worcester Polytechnic Institute) for assistance with early experiments. X-ray absorption spectroscopic studies were performed at the Stanford Synchrotron Radiation Lightsource (SSRL). SSRL is a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program.	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Anjem A, 2012, J BIOL CHEM, V287, P15544, DOI 10.1074/jbc.M111.330365; Arguello JM, 2012, J BIOL CHEM, V287, P13510, DOI 10.1074/jbc.R111.319343; Arguello JM, 2011, BIOCHEMISTRY-US, V50, P9940, DOI 10.1021/bi201418k; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Bennett BD, 2015, APPL ENVIRON MICROB, V81, P7938, DOI 10.1128/AEM.02835-15; Boutigny S, 2014, J EXP BOT, V65, P1529, DOI 10.1093/jxb/eru020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chou CJ, 2004, J BIOL CHEM, V279, P53554, DOI 10.1074/jbc.M407385200; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Eren E, 2007, BIOCHEMISTRY-US, V46, P7754, DOI 10.1021/bi7001345; Eren E, 2006, J BIOL CHEM, V281, P33881, DOI 10.1074/jbc.M605218200; Frawley ER, 2014, MOL MICROBIOL, V93, P609, DOI 10.1111/mmi.12709; Gaballa A, 2002, MOL MICROBIOL, V45, P997, DOI 10.1046/j.1365-2958.2002.03068.x; George G.N., 1995, EXAFSPAK SUITE COMPU; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Guan GH, 2015, MOL MICROBIOL, V98, P787, DOI 10.1111/mmi.13158; Guo JQ, 1997, BIOCHEMISTRY-US, V36, P730, DOI 10.1021/bi9617769; HEYSE S, 1994, J GEN PHYSIOL, V104, P197, DOI 10.1085/jgp.104.2.197; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lucarelli D, 2008, INT J MOL SCI, V9, P1548, DOI 10.3390/ijms9081548; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; McLaughlin HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030928; Mills SA, 2005, BIOCHEMISTRY-US, V44, P13553, DOI 10.1021/bi0507579; Moreno I, 2008, J BIOL CHEM, V283, P9633, DOI 10.1074/jbc.M800736200; Padilla-Benavides T, 2013, J BIOL CHEM, V288, P11334, DOI 10.1074/jbc.M112.448175; Pandey R, 2014, MOL MICROBIOL, V91, P98, DOI 10.1111/mmi.12441; Raimunda D, 2014, MOL MICROBIOL, V91, P185, DOI 10.1111/mmi.12454; Raimunda D, 2012, MOL MICROBIOL, V84, P1139, DOI 10.1111/j.1365-2958.2012.08082.x; Raimunda D, 2012, BBA-BIOMEMBRANES, V1818, P1374, DOI 10.1016/j.bbamem.2012.02.020; Rhine MA, 2014, J AM CHEM SOC, V136, P12560, DOI 10.1021/ja5064444; Rodriguez GM, 2006, TRENDS MICROBIOL, V14, P320, DOI 10.1016/j.tim.2006.05.006; Rodriguez GM, 2006, J BACTERIOL, V188, P424, DOI 10.1128/JB.188.2.424-430.2006; Rosadini CV, 2011, INFECT IMMUN, V79, P3366, DOI 10.1128/IAI.05135-11; Rosenzweig AC, 2012, CURR TOP MEMBR, V69, P113, DOI 10.1016/B978-0-12-394390-3.00005-7; Sala C, 2003, J BACTERIOL, V185, P5357, DOI 10.1128/JB.185.18.5357-5362.2003; Scherer J, 2009, MOL MICROBIOL, V73, P601, DOI 10.1111/j.1365-2958.2009.06792.x; Segel I. H., 1993, ENZYME KINETICS, P534; Seigneurin-Berny D, 2006, J BIOL CHEM, V281, P2882, DOI 10.1074/jbc.M508333200; Smith AT, 2015, NAT CHEM BIOL, V11, P678, DOI [10.1038/NCHEMBIO.1863, 10.1038/nchembio.1863]; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x; Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a; YEOWELL HN, 1982, ANTIMICROB AGENTS CH, V22, P961, DOI 10.1128/AAC.22.6.961; Zielazinski EL, 2012, BIOCHEMISTRY-US, V51, P7891, DOI 10.1021/bi3006708	50	22	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11529	11539		10.1074/jbc.M116.718239	http://dx.doi.org/10.1074/jbc.M116.718239			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27022029	Green Published, hybrid			2022-12-28	WOS:000377264800006
J	McCallum, M; Tammam, S; Little, DJ; Robinson, H; Koo, J; Shah, M; Calmettes, C; Moraes, TF; Burrows, LL; Howell, PL				McCallum, Matthew; Tammam, Stephanie; Little, Dustin J.; Robinson, Howard; Koo, Jason; Shah, Megha; Calmettes, Charles; Moraes, Trevor F.; Burrows, Lori L.; Howell, P. Lynne			PilN Binding Modulates the Structure and Binding Partners of the Pseudomonas aeruginosa Type IVa Pilus Protein PilM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ligand-binding protein; protein chimera; Pseudomonas aeruginosa (P; aeruginosa); type IV pili; x-ray crystallography; PilM; PilN	INNER MEMBRANE PLATFORM; II SECRETION SYSTEM; CYTOPLASMIC DOMAIN; TWITCHING MOTILITY; BIOFILM FORMATION; BIOGENESIS; COMPLEX; ACTIN; RETRACTION; INTERACTS	Pseudomonas aeruginosa is an opportunistic bacterial pathogen that expresses type IVa pili. The pilus assembly system, which promotes surface-associated twitching motility and virulence, is composed of inner and outer membrane subcomplexes, connected by an alignment subcomplex composed of PilMNOP. PilM binds to the N terminus of PilN, and we hypothesize that this interaction causes functionally significant structural changes in PilM. To characterize this interaction, we determined the crystal structures of PilM and a PilM chimera where PilM was fused to the first 12 residues of PilN (PilMPilN(1-12)). Structural analysis, multiangle light scattering coupled with size exclusion chromatography, and bacterial two-hybrid data revealed that PilM forms dimers mediated by the binding of a novel conserved motif in the N terminus of PilM, and binding PilN abrogates this binding interface, resulting in PilM monomerization. Structural comparison of PilM with PilMPilN(1-12) revealed that upon PilN binding, there is a large domain closure in PilM that alters its ATP binding site. Using biolayer interferometry, we found that the association rate of PilN with PilM is higher in the presence of ATP compared with ADP. Bacterial two-hybrid data suggested the connectivity of the cytoplasmic and inner membrane components of the type IVa pilus machinery in P. aeruginosa, with PilM binding to PilB, PilT, and PilC in addition to PilN. Pull-down experiments demonstrated direct interactions of PilM with PilB and PilT. We propose a working model in which dynamic binding of PilN facilitates functionally relevant structural changes in PilM.	[McCallum, Matthew; Little, Dustin J.; Shah, Megha; Calmettes, Charles; Moraes, Trevor F.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [McCallum, Matthew; Tammam, Stephanie; Little, Dustin J.; Koo, Jason; Howell, P. Lynne] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Mol Struct & Funct, 686 Bay St, Toronto, ON M5G 0A4, Canada; [Robinson, Howard] Brookhaven Natl Lab, Photon Sci Div, Upton, NY 11973 USA; [Burrows, Lori L.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Burrows, Lori L.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); United States Department of Energy (DOE); Brookhaven National Laboratory; McMaster University; McMaster University	Howell, PL (corresponding author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Mol Struct & Funct, 686 Bay St, Toronto, ON M5G 0A4, Canada.; Burrows, LL (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.; Burrows, LL (corresponding author), McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada.	burrowl@mcmaster.ca; howell@sickkids.ca		calmettes, charles/0000-0002-2542-4382	Department of Energy; National Institutes of Health National Center for Research Resources; Canadian Foundation for Innovation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Patrick Yip for technical assistance and Liliana Sampaleanu, Ryan Buensuceso, Tiffany Leighton, Hanjeong Harvey, and Daniel Yong for generation of initial PilM vectors and several BACTH constructs and for helpful discussions. Beamline X29 at the National Synchrotron Light Source, Brookhaven National Laboratory, is supported by the Department of Energy and by a grant from the National Institutes of Health National Center for Research Resources. Funds for the x-ray facilities at the Hospital for Sick Children were provided, in part, by the Canadian Foundation for Innovation.	Abendroth J, 2005, J MOL BIOL, V348, P845, DOI 10.1016/j.jmb.2005.02.061; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anyan ME, 2014, P NATL ACAD SCI USA, V111, P18013, DOI 10.1073/pnas.1414661111; Ayers M, 2009, J MOL BIOL, V394, P128, DOI 10.1016/j.jmb.2009.09.034; Bahar O, 2009, MOL PLANT MICROBE IN, V22, P909, DOI 10.1094/MPMI-22-8-0909; Barthel TK, 2001, J BACTERIOL, V183, P5482, DOI 10.1128/JB.183.19.5482-5490.2001; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Berry JL, 2015, FEMS MICROBIOL REV, V39, P134, DOI 10.1093/femsre/fuu001; Bischof LF, 2016, J BIOL CHEM, V291, P6946, DOI 10.1074/jbc.M115.701284; Brown P, 2016, BIOINFORMATICS, V32, P370, DOI 10.1093/bioinformatics/btv580; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Busiek KK, 2012, J BACTERIOL, V194, P1989, DOI 10.1128/JB.06683-11; Camberg JL, 2007, EMBO J, V26, P19, DOI 10.1038/sj.emboj.7601481; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiang P, 2003, J BACTERIOL, V185, P2374, DOI 10.1128/JB.185.7.2374-2378.2003; Chiang P, 2008, MICROBIOL-SGM, V154, P114, DOI 10.1099/mic.0.2007/011320-0; Conrad JC, 2011, BIOPHYS J, V100, P1608, DOI 10.1016/j.bpj.2011.02.020; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Day ES, 2012, BIOCHEMISTRY-US, V51, P9124, DOI 10.1021/bi301039t; Dominguez R., 2000, M CURIE BIOSCIENCE D; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng JA, 2011, ANAL BIOCHEM, V409, P144, DOI 10.1016/j.ab.2010.10.025; Georgiadou M, 2012, MOL MICROBIOL, V84, P857, DOI 10.1111/j.1365-2958.2012.08062.x; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Holmes Ken C., 1993, Trends in Cell Biology, V3, P53, DOI 10.1016/0962-8924(93)90161-S; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karimova G, 2000, INT J MED MICROBIOL, V290, P441; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Karuppiah V, 2011, J BIOL CHEM, V286, P24434, DOI 10.1074/jbc.M111.243535; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krupka M, 2014, MBIO, V5, DOI 10.1128/mBio.02221-14; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Leighton TL, 2015, ENVIRON MICROBIOL, V17, P4148, DOI 10.1111/1462-2920.12849; Leighton TL, 2015, J BACTERIOL, V197, P2229, DOI 10.1128/JB.00220-15; Lu C, 2014, J STRUCT BIOL, V187, P223, DOI 10.1016/j.jsb.2014.07.006; Luo Y, 2015, MBIO, V6, DOI 10.1128/mBio.02456-14; MARTIN PR, 1995, MOL MICROBIOL, V16, P497, DOI 10.1111/j.1365-2958.1995.tb02414.x; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2015, MOL MICROBIOL, V95, P971, DOI 10.1111/mmi.12907; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Roine E, 1996, J BACTERIOL, V178, P410, DOI 10.1128/jb.178.2.410-417.1996; Rumszauer J, 2006, FEBS J, V273, P3261, DOI 10.1111/j.1742-4658.2006.05335.x; Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008; Sandkvist M, 2000, INT J MED MICROBIOL, V290, P345, DOI 10.1016/S1438-4221(00)80038-7; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Szwedziak P, 2013, CURR OPIN MICROBIOL, V16, P745, DOI 10.1016/j.mib.2013.09.003; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Takhar HK, 2013, J BIOL CHEM, V288, P9721, DOI 10.1074/jbc.M113.453506; Tammam S, 2014, ADV M C M, P85, DOI 10.1079/9781780642550.0085; Tammam S, 2013, J BACTERIOL, V195, P2126, DOI 10.1128/JB.00032-13; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor D, 2014, BIOINFORMATICS, V30, P3189, DOI 10.1093/bioinformatics/btu506; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Touhami A, 2006, J BACTERIOL, V188, P370, DOI 10.1128/JB.188.2.370-377.2006; Tsang MJ, 2015, CURR OPIN MICROBIOL, V24, P60, DOI 10.1016/j.mib.2015.01.002; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; WHITCHURCH CB, 1991, GENE, V101, P33, DOI 10.1016/0378-1119(91)90221-V; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408; Yamagata A, 2012, J MOL BIOL, V419, P110, DOI 10.1016/j.jmb.2012.02.041; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	69	24	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11003	11015		10.1074/jbc.M116.718353	http://dx.doi.org/10.1074/jbc.M116.718353			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27022027	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000377042100005
J	Taguchi, Y; Fujinami, D; Kohda, D				Taguchi, Yuya; Fujinami, Daisuke; Kohda, Daisuke			Comparative Analysis of Archaeal Lipid-linked Oligosaccharides That Serve as Oligosaccharide Donors for Asn Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						archaea; evolution; mass spectrometry (MS); N-linked glycosylation; oligosaccharyltransferase; AglB; crenarchaeota; dolichol; euryarchaeota; lipid-linked oligosaccharide	S-LAYER GLYCOPROTEIN; PROTEIN N-GLYCOSYLATION; HALOFERAX-VOLCANII; SULFOLOBUS-ACIDOCALDARIUS; HYPERTHERMOPHILIC ARCHAEON; STRUCTURAL ELUCIDATION; OLIGOSACCHARYLTRANSFERASE; GLYCANS; AGLB; GLYCOSYLTRANSFERASES	The glycosylation of asparagine residues is the predominant protein modification in all three domains of life. An oligosaccharide chain is preassembled on a lipid-phospho carrier and transferred onto asparagine residues by the action of a membrane-bound enzyme, oligosaccharyltransferase. The oligosaccharide donor for the oligosaccharyl transfer reaction is dolichol-diphosphate-oligosaccharide in Eukaryota and polyprenol-diphosphate-oligosaccharide in Eubacteria. The donor in some archaeal species was reportedly dolichol-monophosphate-oligosaccharide. Thus, the difference in the number of phosphate groups aroused interest in whether the use of the dolichol-monophosphate type donors is widespread in the domain Archaea. Currently, all of the archaeal species with identified oligosaccharide donors have belonged to the phylum Euryarchaeota. Here, we analyzed the donor structures of two species belonging to the phylum Crenarchaeota, Pyrobaculum calidifontis and Sulfolobus solfataricus, in addition to two species from the Euryarchaeota, Pyrococcus furiosus and Archaeoglobus fulgidus. The electrospray ionization tandem mass spectrometry analyses confirmed that the two euryarchaeal oligosaccharide donors were the dolichol-monophosphate type and newly revealed that the two crenarchaeal oligosaccharide donors were the dolichol-diphosphate type. This novel finding is consistent with the hypothesis that the ancestor of Eukaryota is rooted within the TACK (Thaum-, Aig-, Cren-, and Korarchaeota) superphylum, which includes Crenarchaea. Our comprehensive study also revealed that one archaeal species could contain two distinct oligosaccharide donors for the oligosaccharyl transfer reaction. The A. fulgidus cells contained two oligosaccharide donors bearing oligosaccharide moieties with different backbone structures, and the S. solfataricus cells contained two oligosaccharide donors bearing stereochemically different dolichol chains.	[Taguchi, Yuya; Fujinami, Daisuke; Kohda, Daisuke] Kyushu Univ, Med Inst Bioregulat, Div Struct Biol, Fukuoka 8128582, Japan; [Kohda, Daisuke] Kyushu Univ, Med Inst Bioregulat, Res Ctr Adv Immunol, Fukuoka 8128582, Japan; [Kohda, Daisuke] Kyushu Univ, Med Inst Bioregulat, Res Ctr Live Prot Dynam, Fukuoka 8128582, Japan	Kyushu University; Kyushu University; Kyushu University	Kohda, D (corresponding author), Kyushu Univ, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kohda@bioreg.kyushu-u.ac.jp	Kohda, Daisuke/I-4990-2019	Kohda, Daisuke/0000-0001-8234-3776; Fujinami, Daisuke/0000-0002-6763-2577	MEXT KAKENHI [24370047, 26119002]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT KAKENHI Grants 24370047 and 26119002 (to D. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Qarn M, 2007, J MOL BIOL, V374, P1224, DOI 10.1016/j.jmb.2007.10.042; Abu-Qarn M, 2006, MOL MICROBIOL, V61, P511, DOI 10.1111/j.1365-2958.2006.05252.x; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Allison GE, 2000, TRENDS MICROBIOL, V8, P17, DOI 10.1016/S0966-842X(99)01646-7; Brochier-Armanet C, 2011, CURR OPIN MICROBIOL, V14, P274, DOI 10.1016/j.mib.2011.04.015; Calo D, 2011, MOL MICROBIOL, V81, P1166, DOI 10.1111/j.1365-2958.2011.07781.x; Chaban B, 2006, MOL MICROBIOL, V61, P259, DOI 10.1111/j.1365-2958.2006.05226.x; Chang MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130482; Cohen-Rosenzweig C, 2014, APPL ENVIRON MICROB, V80, P486, DOI 10.1128/AEM.03191-13; Eichler J, 2013, NAT REV MICROBIOL, V11, P151, DOI 10.1038/nrmicro2957; Fujinami D, 2015, CARBOHYD RES, V413, P55, DOI 10.1016/j.carres.2015.05.010; Fujinami D, 2014, CARBOHYD RES, V387, P30, DOI 10.1016/j.carres.2014.01.021; Gao NG, 2005, METHODS, V35, P323, DOI 10.1016/j.ymeth.2004.10.003; Guan ZQ, 2011, BBA-MOL CELL BIOL L, V1811, P607, DOI 10.1016/j.bbalip.2011.06.022; Guan ZQ, 2012, ENVIRON MICROBIOL, V14, P743, DOI 10.1111/j.1462-2920.2011.02625.x; Guan ZQ, 2010, MOL MICROBIOL, V78, P1294, DOI 10.1111/j.1365-2958.2010.07405.x; Hartley MD, 2012, ARCH BIOCHEM BIOPHYS, V517, P83, DOI 10.1016/j.abb.2011.10.018; Hemmi H, 2001, J BACTERIOL, V183, P401, DOI 10.1128/JB.183.1.401-404.2001; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Igura M, 2011, J BIOL CHEM, V286, P13255, DOI 10.1074/jbc.M110.213900; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Jarrell KF, 2014, MICROBIOL MOL BIOL R, V78, P304, DOI 10.1128/MMBR.00052-13; Kaminski L, 2013, MBIO, V4, DOI 10.1128/mBio.00716-13; Kelleher DJ, 2001, GLYCOBIOLOGY, V11, P321, DOI 10.1093/glycob/11.4.321; Kohda D, 2007, GLYCOBIOLOGY, V17, P1175, DOI 10.1093/glycob/cwm087; Koonin EV, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016188; Kuntz C, 1997, GLYCOBIOLOGY, V7, P897, DOI 10.1093/glycob/7.7.897; Lannoo N, 2015, PLANT SCI, V239, P67, DOI 10.1016/j.plantsci.2015.06.023; Larkin A, 2013, NAT CHEM BIOL, V9, P367, DOI 10.1038/nchembio.1249; Larkin A, 2011, BIOCHEMISTRY-US, V50, P4411, DOI 10.1021/bi200346n; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Magidovich H, 2009, FEMS MICROBIOL LETT, V300, P122, DOI 10.1111/j.1574-6968.2009.01775.x; Maita N, 2010, J BIOL CHEM, V285, P4941, DOI 10.1074/jbc.M109.081752; Matsumoto S, 2013, P NATL ACAD SCI USA, V110, P17868, DOI 10.1073/pnas.1309777110; Matsumoto S, 2012, BIOCHEMISTRY-US, V51, P4157, DOI 10.1021/bi300076u; Meyer BH, 2014, MICROBIOLOGYOPEN, V3, P531, DOI 10.1002/mbo3.185; Meyer BH, 2013, BIOCHEM SOC T, V41, P384, DOI 10.1042/BST20120296; Nothaft H, 2013, J BIOL CHEM, V288, P6912, DOI 10.1074/jbc.R112.417857; Palmieri G, 2013, J PROTEOME RES, V12, P2779, DOI 10.1021/pr400123z; Parente J, 2014, J BIOL CHEM, V289, P11304, DOI 10.1074/jbc.M113.546531; Patiny L, 2013, J CHEM INF MODEL, V53, P1223, DOI 10.1021/ci300563h; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Trent MS, 2001, J BIOL CHEM, V276, P43132, DOI 10.1074/jbc.M106962200; Yurist-Doutsch S, 2008, MOL MICROBIOL, V69, P1234, DOI 10.1111/j.1365-2958.2008.06352.x; Zeitler R, 1998, GLYCOBIOLOGY, V8, P1157, DOI 10.1093/glycob/8.12.1157	46	32	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11042	11054		10.1074/jbc.M115.713156	http://dx.doi.org/10.1074/jbc.M115.713156			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27015803	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000377042100008
J	Fujiwara, N; Usui, T; Ohama, T; Sato, K				Fujiwara, Nobuyuki; Usui, Tatsuya; Ohama, Takashi; Sato, Koichi			Regulation of Beclin 1 Protein Phosphorylation and Autophagy by Protein Phosphatase 2A (PP2A) and Death-associated Protein Kinase 3 (DAPK3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III PHOSPHATIDYLINOSITOL 3-KINASE; BCL-X-L; IN-VIVO; CANCER; IDENTIFICATION; TUMORIGENESIS; INDUCTION; COMPLEXES; STRESS; FAMILY	Autophagy is an evolutionarily conserved intracellular degradation system that is involved in cell survival and activated in various diseases, including cancer. Beclin 1 is a central scaffold protein that assembles components for promoting or inhibiting autophagy. Association of Beclin 1 with its interacting proteins is regulated by the phosphorylation of Beclin 1 by various Ser/Thr kinases, but the Ser/Thr phosphatases that regulate these phosphorylation events remain unknown. Here we identify Ser-90 in Beclin 1 as a regulatory site whose phosphorylation is markedly enhanced in cells treated with okadaic acid, an inhibitor of protein phosphatase 2A (PP2A). Beclin 1 Ser-90 phosphorylation is induced in skeletal muscle tissues isolated from starved mice. The Beclin 1 S90A mutant blocked starvation-induced autophagy. We found association of PP2A B55 alpha with Beclin 1, which dissociate by starvation. We also found that death-associated protein kinase 3 directly phosphorylates Beclin 1 Ser-90. We propose that physiological regulation of Beclin 1 Ser-90 phosphorylation by PP2A and death-associated protein kinase 3 controls autophagy.	[Fujiwara, Nobuyuki; Ohama, Takashi; Sato, Koichi] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Pharmacol, 1677-1 Yoshida, Yamaguchi 7538515, Japan; [Usui, Tatsuya] Yamaguchi Univ, Joint Fac Vet Med, Toxicol Lab, Yamaguchi 7538515, Japan	Yamaguchi University; Yamaguchi University	Ohama, T (corresponding author), Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Pharmacol, 1677-1 Yoshida, Yamaguchi 7538515, Japan.	t.ohama@yamaguchi-u.ac.jp	Usui, Tatsuya/Q-5170-2017	Usui, Tatsuya/0000-0002-1818-2127	Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI) [25660227, 15K14856, 15J07366]	Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI grants 25660227, 15K14856, and 15J07366). The authors declare that they have no conflicts of interest with the contents of this article.	Abrahamsen H, 2012, FEBS LETT, V586, P1584, DOI 10.1016/j.febslet.2012.04.046; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Brautigan DL, 2013, FEBS J, V280, P324, DOI 10.1111/j.1742-4658.2012.08609.x; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Choi KS, 2012, EXP MOL MED, V44, P109, DOI 10.3858/emm.2012.44.2.033; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Fogel AI, 2013, MOL CELL BIOL, V33, P3675, DOI 10.1128/MCB.00079-13; Gong C, 2013, ONCOGENE, V32, P2261, DOI 10.1038/onc.2012.252; Gozuacik D, 2006, AUTOPHAGY, V2, P74, DOI 10.4161/auto.2.2.2459; Graves PR, 2005, J BIOL CHEM, V280, P9363, DOI 10.1074/jbc.M412538200; Gurkar AU, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3189; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kinoshita E, 2004, DALTON T, P1189, DOI 10.1039/b400269e; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Naito T, 2013, J BIOL CHEM, V288, P21074, DOI 10.1074/jbc.M113.456228; Neel BA, 2013, TRENDS ENDOCRIN MET, V24, P635, DOI 10.1016/j.tem.2013.09.004; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Shani G, 2004, MOL CELL BIOL, V24, P8611, DOI 10.1128/MCB.24.19.8611-8626.2004; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Tang HW, 2011, EMBO J, V30, P636, DOI 10.1038/emboj.2010.338; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wei YJ, 2015, ELIFE, V4, DOI 10.7554/eLife.05289; Yabe R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145226; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246	32	66	66	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10858	10866		10.1074/jbc.M115.704908	http://dx.doi.org/10.1074/jbc.M115.704908			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26994142	hybrid, Green Published			2022-12-28	WOS:000377042600035
J	Nishida-Fukuda, H; Araki, R; Shudou, M; Okazaki, H; Tomono, Y; Nakayama, H; Fukuda, S; Sakaue, T; Shirakata, Y; Sayama, K; Hashimoto, K; Detmar, M; Higashiyama, S; Hirakawa, S				Nishida-Fukuda, Hisayo; Araki, Ryoichi; Shudou, Masachika; Okazaki, Hidenori; Tomono, Yasuko; Nakayama, Hironao; Fukuda, Shinji; Sakaue, Tomohisa; Shirakata, Yuji; Sayama, Koji; Hashimoto, Koji; Detmar, Michael; Higashiyama, Shigeki; Hirakawa, Satoshi			Ectodomain Shedding of Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE-1) Is Induced by Vascular Endothelial Growth Factor A (VEGF-A)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHANGIOGENESIS; CD44; METASTASIS; MICE; PSORIASIS; CLEAVAGE; ADHESION; FAMILY; CELLS; TUMOR	Lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1), a type I transmembrane glycoprotein, is known as one of the most specific lymphatic vessel markers in the skin. In this study, we found that the ectodomain of LYVE-1 undergoes proteolytic cleavage, and this process produces soluble LYVE-1. We further identified the cleavage site for ectodomain shedding and generated an uncleavable mutant of LYVE-1. In lymphatic endothelial cells, ectodomain shedding of LYVE-1 was induced by vascular endothelial growth factor (VEGF)-A, an important factor for angiogenesis and lymphangiogenesis under pathological conditions. VEGF-A-induced LYVE-1 ectodomain shedding was mediated via the extracellular signal-regulated kinase (ERK) and a disintegrin and metalloproteinase (ADAM) 17. Wild-type LYVE-1, but not uncleavable LYVE-1, promoted migration of lymphatic endothelial cells in response to VEGF-A. Immuno-staining analyses in human psoriasis skin lesions and VEGF-A transgenic mouse skin suggested that the ectodomain shedding of LYVE-1 occurred in lymphatic vessels undergoing chronic inflammation. These results indicate that the ectodomain shedding of LYVE-1 might be involved in promoting pathological lymphangiogenesis.	[Nishida-Fukuda, Hisayo; Araki, Ryoichi; Okazaki, Hidenori; Shirakata, Yuji; Sayama, Koji; Hashimoto, Koji; Hirakawa, Satoshi] Ehime Univ, Grad Sch Med, Dept Dermatol, Toon 7910295, Japan; [Nishida-Fukuda, Hisayo; Nakayama, Hironao; Fukuda, Shinji; Sakaue, Tomohisa; Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Toon 7910295, Japan; [Shudou, Masachika] Ehime Univ, Grad Sch Med, Adv Res Support Ctr ADRES, Dept Biosci, Toon 7910295, Japan; [Tomono, Yasuko] Shigei Med Res Inst, Div Mol & Cell Biol, Okayama 7010202, Japan; [Nakayama, Hironao; Higashiyama, Shigeki; Hirakawa, Satoshi] JSPS, Strateg Young Researcher Overseas Visiting Progra, Chiyoda Ku, 5-3-1 Kojimachi, Tokyo 1020083, Japan; [Nakayama, Hironao; Fukuda, Shinji; Sakaue, Tomohisa; Higashiyama, Shigeki] Ehime Univ, Proteo Sci Ctr PROS, Div Cell Growth & Tumor Regulat, Toon 7910295, Japan; [Detmar, Michael] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland; [Hirakawa, Satoshi] Hamamatsu Univ, Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan	Ehime University; Ehime University; Ehime University; Japan Society for the Promotion of Science; Ehime University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Hamamatsu University School of Medicine	Hirakawa, S (corresponding author), Hamamatsu Univ, Sch Med, Dept Dermatol, Higashi Ku, Handayama 1-20-1, Hamamatsu, Shizuoka 4313192, Japan.	hirakawa@hama-med.ac.jp		Nishida-Fukuda, Hisayo/0000-0002-4661-779X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [B23390283, 26293257]; Ministry of Health, Labor, and Welfare of Japan [H223G008B1]; Japan Agency for Medical Research and Development Practical Research Project for Rare/Intractable Diseases [15ek0109057h0002];  [MEXT18013037];  [MEXT20013032]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development Practical Research Project for Rare/Intractable Diseases(Japan Agency for Medical Research and Development (AMED)); ; 	This work was supported by Grants-in-aid for Scientific Research B23390283 and 26293257 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S. Hirakawa), Grant-in-aid for Scientific Research H223G008B1 from the Ministry of Health, Labor, and Welfare of Japan (to S. Hirakawa), Grant-in-aid for Scientific Research on Priority Areas MEXT18013037 and MEXT20013032 (to S. Hirakawa), and Japan Agency for Medical Research and Development Practical Research Project for Rare/Intractable Diseases Grant 15ek0109057h0002 (to S. Hirakawa). The authors declare that they have no conflicts of interest with the contents of this article.	Andrys C, 2007, ARCH DERMATOL RES, V298, P479, DOI 10.1007/s00403-006-0723-8; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Cao RH, 2012, P NATL ACAD SCI USA, V109, P15894, DOI 10.1073/pnas.1208324109; DETMAR M, 1994, J EXP MED, V180, P1141, DOI 10.1084/jem.180.3.1141; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Gale NW, 2007, MOL CELL BIOL, V27, P595, DOI 10.1128/MCB.01503-06; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Hirakawa S, 2011, J DERMATOL SCI, V61, P85, DOI 10.1016/j.jdermsci.2010.11.020; Huang SS, 2006, FEBS LETT, V580, P6259, DOI 10.1016/j.febslet.2006.10.028; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; Kajiya K, 2006, AM J PATHOL, V169, P1496, DOI 10.2353/ajpath.2006.060197; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Lucitti JL, 2012, CIRC RES, V111, P1539, DOI 10.1161/CIRCRESAHA.112.279109; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Nakamura H, 2004, CANCER RES, V64, P876, DOI 10.1158/0008-5472.CAN-03-3502; Nakayama H, 2012, MOL BIOL CELL, V23, P1964, DOI 10.1091/mbc.E11-08-0683; Okamoto I, 2002, AM J PATHOL, V160, P441, DOI 10.1016/S0002-9440(10)64863-8; Platonova N, 2013, BLOOD, V121, P1229, DOI 10.1182/blood-2012-08-450502; Tomono Y, 2002, CELL STRUCT FUNCT, V27, P9, DOI 10.1247/csf.27.9; Weskamp G, 2010, CIRC RES, V106, P932, DOI 10.1161/CIRCRESAHA.109.207415; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1	26	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10490	+		10.1074/jbc.M115.683201	http://dx.doi.org/10.1074/jbc.M115.683201			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26966180	hybrid, Green Published			2022-12-28	WOS:000377042600005
J	Young, SK; Baird, TD; Wek, RC				Young, Sara K.; Baird, Thomas D.; Wek, Ronald C.			Translation Regulation of the Glutamyl-prolyl-tRNA Synthetase Gene EPRS through Bypass of Upstream Open Reading Frames with Noncanonical Initiation Codons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; INTEGRATED STRESS-RESPONSE; RIBOSOMAL ENTRY SITE; MAMMALIAN-CELLS; QUALITY-CONTROL; MESSENGER-RNAS; PHOSPHORYLATION; METABOLISM; ACTIVATION; EXPRESSION	In the integrated stress response, phosphorylation of eIF2 alpha. (eIF2 alpha-P) reduces protein synthesis while concomitantly promoting preferential translation of specific transcripts associated with stress adaptation. Translation of the glutamyl-prolyl-tRNA synthetase gene EPRS is enhanced in response to eIF2 alpha-P. To identify the underlying mechanism of translation control, we employed biochemical approaches to determine the regulatory features by which upstream ORFs (uORFs) direct downstream translation control and expression of the EPRS coding region. Our findings reveal that translation of two inhibitory uORE's encoded by noncanonical CUG and UUG initiation codons in the EPRS mRNA 5'-leader serve to dampen levels of translation initiation at the EPRS coding region. By a mechanism suggested to involve increased translation initiation stringency during stress-induced eIF2 alpha-P, we observed facilitated ribosome bypass of these uORFs, allowing for increased translation of the EPRS coding region. Importantly, EPRS protein expression is enhanced through this preferential translation mechanism in response to multiple known activators of eIF2 alpha-P and likely serves to facilitate stress adaptation in response to a variety of cellular stresses. The rules presented here for the regulated ribosome bypass of noncanonical initiation codons in the EPRS 5'-leader add complexity into the nature of uORF-mediated translation control mechanisms during eIF2 alpha-P and additionally illustrate the roles that previously unexamined uORFs with noncanonical initiation codons can play in modulating gene expression.	[Young, Sara K.; Baird, Thomas D.; Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Wek, RC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iu.edu		Young-Baird, Sara/0000-0002-8915-3139; Baird, Thomas/0000-0002-0280-9984	National Institutes of Health [GM049164]; Ralph W. and Grace M. Showalter Research Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph W. and Grace M. Showalter Research Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM049164 (to R. C. W.) and the Ralph W. and Grace M. Showalter Research Trust Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baird TD, 2014, MOL BIOL CELL, V25, P1686, DOI 10.1091/mbc.E14-02-0704; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Bullwinkle T, 2014, ANNU REV GENET, V48, P149, DOI 10.1146/annurev-genet-120213-092101; Bullwinkle TJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02501; Cho SC, 2007, MOL CELL BIOL, V27, P368, DOI 10.1128/MCB.00814-06; Gao XW, 2015, NAT METHODS, V12, P147, DOI 10.1038/nmeth.3208; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Iacono M, 2005, GENE, V349, P97, DOI 10.1016/j.gene.2004.11.041; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Kim YK, 2002, BIOCHEM BIOPH RES CO, V297, P224, DOI 10.1016/S0006-291X(02)02154-X; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Peng W, 2012, SCI TRANSL MED, V4; Starck SR, 2016, SCIENCE, V351, DOI 10.1126/science.aad3867; Teske BF, 2013, MOL BIOL CELL, V24, P2477, DOI 10.1091/mbc.E13-01-0067; Teske BF, 2011, METHOD ENZYMOL, V490, P333, DOI 10.1016/B978-0-12-385114-7.00019-2; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Young SK, 2015, J BIOL CHEM, V290, P28257, DOI 10.1074/jbc.M115.693184; Zaborske JM, 2009, J BIOL CHEM, V284, P25254, DOI 10.1074/jbc.M109.000877; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774	34	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10824	10835		10.1074/jbc.M116.722256	http://dx.doi.org/10.1074/jbc.M116.722256			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27002157	Green Published, hybrid			2022-12-28	WOS:000377042600032
J	Ha, SW; Ju, DH; Hao, WL; Xie, YM				Ha, Seung-Wook; Ju, Donghong; Hao, Weilong; Xie, Youming			Rapidly Translated Polypeptides Are Preferred Substrates for Cotranslational Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FIBROBLASTS; QUALITY-CONTROL; CULTURED-CELLS; CODON USAGE; RIBOSOME; RATES; QUANTIFICATION; UBIQUITINATION; IDENTIFICATION; ELONGATION	Nascent polypeptides are degraded by the proteasome concurrently with their synthesis on the ribosome. This process, called cotranslational protein degradation (CTPD), has been observed for years, but the underlying mechanisms remain poorly understood. Equally unclear are the identities of cellular proteins genuinely subjected to CTPD. Here we report the identification of CTPD substrates in the yeast Saccharomyces cerevisiae via a quantitative proteomic analysis. We compared the abundance of individual ribosome-bound nascent chains between a wild type strain and a mutant defective in CTPD. Of 1,422 proteins acquired from the proteomic analysis, 289 species are efficient CTPD substrates, with >30% of their nascent chains degraded cotranslationally. We found that proteins involved in translation, ribosome biogenesis, nuclear transport, and amino acid metabolism are more likely to be targeted for CTPD. There is a strong correlation between CTPD and the translation efficiency. CTPD occurs preferentially to rapidly translated polypeptides. CTPD is also influenced by the protein sequence length; longer polypeptides are more susceptible to CTPD. In addition, proteins with N-terminal disorder have a higher probability of being degraded cotranslationally. Interestingly, the CTPD efficiency is not related to the half-lives of mature proteins. These results for the first time indicate an inverse correlation between CTPD and cotranslational folding on a proteome scale. The implications of this study with respect to the physiological significance of CTPD are discussed.	[Ha, Seung-Wook; Ju, Donghong; Xie, Youming] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Sch Med, 110 E Warren Ave, Detroit, MI 48201 USA; [Hao, Weilong] Wayne State Univ, Dept Biol Sci, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University	Xie, YM (corresponding author), Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Sch Med, 110 E Warren Ave, Detroit, MI 48201 USA.	xiey@karmanos.org	Hao, Weilong/C-4923-2009	Hao, Weilong/0000-0002-6337-7169	National Institutes of Health [P30 CA022453-28]; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank C. Enenkel, G. Fink, N. Davis, S. Jinks-Robertson, and M. Nomura for yeast strains and plasmids. We thank P. Stemmer and N. Carruthers for mass spectrometry. The Proteomics Core of Wayne State University/Karmanos Cancer Institute is supported by National Institutes of Health Grant P30 CA022453-28).	Aviner R, 2014, NAT PROTOC, V9, P751, DOI 10.1038/nprot.2014.051; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Brachmann CB, 1998, YEAST, V14, P115; BRADLEY MO, 1976, J BIOL CHEM, V251, P3521; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Chaney JL, 2015, ANNU REV BIOPHYS, V44, P143, DOI 10.1146/annurev-biophys-060414-034333; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; ENENKEL C, 1995, J BIOL CHEM, V270, P16499, DOI 10.1074/jbc.270.28.16499; Fishbain S, 2015, NAT STRUCT MOL BIOL, V22, P214, DOI 10.1038/nsmb.2958; Gandhi SJ, 2011, NAT STRUCT MOL BIOL, V18, P27, DOI 10.1038/nsmb.1934; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOLDBERG AL, 1974, ANNU REV BIOCHEM, V43, P835, DOI 10.1146/annurev.bi.43.070174.004155; Ha SW, 2014, J BIOL CHEM, V289, P2701, DOI 10.1074/jbc.M113.524926; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; KNOWLES SE, 1975, BIOCHEM J, V146, P595, DOI 10.1042/bj1460595; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; LOEB JDJ, 1995, P NATL ACAD SCI USA, V92, P7647, DOI 10.1073/pnas.92.17.7647; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; O'Brien EP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1850; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pechmann S, 2013, MOL CELL, V49, P411, DOI 10.1016/j.molcel.2013.01.020; POOLE B, 1973, J BIOL CHEM, V248, P6221; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SHAKESPEARE V, 1976, EXP CELL RES, V100, P1, DOI 10.1016/0014-4827(76)90319-0; Siwiak M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000865; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; WHEATLEY DN, 1980, CELL BIOL INT REP, V4, P1081, DOI 10.1016/0309-1651(80)90045-4; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; Yang JR, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001910; YANO R, 1994, P NATL ACAD SCI USA, V91, P6880, DOI 10.1073/pnas.91.15.6880; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yewdell JW, 1996, J IMMUNOL, V157, P1823; Yu CH, 2015, MOL CELL, V59, P744, DOI 10.1016/j.molcel.2015.07.018; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017; Zheng OY, 2008, PROTEIN SCI, V17, P1256, DOI 10.1110/ps.034660.108	42	13	13	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9827	9834		10.1074/jbc.M116.716175	http://dx.doi.org/10.1074/jbc.M116.716175			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26961882	Green Published, hybrid			2022-12-28	WOS:000375602300039
J	Barington, L; Rummel, PC; Luckmann, M; Pihl, H; Larsen, O; Daugvilaite, V; Johnsen, AH; Frimurer, TM; Karlshoj, S; Rosenkilde, MM				Barington, Line; Rummel, Pia C.; Luckmann, Michael; Pihl, Heidi; Larsen, Olav; Daugvilaite, Viktorija; Johnsen, Anders H.; Frimurer, Thomas M.; Karlshoj, Stefanie; Rosenkilde, Mette M.			Role of Conserved Disulfide Bridges and Aromatic Residues in Extracellular Loop 2 of Chemokine Receptor CCR8 for Chemokine and Small Molecule Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; LIGAND-BINDING; T-CELLS; PROTEIN; ACTIVATION; IDENTIFICATION; RECOGNITION; MODULATION; INHIBITOR; SEQUENCE	Chemokine receptors play important roles in the immune system and are linked to several human diseases. The initial contact of chemokines with their receptors depends on highly specified extracellular receptor features. Here we investigate the importance of conserved extracellular disulfide bridges and aromatic residues in extracellular loop 2 (ECL-2) for ligand binding and activation in the chemokine receptor CCR8. We used inositol 1,4,5-trisphosphate accumulation and radioligand binding experiments to determine the impact of receptor mutagenesis on both chemokine and small molecule agonist and antagonist binding and action in CCR8. We find that the seven-transmembrane (TM) receptor conserved disulfide bridge (7TM bridge) linking transmembrane helix III (TMIII) and ECL-2 is crucial for chemokine and small molecule action, whereas the chemokine receptor conserved disulfide bridge between the N terminus and TMVII is needed only for chemokines. Furthermore, we find that two distinct aromatic residues in ECL-2, Tyr(184) (Cys + 1) and Tyr(187) (Cys + 4), are crucial for binding of the CC chemokines CCL1 (agonist) and MC148 (antagonist), respectively, but not for small molecule binding. Finally, using in silico modeling, we predict an aromatic cluster of interaction partners for Tyr(187) in TMIV (Phe(171)) and TMV (Trp(194)). We show in vitro that these residues are crucial for the binding and action of MC148, thus supporting their participation in an aromatic cluster with Tyr(187). This aromatic cluster appears to be present in a large number of CC chemokine receptors and thereby could play a more general role to be exploited in future drug development targeting these receptors.	[Barington, Line; Rummel, Pia C.; Luckmann, Michael; Pihl, Heidi; Larsen, Olav; Daugvilaite, Viktorija; Karlshoj, Stefanie; Rosenkilde, Mette M.] Univ Copenhagen, Dept Neurosci & Pharmacol, Panum Inst Bldg 18-5,Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Luckmann, Michael; Frimurer, Thomas M.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Frimurer, Thomas M.] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Johnsen, Anders H.] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Rosenkilde, MM (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Panum Inst Bldg 18-5,Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	rosenkilde@sund.ku.dk	DAUGVILAITE, VIKTORIJA/E-2573-2017; Daugvilaite, Viktorija/AAI-1490-2019	DAUGVILAITE, VIKTORIJA/0000-0001-8786-348X; Daugvilaite, Viktorija/0000-0001-8786-348X; Barington, Line/0000-0003-4282-6970; Frimruer, Thomas/0000-0002-9682-8245; Karlshoj, Stefanie/0000-0001-6505-0883; Luckmann, Michael/0000-0002-6294-1768; Rosenkilde, Mette Marie/0000-0001-9600-3254	Det Frie Forskningsrad; Horslev-Fonden; Lundbeckfonden; Novo Nordisk; Novo Nordisk Foundation Center for Basic Metabolic Research; NovoNordisk Foundation Center for Protein Research; Novo Nordisk Fonden [NNF12OC0001900] Funding Source: researchfish	Det Frie Forskningsrad(Det Frie Forskningsrad (DFF)); Horslev-Fonden; Lundbeckfonden(Lundbeckfonden); Novo Nordisk(Novo Nordisk); Novo Nordisk Foundation Center for Basic Metabolic Research(Novo Nordisk Foundation); NovoNordisk Foundation Center for Protein Research; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Det Frie Forskningsrad, Horslev-Fonden, Lundbeckfonden, Novo Nordisk, Novo Nordisk Foundation Center for Basic Metabolic Research, and NovoNordisk Foundation Center for Protein Research. The authors declare that they have no conflicts of interest with the contents of this article.	Abagyan R, 1997, PROTEINS, P29; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Ai LS, 2002, BIOCHEMISTRY-US, V41, P8332, DOI 10.1021/bi025855y; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Blanpain C, 1999, J BIOL CHEM, V274, P18902, DOI 10.1074/jbc.274.27.18902; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Casarosa P, 2001, J BIOL CHEM, V276, P1133, DOI 10.1074/jbc.M008965200; Chalikiopoulos A, 2013, J CHEM INF MODEL, V53, P2863, DOI 10.1021/ci4003848; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Damon I, 1998, P NATL ACAD SCI USA, V95, P6403, DOI 10.1073/pnas.95.11.6403; Gadhe CG, 2015, J BIOMOL STRUCT DYN, V33, P2491, DOI 10.1080/07391102.2014.1002006; GAO JL, 1994, J BIOL CHEM, V269, P28539; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Govaerts C, 2003, J BIOL CHEM, V278, P1892, DOI 10.1074/jbc.M205685200; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Heydorn A, 2004, MOL PHARMACOL, V66, P250, DOI 10.1124/mol.66.2.250; Islam SA, 2013, J EXP MED, V210, P1889, DOI 10.1084/jem.20130240; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jenkins TJ, 2007, J MED CHEM, V50, P566, DOI 10.1021/jm061118e; Jensen PC, 2012, BRIT J PHARMACOL, V166, P258, DOI 10.1111/j.1476-5381.2011.01771.x; Jensen PC, 2008, J BIOL CHEM, V283, P23121, DOI 10.1074/jbc.M803458200; Jensen PC, 2007, MOL PHARMACOL, V72, P327, DOI 10.1124/mol.106.035543; Jin J, 2007, BIOORG MED CHEM LETT, V17, P1722, DOI 10.1016/j.bmcl.2006.12.076; Karlsson AKC, 2011, BIOCHEM BIOPH RES CO, V407, P764, DOI 10.1016/j.bbrc.2011.03.097; Kledal TN, 1998, FEBS LETT, V441, P209, DOI 10.1016/S0014-5793(98)01551-8; Kostenis E, 1998, J BIOL CHEM, V273, P17886, DOI 10.1074/jbc.273.28.17886; LEONG SR, 1994, J BIOL CHEM, V269, P19343; Limatola C, 2005, EXP CELL RES, V307, P65, DOI 10.1016/j.yexcr.2005.02.020; Luttichau HR, 2000, J EXP MED, V191, P171, DOI 10.1084/jem.191.1.171; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; McLean KA, 2004, VIROLOGY, V325, P241, DOI 10.1016/j.virol.2004.04.027; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Panina-Bordignon P, 2001, J CLIN INVEST, V107, P1357, DOI 10.1172/JCI12655; Park SH, 2012, NATURE, V491, P779, DOI 10.1038/nature11580; Pease JE, 2010, CLIN EXP ALLERGY, V40, P1110, DOI 10.1111/j.1365-2222.2010.03552.x; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenkilde MM, 2007, MOL PHARMACOL, V71, P930, DOI 10.1124/mol.106.030031; Rosenkilde MM, 2006, CURR TOP MED CHEM, V6, P1319, DOI 10.2174/15680266106061319; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; Rosenkilde MM, 2004, APMIS, V112, P481, DOI 10.1111/j.1600-0463.2004.apm11207-0808.x; Rummel PC, 2012, BRIT J PHARMACOL, V167, P1206, DOI 10.1111/j.1476-5381.2012.02076.x; Rummel PC, 2013, MOL PHARMACOL, V84, P335, DOI 10.1124/mol.113.086702; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Schwarz MK, 2002, NAT REV DRUG DISCOV, V1, P347, DOI 10.1038/nrd795; Soler D, 2006, J IMMUNOL, V177, P6940, DOI 10.4049/jimmunol.177.10.6940; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Thiele S, 2014, CURR MED CHEM, V21, P3594, DOI 10.2174/0929867321666140716093155; Thiele S, 2012, J MED CHEM, V55, P8164, DOI 10.1021/jm301121j; Thiele S, 2011, J BIOL CHEM, V286, P37543, DOI 10.1074/jbc.M111.243808; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zhang DD, 2015, NATURE, V520, P317, DOI 10.1038/nature14287; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083	64	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16208	16220		10.1074/jbc.M115.706747	http://dx.doi.org/10.1074/jbc.M115.706747			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226537	hybrid, Green Published			2022-12-28	WOS:000380585400025
J	Ishikura, S; Iwaihara, Y; Tanaka, Y; Luo, H; Nishi, K; Doi, K; Koyanagi, M; Okamura, T; Tsunoda, T; Shirasawa, S				Ishikura, Shuhei; Iwaihara, Yuri; Tanaka, Yoko; Luo, Hao; Nishi, Kensuke; Doi, Keiko; Koyanagi, Midori; Okamura, Tadashi; Tsunoda, Toshiyuki; Shirasawa, Senji			The Nuclear Zinc Finger Protein Zfat Maintains Fox01 Protein Levels in Peripheral T Cells by Regulating the Activities of Autophagy and the Akt Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOIMMUNE THYROID-DISEASE; TRANSCRIPTION FACTORS; PROTEASOMAL DEGRADATION; CULTURED-CELLS; BETA-SECRETASE; H+-ATPASE; FOXO1; HOMEOSTASIS; INHIBITION; SURVIVAL	Forkhead box O1 (FoxO1) is a key molecule for the development and functions of peripheral 'I' cells. However, the precise mechanisms regulating FoxO1 expression in peripheral T cells remain elusive. We previously reported that Zfat"-CD4Cre mice showed a marked decline in FoxO1 protein levels in peripheral T cells, partially through proteasomal degradation. Here we have identified the precise mechanisms, apart from proteasorne-mediated degradation, of the decreased FoxO1 levels in Zfat-deficient T cells. First, we confirmed that tamoxifeninducible deletion of Zfat in Zfat ff-CreERT2 mice coincidently decreases FoxO1 protein levels in peripheral T cells, indicating that Zfat is essential for maintaining FoxO1 levels in these cells. Although the proteasome-specific inhibitors lactacystin and epoxomicin only moderately increase FoxO1 protein levels, the inhibitors of lysosomal proteolysis bafilomycin A1 and chloroquine restore the decreased FoxO1 levels in Zfat-deficient T cells to levels comparable with those in control cells. Furthermore, Zfat-deficient 'I' cells show increased numbers of autophagosomes and decreased levels of p62 protein, together indicating that Zfat deficiency promotes lysosomal FoxO1 degradation through autophagy. In addition, Zfat deficiency increases the phosphorylation levels of Thr-308 and Ser-473 of Akt and the relative amounts of cytoplasmic to nuclear FoxO1 protein levels, indicating that Zfat deficiency causes Akt activation, leading to nuclear exclusion of FoxOl. Our findings have demonstrated a novel role of Zfat in maintaining FoxO1 protein levels in peripheral T cells by regulating the activities of autophagy and the Akt signaling pathway.	[Ishikura, Shuhei; Iwaihara, Yuri; Tanaka, Yoko; Luo, Hao; Nishi, Kensuke; Doi, Keiko; Koyanagi, Midori; Tsunoda, Toshiyuki; Shirasawa, Senji] Fukuoka Univ, Fac Med, Dept Cell Biol, Fukuoka 8140180, Japan; [Ishikura, Shuhei; Iwaihara, Yuri; Tanaka, Yoko; Doi, Keiko; Koyanagi, Midori; Tsunoda, Toshiyuki; Shirasawa, Senji] Fukuoka Univ, Cent Res Inst Adv Mol Med, Fukuoka 8140180, Japan; [Okamura, Tadashi] Natl Ctr Global Hlth & Med, Res Inst, Dept Lab Anim Med, Tokyo 1628655, Japan; [Okamura, Tadashi] Natl Ctr Global Hlth & Med, Res Inst, Sect Anim Models, Dept Infect Dis, Tokyo 1628655, Japan	Fukuoka University; Fukuoka University; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Shirasawa, S (corresponding author), Fukuoka Univ, Dept Cell Biol, Fac Med, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	sshirasa@fukuoka-u.ac.jp			JSPS; MEXT-supported Program for the Strategic Research Foundation at Private Universities; Grants-in-Aid for Scientific Research [15K08166] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT-supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research B (to S. S.) from the JSPS and a Grant-in-Aid for the FOAM from the MEXT-supported Program for the Strategic Research Foundation at Private Universities. The authors declare that they have no conflicts of interest with the contents of this article.	Abbenante G, 2000, BIOCHEM BIOPH RES CO, V268, P133, DOI 10.1006/bbrc.2000.2098; Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Arden KC, 2002, ARCH BIOCHEM BIOPHYS, V403, P292, DOI 10.1016/S0003-9861(02)00207-2; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Comabella M, 2009, ARCH NEUROL-CHICAGO, V66, P972, DOI 10.1001/archneurol.2009.150; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Doi K, 2014, ANTICANCER RES, V34, P4489; Doi K, 2012, BIOCHEM BIOPH RES CO, V425, P107, DOI 10.1016/j.bbrc.2012.07.065; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Elliott PJ, 2003, J MOL MED, V81, P235, DOI 10.1007/s00109-003-0422-2; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fujimoto T, 2009, FEBS LETT, V583, P568, DOI 10.1016/j.febslet.2008.12.063; HASHIDA S, 1980, J BIOCHEM-TOKYO, V88, P1805, DOI 10.1093/oxfordjournals.jbchem.a133155; Hawse WF, 2015, J IMMUNOL, V194, P4615, DOI 10.4049/jimmunol.1402554; HAYASHI M, 1992, BIOCHEM BIOPH RES CO, V182, P939, DOI 10.1016/0006-291X(92)91822-8; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Inoue N, 2012, J CLIN IMMUNOL, V32, P1243, DOI 10.1007/s10875-012-9721-0; Ishikura S, 2015, J CELL BIOCHEM, V116, P149, DOI 10.1002/jcb.24954; Ito H, 2009, J ENZYM INHIB MED CH, V24, P279, DOI [10.1080/14756360802166921, 10.1080/14756360802166921 ]; Iwaihara Y, 2015, ANTICANCER RES, V35, P4419; Jia W, 2011, J IMMUNOL, V186, P5313, DOI 10.4049/jimmunol.1002404; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Koyanagi M, 2008, GENOMICS, V91, P451, DOI 10.1016/j.ygeno.2008.01.009; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Laine A, 2015, J IMMUNOL, V195, P1791, DOI 10.4049/jimmunol.1500849; Luo CT, 2016, NATURE, V529, P532, DOI 10.1038/nature16486; Luo CT, 2013, TRENDS IMMUNOL, V34, P531, DOI 10.1016/j.it.2013.08.003; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; McLeod IX, 2011, J IMMUNOL, V187, P5051, DOI 10.4049/jimmunol.1100710; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Newton RH, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00151; Ogawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076254; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schultz ML, 2011, TRENDS NEUROSCI, V34, P401, DOI 10.1016/j.tins.2011.05.006; Shirasawa S, 2004, HUM MOL GENET, V13, P2221, DOI 10.1093/hmg/ddh245; So L, 2012, BIOCHEM J, V442, P465, DOI 10.1042/BJ20112092; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Steinhilb ML, 2001, J BIOL CHEM, V276, P4476, DOI 10.1074/jbc.M008793200; Stephenson LM, 2009, AUTOPHAGY, V5, P625, DOI 10.4161/auto.5.5.8133; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tejera MM, 2013, J IMMUNOL, V191, P187, DOI 10.4049/jimmunol.1300331; Tsunoda T, 2013, ANTICANCER RES, V33, P2833; Tsunoda T, 2010, P NATL ACAD SCI USA, V107, P14199, DOI 10.1073/pnas.1002494107; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; WIBO M, 1974, J CELL BIOL, V63, P430, DOI 10.1083/jcb.63.2.430; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	60	13	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15282	15291		10.1074/jbc.M116.723734	http://dx.doi.org/10.1074/jbc.M116.723734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226588	hybrid, Green Published			2022-12-28	WOS:000380583200034
J	Mitzelfelt, KA; Limphong, P; Choi, MJ; Kondrat, FDL; Lai, SP; Kolander, KD; Kwok, WM; Dai, Q; Grzybowski, MN; Zhang, HL; Taylor, GM; Lui, Q; Thao, MT; Hudson, JA; Barresi, R; Bushby, K; Jungbluth, H; Wraige, E; Geurts, AM; Benesch, JLP; Riedel, M; Christians, ES; Minella, AC; Benjamina, IJ				Mitzelfelt, Katie A.; Limphong, Pattraranee; Choi, Melinda J.; Kondrat, Frances D. L.; Lai, Shuping; Kolander, Kurt D.; Kwok, Wai-Meng; Dai, Qiang; Grzybowski, Michael N.; Zhang, Huali; Taylor, Graydon M.; Lui, Qiang; Thao, Mai T.; Hudson, Judith A.; Barresi, Rita; Bushby, Kate; Jungbluth, Heinz; Wraige, Elizabeth; Geurts, Aron M.; Benesch, Justin L. P.; Riedel, Michael; Christians, Elisabeth S.; Minella, Alex C.; Benjamina, Ivor J.			The Human 343delT HSPB5 Chaperone Associated with Early-onset Skeletal Myopathy Causes Defects in Protein Solubility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; HEAT-SHOCK PROTEINS; PLURIPOTENT STEM-CELLS; FILAMENT INTERACTIONS; MUSCLE; DESMIN; GENE; EXPRESSION; AGGREGATION; DEGRADATION	Mutations of HSP B 5 (also known as CRYAB or all-crystallin), a bona fide heat shock protein and molecular chaperone encoded by the HSPB5 (crystallin, alpha B) gene, are linked to multisystem disorders featuring variable combinations of cataracts, cardiomyopathy, and skeletal myopathy. This study aimed to investigate the pathological mechanisms involved in an early onset myofibrillar myopathy manifesting in a child harboring a homozygous recessive mutation in HSPB5, 343delT. To study HSPB5 343delT protein dynamics, we utilize model cell culture systems including induced pluripotent stein cells derived from the 343delT patient (343delT/343delT) along with isogenic, heterozygous, gene -corrected control cells (WT Kit 343delT) and BHK21 cells, a cell line lacking endogenous HSPB5 expression. 343delT/343delT and WT KI/343delT-induced pluripotent stem cell-derived skeletal myotubes and cardiomyocytes did not express detectable levels of 343delT protein, contributable to the extreme insolubility of the mutant protein. Overexpression of HSPB5 343delT resulted in insoluble mutant protein aggregates and induction of a cellular stress response. Co-expression of 343delT with WT prevented visible aggregation of 343delT and improved its solubility. Additionally, in vitro refolding of 343delT in the presence of WT rescued its solubility. We demonstrate an interaction between WT and 343delT both in vitro and within cells. These data support a loss-of-function model for the myopathy observed in the patient because the insoluble mutant would be unavailable to perform normal functions of HSPB5, although additional gain-of-function effects of the mutant protein cannot be excluded. Additionally, our data highlight the solubilization of 343delT by WT, concordant with the recessive inheritance of the disease and absence of symptoms in carrier individuals.	[Mitzelfelt, Katie A.; Benjamina, Ivor J.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Limphong, Pattraranee] Arcturus Therapeut, San Diego, CA 92121 USA; [Choi, Melinda J.; Lai, Shuping; Kolander, Kurt D.; Dai, Qiang; Grzybowski, Michael N.; Thao, Mai T.; Geurts, Aron M.; Benjamina, Ivor J.] Med Coll Wisconsin, Ctr Cardiovasc, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Kwok, Wai-Meng] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA; [Kwok, Wai-Meng] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Kondrat, Frances D. L.; Benesch, Justin L. P.] Univ Oxford, Dept Chem, Oxford OX1 3TA, England; [Zhang, Huali] Cent S Univ, Xiangya Sch Med, Dept Pathophysiol, Changsha 410078, Hunan, Peoples R China; [Taylor, Graydon M.; Lui, Qiang] Univ Utah, Dept Med, Div Cardiol, Salt Lake City, UT 84132 USA; [Hudson, Judith A.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Northem Genet Serv, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Barresi, Rita] Dent Hosp, Muscle Immunoanalysis Unit, Natl Hlth Serv, England Hlth Sci Serv Rare Neuromuscular Dis, Newcastle Upon Tyne NE2 4AZ, Tyne & Wear, England; [Bushby, Kate] Newcastle Univ, Inst Med Genet, Med Res Council Ctr Neuromuscular Dis,Neuromuscul, John Walton Ctr Muscular Dystrophy Res,Int Ctr Li, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Jungbluth, Heinz; Wraige, Elizabeth] Guys & St Thomas Natl Hlth Serv Fdn Trust, Evelina Childrens Hosp, Neuromuscular Serv, Dept Paediat Neurol, London SE1 7EH, England; [Jungbluth, Heinz] Kings Coll London, Muscle Signalling Sect, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Jungbluth, Heinz] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London SE5 9RX, England; [Riedel, Michael] PharmaCell, NL-6229 EV Maastricht, Netherlands; [Christians, Elisabeth S.] Univ Paris 06, Sorbonne Univ, CNRS, LBDV,UMR 7009, 181 Chemin Lazaret, F-06230 Villefranche Sur Mer, France; [Minella, Alex C.] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA	Utah System of Higher Education; University of Utah; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; University of Oxford; Central South University; Utah System of Higher Education; University of Utah; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; NHS Blood & Transplant (NHSBT); Newcastle University - UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Versiti Blood Center of Wisconsin	Benjamina, IJ (corresponding author), Med Coll Wisconsin, Ctr Cardiovasc, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	ibenjamin@mcw.edu	Barresi, Rita/AAB-9569-2022	Barresi, Rita/0000-0001-7351-959X; Jungbluth, Heinz/0000-0002-7159-3427; Minella, Alex/0000-0001-6693-3362	National Institute of Health [8DP1HL17650-04]; Royal Society; Ruth L. Kirschstein National Research Service Award F31 Individual Fellowship [1F31AR067618-01A1]; Biotechnology and Biological Sciences Research Council [BB/J018082/1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR067618] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008396] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0512-10036] Funding Source: researchfish; BBSRC [BB/J018082/1] Funding Source: UKRI	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); Ruth L. Kirschstein National Research Service Award F31 Individual Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Institute of Health Director's Pioneer Award Grant 8DP1HL17650-04 (to I. J. B.) and a Royal Society University Research Fellowship (to J. L. P. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by Ruth L. Kirschstein National Research Service Award F31 Individual Fellowship 1F31AR067618-01A1.r Supported by the Biotechnology and Biological Sciences Research Council (BB/J018082/1).	Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Bekes M, 2011, J BIOL CHEM, V286, P10238, DOI 10.1074/jbc.M110.205153; BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Christians ES, 2014, CURR PROTEIN PEPT SC, V15, P189, DOI 10.2174/1389203715666140331111518; Christians ES, 2012, INT J BIOCHEM CELL B, V44, P1632, DOI 10.1016/j.biocel.2012.06.006; Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006; Clark AR, 2011, J MOL BIOL, V408, P118, DOI 10.1016/j.jmb.2011.02.020; Elliott JL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0375; Flores-Jasso CF, 2009, ACTA PHARMACOL SIN, V30, P1177, DOI 10.1038/aps.2009.108; Forrest KML, 2011, NEUROMUSCULAR DISORD, V21, P37, DOI 10.1016/j.nmd.2010.11.003; Golenhofen N, 2004, HISTOCHEM CELL BIOL, V122, P415, DOI 10.1007/s00418-004-0711-z; Golenhofen N, 2002, J MOL CELL CARDIOL, V34, P309, DOI 10.1006/jmcc.2001.1513; GOPALSRIVASTAVA R, 1993, MOL CELL BIOL, V13, P7144, DOI 10.1128/MCB.13.11.7144; GOPALSRIVASTAVA R, 1995, MOL CELL BIOL, V15, P7081; Hochberg GKA, 2014, PROG BIOPHYS MOL BIO, V115, P11, DOI 10.1016/j.pbiomolbio.2014.03.003; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; Hosoyama T, 2014, STEM CELL TRANSL MED, V3, P564, DOI 10.5966/sctm.2013-0143; Houck SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025859; Jackstadt R, 2015, BBA-GENE REGUL MECH, V1849, P544, DOI 10.1016/j.bbagrm.2014.04.003; Kotter S, 2014, J CELL BIOL, V204, P187, DOI 10.1083/jcb.201306077; Kondrat F. L., 2015, STRUCTURAL PROTEOMIC, P349; Kumarapeli ARK, 2008, CIRC RES, V103, P1473, DOI 10.1161/CIRCRESAHA.108.180117; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Mainz A, 2015, NAT STRUCT MOL BIOL, V22, P898, DOI 10.1038/nsmb.3108; Mitzelfelt K. A., 2015, BIG BOOK SMALL HEAT, P269; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morrison LE, 2004, AM J PHYSIOL-HEART C, V286, pH847, DOI 10.1152/ajpheart.00715.2003; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Neppl RL, 2014, J BIOL CHEM, V289, P17240, DOI 10.1074/jbc.M114.549584; Panavas Tadas, 2009, V497, P303, DOI 10.1007/978-1-59745-566-4_20; Perng MD, 2004, MOL BIOL CELL, V15, P2335, DOI 10.1091/mbc.E03-12-0893; Perng MD, 1999, J CELL SCI, V112, P2099; Peroutka RJ, 2008, PROTEIN SCI, V17, P1586, DOI 10.1110/ps.035576.108; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Poulain P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009990; Rajagopal P, 2015, ELIFE, V4, DOI 10.7554/eLife.07304; Singh BN, 2007, J MOL BIOL, V366, P756, DOI 10.1016/j.jmb.2006.12.012; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zhang HL, 2010, J MOL CELL CARDIOL, V49, P918, DOI 10.1016/j.yjmcc.2010.09.004	48	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14939	14953		10.1074/jbc.M116.730481	http://dx.doi.org/10.1074/jbc.M116.730481			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226619	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000380583200007
J	Liu, YZ; Cheng, XY; Zhang, T; Lee, S; Yamauchi, J; Xiao, X; Gittes, G; Qu, S; Jiang, CL; Dong, HH				Liu, Yun-Zi; Cheng, Xiaoyun; Zhang, Ting; Lee, Sojin; Yamauchi, Jun; Xiao, Xiangwei; Gittes, George; Qu, Shen; Jiang, Chun-Lei; Dong, H. Henry			Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell ( cell); dyslipidemia; lipid metabolism; obesity; type 2 diabetes; ApoC3; apolipoprotein c	APOLIPOPROTEIN-C-III; TRIGLYCERIDE-RICH LIPOPROTEIN; CYTOKINE-INDUCED APOPTOSIS; LOW-DENSITY LIPOPROTEINS; CORONARY-ARTERY-DISEASE; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; PLASMA-LIPOPROTEINS; OXIDATIVE STRESS; LIPASE ACTIVITY	Hypertriglyceridemia results from increased production and decreased clearance of triglyceride-rich very low-density lipoproteins, a pathological condition that accounts for heightened risk of ischemic vascular diseases in obesity and type 2 diabetes. Despite its intimate association with insulin resistance, whether hypertriglyceridemia constitutes an independent risk for beta cell dysfunction in diabetes is unknown. Answering this fundamental question is stymied by the fact that hypertriglyceridemia is intertwined with hyperglycemia and insulin resistance in obese and diabetic subjects. To circumvent this limitation, we took advantage of apolipoprotein C3 (ApoC3)-transgenic mice, a model with genetic predisposition to hypertriglyceridemia. We showed that ApoC3-transgenic mice, as opposed to age/sex-matched wild-type littermates, develop hypertriglyceridemia with concomitant elevations in plasma cholesterol and non-esterified fatty acid levels. Anti-insulin and anti-glucagon dual immunohistochemistry in combination with morphometric analysis revealed that ApoC3-transgenic and wild-type littermates had similar beta cell and alpha cell masses as well as islet size and architecture. These effects correlated with similar amplitudes of glucose-stimulated insulin secretion and similar degrees of postprandial glucose excursion in ApoC3-transgenic versus wild-type littermates. Oil Red O histology did not visualize lipid infiltration into islets, correlating with the lack of ectopic triglyceride and cholesterol depositions in the pancreata of ApoC3-transgenic versus wild-type littermates. ApoC3-transgenic mice, despite persistent hypertriglyceridemia, maintained euglycemia under both fed and fasting conditions without manifestation of insulin resistance and fasting hyperinsulinemia. Thus, hypertriglyceridemia per se is not an independent risk factor for beta cell dysfunction in ApoC3 transgenic mice.	[Liu, Yun-Zi; Cheng, Xiaoyun; Zhang, Ting; Lee, Sojin; Yamauchi, Jun; Dong, H. Henry] Univ Pittsburgh, Sch Med, Dept Pediat,UPMC, Div Pediat Endocrinol,Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Xiao, Xiangwei; Gittes, George] Univ Pittsburgh, Sch Med, Dept Surg, Div Pediat Surg,Childrens Hosp Pittsburgh,UPMC, Pittsburgh, PA 15224 USA; [Liu, Yun-Zi; Jiang, Chun-Lei] Second Mil Med Univ, Fac Psychol & Mental Hlth, Shanghai 200433, Peoples R China; [Cheng, Xiaoyun; Qu, Shen] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Endocrinol & Metab, Shanghai 200072, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Naval Medical University; Tongji University	Dong, HH (corresponding author), UPMC, Childrens Hosp Pittsburgh, Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	dongh@pitt.edu	Cheng, Xiaoyun/HDM-5535-2022	Xiao, Xiangwei/0000-0003-0890-9203; Dong, H. Henry/0000-0003-0279-5241	National Institutes of Health [R01 DK098437]; Chinese Natural Science Foundation [201306580015]; Chinese College and Education Interdisciplinary Research Fund in Tongji University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese College and Education Interdisciplinary Research Fund in Tongji University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK098437. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors have no conflicts of interest to declare with the contents of this article.; Recipient of Fellowship 201306580015 from the Chinese Natural Science Foundation.; Supported in part by the Chinese College and Education Interdisciplinary Research Fund in Tongji University.	AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; Altomonte J, 2004, J CLIN INVEST, V114, P1493, DOI 10.1172/JCI200419992; Arsenault BJ, 2011, NAT REV CARDIOL, V8, P197, DOI 10.1038/nrcardio.2010.223; Avall K, 2015, P NATL ACAD SCI USA, V112, pE2611, DOI 10.1073/pnas.1423849112; Bard JM, 2001, ARTERIOSCL THROM VAS, V21, P407, DOI 10.1161/01.ATV.21.3.407; Brewer HB, 1999, AM J CARDIOL, V83, p3F; Chan DC, 2006, ARTERIOSCL THROM VAS, V26, P590, DOI 10.1161/01.ATV.0000203519.25116.54; Chan DC, 2002, CLIN CHEM, V48, P278; CHEN M, 1994, J LIPID RES, V35, P1918; Cohn JS, 2004, J CLIN ENDOCR METAB, V89, P3949, DOI 10.1210/jc.2003-032056; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Dallinga-Thie GM, 2001, J LIPID RES, V42, P1450; DeFronzo RA, 1997, NETH J MED, V50, P191, DOI 10.1016/S0300-2977(97)00012-0; Ebara T, 1997, J CLIN INVEST, V99, P2672, DOI 10.1172/JCI119456; Gerritsen G, 2005, J LIPID RES, V46, P1466, DOI 10.1194/jlr.M400479-JLR200; Hegele RA, 1997, ARTERIOSCL THROM VAS, V17, P2753, DOI 10.1161/01.ATV.17.11.2753; HERBERT PN, 1983, METABOLIC BASIS INHE, P589; Hopkins PN, 2003, CIRCULATION, V108, P519, DOI 10.1161/01.CIR.0000081777.17879.85; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Jong MC, 2001, J LIPID RES, V42, P1578; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; KINNUNEN PKJ, 1976, FEBS LETT, V65, P354, DOI 10.1016/0014-5793(76)80145-7; Kozlitina J, 2011, HEPATOLOGY, V53, P467, DOI 10.1002/hep.24072; Krauss RM, 1998, AM J CARDIOL, V81, p13B, DOI 10.1016/S0002-9149(98)00032-0; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Li WW, 1995, J CLIN INVEST, V96, P2601, DOI 10.1172/JCI118324; MAEDA N, 1994, J BIOL CHEM, V269, P23610; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Mann CJ, 1997, J BIOL CHEM, V272, P31348, DOI 10.1074/jbc.272.50.31348; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCCONATHY WJ, 1992, J LIPID RES, V33, P995; Meares GP, 2013, AM J PHYSIOL-ENDOC M, V304, pE614, DOI 10.1152/ajpendo.00424.2012; Nieves DJ, 2003, DIABETES, V52, P172, DOI 10.2337/diabetes.52.1.172; Norata GD, 2015, TRENDS PHARMACOL SCI, V36, P675, DOI 10.1016/j.tips.2015.07.001; Olivieri O, 2002, J LIPID RES, V43, P1450, DOI 10.1194/jlr.M200145-JLR200; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Qin W, 2011, J BIOL CHEM, V286, P27769, DOI 10.1074/jbc.M110.203679; Qu S, 2007, J LIPID RES, V48, P1476, DOI 10.1194/jlr.M600498-JLR200; QUARFORDT SH, 1982, J BIOL CHEM, V257, P4642; REAVEN GM, 1994, J LIPID RES, V35, P820; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; STEWART MW, 1994, J INTERN MED, V236, P41; Storling J, 2011, ENDOCRINOLOGY, V152, P3040, DOI 10.1210/en.2010-1422; Su DM, 2007, DIABETES, V56, P2274, DOI 10.2337/db07-0371; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Talmud PJ, 1997, CURR OPIN LIPIDOL, V8, P154, DOI 10.1097/00041433-199706000-00005; Taskinen MR, 2011, ARTERIOSCL THROM VAS, V31, P2144, DOI 10.1161/ATVBAHA.111.224808; WANG CS, 1985, J CLIN INVEST, V75, P384, DOI 10.1172/JCI111711; Waterworth DM, 2000, J LIPID RES, V41, P1103; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Zhang T, 2016, ENDOCRINOLOGY, V157, P1055, DOI 10.1210/en.2015-1852	56	9	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14695	14705		10.1074/jbc.M115.707885	http://dx.doi.org/10.1074/jbc.M115.707885			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226540	Green Published, hybrid			2022-12-28	WOS:000380366700023
J	Patra, A; Su, Y; Zhang, QQ; Johnson, KM; Guengerich, FP; Egli, M				Patra, Amritraj; Su, Yan; Zhang, Qianqian; Johnson, Kevin M.; Guengerich, F. Peter; Egli, Martin			Structural and Kinetic Analysis of Miscoding Opposite the DNA Adduct 1,N-6-Ethenodeoxyadenosine by Human Translesion DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA enzyme; DNA polymerase; enzyme kinetics; X-ray crystallography	VINYL-CHLORIDE; 1,N(6)-ETHENODEOXYADENOSINE ADDUCT; ETHENO ADDUCTS; IN-VITRO; 1,N-6-ETHENOADENINE; N2,3-ETHENOGUANINE; FLUORESCENCE; REPLICATION; BYPASS; LESION	1,N-6-Ethenodeoxyadenosine (1,N-6-EdA) is the major etheno lesion formed in the reaction of DNA with epoxides substituted with good leaving groups (e.g. vinyl chloride epoxide). This lesion is also formed endogenously in DNA from lipid oxidation. Recombinant human DNA polymerase (hpol ) can replicate oligonucleotide templates containing 1,N-6-EdA. In steady-state kinetic analysis, hpol preferred to incorporate dATP and dGTP, compared with dTTP. Mass spectral analysis of incorporation products also showed preferred purine (A, G) incorporation and extensive -1 frameshifts, suggesting pairing of the inserted purine and slippage before further replication. Five x-ray crystal structures of hpol ternary complexes were determined, three at the insertion and two at the extension stage. Two insertion complexes revealed incoming non-hydrolyzable dATP or dGTP analogs not pairing with but instead in a staggered configuration relative to 1,N-6-EdA in the anti conformation, thus opposite the 5-T in the template, explaining the proclivity for frameshift misincorporation. In another insertion complex, dTTP was positioned opposite 1,N-6-EdA, and the adduct base was in the syn conformation, with formation of two hydrogen bonds. At the extension stage, with either an incorporated dA or dT opposite 1,N-6-EdA and 2-deoxythymidine-5-[(,)-imido]triphosphate opposite the 5-A, the 3-terminal nucleoside of the primer was disordered, consistent with the tendency not to incorporate dTTP opposite 1,N-6-EdA. Collectively, the results show a preference for purine pairing opposite 1,N-6-EdA and for -1 frameshifts.	[Patra, Amritraj; Su, Yan; Zhang, Qianqian; Johnson, Kevin M.; Guengerich, F. Peter; Egli, Martin] Vanderbilt Univ, Dept Biochem, Sch Med, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Zhang, Qianqian] Shanghai CP Guojian Pharmaceut Co, 399 Libing Rd,Zhangjiang High Tech Pk, Shanghai 201203, Peoples R China	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.; Egli, M (corresponding author), Dept Biochem, 868A Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu; martin.egli@vanderbilt.edu			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [T32CA009582, P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010546, P30ES000267, R01ES010375] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank L. Lei for help with protein expression and K. Trisler for assistance in the preparation of the manuscript. Vanderbilt University is a member institution of the Life Sciences Collaborative Access Team at sector 21 of the Advanced Photon Source, Argonne, IL. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARBIN A, 1975, BIOCHEM BIOPH RES CO, V67, P596, DOI 10.1016/0006-291X(75)90854-2; BASU AK, 1987, BIOCHEMISTRY-US, V26, P5626, DOI 10.1021/bi00392a007; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Calabretta A, 2013, BIOCHEMISTRY-US, V52, P1990, DOI 10.1021/bi400116y; Carvalho VM, 2000, CHEM RES TOXICOL, V13, P397, DOI 10.1021/tx9901682; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Chowdhury G., 2011, CURR PROTOC NUCL ACI, P1; Chowdhury G., 2016, ENCY ANAL CHEM; Christov PP, 2009, CHEM RES TOXICOL, V22, P1086, DOI 10.1021/tx900047c; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; DeMott M. S., 2010, CHEM BIOL DNA DAMAGE, P21; DUDOCK BS, 1969, P NATL ACAD SCI USA, V62, P941, DOI 10.1073/pnas.62.3.941; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; Erickson RP, 2003, MUTAT RES-REV MUTAT, V543, P125, DOI 10.1016/S1383-5742(03)00010-3; FEDTKE N, 1990, CARCINOGENESIS, V11, P1287, DOI 10.1093/carcin/11.8.1287; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; GUENGERICH FP, 1992, J AM CHEM SOC, V114, P1074, DOI 10.1021/ja00029a041; INOUE Y, 1979, BIOPOLYMERS, V18, P2175, DOI 10.1002/bip.1979.360180908; KOUCHAKDJIAN M, 1991, BIOCHEMISTRY-US, V30, P1820, DOI 10.1021/bi00221a014; LAIB RJ, 1981, CHEM-BIOL INTERACT, V37, P219, DOI 10.1016/0009-2797(81)90179-4; LEONARD GA, 1994, BIOCHEMISTRY-US, V33, P4755, DOI 10.1021/bi00182a002; LEONARD NJ, 1984, CRC CR REV BIOCH MOL, V15, P125, DOI 10.3109/10409238409102299; LEONARD NJ, 1993, CHEMTRACTS BIOCH MOL, V4, P251; LEONARD NJ, 1992, CHEMTRACTS BIOCH MOL, V3, P273; Levine RL, 2000, CANCER RES, V60, P4098; Levine RL, 2001, J BIOL CHEM, V276, P18717, DOI 10.1074/jbc.M102158200; MALAVEILLE C, 1975, BIOCHEM BIOPH RES CO, V63, P363, DOI 10.1016/0006-291X(75)90697-X; MCCANN J, 1975, P NATL ACAD SCI USA, V72, P5135, DOI 10.1073/pnas.72.12.5135; Moriya M, 1999, IARC SCI PUBL, P263; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandya GA, 1996, BIOCHEMISTRY-US, V35, P11487, DOI 10.1021/bi960170h; Patra A, 2015, J BIOL CHEM, V290, P8028, DOI 10.1074/jbc.M115.637561; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; SANTOS CD, 1991, BIOCHEMISTRY-US, V30, P1828, DOI 10.1021/bi00221a015; SAPARBAEV M, 1995, NUCLEIC ACIDS RES, V23, P3750, DOI 10.1093/nar/23.18.3750; SATTSANGI PD, 1977, J ORG CHEM, V42, P3292, DOI 10.1021/jo00440a020; SECRIST JA, 1972, BIOCHEMISTRY-US, V11, P3499, DOI 10.1021/bi00769a001; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; SINGER B, 1984, CARCINOGENESIS, V5, P1165, DOI 10.1093/carcin/5.9.1165; SINGER B, 1992, P NATL ACAD SCI USA, V89, P9386, DOI 10.1073/pnas.89.20.9386; SPENCER RD, 1974, EUR J BIOCHEM, V45, P425, DOI 10.1111/j.1432-1033.1974.tb03566.x; SWENBERG JA, 1992, CARCINOGENESIS, V13, P727, DOI 10.1093/carcin/13.4.727; Swenberg JA, 2011, TOXICOL SCI, V120, pS130, DOI 10.1093/toxsci/kfq371; Tolentino JH, 2008, NUCLEIC ACIDS RES, V36, P1300, DOI 10.1093/nar/gkm1157; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Weismann CG, 2007, CURR OPIN CARDIOL, V22, P200, DOI 10.1097/HCO.0b013e3280f629c7; Wessels MW, 2010, CLIN GENET, V78, P103, DOI 10.1111/j.1399-0004.2010.01435.x; Wickramaratne S, 2015, J BIOL CHEM, V290, P775, DOI 10.1074/jbc.M114.613638; Yuan BF, 2008, J BIOL CHEM, V283, P23665, DOI 10.1074/jbc.M804047200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhao LL, 2012, ANGEW CHEM INT EDIT, V51, P5466, DOI 10.1002/anie.201109004	56	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14134	14145		10.1074/jbc.M116.732487	http://dx.doi.org/10.1074/jbc.M116.732487			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226627	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000379975100021
J	Shcherbatko, A; Rossi, A; Foletti, D; Zhu, GY; Bogin, O; Casas, MG; Rickert, M; Hasa-Moreno, A; Bartsevich, V; Crameri, A; Steiner, AR; Henningsen, R; Gill, A; Pons, J; Shelton, DL; Rajpal, A; Strop, P				Shcherbatko, Anatoly; Rossi, Andrea; Foletti, Davide; Zhu, Guoyun; Bogin, Oren; Casas, Meritxell Galindo; Rickert, Mathias; Hasa-Moreno, Adela; Bartsevich, Victor; Crameri, Andreas; Steiner, Alexander R.; Henningsen, Robert; Gill, Avinash; Pons, Jaume; Shelton, David L.; Rajpal, Arvind; Strop, Pavel			Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						directed evolution; pain; sodium channel; structure-function; toxin; ceratotoxin; Nav1; 7; engineering	SPIDER-VENOM PEPTIDES; II VOLTAGE SENSOR; HUWENTOXIN-IV; DOMAIN-II; ANALGESIC TARGET; GATING MODIFIER; HAINANTOXIN-IV; NA(V)1.7; ANTAGONIST; MODULATORS	The prominent role of voltage-gated sodium channel 1.7 (Nav1.7) in nociception was revealed by remarkable human clinical and genetic evidence. Development of potent and subtype-selective inhibitors of this ion channel is crucial for obtaining therapeutically useful analgesic compounds. Microproteins isolated from animal venoms have been identified as promising therapeutic leads for ion channels, because they naturally evolved to be potent ion channel blockers. Here, we report the engineering of highly potent and selective inhibitors of the Nav1.7 channel based on tarantula ceratotoxin-1 (CcoTx1). We utilized a combination of directed evolution, saturation mutagenesis, chemical modification, and rational drug design to obtain higher potency and selectivity to the Nav1.7 channel. The resulting microproteins are highly potent (IC50 to Nav1.7 of 2.5 nm) and selective. We achieved 80- and 20-fold selectivity over the closely related Nav1.2 and Nav1.6 channels, respectively, and the IC50 on skeletal (Nav1.4) and cardiac (Nav1.5) sodium channels is above 3000 nm. The lead molecules have the potential for future clinical development as novel therapeutics in the treatment of pain.	[Shcherbatko, Anatoly; Rossi, Andrea; Foletti, Davide; Zhu, Guoyun; Casas, Meritxell Galindo; Rickert, Mathias; Hasa-Moreno, Adela; Pons, Jaume; Shelton, David L.; Rajpal, Arvind; Strop, Pavel] Pfizer Inc, Rinat Labs, San Francisco, CA 94080 USA; [Steiner, Alexander R.; Henningsen, Robert; Gill, Avinash] Sutro Biopharma, San Francisco, CA 94080 USA; [Bogin, Oren; Bartsevich, Victor; Crameri, Andreas] Amunix, Mountain View, CA 94043 USA; [Foletti, Davide] 23andme, 899 W Evelyn Ave, Mountain View, CA 94041 USA; [Bogin, Oren] Chan Bio Ltd, IL-69416 Tel Aviv, Israel; [Rickert, Mathias] Delinia Biosci, 953 Indiana St, San Francisco, CA USA; [Bartsevich, Victor] Precis BioSci, 302 E Pettigrew St, Durham, NC 27701 USA; [Crameri, Andreas] GlaxoSmithKline, Stevenage SG1 2NY, Herts, England; [Gill, Avinash] Genentech Inc, 1DNA Way, San Francisco, CA 94080 USA; [Pons, Jaume] Alexo Therapeut, San Francisco, CA 94080 USA; [Rajpal, Arvind; Strop, Pavel] Bristol Myers Squibb, 700 Bay Rd, Redwood City, CA 94063 USA	Pfizer; GlaxoSmithKline; Roche Holding; Genentech; Bristol-Myers Squibb	Strop, P (corresponding author), Bristol Myers Squibb, 700 Bay Rd, Redwood City, CA 94063 USA.	pavel.strop@bms.com		Galindo Casas, Meritxell/0000-0002-5034-1722				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Billen B, 2008, CURR PHARM DESIGN, V14, P2492, DOI 10.2174/138161208785777423; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; Cai TF, 2015, PEPTIDES, V68, P148, DOI 10.1016/j.peptides.2014.09.005; Chessell IP, 2012, DRUG DISCOV TODAY, V17, P875, DOI 10.1016/j.drudis.2012.03.005; Chow CY, 2015, TOXINS, V7, P2494, DOI 10.3390/toxins7072494; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Estacion M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-92; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Gilchrist John, 2014, Handb Exp Pharmacol, V221, P203, DOI 10.1007/978-3-642-41588-3_10; Goldberg DS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-770; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Harvey AL, 2014, TOXICON, V92, P193, DOI 10.1016/j.toxicon.2014.10.020; King GF, 2014, ACS CHEM NEUROSCI, V5, P749, DOI 10.1021/cn500171p; Klint JK, 2015, BRIT J PHARMACOL, V172, P2445, DOI 10.1111/bph.13081; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lee CW, 2004, BIOCHEMISTRY-US, V43, P890, DOI 10.1021/bi0353373; Lee JH, 2014, CELL, V157, P1393, DOI 10.1016/j.cell.2014.03.064; Li DL, 2004, J BIOL CHEM, V279, P37734, DOI 10.1074/jbc.M405765200; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minassian NA, 2013, J BIOL CHEM, V288, P22707, DOI 10.1074/jbc.M113.461392; Minett MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9967; Murray JK, 2015, J MED CHEM, V58, P2299, DOI 10.1021/jm501765v; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholson GM, 2007, TOXICON, V49, P490, DOI 10.1016/j.toxicon.2006.11.027; Ogata N, 2002, JPN J PHARMACOL, V88, P365, DOI 10.1254/jjp.88.365; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Packer MS, 2015, NAT REV GENET, V16, P379, DOI 10.1038/nrg3927; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Park JH, 2014, J MED CHEM, V57, P6623, DOI 10.1021/jm500687u; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Pineda SS, 2014, FUTURE MED CHEM, V6, P1699, DOI [10.4155/FMC.14.103, 10.4155/fmc.14.103]; Revell JD, 2013, PEPTIDES, V44, P40, DOI 10.1016/j.peptides.2013.03.011; Rong MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065984; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Takahashi H, 2000, J MOL BIOL, V297, P771, DOI 10.1006/jmbi.2000.3609; Takeuchi K, 2002, J MOL BIOL, V321, P517, DOI 10.1016/S0022-2836(02)00595-8; Tripathi A, 2014, CURR OPIN STRUC BIOL, V24, P63, DOI 10.1016/j.sbi.2013.12.001; Wood DLA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-375; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Yang SL, 2013, P NATL ACAD SCI USA, V110, P17534, DOI 10.1073/pnas.1306285110; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Zawada JF, 2011, BIOTECHNOL BIOENG, V108, P1570, DOI 10.1002/bit.23103	51	44	45	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					13974	13986		10.1074/jbc.M116.725978	http://dx.doi.org/10.1074/jbc.M116.725978			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129258	hybrid, Green Published			2022-12-28	WOS:000379975100007
J	Wang, T; Xu, WC; Qin, ML; Yang, Y; Bao, PH; Shen, FX; Zhang, ZL; Xu, J				Wang, Tao; Xu, Wangchao; Qin, Meiling; Yang, Yi; Bao, Puhua; Shen, Fuxiao; Zhang, Zhenlin; Xu, Jin			Pathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); endoplasmic reticulum-associated protein degradation (ERAD); post-translational modification (PTM); stress granule; stress response; sumoylation; hexamer; valosin-containing protein; p97 (VCP)	NEURODEGENERATIVE DISEASES; AAA-ATPASE; OXIDATIVE STRESS; QUALITY-CONTROL; PROTEIN VCP; SUMO; COMPLEX; DEGRADATION; PROTEOSTASIS; MECHANISMS	Valosin-containing protein/p97(VCP) is a hexameric ATPase vital to protein degradation during endoplasmic reticulum stress. It regulates diverse cellular functions including autophagy, chromatin remodeling, and DNA repair. In addition, mutations in VCP cause inclusion body myopathy, Paget disease of the bone, and frontotemporal dementia (IBMPFD), as well as amyotrophic lateral sclerosis. Nevertheless, how the VCP activities were regulated and how the pathogenic mutations affect the function of VCP during stress are not unclear. Here we show that the small ubiquitin-like modifier (SUMO)-ylation of VCP is a normal stress response inhibited by the disease-causing mutations in the N-domain. Under oxidative and endoplasmic reticulum stress conditions, the SUMOylation of VCP facilitates the distribution of VCP to stress granules and nucleus, and promotes the VCP hexamer assembly. In contrast, pathogenic mutations in the VCP N-domain lead to reduced SUMOylation and weakened VCP hexamer formation upon stress. Defective SUMOylation of VCP also causes altered co-factor binding and attenuated endoplasmic reticulum-associated protein degradation. Furthermore, SUMO-defective VCP fails to protect against stress-induced toxicity in Drosophila. Therefore, our results have revealed SUMOylation as a molecular signaling switch to regulate the distribution and functions of VCP during stress response, and suggest that deficiency in VCP SUMOylation caused by pathogenic mutations will render cells vulnerable to stress insults.	[Wang, Tao; Xu, Wangchao; Qin, Meiling; Yang, Yi; Bao, Puhua; Shen, Fuxiao; Xu, Jin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Xu, Wangchao; Yang, Yi] Univ Chinese Acad Sci, Shanghai 200031, Peoples R China; [Zhang, Zhenlin] Shanghai Jiao Tong Univ, Dept Osteoporosis & Bone Dis, Metab Bone Dis & Genet Res Unit, Affiliated Peoples Hosp 6, Shanghai 200233, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University	Xu, J (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai 200031, Peoples R China.	Jin.Xu@ion.ac.cn		Xu, Jin/0000-0001-6617-5311; Wang, Tao/0000-0002-8177-0298	Hundreds of Talents Program, Chinese Academy of Sciences; State Key Laboratory of Neuroscience, Shanghai Pujiang Talent Program Grant [12PJ1410000]; National Science Foundation of China [81371402]	Hundreds of Talents Program, Chinese Academy of Sciences; State Key Laboratory of Neuroscience, Shanghai Pujiang Talent Program Grant; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Hundreds of Talents Program, Chinese Academy of Sciences, the State Key Laboratory of Neuroscience, Shanghai Pujiang Talent Program Grant 12PJ1410000, and National Science Foundation of China Grant 81371402 (to J. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028; Becker J, 2013, NAT STRUCT MOL BIOL, V20, P525, DOI 10.1038/nsmb.2526; Bergink S, 2013, NAT CELL BIOL, V15, P526, DOI 10.1038/ncb2729; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bohm S, 2011, MOL CELL BIOL, V31, P1528, DOI 10.1128/MCB.00962-10; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Buchberger A, 2015, FEBS LETT, V589, P2578, DOI 10.1016/j.febslet.2015.08.028; Chang YC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001288; Chapman E, 2011, MOL BIOSYST, V7, P700, DOI 10.1039/c0mb00176g; Dorval V, 2007, BBA-MOL CELL RES, V1773, P694, DOI 10.1016/j.bbamcr.2007.03.017; Eifler K, 2015, FEBS J, V282, P3669, DOI 10.1111/febs.13378; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; Fessart D, 2013, CANCER LETT, V337, P26, DOI 10.1016/j.canlet.2013.05.030; Foresti O, 2014, SCIENCE, V346, P751, DOI 10.1126/science.1255638; Fujita K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2828; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gu JM, 2013, BONE, V52, P9, DOI 10.1016/j.bone.2012.09.012; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Hubbers CU, 2007, BRAIN, V130, P381, DOI 10.1093/brain/awl238; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Landgrave-Gomez J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00058; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Mathias RA, 2015, MOL CELL PROTEOMICS, V14, P456, DOI 10.1074/mcp.O114.046565; Matsuzaki S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10730; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Mori-Konya C, 2009, GENES CELLS, V14, P483, DOI 10.1111/j.1365-2443.2009.01286.x; Nakamura T, 2012, EXP NEUROL, V238, P12, DOI 10.1016/j.expneurol.2012.06.032; Nalbandian A, 2011, J MOL NEUROSCI, V45, P522, DOI 10.1007/s12031-011-9627-y; Nie MH, 2012, J BIOL CHEM, V287, P29610, DOI 10.1074/jbc.M112.379768; Peng YR, 2010, J NEUROSCI, V30, P16220, DOI 10.1523/JNEUROSCI.3085-10.2010; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Sahin U, 2014, J CELL BIOL, V204, P931, DOI 10.1083/jcb.201305148; Seguin SJ, 2014, CELL DEATH DIFFER, V21, P1838, DOI 10.1038/cdd.2014.103; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; Song CC, 2015, BBA-MOL CELL RES, V1853, P222, DOI 10.1016/j.bbamcr.2014.10.019; Tammsalu T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005146; Tirard M, 2012, P NATL ACAD SCI USA, V109, P21122, DOI 10.1073/pnas.1215366110; Tong L, 2015, MOL NEUROBIOL, V51, P1221, DOI 10.1007/s12035-014-8797-3; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; Wang Q, 2003, BIOCHEM BIOPH RES CO, V300, P253, DOI 10.1016/S0006-291X(02)02840-1; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Zhang Z, 2013, DEV CELL, V25, P636, DOI 10.1016/j.devcel.2013.05.006; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhou T, 2012, NAT PROTOC, V7, P2080, DOI 10.1038/nprot.2012.115	65	36	37	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14373	14384		10.1074/jbc.M116.729343	http://dx.doi.org/10.1074/jbc.M116.729343			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226613	hybrid, Green Published			2022-12-28	WOS:000379975100039
J	Qvit, N; Joshi, AU; Cunningham, AD; Ferreira, JCB; Mochly-Rosen, D				Qvit, Nir; Joshi, Amit U.; Cunningham, Anna D.; Ferreira, Julio C. B.; Mochly-Rosen, Daria			Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Protein-Protein Interaction Inhibitor Reveals a Non-catalytic Role for GAPDH Oligomerization in Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						docking; oligomerization; oxidative stress; peptides; protein kinase; protein kinase C (PKC); protein structure; Pseudosubstrate; glyceraldehyde-3-phosphate dehydrogenase (GAPDH); mitochondria elimination	KINASE-C; DOCKING-SITE; NUCLEAR TRANSLOCATION; DELTA-PKC; REGULATORY DOMAIN; CARDIAC ISCHEMIA; MAP KINASES; EPSILON-PKC; CYCLIN-A; IDENTIFICATION	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), an important glycolytic enzyme, has a non-catalytic (thus a non-canonical) role in inducing mitochondrial elimination under oxidative stress. We recently demonstrated that phosphorylation of GAPDH by protein kinase C (PKC) inhibits this GAPDH-dependent mitochondrial elimination. PKC phosphorylation of GAPDH correlates with increased cell injury following oxidative stress, suggesting that inhibiting GAPDH phosphorylation should decrease cell injury. Using rational design, we identified pseudo-GAPDH (GAPDH) peptide, an inhibitor of PKC-mediated GAPDH phosphorylation that does not inhibit the phosphorylation of other PKC substrates. Unexpectedly, GAPDH decreased mitochondrial elimination and increased cardiac damage in an animal model of heart attack. Either treatment with GAPDH or direct phosphorylation of GAPDH by PKC decreased GAPDH tetramerization, which corresponded to reduced GAPDH glycolytic activity in vitro and ex vivo. Taken together, our study identified the potential mechanism by which oxidative stress inhibits the protective GAPDH-mediated elimination of damaged mitochondria. Our study also identified a pharmacological tool, GAPDH peptide, with interesting properties. GAPDH peptide is an inhibitor of the interaction between PKC and GAPDH and of the resulting phosphorylation of GAPDH by PKC. GAPDH peptide is also an inhibitor of GAPDH oligomerization and thus an inhibitor of GAPDH glycolytic activity. Finally, we found that GAPDH peptide is an inhibitor of the elimination of damaged mitochondria. We discuss how this unique property of increasing cell damage following oxidative stress suggests a potential use for GAPDH peptide-based therapy.	[Qvit, Nir; Joshi, Amit U.; Cunningham, Anna D.; Mochly-Rosen, Daria] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Ferreira, Julio C. B.] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, BR-05508000 Sao Paulo, Brazil	Stanford University; Universidade de Sao Paulo	Qvit, N; Mochly-Rosen, D (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	nirqvit@stanford.edu; mochly@stanford.edu	Ferreira, Julio Cesar Batista/AEU-0494-2022; Joshi, Amit/U-3832-2018; Ferreira, Julio/L-4687-2019; Ferreira, Julio Cesar Batista/I-3177-2012	Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Joshi, Amit/0000-0002-2472-7672; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Mochly-Rosen, Daria/0000-0002-6691-8733	National Institutes of Health [HL52141]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL52141 (to D. M.-R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams PD, 1999, MOL CELL BIOL, V19, P1068; Adams PD, 1996, MOL CELL BIOL, V16, P6623; BAIER G, 1993, J BIOL CHEM, V268, P4997; Begley R, 2004, BIOCHEM BIOPH RES CO, V318, P949, DOI 10.1016/j.bbrc.2004.04.121; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chen L, 2001, CHEM BIOL, V8, P1123, DOI 10.1016/S1074-5521(01)00076-X; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Churchill EN, 2005, CIRC RES, V97, P78, DOI 10.1161/01.RES.0000173896.32522.6e; Dastoor Z, 2001, J CELL SCI, V114, P1643; DeLano W.L, PYMOL MOL GRAPHICS S; Eaton P, 2002, J MOL CELL CARDIOL, V34, P1549, DOI 10.1006/jmcc.2002.2108; El Kadmiri N, 2014, PATHOL BIOL, V62, P333, DOI 10.1016/j.patbio.2014.08.002; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Guharoy M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-286; Guo CM, 2013, CLIN TRANSL ONCOL, V15, P167, DOI 10.1007/s12094-012-0924-x; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; HOAGLAND VD, 1969, BIOCHEMISTRY-US, V8, P594, DOI 10.1021/bi00830a020; Holland PM, 1999, CURR BIOL, V9, pR329, DOI 10.1016/S0960-9822(99)80205-X; Hoshino A, 2012, J MOL CELL CARDIOL, V52, P175, DOI 10.1016/j.yjmcc.2011.10.008; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Hwang S, 2015, EMBO MOL MED, V7, P1307, DOI 10.15252/emmm.201505256; Inagaki K, 2003, CIRCULATION, V108, P2304, DOI 10.1161/01.CIR.0000101682.24138.36; Inagaki K, 2003, CIRCULATION, V108, P869, DOI 10.1161/01.CIR.0000081943.93653.73; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Kim EH, 2007, CANCER RES, V67, P6333, DOI 10.1158/0008-5472.CAN-06-4344; KUMAGAI H, 1983, J BIOCHEM-TOKYO, V93, P1259, DOI 10.1093/oxfordjournals.jbchem.a134260; Lee S, 2003, P NATL ACAD SCI USA, V100, P14707, DOI 10.1073/pnas.2534493100; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Li J, 2005, J BIOL CHEM, V280, P8351, DOI 10.1074/jbc.M409431200; Lonn P, 2015, EXPERT OPIN DRUG DEL, V12, P1627, DOI 10.1517/17425247.2015.1046431; Luciani MG, 2000, J MOL BIOL, V300, P503, DOI 10.1006/jmbi.2000.3830; Ma S, 2015, BBA-MOL BASIS DIS, V1852, P271, DOI 10.1016/j.bbadis.2014.05.010; Mazzola JL, 2003, BBA-GEN SUBJECTS, V1622, P50, DOI 10.1016/S0304-4165(03)00117-X; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Murriel CL, 2004, J BIOL CHEM, V279, P47985, DOI 10.1074/jbc.M405071200; NOLAND TA, 1989, J BIOL CHEM, V264, P20778; Novotny-Diermayr V, 2002, J BIOL CHEM, V277, P49134, DOI 10.1074/jbc.M206727200; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Quinsay MN, 2010, AUTOPHAGY, V6, P855, DOI 10.4161/auto.6.7.13005; Qvit Nir, 2010, Drug Discov Today Dis Mech, V7, pe87, DOI 10.1016/j.ddmec.2010.07.001; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Rizzuti M, 2015, DRUG DISCOV TODAY, V20, P76, DOI 10.1016/j.drudis.2014.09.017; Roitel O, 2003, J MOL BIOL, V326, P1513, DOI 10.1016/S0022-2836(03)00049-4; Saunders PA, 1997, J NEUROCHEM, V69, P1820; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Seidler N. W., 2012, GAPDH BIOL PROPERTIE, P207; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; SODERLING TR, 1990, J BIOL CHEM, V265, P1823; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Tatton NA, 2000, EXP NEUROL, V166, P29, DOI 10.1006/exnr.2000.7489; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Werbovetz KA, 2000, CURR MED CHEM, V7, P835, DOI 10.2174/0929867003374615; White MR, 2015, J BIOL CHEM, V290, P1770, DOI 10.1074/jbc.M114.618165; Yogalingam G, 2013, J BIOL CHEM, V288, P18947, DOI 10.1074/jbc.M113.466870; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	67	17	20	4	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13608	13621		10.1074/jbc.M115.711630	http://dx.doi.org/10.1074/jbc.M115.711630			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129213	Green Published, hybrid			2022-12-28	WOS:000379771100018
J	Zhu, SZ; Hegemann, JD; Fage, CD; Zimmermann, M; Xie, XL; Linne, U; Marahiel, MA				Zhu, Shaozhou; Hegemann, Julian D.; Fage, Christopher D.; Zimmermann, Marcel; Xie, Xiulan; Linne, Uwe; Marahiel, Mohamed A.			Insights into the Unique Phosphorylation of the Lasso Peptide Paeninodin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; biosynthesis; natural product; phosphorylation; post-translational modification; Firmicutes; Lasso peptide; RiPP; kinase	INDEPENDENT-MUTAGENESIS SLIM; NONCANONICAL AMINO-ACIDS; MICROCIN J25; MASS-SPECTROMETRY; HPR KINASE/PHOSPHORYLASE; NATURAL-PRODUCTS; LEADER PEPTIDE; CYCLOSPORINE-A; BOND FORMATION; I-III	Lasso peptides are a new class of ribosomally synthesized and post-translationally modified peptides and thus far are only isolated from proteo- and actinobacterial sources. Typically, lasso peptide biosynthetic gene clusters encode enzymes for biosynthesis and export but not for tailoring. Here, we describe the isolation of the novel lasso peptide paeninodin from the firmicute Paenibacillus dendritiformis C454 and reveal within its biosynthetic cluster a gene encoding a kinase, which we have characterized as a member of a new class of lasso peptide-tailoring kinases. By employing a wide variety of peptide substrates, it was shown that this novel type of kinase specifically phosphorylates the C-terminal serine residue while ignoring those located elsewhere. These experiments also reveal that no other recognition motif is needed for efficient enzymatic phosphorylation of the C-terminal serine. Furthermore, through comparison with homologous HPr kinases and subsequent mutational analysis, we confirmed the essential catalytic residues. Our study reveals how lasso peptides are chemically diversified and sets the foundation for rational engineering of these intriguing natural products.	[Zhu, Shaozhou; Hegemann, Julian D.; Fage, Christopher D.; Zimmermann, Marcel; Xie, Xiulan; Linne, Uwe; Marahiel, Mohamed A.] Univ Marburg, LOEWE Ctr Synthet Microbiol, Dept Chem Biochem, D-35032 Marburg, Germany	Philipps University Marburg	Marahiel, MA (corresponding author), Univ Marburg, Fachbereich Chem Biochem, Hans Meerwein Str 4, D-35032 Marburg, Germany.	marahiel@staff.uni-marburg.de	Hegemann, Julian D./AAU-6461-2020	Hegemann, Julian D./0000-0002-3859-8744; Fage, Christopher Dane/0000-0001-5015-644X; Zimmermann, Marcel/0000-0001-7871-4052	Deutsche Forschungsgemeinschaft; LOEWE Center for Synthetic Microbiology; China Scholarship Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE Center for Synthetic Microbiology; China Scholarship Council(China Scholarship Council)	This work was supported in part by the Deutsche Forschungsgemeinschaft and the LOEWE Center for Synthetic Microbiology. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the China Scholarship Council.	Al Toma RS, 2015, CHEMBIOCHEM, V16, P503, DOI 10.1002/cbic.201402558; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Burkhart BJ, 2015, NAT CHEM BIOL, V11, P564, DOI 10.1038/nchembio.1856; BYSTROV VF, 1988, TETRAHEDRON, V44, P925, DOI 10.1016/S0040-4020(01)86126-3; Cheung WL, 2010, J AM CHEM SOC, V132, P2514, DOI 10.1021/ja910191u; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Chiu J, 2008, J MICROBIOL METH, V73, P195, DOI 10.1016/j.mimet.2008.02.013; Choudhury HG, 2014, P NATL ACAD SCI USA, V111, P9145, DOI 10.1073/pnas.1320506111; Clarke DJ, 2007, ORG BIOMOL CHEM, V5, P2564, DOI 10.1039/b708478a; Ducasse R, 2012, CHEMBIOCHEM, V13, P371, DOI 10.1002/cbic.201100702; Elsard SS, 2015, J ORG CHEM, V80, P10252, DOI 10.1021/acs.joc.5b01878; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Fieulaine S, 2002, P NATL ACAD SCI USA, V99, P13437, DOI 10.1073/pnas.192368699; Gavrish E, 2014, CHEM BIOL, V21, P509, DOI 10.1016/j.chembiol.2014.01.014; Hegemann JD, 2016, MOL BIOSYST, V12, P1106, DOI 10.1039/c6mb00081a; Hegemann JD, 2015, ACCOUNTS CHEM RES, V48, P1909, DOI 10.1021/acs.accounts.5b00156; Hegemann JD, 2014, J MED CHEM, V57, P5829, DOI 10.1021/jm5004478; Hegemann JD, 2014, ANGEW CHEM INT EDIT, V53, P2230, DOI 10.1002/anie.201309267; Hegemann JD, 2013, BIOPOLYMERS, V100, P527, DOI 10.1002/bip.22326; Hegemann JD, 2013, J AM CHEM SOC, V135, P210, DOI 10.1021/ja308173b; Inokoshi J, 2012, APPL MICROBIOL BIOT, V95, P451, DOI 10.1007/s00253-012-3973-8; Jeanne Dit Fouque K, 2015, ANAL CHEM, V87, P1166, DOI 10.1021/ac503772n; KESSLER H, 1990, HELV CHIM ACTA, V73, P1818, DOI 10.1002/hlca.19900730703; Klages J, 2005, CHEMBIOCHEM, V6, P1672, DOI 10.1002/cbic.200500146; Knappe TA, 2009, CHEM BIOL, V16, P1290, DOI 10.1016/j.chembiol.2009.11.009; Li YY, 2015, ACS CHEM BIOL, V10, P2641, DOI 10.1021/acschembio.5b00584; Maksimov MO, 2015, J BIOL CHEM, V290, P30806, DOI 10.1074/jbc.M115.694083; Maksimov MO, 2014, J IND MICROBIOL BIOT, V41, P333, DOI 10.1007/s10295-013-1357-4; Maksimov MO, 2013, J AM CHEM SOC, V135, P12038, DOI 10.1021/ja4054256; Maksimov MO, 2012, P NATL ACAD SCI USA, V109, P15223, DOI 10.1073/pnas.1208978109; Maksimov MO, 2012, NAT PROD REP, V29, P996, DOI 10.1039/c2np20070h; Metelev M, 2015, CHEM BIOL, V22, P241, DOI 10.1016/j.chembiol.2014.11.017; Nessler S, 2005, BBA-PROTEINS PROTEOM, V1754, P126, DOI 10.1016/j.bbapap.2005.07.042; Pan SJ, 2012, CHEM COMMUN, V48, P1880, DOI 10.1039/c2cc17211a; Pavlova O, 2008, J BIOL CHEM, V283, P25589, DOI 10.1074/jbc.M803995200; Piscotta FJ, 2015, CHEM COMMUN, V51, P409, DOI 10.1039/c4cc07778d; Poncet S, 2004, BBA-PROTEINS PROTEOM, V1697, P123, DOI 10.1016/j.bbapap.2003.11.018; Rosengren KJ, 2003, J AM CHEM SOC, V125, P12464, DOI 10.1021/JA0367703; Sirota-Madi A, 2012, J BACTERIOL, V194, P2127, DOI 10.1128/JB.00158-12; Solbiati JO, 1999, J BACTERIOL, V181, P2659, DOI 10.1128/JB.181.8.2659-2662.1999; Wieckowski BM, 2015, FEBS LETT, V589, P1802, DOI 10.1016/j.febslet.2015.05.032; WILLKER W, 1993, MAGN RESON CHEM, V31, P287, DOI 10.1002/mrc.1260310315; Xie XL, 2012, CHEMBIOCHEM, V13, P621, DOI 10.1002/cbic.201100754; Yan KP, 2012, CHEMBIOCHEM, V13, P1046, DOI 10.1002/cbic.201200016; Zimmermann M, 2014, CHEM SCI, V5, P4032, DOI 10.1039/c4sc01428f; Zimmermann M, 2013, CHEM BIOL, V20, P558, DOI 10.1016/j.chembiol.2013.03.013	46	75	75	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13662	13678		10.1074/jbc.M116.722108	http://dx.doi.org/10.1074/jbc.M116.722108			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27151214	Green Published, hybrid			2022-12-28	WOS:000379771100022
J	Chen, YF; Pan, KW; Wang, PZ; Cao, ZY; Wang, WB; Wang, SY; Hu, NG; Xue, JH; Li, H; Jiang, W; Li, G; Zhang, XW				Chen, Yifan; Pan, Kewu; Wang, Pingzhang; Cao, Zhengyi; Wang, Weibin; Wang, Shuya; Hu, Ningguang; Xue, Junhui; Li, Hui; Jiang, Wei; Li, Gang; Zhang, Xiaowei			HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSOR HBP1; INDUCED PREMATURE SENESCENCE; HUMAN FIBROBLASTS; GENE-EXPRESSION; IMMUNE CELLS; CANCER CELLS; DNA-DAMAGE; P53; ACTIVATION; P16	The activity of the CDK inhibitor p21 is associated with diverse biological activities, including cell proliferation, senescence, and tumorigenesis. However, the mechanisms governing transcription of p21 need to be extensively studied. In this study, we demonstrate that the high-mobility group box-containing protein 1 (HBP1) transcription factor is a novel activator of p21 that works as part of a complex mechanism during senescence and tumorigenesis. We found that HBP1 activates the p21 gene through enhancing p53 stability by inhibiting Mdm2-mediated ubiquitination of p53, a well known positive regulator of p21. HBP1 was also found to enhance p21 transcription by inhibiting Wnt/beta-catenin signaling. We identified histone methyltransferase EZH2, the catalytic subunit of polycomb repressive complex 2, as a target of Wnt/beta-catenin signaling. HBP1-mediated repression of EZH2 through Wnt/beta-catenin signaling decreased the level of trimethylation of histone H3 at lysine 27 of overall and specific histone on the p21 promoter, resulting in p21 transactivation. Although intricate, the reciprocal partnership of HBP1 and p21 has exceptional importance. HBP1-mediated elevation of p21 through the Mdm2/p53 and TCF4/EZH2 pathways contributes to both cellular senescence and tumor inhibition. Together, our results suggest that the HBP1 transcription factor orchestrates a complex regulation of key genes during cellular senescence and tumorigenesis with an impact on protein ubiquitination and overall histone methylation state.	[Chen, Yifan; Pan, Kewu; Cao, Zhengyi; Wang, Weibin; Wang, Shuya; Hu, Ningguang; Xue, Junhui; Li, Hui; Jiang, Wei; Li, Gang; Zhang, Xiaowei] Peking Univ, Beijing Key Lab Prot Posttranslat Modificat & Cel, Dept Biochem & Mol Biol, Sch Basic Med Sci,Hlth Sci Ctr, Beijing 100191, Peoples R China; [Wang, Pingzhang] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Immunol, Beijing 100191, Peoples R China	Peking University; Peking University	Zhang, XW (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China.	xiaoweizhang@bjmu.edu.cn			National Natural Science Foundation of China [81170320, 31471292, 81572705]; Beijing Natural Science Foundation [5162013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China Grants 81170320, 31471292, and 81572705 and Beijing Natural Science Foundation Grant 5162013. The authors declare that they have no conflicts of interest with the contents of this article.	Bai J, 2014, DNA CELL BIOL, V33, P337, DOI 10.1089/dna.2014.2340; Baygi ME, 2010, CELL BIOL TOXICOL, V26, P553, DOI 10.1007/s10565-010-9163-5; Becker TM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-4; Bellei B, 2008, CELL SIGNAL, V20, P1750, DOI 10.1016/j.cellsig.2008.06.001; Berasi SP, 2004, MOL CELL BIOL, V24, P3011, DOI 10.1128/MCB.24.7.3011-3024.2004; Cao LL, 2016, ONCOGENE, V35, P301, DOI 10.1038/onc.2015.81; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Chen YC, 2010, ONCOGENE, V29, P3067, DOI 10.1038/onc.2010.97; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Cipriano R, 2011, P NATL ACAD SCI USA, V108, P8668, DOI 10.1073/pnas.1015022108; Escamilla-Powers JR, 2010, J BIOL CHEM, V285, P4847, DOI 10.1074/jbc.M109.074856; Gartel AL, 1998, ONCOGENE, V17, P3463, DOI 10.1038/sj.onc.1202240; Gu ZF, 2014, MOL CELL BIOCHEM, V387, P27, DOI 10.1007/s11010-013-1866-5; Hornsby PJ, 2007, J CLIN ONCOL, V25, P1852, DOI 10.1200/JCO.2006.10.3101; Jackson DP, 2014, MOL PHARMACOL, V85, P533, DOI 10.1124/mol.113.089730; Jackson JG, 2006, CANCER RES, V66, P8356, DOI 10.1158/0008-5472.CAN-06-1752; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lee KW, 2015, CANCER RES, V75, P73, DOI 10.1158/0008-5472.CAN-14-0350; Lemercier C, 2000, MOL CELL BIOL, V20, P6627, DOI 10.1128/MCB.20.18.6627-6637.2000; Li H, 2010, ONCOGENE, V29, P5083, DOI 10.1038/onc.2010.252; Li J, 2015, STEM CELLS, V33, P951, DOI 10.1002/stem.1908; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Lin KM, 2001, LEUKEMIA, V15, P601, DOI 10.1038/sj.leu.2402071; Liu YQ, 2013, J BIOL CHEM, V288, P11572, DOI 10.1074/jbc.M112.434951; Mattia M, 2007, MOL CELL BIOL, V27, P1309, DOI 10.1128/MCB.01520-06; Meng X, 2014, CANCER RES, V74, P7161, DOI 10.1158/0008-5472.CAN-14-1446; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Negishi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095216; Nejman D, 2014, CANCER RES, V74, P1475, DOI 10.1158/0008-5472.CAN-13-3042; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pan KW, 2013, MOL CELL BIOL, V33, P887, DOI 10.1128/MCB.00637-12; Paulson KE, 2007, CANCER RES, V67, P6136, DOI 10.1158/0008-5472.CAN-07-0567; Pu MT, 2015, GENE DEV, V29, P718, DOI 10.1101/gad.254144.114; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Sashida G, 2009, MOL CELL BIOL, V29, P3687, DOI 10.1128/MCB.01551-08; Shih HH, 2001, MOL CELL BIOL, V21, P5723, DOI 10.1128/MCB.21.17.5723-5732.2001; Tevosian SG, 1997, GENE DEV, V11, P383, DOI 10.1101/gad.11.3.383; Tiwari N, 2013, CANCER CELL, V23, P768, DOI 10.1016/j.ccr.2013.04.020; Vigneron AM, 2012, EMBO J, V31, P471, DOI 10.1038/emboj.2011.402; Wan Q, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav019; Wang CH, 2014, FEBS LETT, V588, P4654, DOI 10.1016/j.febslet.2014.10.037; Wang PZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10370; Wang PZ, 2015, NUCLEIC ACIDS RES, V43, pD1133, DOI 10.1093/nar/gku980; Wang WB, 2014, J BIOL CHEM, V289, P3217, DOI 10.1074/jbc.M113.508515; Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001; Xu HR, 2015, BBA-MOL CELL RES, V1853, P65, DOI 10.1016/j.bbamcr.2014.10.002; Yao CJ, 2005, LEUKEMIA, V19, P1958, DOI 10.1038/sj.leu.2403918; Zhang XW, 2006, MOL CELL BIOL, V26, P8252, DOI 10.1128/MCB.00604-06; Zhuma T, 1999, EMBO J, V18, P6396, DOI 10.1093/emboj/18.22.6396	51	21	26	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12688	12705		10.1074/jbc.M116.714147	http://dx.doi.org/10.1074/jbc.M116.714147			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129219	Green Published, hybrid			2022-12-28	WOS:000378119900023
J	Carlson, ML; Bao, H; Duong, F				Carlson, Michael L.; Bao, Huan; Duong, Franck			Formation of a Chloride-conducting State in the Maltose ATP-binding Cassette (ABC) Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATION CHANNEL; FACING CONFORMATION; ALTERNATING ACCESS; MEMBRANE; WATER; MECHANISM; DRIVES; MODEL; FLUX	ATP-binding cassette transporters use an alternating access mechanism to move substrates across cellular membranes. This mode of transport ensures the selective passage of molecules while preserving membrane impermeability. The crystal structures of MalFGK(2), inward-and outward-facing, show that the transporter is sealed against ions and small molecules. It has yet to be determined whether membrane impermeability is maintained when MalFGK(2) cycles between these two conformations. Through the use of a mutant that resides in intermediate conformations close to the transition state, we demonstrate that not only is chloride conductance occurring, but also to a degree large enough to compromise cell viability. Introduction of mutations in the periplasmic gate lead to the formation of a channel that is quasi-permanently open. MalFGK(2) must therefore stay away from these ion-conducting conformations to preserve the membrane barrier; otherwise, a few mutations that increase access to the ion-conducting states are enough to convert an ATP-binding cassette transporter into a channel.	[Carlson, Michael L.; Bao, Huan; Duong, Franck] Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada; [Bao, Huan] Wisconsin Inst Med Res, Dept Neurosci, Madison, WI 53705 USA	University of British Columbia	Duong, F (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	fduong@mail.ubc.ca		Duong Van Hoa, Franck/0000-0001-7328-6124; Bao, Huan/0000-0002-4301-4627	Canadian Institutes of Health Research; Cellular Dynamics of Macromolecular Complexes NSERC-CREATE scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cellular Dynamics of Macromolecular Complexes NSERC-CREATE scholarship	This work is supported by operating grants from the Canadian Institutes of Health Research. The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a Cellular Dynamics of Macromolecular Complexes NSERC-CREATE scholarship.	Bao H, 2014, J BIOL CHEM, V289, P9844, DOI 10.1074/jbc.M113.545525; Bao H, 2013, BBA-BIOMEMBRANES, V1828, P1723, DOI 10.1016/j.bbamem.2013.03.024; Bao H, 2013, J BIOL CHEM, V288, P3439, DOI 10.1074/jbc.M112.431932; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen TY, 2008, PHYSIOL REV, V88, P351, DOI 10.1152/physrev.00058.2006; COVITZ KMY, 1994, EMBO J, V13, P1752, DOI 10.1002/j.1460-2075.1994.tb06439.x; Davidson AL, 2002, J BACTERIOL, V184, P1225, DOI 10.1128/JB.184.5.1225-1233.2002; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DeFelice LJ, 2007, ANNU REV PHYSIOL, V69, P87, DOI 10.1146/annurev.physiol.69.031905.164816; Duquette PP, 2001, P NATL ACAD SCI USA, V98, P3796, DOI 10.1073/pnas.071245198; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jayaram H, 2008, P NATL ACAD SCI USA, V105, P11194, DOI 10.1073/pnas.0804503105; Jordan IK, 2008, P NATL ACAD SCI USA, V105, P18865, DOI 10.1073/pnas.0806306105; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li J, 2015, CURR OPIN STRUC BIOL, V31, P96, DOI 10.1016/j.sbi.2015.04.001; Li J, 2013, P NATL ACAD SCI USA, V110, P7696, DOI 10.1073/pnas.1218986110; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; MacAulay N, 2002, J PHYSIOL-LONDON, V542, P817, DOI 10.1113/jphysiol.2002.020586; Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200; MALONEY PC, 1974, P NATL ACAD SCI USA, V71, P3896, DOI 10.1073/pnas.71.10.3896; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014; Slotboom DJ, 2014, NAT REV MICROBIOL, V12, P79, DOI 10.1038/nrmicro3175; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; van der Does C, 2004, BIOL CHEM, V385, P927, DOI 10.1515/BC.2004.121; Wen PC, 2011, BIOPHYS J, V101, P680, DOI 10.1016/j.bpj.2011.06.031; WOODBURY DJ, 1990, BIOPHYS J, V58, P833, DOI 10.1016/S0006-3495(90)82429-2	33	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12119	12125		10.1074/jbc.M115.711622	http://dx.doi.org/10.1074/jbc.M115.711622			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27059961	Green Published, hybrid			2022-12-28	WOS:000378092800014
J	Naganuma, T; Takagi, S; Kanetake, T; Kitamura, T; Hattori, S; Miyakawa, T; Sassa, T; Kihara, A				Naganuma, Tatsuro; Takagi, Shuyu; Kanetake, Tsukasa; Kitamura, Takuya; Hattori, Satoko; Miyakawa, Tsuyoshi; Sassa, Takayuki; Kihara, Akio			Disruption of the Sjogren-Larsson Syndrome Gene Aldh3a2 in Mice Increases Keratinocyte Growth and Retards Skin Barrier Recovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY ALDEHYDE DEHYDROGENASE; 1-PHOSPHATE METABOLIC PATHWAY; SPHINGOSINE 1-PHOSPHATE; PERMEABILITY BARRIER; OXIDATIVE STRESS; SPHINGOSINE-1-PHOSPHATE LYASE; BIOCHEMICAL-CHARACTERIZATION; ENDOPLASMIC-RETICULUM; ALCOHOL METABOLISM; LIPID MODIFICATION	The fatty aldehyde dehydrogenase (FALDH) ALDH3A2 is the causative gene of Sjogren Larsson syndrome (SLS). To date, the molecular mechanism underlying the symptoms characterizing SLS has been poorly understood. Using Aldh3a2(-/-) mice, we found here that Aldh3a2 was the major FALDH active in undifferentiated keratinocytes. Long-chain base metabolism was greatly impaired in Aldh3a2(-/-) keratinocytes. Phenotypically, the intercellular spaces were widened in the basal layer of the Aldh3a2(-/-) epidermis due to hyperproliferation of keratinocytes. Furthermore, oxidative stress-induced genes were upregulated in Aldh3a2(-/-) keratinocytes. Upon keratinocyte differentiation, the activity of another FALDH, Aldh3b2, surpassed that of Aldh3a2. As a result, Aldh3a2(-/-) mice were indistinguishable from wild-type mice in terms of their whole epidermis FALDH activity, and their skin barrier function was uncompromised under normal conditions. However, perturbation of the stratum corneum caused increased transepidermal water loss and delayed barrier recovery in Aldh3a2(-/-) mice. In conclusion, Aldh3a2(-/-) mice replicated some aspects of SLS symptoms, especially at the basal layer of the epidermis. Our results suggest that hyperproliferation of keratinocytes via oxidative stress responses may partly contribute to the ichthyosis symptoms of SLS.	[Naganuma, Tatsuro; Takagi, Shuyu; Kanetake, Tsukasa; Kitamura, Takuya; Sassa, Takayuki; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; [Hattori, Satoko; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Toyoake, Aichi 4701192, Japan; [Miyakawa, Tsuyoshi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Okazaki, Aichi 4448585, Japan	Hokkaido University; Fujita Health University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	SASSA, Takayuki/B-2519-2012; Hattori, Satoko/AAE-6873-2022; Miyakawa, Tsuyoshi/A-7741-2008; KIHARA, AKIO/A-3802-2012	SASSA, Takayuki/0000-0003-3145-9829; Hattori, Satoko/0000-0002-1047-6454; Miyakawa, Tsuyoshi/0000-0003-0137-8200; KIHARA, AKIO/0000-0001-5889-0788; Naganuma, Tatsuro/0000-0002-8653-5553	Advanced Research and Development Programs for Medical Innovation (AMED-CREST) from the Japan Agency for Medical Research and Development (AMED); Japan Society for the Promotion of Science (JSPS) [26251010]; JSPS [25744]; Grants-in-Aid for Scientific Research [26251010, 14J02202, 16H06276] Funding Source: KAKEN	Advanced Research and Development Programs for Medical Innovation (AMED-CREST) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Advanced Research and Development Programs for Medical Innovation (AMED-CREST) (to A. K.) from the Japan Agency for Medical Research and Development (AMED), by Grant-in-aid for Scientific Research (A) 26251010 (to A. K.) from the Japan Society for the Promotion of Science (JSPS), and by Grant-in-aid for JSPS Fellows 25744 (to T. N.) from JSPS. The authors declare that they have no conflicts of interest with the contents of this article.	ABEDINIA M, 1990, EXP EYE RES, V51, P419, DOI 10.1016/0014-4835(90)90154-M; Abiko Y, 2014, J AGR FOOD CHEM, V62, P10936, DOI 10.1021/jf5030592; Ashibe B, 2007, J BIOL CHEM, V282, P20763, DOI 10.1074/jbc.M611853200; BEAUCHAMP RO, 1985, CRC CR REV TOXICOL, V14, P309, DOI 10.3109/10408448509037461; Caldelari R, 2010, METHODS MOL BIOL, V633, P125, DOI 10.1007/978-1-59745-019-5_10; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; Dreger H, 2010, CARDIOVASC RES, V85, P395, DOI 10.1093/cvr/cvp279; Feingold KR, 2014, BBA-MOL CELL BIOL L, V1841, P280, DOI 10.1016/j.bbalip.2013.11.007; George J, 2013, ISRN DERMATOL, V2013; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Grall A, 2012, NAT GENET, V44, P140, DOI 10.1038/ng.1056; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Hernandez-Quintero M, 2006, CELL TISSUE RES, V325, P77, DOI 10.1007/s00441-006-0173-9; Ikeda M, 2004, BIOCHEM BIOPH RES CO, V325, P338, DOI 10.1016/j.bbrc.2004.10.036; Jackson Brian, 2011, Human Genomics, V5, P283; JAGELL S, 1982, CLIN GENET, V21, P243; Kariya Y, 2005, GENES CELLS, V10, P605, DOI 10.1111/j.1365-2443.2005.00862.x; Kelson TL, 1997, BBA-GEN SUBJECTS, V1335, P99, DOI 10.1016/S0304-4165(96)00126-2; Kihara A, 2003, J BIOL CHEM, V278, P14578, DOI 10.1074/jbc.M211416200; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kihara A, 2014, BBA-MOL CELL BIOL L, V1841, P766, DOI 10.1016/j.bbalip.2013.08.014; Kitamura T, 2015, BIOCHEM J, V465, P79, DOI 10.1042/BJ20140624; Kitamura T, 2013, BBA-MOL CELL BIOL L, V1831, P1395, DOI 10.1016/j.bbalip.2013.05.007; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kondo N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6338; Li DQ, 2012, J BIOL CHEM, V287, P10435, DOI 10.1074/jbc.M111.299669; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Marchitti SA, 2007, BIOCHEM BIOPH RES CO, V356, P792, DOI 10.1016/j.bbrc.2007.03.046; Matsumura H, 2004, BIOCHEM BIOPH RES CO, V321, P275, DOI 10.1016/j.bbrc.2004.06.139; Mitsuishi Y, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00200; Mizutani Y, 2009, BIOCHIMIE, V91, P784, DOI 10.1016/j.biochi.2009.04.001; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Nakajima K, 2011, J DERMATOL SCI, V63, P64, DOI 10.1016/j.jdermsci.2011.03.009; Neuber C, 2014, ANAL CHEM, V86, P9065, DOI 10.1021/ac501677y; Ohkuni A, 2013, BIOCHEM BIOPH RES CO, V442, P195, DOI 10.1016/j.bbrc.2013.11.036; Ohno Y, 2015, P NATL ACAD SCI USA, V112, P7707, DOI 10.1073/pnas.1503491112; Pappa A, 2003, BIOCHEM J, V376, P615, DOI 10.1042/BJ20030810; Piatigorsky J, 2001, CORNEA, V20, P853, DOI 10.1097/00003226-200111000-00015; Rizzo WB, 2005, HUM MUTAT, V26, P1, DOI 10.1002/humu.20181; Rizzo WB, 2000, BBA-MOL BASIS DIS, V1535, P1, DOI 10.1016/S0925-4439(00)00077-6; Rizzo WB, 2000, J LIPID RES, V41, P1077; Rizzo WB, 2008, J LIPID RES, V49, P410, DOI 10.1194/jlr.M700469-JLR200; Rizzo WB, 2007, MOL GENET METAB, V90, P1, DOI 10.1016/j.ymgme.2006.08.006; Rizzo WB, 2014, BBA-MOL CELL BIOL L, V1841, P377, DOI 10.1016/j.bbalip.2013.09.001; Sassa T, 2013, MOL CELL BIOL, V33, P2787, DOI 10.1128/MCB.00192-13; Schafer M, 2012, EMBO MOL MED, V4, P364, DOI 10.1002/emmm.201200219; STOFFEL W, 1970, H-S Z PHYSIOL CHEM, V351, P875, DOI 10.1515/bchm2.1970.351.2.875; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Uchida Y, 2008, J DERMATOL SCI, V51, P77, DOI 10.1016/j.jdermsci.2008.01.002; van den Brink DM, 2004, MOL GENET METAB, V82, P33, DOI 10.1016/j.ymgme.2004.01.019; Verhoeven NM, 1998, FEBS LETT, V429, P225, DOI 10.1016/S0014-5793(98)00574-2; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wakashima T, 2014, J BIOL CHEM, V289, P24736, DOI 10.1074/jbc.M114.571869; WHITE FH, 1984, J ORAL PATHOL MED, V13, P244, DOI 10.1111/j.1600-0714.1984.tb01422.x; Willemsen MAAP, 2001, J NEUROL SCI, V183, P61, DOI 10.1016/S0022-510X(00)00474-3	55	21	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11676	11688		10.1074/jbc.M116.714030	http://dx.doi.org/10.1074/jbc.M116.714030			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27053112	Green Published, hybrid			2022-12-28	WOS:000377264800018
J	Selfridge, AC; Cavadas, MAS; Scholz, CC; Campbell, EL; Welch, LC; Lecuona, E; Colgan, SP; Barrett, KE; Sporn, PHS; Sznajder, JI; Cummins, EP; Taylor, CT				Selfridge, Andrew C.; Cavadas, Miguel A. S.; Scholz, Carsten C.; Campbell, Eric L.; Welch, Lynn C.; Lecuona, Emilia; Colgan, Sean P.; Barrett, Kim E.; Sporn, Peter H. S.; Sznajder, Jacob I.; Cummins, Eoin P.; Taylor, Cormac T.			Hypercapnia Suppresses the HIF-dependent Adaptive Response to Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; NF-KAPPA-B; ERYTHROPOIETIN PRODUCTION; MURINE MODEL; OXYGEN; DEGRADATION; BAFILOMYCIN; CHLOROQUINE; INHIBITION; EXPRESSION	Molecular oxygen and carbon dioxide are the primary gaseous substrate and product of oxidative metabolism, respectively. Hypoxia (low oxygen) and hypercapnia (high carbon dioxide) are co-incidental features of the tissue microenvironment in a range of pathophysiologic states, including acute and chronic respiratory diseases. The hypoxia-inducible factor (HIF) is the master regulator of the transcriptional response to hypoxia; however, little is known about the impact of hypercapnia on gene transcription. Because of the relationship between hypoxia and hypercapnia, we investigated the effect of hypercapnia on the HIF pathway. Hypercapnia suppressed HIF-alpha protein stability and HIF target gene expression both in mice and cultured cells in a manner that was at least in part independent of the canonical O-2-dependent HIF degradation pathway. The suppressive effects of hypercapnia on HIF-alpha protein stability could be mimicked by reducing intracellular pH at a constant level of partial pressure of CO2. Bafilomycin A1, a specific inhibitor of vacuolar-type H+-ATPase that blocks lysosomal degradation, prevented the hypercapnic suppression of HIF-alpha protein. Based on these results, we hypothesize that hypercapnia counter-regulates activation of the HIF pathway by reducing intracellular pH and promoting lysosomal degradation of HIF-alpha subunits. Therefore, hypercapnia may play a key role in the pathophysiology of diseases where HIF is implicated.	[Selfridge, Andrew C.; Scholz, Carsten C.; Barrett, Kim E.; Cummins, Eoin P.; Taylor, Cormac T.] Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland; [Selfridge, Andrew C.; Cavadas, Miguel A. S.; Scholz, Carsten C.; Barrett, Kim E.; Cummins, Eoin P.; Taylor, Cormac T.] Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [Cavadas, Miguel A. S.; Scholz, Carsten C.; Taylor, Cormac T.] Univ Coll Dublin, Syst Biol Ireland, Dublin 4, Ireland; [Scholz, Carsten C.] Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Campbell, Eric L.; Colgan, Sean P.] Univ Colorado Denver, Anschutz Med Campus, Aurora, CO 80045 USA; [Welch, Lynn C.; Lecuona, Emilia; Sporn, Peter H. S.; Sznajder, Jacob I.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Sporn, Peter H. S.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA; [Cavadas, Miguel A. S.] Inst Gulbenkian Ciencias, R Q Ta Grande 6, P-2780156 Oeiras, Portugal; [Barrett, Kim E.] Univ Calif San Diego, Sch Med, Dept Med & Biomed Sci, PhD Program,Div Gastroenterol, La Jolla, CA 92093 USA	University College Dublin; University College Dublin; University College Dublin; University of Zurich; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Instituto Gulbenkian de Ciencia; University of California System; University of California San Diego	Taylor, CT (corresponding author), Univ Coll Dublin, Conway Inst, Dublin 4, Ireland.	cormac.taylor@ucd.ie	Barrett, Kim/AAE-2794-2022; Barrett, Kim Elaine/AAE-7762-2019; Scholz, Carsten C./P-3185-2019; Cummins, Eoin/S-7554-2019; Campbell, Eric/N-5357-2015; Cavadas, Miguel/E-9815-2012	Barrett, Kim Elaine/0000-0002-6704-998X; Scholz, Carsten C./0000-0001-6579-8015; Cummins, Eoin/0000-0002-9346-8299; Sporn, Peter/0000-0002-1006-9437; Campbell, Eric/0000-0003-0744-6577; Cavadas, Miguel/0000-0003-3917-9880	Science Foundation Ireland [11/PI/1005]; National Institutes of Health [HL85534, HL71643, DK50189, HL107629]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085534, R01HL107629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103639, R37DK050189, R01DK095491, R01DK104713] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002182] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Science Foundation Ireland (Grant Number 11/PI/1005). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grants HL85534 and HL71643.; Supportedby National Institutes of Health Grant DK50189.; Supported by National Institutes of Health Grant HL107629.	Ahmadi Z, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-30; BAKER R, 1984, ADV EXP MED BIOL, V169, P597; Barrett TD, 2011, MOL PHARMACOL, V79, P910, DOI 10.1124/mol.110.070508; Bautista AF, 2013, MED GAS RES, V3, DOI 10.1186/2045-9912-3-23; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; Bruning U, 2012, CELL MOL LIFE SCI, V69, P1319, DOI 10.1007/s00018-011-0876-2; Budweiser Stephan, 2008, Int J Chron Obstruct Pulmon Dis, V3, P605; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Casalino-Matsuda SM, 2015, J IMMUNOL, V194, P5388, DOI 10.4049/jimmunol.1500150; COHEN RA, 1981, EXP HEMATOL, V9, P513; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Contreras M, 2015, CURR OPIN ANESTHESIO, V28, P26, DOI 10.1097/ACO.0000000000000151; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins EP, 2014, CELL MOL LIFE SCI, V71, P831, DOI 10.1007/s00018-013-1470-6; Cummins EP, 2010, J IMMUNOL, V185, P4439, DOI 10.4049/jimmunol.1000701; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; ECKARDT KU, 1990, AM J PHYSIOL, V258, pR678, DOI 10.1152/ajpregu.1990.258.3.R678; Egger ME, 2013, J SURG RES, V184, P274, DOI 10.1016/j.jss.2013.04.055; Ferreira JV, 2015, SCI REP-UK, V5, DOI 10.1038/srep10210; Ferreira JV, 2013, AUTOPHAGY, V9, P1349, DOI 10.4161/auto.25190; Gates KL, 2013, AM J RESP CELL MOL, V49, P821, DOI 10.1165/rcmb.2012-0487OC; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Hewitson KS, 2004, CURR PHARM DESIGN, V10, P821, DOI 10.2174/1381612043452884; Hubbi ME, 2014, P NATL ACAD SCI USA, V111, pE3325, DOI 10.1073/pnas.1412840111; Hubbi ME, 2013, J BIOL CHEM, V288, P10703, DOI 10.1074/jbc.M112.414771; Iwata E, 2016, INT J ONCOL, V48, P1493, DOI 10.3892/ijo.2016.3380; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; KRIEGER J, 1989, CHEST, V96, P729, DOI 10.1378/chest.96.4.729; Lang KS, 2003, CELL PHYSIOL BIOCHEM, V13, P257, DOI 10.1159/000074540; MILLER ME, 1979, BLOOD CELLS, V5, P389; Oliver KM, 2012, J BIOL CHEM, V287, P14004, DOI 10.1074/jbc.M112.347971; Onishi Y, 2012, J CANC SCI THERAPY, V4, P7, DOI 10.4172/1948-5956.1000136; Onishi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049189; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Rothman DH, 2002, P NATL ACAD SCI USA, V99, P4167, DOI 10.1073/pnas.022055499; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Schaible B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056491; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schulze H, 2009, BBA-MOL CELL RES, V1793, P674, DOI 10.1016/j.bbamcr.2008.09.020; Semenza GL, 2006, MOL PHARMACOL, V70, P1841, DOI 10.1124/mol.106.031062; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shinojima T, 2007, CARCINOGENESIS, V28, P529, DOI 10.1093/carcin/bgl143; STIGTER D, 1991, P NATL ACAD SCI USA, V88, P4176, DOI 10.1073/pnas.88.10.4176; Takeda D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100530; Tambuwala MM, 2015, J CONTROL RELEASE, V217, P221, DOI 10.1016/j.jconrel.2015.09.022; Taylor CT, 2011, J PHYSIOL-LONDON, V589, P797, DOI 10.1113/jphysiol.2010.201467; To M, 2012, CHEST, V141, P1233, DOI 10.1378/chest.11-1536; Vadasz I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046696; Vohwinkel CU, 2015, J APPL PHYSIOL, V119, P1157, DOI 10.1152/japplphysiol.00226.2015; WOLFPRIESSNITZ J, 1978, BLOOD, V52, P153; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yan ZW, 2013, BIOCHEM BIOPH RES CO, V430, P926, DOI 10.1016/j.bbrc.2012.12.052; ZUCALI JR, 1978, J LAB CLIN MED, V92, P648	53	37	40	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11800	11808		10.1074/jbc.M116.713941	http://dx.doi.org/10.1074/jbc.M116.713941			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27044749	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000377264800029
J	Vodnala, M; Ranjbarian, F; Pavlova, A; de Koning, HP; Hofer, A				Vodnala, Munender; Ranjbarian, Farahnaz; Pavlova, Anna; de Koning, Harry P.; Hofer, Anders			Trypanosoma brucei Methylthioadenosine Phosphorylase Protects the Parasite from the Antitrypanosomal Effect of Deoxyadenosine IMPLICATIONS FOR THE PHARMACOLOGY OF ADENOSINE ANTIMETABOLITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM FORMS; AFRICAN TRYPANOSOMIASIS; RIBONUCLEOTIDE REDUCTASE; DNTP POOLS; IN-VIVO; PURINE; NUCLEOSIDE; DEAMINASE; TRANSPORTERS; EXPRESSION	Trypanosoma brucei causes African sleeping sickness for which no vaccine exists and available treatments are of limited use due to their high toxicity or lack of efficacy. T. brucei cultivated in the presence of deoxyadenosine accumulates high levels of dATP in an adenosine kinase-dependent process and dies within a few hours. Here we show that T. brucei treated with 1 mM deoxyadenosine accumulates higher dATP levels than mammalian cells but that this effect diminishes quickly as the concentration of the deoxynucleoside decreases. Radioactive tracer studies showed that the parasites are partially protected against lower concentrations of deoxyadenosine by the ability to cleave it and use the adenine for ATP synthesis. T. brucei methylthioadenosine phosphorylase (TbMTAP) was found to be responsible for the cleavage as indicated by the phosphate dependence of deoxyadenosine cleavage in T. brucei cell extracts and increased deoxyadenosine sensitivity in TbMTAP knockdown cells. Recombinant TbMTAP exhibited higher turnover number (k(cat)) and K-m values for deoxyadenosine than for the regular substrate, methylthioadenosine. One of the reaction products, adenine, inhibited the enzyme, which might explain why TbMTAP-mediated protection is less efficient at higher deoxyadenosine concentrations. Consequently, T. brucei grown in the presence of adenine demonstrated increased sensitivity to deoxyadenosine. For deoxyadenosine/adenosine analogues to remain intact and be active against the parasite, they need to either be resistant to TbMTAP-mediated cleavage, which is the case with the three known antitrypanosomal agents adenine arabinoside, tubercidin, and cordycepin, or they need to be combined with TbMTAP inhibitors.	[Vodnala, Munender; Ranjbarian, Farahnaz; Pavlova, Anna; Hofer, Anders] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [de Koning, Harry P.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland	Umea University; University of Glasgow	Hofer, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden.	anders.hofer@umu.se		Vodnala, Munender/0000-0002-6219-6243; De Koning, Harry/0000-0002-9963-1827; Hofer, Anders/0000-0003-2890-2957	Swedish Research Council [2012-1932]; Swedish International Development Cooperation Agency [2008-069]; Kempe Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency; Kempe Foundation	This work was supported by Swedish Research Council Grant 2012-1932, Swedish International Development Cooperation Agency Grant 2008-069, and the Kempe Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Salabi MI, 2007, MOL PHARMACOL, V71, P921, DOI 10.1124/mol.106.031559; Berg M, 2010, ANTIMICROB AGENTS CH, V54, P1900, DOI 10.1128/AAC.01787-09; Blackburn MR, 2005, ADV IMMUNOL, V86, P1, DOI 10.1016/S0065-2776(04)86001-2; BRUN R, 1979, ACTA TROP, V36, P289; CHELLO PL, 1972, COMP BIOCHEM PHYSIOL, V43, P543, DOI 10.1016/0305-0491(72)90138-1; Da Silva AS, 2011, PARASITOLOGY, V138, P201, DOI 10.1017/S003118201000123X; Da Silva AS, 2011, EXP PARASITOL, V127, P173, DOI 10.1016/j.exppara.2010.07.010; DAVIES MJ, 1983, PARASITOLOGY, V87, P211, DOI 10.1017/S0031182000052574; De Koning HP, 1999, MOL PHARMACOL, V56, P1162, DOI 10.1124/mol.56.6.1162; de Koning HP, 2005, FEMS MICROBIOL REV, V29, P987, DOI 10.1016/j.femsre.2005.03.004; de Koning HP, 2000, MOL BIOCHEM PARASIT, V106, P93, DOI 10.1016/S0166-6851(99)00203-0; de Koning HP, 1998, J BIOL CHEM, V273, P9486, DOI 10.1074/jbc.273.16.9486; el Kouni MH, 2003, PHARMACOL THERAPEUT, V99, P283, DOI 10.1016/S0163-7258(03)00071-8; Geiser F, 2005, MOL PHARMACOL, V68, P589, DOI 10.1124/mol.104.010298; GHODA LY, 1988, MOL BIOCHEM PARASIT, V27, P109, DOI 10.1016/0166-6851(88)90030-8; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hofer A, 1997, P NATL ACAD SCI USA, V94, P6959, DOI 10.1073/pnas.94.13.6959; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Holmes P, 2013, J INVERTEBR PATHOL, V112, pS11, DOI 10.1016/j.jip.2012.07.014; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Luscher A, 2014, INT J PARASITOL-DRUG, V4, P55, DOI 10.1016/j.ijpddr.2013.12.001; Malvy D, 2011, CLIN MICROBIOL INFEC, V17, P986, DOI 10.1111/j.1469-0691.2011.03536.x; OGBUNUDE POJ, 1985, ANN TROP MED PARASIT, V79, P7, DOI 10.1080/00034983.1985.11811883; Parkinson FE, 2011, CURR TOP MED CHEM, V11, P948; Pelle R, 1998, J BIOL CHEM, V273, P2118, DOI 10.1074/jbc.273.4.2118; Ranjbarian F, 2012, J BIOL CHEM, V287, P17628, DOI 10.1074/jbc.M112.340059; Rottenberg ME, 2005, J INFECT DIS, V192, P1658, DOI 10.1086/496896; SLOWIACZEK P, 1982, ANAL BIOCHEM, V125, P6, DOI 10.1016/0003-2697(82)90376-1; Vodnala M, 2008, J BIOL CHEM, V283, P5380, DOI 10.1074/jbc.M705603200; Vodnala SK, 2013, J MED CHEM, V56, P9861, DOI 10.1021/jm401530a; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Ward CP, 2011, ANTIMICROB AGENTS CH, V55, P2352, DOI 10.1128/AAC.01551-10; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	35	7	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11717	11726		10.1074/jbc.M116.715615	http://dx.doi.org/10.1074/jbc.M116.715615			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27036940	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000377264800022
J	Gopal, U; Gonzalez-Gronow, M; Pizzo, SV				Gopal, Udhayakumar; Gonzalez-Gronow, Mario; Pizzo, Salvatore Vincent			Activated alpha(2)-Macroglobulin Regulates Transcriptional Activation of c-MYC Target Genes through Cell Surface GRP78 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COOH-TERMINAL DOMAIN; PROSTATE-CANCER; HISTONE H3; MONOCLONAL-ANTIBODY; TUMOR-CELLS; GROWTH; PHOSPHORYLATION; LIGATION; EXPRESSION; PROLIFERATION	Activated alpha(2)-macroglobulin (alpha M-2*) signals predominantly through cell surface GRP78 (CS-GRP78) to promote proliferation and survival of cancer cells; however, the molecular mechanism remains obscure. c-MYC is an essential transcriptional regulator that controls cell proliferation. We hypothesize that alpha M-2*/CS-GRP78-evoked key signaling events are required for transcriptional activation of c-MYC target genes. Activation of CS-GRP78 by alpha M-2* requires ligation of the GRP78 primary amino acid sequence (Leu(98)-Leu(115)). After stimulation with alpha M-2*, CS-GRP78 signaling activates 3-phosphoinositide-dependent protein kinase-1 (PDK1) to induce phosphorylation of PLK1, which in turn induces c-MYC transcription. We demonstrate that PLK1 binds directly to c-MYC and promotes its transcriptional activity by phosphorylating Ser(62). Moreover, activated c-MYC is recruited to the E-boxes of target genes FOSLI and ID2 by phosphorylating histone H3 at Ser(10). In addition, targeting the carboxyl-terminal domain of CS-GRP78 with a mAb suppresses transcriptional activation of c-MYC target genes and impairs cell proliferation. This work demonstrates that alpha M-2*JCS-GRP78 acts as an upstream regulator of the PDK1/PLK1 signaling axis to modulate c-MYC transcription and its target genes, suggesting a therapeutic strategy for targeting c-MYC-associated malignant progression.	[Gopal, Udhayakumar; Gonzalez-Gronow, Mario; Pizzo, Salvatore Vincent] Duke Univ, Dept Pathol, Med Ctr, Box 3712, Durham, NC 27710 USA	Duke University	Pizzo, SV (corresponding author), Duke Univ, Dept Pathol, Med Ctr, Box 3712, Durham, NC 27710 USA.	salvatore.pizzo@duke.edu	Gopal, Udhayakumar/K-9092-2019	gopal, Udhayakumar/0000-0003-2110-0601				Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; BORTH W, 1992, FASEB J, V6, P3345, DOI 10.1096/fasebj.6.15.1281457; Cannell IG, 2010, P NATL ACAD SCI USA, V107, P5375, DOI 10.1073/pnas.0910015107; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Cole MD, 2008, NAT REV MOL CELL BIO, V9, P810, DOI 10.1038/nrm2467; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; de Ridder GG, 2012, MELANOMA RES, V22, P225, DOI 10.1097/CMR.0b013e32835312fd; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Hofheinz RD, 2010, CLIN CANCER RES, V16, P4666, DOI 10.1158/1078-0432.CCR-10-0318; King L, 2001, PROTEIN EXPRES PURIF, V22, P148, DOI 10.1006/prep.2001.1424; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lin YG, 2015, ONCOGENE, V34, P5418, DOI 10.1038/onc.2015.4; Liu R, 2013, CLIN CANCER RES, V19, P6802, DOI 10.1158/1078-0432.CCR-13-1106; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Mandelin J, 2015, P NATL ACAD SCI USA, V112, P3776, DOI 10.1073/pnas.1500128112; Misra UK, 2009, J CELL BIOCHEM, V106, P381, DOI 10.1002/jcb.22016; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Misra UK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051735; Misra UK, 2011, J BIOL CHEM, V286, P1248, DOI 10.1074/jbc.M110.129767; Misra UK, 2010, CANCER BIOL THER, V9, P142, DOI 10.4161/cbt.9.2.10422; Misra UK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088373; Misra UK, 2009, MOL CANCER THER, V8, P1350, DOI 10.1158/1535-7163.MCT-08-0990; Mo LH, 2015, MOL CANCER THER, V14, P747, DOI 10.1158/1535-7163.MCT-14-0579; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Peifer C, 2008, CHEMMEDCHEM, V3, P1810, DOI 10.1002/cmdc.200800195; Pootrakul L, 2006, CLIN CANCER RES, V12, P5987, DOI 10.1158/1078-0432.CCR-06-0133; Rasche L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063414; Rauschert N, 2008, LAB INVEST, V88, P375, DOI 10.1038/labinvest.2008.2; Roller C, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00010; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; Sinnreich O, 2004, PROSTATE, V61, P201, DOI 10.1002/pros.20062; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tan J, 2013, CANCER DISCOV, V3, P1156, DOI 10.1158/2159-8290.CD-12-0595; Tan J, 2010, CANCER CELL, V18, P459, DOI 10.1016/j.ccr.2010.10.021; Xiao GQ, 1999, MOL BRAIN RES, V72, P121, DOI 10.1016/S0169-328X(99)00188-6; Zhang C, 2014, ONCOGENE, V33, P5582, DOI 10.1038/onc.2013.505; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	47	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10904	10915		10.1074/jbc.M115.708131	http://dx.doi.org/10.1074/jbc.M115.708131			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27002159	hybrid, Green Published			2022-12-28	WOS:000377042600040
J	Popov-Celeketic, D; Bianchi, F; Ruiz, SJ; Meutiawati, F; Poolman, B				Popov-Celeketic, Dusan; Bianchi, Frans; Ruiz, Stephanie J.; Meutiawati, Febrina; Poolman, Bert			A Plasma Membrane Association Module in Yeast Amino Acid Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; NUCLEAR-PORE COMPLEX; KINASE-A PATHWAY; SACCHAROMYCES-CEREVISIAE; PHEROMONE RESPONSE; MASTER REGULATOR; GENE-EXPRESSION; CELL-SURFACE; CORTICAL ER; PERMEASE	Amino acid permeases (AAPs) in the plasma membrane (PM) of Saccharomyces cerevisiae are responsible for the uptake of amino acids and involved in regulation of their cellular levels. Here, we report on a strong and complex module for PM association found in the C-terminal tail of AAPs. Using in silico analyses and mutational studies we found that the C-terminal sequences of Gap1, Bap2, Hip1, Tat1, Tat2, Mmp1, Sam3, Agp1, and Gnp1 are about 50 residues long, associate with the PM, and have features that discriminate them from the termini of organellar amino acid transporters. We show that this sequence (named PMasseq) contains an amphipathic alpha-helix and the FWC signature, which is palmitoylated by palmitoyltransferase Pfa4. Variations of PMasseq, found in different AAPs, lead to different mobilities and localization patterns, whereas the disruption of the sequence has an adverse effect on cell viability. We propose that PMasseq modulates the function and localization of AAPs along the PM. PMasseq is one of the most complex protein signals for plasma membrane association across species and can be used as a delivery vehicle for the PM.	[Poolman, Bert] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biochem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands; Univ Groningen, Zernike Inst Adv Mat, Nijenborgh 4, NL-9747 AG Groningen, Netherlands; [Popov-Celeketic, Dusan] Univ Utrecht, Fac Sci, Dept Biol, Div Cell Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands	University of Groningen; University of Groningen; Utrecht University	Poolman, B (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biochem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.poolman@rug.nl	Popov-Celeketic, Dusan/O-2371-2016; Bianchi, Frans/E-8796-2018; Institute, Zernike/W-7033-2019; Meutiawati, Febrina/H-3419-2016	Popov-Celeketic, Dusan/0000-0002-0512-6900; Bianchi, Frans/0000-0002-9385-9695; Ruiz, Stephanie/0000-0003-1522-3760	Fonds Economische Structuurversterking from the Dutch Ministry of Economic Affairs, Agriculture and Innovation (ELI); Netherlands Organisation for Scientific Research (NWO) TOP-GO Program [700.10.53]	Fonds Economische Structuurversterking from the Dutch Ministry of Economic Affairs, Agriculture and Innovation (ELI); Netherlands Organisation for Scientific Research (NWO) TOP-GO Program(Netherlands Organization for Scientific Research (NWO))	This work was carried out within the Biotechnology-based Ecologically Balanced Sustainable Industrial Consortium (BE-Basic) Research and Development Program, which was granted a Fonds Economische Structuurversterking subsidy from the Dutch Ministry of Economic Affairs, Agriculture and Innovation (EL&I), and was also supported in part by Netherlands Organisation for Scientific Research (NWO) TOP-GO Program Project 700.10.53. The authors declare that they have no conflicts of interest with the contents of this article.	Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bitinaite Jurate, 2009, Curr Protoc Mol Biol, VChapter 3, DOI 10.1002/0471142727.mb0321s86; BLOBEL G, 1981, HARVEY LECT, V76, P125; Brachmann CB, 1998, YEAST, V14, P115; Celton-Morizur S, 2004, MOL CELL BIOL, V24, P10621, DOI 10.1128/MCB.24.24.10621-10635.2004; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Gatto GJ, 2003, GENOME RES, V13, P617, DOI 10.1101/gr.667603; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Giots F, 2003, MOL MICROBIOL, V47, P1163, DOI 10.1046/j.1365-2958.2003.03365.x; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hein C, 1997, MOL MICROBIOL, V24, P607, DOI 10.1046/j.1365-2958.1997.3771735.x; Hennerdal A, 2011, BIOINFORMATICS, V27, P1322, DOI 10.1093/bioinformatics/btr119; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Juschke C, 2005, J CELL BIOL, V169, P613, DOI 10.1083/jcb.200503033; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Kralt A, 2015, TRAFFIC, V16, P135, DOI 10.1111/tra.12243; Lee CC, 2005, PLASMID, V54, P80, DOI 10.1016/j.plasmid.2004.12.001; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Maass K, 2009, J CELL SCI, V122, P625, DOI 10.1242/jcs.036012; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Malinska K, 2004, J CELL SCI, V117, P6031, DOI 10.1242/jcs.01493; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Malkus P, 2002, J CELL BIOL, V159, P915, DOI 10.1083/jcb.200208074; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Meinema AC, 2013, TRAFFIC, V14, P487, DOI 10.1111/tra.12048; Meinema AC, 2011, SCIENCE, V333, P90, DOI 10.1126/science.1205741; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Neiman AM, 2000, GENETICS, V155, P1643; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Omura F, 2001, FEMS MICROBIOL LETT, V194, P207, DOI 10.1016/S0378-1097(00)00532-2; Petersen B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015079; Phillips R., 2013, PHYS BIOL CELL, P525; Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Saier MH, 2000, MICROBIOL-SGM, V146, P1775, DOI 10.1099/00221287-146-8-1775; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smets B, 2010, CURR GENET, V56, P1, DOI 10.1007/s00294-009-0287-1; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; van Drogen F, 2000, CURR BIOL, V10, P630, DOI 10.1016/S0960-9822(00)00511-X; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Vivero-Pol L, 2005, J AM CHEM SOC, V127, P12770, DOI 10.1021/ja0533850; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020	68	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16024	16037		10.1074/jbc.M115.706770	http://dx.doi.org/10.1074/jbc.M115.706770			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226538	Green Published, hybrid			2022-12-28	WOS:000380585400009
J	Lafaye, C; Van Molle, I; Dufe, VT; Wahni, K; Boudier, A; Leroy, P; Collet, JF; Messens, J				Lafaye, Celine; Van Molle, Inge; Dufe, Veronica Tamu; Wahni, Khadija; Boudier, Ariane; Leroy, Pierre; Collet, Jean-Francois; Messens, Joris			Sulfur Denitrosylation by an Engineered Trx-like DsbG Enzyme Identifies Nucleophilic Cysteine Hydrogen Bonds as Key Functional Determinant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN S-NITROSYLATION; ESCHERICHIA-COLI; DISULFIDE-ISOMERASE; ACTIVE-SITE; REDOX PROPERTIES; IN-VIVO; THIOREDOXIN; SYSTEM; NITROSOTHIOLS; REFINEMENT	Exposure of bacteria to NO results in the nitrosylation of cysteine thiols in proteins and low molecular weight thiols such as GSH. The cells possess enzymatic systems that catalyze the denitrosylation of these modified sulfurs. An important player in these systems is thioredoxin (Trx), a ubiquitous, cytoplasmic oxidoreductase that can denitrosylate proteins in vivo and S-nitrosoglutathione (GSNO) in vitro. However, a periplasmic or extracellular denitrosylase has not been identified, raising the question of how extracytoplasmic proteins are repaired after nitrosative damage. In this study, we tested whether DsbG and DsbC, two Trx family proteins that function in reducing pathways in the Escherichia coli periplasm, also possess denitrosylating activity. Both DsbG and DsbC are poorly reactive toward GSNO. Moreover, DsbG is unable to denitrosylate its specific substrate protein, YbiS. Remarkably, by borrowing the CGPC active site of E. coli Trx-1 in combination with a T200M point mutation, we transformed DsbG into an enzyme highly reactive toward GSNO and YbiS. Thepk, of the nucleophilic cysteine, as well as the redox and thermodynamic properties of the engineered DsbG are dramatically changed and become similar to those of E. coli Trx-1. X-ray structural insights suggest that this results from a loss of two direct hydrogen bonds to the nucleophilic cysteine sulfur in the DsbG mutant. Our results highlight the plasticity of the Trx structural fold and reveal that the subtle change of the number of hydrogen bonds in the active site of Trx-like proteins is the key factor that thermodynamically controls reactivity toward nitrosylated compounds.	[Lafaye, Celine; Dufe, Veronica Tamu; Collet, Jean-Francois] Catholic Univ Louvain, de Duve Inst, 75-39 Ave Hippocrate, B-1200 Brussels, Belgium; [Lafaye, Celine; Dufe, Veronica Tamu; Collet, Jean-Francois] WELBIO, B-1200 Brussels, Belgium; [Lafaye, Celine; Van Molle, Inge; Dufe, Veronica Tamu; Wahni, Khadija; Collet, Jean-Francois; Messens, Joris] Brussels Ctr Redox Biol, B-1050 Brussels, Belgium; [Van Molle, Inge; Dufe, Veronica Tamu; Wahni, Khadija; Messens, Joris] Vlaams Inst Biotechnol, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Van Molle, Inge; Dufe, Veronica Tamu; Wahni, Khadija; Messens, Joris] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Boudier, Ariane; Leroy, Pierre] Univ Lorraine, Fac Pharm, F-54000 Nancy, France; [Collet, Jean-Francois] FRS, Maitre Rech, Brussels, Belgium; [Collet, Jean-Francois] WELBIO, FRFS, Brussels, Belgium; [Messens, Joris] Vlaams Inst Biotechnol, Brussels, Belgium; [Messens, Joris] Vrije Univ Brussel, Brussels, Belgium	Universite Catholique Louvain; WELBIO; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Universite de Lorraine; Fonds de la Recherche Scientifique - FNRS; WELBIO; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Collet, JF (corresponding author), Catholic Univ Louvain, de Duve Inst, 75-39 Ave Hippocrate, B-1200 Brussels, Belgium.; Messens, J (corresponding author), Vrije Univ Brussel, Struct Biol Res Ctr, Oxidat Stress Signaling Lab, Vlaams Inst Biotechnol, Pl Laan 2, B-1050 Brussels, Belgium.	joris.messens@vib-vub.be	Messens, Joris/AAH-3008-2020	Messens, Joris/0000-0002-2128-8264; Collet, Jean-Francois/0000-0001-8069-7036; Van Molle, Inge/0000-0003-0114-9379	OMICS@VIB Marie Curie COFUND fellowship; Vlaams Instituut voor Biotechnologie; Research Foundation Flanders Research Program [G.0305.12]; Flanders Hercules Foundation [HERC16, UABR/09/005]; WELBIO; FRS-Fonds de la Recherche Scientifique	OMICS@VIB Marie Curie COFUND fellowship; Vlaams Instituut voor Biotechnologie; Research Foundation Flanders Research Program; Flanders Hercules Foundation; WELBIO(WELBIO); FRS-Fonds de la Recherche Scientifique	This work was supported by OMICS@VIB Marie Curie COFUND fellowship (to I. V. M.); funds from the Vlaams Instituut voor Biotechnologie; Research Foundation Flanders Research Program G.0305.12; Flanders Hercules Foundation Grants HERC16 and UABR/09/005 for the purification and in house x-ray crystallography platform, respectively; funds from WELBIO; and a Credit de Recherche grant from the FRS-Fonds de la Recherche Scientifique. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Cook JA, 1996, ANAL BIOCHEM, V238, P150, DOI 10.1006/abio.1996.0268; Denoncin K, 2014, J BIOL CHEM, V289, P12356, DOI 10.1074/jbc.M114.554055; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gould N, 2013, J BIOL CHEM, V288, P26473, DOI 10.1074/jbc.R113.460261; Heras B, 2004, P NATL ACAD SCI USA, V101, P8876, DOI 10.1073/pnas.0402769101; Heras B, 2003, STRUCTURE, V11, P139, DOI 10.1016/S0969-2126(03)00005-4; Hiniker A, 2007, P NATL ACAD SCI USA, V104, P11670, DOI 10.1073/pnas.0704692104; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Laver JR, 2013, ANTIOXID REDOX SIGN, V18, P309, DOI 10.1089/ars.2012.4767; Lewin A, 2008, BIOCHEM J, V414, P81, DOI 10.1042/BJ20080356; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Messens J, 2004, J MOL BIOL, V339, P527, DOI 10.1016/j.jmb.2004.04.016; Moore KP, 2002, METHOD ENZYMOL, V359, P256; Mossner E, 1998, PROTEIN SCI, V7, P1233; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura T, 2016, TRENDS PHARMACOL SCI, V37, P73, DOI 10.1016/j.tips.2015.10.002; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Pader I, 2014, P NATL ACAD SCI USA, V111, P6964, DOI 10.1073/pnas.1317320111; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Ren GP, 2009, J BIOL CHEM, V284, P10150, DOI 10.1074/jbc.M809509200; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Roos G, 2007, J MOL BIOL, V368, P800, DOI 10.1016/j.jmb.2007.02.045; Roos G, 2013, ANTIOXID REDOX SIGN, V18, P94, DOI 10.1089/ars.2012.4521; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; SHEVCHIK VE, 1994, EMBO J, V13, P2007, DOI 10.1002/j.1460-2075.1994.tb06470.x; Winterbourn CC, 2013, ANTIOXID REDOX SIGN, V18, P642, DOI 10.1089/ars.2012.4827; Zander T, 1998, METHOD ENZYMOL, V290, P59, DOI 10.1016/S0076-6879(98)90007-6; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016	43	3	3	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15020	15028		10.1074/jbc.M116.729426	http://dx.doi.org/10.1074/jbc.M116.729426			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226614	hybrid, Green Published			2022-12-28	WOS:000380583200014
J	Stepanova, V; Jayaraman, PS; Zaitsev, SV; Lebedeva, T; Bdeir, K; Kershaw, R; Holman, KR; Parfyonova, YV; Semina, EV; Beloglazova, IB; Tkachuk, VA; Cines, DB				Stepanova, Victoria; Jayaraman, Padma-Sheela; Zaitsev, Sergei V.; Lebedeva, Tatiana; Bdeir, Khalil; Kershaw, Rachael; Holman, Kelci R.; Parfyonova, Yelena V.; Semina, Ekaterina V.; Beloglazova, Irina B.; Tkachuk, Vsevolod A.; Cines, Douglas B.			Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CHAIN PROUROKINASE; CORONARY-ARTERY-DISEASE; CELL-MIGRATION; SIGNAL-TRANSDUCTION; STROMAL CELLS; EXTRACELLULAR-MATRIX; KRINGLE DOMAIN; BINDING; NUCLEOLIN; SURFACE	Urokinase-type plasminogen activator (uPA) regulates angiogenesis and vascular permeability through proteolytic degradation of extracellular matrix and intracellular signaling initiated upon its binding to uPAR/CD87 and other cell surface receptors, Here, we describe an additional mechanism by which uPA regulates angiogenesis. Ex vivo VEGF-induced vascular sprouting from Matrigel-embedded aortic rings isolated from uPA knock -out (uPA-1) mice was impaired compared with vessels emanating from wild -type mice. Endothelial cells isolated from uPA' mice show less proliferation and migration in response to VEGF than their wild type counterparts or uPA endothelial cells in which expression of wild type uPA had been restored. We reported previously that uPA is transported from cell surface receptors to nuclei through a mechanism that requires its kringle domain. Intranuclear uPA modulates gene transcription by binding to a subset of transcription factors. Here we report that wild type single-chain uPA, but not uPA variants incapable of nuclear transport, increases the expression of cell surface VEGF receptor 1 (VEGFR1) and VEGF receptor 2 (VEGFR2) by translocating to the nuclei of ECs. Intranuclear single-chain uPA binds directly to and interferes with the function of the transcription factor hematopoietically expressed homeodomain protein or proline-rich homeodomain protein (HHEX/PRH), which thereby lose their physiologic capacity to repress the activity of vehgrl and vegfr2 gene promoters. These studies identify uPA-dependent de -repression of vegfr1 and vegfr2 gene transcription through binding to HHEX/PRH as a novel mechanism by which uPA mediates the pro-angiogenic effects of VEGE and identifies a potential new target for control of pathologic angiogenesis.	[Stepanova, Victoria; Lebedeva, Tatiana; Bdeir, Khalil; Cines, Douglas B.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zaitsev, Sergei V.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Jayaraman, Padma-Sheela; Kershaw, Rachael] Univ Birmingham, Sch Immun & Infect, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Parfyonova, Yelena V.; Semina, Ekaterina V.; Beloglazova, Irina B.; Tkachuk, Vsevolod A.] Russian Cardiol Res Ctr, Moscow 121552, Russia; [Parfyonova, Yelena V.; Semina, Ekaterina V.; Tkachuk, Vsevolod A.] Lomonosov Moscow State Univ, Sch Fac Fundamental Med, Moscow 117192, Russia; [Holman, Kelci R.] Drexel Univ, Coll Arts & Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Birmingham; National Medical Research Center of Cardiology; Lomonosov Moscow State University; Drexel University; University of Pennsylvania	Stepanova, V (corresponding author), 512 Stellar Chance Bldg,422 Curie Blvd, Philadelphia, PA 19104 USA.	vstepano@mail.med.upenn.edu	Tkachuk, Vsevolod/AAE-1136-2022; Semina, Ekaterina V/A-8184-2014; Beloglazova, Irina/A-9173-2014; Parfyonova, Yelena V/B-9307-2014; Tkachuk, Vsevolod A/J-9357-2012	Beloglazova, Irina/0000-0002-2345-3681; Parfyonova, Yelena V/0000-0002-0969-5780; /0000-0002-6500-9095; Tkachuk, Vsevolod/0000-0002-7492-747X; Cines, Douglas/0000-0001-5986-504X	National Institutes of Health [HL116916, CA141228, R21-AI-102177]; Russian Science Foundation [14-24-00086]; Russian Foundation for Basic Research [13-04-02014-a, 16-04-01699]; NATIONAL CANCER INSTITUTE [R21CA141228] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI102177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants HL116916 (to D. B. C.), CA141228 (to V. S.), and R21-AI-102177 (to K. B.). This work was also supported by Russian Science Foundation Grant 14-24-00086 (to V. A. T.) and by Russian Foundation for Basic Research Grants 13-04-02014-a (to Y. V. P.) and 16-04-01699 (to I. B. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander RA, 2012, CARDIOVASC RES, V94, P125, DOI 10.1093/cvr/cvs017; Asuthkar S, 2013, MOL BIOL CELL, V24, P2620, DOI 10.1091/mbc.E12-04-0306; Baramova EN, 1997, FEBS LETT, V405, P157, DOI 10.1016/S0014-5793(97)00175-0; Bdeir K, 2003, BLOOD, V102, P3600, DOI 10.1182/blood-2003-03-0949; Behzadian MA, 2003, FASEB J, V17, P752, DOI 10.1096/fj.02-0484fje; BLASI F, 1988, Fibrinolysis, V2, P73, DOI 10.1016/0268-9499(88)90370-0; Boudreau N, 1997, J CELL BIOL, V139, P257, DOI 10.1083/jcb.139.1.257; Breuss JM, 2012, CELL ADHES MIGR, V6, P535, DOI 10.4161/cam.22243; BUO L, 1994, ANTICANCER RES, V14, P2445; Cao G., 2014, CURR PROTOC TOXICOL, V61, P21; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; CUBELLIS MV, 1986, J BIOL CHEM, V261, P5819; Deindl E, 2003, FASEB J, V17, P1174, DOI 10.1096/fj.02-0800fje; Dellinger MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028947; Devy L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0552com; Dumler I, 1999, CURR BIOL, V9, P1468, DOI 10.1016/S0960-9822(00)80116-5; Dzhoyashvili NA, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0337-4; Efimenko A, 2014, STEM CELL TRANSL MED, V3, P32, DOI 10.5966/sctm.2013-0014; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Eilken HM, 2010, NAT MED, V16, P853, DOI 10.1038/nm0810-853; El Khoury D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-325; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; Ferrara N, 2010, MOL BIOL CELL, V21, P687, DOI 10.1091/mbc.E09-07-0590; Gelinas DS, 2002, BRIT J PHARMACOL, V137, P1021, DOI 10.1038/sj.bjp.0704956; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Gupta K, 1999, EXP CELL RES, V247, P495, DOI 10.1006/excr.1998.4359; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Hofer E, 2007, THROMB HAEMOSTASIS, V97, P355, DOI 10.1160/TH06-08-0470; Kanno S, 2000, ONCOGENE, V19, P2138, DOI 10.1038/sj.onc.1203533; Kapustin A, 2012, BIOCHEM J, V443, P491, DOI 10.1042/BJ20110348; KASAI S, 1985, J BIOL CHEM, V260, P2377; Koolwijk P, 1996, J CELL BIOL, V132, P1177, DOI 10.1083/jcb.132.6.1177; Krust B, 2011, BIOCHIMIE, V93, P426, DOI 10.1016/j.biochi.2010.10.015; Kwak SH, 2005, J LEUKOCYTE BIOL, V78, P937, DOI 10.1189/jlb.0305158; LaRusch GA, 2013, AM J PHYSIOL-HEART C, V305, pH305, DOI 10.1152/ajpheart.00110.2013; Makarova AM, 2011, J BIOL CHEM, V286, P23044, DOI 10.1074/jbc.M110.210195; Makowski GS, 1998, INFLAMMATION, V22, P287, DOI 10.1023/A:1022300216202; MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705; Matsuno H, 2002, BLOOD, V100, P2487, DOI 10.1182/blood-2001-12-0251; Mazar A P, 1999, Angiogenesis, V3, P15, DOI 10.1023/A:1009095825561; MILES LA, 1983, THROMB RES, V29, P407, DOI 10.1016/0049-3848(83)90244-X; Montuori N, 2014, CHEM IMMUNOL ALLERGY, V99, P105, DOI 10.1159/000353310; Nassar T, 2010, AM J RESP CELL MOL, V43, P703, DOI 10.1165/rcmb.2009-0257OC; Nielsen BS, 2001, LAB INVEST, V81, P1485, DOI 10.1038/labinvest.3780363; Noy P, 2010, MOL CELL BIOL, V30, P2120, DOI 10.1128/MCB.01511-09; NYKJAER A, 1994, J BIOL CHEM, V269, P25668; Okumura Y, 1997, FEBS LETT, V402, P181, DOI 10.1016/S0014-5793(96)01523-2; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; PELTZ SW, 1982, BIOCHEMISTRY-US, V21, P2798, DOI 10.1021/bi00540a035; PEPPER MS, 1993, J CELL BIOL, V122, P673, DOI 10.1083/jcb.122.3.673; Plouet J, 1997, J BIOL CHEM, V272, P13390, DOI 10.1074/jbc.272.20.13390; Pluskota E, 2004, J BIOL CHEM, V279, P18063, DOI 10.1074/jbc.M310462200; Prager GW, 2009, BLOOD, V113, P1383, DOI 10.1182/blood-2008-06-164210; Prager GW, 2004, BLOOD, V103, P955, DOI 10.1182/blood-2003-07-2214; Prager GW, 2004, CIRC RES, V94, P1562, DOI 10.1161/01.RES.0000131498.36194.6b; Rhoads Kim, 2005, Lymphatic Research and Biology, V3, P240, DOI 10.1089/lrb.2005.3.240; Rubina Kseniya, 2007, Angiogenesis, V10, P183, DOI 10.1007/s10456-007-9072-2; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; SAKSELA O, 1990, J CELL BIOL, V110, P767, DOI 10.1083/jcb.110.3.767; SALERNO G, 1984, P NATL ACAD SCI-BIOL, V81, P110, DOI 10.1073/pnas.81.1.110; Semina E V, 2015, Tsitologiia, V57, P689; Sobczak Magdalena, 2010, J Vis Exp, DOI 10.3791/2316; Stepanova V, 1999, MOL CELL BIOCHEM, V195, P199, DOI 10.1023/A:1006936623106; Stepanova V, 2008, BLOOD, V112, P100, DOI 10.1182/blood-2007-07-104455; Tarui T, 2006, THROMB HAEMOSTASIS, V95, P524, DOI 10.1160/TH05-06-0457; Tobar N, 2010, MOL CELL BIOCHEM, V340, P195, DOI 10.1007/s11010-010-0418-5; Traktuev DO, 2007, MOL THER, V15, P1939, DOI 10.1038/sj.mt.6300262; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; WUN TC, 1982, J BIOL CHEM, V257, P7262; Yoshioka K, 2012, NAT MED, V18, P1560, DOI 10.1038/nm.2928	74	39	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15029	15045		10.1074/jbc.M115.678490	http://dx.doi.org/10.1074/jbc.M115.678490			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27151212	hybrid, Green Published			2022-12-28	WOS:000380583200015
J	Yang, XX; Zhang, WW; Chen, YL; Li, Y; Sun, L; Liu, Y; Liu, MY; Yu, M; Li, XJ; Han, JH; Duan, YJ				Yang, Xiaoxiao; Zhang, Wenwen; Chen, Yuanli; Li, Yan; Sun, Lei; Liu, Ying; Liu, Mengyang; Yu, Miao; Li, Xiaoju; Han, Jihong; Duan, Yajun			Activation of Peroxisome Proliferator-activated Receptor (PPAR gamma) and CD36 Protein Expression THE DUAL PATHOPHYSIOLOGICAL ROLES OF PROGESTERONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-ARTERY ATHEROSCLEROSIS; ESTROGEN PLUS PROGESTIN; LOW-DENSITY-LIPOPROTEIN; B SCAVENGER RECEPTOR; RANDOMIZED CONTROLLED-TRIAL; DEFECTIVE FATTY-ACID; INSULIN-RESISTANCE; POSTMENOPAUSAL WOMEN; GENE-EXPRESSION; OXIDIZED LDL	Progesterone or its analog, one of components of hormone replacement therapy, may attenuate the cardioprotective effects of estrogen. However, the underlying mechanisms have not been fully elucidated. Expression of CD36, a receptor for oxidized LDL (oxLDL) that enhances macrophage/foam cell formation, is activated by the transcription factor peroxisome proliferator-activated receptor gamma (PPARy). CD36 also functions as a fatty acid transporter to influence fatty acid metabolism and the pathophysiological status of several diseases. In this study, we determined that progesterone induced macrophage CD36 expression, which is related to progesterone receptor (PR) activity. Progesterone enhanced cellular oxLDL uptake in a CD36dependent manner. Mechanistically, progesterone increased PPARy expression and PPARy promoter activity in a PR dependent manner and the binding of PR with the progesterone response element in the PPARy promoter. Specific deletion of macrophage PPARy (MOPPARy KO) expression in mice abolished progesterone -induced macrophage CD36 expression and cellular oxLDL accumulation. We also determined that, associated with gestation and increased serum progesterone levels, CD36 and PPARy expression in mouse adipose tissue, skeletal muscle, and peritoneal macrophages were substantially activated. Taken together, our study demonstrates that progesterone can play dual pathophysiological roles by activating PPARy expression, in which progesterone increases macrophage CD36 expression and oxLDL accumulation, a negative effect on atherosclerosis, and enhances the PPAR gamma-CD36 pathway in adipose tissue and skeletal muscle, a protective effect on pregnancy.	[Yang, Xiaoxiao; Zhang, Wenwen; Li, Yan; Sun, Lei; Liu, Ying; Liu, Mengyang; Yu, Miao; Li, Xiaoju] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Chen, Yuanli] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Han, Jihong; Duan, Yajun] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Collaborat Innovat Ctr Biotherapy, Tianjin 300071, Peoples R China; [Chen, Yuanli; Han, Jihong; Duan, Yajun] Hefei Univ Technol, Coll Biomed Engn, 193 Tongxi Rd, Hefei 230000, Peoples R China	Nankai University; Nankai University; Nankai University; Hefei University of Technology	Han, JH; Duan, YJ (corresponding author), Hefei Univ Technol, Coll Biomed Engn, 193 Tongxi Rd, Hefei 230000, Peoples R China.	jihonghan2008@nankai.edu.cn; yduan@hfut.edu.cn	Liu, Mengyang/AAA-6289-2019	Liu, Mengyang/0000-0002-3790-923X	National Science Foundation of China [81473204, 81573427, 31400694]; Program for Changjiang Scholars and Innovative Research Team in University Grant [IRT13023]; 111 Project [B08011]; International Science and Technology Cooperation Program of China [2015DFA30430]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University Grant(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project(Ministry of Education, China - 111 Project); International Science and Technology Cooperation Program of China	This work was supported by National Science Foundation of China Grants 81473204 (to J. H.), 81573427 (to V. D.), and 31400694 (to Y. C.); Program for Changjiang Scholars and Innovative Research Team in University Grant IRT13023 and 111 Project Grant B08011 (to J. H.); and International Science and Technology Cooperation Program of China Grant 2015DFA30430 (to J. H., Y. D., and Y. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams MR, 1997, ARTERIOSCL THROM VAS, V17, P217, DOI 10.1161/01.ATV.17.1.217; Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Allred KF, 2006, J BIOL CHEM, V281, P1419, DOI 10.1074/jbc.M506046200; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Chen YL, 2012, J BIOL CHEM, V287, P43340, DOI 10.1074/jbc.M112.403394; Corpeleijn E, 2006, DIABETIC MED, V23, P907, DOI 10.1111/j.1464-5491.2006.01888.x; Diep CH, 2015, J MOL ENDOCRINOL, V54, pR31, DOI 10.1530/JME-14-0252; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2004, ARTERIOSCL THROM VAS, V24, P2333, DOI 10.1161/01.ATV.0000148007.06370.68; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Feng JW, 2000, J LIPID RES, V41, P688; Froment P, 2006, J ENDOCRINOL, V189, P199, DOI 10.1677/joe.1.06667; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Han JH, 2000, J BIOL CHEM, V275, P1241, DOI 10.1074/jbc.275.2.1241; Han JH, 2004, CIRCULATION, V109, P790, DOI 10.1161/01.CIR.0000112576.40815.13; Handberg A, 2010, J CLIN ENDOCR METAB, V95, P1939, DOI 10.1210/jc.2009-2002; Handberg A, 2006, CIRCULATION, V114, P1169, DOI 10.1161/CIRCULATIONAHA.106.626135; Hanke H, 1996, ATHEROSCLEROSIS, V121, P129, DOI 10.1016/0021-9150(95)05710-2; Hanke H, 1996, CIRCULATION, V94, P175, DOI 10.1161/01.CIR.94.2.175; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Hodis HN, 2003, NEW ENGL J MED, V349, P535, DOI 10.1056/NEJMoa030830; Hsia J, 2004, CIRCULATION, V109, P620, DOI 10.1161/01.CIR.0000115309.63979.92; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Kim JY, 2008, MOL CELL BIOL, V28, P1770, DOI 10.1128/MCB.01556-07; Koh KK, 2004, ARTERIOSCL THROM VAS, V24, P1171, DOI 10.1161/01.ATV.0000131262.98040.65; Komar CM, 2001, ENDOCRINOLOGY, V142, P4831, DOI 10.1210/en.142.11.4831; Kuwasako T, 2003, DIABETES CARE, V26, P1647, DOI 10.2337/diacare.26.5.1647-a; LIEBERMAN BA, 1993, MOL ENDOCRINOL, V7, P515, DOI 10.1210/me.7.4.515; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; Nickenig G, 2000, CIRCULATION, V102, P1828; Oz HS, 2011, INFLAMM RES, V60, P93, DOI 10.1007/s00011-010-0241-1; PADWICK ML, 1986, NEW ENGL J MED, V315, P930, DOI 10.1056/NEJM198610093151504; Pravenec M, 2001, NAT GENET, V27, P156, DOI 10.1038/84777; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; SMITH DC, 1975, NEW ENGL J MED, V293, P1164, DOI 10.1056/NEJM197512042932302; STURDEE DW, 1978, BRIT MED J, V1, P1575, DOI 10.1136/bmj.1.6127.1575; Sun L, 2003, J LIPID RES, V44, P1877, DOI 10.1194/jlr.M300084-JLR200; Sun YJ, 2010, DIABETES CARE, V33, P2065, DOI 10.2337/dc10-0460; Wassmann K, 2005, CIRC RES, V97, P1046, DOI 10.1161/01.RES.0000188212.57180.55; Yang XX, 2015, J BIOL CHEM, V290, P21788, DOI 10.1074/jbc.M115.654582	46	20	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15108	15118		10.1074/jbc.M116.726737	http://dx.doi.org/10.1074/jbc.M116.726737			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226602	Green Published, hybrid			2022-12-28	WOS:000380583200021
J	Kaster, BC; Knippa, KC; Kaplan, CD; Peterson, DO				Kaster, Benjamin C.; Knippa, Kevin C.; Kaplan, Craig D.; Peterson, David O.			RNA Polymerase II Trigger Loop Mobility: INDIRECT EFFECTS OF Rpb9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein-protein interaction; RNA polymerase II; Saccharomyces cerevisiae; transcription; yeast genetics; Rpb1; Rpb9; trigger loop	SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION ELONGATION; STRUCTURAL BASIS; SUBUNIT RPB9; ALPHA-AMANITIN; IN-VIVO; CLEAVAGE ACTIVITY; 3'-END FORMATION; FACTOR TFIIS; DNA-DAMAGE	Rpb9 is a conserved RNA polymerase II (pol II) subunit, the absence of which confers alterations to pol II enzymatic properties and transcription fidelity. It has been suggested previously that Rpb9 affects mobility of the trigger loop (TL), a structural element of Rpb1 that moves in and out of the active site with each elongation cycle. However, a biochemical mechanism for this effect has not been defined. We find that the mushroom toxin -amanitin, which inhibits TL mobility, suppresses the effect of Rpb9 on NTP misincorporation, consistent with a role for Rpb9 in this process. Furthermore, we have identified missense alleles of RPB9 in yeast that suppress the severe growth defect caused by rpb1-G730D, a substitution within Rpb1 -helix 21 (21). These alleles suggest a model in which Rpb9 indirectly affects TL mobility by anchoring the position of 21, with which the TL directly interacts during opening and closing. Amino acid substitutions in Rpb9 or Rpb1 that disrupt proposed anchoring interactions resulted in phenotypes shared by rpb9 strains, including increased elongation rate in vitro. Combinations of rpb9 with the fast rpb1 alleles that we identified did not result in significantly faster in vitro misincorporation rates than those resulting from rpb9 alone, and this epistasis is consistent with the idea that defects caused by the rpb1 alleles are related mechanistically to the defects caused by rpb9. We conclude that Rpb9 supports intra-pol II interactions that modulate TL function and thus pol II enzymatic properties.	[Kaster, Benjamin C.; Knippa, Kevin C.; Kaplan, Craig D.; Peterson, David O.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Peterson, DO (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	dopeterson@tamu.edu	Kaplan, Craig/AAO-4500-2021	Kaplan, Craig/0000-0002-7518-695X	Texas A&M AgriLife Research; NIGMS, National Institutes of Health [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097260, P41GM103311] Funding Source: NIH RePORTER	Texas A&M AgriLife Research; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Mikhail Kashlev for providing yeast strain BJ5464 His-Bio; Mary Bryk for sharing reagents, equipment, and advice; Diane Hawley and Amber Wadle for valuable discussions; Guillermo Calero for communication of results prior to publication; and Adam Peterson and undergraduate students Jerritt Nunneley, Lauren Rinando Nelson, Jessica Wald, Julianna Hudnall Baker, and J. Colin Klingemann for technical assistance. The support of Texas A&M AgriLife Research is also acknowledged. Molecular graphics and analyses were performed with the UCSF Chimera package. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS, National Institutes of Health, Grant P41-GM103311).	ACKER J, 1993, NUCLEIC ACIDS RES, V21, P5345, DOI 10.1093/nar/21.23.5345; ARNDT KT, 1989, CELL, V56, P527, DOI 10.1016/0092-8674(89)90576-X; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Barnes CO, 2015, MOL CELL, V59, P258, DOI 10.1016/j.molcel.2015.06.034; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Braberg H, 2013, CELL, V154, P775, DOI 10.1016/j.cell.2013.07.033; Brachmann CB, 1998, YEAST, V14, P115; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Bucheli ME, 2005, EMBO J, V24, P2150, DOI 10.1038/sj.emboj.7600687; Bucheli ME, 2007, RNA, V13, P1756, DOI 10.1261/rna.607207; CHAFIN DR, 1995, J BIOL CHEM, V270, P19114, DOI 10.1074/jbc.270.32.19114; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Chen XF, 2007, MOL CELL BIOL, V27, P4617, DOI 10.1128/MCB.00404-07; Costa G L, 1996, Methods Mol Biol, V57, P239; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; Hausner W, 2000, J BIOL CHEM, V275, P12393, DOI 10.1074/jbc.275.17.12393; Hemming SA, 2000, J BIOL CHEM, V275, P35506, DOI 10.1074/jbc.M004721200; Hemming SA, 2000, J BIOL CHEM, V275, P2288, DOI 10.1074/jbc.275.4.2288; HULL MW, 1995, GENE DEV, V9, P481, DOI 10.1101/gad.9.4.481; Hyle JW, 2003, J BIOL CHEM, V278, P28470, DOI 10.1074/jbc.M303736200; Jenks MH, 2008, MOL CELL BIOL, V28, P3883, DOI 10.1128/MCB.00380-08; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; Kaplan CD, 2005, J BIOL CHEM, V280, P913, DOI 10.1074/jbc.M411108200; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; Kaplan CD, 2013, BBA-GENE REGUL MECH, V1829, P39, DOI 10.1016/j.bbagrm.2012.09.007; Kaplan CD, 2012, PLOS GENET, V8, P172, DOI 10.1371/journal.pgen.1002627; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kireeva ML, 2008, MOL CELL, V30, P557, DOI 10.1016/j.molcel.2008.04.017; Kireeva ML, 2003, METHOD ENZYMOL, V370, P138; Knippa K, 2013, BIOCHEMISTRY-US, V52, P7807, DOI 10.1021/bi4009566; Koyama H, 2007, GENES CELLS, V12, P547, DOI 10.1111/j.1365-2443.2007.01072.x; Koyama H, 2010, GENES CELLS, V15, P151, DOI 10.1111/j.1365-2443.2009.01372.x; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Lange U, 2004, MOL MICROBIOL, V52, P1133, DOI 10.1111/j.1365-2958.2004.04039.x; Li SS, 2006, MOL CELL BIOL, V26, P9430, DOI 10.1128/MCB.01656-06; Liu X, 2013, BBA-GENE REGUL MECH, V1829, P2, DOI 10.1016/j.bbagrm.2012.09.003; Malagon F, 2004, GENETICS, V166, P1215, DOI 10.1534/genetics.166.3.1215; Martinez-Rucobo FW, 2013, BBA-GENE REGUL MECH, V1829, P9, DOI 10.1016/j.bbagrm.2012.09.002; Nesser NK, 2006, P NATL ACAD SCI USA, V103, P3268, DOI 10.1073/pnas.0511330103; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roghanian M, 2011, NUCLEIC ACIDS RES, V39, P4352, DOI 10.1093/nar/gkq1359; Rudd MD, 1996, J BIOL CHEM, V271, P21549, DOI 10.1074/jbc.271.35.21549; Shaw RJ, 2001, J BIOL CHEM, V276, P32905, DOI 10.1074/jbc.M105075200; SIKORSKI RS, 1989, GENETICS, V122, P19; Spencer J.F.T., 1989, YEAST GENETICS MANUA; Sun ZW, 1996, NUCLEIC ACIDS RES, V24, P2560, DOI 10.1093/nar/24.13.2560; Svetlov V, 2013, BBA-GENE REGUL MECH, V1829, P20, DOI 10.1016/j.bbagrm.2012.08.009; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Toulme F, 2000, EMBO J, V19, P6853, DOI 10.1093/emboj/19.24.6853; Van Mullem V, 2002, J BIOL CHEM, V277, P10220, DOI 10.1074/jbc.M107207200; Walmacq C, 2012, MOL CELL, V46, P18, DOI 10.1016/j.molcel.2012.02.006; Walmacq C, 2009, J BIOL CHEM, V284, P19601, DOI 10.1074/jbc.M109.006908; Wang BB, 2013, BIOPHYS J, V105, P767, DOI 10.1016/j.bpj.2013.05.060; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wery M, 2004, EMBO J, V23, P4232, DOI 10.1038/sj.emboj.7600326; WIELAND T, 1991, EXPERIENTIA, V47, P1186, DOI 10.1007/BF01918382	60	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14883	14895		10.1074/jbc.M116.714394	http://dx.doi.org/10.1074/jbc.M116.714394			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226557	Green Published, hybrid			2022-12-28	WOS:000380366700039
J	Liu, YD; Zhang, B; Kuang, H; Korakavi, G; Lu, LY; Yu, XC				Liu, Yidan; Zhang, Bin; Kuang, Henry; Korakavi, Gautam; Lu, Lin-Yu; Yu, Xiaochun			Zinc Finger Protein 618 Regulates the Function of UHRF2 (Ubiquitin-like with PHD and Ring Finger Domains 2) as a Specific 5-Hydroxymethylcytosine Reader	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						5-hydroxymethylcytosine (5-hmC); chromatin; DNA demethylation; molecular biology; molecular cell biology	EMBRYONIC STEM-CELLS; DNA METHYLATION; METHYLTRANSFERASE DNMT1; MAMMALIAN DNA; SRA DOMAIN; GENOME; MAINTENANCE; 5-CARBOXYLCYTOSINE; 5-METHYLCYTOSINE; CHROMATIN	5-Hydroxymethylcytosine (5hmC) is an epigenetic modification that is generated by ten-eleven translocation (TET) protein-mediated oxidation of 5-methylcytosine (5mC). 5hmC is associated with transcription regulation and is decreased in many cancers including melanoma. Accumulating evidence has suggested that 5hmC is functionally distinct from 5mC. Ubiquitin-like with PHD and ring finger domains 2 (UHRF2) is the first known specific 5hmC reader that has higher affinity to 5hmC than 5mC, suggesting that UHRF2 might mediate 5hmC's function. Structural analysis has revealed the molecular mechanism of UHRF2-5hmC binding in vitro, but it is not clear how UHRF2 recognizes 5hmC in vivo. In this study, we have identified zinc figure protein 618 (ZNF618) as a novel binding partner of UHRF2. ZNF618 specifically interacts with UHRF2 but not its paralog UHRF1. Importantly, ZNF618 co-localizes with UHRF2 at genomic loci that are enriched for 5hmC. The ZNF618 chromatin localization is independent of its interaction with UHRF2 and is through its first two zinc fingers. Instead, ZNF618 regulates UHRF2 chromatin localization. Collectively, our study suggests that ZNF618 is a key protein that regulates UHRF2 function as a specific 5hmC reader in vivo.	[Liu, Yidan; Zhang, Bin; Lu, Lin-Yu] Zhejiang Univ, Sch Med, Womens Hosp, Key Lab Reprod Genet,Minist Educ, Hangzhou 310006, Zhejiang, Peoples R China; [Liu, Yidan; Zhang, Bin; Lu, Lin-Yu] Zhejiang Univ, Sch Med, Womens Hosp, Womens Reprod Hlth Lab Zhejiang Prov, Hangzhou 310006, Zhejiang, Peoples R China; [Liu, Yidan; Zhang, Bin; Lu, Lin-Yu] Zhejiang Univ, Inst Translat Med, Hangzhou 310029, Zhejiang, Peoples R China; [Kuang, Henry; Korakavi, Gautam; Yu, Xiaochun] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA	Zhejiang University; Zhejiang University; Zhejiang University; City of Hope; Beckman Research Institute of City of Hope	Lu, LY (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Key Lab Reprod Genet,Minist Educ, Hangzhou 310006, Zhejiang, Peoples R China.; Lu, LY (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Womens Reprod Hlth Lab Zhejiang Prov, Hangzhou 310006, Zhejiang, Peoples R China.; Lu, LY (corresponding author), Zhejiang Univ, Inst Translat Med, Hangzhou 310029, Zhejiang, Peoples R China.; Yu, XC (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA.	lulinyu@zju.edu.cn; xyu@coh.org			Zhejiang Provincial Natural Science Foundation of China [LR15H040001]; National Natural Science Foundation of China [81471494]; National Institutes of Health [CA130899, CA132755, CA187209, GM108647]; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA187209, R01CA132755, R01CA130899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108647] Funding Source: NIH RePORTER	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Zhejiang Provincial Natural Science Foundation of China (LR15H040001, to L. Y.), National Natural Science Foundation of China (81471494, to L. Y.), and National Institutes of Health (CA130899, CA132755, CA187209, and GM108647, to X. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of Era of Hope Scholar Award from the Department of Defense and a research scholar of Leukemia and Lymphoma Society. To whom correspondence may be addressed. E-mail: xyu@coh.org.	Bashtrykov P, 2014, J BIOL CHEM, V289, P4106, DOI 10.1074/jbc.M113.528893; Berkyurek AC, 2014, J BIOL CHEM, V289, P379, DOI 10.1074/jbc.M113.523209; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021306; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Grosser C, 2015, EPIGENETICS-US, V10, P819, DOI 10.1080/15592294.2015.1073879; Hashimoto H, 2014, NATURE, V506, P391, DOI 10.1038/nature12905; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu LL, 2015, NATURE, V527, P118, DOI 10.1038/nature15713; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Lu LY, 2015, J BIOL CHEM, V290, P851, DOI 10.1074/jbc.M114.611509; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pichler G, 2011, J CELL BIOCHEM, V112, P2585, DOI 10.1002/jcb.23185; Qin WH, 2015, CELL RES, V25, P911, DOI 10.1038/cr.2015.72; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Song CX, 2012, NAT BIOTECHNOL, V30, P1107, DOI 10.1038/nbt.2398; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Zhang JQ, 2011, CELL RES, V21, P1723, DOI 10.1038/cr.2011.176; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZM, 2015, CELL REP, V12, P1400, DOI 10.1016/j.celrep.2015.07.046; Zhou T, 2014, MOL CELL, V54, P879, DOI 10.1016/j.molcel.2014.04.003	36	11	11	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13679	13688		10.1074/jbc.M116.717314	http://dx.doi.org/10.1074/jbc.M116.717314			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129234	Green Published, hybrid			2022-12-28	WOS:000379771100023
J	Ahn, S; Jung, J; Jang, IA; Madsen, EL; Park, W				Ahn, Sungeun; Jung, Jaejoon; Jang, In-Ae; Madsen, Eugene L.; Park, Woojun			Role of Glyoxylate Shunt in Oxidative Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACINETOBACTER-OLEIVORANS DR1; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; ISOCITRATE LYASE; MYCOBACTERIUM-TUBERCULOSIS; MAMMALIAN-CELLS; METABOLISM; VIRULENCE; ENZYME; PATHOGENESIS	The glyoxylate shunt (GS) is a two-step metabolic pathway (isocitrate lyase, aceA; and malate synthase, glcB) that serves as an alternative to the tricarboxylic acid cycle. The GS bypasses the carbon dioxide-producing steps of the tricarboxylic acid cycle and is essential for acetate and fatty acid metabolism in bacteria. GS can be up-regulated under conditions of oxidative stress, antibiotic stress, and host infection, which implies that it plays important but poorly explored roles in stress defense and pathogenesis. In many bacterial species, including Pseudomonas aeruginosa, aceA and glcB are not in an operon, unlike in Escherichia coli. In P. aeruginosa, we explored relationships between GS genes and growth, transcription profiles, and biofilm formation. Contrary to our expectations, deletion of aceA in P. aeruginosa improved cell growth under conditions of oxidative and antibiotic stress. Transcriptome data suggested that aceA mutants underwent a metabolic shift toward aerobic denitrification; this was supported by additional evidence, including up-regulation of denitrification-related genes, decreased oxygen consumption without lowering ATP yield, increased production of denitrification intermediates (NO and N2O), and increased cyanide resistance. The aceA mutants also produced a thicker exopolysaccharide layer; that is, a phenotype consistent with aerobic denitrification. A bioinformatic survey across known bacterial genomes showed that only microorganisms capable of aerobic metabolism possess the glyoxylate shunt. This trend is consistent with the hypothesis that the GS plays a previously unrecognized role in allowing bacteria to tolerate oxidative stress.	[Ahn, Sungeun; Jung, Jaejoon; Jang, In-Ae; Park, Woojun] Korea Univ, Dept Environm Sci & Ecol Engn, Lab Mol Environm Microbiol, Seoul 02841, South Korea; [Madsen, Eugene L.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	Korea University; Cornell University	Park, W (corresponding author), Korea Univ, Dept Environm Sci & Ecol Engn, Seoul 02841, South Korea.	wpark@korea.ac.kr			National Research Foundation of Korea (NRF) by the Korea government (MSIP) [NRF-2014R1A2A2A05007010]	National Research Foundation of Korea (NRF) by the Korea government (MSIP)	This work was supported by a National Research Foundation of Korea (NRF) grant supported by the Korea government (MSIP) (NRF-2014R1A2A2A05007010). The authors declare that they have no conflicts of interest with the contents of this article.	Akhova AV, 2014, FEMS MICROBIOL LETT, V353, P69, DOI 10.1111/1574-6968.12405; Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; ANDRAE U, 1985, TOXICOL LETT, V28, P93, DOI 10.1016/0378-4274(85)90015-3; Bedhomme M, 2009, J BIOL CHEM, V284, P36282, DOI 10.1074/jbc.M109.064428; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; Bryantseva I, 1999, INT J SYST BACTERIOL, V49, P697, DOI 10.1099/00207713-49-2-697; Chen F, 2003, APPL ENVIRON MICROB, V69, P6715, DOI 10.1128/AEM.69.11.6715-6722.2003; Chung JCS, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120131; CLAASSEN PAM, 1987, ARCH MICROBIOL, V147, P30, DOI 10.1007/BF00492901; CORTAY JC, 1994, J BIOL CHEM, V269, P14885; Diaz-Perez AL, 2007, FEMS MICROBIOL LETT, V269, P309, DOI 10.1111/j.1574-6968.2007.00654.x; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Grostern A, 2012, APPL ENVIRON MICROB, V78, P3298, DOI 10.1128/AEM.00067-12; GUNSALUS RP, 1992, J BACTERIOL, V174, P7069, DOI 10.1128/jb.174.22.7069-7074.1992; Hamada M, 2014, J BACTERIOL, V196, P3881, DOI 10.1128/JB.01978-14; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Heo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110215; IKEDA T, 1991, J BACTERIOL, V173, P1801, DOI 10.1128/jb.173.5.1801-1806.1991; Jung J, 2013, APPL ENVIRON MICROB, V79, P6351, DOI 10.1128/AEM.02350-13; Jung J, 2011, APPL ENVIRON MICROB, V77, P7418, DOI 10.1128/AEM.05231-11; Jung J, 2011, J MICROBIOL, V49, P208, DOI 10.1007/s12275-011-0395-8; Kim EJ, 2003, MICROBIOL-SGM, V149, P2627, DOI 10.1099/mic.0.26276-0; Kim J, 2013, FEMS MICROBIOL LETT, V343, P89, DOI 10.1111/1574-6968.12135; Kim SJ, 2009, CURR OPIN MICROBIOL, V12, P301, DOI 10.1016/j.mib.2009.03.006; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KORNBERG HL, 1966, BIOCHEM J, V99, P1; Kretzschmar U, 2008, ARCH MICROBIOL, V190, P151, DOI 10.1007/s00203-008-0381-7; LAWLEY PD, 1970, BIOCHEM J, V116, P693, DOI 10.1042/bj1160693; Lee Y, 2010, MICROBIOL-SGM, V156, P3762, DOI 10.1099/mic.0.041095-0; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Lindsey TL, 2008, MICROBIOL-SGM, V154, P1616, DOI 10.1099/mic.0.2007/014506-0; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; MALOY SR, 1980, J BACTERIOL, V143, P720, DOI 10.1128/JB.143.2.720-725.1980; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD568, DOI 10.1093/nar/gkt919; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Nandakumar M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5306; Olivares J, 2014, ANTIMICROB AGENTS CH, V58, P3904, DOI 10.1128/AAC.00121-14; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Renilla S, 2012, APPL MICROBIOL BIOT, V93, P2109, DOI 10.1007/s00253-011-3536-4; Resnik E, 1996, J BACTERIOL, V178, P2715, DOI 10.1128/jb.178.9.2715-2717.1996; Rock JD, 2005, BIOCHEM SOC T, V33, P134, DOI 10.1042/BST0330134; Rui B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-122; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; SPIRO S, 1991, TRENDS BIOCHEM SCI, V16, P310, DOI 10.1016/0968-0004(91)90125-F; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; SUNNARBORG A, 1990, J BACTERIOL, V172, P2642, DOI 10.1128/jb.172.5.2642-2649.1990; VANNI P, 1990, COMP BIOCHEM PHYS B, V95, P431, DOI 10.1016/0305-0491(90)90002-B; Wall DM, 2005, INFECT IMMUN, V73, P6736, DOI 10.1128/IAI.73.10.6736-6741.2005; Wang WW, 2013, AMINO ACIDS, V45, P463, DOI 10.1007/s00726-013-1493-1; White D., 2012, PHYSL BIOCH PROKARYO, P214; Whittaker JW, 2012, ARCH BIOCHEM BIOPHYS, V525, P111, DOI 10.1016/j.abb.2011.12.008; Wiens JR, 2014, MBIO, V5, DOI 10.1128/mBio.01010-13	55	118	118	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11928	11938		10.1074/jbc.M115.708149	http://dx.doi.org/10.1074/jbc.M115.708149			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27036942	hybrid, Green Published			2022-12-28	WOS:000377264800040
J	Kafle, P; Amoh, AN; Reaves, JM; Suneby, EG; Tutunjian, KA; Tyson, RL; Schneider, TL				Kafle, Prapti; Amoh, Amanda N.; Reaves, Jocelyn M.; Suneby, Emma G.; Tutunjian, Kathryn A.; Tyson, Reed L.; Schneider, Tanya L.			Molecular Insights into the Impact of Oxidative Stress on the Quorum-Sensing Regulator Protein LasR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; DNA-BINDING; AUTOINDUCER; MECHANISM; VIRULENCE; BIOSYNTHESIS; SUSCEPTIBILITY; INHIBITION; ACTIVATION; EXPRESSION	The LasR regulator protein functions at the top of the Pseudomonas aeruginosa quorum-sensing hierarchy and is implicated in promoting bacterial virulence. Of note is recent evidence that this transcription factor may also respond to oxidative stress. Here, all cysteines in LasR were inspected to deduce their redox sensitivity and to probe the connection between stress response and LasR activity using purified LasR and individual LasR domains. Cys79 in the ligand binding domain of LasR appears to be important for ligand recognition and folding of this domain to potentiate DNA binding but does not seem to be sensitive to oxidative stress when bound to its native ligand. Two cysteines in the DNA binding domain of LasR do form a disulfide bond when treated with hydrogen peroxide, and formation of this Cys(201)-Cys(203) disulfide bond appears to disrupt the DNA binding activity of the transcription factor. Mutagenesis of either of these cysteines leads to expression of a protein that no longer binds DNA. A cell-based reporter assay linking LasR function with beta-galactosidase activity gave results consistent with those obtained with purified LasR. This work provides a possible mechanism for oxidative stress response by LasR and indicates that multiple cysteines within the protein may prove to be useful targets for disabling its activity.	[Kafle, Prapti; Amoh, Amanda N.; Reaves, Jocelyn M.; Suneby, Emma G.; Tutunjian, Kathryn A.; Tyson, Reed L.; Schneider, Tanya L.] Connecticut Coll, Dept Chem, 270 Mohegan Ave, New London, CT 06320 USA	Connecticut College	Schneider, TL (corresponding author), Connecticut Coll, Dept Chem, 270 Mohegan Ave, New London, CT 06320 USA.	tschneid@conncoll.edu	Kafle, Prapti/AAA-2125-2022	Kafle, Prapti/0000-0003-4682-2897	Research Corporation for Science Advancement; Keck Foundation; NSF-S-STEM [1153371]	Research Corporation for Science Advancement(Research Corporation for Science Advancement); Keck Foundation(W.M. Keck Foundation); NSF-S-STEM	This work was supported by a Cottrell College Science Award from the Research Corporation for Science Advancement. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Keck Foundation summer research fellowships.; Supported by NSF-S-STEM 1153371.	Amara N, 2009, J AM CHEM SOC, V131, P10610, DOI 10.1021/ja903292v; BARANGER AM, 1995, NATURE, V376, P606, DOI 10.1038/376606a0; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; Bottomley MJ, 2007, J BIOL CHEM, V282, P13592, DOI 10.1074/jbc.M700556200; Castellanos-Serra L, 2006, NAT PROTOC, V1, P1544, DOI 10.1038/nprot.2006.233; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Chen PR, 2011, ANTIOXID REDOX SIGN, V14, P1107, DOI 10.1089/ars.2010.3374; CHHABRA SR, 1993, J ANTIBIOT, V46, P441, DOI 10.7164/antibiotics.46.441; Churchill MEA, 2011, CHEM REV, V111, P68, DOI 10.1021/cr1000817; Davenport PW, 2015, J BACTERIOL, V197, P2072, DOI 10.1128/JB.02557-14; Deng X, 2013, CELL HOST MICROBE, V13, P358, DOI 10.1016/j.chom.2013.02.004; Drazic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075683; Dubern JF, 2008, MOL BIOSYST, V4, P882, DOI 10.1039/b803796p; Dubern JF, 2006, J BACTERIOL, V188, P2898, DOI 10.1128/JB.188.8.2898-2906.2006; El-Sayed AK, 2001, MICROBIOL-SGM, V147, P2127, DOI 10.1099/00221287-147-8-2127; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Galloway WRJD, 2011, CHEM REV, V111, P28, DOI 10.1021/cr100109t; Gerdt JP, 2015, ORG BIOMOL CHEM, V13, P1453, DOI 10.1039/c4ob02252a; Gerdt JP, 2014, CHEM BIOL, V21, P1361, DOI 10.1016/j.chembiol.2014.08.008; Geske GD, 2005, J AM CHEM SOC, V127, P12762, DOI 10.1021/ja0530321; Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x; Hudaiberdiev S, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00020; Ji QJ, 2012, J BIOL CHEM, V287, P21102, DOI 10.1074/jbc.M112.359737; Kim T, 2014, ACTA CRYSTALLOGR D, V70, P694, DOI 10.1107/S1399004713032355; Kohler T, 2009, P NATL ACAD SCI USA, V106, P6339, DOI 10.1073/pnas.0811741106; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Mattmann ME, 2010, J ORG CHEM, V75, P6737, DOI 10.1021/jo101237e; Moore JD, 2015, J AM CHEM SOC, V137, P14626, DOI 10.1021/jacs.5b06728; Nagano N, 1999, FEBS LETT, V458, P69, DOI 10.1016/S0014-5793(99)01122-9; O'Brien KT, 2015, ACS MED CHEM LETT, V6, P162, DOI 10.1021/ml500459f; Passador L, 1996, J BACTERIOL, V178, P5995, DOI 10.1128/jb.178.20.5995-6000.1996; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Schaefer KN, 2015, BIOCHEMISTRY-US, V54, P932, DOI 10.1021/bi501424v; Schook POP, 2011, MOL MICROBIOL, V79, P846, DOI 10.1111/j.1365-2958.2010.07491.x; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Schuster M, 2004, P NATL ACAD SCI USA, V101, P15833, DOI 10.1073/pnas.0407229101; Schuster M, 2013, ANNU REV MICROBIOL, V67, P43, DOI 10.1146/annurev-micro-092412-155635; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; Suarez-Moreno ZR, 2008, MICROBIOL-SGM, V154, P2048, DOI 10.1099/mic.0.2008/017780-0; Sun F, 2012, P NATL ACAD SCI USA, V109, P9095, DOI 10.1073/pnas.1200603109; Vannini A, 2002, EMBO J, V21, P4393, DOI 10.1093/emboj/cdf459; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zou YZ, 2009, CHEM BIOL, V16, P961, DOI 10.1016/j.chembiol.2009.09.001	49	14	14	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11776	11786		10.1074/jbc.M116.719351	http://dx.doi.org/10.1074/jbc.M116.719351			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27053110	Green Published, hybrid			2022-12-28	WOS:000377264800027
J	Morrill, SA; Exner, AE; Babokhov, M; Reinfeld, BI; Fuchs, SM				Morrill, Summer A.; Exner, Alexandra E.; Babokhov, Michael; Reinfeld, Bradley I.; Fuchs, Stephen M.			DNA Instability Maintains the Repeat Length of the Yeast RNA Polymerase II C-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-QUADRUPLEX MOTIFS; SACCHAROMYCES-CEREVISIAE; MINISATELLITE STABILITY; EVOLUTION; REPLICATION; MUTATIONS; SEQUENCES; HELICASE; PROTEIN; REPAIR	The C-terminal domain (CTD) of RNA polymerase II in eukaryotes is comprised of tandemly repeating units of a conserved seven-amino acid sequence. The number of repeats is, however, quite variable across different organisms. Furthermore, previous studies have identified evidence of rearrangements within the CTD coding region, suggesting that DNA instability may play a role in regulating or maintaining CTD repeat number. The work described here establishes a clear connection between DNA instability and CTD repeat number in Saccharomyces cerevisiae. First, analysis of 36 diverse S. cerevisiae isolates revealed evidence of numerous past rearrangements within the DNA sequence that encodes the CTD. Interestingly, the total number of CTD repeats was relatively static (24-26 repeats in all strains), suggesting a balancing act between repeat expansion and contraction. In an effort to explore the genetic plasticity within this region, we measured the rates of repeat expansion and contraction using novel reporters and a doxycycline-regulated expression system for RPB1. In efforts to determine the mechanisms leading to CTD repeat variability, we identified the presence of DNA secondary structures, specifically G-quadruplex-like DNA, within the CTD coding region. Furthermore, we demonstrated that mutating PIF1, a G-quadruplex-specific helicase, results in increased CTD repeat length polymorphisms. We also determined that RAD52 is necessary for CTD repeat expansion but not contraction, identifying a role for recombination in repeat expansion. Results from these DNA rearrangements may help explain the CTD copy number variation seen across eukaryotes, as well as support a model of CTD expansion and contraction to maintain CTD integrity and overall length.	[Morrill, Summer A.; Exner, Alexandra E.; Babokhov, Michael; Reinfeld, Bradley I.; Fuchs, Stephen M.] Tufts Univ, Dept Biol, 200 Boston Ave,Ste 4700, Medford, MA 02155 USA	Tufts University	Fuchs, SM (corresponding author), Tufts Univ, Dept Biol, 200 Boston Ave,Ste 4700, Medford, MA 02155 USA.	stephen.fuchs@tufts.edu		/0000-0002-1938-1486; Reinfeld, Bradley/0000-0003-4161-8301; Fuchs, Stephen/0000-0001-7261-9214	Tufts University; Russell L. Carpenter scholarship; Tufts Summer Scholars program	Tufts University; Russell L. Carpenter scholarship; Tufts Summer Scholars program	This work was supported by startup funds and a Tufts Collaborates! grant from Tufts University (to S. M. F.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by a Russell L. Carpenter scholarship.; Supported in part by the Tufts Summer Scholars program.	Akada R, 2000, BIOTECHNIQUES, V28, P668, DOI 10.2144/00284st02; Aksenova AY, 2013, P NATL ACAD SCI USA, V110, P19866, DOI 10.1073/pnas.1319313110; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Fuchs SM, 2012, J BIOL CHEM, V287, P3249, DOI 10.1074/jbc.M111.273953; Fuchs SM, 2009, BBA-GENE REGUL MECH, V1789, P26, DOI 10.1016/j.bbagrm.2008.07.008; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; JARMAN AP, 1989, TRENDS GENET, V5, P367, DOI 10.1016/0168-9525(89)90171-6; Kelly MK, 2012, G3-GENES GENOM GENET, V2, P1185, DOI 10.1534/g3.112.003673; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kishore SP, 2009, J MOL EVOL, V68, P706, DOI 10.1007/s00239-009-9245-2; LeClere AR, 2013, FUNGAL GENET BIOL, V50, P33, DOI 10.1016/j.fgb.2012.10.007; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Liu GQ, 2010, NAT CHEM BIOL, V6, P652, DOI [10.1038/nchembio.416, 10.1038/NCHEMBIO.416]; Liu PD, 2008, MOL BIOL EVOL, V25, P719, DOI 10.1093/molbev/msn017; Liu PD, 2010, MOL BIOL EVOL, V27, P2628, DOI 10.1093/molbev/msq151; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Malagon F, 2006, GENETICS, V172, P2201, DOI 10.1534/genetics.105.052415; McDaniel JR, 2010, BIOMACROMOLECULES, V11, P944, DOI 10.1021/bm901387t; MITANI K, 1990, J BIOL CHEM, V265, P15203; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; NONET ML, 1989, GENETICS, V123, P715; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Preston CR, 2002, GENETICS, V161, P711; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; SIKORSKI RS, 1989, GENETICS, V122, P19; Simonti CN, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0327-z; Stump AD, 2013, TRANSCR-AUSTIN, V4, P77, DOI 10.4161/trns.23305; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Wang GL, 2014, DNA REPAIR, V19, P143, DOI 10.1016/j.dnarep.2014.03.017; Weitzmann MN, 1997, J BIOL CHEM, V272, P9517; WEST ML, 1995, GENETICS, V140, P1223; Wilson MA, 2013, NATURE, V502, P393, DOI 10.1038/nature12585; Yang CL, 2014, P NATL ACAD SCI USA, V111, P5920, DOI 10.1073/pnas.1323616111; Zumwalt M, 2007, RNA BIOL, V4, P93, DOI 10.4161/rna.4.2.5039	48	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11540	11550		10.1074/jbc.M115.696252	http://dx.doi.org/10.1074/jbc.M115.696252			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27026700	hybrid, Green Published			2022-12-28	WOS:000377264800007
J	Watkins, HA; Chakravarthy, M; Abhayawardana, RS; Gingell, JJ; Garelja, M; Pardamwar, M; McElhinney, JMWR; Lathbridge, A; Constantine, A; Harris, PWR; Yuen, TY; Brimble, MA; Barwell, J; Poyner, DR; Woolley, MJ; Conner, AC; Pioszak, AA; Reynolds, CA; Hay, DL				Watkins, Harriet A.; Chakravarthy, Madhuri; Abhayawardana, Rekhati S.; Gingell, Joseph J.; Garelja, Michael; Pardamwar, Meenakshi; McElhinney, James M. W. R.; Lathbridge, Alex; Constantine, Arran; Harris, Paul W. R.; Yuen, Tsz-Ying; Brimble, Margaret A.; Barwell, James; Poyner, David R.; Woolley, Michael J.; Conner, Alex C.; Pioszak, Augen A.; Reynolds, Christopher A.; Hay, Debbie L.			Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREDICTING POCKET DRUGGABILITY; FAST INTERACTION REFINEMENT; PHASE PEPTIDE-SYNTHESIS; CLASS-B GPCRS; CALCITONIN-RECEPTOR; COUPLED RECEPTORS; HEART-FAILURE; WEB SERVER; TRANSMEMBRANE HELICES; EXTRACELLULAR LOOPS	Adrenomedullin (AM) is a peptide hormone with numerous effects in the vascular systems. AM signals through the AM(1) and AM(2) receptors formed by the obligate heterodimerization of a G protein-coupled receptor, the calcitonin receptor-like receptor (CLR), and receptor activity-modifying proteins 2 and 3 (RAMP2 and RAMP3), respectively. These different CLR-RAMP interactions yield discrete receptor pharmacology and physiological effects. The effective design of therapeutics that target the individual AM receptors is dependent on understanding the molecular details of the effects of RAMPs on CLR. To understand the role of RAMP2 and -3 on the activation and conformation of the CLR subunit of AM receptors, we mutated 68 individual amino acids in the juxtamembrane region of CLR, a key region for activation of AM receptors, and determined the effects on cAMP signaling. Sixteen CLR mutations had differential effects between the AM(1) and AM(2) receptors. Accompanying this, independent molecular modeling of the full-length AM-bound AM(1) and AM(2) receptors predicted differences in the binding pocket and differences in the electrostatic potential of the two AM receptors. Druggability analysis indicated unique features that could be used to develop selective small molecule ligands for each receptor. The interaction of RAMP2 or RAMP3 with CLR induces conformational variation in the juxtamembrane region, yielding distinct binding pockets, probably via an allosteric mechanism. These subtype-specific differences have implications for the design of therapeutics aimed at specific AM receptors and for understanding the mechanisms by which accessory proteins affect G protein-coupled receptor function.	[Watkins, Harriet A.; Chakravarthy, Madhuri; Abhayawardana, Rekhati S.; Gingell, Joseph J.; Garelja, Michael; Hay, Debbie L.] Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand; [Watkins, Harriet A.; Gingell, Joseph J.; Harris, Paul W. R.; Yuen, Tsz-Ying; Brimble, Margaret A.; Hay, Debbie L.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand; [Harris, Paul W. R.; Yuen, Tsz-Ying; Brimble, Margaret A.] Univ Auckland, Sch Chem Sci, Auckland 1010, New Zealand; [Pardamwar, Meenakshi; McElhinney, James M. W. R.; Lathbridge, Alex; Constantine, Arran; Reynolds, Christopher A.] Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Barwell, James; Poyner, David R.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Woolley, Michael J.; Conner, Alex C.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Pioszak, Augen A.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of Auckland; University of Auckland; University of Auckland; University of Essex; Aston University; University of Birmingham; University of Oklahoma System; University of Oklahoma Health Sciences Center	Hay, DL (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand.; Reynolds, CA (corresponding author), Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	reync@essex.ac.uk; dl.hay@auckland.ac.nz	Hay, Debbie L/D-4441-2009; Reynolds, Christopher/G-1036-2010	Hay, Debbie L/0000-0002-9558-5122; McElhinney, James/0000-0003-0987-4364; Garelja, Michael/0000-0001-5332-1236; Poyner, David R/0000-0003-1590-112X; Reynolds, Christopher/0000-0001-9267-5141; Chakravarthy, Madhuri/0000-0002-4146-0121; Gingell, Joseph/0000-0002-8733-7639	Biotechnology and Biological Sciences Research Council [BB/M006883/1, BB/M007529/1, BB/M000176/1]; National Heart Foundation of New Zealand; Maurice and Phyllis Paykel Trust; Maurice Wilkins Centre for Molecular Biodiscovery; British Heart Foundation [FS/05/054, PG/12/59/29795]; BBSRC [BB/M000176/1, BB/M006883/1, BB/M007529/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104251] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Heart Foundation of New Zealand; Maurice and Phyllis Paykel Trust; Maurice Wilkins Centre for Molecular Biodiscovery; British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Biotechnology and Biological Sciences Research Council Grants BB/M006883/1 (to C. A. R.) and BB/M007529/1 and BB/M000176/1 (to D. P.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the National Heart Foundation of New Zealand, the Maurice and Phyllis Paykel Trust, and the Maurice Wilkins Centre for Molecular Biodiscovery.; Supported by British Heart Foundation Grant FS/05/054.; Supported by British Heart Foundation Grant PG/12/59/29795.	Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Bailey RJ, 2007, BRIT J PHARMACOL, V151, P678, DOI 10.1038/sj.bjp.0707246; Bailey RJ, 2006, PEPTIDES, V27, P1367, DOI 10.1016/j.peptides.2005.11.014; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Barrick CJ, 2012, J MOL CELL CARDIOL, V52, P165, DOI 10.1016/j.yjmcc.2011.10.021; Barwell J, 2011, BBA-MOL CELL RES, V1813, P1906, DOI 10.1016/j.bbamcr.2011.06.005; Booe JM, 2015, MOL CELL, V58, P1040, DOI 10.1016/j.molcel.2015.04.018; Borrel A, 2015, J CHEM INF MODEL, V55, P882, DOI 10.1021/ci5006004; Bortolato A, 2014, BRIT J PHARMACOL, V171, P3132, DOI 10.1111/bph.12689; Burley DS, 2007, HEART FAIL REV, V12, P279, DOI 10.1007/s10741-007-9029-y; Callenberg KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012722; Caron KM, 2001, P NATL ACAD SCI USA, V98, P615, DOI 10.1073/pnas.021548898; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Conner AC, 2005, MOL PHARMACOL, V67, P20, DOI 10.1124/mol.67.1.20; Dackor RT, 2006, MOL CELL BIOL, V26, P2511, DOI 10.1128/MCB.26.7.2511-2518.2006; Dackor R, 2007, J BIOL CHEM, V282, P18094, DOI 10.1074/jbc.M703544200; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dupuis J, 2005, CLIN SCI, V109, P97, DOI 10.1042/CS20040357; Garland SL, 2013, J BIOMOL SCREEN, V18, P947, DOI 10.1177/1087057113498418; Gingell J. J., 2016, CELL DISCOV IN PRESS; Gingell JJ, 2010, PEPTIDES, V31, P1400, DOI 10.1016/j.peptides.2010.03.027; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Harikumar KG, 2009, BIOCHEMISTRY-US, V48, P11773, DOI 10.1021/bi901326k; Harris PWR, 2011, TETRAHEDRON LETT, V52, P6024, DOI 10.1016/j.tetlet.2011.09.010; Harris PWR, 2008, INT J PEPT RES THER, V14, P387, DOI 10.1007/s10989-008-9149-9; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hussein HA, 2015, NUCLEIC ACIDS RES, V43, pW436, DOI 10.1093/nar/gkv462; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kataoka Y, 2010, J CARDIOVASC PHARM, V56, P413, DOI 10.1097/FJC.0b013e3181f15b45; Kato J, 2015, EUR J PHARMACOL, V764, P140, DOI 10.1016/j.ejphar.2015.06.061; Kenakin T. P., 2014, PHARM PRIMER TECHNIQ, P181; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Lainchbury JG, 1999, HYPERTENSION, V34, P70, DOI 10.1161/01.HYP.34.1.70; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SM, 2016, J BIOL CHEM, V291, P8686, DOI 10.1074/jbc.M115.713628; Li XF, 2010, PROTEINS, V78, P3189, DOI 10.1002/prot.22770; Liang LH, 2009, HYPERTENSION, V54, P1254, DOI 10.1161/HYPERTENSIONAHA.109.129783; Lock A, 2014, BBA-BIOMEMBRANES, V1838, P3036, DOI 10.1016/j.bbamem.2014.08.019; Manuela C, 2014, PEPTIDES, V55, P13, DOI 10.1016/j.peptides.2014.01.028; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; Monaghan P, 2008, BIOCHEMISTRY-US, V47, P5889, DOI 10.1021/bi800122f; Nagaya N, 2000, HEART, V84, P653, DOI 10.1136/heart.84.6.653; Nishikimi T, 2013, CURR PROTEIN PEPT SC, V14, P256, DOI 10.2174/13892037113149990045; Perez-Castells J, 2012, BIOPOLYMERS, V97, P45, DOI 10.1002/bip.21700; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Qi T, 2013, BRIT J PHARMACOL, V168, P644, DOI 10.1111/j.1476-5381.2012.02197.x; Qi T, 2008, MOL PHARMACOL, V74, P1059, DOI 10.1124/mol.108.047142; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roy A, 2014, J BIOMOL STRUCT DYN, V32, P364, DOI 10.1080/07391102.2013.770371; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; SITKOFF D, 1994, BIOPHYS CHEM, V51, P397, DOI 10.1016/0301-4622(94)00062-X; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Taddese B, 2014, PLANT PHYSIOL, V164, P287, DOI 10.1104/pp.113.228874; Tadokoro K, 2003, REGUL PEPTIDES, V112, P71, DOI 10.1016/s0167-0115(03)00024-7; Vohra S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0846; Volkamer A, 2012, BIOINFORMATICS, V28, P2074, DOI 10.1093/bioinformatics/bts310; Wang DF, 2005, ABSTR PAP AM CHEM S, V230, pU1360; Wang JG, 2007, BIOORGAN MED CHEM, V15, P374, DOI 10.1016/j.bmc.2006.09.050; Watkins HA, 2014, BRIT J PHARMACOL, V171, P772, DOI 10.1111/bph.12508; Watkins HA, 2012, DRUG DISCOV TODAY, V17, P1006, DOI 10.1016/j.drudis.2012.05.005; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Wong CP, 2012, WORLD J CARDIOL, V4, P206, DOI 10.4330/wjc.v4.i6.206; Woolley MJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0589; Wootten D, 2016, MOL PHARMACOL, V89, P335, DOI 10.1124/mol.115.101246; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Yamauchi A, 2014, J MOL CELL CARDIOL, V77, P73, DOI 10.1016/j.yjmcc.2014.09.017; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859; Yoshizawa T, 2013, HYPERTENSION, V61, P341, DOI 10.1161/HYPERTENSIONAHA.111.00647	79	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11657	11675		10.1074/jbc.M115.688218	http://dx.doi.org/10.1074/jbc.M115.688218			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27013657	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000377264800017
J	Yosef, E; Katz, A; Peleg, Y; Mehlman, T; Karlish, SJD				Yosef, Eliyahu; Katz, Adriana; Peleg, Yoav; Mehlman, Tevie; Karlish, Steven J. D.			Do Src Kinase and Caveolin Interact Directly with Na,K-ATPase?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-ATPASE; SIGNAL-TRANSDUCING FUNCTION; NA/K-ATPASE; TYROSINE KINASES; OUABAIN; PROTEIN; PURIFICATION; STABILIZATION; NA+,K+-ATPASE; EXPRESSION	Much evidence points to a role of Na,K-ATPase in ouabain-dependent signal transduction. Based on experiments with different cell lines and native tissue membranes, a current hypothesis postulates direct interactions between the Na, K-ATPase and Src kinase (non-receptor tyrosine kinase). Na, K-ATPase is proposed to bind Src kinase and inhibit its activity, whereas ouabain, the specific Na, K-ATPase inhibitor, binds and stabilizes the E2 conformation, thus exposing the Src kinase domain and its active site Tyr-418 for activation. Ouabain-dependent signaling is thought to be mediated within caveolae by a complex consisting of Na, K-ATPase, caveolin, and Src kinase. In the current work, we have looked for direct interactions utilizing purified recombinant Na, K-ATPase (human alpha 1 beta 1FXYD1 or porcine alpha 1D369N beta 1FXYD1) and purified human Src kinase and human caveolin 1 or interactions between these proteins in native membrane vesicles isolated from rabbit kidney. By several independent criteria and techniques, no stable interactions were detected between Na, K-ATPase and purified Src kinase. Na,K-ATPase was found to be a substrate for Src kinase phosphorylation at Tyr-144. Clear evidence for a direct interaction between purified human Na, K-ATPase and human caveolin was obtained, albeit with a low molar stoichiometry (1:15-30 caveolin 1/Na,K-ATPase). In native renal membranes, a specific caveolin 14-5 oligomer (95 kDa) was found to be in direct interaction with Na, K-ATPase. We inferred that a small fraction of the renal Na, K-ATPase molecules is in a similar to 1:1 complex with a caveolin 14-5 oligomer. Thus, overall, whereas a direct caveolin 1/Na, K-ATPase interaction is confirmed, the lack of direct Src kinase/Na,K-ATPase binding requires reassessment of the mechanism of ouabain-dependent signaling.	[Yosef, Eliyahu; Katz, Adriana; Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biol Chem, IL-7610001 Rehovot, Israel; [Peleg, Yoav] Weizmann Inst Sci, Israel Struct Prote Ctr, IL-7610001 Rehovot, Israel; [Mehlman, Tevie] Weizmann Inst Sci, Biol Serv Dept, Mass Spectrometry Unit, IL-7610001 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-7610001 Rehovot, Israel.	Steven.Karlish@weizmann.ac.il						Aperia A, 2007, J INTERN MED, V261, P44, DOI 10.1111/j.1365-2796.2006.01745.x; Aperia A, 2016, AM J PHYSIOL-CELL PH, V310, pC491, DOI 10.1152/ajpcell.00359.2015; Aydemir-Koksoy A, 2001, J BIOL CHEM, V276, P46605, DOI 10.1074/jbc.M106178200; Belogus T, 2009, J BIOL CHEM, V284, P31038, DOI 10.1074/jbc.M109.050054; Bozulic LD, 2005, INVEST OPHTH VIS SCI, V46, P618, DOI 10.1167/iovs.04-0809; Clifford RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084306; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; Cornelius F, 2011, J BIOL CHEM, V286, P29882, DOI 10.1074/jbc.M111.259663; Ferrandi M, 2004, J BIOL CHEM, V279, P33306, DOI 10.1074/jbc.M402187200; Ferrandi M, 1999, AM J PHYSIOL-HEART C, V277, pH1338, DOI 10.1152/ajpheart.1999.277.4.H1338; Ferrandi M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001815; Ferrari P, 2006, AM J PHYSIOL-REG I, V290, pR529, DOI 10.1152/ajpregu.00518.2005; Ferrari P, 2010, BBA-MOL BASIS DIS, V1802, P1254, DOI 10.1016/j.bbadis.2010.01.009; Fontana JM, 2013, FEBS J, V280, P5450, DOI 10.1111/febs.12448; Gable ME, 2014, BIOCHEM BIOPH RES CO, V446, P1151, DOI 10.1016/j.bbrc.2014.03.071; Gottlieb-Abraham E, 2013, MOL BIOL CELL, V24, P3881, DOI 10.1091/mbc.E13-03-0163; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Haas M, 2000, J BIOL CHEM, V275, P27832; Habeck M, 2015, J BIOL CHEM, V290, P4829, DOI 10.1074/jbc.M114.611384; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; JORGENSEN PL, 1988, METHOD ENZYMOL, V156, P29; Kapri-Pardes E, 2011, J BIOL CHEM, V286, P42888, DOI 10.1074/jbc.M111.293852; KARLISH SJD, 1993, J BIOL CHEM, V268, P3471; Karni R, 2003, FEBS LETT, V537, P47, DOI 10.1016/S0014-5793(03)00069-3; Kometiani P, 1998, J BIOL CHEM, V273, P15249, DOI 10.1074/jbc.273.24.15249; Lai FF, 2013, J BIOL CHEM, V288, P13295, DOI 10.1074/jbc.M113.467381; LAZARO I, 1991, ANAL BIOCHEM, V192, P257, DOI 10.1016/0003-2697(91)90533-Y; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Li ZC, 2009, J BIOL CHEM, V284, P21066, DOI 10.1074/jbc.M109.013821; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liu J, 2004, KIDNEY INT, V66, P227, DOI 10.1111/j.1523-1755.2004.00723.x; Liu J, 2000, J BIOL CHEM, V275, P27838; Liu LJ, 2011, BIOCHEMISTRY-US, V50, P8664, DOI 10.1021/bi2009008; Liu LJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1550, DOI 10.1152/ajpcell.00555.2002; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Moroco JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105629; Reinhard L, 2013, CELL MOL LIFE SCI, V70, P205, DOI 10.1007/s00018-012-1039-9; Schoner W, 2002, EUR J BIOCHEM, V269, P2440, DOI 10.1046/j.1432-1033.2002.02911.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Strugatsky D, 2003, J BIOL CHEM, V278, P46064, DOI 10.1074/jbc.M308303200; Susa M, 2000, PROTEIN EXPRES PURIF, V19, P99, DOI 10.1006/prep.2000.1221; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Weigand KM, 2012, BBA-BIOMEMBRANES, V1818, P1269, DOI 10.1016/j.bbamem.2012.01.015; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Ye QQ, 2011, J BIOL CHEM, V286, P6225, DOI 10.1074/jbc.M110.202051	49	32	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11736	11750		10.1074/jbc.M116.721084	http://dx.doi.org/10.1074/jbc.M116.721084			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27022017	Green Published, hybrid			2022-12-28	WOS:000377264800024
J	Dey, S; Sidor, A; O'Rourke, B				Dey, Swati; Sidor, Agnieszka; O'Rourke, Brian			Compartment-specific Control of Reactive Oxygen Species Scavenging by Antioxidant Pathway Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antioxidant; cell metabolism; glutathione peroxidase; mitochondria; peroxiredoxin; reactive oxygen species (ROS); redox regulation; thioredoxin; thioredoxin reductase; NADPH	MITOCHONDRIAL THIOREDOXIN; GLUTATHIONE-PEROXIDASE; CARDIOVASCULAR EVENTS; OXIDATIVE STRESS; TARGET PROTEINS; PEROXIREDOXIN 3; VITAMIN-E; IN-VIVO; REDOX; CATALASE	Oxidative stress arises from an imbalance in the production and scavenging rates of reactive oxygen species (ROS) and is a key factor in the pathophysiology of cardiovascular disease and aging. The presence of parallel pathways and multiple intracellular compartments, each having its own ROS sources and antioxidant enzymes, complicates the determination of the most important regulatory nodes of the redox network. Here we quantified ROS dynamics within specific intracellular compartments in the cytosol and mitochondria and determined which scavenging enzymes exert the most control over antioxidant fluxes in H9c2 cardiac myoblasts. We used novel targeted viral gene transfer vectors expressing redox-sensitive GFP fused to sensor domains to measure H2O2 or oxidized glutathione. Using genetic manipulation in heart-derived H9c2 cells, we explored the contribution of specific antioxidant enzymes to ROS scavenging and glutathione redox potential within each intracellular compartment. Our findings reveal that antioxidant flux is strongly dependent on mitochondrial substrate catabolism, with availability of NADPH as a major rate-controlling step. Moreover, ROS scavenging by mitochondria significantly contributes to cytoplasmic ROS handling. The findings provide fundamental information about the control of ROS scavenging by the redox network and suggest novel interventions for circumventing oxidative stress in cardiac cells.	[Dey, Swati; Sidor, Agnieszka; O'Rourke, Brian] Johns Hopkins Univ, Dept Med, Div Cardiol, 720 Rutland Ave,1060 Ross Bldg, Baltimore, MD 21205 USA	Johns Hopkins University	O'Rourke, B (corresponding author), Johns Hopkins Univ, Dept Med, Div Cardiol, 720 Rutland Ave,1060 Ross Bldg, Baltimore, MD 21205 USA.	bor@jhmi.edu		O'Rourke, Brian/0000-0002-5548-4853	NHLBI/National Institutes of Health [R01HL105216, R37HL54598]; Leducq Foundation; American Heart Association [14POST20380749]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105216, R01HL108917, R37HL054598] Funding Source: NIH RePORTER	NHLBI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Leducq Foundation(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI/National Institutes of Health Grants R01HL105216 and R37HL54598 and the Leducq Foundation (to B. O.) and American Heart Association Postdoctoral Fellowship 14POST20380749 (to S. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aon MA, 2010, BBA-BIOENERGETICS, V1797, P865, DOI 10.1016/j.bbabio.2010.02.016; Aon MA, 2007, J BIOL CHEM, V282, P21889, DOI 10.1074/jbc.M702841200; Aon MA, 2012, J GEN PHYSIOL, V139, P479, DOI 10.1085/jgp.201210772; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Birk AV, 2013, J AM SOC NEPHROL, V24, P1250, DOI 10.1681/ASN.2012121216; Blair IA, 2006, CURR DRUG METAB, V7, P853, DOI 10.2174/138920006779010601; Brown DA, 2014, J CARDIOVASC PHARM T, V19, P121, DOI 10.1177/1074248413508003; Brown KK, 2008, FREE RADICAL BIO MED, V45, P494, DOI 10.1016/j.freeradbiomed.2008.04.030; Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216; Calabrese EJ, 2007, TOXICOL APPL PHARM, V222, P122, DOI 10.1016/j.taap.2007.02.015; Cappola TP, 2001, CIRCULATION, V104, P2407, DOI 10.1161/hc4501.098928; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Cox AG, 2008, BIOCHEM PHARMACOL, V76, P1097, DOI 10.1016/j.bcp.2008.08.021; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Doughan AK, 2007, ANTIOXID REDOX SIGN, V9, P1825, DOI 10.1089/ars.2007.1693; Fu YX, 1999, FREE RADICAL BIO MED, V27, P605, DOI 10.1016/S0891-5849(99)00104-5; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; GARCIARUIZ C, 1995, MOL PHARMACOL, V48, P825; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; HOEK JB, 1988, BIOCHEM J, V254, P1; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Kaludercic N, 2014, ANTIOXID REDOX SIGN, V20, P267, DOI 10.1089/ars.2012.4616; Kaludercic N, 2010, CIRC RES, V106, P193, DOI 10.1161/CIRCRESAHA.109.198366; Kelner MJ, 2000, BIOCHEM BIOPH RES CO, V269, P366, DOI 10.1006/bbrc.2000.2267; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kim A, 2010, MAMM GENOME, V21, P534, DOI 10.1007/s00335-010-9299-x; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kortylewski M, 2009, NAT BIOTECHNOL, V27, P925, DOI 10.1038/nbt.1564; Kudin AP, 2012, BBA-BIOENERGETICS, V1817, P1901, DOI 10.1016/j.bbabio.2012.02.023; Kumar V, 2009, FEBS LETT, V583, P997, DOI 10.1016/j.febslet.2009.02.018; Lee MY, 2008, ANTIOXID REDOX SIGN, V10, P1045, DOI 10.1089/ars.2007.1986; Lee S, 2013, ANTIOXID REDOX SIGN, V18, P1165, DOI 10.1089/ars.2011.4322; Liu T, 2014, CIRC RES, V115, P44, DOI 10.1161/CIRCRESAHA.115.303062; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Morgan B, 2011, FREE RADICAL BIO MED, V51, P1943, DOI 10.1016/j.freeradbiomed.2011.08.035; Nelson SK, 2006, FREE RADICAL BIO MED, V40, P341, DOI 10.1016/j.freeradbiomed.2005.08.043; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Qin FZ, 2010, CIRC-HEART FAIL, V3, P306, DOI 10.1161/CIRCHEARTFAILURE.109.864785; RADI R, 1991, J BIOL CHEM, V266, P22028; Roe ND, 2012, VASC PHARMACOL, V57, P168, DOI 10.1016/j.vph.2012.02.004; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; Rydstrom J, 2006, BBA-BIOENERGETICS, V1757, P721, DOI 10.1016/j.bbabio.2006.03.010; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Skulachev VP, 2009, BBA-BIOENERGETICS, V1787, P437, DOI 10.1016/j.bbabio.2008.12.008; Steinhubl SR, 2008, AM J CARDIOL, V101, p14D, DOI 10.1016/j.amjcard.2008.02.003; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Suvorova ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006158; Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461; Tepel M, 2003, CIRCULATION, V107, P992, DOI 10.1161/01.CIR.0000050628.11305.30; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Winterbourn CC, 2014, BBA-GEN SUBJECTS, V1840, P730, DOI 10.1016/j.bbagen.2013.05.004; Wu CG, 2014, MOL CELL PROTEOMICS, V13, P3507, DOI 10.1074/mcp.M114.040931; Wu CG, 2011, J PROTEOMICS, V74, P2498, DOI 10.1016/j.jprot.2011.06.001; Yamamoto M, 2003, J CLIN INVEST, V112, P1395, DOI 10.1172/JCI200317700; Yang KC, 2015, CIRC RES, V116, P1937, DOI 10.1161/CIRCRESAHA.116.304691; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Zhang H, 2007, ARCH BIOCHEM BIOPHYS, V465, P119, DOI 10.1016/j.abb.2007.05.001; Zhang J, 2014, CURR MOL MED, V14, P772; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019	67	71	72	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11185	11197		10.1074/jbc.M116.726968	http://dx.doi.org/10.1074/jbc.M116.726968			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27048652	Green Published, hybrid			2022-12-28	WOS:000377042100021
J	Guo, H; Foncea, R; O'Byrne, SM; Jiang, HF; Zhang, YY; Deis, JA; Blaner, WS; Bernlohr, DA; Chen, XL				Guo, Hong; Foncea, Rocio; O'Byrne, Sheila M.; Jiang, Hongfeng; Zhang, Yuanyuan; Deis, Jessica A.; Blaner, William S.; Bernlohr, David A.; Chen, Xiaoli			Lipocalin 2, a Regulator of Retinoid Homeostasis and Retinoid-mediated Thermogenic Activation in Adipose Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipose tissue; cytokine; energy metabolism; lipid metabolism; retinoid; lipocalin 2	UNCOUPLING PROTEIN GENE; BINDING-PROTEIN; VITAMIN-A; INSULIN-RESISTANCE; HUMAN PLASMA; IN-VITRO; ACID; RECEPTOR; EXPRESSION; METABOLISM	We have recently characterized the role of lipocalin 2 (Lcn2) as a new adipose-derived cytokine in the regulation of adaptive thermogenesis via a non-adrenergic pathway. Herein, we explored a potential non-adrenergic mechanism by which Lcn2 regulates thermogenesis and lipid metabolism. We found that Lcn2 is a retinoic acid target gene, and retinoic acid concurrently stimulated UCP1 and Lcn2 expression in adipocytes. Lcn2 KO mice exhibited a blunted effect of all-trans-retinoic acid (ATRA) on body weight and fat mass, lipid metabolism, and retinoic acid signaling pathway activation in adipose tissue under the high fat diet-induced obese condition. We further demonstrated that Lcn2 is required for the full action of ATRA on the induction of UCP1 and PGC-1 expression in brown adipocytes and the restoration of cold intolerance in Lcn2 KO mice. Interestingly, we discovered that Lcn2 KO mice have decreased levels of retinoic acid and retinol in adipose tissue. The protein levels of STRA6 responsible for retinol uptake were significantly decreased in adipose tissue. The retinol transporter RBP4 was increased in adipose tissue but decreased in the circulation, suggesting the impairment of RBP4 secretion in Lcn2 KO adipose tissue. Moreover, Lcn2 deficiency abolished the ATRA effect on RBP4 expression in adipocytes. All the data suggest that the decreased retinoid level and action are associated with impaired retinol transport and storage in adipose tissue in Lcn2 KO mice. We conclude that Lcn2 plays a critical role in regulating metabolic homeostasis of retinoids and retinoid-mediated thermogenesis in adipose tissue.	[Guo, Hong; Zhang, Yuanyuan; Deis, Jessica A.; Chen, Xiaoli] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA; [Foncea, Rocio; Bernlohr, David A.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA; [O'Byrne, Sheila M.; Jiang, Hongfeng; Blaner, William S.] Columbia Univ Coll Phys & Surg, Dept Med, 630 W 168th St, New York, NY 10032 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Columbia University	Chen, XL (corresponding author), Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA.; Bernlohr, DA (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA.; Blaner, WS (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, 630 W 168th St, New York, NY 10032 USA.	wsb2@columbia.edu; BERNL001@umn.edu; xlchen@umn.edu	jiang, hongfeng/I-6188-2013	Guo, Hong/0000-0001-8024-7086	National Institutes of Health from NIDDK [R01DK080743, P30DK050456]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068437, P30DK050456, T32DK083250, R01DK080743] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK080743 from NIDDK (to X. C.) and P30DK050456 from NIDDK (to Minnesota Obesity Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALVAREZ R, 1995, J BIOL CHEM, V270, P5666, DOI 10.1074/jbc.270.10.5666; Barua AB, 1998, MOL BIOTECHNOL, V10, P167, DOI 10.1007/BF02760863; Berry DC, 2012, BBA-MOL CELL BIOL L, V1821, P168, DOI 10.1016/j.bbalip.2011.07.002; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Blaner WS, 2007, CELL METAB, V5, P164, DOI 10.1016/j.cmet.2007.02.006; BLANER WS, 1989, ENDOCR REV, V10, P308, DOI 10.1210/edrv-10-3-308; Bonet ML, 2000, J ENDOCRINOL, V166, P511, DOI 10.1677/joe.0.1660511; Breustedt DA, 2006, BBA-PROTEINS PROTEOM, V1764, P161, DOI 10.1016/j.bbapap.2005.12.006; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Collins S, 2010, INT J OBESITY, V34, pS28, DOI 10.1038/ijo.2010.180; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P327, DOI 10.1016/S0167-4838(00)00169-2; FLOWER DR, 1993, PROTEIN SCI, V2, P753, DOI 10.1002/pro.5560020507; GarayRojas E, 1996, GENE, V170, P173, DOI 10.1016/0378-1119(95)00896-9; Guo H, 2013, ENDOCRINOLOGY, V154, P3525, DOI 10.1210/en.2013-1289; Guo H, 2010, DIABETES, V59, P1376, DOI 10.2337/db09-1735; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Jin DZ, 2011, FASEB J, V25, P754, DOI 10.1096/fj.10-165175; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kiernan UA, 2002, BIOCHEM BIOPH RES CO, V297, P401, DOI 10.1016/S0006-291X(02)02212-X; Kim SC, 2014, HEPATOLOGY, V59, P1750, DOI 10.1002/hep.26699; Kumar MV, 1999, J LIPID RES, V40, P824; KURLANDSKY SB, 1995, J BIOL CHEM, V270, P17850, DOI 10.1074/jbc.270.30.17850; LALONDE JM, 1994, FASEB J, V8, P1240, DOI 10.1096/fasebj.8.15.8001736; Larose M, 1996, J BIOL CHEM, V271, P31533, DOI 10.1074/jbc.271.49.31533; Bonet ML, 2012, BBA-MOL CELL BIOL L, V1821, P177, DOI 10.1016/j.bbalip.2011.06.001; Marzan CV, 2011, DEV BIOL, V349, P125, DOI 10.1016/j.ydbio.2010.10.018; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Nedelkov D, 2005, P NATL ACAD SCI USA, V102, P10852, DOI 10.1073/pnas.0500426102; Nelson AM, 2008, J CLIN INVEST, V118, P1468, DOI 10.1172/JCI33869; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pino-Lagos K, 2010, BIOFACTORS, V36, P430, DOI 10.1002/biof.117; Puigserver P, 1996, BIOCHEM J, V317, P827, DOI 10.1042/bj3170827; Rabelo R, 1996, ENDOCRINOLOGY, V137, P3488, DOI 10.1210/en.137.8.3488; Ravussin E, 2011, ANNU REV NUTR, V31, P33, DOI 10.1146/annurev-nutr-072610-145209; REPA JJ, 1993, P NATL ACAD SCI USA, V90, P7293, DOI 10.1073/pnas.90.15.7293; Sears IB, 1996, MOL CELL BIOL, V16, P3410; Serra F, 1999, INT J OBESITY, V23, P650, DOI 10.1038/sj.ijo.0800897; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Strom K, 2009, FASEB J, V23, P2307, DOI 10.1096/fj.08-120923; SUNDARESAN PR, 1967, J NUTR, V92, P474, DOI 10.1093/jn/92.4.474; Teruel T, 2003, J BIOL CHEM, V278, P263, DOI 10.1074/jbc.M207200200; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; Valverde AM, 2003, J BIOL CHEM, V278, P10221, DOI 10.1074/jbc.M209363200; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Wei SH, 1997, J BIOL CHEM, V272, P14159, DOI 10.1074/jbc.272.22.14159; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang Q, 2012, ENDOCRINOLOGY, V153, P1519, DOI 10.1210/en.2011-1750; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zhang YY, 2014, J BIOL CHEM, V289, P22063, DOI 10.1074/jbc.M114.559104; Ziouzenkova O, 2008, FEBS LETT, V582, P32, DOI 10.1016/j.febslet.2007.11.081	52	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11216	11229		10.1074/jbc.M115.711556	http://dx.doi.org/10.1074/jbc.M115.711556			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27008859	hybrid, Green Published			2022-12-28	WOS:000377042100023
J	Timpano, S; Uniacke, J				Timpano, Sara; Uniacke, James			Human Cells Cultured under Physiological Oxygen Utilize Two Cap-binding Proteins to recruit Distinct mRNAs for Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTIAL-PRESSURE; HUMAN TISSUES; CANCER-CELLS; LIFE-SPAN; HYPOXIA; HIF-1-ALPHA; HIF-2-ALPHA; EXPRESSION; PROMOTES; AFFINITY	Translation initiation is a focal point of translational control and requires the binding of eIF4E to the 5' cap of mRNA. Under conditions of extreme oxygen depletion (hypoxia), human cells repress eIF4E and switch to an alternative cap-dependent translation mediated by a homolog of eIF4E, eIF4E2. This homolog forms a complex with the oxygen-regulated hypoxia-inducible factor 2 alpha and can escape translation repression. This complex mediates cap-dependent translation under cell culture conditions of 1% oxygen (to mimic tumor microenvironments), whereas eIF4E mediates cap-dependent translation at 21% oxygen (ambient air). However, emerging evidence suggests that culturing cells in ambient air, or "normoxia," is far from physiological or "normal." In fact, oxygen in human tissues ranges from 1-11% or "physioxia." Here we show that two distinct modes of cap-dependent translation initiation are active during physioxia and act on separate pools of mRNAs. The oxygen-dependent activities of eIF4E and eIF4E2 are elucidated by observing their polysome association and the status of mammalian target of rapamycin complex 1 (eIF4E-dependent) or hypoxiainducible factor 2 alpha expression (eIF4E2-dependent). We have identified oxygen conditions where eIF4E is the dominant cap binding protein (21% normoxia or standard cell culture conditions), where eIF4E2 is the dominant cap-binding protein (1% hypoxia or ischemic diseases and cancerous tumors), and where both cap-binding proteins act simultaneously to initiate the translation of distinct mRNAs (1-11% physioxia or during development and stem cell differentiation). These data suggest that the physioxic proteome is generated by initiating translation of mRNAs via two distinct but complementary cap-binding proteins.	[Timpano, Sara; Uniacke, James] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada	University of Guelph	Uniacke, J (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	juniacke@uoguelph.ca			Ontario Ministry of Research and Innovation; Natural Sciences and Engineering Council of Canada [04807]; Queen Elizabeth II Graduate Scholarship in Science and Technology	Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Queen Elizabeth II Graduate Scholarship in Science and Technology	This work was funded by Ontario Ministry of Research and Innovation and the Natural Sciences and Engineering Council of Canada Grant 04807 (to J. U.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Queen Elizabeth II Graduate Scholarship in Science and Technology.	Atkuri KR, 2007, P NATL ACAD SCI USA, V104, P4547, DOI 10.1073/pnas.0611732104; Brooks AJ, 2004, BRIT J ANAESTH, V92, P735, DOI 10.1093/bja/aeh112; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gleadle J., 2001, HYPOXIA, P3; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Harrison JS, 2002, BLOOD, V99, P394, DOI 10.1182/blood.V99.1.394; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Ho JJD, 2016, CELL REP, V14, P1293, DOI 10.1016/j.celrep.2016.01.036; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Joshi B, 2004, EUR J BIOCHEM, V271, P2189, DOI 10.1111/j.1432-1033.2004.04149.x; Le QT, 2006, CLIN CANCER RES, V12, P1507, DOI 10.1158/1078-0432.CCR-05-2049; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Morita M, 2012, MOL CELL BIOL, V32, P3585, DOI 10.1128/MCB.00455-12; Muller M, 2002, ANAESTHESIA, V57, P110, DOI 10.1046/j.0003-2409.2001.02363.x; Muller M, 1998, ANESTH ANALG, V87, P474, DOI 10.1097/00000539-199808000-00045; Newby D, 2005, PLACENTA, V26, P353, DOI 10.1016/j.placenta.2004.07.002; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Rankin EB, 2008, ONCOGENE, V27, P5354, DOI 10.1038/onc.2008.160; Richardson RS, 2006, J PHYSIOL-LONDON, V571, P415, DOI 10.1113/jphysiol.2005.102327; RICHTER A, 1972, J NATL CANCER I, V49, P1705, DOI 10.1093/jnci/49.6.1705; Rouschop KMA, 2011, RADIOTHER ONCOL, V99, P385, DOI 10.1016/j.radonc.2011.05.047; Shatsky IN, 2014, CRIT REV BIOCHEM MOL, V49, P164, DOI 10.3109/10409238.2014.887051; SONENBERG N, 1979, P NATL ACAD SCI USA, V76, P4345, DOI 10.1073/pnas.76.9.4345; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Uniacke J, 2014, CANCER RES, V74, P1379, DOI 10.1158/0008-5472.CAN-13-2278; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Yi TF, 2013, J BIOL CHEM, V288, P18732, DOI 10.1074/jbc.M113.471466; Zuberek J, 2007, RNA, V13, P691, DOI 10.1261/rna.453107	36	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10772	10782		10.1074/jbc.M116.717363	http://dx.doi.org/10.1074/jbc.M116.717363			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27002144	Green Published, hybrid			2022-12-28	WOS:000377042600028
J	Tjondrokoesoemo, A; Schips, TG; Sargent, MA; Vanhoutte, D; Kanisicak, O; Prasad, V; Lin, SCJ; Maillet, M; Molkentin, JD				Tjondrokoesoemo, Andoria; Schips, Tobias G.; Sargent, Michelle A.; Vanhoutte, Davy; Kanisicak, Onur; Prasad, Vikram; Lin, Suh-Chin J.; Maillet, Marjorie; Molkentin, Jeffery D.			Cathepsin S Contributes to the Pathogenesis of Muscular Dystrophy in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; SKELETAL-MUSCLE REGENERATION; MDX MICE; INHIBITION; EXPRESSION; SARCOLEMMA; INTEGRITY; CLEAVAGE; DUCHENNE; COMPLEX	Duchenne muscular dystrophy (DMD) is an X-linked recessive disease caused by mutations in the gene encoding dystrophin. Loss of dystrophin protein compromises the stability of the sarcolemma membrane surrounding each muscle cell fiber, leading to membrane ruptures and leakiness that induces myofiber necrosis, a subsequent inflammatory response, and progressive tissue fibrosis with loss of functional capacity. Cathepsin S (Ctss) is a cysteine protease that is actively secreted in areas of tissue injury and ongoing inflammation, where it participates in extracellular matrix remodeling and healing. Here we show significant induction of Ctss expression and proteolytic activity following acute muscle injury or in muscle from mdx mice, a model of DMD. To examine the functional ramifications associated with greater Ctss expression, the Ctss gene was deleted in the mdx genetic background, resulting in protection from muscular dystrophy pathogenesis that included reduced myofiber turnover and histopathology, reduced fibrosis, and improved running capacity. Mechanistically, deletion of the Ctss gene in the mdx background significantly increased myofiber sarcolemmal membrane stability with greater expression and membrane localization of utrophin, integrins, and beta-dystroglycan, which anchor the membrane to the basal lamina and underlying cytoskeletal proteins. Consistent with these results, skeletal muscle-specific transgenic mice overexpressing Ctss showed increased myofiber necrosis, muscle histopathology, and a functional deficit reminiscent of muscular dystrophy. Hence, Ctss induction during muscular dystrophy is a pathologic event that partially underlies disease pathogenesis, and its inhibition might serve as a new therapeutic strategy in DMD.	[Tjondrokoesoemo, Andoria; Schips, Tobias G.; Sargent, Michelle A.; Vanhoutte, Davy; Kanisicak, Onur; Prasad, Vikram; Lin, Suh-Chin J.; Maillet, Marjorie; Molkentin, Jeffery D.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Molkentin, Jeffery D.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati	Molkentin, JD (corresponding author), Cincinnati Childrens Hosp Med Ctr, 240 Albert Sabin Way,MLC7020, Cincinnati, OH 45229 USA.	jeff.molkentin@cchmc.org	Vanhoutte, Davy/F-8071-2017; Kanisicak, Onur/AAU-4586-2020	Vanhoutte, Davy/0000-0002-8147-6953; Kanisicak, Onur/0000-0002-8393-4874; Molkentin, Jeffery/0000-0002-3558-6529	National Institutes of Health [P01NS072027]; Howard Hughes Medical Institute; German Research Foundation [SCHI 1290/1-1]; American Heart Association [15POST25480009]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS072027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); German Research Foundation(German Research Foundation (DFG)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant P01NS072027 (to J. D. M.) and a grant from the Howard Hughes Medical Institute (to J. D. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by German Research Foundation Grant SCHI 1290/1-1).; Supported by Postdoctoral Fellowship 15POST25480009 from the American Heart Association.	Badorff C, 1999, NAT MED, V5, P320, DOI 10.1038/6543; Barallobre-Barreiro Javier, 2013, Methods Mol Biol, V1005, P215, DOI 10.1007/978-1-62703-386-2_17; Barclay J, 2007, PAIN, V130, P225, DOI 10.1016/j.pain.2006.11.017; Baron D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026952; Blake DJ, 1996, BRAIN PATHOL, V6, P37, DOI 10.1111/j.1750-3639.1996.tb00781.x; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Bromme D, 2011, BIOL EXTRACELL MATR, P23, DOI 10.1007/978-3-642-16861-1_2; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Casar JC, 2004, J CELL SCI, V117, P73, DOI 10.1242/jcs.00828; Cheng XW, 2006, HYPERTENSION, V48, P979, DOI 10.1161/01.HYP.0000242331.99369.2f; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Conus S, 2010, SWISS MED WKLY, V140, P4, DOI 10.4414/smw.2010.13042; de Nooijer R, 2009, ARTERIOSCL THROM VAS, V29, P188, DOI 10.1161/ATVBAHA.108.181578; EARNEST JP, 1995, J BIOL CHEM, V270, P27259, DOI 10.1074/jbc.270.45.27259; Fang J, 2000, J CELL BIOCHEM, V79, P164, DOI 10.1002/1097-4644(2000)79:1<164::AID-JCB10>3.0.CO;2-D; FUKUSHIMA K, 1990, TOXICOL APPL PHARM, V105, P1, DOI 10.1016/0041-008X(90)90353-V; Gumerson JD, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/210797; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; Hollinger K, 2013, ACTA PHYSIOL, V208, P234, DOI 10.1111/apha.12114; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; Kramerova I, 2006, MOL CELL BIOL, V26, P8437, DOI 10.1128/MCB.01296-06; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; Li H, 2009, HUM MOL GENET, V18, P2584, DOI 10.1093/hmg/ddp191; Liu JM, 2008, J BIOL CHEM, V283, P35668, DOI 10.1074/jbc.M804661200; Mantle David, 2002, Adverse Drug Reactions and Toxicological Reviews, V21, P31; Marotta M, 2009, PHYSIOL GENOMICS, V37, P119, DOI 10.1152/physiolgenomics.90370.2008; Millay DP, 2009, P NATL ACAD SCI USA, V106, P19023, DOI 10.1073/pnas.0906591106; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; SATOYOSHI E, 1992, INTERNAL MED, V31, P841, DOI 10.2169/internalmedicine.31.841; Sawada H, 2003, BIOL PHARM BULL, V26, P1025; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Shin JH, 2011, MUSCLE NERVE, V43, P283, DOI 10.1002/mus.21873; Stark AE, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.10.45; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Suzuki H, 1998, J PHARMACOL EXP THER, V284, P1156; Tjondrokoesoemo A, 2016, HUM MOL GENET, V25, P1192, DOI 10.1093/hmg/ddw005; Wein N, 2015, PEDIATR CLIN N AM, V62, P723, DOI 10.1016/j.pcl.2015.03.008; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873	40	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9920	9928		10.1074/jbc.M116.719054	http://dx.doi.org/10.1074/jbc.M116.719054			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26966179	hybrid, Green Published			2022-12-28	WOS:000375602800006
J	Sun, YM; Cote, JF; Du, KY				Sun, Yingmin; Cote, Jean-Francois; Du, Keyong			Elmo2 Is a Regulator of Insulin-dependent Glut4 Membrane Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOBLAST FUSION; GLUCOSE TRANSPORTERS; SIGNAL-TRANSDUCTION; EXCHANGE FACTORS; APOPTOTIC CELLS; RAC ACTIVATION; RHO FAMILIES; PROTEIN; ENGULFMENT; ASSOCIATION	Elmo2, a member of the Elmo protein family, has been implicated in the regulation of Rac1 and Akt activation. Recently, we found that Elmo2 specifically interacts with ClipR-59. Because Akt and Rac1 have been implicated in insulin dependent Glut4 membrane translocation, we hypothesize here that Elmo2 may play a role in insulin-dependent Glut4 membrane translocation. Accordingly, we found that overexpression of Elmo2 enhanced, whereas its knockdown suppressed, insulin-dependent Glut4 membrane translocation in both 3T3-L1 adipocytes and L6 skeletal muscle cells. We also examined whether Elmo2 contributes to the insulin-mediated activation of Rac1 and Akt. We found that Elmo2 is required for insulin-induced Rac1 GTP loading, but not AKT activation, in L6 cells induced by insulin. Instead, Elmo2 is required to promote the insulin-induced membrane association of Akt. Together, our studies demonstrate that Elmo2 is a new regulator of insulin-dependent Glut4 membrane translocation through modulating Rac1 activity and Akt membrane compartmentalization.	[Sun, Yingmin; Du, Keyong] Tufts Med Ctr, Mol Oncol Res Inst, 800 Washington St, Boston, MA 02111 USA; [Cote, Jean-Francois] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	Tufts Medical Center; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Du, KY (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, 800 Washington St, Boston, MA 02111 USA.	kdu@tuftsmedicalcenter.org			National Institutes of Health [RO1 DK084319]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	his work was supported by National Institutes of Health Grant RO1 DK084319 (to K. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Thuraia A, 2015, MOL CELL BIOL, V35, P76, DOI 10.1128/MCB.00764-14; Adekola K, 2012, CURR OPIN ONCOL, V24, P650, DOI 10.1097/CCO.0b013e328356da72; Belman JP, 2014, REV ENDOCR METAB DIS, V15, P55, DOI 10.1007/s11154-013-9276-2; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Chiu TT, 2011, CELL SIGNAL, V23, P1546, DOI 10.1016/j.cellsig.2011.05.022; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Ding JX, 2009, MOL CELL BIOL, V29, P1459, DOI 10.1128/MCB.00754-08; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Graham TE, 2007, HORM METAB RES, V39, P717, DOI 10.1055/s-2007-985879; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Ishikura S, 2008, ACTA PHYSIOL, V192, P61, DOI 10.1111/j.1748-1716.2007.01778.x; Kato S, 2007, BIOCHEM BIOPH RES CO, V353, P933, DOI 10.1016/j.bbrc.2006.12.161; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Klip A, 2014, AM J PHYSIOL-CELL PH, V306, pC879, DOI 10.1152/ajpcell.00069.2014; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Laurin M, 2014, GENE DEV, V28, P533, DOI 10.1101/gad.236349.113; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Li HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2680; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Patel Manishha, 2011, Small GTPases, V2, P268; Patel M, 2010, CURR BIOL, V20, P2021, DOI 10.1016/j.cub.2010.10.028; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ren WY, 2012, J BIOL CHEM, V287, P26890, DOI 10.1074/jbc.M112.357699; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Schaker K, 2015, J BIOL CHEM, V290, P6408, DOI 10.1074/jbc.M114.633701; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Sun L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002785; Sun YM, 2015, J BIOL CHEM, V290, P6130, DOI 10.1074/jbc.M114.616680; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009	33	8	8	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16150	16161		10.1074/jbc.M116.731521	http://dx.doi.org/10.1074/jbc.M116.731521			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226625	hybrid, Green Published			2022-12-28	WOS:000380585400020
J	Gu, MG; Rice, CM				Gu, Meigang; Rice, Charles M.			The Spring -Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; hepatitis C virus (HCV); RNA helicase; RNA virus; structure-function; viral replication	VIRAL DIARRHEA VIRUS; STRAND RNA-SYNTHESIS; CELL-CULTURE; EFFICIENT REPLICATION; PRIMASE INHIBITORS; HEPATOMA-CELLS; IN-VIVO; PROTEIN; DNA; MECHANISM	Genomic DNA replication requires helicases to processively unwind duplexes. Although helicases encoded by positive-strand RNA viruses are necessary for RNA genome replication, their functions are not well understood. We determined structures of the hepatitis C virus helicase (NS3h) in complex with the transition state ATP mimic ADP.AlF4- and compared them with the previous nucleic acid-associated ternary complexes. The results suggested that nucleic acid binding promotes a structural change of the spring helix at the transition state, optimizing the interaction network centered on the nucleophilic water. Analysis of ATP hydrolysis with and without conformational restraints on the spring helix further supported the importance of its action for both nucleic acid-stimulated and basal catalysis. We further found that an F238P substitution, predicted to destabilize the helix, diminished viral RNA replication without significantly affecting ATP-dependent duplex unwinding. The stability of the secondary structure, thus, seems critical for additional functions of NS3h. Taken together, the results suggest that the spring helix may be central to the coordination of multiple modes of NS3h action. Further characterization centered on this element may help understand the molecular details of how the viral helicase facilitates RNA replication. This new structural information may also aid efforts to develop specific inhibitors targeting this essential viral enzyme.	[Gu, Meigang; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA	Rockefeller University	Gu, MG; Rice, CM (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.	mgu@rockefeller.edu; ricec@rockefeller.edu			Marie-Josee and Henry R. Kravis Fellowship at The Rockefeller University; National Institutes of Health (NIH) [CA057973]; Center for Synchrotron Biosciences [P30-EB-009998]; National Center for Research Resources of the National Institutes of Health [1S10RR022321-01]; NATIONAL CANCER INSTITUTE [R01CA057973] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Marie-Josee and Henry R. Kravis Fellowship at The Rockefeller University; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Synchrotron Biosciences; National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in part, by National Institutes of Health (NIH) Grant CA057973 and Center for Synchrotron Biosciences Grant P30-EB-009998 (National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH). This work was also supported by generous gifts from the Greenberg Medical Research Institute, the Starr Foundation, the Richard Salomon Family Foundation, the Ronald A. Shellow, M.D. Memorial Fund, Paul Nash and the MGM Mirage Voice Foundation, and Gregory F. Lloyd Memorial contributions. The use of the Rigaku/MSC microMax 007HF in the Rockefeller University Structural Biology Resource Center was made possible by Grant 1S10RR022321-01 from the National Center for Research Resources of the National Institutes of Health. The authors declare that they have no conflict of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by funds from a Marie-Josee and Henry R. Kravis Fellowship at The Rockefeller University. To whom correspondence may be addressed. E-mail: mgu@rockefeller.edu.	Ahola T, 2000, J VIROL, V74, P8803, DOI 10.1128/JVI.74.19.8803-8811.2000; Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034; Barton DJ, 1997, J VIROL, V71, P8482, DOI 10.1128/JVI.71.11.8482-8489.1997; Belon CA, 2008, BIOTECHNIQUES, V45, P433, DOI 10.2144/000112834; Blight KJ, 2003, J VIROL, V77, P3181, DOI 10.1128/JVI.77.5.3181-3190.2003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng W, 2011, SCIENCE, V333, P1746, DOI 10.1126/science.1206023; Chono K, 2010, J ANTIMICROB CHEMOTH, V65, P1733, DOI 10.1093/jac/dkq198; Chung HY, 2014, J VIROL, V88, P11022, DOI 10.1128/JVI.01582-14; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Crute JJ, 2002, NAT MED, V8, P386, DOI 10.1038/nm0402-386; De I, 1996, J VIROL, V70, P2706; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Grassmann CW, 1999, J VIROL, V73, P9196, DOI 10.1128/JVI.73.11.9196-9205.1999; Gu BH, 2000, J VIROL, V74, P1794, DOI 10.1128/JVI.74.4.1794-1800.2000; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Jennings TA, 2008, BIOCHEMISTRY-US, V47, P1126, DOI 10.1021/bi701048a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kadare G, 1997, J VIROL, V71, P2583; KALLNER A, 1975, CLIN CHIM ACTA, V59, P35, DOI 10.1016/0009-8981(75)90215-6; Kleymann G, 2002, NAT MED, V8, P392, DOI 10.1038/nm0402-392; Knegtel RMA, 1997, J MOL BIOL, V266, P424, DOI 10.1006/jmbi.1996.0776; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Mackintosh SG, 2006, J BIOL CHEM, V281, P3528, DOI 10.1074/jbc.M512100200; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Saeed M, 2012, ANTIMICROB AGENTS CH, V56, P5365, DOI 10.1128/AAC.01256-12; Salam KA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/467869; Simmonds P, 2013, CURR TOP MICROBIOL, V369, P1, DOI 10.1007/978-3-642-27340-7_1; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Soultanas P, 1999, J MOL BIOL, V290, P137, DOI 10.1006/jmbi.1999.2873; SUZICH JA, 1993, J VIROL, V67, P6152, DOI 10.1128/JVI.67.10.6152-6158.1993; Tortorici MA, 2015, J VIROL, V89, P4356, DOI 10.1128/JVI.03165-14; Witteveldt J, 2009, J GEN VIROL, V90, P48, DOI 10.1099/vir.0.006700-0	47	12	12	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14499	14509		10.1074/jbc.M115.704379	http://dx.doi.org/10.1074/jbc.M115.704379			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226535	Green Published, hybrid			2022-12-28	WOS:000380366700008
J	Cordes, T; Wallace, M; Michelucci, A; Divakaruni, AS; Sapcariu, SC; Sousa, C; Koseki, H; Cabrales, P; Murphy, AN; Hiller, K; Metallo, CM				Cordes, Thekla; Wallace, Martina; Michelucci, Alessandro; Divakaruni, Ajit S.; Sapcariu, Sean C.; Sousa, Carole; Koseki, Haruhiko; Cabrales, Pedro; Murphy, Anne N.; Hiller, Karsten; Metallo, Christian M.			Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; macrophage; metabolic regulation; mitochondrial metabolism; mitochondrial respiratory chain complex; immunoresponsive gene 1 (Irg1); itaconate; succinate; succinate dehydrogenase (SDH)	IMMUNE-RESPONSIVE GENE-1; ISOCITRATE LYASE; PYRUVATE-KINASE; METABOLISM; ACID; HYPOXIA; INNATE; MACROPHAGES; ACTIVATION; CYCLE	Metabolic reprogramming is emerging as a hallmark of the innate immune response, and the dynamic control of metabolites such as succinate serves to facilitate the execution of inflammatory responses in macrophages and other immune cells. Immunoresponsive gene 1 (Irg1) expression is induced by inflammatory stimuli, and its enzyme product cis-aconitate decarboxylase catalyzes the production of itaconate from the tricarboxylic acid cycle. Here we identify an immunometabolic regulatory pathway that links Irg1 and itaconate production to the succinate accumulation that occurs in the context of innate immune responses. Itaconate levels and Irg1 expression correlate strongly with succinate during LPS exposure in macrophages and non-immune cells. We demonstrate that itaconate acts as an endogenous succinate dehydrogenase inhibitor to cause succinate accumulation. Loss of itaconate production in activated macrophages from Irg1(-/-) mice decreases the accumulation of succinate in response to LPS exposure. This metabolic network links the innate immune response and tricarboxylic acid metabolism to function of the electron transport chain.	[Cordes, Thekla; Wallace, Martina; Cabrales, Pedro; Metallo, Christian M.] Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr,MC 0412 PFBH 204, La Jolla, CA 92093 USA; [Divakaruni, Ajit S.; Murphy, Anne N.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Metallo, Christian M.] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Michelucci, Alessandro; Sousa, Carole] Luxembourg Inst Hlth, Dept Oncol, NORLUX Neurooncol, L-1526 Luxembourg, Luxembourg; [Michelucci, Alessandro; Sapcariu, Sean C.; Sousa, Carole; Hiller, Karsten] Univ Luxembourg, Luxembourg Ctr Syst Biomed, L-4362 Esch Belval, Luxembourg; [Koseki, Haruhiko] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa 2300045, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Luxembourg Institute of Health; University of Luxembourg; RIKEN	Metallo, CM (corresponding author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr,MC 0412 PFBH 204, La Jolla, CA 92093 USA.	cmetallo@ucsd.edu	SOUSA, Carole/AAH-2269-2021; Sousa, Carole/I-2285-2019; Metallo, Christian/HCH-3476-2022; Cordes, Thekla/AAQ-4465-2020; Cabrales, Pedro/A-1930-2014	Sousa, Carole/0000-0002-8707-8796; Metallo, Christian/0000-0003-2404-3040; Cordes, Thekla/0000-0002-8097-191X; Michelucci, Alessandro/0000-0003-1230-061X; Cabrales, Pedro/0000-0002-8794-2839; Hiller, Karsten/0000-0001-9322-5820; Wallace, Martina/0000-0001-8272-5678	National Institutes of Health [R01CA188652, P01DK054441]; California Institute of Regenerative Medicine (CIRM) [RB5-07356]; Searle scholar award; National Science Foundation [1454425]; NIAID, National Institutes of Health [R01AI082610]; NHLBI, National Institutes of Health [R53HL123015, P01HL110900, R01HL052684]; Fonds National de la Recherche, Luxembourg Grant ATTRACT [A10/03]; AFR Grant [6916713]; HICE Virtual Institute; Deutsche Forschungsgesellschaft (German Research Foundation) [CO1488/1-1]; NATIONAL CANCER INSTITUTE [R01CA188652] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110900, R01HL052684, R56HL123015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Searle scholar award; National Science Foundation(National Science Foundation (NSF)); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fonds National de la Recherche, Luxembourg Grant ATTRACT(Luxembourg National Research Fund); AFR Grant(Luxembourg National Research Fund); HICE Virtual Institute; Deutsche Forschungsgesellschaft (German Research Foundation)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health Grants R01CA188652 (to C. M. M.) and P01DK054441 (to A. N. M.); California Institute of Regenerative Medicine (CIRM) Award RB5-07356 (to C. M. M.); a Searle scholar award (to C. M. M.); National Science Foundation CAREER Award 1454425 (to C. M. M.); NIAID, National Institutes of Health Grant R01AI082610 (to P. C.); NHLBI, National Institutes of Health Grants R53HL123015, P01HL110900, and R01HL052684 (to P. C.); Fonds National de la Recherche, Luxembourg Grant ATTRACT A10/03 (to K. H.); AFR Grant 6916713 (to C.S.); the HICE Virtual Institute (to S. C. S.); and Deutsche Forschungsgesellschaft (German Research Foundation) Grant CO1488/1-1 (to T. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ACKERMANN WW, 1949, P SOC EXP BIOL MED, V72, P1; ADLER J, 1957, J BIOL CHEM, V229, P865; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BAILEY E, 1968, BIOCHEM J, V108, P427, DOI 10.1042/bj1080427; Bar-Or D, 2015, REDOX REP, V20, P193, DOI 10.1179/1351000215Y.0000000005; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; BOOTH AN, 1952, J BIOL CHEM, V195, P697; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Cheon YP, 2003, ENDOCRINOLOGY, V144, P5623, DOI 10.1210/en.2003-0585; Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108; Chouchani ET, 2016, CELL METAB, V23, P254, DOI 10.1016/j.cmet.2015.12.009; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; COOPER RA, 1964, BIOCHEM J, V91, P82, DOI 10.1042/bj0910082; Cordes T, 2015, ANNU REV NUTR, V35, P451, DOI 10.1146/annurev-nutr-071714-034243; Degrandi D, 2009, J INTERF CYTOK RES, V29, P55, DOI 10.1089/jir.2008.0013; DERVARTANIAN DV, 1964, BIOCHIM BIOPHYS ACTA, V92, P233, DOI 10.1016/0926-6569(64)90182-8; Divakaruni AS, 2014, CURR PROTOC TOXICOL, V60, P1, DOI [10.1002/0471140856.tx2502s60, DOI 10.1002/0471140856.TX2502S60]; Eoh H, 2014, P NATL ACAD SCI USA, V111, P4976, DOI 10.1073/pnas.1400390111; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Hall CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4880; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; MCFADDEN BA, 1977, J BACTERIOL, V131, P136, DOI 10.1128/JB.131.1.136-144.1977; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Nemeth B, 2016, FASEB J, V30, P286, DOI 10.1096/fj.15-279398; O'Neill LAJ, 2015, IMMUNITY, V42, P393, DOI 10.1016/j.immuni.2015.02.017; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; PATEL TR, 1978, EXP PARASITOL, V44, P262, DOI 10.1016/0014-4894(78)90107-8; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Preusse M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-293; R Development Core Team, 2009, R LANG ENV STAT COMP; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Smith J, 2011, J VIROL, V85, P11146, DOI 10.1128/JVI.05499-11; Strelko CL, 2011, J AM CHEM SOC, V133, P16386, DOI 10.1021/ja2070889; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Wegner A, 2015, CURR OPIN BIOTECH, V34, P16, DOI 10.1016/j.copbio.2014.11.008; WILLIAMS JO, 1971, BIOCHEMISTRY-US, V10, P1384; WOJTCZAK L, 1969, BIOCHIM BIOPHYS ACTA, V191, P10, DOI 10.1016/0005-2744(69)90310-6; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	52	238	251	14	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14274	14284		10.1074/jbc.M115.685792	http://dx.doi.org/10.1074/jbc.M115.685792			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27189937	hybrid, Green Published			2022-12-28	WOS:000379975100031
J	Shi, SS; Liu, K; Chen, YH; Zhang, SJ; Lin, JY; Gong, CF; Jin, QW; Yang, XJ; Chen, RC; Ji, ZL; Han, AD				Shi, Shasha; Liu, Ke; Chen, Yanheng; Zhang, Shijun; Lin, Juanyu; Gong, Chenfang; Jin, Quanwen; Yang, Xiang-Jiao; Chen, Ruichuan; Ji, Zhiliang; Han, Aidong			Competitive Inhibition of Lysine Acetyltransferase 2B by a Small Motif of the Adenoviral Oncoprotein E1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); acetyltransferase; adenovirus; enzyme inhibitor; structural model	HISTONE ACETYLTRANSFERASE; P300/CBP-ASSOCIATED FACTOR; KINETIC MECHANISM; STRUCTURAL BASIS; GENE-EXPRESSION; COENZYME-A; CELL-CYCLE; PROTEIN; BINDING; GCN5	The adenovirus early region 1A (E1A) oncoprotein hijacks host cells via direct interactions with many key cellular proteins, such as KAT2B, also known as PCAF (p300/CBP associated factor). E1A binds the histone acetyltransferase (HAT) domain of KAT2B to repress its transcriptional activation. However, the molecular mechanism by which E1A inhibits the HAT activity is not known. Here we demonstrate that a short and relatively conserved N-terminal motif (cNM) in the intrinsically disordered E1A protein is crucial for KAT2B interaction, and inhibits its HAT activity through a direct competition with acetyl-CoA, but not its substrate histone H3. Molecular modeling together with a series of mutagenesis experiments suggests that the major helix of E1A cNM binds to a surface of the acetyl-CoA pocket of the KAT2B HAT domain. Moreover, transient expression of the cNM peptide is sufficient to inhibit KAT2B-specific H3 acetylation H3K14ac in vivo. Together, our data define an essential motif cNM in N-terminal E1A as an acetyl-CoA entry blocker that directly associates with the entrance of acetyl-CoA binding pocket to block the HAT domain access to its cofactor.	[Shi, Shasha; Liu, Ke; Chen, Yanheng; Zhang, Shijun; Lin, Juanyu; Gong, Chenfang; Jin, Quanwen; Chen, Ruichuan; Ji, Zhiliang; Han, Aidong] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361102, Peoples R China; [Yang, Xiang-Jiao] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada; [Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3A 1A3, Canada	Xiamen University; McGill University; McGill University	Chen, RC; Ji, ZL (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361102, Peoples R China.; Han, AD (corresponding author), Xiamen Univ, Sch Life Sci, Dept Biochem Sci, Xiamen 361102, Peoples R China.	chenrc@xmu.edu.cn; appo@xmu.edu.cn; ahan@xmu.edu.cn			National Science Foundation of China [31170685, 90919036, 81361120386, 31570751, 31270809];  [0660ZK1022]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This work was supported by the National Science Foundation of China Grants 31170685 and 90919036 (to A. H.), 81361120386, 31570751, and 31270809 (to R. C.) and Project 985 (0660ZK1022). The authors declare that they have no conflicts of interest with the contents of this article.	Ablack JNG, 2012, J VIROL, V86, P8198, DOI 10.1128/JVI.00289-12; Ai NP, 2011, NUCLEIC ACIDS RES, V39, P9592, DOI 10.1093/nar/gkr698; Avvakumov N, 2002, J VIROL, V76, P7968, DOI 10.1128/JVI.76.16.7968-7975.2002; BAYLEY ST, 1994, INT J ONCOL, V5, P425; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Clements A, 2003, MOL CELL, V12, P461, DOI 10.1016/S1097-2765(03)00288-0; Clements A, 1999, EMBO J, V18, P3521, DOI 10.1093/emboj/18.13.3521; DYSON N, 1992, CANCER SURV, V12, P161; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Ferrari R, 2014, CELL HOST MICROBE, V16, P663, DOI 10.1016/j.chom.2014.10.004; Ferreon ACM, 2013, NATURE, V498, P390, DOI 10.1038/nature12294; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P13260, DOI 10.1073/pnas.0906770106; FLINT J, 1989, ANNU REV GENET, V23, P141, DOI 10.1146/annurev.genet.23.1.141; Flint J, 1997, ANNU REV GENET, V31, P177, DOI 10.1146/annurev.genet.31.1.177; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Frisch SM, 2002, NAT REV MOL CELL BIO, V3, P441, DOI 10.1038/nrm827; Gallimore PH, 2001, ONCOGENE, V20, P7824, DOI 10.1038/sj.onc.1204913; GREEN M, 1970, ANNU REV BIOCHEM, V39, P701, DOI 10.1146/annurev.bi.39.070170.003413; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Hu XM, 2014, J BIOL CHEM, V289, P23154, DOI 10.1074/jbc.M114.570812; KIMELMAN D, 1985, J VIROL, V53, P399, DOI 10.1128/JVI.53.2.399-409.1985; Lang SE, 2003, ONCOGENE, V22, P2836, DOI 10.1038/sj.onc.1206376; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Mao YJ, 2011, ANAL BIOCHEM, V415, P21, DOI 10.1016/j.ab.2011.04.004; MORAN E, 1993, CURR OPIN GENET DEV, V3, P63, DOI 10.1016/S0959-437X(05)80342-9; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; NEVINS JR, 1979, J VIROL, V32, P727, DOI 10.1128/JVI.32.3.727-733.1979; O'Connor MJ, 1999, J VIROL, V73, P3574; Pelka P, 2008, J VIROL, V82, P7252, DOI 10.1128/JVI.00104-08; Pelka P, 2009, VIROLOGY, V391, P90, DOI 10.1016/j.virol.2009.05.024; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Rasti M, 2005, J VIROL, V79, P5594, DOI 10.1128/JVI.79.9.5594-5605.2005; Reid JL, 1998, EMBO J, V17, P4469, DOI 10.1093/emboj/17.15.4469; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Shi SS, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/1472-6807-14-2; Shuen M, 2002, J BIOL CHEM, V277, P30844, DOI 10.1074/jbc.M201877200; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; SPRENGEL J, 1994, J VIROL, V68, P379, DOI 10.1128/JVI.68.1.379-389.1994; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Tanner KG, 2000, BIOCHEMISTRY-US, V39, P11961, DOI 10.1021/bi001272h; TRENTIN JJ, 1968, P SOC EXP BIOL MED, V127, P683, DOI 10.3181/00379727-127-32773; Trievel RC, 2000, ANAL BIOCHEM, V287, P319, DOI 10.1006/abio.2000.4855; WANG HGH, 1993, J VIROL, V67, P476, DOI 10.1128/JVI.67.1.476-488.1993; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0	52	3	3	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14363	14372		10.1074/jbc.M115.697300	http://dx.doi.org/10.1074/jbc.M115.697300			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27143356	Green Published, hybrid			2022-12-28	WOS:000379975100038
J	LaRocca, TJ; Sosunov, SA; Shakerley, NL; Ten, VS; Ratner, AJ				LaRocca, Timothy J.; Sosunov, Sergey A.; Shakerley, Nicole L.; Ten, Vadim S.; Ratner, Adam J.			Hyperglycemic Conditions Prime Cells for RIP1-dependent Necroptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; diabetes; glucose; ischemia; necrosis (necrotic death); tumor necrosis factor (TNF); Fas ligand; hyperglycemia; necroptosis; programmed cell death	HYPOXIA-ISCHEMIA; GLUCOSE; APOPTOSIS; DEATH; DEPRIVATION; METABOLISM; HEMOLYSIS; SYSTEM	Necroptosis is a RIP1-dependent programmed cell death (PCD) pathway that is distinct from apoptosis. Downstream effector pathways of necroptosis include formation of advanced glycation end products (AGEs) and reactive oxygen species (ROS), both of which depend on glycolysis. This suggests that increased cellular glucose may prime necroptosis. Here we show that exposure to hyperglycemic levels of glucose enhances necroptosis in primary red blood cells (RBCs), Jurkat T cells, and U937 monocytes. Pharmacologic or siRNA inhibition of RIP1 prevented the enhanced death, confirming it as RIP1-dependent necroptosis. Hyperglycemic enhancement of necroptosis depends upon glycolysis with AGEs and ROS playing a role. Total levels of RIP1, RIP3, and mixed lineage kinase domain-like (MLKL) proteins were increased following treatment with high levels of glucose in Jurkat and U937 cells and was not due to transcriptional regulation. The observed increase in RIP1, RIP3, and MLKL protein levels suggests a potential positive feedback mechanism in nucleated cell types. Enhanced PCD due to hyperglycemia was specific to necroptosis as extrinsic apoptosis was inhibited by exposure to high levels of glucose. Hyperglycemia resulted in increased infarct size in a mouse model of brain hypoxia-ischemia injury. The increased infarct size was prevented by treatment with nec-1s, strongly suggesting that increased necroptosis accounts for exacerbation of this injury in conditions of hyperglycemia. This work reveals that hyperglycemia represents a condition in which cells are extraordinarily susceptible to necroptosis, that local glucose levels alter the balance of PCD pathways, and that clinically relevant outcomes may depend on glucose-mediated effects on PCD.	[LaRocca, Timothy J.; Shakerley, Nicole L.] Albany Coll Pharm & Hlth Sci, Dept Basic & Social Sci, Albany, NY 12208 USA; [Sosunov, Sergey A.; Ten, Vadim S.; Ratner, Adam J.] Columbia Univ, Dept Pediat, New York, NY 10032 USA; [Ratner, Adam J.] NYU, Dept Pediat, New York, NY 10016 USA; [Ratner, Adam J.] NYU, Dept Microbiol, New York, NY 10016 USA	Albany College of Pharmacy & Health Sciences; Columbia University; New York University; New York University	Ratner, AJ (corresponding author), NYU, Depts Pediat, Div Pediat Infect Dis, Sch Med, 550 First Ave,MSB 223, New York, NY 10016 USA.; Ratner, AJ (corresponding author), NYU, Depts Microbiol, Div Pediat Infect Dis, Sch Med, 550 First Ave,MSB 223, New York, NY 10016 USA.	Adam.Ratner@nyumc.org	Shakerley, Nicole L/C-1245-2015	Shakerley, Nicole L/0000-0002-7880-3343; Ratner, Adam/0000-0003-1761-794X	Albany College of Pharmacy and Health Sciences; National Institutes of Health [R01-AI092743, R21-AI111020, R01-NS088197]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092743, R21AI111020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088197] Funding Source: NIH RePORTER	Albany College of Pharmacy and Health Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by startup funds from the Albany College of Pharmacy and Health Sciences (to T. J. L.) and National Institutes of Health Grants R01-AI092743 and R21-AI111020 (to A. J. R.), and R01-NS088197 (to V. S. T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Basu SK, 2016, ARCH DIS CHILD-FETAL, V101, pF149, DOI 10.1136/archdischild-2015-308733; Bernassola F, 2010, CELL DEATH DIFFER, V17, P1, DOI 10.1038/cdd.2009.189; Borutaite V, 2001, FEBS LETT, V500, P114, DOI 10.1016/S0014-5793(01)02593-5; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Caro-Maldonado A, 2010, CELL DEATH DIFFER, V17, P1335, DOI 10.1038/cdd.2010.21; Chang YS, 1998, BRAIN RES, V798, P271, DOI 10.1016/S0006-8993(98)00470-3; Chauvier D, 2007, CELL DEATH DIFFER, V14, P387, DOI 10.1038/sj.cdd.4402044; Darwazeh R, 2013, NEURAL REGEN RES, V8, P2677, DOI 10.3969/j.issn.1673-5374.2013.28.010; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Fulda S., 2013, INT J CELL BIOL; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Klarl BA, 2006, AM J PHYSIOL-CELL PH, V290, pC244, DOI 10.1152/ajpcell.00283.2005; Lang E, 2012, INT J BIOCHEM CELL B, V44, P1236, DOI 10.1016/j.biocel.2012.04.019; LaRocca TJ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.135; LaRocca TJ, 2014, MBIO, V5, DOI 10.1128/mBio.01251-14; Li HK, 2005, DIABETES, V54, P540, DOI 10.2337/diabetes.54.2.540; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Linkermann A, 2013, AM J TRANSPLANT, V13, P2797, DOI 10.1111/ajt.12448; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Munoz-Pinedo C, 2003, J BIOL CHEM, V278, P12759, DOI 10.1074/jbc.M212392200; Nam SY, 2002, ONCOGENE, V21, P337, DOI 10.1038/sj.onc.1205068; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; ROTRUCK JT, 1971, NATURE-NEW BIOL, V231, P223, DOI 10.1038/newbio231223a0; SHELDON RA, 1992, PEDIATR RES, V32, P489, DOI 10.1203/00006450-199210000-00022; Shrikhande GV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014240; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Sonksen PH, 2001, J ENDOCRINOL, V170, P13, DOI 10.1677/joe.0.1700013; Sosunov SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120456; Spies EE, 2014, PEDIATR NEUROL, V50, P586, DOI 10.1016/j.pediatrneurol.2014.01.043; TATO L, 1973, CLIN CHIM ACTA, V49, P349, DOI 10.1016/0009-8981(73)90232-5; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vesely ED, 2009, AM J PHYSIOL-CELL PH, V297, pC759, DOI 10.1152/ajpcell.00213.2009; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482	35	29	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13753	13761		10.1074/jbc.M116.716027	http://dx.doi.org/10.1074/jbc.M116.716027			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129772	Green Published, hybrid			2022-12-28	WOS:000379771100029
J	Datta, A; Bhattacharyya, D; Singh, S; Ghosh, A; Schmidtchen, A; Malmsten, M; Bhunia, A				Datta, Aritreyee; Bhattacharyya, Dipita; Singh, Shalini; Ghosh, Anirban; Schmidtchen, Artur; Malmsten, Martin; Bhunia, Anirban			Role of Aromatic Amino Acids in Lipopolysaccharide and Membrane Interactions of Antimicrobial Peptides for Use in Plant Disease Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER DIFFERENCE NMR; HEPARIN-COFACTOR II; BACTERIAL SPOT; MECHANISM; MSI-594; MICELLES; STRAINS; BINDING; TOMATO; LIGAND	KYE28 (KYEITTIHNLFRKLTHRLFRRNFGYT-LR), the representative sequence of helix D of heparin co-factor II, was demonstrated to be potent against agronomically important Gram-negative plant pathogens Xanthomonas vesicatoria and Xanthomonas oryzae, capable of inhibiting disease symptoms in detached tomato leaves. NMR studies in the presence of lipopolysaccharide provided structural insights into the mechanisms underlying this, notably in relationship to outer membrane permeabilization. The three-dimensional solution structure of KYE28 in LPS is characterized by an N-terminal helical segment, an intermediate loop followed by another short helical stretch, and an extended C terminus. The two termini are in close proximity to each other via aromatic packing interactions, whereas the positively charged residues form an exterior polar shell. To further demonstrate the importance of the aromatic residues for this, a mutant peptide KYE28A, with Ala substitutions at Phe(11), Phe(19), Phe(23), and Tyr(25) was designed, which showed attenuated antimicrobial activity at high salt concentrations, as well as lower membrane disruption and LPS binding abilities compared with KYE28. In contrast to KYE28, KYE28A adopted an extended helical structure in LPS with extended N and C termini. Aromatic packing interactions were completely lost, although hydrophobic interaction between the side chains of hydrophobic residues were still partly retained, imparting an amphipathic character and explaining its residual antimicrobial activity and LPS binding as observed from ellipsometry and isothermal titration calorimetry. We thus present key structural aspects of KYE28, constituting an aromatic zipper, of potential importance for the development of novel plant protection agents and therapeutic agents.	[Datta, Aritreyee; Bhattacharyya, Dipita; Ghosh, Anirban; Bhunia, Anirban] Bose Inst, Dept Biophys, P-1-12 CIT Scheme 7 M, Kolkata 700054, India; [Singh, Shalini; Malmsten, Martin] Uppsala Univ, Dept Pharm, SE-75232 Uppsala, Sweden; [Schmidtchen, Artur] Lund Univ, Div Dermatol & Venereol, Dept Clin Sci, SE-22184 Lund, Sweden; [Schmidtchen, Artur] Nanyang Technol Univ, Lee Kong Chian Sch Med, 11 Mandalay Rd, Singapore 308232, Singapore	Department of Science & Technology (India); Bose Institute; Uppsala University; Lund University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Malmsten, M (corresponding author), Uppsala Univ, Dept Pharm, SE-75232 Uppsala, Sweden.; Bhunia, A (corresponding author), Bose Inst, P-1-12 CIT Scheme 7 M, Kolkata 700054, India.	martin.malmsten@farmaci.uu.se; anirbanbhunia@gmail.com	Ghosh, Anirban/S-9315-2017	Ghosh, Anirban/0000-0001-9837-3339; Malmsten, Martin/0000-0003-0046-5599; Datta, Aritreyee/0000-0001-7757-8415; Bhunia, Anirban/0000-0002-8752-2842	DBT, Government of India [BT/PR3106/INF/22/138/2011]	DBT, Government of India(Department of Biotechnology (DBT) India)	We acknowledge DBT, Government of India, for infrastructure development funding (BT/PR3106/INF/22/138/2011) to Bose Institute for purchasing 700 MHz NMR spectrometer with cryoprobe. Ann-Charlotte Stromdahl and Lise-Britt Walberg are gratefully acknowledged for skillful technical assistance. We thank Prof. Pallob Kundu, Bose Institute, India, for stimulating discussions on plant experiments. We are grateful to Dr. Christian Lindermayer (Helmholtz-Munich, Germany) and Prof. Sampa Das (Bose Institute, India) for providing Xanthomonas bacterial strains. Dr. Kaustuv Sanyal (JNCASR, India) is thanked for providing Candida and Cryptococcus strains. The Central Instrument Facility (CIF) as well as the Madhyamgram Experimental Farm (MEF) of the Bose Institute are greatly acknowledged.	Abbasi PA, 2015, CAN J MICROBIOL, V61, P753, DOI 10.1139/cjm-2015-0228; Bera S, 2015, J COLLOID INTERF SCI, V452, P148, DOI 10.1016/j.jcis.2015.04.031; Bhunia A, 2012, DRUG DISCOV TODAY, V17, P505, DOI 10.1016/j.drudis.2011.12.016; Bhunia A, 2011, BIOPOLYMERS, V96, P273, DOI 10.1002/bip.21530; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Bhunia A, 2009, CHEM-EUR J, V15, P2036, DOI 10.1002/chem.200802635; Bhunia A, 2009, J BIOL CHEM, V284, P21991, DOI 10.1074/jbc.M109.013573; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Datta A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11951; Domadia PN, 2010, J AM CHEM SOC, V132, P18417, DOI 10.1021/ja1083255; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Jeremy B. M., 2002, BIOCHEMISTRY; Junkes C, 2011, EUR BIOPHYS J BIOPHY, V40, P515, DOI 10.1007/s00249-011-0671-x; Kalle M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102577; Kalle M, 2013, J IMMUNOL, V190, P6303, DOI 10.4049/jimmunol.1203030; Kuligowska K, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0394-0; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee DK, 2015, BIOCHEMISTRY-US, V54, P1897, DOI 10.1021/bi501418m; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Makovitzki A, 2007, APPL ENVIRON MICROB, V73, P6629, DOI 10.1128/AEM.01334-07; MALMSTEN M, 1994, J COLLOID INTERF SCI, V166, P333, DOI 10.1006/jcis.1994.1303; Malmsten M, 1998, J COLLOID INTERF SCI, V204, P104, DOI 10.1006/jcis.1998.5568; MALMSTEN M, 1994, LANGMUIR, V10, P1274, DOI 10.1021/la00016a048; Mangoni ML, 2008, J BIOL CHEM, V283, P22907, DOI 10.1074/jbc.M800495200; MARCO GM, 1983, PLANT DIS, V67, P779, DOI 10.1094/PD-67-779; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Manzur JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144142; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Porcelli F, 2006, BIOCHEMISTRY-US, V45, P5793, DOI 10.1021/bi0601813; Post CB, 2003, CURR OPIN STRUC BIOL, V13, P581, DOI 10.1016/j.sbi.2003.09.012; Potnis N, 2015, MOL PLANT PATHOL, V16, P907, DOI 10.1111/mpp.12244; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Ringstad L, 2006, LANGMUIR, V22, P5042, DOI 10.1021/la060317y; Salnikov ES, 2011, BIOCHEMISTRY-US, V50, P3784, DOI 10.1021/bi1018732; Saravanan R, 2011, BBA-BIOMEMBRANES, V1808, P369, DOI 10.1016/j.bbamem.2010.10.001; Schmidtchen A, 2011, BBA-BIOMEMBRANES, V1808, P1081, DOI 10.1016/j.bbamem.2010.12.020; Schmidtchen A, 2009, J BIOL CHEM, V284, P17584, DOI 10.1074/jbc.M109.011650; Scorciapino MA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00171; Scorciapino MA, 2012, BIOPHYS J, V102, P1039, DOI 10.1016/j.bpj.2012.01.048; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Singh S, 2013, BBA-BIOMEMBRANES, V1828, P2709, DOI 10.1016/j.bbamem.2013.06.015; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Timilsina S, 2015, APPL ENVIRON MICROB, V81, P1520, DOI 10.1128/AEM.03000-14; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15963; Yu LL, 2006, ANAL CHIM ACTA, V556, P216, DOI 10.1016/j.aca.2005.09.008; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zweytick D, 2011, J BIOL CHEM, V286, P21266, DOI 10.1074/jbc.M110.195412	58	36	36	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13301	13317		10.1074/jbc.M116.719575	http://dx.doi.org/10.1074/jbc.M116.719575			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27137928	Green Published, hybrid			2022-12-28	WOS:000379770500033
J	Karner, CM; Esen, E; Chen, JK; Hsu, FF; Turk, J; Long, FX				Karner, Courtney M.; Esen, Emel; Chen, Jiakun; Hsu, Fong-Fu; Turk, John; Long, Fanxin			Wnt Protein Signaling Reduces Nuclear Acetyl-CoA Levels to Suppress Gene Expression during Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-5; HISTONE ACETYLATION; BETA-CATENIN; VERTEBRATE GASTRULATION; BONE ANABOLISM; STEM-CELLS; PKC-DELTA; ACTIVATION; METABOLISM; GLYCOLYSIS	Developmental signals in metazoans play critical roles in inducing cell differentiation from multipotent progenitors. The existing paradigm posits that the signals operate directly through their downstream transcription factors to activate expression of cell type-specific genes, which are the hallmark of cell identity. We have investigated the mechanism through which Wnt signaling induces osteoblast differentiation in an osteoblast-adipocyte bipotent progenitor cell line. Unexpectedly, Wnt3a acutely suppresses the expression of a large number of genes while inducing osteoblast differentiation. The suppressed genes include Pparg and Cebpa, which encode adipocyte-specifying transcription factors and suppression of which is sufficient to induce osteoblast differentiation. The large scale gene suppression induced by Wnt3a corresponds to a global decrease in histone acetylation, an epigenetic modification that is associated with gene activation. Mechanistically, Wnt3a does not alter histone acetyltransferase or deacetylase activities but, rather, decreases the level of acetyl-CoA in the nucleus. The Wnt-induced decrease in histone acetylation is independent of beta-catenin signaling but, rather, correlates with suppression of glucose metabolism in the tricarboxylic acid cycle. Functionally, preventing histone deacetylation by increasing nucleocytoplasmic acetyl-CoA levels impairs Wnt3a-induced osteoblast differentiation. Thus, Wnt signaling induces osteoblast differentiation in part through histone deacetylation and epigenetic suppression of an alternative cell fate.	[Karner, Courtney M.; Esen, Emel; Long, Fanxin] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63131 USA; [Esen, Emel; Chen, Jiakun; Long, Fanxin] Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63131 USA; [Long, Fanxin] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63131 USA; [Hsu, Fong-Fu; Turk, John; Long, Fanxin] Washington Univ, Sch Med, Dept Med, St Louis, MO 63131 USA; [Karner, Courtney M.] Duke Univ, Sch Med, Dept Orthopaed Surg, Durham, NC 27710 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Duke University	Long, FX (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63131 USA.; Long, FX (corresponding author), Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63131 USA.; Long, FX (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63131 USA.; Long, FX (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63131 USA.	flong@wustl.edu	Chen, Jiakun/J-2063-2019; Chen, Jiakun/AAP-9621-2021	Chen, Jiakun/0000-0003-1806-2421; Karner, Courtney/0000-0003-0387-4486; Hsu, Fong-Fu/0000-0001-5368-0183	National Institutes of Health [AR060456, 5F32AR060674, P41-RR00954, P60-DK20579, P30-DK56341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060456, F32AR060674, R01AR055923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AR060456 (to F. L.), 5F32AR060674 (to C. M. K.), P41-RR00954 (to J. T.), P60-DK20579 (to J. T.), and P30-DK56341 (to J. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Bracha AL, 2010, NAT CHEM BIOL, V6, P202, DOI 10.1038/NCHEMBIO.301; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Esen E, 2015, J BONE MINER RES, V30, P1959, DOI 10.1002/jbmr.2556; Esen E, 2013, CELL METAB, V17, P745, DOI 10.1016/j.cmet.2013.03.017; Frey JL, 2015, MOL CELL BIOL, V35, P1979, DOI 10.1128/MCB.01343-14; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Guarente L, 2000, GENE DEV, V14, P1021; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joeng KS, 2011, DEV BIOL, V359, P222, DOI 10.1016/j.ydbio.2011.08.020; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Karner CM, 2015, J CLIN INVEST, V125, P551, DOI 10.1172/JCI78470; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Mahmoudi T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000539; McBrian MA, 2013, MOL CELL, V49, P310, DOI 10.1016/j.molcel.2012.10.025; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mohan M, 2010, GENE DEV, V24, P574, DOI 10.1101/gad.1898410; Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002; OGAWA M, 1988, EMBO J, V7, P1337, DOI 10.1002/j.1460-2075.1988.tb02949.x; Pate KT, 2014, EMBO J, V33, P1454, DOI 10.15252/embj.201488598; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910	45	34	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13028	13039		10.1074/jbc.M115.708578	http://dx.doi.org/10.1074/jbc.M115.708578			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129247	Green Published, hybrid			2022-12-28	WOS:000379770500012
J	Croy, HE; Fuller, CN; Giannotti, J; Robinson, P; Foley, AVA; Yamulla, RJ; Cosgriff, S; Greaves, BD; von Kleeck, RA; An, HH; Powers, CM; Tran, JK; Tocker, AM; Jacob, KD; Davis, BK; Roberts, DM				Croy, Heather E.; Fuller, Caitlyn N.; Giannotti, Jemma; Robinson, Paige; Foley, Andrew V. A.; Yamulla, Robert J.; Cosgriff, Sean; Greaves, Bradford D.; von Kleeck, Ryan A.; An, Hyun Hyung; Powers, Catherine M.; Tran, Julie K.; Tocker, Aaron M.; Jacob, Kimberly D.; Davis, Beckley K.; Roberts, David M.			The Poly(ADP-ribose) Polymerase Enzyme Tankyrase Antagonizes Activity of the beta-Catenin Destruction Complex through ADP-ribosylation of Axin and APC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOMATOUS POLYPOSIS-COLI; SMALL-MOLECULE INHIBITOR; CANCER CELLS; WNT PATHWAY; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; E3 LIGASE; DEGRADATION; PROTEIN; SIAH-1	Most colon cancer cases are initiated by truncating mutations in the tumor suppressor, adenomatous polyposis coli (APC). APC is a critical negative regulator of the Wnt signaling pathway that participates in a multi-protein "destruction complex" to target the key effector protein beta-catenin for ubiquitin-mediated proteolysis. Prior work has established that the poly(ADPribose) polymerase (PARP) enzyme Tankyrase (TNKS) antagonizes destruction complex activity by promoting degradation of the scaffold protein Axin, and recent work suggests that TNKS inhibition is a promising cancer therapy. We performed a yeast two-hybrid (Y2H) screen and uncovered TNKS as a putative binding partner of Drosophila APC2, suggesting that TNKS may play multiple roles in destruction complex regulation. We find that TNKS binds a C-terminal RPQPSG motif in Drosophila APC2, and that this motif is conserved in human APC2, but not human APC1. In addition, we find that APC2 can recruit TNKS into the beta-catenin destruction complex, placing the APC2/TNKS interaction at the correct intracellular location to regulate beta-catenin proteolysis. We further show that TNKS directly PARylates both Drosophila Axin and APC2, but that PARylation does not globally regulate APC2 protein levels as it does for Axin. Moreover, TNKS inhibition in colon cancer cells decreases beta-catenin signaling, which we find cannot be explained solely through Axin stabilization. Instead, our findings suggest that TNKS regulates destruction complex activity at the level of both Axin and APC2, providing further mechanistic insight into TNKS inhibition as a potential Wnt pathway cancer therapy.	[Croy, Heather E.; Fuller, Caitlyn N.; Giannotti, Jemma; Robinson, Paige; Foley, Andrew V. A.; Yamulla, Robert J.; Cosgriff, Sean; Greaves, Bradford D.; von Kleeck, Ryan A.; An, Hyun Hyung; Powers, Catherine M.; Tran, Julie K.; Tocker, Aaron M.; Jacob, Kimberly D.; Davis, Beckley K.; Roberts, David M.] Franklin & Marshall Coll, Dept Biol, POB 3003, Lancaster, PA 17604 USA	Franklin & Marshall College	Roberts, DM (corresponding author), Franklin & Marshall Coll, Dept Biol, POB 3003, Lancaster, PA 17604 USA.	david.roberts@fandm.edu		Yamulla, Robert/0000-0002-0276-3592	National Institutes of Health [R15 GM107796]; Franklin AMP; Marshall College; Undergraduate Science Education Award from the Howard Hughes Medical Institute to Franklin AMP; Marshall College [52007538]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM107796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Franklin AMP; Marshall College; Undergraduate Science Education Award from the Howard Hughes Medical Institute to Franklin AMP; Marshall College; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R15 GM107796 (to D. M. R.), startup funds from Franklin & Marshall College (to D. M. R.), and an Undergraduate Science Education Award from the Howard Hughes Medical Institute to Franklin & Marshall College (52007538). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Bao RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048670; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Callow MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022595; Casas-Selves M, 2012, CANCER RES, V72, P4154, DOI 10.1158/0008-5472.CAN-11-2848; Chandra SHV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034479; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Choi J, 2004, J BIOL CHEM, V279, P49188, DOI 10.1074/jbc.M404655200; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DaRosa PA, 2015, NATURE, V517, P223, DOI 10.1038/nature13826; de la Roche M, 2014, CANCER RES, V74, P1495, DOI 10.1158/0008-5472.CAN-13-2682; Delgado ER, 2014, AM J PATHOL, V184, P2111, DOI 10.1016/j.ajpath.2014.04.002; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Fearon ER, 2009, CANCER CELL, V16, P366, DOI 10.1016/j.ccr.2009.10.007; Feng Y, 2014, CELL SIGNAL, V26, P1717, DOI 10.1016/j.cellsig.2014.04.014; Gwak J, 2009, BIOCHEM BIOPH RES CO, V387, P444, DOI 10.1016/j.bbrc.2009.07.027; Haikarainen T, 2014, CURR PHARM DESIGN, V20, P6472, DOI 10.2174/1381612820666140630101525; Haikarainen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065404; Tran H, 2013, J BIOL CHEM, V288, P3753, DOI 10.1074/jbc.M112.415240; Tran H, 2012, J BIOL CHEM, V287, P28552, DOI 10.1074/jbc.M112.387878; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; James RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050457; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kunttas-Tatli E, 2014, MOL BIOL CELL, V25, P3424, DOI 10.1091/mbc.E14-04-0885; Lau T, 2013, CANCER RES, V73, P3132, DOI 10.1158/0008-5472.CAN-12-4562; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; Mendoza-Topaz C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110013; Morrone S, 2012, P NATL ACAD SCI USA, V109, P1500, DOI 10.1073/pnas.1116618109; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Pronobis MI, 2015, ELIFE, V4, DOI 10.7554/eLife.08022; Riffell JL, 2012, NAT REV DRUG DISCOV, V11, P923, DOI 10.1038/nrd3868; Roberts DM, 2011, MOL BIOL CELL, V22, P1845, DOI 10.1091/mbc.E10-11-0871; Schneikert J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068072; Scholer-Dahirel A, 2011, P NATL ACAD SCI USA, V108, P17135, DOI 10.1073/pnas.1104182108; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Thorvaldsen TE, 2015, MOL CANCER RES, V13, P1487, DOI 10.1158/1541-7786.MCR-15-0125; Waaler J, 2012, CANCER RES, V72, P2822, DOI 10.1158/0008-5472.CAN-11-3336; Yamulla RJ, 2014, GENETICS, V197, P1285, DOI 10.1534/genetics.114.166496; Yu X, 1999, MECH DEVELOP, V84, P69, DOI 10.1016/S0925-4773(99)00072-6; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zhou ZD, 2011, CELL ADHES MIGR, V5, P463, DOI 10.4161/cam.5.6.18356	47	24	24	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12747	12760		10.1074/jbc.M115.705442	http://dx.doi.org/10.1074/jbc.M115.705442			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27068743	Green Published, hybrid			2022-12-28	WOS:000378119900027
J	Delgado, DA; Doherty, K; Cheng, QH; Kim, H; Xu, DW; Dong, H; Grewer, C; Qiang, W				Delgado, Dennis A.; Doherty, Katelynne; Cheng, Qinghui; Kim, Hyeongeun; Xu, Dawei; Dong, He; Grewer, Christof; Qiang, Wei			Distinct Membrane Disruption Pathways Are Induced by 40-Residue beta-Amyloid Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; FORMS ION CHANNELS; ALZHEIMERS-DISEASE; LIPID-BILAYERS; A-BETA; FIBRIL GROWTH; PROTEIN; BRAIN; OLIGOMERS; FUSION	Cellular membrane disruption induced by beta-amyloid (A beta) peptides has been considered one of the major pathological mechanisms for Alzheimer disease. Mechanistic studies of the membrane disruption process at a high-resolution level, on the other hand, are hindered by the co-existence of multiple possible pathways, even in simplified model systems such as the phospholipid liposome. Therefore, separation of these pathways is crucial to achieve an in-depth understanding of theA beta-induced membrane disruption process. This study, which utilized a combination of multiple biophysical techniques, shows that the peptide-to-lipid (P:L) molar ratio is an important factor that regulates the selection of dominant membrane disruption pathways in the presence of 40-residue A beta peptides in liposomes. Three distinct pathways (fibrillation with membrane content leakage, vesicle fusion, and lipid uptake through a temporarily stable ionic channel) become dominant in model liposome systems under specific conditions. These individual systems are characterized by both the initial states of A beta peptides and the P:L molar ratio. Our results demonstrated the possibility to generate simplified A beta-membrane model systems with a homogeneous membrane disruption pathway, which will benefit high-resolution mechanistic studies in the future. Fundamentally, the possibility of pathway selection controlled by P:L suggests that the driving forces for A beta aggregation and A beta-membrane interactions may be similar at the molecular level.	[Delgado, Dennis A.; Doherty, Katelynne; Cheng, Qinghui; Kim, Hyeongeun; Grewer, Christof; Qiang, Wei] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA; [Xu, Dawei; Dong, He] Clarkson Univ, Dept Chem & Biomol Sci, Potsdam, NY 13699 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Clarkson University	Qiang, W (corresponding author), SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA.	wqiang@binghamton.edu		Dong, He/0000-0002-8494-0475	National Science Foundation Major Research Instrumentation Program [NSF 0922815]	National Science Foundation Major Research Instrumentation Program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The NMR facility at Binghamton University was supported by the National Science Foundation Major Research Instrumentation Program (NSF 0922815). We acknowledge support from Dr. Ming An for using the rotatory evaporator for sample preparation and the mass spectrometry facility from the University of Illinois.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Akinlolu RD, 2015, BIOCHEMISTRY-US, V54, P3416, DOI 10.1021/acs.biochem.5b00321; Bak M, 2000, J MAGN RESON, V147, P296, DOI 10.1006/jmre.2000.2179; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; CALDERON RO, 1995, J NEUROCHEM, V64, P424; Capone R, 2012, J CHEM THEORY COMPUT, V8, P1143, DOI 10.1021/ct200885r; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chiang PK, 2008, CURR MOL MED, V8, P580, DOI 10.2174/156652408785747951; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Connelly L, 2012, BIOCHEMISTRY-US, V51, P3031, DOI 10.1021/bi300257e; Drechsler A, 2010, BBA-BIOMEMBRANES, V1798, P244, DOI 10.1016/j.bbamem.2009.10.012; Eckert GP, 2010, CURR PROTEIN PEPT SC, V11, P319, DOI 10.2174/138920310791330668; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Fletcher TG, 1997, PROTEIN SCI, V6, P666; Funato H, 1998, AM J PATHOL, V152, P1633; Hasegawa K, 2002, BIOCHEMISTRY-US, V41, P13489, DOI 10.1021/bi020369w; Hayashi H, 2000, BBA-MOL CELL BIOL L, V1483, P81, DOI 10.1016/S1388-1981(99)00174-2; Kawahara M, 1997, BIOPHYS J, V73, P67, DOI 10.1016/S0006-3495(97)78048-2; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Komatsu H, 2010, J BIOL CHEM, V285, P41843, DOI 10.1074/jbc.M110.165068; Lal R, 2007, BBA-BIOMEMBRANES, V1768, P1966, DOI 10.1016/j.bbamem.2007.04.021; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Mason RP, 1999, J BIOL CHEM, V274, P18801, DOI 10.1074/jbc.274.26.18801; Mason RP, 1996, BIOCHEM BIOPH RES CO, V222, P78, DOI 10.1006/bbrc.1996.0699; McLaurin J, 1997, EUR J BIOCHEM, V245, P355, DOI 10.1111/j.1432-1033.1997.t01-2-00355.x; Moscho A, 1996, P NATL ACAD SCI USA, V93, P11443, DOI 10.1073/pnas.93.21.11443; MULLER WE, 1995, BRAIN RES, V674, P133, DOI 10.1016/0006-8993(94)01463-R; OBRIEN JS, 1965, J LIPID RES, V6, P537; Oshima N, 2001, AM J PATHOL, V158, P2209, DOI 10.1016/S0002-9440(10)64693-7; Ostroumova OS, 2011, FEBS J, V278, P461, DOI 10.1111/j.1742-4658.2010.07967.x; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Peters I, 2009, BBA-BIOMEMBRANES, V1788, P964, DOI 10.1016/j.bbamem.2009.01.012; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Potapov A, 2015, J AM CHEM SOC, V137, P8294, DOI 10.1021/jacs.5b04843; Qiang W, 2015, BBA-BIOMEMBRANES, V1848, P266, DOI 10.1016/j.bbamem.2014.04.011; Qiang W, 2014, BIOCHEMISTRY-US, V53, P7503, DOI 10.1021/bi501003n; Qiang W, 2013, J AM CHEM SOC, V135, P6860, DOI 10.1021/ja311963f; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Qiang W, 2011, J AM CHEM SOC, V133, P4018, DOI 10.1021/ja109679q; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Sciacca MFM, 2012, BIOPHYS J, V103, P702, DOI 10.1016/j.bpj.2012.06.045; Sengupta P, 2003, BIOCHEMISTRY-US, V42, P10506, DOI 10.1021/bi0341410; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666; Vestergaard MC, 2013, BBA-BIOMEMBRANES, V1828, P1314, DOI 10.1016/j.bbamem.2013.01.015; Wang T, 2012, BIOPHYS J, V102, P787, DOI 10.1016/j.bpj.2012.01.010; Widenbrant MJO, 2006, BIOPHYS J, V91, P4071, DOI 10.1529/biophysj.106.085944; Yip CM, 2002, J MOL BIOL, V318, P97, DOI 10.1016/S0022-2836(02)00028-1; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Yu X, 2013, PHYS CHEM CHEM PHYS, V15, P8878, DOI 10.1039/c3cp44448a; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	56	38	39	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12233	12244		10.1074/jbc.M116.720656	http://dx.doi.org/10.1074/jbc.M116.720656			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27056326	Green Published, hybrid			2022-12-28	WOS:000378092800024
J	Ishizuka, S; Askew, EB; Ishizuka, N; Knudson, CB; Knudson, W				Ishizuka, Shinya; Askew, Emily B.; Ishizuka, Naoko; Knudson, Cheryl B.; Knudson, Warren			4-Methylumbelliferone Diminishes Catabolically Activated Articular Chondrocytes and Cartilage Explants via a Mechanism Independent of Hyaluronan Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; MESENCHYMAL STEM-CELLS; UDP-GLUCURONIC ACID; TIME RT-PCR; NF-KAPPA-B; TRANSCRIPTION FACTORS; GROWTH-FACTOR; SYNTHASE 2; MATRIX-METALLOPROTEINASE; PERICELLULAR MATRIX	Depletion of the cartilage proteoglycan aggrecan is one of the earliest events that occurs in association with osteoarthritis. This loss is often accompanied by a coordinate loss in another glycosaminoglycan, hyaluronan. Chondrocytes experimentally depleted of cell-associated hyaluronan respond by switching to a pro-catabolic metabolism that includes enhanced production of endogenous inflammatory mediators and increased synthesis of matrix metalloproteinases. Hyaluronan turnover is also increased. Together, such a response provides for possible establishment of a self-perpetuating spiral of events that maintains or prolongs the pro-catabolic state. Chondrocytes or cartilage can also be activated by treatment with pro-inflammatory cytokines and mediators such as IL-1 beta, TNF alpha, LPS, fibronectin fragments, and hyaluronan oligosaccharides. To determine the mechanism of chondrocyte activation due to hyaluronan loss, a depletion method was required that did not include degrading the hyaluronan. In recent years, several laboratories have used the coumarin derivative, 4-methylumbelliferone, as a potent inhibitor of hyaluronan biosynthesis, due in part to its ability to sequester intracellular UDP-glucuronic acid and inhibition of hyaluronan synthase transcription. However, contrary to our expectation, although 4-methylumbelliferone was indeed an inhibitor of hyaluronan biosynthesis, this depletion did not give rise to an activation of chondrocytes or cartilage. Rather, 4-methylumbelliferone directly and selectively blocked gene products associated with the pro-catabolic metabolic state of chondrocytes and did so through a mechanism preceding and independent of hyaluronan inhibition. These data suggest that 4-methylumbelliferone has additional useful applications to block pro-inflammatory cell activation events but complicates how it is used for defining functions related to hyaluronan.	[Ishizuka, Shinya; Askew, Emily B.; Ishizuka, Naoko; Knudson, Cheryl B.; Knudson, Warren] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, 600 Moye Blvd,Mailstop 620, Greenville, NC 27834 USA	University of North Carolina; East Carolina University	Knudson, W (corresponding author), E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, 600 Moye Blvd,Mailstop 620, Greenville, NC 27834 USA.	knudsonw@ecu.edu		Ishizuka, Shinya/0000-0003-1877-9502	National Institutes of Health [R21 AR066581, R01-AR039507]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR066581, R01AR039507] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported in part by National Institutes of Health Grants R21 AR066581 ( to W. K.) and R01-AR039507 ( to C. B. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Ariyoshi W, 2012, ARTHRITIS RHEUM-US, V64, P187, DOI 10.1002/art.33329; Ariyoshi W, 2010, J BIOL CHEM, V285, P36216, DOI 10.1074/jbc.M110.129270; Bock KW, 2010, BIOCHEM PHARMACOL, V80, P771, DOI 10.1016/j.bcp.2010.04.034; Demircan K, 2005, ARTHRITIS RHEUM-US, V52, P1451, DOI 10.1002/art.21010; Ding L, 2012, GASTROENTEROLOGY, V142, P305, DOI 10.1053/j.gastro.2011.10.025; Durigova M, 2008, OSTEOARTHR CARTILAGE, V16, P98, DOI 10.1016/j.joca.2007.05.002; Fosang AJ, 2008, EUR CELLS MATER, V15, P11, DOI 10.22203/eCM.v015a02; Fukui N, 2006, J BIOL CHEM, V281, P27229, DOI 10.1074/jbc.M603385200; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Haapala J, 1996, J RHEUMATOL, V23, P1586; Hanioka N, 2012, CHEMOSPHERE, V89, P526, DOI 10.1016/j.chemosphere.2012.05.039; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hascall VC, 2014, MATRIX BIOL, V35, P14, DOI 10.1016/j.matbio.2014.01.014; He B, 2004, J BIOL CHEM, V279, P30643, DOI 10.1074/jbc.M403117200; HOLMES MWA, 1988, BIOCHEM J, V250, P435, DOI 10.1042/bj2500435; Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbrc.2004.06.029; Jokela TA, 2011, J BIOL CHEM, V286, P33632, DOI 10.1074/jbc.M111.265637; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; Knudson W, 2000, ARTHRITIS RHEUM-US, V43, P1165, DOI 10.1002/1529-0131(200005)43:5<1165::AID-ANR27>3.0.CO;2-H; Knudson W, 1996, EXP CELL RES, V228, P216, DOI 10.1006/excr.1996.0320; KNUDSON W, 1991, J CELL SCI, V99, P227; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Lark MW, 1997, J CLIN INVEST, V100, P93, DOI 10.1172/JCI119526; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Lokeshwar VB, 2010, CANCER RES, V70, P2613, DOI 10.1158/0008-5472.CAN-09-3185; Luo N, 2014, ARTHRITIS RHEUMATOL, V66, P1547, DOI 10.1002/art.38388; Masuda K, 2003, J ORTHOP RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2; Mehlhorn AT, 2006, TISSUE ENG, V12, P2853, DOI 10.1089/ten.2006.12.2853; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; MORALES TI, 1988, J BIOL CHEM, V263, P3632; Mu N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20059; Nakamura R, 2007, CELL BIOL INT, V31, P1022, DOI 10.1016/j.cellbi.2007.03.016; NG CK, 1992, ARCH BIOCHEM BIOPHYS, V298, P70, DOI 10.1016/0003-9861(92)90095-E; Nishida Y, 2000, ARTHRITIS RHEUM, V43, P1315, DOI 10.1002/1529-0131(200006)43:6<1315::AID-ANR14>3.0.CO;2-#; Ohno S, 2006, J BIOL CHEM, V281, P17952, DOI 10.1074/jbc.M602750200; Ohno S, 2005, ARTHRITIS RHEUM-US, V52, P800, DOI 10.1002/art.20937; Ohno-Nakahara M, 2004, J BIOCHEM, V135, P567, DOI 10.1093/jb/mvh069; Ono Y, 2014, CARTILAGE, V5, P172, DOI 10.1177/1947603514528354; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PITA JC, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P455; Rasmussen TB, 2003, ARCH VIROL, V148, P2005, DOI 10.1007/s00705-003-0145-2; Rilla K, 2004, J INVEST DERMATOL, V123, P708, DOI 10.1111/j.0022-202X.2004.23409.x; RIZKALLA G, 1992, J CLIN INVEST, V90, P2268, DOI 10.1172/JCI116113; Roughley Peter J, 2014, J Exp Orthop, V1, P8, DOI 10.1186/s40634-014-0008-7; Rowland A, 2015, DRUG METAB DISPOS, V43, P147, DOI 10.1124/dmd.114.060509; Sandy JD, 2001, BIOCHEM J, V358, P615, DOI 10.1042/0264-6021:3580615; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Strandberg Y, 2005, CYTOKINE, V31, P72, DOI 10.1016/j.cyto.2005.02.010; Sztrolovics R, 2002, BIOCHEM J, V362, P473, DOI 10.1042/0264-6021:3620473; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Takahashi N, 2010, ARTHRITIS RHEUM-US, V62, P1338, DOI 10.1002/art.27410; Tew SR, 2014, ARTHRITIS RHEUMATOL, V66, P3052, DOI 10.1002/art.38849; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Toole B. P., 1991, CELL BIOL EXTRACELLU, P305; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Toole BP, 1997, J INTERN MED, V242, P35, DOI 10.1046/j.1365-2796.1997.00171.x; Torihashi S, 2015, J BIOL CHEM, V290, P22771, DOI 10.1074/jbc.M114.629774; Tortorella MD, 2000, J BIOL CHEM, V275, P18566, DOI 10.1074/jbc.M909383199; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; Uchaipichat V, 2004, DRUG METAB DISPOS, V32, P413, DOI 10.1124/dmd.32.4.413; Urakawa H, 2012, INT J CANCER, V130, P454, DOI 10.1002/ijc.26014; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Webber J, 2009, AM J PATHOL, V175, P148, DOI 10.2353/ajpath.2009.080837; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Yates TJ, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv085; Yoshioka Y, 2015, HISTOCHEM CELL BIOL, V144, P167, DOI 10.1007/s00418-015-1325-3; Yoshioka Y, 2013, ARTHRITIS RHEUM-US, V65, P1160, DOI 10.1002/art.37861	76	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12087	12104		10.1074/jbc.M115.709683	http://dx.doi.org/10.1074/jbc.M115.709683			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27129266	Green Published, hybrid			2022-12-28	WOS:000378092800012
J	Patel, A; Mohl, BP; Roy, P				Patel, Avnish; Mohl, Bjorn-Patrick; Roy, Polly			Entry of Bluetongue Virus Capsid Requires the Late Endosome-specific Lipid Lysobisphosphatidic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION PROTEINS; CELL ENTRY; FUNCTIONAL-CHARACTERIZATION; CHOLESTEROL TRANSPORT; NONENVELOPED VIRUS; GLYCOPROTEIN-G; VIRAL FUSION; PARTICLES; REOVIRUS; ENDOCYTOSIS	The entry of viruses into host cells is one of the key processes of infection. The mechanisms of cellular entry for enveloped virus have been well studied. The fusion proteins as well as the facilitating cellular lipid factors involved in the viral fusion entry process have been well characterized. The process of non-enveloped virus cell entry, in comparison, remains poorly defined, particularly for large complex capsid viruses of the family Reoviridae, which comprises a range of mammalian pathogens. These viruses enter cells without the aid of a limiting membrane and thus cannot fuse with host cell membranes to enter cells. Instead, these viruses are believed to penetrate membranes of the host cell during endocytosis. However, the molecular mechanism of this process is largely undefined. Here we show, utilizing an in vitro liposome penetration assay and cell biology, that bluetongue virus (BTV), an archetypal member of the Reoviridae, utilizes the late endosome-specific lipid lysobisphosphatidic acid for productive membrane penetration and viral entry. Further, we provide preliminary evidence that lipid lysobisphosphatidic acid facilitates pore expansion during membrane penetration, suggesting a mechanism for lipid factor requirement of BTV. This finding indicates that despite the lack of a membrane envelope, the entry process of BTV is similar in specific lipid requirements to enveloped viruses that enter cells through the late endosome. These results are the first, to our knowledge, to demonstrate that a large non-enveloped virus of the Reoviridae has specific lipid requirements for membrane penetration and host cell entry.	[Patel, Avnish; Mohl, Bjorn-Patrick; Roy, Polly] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Roy, P (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England.	polly.roy@lshtm.ac.uk		Roy, Polly/0000-0001-6535-6911	Wellcome Trust; National Institutes of Health	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded in part by the Wellcome Trust and the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agosto MA, 2006, P NATL ACAD SCI USA, V103, P16496, DOI 10.1073/pnas.0605835103; Belnap DM, 2000, J VIROL, V74, P1342, DOI 10.1128/JVI.74.3.1342-1354.2000; Boisvert M, 2010, J VIROL, V84, P7782, DOI 10.1128/JVI.00479-10; Bowne J G, 1971, Adv Vet Sci Comp Med, V15, P1; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Bubeck D, 2005, J VIROL, V79, P7745, DOI 10.1128/JVI.79.12.7745-7755.2005; Celma CC, 2014, VET MICROBIOL, V174, P139, DOI 10.1016/j.vetmic.2014.09.012; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Diaz-Salinas MA, 2014, J VIROL, V88, P4389, DOI 10.1128/JVI.03457-13; Dowling W, 2000, J VIROL, V74, P6368, DOI 10.1128/JVI.74.14.6368-6376.2000; Du JZ, 2014, J VIROL, V88, P12656, DOI 10.1128/JVI.01815-14; EATON BT, 1990, CURR TOP MICROBIOL, V162, P89; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; Elbers ARW, 2008, PREV VET MED, V87, P21, DOI 10.1016/j.prevetmed.2008.06.004; Epand RM, 2003, BBA-BIOMEMBRANES, V1614, P116, DOI 10.1016/S0005-2736(03)00169-X; Forzan M, 2007, J VIROL, V81, P4819, DOI 10.1128/JVI.02284-06; FRENCH TJ, 1990, J VIROL, V64, P1530, DOI 10.1128/JVI.64.4.1530-1536.1990; Gold S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011360; Grover A, 2012, ANGEW CHEM INT EDIT, V51, P4838, DOI 10.1002/anie.201108107; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hassan SH, 2001, J VIROL, V75, P8356, DOI 10.1128/JVI.75.18.8356-8367.2001; Hassan SS, 1999, J VIROL, V73, P9832, DOI 10.1128/JVI.73.12.9832-9842.1999; HUGHSON FM, 1995, CURR BIOL, V5, P265, DOI 10.1016/S0960-9822(95)00057-1; HUISMANS H, 1987, VIROLOGY, V157, P180, DOI 10.1016/0042-6822(87)90327-8; Ivanovic T, 2008, EMBO J, V27, P1289, DOI 10.1038/emboj.2008.60; Jenckel M, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00016-15; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; KIELIAN MC, 1984, J VIROL, V52, P281, DOI 10.1128/JVI.52.1.281-283.1984; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Lins B, 2014, FUTURE VIROL, V9, P1105, DOI 10.2217/FVL.14.82; LIU HM, 1992, J GEN VIROL, V73, P2577, DOI 10.1099/0022-1317-73-10-2577; Maclachlan NJ, 2011, PREV VET MED, V102, P107, DOI 10.1016/j.prevetmed.2011.04.005; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MARTIN SA, 1972, VIROLOGY, V50, P495, DOI 10.1016/0042-6822(72)90400-X; Matos PM, 2013, J BIOL CHEM, V288, P12416, DOI 10.1074/jbc.M113.462028; Matsuda M, 2014, J GEN VIROL, V95, P2658, DOI 10.1099/vir.0.068528-0; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mertens PPC., 2005, VIRUS TAXONOMY, P466; NANDI P, 1992, J VIROL, V66, P3363, DOI 10.1128/JVI.66.6.3363-3367.1992; Nason EL, 2004, J VIROL, V78, P8059, DOI 10.1128/JVI.78.15.8059-8067.2004; Padilla-Parra S, 2012, P NATL ACAD SCI USA, V109, P17627, DOI 10.1073/pnas.1211714109; Panjwani A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004294; Pattanakitsakul SN, 2010, J PROTEOME RES, V9, P4640, DOI 10.1021/pr100357f; Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014; PRASAD BVV, 1992, J VIROL, V66, P2135, DOI 10.1128/JVI.66.4.2135-2142.1992; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Schulz WL, 2012, J VIROL, V86, P12665, DOI 10.1128/JVI.01861-12; Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VERWOERD D W, 1972, Onderstepoort Journal of Veterinary Research, V39, P185; VERWOERD DW, 1972, J VIROL, V10, P783, DOI 10.1128/JVI.10.4.783-794.1972; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131; Zhang X, 2016, NAT STRUCT MOL BIOL, V23, P74, DOI 10.1038/nsmb.3134; Zhang X, 2010, P NATL ACAD SCI USA, V107, P6292, DOI 10.1073/pnas.0913403107; Zhao YG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng006	67	23	23	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12408	12419		10.1074/jbc.M115.700856	http://dx.doi.org/10.1074/jbc.M115.700856			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27036941	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000378092800038
J	Lamech, LT; Saoji, M; Paukstelis, PJ; Lambowitz, AM				Lamech, Lilian T.; Saoji, Maithili; Paukstelis, Paul J.; Lambowitz, Alan M.			Structural Divergence of the Group I Intron Binding Surface in Fungal Mitochondrial Tyrosyl-tRNA Synthetases That Function in RNA Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RIBOSOMAL-RNA; KMSKS LOOP; PROTEIN; DOMAIN; SEQUENCE; REVEALS; EVOLUTION; ELECTROSTATICS; INVOLVEMENT	The mitochondrial tyrosyl-tRNA synthetases (mtTyrRSs) of Pezizomycotina fungi, a subphylum that includes many pathogenic species, are bifunctional proteins that both charge mitochondrial tRNATyr and act as splicing cofactors for autocatalytic group I introns. Previous studies showed that one of these proteins, Neurospora crassa CYT-18, binds group I introns by using both its N-terminal catalytic and C-terminal anticodon binding domains and that the catalytic domain uses a newly evolved group I intron binding surface that includes an N-terminal extension and two small insertions (insertions 1 and 2) with distinctive features not found in non-splicing mtTyrRSs. To explore how this RNA binding surface diverged to accommodate different group I introns in other Pezizomycotina fungi, we determined x-ray crystal structures of C-terminally truncated Aspergillus nidulans and Coccidioides posadasii mtTyrRSs. Comparisons with previous N. crassa CYT-18 structures and a structural model of the Aspergillus fumigatus mtTyrRS showed that the overall topology of the group I intron binding surface is conserved but with variations in key intron binding regions, particularly the Pezizomycotina-specific insertions. These insertions, which arose by expansion of flexible termini or internal loops, show greater variation in structure and amino acids potentially involved in group I intron binding than do neighboring protein core regions, which also function in intron binding but may be more constrained to preserve mtTyrRS activity. Our results suggest a structural basis for the intron specificity of different Pezizomycotina mtTyrRSs, highlight flexible terminal and loop regions as major sites for enzyme diversification, and identify targets for therapeutic intervention by disrupting an essential RNA-protein interaction in pathogenic fungi.	[Lamech, Lilian T.; Lambowitz, Alan M.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Lamech, Lilian T.; Lambowitz, Alan M.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Saoji, Maithili; Paukstelis, Paul J.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University System of Maryland; University of Maryland College Park	Lambowitz, AM (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.; Lambowitz, AM (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	lambowitz@austin.utexas.edu			Office of Science, Office of Basic Energy Sciences of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037949, R01GM037951, R37GM037951] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Instrumentation for x-ray crystallography and technical assistance for this work were provided by the Macromolecular Crystallography Facility of the Institute for Cellular and Molecular Biology at the University of Texas at Austin. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aravind L, 1999, J MOL EVOL, V48, P291, DOI 10.1007/PL00006472; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bonnefond L, 2005, RNA, V11, P558, DOI 10.1261/rna.7246805; Bonnefond L, 2007, STRUCTURE, V15, P1505, DOI 10.1016/j.str.2007.09.018; BRICK P, 1987, J MOL BIOL, V194, P287, DOI 10.1016/0022-2836(87)90376-7; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; Caprara MG, 1996, J MOL BIOL, V257, P512, DOI 10.1006/jmbi.1996.0182; CARTER P, 1986, P NATL ACAD SCI USA, V83, P1189, DOI 10.1073/pnas.83.5.1189; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen X, 2004, RNA, V10, P634, DOI 10.1261/rna.5212604; CHERNIACK AD, 1990, CELL, V62, P745, DOI 10.1016/0092-8674(90)90119-Y; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dewal MB, 2011, CURR MED CHEM, V18, P2420; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards TA, 2011, AMINO ACIDS, V41, P743, DOI 10.1007/s00726-011-0880-8; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FIRST EA, 1995, BIOCHEMISTRY-US, V34, P5030, DOI 10.1021/bi00015a014; Geng C, 2014, BIOCHEMISTRY-US, V53, P1311, DOI 10.1021/bi401614h; Gerstner RB, 2001, BIOCHEMISTRY-US, V40, P7165, DOI 10.1021/bi010026i; Golden BL, 1998, SCIENCE, V282, P259, DOI 10.1126/science.282.5387.259; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; GUO QB, 1992, GENE DEV, V6, P1357, DOI 10.1101/gad.6.8.1357; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hougland J. L., 2005, RNA WORLD, P133; JAKES R, 1975, BIOCHEMISTRY-US, V14, P3344, DOI 10.1021/bi00686a009; Joardar V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-698; KAMPER U, 1992, MOL CELL BIOL, V12, P499; KITTLE JD, 1991, GENE DEV, V5, P1009, DOI 10.1101/gad.5.6.1009; Kobayashi T, 2005, J MOL BIOL, V346, P105, DOI 10.1016/j.jmb.2004.11.034; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; LAMBOWITZ AM, 1990, TRENDS BIOCHEM SCI, V15, P440, DOI 10.1016/0968-0004(90)90283-H; Lamech LT, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002028; MANNELLA CA, 1979, P NATL ACAD SCI USA, V76, P2635, DOI 10.1073/pnas.76.6.2635; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MOHR G, 1992, CELL, V69, P483, DOI 10.1016/0092-8674(92)90449-M; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oren I, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12642; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paukstelis PJ, 2008, P NATL ACAD SCI USA, V105, P6010, DOI 10.1073/pnas.0801722105; Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413; Paukstelis PJ, 2011, BIOCHEMISTRY-US, V50, P3816, DOI 10.1021/bi200189u; Paukstelis PJ, 2005, MOL CELL, V17, P417, DOI 10.1016/j.molcel.2004.12.026; Qiu XY, 2001, PROTEIN SCI, V10, P2008, DOI 10.1110/ps.18001; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saldanha R, 1996, J MOL BIOL, V261, P23, DOI 10.1006/jmbi.1996.0439; SALDANHA RJ, 1995, BIOCHEMISTRY-US, V34, P1275, DOI 10.1021/bi00004a022; Smirnova EV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P15, DOI 10.1134/S0006297912010026; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Stahley MR, 2007, J MOL BIOL, V372, P89, DOI 10.1016/j.jmb.2007.06.026; Staker BL, 2000, EMBO J, V19, P749, DOI 10.1093/emboj/19.4.749; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Verweij P. E., 2006, Manual of clinical microbiology: Volume 2, P1802; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wallweber GJ, 1997, RNA, V3, P114; Wheat LJ, 2009, CLIN CHEST MED, V30, P379, DOI 10.1016/j.ccm.2009.02.011; Wilke CO, 2010, CURR OPIN STRUC BIOL, V20, P385, DOI 10.1016/j.sbi.2010.03.004; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolf YI, 1999, GENOME RES, V9, P689; Xin Y, 2000, J MOL BIOL, V303, P287, DOI 10.1006/jmbi.2000.4125; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373	71	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11911	11927		10.1074/jbc.M116.725390	http://dx.doi.org/10.1074/jbc.M116.725390			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27036943	hybrid, Green Published			2022-12-28	WOS:000377264800039
J	Sun, GY; Zhou, ZP; Liu, X; Gai, KX; Liu, QQ; Cha, J; Kaleri, FN; Wang, Y; He, Q				Sun, Guangyan; Zhou, Zhipeng; Liu, Xiao; Gai, Kexin; Liu, Qingqing; Cha, Joonseok; Kaleri, Farah Naz; Wang, Ying; He, Qun			Suppression of WHITE COLLAR-independent frequency Transcription by Histone H3 Lysine 36 Methyltransferase SET-2 Is Necessary for Clock Function in Neurospora	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circadian rhythm; clock gene; gene transcription; histone modification; Neurospora; SET-2 pathway; WC-independent frq	NEGATIVE FEEDBACK LOOP; CIRCADIAN CLOCK; GENE-EXPRESSION; DNA METHYLATION; LIGHT RESPONSES; PROTEIN; CRASSA; CHROMATIN; PHOSPHORYLATION; RHYTHMS	The circadian system in Neurospora is based on the transcriptional/translational feedback loops and rhythmic frequency (frq) transcription requires the WHITE COLLAR (WC) complex. Our previous paper has shown that frq could be transcribed in a WC-independent pathway in a strain lacking the histone H3K36 methyltransferase, SET-2 (su(var)3-9-enhancer-of-zeste-trithorax-2) (1), but the mechanism was unclear. Here we disclose that loss of histone H3K36 methylation, due to either deletion of SET-2 or H3K36R mutation, results in arrhythmic frq transcription and loss of overt rhythmicity. Histone acetylation at frq locus increases in set-2(KO) mutant. Consistent with these results, loss of H3K36 methylation readers, histone deacetylase RPD-3 (reduced potassium dependence 3) or EAF-3 (essential SAS-related acetyltransferase-associated factor 3), also leads to hyperacetylation of histone at frq locus and WC-independent frq expression, suggesting that proper chromatin modification at frq locus is required for circadian clock operation. Furthermore, a mutant strain with three amino acid substitutions (histone H3 lysine 9, 14, and 18 to glutamine) was generated to mimic the strain with hyperacetylation state of histone H3. H3K9QK14QK18Q mutant exhibits the same defective clock phenotype as rpd-3(KO) mutant. Our results support a scenario in which H3K36 methylation is required to establish a permissive chromatin state for circadian frq transcription by maintaining proper acetylation status at frq locus.	[Sun, Guangyan; Zhou, Zhipeng; Liu, Xiao; Gai, Kexin; Liu, Qingqing; Kaleri, Farah Naz; Wang, Ying; He, Qun] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Sun, Guangyan; Zhou, Zhipeng; Liu, Xiao; Gai, Kexin; Liu, Qingqing; Kaleri, Farah Naz; Wang, Ying; He, Qun] China Agr Univ, Coll Biol Sci, MOA Key Lab Soil Microbiol, Beijing 100193, Peoples R China; [Zhou, Zhipeng] China Agr Univ, Coll Agr & Biotechnol, Beijing 100193, Peoples R China; [Cha, Joonseok] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	China Agricultural University; China Agricultural University; China Agricultural University; University of Texas System; University of Texas Southwestern Medical Center Dallas	He, Q (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	qunhe@cau.edu.cn	liu, qingqing/HHD-0360-2022; Cha, Joonseok/AAE-9918-2020; Liu, Qing/GWC-9222-2022		State Key Program of National Natural Science of China [31330004]; National Basic Research Program of China [2012CB947600]	State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This project was supported by grants from a project supported by the State Key Program of National Natural Science of China (31330004) and National Basic Research Program of China (973 Program) Grant (2012CB947600) (to Q. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adhvaryu KK, 2005, EUKARYOT CELL, V4, P1455, DOI 10.1128/EC.4.8.1455-1464.2005; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Baker CL, 2012, FEMS MICROBIOL REV, V36, P95, DOI 10.1111/j.1574-6976.2011.00288.x; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; Belden WJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002166; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cha J, 2013, EMBO REP, V14, P923, DOI 10.1038/embor.2013.131; Cheng P, 2002, MOL CELL BIOL, V22, P517, DOI 10.1128/MCB.22.2.517-524.2002; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Collett MA, 2001, MOL CELL BIOL, V21, P2619, DOI 10.1128/MCB.21.8.2619-2628.2001; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Curtis AM, 2004, J BIOL CHEM, V279, P7091, DOI 10.1074/jbc.M311973200; Dunlap JC, 2006, J BIOL CHEM, V281, P28489, DOI 10.1074/jbc.R600018200; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gooch VD, 2008, EUKARYOT CELL, V7, P28, DOI 10.1128/EC.00257-07; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Liu X, 2015, MOL CELL BIOL, V35, P2088, DOI 10.1128/MCB.00709-14; Liu Y, 2006, EUKARYOT CELL, V5, P1184, DOI 10.1128/EC.00133-06; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Raduwan H, 2013, J BIOL CHEM, V288, P8380, DOI 10.1074/jbc.M112.359935; Smith KM, 2010, GENETICS, V186, P1207, DOI 10.1534/genetics.110.123315; Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Wang JY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001232; Xu H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001132; Xue ZH, 2014, NATURE, V514, P650, DOI 10.1038/nature13671; Yang SL, 2014, NUCLEIC ACIDS RES, V42, P6183, DOI 10.1093/nar/gku261; Yang YH, 2002, GENE DEV, V16, P994, DOI 10.1101/gad.965102; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhao YB, 2010, J BIOL CHEM, V285, P4355, DOI 10.1074/jbc.M109.034710; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833; Zhou ZP, 2013, P NATL ACAD SCI USA, V110, pE4867, DOI 10.1073/pnas.1315133110; Zhou ZP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002712	51	8	9	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11055	11063		10.1074/jbc.M115.711333	http://dx.doi.org/10.1074/jbc.M115.711333			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27002152	Green Published, hybrid			2022-12-28	WOS:000377042100009
J	Amparyup, P; Sutthangkul, J; Charoensapsri, W; Tassanakajon, A				Amparyup, Piti; Sutthangkul, Jantiwan; Charoensapsri, Walaiporn; Tassanakajon, Anchalee			Pattern recognition protein binds to lipopolysaccharide and beta-1,3-glucan and activates shrimp prophenoloxidase system (vol 287, pg 10060, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Charoensapsri, Walaiporn/0000-0002-8651-383X				Amparyup P, 2012, J BIOL CHEM, V287, P10060, DOI 10.1074/jbc.M111.294744	1	8	8	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10949	10949		10.1074/jbc.A111.294744	http://dx.doi.org/10.1074/jbc.A111.294744			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27197237	Green Published, hybrid			2022-12-28	WOS:000377042600044
J	Bergom, C; Hauser, AD; Rymaszewski, A; Gonyo, P; Prokop, JW; Jennings, BC; Lawton, AJ; Frei, A; Lorimer, EL; Aguilera-Barrantes, I; Mackinnon, AC; Noon, K; Fierke, CA; Williams, CL				Bergom, Carmen; Hauser, Andrew D.; Rymaszewski, Amy; Gonyo, Patrick; Prokop, Jeremy W.; Jennings, Benjamin C.; Lawton, Alexis J.; Frei, Anne; Lorimer, Ellen L.; Aguilera-Barrantes, Irene; Mackinnon, Alexander C., Jr.; Noon, Kathleen; Fierke, Carol A.; Williams, Carol L.			The tumor-suppressive small GTPase DiRas1 binds the noncanonical guanine nucleotide exchange factor SmgGDS and antagonizes SmgGDS interactions with oncogenic small GTPases (vol 290, pg 20245, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Prokop, Jeremy/AAG-4931-2019	Mackinnon, Alexander/0000-0002-2036-8529; Prokop, Jeremy/0000-0002-1818-9695; Bergom, Carmen/0000-0002-0886-5055	NCI NIH HHS [R01 CA188871] Funding Source: Medline; NIGMS NIH HHS [R01 GM040602] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA188871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040602] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERGOM C, 2015, J BIOL CHEM, V290, P20245	1	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10948	10948		10.1074/jbc.A115.696831	http://dx.doi.org/10.1074/jbc.A115.696831			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27197236	hybrid, Green Published			2022-12-28	WOS:000377042600043
J	Wong, BH; Chan, JP; Cazenave-Gassiot, A; Poh, RW; Foo, JC; Galam, DLA; Ghosh, S; Nguyen, LN; Barathi, VA; Yeo, SW; Luu, CD; Wenk, MR; Silver, DL				Wong, Bernice H.; Chan, Jia Pei; Cazenave-Gassiot, Amaury; Poh, Rebecca W.; Foo, Juat Chin; Galam, Dwight L. A.; Ghosh, Sujoy; Nguyen, Long N.; Barathi, Veluchamy A.; Yeo, Sia W.; Luu, Chi D.; Wenk, Markus R.; Silver, David L.			Mfsd2a Is a Transporter for the Essential omega-3 Fatty Acid Docosahexaenoic Acid (DHA) in Eye and Is Important for Photoreceptor Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL-PIGMENT EPITHELIUM; BRAIN; EXPRESSION; PHAGOCYTOSIS; PERICYTES; DISEASE; ORGANIZATION; CLONING; HEALTH; VEGF	Eye photoreceptor membrane discs in outer rod segments are highly enriched in the visual pigment rhodopsin and the omega-3 fatty acid docosahexaenoic acid (DHA). The eye acquires DHA from blood, but transporters for DHA uptake across the blood-retinal barrier or retinal pigment epithelium have not been identified. Mfsd2a is a newly described sodium-dependent lysophosphatidylcholine (LPC) symporter expressed at the blood-brain barrier that transports LPCs containing DHA and other long-chain fatty acids. LPC transport via Mfsd2a has been shown to be necessary for human brain growth. Here we demonstrate that Mfsd2a is highly expressed in retinal pigment epithelium in embryonic eye, before the development of photoreceptors, and is the primary site of Mfsd2a expression in the eye. Eyes from whole body Mfsd2a-deficient (KO) mice, but not endothelium-specific Mfsd2a-deficient mice, were DHA-deficient and had significantly reduced LPC/DHA transport in vivo. Fluorescein angiography indicated normal blood-retinal barrier function. Histological and electron microscopic analysis indicated that Mfsd2a KO mice exhibited a specific reduction in outer rod segment length, disorganized outer rod segment discs, and mislocalization of and reduction in rhodopsin early in postnatal development without loss of photoreceptors. Minor photoreceptor cell loss occurred in adult Mfsd2a KO mice, but electroretinography indicated visual function was normal. The developing eyes of Mfsd2a KO mice had activated microglia and up-regulation of lipogenic and cholesterogenic genes, likely adaptations to loss of LPC transport. These findings identify LPC transport via Mfsd2a as an important pathway for DHA uptake in eye and for development of photoreceptor membrane discs.	[Wong, Bernice H.; Chan, Jia Pei; Galam, Dwight L. A.; Ghosh, Sujoy; Silver, David L.] Duke Natl Univ Singapore, Grad Sch Med, Signature Res Program Cardiovasc & Metab Disorder, 8 Coll Rd, Singapore 169857, Singapore; [Ghosh, Sujoy] Duke Natl Univ Singapore, Grad Sch Med, Ctr Computat Biol, 8 Coll Rd, Singapore 169857, Singapore; [Barathi, Veluchamy A.] Duke Natl Univ Singapore, Grad Sch Med, ACP Ophthalmol, 8 Coll Rd, Singapore 169857, Singapore; [Cazenave-Gassiot, Amaury; Foo, Juat Chin; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, 8 Med Dr,Block MD 7, Singapore 117597, Singapore; [Poh, Rebecca W.] Carl Zeiss Pte Ltd, Microscopy Business Grp, 50 Kaki Bukit Pl,05-01, Singapore 415926, Singapore; [Nguyen, Long N.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, 5 Sci Dr 2,Bldg MD4,Level 1-03A, Singapore 117545, Singapore; [Barathi, Veluchamy A.; Yeo, Sia W.; Luu, Chi D.] Singapore Eye Res Inst, 11 Third Hosp Ave, Singapore 168751, Singapore; [Barathi, Veluchamy A.] Natl Univ Singapore, Yong Loo Lin Sch Med, 1E Kent Ridge Rd 119228,NUHS Tower Block,Level 11, Singapore 117597, Singapore; [Luu, Chi D.] Ctr Eye Res Australia, Level 1,32 Gisborne St, East Melbourne, Vic 3002, Australia	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Carl Zeiss AG; National University of Singapore; National University of Singapore; Singapore National Eye Center; National University of Singapore; Centre for Eye Research Australia	Silver, DL (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Signature Res Program Cardiovasc & Metab Disorder, 8 Coll Rd, Singapore 169857, Singapore.	david.silver@duke-nus.edu.sg	Nguyen, Long/AAY-6172-2021; foo, juat chin/AAH-8931-2019; Ghosh, Sujoy/I-3729-2017; Cazenave-Gassiot, Amaury/E-4536-2014	foo, juat chin/0000-0002-9189-4585; Ghosh, Sujoy/0000-0002-7601-165X; Cazenave-Gassiot, Amaury/0000-0002-3050-634X; Nguyen, Long N/0000-0002-9857-2239; Galam, Dwight Lark/0000-0002-1158-1969; Wong, Bernice/0000-0001-8981-1376; Luu, Chi/0000-0002-7604-7097	Singapore Ministry of Health National Medical Research Council [CBRG/069/2014]; Singapore Ministry of Education Tier2 Grant [MOE2014-T2-2-018]; National Medical Research Council [NMRC/CG/SERI/2013]	Singapore Ministry of Health National Medical Research Council(Ministry of Health-SingaporeNational Medical Research Council, Singapore); Singapore Ministry of Education Tier2 Grant(Ministry of Education, Singapore); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Singapore Ministry of Health National Medical Research Council Grant CBRG/069/2014 (to D. L. S.), the Singapore Ministry of Education Tier2 Grant MOE2014-T2-2-018 (to D. L. S.), and National Medical Research Council Grant NMRC/CG/SERI/2013 (to V. A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Alakbarzade V, 2015, NAT GENET, V47, P814, DOI 10.1038/ng.3313; Amadio M, 2016, PHARMACOL RES, V103, P253, DOI 10.1016/j.phrs.2015.11.027; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Berger JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050629; BOSCH E, 1993, J HISTOCHEM CYTOCHEM, V41, P253, DOI 10.1177/41.2.8419462; Burgoyne T, 2015, P NATL ACAD SCI USA, V112, P15922, DOI 10.1073/pnas.1509285113; Byrne LC, 2015, MOL THER, V23, P290, DOI 10.1038/mt.2014.181; Castoreno AB, 2005, P NATL ACAD SCI USA, V102, P13129, DOI 10.1073/pnas.0506716102; Chertov AO, 2011, J BIOL CHEM, V286, P34700, DOI 10.1074/jbc.M111.279752; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; CUNHAVAZ J, 1979, SURV OPHTHALMOL, V23, P279, DOI 10.1016/0039-6257(79)90158-9; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Ding JD, 2015, J CELL BIOL, V211, P495, DOI 10.1083/jcb.201508093; Ethayathulla AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4009; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Guemez-Gamboa A, 2015, NAT GENET, V47, P809, DOI 10.1038/ng.3311; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Kidd PM, 2007, ALTERN MED REV, V12, P207; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Lindsay KJ, 2014, P NATL ACAD SCI USA, V111, P15579, DOI 10.1073/pnas.1412441111; Mustafi D, 2013, FASEB J, V27, P4585, DOI 10.1096/fj.13-237537; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Price BA, 2011, INVEST OPHTH VIS SCI, V52, P9728, DOI 10.1167/iovs.11-8654; Robinson R, 2011, INVEST OPHTH VIS SCI, V52, P7423, DOI 10.1167/iovs.11-7912; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; STEINBERG RH, 1985, DOC OPHTHALMOL, V60, P327, DOI 10.1007/BF00158922; Tual-Chalot S, 2013, JOVE-J VIS EXP, DOI 10.3791/50546; Volland S, 2015, P NATL ACAD SCI USA, V112, P14870, DOI 10.1073/pnas.1516309112; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Weisinger HS, 2002, LIPIDS, V37, P759, DOI 10.1007/s11745-002-0958-3; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700	41	81	84	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10501	10514		10.1074/jbc.M116.721340	http://dx.doi.org/10.1074/jbc.M116.721340			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27008858	Green Published, hybrid			2022-12-28	WOS:000377042600006
J	Perez, RE; Shen, H; Duan, L; Kim, RH; Kim, T; Park, NH; Maki, CG				Perez, Ricardo E.; Shen, Hong; Duan, Lei; Kim, Reuben H.; Kim, Terresa; Park, No-Hee; Maki, Carl G.			Modeling the Etiology of p53-mutated Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONPOLYPOSIS COLON-CANCER; SPORADIC COLORECTAL CARCINOMAS; REPAIR-GENE DEFECTS; MISMATCH-REPAIR; MICROSATELLITE INSTABILITY; P53 GENE; TUMOR-CELLS; HPRT LOCUS; MUTATION; LINES	p53 gene mutations are among the most common alterations in cancer. In most cases, missense mutations in one TP53 allele are followed by loss-of-heterozygosity (I,OH), so tumors express only mutant p53. TP5.3 mutations and LOH have been linked, in many cases, with poor therapy response and worse outcome. Despite this, remarkably little is known about how TP53 point mutations are acquired, how LOH occurs, or the cells involved. Nutlin-3a occupies the p53-binding site in MDM2 and blocks p53-MDM2 interaction, resulting in the stabilization and activation of p53 and subsequent growth arrest or apoptosis. We leveraged the powerful growth inhibitory activity of Nutlin-3a to select p53-mutated cells and examined how TP53 mutations arise and how the remaining wild-type allele is lost or inactivated. Mismatch repair (MMR)-deficient colorectal cancer cells formed heterozygote (p53 wild-type/mutant) colonies when cultured in low doses of Nutlin-3a, whereas MMR-corrected counterparts did not. Placing these heterozygotes in higher Nutlin-3a doses selected clones in which the remaining wild-type TP53 was silenced. Our data suggest silencing occurred through a novel mechanism that does not involve DNA methylation, his tone methylation, or histone deacetylation. These data indicate MMR deficiency in colorectal cancer can give rise to initiating TP53 mutations and that TP53 silencing occurs via a copy-neutral mechanism. Moreover, the data highlight the use of MDM2 antagonists as tools to study mechanisms of TP53 mutation acquisition and wild-type allele loss or silencing in cells with defined genetic backgrounds.	[Maki, Carl G.] Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Kim, Reuben H.; Kim, Terresa; Park, No-Hee] Univ Calif Los Angeles, Shapiro Family Lab Viral Oncol & Aging Res, Sch Dent, Los Angeles, CA 90095 USA; [Kim, Reuben H.; Kim, Terresa; Park, No-Hee] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Rush University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Maki, CG (corresponding author), Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA.	carl_maki@rush.edu			National Institutes of Health from NCI [1R01CA137598-01A1, 1R21CA178733-01]; NIDCR [R01DE023874]; NATIONAL CANCER INSTITUTE [R01CA137598, R21CA178733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023874] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants 1R01CA137598-01A1 and 1R21CA178733-01 from NCI (to C. G. M.) and Grant R01DE023874 from NIDCR (to R. H. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Amatya VJ, 2005, ACTA NEUROPATHOL, V110, P178, DOI 10.1007/s00401-005-1041-5; BAKER SJ, 1990, CANCER RES, V50, P7717; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Barrera LN, 2013, EUR J NUTR, V52, P1327, DOI 10.1007/s00394-012-0442-1; BHATTACHARYYA NP, 1994, P NATL ACAD SCI USA, V91, P6319, DOI 10.1073/pnas.91.14.6319; Buglioni S, 2001, AM J CLIN PATHOL, V116, P360, DOI 10.1309/V7UW-UT2E-JVYH-DGWK; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cottu PH, 1996, ONCOGENE, V13, P2727; Done SJ, 2001, J NATL CANCER I, V93, P700, DOI 10.1093/jnci/93.9.700; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fulci G, 2002, CANCER RES, V62, P2897; Glaab WE, 1997, CARCINOGENESIS, V18, P1, DOI 10.1093/carcin/18.1.1; Glaab WE, 1998, CARCINOGENESIS, V19, P1931, DOI 10.1093/carcin/19.11.1931; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hasegawa A, 2004, ANTICANCER RES, V24, P2047; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Holstege H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-654; Hurt EM, 2006, CANCER BIOL THER, V5, P1154, DOI 10.4161/cbt.5.9.3001; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; KIKUCHIYANOSHITA R, 1992, CANCER RES, V52, P3965; KIM HG, 1994, AM J PATHOL, V145, P148; Kim RH, 2015, AGING CELL, V14, P838, DOI 10.1111/acel.12364; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KOI M, 1994, CANCER RES, V54, P4308; Konishi M, 1996, GASTROENTEROLOGY, V111, P307, DOI 10.1053/gast.1996.v111.pm8690195; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Lynch HT, 2015, NAT REV CANCER, V15, P181, DOI 10.1038/nrc3878; Mancuso T, 1997, NUCLEIC ACIDS RES, V25, P3643, DOI 10.1093/nar/25.18.3643; MARRA G, 1995, J NATL CANCER I, V87, P1114, DOI 10.1093/jnci/87.15.1114; Melcher R, 2011, CARCINOGENESIS, V32, P636, DOI 10.1093/carcin/bgr011; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Peltonen K, 2005, PIGM CELL RES, V18, P196, DOI 10.1111/j.1600-0749.2005.00225.x; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Raschle M, 2002, J BIOL CHEM, V277, P21810, DOI 10.1074/jbc.M108787200; Risinger JI, 1996, NAT GENET, V14, P102, DOI 10.1038/ng0996-102; Rustgi AK, 2007, GENE DEV, V21, P2525, DOI 10.1101/gad.1593107; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; SHIBATA D, 1994, NAT GENET, V6, P273, DOI 10.1038/ng0394-273; Simms LA, 1998, ONCOGENE, V17, P2003, DOI 10.1038/sj.onc.1202109; Sjogren S, 1996, J NATL CANCER I, V88, P173, DOI 10.1093/jnci/88.3-4.173; Soong R, 1996, BRIT J CANCER, V74, P562, DOI 10.1038/bjc.1996.401; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Takahashi M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198804; Tindall KR, 1998, MUTAT RES-FUND MOL M, V402, P15, DOI 10.1016/S0027-5107(97)00277-7; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Umar A, 1998, GENETICS, V148, P1637; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Walker DR, 1999, ONCOGENE, V18, P211, DOI 10.1038/sj.onc.1202298; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yan W, 2013, ONCOGENE, V32, P599, DOI 10.1038/onc.2012.81	59	8	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10131	10147		10.1074/jbc.M116.724781	http://dx.doi.org/10.1074/jbc.M116.724781			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	27022024	hybrid, Green Published			2022-12-28	WOS:000375602800024
J	Sun, QY; Qi, X; Zhang, Y; Wu, XD; Liang, MF; Li, C; Li, DX; Cardona, CJ; Xing, Z				Sun, Qiyu; Qi, Xian; Zhang, Yan; Wu, Xiaodong; Liang, Mifang; Li, Chuan; Li, Dexin; Cardona, Carol J.; Xing, Zheng			Synaptogyrin-2 Promotes Replication of a Novel Tick-borne Bunyavirus through Interacting with Viral Nonstructural Protein NSs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBOCYTOPENIA SYNDROME VIRUS; INTRACELLULAR LIPID DROPLETS; SEVERE FEVER; INCLUSION-BODIES; ANIMAL-CELLS; PC12 CELLS; NUCLEOPROTEIN; CHINA; INTERFERON; CELLUGYRIN	Synaptogyrin-2 is a non-neuronal member of the synaptogyrin family involved in synaptic vesicle biogenesis and trafficking. Little is known about the function of synaptogyrin-2. Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease characterized by high fever, thrombocytopenia, and leukocytopenia with high mortality, caused by a novel tick-borne phlebovirus in the family Bunyaviridae. Our previous studies have shown that the viral nonstructural protein NSs forms inclusion bodies (IBs) that are involved in viral immune evasion, as well as viral RNA replication. In this study, we sought to elucidate the mechanism by which NSs formed the IBs, a lipid droplet-based structure confirmed by NSs co-localization with perilipin A and adipose differentiation-related protein (ADRP). Through a high throughput screening, we identified synaptogyrin-2 to be highly up-regulated in response to SFTS bunyavirus (SFTSV) infection and to be a promoter of viral replication. We demonstrated that synaptogyrin-2 interacted with NSs and was translocated into the IBs, which were reconstructed from lipid droplets into large structures in infection. Viral RNA replication decreased, and infectious virus titers were lowered significantly when synaptogyrin-2 was silenced in specific shRNA-expressing cells, which correlated with the reduced number of the large IBs restructured from regular lipid droplets. We hypothesize that synaptogyrin-2 is essential to promoting the formation of the IBs to become virus factories for viral RNA replication through its interaction with NSs. These findings unveil the function of synaptogyrin-2 as an enhancer in viral infection.	[Sun, Qiyu; Zhang, Yan; Wu, Xiaodong; Xing, Zheng] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Sun, Qiyu; Zhang, Yan; Wu, Xiaodong; Xing, Zheng] Nanjing Univ, Sch Med, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China; [Qi, Xian] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing 210009, Jiangsu, Peoples R China; [Liang, Mifang; Li, Chuan; Li, Dexin] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China; [Cardona, Carol J.; Xing, Zheng] Univ Minnesota, Coll Vet Med, Vet & Biomed Sci, St Paul, MN 55108 USA	Nanjing University; Nanjing University; Jiangsu Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Minnesota System; University of Minnesota Twin Cities	Xing, Z (corresponding author), Nanjing Univ, Sch Med, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.; Xing, Z (corresponding author), Univ Minnesota, 300D Vet Sci Bldg,1971 Commonwealth Ave, St Paul, MN 55108 USA.	zxing@umn.edu	Xing, Zheng/O-3137-2015	Xing, Zheng/0000-0002-7288-0268	National Natural Science Foundation of China [81571993]; Mega Infectious Diseases Program from the Ministry of Science and Technology of China [2014ZX10004001-002]; 973 Grant from the Ministry of Science and Technology of China [2011CB504705]; Natural Science Foundation of Jiangsu Province [BK20131450]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Mega Infectious Diseases Program from the Ministry of Science and Technology of China; 973 Grant from the Ministry of Science and Technology of China; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by National Natural Science Foundation of China Grant 81571993, Grant 2014ZX10004001-002 from the Mega Infectious Diseases Program from the Ministry of Science and Technology of China (to ZX), 973 Grant (2011CB504705 from the Ministry of Science and Technology of China (to M. L. and D. L.), and Grant BK20131450 from the Natural Science Foundation of Jiangsu Province (to X. Q.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham C, 2011, NEUROSCIENCE, V190, P75, DOI 10.1016/j.neuroscience.2011.05.069; Belfort GM, 2005, J BIOL CHEM, V280, P7262, DOI 10.1074/jbc.M404851200; Belfort GM, 2003, J BIOL CHEM, V278, P47971, DOI 10.1074/jbc.M304174200; Bragina L, 2010, NEUROSCIENCE, V165, P934, DOI 10.1016/j.neuroscience.2009.11.009; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; Carromeu C, 2007, ARCH VIROL, V152, P2259, DOI 10.1007/s00705-007-1048-4; Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980; Cheung W, 2010, J VIROL, V84, P6782, DOI 10.1128/JVI.01757-09; Cui F, 2013, AM J TROP MED HYG, V88, P510, DOI 10.4269/ajtmh.11-0760; Derdowski A, 2008, J GEN VIROL, V89, P2698, DOI 10.1099/vir.0.2008/004051-0; Elliott RM, 2014, CURR OPIN VIROL, V5, P50, DOI 10.1016/j.coviro.2014.01.011; Fabbretti E, 1999, J GEN VIROL, V80, P333, DOI 10.1099/0022-1317-80-2-333; Gai ZT, 2012, J INFECT DIS, V206, P1095, DOI 10.1093/infdis/jis472; Gao W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030328; GARCIA J, 1993, VIROLOGY, V195, P243, DOI 10.1006/viro.1993.1366; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hubner K, 2002, INT REV CYTOL, V214, P103; Janz R, 1998, J BIOL CHEM, V273, P2851, DOI 10.1074/jbc.273.5.2851; Kedra D, 1998, HUM GENET, V103, P131, DOI 10.1007/s004390050795; Khor VK, 2013, CURR OPIN CLIN NUTR, V16, P632, DOI 10.1097/MCO.0b013e3283651106; Kim WY, 2015, CLIN INFECT DIS, V60, P1681, DOI 10.1093/cid/civ128; KONDRUP J, 1984, DAN MED BULL, V31, P109; Li DX, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.1; Lifland AW, 2012, J VIROL, V86, P8245, DOI 10.1128/JVI.00215-12; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Listenberger LL, 2007, CURR PROTOC CELL BIO, DOI [DOI 10.1002/0471143030.CB2402S35, 10.1002/0471143030.cb2402s35]; Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758; LONDOS C, 1995, BIOCHEM SOC T, V23, P611, DOI 10.1042/bst0230611; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; MATUMOTO M., 1949, JAP JOUR EXPTL MED, V20, P175; McIntosh AL, 2010, LIPIDS, V45, P465, DOI 10.1007/s11745-010-3424-1; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Netherton C, 2007, ADV VIRUS RES, V70, P101, DOI 10.1016/S0065-3527(07)70004-0; Netherton CL, 2011, CURR OPIN VIROL, V1, P381, DOI 10.1016/j.coviro.2011.09.008; Ning YJ, 2015, J VIROL, V89, P4227, DOI 10.1128/JVI.00154-15; Ning YJ, 2014, J MOL CELL BIOL, V6, DOI 10.1093/jmcb/mju015; Niu GY, 2013, EMERG INFECT DIS, V19, P756, DOI 10.3201/eid1905.120245; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Park SW, 2014, TICKS TICK-BORNE DIS, V5, P975, DOI 10.1016/j.ttbdis.2014.07.020; Ploen D, 2013, EUR J CELL BIOL, V92, P374, DOI 10.1016/j.ejcb.2013.12.003; Qu BQ, 2012, J VIROL, V86, P8388, DOI 10.1128/JVI.00612-12; Santiago FW, 2014, J VIROL, V88, P4572, DOI 10.1128/JVI.03021-13; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Shimojima Masayuki, 2013, Uirusu, V63, P7; SPEHNER D, 1991, J VIROL, V65, P6296, DOI 10.1128/JVI.65.11.6296-6300.1991; Stevens RJ, 2012, J NEUROSCI, V32, P18054, DOI 10.1523/JNEUROSCI.2668-12.2012; Storey SM, 2011, AM J PHYSIOL-ENDOC M, V301, pE991, DOI 10.1152/ajpendo.00109.2011; Stubbs AM, 2014, ANN EMERG MED, V64, P314, DOI [10.1016/j.annemergmed.2014.06.011, 10.1016/j.annemergmed.2014.06.012]; Sun QY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11816; Sun YL, 2012, J INFECT DIS, V206, P1085, DOI 10.1093/infdis/jis452; Sztalryd C, 2014, BIOCHIMIE, V96, P96, DOI 10.1016/j.biochi.2013.08.026; Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603; VALTORTA F, 1989, CELL BIOL INT REP, V13, P1023, DOI 10.1016/0309-1651(89)90017-9; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Wu XD, 2014, FASEB J, V28, P2504, DOI 10.1096/fj.13-243857; Wu XD, 2014, J VIROL, V88, P3067, DOI 10.1128/JVI.03510-13; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095	59	21	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16138	16149		10.1074/jbc.M116.715599	http://dx.doi.org/10.1074/jbc.M116.715599			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226560	hybrid, Green Published			2022-12-28	WOS:000380585400019
J	Beyrakhova, KA; van Straaten, K; Li, L; Boniecki, MT; Anderson, DH; Cygler, M				Beyrakhova, Ksenia A.; van Straaten, Karin; Li, Lei; Boniecki, Michal T.; Anderson, Deborah H.; Cygler, Miroslaw			Structural and Functional Investigations of the Effector Protein LpiR1 from Legionella pneumophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERVER; MODEL; ENVIRONMENT; PREDICTION; SECRETION; SEQUENCE	Legionella pneumophila is a causative agent of a severe pneumonia, known as Legionnaires' disease. Legionella pathogenicity is mediated by specific virulence factors, called bacterial effectors, which are injected into the invaded host cell by the bacterial type IV secretion system. Bacterial effectors are involved in complex interactions with the components of the host cell immune and signaling pathways, which eventually lead to bacterial survival and replication inside the mammalian cell. Structural and functional studies of bacterial effectors are, therefore, crucial for elucidating the mechanisms of Legionella virulence. Here we describe the crystal structure of the LpiR1 (Lpg0634) effector protein and investigate the effects of its overexpression in mammalian cells. LpiR1 is an alpha-helical protein that consists of two similar domains aligned in an antiparallel fashion. The hydrophilic cleft between the domains might serve as a binding site for a potential host cell interaction partner. LpiR1 binds the phosphate group at a conserved site and is stabilized by Mn2+, Ca2+, or Mg2+ ions. When overexpressed in mammalian cells, a GFP-LpiR1 fusion protein is localized in the cytoplasm. Intracellular signaling antibody array analysis revealed small changes in the phosphorylation state of several components of the Akt signaling pathway in HEK293T cells overexpressing LpiR1.	[Beyrakhova, Ksenia A.; van Straaten, Karin; Li, Lei; Boniecki, Michal T.; Cygler, Miroslaw] Univ Saskatchewan, Saskatchewan Canc Agcy, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Anderson, Deborah H.] Univ Saskatchewan, Saskatchewan Canc Agcy, Canc Res, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan; University of Saskatchewan	Cygler, M (corresponding author), Univ Saskatchewan, Saskatchewan Canc Agcy, Dept Biochem, Saskatoon, SK S7N 5E5, Canada.	miroslaw.cygler@usask.ca		Boniecki, Michal/0000-0002-0854-0891	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We acknowledge the Protein Characterization and Crystallization Facility, College of Medicine, University of Saskatchewan for access to the crystallization robot and the 08ID-1 beamline at the Canadian Light Source (CLS) for diffraction data collection. Canadian Light Source is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research. We thank Dr. Wei Xiao and Dr. Zhaojia Wu (Department of Microbiology and Immunology, University of Saskatchewan) for providing pcDNA4/TO-HA and pEGF-N1 plasmids and mammalian cells used in this work. We also thank Dr. Alla Gagarinova for helpful discussions and Dr. Alexander Grigoryan (College of Agriculture and Bioresources, University of Saskatchewan) for help with the phylogenetic analysis.	Abraham AL, 2009, J MOL BIOL, V394, P522, DOI 10.1016/j.jmb.2009.09.031; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Bruggemann H, 2006, CURR OPIN MICROBIOL, V9, P86, DOI 10.1016/j.mib.2005.12.009; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burstein D, 2016, NAT GENET, V48, P167, DOI 10.1038/ng.3481; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Grochulski P, 2011, J SYNCHROTRON RADIAT, V18, P681, DOI 10.1107/S0909049511019431; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hayashi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011718; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Ko KS, 2002, J CLIN MICROBIOL, V40, P2653, DOI 10.1128/JCM.40.7.2653-2658.2002; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Qin ZS, 2013, NUCLEIC ACIDS RES, V41, P7356, DOI 10.1093/nar/gkt542; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vincent CD, 2006, MOL MICROBIOL, V62, P1278, DOI 10.1111/j.1365-2958.2006.05446.x; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	31	3	3	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15767	15777		10.1074/jbc.M115.708701	http://dx.doi.org/10.1074/jbc.M115.708701			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226543	hybrid, Green Published			2022-12-28	WOS:000380584200029
J	Li, XM; Ortega, B; Kim, B; Welling, PA				Li, Xiangming; Ortega, Bernardo; Kim, Boyoung; Welling, Paul A.			A Common Signal Patch Drives AP-1 Protein-dependent Golgi Export of Inwardly Rectifying Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN ADAPTER COMPLEXES; DISTAL CONVOLUTED TUBULE; RECTIFIER K+ CHANNEL; ENDOPLASMIC-RETICULUM; STRUCTURAL EXPLANATION; BASOLATERAL POLARITY; ANGSTROM RESOLUTION; ATP CHANNELS; KIR2.1; RECOGNITION	Nearly all members of the inwardly rectifying potassium (Kir) channel family share a cytoplasmic domain structure that serves as an unusual AP-1 clathrin adaptor-dependent Golgi export signal in one Kir channel, Kir2.1 (KCNJ2), raising the question whether Kir channels share a common Golgi export mechanism. Here we explore this idea, focusing on two structurally and functionally divergent Kir family members, Kir2.3 (KCNJ4) and Kir4.1/5.1 (KCNJ10/16), which have similar to 50% amino identity. We found that Golgi export of both channels is blocked upon siRNA-mediated knockdown of the AP-1 gamma subunit, as predicted for the common AP-1-dependent trafficking process. A comprehensive mutagenic analysis, guided by homology mapping in atomic resolution models of Kir2.1, Kir2.3, and Kir4.1/5.1, identified a common structure that serves as a recognition site for AP-1 binding and governs Golgi export. Larger than realized from previous studies with Kir2.1, the signal is created by a patch of residues distributed at the confluence of cytoplasmic N and C termini. The signal involves a stretch of hydrophobic residues from the C-terminal region that form a hydrophobic cleft, an adjacent cluster of basic residues within the N terminus, and a potential network of salt bridges that join the N-and C-terminal poles together. Because patch formation and AP-1 binding are dependent on proper folding of the cytoplasmic domains, the signal provides a common quality control mechanism at the Golgi for Kir channels. These findings identify a new proteostatic mechanism that couples protein folding of channels to forward trafficking in the secretory pathway.	[Li, Xiangming; Kim, Boyoung; Welling, Paul A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Ortega, Bernardo] SUNY Coll Brockport, Dept Biol, Brockport, NY 14420 USA	University System of Maryland; University of Maryland Baltimore; State University of New York (SUNY) System	Welling, PA (corresponding author), Univ Maryland, Sch Med, Rm 5029 Bressler,655 W Baltimore St, Baltimore, MD 21201 USA.	pwelling@som.umaryland.edu			NIDDK, National Institutes of Health [DK063049, DK054231]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054231, R01DK063049] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by funds from the NIDDK, National Institutes of Health (DK063049, DK054231, and DK063049 to P. A. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arakel EC, 2014, J CELL SCI, V127, P2106, DOI 10.1242/jcs.141440; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2014, J CELL BIOL, V204, P7, DOI 10.1083/jcb.201310021; de la Fuente-Ortega E, 2015, MOL BIOL CELL, V26, P1728, DOI 10.1091/mbc.E15-01-0047; Deborde S, 2008, NATURE, V452, P719, DOI 10.1038/nature06828; Doray B, 2001, MOL BIOL CELL, V12, P1925, DOI 10.1091/mbc.12.7.1925; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Farias GG, 2012, NEURON, V75, P810, DOI 10.1016/j.neuron.2012.07.007; Folsch H, 2003, J CELL BIOL, V163, P351, DOI 10.1083/jcb.200309020; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Gravotta D, 2012, DEV CELL, V22, P811, DOI 10.1016/j.devcel.2012.02.004; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Jain S, 2015, MOL BIOL CELL, V26, P218, DOI 10.1091/mbc.E14-07-1177; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; LeBorgne R, 1996, J BIOL CHEM, V271, P2162; Lourdel S, 2002, J PHYSIOL-LONDON, V538, P391, DOI 10.1113/jphysiol.2001.012961; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Ma DH, 2007, J BIOL CHEM, V282, P5781, DOI 10.1074/jbc.M608776200; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mattera R, 2011, J BIOL CHEM, V286, P2022, DOI 10.1074/jbc.M110.197178; Miller SE, 2011, CELL, V147, P1118, DOI 10.1016/j.cell.2011.10.038; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; O'Connell AD, 2005, P NATL ACAD SCI USA, V102, P9954, DOI 10.1073/pnas.0504332102; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Ren XF, 2013, CELL, V152, P755, DOI 10.1016/j.cell.2012.12.042; Shih W, 1995, J BIOL CHEM, V270, P31083, DOI 10.1074/jbc.270.52.31083; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Traub LM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016790; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; Traub LM, 1997, CURR OPIN CELL BIOL, V9, P527, DOI 10.1016/S0955-0674(97)80029-4; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang CB, 2014, P NATL ACAD SCI USA, V111, P11864, DOI 10.1073/pnas.1411705111	46	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14963	14972		10.1074/jbc.M116.729822	http://dx.doi.org/10.1074/jbc.M116.729822			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226616	hybrid, Green Published			2022-12-28	WOS:000380583200009
J	Lei, DS; Rames, M; Zhang, X; Zhang, L; Zhang, SL; Ren, G				Lei, Dongsheng; Rames, Matthew; Zhang, Xing; Zhang, Lei; Zhang, Shengli; Ren, Gang			Insights into the Tunnel Mechanism of Cholesteryl Ester Transfer Protein through All-atom Molecular Dynamics Simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; cholesterol metabolism; cholesterol regulation; cholesterol-binding protein; lipid metabolism; lipid transport; lipid-protein interaction; lipoprotein metabolism; molecular dynamics	LOW-DENSITY-LIPOPROTEIN; LIPID-TRANSFER; SURFACE-LIPIDS; HEART-DISEASE; CETP; IMPLICIT; BINDING; MODEL; HDL; PHOSPHATIDYLCHOLINE	Cholesteryl ester transfer protein (CETP) mediates cholesteryl ester (CE) transfer from the atheroprotective high density lipoprotein (HDL) cholesterol to the atherogenic low density lipoprotein cholesterol. In the past decade, this property has driven the development of CETP inhibitors, which have been evaluated in large scale clinical trials for treating cardiovascular diseases. Despite the pharmacological interest, little is known about the fundamental mechanism of CETP in CE transfer. Recent electron microscopy (EM) experiments have suggested a tunnel mechanism, and molecular dynamics simulations have shown that the flexible N-terminal distal end of CETP penetrates into the HDL surface and takes up a CE molecule through an open pore. However, it is not known whether a CE molecule can completely transfer through an entire CETP molecule. Here, we used all-atom molecular dynamics simulations to evaluate this possibility. The results showed that a hydrophobic tunnel inside CETP is sufficient to allow a CE molecule to completely transfer through the entire CETP within a predicted transfer time and at a rate comparable with those obtained through physiological measurements. Analyses of the detailed interactions revealed several residues that might be critical for CETP function, which may provide important clues for the effective development of CETP inhibitors and treatment of cardiovascular diseases.	[Lei, Dongsheng; Rames, Matthew; Zhang, Xing; Ren, Gang] Lawrence Berkeley Natl Lab, Mol Foundry, Lawrence, CA 94720 USA; [Lei, Dongsheng; Zhang, Xing; Zhang, Lei; Zhang, Shengli] Xi An Jiao Tong Univ, Dept Appl Phys, Xian 710049, Shaanxi, Peoples R China	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Xi'an Jiaotong University	Ren, G (corresponding author), Lawrence Berkeley Natl Lab, Mol Foundry, Lawrence, CA 94720 USA.; Zhang, SL (corresponding author), Xi An Jiao Tong Univ, Dept Appl Phys, Xian 710049, Shaanxi, Peoples R China.	zhangsl@xjtu.edu.cn; gren@lbl.gov	Lei, Dongsheng/AAH-4177-2020; Lei, Dongsheng/K-3485-2012; Zhang, Lei/G-6427-2012; Ren, Gang/B-1567-2012	Lei, Dongsheng/0000-0003-1640-0693; Zhang, Lei/0000-0002-4880-824X; Ren, Gang/0000-0002-8036-2321	National Institutes of Health from the NHLBI [1R01HL115153]; National Natural Science Foundation of China [11074196, 11374237]; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104427] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R01HL115153 from the NHLBI (to G. R.) and National Natural Science Foundation of China Grants 11074196 and 11374237 (to S. Z.). The work performed at the Molecular Foundry was supported by the Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Armen RS, 1998, BIOPHYS J, V75, P734, DOI 10.1016/S0006-3495(98)77563-0; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; BARTER PJ, 1980, J LIPID RES, V21, P238; Berka K, 2012, NUCLEIC ACIDS RES, V40, pW222, DOI 10.1093/nar/gks363; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; CAMEJO G, 1976, ATHEROSCLEROSIS, V24, P341, DOI 10.1016/0021-9150(76)90126-X; Cilpa-Karhu G, 2015, J LIPID RES, V56, P98, DOI 10.1194/jlr.M054288; Cournia Z, 2005, J COMPUT CHEM, V26, P1383, DOI 10.1002/jcc.20277; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Elder RM, 2012, BIOPHYS J, V102, P2331, DOI 10.1016/j.bpj.2012.04.013; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Feller SE, 1997, BIOPHYS J, V73, P2269, DOI 10.1016/S0006-3495(97)78259-6; Garcia-Gonzalez V, 2014, J STRUCT BIOL, V186, P19, DOI 10.1016/j.jsb.2014.02.002; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gotto AM, 2012, EXPERT REV CARDIOVAS, V10, P955, DOI [10.1586/ERC.12.82, 10.1586/erc.12.82]; GREST GS, 1986, PHYS REV A, V33, P3628, DOI 10.1103/PhysRevA.33.3628; Nguyen H, 2015, J CHEM THEORY COMPUT, V11, P3714, DOI 10.1021/acs.jctc.5b00271; Hall A, 2008, J PHYS CHEM B, V112, P13772, DOI 10.1021/jp803950w; HANNUKSELA M, 1992, J LIPID RES, V33, P737; Heikela M, 2006, BIOPHYS J, V90, P2247, DOI 10.1529/biophysj.105.069849; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IBDAH JA, 1989, BIOCHEMISTRY-US, V28, P1126, DOI 10.1021/bi00429a029; IHM J, 1982, J LIPID RES, V23, P1328; Jarvis L, 2015, CHEM ENG NEWS, V93, P9; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kleinjung J, 2014, CURR OPIN STRUC BIOL, V25, P126, DOI 10.1016/j.sbi.2014.04.003; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lassel TS, 1998, ARTERIOSCL THROM VAS, V18, P65, DOI 10.1161/01.ATV.18.1.65; Lauer ME, 2016, J STRUCT BIOL, V194, P191, DOI 10.1016/j.jsb.2016.02.016; Lei DS, 2013, PROTEINS, V81, P415, DOI 10.1002/prot.24200; Lund-Katz S, 2003, FRONT BIOSCI-LANDMRK, V8, pD1044, DOI 10.2741/1077; MCLEAN LR, 1984, BIOCHEMISTRY-US, V23, P4624, DOI 10.1021/bi00315a017; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nicholls SJ, 2011, JAMA-J AM MED ASSOC, V306, P2099, DOI 10.1001/jama.2011.1649; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; Ren G, 2010, P NATL ACAD SCI USA, V107, P1059, DOI 10.1073/pnas.0908004107; SAKAI N, 1991, ARTERIOSCLER THROMB, V11, P71, DOI 10.1161/01.ATV.11.1.71; Schlenkrich Michael, 1996, P31; Schmidtke P, 2010, NUCLEIC ACIDS RES, V38, pW582, DOI 10.1093/nar/gkq383; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; SLOTTE JP, 1990, J LIPID RES, V31, P2235; TALL AR, 1986, J LIPID RES, V27, P361; TALL AR, 1993, J LIPID RES, V34, P1255; WANG SK, 1993, J BIOL CHEM, V268, P1955; WEINBERG RB, 1992, J BIOL CHEM, V267, P8977; Zhang L, 2012, NAT CHEM BIOL, V8, P342, DOI [10.1038/NCHEMBIO.796, 10.1038/nchembio.796]; Zhang L, 2011, J LIPID RES, V52, P175, DOI 10.1194/jlr.D010959; Zhang LQ, 2013, PROTEINS, V81, P365, DOI 10.1002/prot.24192; Zhang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08741	51	13	13	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14034	14044		10.1074/jbc.M116.715565	http://dx.doi.org/10.1074/jbc.M116.715565			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27143480	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000379975100012
J	LoRicco, JG; Xu, CS; Neidleman, J; Bergkvist, M; Greene, WC; Roan, NR; Makhatadze, GI				LoRicco, Josephine G.; Xu, Changmingzi Sherry; Neidleman, Jason; Bergkvist, Magnus; Greene, Warner C.; Roan, Nadia R.; Makhatadze, George I.			Gallic Acid Is an Antagonist of Semen Amyloid Fibrils That Enhance HIV-1 Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; atomic force microscopy (AFM); biophysics; confocal microscopy; fluorescence; HIV-1; SEVI; Semen; Semenogelin	NF-KAPPA-B; MEDIATED ENHANCEMENT; SEMINAL PLASMA; THIOFLAVIN T; EPITHELIAL-CELLS; ALPHA-SYNUCLEIN; SEVI; EXPRESSION; CYTOKINE; PEPTIDE	Recent in vitro studies have demonstrated that amyloid fibrils found in semen from healthy and HIV-infected men, as well as semen itself, can markedly enhance HIV infection rates. Semen fibrils are made up of multiple naturally occurring peptide fragments derived from semen. The best characterized of these fibrils are SEVI (semen-derived enhancer of viral infection), made up of residues 248-286 of prostatic acidic phosphatase, and the SEM1 fibrils, made up of residues 86-107 of semenogelin 1. A small molecule screen for antagonists of semen fibrils identified four compounds that lowered semen-mediated enhancement of HIV-1 infectivity. One of the four, gallic acid, was previously reported to antagonize other amyloids and to exert anti-inflammatory effects. To better understand the mechanism by which gallic acid modifies the properties of semen amyloids, we performed biophysical measurements (atomic force microscopy, electron microscopy, confocal microscopy, thioflavin T and Congo Red fluorescence assays, zeta potential measurements) and quantitative assays on the effects of gallic acid on semen-mediated enhancement of HIV infection and inflammation. Our results demonstrate that gallic acid binds to both SEVI and SEM1 fibrils and modifies their surface electrostatics to render them less cationic. In addition, gallic acid decreased semen-mediated enhancement of HIV infection but did not decrease the inflammatory response induced by semen. Together, these observations identify gallic acid as a non-polyanionic compound that inhibits semen-mediated enhancement of HIV infection and suggest the potential utility of incorporating gallic acid into a multicomponent microbicide targeting both the HIV virus and host components that promote viral infection.	[LoRicco, Josephine G.; Xu, Changmingzi Sherry; Makhatadze, George I.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Rm 3244A,110 8th St, Troy, NY 12180 USA; [LoRicco, Josephine G.; Xu, Changmingzi Sherry; Makhatadze, George I.] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA; [Neidleman, Jason; Greene, Warner C.; Roan, Nadia R.] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Bergkvist, Magnus] SUNY Polytech Inst, Coll Nanoscale Sci, Albany, NY 12203 USA; [Bergkvist, Magnus] SUNY Polytech Inst, Coll Engn, Albany, NY 12203 USA; [Roan, Nadia R.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94158 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of California System; University of California San Francisco; The J David Gladstone Institutes; SUNY Polytechnic Institute; SUNY Polytechnic Institute; University of California System; University of California San Francisco	Makhatadze, GI (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Rm 3244A,110 8th St, Troy, NY 12180 USA.; Roan, NR (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA.; Roan, NR (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94158 USA.	nadia.roan@ucsf.edu; makhag@rpi.edu		LoRicco, Josephine/0000-0002-1550-2463	National Institutes of Health (NIH) [R21GM101134, R00AI104262, R21AI120774]; NIH; University of California; San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS Research [P30-AI027763]; Department of Defense [W81XWH-11-1-0562]; NIH [5T32GM067545-10]; NATIONAL CANCER INSTITUTE [R21CA120774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R00AI104262, R21AI116252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM101134, T32GM067545] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS Research; Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) Grants R21GM101134 (to G. I. M.) and R00AI104262 and R21AI120774 (to N. R. R.). Grant funding for this project was also received from NIH, University of California, San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS Research, Grant P30-AI027763 (to N. R. R.). In addition, funding was provided from Department of Defense Grant W81XWH-11-1-0562 (to W. C. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NIH Training Grant 5T32GM067545-10.	Ardah MT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00197; Arnold F, 2012, J VIROL, V86, P1244, DOI 10.1128/JVI.06121-11; Buxbaum JN, 2012, J MOL BIOL, V421, P142, DOI 10.1016/j.jmb.2012.01.024; Capule CC, 2012, J AM CHEM SOC, V134, P905, DOI 10.1021/ja210931b; Castellano LM, 2015, BIOL OPEN, V4, P1206, DOI 10.1242/bio.010215; Chen JC, 2014, HUM REPROD, V29, P1255, DOI 10.1093/humrep/deu047; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Di Giovanni S, 2010, J BIOL CHEM, V285, P14941, DOI 10.1074/jbc.M109.080390; Doane TL, 2012, ACCOUNTS CHEM RES, V45, P317, DOI 10.1021/ar200113c; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; French KC, 2014, BIOCHEMISTRY-US, V53, P3267, DOI 10.1021/bi500427r; French KC, 2012, BIOCHEMISTRY-US, V51, P10127, DOI 10.1021/bi301406d; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Grant RM, 2008, SCIENCE, V321, P532, DOI 10.1126/science.1160355; Hauber I, 2009, P NATL ACAD SCI USA, V106, P9033, DOI 10.1073/pnas.0811827106; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Jayamani J, 2014, EUR J MED CHEM, V85, P352, DOI 10.1016/j.ejmech.2014.07.111; Kim KA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-55; Kim SH, 2006, TOXICOL SCI, V91, P123, DOI 10.1093/toxsci/kfj063; Krainer G, 2015, METHODS, V76, P116, DOI 10.1016/j.ymeth.2014.10.034; KROES BH, 1992, PLANTA MED, V58, P499, DOI 10.1055/s-2006-961535; Liu YQ, 2014, BBA-PROTEINS PROTEOM, V1844, P1481, DOI 10.1016/j.bbapap.2014.04.013; Liu YQ, 2013, BIOORG MED CHEM LETT, V23, P6336, DOI 10.1016/j.bmcl.2013.09.071; McCrate OA, 2013, CHEM COMMUN, V49, P4193, DOI 10.1039/c2cc37792f; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Olsen JS, 2010, J BIOL CHEM, V285, P35488, DOI 10.1074/jbc.M110.163659; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Picken MM, 2010, ARCH PATHOL LAB MED, V134, P545, DOI 10.1043/1543-2165-134.4.545; Popovych N, 2012, J PHYS CHEM B, V116, P3650, DOI 10.1021/jp2121577; Roan NR, 2014, J VIROL, V88, P7221, DOI 10.1128/JVI.00269-14; Roan NR, 2012, M S-MED SCI, V28, P358, DOI 10.1051/medsci/2012284008; Roan NR, 2011, CELL HOST MICROBE, V10, P541, DOI 10.1016/j.chom.2011.10.010; Roan NR, 2010, J BIOL CHEM, V285, P1861, DOI 10.1074/jbc.M109.066167; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Robbins KJ, 2012, LANGMUIR, V28, P16490, DOI 10.1021/la303677t; Rollenhagen C, 2011, MUCOSAL IMMUNOL, V4, P671, DOI 10.1038/mi.2011.34; Shanmuganathan A, 2013, PROTEIN EXPRES PURIF, V88, P196, DOI 10.1016/j.pep.2013.01.003; Sharkey DJ, 2007, MOL HUM REPROD, V13, P491, DOI 10.1093/molehr/gam028; Sharkey DJ, 2012, J IMMUNOL, V188, P2445, DOI 10.4049/jimmunol.1102736; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Sulatskaya AI, 2012, J PHYS CHEM B, V116, P2538, DOI 10.1021/jp2083055; Tang QY, 2013, J VIROL, V87, P12583, DOI 10.1128/JVI.02083-13; Usmani SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4508; West MJ, 2001, J VIROL, V75, P8524, DOI 10.1128/JVI.75.18.8524-8537.2001; Ye ZQ, 2009, BIOCHEMISTRY-US, V48, P11582, DOI 10.1021/bi901709j; Yoon CH, 2013, JOINT BONE SPINE, V80, P274, DOI 10.1016/j.jbspin.2012.08.010; Zirafi O, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009634	48	11	11	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14045	14055		10.1074/jbc.M116.718684	http://dx.doi.org/10.1074/jbc.M116.718684			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226574	Green Published, hybrid			2022-12-28	WOS:000379975100013
J	Schutz, I; Lopez-Hernandez, T; Gao, Q; Puchkov, D; Jabs, S; Nordmeyer, D; Schmudde, M; Ruhl, E; Graf, CM; Haucke, V				Schuetz, Irene; Lopez-Hernandez, Tania; Gao, Qi; Puchkov, Dmytro; Jabs, Sabrina; Nordmeyer, Daniel; Schmudde, Madlen; Ruehl, Eckart; Graf, Christina M.; Haucke, Volker			Lysosomal Dysfunction Caused by Cellular Accumulation of Silica Nanoparticles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; caveolae; endocytosis; endosome; lysosome; silica nanoparticles	SURFACE FUNCTIONALIZATION; MEMBRANE; INTERNALIZATION; MECHANISMS; AUTOPHAGY; DELIVERY; CELLS; SIZE	Nanoparticles (NPs) are widely used as components of drugs or cosmetics and hold great promise for biomedicine, yet their effects on cell physiology remain poorly understood. Here we demonstrate that clathrin-independent dynamin 2-mediated caveolar uptake of surface-functionalized silica nanoparticles (SiNPs) impairs cell viability due to lysosomal dysfunction. We show that internalized SiNPs accumulate in lysosomes resulting in inhibition of autophagy-mediated protein turnover and impaired degradation of internalized epidermal growth factor, whereas endosomal recycling proceeds unperturbed. This phenotype is caused by perturbed delivery of cargo via autophagosomes and late endosomes to SiNP-filled cathepsin B/L-containing lysosomes rather than elevated lysosomal pH or altered mTOR activity. Given the importance of autophagy and lysosomal protein degradation for cellular proteostasis and clearance of aggregated proteins, these results raise the question of beneficial use of NPs in biomedicine and beyond.	[Schuetz, Irene; Lopez-Hernandez, Tania; Puchkov, Dmytro; Jabs, Sabrina; Haucke, Volker] Leibniz Inst Mol Pharmakol FMP, Robert Rossle Str 10, D-13125 Berlin, Germany; [Gao, Qi; Nordmeyer, Daniel; Schmudde, Madlen; Ruehl, Eckart; Graf, Christina M.; Haucke, Volker] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Jabs, Sabrina] Max Delbruck Ctr Mol Med MDC, Robert Rossle Str 10, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Haucke, V (corresponding author), Leibniz Inst Mol Pharmakol FMP, Robert Rossle Str 10, D-13125 Berlin, Germany.	haucke@fmp-berlin.de	Hernandez, Tania Lopez/AAH-8754-2019; Jabs, Sabrina/F-9026-2019	Jabs, Sabrina/0000-0001-8065-8002; Puchkov, Dmytro/0000-0001-8341-4847; Lopez-Hernandez, Tania/0000-0002-0814-2850	Deutsche Forschungsgemeinschaft (DFG) [SFB 765/TP B04, C04, SPP1313/NANO-SELECT]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (SFB 765/TP B04, C05, SPP1313/NANO-SELECT). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Rawi M, 2011, ARCH TOXICOL, V85, P813, DOI 10.1007/s00204-010-0642-5; Arriagada FJ, 1999, J COLLOID INTERF SCI, V211, P210, DOI 10.1006/jcis.1998.5985; Chaudhary N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001832; Cheng ZL, 2012, SCIENCE, V338, P903, DOI 10.1126/science.1226338; Cleal K, 2013, CURR PHARM DESIGN, V19, P2878; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Fisichella M, 2010, J NANOSCI NANOTECHNO, V10, P2314, DOI 10.1166/jnn.2010.1917; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Graf C, 2012, LANGMUIR, V28, P7598, DOI 10.1021/la204913t; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Howes MT, 2010, CURR OPIN CELL BIOL, V22, P519, DOI 10.1016/j.ceb.2010.04.001; Kenzaoui BH, 2012, BIOCHEM J, V441, P813, DOI 10.1042/BJ20111252; Liang H, 2014, J APPL TOXICOL, V34, P367, DOI 10.1002/jat.2953; Luzio JP, 2010, BIOCHEM SOC T, V38, P1413, DOI 10.1042/BST0381413; Ma NN, 2013, J NANOSCI NANOTECHNO, V13, P6485, DOI 10.1166/jnn.2013.7525; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moreau K, 2013, TRENDS BIOCHEM SCI, V38, P57, DOI 10.1016/j.tibs.2012.11.004; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Pinot M, 2014, SCIENCE, V345, P693, DOI 10.1126/science.1255288; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Sandhoff K, 2013, J NEUROSCI, V33, P10195, DOI 10.1523/JNEUROSCI.0822-13.2013; Santra S, 2001, ANAL CHEM, V73, P4988, DOI 10.1021/ac010406+; Schwake M, 2013, TRAFFIC, V14, P739, DOI 10.1111/tra.12056; Sengupta S, 2005, NATURE, V436, P568, DOI 10.1038/nature03794; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Treuel L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0939; von Kleist L, 2012, TRAFFIC, V13, P495, DOI 10.1111/j.1600-0854.2011.01292.x; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k; Zhang FF, 2004, ANAL BIOANAL CHEM, V380, P637, DOI 10.1007/s00216-004-2804-x	35	67	68	1	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14170	14184		10.1074/jbc.M115.710947	http://dx.doi.org/10.1074/jbc.M115.710947			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226546	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000379975100024
J	Hinz, C; Aldrovandi, M; Uhlson, C; Marnett, LJ; Longhurst, HJ; Warner, TD; Alam, S; Slatter, DA; Lauder, SN; Allen-Redpath, K; Collins, PW; Murphy, RC; Thomas, CP; O'Donnell, VB				Hinz, Christine; Aldrovandi, Maceler; Uhlson, Charis; Marnett, Lawrence J.; Longhurst, Hilary J.; Warner, Timothy D.; Alam, Saydul; Slatter, David A.; Lauder, Sarah N.; Allen-Redpath, Keith; Collins, Peter W.; Murphy, Robert C.; Thomas, Christopher P.; O'Donnell, Valerie B.			Human Platelets Utilize Cycloxygenase-1 to Generate Dioxolane A(3), a Neutrophil-activating Eicosanoid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclooxygenase (COX); eicosanoid; eicosanoid biosynthesis; lipid; platelet; lipidomics	CYCLOOXYGENASE ACTIVE-SITE; ENDOPEROXIDE-H SYNTHASE-1; ARACHIDONIC-ACID; FATTY-ACIDS; IN-VIVO; AUTOXIDATION; LIPOXYGENASE; OXYGENATION; PRODUCTS; IDENTIFICATION	Eicosanoids are important mediators of fever, pain, and inflammation that modulate cell signaling during acute and chronic disease. We show by using lipidomics that thrombin-activated human platelets generate a new type of eicosanoid that both stimulates and primes human neutrophil integrin (Mac-1) expression, in response to formylmethionylleucylphenylalanine. Detailed characterization proposes a dioxolane structure, 8-hydroxy-9,11-dioxolane eicosatetraenoic acid (dioxolane A(3), DXA(3)). The lipid is generated in nanogram amounts by platelets from endogenous arachidonate during physiological activation, with inhibition by aspirin in vitro or in vivo, implicating cyclooxygenase-1 (COX). Pharmacological and genetic studies on human/murine platelets revealed that DXA(3) formation requires protease-activated receptors 1 and 4, cytosolic phospholipase A(2) (cPLA(2)), Src tyrosine kinases, p38 MAPK, phospholipase C, and intracellular calcium. From data generated by purified COX isoforms and chemical oxidation, we propose that DXA(3) is generated by release of an intermediate from the active site followed by oxygenation at C8. In summary, a new neutrophil-activating platelet-derived lipid generated by COX-1 is presented that can activate or prime human neutrophils, suggesting a role in innate immunity and acute inflammation.	[Hinz, Christine; Aldrovandi, Maceler; Alam, Saydul; Slatter, David A.; Lauder, Sarah N.; Allen-Redpath, Keith; Collins, Peter W.; Thomas, Christopher P.; O'Donnell, Valerie B.] Cardiff Univ, Sch Med, Syst Immun Res Inst, Cardiff CF14 4XN, S Glam, Wales; [Hinz, Christine; Aldrovandi, Maceler; Alam, Saydul; Slatter, David A.; Lauder, Sarah N.; Allen-Redpath, Keith; Collins, Peter W.; Thomas, Christopher P.; O'Donnell, Valerie B.] Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [Uhlson, Charis; Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Marnett, Lawrence J.] Vanderbilt Ingram Canc Ctr, Ctr Mol Toxicol, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Longhurst, Hilary J.; Warner, Timothy D.] Queen Mary Univ London, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England	Cardiff University; Cardiff University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Vanderbilt University; University of London; Queen Mary University London	O'Donnell, VB (corresponding author), Cardiff Univ, Sch Med, Syst Immun Res Inst, Cardiff CF14 4XN, S Glam, Wales.	O-DonnellVB@cardiff.ac.uk	Thomas, Christopher P/R-5243-2016; Slatter, David/AAV-5771-2020; Slatter, David/AAW-6938-2021	Thomas, Christopher P/0000-0001-5840-8613; /0000-0003-4089-8460	Wellcome Trust [94143/Z/10/Z]; British Heart Foundation [RG/12/11/29815]; National Institutes of Health [U54HL117798]; Wellcome Trust/NISCHR ISSF Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798] Funding Source: NIH RePORTER; Medical Research Council [MR/M011445/1] Funding Source: researchfish; MRC [MR/M011445/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust/NISCHR ISSF Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Wellcome Trust 94143/Z/10/Z, British Heart Foundation Grant RG/12/11/29815 (to V. B. O. and P. W. C.), and National Institutes of Health Grant U54HL117798 (to R. C. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Wellcome Trust/NISCHR ISSF Fellowship.	Aldrovandi M, 2013, J LIPID RES, V54, P3085, DOI 10.1194/jlr.M041533; ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; ARNAOUT MA, 1990, BLOOD, V75, P1037; Brooke MA, 2014, GUT, V63, P96, DOI 10.1136/gutjnl-2012-303581; Coffey MJ, 2004, CIRC RES, V94, P1598, DOI 10.1161/01.RES.0000132281.78948.65; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Dovizio M, 2014, BASIC CLIN PHARMACOL, V114, P118, DOI 10.1111/bcpt.12156; Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982; HAMBERG M, 1967, J BIOL CHEM, V242, P5344; Harman CA, 2004, J BIOL CHEM, V279, P42929, DOI 10.1074/jbc.M403013200; Havrilla CM, 2000, J AM CHEM SOC, V122, P8042, DOI 10.1021/ja001180f; Hermanson DJ, 2014, TRENDS PHARMACOL SCI, V35, P358, DOI 10.1016/j.tips.2014.04.006; MARNETT LJ, 1984, MOL PHARMACOL, V26, P328; Martinod K, 2014, BLOOD, V123, P2768, DOI 10.1182/blood-2013-10-463646; Maskrey BH, 2007, J BIOL CHEM, V282, P20151, DOI 10.1074/jbc.M611776200; Maugeri N, 2014, J THROMB HAEMOST, V12, P2074, DOI 10.1111/jth.12710; ODENWALLER R, 1990, METHOD ENZYMOL, V187, P479; OLIW EH, 1993, ARCH BIOCHEM BIOPHYS, V305, P288, DOI 10.1006/abbi.1993.1425; Ostermann AI, 2015, ANAL BIOANAL CHEM, V407, P1403, DOI 10.1007/s00216-014-8377-4; PORTER NA, 1980, BIOCHEM BIOPH RES CO, V92, P349, DOI 10.1016/0006-291X(80)90340-X; Powell WS, 1997, J IMMUNOL, V159, P2952; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; ROZA M, 1978, BIOCHIM BIOPHYS ACTA, V528, P119, DOI 10.1016/0005-2760(78)90057-7; Sahin IH, 2014, CANCER LETT, V345, P249, DOI 10.1016/j.canlet.2013.09.001; Shen X, 2013, CURR MED CHEM, V20, P4153; Smith W L, 1990, Methods Enzymol, V187, P1; Teder T, 2014, J LIPID RES, V55, P2587, DOI 10.1194/jlr.M054072; Thomas CP, 2010, J BIOL CHEM, V285, P6891, DOI 10.1074/jbc.M109.078428; Thuresson ED, 2000, J BIOL CHEM, V275, P8501, DOI 10.1074/jbc.275.12.8501; TONNESEN MG, 1989, J CLIN INVEST, V83, P637, DOI 10.1172/JCI113928; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Yin HY, 2007, J BIOL CHEM, V282, P29890, DOI 10.1074/jbc.M703108200; Yin HY, 2004, J BIOL CHEM, V279, P3766, DOI 10.1074/jbc.M307137200; Yin HY, 2003, J BIOL CHEM, V278, P16720, DOI 10.1074/jbc.M300604200; Yin HY, 2002, J AM CHEM SOC, V124, P7745, DOI 10.1021/ja0201092; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035	37	13	13	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13448	13464		10.1074/jbc.M115.700609	http://dx.doi.org/10.1074/jbc.M115.700609			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129261	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000379771100005
J	Dedic, E; Alsarraf, H; Welner, DH; Ostergaard, O; Klychnikov, OI; Hensbergen, PJ; Corver, J; van Leeuwen, HC; Jorgensen, R				Dedic, Emil; Alsarraf, Husam; Welner, Ditte Hededam; Ostergaard, Ole; Klychnikov, Oleg I.; Hensbergen, Paul J.; Corver, Jeroen; van Leeuwen, Hans C.; Jorgensen, Rene			A Novel Fic (Filamentation Induced by cAMP) Protein from Clostridium difficile Reveals an Inhibitory Motif-independent Adenylylation/AMPylation Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIN-B; DOMAIN; AMPYLATION; SCATTERING; PROGRAM; BINDING; SYSTEM; RHO; MACROMOLECULES; EXPRESSION	Filamentation induced by cAMP (Fic) domain proteins have been shown to catalyze the transfer of the AMP moiety from ATP onto a protein target. This type of post-translational modification was recently shown to play a crucial role in pathogenicity mediated by two bacterial virulence factors. Herein we characterize a novel Fic domain protein that we identified from the human pathogen Clostridium difficile. The crystal structure shows that the protein adopts a classical all-helical Fic fold, which belongs to class II of Fic domain proteins characterized by an intrinsic N-terminal autoinhibitory alpha-helix. A conserved glutamate residue in the inhibitory helix motif was previously shown in other Fic domain proteins to prevent proper binding of the ATP gamma-phosphate. However, here we demonstrate that both ATP binding and autoadenylylation activity of the C. difficile Fic domain protein are independent of the inhibitory motif. In support of this, the crystal structure of a mutant of this Fic protein in complex with ATP reveals that the gamma-phosphate adopts a conformation unique among Fic domains that seems to override the effect of the inhibitory helix. These results provide important structural insight into the adenylylation reaction mechanism catalyzed by Fic domains. Our findings reveal the presence of a class II Fic domain protein in the human pathogen C. difficile that is not regulated by autoinhibition and challenge the current dogma that all class I-III Fic domain proteins are inhibited by the inhibitory alpha-helix.	[Dedic, Emil; Alsarraf, Husam; Welner, Ditte Hededam; Jorgensen, Rene] Statens Serum Inst, Dept Microbiol & Infect Control, Artillerivej 5, DK-2300 Copenhagen S, Denmark; [Ostergaard, Ole] Statens Serum Inst, Dept Autoimmunol & Biomarkers, DK-2300 Copenhagen S, Denmark; [Klychnikov, Oleg I.; Hensbergen, Paul J.] Leiden Univ, Med Ctr, Ctr Prote & Metabol, NL-2300 RC Leiden, Netherlands; [Corver, Jeroen; van Leeuwen, Hans C.] Leiden Univ, Med Ctr, Dept Med Microbiol, Sect Expt Bacteriol, NL-2300 RC Leiden, Netherlands; [Dedic, Emil] ETH, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Statens Serum Institut; Statens Serum Institut; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Swiss Federal Institutes of Technology Domain; ETH Zurich	Jorgensen, R (corresponding author), Statens Serum Inst, Dept Microbiol & Infect Control, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	renj@ssi.dk	Alsarraf, Husam/G-2918-2017; Klychnikov, Oleg I./AAN-6167-2020; Jørgensen, René/P-5619-2014	Klychnikov, Oleg I./0000-0002-0383-9237; Jørgensen, René/0000-0003-0672-466X; Welner, Ditte Hededam/0000-0001-9297-4133; Alsarraf, Husam/0000-0001-8147-9647; Ostergaard, Ole/0000-0003-3160-8548; Corver, Jeroen/0000-0002-9262-5475; Hensbergen, Paul/0000-0002-3193-5445	Det Frie Forskningsrad Sapere Aude Starting Grant/Medical Sciences from the Danish Council for Independent Research [11-104831]	Det Frie Forskningsrad Sapere Aude Starting Grant/Medical Sciences from the Danish Council for Independent Research	This work was supported by Det Frie Forskningsrad Sapere Aude Starting Grant 11-104831/Medical Sciences from the Danish Council for Independent Research. Access to synchrotron beam time was made possible by support from DANSCATT. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Boivin S, 2013, PROTEIN EXPRES PURIF, V91, P192, DOI 10.1016/j.pep.2013.08.002; Bunney TD, 2014, STRUCTURE, V22, P1831, DOI 10.1016/j.str.2014.10.007; Campanacci V, 2013, EMBO J, V32, P1469, DOI 10.1038/emboj.2013.82; Castro-Roa D, 2013, NAT CHEM BIOL, V9, P811, DOI [10.1038/NCHEMBIO.1364, 10.1038/nchembio.1364]; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DeLano W.L, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Elliott B, 2007, INTERN MED J, V37, P561, DOI 10.1111/j.1445-5994.2007.01403.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Garcia-Pino A, 2014, TRENDS BIOCHEM SCI, V39, P121, DOI 10.1016/j.tibs.2014.01.001; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Goepfert A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064901; Goody PR, 2012, EMBO J, V31, P1774, DOI 10.1038/emboj.2012.16; Ham H, 2014, J BIOL CHEM, V289, P36059, DOI 10.1074/jbc.M114.612515; Harms A, 2015, CELL REP, V12, P1497, DOI 10.1016/j.celrep.2015.07.056; JUST I, 1995, J CLIN INVEST, V95, P1026, DOI 10.1172/JCI117747; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Li Y, 2011, J AM SOC MASS SPECTR, V22, P752, DOI 10.1007/s13361-011-0084-1; Luong P, 2010, J BIOL CHEM, V285, P20155, DOI 10.1074/jbc.M110.114884; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; Mattoo S, 2011, J BIOL CHEM, V286, P32834, DOI 10.1074/jbc.M111.227603; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McFarland LV, 2007, AM J INFECT CONTROL, V35, P237, DOI 10.1016/j.ajic.2006.06.004; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Palanivelu DV, 2011, PROTEIN SCI, V20, P492, DOI 10.1002/pro.581; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Poutanen SM, 2004, CAN MED ASSOC J, V171, P51, DOI 10.1503/cmaj.1031189; Quesada-Gomez C, 2015, J CLIN MICROBIOL, V53, P1216, DOI 10.1128/JCM.03058-14; Rahman M, 2012, NAT NEUROSCI, V15, P871, DOI 10.1038/nn.3102; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Sanyal A, 2015, J BIOL CHEM, V290, P8482, DOI 10.1074/jbc.M114.618348; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Stanger FV, 2016, P NATL ACAD SCI USA, V113, pE529, DOI 10.1073/pnas.1516930113; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Welner D, 2014, ACTA CRYSTALLOGR F, V70, P827, DOI 10.1107/S2053230X1400987X; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	66	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13286	13300		10.1074/jbc.M115.705491	http://dx.doi.org/10.1074/jbc.M115.705491			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27076635	Green Published, hybrid			2022-12-28	WOS:000379770500032
J	Kumar, V; Ero, R; Ahmed, T; Goh, KJ; Zhan, Y; Bhushan, S; Gao, YG				Kumar, Veerendra; Ero, Rya; Ahmed, Tofayel; Goh, Kwok Jian; Zhan, Yin; Bhushan, Shashi; Gao, Yong-Gui			Structure of the GTP Form of Elongation Factor 4 (EF4) Bound to the Ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; LEPA CONTRIBUTES; RNA; GENE	Elongation factor 4 (EF4) is a member of the family of ribosome-dependent translational GTPase factors, along with elongation factor G and BPI-inducible protein A. Although EF4 is highly conserved in bacterial, mitochondrial, and chloroplast genomes, its exact biological function remains controversial. Here we present the cryo-EM reconstitution of the GTP form of EF4 bound to the ribosome with P and E site tRNAs at 3.8-angstrom resolution. Interestingly, our structure reveals an unrotated ribosome rather than a clockwise-rotated ribosome, as observed in the presence of EF4-GDP and P site tRNA. In addition, we also observed a counterclockwise-rotated form of the above complex at 5.7-angstrom resolution. Taken together, our results shed light on the interactions formed between EF4, the ribosome, and the P site tRNA and illuminate the GTPase activation mechanism at previously unresolved detail.	[Kumar, Veerendra; Gao, Yong-Gui] ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore; [Kumar, Veerendra; Ero, Rya; Ahmed, Tofayel; Goh, Kwok Jian; Zhan, Yin; Bhushan, Shashi; Gao, Yong-Gui] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Bhushan, Shashi; Gao, Yong-Gui] Nanyang Technol Univ, Inst Biol Struct, Singapore 636921, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Gao, YG (corresponding author), ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.; Gao, YG (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.; Gao, YG (corresponding author), Nanyang Technol Univ, Inst Biol Struct, Singapore 636921, Singapore.	ygao@ntu.edu.sg	Gao, Yonggui/A-9473-2015; Ahmed, Tofayel/AAV-7091-2021; Ahmed, Tofayel/R-4346-2019; Gao, Yong Gui/A-2187-2011	Gao, Yonggui/0000-0001-7298-0835; Ahmed, Tofayel/0000-0002-2305-7750; Ahmed, Tofayel/0000-0002-7214-1000; YIN, ZHAN/0000-0002-3846-0147; Bhushan, Shashi/0000-0002-8514-5959; Kumar, Veerendra/0000-0002-9241-1303; Goh, Kwok Jian/0000-0002-9825-8071	Singapore National Research Foundation [NRF-RF2009-RF001-267]; Ministry of Education of Singapore; Nanyang Technological University Startup Grant; Ministry of Education Singapore	Singapore National Research Foundation(National Research Foundation, Singapore); Ministry of Education of Singapore(Ministry of Education, Singapore); Nanyang Technological University Startup Grant(Nanyang Technological University); Ministry of Education Singapore(Ministry of Education, Singapore)	This work was supported by Singapore National Research Foundation Grant NRF-RF2009-RF001-267 (to Y. G. G.), a Tier II grant from the Ministry of Education of Singapore (to Y. G. G.), a Nanyang Technological University Startup Grant (to S. B.), and a Tier I grant from the Ministry of Education Singapore (to S. B). The authors declare that they have no conflicts of interest with the contents of this article.	Badu-Nkansah A, 2010, FEMS MICROBIOL LETT, V311, P147, DOI 10.1111/j.1574-6968.2010.02083.x; Balakrishnan R, 2014, NUCLEIC ACIDS RES, V42, P13370, DOI 10.1093/nar/gku1098; Chen Y, 2013, NAT STRUCT MOL BIOL, V20, P1077, DOI 10.1038/nsmb.2645; Colca JR, 2003, J BIOL CHEM, V278, P21972, DOI 10.1074/jbc.M302109200; Connell SR, 2008, NAT STRUCT MOL BIOL, V15, P910, DOI 10.1038/nsmb.1469; Cunha CE, 2013, TRANSLATION, V1, DOI 10.4161/trla.24315; De Laurentiis EI, 2015, SCI REP-UK, V5, DOI 10.1038/srep08573; DIBB NJ, 1986, J BACTERIOL, V166, P83, DOI 10.1128/jb.166.1.83-87.1986; Evans RN, 2008, P NATL ACAD SCI USA, V105, P4673, DOI 10.1073/pnas.0801308105; Feng S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058829; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gagnon MG, 2016, P NATL ACAD SCI USA, V113, P4994, DOI 10.1073/pnas.1522932113; Gagnon MG, 2014, SCIENCE, V345, P684, DOI 10.1126/science.1253525; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Koch M, 2015, P NATL ACAD SCI USA, V112, pE2561, DOI 10.1073/pnas.1505231112; Kumar V, 2015, P NATL ACAD SCI USA, V112, P10944, DOI 10.1073/pnas.1513216112; Li LP, 2014, MBIO, V5, DOI 10.1128/mBio.01708-14; Liu HQ, 2011, P NATL ACAD SCI USA, V108, P16223, DOI 10.1073/pnas.1103820108; Liu HQ, 2010, J MOL BIOL, V396, P1043, DOI 10.1016/j.jmb.2009.12.043; Margus T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-15; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Pech M, 2011, P NATL ACAD SCI USA, V108, P3199, DOI 10.1073/pnas.1012994108; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pulk A, 2013, SCIENCE, V340, P1544, DOI 10.1126/science.1235970; Qin Y, 2006, CELL, V127, P721, DOI 10.1016/j.cell.2006.09.037; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Selmer M, 2012, ACTA CRYSTALLOGR D, V68, P578, DOI 10.1107/S0907444912006348; Shoji S, 2010, BIOCHIMIE, V92, P157, DOI 10.1016/j.biochi.2009.11.002; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Yamamoto H, 2014, NAT REV MICROBIOL, V12, P89, DOI 10.1038/nrmicro3176; Yang F, 2014, PROTEIN CELL, V5, P563, DOI 10.1007/s13238-014-0050-3; Zhang DJ, 2016, NAT STRUCT MOL BIOL, V23, P125, DOI 10.1038/nsmb.3160; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhou J, 2013, SCIENCE, V340, P1543, DOI 10.1126/science.1236086	37	11	11	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					12943	12950		10.1074/jbc.M116.725945	http://dx.doi.org/10.1074/jbc.M116.725945			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27137929	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000379770500005
J	Perry, RJ; Borders, CB; Cline, GW; Zhang, XM; Alves, TC; Petersen, KF; Rothman, DL; Kibbey, RG; Shulman, GI				Perry, Rachel J.; Borders, Candace B.; Cline, Gary W.; Zhang, Xian-Man; Alves, Tiago C.; Petersen, Kitt Falk; Rothman, Douglas L.; Kibbey, Richard G.; Shulman, Gerald I.			Propionate Increases Hepatic Pyruvate Cycling and Anaplerosis and Alters Mitochondrial Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TCA CYCLE; GLUCONEOGENESIS; LIVER; RATS; CARBOXYLASE; FLUXES; REVERSIBILITY; HYPOGLYCEMIA; SPECIFICITY; ZONATION	In mammals, pyruvate kinase (PK) plays a key role in regulating the balance between glycolysis and gluconeogenesis; however, in vivo regulation of PK flux by gluconeogenic hormones and substrates is poorly understood. To this end, we developed a novel NMR-liquid chromatography/tandem-mass spectrometry (LC-MS/MS) method to directly assess pyruvate cycling relative to mitochondrial pyruvate metabolism (VPyr-Cyc/V-Mito) in vivo using [3-C-13] lactate as a tracer. Using this approach, VPyr-Cyc/V-Mito was only 6% in overnight fasted rats. In contrast, when propionate was infused simultaneously at doses previously used as a tracer, it increased VPyr-Cyc/V-Mito by 20-30-fold, increased hepatic TC Ametabolite concentrations 2-3-fold, and increased endogenous glucose production rates by 20-100%. The physiologic stimuli, glucagon and epinephrine, both increased hepatic glucose production, but only glucagon suppressed VPyr-Cyc/V-Mito. These data show that under fasting conditions, when hepatic gluconeogenesis is stimulated, pyruvate recycling is relatively low in liver compared with V-Mito flux and that liver metabolism, in particular pyruvate cycling, is sensitive to propionate making it an unsuitable tracer to assess hepatic glycolytic, gluconeogenic, and mitochondrial metabolism in vivo.	[Perry, Rachel J.; Borders, Candace B.; Cline, Gary W.; Zhang, Xian-Man; Alves, Tiago C.; Petersen, Kitt Falk; Kibbey, Richard G.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06519 USA; [Kibbey, Richard G.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06519 USA; [Rothman, Douglas L.] Yale Univ, Sch Med, Dept Radiol & Biomed Imaging, 333 Cedar St, New Haven, CT 06519 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06519 USA; [Rothman, Douglas L.] Yale Univ, Dept Biomed Engn, New Haven, CT 06519 USA; [Petersen, Kitt Falk; Shulman, Gerald I.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-1017 Copenhagen, Denmark	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Novo Nordisk Foundation; University of Copenhagen	Kibbey, RG; Shulman, GI (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06519 USA.; Kibbey, RG; Shulman, GI (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06519 USA.; Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06519 USA.; Shulman, GI (corresponding author), Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-1017 Copenhagen, Denmark.	richard.kibbey@yale.edu; gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Perry, Rachel/0000-0003-0748-8064	National Institutes of Health [R01 DK-40936, P30 DK-45735, U24 DK-059635, T32 DK-101019, R01 NS-087568, R01 DK-056886, R01 DK-092606, R01 DK-093959, R01 AG-23686, UL1 TR-000142]; Gilead Sciences; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056886, R01DK092606, T32DK101019, R01DK093959, R01DK040936, P30DK034989, P30DK045735, U24DK059635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilead Sciences(Gilead Sciences); Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01 DK-40936, P30 DK-45735, U24 DK-059635, T32 DK-101019, R01 NS-087568, R01 DK-056886, R01 DK-092606, R01 DK-093959, R01 AG-23686, and UL1 TR-000142, Gilead Sciences, and the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alves TC, 2015, CELL METAB, V22, P936, DOI 10.1016/j.cmet.2015.08.021; Alves TC, 2011, HEPATOLOGY, V53, P1175, DOI 10.1002/hep.24170; Befroy DE, 2014, NAT MED, V20, P98, DOI 10.1038/nm.3415; Browning JD, 2012, AM J PHYSIOL-ENDOC M, V303, pE1304, DOI 10.1152/ajpendo.00306.2012; Burgess SC, 2003, ANAL BIOCHEM, V312, P228, DOI 10.1016/S0003-2697(02)00465-7; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Burgess SC, 2015, NAT MED, V21, P108, DOI 10.1038/nm.3789; Hasenour CM, 2015, AM J PHYSIOL-ENDOC M, V309, pE191, DOI 10.1152/ajpendo.00003.2015; HILTUNEN JK, 1981, BIOCHIM BIOPHYS ACTA, V678, P115, DOI 10.1016/0304-4165(81)90054-4; Jin ES, 2005, AM J PHYSIOL-ENDOC M, V288, pE654, DOI 10.1152/ajpendo.00365.2004; Jin ES, 2004, ANAL BIOCHEM, V327, P149, DOI 10.1016/j.ab.2003.12.036; Jones JG, 1998, AM J PHYSIOL-ENDOC M, V275, pE843, DOI 10.1152/ajpendo.1998.275.5.E843; JUNGERMANN K, 1987, Diabetes Metabolism Reviews, V3, P269; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Kumashiro N, 2013, DIABETES, V62, P2183, DOI 10.2337/db12-1311; Mravec B, 2008, ANN NY ACAD SCI, V1148, P196, DOI 10.1196/annals.1410.010; Perry RJ, 2014, NAT MED, V20, P759, DOI 10.1038/nm.3579; PETERSEN KF, 1995, METABOLISM, V44, P1380, DOI 10.1016/0026-0495(95)90133-7; POWELL AM, 1993, J CLIN INVEST, V92, P2667, DOI 10.1172/JCI116883; Previs SF, 2015, AM J PHYSIOL-ENDOC M, V309, pE727, DOI 10.1152/ajpendo.00216.2015; Puchowicz MA, 1999, AM J PHYSIOL-ENDOC M, V277, pE1022, DOI 10.1152/ajpendo.1999.277.6.E1022; Purmal C, 2014, AM J PHYSIOL-HEART C, V307, pH1134, DOI 10.1152/ajpheart.00407.2014; Reszko AE, 2003, J BIOL CHEM, V278, P34959, DOI 10.1074/jbc.M302013200; Satapati S, 2015, J CLIN INVEST, V125, P4447, DOI 10.1172/JCI82204; SCRUTTON MC, 1974, J BIOL CHEM, V249, P7057; Shi ZQ, 1996, ENDOCRINOLOGY, V137, P3193, DOI 10.1210/en.137.8.3193; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Vatner DF, 2013, AM J PHYSIOL-ENDOC M, V305, pE89, DOI 10.1152/ajpendo.00573.2012	28	46	47	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12161	12170		10.1074/jbc.M116.720631	http://dx.doi.org/10.1074/jbc.M116.720631			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27002151	hybrid, Green Published			2022-12-28	WOS:000378092800018
J	Krauson, AJ; Carattino, MD				Krauson, Aram J.; Carattino, Marcelo D.			The Thumb Domain Mediates Acid-sensing Ion Channel Desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acid sensing ion channel (ASIC); conformational change; epithelial sodium channel (ENaC); ion channel; receptor desensitization	RECEPTOR DESENSITIZATION; ASIC1A CHANNELS; CATION CHANNEL; SODIUM-CHANNEL; CONTRIBUTES; SUBUNIT; PAIN; EXPRESSION; AMILORIDE; CLONING	Acid-sensing ion channels (ASICs) are cation-selective proton-gated channels expressed in neurons that participate in diverse physiological processes, including nociception, synaptic plasticity, learning, and memory. ASIC subunits contain intracellular N and C termini, two transmembrane domains that constitute the pore, and a large extracellular loop with defined domains termed the finger, -ball, thumb, palm, and knuckle. Here we examined the contribution of the finger, -ball, and thumb domains to activation and desensitization through the analysis of chimeras and the assessment of the effect of covalent modification of introduced Cys at the domain-domain interfaces. Our studies with ASIC1a-ASIC2a chimeras showed that swapping the thumb domain between subunits results in faster channel desensitization. Likewise, the covalent modification of Cys residues at selected positions in the -ball-thumb interface accelerates the desensitization of the mutant channels. Studies of accessibility with thiol-reactive reagents revealed that the -ball and thumb domains reside apart in the resting state but that they become closer to each other in response to extracellular acidification. We propose that the thumb domain moves upon continuous exposure to an acidic extracellular milieu, assisting with the closing of the pore during channel desensitization.	[Krauson, Aram J.; Carattino, Marcelo D.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, S935 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carattino, MD (corresponding author), Univ Pittsburgh, Dept Med, Renal Electrolyte Div, S935 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	mdc4@pitt.edu	Krauson, Aram/ABH-1593-2021; Krauson, Aram J/M-4866-2013	Krauson, Aram/0000-0001-7948-5730; Krauson, Aram J/0000-0001-7948-5730	National Institutes of Health [R01 DK084060, T32 DK061296]; Cellular Physiology Core of the Pittsburgh Center for Kidney Research Grant [P30-DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK061296, R01DK084060, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular Physiology Core of the Pittsburgh Center for Kidney Research Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK084060, T32 DK061296, and by Cellular Physiology Core of the Pittsburgh Center for Kidney Research Grant P30-DK079307. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akopian AN, 2000, NEUROREPORT, V11, P2217, DOI 10.1097/00001756-200007140-00031; Arias RL, 2008, NEUROBIOL DIS, V31, P334, DOI 10.1016/j.nbd.2008.05.008; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Bonifacio G, 2014, J GEN PHYSIOL, V143, P105, DOI 10.1085/jgp.201311053; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Coryell MW, 2008, J NEUROSCI, V28, P13738, DOI 10.1523/JNEUROSCI.3907-08.2008; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; de Weille JR, 1998, FEBS LETT, V433, P257, DOI 10.1016/S0014-5793(98)00916-8; Della Vecchia MC, 2013, J BIOL CHEM, V288, P5487, DOI 10.1074/jbc.M112.441964; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Duan B, 2007, J NEUROSCI, V27, P11139, DOI 10.1523/JNEUROSCI.3364-07.2007; Duan B, 2011, J NEUROSCI, V31, P2101, DOI 10.1523/JNEUROSCI.4351-10.2011; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Frey EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071733; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Gautam M, 2013, FASEB J, V27, P793, DOI 10.1096/fj.12-220400; Gielen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7829; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grunder S, 2000, NEUROREPORT, V11, P1607; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hu R, 2011, ANN SURG, V254, P353, DOI 10.1097/SLA.0b013e31822645b4; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Krauson AJ, 2013, J BIOL CHEM, V288, P34375, DOI 10.1074/jbc.M113.504324; Kusama N, 2013, AM J PHYSIOL-CELL PH, V304, pC89, DOI 10.1152/ajpcell.00216.2012; Kusama N, 2010, J BIOL CHEM, V285, P17425, DOI 10.1074/jbc.M109.091561; Langlhofer G, 2015, NEUROSCI LETT, V600, P176, DOI 10.1016/j.neulet.2015.06.017; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; McKinnon NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035563; Meiselbach H, 2014, J BIOL CHEM, V289, P29135, DOI 10.1074/jbc.M114.559138; Passero CJ, 2010, AM J PHYSIOL-RENAL, V299, pF854, DOI 10.1152/ajprenal.00316.2010; Passero CJ, 2009, J BIOL CHEM, V284, P36473, DOI 10.1074/jbc.M109.055418; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Ramaswamy SS, 2013, J BIOL CHEM, V288, P35896, DOI 10.1074/jbc.M113.478982; Roy S, 2013, FASEB J, V27, P5034, DOI 10.1096/fj.13-230680; Tolino LA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202366; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Weng JY, 2010, J NEUROSCI, V30, P6548, DOI 10.1523/JNEUROSCI.0582-10.2010; Wong HK, 2008, HUM MOL GENET, V17, P3223, DOI 10.1093/hmg/ddn218; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Zhang JL, 2013, MOL NEUROBIOL, V48, P97, DOI 10.1007/s12035-013-8420-z; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	56	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11407	11419		10.1074/jbc.M115.702316	http://dx.doi.org/10.1074/jbc.M115.702316			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27015804	Green Published, hybrid			2022-12-28	WOS:000377042100038
J	Sankhala, RS; Lokareddy, RK; Cingolani, G				Sankhala, Rajeshwer S.; Lokareddy, Ravi K.; Cingolani, Gino			Divergent Evolution of Nuclear Localization Signal Sequences in Herpesvirus Terminase Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						herpesvirus; nuclear translocation; nuclear transport; virus assembly; virus entry; genome packaging motor; importin; terminase	SIMPLEX-VIRUS TYPE-1; IMPORTIN-ALPHA ISOFORMS; HUMAN CYTOMEGALOVIRUS; STRUCTURAL BASIS; PORTAL PROTEIN; DNA-RECOGNITION; GENE-PRODUCT; CRYSTALLOGRAPHIC ANALYSIS; FUNCTIONAL DOMAINS; CRYSTAL-STRUCTURE	The tripartite terminase complex of herpesviruses assembles in the cytoplasm of infected cells and exploits the host nuclear import machinery to gain access to the nucleus, where capsid assembly and genome-packaging occur. Here we analyzed the structure and conservation of nuclear localization signal (NLS) sequences previously identified in herpes simplex virus 1 (HSV-1) large terminase and human cytomegalovirus (HCMV) small terminase. We found a monopartite NLS at the N terminus of large terminase, flanking the ATPase domain, that is conserved only in -herpesviruses. In contrast, small terminase exposes a classical NLS at the far C terminus of its helical structure that is conserved only in two genera of the -subfamily and absent in - and -herpesviruses. In addition, we predicted a classical NLS in the third terminase subunit that is partially conserved among herpesviruses. Bioinformatic analysis revealed that both location and potency of NLSs in terminase subunits evolved more rapidly than the rest of the amino acid sequence despite the selective pressure to keep terminase gene products active and localized in the nucleus. We propose that swapping NLSs among terminase subunits is a regulatory mechanism that allows different herpesviruses to regulate the kinetics of terminase nuclear import, reflecting a mechanism of virus:host adaptation.	[Sankhala, Rajeshwer S.; Lokareddy, Ravi K.; Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA; [Cingolani, Gino] CNR, Inst Biomembranes & Bioenerget, Via Amendola 165-A, I-70126 Bari, Italy	Jefferson University; Consiglio Nazionale delle Ricerche (CNR)	Cingolani, G (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	gino.cingolani@jefferson.edu			National Institutes of Health [R01GM100888, P30 CA56036]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100888] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD017987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01GM100888 (to G. C.). Research in this publication includes work carried out at the Sidney Kimmel Cancer Center X-ray Crystallography and Molecular Interaction Facility, which is supported in part by National Institutes of Health Grant P30 CA56036 (NCI). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ADDISON C, 1990, J GEN VIROL, V71, P2377, DOI 10.1099/0022-1317-71-10-2377; Adelman K, 2001, P NATL ACAD SCI USA, V98, P3086, DOI 10.1073/pnas.061555698; Arvin A, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P1, DOI 10.2277/ 0521827140; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baines Joel D., 2005, P135; Baumann RG, 2003, J BIOL CHEM, V278, P4618, DOI 10.1074/jbc.M208574200; Bednenko J, 2003, TRAFFIC, V4, P127, DOI 10.1034/j.1600-0854.2003.00109.x; Bhardwaj A, 2014, CURR OPIN STRUC BIOL, V25, P1, DOI 10.1016/j.sbi.2013.10.005; BOGNER E, 1993, VIROLOGY, V196, P290, DOI 10.1006/viro.1993.1477; Bogner E, 1998, J VIROL, V72, P2259, DOI 10.1128/JVI.72.3.2259-2264.1998; Borst EM, 2013, J VIROL, V87, P1720, DOI 10.1128/JVI.01955-12; Brown J, 2002, STRUCTURE FUNCTION R, P111; Brown JC, 2011, CURR OPIN VIROL, V1, P142, DOI 10.1016/j.coviro.2011.06.003; Buttner CR, 2012, P NATL ACAD SCI USA, V109, P811, DOI 10.1073/pnas.1110270109; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Champier G, 2008, ANTIVIR THER, V13, P643; Champier G, 2007, ANTIVIR THER, V12, P217; Chang CW, 2013, TRAFFIC, V14, P1144, DOI 10.1111/tra.12098; Chang CW, 2012, PLANT CELL, V24, P5074, DOI 10.1105/tpc.112.104422; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Barros AC, 2016, J MOL BIOL, V428, P2120, DOI 10.1016/j.jmb.2016.01.019; de Beer T, 2002, MOL CELL, V9, P981, DOI 10.1016/S1097-2765(02)00537-3; DeLano W.L, PYMOL MOL GRAPHICS S; Dittmer A, 2005, J VIROL, V79, P14660, DOI 10.1128/JVI.79.23.14660-14667.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; Giesen K, 2000, J GEN VIROL, V81, P2231, DOI 10.1099/0022-1317-81-9-2231; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Guo PX, 2014, BIOTECHNOL ADV, V32, P853, DOI 10.1016/j.biotechadv.2014.01.006; Heming JD, 2014, J VIROL, V88, P225, DOI 10.1128/JVI.02632-13; Higgs MR, 2008, J GEN VIROL, V89, P1709, DOI 10.1099/vir.0.2008/000448-0; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Koerner C, 2003, J BIOL CHEM, V278, P16216, DOI 10.1074/jbc.M301137200; Koslowski KM, 1997, J VIROL, V71, P9118, DOI 10.1128/JVI.71.12.9118-9123.1997; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leffers G, 2000, J BIOL CHEM, V275, P37127, DOI 10.1074/jbc.M003357200; Liu SX, 2014, CELL, V157, P702, DOI 10.1016/j.cell.2014.02.034; Lokareddy RK, 2015, STRUCTURE, V23, P1305, DOI 10.1016/j.str.2015.04.017; Lott K, 2011, J BIOL CHEM, V286, P28160, DOI 10.1074/jbc.M111.228007; Lott K, 2011, BBA-MOL CELL RES, V1813, P1578, DOI 10.1016/j.bbamcr.2010.10.012; Lott K, 2010, J BIOL CHEM, V285, P13769, DOI 10.1074/jbc.M109.095760; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; McGeoch DJ, 2005, J VIROL, V79, P725, DOI 10.1128/JVI.79.2.725-731.2005; McNulty R, 2015, J MOL BIOL, V427, P3285, DOI 10.1016/j.jmb.2015.08.013; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Milles S, 2015, CELL, V163, P734, DOI 10.1016/j.cell.2015.09.047; Mocarski ES, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P44; Nadal M, 2010, P NATL ACAD SCI USA, V107, P16078, DOI 10.1073/pnas.1007144107; Nardozzi J, 2010, J MOL BIOL, V402, P83, DOI 10.1016/j.jmb.2010.07.013; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Olia AS, 2011, NAT STRUCT MOL BIOL, V18, P597, DOI 10.1038/nsmb.2023; Ostapchuk P, 2005, J CELL BIOCHEM, V96, P25, DOI 10.1002/jcb.20523; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859; Pumroy RA, 2015, BIOCHEM J, V466, P13, DOI 10.1042/BJ20141186; Pumroy RA, 2015, STRUCTURE, V23, P374, DOI 10.1016/j.str.2014.11.015; Rao JH, 1998, SCIENCE, V280, P708, DOI 10.1126/science.280.5364.708; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Roman N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082038; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Roy A, 2012, STRUCTURE, V20, P1403, DOI 10.1016/j.str.2012.05.014; Roy A, 2012, J BIOL CHEM, V287, P28196, DOI 10.1074/jbc.M112.349894; Sankhala RS, 2015, STRUCTURE, V23, P1777, DOI 10.1016/j.str.2015.09.002; Savva CGW, 2004, FEBS LETT, V563, P135, DOI 10.1016/S0014-5793(04)00283-2; Sigamani SS, 2013, J VIROL, V87, P7140, DOI 10.1128/JVI.00311-13; Smits C, 2009, EMBO REP, V10, P592, DOI 10.1038/embor.2009.53; Sun SY, 2007, MOL CELL, V25, P943, DOI 10.1016/j.molcel.2007.02.013; Sun S, 2012, P NATL ACAD SCI USA, V109, P817, DOI 10.1073/pnas.1110224109; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Trus BL, 2004, J VIROL, V78, P12668, DOI 10.1128/JVI.78.22.12668-12671.2004; White CA, 2003, J VIROL, V77, P6351, DOI 10.1128/JVI.77.11.6351-6358.2003; Yang K, 2007, J VIROL, V81, P6419, DOI 10.1128/JVI.00047-07; Yu D, 1998, J VIROL, V72, P7428, DOI 10.1128/JVI.72.9.7428-7439.1998; Zhao HY, 2013, P NATL ACAD SCI USA, V110, P8075, DOI 10.1073/pnas.1301133110; Zhao HY, 2010, P NATL ACAD SCI USA, V107, P1971, DOI 10.1073/pnas.0908569107	92	18	20	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11420	11433		10.1074/jbc.M116.724393	http://dx.doi.org/10.1074/jbc.M116.724393			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27033706	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000377042100039
J	Einholm, AP; Nielsen, HN; Holm, R; Toustrup-Jensen, MS; Vilsen, B				Einholm, Anja P.; Nielsen, Hang N.; Holm, Rikke; Toustrup-Jensen, Mads S.; Vilsen, Bente			Importance of a Potential Protein Kinase A Phosphorylation Site of Na+, K+-ATPase and Its Interaction Network for Na+ Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4TH TRANSMEMBRANE SEGMENT; CRYSTAL-STRUCTURE; ADENOSINE-TRIPHOSPHATE; INORGANIC-PHOSPHATE; ALPHA-SUBUNIT; SODIUM; NA+,K+-ATPASE; MUTATION; AFFINITY; PUMP	The molecular mechanism underlying PKA-mediated regulation of Na+, K+ -ATPase was explored in mutagenesis studies of the potential PKA site at Ser-938 and surrounding charged residues. The phosphomimetic mutations S938D/E interfered with Na+ binding from the intracellular side of the membrane, whereas Na+ binding from the extracellular side was unaffected. The reduction of Na+ affinity is within the range expected for physiological regulation of the intracellular Na+ concentration, thus supporting the hypothesis that PKA-mediated phosphorylation of Ser-938 regulates Na+, K+ -ATPase activity in vivo. Ser938 is located in the intracellular loop between transmembrane segments M8 and M9. An extended bonding network connects this loop with M10, the C terminus, and the Na+ binding region. Charged residues Asp-997, Glu-998, Arg-1000, and Lys-1001 in M10, participating in this bonding network, are crucial to Na+ interaction. Replacement of Arg-1005, also located in the vicinity of Ser-938, with alanine, lysine, methionine, or serine resulted in wild type-like Na+ and K+ affinities and catalytic turnover rate. However, when combined with the phosphomimetic mutation S938E only lysine substitution of Arg-1005 was compatible with Na+, K+-ATPase function, and the Na+ affinity of this double mutant was reduced even more than in single mutant S938E. This result indicates that the positive side chain of Arg-1005 or the lysine substituent plays a mechanistic role as interaction partner of phosphorylated Ser-938, transducing the phosphorylation signal into a reduced affinity of Na+ site III. Electrostatic interaction of Glu-998 is of minor importance for the reduction of Na+ affinity by phosphomimetic S938E as revealed by combining S938E with E998A.	[Einholm, Anja P.; Nielsen, Hang N.; Holm, Rikke; Toustrup-Jensen, Mads S.; Vilsen, Bente] Aarhus Univ, Dept Biomed, Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark	Aarhus University	Einholm, AP (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark.	ape@biomed.au.dk		Vilsen, Bente/0000-0002-4727-9382; Toustrup-Jensen, Mads Schak/0000-0003-2064-5861	Danish Medical Research Council, L'Oreal Denmark; Novo Nordisk Foundation; Riisfort Foundation; Lundbeck Foundation; Lundbeck Foundation [R118-2012-11726] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0013409] Funding Source: researchfish	Danish Medical Research Council, L'Oreal Denmark(L'Oreal Group); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Riisfort Foundation; Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported in part by grants from the Danish Medical Research Council, L'Oreal Denmark, the Novo Nordisk Foundation, the Riisfort Foundation, and the Lundbeck Foundation. The authors declare that they have no conflict of interest with the contents of this article.	ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Azarias G, 2013, J BIOL CHEM, V288, P2734, DOI 10.1074/jbc.M112.425785; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cheng XJ, 1997, AM J PHYSIOL-CELL PH, V273, pC893, DOI 10.1152/ajpcell.1997.273.3.C893; Codina J, 2006, J AM SOC NEPHROL, V17, P1833, DOI 10.1681/ASN.2006010032; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; Fernandez DM, 2008, HEADACHE, V48, P101, DOI [10.1111/j.1526-4610.2007.00848, 10.1111/j.1526-4610.2007.00848.x]; FISONE G, 1994, J BIOL CHEM, V269, P9368; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; GARRAHAN PJ, 1967, J PHYSIOL-LONDON, V192, P217, DOI 10.1113/jphysiol.1967.sp008297; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; GLYNN IM, 1993, J PHYSIOL-LONDON, V462, P1; Heinzen EL, 2014, LANCET NEUROL, V13, P503, DOI 10.1016/S1474-4422(14)70011-0; Holm R, 2015, J BIOL CHEM, V290, P9801, DOI 10.1074/jbc.M114.625509; Jen JC, 2007, J NEUROL NEUROSUR PS, V78, P523, DOI 10.1136/jnnp.2006.103267; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KAPLAN JH, 1980, NATURE, V288, P587, DOI 10.1038/288587a0; KARLISH SJD, 1978, BIOCHIM BIOPHYS ACTA, V527, P115, DOI 10.1016/0005-2744(78)90261-9; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; POST RL, 1969, J GEN PHYSIOL, V54, pS306, DOI 10.1085/jgp.54.1.306; POST RL, 1972, J BIOL CHEM, V247, P6530; Poulsen H, 2012, J BIOL CHEM, V287, P15959, DOI 10.1074/jbc.M112.340406; Poulsen H, 2010, FEBS LETT, V584, P2589, DOI 10.1016/j.febslet.2010.04.035; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sweadner KJ, 2001, AM J PHYSIOL-CELL PH, V280, pC1017, DOI 10.1152/ajpcell.2001.280.4.C1017; TANIGUCHI K, 1975, J BIOL CHEM, V250, P3010; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Toustrup-Jensen M, 2001, BIOCHEMISTRY-US, V40, P5521, DOI 10.1021/bi002367m; Toustrup-Jensen MS, 2014, J BIOL CHEM, V289, P3186, DOI 10.1074/jbc.M113.543272; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; VILSEN B, 1992, FEBS LETT, V314, P301, DOI 10.1016/0014-5793(92)81494-7; Vilsen B, 1997, BIOCHEMISTRY-US, V36, P13312, DOI 10.1021/bi971030q; Woods AS, 2005, J PROTEOME RES, V4, P1397, DOI 10.1021/pr050077s; YODA S, 1986, J BIOL CHEM, V261, P1147	42	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10934	+		10.1074/jbc.M115.701201	http://dx.doi.org/10.1074/jbc.M115.701201			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27013656	hybrid, Green Published			2022-12-28	WOS:000377042600042
J	Girardi, E; Wang, J; Zajonc, DM				Girardi, Enrico; Wang, Jing; Zajonc, Dirk M.			Structure of an alpha-Helical Peptide and Lipopeptide Bound to the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule CD1d	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID ANTIGEN PRESENTATION; T-CELL-RECEPTOR; MOUSE CD1; NKT CELLS; RECOGNITION; BINDING; ACTIVATION; PROTEINS	Mouse CD1d is a nonclassical MHC molecule able to present lipids and glycolipids to a specialized subset of T cells known as natural killer T cells. The antigens presented by CD1d have been shown to cover a broad range of chemical structures and to follow precise rules determining the potency of the antigen in the context of T cell activation. Together with lipids, initial reports suggested that CD1d can also bind and present hydrophobic peptides with (F/W)XX(I/L/M)XXVV. However, the exact location of peptide binding and the molecular basis for the required motif are currently unknown. Here we present the crystal structure of the first peptide identified to bind CD1d, p99, and show that it binds in the antigen-binding groove of CD1d in a manner compatible with its presentation to T cell receptors. Interestingly, the peptide adopts an alpha-helical conformation, which orients the motif residues toward its deep binding groove, therefore explaining the molecular requirements for peptide binding. Moreover, we demonstrate that a lipopeptide version of the same peptide is able to bind CD1d in a similar conformation, identifying another class of molecules binding this antigen-presenting molecule.	[Girardi, Enrico; Wang, Jing; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol, Div Cell Biol, 9420 Athena Circle, La Jolla, CA 92037 USA; [Zajonc, Dirk M.] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium	La Jolla Institute for Immunology; Ghent University	Zajonc, DM (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 9420 Athena Circle, La Jolla, CA 92037 USA.	dzajonc@lji.org	Girardi, Enrico/AAD-2260-2020; Girardi, Enrico/L-4033-2014	Girardi, Enrico/0000-0003-3508-2723; Girardi, Enrico/0000-0003-3508-2723	National Institutes of Health [AI107318]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI107318 (to D. M. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams EJ, 2013, ANNU REV IMMUNOL, V31, P529, DOI 10.1146/annurev-immunol-032712-095912; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Brossay L, 1998, IMMUNOL REV, V163, P139, DOI 10.1111/j.1600-065X.1998.tb01193.x; CASTANO AR, 1995, SCIENCE, V269, P223, DOI 10.1126/science.7542403; CEASE KB, 1986, J EXP MED, V164, P1779, DOI 10.1084/jem.164.5.1779; Cho S, 2005, VIROLOGY, V337, P242, DOI 10.1016/j.virol.2005.04.020; Cox D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005325; DELISI C, 1985, P NATL ACAD SCI USA, V82, P7048, DOI 10.1073/pnas.82.20.7048; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Girardi E, 2012, IMMUNOL REV, V250, P167, DOI 10.1111/j.1600-065X.2012.01166.x; Gunther S, 2010, P NATL ACAD SCI USA, V107, P22219, DOI 10.1073/pnas.1014708107; GUO HC, 1992, NATURE, V360, P364, DOI 10.1038/360364a0; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Lee DJ, 1998, J EXP MED, V187, P433, DOI 10.1084/jem.187.3.433; Liu YW, 2011, J CLIN INVEST, V121, P249, DOI 10.1172/JCI43964; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; McMurtrey C, 2016, ELIFE, V5, DOI 10.7554/eLife.12556; Moll M, 2010, BLOOD, V116, P1876, DOI 10.1182/blood-2009-09-243667; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Paletta D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143449; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sullivan BA, 2010, J IMMUNOL, V184, P141, DOI 10.4049/jimmunol.0902880; Tangri S, 1998, P NATL ACAD SCI USA, V95, P14314, DOI 10.1073/pnas.95.24.14314; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047989; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zajonc DM, 2007, CURR TOP MICROBIOL, V314, P27; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	35	9	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10677	10683		10.1074/jbc.M115.702118	http://dx.doi.org/10.1074/jbc.M115.702118			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27006394	Green Published, hybrid			2022-12-28	WOS:000377042600020
J	Aman, TK; Gordon, SE; Zagotta, WN				Aman, Teresa K.; Gordon, Sharona E.; Zagotta, William N.			Regulation of CNGA1 Channel Gating by Interactions with the Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-GATED CHANNEL; METAL ION FRET; ACTIVATED CHANNELS; PLASMA-MEMBRANE; ENERGY-TRANSFER; SYNAPTIC PLASTICITY; PACEMAKER CHANNELS; FLUORESCENT-PROBE; MAMMALIAN-CELLS; DISTANCE PROBES	Cyclic nucleotide-gated (CNG) channels are expressed in rod photoreceptors and open in response to direct binding of cyclic nucleotides. We have previously shown that potentiation of CNGA1 channels by transition metals requires a histidine in the A' helix following the S6 transmembrane segment. Here, we used transition metal ion FRET and patch clamp fluorometry with a fluorescent, noncanonical amino acid (3-(6-acetylnaphthalen-2-ylamino)-2-aminopropanoic acid (Anap)) to show that the potentiating transition metal Co2+ binds in or near the A' helix. Adding high-affinity metal-binding sites to the membrane (stearoyl-nitrilotriacetic acid (C18-NTA)) increased potentiation for low Co2+ concentrations, indicating that the membrane can coordinate metal ions with the A' helix. These results suggest that restraining the A' helix to the plasma membrane potentiates CNGA1 channel opening. Similar interactions between the A' helix and the plasma membrane may underlie regulation of structurally related hyperpolarization-activated cyclic nucleotide-gated (HCN) and voltage-gated potassium subfamily H (KCNH) channels by plasma membrane components.	[Aman, Teresa K.; Gordon, Sharona E.; Zagotta, William N.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	zagotta@uw.edu			NEI of the National Institutes of Health [R01EY010329, R01EY017564]; NINDS [F32NS077622]; National Institute of Mental Health [R01MH102378]; National Institutes of Health [R01GM100718]; American Heart Association [14IRG18770000]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025429] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010329, P30EY001730, R01EY017564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS077622] Funding Source: NIH RePORTER	NEI of the National Institutes of Health; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NEI of the National Institutes of Health under Grants R01EY010329 (to W. N. Z.) and R01EY017564 (to S. E. G.), by the NINDS under Grant F32NS077622 (to T. K. A.), by the National Institute of Mental Health under Grant R01MH102378 (to W. N. Z.), by the NIGMS of the National Institutes of Health under Grant R01GM100718 (to S. E. G. and W. N. Z.), and by the American Heart Association under Grant 14IRG18770000 (to W. N. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANDEREGG G, 1982, PURE APPL CHEM, V54, P2693, DOI 10.1351/pac198254122693; Bradley J, 1997, J NEUROSCI, V17, P1993; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Charles A, 2001, MOL ENDOCRINOL, V15, P997, DOI 10.1210/me.15.6.997; Chatterjee A, 2013, J AM CHEM SOC, V135, P12540, DOI 10.1021/ja4059553; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Flynn GE, 2011, J BIOL CHEM, V286, P15535, DOI 10.1074/jbc.M110.214650; Ganetzky B, 1999, ANN NY ACAD SCI, V868, P356, DOI 10.1111/j.1749-6632.1999.tb11297.x; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; Gordon SE, 2016, J GEN PHYSIOL, V147, P189, DOI 10.1085/jgp.201511530; HORROCKS WD, 1975, P NATL ACAD SCI USA, V72, P4764, DOI 10.1073/pnas.72.12.4764; Hsieh TY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099395; Hua L, 2005, J GEN PHYSIOL, V125, P335, DOI 10.1085/jgp.200409187; ILDEFONSE M, 1991, J MEMBRANE BIOL, V123, P133, DOI 10.1007/BF01998084; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Kalstrup T, 2013, P NATL ACAD SCI USA, V110, P8272, DOI 10.1073/pnas.1220398110; KARPEN JW, 1993, J GEN PHYSIOL, V101, P1, DOI 10.1085/jgp.101.1.1; Kesters D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116369; Kingston PA, 1999, SYNAPSE, V32, P1, DOI 10.1002/(SICI)1098-2396(199904)32:1<1::AID-SYN1>3.0.CO;2-M; LATT SA, 1972, BIOCHEMISTRY-US, V11, P3015, DOI 10.1021/bi00766a013; LATT SA, 1970, P NATL ACAD SCI USA, V67, P1383, DOI 10.1073/pnas.67.3.1383; Lee HS, 2009, J AM CHEM SOC, V131, P12921, DOI 10.1021/ja904896s; Li XF, 2015, J GEN PHYSIOL, V146, P357, DOI 10.1085/jgp.201511491; Michalakis S, 2011, GENES BRAIN BEHAV, V10, P137, DOI 10.1111/j.1601-183X.2010.00646.x; Puljung MC, 2013, J BIOL CHEM, V288, P12944, DOI 10.1074/jbc.M113.464123; Richmond TA, 2000, BIOCHEM BIOPH RES CO, V268, P462, DOI 10.1006/bbrc.1999.1244; Sandtner W, 2007, BIOPHYS J, V93, pL45, DOI 10.1529/biophysj.107.119073; SILLEN LG, 1964, SPECIAL PUBLICATION, V17; Taraska JW, 2009, P NATL ACAD SCI USA, V106, P16227, DOI 10.1073/pnas.0905207106; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Trudeau MC, 2004, J GEN PHYSIOL, V124, P211, DOI 10.1085/jgp.200409101; Wen M, 2015, CHEM COMMUN, V51, P8153, DOI 10.1039/c5cc01418b; Womack KB, 2000, J NEUROSCI, V20, P2792; Yu XZ, 2013, STRUCTURE, V21, P9, DOI 10.1016/j.str.2012.11.013; Zagotta WN, 2016, J GEN PHYSIOL, V147, P201, DOI 10.1085/jgp.201511531; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243	41	18	18	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9939	9947		10.1074/jbc.M116.723932	http://dx.doi.org/10.1074/jbc.M116.723932			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26969165	Green Published, hybrid			2022-12-28	WOS:000375602800009
J	Bhattacharjee, A; Yang, HJ; Duffy, M; Robinson, E; Conrad-Antoville, A; Lu, YW; Capps, T; Braiterman, L; Wolfgang, M; Murphy, MP; Yi, L; Kaler, SG; Lutsenko, S; Ralle, M				Bhattacharjee, Ashima; Yang, Haojun; Duffy, Megan; Robinson, Emily; Conrad-Antoville, Arianrhod; Lu, Ya-Wen; Capps, Tony; Braiterman, Lelita; Wolfgang, Michael; Murphy, Michael P.; Yi, Ling; Kaler, Stephen G.; Lutsenko, Svetlana; Ralle, Martina			The Activity of Menkes Disease Protein ATP7A Is Essential for Redox Balance in Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY COPPER THERAPY; TX-J MOUSE; WILSON-DISEASE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; MURINE HOMOLOG; IN-VIVO; MODEL; CELLS; MICE	Copper-transporting ATPase ATP7A is essential for mammalian copper homeostasis. Loss of ATP7A activity is associated with fatal Menkes disease and various other pathologies. In cells, ATP7A inactivation disrupts copper transport from the cytosol into the secretory pathway. Using fibroblasts from Menkes disease patients and mouse 3T3-L1 cells with a CRISPR/Cas9-inactivated ATP7A, we demonstrate that ATP7A dysfunction is also damaging to mitochondrial redox balance. In these cells, copper accumulates in nuclei, cytosol, and mitochondria, causing distinct changes in their redox environment. Quantitative imaging of live cells using GRX1-roGFP2 and HyPer sensors reveals highest glutathione oxidation and elevation of H2O2 in mitochondria, whereas the redox environment of nuclei and the cytosol is much less affected. Decreasing the H2O2 levels in mitochondria with MitoQ does not prevent glutathione oxidation; i.e. elevated copper and not H2O2 is a primary cause of glutathione oxidation. Redox misbalance does not significantly affect mitochondrion morphology or the activity of respiratory complex IV but markedly increases cell sensitivity to even mild glutathione depletion, resulting in loss of cell viability. Thus, ATP7A activity protects mitochondria from excessive copper entry, which is deleterious to redox buffers. Mitochondrial redox misbalance could significantly contribute to pathologies associated with ATP7A inactivation in tissues with paradoxical accumulation of copper (i.e. renal epithelia).	[Bhattacharjee, Ashima; Yang, Haojun; Lu, Ya-Wen; Lutsenko, Svetlana] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Braiterman, Lelita] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Wolfgang, Michael] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Duffy, Megan; Robinson, Emily; Conrad-Antoville, Arianrhod; Capps, Tony; Ralle, Martina] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Yi, Ling; Kaler, Stephen G.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Translat Neurosci, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lutsenko, S (corresponding author), 725 N Wolfe St, Baltimore, MD 21205 USA.; Ralle, M (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	Lutsenko@jhmi.edu; rallem@ohsu.edu	Ralle, Martina/H-2936-2019; Kaler, Stephen/GPT-3845-2022; Murphy, Michael/C-2120-2009	Duffy, Megan/0000-0002-3212-4927; Murphy, Michael/0000-0003-1115-9618	Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; MRC [MC_U105663142] Funding Source: UKRI; Medical Research Council [MC_U105663142] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008768] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090016, R01GM101502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072241] Funding Source: NIH RePORTER	Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr Ann Hubbard (Johns Hopkins University School of Medicine) for XS and YS cells, Dr. Tobias P. Dick (German Cancer Research Center (DKFZ), Heidelberg, Germany) for the GRX1-roGFP2 construct, and Dr. Vadim Gladyshev (Brigham and Women's Hospital, Harvard Medical School) for the HyPer constructs. The Elemental Analysis Core at Oregon Health and Science University performed ICP-MS measurements. We acknowledge use of the Advanced Photon Source at Argonne National Laboratory, supported by the Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. We thank the staff of Johns Hopkins School of Medicine MicFac facility for help with EM sample sectioning and staining.	ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bersani NA, 2002, METHOD ENZYMOL, V347, P317; Burkhead JL, 2011, J MOL BIOL, V406, P44, DOI 10.1016/j.jmb.2010.12.001; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; Du T, 2008, PROTEOMICS, V8, P1819, DOI 10.1002/pmic.200700895; GOKA TJ, 1976, P NATL ACAD SCI USA, V73, P604, DOI 10.1073/pnas.73.2.604; Grimes A, 1997, HUM MOL GENET, V6, P1037, DOI 10.1093/hmg/6.7.1037; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Gupta A, 2011, P NATL ACAD SCI USA, V108, P5390, DOI 10.1073/pnas.1014959108; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hamilton JP, 2016, HEPATOLOGY, V63, P1828, DOI 10.1002/hep.28406; Hodgkinson VL, 2015, J PATHOL, V236, P241, DOI 10.1002/path.4511; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Jones DP, 2006, CHEM-BIOL INTERACT, V163, P38, DOI 10.1016/j.cbi.2006.07.008; Kaler SG, 1995, ANN NEUROL, V38, P921, DOI 10.1002/ana.410380613; Kaler SG, 1996, BIOCHEM MOL MED, V57, P37, DOI 10.1006/bmme.1996.0007; Kaler SG, 2011, NAT REV NEUROL, V7, P15, DOI 10.1038/nrneurol.2010.180; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kodama H, 2005, J INHERIT METAB DIS, V28, P971, DOI 10.1007/s10545-005-0150-6; La Fontaine S, 2001, HUM MOL GENET, V10, P361, DOI 10.1093/hmg/10.4.361; La Fontaine S, 2010, INT J BIOCHEM CELL B, V42, P206, DOI 10.1016/j.biocel.2009.11.007; Leary SC, 2013, MOL BIOL CELL, V24, P683, DOI 10.1091/mbc.E12-09-0705; Lenartowicz M, 2001, FOLIA HISTOCHEM CYTO, V39, P275; Lenartowicz M, 2010, BIOL TRACE ELEM RES, V136, P204, DOI 10.1007/s12011-009-8533-4; Liu PC, 2005, MOL GENET METAB, V85, P291, DOI 10.1016/j.ymgme.2005.04.007; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malinouski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014564; Marthandan S, 2011, FREE RADICAL RES, V45, P351, DOI 10.3109/10715762.2010.532497; Maryon EB, 2013, AM J PHYSIOL-CELL PH, V304, pC768, DOI 10.1152/ajpcell.00417.2012; Medici V, 2014, EPIGENETICS-US, V9, P286, DOI 10.4161/epi.27110; MENKES JH, 1962, PEDIATRICS, V29, P764; MERCER JFB, 1994, NAT GENET, V6, P374, DOI 10.1038/ng0494-374; Morgan B, 2011, FREE RADICAL BIO MED, V51, P1943, DOI 10.1016/j.freeradbiomed.2011.08.035; Nomura S, 2014, J NUCL MED, V55, P845, DOI 10.2967/jnumed.113.131797; Petris MJ, 2000, HUM MOL GENET, V9, P2845, DOI 10.1093/hmg/9.19.2845; Pletjushkina OY, 2006, BIOCHEMISTRY-MOSCOW+, V71, P60, DOI 10.1134/S0006297906010093; Ralle M, 2010, J BIOL CHEM, V285, P30875, DOI 10.1074/jbc.M110.114447; Roberts EA, 2008, MOL GENET METAB, V93, P54, DOI 10.1016/j.ymgme.2007.08.127; Rodriguez S, 2012, CHEM BIOL, V19, P391, DOI 10.1016/j.chembiol.2011.12.022; Rota C, 1999, FREE RADICAL BIO MED, V27, P873, DOI 10.1016/S0891-5849(99)00137-9; ROYCE PM, 1980, BIOCHEM J, V192, P579, DOI 10.1042/bj1920579; Schushan M, 2012, METALLOMICS, V4, P669, DOI 10.1039/c2mt20025b; Sheline CT, 2004, ANN NEUROL, V55, P645, DOI 10.1002/ana.20047; Vogt S, 2003, J PHYS IV, V104, P635, DOI 10.1051/jp4:20030160; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Williams TD, 2008, AQUAT TOXICOL, V90, P83, DOI 10.1016/j.aquatox.2008.07.019; Wilmarth PA, 2012, METALLOMICS, V4, P660, DOI 10.1039/c2mt20017a; Wooton-Kee CR, 2015, J CLIN INVEST, V125, P3449, DOI 10.1172/JCI78991; Zischka H, 2011, J CLIN INVEST, V121, P1508, DOI 10.1172/JCI45401	52	41	41	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16644	16658		10.1074/jbc.M116.727248	http://dx.doi.org/10.1074/jbc.M116.727248			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27226607	hybrid, Green Published			2022-12-28	WOS:000380826700023
J	Chan, CY; Dominguez, D; Parra, KJ				Chan, Chun-Yuan; Dominguez, Dennis; Parra, Karlett J.			Regulation of Vacuolar H plus -ATPase (V-ATPase) Reassembly by Glycolysis Flow in 6-Phosphofructo-1-kinase (PFK-1)-deficient Yeast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSLOCATING ATPASE; SACCHAROMYCES-CEREVISIAE; MUTATIONAL ANALYSIS; CYTOSOLIC PH; IN-VIVO; ESCHERICHIA-COLI; V-0 SUBUNIT; GLUCOSE; PATHWAY; PUMP	Yeast 6-phosphofructo-1-kinase (PFK-1) has two subunits, Pfk1p and Pfk2p. Deletion of Pfk2p alters glucose-dependent V-ATPase reassembly and vacuolar acidification (Chan, C. Y., and Parra, K. J. (2014) Yeast phosphofructokinase-1 subunit Pfk2p is necessary for pH homeostasis and glucose-dependent vacuolar ATPase reassembly. J. Biol. Chem. 289, 19448-19457). This study capitalized on the mechanisms suppressing vacuolar H(+)-ATPase (V-ATPase) in pfk2 Delta to gain new knowledge of the mechanisms underlying glucose-dependent V-ATPase regulation. Because V-ATPase is fully assembled in pfk2 Delta, and glycolysis partially suppressed at steady state, we manipulated glycolysis and assessed its direct involvement on V-ATPase function. At steady state, the ratio of proton transport to ATP hydrolysis increased 24% after increasing the glucose concentration from 2% to 4% to enhance the glycolysis flow in pfk2 Delta. Tighter coupling restored vacuolar pH when glucose was abundant and glycolysis operated below capacity. After readdition of glucose to glucose-deprived cells, glucose-dependent V1Vo reassembly was proportional to the glycolysis flow. Readdition of 2% glucose to pfk2 Delta cells, which restored 62% of ethanol concentration, led to equivalent 60% V1Vo reassembly levels. Steady-state level of assembly (100% reassembly) was reached at 4% glucose when glycolysis reached a threshold in pfk2 Delta (=40% the wild-type flow). At 4% glucose, the level of Pfk1p co-immunoprecipitated with V-ATPase decreased 58% in pfk2 Delta, suggesting that Pfk1p binding to V-ATPase may be inhibitory in the mutant. We concluded that V-ATPase activity at steady state and V-ATPase reassembly after readdition of glucose to glucose-deprived cells are controlled by the glycolysis flow. We propose a new mechanism by which glucose regulates V-ATPase catalytic activity that occurs at steady state without changing V1Vo assembly	[Chan, Chun-Yuan; Dominguez, Dennis; Parra, Karlett J.] Univ New Mexico, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Chan, Chun-Yuan] Van Andel Inst, Grand Rapids, MI 49503 USA	University of New Mexico; University of New Mexico's Health Sciences Center; Van Andel Institute	Parra, KJ (corresponding author), Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, MSC08 4670, Albuquerque, NM 87131 USA.	kjparra@salud.unm.edu	Chan, Chun Yuan/F-5811-2010		National Institutes of Health [R01GM086495]; American Heart Association [14PRE19020015]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM086495 (to K. J. P.) and American Heart Association Grant 14PRE19020015 (to C. Y. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; ARAI H, 1989, BIOCHEMISTRY-US, V28, P3075, DOI 10.1021/bi00433a051; ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911; Banaszak K, 2011, J MOL BIOL, V407, P284, DOI 10.1016/j.jmb.2011.01.019; Bond S, 2008, J BIOL CHEM, V283, P36513, DOI 10.1074/jbc.M805232200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Chan CY, 2014, J BIOL CHEM, V289, P19448, DOI 10.1074/jbc.M114.569855; Chan CY, 2012, J BIOL CHEM, V287, P10236, DOI 10.1074/jbc.M111.321133; Cotter K, 2015, TRENDS BIOCHEM SCI, V40, P611, DOI 10.1016/j.tibs.2015.08.005; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; Dechant R, 2014, MOL CELL, V55, P409, DOI 10.1016/j.molcel.2014.06.002; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; DOHERTY RD, 1993, J BIOL CHEM, V268, P16845; Ediger B, 2009, J BIOL CHEM, V284, P19522, DOI 10.1074/jbc.M109.013375; Fogarty FM, 2014, ONCOGENE, V33, P4653, DOI 10.1038/onc.2013.403; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; HEINISCH J, 1986, MOL GEN GENET, V202, P75, DOI 10.1007/BF00330520; HEINISCH J, 1986, CURR GENET, V11, P227, DOI 10.1007/BF00420611; Hinton A, 2009, PFLUG ARCH EUR J PHY, V457, P589, DOI 10.1007/s00424-007-0382-4; HO MN, 1993, J BIOL CHEM, V268, P18286; Ibanez AJ, 2013, P NATL ACAD SCI USA, V110, P8790, DOI 10.1073/pnas.1209302110; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Kane PM, 2016, ADV EXP MED BIOL, V892, P33, DOI 10.1007/978-3-319-25304-6_3; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kohio HP, 2013, VIROLOGY, V444, P301, DOI 10.1016/j.virol.2013.06.026; Kresnowati MTAP, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100083; Lenzen S, 2014, J BIOL CHEM, V289, P12189, DOI 10.1074/jbc.R114.557314; Liberman R, 2014, J BIOL CHEM, V289, P1355, DOI 10.1074/jbc.M113.524561; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4128, DOI 10.1021/bi00313a018; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; Marshansky V, 2014, BBA-BIOENERGETICS, V1837, P857, DOI 10.1016/j.bbabio.2014.01.018; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Muller ML, 1999, J BIOL CHEM, V274, P10706, DOI 10.1074/jbc.274.16.10706; Nelson N, 2003, J BIOENERG BIOMEMBR, V35, P281, DOI 10.1023/A:1025768529677; OHYA Y, 1991, J BIOL CHEM, V266, P13971; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Owegi MA, 2005, J BIOL CHEM, V280, P18393, DOI 10.1074/jbc.M412567200; Parra KJ, 2014, EUKARYOT CELL, V13, P706, DOI 10.1128/EC.00050-14; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1996, J BIOL CHEM, V271, P19592, DOI 10.1074/jbc.271.32.19592; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Poulsen AK, 2008, BIOCHEMISTRY-US, V47, P7477, DOI 10.1021/bi800396e; Rienmuller F, 2012, J BIOL CHEM, V287, P8986, DOI 10.1074/jbc.M111.310367; Schroder TD, 2013, FEBS J, V280, P6033, DOI 10.1111/febs.12522; Sennoune SR, 2012, CURR PROTEIN PEPT SC, V13, P152; Shao E, 2003, J BIOL CHEM, V278, P12985, DOI 10.1074/jbc.M212096200; Smardon AM, 2014, J BIOL CHEM, V289, P32316, DOI 10.1074/jbc.M114.574442; Smets B, 2010, CURR GENET, V56, P1, DOI 10.1007/s00294-009-0287-1; Su Y, 2008, AM J PHYSIOL-RENAL, V295, pF950, DOI 10.1152/ajprenal.90258.2008; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Tabke K, 2014, BIOCHEM J, V462, P185, DOI 10.1042/BJ20131293; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365	63	11	12	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15820	15829		10.1074/jbc.M116.717488	http://dx.doi.org/10.1074/jbc.M116.717488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226568	Green Published, hybrid			2022-12-28	WOS:000380584200034
J	Stachler, AE; Marchfelder, A				Stachler, Aris-Edda; Marchfelder, Anita			Gene Repression in Haloarchaea Using the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-Cas I-B System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARCHAEON HALOFERAX-VOLCANII; IMMUNE-SYSTEM; CAS SYSTEMS; RNA; DNA; DEGRADATION; DEFENSE; REQUIREMENTS; BIOGENESIS; NUCLEASE	The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas system is used by bacteria and archaea to fend off foreign genetic elements. Since its discovery it has been developed into numerous applications like genome editing and regulation of transcription in eukaryotes and bacteria. For archaea currently no tools for transcriptional repression exist. Because molecular biology analyses in archaea become more and more widespread such a tool is vital for investigating the biological function of essential genes in archaea. Here we use the model archaeon Haloferax volcanii to demonstrate that its endogenous CRISPR-Cas system I-B can be harnessed to repress gene expression in archaea. Deletion of cas3 and cas6b genes results in efficient repression of transcription. crRNAs targeting the promoter region reduced transcript levels down to 8%. crRNAs targeting the reading frame have only slight impact on transcription. crRNAs that target the coding strand repress expression only down to 88%, whereas crRNAs targeting the template strand repress expression down to 8%. Repression of an essential gene results in reduction of transcription levels down to 22%. Targeting efficiencies can be enhanced by expressing a catalytically inactive Cas3 mutant. Genes can be targeted on plasmids or on the chromosome, they can be monocistronic or part of a polycistronic operon.	[Stachler, Aris-Edda; Marchfelder, Anita] Univ Ulm, Dept Biol 2, D-89069 Ulm, Germany	Ulm University	Marchfelder, A (corresponding author), Univ Ulm, Biol 2, D-89069 Ulm, Germany.	anita.marchfelder@uni-ulm.de		Marchfelder, Anita/0000-0002-1382-1794	Deutsche Forschungsgemeinschaft in the frame of the Deutsche Forschungsgemeinschaft Forschergruppe FOR1680 [MA1538/16-2]	Deutsche Forschungsgemeinschaft in the frame of the Deutsche Forschungsgemeinschaft Forschergruppe FOR1680(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant MA1538/16-2 in the frame of the Deutsche Forschungsgemeinschaft Forschergruppe FOR1680. The authors declare that they have no conflicts of interest with the contents of this article.	Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; Alstetter M., 2012, BIOLOGY, VII; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; Brendel J, 2014, J BIOL CHEM, V289, P7164, DOI 10.1074/jbc.M113.508184; Cass SDB, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150043; Cavicchioli R, 2011, NAT REV MICROBIOL, V9, P51, DOI 10.1038/nrmicro2482; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Charpentier E, 2013, NATURE, V495, P50, DOI 10.1038/495050a; CLINE SW, 1989, J BACTERIOL, V171, P4987, DOI 10.1128/jb.171.9.4987-4991.1989; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Delmas S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000552; Dierolf J., 2010, BIOLOGY, VII; Fineran PC, 2014, CURR OPIN MICROBIOL, V18, P83, DOI 10.1016/j.mib.2014.02.007; Gasiunas G, 2014, CELL MOL LIFE SCI, V71, P449, DOI 10.1007/s00018-013-1438-6; Gong B, 2014, P NATL ACAD SCI USA, V111, P16359, DOI 10.1073/pnas.1410806111; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; Hawkins M, 2013, NATURE, V503, P544, DOI 10.1038/nature12650; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Large A, 2007, MOL MICROBIOL, V66, P1092, DOI 10.1111/j.1365-2958.2007.05980.x; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Maier LK, 2015, BIOCHIMIE, V117, P129, DOI 10.1016/j.biochi.2015.02.023; Maier Lisa-Katharina, 2015, Life-Basel, V5, P521, DOI 10.3390/life5010521; Maier LK, 2015, J BIOL CHEM, V290, P4192, DOI 10.1074/jbc.M114.617506; Maier Lisa-Katharina, 2012, Mob Genet Elements, V2, P228; Maier LK, 2013, RNA BIOL, V10, P865, DOI 10.4161/rna.24282; Maier LK, 2013, BIOCHEM SOC T, V41, P374, DOI 10.1042/BST20120263; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Pfeiffer F, 2008, ARCH MICROBIOL, V190, P281, DOI 10.1007/s00203-008-0389-z; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rath D, 2015, BIOCHIMIE, V117, P119, DOI 10.1016/j.biochi.2015.03.025; Rath D, 2015, NUCLEIC ACIDS RES, V43, P237, DOI 10.1093/nar/gku1257; Schwarz T., 2015, BIOLOGY, VII; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Staals R. H., 2013, CRISPR CAS SYSTEMS, P145; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Stoll B, 2013, BIOCHEM SOC T, V41, P1444, DOI 10.1042/BST20130098; Terns RM, 2014, TRENDS GENET, V30, P111, DOI 10.1016/j.tig.2014.01.003; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Zebec Z, 2014, NUCLEIC ACIDS RES, V42, P5280, DOI 10.1093/nar/gku161	48	41	43	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15226	15242		10.1074/jbc.M116.724062	http://dx.doi.org/10.1074/jbc.M116.724062			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226589	Green Published, hybrid			2022-12-28	WOS:000380583200030
J	Aldinucci, A; Bonechi, E; Manuelli, C; Nosi, D; Masini, E; Passani, MB; Ballerini, C				Aldinucci, Alessandra; Bonechi, Elena; Manuelli, Cinzia; Nosi, Daniele; Masini, Emanuela; Passani, Maria Beatrice; Ballerini, Clara			Histamine Regulates Actin Cytoskeleton in Human Toll-like Receptor 4-activated Monocyte-derived Dendritic Cells Tuning CD4(+) T Lymphocyte Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; cytoskeleton; dendritic cell; histamine; immunology; innate immunity	IMMUNE REGULATION; PERIPHERAL-BLOOD; EXPRESSION; DIFFERENTIATION; ACTIVATION; INNATE; ANTIHISTAMINES; INFLAMMATION; POLARIZATION; MODULATION	Histamine, a major mediator in allergic diseases, differentially regulates the polarizing ability of dendritic cells after Toll-like receptor (TLR) stimulation, by not completely explained mechanisms. In this study we investigated the effects of histamine on innate immune reaction during the response of human monocyte-derived DCs (mDCs) to different TLR stimuli: LPS, specific for TLR4, and Pam3Cys, specific for heterodimer molecule TLR1/TLR2. We investigated actin remodeling induced by histamine together with mDCs phenotype, cytokine production, and the stimulatory and polarizing ability of Th0. By confocal microscopy and RT-PCR expression of Rac1/CdC42 Rho GTPases, responsible for actin remodeling, we show that histamine selectively modifies actin cytoskeleton organization induced by TLR4, but not TLR2 and this correlates with increased IL4 production and decreased IFN by primed T cells. We also demonstrate that histamine-induced cytoskeleton organization is at least in part mediated by down-regulation of small Rho GTPase CdC42 and the protein target PAK1, but not by down-regulation of Rac1. The presence and relative expression of histamine receptors HR1-4 and TLRs were determined as well. Independently of actin remodeling, histamine down-regulates IL12p70 and CXCL10 production in mDCs after TLR2 and TLR4 stimulation. We also observed a trend of IL10 up-regulation that, despite previous reports, did not reach statistical significance.	[Aldinucci, Alessandra; Bonechi, Elena; Masini, Emanuela; Ballerini, Clara] Univ Florence, Dept Neurosci Psychol Drugs & Child Hlth, I-50137 Florence, Italy; [Manuelli, Cinzia; Nosi, Daniele] Univ Florence, Dept Clin & Expt Med, I-50137 Florence, Italy; [Passani, Maria Beatrice] Univ Florence, Dept Hlth Sci, I-50137 Florence, Italy	University of Florence; University of Florence; University of Florence	Ballerini, C (corresponding author), Univ Florence, Dept Neurosci Psychol Drugs & Child Hlth, I-50137 Florence, Italy.	clara.ballerini@unifi.it		ballerini, clara/0000-0002-7812-9029; Aldinucci, Alessandra/0000-0003-4556-913X; passani, beatrice/0000-0002-7729-9069; Nosi, Daniele/0000-0002-1903-5145; Bonechi, Elena/0000-0001-6406-5776	Ente Cassa di Risparmio Project [MASI-CRF13]	Ente Cassa di Risparmio Project	This work was supported in part by Ente Cassa di Risparmio Project MASI-CRF13. The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Aldinucci A, 2010, J IMMUNOL, V185, P5102, DOI 10.4049/jimmunol.1001332; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bashir MEH, 2004, J IMMUNOL, V172, P6978, DOI 10.4049/jimmunol.172.11.6978; Beghdadi W, 2008, J EXP MED, V205, P395, DOI 10.1084/jem.20071548; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; Caron G, 2001, J IMMUNOL, V167, P3682, DOI 10.4049/jimmunol.167.7.3682; Carroll-Portillo A, 2015, J CELL BIOL, V210, P851, DOI 10.1083/jcb.201412074; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Deifl S, 2014, ALLERGY, V69, P1602, DOI 10.1111/all.12501; Farina C, 2004, INT IMMUNOL, V16, P799, DOI 10.1093/intimm/dxh083; Ferstl R, 2012, FRONT BIOSCI-LANDMRK, V17, P40, DOI 10.2741/3914; Frei R, 2013, J ALLERGY CLIN IMMUN, V132, P194, DOI 10.1016/j.jaci.2013.01.013; Glatzer F, 2014, INT ARCH ALLERGY IMM, V163, P11, DOI 10.1159/000355960; Gutzmer R, 2002, J ALLERGY CLIN IMMUN, V109, P524, DOI 10.1067/mai.2002.121944; Gutzmer R, 2005, J IMMUNOL, V174, P5224, DOI 10.4049/jimmunol.174.9.5224; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Idzko M, 2002, J ALLERGY CLIN IMMUN, V109, P839, DOI 10.1067/mai.2002.124044; Jang Sujeong, 2012, Chonnam Med J, V48, P7, DOI 10.4068/cmj.2012.48.1.7; Jutel M, 2002, CURR OPIN IMMUNOL, V14, P735, DOI 10.1016/S0952-7915(02)00395-3; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kong L, 2008, CELL RES, V18, P745, DOI 10.1038/cr.2008.65; Kucuksezer UC, 2013, J ALLERGY CLIN IMMUN, V131, P875, DOI 10.1016/j.jaci.2012.10.051; Mazzoni A, 2001, J CLIN INVEST, V108, P1865, DOI 10.1172/JCI13930; Metz M, 2011, INT ARCH ALLERGY IMM, V155, P355, DOI 10.1159/000321614; Morrison VL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6359; O'Mahony L, 2011, J ALLERGY CLIN IMMUN, V128, P1153, DOI 10.1016/j.jaci.2011.06.051; Reuter S, 2012, J IMMUNOL, V188, P5123, DOI 10.4049/jimmunol.1101618; Shao L, 2015, INT J CLIN EXP PATHO, V8, P5263; Simon T, 2012, INT IMMUNOL, V24, P107, DOI 10.1093/intimm/dxr107; Smolinska S, 2014, ALLERGY, V69, P273, DOI 10.1111/all.12330; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Yang CB, 2012, EXP PHYSIOL, V97, P1315, DOI 10.1113/expphysiol.2012.065854; Zhai RR, 2013, VIROLOGY, V442, P163, DOI 10.1016/j.virol.2013.04.009; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	39	8	9	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14803	14814		10.1074/jbc.M116.720680	http://dx.doi.org/10.1074/jbc.M116.720680			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226579	Green Published, hybrid			2022-12-28	WOS:000380366700032
J	Mosca, B; Eckhardt, J; Bergamelli, L; Treves, S; Bongianino, R; De Negri, M; Priori, SG; Protasi, F; Zorzato, F				Mosca, Barbara; Eckhardt, Jan; Bergamelli, Leda; Treves, Susan; Bongianino, Rossana; De Negri, Marco; Priori, Silvia G.; Protasi, Feliciano; Zorzato, Francesco			Role of the JP45-Calsequestrin Complex on Calcium Entry in Slow Twitch Skeletal Muscles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium-binding protein; excitation-contraction coupling (E-C coupling); gene knockout; muscle physiology; sarcoplasmic reticulum (SR)	SARCOPLASMIC-RETICULUM MEMBRANE; CA2+ ENTRY; RYANODINE RECEPTOR; STRIATED-MUSCLES; CHANNEL ACTIVITY; PROTEIN JP-45; CALSEQUESTRIN; FIBERS; MICE; RELEASE	We exploited a variety of mouse models to assess the roles of JP45-CASQ1 (CASQ, calsequestrin) and JP45-CASQ2 on calcium entry in slow twitch muscles. In flexor digitorum brevis (FDB) fibers isolated from JP45-CASQ1-CASQ2 triple KO mice, calcium transients induced by tetanic stimulation rely on calcium entry via La3+- and nifedipine-sensitive calcium channels. The comparison of excitation-coupled calcium entry (ECCE) between FDB fibers from WT, JP45KO, CASQ1KO, CASQ2KO, JP45-CASQ1 double KO, JP45-CASQ2 double KO, and JP45-CASQ1-CASQ2 triple KO shows that ECCE enhancement requires ablation of both CASQs and JP45. Calcium entry activated by ablation of both JP45-CASQ1 and JP45-CASQ2 complexes supports tetanic force development in slow twitch soleus muscles. In addition, we show that CASQs interact with JP45 at Ca2+ concentrations similar to those present in the lumen of the sarcoplasmic reticulum at rest, whereas Ca2+ concentrations similar to those present in the SR lumen after depolarization-induced calcium release cause the dissociation of JP45 from CASQs. Our results show that the complex JP45-CASQs is a negative regulator of ECCE and that tetanic force development in slow twitch muscles is supported by the dynamic interaction between JP45 and CASQs.	[Eckhardt, Jan; Treves, Susan; Zorzato, Francesco] Univ Basel Hosp, Dept Anaesthesia, Hebelstr 20, CH-4031 Basel, Switzerland; [Eckhardt, Jan; Treves, Susan; Zorzato, Francesco] Univ Basel Hosp, Dept Biomed, Hebelstr 20, CH-4031 Basel, Switzerland; [Protasi, Feliciano] Univ G DAnnunzio, Ctr Res Ageing & Translat Med, I-66100 Chieti, Italy; [Protasi, Feliciano] Univ G DAnnunzio, DNICS, I-66100 Chieti, Italy; [Bongianino, Rossana; De Negri, Marco; Priori, Silvia G.] Fdn Salvatore Maugeri, Mol Cardiol Labs, Via Maugeri 10-10, I-27100 Pavia, Italy; [Priori, Silvia G.] Univ Pavia, Dept Mol Med, Pavia, Italy; [Mosca, Barbara; Bergamelli, Leda; Treves, Susan; Zorzato, Francesco] Univ Ferrara, Dept Life Sci & Biotechnol, Via Borsari 46, I-44100 Ferrara, Italy	University of Basel; University of Basel; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; University of Ferrara	Zorzato, F (corresponding author), Univ Ferrara, Dept Life Sci & Biotechnol, Via Borsari 46, I-44100 Ferrara, Italy.	zor@unife.it	denegri, marco/D-9307-2019; /AAD-2015-2020; Priori, Silvia G G/A-6116-2014; Priori, Silvia G/ABH-6894-2020	denegri, marco/0000-0003-1665-0625; Priori, Silvia G G/0000-0001-6877-0288; Priori, Silvia G/0000-0001-6877-0288; Treves, Susan/0000-0002-0007-9631; Bongianino, Rossana/0000-0002-7880-1065	Department of Anesthesiology University Hospital Basel; Association Francaise contre les Myopathies; Telethon Italy [GGP14003, GGP13213]	Department of Anesthesiology University Hospital Basel; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Telethon Italy(Fondazione Telethon)	This work was supported by the Department of Anesthesiology University Hospital Basel, Association Francaise contre les Myopathies and Telethon Italy Grant GGP14003 (F. Z.), and Telethon Italy Grant GGP13213 (to F. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson AA, 2006, J CELL SCI, V119, P2145, DOI 10.1242/jcs.02935; Bannister RA, 2009, J GEN PHYSIOL, V133, P79, DOI 10.1085/jgp.200810105; Baylor SM, 2007, J GEN PHYSIOL, V130, P283, DOI 10.1085/jgp.200709827; Beqollari D, 2015, J GEN PHYSIOL, V146, P97, DOI 10.1085/jgp.201411314; BIRAL D, 1992, FEBS LETT, V299, P175, DOI 10.1016/0014-5793(92)80241-8; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Calderon JC, 2010, J PHYSIOL-LONDON, V588, P267, DOI 10.1113/jphysiol.2009.180893; Canato M, 2010, P NATL ACAD SCI USA, V107, P22326, DOI 10.1073/pnas.1009168108; CARLSEN RC, 1985, CAN J PHYSIOL PHARM, V63, P958, DOI 10.1139/y85-158; CLEMENTI E, 1992, J BIOL CHEM, V267, P2164; Delbono O, 2007, P NATL ACAD SCI USA, V104, P20108, DOI 10.1073/pnas.0707389104; Denegri M, 2012, CIRC RES, V110, P663, DOI 10.1161/CIRCRESAHA.111.263939; FRANZINIARMSTRONG C, 1994, ANNU REV PHYSIOL, V56, P509, DOI 10.1146/annurev.ph.56.030194.002453; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gonzalez E, 2003, J PHYSIOL-LONDON, V552, P833, DOI 10.1113/jphysiol.2003.048165; Hollingworth S, 2009, BIOPHYS J, V97, P1864, DOI 10.1016/j.bpj.2009.07.021; Horstick EJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2952; KADENBACH B, 1983, ANAL BIOCHEM, V129, P517, DOI 10.1016/0003-2697(83)90586-9; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; LEUNG AT, 1987, J BIOL CHEM, V262, P7943; Maguire PB, 1997, BIOCHEM BIOPH RES CO, V240, P721, DOI 10.1006/bbrc.1997.7729; MELZER W, 1995, BBA-REV BIOMEMBRANES, V1241, P59, DOI 10.1016/0304-4157(94)00014-5; Mosca B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2496; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; Olojo RO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027036; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Paolini C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/634075; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; SCHNEIDER MF, 1994, ANNU REV PHYSIOL, V56, P463, DOI 10.1146/annurev.ph.56.030194.002335; Shin DW, 2000, FEBS LETT, V486, P178, DOI 10.1016/S0014-5793(00)02246-8; Sztretye M, 2011, J GEN PHYSIOL, V138, P231, DOI 10.1085/jgp.201010592; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Tomasi M, 2012, AM J PHYSIOL-CELL PH, V302, pC575, DOI 10.1152/ajpcell.00119.2011; Treves S, 2009, J PHYSIOL-LONDON, V587, P3071, DOI 10.1113/jphysiol.2009.171876; Yarotskyy V, 2012, BIOPHYS J, V103, P202, DOI 10.1016/j.bpj.2012.06.001; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Ziman AP, 2010, BIOPHYS J, V99, P2705, DOI 10.1016/j.bpj.2010.08.032; Zorzato F, 2000, BIOCHEM J, V351, P537, DOI 10.1042/0264-6021:3510537	41	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14555	14565		10.1074/jbc.M115.709071	http://dx.doi.org/10.1074/jbc.M115.709071			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27189940	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000380366700012
J	Irie, K; Tsujimura, K; Nakashima, H; Nakashima, K				Irie, Koichiro; Tsujimura, Keita; Nakashima, Hideyuki; Nakashima, Kinichi			MicroRNA-214 Promotes Dendritic Development by Targeting the Schizophrenia-associated Gene Quaking (Qki)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dendrite; microRNA (miRNA); neurite outgrowth; neurodevelopment; RNA binding protein; schizophrenia	RNA-BINDING PROTEIN; MESSENGER-RNA; OLIGODENDROCYTE DIFFERENTIATION; HIPPOCAMPAL-NEURONS; STAR PROTEIN; MYELINATION; EXPRESSION; MATURATION; MICE; METAANALYSIS	Proper dendritic elaboration of neurons is critical for the formation of functional circuits during brain development. Defects in dendrite morphogenesis are associated with neuropsychiatric disorders, and microRNAs are emerging as regulators of aspects of neuronal maturation such as axonal and dendritic growth, spine formation, and synaptogenesis. Here, we show that miR-214 plays a pivotal role in the regulation of dendritic development. Overexpression of miR-214 increased dendrite size and complexity, whereas blocking of endogenous miR-214-3p, a mature form of miR-214, inhibited dendritic morphogenesis. We also found that miR-214-3p targets quaking (Qki), which is implicated in psychiatric diseases such as schizophrenia, through conserved target sites located in the 3-untranslated region of Qki mRNA, thereby down-regulating Qki protein levels. Overexpression and knockdown of Qki impaired and enhanced dendritic formation, respectively. Moreover, overexpression of Qki abolished the dendritic growth induced by miR-214 overexpression. Taken together, our findings reveal a crucial role for the miR-214-Qki pathway in the regulation of neuronal dendritic development.	[Irie, Koichiro; Tsujimura, Keita; Nakashima, Hideyuki; Nakashima, Kinichi] Kyushu Univ, Grad Sch Med Sci, Dept Stem Cell Biol & Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan	Kyushu University	Nakashima, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Stem Cell Biol & Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.; Tsujimura, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	tsujimura@med.nagoya-u.ac.jp; kin1@scb.med.kyushu-u.ac.jp		Tsujimura, Keita/0000-0002-7464-6133	 [24240051];  [27-7]	; 	This work was supported in part by a Grant-in-aid for Scientific Research (A) 24240051, a grant-in-aid for scientific research on innovative areas: Foundation of Synapse and Neurocircuit Pathology, and Intramural Research Grant 27-7 for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry. The authors declare that they have no conflicts of interest with the contents of this article.	Aberg K, 2006, AM J MED GENET B, V141B, P84, DOI 10.1002/ajmg.b.30243; Aberg K, 2006, P NATL ACAD SCI USA, V103, P7482, DOI 10.1073/pnas.0601213103; Aurora AB, 2012, J CLIN INVEST, V122, P1222, DOI 10.1172/JCI59327; Chen HL, 2010, BIOCHEM BIOPH RES CO, V394, P921, DOI 10.1016/j.bbrc.2010.03.076; Chenard CA, 2008, J NEUROSCI RES, V86, P233, DOI 10.1002/jnr.21485; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Dajas-Bailador F, 2012, NAT NEUROSCI, V15, P697, DOI 10.1038/nn.3082; Doukhanine E, 2010, MOL BIOL CELL, V21, P3029, DOI 10.1091/mbc.E10-04-0305; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; Fanous AH, 2007, AM J MED GENET B, V144B, P589, DOI 10.1002/ajmg.b.30442; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Hall MP, 2013, RNA, V19, P627, DOI 10.1261/rna.038422.113; Haroutunian V, 2006, AM J PSYCHIAT, V163, P1834, DOI 10.1176/appi.ajp.163.10.1834; HUME RI, 1981, NATURE, V293, P469, DOI 10.1038/293469a0; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; JUSTICE MJ, 1988, GENET RES, V51, P95, DOI 10.1017/S0016672300024101; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Klempan TA, 2009, BIOL PSYCHIAT, V66, P824, DOI 10.1016/j.biopsych.2009.05.010; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Larocque D, 2002, NEURON, V36, P815, DOI 10.1016/S0896-6273(02)01055-3; Larocque Daniel, 2005, RNA Biol, V2, P37, DOI 10.4161/rna.2.2.1603; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739; Li ZH, 2003, DEV GROWTH DIFFER, V45, P449; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; Liu J, 2010, J BIOL CHEM, V285, P26599, DOI 10.1074/jbc.M110.115824; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; McCullumsmith RE, 2007, SCHIZOPHR RES, V90, P15, DOI 10.1016/j.schres.2006.11.017; Motti D, 2012, SEMIN FETAL NEONAT M, V17, P347, DOI 10.1016/j.siny.2012.07.008; Mumm JS, 2006, NEURON, V52, P609, DOI 10.1016/j.neuron.2006.10.004; Ng MYM, 2009, MOL PSYCHIATR, V14, P774, DOI 10.1038/mp.2008.135; Parrish JZ, 2007, GENE DEV, V21, P956, DOI 10.1101/gad.1514507; Pilotte J, 2001, GENE DEV, V15, P845, DOI 10.1101/gad.860301; Qurashi A, 2010, CURR PSYCHIAT REP, V12, P154, DOI 10.1007/s11920-010-0102-1; Rosoklija G, 2000, ARCH GEN PSYCHIAT, V57, P349, DOI 10.1001/archpsyc.57.4.349; Saccomanno L, 1999, P NATL ACAD SCI USA, V96, P12605, DOI 10.1073/pnas.96.22.12605; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; SNIDER WD, 1987, J NEUROSCI, V7, P1760; Soetanto A, 2010, ARCH GEN PSYCHIAT, V67, P448, DOI 10.1001/archgenpsychiatry.2010.48; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tsujimura K, 2015, CELL REP, V12, P1887, DOI 10.1016/j.celrep.2015.08.028; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Xu CX, 2012, J BIOL CHEM, V287, P34970, DOI 10.1074/jbc.M112.374611; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zhao LX, 2006, MOL BIOL CELL, V17, P4179, DOI 10.1091/mbc.E06-04-0355; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	56	23	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13891	13904		10.1074/jbc.M115.705749	http://dx.doi.org/10.1074/jbc.M115.705749			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129236	Green Published, hybrid			2022-12-28	WOS:000379771100042
J	Mahalingam, M; Perez, CF; Fessenden, JD				Mahalingam, Mohana; Perez, Claudio F.; Fessenden, James D.			Fluorescence Resonance Energy Transfer-based Structural Analysis of the Dihydropyridine Receptor (1S) Subunit Reveals Conformational Differences Induced by Binding of the beta(1a) Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; dihydropyridine receptor (DHPR); excitation-contraction coupling (E-C coupling); fluorescence resonance energy transfer (FRET); skeletal muscle	II-III LOOP; TYPE-1 RYANODINE RECEPTOR; SLOW CALCIUM CURRENT; SKELETAL-MUSCLE; ALPHA(1S) SUBUNIT; MUSCULAR DYSGENESIS; IN-VITRO; IV LOOP; CHANNEL; PROTEIN	The skeletal muscle dihydropyridine receptor (1S) subunit plays a key role in skeletal muscle excitation-contraction coupling by sensing membrane voltage changes and then triggering intracellular calcium release. The cytoplasmic loops connecting four homologous (1S) structural domains have diverse functions, but their structural arrangement is poorly understood. Here, we used a novel FRET-based method to characterize the relative proximity of these intracellular loops in (1S) subunits expressed in intact cells. In dysgenic myotubes, energy transfer was observed from an N-terminal-fused YFP to a FRET acceptor, ReAsH (resorufin arsenical hairpin binder), targeted to each (1S) intracellular loop, with the highest FRET efficiencies measured to the (1S) II-III loop and C-terminal tail. However, in HEK-293T cells, FRET efficiencies from the (1S) N terminus to the II-III and III-IV loops and the C-terminal tail were significantly lower, thus suggesting that these loop structures are influenced by the cellular microenvironment. The addition of the (1a) dihydropyridine receptor subunit enhanced FRET to the II-III loop, thus indicating that (1a) binding directly affects II-III loop conformation. This specific structural change required the C-terminal 36 amino acids of (1a), which are essential to support EC coupling. Direct FRET measurements between (1S) and (1a) confirmed that both wild type and truncated (1a) bind similarly to (1S). These results provide new insights into the role of muscle-specific proteins on the structural arrangement of (1S) intracellular loops and point to a new conformational effect of the (1a) subunit in supporting skeletal muscle excitation-contraction coupling.	[Mahalingam, Mohana; Perez, Claudio F.; Fessenden, James D.] Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Perez, CF; Fessenden, JD (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	cperez@zeus.bwh.harvard.edu; jfessenden@zeus.bwh.harvard.edu			National Institutes of Health [R03AR066359, R01AR059124, R01AR067738]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059124, R03AR066359, R01AR067738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants R03AR066359 (to C. F. P.), R01AR059124 (to J. D. F.), and R01AR067738 (to C. F. P. and J. D. F.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Bannister RA, 2008, J BIOL CHEM, V283, P23217, DOI 10.1074/jbc.M804312200; Bannister RA, 2009, J GEN PHYSIOL, V134, P35, DOI 10.1085/jgp.200910241; BEAM KG, 1986, NATURE, V320, P168, DOI 10.1038/320168a0; Beurg M, 1997, BIOPHYS J, V73, P807, DOI 10.1016/S0006-3495(97)78113-X; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHAUDHARI N, 1989, DEV BIOL, V133, P456, DOI 10.1016/0012-1606(89)90049-3; Chen YY, 2014, BIOCHEM J, V460, P261, DOI 10.1042/BJ20131553; Coronado R, 2004, BIOL RES, V37, P565; Dayal A, 2013, P NATL ACAD SCI USA, V110, P7488, DOI 10.1073/pnas.1301087110; Eltit JM, 2014, J BIOL CHEM, V289, P36116, DOI 10.1074/jbc.M114.615526; Fessenden JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064686; Fessenden JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007338; Flucher BE, 2000, J CELL BIOL, V151, P467, DOI 10.1083/jcb.151.2.467; Flucher BE, 2005, J MUSCLE RES CELL M, V26, P1, DOI 10.1007/s10974-005-9000-2; Flucher BE, 2000, FEBS LETT, V474, P93, DOI 10.1016/S0014-5793(00)01583-0; FLUCHER BE, 1994, MOL BIOL CELL, V5, P1105, DOI 10.1091/mbc.5.10.1105; Girgenrath T, 2013, J BIOL CHEM, V288, P16073, DOI 10.1074/jbc.M113.463299; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Griffin BA, 2000, METHOD ENZYMOL, V327, P565; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Karunasekara Y, 2009, EUR BIOPHYS J BIOPHY, V39, P75, DOI 10.1007/s00249-009-0467-4; KNUDSON CM, 1989, J BIOL CHEM, V264, P1345; Lee DY, 2008, BLOOD, V111, P2280, DOI 10.1182/blood-2007-07-100032; Mahalingam M, 2015, METHOD ENZYMOL, V556, P455, DOI 10.1016/bs.mie.2014.11.049; Nakai J, 1998, J BIOL CHEM, V273, P24983, DOI 10.1074/jbc.273.39.24983; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polster A, 2012, J BIOL CHEM, V287, P41560, DOI 10.1074/jbc.M112.404194; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Proenza C, 2000, J BIOL CHEM, V275, P29935, DOI 10.1074/jbc.C000464200; Raina SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038594; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Schredelseker J, 2009, J BIOL CHEM, V284, P1242, DOI 10.1074/jbc.M807767200; Sheridan DC, 2003, BIOPHYS J, V84, P220, DOI 10.1016/S0006-3495(03)74844-9; Stroffekova K, 2001, PFLUG ARCH EUR J PHY, V442, P859, DOI 10.1007/s004240100619; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Weiss RG, 2004, AM J PHYSIOL-CELL PH, V287, pC1094, DOI 10.1152/ajpcell.00173.2004; WITCHER DR, 1995, J BIOL CHEM, V270, P18088, DOI 10.1074/jbc.270.30.18088; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395	44	4	4	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13762	13770		10.1074/jbc.M115.704049	http://dx.doi.org/10.1074/jbc.M115.704049			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129199	Green Published, hybrid			2022-12-28	WOS:000379771100030
J	Acevedo, J; Yan, S; Michael, WM				Acevedo, Julyana; Yan, Shan; Michael, W. Matthew			Direct Binding to Replication Protein A (RPA)-coated Single-stranded DNA Allows Recruitment of the ATR Activator TopBP1 to Sites of DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CHECKPOINT; POLYMERASE-ALPHA; DISTINCT MODES; MRN COMPLEX; PHOSPHORYLATION; CHK1; RAD9-HUS1-RAD1; KINASE; SSDNA; RPA	A critical event for the ability of cells to tolerate DNA damage and replication stress is activation of the ATR kinase. ATR activation is dependent on the BRCT (BRCA1 C terminus) repeat-containing protein TopBP1. Previous work has shown that recruitment of TopBP1 to sites of DNA damage and stalled replication forks is necessary for downstream events in ATR activation; however, the mechanism for this recruitment was not known. Here, we use protein binding assays and functional studies in Xenopus egg extracts to show that TopBP1 makes a direct interaction, via its BRCT2 domain, with RPA-coated single-stranded DNA. We identify a point mutant that abrogates this interaction and show that this mutant fails to accumulate at sites of DNA damage and that the mutant cannot activate ATR. These data thus supply a mechanism for how the critical ATR activator, TopBP1, senses DNA damage and stalled replication forks to initiate assembly of checkpoint signaling complexes.	[Acevedo, Julyana; Michael, W. Matthew] Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol Sect, Rm 104B RRI,1050 Childs Way, Los Angeles, CA 90089 USA; [Yan, Shan] Univ N Carolina, Dept Biol Sci, Charlotte, NC 28223 USA	University of Southern California; University of North Carolina; University of North Carolina Charlotte	Michael, WM (corresponding author), Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol Sect, Rm 104B RRI,1050 Childs Way, Los Angeles, CA 90089 USA.	mattm@usc.edu	Yan, Shan/I-2298-2013; McDermott, Michael Francis/GZM-5330-2022	Yan, Shan/0000-0001-8106-6295; 	National Institutes of Health [R01GM099825]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099825, R15GM101571, R15GM114713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM099825 (to W. M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Ball HL, 2005, J BIOL CHEM, V280, P31390, DOI 10.1074/jbc.M504961200; Burdova K, 2015, MOL CELL, V59, P603, DOI 10.1016/j.molcel.2015.06.026; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Cooper TJ, 2014, EXP CELL RES, V329, P124, DOI 10.1016/j.yexcr.2014.07.016; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Duursma AM, 2013, MOL CELL, V50, P116, DOI 10.1016/j.molcel.2013.03.006; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Gerloff DL, 2012, FEBS LETT, V586, P2711, DOI 10.1016/j.febslet.2012.05.005; Gong ZH, 2010, MOL CELL, V37, P438, DOI 10.1016/j.molcel.2010.01.002; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Hashimoto Y, 2003, EMBO J, V22, P2526, DOI 10.1093/emboj/cdg238; Kondo S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001350; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; LaRocque JR, 2007, GENETICS, V175, P1023, DOI 10.1534/genetics.106.067330; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lee J, 2013, MOL BIOL CELL, V24, P1343, DOI 10.1091/mbc.E13-01-0025; Lee J, 2010, MOL BIOL CELL, V21, P926, DOI 10.1091/mbc.E09-11-0958; Liu QH, 2000, GENE DEV, V14, P1448; Lyndaker AM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003320; Marechal A, 2015, CELL RES, V25, P9, DOI 10.1038/cr.2014.147; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Namiki Y, 2006, P NATL ACAD SCI USA, V103, P580, DOI 10.1073/pnas.0510223103; Ohashi E, 2014, DNA REPAIR, V21, P1, DOI 10.1016/j.dnarep.2014.05.001; Petersen P, 2006, MOL CELL BIOL, V26, P1997, DOI 10.1128/MCB.26.5.1997-2011.2006; Rappas M, 2011, NUCLEIC ACIDS RES, V39, P313, DOI 10.1093/nar/gkq743; Shiotani B, 2013, CELL REP, V3, P1651, DOI 10.1016/j.celrep.2013.04.018; Sirbu BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012724; Takeishi Y, 2010, GENES CELLS, V15, P761, DOI 10.1111/j.1365-2443.2010.01418.x; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Wang HY, 2004, CANCER RES, V64, P7139, DOI 10.1158/0008-5472.CAN-04-1289; Wanrooij PH, 2015, DNA REPAIR, V32, P17, DOI 10.1016/j.dnarep.2015.04.009; Wardlaw CP, 2014, DNA REPAIR, V22, P165, DOI 10.1016/j.dnarep.2014.06.004; Yan S, 2006, J CELL BIOL, V173, P181, DOI 10.1083/jcb.200601076; Yan S, 2009, J CELL BIOL, V184, P793, DOI 10.1083/jcb.200810185; Yoo HY, 2007, J BIOL CHEM, V282, P17501, DOI 10.1074/jbc.M701770200; Yoo HY, 2009, MOL BIOL CELL, V20, P2351, DOI 10.1091/mbc.E08-12-1190; Yoo HY, 2006, GENE DEV, V20, P772, DOI 10.1101/gad.1398806; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	47	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13124	13131		10.1074/jbc.M116.729194	http://dx.doi.org/10.1074/jbc.M116.729194			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129245	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000379770500020
J	Chen, YTS; Wu, JH; Modrich, P; Hsieh, TS				Chen, Yu-tsung Shane; Wu, Jianhong; Modrich, Paul; Hsieh, Tao-shih			The C-terminal 20 Amino Acids of Drosophila Topoisomerase 2 Are Required for Binding to a BRCA1 C Terminus (BRCT) Domain-containing Protein, Mus101, and Fidelity of DNA Segregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION CHECKPOINT CONTROL; CASEIN KINASE-II; ANAPHASE BRIDGES; IN-VITRO; PHOSPHORYLATION; ALPHA; TOPBP1; CLEAVAGE; COMPLEX; YEAST	Eukaryotic topoisomerase 2 (Top2) and one of its interacting partners, topoisomerase II beta binding protein 1 (TopBP1) are two proteins performing essential cellular functions. We mapped the interacting domains of these two proteins using co-immunoprecipitation and pulldown experiments with truncated or mutant Drosophila Top2 with various Ser-to-Ala substitutions. We discovered that the last 20 amino acids of Top2 represent the key region for binding with Mus101 (the Drosophila homolog of TopBP1) and that phosphorylation of Ser-1428 and Ser-1443 is important for Top2 to interact with the N terminus of Mus101, which contains the BRCT1/2 domains. The interaction between Mus101 and the Top2 C-terminal regulatory domain is phosphorylation-dependent because treatment with phosphatase abolishes their association in pulldown assays. The binding affinity of N-terminal Mus101 with a synthetic phosphorylated peptide spanning the last 25 amino acids of Top2 (with Ser(P)-1428 and Ser(P)-1443) was determined by surface plasmon resonance with a K-d of 0.57 mu M. In an in vitro decatenation assay, Mus101 can specifically reduce the decatenation activity of Top2, and dephosphorylation of Top2 attenuates this response. Next, we endeavored to establish a cellular system for testing the biological function of Top2-Mus101 interaction. Top2-silenced S2 cells rescued by Top2 Delta 20, Top2 with 20 amino acids truncated from the C terminus, developed abnormally high chromosome numbers, which implies that Top2-Mus101 interaction is important for maintaining the fidelity of chromosome segregation during mitosis.	[Chen, Yu-tsung Shane; Wu, Jianhong; Modrich, Paul; Hsieh, Tao-shih] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Hsieh, Tao-shih] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Hsieh, Tao-shih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Modrich, Paul] Howard Hughes Med Inst, Chevy Chase, MD USA	Duke University; Duke University; Howard Hughes Medical Institute; Academia Sinica - Taiwan; Howard Hughes Medical Institute	Hsieh, TS (corresponding author), 128 Sec 2,Acad Rd, Taipei 115, Taiwan.	hsieh002@gate.sinica.edu.tw	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Modrich, Paul/0000-0001-8708-9885; Wu, Jian/0000-0002-3394-1507	National Institute of Health [GM29006, GM45190]; Taiwan's Ministry of Science and Technology [334122]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045190, R01GM029006] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan's Ministry of Science and Technology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health Grants GM29006 (to T. S. H.) and GM45190 (to P. M.), Taiwan's Ministry of Science and Technology Grant 334122 (to T. S. H.), and the Howard Hughes Medical Institute (to P. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ACKERMAN P, 1985, P NATL ACAD SCI USA, V82, P3164, DOI 10.1073/pnas.82.10.3164; Agostinho M, 2008, CANCER RES, V68, P2409, DOI 10.1158/0008-5472.CAN-07-2092; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Bai LP, 2014, CELL SIGNAL, V26, P857, DOI 10.1016/j.cellsig.2014.01.006; Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; Bloom KS, 2014, ANNU REV GENET, V48, P457, DOI 10.1146/annurev-genet-120213-092033; Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; Broderick R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7572; Chen SH, 2013, ANNU REV BIOCHEM, V82, P139, DOI 10.1146/annurev-biochem-061809-100002; Chikamori K, 2003, J BIOL CHEM, V278, P12696, DOI 10.1074/jbc.M300837200; CRENSHAW DG, 1993, J BIOL CHEM, V268, P21328; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; DEVORE RF, 1992, CANCER RES, V52, P2156; Germann SM, 2014, J CELL BIOL, V204, P45, DOI 10.1083/jcb.201305157; Haley B, 2010, P NATL ACAD SCI USA, V107, P11435, DOI 10.1073/pnas.1006689107; Harkins TT, 1998, BIOCHEMISTRY-US, V37, P7299, DOI 10.1021/bi9729108; Kumagai A, 2011, J CELL BIOL, V193, P995, DOI 10.1083/jcb.201102003; Kurz EU, 2000, J BIOL CHEM, V275, P13948, DOI 10.1074/jbc.275.18.13948; Li H, 2008, J BIOL CHEM, V283, P6209, DOI 10.1074/jbc.M709007200; LIU LF, 1983, J BIOL CHEM, V258, P5365; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; MORRISON A, 1979, CELL, V17, P175, DOI 10.1016/0092-8674(79)90305-2; Morrison C, 2002, NUCLEIC ACIDS RES, V30, P5318, DOI 10.1093/nar/gkf665; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Qi XM, 2011, J BIOL CHEM, V286, P35883, DOI 10.1074/jbc.M111.229260; Rappas M, 2011, NUCLEIC ACIDS RES, V39, P313, DOI 10.1093/nar/gkq743; Ryu H, 2010, J CELL BIOL, V191, P783, DOI 10.1083/jcb.201004033; SAKA Y, 1994, EMBO J, V13, P5319, DOI 10.1002/j.1460-2075.1994.tb06866.x; SANDER M, 1983, J BIOL CHEM, V258, P8421; SANDER M, 1984, P NATL ACAD SCI-BIOL, V81, P6938, DOI 10.1073/pnas.81.22.6938; Schmidt BH, 2012, NAT STRUCT MOL BIOL, V19, P1147, DOI 10.1038/nsmb.2388; Stros M, 2007, NUCLEIC ACIDS RES, V35, P5001, DOI 10.1093/nar/gkm525; Takeishi Y, 2010, GENES CELLS, V15, P761, DOI 10.1111/j.1365-2443.2010.01418.x; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Wang JD, 2011, J CELL BIOL, V193, P267, DOI 10.1083/jcb.201010026; Yamane K, 1997, EUR J BIOCHEM, V250, P794, DOI 10.1111/j.1432-1033.1997.00794.x; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	40	1	1	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13216	13228		10.1074/jbc.M116.721357	http://dx.doi.org/10.1074/jbc.M116.721357			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129233	hybrid, Green Published			2022-12-28	WOS:000379770500027
J	Welk, V; Coux, O; Kleene, V; Abeza, C; Trumbach, D; Eickelberg, O; Meiners, S				Welk, Vanessa; Coux, Olivier; Kleene, Vera; Abeza, Claire; Truembach, Dietrich; Eickelberg, Oliver; Meiners, Silke			Inhibition of Proteasome Activity Induces Formation of Alternative Proteasome Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REG-GAMMA-PROTEASOME; ACTIVATOR PA200; IONIZING-RADIATION; MULTIPLE-MYELOMA; LUNG FIBROBLASTS; CORE PARTICLE; DNA-REPAIR; DEGRADATION; EXPRESSION; PROTEIN	The proteasome is an intracellular protease complex consisting of the 20S catalytic core and its associated regulators, including the 19S complex, PA28 alpha beta, PA28 gamma, PA200, and PI31. Inhibition of the proteasome induces autoregulatory de novo formation of 20S and 26S proteasome complexes. Formation of alternative proteasome complexes, however, has not been investigated so far. We here show that catalytic proteasome inhibition results in fast recruitment of PA28 gamma and PA200 to 20S and 26S proteasomes within 2-6 h. Rapid formation of alternative proteasome complexes did not involve transcriptional activation of PA28 gamma and PA200 but rather recruitment of preexisting activators to 20S and 26S proteasome complexes. Recruitment of proteasomal activators depended on the extent of active site inhibition of the proteasome with inhibition of beta 5 active sites being sufficient for inducing recruitment. Moreover, specific inhibition of 26S proteasome activity via siRNA-mediated knockdown of the 19S subunit RPN6 induced recruitment of only PA200 to 20S proteasomes, whereas PA28 gamma was not mobilized. Here, formation of alternative PA200 complexes involved transcriptional activation of the activator. Alternative proteasome complexes persisted when cells had regained proteasome activity after pulse exposure to proteasome inhibitors. Knockdown of PA28 gamma sensitized cells to proteasome inhibitor-mediated growth arrest. Thus, formation of alternative proteasome complexes appears to be a formerly unrecognized but integral part of the cellular response to impaired proteasome function and altered proteostasis.	[Welk, Vanessa; Kleene, Vera; Eickelberg, Oliver; Meiners, Silke] Univ Munich, Univ Hosp, CPC, Helmholtz Zentrum Munchen, D-81377 Munich, Germany; [Welk, Vanessa; Kleene, Vera; Eickelberg, Oliver; Meiners, Silke] German Ctr Lung Res DZL, D-81377 Munich, Germany; [Coux, Olivier; Abeza, Claire] Univ Montpellier, CNRS, UMR 5237, CRBM, F-34293 Montpellier, France; [Truembach, Dietrich] Helmholtz Zentrum Munchen, Inst Dev Genet, D-85764 Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Meiners, S (corresponding author), Max Lebsche Pl 31, D-81377 Munich, Germany.	silke.meiners@helmholtz-muenchen.de	Coux, Olivier/B-3406-2010; Meiners, S/M-9822-2014; Coux, Olivier/P-6847-2019	Coux, Olivier/0000-0001-8455-3849; Meiners, S/0000-0003-3678-7995; Coux, Olivier/0000-0001-8455-3849	COST Action PROTEOSTASIS [BM1307]; European ITN program "UPSTREAM"; Helmholtz Alliance ICEMED, Imaging and Curing Environmental Metabolic Diseases through the Initiative and Network Fund of the Helmholtz Association; Helmholtz Graduate School, Lung Biology and Disease	COST Action PROTEOSTASIS(European Cooperation in Science and Technology (COST)); European ITN program "UPSTREAM"; Helmholtz Alliance ICEMED, Imaging and Curing Environmental Metabolic Diseases through the Initiative and Network Fund of the Helmholtz Association; Helmholtz Graduate School, Lung Biology and Disease	This work was supported in part by the COST Action BM1307 PROTEOSTASIS, the European ITN program "UPSTREAM," and the Helmholtz Alliance ICEMED, Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the Helmholtz Graduate School, Lung Biology and Disease.	Acosta-Alvear D, 2015, ELIFE, V4, DOI 10.7554/eLife.08153; Arciniega M, 2014, P NATL ACAD SCI USA, V111, P9479, DOI 10.1073/pnas.1408018111; Baldin V, 2008, MOL BIOL CELL, V19, P1706, DOI 10.1091/mbc.E07-07-0637; Blickwedehl J, 2008, P NATL ACAD SCI USA, V105, P16165, DOI 10.1073/pnas.0803145105; Blickwedehl J, 2007, RADIAT RES, V167, P663, DOI 10.1667/RR0690.1; Blickwedehl J, 2012, MOL CANCER RES, V10, P937, DOI 10.1158/1541-7786.MCR-11-0493-T; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Dahlmann B, 2016, ARCH BIOCHEM BIOPHYS, V591, P132, DOI 10.1016/j.abb.2015.12.012; Di Napoli Mario, 2005, Curr Opin Investig Drugs, V6, P686; Dick LR, 2010, DRUG DISCOV TODAY, V15, P243, DOI 10.1016/j.drudis.2010.01.008; Dick TP, 1996, CELL, V86, P253, DOI 10.1016/S0092-8674(00)80097-5; Dong SX, 2013, CELL METAB, V18, P380, DOI 10.1016/j.cmet.2013.08.012; Fabre B, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145497; Fabre B, 2014, J PROTEOME RES, V13, P3027, DOI 10.1021/pr500193k; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fort P, 2015, GENOME BIOL EVOL, V7, P1363, DOI 10.1093/gbe/evv068; Glickman MH, 2001, CURR PROTOC PROTEIN; Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Herndon TM, 2013, CLIN CANCER RES, V19, P4559, DOI 10.1158/1078-0432.CCR-13-0755; JORDANA M, 1988, THORAX, V43, P552, DOI 10.1136/thx.43.7.552; JORDANA M, 1987, J LEUKOCYTE BIOL, V42, P51, DOI 10.1002/jlb.42.1.51; Kane RC, 2006, CLIN CANCER RES, V12, P2955, DOI 10.1158/1078-0432.CCR-06-0170; Keller IE, 2015, SCI REP-UK, V5, DOI 10.1038/srep10230; Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Le Feuvre AY, 2009, PROTEIN EXPRES PURIF, V64, P219, DOI 10.1016/j.pep.2008.10.014; Li J, 2001, BIOCHIMIE, V83, P373, DOI 10.1016/S0300-9084(01)01236-6; Li XH, 2014, J BIOL CHEM, V289, P17392, DOI 10.1074/jbc.M114.561183; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Liu JA, 2010, J CELL SCI, V123, P4076, DOI 10.1242/jcs.067405; Livnat-Levanon N, 2014, CELL REP, V7, P1371, DOI 10.1016/j.celrep.2014.04.030; Lokireddy S, 2015, P NATL ACAD SCI USA, V112, pE7176, DOI 10.1073/pnas.1522332112; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Meiners S, 2006, FREE RADICAL BIO MED, V40, P2232, DOI 10.1016/j.freeradbiomed.2006.03.003; Meiners S, 2014, ANTIOXID REDOX SIGN, V21, P2364, DOI 10.1089/ars.2013.5798; Murata S, 1999, J BIOL CHEM, V274, P38211, DOI 10.1074/jbc.274.53.38211; Myeku N, 2016, NAT MED, V22, P46, DOI 10.1038/nm.4011; Ortega J, 2005, J MOL BIOL, V346, P1221, DOI 10.1016/j.jmb.2004.12.049; Ossendorp F, 2005, J IMMUNOL, V174, P7815, DOI 10.4049/jimmunol.174.12.7815; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Realini C, 1997, J BIOL CHEM, V272, P25483, DOI 10.1074/jbc.272.41.25483; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruschak AM, 2012, P NATL ACAD SCI USA, V109, pE3454, DOI 10.1073/pnas.1213640109; Santamaria PG, 2003, J BIOL CHEM, V278, P6687, DOI 10.1074/jbc.M209420200; Savulescu AF, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.006890; Schmidt M, 2014, BBA-MOL CELL RES, V1843, P13, DOI 10.1016/j.bbamcr.2013.08.012; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Semren N, 2015, AM J RESP CRIT CARE, V192, P1089, DOI 10.1164/rccm.201412-2270OC; Sha Z, 2014, CURR BIOL, V24, P1573, DOI 10.1016/j.cub.2014.06.004; Shibatani T, 2006, MOL BIOL CELL, V17, P4962, DOI 10.1091/mbc.E06-04-0311; Smulski PA, 2009, STRUCTURE, V17, P1137, DOI 10.1016/j.str.2009.06.011; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; Tsvetkov P, 2015, ELIFE, V4, DOI 10.7554/eLife.08467; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; van Rijt SH, 2012, AM J PHYSIOL-LUNG C, V303, pL814, DOI 10.1152/ajplung.00128.2012; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Wojcik C, 2002, J BIOL CHEM, V277, P6188, DOI 10.1074/jbc.M109996200; Wojcik C, 1999, CELL MOL LIFE SCI, V56, P908, DOI 10.1007/s000180050483; Yu GW, 2010, J MOL CELL BIOL, V2, P192, DOI 10.1093/jmcb/mjq009; Zhang Z, 2008, EMBO J, V27, P852, DOI 10.1038/emboj.2008.25	70	32	33	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13147	13159		10.1074/jbc.M116.717652	http://dx.doi.org/10.1074/jbc.M116.717652			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129254	hybrid, Green Published			2022-12-28	WOS:000379770500022
J	Del Giudice, MG; Dohmer, PH; Spera, JM; Laporte, FT; Marchesini, MI; Czibener, C; Ugalde, JE				Giselda Del Giudice, Mariela; Hans Dohmer, Peter; Manuel Spera, Juan; Tomas Laporte, Fernando; Ines Marchesini, Maria; Czibener, Cecilia; Esteban Ugalde, Juan			VirJ Is a Brucella Virulence Factor Involved in the Secretion of Type IV Secreted Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA TRANSFER; ABORTUS; IDENTIFICATION; AGROBACTERIUM; PROTEIN; MACHINERY; HOMOLOG; SYSTEMS; SPP.; GENE	The VirB secretion apparatus in Brucella belongs to the type IV secretion systems present in many pathogenic bacteria and is absolutely necessary for the efficient evasion of the Brucella-containing vacuole from the phagocytic route in professional phagocytes. This system is responsible for the secretion of a plethora of effector proteins that alter the biology of the host cell and promote the intracellular replication process. Although many VirB substrates have been identified in Brucella, we still know very little about the secretion mechanism that mediates their translocation across the two membranes and the periplasmic space. In this manuscript, we describe the identification of a gene, virJ, that codes for a protein with periplasmic localization that is involved in the intracellular replication process and virulence in mice. Our analysis revealed that this protein is necessary for the secretion of at least two VirB substrates that have a periplasmic intermediate and that it directly interacts with them. We additionally show that VirJ also associates with the apparatus per se and that its absence affects the assembly of the complex. We hypothesize that VirJ is part of a secretion platform composed of the translocon and several secretion substrates and that it probably coordinates the proper assembly of this macromolecular complex.	[Giselda Del Giudice, Mariela; Hans Dohmer, Peter; Manuel Spera, Juan; Tomas Laporte, Fernando; Ines Marchesini, Maria; Czibener, Cecilia; Esteban Ugalde, Juan] Univ Nacl San Martin, Consejo Nacl Invest Cient & Tecn, Inst Invest Biotecnol IIB INTECH, Inst Invest Biotecnol Dr Rodolfo A Ugalde, RA-1650 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Czibener, C; Ugalde, JE (corresponding author), Univ Nacl San Martin, IIB INTECH, Inst Invest Biotecnol Dr Rodolfo A Ugalde, UNSAM, Avda 25 Mayo & Francia,Campus Miguelete, RA-1650 Buenos Aires, DF, Argentina.	czibener@iibintech.com.ar; jugalde@iibintech.com.ar		Marchesini, Ines/0000-0002-8540-2337	University of San Martin;  [PICT-PRH08-160];  [PICT-PRH08-230]	University of San Martin; ; 	This work was supported by Grants PICT-PRH08-160 and PICT-PRH08-230 ( to C. C. and J. E. U., respectively) and grants from the University of San Martin ( to C. C. and J. E. U.). The authors declare that they have no conflicts of interest with the contents of this article.	Burns DL, 2003, CURR OPIN MICROBIOL, V6, P29, DOI 10.1016/S1369-5274(02)00006-1; Cambronne ED, 2007, PLOS PATHOG, V3, P1837, DOI 10.1371/journal.ppat.0030188; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Cossart P, 2010, CURR OPIN CELL BIOL, V22, P547, DOI 10.1016/j.ceb.2010.05.006; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; Czibener C, 2012, MICROBES INFECT, V14, P79, DOI 10.1016/j.micinf.2011.08.012; de Barsy M, 2011, CELL MICROBIOL, V13, P1044, DOI 10.1111/j.1462-5822.2011.01601.x; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Del Giudice MG, 2013, INFECT IMMUN, V81, P956, DOI 10.1128/IAI.01158-12; Dohmer PH, 2014, CELL MICROBIOL, V16, P396, DOI 10.1111/cmi.12224; Guidolin LS, 2015, J BACTERIOL, V197, P1640, DOI 10.1128/JB.00068-15; Marchesini MI, 2011, CELL MICROBIOL, V13, P1261, DOI 10.1111/j.1462-5822.2011.01618.x; Lacerda TLS, 2013, CURR OPIN MICROBIOL, V16, P45, DOI 10.1016/j.mib.2012.11.005; Low HH, 2014, NATURE, V508, P550, DOI 10.1038/nature13081; Myeni S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003556; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nagai H, 2001, EMBO J, V20, P5962, DOI 10.1093/emboj/20.21.5962; Nester EW, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00730; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; PAN SQ, 1995, MOL MICROBIOL, V17, P259, DOI 10.1111/j.1365-2958.1995.mmi_17020259.x; Pantoja M, 2002, MOL MICROBIOL, V45, P1325, DOI 10.1046/j.1365-2958.2002.03098.x; Quanquin NM, 1999, INFECT IMMUN, V67, P4603, DOI 10.1128/IAI.67.9.4603-4612.1999; Salcedo S. P., 2013, CELL INFECT MICROBIO, V3, P28; Sieira R, 2000, J BACTERIOL, V182, P4849, DOI 10.1128/JB.182.17.4849-4855.2000; Ugalde JE, 2003, INFECT IMMUN, V71, P6264, DOI 10.1128/IAI.71.11.6264-6269.2003	28	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12383	12393		10.1074/jbc.M116.730994	http://dx.doi.org/10.1074/jbc.M116.730994			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27059960	hybrid, Green Published			2022-12-28	WOS:000378092800036
J	Heier, C; Taschler, U; Radulovic, M; Aschauer, P; Eichmann, TO; Grond, S; Wolinski, H; Oberer, M; Zechner, R; Kohlwein, SD; Zimmermann, R				Heier, Christoph; Taschler, Ulrike; Radulovic, Maja; Aschauer, Philip; Eichmann, Thomas O.; Grond, Susanne; Wolinski, Heimo; Oberer, Monika; Zechner, Rudolf; Kohlwein, Sepp D.; Zimmermann, Robert			Monoacylglycerol Lipases Act as Evolutionarily Conserved Regulators of Non-oxidative Ethanol Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID ETHYL-ESTERS; YEAST SACCHAROMYCES-CEREVISIAE; RAT-LIVER MICROSOMES; MITOCHONDRIAL DYSFUNCTION; LIPID PARTICLES; GENES ENCODE; FATTY-ACIDS; ALCOHOL; ACYLTRANSFERASE; PURIFICATION	Fatty acid ethyl esters (FAEEs) are non-oxidative metabolites of ethanol that accumulate in human tissues upon ethanol intake. Although FAEEs are considered as toxic metabolites causing cellular dysfunction and tissue damage, the enzymology of FAEE metabolism remains poorly understood. In this study, we used a biochemical screen in Saccharomyces cerevisiae to identify and characterize putative hydrolases involved in FAEE catabolism. We found that Yju3p, the functional orthologue of mammalian monoacylglycerol lipase (MGL), contributes >90% of cellular FAEE hydrolase activity, and its loss leads to the accumulation of FAEE. Heterologous expression of mammalian MGL in yju3 Delta mutants restored cellular FAEE hydrolase activity and FAEE catabolism. Moreover, overexpression or pharmacological inhibition of MGL in mouse AML-12 hepatocytes decreased or increased FAEE levels, respectively. FAEEs were transiently incorporated into lipid droplets (LDs) and both Yju3p and MGL co-localized with these organelles. We conclude that the storage of FAEE in inert LDs and their mobilization by LD-resident FAEE hydrolases facilitate a controlled metabolism of these potentially toxic lipid metabolites.	[Heier, Christoph; Taschler, Ulrike; Radulovic, Maja; Aschauer, Philip; Eichmann, Thomas O.; Grond, Susanne; Wolinski, Heimo; Oberer, Monika; Zechner, Rudolf; Kohlwein, Sepp D.; Zimmermann, Robert] Graz Univ, Inst Mol Biosci, Heinrichstr 31-2, A-8010 Graz, Austria; [Wolinski, Heimo; Kohlwein, Sepp D.] BioTechMed Graz, A-8010 Graz, Austria	University of Graz	Heier, C; Zimmermann, R (corresponding author), Graz Univ, Inst Mol Biosci, Heinrichstr 31-2, A-8010 Graz, Austria.	christoph.heier@uni-graz.at; robert.zimmermann@uni-graz.at		Wolinski, Heimo/0000-0002-1583-6092; Taschler, Ulrike/0000-0001-9000-1602; Kohlwein, Sepp Dieter/0000-0002-1030-0598; Eichmann, Thomas O./0000-0002-8521-2795; Grond, Susanne/0000-0002-7121-9013; Oberer, Monika/0000-0003-2525-9513; Zechner, Rudolf/0000-0001-5483-1182; Zimmermann, Robert/0000-0002-7354-870X; Heier, Christoph/0000-0001-6858-408X	Austrian Science Fund (FWF) [P21296, P24294, P24857]; SFB Lipotox [F3002]; DK Molecular Enzymology [W901]; Wittgenstein Award [Z136]; Austrian Science Fund (FWF) [W 901, F 3002, P 24857] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); SFB Lipotox(German Research Foundation (DFG)); DK Molecular Enzymology(Austrian Science Fund (FWF)); Wittgenstein Award(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF) Grants P21296, P24294, and P24857, SFB Lipotox F3002, the DK Molecular Enzymology W901, and Wittgenstein Award Z136. The authors declare that they have no conflicts of interest with the contents of this article.	Aschauer P, 2016, BBA-MOL CELL BIOL L, V1861, P462, DOI 10.1016/j.bbalip.2016.02.005; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Auesukaree C, 2009, J APPL GENET, V50, P301, DOI 10.1007/BF03195688; Auwarter V, 2001, CLIN CHEM, V47, P2114; BORA PS, 1989, FEBS LETT, V258, P236, DOI 10.1016/0014-5793(89)81662-X; Bora PS, 1996, J MOL CELL CARDIOL, V28, P2027, DOI 10.1006/jmcc.1996.0195; Bouchoux J, 2011, BIOL CELL, V103, P499, DOI 10.1042/BC20110024; Cederbaum AI, 2012, CLIN LIVER DIS, V16, P667, DOI 10.1016/j.cld.2012.08.002; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Currie E, 2014, J LIPID RES, V55, P1465, DOI 10.1194/jlr.M050229; Debelyy MO, 2011, EUKARYOT CELL, V10, P776, DOI 10.1128/EC.05040-11; Diczfalusy MA, 2001, J LIPID RES, V42, P1025; Diczfalusy MA, 1999, EUR J BIOCHEM, V259, P404, DOI 10.1046/j.1432-1327.1999.00052.x; Ding YB, 2012, ACTA BIOCH BIOPH SIN, V44, P394, DOI 10.1093/abbs/gms008; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Doyle KM, 1996, JAMA-J AM MED ASSOC, V276, P1152, DOI 10.1001/jama.276.14.1152; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; GRIGOR MR, 1973, BIOCHIM BIOPHYS ACTA, V306, P26, DOI 10.1016/0005-2760(73)90204-X; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; HADVARY P, 1991, J BIOL CHEM, V266, P2021; Heier C, 2010, BBA-MOL CELL BIOL L, V1801, P1063, DOI 10.1016/j.bbalip.2010.06.001; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Huang W, 2014, GUT, V63, P1313, DOI 10.1136/gutjnl-2012-304058; Iglesias J, 2016, J LIPID RES, V57, P131, DOI 10.1194/jlr.D058438; Jandrositz A, 2005, BBA-MOL CELL BIOL L, V1735, P50, DOI 10.1016/j.bbalip.2005.04.005; Khor VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105047; Knight MJ, 2014, YEAST, V31, P463, DOI 10.1002/yea.3046; Koffel R, 2005, MOL CELL BIOL, V25, P1655, DOI 10.1128/MCB.25.5.1655-1668.2005; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; LANGE LG, 1983, J CLIN INVEST, V72, P724, DOI 10.1172/JCI111022; LAPOSATA EA, 1986, SCIENCE, V231, P497, DOI 10.1126/science.3941913; LAPOSATA EA, 1990, J BIOL CHEM, V265, P9688; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Mann RE, 2003, ALCOHOL RES HEALTH, V27, P209; MOGELSON S, 1984, BIOCHEMISTRY-US, V23, P4075, DOI 10.1021/bi00313a010; Mohan SS, 2015, ALCOHOL CLIN EXP RES, V39, P434, DOI 10.1111/acer.12647; Molina PE, 2014, PHYSIOLOGY, V29, P203, DOI 10.1152/physiol.00055.2013; Neal A, 2006, BBA-MOL CELL BIOL L, V1761, P757, DOI 10.1016/j.bbalip.2006.04.009; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Piano MR, 2014, CARDIOVASC TOXICOL, V14, P291, DOI 10.1007/s12012-014-9252-4; POLOKOFF MA, 1978, J BIOL CHEM, V253, P7173; Rajakumari S, 2010, J BIOL CHEM, V285, P15769, DOI 10.1074/jbc.M109.076331; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; RILEY DJS, 1990, BIOCHEMISTRY-US, V29, P3848, DOI 10.1021/bi00468a007; Saerens SMG, 2006, J BIOL CHEM, V281, P4446, DOI 10.1074/jbc.M512028200; Saerens SMG, 2010, MICROB BIOTECHNOL, V3, P165, DOI 10.1111/j.1751-7915.2009.00106.x; Schiabor KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113899; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Schneider A, 2005, DIGEST DIS, V23, P222, DOI 10.1159/000090169; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Selvaraju K, 2014, BBA-MOL CELL BIOL L, V1841, P1383, DOI 10.1016/j.bbalip.2014.06.013; Shield KD, 2013, ALCOHOL RES-CURR REV, V35, P155; Subbanna S, 2015, J NEUROCHEM, V134, P276, DOI 10.1111/jnc.13120; SZCZEPIORKOWSKI ZM, 1995, GASTROENTEROLOGY, V108, P515, DOI 10.1016/0016-5085(95)90081-0; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; Treloar T, 1996, BBA-LIPID LIPID MET, V1299, P160, DOI 10.1016/0005-2760(95)00199-9; Valachovic M, 2016, BIOCHEM BIOPH RES CO, V469, P1123, DOI 10.1016/j.bbrc.2015.12.050; Varthini LV, 2015, FEBS LETT, V589, P23, DOI 10.1016/j.febslet.2014.11.019; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Werner J, 1997, GASTROENTEROLOGY, V113, P286, DOI 10.1016/S0016-5085(97)70106-9; Wolinski H, 2011, J CELL SCI, V124, P3894, DOI 10.1242/jcs.091454; Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245; Zelner I, 2013, DRUG METAB REV, V45, P277, DOI 10.3109/03602532.2013.795584; Zhang HN, 2011, J PROTEOME RES, V10, P4757, DOI 10.1021/pr200553c	69	12	12	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11865	11875		10.1074/jbc.M115.705541	http://dx.doi.org/10.1074/jbc.M115.705541			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27036938	Green Published, hybrid			2022-12-28	WOS:000377264800035
J	Miura, K; Ishioka, M; Minami, S; Horie, Y; Ohshima, S; Goto, T; Ohnishi, H				Miura, Kouichi; Ishioka, Mitsuaki; Minami, Shinichiro; Horie, Yasuo; Ohshima, Shigetoshi; Goto, Takashi; Ohnishi, Hirohide			Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE AMINOTRANSFERASE LEVELS; VIRUS-ASSOCIATED CIRRHOSIS; FATTY LIVER-DISEASE; CANCER STEM-CELLS; NONALCOHOLIC STEATOHEPATITIS; HEPATITIS-C; INNATE IMMUNITY; TLR4; MICROBIOTA; EXPRESSION	The role of Toll-like receptor (TLR) signaling has attracted much attention in the development of hepatic inflammation and hepatocellular carcinoma (HCC). We herein sought to determine the role of TLRs and responsible cells in steatohepatitis-related HCC. We used hepatocyte-specific Pten-deficient (Pten(Delta hep)) mice, which exhibit steatohepatitis followed by liver tumor formation, including HCC. We then generated Pten(Delta hep)/Tlr4(-/-) and Pten(Delta hep)/Tlr2(-/-) double-mutant mice and investigated the role of macrophages using reconstitution of bone marrow (BM)-derived cells, chemical depletion of macrophages, and isolated macrophages. Tlr4 but not Tlr2 deficiency in the Pten(Delta hep) mice suppressed tumor growth as well as hepatic inflammation. Gut sterilization by an antibiotic mixture reduced the portal LPS levels as well as tumor growth in the Pten(Delta hep) mice. Tumor growth was also decreased by reconstitution of BM-derived cells to Tlr4(-/-) BM cells. In addition, chemical depletion of macrophages significantly reduced tumor size and numbers. Macrophages expressing Ly6C were increased in number, which was associated with inflammation and tumor progression in the Pten(Delta hep) mice. Hepatic macrophages isolated from the Pten(Delta hep) mice abundantly expressed the Ly6C gene and produced much more IL-6 and TNF alpha in response to LPS. These proinflammatory cytokines induced the proliferation of HCC cells as well as oval cells, putative cancer progenitor cells. Indeed, putative cancer progenitor cells emerged before the development of macroscopic liver tumors and then increased in number under sustained inflammation. TLR4 on macrophages contributes to the development of steatohepatitis-related HCC in mice.	[Miura, Kouichi; Ishioka, Mitsuaki; Minami, Shinichiro; Horie, Yasuo; Ohshima, Shigetoshi; Goto, Takashi; Ohnishi, Hirohide] Akita Univ, Grad Sch Med, Dept Gastroenterol & Hepatobiliary Pancreatol, 1-1-1 Hondo, Akita, Akita 0108543, Japan	Akita University	Miura, K (corresponding author), Akita Univ, Grad Sch Med, Dept Gastroenterol & Hepatobiliary Pancreatol, 1-1-1 Hondo, Akita, Akita 0108543, Japan.	miura116@doc.med.akita-u.ac.jp		Ishioka, Mitsuaki/0000-0002-7853-4454	Japan Society for the Promotion of Science; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Foundation for Promotion of Cancer Research in Japan; Mishima Kaiun Memorial Foundation; Nakayama Cancer Research Institute (Gastrointestinal Cancer Project)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Foundation for Promotion of Cancer Research in Japan; Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Nakayama Cancer Research Institute (Gastrointestinal Cancer Project)	Supported by a grant-in-aid for scientific research from Japan Society for the Promotion of Science, Takeda Science Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Foundation for Promotion of Cancer Research in Japan, Mishima Kaiun Memorial Foundation, and Nakayama Cancer Research Institute (Gastrointestinal Cancer Project).	Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fan QM, 2014, CANCER LETT, V352, P160, DOI 10.1016/j.canlet.2014.05.008; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Galicia VA, 2010, GASTROENTEROLOGY, V139, P2170, DOI 10.1053/j.gastro.2010.09.002; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Himes RW, 2010, FASEB J, V24, P731, DOI 10.1096/fj.09-141929; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Hu TH, 2003, CANCER, V97, P1929, DOI 10.1002/cncr.11266; Jin JS, 2012, MICROBIOL IMMUNOL, V56, P729, DOI 10.1111/j.1348-0421.2012.00502.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kirillova I, 1999, CELL GROWTH DIFFER, V10, P819; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kudo H, 2009, J HEPATOL, V51, P168, DOI 10.1016/j.jhep.2009.02.032; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Matthews VB, 2004, WOUND REPAIR REGEN, V12, P650, DOI 10.1111/j.1067-1927.2004.12605.x; Miura K, 2014, WORLD J GASTROENTERO, V20, P7381, DOI 10.3748/wjg.v20.i23.7381; Miura K, 2013, HEPATOLOGY, V57, P577, DOI 10.1002/hep.26081; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Osawa Y, 2013, J CLIN INVEST, V123, P834, DOI 10.1172/JCI65188; Paik YH, 2006, LAB INVEST, V86, P676, DOI 10.1038/labinvest.3700422; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Rivera CA, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-52; Romics L, 2004, HEPATOLOGY, V40, P555, DOI 10.1002/hep.20350; Rountree CB, 2009, STEM CELLS, V27, P290, DOI 10.1634/stemcells.2008-0332; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sell S, 2008, J CLIN ONCOL, V26, P2800, DOI 10.1200/JCO.2007.15.5945; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Tarao K, 1999, CANCER, V86, P589, DOI 10.1002/(SICI)1097-0142(19990815)86:4<589::AID-CNCR7>3.0.CO;2-K; Tarao K, 1997, CANCER, V79, P688, DOI 10.1002/(SICI)1097-0142(19970215)79:4<688::AID-CNCR5>3.0.CO;2-A; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Wang ZY, 2013, HEPATOLOGY, V57, P1869, DOI 10.1002/hep.26234; Yamashita T, 2013, HEPATOLOGY, V57, P1484, DOI 10.1002/hep.26168; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347	44	39	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11504	11517		10.1074/jbc.M115.709048	http://dx.doi.org/10.1074/jbc.M115.709048			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27022031	Green Published, hybrid			2022-12-28	WOS:000377264800004
J	Muller, A; Eller, J; Albrecht, F; Prochnow, P; Kuhlmann, K; Bandow, JE; Slusarenko, AJ; Leichert, LIO				Mueller, Alexandra; Eller, Jakob; Albrecht, Frank; Prochnow, Pascal; Kuhlmann, Katja; Bandow, Julia Elisabeth; Slusarenko, Alan John; Leichert, Lars Ingo Ole			Allicin Induces Thiol Stress in Bacteria through S-Allylmercapto Modification of Protein Cysteines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; HEAT-SHOCK RESPONSE; ESCHERICHIA-COLI; ANTIBACTERIAL PRINCIPLE; ISOCITRATE LYASE; MODE; IDENTIFICATION; THIOREDOXIN; ANTIOXIDANT; GLUTATHIONE	Allicin (diallyl thiosulfinate) from garlic is a highly potent natural antimicrobial substance. It inhibits growth of a variety of microorganisms, among them antibiotic-resistant strains. However, the precise mode of action of allicin is unknown. Here, we show that growth inhibition of Escherichia coli during allicin exposure coincides with a depletion of the glutathione pool and S-allylmercapto modification of proteins, resulting in overall decreased total sulfhydryl levels. This is accompanied by the induction of the oxidative and heat stress response. We identified and quantified the allicin-induced modification S-allylmercaptocysteine for a set of cytoplasmic proteins by using a combination of label-free mass spectrometry and differential isotope-coded affinity tag labeling of reduced and oxidized thiol residues. Activity of isocitrate lyase AceA, an S-allylmercapto-modified candidate protein, is largely inhibited by allicin treatment in vivo. Allicin-induced protein modifications trigger protein aggregation, which largely stabilizes RpoH and thereby induces the heat stress response. At sublethal concentrations, the heat stress response is crucial to overcome allicin stress. Our results indicate that the mode of action of allicin is a combination of a decrease of glutathione levels, unfolding stress, and inactivation of crucial metabolic enzymes through S-allylmercapto modification of cysteines.	[Mueller, Alexandra; Eller, Jakob; Leichert, Lars Ingo Ole] Ruhr Univ Bochum, Inst Biochem & Pathobiochem Microbial Biochem, D-44780 Bochum, Germany; [Prochnow, Pascal; Bandow, Julia Elisabeth] Ruhr Univ Bochum, Angew Mikrobiol, D-44780 Bochum, Germany; [Kuhlmann, Katja] Ruhr Univ Bochum, Med Proteom Ctr, D-44780 Bochum, Germany; [Albrecht, Frank; Slusarenko, Alan John] Rhein Westfal Tech Hsch Aachen Univ, Dept Plant Physiol, D-52056 Aachen, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; RWTH Aachen University	Leichert, LIO (corresponding author), Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Microbial Biochem, Univ Str 150, D-44780 Bochum, Germany.	lars.leichert@ruhr-uni-bochum.de	Slusarenko, Alan/AAD-2785-2020; Leichert, Lars I./B-4762-2009; Bandow, Julia/K-8854-2012	Leichert, Lars I./0000-0002-5666-9681; Bandow, Julia/0000-0003-4100-8829; Baumann, Alexandra/0000-0002-6527-5262	Deutsche Forschungsgemeinschaft under German Research Foundation [LE 2905/1-1, SPP1710]; European Research Council (ERC) under the European Union [281384-FuMe]; Ruhr University Research SchoolPLUS; Richtlinien zur Forderung des wissenschaftlichen Nachwuchses der Rheinisch-Westfalischen Technischen Hochschule Aachen (RFwN); Rheinisch-Westfalische Technische Hochschule Aachen (RWTH); German Federal state of North Rhine-Westphalia	Deutsche Forschungsgemeinschaft under German Research Foundation(German Research Foundation (DFG)); European Research Council (ERC) under the European Union(European Research Council (ERC)); Ruhr University Research SchoolPLUS; Richtlinien zur Forderung des wissenschaftlichen Nachwuchses der Rheinisch-Westfalischen Technischen Hochschule Aachen (RFwN); Rheinisch-Westfalische Technische Hochschule Aachen (RWTH); German Federal state of North Rhine-Westphalia	This work was supported in part by Deutsche Forschungsgemeinschaft Grant LE 2905/1-1 under Priority Program SPP1710 of the German Research Foundation and by the European Research Council (ERC) under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC Grant Agreement 281384-FuMe (to L. I. O. L.). This manuscript was written in part during a paper writing retreat sponsored by the Ruhr University Research SchoolPLUS. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Richtlinien zur Forderung des wissenschaftlichen Nachwuchses der Rheinisch-Westfalischen Technischen Hochschule Aachen (RFwN) and Rheinisch-Westfalische Technische Hochschule Aachen (RWTH).; Supported by funding from the German Federal state of North Rhine-Westphalia "Translation innovativer Antibiotika aus NRW."	Albada HB, 2012, BEILSTEIN J ORG CHEM, V8, P1753, DOI 10.3762/bjoc.8.200; Ankri S, 1999, MICROBES INFECT, V1, P125, DOI 10.1016/S1286-4579(99)80003-3; Appel E, 2010, ANTIMICROB AGENTS CH, V54, P898, DOI 10.1128/AAC.01267-09; Arsene F, 2000, INT J FOOD MICROBIOL, V55, P3, DOI 10.1016/S0168-1605(00)00206-3; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; ASLUND F, 1994, P NATL ACAD SCI USA, V91, P9813, DOI 10.1073/pnas.91.21.9813; Banerjee SK, 2003, PHYTOTHER RES, V17, P97, DOI 10.1002/ptr.1281; Borlinghaus J, 2014, MOLECULES, V19, P12591, DOI 10.3390/molecules190812591; Cai Y, 2007, J ANTIBIOT, V60, P335, DOI 10.1038/ja.2007.45; Cavallito CJ, 1944, J AM CHEM SOC, V66, P1950, DOI 10.1021/ja01239a048; Cavallito CJ, 1944, J AM CHEM SOC, V66, P1952, DOI 10.1021/ja01239a049; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; CHELL RM, 1978, BIOCHEM J, V173, P165, DOI 10.1042/bj1730165; Cotgreave IA, 2002, METHOD ENZYMOL, V348, P175, DOI 10.1016/S0076-6879(02)48636-3; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Curtis H, 2004, PHYSIOL MOL PLANT P, V65, P79, DOI 10.1016/j.pmpp.2004.11.006; Cutler RR, 2004, BRIT J BIOMED SCI, V61, P71, DOI 10.1080/09674845.2004.11732646; DERMAN AI, 1993, SCIENCE, V262, P1744, DOI 10.1126/science.8259521; ELLMORE GS, 1994, AM J BOT, V81, P89, DOI 10.2307/2445567; FELDBERG RS, 1988, ANTIMICROB AGENTS CH, V32, P1763, DOI 10.1128/AAC.32.12.1763; FREEMAN F, 1995, J AGR FOOD CHEM, V43, P2332, DOI 10.1021/jf00057a004; GHANNOUM MA, 1988, J GEN MICROBIOL, V134, P2917; Gruhlke MCH, 2010, FREE RADICAL BIO MED, V49, P1916, DOI 10.1016/j.freeradbiomed.2010.09.019; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; LANCASTER JE, 1981, PLANT SCI LETT, V22, P169, DOI 10.1016/0304-4211(81)90139-5; Lawson LD, 2005, J AGR FOOD CHEM, V53, P6254, DOI 10.1021/jf050536+; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Leichert LIO, 2003, J BACTERIOL, V185, P1967, DOI 10.1128/JB.185.6.1967-1975.2003; MIRELMAN D, 1987, J INFECT DIS, V156, P243, DOI 10.1093/infdis/156.1.243; Miron T, 2000, BBA-BIOMEMBRANES, V1463, P20, DOI 10.1016/S0005-2736(99)00174-1; Muller A, 2013, J BACTERIOL, V195, P2807, DOI 10.1128/JB.00127-13; Neidhardt F. C., 1996, ESCHERICHIA COLI SAL, P14; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Obrist M, 2005, J BACTERIOL, V187, P3807, DOI 10.1128/JB.187.11.3807-3813.2005; Rabinkov A, 2000, BBA-MOL CELL RES, V1499, P144, DOI 10.1016/S0167-4889(00)00119-1; Rabinkov A, 1998, BBA-GEN SUBJECTS, V1379, P233, DOI 10.1016/S0304-4165(97)00104-9; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rao R., 1949, P INDIAN ACAD SCI B, V29, P148; Rivlin RS, 2001, J NUTR, V131, p951S, DOI 10.1093/jn/131.3.951S; ROBERTSON AGS, 1995, BIOCHEM J, V305, P239, DOI 10.1042/bj3050239; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sone M, 1997, J BIOL CHEM, V272, P6174, DOI 10.1074/jbc.272.10.6174; Stoll A., 2006, ADV ENZYMOLOGY RELAT, V11, P377; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wallock-Richards D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112726; Wenzel M, 2013, ACS CHEM BIOL, V8, P1442, DOI 10.1021/cb4000844; Wenzel M, 2011, ANTIMICROB AGENTS CH, V55, P2590, DOI 10.1128/AAC.00078-11; WILLS ED, 1956, BIOCHEM J, V63, P514, DOI 10.1042/bj0630514; YAMADA Y, 1977, ANTIMICROB AGENTS CH, V11, P743, DOI 10.1128/AAC.11.4.743; Zhang H, 2009, PROTEINS, V76, P617, DOI 10.1002/prot.22375; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235	53	79	83	3	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11477	11490		10.1074/jbc.M115.702308	http://dx.doi.org/10.1074/jbc.M115.702308			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27008862	Green Published, hybrid			2022-12-28	WOS:000377264800002
J	Czikora, A; Lundberg, DJ; Abramovitz, A; Lewin, NE; Kedei, N; Peach, ML; Zhou, XL; Merritt, RC; Craft, EA; Braun, DC; Blumberg, PM				Czikora, Agnes; Lundberg, Daniel J.; Abramovitz, Adelle; Lewin, Nancy E.; Kedei, Noemi; Peach, Megan L.; Zhou, Xiaoling; Merritt, Raymond C., Jr.; Craft, Elizabeth A.; Braun, Derek C.; Blumberg, Peter M.			Structural Basis for the Failure of the C1 Domain of Ras Guanine Nucleotide Releasing Protein 2 (RasGRP2) to Bind Phorbol Ester with High Affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cloning; guanine nucleotide exchange factor (GEF); phorbol ester; protein kinase C (PKC); Ras-related protein 1 (Rap1); C1 domain; RasGRP2	KINASE-C; CALDAG-GEFI; EXCHANGE FACTOR; MOLECULAR-DYNAMICS; DIACYLGLYCEROL BINDING; MEMBRANE INTERACTIONS; CRYSTAL-STRUCTURE; SWISS-MODEL; ACTIVATION; LIGAND	The C1 domain represents the recognition module for diacylglycerol and phorbol esters in protein kinase C, Ras guanine nucleotide releasing protein (RasGRP), and related proteins. RasGRP2 is exceptional in that its C1 domain has very weak binding affinity (K-d = 2890 +/- 240 nm for [H-3]phorbol 12,13-dibutyrate. We have identified four amino acid residues responsible for this lack of sensitivity. Replacing Asn(7), Ser(8), Ala(19), and Ile(21) with the corresponding residues from RasGRP1/3 (Thr(7), Tyr(8), Gly(19), and Leu(21), respectively) conferred potent binding affinity (K-d = 1.47 +/- 0.03 nm) in vitro and membrane translocation in response to phorbol 12-myristate 13-acetate in LNCaP cells. Mutant C1 domains incorporating one to three of the four residues showed intermediate behavior with S8Y making the greatest contribution. Binding activity for diacylglycerol was restored in parallel. The requirement for anionic phospholipid for [H-3]phorbol 12,13-dibutyrate binding was determined; it decreased in going from the single S8Y mutant to the quadruple mutant. The full-length RasGRP2 protein with the mutated C1 domains also showed strong phorbol ester binding, albeit modestly weaker than that of the C1 domain alone (K-d = 8.2 +/- 1.1 nm for the full-length protein containing all four mutations), and displayed translocation in response to phorbol ester. RasGRP2 is a guanyl exchange factor for Rap1. Consistent with the ability of phorbol ester to induce translocation of the full-length RasGRP2 with the mutated C1 domain, phorbol ester enhanced the ability of the mutated RasGRP2 to activate Rap1. Modeling confirmed that the four mutations helped the binding cleft maintain a stable conformation.	[Czikora, Agnes; Abramovitz, Adelle; Lewin, Nancy E.; Kedei, Noemi; Zhou, Xiaoling; Blumberg, Peter M.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Lundberg, Daniel J.; Merritt, Raymond C., Jr.; Craft, Elizabeth A.; Braun, Derek C.] Gallaudet Univ, Dept Sci Technol & Math, Washington, DC 20002 USA; [Peach, Megan L.] Frederick Natl Lab Canc Res, Basic Sci Program, Leidos Biomed Res Inc, Biol Chem Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Blumberg, PM (corresponding author), NCI, Bldg 37,Rm 4048,37 Convent Dr MSC4255, Bethesda, MD 20892 USA.	blumberp@dc37a.nci.nih.gov	zhou, xuan/GZA-8157-2022	Peach, Megan/0000-0002-4290-5268	Intramural Research Program; Center for Cancer Research; NCI; National Institutes of Health [Z1A BC 005270]; NCI, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [Z01BC005270, ZIABC005270] Funding Source: NIH RePORTER	Intramural Research Program; Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Intramural Research Program, Center for Cancer Research, NCI, National Institutes of Health Project Z1A BC 005270 and in part with federal funds from the NCI, National Institutes of Health under Contract HHSN261200800001E. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alon R, 2003, BLOOD, V101, P4437, DOI 10.1182/blood-2002-11-3427; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bertolini TM, 2003, J ORG CHEM, V68, P5028, DOI 10.1021/jo030029w; Blumberg PM, 2008, CURR DRUG TARGETS, V9, P641, DOI 10.2174/138945008785132376; Braun DC, 2005, MOL CANCER THER, V4, P141; Caloca MJ, 2004, J BIOL CHEM, V279, P20435, DOI 10.1074/jbc.M313013200; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Canault M, 2014, J EXP MED, V211, P1346, DOI 10.1084/jem.20130477; Carbo C, 2010, J LEUKOCYTE BIOL, V88, P313, DOI 10.1189/jlb.0110049; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Churchill EN, 2009, TRENDS ENDOCRIN MET, V20, P25, DOI 10.1016/j.tem.2008.10.002; Clyde-Smith J, 2000, J BIOL CHEM, V275, P32260, DOI 10.1074/jbc.M006087200; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Das J, 2014, CHEM REV, V114, P12108, DOI 10.1021/cr300481j; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Dupuy AJ, 2001, J BIOL CHEM, V276, P11804, DOI 10.1074/jbc.M008970200; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fuller DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038796; Geczy T, 2012, J BIOL CHEM, V287, P13137, DOI 10.1074/jbc.M111.320010; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo FF, 2001, J BIOL CHEM, V276, P25568, DOI 10.1074/jbc.M101277200; HERMANS J, 1969, NATURE, V224, P175, DOI 10.1038/224175a0; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurley JH, 1997, PROTEIN SCI, V6, P477; Igumenova TI, 2015, BIOCHEMISTRY-US, V54, P4953, DOI 10.1021/acs.biochem.5b00565; Irie K, 2004, BIOORGAN MED CHEM, V12, P4575, DOI 10.1016/j.bmc.2004.07.008; Irie K, 2002, PHARMACOL THERAPEUT, V93, P271, DOI 10.1016/S0163-7258(02)00196-1; Iwig JS, 2013, ELIFE, V2, DOI 10.7554/eLife.00813; Johnson JE, 2007, BIOCHEM J, V406, P223, DOI 10.1042/BJ20070294; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Kelsey JS, 2014, CHEMBIOCHEM, V15, P1131, DOI 10.1002/cbic.201400041; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Lewin Nancy E, 2003, Methods Mol Biol, V233, P129; Li JN, 2014, J AM CHEM SOC, V136, P11757, DOI 10.1021/ja505369r; Lorenzo PS, 2000, MOL PHARMACOL, V57, P840; Lorenzo PS, 2001, CANCER RES, V61, P943; Lucic I, 2016, J MOL BIOL, V428, P121, DOI 10.1016/j.jmb.2015.11.001; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Melowic HR, 2007, J BIOL CHEM, V282, P21467, DOI 10.1074/jbc.M700119200; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mott HR, 1996, P NATL ACAD SCI USA, V93, P8312, DOI 10.1073/pnas.93.16.8312; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pasvolsky R, 2007, J EXP MED, V204, P1571, DOI 10.1084/jem.20070058; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pu YM, 2014, J MED CHEM, V57, P3835, DOI 10.1021/jm500165n; Riches JC, 2014, BLOOD, V123, P4101, DOI 10.1182/blood-2014-01-552307; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shindo M, 2003, J BIOL CHEM, V278, P18448, DOI 10.1074/jbc.M300400200; Shindo M, 2001, BIOORGAN MED CHEM, V9, P2073, DOI 10.1016/S0968-0896(01)00100-6; Sosa MS, 2009, BIOCHEMISTRY-US, V48, P8171, DOI 10.1021/bi9010623; Stadtmann A, 2011, EUR J IMMUNOL, V41, P2074, DOI 10.1002/eji.201041196; Stahelin RV, 2009, J LIPID RES, V50, pS299, DOI 10.1194/jlr.R800078-JLR200; Stefanini L, 2010, PLATELETS, V21, P239, DOI 10.3109/09537101003639931; Stewart MD, 2014, J BIOL CHEM, V289, P27653, DOI 10.1074/jbc.M114.585570; Stewart MD, 2011, J MOL BIOL, V408, P949, DOI 10.1016/j.jmb.2011.03.020; Stone JC, 2006, BIOCHEM SOC T, V34, P858, DOI 10.1042/BST0340858; Stone James C, 2011, Genes Cancer, V2, P320, DOI 10.1177/1947601911408082; Subramanian H, 2013, J THROMB HAEMOST, V11, P1574, DOI 10.1111/jth.12271; Wang QMJ, 2001, J BIOL CHEM, V276, P19580, DOI 10.1074/jbc.M010089200; Xu RX, 1997, BIOCHEMISTRY-US, V36, P10709, DOI 10.1021/bi970833a; Zahedi B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.189605; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Ziemba BP, 2014, BIOCHEMISTRY-US, V53, P1697, DOI 10.1021/bi4016082	72	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11133	11147		10.1074/jbc.M116.725333	http://dx.doi.org/10.1074/jbc.M116.725333			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27022025	hybrid, Green Published			2022-12-28	WOS:000377042100017
J	Bourguignon, LYW; Wong, G; Shiina, M				Bourguignon, Lilly Y. W.; Wong, Gabriel; Shiina, Marisa			Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALDEHYDE DEHYDROGENASE; GENE-EXPRESSION; CD44; METHYLATION; PROGRESSION; LEUKEMIA; RECEPTOR; MARKER; SENSITIVITY	Human head and neck squamous cell carcinoma is a solid tumor malignancy associated with major morbidity and mortality. In this study, we determined that human head and neck squamous cell carcinoma-derived HSC-3 cells contain a sub-population of cancer stem cells (CSCs) characterized by a high level of CD44v3 and aldehyde dehydrogenase-1 (ALDH1) expression. Importantly, matrix hyaluronan (HA) induces the up-regulation of stem cell markers that display the hallmark CSC properties. Histone methyltransferase, DOT1L, is also up-regulated by HA in CSCs (isolated from HSC-3 cells). Further analyses indicate that the stimulation of microRNA-10b (miR-10b) expression is DOT1L-specific and HA/CD44-dependent in CSCs. This process subsequently results in the overexpression of RhoGTPases and survival proteins leading to tumor cell invasion and cisplatin resistance. Treatment of CSCs with DOT1L-specific small interfering RNAs (siRNAs) effectively blocks HA/CD44-mediated expression of DOT1L, miR-10b production, and RhoGTPase/survival protein up-regulation as well as reduces tumor cell invasion and enhances chemosensitivity. CSCs were also transfected with a specific anti-miR-10b inhibitor to silence miR-10b expression and block its target functions. Our results demonstrate that the anti-miR-10 inhibitor not only decreases RhoGTPase/survival protein expression and tumor cell invasion, but also increases chemosensitivity in HA-treated CSCs. Taken together, these findings strongly support the contention that histone methyltransferase, DOT1L-associated epigenetic changes induced by HA play pivotal roles in miR-10 production leading to up-regulation of RhoGTPase and survival proteins. All of these events are critically important for the acquisition of cancer stem cell properties, including self-renewal, tumor cell invasion, and chemotherapy resistance in HA/CD44-activated head and neck cancer.	Univ Calif San Francisco, Dept Med, Endocrine Unit, 4150 Clement St, San Francisco, CA 94121 USA; San Francisco VA Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Bourguignon, LYW (corresponding author), Univ Calif San Francisco, San Francisco Med Ctr, Dept Med, 4150 Clement St, San Francisco, CA 94121 USA.	lilly.bourguignon@ucsf.edu			Veterans Affairs Merit Review Award RR [D-1I01 RX000601]; Veterans Affairs Merit Review Award BLR [D-5I01 BX000628]; National Institutes of Health from USPHS [R01 CA66163]; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA066163] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000601, I01BX000628] Funding Source: NIH RePORTER	Veterans Affairs Merit Review Award RR(US Department of Veterans Affairs); Veterans Affairs Merit Review Award BLR(US Department of Veterans Affairs); National Institutes of Health from USPHS; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs Merit Review Awards RR and D-1I01 RX000601 and BLR and D-5I01 BX000628, National Institutes of Health Grant R01 CA66163 from USPHS, and a Department of Defense grant. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Astachov L, 2011, FRONT BIOSCI-LANDMRK, V16, P261, DOI 10.2741/3687; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Bourguignon LYW, 2014, ADV CANCER RES, V123, P255, DOI 10.1016/B978-0-12-800092-2.00010-1; Bourguignon Lilly Y W, 2012, Small GTPases, V3, P53, DOI 10.4161/sgtp.19110; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; Bradford CR, 2003, HEAD NECK-J SCI SPEC, V25, P654, DOI 10.1002/hed.10274; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; Choudhary M, 2007, STEM CELLS, V25, P3045, DOI 10.1634/stemcells.2007-0296; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Guessous F, 2013, J NEURO-ONCOL, V112, P153, DOI 10.1007/s11060-013-1047-0; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Haylock DN, 2006, REGEN MED, V1, P437, DOI 10.2217/17460751.1.4.437; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Janzen CJ, 2006, MOL CELL, V23, P497, DOI 10.1016/j.molcel.2006.06.027; Kato T, 2000, HEAD NECK-J SCI SPEC, V22, P748, DOI 10.1002/1097-0347(200012)22:8<748::AID-HED2>3.3.CO;2-Y; Kim W, 2012, J BIOL CHEM, V287, P5588, DOI 10.1074/jbc.M111.328138; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Seton-Rogers S, 2009, NAT REV CANCER, V9, P610, DOI 10.1038/nrc2719; Shiga H, 2000, HEAD NECK-J SCI SPEC, V22, P599, DOI 10.1002/1097-0347(200009)22:6<599::AID-HED9>3.0.CO;2-M; Shiina M., 2015, INT J CELL BIOL, V2015; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sun X, 2014, ONCOGENE, V33, P4967, DOI [10.1038/onc.2013.492, 10.1038/onc.2014.224]; Toole BP, 2002, AM J PATHOL, V161, P745, DOI 10.1016/S0002-9440(10)64232-0; UNDERHILL C, 1992, J CELL SCI, V103, P293; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang SJ, 2011, AM J PATHOL, V178, P956, DOI 10.1016/j.ajpath.2010.11.077; Wang SJ, 2009, LARYNGOSCOPE, V119, P1518, DOI 10.1002/lary.20506; WHEATLEY SC, 1995, CELL ADHES COMMUN, V3, P217, DOI 10.3109/15419069509081288	42	47	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10571	10585		10.1074/jbc.M115.700021	http://dx.doi.org/10.1074/jbc.M115.700021			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27002147	Green Published, hybrid			2022-12-28	WOS:000377042600012
J	Ioannou, MS; Girard, M; McPherson, PS				Ioannou, Maria S.; Girard, Martine; McPherson, Peter S.			Rab13 Traffics on Vesicles Independent of Prenylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP DISSOCIATION INHIBITOR; SMALL GTPASE RAB13; C-TERMINAL DOMAIN; MEMBRANE COMPARTMENTS; NEURITE OUTGROWTH; EPITHELIAL-CELLS; PROTEIN; PATHWAY; RAB35; TRANSFERRIN	Rab GTPases are critical regulators of membrane trafficking. The canonical view is that Rabs are soluble in their inactive GDP-bound form, and only upon activation and conversion to their GTP-bound state are they anchored to membranes through membrane insertion of a C-terminal prenyl group. Here we demonstrate that C-terminal prenylation is not required for Rab13 to associate with and traffic on vesicles. Instead, inactive Rab13 appears to associate with vesicles via protein-protein interactions. Only following activation does Rab13 associate with the plasma membrane, presumably with insertion of the C-terminal prenyl group into the membrane.	[Ioannou, Maria S.; Girard, Martine; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Univ, Montreal, PQ H3A 2B4, Canada	McGill University	McPherson, PS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Univ, Montreal, PQ H3A 2B4, Canada.	peter.mcpherson@mcgill.ca			Canadian Institutes of Health Research [MOP-62684]; Jeanne Timmins Costello fellowship; Anne and Richard Sievers Award in Neuroscience	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Jeanne Timmins Costello fellowship; Anne and Richard Sievers Award in Neuroscience	This work was supported by Canadian Institutes of Health Research Grant MOP-62684 (to P. S. M.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Jeanne Timmins Costello fellowship and an Anne and Richard Sievers Award in Neuroscience.	Abou-Zeid N, 2011, MOL BIOL CELL, V22, P3431, DOI 10.1091/mbc.E11-01-0030; Ali BR, 2004, J CELL SCI, V117, P6401, DOI 10.1242/jcs.01542; Allaire PD, 2013, J CELL SCI, V126, P722, DOI 10.1242/jcs.112375; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; Cherry S, 2013, ELIFE, V2, DOI 10.7554/eLife.01064; Di Giovanni S, 2005, J BIOL CHEM, V280, P2084, DOI 10.1074/jbc.M411975200; FARNSWORTH CL, 1991, MOL CELL BIOL, V11, P4822, DOI 10.1128/MCB.11.10.4822; GALLI T, 1994, J CELL BIOL, V125, P1015, DOI 10.1083/jcb.125.5.1015; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; Girard M, 2005, J BIOL CHEM, V280, P40135, DOI 10.1074/jbc.M505036200; Gomes AQ, 2003, MOL BIOL CELL, V14, P1882, DOI 10.1091/mbc.E02-10-0639; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Ioannou MS, 2015, J CELL BIOL, V208, P629, DOI 10.1083/jcb.201407068; JOBERTY G, 1993, FEBS LETT, V330, P323, DOI 10.1016/0014-5793(93)80897-4; Kohler K, 2004, J CELL BIOL, V165, P175, DOI 10.1083/jcb.200312118; Kumari R, 2011, METHODS MOL BIOL, V746, P411, DOI 10.1007/978-1-61779-126-0_24; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Li F, 2014, P NATL ACAD SCI USA, V111, P2572, DOI 10.1073/pnas.1313655111; Marat AL, 2012, MOL BIOL CELL, V23, P163, DOI 10.1091/mbc.E11-05-0474; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Marzesco AM, 1998, J BIOL CHEM, V273, P22340, DOI 10.1074/jbc.273.35.22340; Marzesco AM, 2002, MOL BIOL CELL, V13, P1819, DOI 10.1091/mbc.02-02-0029; Militello RD, 2013, TRAFFIC, V14, P502, DOI 10.1111/tra.12057; Mochizuki Y, 2013, J BIOL CHEM, V288, P1009, DOI 10.1074/jbc.M112.395087; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nokes RL, 2008, J CELL BIOL, V182, P845, DOI 10.1083/jcb.200802176; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; Pereira-Leal JB, 2001, FEBS LETT, V498, P197, DOI 10.1016/S0014-5793(01)02483-8; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; Sakane A, 2010, MOL CELL BIOL, V30, P1077, DOI 10.1128/MCB.01067-09; Savina A, 2002, J CELL SCI, V115, P2505; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SOLDATI T, 1993, MOL BIOL CELL, V4, P425, DOI 10.1091/mbc.4.4.425; Stenmark H, 2001, GENOME BIOL, V2; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Wu CS, 2011, J BIOL CHEM, V286, P23511, DOI 10.1074/jbc.M111.245209; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8; Yang PS, 2011, CANCER SCI, V102, P2172, DOI 10.1111/j.1349-7006.2011.02089.x	47	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10726	10735		10.1074/jbc.M116.722298	http://dx.doi.org/10.1074/jbc.M116.722298			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26969162	Green Published, hybrid			2022-12-28	WOS:000377042600024
J	Cunningham, KE; Vincent, G; Sodhi, CP; Novak, EA; Ranganathan, S; Egan, CE; Stolz, DB; Rogers, MB; Firek, B; Morowitz, MJ; Gittes, GK; Zuckerbraun, BS; Hackam, DJ; Mollen, KP				Cunningham, Kellie E.; Vincent, Garret; Sodhi, Chhinder P.; Novak, Elizabeth A.; Ranganathan, Sarangarajan; Egan, Charlotte E.; Stolz, Donna Beer; Rogers, Matthew B.; Firek, Brian; Morowitz, Michael J.; Gittes, George K.; Zuckerbraun, Brian S.; Hackam, David J.; Mollen, Kevin P.			Peroxisome Proliferator-activated Receptor-gamma Coactivator 1-alpha (PGC1 alpha) Protects against Experimental Murine Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; EPITHELIAL BARRIER FUNCTION; DEXTRAN SULFATE SODIUM; ULCERATIVE-COLITIS; MITOCHONDRIAL BIOGENESIS; OXIDATIVE STRESS; SKELETAL-MUSCLE; CROHNS-DISEASE; INTESTINAL INFLAMMATION; METABOLIC REGULATOR	Peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PG CM) is the primary regulator of mitochondrial biogenesis and was recently found to be highly expressed within the intestinal epithelium. PGC1 alpha is decreased in the intestinal epithelium of patients with inflammatory bowel disease, but its role in pathogenesis is uncertain. We now hypothesize that PGC1 alpha protects against the development of colitis and helps to maintain the integrity of the intestinal barrier. We selectively deleted PGC1 alpha from the intestinal epithelium of mice by breeding a PGC1 alpha(loxP/loxP) mouse with a villin-cre mouse. Their progeny (pGC1 alpha(Delta IEC) mice) were subjected to 2% dextran sodium sulfate (DSS) colitis for 7 days. The SIRT1 agonist SRT1720 was used to enhance PGC1 alpha activation in wild-type mice during DSS exposure. Mice lacking PGC1 alpha within the intestinal epithelium were more susceptible to DSS colitis than their wild-type littermates. Pharmacologic activation of PGC1 alpha successfully ameliorated disease and restored mitochondrial integrity. These findings suggest that a depletion of PGC1 alpha in the intestinal epithelium contributes to inflammatory changes through a failure of mitochondrial structure and function as well as a breakdown of the intestinal barrier, which leads to increased bacterial translocation. PGC1 alpha induction helps to maintain mitochondrial integrity, enhance intestinal barrier function, and decrease inflammation.	[Vincent, Garret; Novak, Elizabeth A.; Egan, Charlotte E.; Rogers, Matthew B.; Firek, Brian; Morowitz, Michael J.; Gittes, George K.; Mollen, Kevin P.] UPMC, Div Pediat Surg, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Cunningham, Kellie E.; Vincent, Garret; Novak, Elizabeth A.; Egan, Charlotte E.; Rogers, Matthew B.; Firek, Brian; Morowitz, Michael J.; Gittes, George K.; Zuckerbraun, Brian S.; Mollen, Kevin P.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213 USA; [Sodhi, Chhinder P.; Hackam, David J.] Johns Hopkins Univ, Dept Surg, Baltimore, MD 21218 USA; [Ranganathan, Sarangarajan] UPMC, Dept Pathol, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Stolz, Donna Beer] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mollen, KP (corresponding author), UPMC, Childrens Hosp Pittsburgh, 4401 Penn Ave,Fac Pavil Ste 7000, Pittsburgh, PA 15224 USA.	kevin.mollen@chp.edu		Mollen, Kevin/0000-0001-7629-2722; Ranganathan, Sarangarajan/0000-0001-6214-9167; Hackam, David/0000-0001-5195-8807	National Institutes of Health [DK101753, GM078238, DK083752]; Association for Academic Surgery; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083752, P30DK057521, K08DK101753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association for Academic Surgery; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK101753 (to K. P. M.), GM078238 (to D. J. H.), and DK083752 (to D. J. H.) and the Association for Academic Surgery (to K. P. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Aquilano K, 2013, CURR MOL MED, V13, P140, DOI 10.2174/156652413804486241; Bar F, 2013, GASTROENTEROLOGY, V145, P1055, DOI 10.1053/j.gastro.2013.07.015; Baldelli S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.458; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen Y, 2015, J BIOL CHEM, V290, P20580, DOI 10.1074/jbc.M115.653584; D'Errico I, 2011, P NATL ACAD SCI USA, V108, P6603, DOI 10.1073/pnas.1016354108; Damiani C. R., 2007, J GASTROEN HEPATOL, V22, P1846; DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1; Funk JA, 2010, J PHARMACOL EXP THER, V333, P593, DOI 10.1124/jpet.109.161992; Garcia MM, 2011, J PATHOL, V225, P324, DOI 10.1002/path.2881; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Glover LE, 2013, P NATL ACAD SCI USA, V110, P19820, DOI 10.1073/pnas.1302840110; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Isman CA, 2003, J ENDOCRINOL, V177, P471, DOI 10.1677/joe.0.1770471; Jian BX, 2012, MOL MED, V18, P209, DOI 10.2119/molmed.2011.00365; KAMEYAMA J, 1984, TOHOKU J EXP MED, V143, P253, DOI 10.1620/tjem.143.253; Kappelman MD, 2007, CLIN GASTROENTEROL H, V5, P1424, DOI 10.1016/j.cgh.2007.07.012; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leick L, 2010, AM J PHYSIOL-ENDOC M, V299, pE456, DOI 10.1152/ajpendo.00648.2009; Lewis K, 2009, ANN NY ACAD SCI, V1165, P327, DOI 10.1111/j.1749-6632.2009.04036.x; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Liu D, 2014, INT J BIOCHEM CELL B, V57, P7, DOI 10.1016/j.biocel.2014.09.018; Long MD, 2014, INFLAMM BOWEL DIS, V20, P398, DOI 10.1097/01.MIB.0000435441.30107.8b; Ma CX, 2006, CELL MICROBIOL, V8, P1669, DOI 10.1111/j.1462-5822.2006.00741.x; Mehlem A., 2016, DIABETES, V2016; Merga Y, 2014, DIGEST DIS, V32, P475, DOI 10.1159/000358156; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Nazli A, 2004, AM J PATHOL, V164, P947, DOI 10.1016/S0002-9440(10)63182-3; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Novak EA, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00062; Oku T, 2006, INFLAMM BOWEL DIS, V12, P630, DOI 10.1097/01.MIB.0000225335.68614.73; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pallas M, 2009, CURR NEUROVASC RES, V6, P70, DOI 10.2174/156720209787466019; Pavlick KP, 2002, FREE RADICAL BIO MED, V33, P311, DOI 10.1016/S0891-5849(02)00853-5; Rodenburg W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-144; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; ROEDIGER WEW, 1980, LANCET, V2, P712; Santhanam S, 2012, INFLAMM BOWEL DIS, V18, P2158, DOI 10.1002/ibd.22926; Schurmann G, 1999, INT J COLORECTAL DIS, V14, P41, DOI 10.1007/s003840050181; Segui J, 2004, J LEUKOCYTE BIOL, V76, P537, DOI 10.1189/jlb.0304196; Shikhare G, 2010, J GASTROENTEROL, V45, P673, DOI 10.1007/s00535-010-0241-5; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Sifroni KG, 2010, MOL CELL BIOCHEM, V342, P111, DOI 10.1007/s11010-010-0474-x; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Taylor CT, 2010, ARTERIOSCL THROM VAS, V30, P643, DOI 10.1161/ATVBAHA.108.181628; Ussakli CH, 2013, JNCI-J NATL CANCER I, V105, P1239, DOI 10.1093/jnci/djt167; Wang A, 2014, AM J PATHOL, V184, P2516, DOI 10.1016/j.ajpath.2014.05.019; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamazaki Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE1179, DOI 10.1152/ajpendo.90997.2008; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104; Zhu H, 2012, EXP BIOL MED, V237, P474, DOI 10.1258/ebm.2011.011358	73	43	43	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10184	10200		10.1074/jbc.M115.688812	http://dx.doi.org/10.1074/jbc.M115.688812			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26969166	Green Published, hybrid			2022-12-28	WOS:000375602800028
J	Kim-Muller, JY; Kim, YJR; Fan, JS; Zhao, SG; Banks, AS; Prentki, M; Accili, D				Kim-Muller, Ja Young; Kim, Young Jung R.; Fan, Jason; Zhao, Shangang; Banks, Alexander S.; Prentki, Marc; Accili, Domenico			FoxO1 Deacetylation Decreases Fatty Acid Oxidation in beta-Cells and Sustains Insulin Secretion in Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD PROTEIN FOXO1; TRANSCRIPTION FACTORS; REGULATES FOXO1; GLUCOSE; MICE; METABOLISM; RECEPTOR; FAILURE; MASS; DIFFERENTIATION	Pancreatic beta-cell dysfunction contributes to onset and progression of type 2 diabetes. In this state beta-cells become metabolically inflexible, losing the ability to select between carbohydrates and lipids as substrates for mitochondrial oxidation. These changes lead to beta-cell dedifferentiation. We have proposed that FoxO proteins are activated through deacetylation-dependent nuclear translocation to forestall the progression of these abnormalities. However, how deacetylated FoxO exert their actions remains unclear. To address this question, we analyzed islet function in mice homozygous for knock-in alleles encoding deacetylated FoxO1 (6KR). Islets expressing 6KR mutant FoxO1 have enhanced insulin secretion in vivo and ex vivo and decreased fatty acid oxidation ex vivo. Remarkably, the gene expression signature associated with FoxO1 deacetylation differs from wild type by only similar to 2% of the > 4000 genes regulated in response to re-feeding. But this narrow swath includes key genes required for beta-cell identity, lipid metabolism, and mitochondrial fatty acid and solute transport. The data support the notion that deacetylated FoxO1 protects beta-cell function by limiting mitochondrial lipid utilization and raise the possibility that inhibition of fatty acid oxidation in beta-cells is beneficial to diabetes treatment.	[Kim-Muller, Ja Young; Kim, Young Jung R.; Fan, Jason; Accili, Domenico] Columbia Univ, Naomi Berrie Diabet Ctr, Dept Med, New York, NY 10032 USA; [Kim-Muller, Ja Young] Merck Res Labs, Boston, MA USA; [Zhao, Shangang; Prentki, Marc] Univ Montreal, Mol Nutr Unit, Montreal, PQ H2X 0A9, Canada; [Zhao, Shangang; Prentki, Marc] Univ Montreal, Montreal Diabet Res Ctr, CRCHUM, Montreal, PQ H2X 0A9, Canada; [Zhao, Shangang; Prentki, Marc] Univ Montreal, Dept Nutr, Montreal, PQ H2X 0A9, Canada; [Zhao, Shangang; Prentki, Marc] Univ Montreal, Dept Biochem, Montreal, PQ H2X 0A9, Canada; [Zhao, Shangang; Prentki, Marc] Univ Montreal, Dept Mol Med, Montreal, PQ H2X 0A9, Canada; [Banks, Alexander S.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Columbia University; Merck & Company; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Harvard University; Brigham & Women's Hospital	Accili, D (corresponding author), Dept Med, 1150 St Nicholas Ave,Room238, New York, NY 10032 USA.; Accili, D (corresponding author), Naomi Berrie Diabet Ctr, 1150 St Nicholas Ave,Room238, New York, NY 10032 USA.	da230@columbia.edu	ZHao, Shangang/H-5730-2019; Kim, Youngjung/F-6176-2017; Banks, Alexander/B-4832-2012	Zhao, Shangang/0000-0002-9209-8206; Fan, Jason/0000-0003-3481-1728; Kim, Youngjung/0000-0002-6345-1138; Banks, Alexander/0000-0003-1787-6925	National Institutes Grants [DK057539, DK64819, DK63608]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539, R01DK058282, P30DK063608, P30DK026687, R01DK064819] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020056] Funding Source: NIH RePORTER	National Institutes Grants; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes Grants DK057539, DK64819, and DK63608 (to the Columbia University Diabetes Research Center). The authors declare that they have no conflict of interest that relates to this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Banks AS, 2011, CELL METAB, V14, P587, DOI 10.1016/j.cmet.2011.09.012; Brun T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082364; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Cavener DR, 2010, TRENDS ENDOCRIN MET, V21, P714, DOI 10.1016/j.tem.2010.08.005; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; Chu RY, 2004, MOL CELL BIOL, V24, P6288, DOI 10.1128/MCB.24.14.6288-6297.2004; Chu ZL, 2007, ENDOCRINOLOGY, V148, P2601, DOI 10.1210/en.2006-1608; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; Delghingaro-Augusto V, 2009, DIABETOLOGIA, V52, P1122, DOI 10.1007/s00125-009-1317-8; Ferrannini E, 2010, CELL METAB, V11, P349, DOI 10.1016/j.cmet.2010.04.009; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Gosmain Y, 2011, DIABETES OBES METAB, V13, P31, DOI 10.1111/j.1463-1326.2011.01445.x; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Haeusler RA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6190; Kanai Y, 2013, MOL ASPECTS MED, V34, P108, DOI 10.1016/j.mam.2013.01.001; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kim-Muller JY, 2014, CELL METAB, V20, P593, DOI 10.1016/j.cmet.2014.08.012; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kowluru A, 2010, ENDOCR REV, V31, P52, DOI 10.1210/er.2009-0022; Martinez SC, 2006, DIABETES, V55, P1581, DOI 10.2337/db05-0678; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; Pajvani UB, 2015, DIABETOLOGIA, V58, P2459, DOI 10.1007/s00125-015-3722-5; Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Prentki M, 2012, MOL CELL ENDOCRINOL, V353, P88, DOI 10.1016/j.mce.2011.11.004; Qiang L, 2012, J BIOL CHEM, V287, P13944, DOI 10.1074/jbc.M111.332767; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Ren P, 2015, J PATHOL, V235, P90, DOI 10.1002/path.4429; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Soni MS, 2014, DIABETES, V63, P3805, DOI 10.2337/db13-1677; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Talchai SC, 2015, DIABETES, V64, P2868, DOI 10.2337/db14-1696; Xuan SH, 2010, J BIOL CHEM, V285, P41044, DOI 10.1074/jbc.M110.144790	39	30	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10162	10172		10.1074/jbc.M115.705608	http://dx.doi.org/10.1074/jbc.M115.705608			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26984405	Green Published, hybrid			2022-12-28	WOS:000375602800026
J	[Anonymous]				[Anonymous]			Revealing the Impact of Oxygen on Molecular Biology: The Work of Howard Mason	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material																			0	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9851	+		10.1074/jbc.O116.000002	http://dx.doi.org/10.1074/jbc.O116.000002			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	27129197	hybrid, Green Published			2022-12-28	WOS:000375602300041
J	Moghal, A; Hwang, L; Faull, K; Ibba, M				Moghal, Adil; Hwang, Lin; Faull, Kym; Ibba, Michael			Multiple Quality Control Pathways Limit Non-protein Amino Acid Use by Yeast Cytoplasmic Phenylalanyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; GENETIC-CODE; PROTEIN-BIOSYNTHESIS; MISTRANSLATION; TRANSLATION; TYROSINE; SPECIFICITY; FREQUENCY; ERRORS; CELLS	Non-protein amino acids, particularly isomers of the proteinogenic amino acids, present a threat to proteome integrity if they are mistakenly inserted into proteins. Quality control during aminoacyl-tRNA synthesis reduces non-protein amino acid incorporation by both substrate discrimination and proofreading. For example phenylalanyl-tRNA synthetase (PheRS) proofreads the non-protein hydroxylated phenylalanine derivative m-Tyr after its attachment to tRNAPhe. We now show in Saccharomyces cerevisiae that PheRS misacylation of tRNAPhe with the more abundant Phe oxidation product o-Tyr is limited by kinetic discrimination against o-Tyr-AMP in the transfer step followed by o-Tyr-AMP release from the synthetic active site. This selective rejection of a non-protein aminoacyl-adenylate is in addition to known kinetic discrimination against certain non-cognates in the activation step as well as catalytic hydrolysis of mispaired aminoacyl-tRNAPhe species. We also report an unexpected resistance to cytotoxicity by a S. cerevisiae mutant with ablated post-transfer editing activity when supplemented with o-Tyr, cognate Phe, or Ala, the latter of which is not a substrate for activation by this enzyme. Our phenotypic, metabolomic, and kinetic analyses indicate at least three modes of discrimination against non-protein amino acids by S. cerevisiae PheRS and support a non-canonical role for SccytoPheRS post-transfer editing in response to amino acid stress.	[Moghal, Adil; Ibba, Michael] Ohio State Univ, Dept Microbiol, Ohio State Biochem Program, Columbus, OH 43210 USA; [Hwang, Lin; Faull, Kym] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA	Ohio State University; University of California System; University of California Los Angeles	Ibba, M (corresponding author), Ohio State Univ, Dept Microbiol, 484 West 12th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu		Moghal, Adil/0000-0003-4097-331X	National Institutes of Health [T32 GM008512, GM086252]; National Science Foundation [MCB-1412611, MCB 1412773]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM086252, T32GM008512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant Training Grants T32 GM008512 and GM086252 (to A. M.). This work was also supported by National Science Foundation Grants MCB-1412611 and MCB 1412773. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bertin C, 2007, P NATL ACAD SCI USA, V104, P16964, DOI 10.1073/pnas.0707198104; Bullwinkle T, 2014, ANNU REV GENET, V48, P149, DOI 10.1146/annurev-genet-120213-092101; Bullwinkle TJ, 2016, P NATL ACAD SCI USA, V113, P2252, DOI 10.1073/pnas.1525206113; Bullwinkle TJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02501; Chen X, 2011, NUCLEIC ACIDS RES, V39, P235, DOI 10.1093/nar/gkq763; Cvetesic N, 2014, EMBO J, V33, P1639, DOI 10.15252/embj.201488199; FAULL KF, 1977, PEDIATR RES, V11, P631, DOI 10.1203/00006450-197705000-00002; Gomes AC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r206; Goodarzi H, 2015, CELL, V161, P790, DOI 10.1016/j.cell.2015.02.053; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Hendrickson TL, 2002, MOL CELL, V9, P353, DOI 10.1016/S1097-2765(02)00449-5; IBBA M, 1994, BIOCHEMISTRY-US, V33, P7107, DOI 10.1021/bi00189a013; Li L, 2011, P NATL ACAD SCI USA, V108, P9378, DOI 10.1073/pnas.1016460108; Ling JQ, 2012, J BIOL CHEM, V287, P28518, DOI 10.1074/jbc.M112.372920; Ling JQ, 2010, P NATL ACAD SCI USA, V107, P4028, DOI 10.1073/pnas.1000315107; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; LOFTFIELD RB, 1963, BIOCHEM J, V89, P82, DOI 10.1042/bj0890082; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Poljak A, 2003, REDOX REP, V8, P371, DOI 10.1179/135100003225003401; Popp O, 2015, BIOTECHNOL BIOENG, V112, P1187, DOI 10.1002/bit.25528; Raina M, 2014, J BIOL CHEM, V289, P17780, DOI 10.1074/jbc.M114.564609; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Tan M, 2010, J BIOL CHEM, V285, P3235, DOI 10.1074/jbc.M109.060616; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Yadavalli SS, 2013, NUCLEIC ACIDS RES, V41, P1104, DOI 10.1093/nar/gks1240	28	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15796	15805		10.1074/jbc.M116.726828	http://dx.doi.org/10.1074/jbc.M116.726828			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226603	Green Published, hybrid			2022-12-28	WOS:000380584200032
J	Das, F; Dey, N; Bera, A; Kasinath, BS; Ghosh-Choudhury, N; Choudhury, GG				Das, Falguni; Dey, Nirmalya; Bera, Amit; Kasinath, Balakuntalam S.; Ghosh-Choudhury, Nandini; Choudhury, Goutam Ghosh			MicroRNA-214 Reduces Insulin-like Growth Factor-1 (IGF-1) Receptor Expression and Downstream mTORC1 Signaling in Renal Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; cancer; cell signaling; microRNA (miRNA); mTOR complex (mTORC)	PHASE-III TRIAL; MAMMALIAN TARGET; CLEAR-CELL; MESSENGER-RNA; TRANSLATION INITIATION; TUMOR PROGRESSION; PROMOTER ACTIVITY; MESANGIAL CELLS; CANCER; RAPAMYCIN	Elevated IGF-1/insulin-like growth factor-1 receptor (IGF-1R) autocrine/paracrine signaling in patients with renal cell carcinoma is associated with poor prognosis of the disease independent of their von Hippel-Lindau (VHL) status. Increased expression of IGF-1R in renal cancer cells correlates with their potency of tumor development and progression. The mechanism by which expression of IGF-1R is increased in renal carcinoma is not known. We report that VHL-deficient and VHL-positive renal cancer cells possess significantly decreased levels of mature, pre-, and pri-miR-214 than normal proximal tubular epithelial cells. We identified an miR-214 recognition element in the 3UTR of IGF-1R mRNA and confirmed its responsiveness to miR-214. Overexpression of miR-214 decreased the IGF-1R protein levels, resulting in the inhibition of Akt kinase activity in both types of renal cancer cells. IGF-1 provoked phosphorylation and inactivation of PRAS40 in an Akt-dependent manner, leading to the activation of mTORC1 signal transduction to increase phosphorylation of S6 kinase and 4EBP-1. Phosphorylation-deficient mutants of PRAS40 and 4EBP-1 significantly inhibited IGF-1R-driven proliferation of renal cancer cells. Expression of miR-214 suppressed IGF-1R-induced phosphorylation of PRAS40, S6 kinase, and 4EBP-1, indicating inhibition of mTORC1 activity. Finally, miR-214 significantly blocked IGF-1R-forced renal cancer cell proliferation, which was reversed by expression of 3UTR-less IGF-1R and constitutively active mTORC1. Together, our results identify a reciprocal regulation of IGF-1R levels and miR-214 expression in renal cancer cells independent of VHL status. Our data provide evidence for a novel mechanism for IGF-1R-driven renal cancer cell proliferation involving miR-214 and mTORC1.	[Kasinath, Balakuntalam S.; Ghosh-Choudhury, Nandini; Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Vet Affairs Res & Geriatr Res, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Educ & Clin Ctr, San Antonio, TX 78229 USA; [Das, Falguni; Dey, Nirmalya; Bera, Amit; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Choudhury, GG (corresponding author), South Texas Vet Hlth Care Syst, Vet Affairs Res & Geriatr Res, San Antonio, TX 78229 USA.; Choudhury, GG (corresponding author), South Texas Vet Hlth Care Syst, Educ & Clin Ctr, San Antonio, TX 78229 USA.; Choudhury, GG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu			Veterans Affairs Research Service Merit Review Grant [2 I01 BX000926]; National Institutes of Health [RO1 DK50190]; Veterans Affairs Merit Review Grant [5I01BX001340, 5I01BX000150]; Veterans Affairs Senior Research Career Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000926] Funding Source: NIH RePORTER	Veterans Affairs Research Service Merit Review Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Grant(US Department of Veterans Affairs); Veterans Affairs Senior Research Career Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by the Veterans Affairs Research Service Merit Review Grant 2 I01 BX000926 and National Institutes of Health Grant RO1 DK50190 (to G. G. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Veterans Affairs Merit Review Grant 5I01BX001340.; Supported by Veterans Affairs Merit Review Grant 5I01BX000150.; Recipient of a Veterans Affairs Senior Research Career Scientist Award. To whom correspondence should be addressed. E-mail: choudhuryg@uthscsa.edu.	Abou Youssif T, 2011, CANCER-AM CANCER SOC, V117, P290, DOI 10.1002/cncr.25402; ALMEIDA A, 1994, GENE CHROMOSOME CANC, V11, P63, DOI 10.1002/gcc.2870110110; [Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BASERGA R, 1995, CANCER RES, V55, P249; Bera A, 2014, EXP CELL RES, V328, P99, DOI 10.1016/j.yexcr.2014.06.022; Bera A, 2013, CELL SIGNAL, V25, P2575, DOI 10.1016/j.cellsig.2013.08.005; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Burgos SA, 2010, DOMEST ANIM ENDOCRIN, V38, P211, DOI 10.1016/j.domaniend.2009.10.005; Cheung C, 2005, INT J UROL, V12, P17, DOI 10.1111/j.1442-2042.2004.00993.x; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Cho D, 2007, CLIN GENITOURIN CANC, V5, P379, DOI 10.3816/CGC.2007.n.020; Choudhury GG, 2001, J BIOL CHEM, V276, P35636, DOI 10.1074/jbc.M100946200; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Das F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109608; Das F, 2012, J BIOL CHEM, V287, P3808, DOI 10.1074/jbc.M111.246397; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Del Bufalo D, 2006, CANCER RES, V66, P5549, DOI 10.1158/0008-5472.CAN-05-2825; Dey N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037366; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Dey N, 2010, J CELL PHYSIOL, V225, P27, DOI 10.1002/jcp.22186; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; Giraud S, 2001, J BIOL CHEM, V276, P5668, DOI 10.1074/jbc.M005928200; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Grosshans H, 2010, CANCER CELL, V18, P295, DOI 10.1016/j.ccr.2010.10.005; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Kaelin WG, 2009, CANCER-AM CANCER SOC, V115, P2262, DOI 10.1002/cncr.24232; KALEKO M, 1990, MOL CELL BIOL, V10, P464, DOI 10.1128/MCB.10.2.464; Karumanchi SA, 2002, CURR OPIN NEPHROL HY, V11, P37, DOI 10.1097/00041552-200201000-00006; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Mahimainathan L, 2009, J BIOL CHEM, V284, P27790, DOI 10.1074/jbc.M109.028860; Mandal CC, 2011, J BIOL CHEM, V286, P11314, DOI 10.1074/jbc.M110.193714; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maor SB, 2000, MOL GENET METAB, V69, P130, DOI 10.1006/mgme.1999.2958; McDermott DF, 2005, J CLIN ONCOL, V23, P133, DOI 10.1200/JCO.2005.03.206; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Meng Z, 2005, NUCLEIC ACIDS RES, V33, P2962, DOI 10.1093/nar/gki603; Meng Z, 2008, J CELL PHYSIOL, V217, P172, DOI 10.1002/jcp.21486; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Neal CS, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-64; Negrier S, 1998, NEW ENGL J MED, V338, P1272, DOI 10.1056/NEJM199804303381805; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Parker AS, 2004, CANCER-AM CANCER SOC, V100, P2577, DOI 10.1002/cncr.20322; Parker AS, 2003, J UROLOGY, V170, P420, DOI 10.1097/01.ju.0000071474.70103.92; Parker AS, 2002, HUM PATHOL, V33, P801, DOI 10.1053/hupa.2002.126186; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Qian CN, 2009, CANCER RES, V69, P8256, DOI 10.1158/0008-5472.CAN-09-1689; Rasmuson T, 2004, ACTA ONCOL, V43, P744, DOI 10.1080/02841860410017260; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rodon J, 2008, MOL CANCER THER, V7, P2575, DOI 10.1158/1535-7163.MCT-08-0265; Rosendahl A, 2004, INT J ONCOL, V25, P1327; Rosendahl AH, 2008, INT J CANCER, V123, P1286, DOI 10.1002/ijc.23642; Rouviere O, 2006, NAT CLIN PRACT ONCOL, V3, P200, DOI 10.1038/ncponc0479; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Scapoli L, 2010, INT J IMMUNOPATH PH, V23, P1229, DOI 10.1177/039463201002300427; Schips L, 2004, AM J CLIN PATHOL, V122, P931, DOI 10.1309/G7PY0RE7T86HQYV; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Traynor K, 2009, AM J HEALTH-SYST PH, V66, P788, DOI 10.2146/news090037; Venkatesan B, 2008, FASEB J, V22, P3469, DOI 10.1096/fj.08-109488; Wang YH, 2009, MECH DEVELOP, V126, P781, DOI 10.1016/j.mod.2009.08.005; WERNER H, 1993, P NATL ACAD SCI USA, V90, P5828, DOI 10.1073/pnas.90.12.5828; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yakar S, 2005, J Endocrinol Invest, V28, P19; Yakar S, 2005, CYTOKINE GROWTH F R, V16, P407, DOI 10.1016/j.cytogfr.2005.01.010; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yi ZJ, 2010, J CANCER RES CLIN, V136, P855, DOI 10.1007/s00432-009-0726-x; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699; Yu ZW, 2010, ORAL ONCOL, V46, P317, DOI 10.1016/j.oraloncology.2010.02.002; Zhang XJ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-46; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	91	32	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14662	14676		10.1074/jbc.M115.694331	http://dx.doi.org/10.1074/jbc.M115.694331			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226530	Green Published, hybrid			2022-12-28	WOS:000380366700021
J	Valencia-Sanchez, MI; Rodriguez-Hernandez, A; Ferreira, R; Santamaria-Suarez, HA; Arciniega, M; Dock-Bregeon, AC; Moras, D; Beinsteiner, B; Mertens, H; Svergun, D; Brieba, LG; Grotli, M; Torres-Larios, A				Igor Valencia-Sanchez, Marco; Rodriguez-Hernandez, Annia; Ferreira, Ruben; Anibal Santamaria-Suarez, Hugo; Arciniega, Marcelino; Dock-Bregeon, Anne-Catherine; Moras, Dino; Beinsteiner, Brice; Mertens, Haydyn; Svergun, Dmitri; Brieba, Luis G.; Grotli, Morten; Torres-Larios, Alfredo			Structural Insights into the Polyphyletic Origins of Glycyl tRNA Synthetases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; crystal structure; molecular evolution; structure-function; substrate specificity	HORIZONTAL GENE-TRANSFER; ESCHERICHIA-COLI; SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; BETA-SUBUNIT; AMINO-ACIDS; PROTEIN; EVOLUTION; CODE	Glycyl tRNA synthetase (GlyRS) provides a unique case among class II aminoacyl tRNA synthetases, with two clearly widespread types of enzymes: a dimeric ((2)) species present in some bacteria, archaea, and eukaryotes; and a heterotetrameric form ((22)) present in most bacteria. Although the differences between both types of GlyRS at the anticodon binding domain level are evident, the extent and implications of the variations in the catalytic domain have not been described, and it is unclear whether the mechanism of amino acid recognition is also dissimilar. Here, we show that the -subunit of the (22) GlyRS from the bacterium Aquifex aeolicus is able to perform the first step of the aminoacylation reaction, which involves the activation of the amino acid with ATP. The crystal structure of the -subunit in the complex with an analog of glycyl adenylate at 2.8 angstrom resolution presents a conformational arrangement that properly positions the cognate amino acid. This work shows that glycine is recognized by a subset of different residues in the two types of GlyRS. A structural and sequence analysis of class II catalytic domains shows that bacterial GlyRS is closely related to alanyl tRNA synthetase, which led us to define a new subclassification of these ancient enzymes and to propose an evolutionary path of (22) GlyRS, convergent with (2) GlyRS and divergent from AlaRS, thus providing a possible explanation for the puzzling existence of two proteins sharing the same fold and function but not a common ancestor.	[Igor Valencia-Sanchez, Marco; Rodriguez-Hernandez, Annia; Anibal Santamaria-Suarez, Hugo; Arciniega, Marcelino; Torres-Larios, Alfredo] Univ Nacl Autonoma Mexico, Dept Bioquim & Biol Estructural, Inst Fisiol Celular, Circuito Exterior S-N,Ciudad Univ, Mexico City 04510, DF, Mexico; [Rodriguez-Hernandez, Annia; Brieba, Luis G.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Irapuato 04510, Guanajuato, Mexico; [Ferreira, Ruben; Grotli, Morten] Univ Gothenburg, Dept Chem & Mol Biol, SE-41296 Gothenburg, Sweden; [Dock-Bregeon, Anne-Catherine] CNRS, Lab Biol Integrat Milieux Marins, F-29680 Roscoff, France; [Moras, Dino; Beinsteiner, Brice] CNRS, Ctr Integrat Biol, Dept Integrated Struct Biol, Inst Genet & Mol & Cellular Biol,UMR 7104, 1 Rue Laurent Fries, Illkirch Graffenstaden, France; [Mertens, Haydyn; Svergun, Dmitri] DESY, Hamburg Outstat, European Mol Biol Lab, Notkestr 85, D-22603 Hamburg, Germany	Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; University of Gothenburg; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Torres-Larios, A (corresponding author), Circuito Exterior S-N,Ciudad Univ, Mexico City 04510, DF, Mexico.	torres@ifc.unam.mx	Grötli, Morten/A-8735-2010; Rodriguez-Hernandez, Annia/AAF-2479-2020; Brieba, Luis/I-8447-2016	Grötli, Morten/0000-0003-3621-4222; Rodriguez-Hernandez, Annia/0000-0002-6206-3766; Brieba, Luis/0000-0002-6073-5207; Dock-Bregeon, Anne-Catherine/0000-0002-6913-4061; Svergun, Dmitri/0000-0003-0830-5696; Mertens, Haydyn/0000-0002-5664-744X; Arciniega, Marcelino/0000-0002-7526-6941; Torres-Larios, Alfredo/0000-0002-0702-350X; Valencia, Marco/0000-0002-7199-4546	United States Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor Grant [085P1000817]	United States Department of Energy(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor Grant	We thank Elizabeth Nallely Cabrera Gonzalez and Nevena Cvetesic for scientific and technical guidance, Prof. John J. Perona for the gift of gene coding for the tRNA nucleotidyltransferase, and Martha Contreras and Beatriz Aguirre Lopez for technical support. The critical reading by Jonathan Ipsaro and Rajan Sankaranarayanan is greatly acknowledged. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science at Argonne National Laboratory, was supported by the United States Department of Energy under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and Michigan Technology Tri-Corridor Grant 085P1000817.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Arnez JG, 1999, J MOL BIOL, V286, P1449, DOI 10.1006/jmbi.1999.2562; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; BERG P, 1956, J BIOL CHEM, V222, P1015; BERG P, 1958, P NATL ACAD SCI USA, V44, P78, DOI 10.1073/pnas.44.2.78; BERGMANN F, 1961, J BIOL CHEM, V236, P1735; Bilokapic S, 2006, EMBO J, V25, P2498, DOI 10.1038/sj.emboj.7601129; Blanchet CE, 2015, J SYNCHROTRON RADIAT, V22, P461, DOI 10.1107/S160057751402829X; BURBAUM JJ, 1990, PROTEINS, V7, P99, DOI 10.1002/prot.340070202; BURBAUM JJ, 1991, J BIOL CHEM, V266, P16965; Caetano-Anolles G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072225; Chang JM, 2014, MOL BIOL EVOL, V31, P1625, DOI 10.1093/molbev/msu117; Chien CI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094659; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; de Pouplana LR, 2001, CELL, V104, P191, DOI 10.1016/S0092-8674(01)00204-5; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Englert M, 2013, FEBS LETT, V587, P3360, DOI 10.1016/j.febslet.2013.08.037; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Finarov I, 2010, STRUCTURE, V18, P343, DOI 10.1016/j.str.2010.01.002; Fournier GP, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0350-0; Fournier GP, 2009, PHILOS T R SOC B, V364, P2229, DOI 10.1098/rstb.2009.0033; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Freist W, 1996, BIOL CHEM H-S, V377, P343; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Giege R., 2013, ECOSAL PLUS, DOI [10.1128/ecosalplus.ESP-0002-201, DOI 10.1128/ECOSALPLUS.ESP-0002-201]; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kavran JM, 2007, P NATL ACAD SCI USA, V104, P11268, DOI 10.1073/pnas.0704769104; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P935, DOI 10.1107/S090744490703315X; Klipcan L, 2013, TRENDS BIOCHEM SCI, V38, P229, DOI 10.1016/j.tibs.2012.11.002; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Lichtarge O, 2001, NAT STRUCT BIOL, V8, P918, DOI 10.1038/nsb1101-918; LOGAN DT, 1995, EMBO J, V14, P4156, DOI 10.1002/j.1460-2075.1995.tb00089.x; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Majorek KA, 2014, NUCLEIC ACIDS RES, V42, P4160, DOI 10.1093/nar/gkt1414; Mazauric MH, 1996, EUR J BIOCHEM, V241, P814, DOI 10.1111/j.1432-1033.1996.00814.x; Mazauric MH, 1998, EUR J BIOCHEM, V251, P744, DOI 10.1046/j.1432-1327.1998.2510744.x; MCDONALD T, 1980, BIOCHEMISTRY-US, V19, P1402, DOI 10.1021/bi00548a022; NAGEL GM, 1984, NUCLEIC ACIDS RES, V12, P4377, DOI 10.1093/nar/12.10.4377; Nawaz M., 2008, WILEY ENCY CHEM BIOL, DOI [10.1002/9780470048672.wecb008, DOI 10.1002/9780470048672.WECB008]; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; O'Donoghue P, 2005, J MOL BIOL, V346, P875, DOI 10.1016/j.jmb.2004.11.053; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Okamoto Koji, 2005, Nucleic Acids Symp Ser (Oxf), P299, DOI 10.1093/nass/49.1.299; OSTREM DL, 1970, P NATL ACAD SCI USA, V67, P1967, DOI 10.1073/pnas.67.4.1967; OSTREM DL, 1974, BIOCHEMISTRY-US, V13, P1338, DOI 10.1021/bi00704a006; Pang YLJ, 2014, WIRES RNA, V5, P461, DOI 10.1002/wrna.1224; Perona JJ, 2012, BIOCHEMISTRY-US, V51, P8705, DOI 10.1021/bi301180x; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; PREISS J, 1959, P NATL ACAD SCI USA, V45, P319, DOI 10.1073/pnas.45.3.319; Redwan IN, 2012, EUR J ORG CHEM, V2012, P3665, DOI 10.1002/ejoc.201200329; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Rodriguez-Hernandez A, 2011, STRUCTURE, V19, P386, DOI 10.1016/j.str.2010.12.017; Rodriguez-Hernandez A, 2010, BIOCHEMISTRY-US, V49, P6727, DOI 10.1021/bi100886z; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; Schimmel P, 2008, PROTEIN SCI, V17, P1643, DOI 10.1110/ps.037242.108; Schimmel P, 2011, PHILOS T R SOC B, V366, P2965, DOI 10.1098/rstb.2011.0158; SHIBA K, 1994, J BIOL CHEM, V269, P30049; Smith TF, 2015, FEBS LETT, V589, P3499, DOI 10.1016/j.febslet.2015.10.006; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Swairjo MA, 2004, MOL CELL, V13, P829, DOI 10.1016/S1097-2765(04)00126-1; Tan Kemin, 2012, Journal of Structural and Functional Genomics, V13, P233, DOI 10.1007/s10969-012-9142-6; Tang SN, 2005, FEBS LETT, V579, P1441, DOI 10.1016/j.febslet.2005.01.045; TOTH MJ, 1990, J BIOL CHEM, V265, P1000; TOTH MJ, 1990, J BIOL CHEM, V265, P1005; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wolf YI, 1999, GENOME RES, V9, P689; Yanagisawa T, 2008, J MOL BIOL, V378, P634, DOI 10.1016/j.jmb.2008.02.045	84	9	10	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14430	14446		10.1074/jbc.M116.730382	http://dx.doi.org/10.1074/jbc.M116.730382			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226617	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000380366700003
J	Sawicka, M; Wanrooij, PH; Darbari, VC; Tannous, E; Hailemariam, S; Bose, D; Makarova, AV; Burgers, PM; Zhang, XD				Sawicka, Marta; Wanrooij, Paulina H.; Darbari, Vidya C.; Tannous, Elias; Hailemariam, Sarem; Bose, Daniel; Makarova, Alena V.; Burgers, Peter M.; Zhang, Xiaodong			The Dimeric Architecture of Checkpoint Kinases Mec1(ATR) and Tel1(ATM) Reveal a Common Structural Organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						checkpoint control; DNA damage response; nucleic acid enzymology; phosphatidylinositol kinase (PI Kinase); protein structure; serine; threonine protein kinase	CRYO-EM STRUCTURE; DNA-DAMAGE CHECKPOINT; REPLICATION PROTEIN-A; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; CATALYTIC SUBUNIT; MEC1 KINASE; ATM KINASE; 3-DIMENSIONAL STRUCTURE	The phosphatidylinositol 3-kinase-related protein kinases are key regulators controlling a wide range of cellular events. The yeast Tel1 and Mec1Ddc2 complex (ATM and ATR-ATRIP in humans) play pivotal roles in DNA replication, DNA damage signaling, and repair. Here, we present the first structural insight for dimers of Mec1Ddc2 and Tel1 using single-particle electron microscopy. Both kinases reveal a head to head dimer with one major dimeric interface through the N-terminal HEAT (named after Huntingtin, elongation factor 3, protein phosphatase 2A, and yeast kinase TOR1) repeat. Their dimeric interface is significantly distinct from the interface of mTOR complex 1 dimer, which oligomerizes through two spatially separate interfaces. We also observe different structural organizations of kinase domains of Mec1 and Tel1. The kinase domains in the Mec1Ddc2 dimer are located in close proximity to each other. However, in the Tel1 dimer they are fully separated, providing potential access of substrates to this kinase, even in its dimeric form.	[Sawicka, Marta; Darbari, Vidya C.; Bose, Daniel; Zhang, Xiaodong] Imperial Coll London, Sect Struct Biol, Dept Med, London SW7 2AZ, England; [Wanrooij, Paulina H.; Tannous, Elias; Hailemariam, Sarem; Makarova, Alena V.; Burgers, Peter M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Wanrooij, Paulina H.] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Bose, Daniel] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Imperial College London; Washington University (WUSTL); Umea University; University of Pennsylvania; Pennsylvania Medicine	Zhang, XD (corresponding author), Imperial Coll London, Sect Struct Biol, Dept Med, London SW7 2AZ, England.; Burgers, PM (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	burgers@biochem.wustl.edu; xiaodong.zhang@imperial.ac.uk	Makarova, Alena Vladimirovna/I-1338-2014; Wanrooij, Paulina/R-1509-2019; Burgers, Peter M/AAW-6621-2021; Bose, Daniel/AAI-2775-2020	Wanrooij, Paulina/0000-0002-8607-7564; Bose, Daniel/0000-0002-0276-6486; Darbari, Vidya/0000-0002-3387-5108; Sawicka, Marta/0000-0003-4589-4290; Tannous, Elias/0000-0001-8073-1599	Wellcome Trust [WT/098412/Z/12/Z]; National Institutes of Health [GM083970]; Biotechnology and Biological Sciences Research Council; Emil Aaltonen Foundation; Swedish Cultural Foundation in Finland; BBSRC [BB/H012249/1] Funding Source: UKRI; MRC [MR/J001201/1, MR/N006828/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1235357, BB/H012249/1] Funding Source: researchfish; Medical Research Council [MR/N006828/1, MR/J001201/1] Funding Source: researchfish; Wellcome Trust [098412/Z/12/Z] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083970, R35GM118129] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Emil Aaltonen Foundation; Swedish Cultural Foundation in Finland; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Wellcome Trust Senior Investigator Award WT/098412/Z/12/Z (to X. Z.) and National Institutes of Health Grant GM083970 (to P. M. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Biotechnology and Biological Sciences Research Council doctoral studentship.; Supported by the Emil Aaltonen Foundation and the Swedish Cultural Foundation in Finland. Present address: Dept. of Medical Biochemistry and Biophysics, Umea University, SE-901 87 Umea, Sweden.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Arias-Palomo E, 2011, GENE DEV, V25, P153, DOI 10.1101/gad.606911; Aylett CHS, 2016, SCIENCE, V351, P48, DOI 10.1126/science.aaa3870; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Ball HL, 2005, J BIOL CHEM, V280, P31390, DOI 10.1074/jbc.M504961200; Boskovic J, 2003, EMBO J, V22, P5875, DOI 10.1093/emboj/cdg555; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Deniaud A, 2015, NUCLEIC ACIDS RES, V43, P7600, DOI 10.1093/nar/gkv668; Flott S, 2011, EMBO REP, V12, P833, DOI 10.1038/embor.2011.127; Gaubitz C, 2015, MOL CELL, V58, P977, DOI 10.1016/j.molcel.2015.04.031; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Itakura E, 2005, MOL BIOL CELL, V16, P5551, DOI 10.1091/mbc.E05-05-0427; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Lau WCY, 2016, CELL CYCLE, V15, P1117, DOI 10.1080/15384101.2016.1158362; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Llorca O, 2003, ONCOGENE, V22, P3867, DOI 10.1038/sj.onc.1206649; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Melero R, 2014, STRUCTURE, V22, P1105, DOI 10.1016/j.str.2014.05.015; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; Moser BA, 2011, NAT STRUCT MOL BIOL, V18, P1408, DOI 10.1038/nsmb.2187; Nakada D, 2005, MOL BIOL CELL, V16, P5227, DOI 10.1091/mbc.E05-05-0405; Navadgi-Patil VM, 2011, J BIOL CHEM, V286, P40999, DOI 10.1074/jbc.M111.283994; Navadgi-Patil VM, 2009, DNA REPAIR, V8, P996, DOI 10.1016/j.dnarep.2009.03.011; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Paciotti V, 2000, GENE DEV, V14, P2046; Paciotti V, 1998, EMBO J, V17, P4199, DOI 10.1093/emboj/17.14.4199; Paciotti V, 2001, MOL CELL BIOL, V21, P3913, DOI 10.1128/MCB.21.12.3913-3925.2001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfander B, 2011, EMBO J, V30, P4897, DOI 10.1038/emboj.2011.345; Rivera-Calzada A, 2005, STRUCTURE, V13, P243, DOI 10.1016/j.str.2004.12.006; Rivera-Calzada A, 2015, AIMS BIOPHYS, V2, P36, DOI 10.3934/biophy.2015.2.36; Rouse J, 2000, EMBO J, V19, P5801, DOI 10.1093/emboj/19.21.5801; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Seidel JJ, 2008, MOL CELL BIOL, V28, P5736, DOI 10.1128/MCB.00326-08; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wakayama T, 2001, MOL CELL BIOL, V21, P755, DOI 10.1128/MCB.21.3.755-764.2001; Williams DR, 2008, STRUCTURE, V16, P468, DOI 10.1016/j.str.2007.12.014; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	63	28	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13436	13447		10.1074/jbc.M115.708263	http://dx.doi.org/10.1074/jbc.M115.708263			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129217	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000379771100004
J	Schmid-Siegert, E; Stepushenko, O; Glauser, G; Farmer, EE				Schmid-Siegert, Emanuel; Stepushenko, Olga; Glauser, Gaetan; Farmer, Edward E.			Membranes as Structural Antioxidants RECYCLING OF MALONDIALDEHYDE TO ITS SOURCE IN OXIDATION-SENSITIVE CHLOROPLAST FATTY ACIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PEROXIDATION; SINGLET OXYGEN; MALONIC SEMIALDEHYDE; GENE-EXPRESSION; ACETYL-COENZYME; PHOTOSYSTEM-II; LINOLENIC ACID; FATTY-ACIDS; ARABIDOPSIS; METABOLISM	Genetic evidence suggests that membranes rich in polyunsaturated fatty acids (PUFAs) act as supramolecular antioxidants that capture reactive oxygen species, thereby limiting damage to proteins. This process generates lipid fragmentation products including malondialdehyde (MDA), an archetypal marker of PUFA oxidation. We observed transient increases in levels of endogenous MDA in wounded Arabidopsis thaliana leaves, raising the possibility that MDA is metabolized. We developed a rigorous ion exchange method to purify enzymatically generated C-13- and C-14-MDA. Delivered as a volatile to intact plants, MDA was efficiently incorporated into lipids. Mass spectral and genetic analyses identified the major chloroplast galactolipid: alpha-linolenic acid (18:3)-7Z,10Z,13Z-hexadecatrienoic acid (16:3)-monogalactosyldiacylglycerol (18:3-16:3-MGDG) as an end-product of MDA incorporation. Consistent with this, the fad3-2 fad7-2 fad8 mutant that lacks tri-unsaturated fatty acids incorporated C-14-MDA into 18:2-16:2-MGDG. Saponification of C-14-labeled 18:3-16:3-MGDG revealed 84% of C-14-label in the acyl groups with the remaining 16% in the head group. 18:3-16:3-MGDG is enriched proximal to photosystem II and is likely a major in vivo source of MDA in photosynthetic tissues. We propose that nonenzymatically generated lipid fragments such as MDA are recycled back into plastidic galactolipids that, in their role as cell protectants, can again be fragmented into MDA.	[Schmid-Siegert, Emanuel; Stepushenko, Olga; Farmer, Edward E.] Univ Lausanne, Dept Plant Mol Biol, Biophore, CH-1015 Lausanne, Switzerland; [Glauser, Gaetan] Univ Neuchatel, Neuchatel Platform Analyt Chem, CH-2009 Neuchatel, Switzerland; [Schmid-Siegert, Emanuel] Swiss Inst Bioinformat, Vital IT Grp, Batiment Genopode, CH-1015 Lausanne, Switzerland	University of Lausanne; University of Neuchatel; Swiss Institute of Bioinformatics	Farmer, EE (corresponding author), Univ Lausanne, Dept Plant Mol Biol, Biophore, CH-1015 Lausanne, Switzerland.	edward.farmer@unil.ch	Glauser, Gaetan/K-7574-2017; Schmid-Siegert, Emanuel/N-8657-2019	Glauser, Gaetan/0000-0002-0983-8614; Schmid-Siegert, Emanuel/0000-0003-1339-5120	National Center of Competence in Research "Plant Survival" grant; Swiss National Science Foundation [3100A0-122441, 31003A-138235]	National Center of Competence in Research "Plant Survival" grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported with a National Center of Competence in Research "Plant Survival" grant and Swiss National Science Foundation Grants 3100A0-122441 and 31003A-138235. The authors declare that they have no conflicts of interest with the contents of this article.	Aronsson H, 2008, PLANT PHYSIOL, V148, P580, DOI 10.1104/pp.108.123372; Behal RH, 2002, ARCH BIOCHEM BIOPHYS, V402, P259, DOI 10.1016/S0003-9861(02)00086-3; Biswas MS, 2015, PLANT PHYSIOL, V168, P885, DOI 10.1104/pp.115.256834; BLOCK MA, 1983, J BIOL CHEM, V258, P3281; Blokhina O, 2010, PHYSIOL PLANTARUM, V138, P447, DOI 10.1111/j.1399-3054.2009.01340.x; Botte CY, 2011, NAT CHEM BIOL, V7, P834, DOI 10.1038/nchembio.658; Brooks C., 1971, J CHROMATOGR, V9, P193; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; DRAPER HH, 1986, LIPIDS, V21, P305, DOI 10.1007/BF02536418; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Farmer EE, 2013, ANNU REV PLANT BIOL, V64, P429, DOI 10.1146/annurev-arplant-050312-120132; Flors C, 2006, J EXP BOT, V57, P1725, DOI 10.1093/jxb/erj181; FRANKEL EN, 2012, LIPID OXIDATION; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; HOLTE LL, 1990, ANAL BIOCHEM, V188, P136, DOI 10.1016/0003-2697(90)90541-G; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Kariola T, 2005, PLANT CELL, V17, P282, DOI 10.1105/tpc.104.025817; Kobayashi K, 2013, PLANT J, V73, P250, DOI 10.1111/tpj.12028; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Li-Beisson Y., 2010, ARABIDOPSIS BOOK, V8, DOI [10.1199/tab.0161, DOI 10.1199/TAB.0133, 10.1199/tab.0133]; Lin M, 2008, PLANT PHYSIOL, V147, P1822, DOI 10.1104/pp.108.121269; Liu JK, 1997, ANAL BIOCHEM, V245, P161, DOI 10.1006/abio.1996.9990; LLOYD D, 1965, BIOCHEM J, V96, P766, DOI 10.1042/bj0960766; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Maeda H, 2007, CURR OPIN PLANT BIOL, V10, P260, DOI 10.1016/j.pbi.2007.04.006; Mano J, 2012, PLANT PHYSIOL BIOCH, V59, P90, DOI 10.1016/j.plaphy.2012.03.010; Marnett LJ, 2002, TOXICOLOGY, V181, P219, DOI 10.1016/S0300-483X(02)00448-1; MARNETT LJ, 1980, CANCER RES, V40, P276; MARNETT LJ, 1985, PROSTAGLANDINS, V30, P241, DOI 10.1016/0090-6980(85)90188-1; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Mene-Saffrane L, 2009, J BIOL CHEM, V284, P1702, DOI 10.1074/jbc.M807114200; Pospisil P, 2014, J PHOTOCH PHOTOBIO B, V137, P39, DOI 10.1016/j.jphotobiol.2014.04.025; Ramel F, 2012, PLANT PHYSIOL, V158, P1267, DOI 10.1104/pp.111.182394; Rastogi A, 2014, PLANT CELL ENVIRON, V37, P392, DOI 10.1111/pce.12161; Refsgaard HHF, 2000, P NATL ACAD SCI USA, V97, P611, DOI 10.1073/pnas.97.2.611; Robinson T., 1963, ORGANIC CONSTITUENTS, V40, P36; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; ROUGHAN PG, 1970, BIOCHEM J, V117, P1; Russell NJ, 1999, MICROBIOL-UK, V145, P767, DOI 10.1099/13500872-145-4-767; Sattler SE, 2006, PLANT CELL, V18, P3706, DOI 10.1105/tpc.106.044065; Schmid-Siegert E, 2012, J BIOL CHEM, V287, P8954, DOI 10.1074/jbc.M111.322842; SCHOLEM RD, 1983, BIOCHEM J, V216, P81, DOI 10.1042/bj2160081; SIU GM, 1982, LIPIDS, V17, P349, DOI 10.1007/BF02535193; SLACK CR, 1975, BIOCHEM J, V152, P217, DOI 10.1042/bj1520217; SUMMERFIELD FW, 1978, BIOCHEM BIOPH RES CO, V82, P547, DOI 10.1016/0006-291X(78)90909-9; Triantaphylides C, 2008, PLANT PHYSIOL, V148, P960, DOI 10.1104/pp.108.125690; Vijayan P, 2002, PLANT PHYSIOL, V129, P876, DOI 10.1104/pp.004341; Wada H., 2010, LIPIDS PHOTOSYNTHESI, P265; Wang SW, 2014, PLANT PHYSIOL, V165, P1144, DOI 10.1104/pp.114.238899; Weber H, 2004, PLANT J, V37, P877, DOI 10.1111/j.1365-313X.2003.02013.x; Yamauchi Y, 2008, PLANT PHYSIOL BIOCH, V46, P786, DOI 10.1016/j.plaphy.2008.04.018; Yamauchi Y, 2011, J BIOL CHEM, V286, P6999, DOI 10.1074/jbc.M110.202226; YEO HC, 1994, ANAL BIOCHEM, V220, P391, DOI 10.1006/abio.1994.1355; Zoeller M, 2012, PLANT PHYSIOL, V160, P365, DOI 10.1104/pp.112.202846	54	41	41	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13005	13013		10.1074/jbc.M116.729921	http://dx.doi.org/10.1074/jbc.M116.729921			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27143359	Green Published, hybrid			2022-12-28	WOS:000379770500010
J	Yang, DH; de Graaf, C; Yang, LL; Song, GJ; Dai, AT; Cai, XQ; Feng, Y; Reedtz-Runge, S; Hanson, MA; Yang, HY; Jiang, HL; Stevens, RC; Wang, MW				Yang, Dehua; de Graaf, Chris; Yang, Linlin; Song, Gaojie; Dai, Antao; Cai, Xiaoqing; Feng, Yang; Reedtz-Runge, Steffen; Hanson, Michael A.; Yang, Huaiyu; Jiang, Hualiang; Stevens, Raymond C.; Wang, Ming-Wei			Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICOTROPIN-RELEASING-FACTOR; 2ND TRANSMEMBRANE HELIX; LIGAND-BINDING; AMINO-TERMINUS; SPATIAL APPROXIMATIONS; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; DRUG TARGETS; RESIDUES; ACTIVATION	The glucagon-like peptide-1 receptor (GLP-1R) belongs to the secretin-like (class B) family of G protein-coupled receptors. Members of the class B family are distinguished by their large extracellular domain, which works cooperatively with the canonical seven-transmembrane (7TM) helical domain to signal in response to binding of various peptide hormones. We have combined structure-based site-specific mutational studies with molecular dynamics simulations of a full-length model of GLP-1R bound to multiple peptide ligand variants. Despite the high sequence similarity between GLP-1R and its closest structural homologue, the glucagon receptor (GCGR), nearly half of the 62 stably expressed mutants affected GLP-1R in a different manner than the corresponding mutants in GCGR. The molecular dynamics simulations of wild-type and mutant GLP-1R center dot ligand complexes provided molecular insights into GLP-1R-specific recognition mechanisms for the N terminus of GLP-1 by residues in the 7TM pocket and explained how glucagon-mimicking GLP-1 mutants restored binding affinity for (GCGR-mimicking) GLP-1R mutants. Structural analysis of the simulations suggested that peptide ligand binding mode variations in the 7TM binding pocket are facilitated by movement of the extracellular domain relative to the 7TM bundle. These differences in binding modes may account for the pharmacological differences between GLP-1 peptide variants.	[Yang, Dehua; Dai, Antao; Cai, Xiaoqing; Feng, Yang; Wang, Ming-Wei] Chinese Acad Sci, Natl Ctr Drug Screening, Shanghai Inst Mat Med, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China; [Yang, Dehua; Dai, Antao; Cai, Xiaoqing; Feng, Yang; Wang, Ming-Wei] Chinese Acad Sci, CAS Key Lab Receptor Res, Shanghai Inst Mat Med, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China; [de Graaf, Chris] Vrije Univ Amsterdam, AIMMS, Div Med Chem, Fac Sci, De Boelelaan 1083, NL-1081 HV Amsterdam, Netherlands; [Yang, Linlin; Yang, Huaiyu; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China; [Song, Gaojie; Stevens, Raymond C.] ShanghaiTech Univ, iHuman Inst, 99 Haike Rd, Shanghai 201203, Peoples R China; [Reedtz-Runge, Steffen] Novo Nordisk, Dept Prot Struct, Novo Nordisk Pk, DK-2760 Malov, Denmark; [Hanson, Michael A.] GPCR Consortium, San Marcos, CA 92078 USA; [Stevens, Raymond C.] Univ Southern Calif, Dept Biol Sci, Bridge Inst, Los Angeles, CA 90089 USA; [Stevens, Raymond C.] Univ Southern Calif, Dept Chem, Bridge Inst, Los Angeles, CA 90089 USA; [Wang, Ming-Wei] Fudan Univ, Sch Pharm, 826 Zhang Heng Rd, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Vrije Universiteit Amsterdam; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; ShanghaiTech University; Novo Nordisk; University of Southern California; University of Southern California; Fudan University	Wang, MW (corresponding author), Chinese Acad Sci, Natl Ctr Drug Screening, Shanghai Inst Mat Med, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.; Wang, MW (corresponding author), Chinese Acad Sci, CAS Key Lab Receptor Res, Shanghai Inst Mat Med, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.	mwwang@simm.ac.cn	Stevens, Raymond/K-7272-2015; Yang, Dehua/M-5789-2019; Yang, Dehua/S-6156-2017; de Graaf, Chris/J-8549-2017	Stevens, Raymond/0000-0002-4522-8725; de Graaf, Chris/0000-0002-1226-2150	Ministry of Science and Technology of China [2012CB518005, 2012AA020302, 2013ZX09507001, 91313000]; National Natural Science Foundation of China [81573479, 81373463, 21422208, 81230076, 21210003]; National Health and Family Planning Commission of China [2013ZX09507001, 2012ZX09304-011, 2013ZX09401003-005, 2013ZX09507-002]; Shanghai Science and Technology Development Fund [15DZ2291600, 14431901200]; National Institutes of Health [U54 GM094618]; European Cooperation in Science and Technology Action [CM1207]; Netherlands eScience Center (NLeSC)/Netherlands Organisation for Scientific Research (NWO) Enabling Technologies Project, 3D-e-Chem [027.014.201]; CAS-Novo Nordisk Research Fund; SA-SIBS Scholarship Program; Thousand Talents Program in China (Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Family Planning Commission of China; Shanghai Science and Technology Development Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Cooperation in Science and Technology Action; Netherlands eScience Center (NLeSC)/Netherlands Organisation for Scientific Research (NWO) Enabling Technologies Project, 3D-e-Chem; CAS-Novo Nordisk Research Fund; SA-SIBS Scholarship Program; Thousand Talents Program in China (Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Ministry of Science and Technology of China Grants 2012CB518005 (to H. Y.), 2012AA020302, 2013ZX09507001, and 91313000 (to H. J.), National Natural Science Foundation of China Grants 81573479 and 81373463 (to D. Y.), 21422208 (to H. Y.), and 81230076 and 21210003 (to H. J.), National Health and Family Planning Commission of China Grants 2012ZX09304-011, 2013ZX09401003-005, 2013ZX09507001, and 2013ZX09507-002 (to M.-W. W.), Shanghai Science and Technology Development Fund 15DZ2291600 and 14431901200 (to M.-W. W.), National Institutes of Health Grant U54 GM094618 (to R. C. S.), European Cooperation in Science and Technology Action CM1207 (GPCR-Ligand Interactions, Structures, and Transmembrane Signaling: A European Research Network (GLISTEN)) (to C. dG.), and Netherlands eScience Center (NLeSC)/Netherlands Organisation for Scientific Research (NWO) Enabling Technologies Project, 3D-e-Chem, 027.014.201 (to C. dG.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by CAS-Novo Nordisk Research Fund.r Supported by SA-SIBS Scholarship Program.r Supported by the Thousand Talents Program in China (Chinese Academy of Sciences).	Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BRAUN W, 1983, J MOL BIOL, V169, P921, DOI 10.1016/S0022-2836(83)80143-0; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Ceraudo E, 2012, FASEB J, V26, P2060, DOI 10.1096/fj.11-196444; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; Di Paolo E, 1999, RECEPTOR CHANNEL, V6, P309; Di Paolo E, 1998, FEBS LETT, V424, P207, DOI 10.1016/S0014-5793(98)00175-6; Dods RL, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150253; Dong MQ, 2012, FASEB J, V26, P5092, DOI 10.1096/fj.12-212399; Donnelly D, 2012, BRIT J PHARMACOL, V166, P27, DOI 10.1111/j.1476-5381.2011.01687.x; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gardella TJ, 2001, TRENDS ENDOCRIN MET, V12, P210, DOI 10.1016/S1043-2760(01)00409-X; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hinke SA, 2001, BBA-PROTEIN STRUCT M, V1547, P143, DOI 10.1016/S0167-4838(01)00181-9; HJORTH SA, 1994, J BIOL CHEM, V269, P30121; Hoang HN, 2015, J MED CHEM, V58, P4080, DOI 10.1021/acs.jmedchem.5b00166; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inooka H, 2001, NAT STRUCT BIOL, V8, P161, DOI 10.1038/84159; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Mathi SK, 1997, MOL ENDOCRINOL, V11, P424, DOI 10.1210/me.11.4.424; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MOJSOV S, 1992, INT J PEPT PROT RES, V40, P333; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; Moon MJ, 2015, J BIOL CHEM, V290, P5696, DOI 10.1074/jbc.M114.612606; Neidigh JW, 2001, BIOCHEMISTRY-US, V40, P13188, DOI 10.1021/bi010902s; Neumann JM, 2008, TRENDS BIOCHEM SCI, V33, P314, DOI 10.1016/j.tibs.2008.05.001; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Perret J, 2002, BIOCHEM J, V362, P389, DOI 10.1042/0264-6021:3620389; RIVIER J, 1984, SCIENCE, V224, P889, DOI 10.1126/science.6326264; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2003, J BIOL CHEM, V278, P28005, DOI 10.1074/jbc.M301085200; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Runge S, 2007, BIOCHEMISTRY-US, V46, P5830, DOI 10.1021/bi062309m; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Solano RM, 2001, J BIOL CHEM, V276, P1084, DOI 10.1074/jbc.M007686200; Tseng CC, 1997, BIOCHEM BIOPH RES CO, V232, P96, DOI 10.1006/bbrc.1997.6231; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; UNSON CG, 1989, PEPTIDES, V10, P1171, DOI 10.1016/0196-9781(89)90010-7; Wilmen A, 1997, PEPTIDES, V18, P301, DOI 10.1016/S0196-9781(96)00321-X; Wootten D, 2016, MOL PHARMACOL, V89, P335, DOI 10.1124/mol.115.101246; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859; Yaqub T, 2010, MOL PHARMACOL, V77, P547, DOI 10.1124/mol.109.060111	59	39	41	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					12991	13004		10.1074/jbc.M116.721977	http://dx.doi.org/10.1074/jbc.M116.721977			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27059958	hybrid, Green Published			2022-12-28	WOS:000379770500009
J	Oecal, S; Socher, E; Uthoff, M; Ernst, C; Zaucke, F; Sticht, H; Baumann, U; Gebauer, JM				Oecal, Sinan; Socher, Eileen; Uthoff, Matthias; Ernst, Corvin; Zaucke, Frank; Sticht, Heinrich; Baumann, Ulrich; Gebauer, Jan M.			The pH-dependent Client Release from the Collagen-specific Chaperone HSP47 Is Triggered by a Tandem Histidine Pair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE; CIRCULAR-DICHROISM; I COLLAGEN; BINDING; RECOGNITION; STABILITY; EVOLUTION; PROTOCOL	Heat shock protein 47 (HSP47) is an endoplasmic reticulum (ER)-resident collagen-specific chaperone and essential for proper formation of the characteristic collagen triple helix. It preferentially binds to the folded conformation of its clients and accompanies them from the ER to the Golgi compartment, where it releases them and is recycled back to the ER. Unlike other chaperones, the binding and release cycles are not governed by nucleotide exchange and hydrolysis, but presumably the dissociation of the HSP47-procollagen complex is triggered by the lower pH in the Golgi (pH 6.3) compared with the ER (pH 7.4). Histidine residues have been suggested as triggers due to their approximate textbook pK(a) value of 6.1 for their side chains. We present here an extensive theoretical and experimental study of the 14 histidine residues present in canine HSP47, where we have mutated all histidine residues in the collagen binding interface and additionally all of those that were predicted to undergo a significant change in protonation state between pH 7 and 6. These mutants were characterized by bio-layer interferometry for their pH-dependent binding to a collagen model. One mutant (H238N) loses binding, which can be explained by a rearrangement of the Arg(222) and Asp(385) residues, which are crucial for specific collagen recognition. Most of the other mutants were remarkably silent, but a double mutant with His(273) and His(274) exchanged for asparagines exhibits a much less pronounced pH dependence of collagen binding. This effect is mainly caused by a lower k(off) at the low pH values.	[Oecal, Sinan; Uthoff, Matthias; Ernst, Corvin; Baumann, Ulrich; Gebauer, Jan M.] Univ Cologne, Inst Biochem, Otto Fischer Str 12-14, D-50674 Cologne, Germany; [Socher, Eileen; Sticht, Heinrich] Univ Erlangen Nurnberg, Inst Biochem, Div Bioinformat, Fahrstr 17, D-91054 Erlangen, Germany; [Zaucke, Frank] Univ Cologne, Fac Med, Ctr Biochem, Joseph Stelzmann Str 52, D-50931 Cologne, Germany	University of Cologne; University of Erlangen Nuremberg; University of Cologne	Baumann, U; Gebauer, JM (corresponding author), Univ Cologne, Inst Biochem, Otto Fischer Str 12-14, D-50674 Cologne, Germany.	ubaumann@uni-koeln.de; jan.gebauer@uni-koeln.de	Baumann, Ulrich/B-1220-2013; Zaucke, Frank/AAT-2688-2021; Gebauer, Jan M/C-3085-2009; Zaucke, Frank/E-2077-2012	Gebauer, Jan M/0000-0002-3989-4748; Sticht, Heinrich/0000-0001-5644-045X; Socher, Eileen/0000-0002-6239-3749; Uthoff, Matthias/0000-0002-6477-5505	German Research Council [SFB829/B11, SFB796/A2, BA 1264/2-1]; University of Cologne	German Research Council(German Research Foundation (DFG)); University of Cologne	This work was supported by German Research Council Grants SFB829/B11, SFB796/A2, and BA 1264/2-1 and by the University of Cologne. The authors declare that they have no conflicts of interest with the contents of this article.	Abdul-Wahab MF, 2013, J BIOL CHEM, V288, P4452, DOI 10.1074/jbc.M112.409029; Case D. A., 2012, AMBER; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Du CL, 2008, APPL MICROBIOL BIOT, V79, P195, DOI 10.1007/s00253-008-1427-0; Edgcomb SP, 2002, PROTEINS, V49, P1, DOI 10.1002/prot.10177; ElThaher TSH, 1996, PROTEIN PEPTIDE LETT, V3, P1; Findlay JWA, 2007, AAPS J, V9, pE260, DOI 10.1208/aapsj0902029; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Gebauer JM, 2016, MATRIX BIOL, V49, P106, DOI 10.1016/j.matbio.2015.07.001; HIRAYOSHI K, 1991, MOL CELL BIOL, V11, P4036, DOI 10.1128/MCB.11.8.4036; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Ishida Y, 2011, METHOD ENZYMOL, V499, P167, DOI 10.1016/B978-0-12-386471-0.00009-2; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Koide T, 2005, TOP CURR CHEM, V247, P85, DOI 10.1007/b103820; Macdonald JR, 2001, J BIOL CHEM, V276, P25399, DOI 10.1074/jbc.M102471200; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Ono T, 2012, J BIOL CHEM, V287, P6810, DOI 10.1074/jbc.M111.280248; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Socher E, 2016, SCI REP-UK, V6, DOI 10.1038/srep22523; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Thomson CA, 2000, BIOCHEM J, V349, P877, DOI 10.1042/bj3490877; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Whisstock JC, 2010, J BIOL CHEM, V285, P24307, DOI 10.1074/jbc.R110.141408; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	36	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12612	12626		10.1074/jbc.M115.706069	http://dx.doi.org/10.1074/jbc.M115.706069			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129216	Green Published, hybrid			2022-12-28	WOS:000378119900018
J	Meyer, V; Holden, MR; Weismiller, HA; Eaton, GR; Eaton, SS; Margittai, M				Meyer, Virginia; Holden, Michael R.; Weismiller, Hilary A.; Eaton, Gareth R.; Eaton, Sandra S.; Margittai, Martin			Fracture and Growth Are Competing Forces Determining the Fate of Conformers in Tau Fibril Populations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; PROGRESSIVE SUPRANUCLEAR PALSY; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; AMYLOID FIBRILS; BETA-STRUCTURE; PRION STRAIN; NEURODEGENERATIVE DISEASES; SEEDING BARRIER; MOLECULAR-BASIS	Tau fibrils are pathological aggregates that can transfer between neurons and then recruit soluble Tau monomers by template-assisted conversion. The propagation of different fibril polymorphs is thought to be a contributing factor to phenotypic diversity in Alzheimer disease and other Tauopathies. We found that a homogeneous population of Tau fibrils composed of the truncated version K18 (residues 244-372) gradually converted to a new set of fibril conformers when subjected to multiple cycles of seeding and growth. Using double electronelectron resonance (DEER) spectroscopy, we observed that the distances between spin labels at positions 311 and 328 in the fibril core progressively decreased. The findings were corroborated by changes in turbidity, morphology, and protease sensitivity. Fibrils that were initially formed under stirring conditions exhibited an increased fragility compared with fibrils formed quiescently after multiple cycles of seeding. The quiescently formed fibrils were marked by accelerated growth. The difference in fragility and growth between the different conformers explains how the change in incubation condition could lead to the amplification of a minor subpopulation of fibrils. Under quiescent conditions where fibril breakage is minimal, faster growing fibrils have a selective advantage. The findings are of general importance as they suggest that changes in selective pressures during fibril propagation in the human brain could result in the emergence of new fibril conformers with varied clinicopathological consequences.	[Meyer, Virginia; Holden, Michael R.; Weismiller, Hilary A.; Eaton, Gareth R.; Eaton, Sandra S.; Margittai, Martin] Univ Denver, Dept Chem & Biochem, 2190 East Iliff Ave, Denver, CO 80208 USA	University of Denver	Margittai, M (corresponding author), Univ Denver, Dept Chem & Biochem, 2190 East Iliff Ave, Denver, CO 80208 USA.	martin.margittai@du.edu	Margittai, Martin/D-5039-2014; Meyer, Virginia/ABF-6246-2021	Margittai, Martin/0000-0003-1903-5927; Eaton, Gareth R/0000-0001-7429-8469; Eaton, Sandra S/0000-0002-2731-7986	National Institutes of Health [R01NS076619]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01NS076619 ( to M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Bedrood S, 2012, J BIOL CHEM, V287, P5235, DOI 10.1074/jbc.M111.327817; Berliner L. J., 2000, BIOL MAGNETIC RESONA; BERLINER LJ, 1982, ANAL BIOCHEM, V119, P450, DOI 10.1016/0003-2697(82)90612-1; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buee L, 1999, BRAIN PATHOL, V9, P681; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Daebel V, 2012, J AM CHEM SOC, V134, P13982, DOI 10.1021/ja305470p; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Dinkel PD, 2011, BIOCHEMISTRY-US, V50, P4330, DOI 10.1021/bi2004685; Dujardin S, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-14; Elbaum-Garfinkle S, 2012, J AM CHEM SOC, V134, P16607, DOI 10.1021/ja305206m; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Helsen CW, 2012, PRION, V6, P234, DOI 10.4161/pri.19913; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2000, BIO MAGN RE, V19, P493; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Karyagina I, 2011, BIOPHYS J, V101, pL1, DOI 10.1016/j.bpj.2011.05.052; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; LANSBURY PT, 1995, CHEM BIOL, V2, P1, DOI 10.1016/1074-5521(95)90074-8; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Mahal SP, 2010, P NATL ACAD SCI USA, V107, P22653, DOI 10.1073/pnas.1013014108; Makarava N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003759; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2006, METHOD ENZYMOL, V413, P122, DOI 10.1016/S0076-6879(06)13007-4; Meyer V, 2016, METHODS MOL BIOL, V1345, P185, DOI 10.1007/978-1-4939-2978-8_12; Meyer V, 2014, BIOCHEMISTRY-US, V53, P5804, DOI 10.1021/bi501050g; Meyer V, 2014, ANGEW CHEM INT EDIT, V53, P1590, DOI 10.1002/anie.201308473; MILOV AD, 1981, FIZ TVERD TELA+, V23, P975; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9; NOVAK M, 1993, EMBO J, V12, P365, DOI 10.1002/j.1460-2075.1993.tb05665.x; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Pornsuwan S, 2013, ANGEW CHEM INT EDIT, V52, P10290, DOI 10.1002/anie.201304747; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P911, DOI 10.1093/jnen/63.9.911; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Siddiqua A, 2012, J AM CHEM SOC, V134, P10271, DOI 10.1021/ja303498q; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Sweeny EA, 2016, J MOL BIOL, V428, P1870, DOI 10.1016/j.jmb.2015.11.016; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Tycko R, 2015, NEURON, V86, P632, DOI 10.1016/j.neuron.2015.03.017; Verny M, 1996, BRAIN, V119, P1123, DOI 10.1093/brain/119.4.1123; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Walker LC, 2013, JAMA NEUROL, V70, P304, DOI 10.1001/jamaneurol.2013.1453; Weissmann C, 2011, EMBO REP, V12, P1109, DOI 10.1038/embor.2011.192; Williams DR, 2009, LANCET NEUROL, V8, P270, DOI 10.1016/S1474-4422(09)70042-0; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yu X, 2012, J BIOL CHEM, V287, P14950, DOI 10.1074/jbc.M112.340794	76	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12271	12281		10.1074/jbc.M116.715557	http://dx.doi.org/10.1074/jbc.M116.715557			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27080260	Green Published, hybrid			2022-12-28	WOS:000378092800027
J	van de Weerd, R; Boot, M; Maaskant, J; Sparrius, M; Verboom, T; van Leeuwen, LM; Burggraaf, MJ; Paauw, NJ; Dainese, E; Manganelli, R; Bitter, W; Appelmelk, B; Geurtsen, J				van de Weerd, Robert; Boot, Maikel; Maaskant, Janneke; Sparrius, Marion; Verboom, Theo; van Leeuwen, Lisanne M.; Burggraaf, Maroeska J.; Paauw, Nanne J.; Dainese, Elisa; Manganelli, Riccardo; Bitter, Wilbert; Appelmelk, Ben J.; Geurtsen, Jeroen			Inorganic Phosphate Limitation Modulates Capsular Polysaccharide Composition in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-COMPONENT REGULATORY SYSTEM; STRINGENT RESPONSE; ALPHA-GLUCAN; CELL-WALL; POLYPHOSPHATE KINASE; POSITIVE FEEDBACK; GENE-EXPRESSION; STRESS-RESPONSE; SIGMA-FACTOR; TUBERCULOSIS	Mycobacterium tuberculosis is protected by an unusual and highly impermeable cell envelope that is critically important for the successful colonization of the host. The outermost surface of this cell envelope is formed by capsular polysaccharides that play an important role in modulating the initial interactions once the bacillus enters the body. Although the bioenzymatic steps involved in the production of the capsular polysaccharides are emerging, information regarding the ability of the bacterium to modulate the composition of the capsule is still unknown. Here, we study the mechanisms involved in regulation of mycobacterial capsule biosynthesis using a high throughput screen for gene products involved in capsular alpha-glucan production. Utilizing this approach we identified a group of mutants that all carried mutations in the ATP-binding cassette phosphate transport locus pst. These mutants collectively exhibited a strong overproduction of capsular polysaccharides, including alpha-glucan and arabinomannan, suggestive of a role for inorganic phosphate (Pi) metabolism in modulating capsular polysaccharide production. These findings were corroborated by the observation that growth under low Pi conditions as well as chemical activation of the stringent response induces capsule production in a number of mycobacterial species. This induction is, in part, dependent on sigma factor E. Finally, we show that Mycobacterium marinum, a model organism for M. tuberculosis, encounters Pi stress during infection, which shows the relevance of our findings in vivo.	[van de Weerd, Robert; Boot, Maikel; Maaskant, Janneke; Sparrius, Marion; Verboom, Theo; van Leeuwen, Lisanne M.; Burggraaf, Maroeska J.; Bitter, Wilbert; Appelmelk, Ben J.; Geurtsen, Jeroen] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands; [Paauw, Nanne J.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, POB 7057, NL-1007 MB Amsterdam, Netherlands; [Bitter, Wilbert] Vrije Univ Amsterdam, Dept Mol Microbiol, Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands; [Dainese, Elisa; Manganelli, Riccardo] Univ Padua, Dept Mol Med, Via Gabelli 63, I-35121 Padua, Italy; [Geurtsen, Jeroen] Crucell Holland BV, Janssen Pharmaceut Companies Johnson & Johnson, Bacterial Vaccines Discovery & Early Dev, Archimedesweg 4-6, NL-2333 CN Leiden, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Padua; Johnson & Johnson; Janssen Pharmaceuticals	Appelmelk, B (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands.	bj.appelmelk@vumc.nl	Manganelli, Riccardo/A-7361-2009; Bitter, Wilbert/ABG-3726-2020; Bitter, W/CAJ-5778-2022; Bitter, Wilbert/AAA-6872-2019	Manganelli, Riccardo/0000-0003-0940-7336; Bitter, Wilbert/0000-0001-8347-6511; 	Netherlands Organization of Scientific Research (NWO) [V-ICI_81902004]; Innovative Medicines Initiative Joint Undertaking Grant [115337]; European Union; European Federation of Pharmaceutical Industries and Associations companies'	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Innovative Medicines Initiative Joint Undertaking Grant; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations companies'	This work was supported by Netherlands Organization of Scientific Research (NWO) Grant V-ICI_81902004 (to R. v. d. W.), Innovative Medicines Initiative Joint Undertaking Grant Agreement 115337 (to M. B.), and further resources composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Associations companies' in kind contribution. The authors declare no conflict of interest.	Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Baba O, 1993, Kokubyo Gakkai Zasshi, V60, P264; Boutte CC, 2013, TRENDS MICROBIOL, V21, P174, DOI 10.1016/j.tim.2013.01.002; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; CHAPMAN GB, 1959, J BACTERIOL, V77, P205, DOI 10.1128/JB.77.2.205-211.1959; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; Chuang YM, 2015, MBIO, V6, DOI 10.1128/mBio.02428-14; Connolly LE, 2009, CELL HOST MICROBE, V6, P1, DOI 10.1016/j.chom.2009.07.001; Cywes C, 1997, INFECT IMMUN, V65, P4258, DOI 10.1128/IAI.65.10.4258-4266.1997; Daffe M., 1999, Tubercle and Lung Disease, V79, P153, DOI 10.1054/tuld.1998.0200; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Dinadayala P, 2008, GLYCOBIOLOGY, V18, P502, DOI 10.1093/glycob/cwn031; Elliott SR, 2016, MOL MICROBIOL, V100, P510, DOI 10.1111/mmi.13332; Ferraris DM, 2014, PROTEINS, V82, P2268, DOI 10.1002/prot.24548; Gagliardi MC, 2007, CELL MICROBIOL, V9, P2081, DOI 10.1111/j.1462-5822.2007.00940.x; Geurtsen J, 2009, J IMMUNOL, V183, P5221, DOI 10.4049/jimmunol.0900768; Glover RT, 2007, J BACTERIOL, V189, P5495, DOI 10.1128/JB.00190-07; HANKS J H, 1961, Int J Lepr, V29, P84; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; James JN, 2012, MICROBIOL-SGM, V158, P2724, DOI 10.1099/mic.0.060319-0; Kanjee U, 2012, MOL MICROBIOL, V85, P1029, DOI 10.1111/j.1365-2958.2012.08177.x; LEMASSU A, 1994, BIOCHEM J, V297, P351, DOI 10.1042/bj2970351; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Manganelli R, 2010, MOL MICROBIOL, V75, P538, DOI 10.1111/j.1365-2958.2009.07009.x; Pashley CA, 2003, FEMS MICROBIOL LETT, V229, P211, DOI 10.1016/S0378-1097(03)00823-1; Peirs P, 2005, INFECT IMMUN, V73, P1898, DOI 10.1128/IAI.73.3.1898-1902.2005; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Rifat D, 2009, J INFECT DIS, V200, P1126, DOI 10.1086/605700; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Sanyal S, 2013, MICROBIOL-SGM, V159, P2074, DOI 10.1099/mic.0.068452-0; Sharma UK, 2010, FEMS MICROBIOL REV, V34, P646, DOI 10.1111/j.1574-6976.2010.00223.x; Starosta AL, 2014, FEMS MICROBIOL REV, V38, P1172, DOI 10.1111/1574-6976.12083; Stokes RW, 2004, INFECT IMMUN, V72, P5676, DOI 10.1128/IAI.72.10.5676-5686.2004; Stoop EJM, 2011, DIS MODEL MECH, V4, P526, DOI 10.1242/dmm.006676; Sureka K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001771; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; Tischler AD, 2013, INFECT IMMUN, V81, P317, DOI 10.1128/IAI.01136-12; van de Weerd R, 2015, CHEMBIOCHEM, V16, P977, DOI 10.1002/cbic.201402713; Vanzembergh F, 2010, TUBERCULOSIS, V90, P338, DOI 10.1016/j.tube.2010.09.004; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]; Zhang Y, 2012, ANTIMICROB AGENTS CH, V56, P2223, DOI 10.1128/AAC.06288-11	44	15	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11787	11799		10.1074/jbc.M116.722454	http://dx.doi.org/10.1074/jbc.M116.722454			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27044743	Green Published, hybrid			2022-12-28	WOS:000377264800028
J	Jensen, DD; Zhao, PS; Jimenez-Vargas, NN; Lieu, T; Gerges, M; Yeatman, HR; Canals, M; Vanner, SJ; Poole, DP; Bunnett, NW				Jensen, Dane D.; Zhao, Peishen; Jimenez-Vargas, Nestor N.; Lieu, TinaMarie; Gerges, Marina; Yeatman, Holly R.; Canals, Meritxell; Vanner, Stephen J.; Poole, Daniel P.; Bunnett, Nigel W.			Protein Kinase D and G Subunits Mediate Agonist-evoked Translocation of Protease-activated Receptor-2 from the Golgi Apparatus to the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-helix receptor; Golgi; protein kinase D (PKD); protein trafficking (Golgi); receptor desensitization	ARRESTIN-DEPENDENT ENDOCYTOSIS; BETA-GAMMA COMPLEX; CELL-SURFACE; SUBSTANCE-P; PARACELLULAR PERMEABILITY; TRAFFICKING; ENDOSOMES; INFLAMMATION; TRANSPORT; NEURONS	Agonist-evoked endocytosis of G protein-coupled receptors has been extensively studied. The mechanisms by which agonists stimulate mobilization and plasma membrane translocation of G protein-coupled receptors from intracellular stores are unexplored. Protease-activated receptor-2 (PAR(2)) traffics to lysosomes, and sustained protease signaling requires mobilization and plasma membrane trafficking of PAR(2) from Golgi stores. We evaluated the contribution of protein kinase D (PKD) and G to this process. In HEK293 and KNRK cells, the PAR(2) agonists trypsin and 2-furoyl-LIGRLO-NH2 activated PKD in the Golgi apparatus, where PKD regulates protein trafficking. PAR(2) activation induced translocation of G, a PKD activator, to the Golgi apparatus, determined by bioluminescence resonance energy transfer between G-Venus and giantin-Rluc8. Inhibitors of PKD (CRT0066101) and G (gallein) prevented PAR(2)-stimulated activation of PKD. CRT0066101, PKD1 siRNA, and gallein all inhibited recovery of PAR(2)-evoked Ca2+ signaling. PAR(2) with a photoconvertible Kaede tag was expressed in KNRK cells to examine receptor translocation from the Golgi apparatus to the plasma membrane. Irradiation of the Golgi region (405 nm) induced green-red photo-conversion of PAR(2)-Kaede. Trypsin depleted PAR(2)-Kaede from the Golgi apparatus and repleted PAR(2)-Kaede at the plasma membrane. CRT0066101 inhibited PAR(2)-Kaede translocation to the plasma membrane. CRT0066101 also inhibited sustained protease signaling to colonocytes and nociceptive neurons that naturally express PAR(2) and mediate protease-evoked inflammation and nociception. Our results reveal a major role for PKD and G in agonist-evoked mobilization of intracellular PAR(2) stores that is required for sustained signaling by extracellular proteases.	[Jensen, Dane D.; Zhao, Peishen; Lieu, TinaMarie; Gerges, Marina; Yeatman, Holly R.; Canals, Meritxell; Poole, Daniel P.; Bunnett, Nigel W.] Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia; [Jensen, Dane D.; Zhao, Peishen; Lieu, TinaMarie; Canals, Meritxell; Poole, Daniel P.; Bunnett, Nigel W.] Monash Univ, Australian Res Council, Ctr Excellence Convergent Bionano Sci & Technol, Parkville, Vic 3052, Australia; [Poole, Daniel P.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia; [Bunnett, Nigel W.] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3010, Australia; [Jimenez-Vargas, Nestor N.; Vanner, Stephen J.] Queens Univ, Div Gastroenterol, Gastrointestinal Dis Res Unit, Kingston, ON K7L 3N6, Canada	Monash University; University of Melbourne; University of Melbourne; Queens University - Canada	Poole, DP; Bunnett, NW (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	daniel.poole@monash.edu; nigel.bunnett@monash.edu	Zhao, Peishen/AFQ-6840-2022; Lieu, TinaMarie/AAM-7691-2020; Poole, Daniel/AET-6645-2022	Poole, Daniel/0000-0002-6168-8422; Bunnett, Nigel W./0000-0003-3367-0644; Jimenez-Vargas, Nestor N/0000-0001-6595-1884; Canals, Meritxell/0000-0002-7942-5006; Jensen, Dane D./0000-0001-6540-2375	National Health and Medical Research Council; Australian Research Council; Monash University; Takeda Pharmaceuticals, Inc.	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Monash University(Monash University); Takeda Pharmaceuticals, Inc.(Takeda Pharmaceutical Company Ltd)	This work was supported by the National Health and Medical Research Council, The Australian Research Council, and Monash University. Research in the authors' laboratory was funded in part by Takeda Pharmaceuticals, Inc.	Akgoz M, 2004, J BIOL CHEM, V279, P51541, DOI 10.1074/jbc.M410639200; Amadesi S, 2009, J COMP NEUROL, V516, P141, DOI 10.1002/cne.22104; Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Bohm SK, 1996, BIOCHEM J, V314, P1009; Cenac N, 2003, J IMMUNOL, V170, P4296, DOI 10.4049/jimmunol.170.8.4296; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Corvera CU, 1997, J CLIN INVEST, V100, P1383, DOI 10.1172/JCI119658; Cottrell GS, 2007, GASTROENTEROLOGY, V132, P2422, DOI 10.1053/j.gastro.2007.03.101; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Anel AMD, 2007, BIOCHEM J, V406, P157, DOI 10.1042/BJ20070359; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Gupta A, 2015, BRIT J PHARMACOL, V172, P704, DOI 10.1111/bph.12833; Hansen KK, 2005, P NATL ACAD SCI USA, V102, P8363, DOI 10.1073/pnas.0409535102; Irannejad R, 2014, CURR OPIN CELL BIOL, V27, P109, DOI 10.1016/j.ceb.2013.10.003; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jacob C, 2005, J BIOL CHEM, V280, P31936, DOI 10.1074/jbc.M506338200; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jensen DD, 2014, J BIOL CHEM, V289, P20283, DOI 10.1074/jbc.M114.578179; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; Kong WY, 1997, P NATL ACAD SCI USA, V94, P8884, DOI 10.1073/pnas.94.16.8884; Koreishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059821; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Luo WB, 2007, J BIOL CHEM, V282, P30246, DOI 10.1074/jbc.M703205200; McConalogue K, 1999, J BIOL CHEM, V274, P16257, DOI 10.1074/jbc.274.23.16257; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Oh P, 2012, J BIOL CHEM, V287, P17353, DOI 10.1074/jbc.M111.338897; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Padilla BE, 2007, J CELL BIOL, V179, P981, DOI 10.1083/jcb.200704053; Pelayo JC, 2011, J PHYSIOL-LONDON, V589, P5213, DOI 10.1113/jphysiol.2011.214452; Poole DP, 2011, GASTROENTEROLOGY, V141, P982, DOI 10.1053/j.gastro.2011.05.042; Roosterman D, 2007, P NATL ACAD SCI USA, V104, P11838, DOI 10.1073/pnas.0701910104; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Saini DK, 2007, J BIOL CHEM, V282, P24099, DOI 10.1074/jbc.M701191200; Saini DK, 2010, P NATL ACAD SCI USA, V107, P11417, DOI 10.1073/pnas.1003042107; Coria AS, 2014, BIOL CELL, V106, P30, DOI 10.1111/boc.201300052; Steinberg SF, 2012, MOL PHARMACOL, V81, P284, DOI 10.1124/mol.111.075986; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Vergnolle N, 2001, NAT MED, V7, P821, DOI 10.1038/89945; Wang H, 2008, J BIOL CHEM, V283, P809, DOI 10.1074/jbc.M703021200; Wang HY, 2010, FASEB J, V24, P1971, DOI 10.1096/fj.09-137646; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Zhao PS, 2015, J BIOL CHEM, V290, P13875, DOI 10.1074/jbc.M115.642736; Zhao PS, 2014, J BIOL CHEM, V289, P27215, DOI 10.1074/jbc.M114.599712; Zhao PS, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00067	55	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11285	11299		10.1074/jbc.M115.710681	http://dx.doi.org/10.1074/jbc.M115.710681			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27030010	Green Published, hybrid			2022-12-28	WOS:000377042100028
J	Li, HG; Hwang, Y; Perry, K; Bushman, F; Van Duyne, GD				Li, Huiguang; Hwang, Young; Perry, Kay; Bushman, Frederic; Van Duyne, Gregory D.			Structure and Metal Binding Properties of a Poxvirus Resolvase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme structure; Holliday junction; metalloenzyme; poxvirus; viral replication; resolvase	HOLLIDAY JUNCTION RESOLVASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; VACCINIA VIRUS; DNA JUNCTIONS; SUBSTRATE-SPECIFICITY; RNASE-H; GENETIC-RECOMBINATION; T7 ENDONUCLEASE; RUVC RESOLVASE	Poxviruses replicate their linear genomes by forming concatemers that must be resolved into monomeric units to produce new virions. A viral resolvase cleaves DNA four-way junctions extruded at the concatemer junctions to produce monomeric genomes. This cleavage reaction is required for viral replication, so the resolvase is an attractive target for small molecule inhibitors. To provide a platform for understanding resolvase mechanism and designing inhibitors, we have determined the crystal structure of the canarypox virus (CPV) resolvase. CPV resolvase is dimer of RNase H superfamily domains related to Escherichia coli RuvC, with an active site lined by highly conserved acidic residues that bind metal ions. There are several intriguing structural differences between resolvase and RuvC, and a model of the CPV resolvaseHolliday junction complex provides insights into the consequences of these differences, including a plausible explanation for the weak sequence specificity exhibited by the poxvirus enzymes. The model also explains why the poxvirus resolvases are more promiscuous than RuvC, cleaving a variety of branched, bulged, and flap-containing substrates. Based on the unique active site structure observed for CPV resolvase, we have carried out a series of experiments to test divalent ion usage and preferences. We find that the two resolvase metal binding sites have different preferences for Mg(2+)versus Mn2+. Optimal resolvase activity is maintained with 5 mu m Mn2+ and 100 mu m Mg2+, concentrations that are well below those required for either metal alone. Together, our findings provide biochemical insights and structural models that will facilitate studying poxvirus replication and the search for efficient poxvirus inhibitors.	[Li, Huiguang; Van Duyne, Gregory D.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Li, Huiguang] Univ Penn, Perelman Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA; [Hwang, Young; Bushman, Frederic] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Perry, Kay] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14850 USA; [Perry, Kay] Argonne Natl Lab, 9700 S Cass Ave, Argonne, IL 60439 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Van Duyne, GD (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.; Bushman, F (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	bushman@mail.med.upenn.edu; vanduyne@mail.med.upenn.edu			NIAID; National Institutes of Health Mid-Atlantic Regional Center of Excellence for Biodefense Research Grants [U54 AI057168, U01 AI 082015]; National Institutes of Health [P41 GM103403]; Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082015, U54AI057168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Mid-Atlantic Regional Center of Excellence for Biodefense Research Grants; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIAID, National Institutes of Health Mid-Atlantic Regional Center of Excellence for Biodefense Research Grants U54 AI057168 and U01 AI 082015 and National Institutes of Health Grant P41 GM103403 (to the NE-CAT beamlines). The Advanced Photon Source is a U.S. Department of Energy Office of Science User Facility operated by Argonne National Laboratory under Contract DE-AC02-06CH11357. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARIYOSHI M, 1994, CELL, V78, P1063, DOI 10.1016/0092-8674(94)90280-1; ASH DE, 1982, J BIOL CHEM, V257, P9261; Bennett RJ, 1996, P NATL ACAD SCI USA, V93, P12217, DOI 10.1073/pnas.93.22.12217; BENNETT RJ, 1995, P NATL ACAD SCI USA, V92, P5635, DOI 10.1073/pnas.92.12.5635; BENNETT RJ, 1995, J MOL BIOL, V252, P213, DOI 10.1006/jmbi.1995.0489; Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Ceschini S, 2001, EMBO J, V20, P6601, DOI 10.1093/emboj/20.23.6601; Chen L, 2013, NUCLEIC ACIDS RES, V41, P648, DOI 10.1093/nar/gks1015; Culyba M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks325; Culyba MJ, 2007, J BIOL CHEM, V282, P34644, DOI 10.1074/jbc.M705322200; Culyba MJ, 2006, VIROLOGY, V352, P466, DOI 10.1016/j.virol.2006.05.007; Culyba MJ, 2010, J MOL BIOL, V399, P182, DOI 10.1016/j.jmb.2010.03.054; Culyba MJ, 2009, J BIOL CHEM, V284, P1190, DOI 10.1074/jbc.M807864200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fogg JM, 1999, BIOCHEMISTRY-US, V38, P11349, DOI 10.1021/bi990926n; Fogg JM, 2001, J MOL BIOL, V313, P751, DOI 10.1006/jmbi.2001.5081; Garcia AD, 2000, P NATL ACAD SCI USA, V97, P8926, DOI 10.1073/pnas.150238697; Garcia AD, 2006, J BIOL CHEM, V281, P11618, DOI 10.1074/jbc.M600182200; Garcia AD, 2001, J VIROL, V75, P6460, DOI 10.1128/JVI.75.14.6460-6471.2001; Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175; Gorecka KM, 2013, NUCLEIC ACIDS RES, V41, P9945, DOI 10.1093/nar/gkt769; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; Hadden JM, 2002, EMBO J, V21, P3505, DOI 10.1093/emboj/cdf337; Hadden JM, 2007, NATURE, V449, P621, DOI 10.1038/nature06158; Haller SL, 2014, INFECT GENET EVOL, V21, P15, DOI 10.1016/j.meegid.2013.10.014; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kvaratskhelia M, 1999, BIOCHEMISTRY-US, V38, P16613, DOI 10.1021/bi9921788; Lai B, 2003, BIOCHEMISTRY-US, V42, P785, DOI 10.1021/bi026960a; Lilley DMJ, 2010, BIOCHEM SOC T, V38, P399, DOI 10.1042/BST0380399; Lilley DMJ, 2000, P NATL ACAD SCI USA, V97, P9351, DOI 10.1073/pnas.97.17.9351; MERCHLINSKY M, 1988, J MOL BIOL, V199, P399, DOI 10.1016/0022-2836(88)90613-4; MOSS B, 1991, SCIENCE, V252, P1662, DOI 10.1126/science.2047875; Moss B, 2001, VIROLOGY, P2637; Nguyen BYT, 2011, ANN NY ACAD SCI, V1222, P83, DOI 10.1111/j.1749-6632.2011.05972.x; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Nowotny M, 2006, EMBO J, V25, P1924, DOI 10.1038/sj.emboj.7601076; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Read RJ, 2011, ACTA CRYSTALLOGR D, V67, P338, DOI 10.1107/S0907444910051371; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sha RJ, 2000, BIOCHEMISTRY-US, V39, P11982, DOI 10.1021/bi001037z; SHAH R, 1994, CELL, V79, P853, DOI 10.1016/0092-8674(94)90074-4; Shida T, 1996, J BIOL CHEM, V271, P26105, DOI 10.1074/jbc.271.42.26105; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; White MF, 1997, J MOL BIOL, V266, P122, DOI 10.1006/jmbi.1996.0795; Yamada K, 2004, CURR OPIN STRUC BIOL, V14, P130, DOI 10.1016/j.sbi.2004.03.005; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3	52	5	5	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11094	11104		10.1074/jbc.M115.709139	http://dx.doi.org/10.1074/jbc.M115.709139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27013661	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000377042100013
J	Saito, S; Ohkita, M; Saito, CT; Takahashi, K; Tominaga, M; Ohta, T				Saito, Shigeru; Ohkita, Masashi; Saito, Claire T.; Takahashi, Kenji; Tominaga, Makoto; Ohta, Toshio			Evolution of Heat Sensors Drove Shifts in Thermosensation between Xenopus Species Adapted to Different Thermal Niches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; molecular evolution; receptor structure-function; transient receptor potential channels (TRP channels); Xenopus; functional evolution; molecular basis; thermal sensor	CAPSAICIN RECEPTOR; MOLECULAR-BASIS; TRPV1; TROPICALIS; CHANNEL; TRPA1; GENOME; SENSITIVITIES; DETERMINANTS; MECHANISMS	Temperature is one of the most critical environmental factors affecting survival, and thus species that inhabit different thermal niches have evolved thermal sensitivities suitable for their respective habitats. During the process of shifting thermal niches, various types of genes expressed in diverse tissues, including those of the peripheral to central nervous systems, are potentially involved in the evolutionary changes in thermosensation. To elucidate the molecular mechanisms behind the evolution of thermosensation, thermal responses were compared between two species of clawed frogs (Xenopus laevis and Xenopus tropicalis) adapted to different thermal environments. X. laevis was much more sensitive to heat stimulation than X. tropicalis at the behavioral and neural levels. The activity and sensitivity of the heat-sensing TRPA1 channel were higher in X. laevis compared with those of X. tropicalis. The thermal responses of another heat-sensing channel, TRPV1, also differed between the two Xenopus species. The species differences in Xenopus TRPV1 heat responses were largely determined by three amino acid substitutions located in the first three ankyrin repeat domains, known to be involved in the regulation of rat TRPV1 activity. In addition, Xenopus TRPV1 exhibited drastic species differences in sensitivity to capsaicin, contained in chili peppers, between the two Xenopus species. Another single amino acid substitution within Xenopus TRPV1 is responsible for this species difference, which likely alters the neural and behavioral responses to capsaicin. These combined subtle amino acid substitutions in peripheral thermal sensors potentially serve as a driving force for the evolution of thermal and chemical sensation.	[Saito, Shigeru; Saito, Claire T.; Tominaga, Makoto] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Saito, Shigeru; Tominaga, Makoto] SOKENDAI, Dept Physiol Sci, Okazaki, Aichi 4448787, Japan; [Ohkita, Masashi; Takahashi, Kenji; Ohta, Toshio] Tottori Univ, Fac Agr, Dept Vet Pharmacol, Tottori 6808553, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; Tottori University	Saito, S (corresponding author), Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan.; Ohta, T (corresponding author), Tottori Univ, Fac Agr, Dept Vet Pharmacol, Tottori 6808553, Japan.	sshigeru@nips.ac.jp; tohta@muses.tottori-u.ac.jp	Saito, Shigeru/B-4698-2015	Saito, Shigeru/0000-0002-6237-8979	Ministry of Education, Culture, Sports, Science, and Technology of Japan [15H05927, 16K07470, 26292150]; Grants-in-Aid for Scientific Research [16K07470] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 15H05927 (to M. T.), 16K07470 (to S. S.), and 26292150 (to T. O.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3501; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gau P, 2013, J NEUROSCI, V33, P5249, DOI 10.1523/JNEUROSCI.5403-12.2013; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hirsch N, 2002, DEV DYNAM, V225, P422, DOI 10.1002/dvdy.10178; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Joseph J, 2013, J BIOL CHEM, V288, P35690, DOI 10.1074/jbc.M113.513374; Kashiwagi K, 2010, EXP ANIM TOKYO, V59, P395, DOI 10.1538/expanim.59.395; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Myers BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005741; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Ohkita M, 2012, J BIOL CHEM, V287, P2388, DOI 10.1074/jbc.M111.305698; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Prober DA, 2008, J NEUROSCI, V28, P10102, DOI 10.1523/JNEUROSCI.2740-08.2008; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Saito S, 2015, CELL CALCIUM, V57, P214, DOI 10.1016/j.ceca.2014.12.001; Saito S, 2014, MOL BIOL EVOL, V31, P708, DOI 10.1093/molbev/msu001; Saito S, 2012, J BIOL CHEM, V287, P30743, DOI 10.1074/jbc.M112.362194; Saito S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002041; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tinsley RC, 1996, BIOL XENOPUS; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yokoyama S, 2013, MOL BIOL EVOL, V30, P1495, DOI 10.1093/molbev/mst075	40	23	23	1	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11446	11459		10.1074/jbc.M115.702498	http://dx.doi.org/10.1074/jbc.M115.702498			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27022021	Green Published, hybrid			2022-12-28	WOS:000377042100041
J	Martin, KR; Kantari-Mimoun, C; Yin, M; Pederzoli-Ribeil, M; Angelot-Delettre, F; Ceroi, A; Grauffel, C; Benhamou, M; Reuter, N; Saas, P; Frachet, P; Boulanger, CM; Witko-Sarsat, V				Martin, Katherine R.; Kantari-Mimoun, Chahrazade; Yin, Min; Pederzoli-Ribeil, Magali; Angelot-Delettre, Fanny; Ceroi, Adam; Grauffel, Cedric; Benhamou, Marc; Reuter, Nathalie; Saas, Philippe; Frachet, Philippe; Boulanger, Chantal M.; Witko-Sarsat, Veronique			Proteinase 3 Is a Phosphatidylserine-binding Protein That Affects the Production and Function of Microvesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL-DERIVED MICROPARTICLES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; APOPTOTIC CELLS; PLATELET MICROPARTICLES; MACROPHAGE PHAGOCYTOSIS; MEMBRANE EXPRESSION; SURFACE EXPRESSION; SERINE-PROTEASE; VASCULITIS; AUTOANTIGEN	Proteinase 3 (PR3), the autoantigen in granulomatosis with polyangiitis, is expressed at the plasma membrane of resting neutrophils, and this membrane expression increases during both activation and apoptosis. Using surface plasmon resonance and protein-lipid overlay assays, this study demonstrates that PR3 is a phosphatidylserine-binding protein and this interaction is dependent on the hydrophobic patch responsible for membrane anchorage. Molecular simulations suggest that PR3 interacts with phosphatidylserine via a small number of amino acids, which engage in long lasting interactions with the lipid heads. As phosphatidylserine is a major component of microvesicles (MVs), this study also examined the consequences of this interaction on MV production and function. PR3-expressing cells produced significantly fewer MVs during both activation and apoptosis, and this reduction was dependent on the ability of PR3 to associate with the membrane as mutating the hydrophobic patch restored MV production. Functionally, activation-evoked MVs from PR3-expressing cells induced a significantly larger respiratory burst in human neutrophils compared with control MVs. Conversely, MVs generated during apoptosis inhibited the basal respiratory burst in human neutrophils, and those generated from PR3-expressing cells hampered this inhibition. Given that membrane expression of PR3 is increased in patients with granulomatosis with polyangiitis, MVs generated from neutrophils expressing membrane PR3 may potentiate oxidative damage of endothelial cells and promote the systemic inflammation observed in this disease.	[Martin, Katherine R.; Kantari-Mimoun, Chahrazade; Pederzoli-Ribeil, Magali; Witko-Sarsat, Veronique] INSERM, U1016, Inst Cochin, F-75014 Paris, France; [Martin, Katherine R.; Kantari-Mimoun, Chahrazade; Pederzoli-Ribeil, Magali; Witko-Sarsat, Veronique] CNRS UMR8104, F-75014 Paris, France; [Martin, Katherine R.; Kantari-Mimoun, Chahrazade; Yin, Min; Pederzoli-Ribeil, Magali; Boulanger, Chantal M.; Witko-Sarsat, Veronique] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Martin, Katherine R.; Kantari-Mimoun, Chahrazade; Pederzoli-Ribeil, Magali; Benhamou, Marc; Witko-Sarsat, Veronique] Labex Inflamex, Ctr Excellence, F-75013 Paris, France; [Yin, Min; Boulanger, Chantal M.] INSERM, Paris Cardiovasc Res Ctr PARCC, U970, F-75015 Paris, France; [Angelot-Delettre, Fanny; Ceroi, Adam; Saas, Philippe] Univ Bourgogne Franche Comte, INSERM, UMR1098, Etab Francais Sang Bourgogne Franche Comte, F-25000 Besancon, France; [Angelot-Delettre, Fanny; Ceroi, Adam; Saas, Philippe] Labex LipSTIC, Ctr Excellence, F-25000 Besancon, France; [Grauffel, Cedric; Reuter, Nathalie] Univ Bergen, Dept Informat, N-5008 Bergen, Norway; [Grauffel, Cedric; Reuter, Nathalie] Univ Bergen, Dept Mol Biol, N-5008 Bergen, Norway; [Benhamou, Marc] Univ Paris Diderot, INSERM U1149, CNRS ERL8252, F-75018 Paris, France; [Frachet, Philippe] Univ Grenoble Alpes, IBS, F-38044 Grenoble, France; [Frachet, Philippe] CNRS, IBS, F-38044 Grenoble, France; [Frachet, Philippe] Commissariat Energie Atom, IBS, F-38000 Grenoble, France; [Grauffel, Cedric] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Bergen; University of Bergen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Academia Sinica - Taiwan	Witko-Sarsat, V (corresponding author), INSERM, U1016, Inst Cochin, F-75014 Paris, France.; Witko-Sarsat, V (corresponding author), CNRS UMR8104, F-75014 Paris, France.; Witko-Sarsat, V (corresponding author), Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France.; Witko-Sarsat, V (corresponding author), Labex Inflamex, Ctr Excellence, F-75013 Paris, France.	veronique.witko@inserm.fr	frachet, philippe/Q-2869-2019; Saas, Philippe/M-9605-2019; Reuter, Nathalie/G-2037-2012; Boulanger, Chantal M./K-4349-2017; Witko-Sarsat, Veronique/L-9714-2017; Frachet, philippe/C-3797-2018	frachet, philippe/0000-0002-1658-3859; Saas, Philippe/0000-0002-8857-9939; Reuter, Nathalie/0000-0002-3649-7675; Boulanger, Chantal M./0000-0002-3687-651X; Witko-Sarsat, Veronique/0000-0002-5296-9601; Frachet, philippe/0000-0002-1658-3859; CEROI, Adam/0000-0001-9101-347X; DELETTRE, Fanny/0000-0003-0801-0986; Benhamou, Marc/0000-0001-7763-3795; Martin, Katherine/0000-0001-9453-9573	Investissements d'Avenir Program [ANR-11-IDEX-0005-02]; Sorbonne Paris Cite; Labex Inflamex; Departements Hospitalo Universitaires Autoimmune and Hormonal Diseases (DHU-AUTHORS); Labex LipSTIC [ANR-11-LABX-0021]; Chancellerie des Universites de Paris; National Health and Medical Research Council Early Career Research Fellowship [1092602]; Vaincre la Mucoviscidose; Norges Forskninsgrad FRIMEDBIO [214167]; NOTUR [4700k]	Investissements d'Avenir Program(French National Research Agency (ANR)); Sorbonne Paris Cite; Labex Inflamex; Departements Hospitalo Universitaires Autoimmune and Hormonal Diseases (DHU-AUTHORS); Labex LipSTIC; Chancellerie des Universites de Paris; National Health and Medical Research Council Early Career Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Vaincre la Mucoviscidose; Norges Forskninsgrad FRIMEDBIO; NOTUR	This work was supported in part by the Investissements d'Avenir Program (Grant ANR-11-IDEX-0005-02), Sorbonne Paris Cite, Labex Inflamex, Departements Hospitalo Universitaires Autoimmune and Hormonal Diseases (DHU-AUTHORS), Labex LipSTIC (Grant ANR-11-LABX-0021), and the Chancellerie des Universites de Paris (Legs Poix to V. W.-S.). All authors declare that they have no significant competing financial, professional or personal interests that might have influenced the performance or presentation of the work described in this manuscript.r Supported by funding from the Labex Inflamex and National Health and Medical Research Council Early Career Research Fellowship 1092602.r Supported by a doctoral fellowship from Vaincre la Mucoviscidose.r Supported by Norges Forskninsgrad FRIMEDBIO Grant 214167 and NOTUR computing resources grant 4700k.	Abdgawad M, 2010, CLIN EXP IMMUNOL, V161, P89, DOI 10.1111/j.1365-2249.2010.04154.x; Amir-Moazami O, 2008, J BIOL CHEM, V283, P25514, DOI 10.1074/jbc.M705320200; Angelot F, 2009, HAEMATOL-HEMATOL J, V94, P1502, DOI 10.3324/haematol.2009.010934; Bauer S, 2007, J LEUKOCYTE BIOL, V81, P458, DOI 10.1189/jlb.0806514; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Brogan PA, 2004, ARTHRITIS RHEUM, V50, P927, DOI 10.1002/art.20199; CAMPANELLI D, 1990, J EXP MED, V172, P1709, DOI 10.1084/jem.172.6.1709; Cloutier N, 2013, EMBO MOL MED, V5, P235, DOI 10.1002/emmm.201201846; Dalli J, 2008, BLOOD, V112, P2512, DOI 10.1182/blood-2008-02-140533; Dalli J, 2014, EMBO MOL MED, V6, P27, DOI 10.1002/emmm.201303503; Daniel L, 2006, KIDNEY INT, V69, P1416, DOI 10.1038/sj.ki.5000306; Durant S, 2004, J LEUKOCYTE BIOL, V75, P87, DOI 10.1189/jlb.0203079; Erdbruegger U, 2008, RHEUMATOLOGY, V47, P1820, DOI 10.1093/rheumatology/ken373; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; Gabillet J, 2012, J IMMUNOL, V189, P2574, DOI 10.4049/jimmunol.1200600; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Hajjar E, 2007, FEBS LETT, V581, P5685, DOI 10.1016/j.febslet.2007.11.029; HALBWACHSMECARELLI L, 1995, FEBS LETT, V374, P29, DOI 10.1016/0014-5793(95)01073-N; Headland SE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5608; Hong Y, 2012, J AM SOC NEPHROL, V23, P49, DOI 10.1681/ASN.2011030298; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kantari C, 2007, BLOOD, V110, P4086, DOI 10.1182/blood-2007-03-080457; Kantari C, 2011, J LEUKOCYTE BIOL, V90, P941, DOI 10.1189/jlb.1210695; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Korkmaz B, 2008, J BIOL CHEM, V283, P35976, DOI 10.1074/jbc.M806754200; Lepse N, 2011, AUTOIMMUN REV, V11, P77, DOI 10.1016/j.autrev.2011.08.002; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Mesri C, 1998, J IMMUNOL, V161, P4382; Millet A, 2015, J CLIN INVEST, V125, P4107, DOI 10.1172/JCI78182; Morel O, 2011, ARTERIOSCL THROM VAS, V31, P15, DOI 10.1161/ATVBAHA.109.200956; Nielsen CT, 2012, ARTHRITIS RHEUM-US, V64, P1227, DOI 10.1002/art.34381; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pitanga TN, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-21; Qian Y, 2004, J IMMUNOL, V172, P625, DOI 10.4049/jimmunol.172.1.625; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Rautou PE, 2011, CIRC RES, V108, P335, DOI 10.1161/CIRCRESAHA.110.237420; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Reid VL, 2012, BRIT J ANAESTH, V109, P503, DOI 10.1093/bja/aes321; Scanu A, 2008, J LEUKOCYTE BIOL, V83, P921, DOI 10.1189/jlb.0807551; Schillinger AS, 2014, BBA-BIOMEMBRANES, V1838, P3191, DOI 10.1016/j.bbamem.2014.09.003; SCHMID I, 1994, J IMMUNOL METHODS, V170, P145, DOI 10.1016/0022-1759(94)90390-5; Schreiber A, 2013, J LEUKOCYTE BIOL, V94, P623, DOI 10.1189/jlb.1012525; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5; Venable RM, 2013, J PHYS CHEM B, V117, P10183, DOI 10.1021/jp401512z; Vion AC, 2013, CIRC RES, V112, P1323, DOI 10.1161/CIRCRESAHA.112.300818; von Vietinghoff S, 2007, BLOOD, V109, P4487, DOI 10.1182/blood-2006-10-055327; Witko-Sarsat V, 1999, BLOOD, V94, P2487, DOI 10.1182/blood.V94.7.2487.419k07_2487_2496; Witko-Sarsat V, 1999, J AM SOC NEPHROL, V10, P1224; Witko-Sarsat V, 2002, J BIOL CHEM, V277, P47338, DOI 10.1074/jbc.M202789200; Witko-Sarsat W, 2003, KIDNEY INT, V64, P82, DOI 10.1046/j.1523-1755.2003.00044.x; ZIMMER M, 1992, P NATL ACAD SCI USA, V89, P8215, DOI 10.1073/pnas.89.17.8215	56	30	33	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10476	10489		10.1074/jbc.M115.698639	http://dx.doi.org/10.1074/jbc.M115.698639			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26961880	hybrid, Green Published			2022-12-28	WOS:000377042600004
J	Demers-Lamarche, J; Guillebaud, G; Tlili, M; Todkar, K; Belanger, N; Grondin, M; Nguyen, AP; Michel, J; Germain, M				Demers-Lamarche, Julie; Guillebaud, Gerald; Tlili, Mouna; Todkar, Kiran; Belanger, Noemie; Grondin, Martine; Nguyen, Angela P.; Michel, Jennifer; Germain, Marc			Loss of Mitochondrial Function Impairs Lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; PARKINSONS-DISEASE; COMPLEX-I; HUNTINGTONS-DISEASE; MOUSE MODEL; AUTOPHAGY; PINK1; DYSFUNCTION; DEGRADATION; PATHOLOGY	Alterations in mitochondrial function, as observed in neurodegenerative diseases, lead to disrupted energy metabolism and production of damaging reactive oxygen species. Here, we demonstrate that mitochondrial dysfunction also disrupts the structure and function of lysosomes, the main degradation and recycling organelle. Specifically, inhibition of mitochondrial function, following deletion of the mitochondrial protein AIF, OPA1, or PINK1, as well as chemical inhibition of the electron transport chain, impaired lysosomal activity and caused the appearance of large lysosomal vacuoles. Importantly, our results show that lysosomal impairment is dependent on reactive oxygen species. Given that alterations in both mitochondrial function and lysosomal activity are key features of neurodegenerative diseases, this work provides important insights into the etiology of neurodegenerative diseases.	[Michel, Jennifer; Germain, Marc] Univ Quebec Trois Rivieres, Grp Rech Signalisat Cellulaire, Dept Med Biol, Trois Rivieres, PQ G9A 5H7, Canada; [Demers-Lamarche, Julie; Guillebaud, Gerald; Todkar, Kiran; Germain, Marc] Univ Quebec Trois Rivieres, Ctr Rech Biomed, Trois Rivieres, PQ G9A 5H7, Canada; [Nguyen, Angela P.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Trois Rivieres; University of Ottawa	Germain, M (corresponding author), Univ Quebec Trois Rivieres, Dept Med Biol, 3351 Blvd Forges, Trois Rivieres, PQ G9A 5H7, Canada.	marc.germain1@uqtr.ca			Natural Sciences and Engineering Research Council of Canada; Fonds de Recherche du Quebec-Sante	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of graduate scholarships from the Fonds de Recherche du Quebec-Sante and the Natural Sciences and Engineering Research Council of Canada.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amo T, 2011, NEUROBIOL DIS, V41, P111, DOI 10.1016/j.nbd.2010.08.027; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Arduino DM, 2012, HUM MOL GENET, V21, P4680, DOI 10.1093/hmg/dds309; Baixauli F, 2015, CELL METAB, V22, P485, DOI 10.1016/j.cmet.2015.07.020; Batelli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001884; Ben-Gedalya T, 2012, TRAFFIC, V13, P635, DOI 10.1111/j.1600-0854.2012.01330.x; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Cox TM, 2012, J PATHOL, V226, P241, DOI 10.1002/path.3021; Dairaku T, 2014, MOL GENET METAB, V111, P193, DOI 10.1016/j.ymgme.2013.11.003; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Dodson M, 2013, FREE RADICAL BIO MED, V63, P207, DOI 10.1016/j.freeradbiomed.2013.05.014; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Esteves AR, 2009, ANTIOXID REDOX SIGN, V11, P439, DOI [10.1089/ars.2008.2247, 10.1089/ARS.2008.2247]; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Germain M, 2013, HUM MOL GENET, V22, P952, DOI 10.1093/hmg/dds500; Germain M, 2011, EMBO J, V30, P395, DOI 10.1038/emboj.2010.327; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Graef M, 2011, EMBO J, V30, P2101, DOI 10.1038/emboj.2011.104; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Gustaw-Rothenburg K, 2010, BIOMARK MED, V4, P15, DOI 10.2217/BMM.09.86; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Karuppagounder SS, 2009, NEUROBIOL AGING, V30, P1587, DOI 10.1016/j.neurobiolaging.2007.12.013; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004; Mailloux RJ, 2013, TRENDS BIOCHEM SCI, V38, P592, DOI 10.1016/j.tibs.2013.09.001; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Moran M, 2012, FREE RADICAL BIO MED, V53, P595, DOI 10.1016/j.freeradbiomed.2012.05.009; Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Oliveira JMA, 2007, J NEUROCHEM, V101, P241, DOI 10.1111/j.1471-4159.2006.04361.x; Osellame LD, 2013, CELL METAB, V17, P941, DOI 10.1016/j.cmet.2013.04.014; Pagano G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/541230; Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Patten DA, 2010, J ALZHEIMERS DIS, V20, pS357, DOI 10.3233/JAD-2010-100498; Perzov N, 2002, J EXP BIOL, V205, P1209; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Raimundo N, 2014, TRENDS MOL MED, V20, P282, DOI 10.1016/j.molmed.2014.01.005; Scarffe LA, 2014, TRENDS NEUROSCI, V37, P315, DOI 10.1016/j.tins.2014.03.004; Schultheis PJ, 2013, HUM MOL GENET, V22, P2067, DOI 10.1093/hmg/ddt057; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Starkov AA, 2001, BIOCHEM BIOPH RES CO, V281, P645, DOI 10.1006/bbrc.2001.4409; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; TURK B, 1994, BIOCHEMISTRY-US, V33, P14800, DOI 10.1021/bi00253a019; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Xie YX, 2015, NEURON, V87, P355, DOI 10.1016/j.neuron.2015.06.026; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	68	127	127	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10263	10276		10.1074/jbc.M115.695825	http://dx.doi.org/10.1074/jbc.M115.695825			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26987902	Green Published, hybrid			2022-12-28	WOS:000375602800034
J	Hossain, ST; Deutscher, MP				Hossain, Sk Tofajjen; Deutscher, Murray P.			Helicase Activity Plays a Crucial Role for RNase R Function in Vivo and for RNA Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; POLYNUCLEOTIDE PHOSPHORYLASE; STRUCTURED RNA; NUCLEASE DOMAIN; RIBOSOMAL-RNA; DEGRADOSOME; DEGRADATION; PROTEIN; DECAY; CSDA	RNase R is a 3' to 5' hydrolytic exoribonuclease that has the unusual ability to digest highly structured RNA. The enzyme possesses an intrinsic, ATP-dependent RNA helicase activity that is essential in vitro for efficient nuclease activity against double-stranded RNA substrates, particularly at lower temperatures, with more stable RNA duplexes, and for duplexes with short 3' overhangs. Here, we inquired whether the helicase activity was also important for RNase R function in vivo and for RNA metabolism. We find that strains containing a helicase-deficient RNase R due to mutations in its ATP-binding Walker motifs exhibit growth defects at low temperatures. Most importantly, cells also lacking polynucleotide phosphorylase ( PNPase), and dependent for growth on RNase R, grow extremely poorly at 34, 37, and 42 degrees C and do not grow at all at 31 degrees C. Northern analysis revealed that in these cells, fragments of 16S and 23S rRNA accumulate to high levels, leading to interference with ribosome maturation and ultimately to cell death. These findings indicate that the intrinsic helicase activity of RNase R is required for its proper functioning in vivo and for effective RNA metabolism.	[Hossain, Sk Tofajjen; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	m.deutscher@med.miami.edu		Hossain, Sk Tofajjen/0000-0002-1448-1015	National Institutes of Health [GM 16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016317, F32GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant GM 16317 (to M. P. D.) from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Awano N, 2007, J BACTERIOL, V189, P5808, DOI 10.1128/JB.00655-07; Awano N, 2010, J BACTERIOL, V192, P1344, DOI 10.1128/JB.01368-09; Basturea GN, 2011, RNA, V17, P338, DOI 10.1261/rna.2448911; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Hossain ST, 2016, J BIOL CHEM, V291, P7877, DOI 10.1074/jbc.M116.717991; Hossain ST, 2015, J BIOL CHEM, V290, P15697, DOI 10.1074/jbc.M115.650176; HUANG S, 1992, J BIOL CHEM, V267, P25609; Jagessar KL, 2010, RNA, V16, P1386, DOI 10.1261/rna.2015610; Khemici V, 2004, MOL MICROBIOL, V51, P777, DOI 10.1046/j.1365-2958.2003.03862.x; Liang WX, 2010, J BIOL CHEM, V285, P29054, DOI 10.1074/jbc.C110.168641; Lin PH, 2005, P NATL ACAD SCI USA, V102, P16590, DOI 10.1073/pnas.0500994102; Liou GG, 2002, J BIOL CHEM, V277, P41157, DOI 10.1074/jbc.M206618200; Prud'homme-Genereux A, 2004, MOL MICROBIOL, V54, P1409, DOI 10.1111/j.1365-2958.2004.04360.x; Purusharth RI, 2007, J BIOL CHEM, V282, P16267, DOI 10.1074/jbc.M605588200; Sulthana S, 2013, J BIOL CHEM, V288, P12574, DOI 10.1074/jbc.C113.459172; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Vincent HA, 2009, J MOL BIOL, V387, P570, DOI 10.1016/j.jmb.2009.01.068; Vincent HA, 2009, J BIOL CHEM, V284, P486, DOI 10.1074/jbc.M806468200; Yamanaka K, 2001, J BACTERIOL, V183, P2808, DOI 10.1128/JB.183.9.2808-2816.2001; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	23	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9438	9443		10.1074/jbc.C116.726091	http://dx.doi.org/10.1074/jbc.C116.726091			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	27022019	Green Published, hybrid			2022-12-28	WOS:000375602300005
J	Jones, PD; Kaiser, MA; Najafabadi, MG; Mcvey, DG; Beveridge, AJ; Schofield, CL; Samani, NJ; Webb, TR				Jones, Peter D.; Kaiser, Michael A.; Najafabadi, Maryam Ghaderi; Mcvey, David G.; Beveridge, Allan J.; Schofield, Christine L.; Samani, Nilesh J.; Webb, Tom R.			The Coronary Artery Disease-associated Coding Variant in Zinc Finger C3HC-type Containing 1 (ZC3HC1) Affects Cell Cycle Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-INTERACTION PARTNER; PLURIPOTENT STEM-CELLS; SMOOTH-MUSCLE-CELLS; MOLECULAR-DYNAMICS; CANDIDATE GENES; INACTIVATION; ATHEROSCLEROSIS; PHOSPHORYLATION; LOCALIZATION; LOCI	Genome-wide association studies have to date identified multiple coronary artery disease (CAD)-associated loci; however, for most of these loci the mechanism by which they affect CAD risk is unclear. The CAD-associated locus 7q32.2 is unusual in that the lead variant, rs11556924, is not in strong linkage disequilibrium with any other variant and introduces a coding change in ZC3HC1, which encodes NIPA. In this study, we show that rs11556924 polymorphism is associated with lower regulatory phosphorylation of NIPA in the risk variant, resulting in NIPA with higher activity. Using a genome-editing approach we show that this causes an effective decrease in cyclin-B1 stability in the nucleus, thereby slowing its nuclear accumulation. By perturbing the rate of nuclear cyclin-B1 accumulation, rs11556924 alters the regulation of mitotic progression resulting in an extended mitosis. This study shows that the CAD-associated coding polymorphism in ZC3HC1 alters the dynamics of cell-cycle regulation by NIPA.	[Jones, Peter D.; Kaiser, Michael A.; Najafabadi, Maryam Ghaderi; Mcvey, David G.; Beveridge, Allan J.; Samani, Nilesh J.; Webb, Tom R.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Jones, Peter D.; Kaiser, Michael A.; Najafabadi, Maryam Ghaderi; Mcvey, David G.; Beveridge, Allan J.; Samani, Nilesh J.; Webb, Tom R.] Univ Leicester, Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England; [Schofield, Christine L.] Horizon Discovery Ltd, 7100 Cambridge Res Pk, Cambridge CB25 9TL, England	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Webb, TR (corresponding author), Univ Leicester, Glenfield Hosp, Cardiovasc Res Ctr, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England.	tw126@le.ac.uk	Webb, Tom/GMW-5311-2022; Webb, Tom/C-6237-2011	Webb, Tom/0000-0001-5998-8226; McVey, David Graham/0000-0002-6402-2546; Jones, Peter/0000-0002-6667-7562	Leducq Foundation [12CVD02]; European Union [261123]; National Institute for Health Research [NF-SI-0611-10170] Funding Source: researchfish	Leducq Foundation(Leducq Foundation); European Union(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a Transatlantic Networks of Excellence Award (12CVD02) from The Leducq Foundation and the FP7 European Union funded project CVgenes@target (261123). The authors declare that they have no conflicts of interest with the contents of this article.	Bassermann F, 2005, CELL, V122, P45, DOI 10.1016/j.cell.2005.04.034; Bassermann F, 2007, J BIOL CHEM, V282, P15965, DOI 10.1074/jbc.M610819200; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Boehm Manfred, 2003, Prog Cell Cycle Res, V5, P19; Braenne I, 2015, ARTERIOSCL THROM VAS, V35, P2207, DOI 10.1161/ATVBAHA.115.306108; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Erbilgin A, 2013, J LIPID RES, V54, P1894, DOI 10.1194/jlr.M037085; Ericson K, 2010, P NATL ACAD SCI USA, V107, P2598, DOI 10.1073/pnas.0914018107; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Hayashi K, 2008, P NATL ACAD SCI USA, V105, P5632, DOI 10.1073/pnas.0711146105; Herring BP, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-21; Hurley PJ, 2007, ONCOGENE, V26, P2535, DOI 10.1038/sj.onc.1210049; Illert AL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.373464; Illert AL, 2012, DEVELOPMENT, V139, P2523, DOI 10.1242/dev.073072; Kan YN, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004251; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Khan IF, 2011, NAT PROTOC, V6, P482, DOI 10.1038/nprot.2011.301; Kim HS, 2014, STEM CELLS DEV, V23, P2673, DOI 10.1089/scd.2014.0167; Li J, 1997, P NATL ACAD SCI USA, V94, P502, DOI 10.1073/pnas.94.2.502; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lopez-Mejias R, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4335; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mercer J, 2005, CIRC RES, V96, P667, DOI 10.1161/01.RES.0000161069.15577.ca; MORISHITA R, 1994, GENE, V149, P13, DOI 10.1016/0378-1119(94)90406-5; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PINES J, 1994, EMBO J, V13, P3772, DOI 10.1002/j.1460-2075.1994.tb06688.x; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Silvestre-Roig C, 2013, ARTERIOSCL THROM VAS, V33, P1036, DOI 10.1161/ATVBAHA.112.300580; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Spisak S, 2015, NAT MED, V21, P1357, DOI 10.1038/nm.3975; Team RC, 2014, R LANG ENV STAT COMP; Topaloglu O, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni160; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Yamase Y, 2016, BIOMED REP, V4, P178, DOI 10.3892/br.2015.551; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	49	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16318	16327		10.1074/jbc.M116.734020	http://dx.doi.org/10.1074/jbc.M116.734020			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226629	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000380585400035
J	Rwere, F; Xia, CW; Im, S; Haque, MM; Stuehr, DJ; Waskell, L; Kim, JJP				Rwere, Freeborn; Xia, Chuanwu; Im, Sangchoul; Haque, Mohammad M.; Stuehr, Dennis J.; Waskell, Lucy; Kim, Jung-Ja P.			Mutants of Cytochrome P450 Reductase Lacking Either Gly-141 or Gly-143 Destabilize Its FMN Semiquinone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; electron transfer; flavoprotein; mutagenesis; oxidation-reduction (redox); cytochrome P45 oxidoreductase; diflavin oxidoreductase; microsomal electron transport system; redox potential	CLOSTRIDIUM-BEIJERINCKII FLAVODOXIN; MONONUCLEOTIDE-BINDING DOMAIN; FLAVIN ADENINE-DINUCLEOTIDE; NITRIC-OXIDE SYNTHASE; ACTIVE-SITE PROBES; ELECTRON-TRANSFER; REDOX PROPERTIES; P450 OXIDOREDUCTASE; STRUCTURAL BASIS; BACILLUS-MEGATERIUM	NADPH-cytochrome P450 oxidoreductase transfers electrons from NADPH to cytochromes P450 via its FAD and FMN. To understand the biochemical and structural basis of electron transfer from FMN-hydroquinone to its partners, three deletion mutants in a conserved loop near the FMN were characterized. Comparison of oxidized and reduced wild type and mutant structures reveals that the basis for the air stability of the neutral blue semiquinone is protonation of the flavin N5 and strong H-bond formation with the Gly-141 carbonyl. The Gly-143 protein had moderately decreased activity with cytochrome P450 and cytochrome c. It formed a flexible loop, which transiently interacts with the flavin N5, resulting in the generation of both an unstable neutral blue semiquinone and hydroquinone. The Gly-141 and G141/E142N mutants were inactive with cytochrome P450 but fully active in reducing cytochrome c. In the Gly-141 mutants, the backbone amide of Glu/Asn-142 forms an H-bond to the N5 of the oxidized flavin, which leads to formation of an unstable red anionic semiquinone with a more negative potential than the hydroquinone. The semiquinone of G141/E142N was slightly more stable than that of Gly-141, consistent with its crystallographically demonstrated more rigid loop. Nonetheless, both Gly-141 red semiquinones were less stable than those of the corresponding loop in cytochrome P450 BM3 and the neuronal NOS mutant (Gly-810). Our results indicate that the catalytic activity of cytochrome P450 oxidoreductase is a function of the length, sequence, and flexibility of the 140s loop and illustrate the sophisticated variety of biochemical mechanisms employed in fine-tuning its redox properties and function.	[Rwere, Freeborn; Im, Sangchoul; Waskell, Lucy] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48105 USA; [Rwere, Freeborn; Im, Sangchoul; Waskell, Lucy] Vet Affairs Med Ctr, Ann Arbor, MI 48105 USA; [Xia, Chuanwu; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Haque, Mohammad M.; Stuehr, Dennis J.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Medical College of Wisconsin; Cleveland Clinic Foundation	Kim, JJP (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.; Waskell, L (corresponding author), Univ Michigan, Sch Med, Dept Anesthesiol Res, 2215 Fuller Rd,Bldg 31, Ann Arbor, MI 48105 USA.	waskell@umich.edu; jjkim@mcw.edu	Rwere, Freeborn/ABF-3335-2021	Rwere, Freeborn/0000-0002-7037-6850; HAQUE, MOHAMMAD/0000-0003-0852-6368	National Institutes of Health [GM035533, GM094209, GM097031, GM51491]; Veterans Affairs Merit review grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094209, R01GM097031, R01GM035533, R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit review grant(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM035533 and GM094209, a Veterans Affairs Merit review grant (to L. W.), and National Institutes of Health Grants GM097031 (to J. J. K.) and GM51491 (to D. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANDERSON RF, 1983, BIOCHIM BIOPHYS ACTA, V722, P158, DOI 10.1016/0005-2728(83)90169-X; Breinlinger EC, 1998, J AM CHEM SOC, V120, P8606, DOI 10.1021/ja9809556; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chang CW, 2010, J AM CHEM SOC, V132, P12741, DOI 10.1021/ja1050154; Chang FC, 1999, BIOCHEMISTRY-US, V38, P7168, DOI 10.1021/bi982203u; Chen HC, 2008, BIOCHEMISTRY-US, V47, P13788, DOI 10.1021/bi800954h; Cui DT, 2011, J PHYS CHEM B, V115, P7788, DOI 10.1021/jp202138d; Das A, 2009, BIOCHEMISTRY-US, V48, P12104, DOI 10.1021/bi9011435; Deane CM, 1999, PROTEIN ENG, V12, P1025, DOI 10.1093/protein/12.12.1025; DRAPER RD, 1968, ARCH BIOCHEM BIOPHYS, V125, P802, DOI 10.1016/0003-9861(68)90517-1; Dutton P L, 1978, Methods Enzymol, V54, P411; EDMONDSO.DE, 1972, BIOCHEMISTRY-US, V11, P1133, DOI 10.1021/bi00757a003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans EW, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0037; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; GHISLA S, 1986, BIOCHEM J, V239, P1; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Goni G, 2008, BIOCHEMISTRY-US, V47, P1207, DOI 10.1021/bi7017392; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Hanley SC, 2004, BIOCHEM BIOPH RES CO, V325, P1418, DOI 10.1016/j.bbrc.2004.10.189; Hoover DM, 1999, J MOL BIOL, V294, P725, DOI 10.1006/jmbi.1999.3152; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Im SC, 2011, ARCH BIOCHEM BIOPHYS, V507, P144, DOI 10.1016/j.abb.2010.10.023; IYANAGI T, 1974, BIOCHEMISTRY-US, V13, P1701, DOI 10.1021/bi00705a023; Iyanagi T, 2012, ARCH BIOCHEM BIOPHYS, V528, P72, DOI 10.1016/j.abb.2012.09.002; JOHANSSON LBA, 1979, BIOCHEMISTRY-US, V18, P4249, DOI 10.1021/bi00586a033; Kasim M, 2009, BIOCHEMISTRY-US, V48, P5131, DOI 10.1021/bi900607q; Koziol L, 2013, J PHYS CHEM A, V117, P12946, DOI 10.1021/jp407193c; KURZBAN GP, 1986, J BIOL CHEM, V261, P7824; LEENDERS R, 1994, BIOPHYS J, V66, P634, DOI 10.1016/S0006-3495(94)80837-9; Li HY, 2008, J BIOL CHEM, V283, P34762, DOI 10.1074/jbc.M806949200; Ludwig ML, 1997, BIOCHEMISTRY-US, V36, P1259, DOI 10.1021/bi962180o; LUSCHINSKY CL, 1991, FLAVINS AND FLAVOPROTEINS 1990, P409; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Massey V, 2002, INT CONGR SER, V1233, P3, DOI 10.1016/S0531-5131(02)00519-8; Massey V, 1980, BIOCHEM SOC T, V8, P246, DOI 10.1042/bst0080246; Mayhew SG, 1999, EUR J BIOCHEM, V265, P698, DOI 10.1046/j.1432-1327.1999.00767.x; McPherson A., 1999, CRYSTALLIZATION BIOL; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Miura R, 2001, CHEM REC, V1, P183, DOI 10.1002/tcr.1007; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; NISHIMOTO K, 1978, BIOCHIM BIOPHYS ACTA, V526, P34, DOI 10.1016/0005-2744(78)90287-5; O'Farrell PA, 1998, BIOCHEMISTRY-US, V37, P8405, DOI 10.1021/bi973193k; OPRIAN DD, 1982, J BIOL CHEM, V257, P8935; ORTIZ D, 2010, CHEM REV, V110, P932; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paine M.J.I., 2005, CYTOCHROME P450 STRU, P115, DOI DOI 10.1007/0-387-27447-2_4; PORTER TD, 1986, BIOCHEMISTRY-US, V25, P1682, DOI 10.1021/bi00355a036; Rohr AK, 2010, ANGEW CHEM INT EDIT, V49, P2324, DOI 10.1002/anie.200907143; Saribas AS, 2001, PROTEIN EXPRES PURIF, V21, P303, DOI 10.1006/prep.2000.1377; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Senda T, 2009, ANTIOXID REDOX SIGN, V11, P1741, DOI 10.1089/ARS.2008.2348; Sevrioukova I, 1996, BIOCHEMISTRY-US, V35, P7058, DOI 10.1021/bi960060a; Sevrioukova I, 1996, BIOCHEMISTRY-US, V35, P7528, DOI 10.1021/bi960330p; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; SHEN AL, 1989, J BIOL CHEM, V264, P7584; VERMILION JL, 1981, J BIOL CHEM, V256, P266; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; WATT W, 1991, J MOL BIOL, V218, P195, DOI 10.1016/0022-2836(91)90884-9; Wolthers KR, 2003, BIOCHEMISTRY-US, V42, P3911, DOI 10.1021/bi027290b; Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108; Xia CW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230532; Yang AS, 1996, J MOL BIOL, V259, P873, DOI 10.1006/jmbi.1996.0364; Zhang HM, 2003, BIOCHEMISTRY-US, V42, P11594, DOI 10.1021/bi034968u; ZHOU ZM, 1995, BIOCHEMISTRY-US, V34, P3183, DOI 10.1021/bi00010a007	70	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14639	14661		10.1074/jbc.M116.724625	http://dx.doi.org/10.1074/jbc.M116.724625			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27189945	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000380366700020
J	Wilson, M; Tsakraklides, V; Tran, M; Xiao, YY; Zhang, Y; Perkins, AS				Wilson, Michael; Tsakraklides, Vasiliki; Minh Tran; Xiao, Ying-Yi; Zhang, Yi; Perkins, Archibald S.			EVI1 Interferes with Myeloid Maturation via Transcriptional Repression of Cebpa, via Binding to Two Far Downstream Regulatory Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CCAAT-enhancer-binding protein (CEBP); leukemia; myeloid cell; transcription regulation; transcription target gene	POINT MUTATIONS; GENE-TRANSFER; ZINC FINGERS; EXPRESSION; DIFFERENTIATION; PROTEIN; CELLS; DNA; IDENTIFICATION; ENHANCERS	One mechanism by which oncoproteins work is through perturbation of cellular maturation; understanding the mechanisms by which this occurs can lead to the development of targeted therapies. EVI1 is a zinc finger oncoprotein involved in the development of acute myeloid leukemia; previous work has shown it to interfere with the maturation of granulocytes from immature precursors. Here we investigate the mechanism by which that occurs, using an immortalized hematopoietic progenitor cell line, EML-C1, as a model system. We document that overexpression of EVI1 abrogates retinoic acid-induced maturation of EML cells into committed myeloid cells, a process that can be documented by the down-regulation of stem cell antigen-1 and acquisition of responsiveness to granulocyte-macrophage colony-stimulating factor. We show that this requires DNA binding capacity of EVI1, suggesting that downstream target genes are involved. We identify the myeloid regulator Cebpa as a target gene and identify two EVI1 binding regions within evolutionarily conserved enhancer elements at +35 and +37 kb relative to the gene. EVI1 can strongly suppress Cebpa transcription, and add-back of Cebpa into EVI1-expressing EML cells partially corrects the block in maturation. We identify the DNA sequences to which EVI1 binds at +35 and +37 kb and show that mutation of one of these releases Cebpa from EVI1-induced suppression. We observe a more complex picture in primary bone marrow cells, where EVI1 suppresses Cebpa in stem cells but not in more committed progenitors. Our data thus identify a regulatory node by which EVI1 contributes to leukemia, and this represents a possible therapeutic target for treatment of EVI1-expressing leukemia.	[Wilson, Michael; Zhang, Yi; Perkins, Archibald S.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Tsakraklides, Vasiliki; Minh Tran; Xiao, Ying-Yi] Yale Univ, Dept Pathol, New Haven, CT 06520 USA	University of Rochester; Yale University	Zhang, Y; Perkins, AS (corresponding author), 601 Elmwood Ave, Rochester, NY 14642 USA.	yi_zhang@urmc.rochester.edu; archibald_perkins@urmc.rochester.edu		Zhang, Yi/0000-0003-2785-1780; Tsakraklides, Vasiliki/0000-0003-1998-1075	National Institutes of Health [R01-CA081216, P01HL63357, 5 U24 DK58776, NYSTEM C029547, NYSTEM C026423]; NATIONAL CANCER INSTITUTE [R01CA081216] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL063357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01-CA081216 (to A. S. P.), P01HL63357 (to A. S. P.), 5 U24 DK58776 (to Y. Z.), NYSTEM C029547 (to Y. Z.), and NYSTEM C026423 (to Y. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez-Errico D, 2015, NAT REV IMMUNOL, V15, P7, DOI 10.1038/nri3777; Bindels EMJ, 2012, BLOOD, V119, P5838, DOI 10.1182/blood-2011-11-393827; BRUNELLE A, 1987, P NATL ACAD SCI USA, V84, P6673, DOI 10.1073/pnas.84.19.6673; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen L, 2014, SCIENCE, V345, P1580, DOI 10.1126/science.1251033; Chi YQ, 2003, J BIOL CHEM, V278, P49806, DOI 10.1074/jbc.M309645200; Chim CS, 2002, BRIT J HAEMATOL, V119, P988, DOI 10.1046/j.1365-2141.2002.03952.x; Cooper S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126385; Dostie J, 2007, NAT PROTOC, V2, P988, DOI 10.1038/nprot.2007.116; FUNABIKI T, 1994, ONCOGENE, V9, P1575; Glass C, 2014, BLOOD CELL MOL DIS, V53, P67, DOI 10.1016/j.bcmd.2014.01.002; Glass C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067134; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Guo H, 2012, BLOOD, V119, P4408, DOI 10.1182/blood-2011-12-397091; Hasemann MS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004079; Heath V, 2004, BLOOD, V104, P1639, DOI 10.1182/blood-2003-11-3963; Helbling D, 2004, P NATL ACAD SCI USA, V101, P13312, DOI 10.1073/pnas.0404731101; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hoyt PR, 1997, MECH DEVELOP, V65, P55, DOI 10.1016/S0925-4773(97)00057-9; IHLE JN, 1985, CONTEMP TOP MOLEC IM, V10, P93; Kilbey A, 1999, CELL GROWTH DIFFER, V10, P601; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Konrad TA, 2009, J LEUKOCYTE BIOL, V86, P813, DOI 10.1189/jlb.0109042; KREIDER BL, 1993, P NATL ACAD SCI USA, V90, P6454, DOI 10.1073/pnas.90.14.6454; Laricchia-Robbio L, 2006, MOL CELL BIOL, V26, P7658, DOI 10.1128/MCB.00363-06; Laricchia-Robbio L, 2009, CANCER RES, V69, P1633, DOI 10.1158/0008-5472.CAN-08-2562; Leroy H, 2005, LEUKEMIA, V19, P329, DOI 10.1038/sj.leu.2403614; Louz D, 2000, LEUKEMIA, V14, P1876, DOI 10.1038/sj.leu.2401887; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; MORISHITA K, 1992, MOL CELL BIOL, V12, P183, DOI 10.1128/MCB.12.1.183; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; MUCENSKI ML, 1988, MOL CELL BIOL, V8, P301, DOI 10.1128/MCB.8.1.301; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PERKINS AS, 1991, MOL CELL BIOL, V11, P2665, DOI 10.1128/MCB.11.5.2665; Perkins AS, 1996, J BIOL CHEM, V271, P1104, DOI 10.1074/jbc.271.2.1104; Perrotti D, 2002, NAT GENET, V30, P48, DOI 10.1038/ng791; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Su MY, 2013, J BIOL CHEM, V288, P8433, DOI 10.1074/jbc.M112.413260; Tanaka KF, 2010, BIOL PSYCHIAT, V67, P770, DOI 10.1016/j.biopsych.2009.12.020; Tokita K, 2007, CANCER SCI, V98, P1752, DOI 10.1111/j.1349-7006.2007.00597.x; TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wouters BJ, 2007, BLOOD, V110, P3706, DOI 10.1182/blood-2007-02-073486; Yatsula B, 2005, J BIOL CHEM, V280, P30712, DOI 10.1074/jbc.M504293200; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang B, 2013, GENOME RES, V23, P917, DOI 10.1101/gr.149674.112; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhang Y, 2011, BIOCHEMISTRY-US, V50, P10431, DOI 10.1021/bi200962u; Zhang Y, 2011, BLOOD, V118, P3853, DOI 10.1182/blood-2011-02-334680	56	10	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13591	13607		10.1074/jbc.M115.708156	http://dx.doi.org/10.1074/jbc.M115.708156			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129260	Green Published, hybrid			2022-12-28	WOS:000379771100017
J	Chaubal, A; Todi, SV; Pile, LA				Chaubal, Ashlesha; Todi, Sokol V.; Pile, Lori A.			Inter-isoform-dependent Regulation of the Drosophila Master Transcriptional Regulator SIN3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; CHROMATIN; COMPLEX; COREPRESSOR; PROTEINS; PATHWAY; LIFE	SIN3 is a transcriptional corepressor that acts as a scaffold for a histone deacetylase (HDAC) complex. The SIN3 complex regulates various biological processes, including organ development, cell proliferation, and energy metabolism. Little is known, however, about the regulation of SIN3 itself. There are two major isoforms of Drosophila SIN3, 187 and 220, which are differentially expressed. Intrigued by the developmentally timed exchange of SIN3 isoforms, we examined whether SIN3 187 controls the fate of the 220 counterpart. Here, we show that in developing tissue, there is interplay between SIN3 isoforms: when SIN3 187 protein levels increase, SIN3 220 protein decreases concomitantly. SIN3 187 has a dual effect on SIN3 220. Expression of 187 leads to reduced 220 transcript, while also increasing the turnover of SIN3 220 protein by the proteasome. These data support the presence of a novel, inter-isoform-dependent mechanism that regulates the amount of SIN3 protein, and potentially the level of specific SIN3 complexes, during distinct developmental stages.	[Chaubal, Ashlesha; Pile, Lori A.] Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall,Biol Sci Bldg, Detroit, MI 48202 USA; [Todi, Sokol V.] Wayne State Univ, Dept Pharmacol, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Pile, LA (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall,Biol Sci Bldg, Detroit, MI 48202 USA.	loripile@wayne.edu		Chaubal, Ashlesha/0000-0002-7276-8946; TODI, SOKOL/0000-0003-4399-5549	National Institutes of Health [1R01GM088886-01A2]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088886] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R01GM088886-01A2 (to L. A. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barnes VL, 2014, AGING-US, V6, P645, DOI 10.18632/aging.100684; Blount JR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5638; BRAND AH, 1993, DEVELOPMENT, V118, P401; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Gajan A, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0053-9; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Kadamb R, 2013, EUR J CELL BIOL, V92, P237, DOI 10.1016/j.ejcb.2013.09.001; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kong QH, 2010, BIOCHEM BIOPH RES CO, V393, P708, DOI 10.1016/j.bbrc.2010.02.066; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Neufeld TP, 1998, GENETICS, V148, P277; Pennetta G, 1998, DEV GENES EVOL, V208, P531, DOI 10.1007/s004270050212; Pile LA, 2000, EMBO J, V19, P6131, DOI 10.1093/emboj/19.22.6131; Pungaliya P, 2007, J PROTEOME RES, V6, P3918, DOI 10.1021/pr0703674; Saha N, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2428-5; Sambrook J, 2001, MOL CLONING LAB MANU; Sharma V, 2008, DEV DYNAM, V237, P3040, DOI 10.1002/dvdy.21706; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Spain MM, 2010, J BIOL CHEM, V285, P27457, DOI 10.1074/jbc.M110.130245; Swaminathan A, 2010, MECH DEVELOP, V127, P96, DOI 10.1016/j.mod.2009.10.003	25	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11566	11571		10.1074/jbc.C116.724799	http://dx.doi.org/10.1074/jbc.C116.724799			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27129248	Green Published, hybrid			2022-12-28	WOS:000377264800009
J	Udwan, K; Brideau, G; Fila, M; Edwards, A; Vogt, B; Doucet, A				Udwan, Khalil; Brideau, Gaelle; Fila, Marc; Edwards, Aurelie; Vogt, Bruno; Doucet, Alain			Oxidative Stress and Nuclear Factor B (NF-B) Increase Peritoneal Filtration and Contribute to Ascites Formation in Nephrotic Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						albumin; NF-kappa B (NF-KB); oxidative stress; permeability; water channel	TUMOR-NECROSIS-FACTOR; KAPPA-B; INTRAPERITONEAL PRESSURE; HYDRAULIC CONDUCTIVITY; ALPHA; ACTIVATION; TRANSPORT; MECHANISM; REVEALS; FLUID	Water accumulation in the interstitium (edema) and the peritoneum (ascites) of nephrotic patients is classically thought to stem from the prevailing low plasma albumin concentration and the decreased transcapillary oncotic pressure gradient. However, several clinical and experimental observations suggest that it might also stem from changes in capillary permeability. We addressed this hypothesis by studying the peritoneum permeability of rats with puromycin aminonucleoside-induced nephrotic syndrome. The peritoneum of puromycin aminonucleoside rats displayed an increase in the water filtration coefficient of paracellular and transcellular pathways, and a decrease in the reflection coefficient to proteins. It also displayed oxidative stress and subsequent activation of NF-B. Scavenging of reactive oxygen species and inhibition of NF-B prevented the changes in the water permeability and reflection coefficient to proteins and reduced the volume of ascites by over 50%. Changes in water permeability were associated with the overexpression of the water channel aquaporin 1, which was prevented by reactive oxygen species scavenging and inhibition of NF-B. In conclusion, nephrotic syndrome is associated with an increased filtration coefficient of the peritoneum and a decreased reflection coefficient to proteins. These changes, which account for over half of ascite volume, are triggered by oxidative stress and subsequent activation of NF-B.	[Udwan, Khalil; Brideau, Gaelle; Fila, Marc; Edwards, Aurelie; Doucet, Alain] Univ Paris 05, Univ Paris 06, Sorbonne Univ,Ctr Rech Cordeliers,ERL8228, INSERM,Sorbonne Paris Cite,UMR S 1138,CNRS, F-75006 Paris, France; [Fila, Marc] Univ Paris 07, Ctr Hosp Univ CHU Robert Debre, APHP, Dept Pediat Nephrol, F-75020 Paris, France; [Vogt, Bruno] Univ Hosp Bern, Inselspital, Dept Nephrol & Hypertens, CH-3010 Bern, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Bern; University Hospital of Bern	Doucet, A (corresponding author), Ctr Rech Cordeliers, ERL8228, 15 Rue Ecole Med, F-75270 Paris 06, France.	alain.doucet@crc.jussieu.fr	Vogt, Bruno/AAS-2876-2020	Vogt, Bruno/0000-0002-1548-6387	Fondation du Rein (Prix Syndrome Nephrotique FDR/FRM Alain Doucet); An-Najah University (Nablus, Palestine); UPMC (Paris, France)	Fondation du Rein (Prix Syndrome Nephrotique FDR/FRM Alain Doucet); An-Najah University (Nablus, Palestine); UPMC (Paris, France)	This work was supported in part by a grant from the Fondation du Rein (Prix Syndrome Nephrotique 2012 FDR/FRM Alain Doucet). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by grants from An-Najah University (Nablus, Palestine) and UPMC (Paris, France).	Adamson RH, 2014, AM J PHYSIOL-HEART C, V306, pH1011, DOI 10.1152/ajpheart.00829.2013; Boueiz A, 2009, MICROVASC RES, V77, P26, DOI 10.1016/j.mvr.2008.10.005; Broyer M., 1998, OXFORD TXB CLIN NEPH, P493; Camerer E, 2009, J CLIN INVEST, V119, P1871, DOI 10.1172/JCI38575; Cameron J., 1998, OXFORD TXB CLIN NEPH, P461; Cheng XL, 2015, BIOCHEM BIOPH RES CO, V461, P275, DOI 10.1016/j.bbrc.2015.04.015; Dechenes G, 2000, J AM SOC NEPHROL, V11, P604, DOI 10.1681/ASN.V114604; Devuyst O, 2014, KIDNEY INT, V85, P750, DOI 10.1038/ki.2013.250; Ece A, 2005, PEDIATR NEPHROL, V20, P1279, DOI 10.1007/s00467-005-1956-z; Evans TW, 2002, ALIMENT PHARM THER, V16, P6, DOI 10.1046/j.1365-2036.16.s5.2.x; FAUCHALD P, 1985, ACTA MED SCAND, V217, P127; Fiordaliso F, 2004, J MOL CELL CARDIOL, V37, P959, DOI 10.1016/j.yjmcc.2004.07.008; Flessner MF, 2005, AM J PHYSIOL-RENAL, V288, pF433, DOI 10.1152/ajprenal.00313.2004; Granqvist A, 2010, AM J PHYSIOL-RENAL, V299, pF898, DOI 10.1152/ajprenal.00124.2010; Kaltschmidt B, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-16; KOOMANS HA, 1985, NEPHRON, V40, P391, DOI 10.1159/000183505; Kumar A, 2011, DIABETES OBES METAB, V13, P750, DOI 10.1111/j.1463-1326.2011.01402.x; Lewis DM, 1998, KIDNEY INT, V54, P1261, DOI 10.1046/j.1523-1755.1998.00100.x; Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014; Ma T, 2013, INT UROL NEPHROL, V45, P1187, DOI 10.1007/s11255-012-0355-1; MALIK AB, 1985, FED PROC, V44, P36; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Matsumura H, 2006, CLIN NEPHROL, V66, P405; Minnear FL, 2005, AM J PHYSIOL-HEART C, V289, pH840, DOI 10.1152/ajpheart.00026.2005; Mishra OP, 2011, PEDIATR NEPHROL, V26, P251, DOI 10.1007/s00467-010-1696-6; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; NITTA S, 1981, TOHOKU J EXP MED, V135, P43, DOI 10.1620/tjem.135.43; OLIVER WJ, 1963, J LAB CLIN MED, V62, P449; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Rippe B, 2006, PERITON DIALYSIS INT, V26, P317; Rusthoven E, 2005, PERITON DIALYSIS INT, V25, P352; SCHIEVEN GL, 1993, BLOOD, V82, P1212, DOI 10.1182/blood.V82.4.1212.bloodjournal8241212; Schoonbroodt S, 2000, J IMMUNOL, V164, P4292, DOI 10.4049/jimmunol.164.8.4292; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Skinner RA, 1999, J TRAUMA, V47, P486, DOI 10.1097/00005373-199909000-00009; Su X, 2004, RESP PHYSIOL NEUROBI, V142, P1, DOI 10.1016/j.resp.2004.05.001; Tolle M, 2008, ARTERIOSCL THROM VAS, V28, P1542, DOI 10.1161/ATVBAHA.107.161042; Waniewski J, 2009, AM J PHYSIOL-HEART C, V296, pH1960, DOI 10.1152/ajpheart.00121.2009; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Zhang CX, 2014, ONCOTARGET, V5, P4392, DOI 10.18632/oncotarget.2025; Zhao LX, 2012, J CELL MOL MED, V16, P1840, DOI 10.1111/j.1582-4934.2011.01479.x	42	8	9	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11105	11113		10.1074/jbc.M116.724690	http://dx.doi.org/10.1074/jbc.M116.724690			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27033704	Green Published, hybrid			2022-12-28	WOS:000377042100014
J	Harlan, BA; Pehar, M; Sharma, DR; Beeson, G; Beeson, CC; Vargas, MR				Harlan, Benjamin A.; Pehar, Mariana; Sharma, Deep R.; Beeson, Gyda; Beeson, Craig C.; Vargas, Marcelo R.			Enhancing NAD(+) Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR-NEURON DEGENERATION; NICOTINAMIDE RIBOSIDE; NRF2 ACTIVATION; MOUSE MODEL; METABOLISM; SIRT3; BIOSYNTHESIS; LOCALIZATION; MITOCHONDRIA; INHIBITION	Nicotinamide adenine dinucleotide (NAD(+)) participates in redox reactions and NAD(+)-dependent signaling pathways. Although the redox reactions are critical for efficient mitochondrial metabolism, they are not accompanied by any net consumption of the nucleotide. On the contrary, NAD(+)-dependent signaling processes lead to its degradation. Three distinct families of enzymes consume NAD(+) as substrate: poly(ADP-ribose) polymerases, ADP-ribosyl cyclases (CD38 and CD157), and sirtuins (SIRT1-7). Because all of the above enzymes generate nicotinamide as a byproduct, mammalian cells have evolved an NAD(+) salvage pathway capable of resynthesizing NAD(+) from nicotinamide. Overexpression of the rate-limiting enzyme in this pathway, nicotinamide phosphoribosyltransferase, increases total and mitochondrial NAD(+) levels in astrocytes. Moreover, targeting nicotinamide phosphoribosyltransferase to the mitochondria also enhances NAD(+) salvage pathway in astrocytes. Supplementation with the NAD(+) precursors nicotinamide mononucleotide and nicotinamide riboside also increases NAD(+) levels in astrocytes. Amyotrophic lateral sclerosis (ALS) is caused by the progressive degeneration of motor neurons in the spinal cord, brain stem, and motor cortex. Superoxide dismutase 1 (SOD1) mutations account for up to 20% of familial ALS and 1-2% of apparently sporadic ALS cases. Primary astrocytes isolated from mutant human superoxide dismutase 1-overexpressing mice as well as human post-mortem ALS spinal cord-derived astrocytes induce motor neuron death in co-culture. Increasing total and mitochondrial NAD(+) content in ALS astrocytes increases oxidative stress resistance and reverts their toxicity toward co-cultured motor neurons. Taken together, our results suggest that enhancing the NAD(+) salvage pathway in astrocytes could be a potential therapeutic target to prevent astrocyte-mediated motor neuron death in ALS.	[Harlan, Benjamin A.; Pehar, Mariana; Sharma, Deep R.; Vargas, Marcelo R.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Basic Sci Bldg,Rm 358,MSC 509,173 Ashley Ave, Charleston, SC 29425 USA; [Beeson, Gyda; Beeson, Craig C.] Med Univ S Carolina, South Carolina Coll Pharm Drug Discovery & Biomed, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Vargas, MR (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Basic Sci Bldg,Rm 358,MSC 509,173 Ashley Ave, Charleston, SC 29425 USA.	vargasm@musc.edu		Harlan, Benjamin/0000-0001-9026-543X	National Institutes of Health from the Extramural Research Facilities Program of the National Center for Research Resources [C06 RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089640] Funding Source: NIH RePORTER	National Institutes of Health from the Extramural Research Facilities Program of the National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Mathias Ziegler for the mitoPARP and mitoEGFP plasmids. We also thank the depositing laboratories of the SIRT1 and SIRT3 plasmids. This work utilized a facility constructed with support from National Institutes of Health Grant C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources to the Medical University of South Carolina.	Aksoy P, 2006, BIOCHEM BIOPH RES CO, V345, P1386, DOI 10.1016/j.bbrc.2006.05.042; Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Bai P, 2015, MOL CELL, V58, P947, DOI 10.1016/j.molcel.2015.01.034; Bai P, 2012, CELL METAB, V16, P290, DOI 10.1016/j.cmet.2012.06.016; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Bao JJ, 2010, J CELL BIOCHEM, V110, P238, DOI 10.1002/jcb.22531; Barile M, 1996, BIOCHEM MOL BIOL INT, V38, P297; Bause AS, 2013, EXP GERONTOL, V48, P634, DOI 10.1016/j.exger.2012.08.007; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Canto C, 2013, MOL ASPECTS MED, V34, P1168, DOI 10.1016/j.mam.2013.01.004; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Stefano M, 2013, FEBS J, V280, P4711, DOI 10.1111/febs.12433; Dittenhafer-Reed KE, 2015, CELL METAB, V21, P637, DOI 10.1016/j.cmet.2015.03.007; Dolle C, 2010, CELL MOL LIFE SCI, V67, P433, DOI 10.1007/s00018-009-0190-4; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Felici R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076938; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Li W, 2015, METHODS MOL BIOL, V1241, P39, DOI 10.1007/978-1-4939-1875-1_4; LOWRY OH, 1961, J BIOL CHEM, V236, P2756; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Mayo L, 2008, J IMMUNOL, V181, P92, DOI 10.4049/jimmunol.181.1.92; Mecleiros DM, 2008, METHODS, V46, P288, DOI 10.1016/j.ymeth.2008.09.026; Meyer K, 2014, P NATL ACAD SCI USA, V111, P829, DOI 10.1073/pnas.1314085111; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Niere M, 2008, MOL CELL BIOL, V28, P814, DOI 10.1128/MCB.01766-07; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Partida-Sanchez S, 2007, ADV EXP MED BIOL, V590, P171; Pehar M, 2016, MOL CELL PROTEOMICS, V15, P493, DOI 10.1074/mcp.M115.049288; Pehar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103438; Pittelli M, 2010, J BIOL CHEM, V285, P34106, DOI 10.1074/jbc.M110.136739; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Ravits J, 2013, AMYOTROPH LAT SCL FR, V14, P5, DOI 10.3109/21678421.2013.778548; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ruddick Jon P., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000068; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Song WJ, 2013, NEUROBIOL DIS, V51, P72, DOI 10.1016/j.nbd.2012.07.004; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Tang KS, 2010, GLIA, V58, P446, DOI 10.1002/glia.20936; Tesla R, 2012, P NATL ACAD SCI USA, V109, P17016, DOI 10.1073/pnas.1213960109; VanLinden MR, 2015, J BIOL CHEM, V290, P27644, DOI 10.1074/jbc.M115.654129; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Vargas MR, 2006, J NEUROCHEM, V97, P687, DOI 10.1111/j.1471-4159.2006.03742.x; Vargas MR, 2005, J BIOL CHEM, V280, P25571, DOI 10.1074/jbc.M501920200; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Watanabe S, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0062-1; Wilhelm F, 2011, J NEUROSCI RES, V89, P1956, DOI 10.1002/jnr.22638; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Ying WH, 2001, P NATL ACAD SCI USA, V98, P12227, DOI 10.1073/pnas.211202598; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206	72	58	60	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10836	10846		10.1074/jbc.M115.698779	http://dx.doi.org/10.1074/jbc.M115.698779			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27002158	Green Published, hybrid			2022-12-28	WOS:000377042600033
J	Knights, AJ; Yik, JJ; Jusoh, HM; Norton, LJ; Funnell, APW; Pearson, RCM; Bell-Anderson, KS; Crossley, M; Quinlan, KGR				Knights, Alexander J.; Yik, Jinfen J.; Jusoh, Hanapi Mat; Norton, Laura J.; Funnell, Alister P. W.; Pearson, Richard C. M.; Bell-Anderson, Kim S.; Crossley, Merlin; Quinlan, Kate G. R.			Kruppel-like Factor 3 (KLF3/BKLF) Is Required for Widespread Repression of the Inflammatory Modulator Galectin-3 (Lgals3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL BINDING-PROTEIN; ADIPOSE-TISSUE; CO-REPRESSOR; IN-VIVO; HEART-FAILURE; DNA-BINDING; FACTOR GENE; ACTIVATION; EXPRESSION; CELLS	The Lgals3 gene encodes a multifunctional beta-galactoside-binding protein, galectin-3. Galectin-3 has been implicated in a broad range of biological processes from chemotaxis and inflammation to fibrosis and apoptosis. The role of galectin-3 as a modulator of inflammation has been studied intensively, and recent evidence suggests that it may serve as a protective factor in obesity and other metabolic disorders. Despite considerable interest in galectin-3, little is known about its physiological regulation at the transcriptional level. Here, using knockout mice, chromatin immunoprecipitations, and cellular and molecular analyses, we show that the zinc finger transcription factor Kruppel-like factor 3 (KLF3) directly represses galectin-3 transcription. We find that galectin-3 is broadly up-regulated in KLF3-deficient mouse tissues, that KLF3 occupies regulatory regions of the Lgals3 gene, and that KLF3 directly binds its cognate elements (CACCC boxes) in the galectin-3 promoter and represses its activation in cellular assays. We also provide mechanistic insights into the regulation of Lgals3, demonstrating that C-terminal binding protein (CtBP) is required to drive optimal KLF3-mediated silencing. These findings help to enhance our understanding of how expression of the inflammatory modulator galectin-3 is controlled, opening up avenues for potential therapeutic interventions in the future.	[Knights, Alexander J.; Yik, Jinfen J.; Norton, Laura J.; Funnell, Alister P. W.; Pearson, Richard C. M.; Crossley, Merlin; Quinlan, Kate G. R.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Jusoh, Hanapi Mat] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Bell-Anderson, Kim S.] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney	Quinlan, KGR (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	kate.quinlan@unsw.edu.au	Bell-Anderson, Kim/A-5588-2009; Knights, Alexander/AAL-1769-2021; Crossley, Merlin/D-7888-2011	Quinlan, Kate/0000-0002-5722-8183; Crossley, Merlin/0000-0003-2057-3642; Norton, Laura/0000-0002-7950-381X; Knights, Alexander/0000-0001-8402-2212	National Health and Medical Research Council [APP1025877]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council Grant APP1025877. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad T, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.004374; Bell-Anderson KS, 2013, DIABETES, V62, P2728, DOI 10.2337/db12-1745; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Burdach J, 2014, NUCLEIC ACIDS RES, V42, P276, DOI 10.1093/nar/gkt895; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Crossley M, 1996, MOL CELL BIOL, V16, P1695; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; de Boer RA, 2009, EUR J HEART FAIL, V11, P811, DOI 10.1093/eurjhf/hfp097; Dewi V, 2015, J BIOL CHEM, V290, P8591, DOI 10.1074/jbc.M115.638338; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Funnell APW, 2007, MOL CELL BIOL, V27, P2777, DOI 10.1128/MCB.01658-06; Funnell APW, 2012, MOL CELL BIOL, V32, P3281, DOI 10.1128/MCB.00173-12; Hancock D, 2010, BIOCHEM MOL BIOL EDU, V38, P309, DOI 10.1002/bmb.20414; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; HO MK, 1982, J IMMUNOL, V128, P1221; Iacobini C, 2004, FASEB J, V18, P1773, DOI 10.1096/fj.04-2031fje; Jack BHA, 2011, INT J BIOCHEM CELL B, V43, P693, DOI 10.1016/j.biocel.2011.01.017; Karlsen AE, 2006, BIOCHEM BIOPH RES CO, V344, P406, DOI 10.1016/j.bbrc.2006.03.105; Kaushik DK, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-68; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kelsey L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003612; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; MacKinnon AC, 2013, GLYCOBIOLOGY, V23, P654, DOI 10.1093/glycob/cwt006; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Pang JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057915; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Pearson RCM, 2011, IUBMB LIFE, V63, P86, DOI 10.1002/iub.422; Pejnovic NN, 2013, ADIPOCYTE, V2, P266, DOI 10.4161/adip.24881; Pejnovic NN, 2013, DIABETES, V62, P1932, DOI 10.2337/db12-0222; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Srivatsan V, 2015, EUR J PREV CARDIOL, V22, P1096, DOI 10.1177/2047487314552797; Stock M, 2003, J BIOL CHEM, V278, P17360, DOI 10.1074/jbc.M207631200; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Vu TT, 2011, J IMMUNOL, V187, P5032, DOI 10.4049/jimmunol.1101450; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Ueda J, 2006, J BIOL CHEM, V281, P20120, DOI 10.1074/jbc.M603087200; Vladimirova V, 2008, J NEUROSCI RES, V86, P2450, DOI 10.1002/jnr.21686; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Zhang HY, 2009, ENDOCRINE, V35, P101, DOI 10.1007/s12020-008-9129-z; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	50	13	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16048	16058		10.1074/jbc.M116.715748	http://dx.doi.org/10.1074/jbc.M116.715748			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226561	Green Published, hybrid			2022-12-28	WOS:000380585400011
J	Mashiko, T; Sakashita, E; Kasashima, K; Tominaga, K; Kuroiwa, K; Nozaki, Y; Matsuura, T; Hamamoto, T; Endo, H				Mashiko, Takafumi; Sakashita, Eiji; Kasashima, Katsumi; Tominaga, Kaoru; Kuroiwa, Kenji; Nozaki, Yasuyuki; Matsuura, Tohru; Hamamoto, Toshiro; Endo, Hitoshi			Developmentally Regulated RNA-binding Protein 1 (Drb1)/RNA-binding Motif Protein 45 (RBM45), a Nuclear-Cytoplasmic Trafficking Protein, Forms TAR DNA-binding Protein 43 (TDP-43)-mediated Cytoplasmic Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; LINKED MUTATIONS; EXPORT SIGNAL; IN-VIVO; TDP-43; LOCALIZATION; ALS; TRANSPORT; FUS	Cytoplasmic protein aggregates are one of the pathological hallmarks of neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FT LD). Several RNA-binding proteins have been identified as components of inclusion bodies. Developmentally regulated RNA-binding protein 1 (Drbl)/RNA-binding motif protein 45 is an RNA-binding protein that was recently described as a component in ALS- and FTLD-related inclusion bodies. However, the molecular mechanism underlying cytoplasmic Drbl aggregation remains unclear. Here, using an in vitro cellular model, we demonstrated that Drbl co-localizes with cytoplasmic aggregates mediated by TAR DNA-binding protein 43, a major component of ALS and FTLD-related inclusion bodies. We also defined the domains involved in the subcellular localization of Drbl to clarify the role of Drbl in the formation of cytoplasmic aggregates in ALS and FTLD. Drbl predominantly localized in the nucleus via a classical nuclear localization signal in its carboxyl terminus and is a shuttling protein between the nucleus and cytoplasm. Furthermore, we identify a double leucine motif serving as a nuclear export signal. The Drbl mutant, presenting mutations in both nuclear localization signal and nuclear export signal, is prone to aggregate in the cytoplasm. The mutant Drb 1-induced cytoplasmic aggregates not only recruit TAR DNA-binding protein 43 but also decrease the mitochondrial membrane potential. Taken together, these results indicate that perturbation of Drbl nuclear cytoplasmic trafficking induces toxic cytoplasmic aggregates, suggesting that mislocalization of Drbl is involved in the cause of cytotoxicity in neuronal cells.	[Mashiko, Takafumi; Sakashita, Eiji; Kasashima, Katsumi; Tominaga, Kaoru; Kuroiwa, Kenji; Hamamoto, Toshiro; Endo, Hitoshi] Jichi Med Univ, Sch Med, Dept Biochem, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan; [Nozaki, Yasuyuki] Jichi Med Univ, Sch Med, Dept Pediat, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan; [Matsuura, Tohru] Jichi Med Univ, Sch Med, Div Neurol, Dept Internal Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan	Jichi Medical University; Jichi Medical University; Jichi Medical University	Endo, H (corresponding author), Jichi Med Univ, Sch Med, Dept Biochem, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	hendo@jichi.ac.jp	Tominaga, Kaoru/AAL-4250-2020	Tominaga, Kaoru/0000-0001-8799-528X	Jichi Medical University; MEXT	Jichi Medical University; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Jichi Medical University graduate student start-up grants for young investigators, a Jichi Medical University graduate student research award, a Jichi Medical University young investigator award, and the MEXT-Supported Program for Strategic Research Foundation at Private Universities 2011-2015 and 2013-2017. The authors declare that they have no conflicts of interest with the contents of this article.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Bakkar N, 2015, MOL CELL BIOL, V35, P2385, DOI 10.1128/MCB.00087-15; Blokhuis AM, 2013, ACTA NEUROPATHOL, V125, P777, DOI 10.1007/s00401-013-1125-6; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Carri MT, 1997, FEBS LETT, V414, P365, DOI 10.1016/S0014-5793(97)01051-X; Collins M, 2012, ACTA NEUROPATHOL, V124, P717, DOI 10.1007/s00401-012-1045-x; Cozzolino M, 2012, PROG NEUROBIOL, V97, P54, DOI 10.1016/j.pneurobio.2011.06.003; Hans F, 2014, J BIOL CHEM, V289, P19164, DOI 10.1074/jbc.M114.561704; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kasashima K, 1999, GENES CELLS, V4, P667, DOI 10.1046/j.1365-2443.1999.00292.x; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kino Y, 2011, NUCLEIC ACIDS RES, V39, P2781, DOI 10.1093/nar/gkq1162; Kinoshita Y, 2009, J NEUROPATH EXP NEUR, V68, P1184, DOI 10.1097/NEN.0b013e3181bc3bec; Konno T, 2014, NEUROPATH APPL NEURO, V40, P783, DOI 10.1111/nan.12157; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lattante S, 2013, HUM MUTAT, V34, P812, DOI 10.1002/humu.22319; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Li Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14262; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; MICHAEL WM, 1995, CELL, V83, P415; Nagara Y, 2013, BRAIN PATHOL, V23, P534, DOI 10.1111/bpa.12040; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Patel VP, 2011, INT J CLIN EXP PATHO, V4, P215; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; Tamada H, 2002, BIOCHEM BIOPH RES CO, V297, P96, DOI 10.1016/S0006-291X(02)02132-0; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Winton MJ, 2008, FEBS LETT, V582, P2252, DOI 10.1016/j.febslet.2008.05.024; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zinszner H, 1997, J CELL SCI, V110, P1741	45	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14996	15007		10.1074/jbc.M115.712232	http://dx.doi.org/10.1074/jbc.M115.712232			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226551	Green Published, hybrid			2022-12-28	WOS:000380583200012
J	Guerra-Moreno, A; Hanna, J				Guerra-Moreno, Angel; Hanna, John			Tmc1 Is a Dynamically Regulated Effector of the Rpn4 Proteotoxic Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteasome; protein degradation; proteostasis; stress response; yeast; Rpn4; Tmc1; arsenite	SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; PROTEASOMAL DEGRADATION; POLYUBIQUITIN GENE; PROTEIN; RESISTANCE; BINDING; CELLS; YEAST; PROTEOSTASIS	The ubiquitin-proteasome system represents the major pathway of selective intracellular protein degradation in eukaryotes. Misfolded proteins represent an important class of substrates for this pathway, and the failure to destroy misfolded proteins is associated with a number of human diseases. The transcription factor Rpn4 mediates a key proteotoxic stress response whose best known function is to control proteasome abundance by a homeostatic feedback mechanism. Here we identify the uncharacterized zinc finger protein Tmc1 as a dynamically regulated stress-responsive protein. Rpn4 induces TMC1 transcription in response to misfolded proteins. However, this response is counteracted by rapid proteasome-dependent degradation of Tmc1, which serves to normalize Tmc1 protein levels after induction. Precise control of Tmc1 levels is needed in vivo to survive multiple stressors related to proteostasis. Thus, Tmc1 represents a novel effector and substrate of the Rpn4 proteotoxic stress response.	[Hanna, John] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Hanna, John] Harvard Med Sch, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hanna, J (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.; Hanna, J (corresponding author), Harvard Med Sch, 75 Francis St, Boston, MA 02115 USA.	jwhanna@partners.org	Angel, Guerra-Moreno/AAF-7135-2021; Guerra-Moreno, Angel/K-6258-2015	Angel, Guerra-Moreno/0000-0003-2321-1129; Guerra-Moreno, Angel/0000-0003-2321-1129	National Institutes of Health [DP5-OD019800]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD019800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant DP5-OD019800 (to J. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Guerra-Moreno A, 2015, J BIOL CHEM, V290, P29695, DOI 10.1074/jbc.M115.684969; Hanna J, 2014, J BIOL CHEM, V289, P1876, DOI 10.1074/jbc.M113.534032; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hwang GW, 2006, FEBS LETT, V580, P6813, DOI 10.1016/j.febslet.2006.11.045; Ilina Y, 2008, BIOCHEM J, V415, P467, DOI 10.1042/BJ20080713; Jacobson T, 2012, J CELL SCI, V125, P5073, DOI 10.1242/jcs.107029; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Ju DH, 2004, J BIOL CHEM, V279, P23851, DOI 10.1074/jbc.C400111200; Ju DH, 2008, MOL CELL BIOL, V28, P1404, DOI 10.1128/MCB.01787-07; JUNGMANN J, 1993, NATURE, V361, P369, DOI 10.1038/361369a0; Kim MN, 2015, BBA-MOL CELL RES, V1853, P996, DOI 10.1016/j.bbamcr.2015.02.010; Kirkpatrick DS, 2003, TOXICOL APPL PHARM, V186, P101, DOI 10.1016/S0041-008X(02)00019-4; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Matyskiela ME, 2013, J MOL BIOL, V425, P199, DOI 10.1016/j.jmb.2012.11.001; Pan XW, 2010, GENETICS, V186, P725, DOI 10.1534/genetics.110.117655; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Sa-Moura B, 2013, J BIOL CHEM, V288, P33682, DOI 10.1074/jbc.M113.521088; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Valasek L, 2001, J BIOL CHEM, V276, P43351, DOI 10.1074/jbc.M106887200; Wang L, 2004, J BIOL CHEM, V279, P55218, DOI 10.1074/jbc.M410085200; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	30	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14788	14795		10.1074/jbc.M116.726398	http://dx.doi.org/10.1074/jbc.M116.726398			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226598	Green Published, hybrid			2022-12-28	WOS:000380366700030
J	Liu, TT; Grubisha, MJ; Frahm, KA; Wendell, SG; Liu, JY; Ricke, WA; Auchus, RJ; DeFranco, DB				Liu, Teresa T.; Grubisha, Melanie J.; Frahm, Krystle A.; Wendell, Stacy G.; Liu, Jiayan; Ricke, William A.; Auchus, Richard J.; DeFranco, Donald B.			Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor (ER) Response to 5-Reductase Inhibition in Prostate Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclooxygenase (COX); prostaglandin; prostate; steroidogenesis; transforming growth factor (TGF-)	DUAL 5-ALPHA-REDUCTASE INHIBITOR; ANTIINFLAMMATORY DRUG-USE; RIBONUCLEIC-ACID LEVELS; SIDE-CHAIN CLEAVAGE; COMBINATION THERAPY; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; REDUCTASE INHIBITOR; ANDROGEN RECEPTOR; GENE-EXPRESSION; CANCER CELLS	Current pharmacotherapies for symptomatic benign prostatic hyperplasia (BPH), an androgen receptor-driven, inflammatory disorder affecting elderly men, include 5-reductase (5AR) inhibitors (i.e. dutasteride and finasteride) to block the conversion of testosterone to the more potent androgen receptor ligand dihydrotestosterone. Because dihydrotestosterone is the precursor for estrogen receptor (ER) ligands, 5AR inhibitors could potentially limit ER activation, which maintains prostate tissue homeostasis. We have uncovered signaling pathways in BPH-derived prostate epithelial cells (BPH-1) that are impacted by 5AR inhibition. The induction of apoptosis and repression of the cell adhesion protein E-cadherin by the 5AR inhibitor dutasteride requires both ER and TGF. Dutasteride also induces cyclooxygenase type 2 (COX-2), which functions in a negative feedback loop in TGF and ER signaling pathways as evidenced by the potentiation of apoptosis induced by dutasteride or finasteride upon pharmacological inhibition or shRNA-mediated ablation of COX-2. Concurrently, COX-2 positively impacts ER action through its effect on the expression of a number of steroidogenic enzymes in the ER ligand metabolic pathway. Therefore, effective combination pharmacotherapies, which have included non-steroidal anti-inflammatory drugs, must take into account biochemical pathways affected by 5AR inhibition and opposing effects of COX-2 on the tissue-protective action of ER.	[Liu, Teresa T.; Grubisha, Melanie J.; Frahm, Krystle A.; Wendell, Stacy G.; DeFranco, Donald B.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, 7041 Biomed Sci Tower 3,3501 Fifth Ave, Pittsburgh, PA 15260 USA; [Liu, Jiayan; Auchus, Richard J.] Univ Michigan, Sch Med, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Liu, Jiayan; Auchus, Richard J.] Univ Michigan, Sch Med, Dept Pharmacol, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Ricke, William A.] Univ Wisconsin, Dept Urol, Madison, WI 53705 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison	DeFranco, DB (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, 7041 Biomed Sci Tower 3,3501 Fifth Ave, Pittsburgh, PA 15260 USA.	dod1@pitt.edu	Gelhaus, Stacy/AAF-2570-2019		National Institutes of Health [5T32DK007774-15, R01GM086596]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK104310, K12DK100022, T32DK007052, T32DK007774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants 5T32DK007774-15 (to T. T. L.) and R01GM086596 (to R. J. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Alonso-Magdalena P, 2009, P NATL ACAD SCI USA, V106, P2859, DOI 10.1073/pnas.0812666106; Baltaci S, 2001, BJU INT, V88, P100, DOI 10.1046/j.1464-410x.2001.02231.x; Barkin J, 2003, EUR UROL, V44, P461, DOI 10.1016/S0302-2838(03)00367-1; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Beaudoin C, 1997, MOL CELL ENDOCRINOL, V133, P63, DOI 10.1016/S0303-7207(97)00143-3; BERRY SJ, 1984, J UROLOGY, V132, P474, DOI 10.1016/S0022-5347(17)49698-4; CHUTE CG, 1993, J UROLOGY, V150, P85, DOI 10.1016/S0022-5347(17)35405-8; Cunha GR, 1996, PROSTATE, P22; Di Silverio F, 2005, EUR UROL, V47, P72, DOI 10.1016/j.eururo.2004.08.024; Fiandalo MV, 2014, INT J BIOL SCI, V10, P596, DOI 10.7150/ijbs.8780; Grubisha MJ, 2012, MOL ENDOCRINOL, V26, P940, DOI 10.1210/me.2011-1371; Guerini V, 2005, CANCER RES, V65, P5445, DOI 10.1158/0008-5472.CAN-04-1941; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; ISAACS JT, 1989, PROSTATE, P33; Ishizaki F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01528; Jiang M, 2010, STEM CELLS, V28, P344, DOI 10.1002/stem.284; Kim HK, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/783287; Kirby RS, 2000, UROLOGY, V56, P3, DOI 10.1016/S0090-4295(00)00747-0; Konig JE, 2004, PROSTATE, V58, P121, DOI 10.1002/pros.10317; Kramer G, 2006, CURR OPIN UROL, V16, P25; Kramer G, 2002, PROSTATE, V52, P43, DOI 10.1002/pros.10084; Lau KM, 2000, CANCER RES, V60, P3175; Lazier CB, 2004, PROSTATE, V58, P130, DOI 10.1002/pros.10340; LEPOR H, 1990, PROSTATE, P75; Liu TT, 2015, RNA, V21, P1159, DOI 10.1261/rna.045559.114; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; McPherson S. J., 2006, E SCHERING FDN S P, V1,, P131; McPherson SJ, 2010, P NATL ACAD SCI USA, V107, P3123, DOI 10.1073/pnas.0905524107; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; Nickel JC, 2008, EUR UROL, V54, P1379, DOI 10.1016/j.eururo.2007.11.026; Nickel JC, 1999, BJU INT, V84, P976; Oliveira AG, 2007, STEROIDS, V72, P914, DOI 10.1016/j.steroids.2007.08.001; Parsons JK, 2012, EUR UROL, V62, P234, DOI 10.1016/j.eururo.2012.03.007; PAYNE AH, 1991, ENDOCRINOLOGY, V129, P1429, DOI 10.1210/endo-129-3-1429; Pelletier G, 2008, BEST PRACT RES CL EN, V22, P223, DOI 10.1016/j.beem.2008.02.004; Ren RQ, 2007, BLOOD, V109, P2847, DOI 10.1182/blood-2006-08-039743; Roehrborn CG, 2015, PROSTATE CANCER P D, V18, P43, DOI 10.1038/pcan.2014.43; Roehrborn CG, 2002, UROLOGY, V60, P434, DOI 10.1016/S0090-4295(02)01905-2; Roehrborn CG, 2011, UROLOGY, V78, P641, DOI 10.1016/j.urology.2011.03.063; Samarasinghe RA, 2011, P NATL ACAD SCI USA, V108, P16657, DOI 10.1073/pnas.1102821108; Schenk JM, 2012, AM J EPIDEMIOL, V176, P156, DOI 10.1093/aje/kwr524; Schmidt LJ, 2004, J ANDROL, V25, P944; Sewer MB, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290163; Simanainen U, 2007, ENDOCRINOLOGY, V148, P2264, DOI 10.1210/en.2006-1223; St Sauver JL, 2006, AM J EPIDEMIOL, V164, P760, DOI 10.1093/aje/kwj258; Steckelbroeck S, 2004, J BIOL CHEM, V279, P10784, DOI 10.1074/jbc.M313308200; Susperregui ARG, 2011, MOL ENDOCRINOL, V25, P1006, DOI 10.1210/me.2010-0515; Sutcliffe S, 2012, BJU INT, V110, P1050, DOI 10.1111/j.1464-410X.2011.10867.x; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TREMBLAY Y, 1993, MOL ENDOCRINOL, V7, P355, DOI 10.1210/me.7.3.355; Wang WZ, 2004, PROSTATE, V61, P60, DOI 10.1002/pros.20061; Weihua Z, 2002, P NATL ACAD SCI USA, V99, P13589, DOI 10.1073/pnas.162477299; Wikstrom P, 1998, PROSTATE, V37, P19, DOI 10.1002/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO;2-3; Wilson JD, 2003, ENDOCRINOLOGY, V144, P575, DOI 10.1210/en.2002-220721; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104	60	6	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14747	14760		10.1074/jbc.M115.711515	http://dx.doi.org/10.1074/jbc.M115.711515			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226548	Green Published, hybrid			2022-12-28	WOS:000380366700027
J	McDaniel, SL; Fligor, JE; Ruan, C; Cui, HC; Bridgers, JB; DiFiore, JV; Guo, AH; Li, B; Strahl, BD				McDaniel, Stephen L.; Fligor, Jennifer E.; Ruan, Chun; Cui, Haochen; Bridgers, Joseph B.; DiFiore, Julia V.; Guo, Angela H.; Li, Bing; Strahl, Brian D.			Combinatorial Histone Readout by the Dual Plant Homeodomain (PHD) Fingers of Rco1 Mediates Rpd3S Chromatin Recruitment and the Maintenance of Transcriptional Fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; gene transcription; histone acetylation; histone deacetylase (HDAC); PHD finger; Rco1; Rpd3S	DEACETYLASE COMPLEX; SET2 METHYLATION; CODING REGIONS; BUR1 KINASE; H3; ELONGATION; RECOGNITION; LYSINE-36; PROMOTER; EXCHANGE	The plant homeodomain (PHD) finger is found in many chromatin-associated proteins and functions to recruit effector proteins to chromatin through its ability to bind both methylated and unmethylated histone residues. Here, we show that the dual PHD fingers of Rco1, a member of the Rpd3S histone deacetylase complex recruited to transcribing genes, operate in a combinatorial manner in targeting the Rpd3S complex to histone H3 in chromatin. Although mutations in either the first or second PHD finger allow for Rpd3S complex formation, the assembled complexes from these mutants cannot recognize nucleosomes or function to maintain chromatin structure and prevent cryptic transcriptional initiation from within transcribed regions. Taken together, our findings establish a critical role of combinatorial readout in maintaining chromatin organization and in enforcing the transcriptional fidelity of genes.	[McDaniel, Stephen L.; DiFiore, Julia V.; Strahl, Brian D.] Univ North Carolina Chapel Hill, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Bridgers, Joseph B.; Guo, Angela H.; Strahl, Brian D.] Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Fligor, Jennifer E.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Ruan, Chun; Cui, Haochen; Li, Bing] Univ Texas Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas	Strahl, BD (corresponding author), UNC Sch Med, 3060 Genet Med CB 7260, Chapel Hill, NC 27599 USA.	brian_strahl@med.unc.edu	Peptide Synthesis and Array Facility, High-Throughput/AFI-7866-2022; Strahl, Brian D/C-7601-2012	Strahl, Brian D/0000-0002-4947-6259; Guo, Angela/0000-0001-5265-7205; Bridgers, Joseph/0000-0002-0585-4131	NIGMS, National Institutes of Health [GM110058]; National Institutes of Health [T32 GM007092, GM090077]; Welch Foundation [I-1713]; NATIONAL CANCER INSTITUTE [F31CA165891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110058, T32GM007092, R01GM090077] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant GM110058 (to B. D. S.), National Institutes of Health Grants T32 GM007092 (to S. L. M. and J. V. D.) and GM090077 (to B. L.), and Welch Foundation Grant I-1713 (to B. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chu YY, 2006, MOL CELL BIOL, V26, P3029, DOI 10.1128/MCB.26.8.3029-3038.2006; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Gilbert TM, 2014, MOL CELL PROTEOMICS, V13, P2883, DOI 10.1074/mcp.M114.038224; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Huh JW, 2012, EMBO J, V31, P3564, DOI 10.1038/emboj.2012.221; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Kumar GS, 2012, J MOL BIOL, V422, P519, DOI 10.1016/j.jmb.2012.06.013; Kwan AHY, 2003, STRUCTURE, V11, P803, DOI 10.1016/S0969-2126(03)00122-9; Lalonde ME, 2014, GENE DEV, V28, P1029, DOI 10.1101/gad.236331.113; Lee CH, 2013, MOL CELL, V52, P255, DOI 10.1016/j.molcel.2013.08.024; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Lickwar CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004886; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Ruan C, 2016, J BIOL CHEM, V291, P5428, DOI 10.1074/jbc.M115.703637; Ruan C, 2015, CELL REP, V10, P204, DOI 10.1016/j.celrep.2014.12.027; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Silva AC, 2012, J BIOL CHEM, V287, P1709, DOI 10.1074/jbc.M111.316489; Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wang SS, 2011, MOL CELL BIOL, V31, P3171, DOI 10.1128/MCB.05017-11; Yun M, 2012, METHODS MOL BIOL, V833, P237, DOI 10.1007/978-1-61779-477-3_15; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42	31	13	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14796	14802		10.1074/jbc.M116.720193	http://dx.doi.org/10.1074/jbc.M116.720193			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226578	Green Published, hybrid			2022-12-28	WOS:000380366700031
J	Persson, A; Tykesson, E; Westergren-Thorsson, G; Malmstrom, A; Ellervik, U; Mani, K				Persson, Andrea; Tykesson, Emil; Westergren-Thorsson, Gunilla; Malmstrom, Anders; Ellervik, Ulf; Mani, Katrin			Xyloside-primed Chondroitin Sulfate/Dermatan Sulfate from Breast Carcinoma Cells with a Defined Disaccharide Composition Has Cytotoxic Effects in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; chondroitin sulfate; dermatan sulfate; glycosaminoglycan; heparan sulfate; high-performance liquid chromatography (HPLC); structure-function; disaccharide fingerprint; xyloside	BETA-D-XYLOSIDES; HEPARAN-SULFATE; TUMOR-GROWTH; GLYCOSAMINOGLYCANS; BIOSYNTHESIS; FIBROBLASTS; PROLIFERATION; PROTEOGLYCAN; CANCER; ATTENUATION	We previously reported that the xyloside 2-(6-hydroxynaphthyl) -d-xylopyranoside (XylNapOH), in contrast to 2-naphthyl -d-xylopyranoside (XylNap), specifically reduces tumor growth both in vitro and in vivo. Although there are indications that this could be mediated by the xyloside-primed glycosaminoglycans (GAGs) and that these differ in composition depending on xyloside and cell type, detailed knowledge regarding a structure-function relationship is lacking. In this study we isolated XylNapOH- and XylNap-primed GAGs from a breast carcinoma cell line, HCC70, and a breast fibroblast cell line, CCD-1095Sk, and demonstrated that both XylNapOH- and XylNap-primed chondroitin sulfate/dermatan sulfate GAGs derived from HCC70 cells had a cytotoxic effect on HCC70 cells and CCD-1095Sk cells. The cytotoxic effect appeared to be mediated by induction of apoptosis and was inhibited in a concentration-dependent manner by the XylNap-primed heparan sulfate GAGs. In contrast, neither the chondroitin sulfate/dermatan sulfate nor the heparan sulfate derived from CCD-1095Sk cells primed on XylNapOH or XylNap had any effect on the growth of HCC70 cells or CCD-105Sk cells. These observations were related to the disaccharide composition of the XylNapOH- and XylNap-primed GAGs, which differed between the two cell lines but was similar when the GAGs were derived from the same cell line. To our knowledge this is the first report on cytotoxic effects mediated by chondroitin sulfate/dermatan sulfate.	[Persson, Andrea; Tykesson, Emil; Westergren-Thorsson, Gunilla; Malmstrom, Anders; Mani, Katrin] Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden; [Ellervik, Ulf] Lund Univ, Ctr Anal & Synth, Ctr Chem & Chem Engn, SE-22184 Lund, Sweden	Lund University; Lund University	Persson, A (corresponding author), Biomed Ctr A13, SE-22184 Lund, Sweden.	andrea.persson@med.lu.se	Tykesson, Emil/F-9879-2014	Tykesson, Emil/0000-0002-0511-9831; Mani, Katrin/0000-0002-1821-0634; Malmstrom, Anders/0000-0002-6691-146X	Alfred Osterlund Foundation; Crafoord Foundation; Foundation of the Hedda and John Forssman Fund; Lund University; Medical Faculty at Lund University; Swedish Cancer Society; Swedish Foundation for Strategic Research; Swedish Research Council	Alfred Osterlund Foundation; Crafoord Foundation; Foundation of the Hedda and John Forssman Fund; Lund University; Medical Faculty at Lund University; Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Alfred Osterlund Foundation, the Crafoord Foundation, the Foundation of the Hedda and John Forssman Fund, Lund University, the Medical Faculty at Lund University, the Swedish Cancer Society, the Swedish Foundation for Strategic Research, and the Swedish Research Council. The authors declare that they have no conflicts of interest with the contents of this article.	Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Denholm EM, 2001, EUR J PHARMACOL, V416, P213, DOI 10.1016/S0014-2999(01)00884-6; FARACH MC, 1988, BIOL REPROD, V39, P443, DOI 10.1095/biolreprod39.2.443; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; FERRO DR, 1990, CARBOHYD RES, V195, P157, DOI 10.1016/0008-6215(90)84164-P; FRANSSON LA, 1992, BIOCHIM BIOPHYS ACTA, V1137, P287, DOI 10.1016/0167-4889(92)90149-6; FRITZ TA, 1994, J BIOL CHEM, V269, P300; Jacobsson M, 2006, J MED CHEM, V49, P1932, DOI 10.1021/jm0512488; Joo EJ, 2014, OMICS, V18, P231, DOI 10.1089/omi.2013.0128; Kawashima H, 2000, J BIOL CHEM, V275, P35448, DOI 10.1074/jbc.M003387200; Linhardt RJ, 2006, ADV PHARMACOL, V53, P187, DOI 10.1016/S1054-3589(05)53009-6; Liu DF, 2002, P NATL ACAD SCI USA, V99, P568, DOI 10.1073/pnas.012578299; Mani K, 2004, GLYCOBIOLOGY, V14, P387, DOI 10.1093/glycob/cwh035; Mani K, 1998, CANCER RES, V58, P1099; MARGOLIS RK, 1991, J CELL SCI, V99, P237; MATUOKA K, 1984, CELL STRUCT FUNCT, V9, P357, DOI 10.1247/csf.9.357; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Mizumoto S, 2015, CURR OPIN STRUC BIOL, V34, P35, DOI 10.1016/j.sbi.2015.06.004; Muto J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025480; Nilsson U, 2010, CANCER RES, V70, P3771, DOI 10.1158/0008-5472.CAN-09-4331; Raman K, 2011, BIOCHEM BIOPH RES CO, V404, P86, DOI 10.1016/j.bbrc.2010.11.069; Smetsers TFCM, 2003, CANCER RES, V63, P2965; Stachtea XN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140279; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Sugahara KN, 2008, CANCER RES, V68, P7191, DOI 10.1158/0008-5472.CAN-07-6198; Syrokou A, 1999, CELL PROLIFERAT, V32, P85, DOI 10.1046/j.1365-2184.1999.32230085.x; Toomey JR, 2006, J THROMB HAEMOST, V4, P1989, DOI 10.1111/j.1538-7836.2006.02064.x; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Victor XV, 2009, J BIOL CHEM, V284, P25842, DOI 10.1074/jbc.M109.043208; WESTERGRENTHORSSON G, 1991, J CELL PHYSIOL, V147, P523, DOI 10.1002/jcp.1041470319; WESTERGRENTHORSSON G, 1993, EXP CELL RES, V206, P93, DOI 10.1006/excr.1993.1124; Weyers A, 2012, OMICS, V16, P79, DOI 10.1089/omi.2011.0102; Willis CM, 2012, J BIOL CHEM, V287, P37042, DOI 10.1074/jbc.M112.391490	33	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14871	14882		10.1074/jbc.M116.716829	http://dx.doi.org/10.1074/jbc.M116.716829			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226567	Green Published, hybrid			2022-12-28	WOS:000380366700038
J	Yun, BL; Guan, XL; Liu, YZ; Zhang, Y; Wang, YQ; Qi, XL; Cui, HY; Liu, CJ; Zhang, YP; Gao, HL; Gao, L; Li, K; Gao, YL; Wang, XM				Yun, Bing-Ling; Guan, Xiao-Lu; Liu, Yong-Zhen; Zhang, Yao; Wang, Yong-Qiang; Qi, Xiao-Le; Cui, Hong-Yu; Liu, Chang-Jun; Zhang, Yan-Ping; Gao, Hong-Lei; Gao, Li; Li, Kai; Gao, Yu-Long; Wang, Xiao-Mei			Integrin v1 Modulation Affects Subtype B Avian Metapneumovirus Fusion Protein-mediated Cell-Cell Fusion and Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fusion protein; infection; integrin; membrane fusion; viral replication; aMPV; B; fusogenicity	NEWCASTLE-DISEASE VIRUS; RESPIRATORY SYNCYTIAL VIRUS; PARAMYXOVIRUS MEMBRANE-FUSION; LOW-PH; F-PROTEIN; HEMAGGLUTININ-NEURAMINIDASE; ATTACHMENT PROTEIN; IN-VITRO; ENTRY; ACTIVATION	Avian metapneumovirus (aMPV) fusion (F) protein mediates virus-cell membrane fusion to initiate viral infection, which requires F protein binding to its receptor(s) on the host cell surface. However, the receptor(s) for aMPV F protein is still not identified. All known subtype B aMPV (aMPV/B) F proteins contain a conserved Arg-Asp-Asp (RDD) motif, suggesting that the aMPV/B F protein may mediate membrane fusion via the binding of RDD to integrin. When blocked with integrin-specific peptides, aMPV/B F protein fusogenicity and viral replication were significantly reduced. Specifically we identified integrin v and/or 1-mediated F protein fusogenicity and viral replication using antibody blocking, small interfering RNAs (siRNAs) knockdown, and overexpression. Additionally, overexpression of integrin v and 1 in aMPV/B non-permissive cells conferred aMPV/B F protein binding and aMPV/B infection. When RDD was altered to RAE (Arg-Ala-Glu), aMPV/B F protein binding and fusogenic activity were profoundly impaired. These results suggest that integrin v1 is a functional receptor for aMPV/B F protein-mediated membrane fusion and virus infection, which will provide new insights on the fusogenic mechanism and pathogenesis of aMPV.	[Yun, Bing-Ling; Guan, Xiao-Lu; Liu, Yong-Zhen; Zhang, Yao; Wang, Yong-Qiang; Qi, Xiao-Le; Cui, Hong-Yu; Liu, Chang-Jun; Zhang, Yan-Ping; Gao, Hong-Lei; Gao, Li; Li, Kai; Gao, Yu-Long; Wang, Xiao-Mei] Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Avian Infect Dis, State Key Lab Vet Biotechnol, 427 Maduan St, Harbin 150001, Heilongjiang, Peoples R China; [Wang, Xiao-Mei] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Gao, YL; Wang, XM (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Avian Infect Dis, State Key Lab Vet Biotechnol, 427 Maduan St, Harbin 150001, Heilongjiang, Peoples R China.	ylg@hvri.ac.cn; xmw@hvri.ac.cn			fund for the Modern Agro-industry Technology Research System [nycytx-42-G3-01]	fund for the Modern Agro-industry Technology Research System	This work was supported by the fund for the Modern Agro-industry Technology Research System number nycytx-42-G3-01. The authors declare that they have no conflicts of interest with the contents of this article.	Aung YH, 2008, AVIAN PATHOL, V37, P65, DOI 10.1080/03079450701802222; Avitabile E, 2004, J VIROL, V78, P8015, DOI 10.1128/JVI.78.15.8015-8025.2004; BAGAI S, 1995, J VIROL, V69, P6712, DOI 10.1128/JVI.69.11.6712-6719.1995; Biacchesi S, 2004, J VIROL, V78, P12877, DOI 10.1128/JVI.78.23.12877-12887.2004; Bose S, 2014, J VIROL, V88, P3925, DOI 10.1128/JVI.03741-13; Bose S, 2013, J VIROL, V87, P13520, DOI 10.1128/JVI.02123-13; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chu JJH, 2004, J BIOL CHEM, V279, P54533, DOI 10.1074/jbc.M410208200; Cook JKA, 2000, VET J, V160, P118, DOI 10.1053/tvjl.2000.0486; Cox RG, 2012, J VIROL, V86, P12148, DOI 10.1128/JVI.01133-12; Cseke G, 2009, P NATL ACAD SCI USA, V106, P1566, DOI 10.1073/pnas.0801433106; de Graaf M, 2009, J GEN VIROL, V90, P1408, DOI 10.1099/vir.0.009688-0; Dutch RE, 1998, J VIROL, V72, P7745, DOI 10.1128/JVI.72.10.7745-7753.1998; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Gallo SA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-90; GOUGH RE, 2003, DIS POULTRY, P92; Gout E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/541939; Guionie O, 2007, J VIROL METHODS, V139, P150, DOI 10.1016/j.jviromet.2006.09.022; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Heikkila O, 2009, J GEN VIROL, V90, P197, DOI 10.1099/vir.0.004838-0; Herfst S, 2008, J VIROL, V82, P8891, DOI 10.1128/JVI.00472-08; Jardetzky TS, 2014, CURR OPIN VIROL, V5, P24, DOI 10.1016/j.coviro.2014.01.005; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; Kinzler ER, 2005, J VIROL, V79, P7827, DOI 10.1128/JVI.79.12.7827-7837.2005; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lamb RA, 2006, VIROLOGY, V344, P30, DOI 10.1016/j.virol.2005.09.007; Li PH, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-154; Ling R, 2008, J GEN VIROL, V89, P525, DOI 10.1099/vir.0.83309-0; Liu Q, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003770; Mase M, 2003, AVIAN DIS, V47, P481, DOI 10.1637/0005-2086(2003)047[0481:POAPSA]2.0.CO;2; Mirza AM, 2011, J BIOL CHEM, V286, P17851, DOI 10.1074/jbc.M111.233965; MOORE JP, 1993, VIRAL FUSION MECHANI, P233; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; Pebworth MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110453; Porotto M, 2003, J VIROL, V77, P3647, DOI 10.1128/JVI.77.6.3647-3654.2003; Rothwangl KB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-12; Schowalter RM, 2006, J VIROL, V80, P10931, DOI 10.1128/JVI.01287-06; Schowalter RM, 2009, J VIROL, V83, P1511, DOI 10.1128/JVI.01381-08; Smith EC, 2013, J BIOL CHEM, V288, P35726, DOI 10.1074/jbc.M113.514554; StoneHulslander J, 1997, J VIROL, V71, P6287, DOI 10.1128/JVI.71.9.6287-6295.1997; Talekar A, 2013, J VIROL, V87, P10980, DOI 10.1128/JVI.01646-13; Triantafilou K, 2000, J VIROL, V74, P5856, DOI 10.1128/JVI.74.13.5856-5862.2000; Van de Walle GR, 2008, J VIROL, V82, P11859, DOI 10.1128/JVI.00868-08; Wei YW, 2014, J VIROL, V88, P4338, DOI 10.1128/JVI.03491-13; Wei YW, 2012, J VIROL, V86, P11800, DOI 10.1128/JVI.00232-12; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Xu R, 2013, MBIO, V4, DOI 10.1128/mBio.00803-13; Yun BL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15584; Yun BL, 2015, ARCH VIROL, V160, P2445, DOI 10.1007/s00705-015-2524-x; Zaitsev V, 2004, J VIROL, V78, P3733, DOI 10.1128/JVI.78.7.3733-3741.2004; Zhang BS, 2008, J VIROL, V82, P1204, DOI 10.1128/JVI.01393-07	52	6	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14815	14825		10.1074/jbc.M115.711382	http://dx.doi.org/10.1074/jbc.M115.711382			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226547	Green Published, hybrid			2022-12-28	WOS:000380366700033
J	Bahl, K; Xie, SW; Spagnol, G; Sorgen, P; Naslavsky, N; Caplan, S				Bahl, Kriti; Xie, Shuwei; Spagnol, Gaelle; Sorgen, Paul; Naslavsky, Naava; Caplan, Steve			EHD3 Protein Is Required for Tubular Recycling Endosome Stabilization, and an Asparagine-Glutamic Acid Residue Pair within Its Eps15 Homology (EH) Domain Dictates Its Selective Binding to NPF Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; NMR; receptor recycling; trafficking; vesicles; EHD1; EHD3; MICAL-L1; Rabankyrin-5; tubular recycling endosome	ENDOCYTIC TRAFFICKING; PHOSPHATIDIC-ACID; BIOGENESIS; MECHANISMS; TRANSPORT; INTERACT; MICAL-L1; MOTIFS; FAMILY	An elaborate network of dynamic lipid membranes, termed tubular recycling endosomes (TRE), coordinates the process of endocytic recycling in mammalian cells. The C-terminal Eps15 homology domain (EHD)-containing proteins have been implicated in the bending and fission of TRE, thus regulating endocytic recycling. EHD proteins have an EH domain that interacts with proteins containing an NPF motif. We found that NPF-containing EHD1 interaction partners such as molecules interacting with CasL-like1 (MICAL-L1) and Syndapin2 are essential for TRE biogenesis. Also crucial for TRE biogenesis is the generation of phosphatidic acid, an essential lipid component of TRE that serves as a docking point for MICAL-L1 and Syndapin2. EHD1 and EHD3 have 86% amino acid identity; they homo- and heterodimerize and partially co-localize to TRE. Despite their remarkable identity, they have distinct mechanistic functions. EHD1 induces membrane vesiculation, whereas EHD3 supports TRE biogenesis and/or stabilization by an unknown mechanism. While using phospholipase D inhibitors (which block the conversion of glycerophospholipids to phosphatidic acid) to deplete cellular TRE, we observed that, upon inhibitor washout, there was a rapid and dramatic regeneration of MICAL-L1-marked TRE. Using this synchronized TRE biogenesis system, we determined that EHD3 is involved in the stabilization of TRE rather than in their biogenesis. Moreover, we identify the residues Ala-519/Asp-520 of EHD1 and Asn-519/Glu-520 of EHD3 as defining the selectivity of these two paralogs for NPF-containing binding partners, and we present a model to explain the atomic mechanism and provide new insight for their differential roles in vesiculation and tubulation, respectively.	[Caplan, Steve] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Caplan, Steve] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Caplan, S (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Caplan, S (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	scaplan@unmc.edu	Xie, Shuwei/ABA-4923-2021	Spagnol, Gaelle/0000-0002-3201-4840	National Institutes of Health [R01GM074876, R01GM072631]; NIGMS, National Institutes of Health institutional development award [P30GM106397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072631, R01GM074876, P30GM106397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health institutional development award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work supported by National Institutes of Health Grants R01GM074876 (to S. C.) and R01GM072631 (to P. S.) and NIGMS, National Institutes of Health institutional development award P30GM106397.	Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Cabasso O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134053; Cai BS, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00022; Cai BS, 2013, J BIOL CHEM, V288, P30172, DOI 10.1074/jbc.M113.488627; Cai BS, 2012, MOL BIOL CELL, V23, P1874, DOI 10.1091/mbc.E11-10-0881; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Chi RJ, 2015, CELL MOL LIFE SCI, V72, P3441, DOI 10.1007/s00018-015-1935-x; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Giridharan SSP, 2013, MOL BIOL CELL, V24, P1776, DOI 10.1091/mbc.E13-01-0026; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; Henmi Y, 2016, EXP CELL RES, V342, P1, DOI 10.1016/j.yexcr.2016.02.011; Henry GD, 2010, BIOCHEMISTRY-US, V49, P3381, DOI 10.1021/bi100065r; Jakobsson J, 2011, J NEUROSCI, V31, P13972, DOI 10.1523/JNEUROSCI.1289-11.2011; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; Jovic M, 2009, MOL BIOL CELL, V20, P2731, DOI 10.1091/mbc.E08-11-1102; Kieken F, 2007, J BIOMOL NMR, V39, P323, DOI 10.1007/s10858-007-9196-0; Kieken F, 2010, J BIOL CHEM, V285, P8687, DOI 10.1074/jbc.M109.045666; Kieken F, 2009, PROTEIN SCI, V18, P2471, DOI 10.1002/pro.258; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2005, J CELL SCI, V118, P4093, DOI 10.1242/jcs.02595; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Naslavsky N, 2011, TRENDS CELL BIOL, V21, P122, DOI 10.1016/j.tcb.2010.10.003; Pohl U, 2000, GENOMICS, V63, P255, DOI 10.1006/geno.1999.6087; Reinecke James, 2014, Biomol Concepts, V5, P143, DOI 10.1515/bmc-2014-0003; Reinecke JB, 2015, TRAFFIC, V16, P48, DOI 10.1111/tra.12234; Sharma Mahak, 2010, Commun Integr Biol, V3, P181; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; van Weering JRT, 2014, SEMIN CELL DEV BIOL, V31, P40, DOI 10.1016/j.semcdb.2014.03.015; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; Xie SW, 2016, MOL BIOL CELL, V27, P108, DOI 10.1091/mbc.E15-07-0514; Xie SW, 2014, J BIOL CHEM, V289, P31914, DOI 10.1074/jbc.M114.594291; Zhang J, 2012, TRAFFIC, V13, P745, DOI 10.1111/j.1600-0854.2012.01334.x	41	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13465	13478		10.1074/jbc.M116.716407	http://dx.doi.org/10.1074/jbc.M116.716407			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27189942	Green Published, hybrid			2022-12-28	WOS:000379771100006
J	Golan, Y; Itsumura, N; Glaser, F; Berman, B; Kambe, T; Assaraf, YG				Golan, Yarden; Itsumura, Naoya; Glaser, Fabian; Berman, Bluma; Kambe, Taiho; Assaraf, Yehuda G.			Molecular Basis of Transient Neonatal Zinc Deficiency: NOVEL ZnT2 MUTATIONS DISRUPTING ZINC BINDING AND PERMEATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dimerization; metal homeostasis; mutant; transport; zinc; bimolecular fluorescence complementation; neonatal zinc deficiency; transport metals; zinc transport	MAMMARY-GLAND DEVELOPMENT; TRANSPORTERS; SLC30A2; FAMILY; GENE; HAPLOINSUFFICIENCY; SERVER	A gradually increasing number of transient neonatal zinc deficiency (TNZD) cases was recently reported, all of which were associated with inactivating ZnT2 mutations. Here we characterized the impact of three novel heterozygous ZnT2 mutations G280R, T312M, and E355Q, which cause TNZD in exclusively breastfed infants of Japanese mothers. We used the bimolecular fluorescence complementation (BiFC) assay to provide direct visual evidence for the in situ dimerization of these ZnT2 mutants, and to explore their subcellular localization. Moreover, using three complementary functional assays, zinc accumulation using BiFC-Zinquin and Zinpyr-1 fluorescence as well as zinc toxicity assay, we determined the impact of these ZnT2 mutations on vesicular zinc accumulation. Although all three mutants formed homodimers with the wild type (WT) ZnT2 and retained substantial vesicular localization, as well as vesicular zinc accumulation, they had no dominant-negative effect over the WT ZnT2. Furthermore, using advanced bioinformatics, structural modeling, and site-directed mutagenesis we found that these mutations localized at key residues, which play an important physiological role in zinc coordination (G280R and E355Q) and zinc permeation (T312M). Collectively, our findings establish that some heterozygous loss of function ZnT2 mutations disrupt zinc binding and zinc permeation, thereby suggesting a haploinsufficiency state for the unaffected WT ZnT2 allele in TNZD pathogenesis. These results highlight the burning need for the development of a suitable genetic screen for the early diagnosis of TNZD to prevent morbidity.	[Golan, Yarden; Berman, Bluma; Assaraf, Yehuda G.] Technion, Fred Wyszkowski Canc Res Lab, Dept Biol, IL-32000 Haifa, Israel; [Glaser, Fabian] Technion, Lorry I Lokey Interdisciplinary Ctr Life Sci & En, Bioinformat Knowledge Unit, IL-32000 Haifa, Israel; [Itsumura, Naoya; Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Kyoto University	Assaraf, YG (corresponding author), Technion, Fred Wyszkowski Canc Res Lab, Dept Biol, IL-32000 Haifa, Israel.; Kambe, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	kambe1@kais.kyoto-u.ac.jp; assaraf@tx.technion.ac.il		Assaraf, Yehuda G./0000-0001-6692-8221; Golan, Yarden/0000-0002-3043-3638	Grants-in-Aid for Scientific Research [15J08478] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Alam S, 2015, J MAMMARY GLAND BIOL, V20, P159, DOI 10.1007/s10911-015-9338-z; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Coromilas A, 2011, PEDIATR DERMATOL, V28, P697, DOI 10.1111/j.1525-1470.2011.01637.x; Coudray N, 2013, P NATL ACAD SCI USA, V110, P2140, DOI 10.1073/pnas.1215455110; Fujimoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077445; Golan Y, 2015, J BIOL CHEM, V290, P9050, DOI 10.1074/jbc.M114.617332; Hennigar SR, 2015, J CELL PHYSIOL, V230, P2345, DOI 10.1002/jcp.24992; Ho G, 2011, HUM MUTAT, V32, pE1976, DOI 10.1002/humu.21399; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Huo J, 2010, ARCH DERMATOL RES, V302, P769, DOI 10.1007/s00403-010-1081-0; Itsumura N., 2016, PEDIAT RES IN PRESS; Itsumura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064045; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kambe T, 2011, BIOSCI BIOTECH BIOCH, V75, P1036, DOI 10.1271/bbb.110056; Kasana S, 2015, J TRACE ELEM MED BIO, V29, P47, DOI 10.1016/j.jtemb.2014.10.003; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Lasry I, 2014, J BIOL CHEM, V289, P7275, DOI 10.1074/jbc.M113.533786; Lasry I, 2012, J BIOL CHEM, V287, P29348, DOI 10.1074/jbc.M112.368159; Lee S, 2015, J BIOL CHEM, V290, P13064, DOI 10.1074/jbc.M115.637439; Lessen R, 2015, J ACAD NUTR DIET, V115, P444, DOI 10.1016/j.jand.2014.12.014; Navarro ML, 2014, PEDIATR DERMATOL, V31, P251, DOI 10.1111/pde.12257; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; McCormick NH, 2014, J MAMMARY GLAND BIOL, V19, P59, DOI 10.1007/s10911-013-9314-4; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Miletta MC, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/259189; Murthy Sambasiviah C, 2010, Dermatol Online J, V16, P3; Page DT, 2009, P NATL ACAD SCI USA, V106, P1989, DOI 10.1073/pnas.0804428106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Prasad AS, 2003, BMJ-BRIT MED J, V326, P409, DOI 10.1136/bmj.326.7386.409; Savignac M, 2011, BBA-MOL CELL RES, V1813, P1111, DOI 10.1016/j.bbamcr.2010.12.006; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sedic M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8505; Sharma M, 2014, DNA RES, V21, P267, DOI 10.1093/dnares/dst056; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]	35	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13546	13559		10.1074/jbc.M116.732693	http://dx.doi.org/10.1074/jbc.M116.732693			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27137936	Green Published, hybrid			2022-12-28	WOS:000379771100013
J	Hu, PP; Morales, R; Duran-Aniotz, C; Moreno-Gonzalez, I; Khan, U; Soto, C				Hu, Ping Ping; Morales, Rodrigo; Duran-Aniotz, Claudia; Moreno-Gonzalez, Ines; Khan, Uffaf; Soto, Claudio			Role of Prion Replication in the Strain-dependent Brain Regional Distribution of Prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMISSIBLE MINK ENCEPHALOPATHY; MISFOLDING CYCLIC AMPLIFICATION; CELL PANEL ASSAY; INFECTIOUS PRIONS; MOLECULAR-BASIS; IN-VITRO; SCRAPIE; PROTEIN; HAMSTERS; DISEASE	One intriguing feature of prion diseases is their strain variation. Prion strains are differentiated by the clinical consequences they generate in the host, their biochemical properties, and their potential to infect other animal species. The selective targeting of these agents to specific brain structures have been extensively used to characterize prion strains. However, the molecular basis dictating strain-specific neurotropism are still elusive. In this study, isolated brain structures from animals infected with four hamster prion strains (HY, DY, 139H, and SSLOW) were analyzed for their content of protease-resistant PrPSc. Our data show that these strains have different profiles of PrP deposition along the brain. These patterns of accumulation, which were independent of regional PrPC production, were not reproduced by in vitro replication when different brain regions were used as substrate for the misfolding-amplification reaction. On the contrary, our results show that in vitro replication efficiency depended exclusively on the amount of PrPC present in each part of the brain. Our results suggest that the variable regional distribution of PrPSc in distinct strains is not determined by differences on prion formation, but on other factors or cellular pathways. Our findings may contribute to understand the molecular mechanisms of prion pathogenesis and strain diversity.	[Hu, Ping Ping; Morales, Rodrigo; Duran-Aniotz, Claudia; Moreno-Gonzalez, Ines; Khan, Uffaf; Soto, Claudio] Univ Texas Houston, Sch Med, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Dept Neurol, Houston, TX 77030 USA; [Hu, Ping Ping] Chongqing Univ, Innovat Drug Res Ctr, Chongqing 401331, Peoples R China; [Duran-Aniotz, Claudia; Soto, Claudio] Univ Los Andes, Fac Med, Ave San Carlos de Apoquindo 2200, Santiago, Chile	University of Texas System; University of Texas Health Science Center Houston; Chongqing University; Universidad de los Andes - Chile	Soto, C (corresponding author), Univ Texas Med Sch, 6431 Fannin St MSE R422, Houston, TX 77030 USA.	Claudio.Soto@uth.tmc.edu	Moreno-Gonzalez, Ines/AAA-2222-2019; Morales, Rodrigo/K-7173-2015; Moreno-Gonzalez, Ines/AAO-1694-2021	Moreno-Gonzalez, Ines/0000-0003-3875-0889; Duran-Aniotz, Claudia/0000-0003-2503-8366	National Institutes of Health [R01NS049173, P01AI077774, P01AI106705]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI077774, P01AI106705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078745, R01NS049173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grants R01NS049173, P01AI077774, and P01AI106705 (to C. S.). C. S. is the inventor on several patents related to the PMCA technology and is currently Founder, Chief Scientific Officer and Vice-President of Amprion Inc, a bio-tech company focusing on the commercial utilization of PMCA for prion diagnosis. R. M. is the inventor in some patent applications related to the PMCA technique. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abid K, 2010, FEBS LETT, V584, P2409, DOI 10.1016/j.febslet.2010.04.040; Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Bartz JC, 2005, J VIROL, V79, P11858, DOI 10.1128/JVI.79.18.11858-11863.2005; Bartz JC, 2000, J VIROL, V74, P5542, DOI 10.1128/JVI.74.12.5542-5547.2000; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; DeArmond SJ, 1997, NEURON, V19, P1337, DOI 10.1016/S0896-6273(00)80424-9; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Falsig J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002985; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; HECKER R, 1992, GENE DEV, V6, P1213, DOI 10.1101/gad.6.7.1213; Jeffrey M, 2014, NEUROPATH APPL NEURO, V40, P296, DOI 10.1111/nan.12053; Karapetyan YE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005730; KIMBERLIN RH, 1987, J GEN VIROL, V68, P1875, DOI 10.1099/0022-1317-68-7-1875; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Morales R, 2007, BBA-MOL BASIS DIS, V1772, P681, DOI 10.1016/j.bbadis.2006.12.006; Morales R, 2012, NAT PROTOC, V7, P1397, DOI 10.1038/nprot.2012.067; Moudjou M, 2014, MBIO, V5, DOI 10.1128/mBio.00829-13; PATTISON IH, 1961, J COMP PATHOL THERAP, V71, P101, DOI 10.1016/S0368-1742(61)80013-1; Piro JR, 2009, J VIROL, V83, P5321, DOI 10.1128/JVI.02502-08; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saa P, 2012, J VIROL, V86, P10494, DOI 10.1128/JVI.01286-12; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; WEISSMANN C, 1991, NATURE, V352, P679, DOI 10.1038/352679a0	37	6	6	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12880	12887		10.1074/jbc.M115.681791	http://dx.doi.org/10.1074/jbc.M115.681791			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27056328	Green Published, hybrid			2022-12-28	WOS:000378119900038
J	Zhao, NN; Maxson, JE; Zhang, RH; Wahedi, M; Enns, CA; Zhang, AS				Zhao, Ningning; Maxson, Julia E.; Zhang, Richard H.; Wahedi, Mastura; Enns, Caroline A.; Zhang, An-Sheng			Neogenin Facilitates the Induction of Hepcidin Expression by Hemojuvelin in the Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN; 1Q-LINKED JUVENILE HEMOCHROMATOSIS; REPULSIVE GUIDANCE MOLECULE; SYSTEMIC IRON HOMEOSTASIS; SOLUBLE HEMOJUVELIN; PLASMA-MEMBRANE; DOWN-REGULATION; MESSENGER-RNA; OVERLOAD; TMPRSS6	Hemojuvelin (HJV) regulates iron homeostasis by direct interaction with bone morphogenetic protein (BMP) ligands to induce hepcidin expression through the BMP signaling pathway in the liver. Crystallography studies indicate that HJV can simultaneously bind to both BMP2 and the ubiquitously expressed cell surface receptor neogenin. However, the role of the neogenin-HJV interaction in the function of HJV is unknown. Here we identify a mutation in HJV that specifically lowers its interaction with neogenin. Expression of this mutant Hjv in the liver of Hjv(-/-) mice dramatically attenuated its induction of BMP signaling and hepcidin mRNA, suggesting that interaction with neogenin is critical for the iron regulatory function of HJV. Further studies revealed that neogenin co-immunoprecipitated with ALK3, an essential type-I BMP receptor for hepatic hepcidin expression. Neogenin has also been shown to facilitate the cleavage of HJV by furin in transfected cells. Surprisingly, although cleavage of HJV by furin has been implicated in the regulation of HJV function in cell culture models and furin-cleaved soluble Hjv is detectable in the serum of mice, mutating the furin cleavage site did not alter the stimulation of hepcidin expression by Hjv in mice. In vivo studies validated the important role of HJV-BMP interaction for Hjv stimulation of BMP signaling and hepcidin expression. Together these data support a model in which neogenin acts as a scaffold to facilitate assembly of the HJV.BMP.BMP receptor complex to induce hepcidin expression.	[Zhao, Ningning; Maxson, Julia E.; Zhang, Richard H.; Wahedi, Mastura; Enns, Caroline A.; Zhang, An-Sheng] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97239 USA	Oregon Health & Science University	Zhang, AS (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhanga@ohsu.edu			National Institutes of Health [R01DK102791, R01DK072166, K99DK104066, K99CA190605]; NATIONAL CANCER INSTITUTE [K99CA190605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072166, R01DK102791, K99DK104066, R37DK054488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK102791 ( to A. S. Z.), R01DK072166 ( to C. A. E.), K99DK104066 ( to N. Z.), and K99CA190605 ( to J. E. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Bell CH, 2013, SCIENCE, V341, P77, DOI 10.1126/science.1232322; Besson-Fournier C, 2012, BLOOD, V120, P431, DOI 10.1182/blood-2012-02-411470; Chen W, 2011, BLOOD, V117, P6319, DOI 10.1182/blood-2010-12-327957; D'Alessio F, 2012, J HEPATOL, V57, P1052, DOI 10.1016/j.jhep.2012.06.015; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Enns CA, 2012, J BIOL CHEM, V287, P35104, DOI 10.1074/jbc.M112.363937; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Gkouvatsos K, 2011, HEPATOLOGY, V54, P1800, DOI 10.1002/hep.24547; Gutschow P, 2015, HAEMATOLOGICA, V100, P167, DOI 10.3324/haematol.2014.116723; Healey EG, 2015, NAT STRUCT MOL BIOL, V22, P458, DOI 10.1038/nsmb.3016; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kuns-Hashimoto R, 2008, AM J PHYSIOL-CELL PH, V294, pC994, DOI 10.1152/ajpcell.00563.2007; Lanzara C, 2004, BLOOD, V103, P4317, DOI 10.1182/blood-2004-01-0192; Latour C, 2016, HEPATOLOGY, V63, P126, DOI 10.1002/hep.28254; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Lefebvre T, 2015, CLIN CHEM LAB MED, V53, P1557, DOI 10.1515/cclm-2014-1093; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Lin L, 2008, BLOOD CELL MOL DIS, V40, P122, DOI 10.1016/j.bcmd.2007.06.023; Matsunaga E, 2004, DEV GROWTH DIFFER, V46, P481; Maxson JE, 2010, J BIOL CHEM, V285, P39021, DOI 10.1074/jbc.M110.183160; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nai A, 2016, BLOOD, V127, P2327, DOI 10.1182/blood-2015-11-681494; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Silvestri L, 2007, BLOOD, V109, P4503, DOI 10.1182/blood-2006-08-041004; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Valore EV, 2008, BLOOD CELL MOL DIS, V40, P132, DOI 10.1016/j.bcmd.2007.07.009; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Yang F, 2008, BIOCHEMISTRY-US, V47, P4237, DOI 10.1021/bi800036h; Zhang AS, 2008, J BIOL CHEM, V283, P17494, DOI 10.1074/jbc.M710527200; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2010, J BIOL CHEM, V285, P16416, DOI 10.1074/jbc.M110.109488; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200	42	28	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12322	12335		10.1074/jbc.M116.721191	http://dx.doi.org/10.1074/jbc.M116.721191			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27072365	hybrid, Green Published			2022-12-28	WOS:000378092800031
J	Deuis, JR; Dekan, Z; Inserra, MC; Lee, TH; Aguilar, MI; Craik, DJ; Lewis, RJ; Alewood, PF; Mobli, M; Schroeder, CI; Henriques, ST; Vetter, I				Deuis, Jennifer R.; Dekan, Zoltan; Inserra, Marco C.; Lee, Tzong-Hsien; Aguilar, Marie-Isabel; Craik, David J.; Lewis, Richard J.; Alewood, Paul F.; Mobli, Mehdi; Schroeder, Christina I.; Henriques, Sonia Troeira; Vetter, Irina			Development of a mu O-Conotoxin Analogue with Improved Lipid Membrane Interactions and Potency for the Analgesic Sodium Channel Na(V)1.8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; VOLTAGE SENSORS; PAIN; INHIBITION; PROGRAM; BINDING; MRVIB; ELECTROGENESIS; PRP(106-126); SPECTROSCOPY	The mu O-conotoxins MrVIA, MrVIB, and MfVIA inhibit the voltage-gated sodium channel Na(V)1.8, a well described target for the treatment of pain; however, little is known about the residues or structural elements that define this activity. In this study, we determined the three-dimensional structure of MfVIA, examined its membrane binding properties, performed alanine-scanning mutagenesis, and identified residues important for its activity at human Na(V)1.8. Asecond round of mutations resulted in (E5K,E8K)MfVIA, a double mutant with greater positive surface charge and greater affinity for lipid membranes compared with MfVIA. This analogue had increased potency at Na(V)1.8 and was analgesic in the mouse formalin assay.	[Deuis, Jennifer R.; Dekan, Zoltan; Inserra, Marco C.; Craik, David J.; Lewis, Richard J.; Alewood, Paul F.; Schroeder, Christina I.; Henriques, Sonia Troeira; Vetter, Irina] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Mobli, Mehdi] Univ Queensland, Ctr Adv Imaging, St Lucia, Qld 4072, Australia; [Deuis, Jennifer R.; Inserra, Marco C.; Vetter, Irina] Univ Queensland, Sch Pharm, Woolloongabba, Qld 4102, Australia; [Lee, Tzong-Hsien; Aguilar, Marie-Isabel] Monash Univ, Dept Biochem & Mol Biol, Wellington Rd, Clayton, Vic 3800, Australia	University of Queensland; University of Queensland; University of Queensland; Monash University	Schroeder, CI; Henriques, ST; Vetter, I (corresponding author), Univ Queensland, Inst Mol Biosci, 306 Carmody Rd,Bldg 80, St Lucia, Qld 4067, Australia.	c.schroeder@imb.uq.edu.au; s.henriques@imb.uq.edu.au; i.vetter@uq.edu.au	Schroeder, Cristina I./K-2042-2014; Vetter, Irina/A-6035-2010; Henriques, Sonia Troeira/J-3500-2016; Craik, David/B-1695-2010; Mobli, Mehdi/O-7244-2014; Lewis, Richard/T-8763-2019; Deuis, Jennifer/R-2440-2017	Schroeder, Cristina I./0000-0002-6737-6374; Vetter, Irina/0000-0002-3594-9588; Henriques, Sonia Troeira/0000-0001-9564-9651; Craik, David/0000-0003-0007-6796; Mobli, Mehdi/0000-0003-2420-4262; Lewis, Richard/0000-0003-3470-923X; Deuis, Jennifer/0000-0002-5107-8938; Alewood, Paul/0000-0001-7454-6522; Dekan, Zoltan/0000-0002-6841-4176	Australian postgraduate award; Australian Future Fellowships [FT130101215, FT10100925]; University of Queensland; National Health and Medical Research Council (NHMRC) [APP1080405]	Australian postgraduate award(Australian Government); Australian Future Fellowships; University of Queensland(University of Queensland); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by an Australian postgraduate award (to J. R. D.), Australian Future Fellowships FT130101215 (to I. V.) and FT10100925 (to M. M.), a University of Queensland early career researcher grant (to I. V.), and National Health and Medical Research Council (NHMRC) Project Grant APP1080405 (to C. I. S., S. T. H., and M. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbadie C, 1997, PAIN, V69, P101, DOI 10.1016/S0304-3959(96)03285-X; Adams DJ, 2003, J BIOL CHEM, V278, P4057, DOI 10.1074/jbc.M209969200; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Blair NT, 2002, J NEUROSCI, V22, P10277; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bulaj G, 2006, BIOCHEMISTRY-US, V45, P7404, DOI 10.1021/bi060159+; Cardoso FC, 2015, MOL PHARMACOL, V88, P291, DOI 10.1124/mol.115.098178; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; CODERRE TJ, 1990, BRAIN RES, V535, P155, DOI 10.1016/0006-8993(90)91835-5; Daly NL, 2004, J BIOL CHEM, V279, P25774, DOI 10.1074/jbc.M313002200; de Araujo AD, 2011, ANGEW CHEM INT EDIT, V50, P6527, DOI 10.1002/anie.201101642; DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711; Deuis JR, 2013, PAIN, V154, P1749, DOI 10.1016/j.pain.2013.05.032; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Ekberg J, 2006, P NATL ACAD SCI USA, V103, P17030, DOI 10.1073/pnas.0601819103; Fukuoka T, 2008, J COMP NEUROL, V510, P188, DOI 10.1002/cne.21786; Gingras J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105895; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hall K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05479; Henriques ST, 2008, BIOPHYS J, V95, P1877, DOI 10.1529/biophysj.108.131458; Henriques ST, 2012, J BIOL CHEM, V287, P33629, DOI 10.1074/jbc.M112.372011; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Henriques ST, 2009, BIOCHEMISTRY-US, V48, P4198, DOI 10.1021/bi900009d; Henriques ST, 2005, BBA-BIOMEMBRANES, V1669, P75, DOI 10.1016/j.bbamem.2004.11.017; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Kerr BJ, 2001, NEUROREPORT, V12, P3077, DOI 10.1097/00001756-200110080-00019; Knapp O, 2012, BRIT J PHARMACOL, V166, P2148, DOI 10.1111/j.1476-5381.2012.01955.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laird JMA, 2002, J NEUROSCI, V22, P8352; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Lee TH, 2015, BBA-BIOMEMBRANES, V1848, P1868, DOI 10.1016/j.bbamem.2015.05.012; Lee TH, 2010, BBA-BIOMEMBRANES, V1798, P1977, DOI 10.1016/j.bbamem.2010.06.023; Leipold E, 2007, CHANNELS, V1, P253, DOI 10.4161/chan.4847; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Liu ZH, 2013, J BIOL CHEM, V288, P20392, DOI 10.1074/jbc.M112.426627; Mashaghi A, 2008, ANAL CHEM, V80, P3666, DOI 10.1021/ac800027s; MCINTOSH JM, 1995, J BIOL CHEM, V270, P16796, DOI 10.1074/jbc.270.28.16796; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Minett MS, 2014, CELL REP, V6, P301, DOI 10.1016/j.celrep.2013.12.033; Nassar MA, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-24; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Prinz Heino, 2010, J Chem Biol, V3, P37, DOI 10.1007/s12154-009-0029-3; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Scanlon MJ, 1997, STRUCTURE, V5, P1585, DOI 10.1016/S0969-2126(97)00307-9; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shields SD, 2012, PAIN, V153, P2017, DOI 10.1016/j.pain.2012.04.022; Torcato IM, 2013, BBA-BIOMEMBRANES, V1828, P944, DOI 10.1016/j.bbamem.2012.12.002; TRIMMER JS, 1990, DEV BIOL, V142, P360, DOI 10.1016/0012-1606(90)90356-N; Vetter I, 2012, BIOCHEM PHARMACOL, V84, P540, DOI 10.1016/j.bcp.2012.05.008; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wilson MJ, 2011, J PHARMACOL EXP THER, V338, P687, DOI 10.1124/jpet.110.178343; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880; Zorn S, 2006, FEBS LETT, V580, P1360, DOI 10.1016/j.febslet.2006.01.057	62	33	34	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11829	11842		10.1074/jbc.M116.721662	http://dx.doi.org/10.1074/jbc.M116.721662			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27026701	Green Published, hybrid			2022-12-28	WOS:000377264800032
J	Ali, SR; Singh, AK; Laezza, F				Ali, Syed R.; Singh, Aditya K.; Laezza, Fernanda			Identification of Amino Acid Residues in Fibroblast Growth Factor 14 (FGF14) Required for Structure-Function Interactions with Voltage-gated Sodium Channel Nav1.6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid; electrophysiology; fibroblast growth factor (FGF); ion channel; protein-protein interaction; FGF14; Nav1; 6; hot spots; split-luciferase assay; voltage-gated sodium channels	FACTOR HOMOLOGOUS FACTOR; PROTEIN-PROTEIN INTERACTIONS; THERAPEUTIC TARGETS; ANTIEPILEPTIC DRUGS; CRYSTAL-STRUCTURE; MODULATION; PHARMACOLOGY; EPILEPSY; COMPLEX; FIBROBLAST-GROWTH-FACTOR-14	The voltage-gated Na+ (Nav) channel provides the basis for electrical excitability in the brain. This channel is regulated by a number of accessory proteins including fibroblast growth factor 14 (FGF14), a member of the intracellular FGF family. In addition to forming homodimers, FGF14 binds directly to the Nav1.6 channel C-tail, regulating channel gating and expression, properties that are required for intrinsic excitability in neurons. Seeking amino acid residues with unique roles at the protein-protein interaction interface (PPI) of FGF14Nav1.6, we engineered model-guided mutations of FGF14 and validated their impact on the FGF14Nav1.6 complex and the FGF14:FGF14 dimer formation using a luciferase assay. Divergence was found in the beta-9 sheet of FGF14 where an alanine (Ala) mutation of Val-160 impaired binding to Nav1.6 but had no effect on FGF14:FGF14 dimer formation. Additional analysis revealed also a key role of residues Lys-74/Ile-76 at the N-terminal of FGF14 in the FGF14Nav1.6 complex and FGF14:FGF14 dimer formation. Using whole-cell patch clamp electrophysiology, we demonstrated that either the FGF14(V160A) or the FGF14(K74A/I76A) mutation was sufficient to abolish the FGF14-dependent regulation of peak transient Na+ currents and the voltage-dependent activation and steady-state inactivation of Nav1.6; but only V160A with a concomitant alanine mutation at Tyr-158 could impede FGF14-dependent modulation of the channel fast inactivation. Intrinsic fluorescence spectroscopy of purified proteins confirmed a stronger binding reduction of FGF14(V160A) to the Nav1.6 C-tail compared with FGF14(K74A/I76A). Altogether these studies indicate that the beta-9 sheet and the N terminus of FGF14 are well positioned targets for drug development of PPI-based allosteric modulators of Nav channels.	[Ali, Syed R.; Singh, Aditya K.; Laezza, Fernanda] Univ Texas Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA; [Ali, Syed R.] Univ Texas Med Branch, Pharmacol & Toxicol Grad Program, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Addict Res Ctr, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Ctr Environm Toxicol, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Laezza, F (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA.	felaezza@utmb.edu	Laezza, Fernanda/X-4076-2019; Laezza, Fernanda/L-6019-2016	Laezza, Fernanda/0000-0003-1141-1852; Laezza, Fernanda/0000-0003-1141-1852; Singh, Aditya/0000-0001-7549-8163	National Institutes of Health from NIGMS (Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia) [R01MH095995, 1 T32 GM089657-04]; John Sealy Memorial Endowment Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM089657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095995] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS (Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia); John Sealy Memorial Endowment Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grants R01MH095995 (to F. L.) and 1 T32 GM089657-04 (to S. R. A.) from NIGMS (a training fellowship from the Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia). This work was also supported by the John Sealy Memorial Endowment Fund (to F. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali S, 2014, CNS NEUROL DISORD-DR, V13, P1559, DOI 10.2174/1871527313666141126103309; Bath KG, 2013, EPILEPSY BEHAV, V26, P427, DOI 10.1016/j.yebeh.2012.10.031; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Chahine M, 2008, CNS NEUROL DISORD-DR, V7, P144, DOI 10.2174/187152708784083830; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Clare JJ, 2000, DRUG DISCOV TODAY, V5, P506, DOI 10.1016/S1359-6446(00)01570-1; Cohen M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000470; Cusdin FS, 2008, TRAFFIC, V9, P17, DOI 10.1111/j.1600-0854.2007.00673.x; Denac H, 2000, N-S ARCH PHARMACOL, V362, P453, DOI 10.1007/s002100000319; Dib-Hajj SD, 2009, PAIN MED, V10, P1260, DOI 10.1111/j.1526-4637.2009.00719.x; Dib-Hajj SD, 2009, BRAIN RES REV, V60, P65, DOI 10.1016/j.brainresrev.2008.12.005; Drendall CI, 2010, PROTEIN EXPRES PURIF, V70, P196, DOI 10.1016/j.pep.2009.12.003; Eijkelkamp N, 2012, BRAIN, V135, P2585, DOI 10.1093/brain/aws225; Emmett MR, 2014, NEUROPSYCHOPHARMACOL, V39, P5, DOI 10.1038/npp.2013.156; Farber NB, 2002, MOL PSYCHIATR, V7, P726, DOI 10.1038/sj.mp.4001087; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Gregoret LM, 1998, FOLD DES, V3, P119, DOI 10.1016/S1359-0278(98)00017-0; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hsu WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117246; Jiang L, 2002, J BIOL CHEM, V277, P37732, DOI 10.1074/jbc.M204514200; Laedermann CJ, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-19; Laezza F, 2009, MOL CELL NEUROSCI, V42, P90, DOI 10.1016/j.mcn.2009.05.007; Lampert A, 2010, PFLUG ARCH EUR J PHY, V460, P249, DOI 10.1007/s00424-009-0779-3; Large CH, 2011, J PHARMACOL EXP THER, V338, P100, DOI 10.1124/jpet.110.178475; Leterrier C, 2010, NEUROSCI LETT, V486, P92, DOI 10.1016/j.neulet.2010.08.079; Liu CJ, 2003, J BIOL CHEM, V278, P1029, DOI 10.1074/jbc.M207074200; Liu CJ, 2001, J BIOL CHEM, V276, P18925, DOI 10.1074/jbc.M101606200; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; Mantegazza M, 2005, P NATL ACAD SCI USA, V102, P18177, DOI 10.1073/pnas.0506818102; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Marban E, 1998, J PHYSIOL-LONDON, V508, P647, DOI 10.1111/j.1469-7793.1998.647bp.x; Moller M, 2002, BIOCHEM MOL BIOL EDU, V30, P175, DOI 10.1002/bmb.2002.494030030035; Mullen SA, 2009, ARCH NEUROL-CHICAGO, V66, P21, DOI 10.1001/archneurol.2008.559; Musa H, 2015, P NATL ACAD SCI USA, V112, P12528, DOI 10.1073/pnas.1516430112; Ochiai K, 2011, FEBS LETT, V585, P1771, DOI 10.1016/j.febslet.2011.05.027; Olsen SK, 2003, J BIOL CHEM, V278, P34226, DOI 10.1074/jbc.M303183200; Papale LA, 2010, J BIOL CHEM, V285, P16553, DOI 10.1074/jbc.M109.090084; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pitteri S, 2010, DIS MARKERS, V28, P233, DOI [10.1155/2010/270859, 10.3233/DMA-2010-0696]; Post RM, 1998, NEUROPSYCHOPHARMACOL, V19, P206, DOI 10.1016/S0893-133X(98)00020-7; Prakriya M, 2000, NEURON, V26, P671, DOI 10.1016/S0896-6273(00)81203-9; Probst V, 2003, J AM COLL CARDIOL, V41, P643, DOI 10.1016/S0735-1097(02)02864-4; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Rodriguez-Murillo L, 2014, NEUROPSYCHOPHARMACOL, V39, P934, DOI 10.1038/npp.2013.293; Rush AM, 2006, EUR J NEUROSCI, V23, P2551, DOI 10.1111/j.1460-9568.2006.04789.x; Savio-Galimberti E, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00124; Schoorlemmer J, 2001, CURR BIOL, V11, P793, DOI 10.1016/S0960-9822(01)00232-9; Shavkunov A, 2012, ASSAY DRUG DEV TECHN, V10, P148, DOI 10.1089/adt.2011.413; Shavkunov AS, 2015, METHODS MOL BIOL, V1278, P497, DOI 10.1007/978-1-4939-2425-7_33; Shavkunov AS, 2013, J BIOL CHEM, V288, P19370, DOI 10.1074/jbc.M112.445924; Stoilova-McPhie S., 2013, AUSTIN J PHARM THER, V1, ppii5; Tang ZL, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0347-1; Teiwes J, 2007, AM J HYPERTENS, V20, P109, DOI 10.1016/j.amjhyper.2006.05.022; Tempia F, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00205; Theile JW, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00054; Tobi D, 2000, PROTEINS, V41, P40, DOI 10.1002/1097-0134(20001001)41:1<40::AID-PROT70>3.0.CO;2-U; van Swieten JC, 2003, AM J HUM GENET, V72, P191, DOI 10.1086/345488; Verbeek EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037384; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 2002, NEURON, V35, P25, DOI 10.1016/S0896-6273(02)00744-4; Wildburger NC, 2015, MOL CELL PROTEOMICS, V14, P1288, DOI 10.1074/mcp.M114.040055; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004; Woods CG, 2015, EUR J HUM GENET, V23, P561, DOI [10.1038/ejhg.2014.166, 10.1038/ejhg.2015.163]; Wright GEB, 2015, CLIN GENET, V88, P342, DOI 10.1111/cge.12652; Xiao ML, 2007, MOL CELL NEUROSCI, V34, P366, DOI 10.1016/j.mcn.2006.11.020; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207	72	22	22	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11268	11284		10.1074/jbc.M115.703868	http://dx.doi.org/10.1074/jbc.M115.703868			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	26994141	Green Published, hybrid			2022-12-28	WOS:000377042100027
J	Garyu, JW; Uduman, M; Stewart, A; Rui, JX; Deng, SY; Shenson, J; Staron, MM; Kaech, SM; Kleinstein, SH; Herold, KC				Garyu, Justin W.; Uduman, Mohamed; Stewart, Alex; Rui, Jinxiu; Deng, Songyan; Shenson, Jared; Staron, Matt M.; Kaech, Susan M.; Kleinstein, Steven H.; Herold, Kevan C.			Characterization of Diabetogenic CD8+T Cells: IMMUNE THERAPY WITH METABOLIC BLOCKADE*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmunity; beta cell (B-cell); immunology; T-cell; type 1 diabetes	CD8(+) T-CELLS; TYPE-1 DIABETES PATIENTS; AVIDITY MATURATION; AEROBIC GLYCOLYSIS; RECENT-ONSET; NOD MICE; EFFECTOR; AUTOIMMUNITY; DIFFERENTIATION; IDENTIFICATION	Type 1 diabetes mellitus is caused by the killing of insulin-producing cells by CD8+T cells. The disease progression, which is chronic, does not follow a course like responses to conventional antigens such as viruses, but accelerates as glucose tolerance deteriorates. To identify the unique features of the autoimmune effectors that may explain this behavior, we analyzed diabetogenic CD8+ T cells that recognize a peptide from the diabetes antigen IGRP (NRP-V7-reactive) in prediabetic NOD mice and compared them to others that shared their phenotype (CD44(+)CD62L(lo)PD-1(+)CXCR3(+)) but negative for diabetes antigen tetramers and to LCMV (lymphocytic choriomeningitis)-reactive CD8+ T cells. There was an increase in the frequency of the NRP-V7-reactive cells coinciding with the time of glucose intolerance. The T cells persisted in hyperglycemic NOD mice maintained with an insulin pellet despite destruction of cells. We compared gene expression in the three groups of cells compared with the other two subsets of cells, and the NRP-V7-reactive cells exhibited gene expression of memory precursor effector cells. They had reduced cellular proliferation and were less dependent on oxidative phosphorylation. When prediabetic NOD mice were treated with 2-deoxyglucose to block aerobic glycolysis, there was a reduction in the diabetes antigen versus other cells of similar phenotype and loss of lymphoid cells infiltrating the islets. In addition, treatment of NOD mice with 2-deoxyglucose resulted in improved cell granularity. These findings identify a link between metabolic disturbances and autoreactive T cells that promotes development of autoimmune diabetes.	[Garyu, Justin W.; Stewart, Alex; Rui, Jinxiu; Deng, Songyan; Shenson, Jared; Staron, Matt M.; Kaech, Susan M.; Kleinstein, Steven H.; Herold, Kevan C.] Yale Univ, Dept Immunobiol, 300 George St,353E, New Haven, CT 06520 USA; [Herold, Kevan C.] Yale Univ, Internal Med, New Haven, CT 06520 USA; [Uduman, Mohamed; Kleinstein, Steven H.] Yale Univ, Interdept Program Computat Biol, New Haven, CT 06520 USA; [Uduman, Mohamed; Kleinstein, Steven H.] Yale Univ, Dept Pathol, New Haven, CT 06520 USA; [Kaech, Susan M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute	Herold, KC (corresponding author), Yale Univ, Dept Immunobiol, 300 George St,353E, New Haven, CT 06520 USA.	kevan.herold@yale.edu		Shenson, Jared/0000-0001-7751-7508; Uduman, Mohamed/0000-0002-9725-0705	National Institutes of Health [R01 DK057846, U01 AI02011, UC4 DK104205]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057846, UC4DK104205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK057846, U01 AI02011, and UC4 DK104205. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akirav EM, 2011, P NATL ACAD SCI USA, V108, P19018, DOI 10.1073/pnas.1111008108; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Campos-Mora M, 2015, IMMUNOL CELL BIOL, V93, P113, DOI 10.1038/icb.2014.77; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chee J, 2014, J IMMUNOL, V192, P572, DOI 10.4049/jimmunol.1302100; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Cui WG, 2014, J IMMUNOL, V192, P4221, DOI 10.4049/jimmunol.1302569; Delmastro-Greenwood MM, 2014, ANTIOXID REDOX SIGN, V20, P2465, DOI 10.1089/ars.2013.5257; Delmastro-Greenwood MM, 2013, ANTIOXID REDOX SIGN, V19, P1902, DOI 10.1089/ars.2012.5167; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Han BY, 2005, J CLIN INVEST, V115, P1879, DOI 10.1172/JCI24219; Herold KC, 2015, J CLIN INVEST, V125, P1163, DOI 10.1172/JCI78142; Herold KC, 2013, NAT REV IMMUNOL, V13, P243, DOI 10.1038/nri3422; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jackson SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110707; Jarchum I, 2008, CLIN IMMUNOL, V127, P359, DOI 10.1016/j.clim.2008.01.015; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Katsuta H, 2012, ENDOCRINOLOGY, V153, P5180, DOI 10.1210/en.2012-1257; Krishnamurthy B, 2008, J IMMUNOL, V180, P4458, DOI 10.4049/jimmunol.180.7.4458; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Lieberman SM, 2004, J IMMUNOL, V173, P6727, DOI 10.4049/jimmunol.173.11.6727; Mallone R, 2007, DIABETES, V56, P613, DOI 10.2337/db06-1419; Martinuzzi E, 2008, DIABETES, V57, P1312, DOI 10.2337/db07-1594; Moore A, 2004, DIABETES, V53, P1459, DOI 10.2337/diabetes.53.6.1459; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Samanta D, 2011, P NATL ACAD SCI USA, V108, P13682, DOI 10.1073/pnas.1110971108; Santamaria P, 2003, ANN NY ACAD SCI, V1005, P88, DOI 10.1196/annals.1288.010; Serreze DV, 2007, ANN NY ACAD SCI, V1103, P103, DOI 10.1196/annals.1394.019; Sherry NA, 2006, DIABETES, V55, P3238, DOI 10.2337/db05-1034; Skowera A, 2015, DIABETES, V64, P916, DOI 10.2337/db14-0332; Standifer NE, 2006, DIABETES, V55, P3061, DOI 10.2337/db06-0066; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Trudeau JD, 2003, J CLIN INVEST, V111, P217, DOI 10.1172/JCI200316409; Unger WWJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049213; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072955	44	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11230	11240		10.1074/jbc.M115.713362	http://dx.doi.org/10.1074/jbc.M115.713362			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	26994137	hybrid, Green Published			2022-12-28	WOS:000377042100024
J	Raynaud, S; Ragel, P; Rojas, T; Merida, A				Raynaud, Sandy; Ragel, Paula; Rojas, Tomas; Merida, Angel			The N-terminal Part of Arabidopsis thaliana Starch Synthase 4 Determines the Localization and Activity of the Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-GLYCOGEN-SYNTHASE; CLASS IV; PURIFICATION; GRANULE; PLANTS; BIOSYNTHESIS; PROTEINS; GLUCOSE; BINDING	Starch synthase 4 (SS4) plays a specific role in starch synthesis because it controls the number of starch granules synthesized in the chloroplast and is involved in the initiation of the starch granule. We showed previously that SS4 interacts with fibrillins 1 and is associated with plastoglobules, suborganelle compartments physically attached to the thylakoid membrane in chloroplasts. Both SS4 localization and its interaction with fibrillins 1 were mediated by the N-terminal part of SS4. Here we show that the coiled-coil region within the N-terminal portion of SS4 is involved in both processes. Elimination of this region prevents SS4 from binding to fibrillins 1 and alters SS4 localization in the chloroplast. We also show that SS4 forms dimers, which depends on a region located between the coiled-coil region and the glycosyltransferase domain of SS4. This region is highly conserved between all SS4 enzymes sequenced to date. We show that the dimerization seems to be necessary for the activity of the enzyme. Both dimerization and the functionality of the coiled-coil region are conserved among SS4 proteins from phylogenetically distant species, such as Arabidopsis and Brachypodium. This finding suggests that the mechanism of action of SS4 is conserved among different plant species.	[Raynaud, Sandy; Ragel, Paula; Rojas, Tomas; Merida, Angel] Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Ave Amer Vespucio 49, Seville 41092, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF)	Merida, A (corresponding author), Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Ave Amer Vespucio 49, Seville 41092, Spain.	angel.merida@csic.es	Berlanga, Ángel Mérida/E-7623-2013; Ragel, Paula/AAA-3374-2021	Berlanga, Ángel Mérida/0000-0002-0880-2329; Ragel, Paula/0000-0002-8698-0833	Secretaria de Estado de Investigacion, Desarrollo e Innovacion [BIO2012-35043]; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia [BIO1180]; European Union-FEDER	Secretaria de Estado de Investigacion, Desarrollo e Innovacion; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia(Junta de Andalucia); European Union-FEDER(European Commission)	This work was funded by grants BIO2012-35043 from the Secretaria de Estado de Investigacion, Desarrollo e Innovacion and BIO1180 from the Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia and the European Union-FEDER. The authors declare that they have no conflicts of interest with the contents of this article.	Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cuesta-Seijo JA, 2013, ACTA CRYSTALLOGR D, V69, P1013, DOI 10.1107/S090744491300440X; D'Hulst C., 2012, SEB ESSENTIAL REV EX, P55; D'Hulst C, 2010, NEW PHYTOL, V188, P13, DOI 10.1111/j.1469-8137.2010.03361.x; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Gamez-Arjona FM, 2014, PLANT J, V80, P305, DOI 10.1111/tpj.12633; Gamez-Arjona FM, 2011, PLANT BIOTECHNOL J, V9, P1049, DOI 10.1111/j.1467-7652.2011.00626.x; Horcajada C, 2006, J BIOL CHEM, V281, P2923, DOI 10.1074/jbc.M507394200; Imparl-Radosevich JM, 1999, FEBS LETT, V457, P357, DOI 10.1016/S0014-5793(99)01066-2; Imparl-Radosevich JM, 1998, ARCH BIOCHEM BIOPHYS, V353, P64, DOI 10.1006/abbi.1998.0613; JETT MF, 1979, J BIOL CHEM, V254, P6739; Leterrier M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-98; Momma M, 2012, BIOSCI BIOTECH BIOCH, V76, P1591, DOI 10.1271/bbb.120305; Moran-Zorzano MT, 2007, FEBS LETT, V581, P4423, DOI 10.1016/j.febslet.2007.08.017; Rohila JS, 2004, PLANT J, V38, P172, DOI 10.1111/j.1365-313X.2004.02031.x; Roldan I, 2007, PLANT J, V49, P492, DOI 10.1111/j.1365-313X.2006.02968.x; Rose A, 2004, CELL MOL LIFE SCI, V61, P1996, DOI 10.1007/s00018-004-4039-6; Santelia D, 2011, CURR OPIN BIOTECH, V22, P271, DOI 10.1016/j.copbio.2010.11.014; Seung D, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002080; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Szydlowski N, 2009, PLANT CELL, V21, P2443, DOI 10.1105/tpc.109.066522; TAKAHARA H, 1978, BIOCHIM BIOPHYS ACTA, V522, P363, DOI 10.1016/0005-2744(78)90070-0; TAKEDA Y, 1975, J BIOL CHEM, V250, P8943; WITITSUWANNAKUL D, 1977, J BIOL CHEM, V252, P7812; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Yuan LX, 2013, PLANT CELL, V25, P974, DOI 10.1105/tpc.112.108027; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301	28	24	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10759	10771		10.1074/jbc.M115.698332	http://dx.doi.org/10.1074/jbc.M115.698332			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26969163	Green Published, hybrid			2022-12-28	WOS:000377042600027
J	Smagris, E; Gilyard, S; BasuRay, S; Cohen, JC; Hobbs, HH				Smagris, Eriks; Gilyard, Shenise; BasuRay, Soumik; Cohen, Jonathan C.; Hobbs, Helen H.			Inactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; SUPERFAMILY MEMBER 2; HEPATOCELLULAR-CARCINOMA; HEPATIC STEATOSIS; CONFERS SUSCEPTIBILITY; WIDE ASSOCIATION; PNPLA3 RS738409; VARIANT; RISK; CHOLESTEROL	A missense mutation (E167K) in TM6SF2 (transmembrane 6 superfamily member 2), a polytopic protein of unknown function, is associated with the full spectrum of fatty liver disease. To investigate the role of TM6SF2 in hepatic triglyceride (TG) metabolism, we inactivated the gene in mice. Chronic inactivation of Tm6sf2 in mice is associated with hepatic steatosis, hypocholesterolemia, and transaminitis, thus recapitulating the phenotype observed in humans. No dietary challenge was required to elicit the phenotype. Immunocytochemical and cell fractionation studies revealed that TM6SF2 was present in the endoplasmic reticulum and Golgi complex, whereas the excess neutral lipids in the Tm6sf2(-/-) mice were located in lipid droplets. Plasma VLDL-TG levels were reduced in the KO animals due to a 3-fold decrease in VLDL-TG secretion rate without any associated reduction in hepatic apoB secretion. Both VLDL particle size and plasma cholesterol levels were significantly reduced in KO mice. Despite levels of TM6SF2 protein being 10-fold higher in the small intestine than in the liver, dietary lipid absorption was only modestly reduced in the KO mice. Our data, taken together, reveal that TM6SF2 is required to mobilize neutral lipids for VLDL assembly but is not required for secretion of apoB-containing lipoproteins. Despite TM6SF2 being located in the endoplasmic reticulum and Golgi complex, the lipids that accumulate in its absence reside in lipid droplets.	[Smagris, Eriks; Gilyard, Shenise; BasuRay, Soumik; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Smagris, Eriks; Gilyard, Shenise; Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cohen, JC; Hobbs, HH (corresponding author), Dept Mol Genet, L5-134,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jonathan.cohen@utsouthwestern.edu; helen.hobbs@utsouthwestern.edu			National Institute of Health [PO1 HL20948, R01 DK090066]; American Liver Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090066] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Liver Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health Grants PO1 HL20948 and R01 DK090066. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by a postdoctoral research fellowship award from the American Liver Foundation.	ACTON SL, 1994, J BIOL CHEM, V269, P21003; Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; Browning JD, 2004, AM J GASTROENTEROL, V99, P292, DOI 10.1111/j.1572-0241.2004.04059.x; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Buch S, 2015, NAT GENET, V47, P1443, DOI 10.1038/ng.3417; Burza MA, 2014, LIVER INT, V34, P514, DOI 10.1111/liv.12310; Chen WQ, 2010, HEPATOLOGY, V52, P1134, DOI 10.1002/hep.23812; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Dongiovanni P, 2015, HEPATOLOGY, V61, P506, DOI 10.1002/hep.27490; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Engelking LJ, 2012, J LIPID RES, V53, P1359, DOI 10.1194/jlr.M027599; Falleti E, 2016, DIGEST LIVER DIS, V48, P69, DOI 10.1016/j.dld.2015.09.009; Falleti E, 2011, LIVER INT, V31, P1137, DOI 10.1111/j.1478-3231.2011.02534.x; Fan YB, 2016, GASTROENTEROLOGY, V150, P1208, DOI 10.1053/j.gastro.2016.01.005; FISHER RM, 1995, CLIN CHIM ACTA, V236, P7, DOI 10.1016/0009-8981(95)06032-3; FOLCH J, 1957, J BIOL CHEM, V226, P497; Goffredo M, 2016, HEPATOLOGY, V63, P117, DOI 10.1002/hep.28283; Guan HP, 2009, J BIOL CHEM, V284, P24644, DOI 10.1074/jbc.M109.034397; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Holmen OL, 2014, NAT GENET, V46, P345, DOI 10.1038/ng.2926; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Jones C, 2007, J CLIN INVEST, V117, P165, DOI 10.1172/JCI29415; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Li JZ, 2012, J CLIN INVEST, V122, P4130, DOI 10.1172/JCI65179; Li ZQ, 2015, GASTROENTEROLOGY, V149, P1519, DOI 10.1053/j.gastro.2015.07.012; LIN MCM, 1994, J BIOL CHEM, V269, P29138; Liu YL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5309; Manchekar M, 2015, J BIOL CHEM, V290, P8196, DOI 10.1074/jbc.M114.602748; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Nischalke HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027087; Okazaki H, 2010, J BIOL CHEM, V285, P6801, DOI 10.1074/jbc.M109.079459; Ouguerram K, 2012, ARTERIOSCL THROM VAS, V32, P1520, DOI 10.1161/ATVBAHA.112.245076; Phillips MC, 2013, J LIPID RES, V54, P2034, DOI 10.1194/jlr.R034025; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rong X, 2015, ELIFE, V4, DOI 10.7554/eLife.06557; Sanchez-Pulido L, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00439; Schumacher MM, 2015, ELIFE, V4, DOI [10.7554/eLife.05560, 10.7554/eLife.04490]; Smagris E, 2015, HEPATOLOGY, V61, P108, DOI 10.1002/hep.27242; Sookoian S, 2015, HEPATOLOGY, V61, P515, DOI 10.1002/hep.27556; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Trepo E, 2014, HEPATOLOGY, V59, P2170, DOI 10.1002/hep.26767; Vitale N, 1998, P NATL ACAD SCI USA, V95, P8613, DOI 10.1073/pnas.95.15.8613; Wang J, 2015, J LIPID RES, V56, P319, DOI 10.1194/jlr.M054544; Wang Y, 2015, P NATL ACAD SCI USA, V112, P11630, DOI 10.1073/pnas.1515374112; Wang Y, 2015, J LIPID RES, V56, P1296, DOI 10.1194/jlr.M054882; WETTERAU JR, 1992, SCIENCE, V258, P999; Yao ZM, 2013, CURR OPIN LIPIDOL, V24, P160, DOI 10.1097/MOL.0b013e32835aebe7	57	125	127	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10659	10676		10.1074/jbc.M116.719955	http://dx.doi.org/10.1074/jbc.M116.719955			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27013658	Green Published, hybrid			2022-12-28	WOS:000377042600019
J	Liu, CP; Stonestrom, AJ; Christian, T; Yong, J; Takase, R; Hou, YM; Yang, XL				Liu, Cuiping; Stonestrom, Aaron J.; Christian, Thomas; Yong, Jeongsik; Takase, Ryuichi; Hou, Ya-Ming; Yang, Xiaolu			Molecular Basis and Consequences of the Cytochrome c-tRNA Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; TERTIARY INTERACTION; CASPASE ACTIVATION; QUALITY-CONTROL; CCA ADDITION; AMINOACYLATION; APOPTOSIS; RECOGNITION; SYNTHETASES; MECHANISMS	The intrinsic apoptosis pathway occurs through the release of mitochondrial cytochrome c to the cytosol, where it promotes activation of the caspase family of proteases. The observation that tRNA binds to cytochrome c revealed a previously unexpected mode of apoptotic regulation. However, the molecular characteristics of this interaction, and its impact on each interaction partner, are not well understood. Using a novel fluorescence assay, we show here that cytochrome c binds to tRNA with an affinity comparable with other tRNA-protein binding interactions and with a molecular ratio of similar to 3:1. Cytochrome c recognizes the tertiary structural features of tRNA, particularly in the core region. This binding is independent of the charging state of tRNA but is regulated by the redox state of cytochrome c. Compared with reduced cytochrome c, oxidized cytochrome c binds to tRNA with a weaker affinity, which correlates with its stronger pro-apoptotic activity. tRNA binding both facilitates cytochrome c reduction and inhibits the peroxidase activity of cytochrome c, which is involved in its release from mitochondria. Together, these findings provide new insights into the cytochrome c-tRNA interaction and apoptotic regulation.	[Liu, Cuiping; Christian, Thomas; Takase, Ryuichi; Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Stonestrom, Aaron J.; Yang, Xiaolu] Univ Penn, Dept Canc Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Stonestrom, Aaron J.; Yang, Xiaolu] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yong, Jeongsik] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Jefferson University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Minnesota System; University of Minnesota Twin Cities	Hou, YM (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.; Yang, XL (corresponding author), Univ Penn, Dept Canc Biol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Yang, XL (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.	ya-ming.hou@jefferson.edu; xyang@mail.med.upenn.edu		Takase, Ryuichi/0000-0002-7423-9407; Stonestrom, Aaron/0000-0002-0602-1158	National Institutes of Health [R01 GM081601, U01 GM108972, R01 GM114343, R01 GM060911, R21 CA178581]; United States Department of Defense Grant [W81XWH-13-1-0446]; NATIONAL CANCER INSTITUTE [R21CA178581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM108972, R01GM060911, R01GM114343, R01GM081601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense Grant(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01 GM081601, U01 GM108972, and R01 GM114343 (to Y.M.H.), R01 GM060911, and R21 CA178581 and United States Department of Defense Grant W81XWH-13-1-0446 (to X.Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Betteridge T, 2007, RNA, V13, P1594, DOI 10.1261/rna.475407; Borutaite V, 2007, J BIOL CHEM, V282, P31124, DOI 10.1074/jbc.M700322200; Chang HY, 2000, MICROBIOL MOL BIOL R, V64, P821, DOI 10.1128/MMBR.64.4.821-846.2000; Christian T, 2000, J MOL BIOL, V303, P503, DOI 10.1006/jmbi.2000.4169; Degen WGJ, 2000, CELL DEATH DIFFER, V7, P616, DOI 10.1038/sj.cdd.4400672; Dupasquier M, 2008, J MOL BIOL, V379, P579, DOI 10.1016/j.jmb.2008.04.005; Giege R, 2008, NAT STRUCT MOL BIOL, V15, P1007, DOI 10.1038/nsmb.1498; Hamann CS, 2000, J MOL BIOL, V295, P777, DOI 10.1006/jmbi.1999.3353; Hamann CS, 1997, BIOCHEMISTRY-US, V36, P7967, DOI 10.1021/bi970517w; Hauenstein S, 2004, NAT STRUCT MOL BIOL, V11, P1134, DOI 10.1038/nsmb849; Hauenstein SI, 2008, J BIOL CHEM, V283, P21997, DOI 10.1074/jbc.M801838200; Hou YM, 2013, ANTIOXID REDOX SIGN, V19, P583, DOI 10.1089/ars.2012.5171; HOU YM, 1994, BIOCHEMISTRY-US, V33, P4677, DOI 10.1021/bi00181a603; HOU YM, 1993, P NATL ACAD SCI USA, V90, P6776, DOI 10.1073/pnas.90.14.6776; Igarashi T, 2011, J MOL BIOL, V414, P28, DOI 10.1016/j.jmb.2011.09.036; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Keilin D, 1925, P R SOC LOND B-CONTA, V98, P312, DOI 10.1098/rspb.1925.0039; Kim HE, 2008, MOL CELL, V30, P239, DOI 10.1016/j.molcel.2008.03.014; Kim S, 2009, RNA, V15, P1827, DOI 10.1261/rna.1669109; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu CP, 2007, J MOL BIOL, V367, P1063, DOI 10.1016/j.jmb.2007.01.050; Liu CP, 2012, RNA, V18, P213, DOI 10.1261/rna.029983.111; Liu CP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1331; Liu CP, 2009, METHOD ENZYMOL, V469, P69, DOI 10.1016/S0076-6879(09)69004-2; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Mak J, 1997, J VIROL, V71, P8087, DOI 10.1128/JVI.71.11.8087-8095.1997; Mei YD, 2010, PROTEIN CELL, V1, P795, DOI 10.1007/s13238-010-0107-x; Mei YD, 2010, CELL CYCLE, V9, P2936, DOI 10.4161/cc.9.15.12316; Mei YD, 2010, MOL CELL, V37, P668, DOI 10.1016/j.molcel.2010.01.023; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Saikia M, 2014, MOL CELL BIOL, V34, P2450, DOI 10.1128/MCB.00136-14; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Slater EC, 2003, J BIOL CHEM, V278, P16455, DOI 10.1074/jbc.X200011200; Suryanarayana T, 2012, MOL BIOL REP, V39, P9187, DOI 10.1007/s11033-012-1791-9; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Yamashita S, 2014, STRUCTURE, V22, P315, DOI 10.1016/j.str.2013.12.002; Yuan JY, 2006, MOL CELL, V23, P1, DOI 10.1016/j.molcel.2006.06.008; Zhang CM, 2006, J MOL BIOL, V361, P300, DOI 10.1016/j.jmb.2006.06.015; Zhang CM, 2005, BIOCHEMISTRY-US, V44, P7240, DOI 10.1021/bi050285y; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	52	13	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10426	10436		10.1074/jbc.M115.697789	http://dx.doi.org/10.1074/jbc.M115.697789			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26961879	hybrid, Green Published			2022-12-28	WOS:000375602800046
J	Ou, Y; Chan, G; Zuo, J; Rattner, JB; van der Hoorn, FA				Ou, Young; Chan, Gordon; Zuo, Jeremy; Rattner, Jerome B.; van der Hoorn, Frans A.			Purinergic A2b Receptor Activation by Extracellular Cues Affects Positioning of the Centrosome and Nucleus and Causes Reduced Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A(2B) ADENOSINE RECEPTORS; ACUTE LUNG INJURY; NEURONAL MIGRATION; EXCHANGE FACTOR; DROSOPHILA EYE; SUBCELLULAR-LOCALIZATION; NERVOUS-SYSTEM; CYCLIC-AMP; DYNEIN; RAP1B	The tight, relative positioning of the nucleus and centrosome in mammalian cells is important for the regulation of cell migration. Under pathophysiological conditions, the purinergic A2b receptor can regulate cell motility, but the underlying mechanism remains unknown. Expression of A2b, normally low, is increased in tissues experiencing adverse physiological conditions, including hypoxia and inflammation. ATP is released from such cells. We investigated whether extracellular cues can regulate centrosome-nucleus positioning and cell migration. We discovered that hypoxia as well as extracellular ATP cause a reversible increase in the distance between the centrosome and nucleus and reduced cell motility. We uncovered the underlying pathway: both treatments act through the A2b receptor and specifically activate the Epac1/RapGef3 pathway. We show that cells lacking A2b do not respond in this manner to hypoxia or ATP but transfection of A2b restores this response, that Epac1 is critically involved, and that Rap1B is important for the relative positioning of the centrosome and nucleus. Our results represent, to our knowledge, the first report demonstrating that pathophysiological conditions can impact the distance between the centrosome and nucleus. Furthermore, we identify the A2b receptor as a central player in this process.	[Ou, Young; Zuo, Jeremy; van der Hoorn, Frans A.] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Rattner, Jerome B.] Univ Calgary, Cumming Sch Med, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Chan, Gordon] Univ Alberta, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Chan, Gordon] Univ Alberta, Canc Res Inst Northern Alberta, Edmonton, AB T6G 1Z2, Canada	University of Calgary; University of Calgary; University of Alberta; University of Alberta	van der Hoorn, FA (corresponding author), Cumming Sch Med, Dept Biochem & Mol Biol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	fvdhoorn@ucalgary.ca	Chan, Gordon/AAN-7784-2020	Chan, Gordon/0000-0003-0497-9407	Canadian Institutes of Health Research Grant [MOP 111008]; Alberta Innovates - Health Solutions	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Alberta Innovates - Health Solutions	This work was supported by Canadian Institutes of Health Research Grant MOP 111008 (to F. A. V. D. H.) and a summer studentship from Alberta Innovates - Health Solutions (to J. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Agircan FG, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0461; Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Archambault V, 2008, GENE DEV, V22, P2707, DOI 10.1101/gad.486808; Archambault V, 2007, PLOS GENET, V3, P2163, DOI 10.1371/journal.pgen.0030200; Archambault V, 2012, CELL CYCLE, V11, P1490, DOI 10.4161/cc.19724; Awasthi A, 2010, J EXP MED, V207, P1923, DOI 10.1084/jem.20100040; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Brock TG, 2008, EXP CELL RES, V314, P255, DOI 10.1016/j.yexcr.2007.10.011; Brugerolle G, 2003, PROTOPLASMA, V222, P13, DOI 10.1007/s00709-003-0016-4; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Burakov AV, 2013, CELL BIOL INT, V37, P95, DOI 10.1002/cbin.10016; Burnstock G, 2014, EXP PHYSIOL, V99, P16, DOI 10.1113/expphysiol.2013.071951; Carmona G, 2009, BLOOD, V113, P488, DOI 10.1182/blood-2008-02-138438; Cauwels A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.70; Chouker A, 2012, TRANSPLANTATION, V94, P894, DOI 10.1097/TP.0b013e31826a9a46; Chrzanowska-Wodnicka M, 2008, BLOOD, V111, P2647, DOI 10.1182/blood-2007-08-109710; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Dale N, 2009, CURR NEUROPHARMACOL, V7, P160, DOI 10.2174/157015909789152146; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dobyns W B, 1987, Birth Defects Orig Artic Ser, V23, P225; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Edwards HV, 2012, SEMIN CELL DEV BIOL, V23, P181, DOI 10.1016/j.semcdb.2011.09.005; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Fitzgerald C, 2006, J BIOL CHEM, V281, P38172, DOI 10.1074/jbc.M606010200; Fredholm BB, 2001, BIOCHEM PHARMACOL, V61, P443, DOI 10.1016/S0006-2952(00)00570-0; Frick JS, 2009, J IMMUNOL, V182, P4957, DOI 10.4049/jimmunol.0801324; Gloerich M, 2011, J CELL BIOL, V193, P1009, DOI 10.1083/jcb.201011126; Grenz A, 2012, J CLIN INVEST, V122, P693, DOI 10.1172/JCI60214; Gundersen GG, 2013, CELL, V152, P1376, DOI 10.1016/j.cell.2013.02.031; Gupta M, 2005, J BIOL CHEM, V280, P8109, DOI 10.1074/jbc.M413697200; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Jodoin JN, 2012, MOL BIOL CELL, V23, P4713, DOI 10.1091/mbc.E12-07-0558; Kim YC, 2000, J MED CHEM, V43, P1165, DOI 10.1021/jm990421v; KLINZ FJ, 1992, EUR J BIOCHEM, V207, P207, DOI 10.1111/j.1432-1033.1992.tb17039.x; Kracklauer MP, 2007, FLY, V1, P75, DOI 10.4161/fly.4254; Li AH, 1998, J MED CHEM, V41, P3186, DOI 10.1021/jm980093j; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin KT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6917; Luxton GWG, 2011, CURR OPIN CELL BIOL, V23, P579, DOI 10.1016/j.ceb.2011.08.001; Luxton GWG, 2011, NUCLEUS-PHILA, V2, P173, DOI [10.4161/nucl.2.3.16243, 10.1073/pnas.1000824108]; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; Manneville JB, 2006, BIOL CELL, V98, P557, DOI 10.1042/BC20060017; Marshall J, 2011, METHODS MOL BIOL, V769, P97, DOI 10.1007/978-1-61779-207-6_8; Melani A, 2012, EXP NEUROL, V233, P193, DOI 10.1016/j.expneurol.2011.09.036; Mitra RS, 2003, ONCOGENE, V22, P6243, DOI 10.1038/sj.onc.1206534; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Muller CE, 1998, BIOORGAN MED CHEM, V6, P707, DOI 10.1016/S0968-0896(98)00025-X; Nakagawa S, 2014, AM J PHYSIOL-RENAL, V307, pF1404, DOI 10.1152/ajprenal.00196.2014; Ntantie E, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003374; Ou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048773; Ou YY, 2002, J CELL SCI, V115, P1825; Patterson K, 2004, MOL BIOL CELL, V15, P600, DOI 10.1091/mbc.E03-06-0374; Ponsioen B, 2009, MOL CELL BIOL, V29, P2521, DOI 10.1128/MCB.01630-08; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; SEMENZA GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI DOI 10.1016/J.BBAMCR.2015.05.036; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; SNYDER M, 1994, CHROMOSOMA, V103, P369, DOI 10.1007/BF00362281; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Splinter D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000350; Steininger TS, 2011, BRAIN RES, V1407, P1, DOI 10.1016/j.brainres.2011.06.050; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; TOMLINSON A, 1986, SCIENCE, V231, P400, DOI 10.1126/science.231.4736.400; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; van Hooren KWEM, 2012, J BIOL CHEM, V287, P24713, DOI 10.1074/jbc.M111.321976; Wakai A, 2001, SHOCK, V15, P297, DOI 10.1097/00024382-200115040-00008; Weyler S, 2006, CHEMMEDCHEM, V1, P891, DOI 10.1002/200600066; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Wittchen Erika S, 2011, Small GTPases, V2, P65; Xaus J, 1999, J IMMUNOL, V162, P3607; Yamada M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3033; Yan JL, 2008, MOL CELL BIOL, V28, P5803, DOI 10.1128/MCB.00393-08; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Yang Y, 2015, ONCOL REP, V34, P2385, DOI 10.3892/or.2015.4234; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zhu J, 2010, MOL BIOL CELL, V21, P4418, DOI 10.1091/mbc.E10-07-0627; Zocchi C, 1996, J PHARMACOL EXP THER, V276, P398	90	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15388	15403		10.1074/jbc.M116.721241	http://dx.doi.org/10.1074/jbc.M116.721241			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226580	Green Published, hybrid			2022-12-28	WOS:000380583200042
J	Gross, SM; Rotwein, P				Gross, Sean M.; Rotwein, Peter			Unraveling Growth Factor Signaling and Cell Cycle Progression in Individual Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; cell proliferation; cell signaling; growth factor; signal transduction	RESTRICTION POINT; NEGATIVE REGULATORS; DNA-SYNTHESIS; PROLIFERATION; DYNAMICS; RECEPTOR; DISTINCT; INSULIN; PROTEIN; PHASES	Cultured cells require the actions of growth factors to enter the cell cycle, but how individual members of a population respond to the same stimulus remains unknown. Here we have employed continuous monitoring by live cell imaging in a dual-reporter cell model to investigate the regulation of short-term growth factor signaling (protein kinase B (PKB/Akt) activity) and longer-term progression through the cell cycle (cyclin-dependent kinase 2 activity). In the total population, insulin-like growth factor-I (IGF-I)-enhanced cell cycle entry by >5-fold compared with serum-free medium (from 13.5 to 78%), but at the single cell level we observed a broad distribution in the timing of G1 exit (4-24 h, mean approximate to 12 h) that did not vary with either the amount or duration of IGF-I treatment. Cells that failed to re-enter the cell cycle exhibited similar responses to IGF-I in terms of integrated Akt activity and migration distance compared with those that did. We made similar observations with EGF, PDGF-AA, and PDGF-BB. As potential thresholds of growth factor-mediated cell cycle progression appeared to be heterogeneous within the population, the longer-term proliferative outcomes of individual cells to growth factor stimulation could not be predicted based solely on acute Akt signaling responses, no matter how robust these might be. Thus, although we could define a relationship at the population level between growth factor-induced Akt signaling dynamics and cell cycle progression, we could not predict the fate of individual cells.	[Gross, Sean M.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Rotwein, Peter] Texas Tech Hlth Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci, 5001 El Paso Dr, El Paso, TX 79905 USA	Oregon Health & Science University	Rotwein, P (corresponding author), Texas Tech Hlth Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci, 5001 El Paso Dr, El Paso, TX 79905 USA.	peter.rotwein@ttuhsc.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	National Institutes of Health [R01 DK042748-26]; NATIONAL CANCER INSTITUTE [T32CA106195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by National Institutes of Health research grant, R01 DK042748-26 (to P. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barr AR, 2016, CELL SYST, V2, P27, DOI 10.1016/j.cels.2016.01.001; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Gross SM, 2016, J CELL SCI, V129, P2052, DOI 10.1242/jcs.183764; Gross SM, 2015, J CELL SCI, V128, P2509, DOI 10.1242/jcs.168773; Gross SM, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-10; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Jones SM, 2001, FEBS LETT, V490, P110, DOI 10.1016/S0014-5793(01)02113-5; Lemmon MA, 2016, CELL, V164, P1172, DOI 10.1016/j.cell.2016.02.047; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mulvihill MJ, 2009, FUTURE MED CHEM, V1, P1153, DOI 10.4155/FMC.09.89; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Overton KW, 2014, P NATL ACAD SCI USA, V111, pE4386, DOI 10.1073/pnas.1409797111; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; PLEDGER WJ, 1978, P NATL ACAD SCI USA, V75, P2839, DOI 10.1073/pnas.75.6.2839; PLEDGER WJ, 1977, P NATL ACAD SCI USA, V74, P4481, DOI 10.1073/pnas.74.10.4481; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; STILES CD, 1979, P NATL ACAD SCI USA, V76, P1279, DOI 10.1073/pnas.76.3.1279; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Yuan X, 2014, MOL BIOL CELL, V25, P441, DOI 10.1091/mbc.E13-08-0480; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; Zwang YR, 2011, MOL CELL, V42, P524, DOI 10.1016/j.molcel.2011.04.017	30	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14628	14638		10.1074/jbc.M116.734194	http://dx.doi.org/10.1074/jbc.M116.734194			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226630	Green Published, hybrid			2022-12-28	WOS:000380366700019
J	Knyphausen, P; de Boor, S; Kuhlmann, N; Scislowski, L; Extra, A; Baldus, L; Schacherl, M; Baumann, U; Neundorf, I; Lammers, M				Knyphausen, Philipp; de Boor, Susanne; Kuhlmann, Nora; Scislowski, Lukas; Extra, Antje; Baldus, Linda; Schacherl, Magdalena; Baumann, Ulrich; Neundorf, Ines; Lammers, Michael			Insights into Lysine Deacetylation of Natively Folded Substrate Proteins by Sirtuins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; GTPase; p53; sirtuin; synthetic biology	STRUCTURAL BASIS; SIRT3-MEDIATED DEACETYLATION; HISTONE DEACETYLASES; STRUCTURE VALIDATION; COREPRESSOR COMPLEX; DIFFRACTION DATA; TRANSGENIC MICE; DRUG TARGET; DNA-BINDING; ADP-RIBOSE	Sirtuins are NAD(+)-dependent lysine deacylases, regulating a variety of cellular processes. The nuclear Sirt1, the cytosolic Sirt2, and the mitochondrial Sirt3 are robust deacetylases, whereas the other sirtuins have preferences for longer acyl chains. Most previous studies investigated sirtuin-catalyzed deacylation on peptide substrates only. We used the genetic code expansion concept to produce natively folded, site-specific, and lysine-acetylated Sirt1-3 substrate proteins, namely Ras-related nuclear, p53, PEPCK1, superoxide dismutase, cyclophilin D, and Hsp10, and analyzed the deacetylation reaction. Some acetylated proteins such as Ras-related nuclear, p53, and Hsp10 were robustly deacetylated by Sirt1-3. However, other reported sirtuin substrate proteins such as cyclophilin D, superoxide dismutase, and PEPCK1 were not deacetylated. Using a structural and functional approach, we describe the ability of Sirt1-3 to deacetylate two adjacent acetylated lysine residues. The dynamics of this process have implications for the lifetime of acetyl modifications on di-lysine acetylation sites and thus constitute a new mechanism for the regulation of proteins by acetylation. Our studies support that, besides the primary sequence context, the protein structure is a major determinant of sirtuin substrate specificity.	[Knyphausen, Philipp; de Boor, Susanne; Kuhlmann, Nora; Scislowski, Lukas; Extra, Antje; Baldus, Linda; Lammers, Michael] Univ Cologne, Inst Genet, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Knyphausen, Philipp; de Boor, Susanne; Kuhlmann, Nora; Scislowski, Lukas; Extra, Antje; Baldus, Linda; Lammers, Michael] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Schacherl, Magdalena; Baumann, Ulrich; Neundorf, Ines] Univ Cologne, Inst Biochem, Zulpicher Str 47b, D-50674 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	Lammers, M (corresponding author), Univ Cologne, Inst Genet, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.; Lammers, M (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.	michael.lammers@uni-koeln.de	Baumann, Ulrich/B-1220-2013; Schacherl, Magdalena/AAT-6362-2021; Schacherl, Magdalena/M-1590-2014; Lammers, Michael/AAX-1164-2020	Schacherl, Magdalena/0000-0002-5478-2509; Schacherl, Magdalena/0000-0002-5478-2509; Lammers, Michael/0000-0003-4168-4640; Neundorf, Ines/0000-0001-6450-3991	Emmy Noether Programme of the German Research Foundation (Deutsche Forschungsgemeinschaft) [LA2984-1/1]; European Community [283570]; International Graduate School in Development Health and Disease	Emmy Noether Programme of the German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); European Community(European Commission); International Graduate School in Development Health and Disease	This work was supported in part by Emmy Noether Programme of the German Research Foundation (Deutsche Forschungsgemeinschaft) Grant LA2984-1/1 and by European Community's Seventh Framework Programme FP7/2007-2013b by Grant 283570 (BioStruct-X). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the International Graduate School in Development Health and Disease.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Anderson G, 2014, MOL NEUROBIOL, V49, P771, DOI 10.1007/s12035-013-8554-z; Arbely E, 2011, P NATL ACAD SCI USA, V108, P8251, DOI 10.1073/pnas.1105028108; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Baur JA, 2010, SCIENCE, V329, P1012, DOI 10.1126/science.329.5995.1012; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Braidy N, 2012, CURR OPIN PSYCHIATR, V25, P226, DOI 10.1097/YCO.0b013e32835112c1; Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; Case CL, 2007, BBA-GEN SUBJECTS, V1770, P1576, DOI 10.1016/j.bbagen.2007.07.012; Chakraborty C, 2013, CURR DRUG TARGETS, V14, P666, DOI 10.2174/1389450111314060008; Chalkiadaki A, 2015, NAT REV CANCER, V15, DOI 10.1038/nrc3985; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dan L, 2012, HAEMATOL-HEMATOL J, V97, P551, DOI 10.3324/haematol.2011.055236; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Boor S, 2015, P NATL ACAD SCI USA, V112, pE3679, DOI 10.1073/pnas.1505995112; DeLano W.L, PYMOL MOL GRAPHICS S; Denu JM, 2012, J BIOL CHEM, V287, P42417, DOI 10.1074/jbc.R112.428862; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Dittenhafer-Reed KE, 2011, CHEMBIOCHEM, V12, P281, DOI 10.1002/cbic.201000434; Donadini A, 2013, CURR DRUG TARGETS, V14, P653, DOI 10.2174/1389450111314060006; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Feldman JL, 2015, BIOCHEMISTRY-US, V54, P3037, DOI 10.1021/acs.biochem.5b00150; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Frazzi R, 2013, INT J CANCER, V132, P1013, DOI 10.1002/ijc.27748; Gertz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049761; Nguyen GTT, 2013, ACTA CRYSTALLOGR D, V69, P1423, DOI 10.1107/S0907444913015448; Gnad F, 2010, BIOINFORMATICS, V26, P1666, DOI 10.1093/bioinformatics/btq260; Goldenson B, 2015, ONCOGENE, V34, P537, DOI 10.1038/onc.2014.14; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guarente L, 2012, NAT REV MOL CELL BIO, V13, P207, DOI 10.1038/nrm3308; Gurard-Levin ZA, 2010, ACS CHEM BIOL, V5, P863, DOI 10.1021/cb100088g; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Hirsch BM, 2011, MOL BIOSYST, V7, P16, DOI 10.1039/c0mb00033g; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Imai SI, 2010, PHARMACOL RES, V62, P42, DOI 10.1016/j.phrs.2010.01.006; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; IVY JM, 1986, MOL CELL BIOL, V6, P688, DOI 10.1128/MCB.6.2.688; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kelly RDW, 2013, BIOCHEM SOC T, V41, P741, DOI 10.1042/BST20130010; Khan AN, 2005, J BIOL CHEM, V280, P36073, DOI 10.1074/jbc.M508247200; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Knyphausen Philipp, 2015, Small GTPases, V6, P189, DOI 10.1080/21541248.2015.1103399; Kuhlmann N, 2016, J BIOL CHEM, V291, P5484, DOI 10.1074/jbc.M115.707091; Kuhlmann N, 2016, BIOCHEMISTRY-US, V55, P304, DOI 10.1021/acs.biochem.5b01242; Landry SJ, 1997, BIOCHEMISTRY-US, V36, P10975, DOI 10.1021/bi971141p; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Lu ZP, 2015, J BIOL CHEM, V290, P2466, DOI 10.1074/jbc.M114.606228; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Marmorstein R, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018762; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Montgomery DC, 2014, J AM CHEM SOC, V136, P8669, DOI 10.1021/ja502372j; Morimoto J, 2012, ANGEW CHEM INT EDIT, V51, P3423, DOI 10.1002/anie.201108118; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakagawa Takashi, 2014, Cell Metab, V20, P192, DOI 10.1016/j.cmet.2014.06.001; Nishida Y, 2015, MOL CELL, V59, P321, DOI 10.1016/j.molcel.2015.05.022; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Rauh D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3327; Reed SM, 2015, CANCERS, V7, P30, DOI 10.3390/cancers7010030; RINE J, 1987, GENETICS, V116, P9; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Simic Z, 2015, CHEMBIOCHEM, V16, P2337, DOI 10.1002/cbic.201500364; Sinclair DA, 2014, ANNU REV PHARMACOL, V54, P363, DOI 10.1146/annurev-pharmtox-010611-134657; Smith BC, 2008, CHEM BIOL, V15, P1002, DOI 10.1016/j.chembiol.2008.09.009; Smith BC, 2007, J BIOL CHEM, V282, P37256, DOI 10.1074/jbc.M707878200; Smith BC, 2006, STRUCTURE, V14, P1207, DOI 10.1016/j.str.2006.07.004; Smith BC, 2011, ACS CHEM BIOL, V6, P146, DOI 10.1021/cb100218d; Suzuki T, 2009, BIOORG MED CHEM LETT, V19, P5670, DOI 10.1016/j.bmcl.2009.08.028; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Weinert BT, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134766; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Winnik S, 2015, EUR HEART J, V36, P3404, DOI 10.1093/eurheartj/ehv290; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yamagata K, 2014, STRUCTURE, V22, P345, DOI 10.1016/j.str.2013.12.001; Yang SH, 2001, MOL CELL BIOL, V21, P2802, DOI 10.1128/MCB.21.8.2802-2814.2001; Yang T, 2012, J BIOL CHEM, V287, P40279, DOI 10.1074/jbc.M112.349704; Yuan H, 2012, J BIOL CHEM, V287, P42428, DOI 10.1074/jbc.R112.372300; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang ZN, 2014, STEM CELLS, V32, P157, DOI 10.1002/stem.1532; Zhao KH, 2003, STRUCTURE, V11, P1403, DOI 10.1016/j.str.2003.09.016	110	31	33	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14677	14694		10.1074/jbc.M116.726307	http://dx.doi.org/10.1074/jbc.M116.726307			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226597	Green Published, hybrid			2022-12-28	WOS:000380366700022
J	Linde, M; Peterhoff, D; Sterner, R; Babinger, P				Linde, Mona; Peterhoff, David; Sterner, Reinhard; Babinger, Patrick			Identification and Characterization of Heptaprenylglyceryl Phosphate Processing Enzymes in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); acetyltransferase; enzyme; lipid ether; phosphatase; maltose	ESCHERICHIA-COLI; ACYL MIGRATION; SUBSTRATE-SPECIFICITY; BIOSYNTHESIS; ARCHAEA; BACTERIA; MALTOSE; ACETYLTRANSFERASE; ACYLTRANSFERASES; TRANSACETYLASE	In Archaea, ether lipids play an essential role as the main building blocks of the cellular membrane. Recently, ether lipids have also been discovered in the domain of Bacteria, and the key enzymes that catalyze their synthesis, glycerol-1-phosphate dehydrogenase and heptaprenylglyceryl phosphate synthase, have been described. In Bacillales, heptaprenylglyceryl phosphate does not become linked to a second polyprenyl moiety like ether lipids in Archaea but is dephosphorylated and acetylated. Here, we report on the enzymes that catalyze these reactions. We enriched the phosphatase activity from a B. subtilis cell extract and suppose that dephosphorylation is catalyzed by the phosphatase PhoB or by any other phosphatase in an unspecific manner. By screening a B. subtilis knock-out library for deficiency in acetylation, the yvoF gene product was identified to be the acetyltransferase. The acetyl-CoA-dependent enzyme YvoF is a close relative of maltose O-acetyltransferase (MAT). Its catalytic properties were analyzed and compared with MAT. YvoF and MAT partially overlap in substrate and product range in vitro, but MAT is not able to complement the yvoF knock-out in vivo.	[Linde, Mona; Peterhoff, David; Sterner, Reinhard; Babinger, Patrick] Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany; [Peterhoff, David] Univ Regensburg, Inst Med Microbiol & Hyg, D-93042 Regensburg, Germany	University of Regensburg; University of Regensburg	Babinger, P (corresponding author), Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany.	patrick.babinger@ur.de	Sterner, Reinhard/ABI-6781-2020; Peterhoff, David/ABD-6746-2020	Sterner, Reinhard/0000-0001-8177-8460; Babinger, Patrick/0000-0002-7490-6732	Deutsche Forschungsgemeinschaft [BA 3943/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Research Grant BA 3943/2-1 from the Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Fattah WR, 2005, J BACTERIOL, V187, P5166, DOI 10.1128/JB.187.15.5166-5178.2005; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOOS W, 1981, J BACTERIOL, V146, P725, DOI 10.1128/JB.146.2.725-732.1981; BRAND B, 1991, J BIOL CHEM, V266, P14113; Doud EH, 2011, J AM CHEM SOC, V133, P1270, DOI 10.1021/ja109578b; Fischer E, 1920, BER DTSCH CHEM GES, V53, P1621, DOI 10.1002/cber.19200530904; Galinier A, 1998, P NATL ACAD SCI USA, V95, P1823, DOI 10.1073/pnas.95.4.1823; Glansdorff N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-29; Guldan H, 2008, BIOCHEMISTRY-US, V47, P7376, DOI 10.1021/bi8005779; Guldan H, 2011, ANGEW CHEM INT EDIT, V50, P8188, DOI 10.1002/anie.201101832; HULETT FM, 1991, J BIOL CHEM, V266, P1077; Jain S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00641; Kates M., 1986, TECHNIQUES LIPIDOLOG, V2nd; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; KODALI DR, 1990, CHEM PHYS LIPIDS, V52, P163, DOI 10.1016/0009-3084(90)90111-4; Koga Y, 2007, MICROBIOL MOL BIOL R, V71, P97, DOI 10.1128/MMBR.00033-06; Koga Y, 2011, J MOL EVOL, V72, P274, DOI 10.1007/s00239-011-9428-5; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Lo Leggio L, 2003, BIOCHEMISTRY-US, V42, P5225, DOI 10.1021/bi0271446; Lombard J, 2012, ARCHAEA, V2012, DOI 10.1155/2012/630910; Lombard J, 2012, NAT REV MICROBIOL, V10, P507, DOI 10.1038/nrmicro2815; Lyubachevskaya G, 2000, LIPIDS, V35, P1353, DOI 10.1007/s11745-000-0652-5; Payandeh J, 2007, J MOL EVOL, V64, P364, DOI 10.1007/s00239-006-0141-8; Pereto J, 2004, TRENDS BIOCHEM SCI, V29, P469, DOI 10.1016/j.tibs.2004.07.002; Peterhoff D, 2014, MOL MICROBIOL, V92, P885, DOI 10.1111/mmi.12596; Peterhoff D, 2012, CHEMBIOCHEM, V13, P1297, DOI 10.1002/cbic.201200127; Ren FF, 2013, CHEMBIOCHEM, V14, P195, DOI 10.1002/cbic.201200748; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Roderick SL, 2005, CR BIOL, V328, P568, DOI 10.1016/j.crvi.2005.03.005; STECK T L, 1973, Journal of Supramolecular Structure, V1, P220, DOI 10.1002/jss.400010307; Turon F, 2003, CHEM PHYS LIPIDS, V125, P41, DOI 10.1016/S0009-3084(03)00069-0; VUORIO R, 1994, FEBS LETT, V337, P289, DOI 10.1016/0014-5793(94)80211-4; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; ZABIN I, 1962, J BIOL CHEM, V237, P253; ZHANG DL, 1993, J AM CHEM SOC, V115, P1270, DOI 10.1021/ja00057a008	36	5	5	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14861	14870		10.1074/jbc.M115.711994	http://dx.doi.org/10.1074/jbc.M115.711994			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226549	Green Published, hybrid			2022-12-28	WOS:000380366700037
J	Gangalum, RK; Bhat, AM; Kohan, SA; Bhat, SP				Gangalum, Rajendra K.; Bhat, Ankur M.; Kohan, Sirus A.; Bhat, Suraj P.			Inhibition of the Expression of the Small Heat Shock Protein alpha B-Crystallin Inhibits Exosome Secretion in Human Retinal Pigment Epithelial Cells in Culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING OCULAR LENS; PLASMA-MEMBRANE; BIOGENESIS; COMPARTMENTS; TRAFFICKING; DISEASE; ALIX	Exosomes carry cell type-specific molecular cargo to extracellular destinations and therefore act as lateral vectors of intercellular communication and transfer of genetic information from one cell to the other. We have shown previously that the small heat shock protein alpha B-crystallin (alpha B) is exported out of the adult human retinal pigment epithelial cells (ARPE19) packaged in exosomes. Here, we demonstrate that inhibition of the expression of alpha B via shRNA inhibits exosome secretion from ARPE19 cells indicating that exosomal cargo may have a role in exosome biogenesis (synthesis and/or secretion). Sucrose density gradient fractionation of the culture medium and cellular extracts suggests continued synthesis of exosomes but an inhibition of exosome secretion. In cells where alpha B expression was inhibited, the distribution of CD63 (LAMP3), an exosome marker, is markedly altered from the normal dispersed pattern to a stacked perinuclear presence. Interestingly, the total anti-CD63(LAMP3) immunofluorescence in the native and alpha B-inhibited cells remains unchanged suggesting continued exosome synthesis under conditions of impaired exosome secretion. Importantly, inhibition of the expression of alpha B results in a phenotype of the RPE cell that contains an increased number of vacuoles and enlarged (fused) vesicles that show increased presence of CD63(LAMP3) and LAMP1 indicating enhancement of the endolysosomal compartment. This is further corroborated by increased Rab7 labeling of this compartment (Rab-GTPase 7 is known to be associated with late endosome maturation). These data collectively point to a regulatory role for alpha B in exosome biogenesis possibly via its involvement at a branch point in the endocytic pathway that facilitates secretion of exosomes.	[Gangalum, Rajendra K.; Bhat, Ankur M.; Bhat, Suraj P.] UCLA, Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Bhat, Suraj P.] UCLA, Inst Mol Biol, Los Angeles, CA 90095 USA; [Kohan, Sirus A.; Bhat, Suraj P.] UCLA, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bhat, SP (corresponding author), UCLA, Geffen Sch Med, 100 Stein Plaza, Los Angeles, CA 90095 USA.	bhat@jsei.ucla.edu	; Gangalum, Rajendra K/H-1369-2013	Bhat, Suraj P/0000-0003-4707-5870; Gangalum, Rajendra K/0000-0002-8746-0266	NEI, National Institutes of Health [1R01EY024929]; Gerald Oppenheimer Family Foundation for the Prevention of Eye Disease Endowment Fund; NATIONAL EYE INSTITUTE [P30EY000331, R01EY024929] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Gerald Oppenheimer Family Foundation for the Prevention of Eye Disease Endowment Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NEI, National Institutes of Health grant 1R01EY024929 (to S. P. B.) and the Gerald Oppenheimer Family Foundation for the Prevention of Eye Disease Endowment Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alge CS, 2002, INVEST OPHTH VIS SCI, V43, P3575; An EY, 2008, MOL VIS, V14, P2292; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Bhat SP, 2003, PROG DRUG RES, V60, P205; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bhat Suraj P, 2011, Commun Integr Biol, V4, P739; BOK D, 1985, INVEST OPHTH VIS SCI, V26, P1659; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Brinton LT, 2015, CELL MOL LIFE SCI, V72, P659, DOI 10.1007/s00018-014-1764-3; Bsibsi M, 2014, ACTA NEUROPATHOL, V128, P215, DOI 10.1007/s00401-014-1317-8; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cobb BA, 2000, J BIOL CHEM, V275, P6664, DOI 10.1074/jbc.275.9.6664; D'Antonio M, 2006, GLIA, V53, P501, DOI 10.1002/glia.20309; De S, 2007, ARCH OPHTHALMOL-CHIC, V125, P641, DOI 10.1001/archopht.125.5.641; Duran JM, 2012, EMBO J, V31, P4535, DOI 10.1038/emboj.2012.317; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Fuhrmann S, 2014, EXP EYE RES, V123, P141, DOI 10.1016/j.exer.2013.09.003; Gangalum RK, 2012, J BIOL CHEM, V287, P42407, DOI 10.1074/jbc.M112.414854; Gangalum RK, 2011, J BIOL CHEM, V286, P3261, DOI 10.1074/jbc.M110.160135; Gangalum RK, 2009, INVEST OPHTH VIS SCI, V50, P3283, DOI 10.1167/iovs.08-3052; Gangalum RK, 2004, J BIOL CHEM, V279, P43374, DOI 10.1074/jbc.C400371200; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; Hurley JH, 2012, NAT CELL BIOL, V14, P654, DOI 10.1038/ncb2530; Jing Z, 2013, CELL STRESS CHAPERON, V18, P377, DOI 10.1007/s12192-012-0386-7; Keller P, 1997, J CELL SCI, V110, P3001; KIBBELAAR MA, 1979, EXP EYE RES, V29, P679, DOI 10.1016/0014-4835(79)90024-1; Kobayashi T, 2000, MOL BIOL CELL, V11, P1829, DOI 10.1091/mbc.11.5.1829; KOK JW, 1990, EUR J CELL BIOL, V53, P173; Lobert VH, 2011, PHYSIOLOGY, V26, P171, DOI 10.1152/physiol.00054.2010; Manjithaya R, 2011, TRENDS CELL BIOL, V21, P67, DOI 10.1016/j.tcb.2010.09.009; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; NAGINENI CN, 1989, FEBS LETT, V249, P89, DOI 10.1016/0014-5793(89)80022-5; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Perrett RM, 2015, MOL CELL NEUROSCI, V66, P21, DOI 10.1016/j.mcn.2015.02.009; Persson S, 2009, J NEUROSCI METH, V184, P42, DOI 10.1016/j.jneumeth.2009.07.017; Robinson DG, 2014, TRENDS PLANT SCI, V19, P134, DOI 10.1016/j.tplants.2013.10.008; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Segev N, 2011, SEMIN CELL DEV BIOL, V22, P33, DOI 10.1016/j.semcdb.2010.11.005; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Tagliaferro P, 2015, NEUROBIOL DIS, V82, P359, DOI 10.1016/j.nbd.2015.07.009; Villarroya-Beltri C, 2014, SEMIN CANCER BIOL, V28, P3, DOI 10.1016/j.semcancer.2014.04.009; Yang JM, 2013, BIOCHEM SOC T, V41, P277, DOI 10.1042/BST20120275; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang M, 2013, SCIENCE, V340, P559, DOI 10.1126/science.1234740; Zhu H, 2013, MOL BIOL CELL, V24, P1619, DOI 10.1091/mbc.E12-07-0544	47	26	31	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					12930	12942		10.1074/jbc.M115.698530	http://dx.doi.org/10.1074/jbc.M115.698530			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129211	Green Published, hybrid			2022-12-28	WOS:000379770500004
J	Wang, X; Liu, L				Wang, Xiao; Liu, Lin			Crystal Structure and Catalytic Mechanism of 7-Hydroxymethyl Chlorophyll a Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; STRUCTURE REFINEMENT; OXYGENASE CAO; BIOSYNTHESIS; DEGRADATION; CONVERSION; GREEN; PROTEIN; IDENTIFICATION; BREAKDOWN	7-Hydroxymethyl chlorophyll a reductase (HCAR) catalyzes the second half-reaction in chlorophyll b to chlorophyll a conversion. HCAR is required for the degradation of light-harvesting complexes and is necessary for efficient photosynthesis by balancing the chlorophyll a/b ratio. Reduction of the hydroxymethyl group uses redox cofactors [4Fe-4S] cluster and FAD to transfer electrons and is difficult because of the strong carbon-oxygen bond. Here, we report the crystal structure of Arabidopsis HCAR at 2.7-angstrom resolution and reveal that two [4Fe-4S] clusters and one FAD within a very short distance form a consecutive electron pathway to the substrate pocket. In vitro kinetic analysis confirms the ferredoxin-dependent electron transport chain, thus supporting a proton-activated electron transfer mechanism. HCAR resembles a partial reconstruction of an archaeal F-420-reducing [NiFe] hydrogenase, which suggests a common mode of efficient proton-coupled electron transfer through conserved cofactor arrangements. Furthermore, the trimeric form of HCAR provides a biological clue of its interaction with light-harvesting complex II.	[Wang, Xiao; Liu, Lin] Chinese Acad Sci, Inst Bot, CAS Ctr Excellence Mol Plant Sci, Key Lab Photobiol, 20 Nanxincun, Beijing 100093, Peoples R China; [Wang, Xiao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, L (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Mol Plant Sci, Key Lab Photobiol, Inst Bot, 20 Nanxincun, Beijing 100093, Peoples R China.	liulin@ibcas.ac.cn			National Basic Research Program of China [2011CBA00901]; National Natural Science Foundation of China [31370759]; Chinese Academy of Sciences [KGZD-EW-T05]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China Grant 2011CBA00901, National Natural Science Foundation of China Grant 31370759, and Key Research Program Grant KGZD-EW-T05 from the Chinese Academy of Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Allegretti M, 2014, ELIFE, V3, DOI 10.7554/eLife.01963; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Belevich I, 2006, NATURE, V440, P829, DOI 10.1038/nature04619; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espineda CE, 1999, P NATL ACAD SCI USA, V96, P10507, DOI 10.1073/pnas.96.18.10507; Folly P, 1999, J BIOL CHEM, V274, P21811, DOI 10.1074/jbc.274.31.21811; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Hortensteiner S, 2011, BBA-BIOENERGETICS, V1807, P977, DOI 10.1016/j.bbabio.2010.12.007; HOLT AS, 1959, PLANT PHYSIOL, V34, P310, DOI 10.1104/pp.34.3.310; Horie Y, 2009, J BIOL CHEM, V284, P17449, DOI 10.1074/jbc.M109.008912; Islam MR, 2008, PLANT PHYSIOL, V148, P1068, DOI 10.1104/pp.108.123117; Ito H, 1996, J BIOL CHEM, V271, P1475, DOI 10.1074/jbc.271.3.1475; Ito H, 2008, J BIOL CHEM, V283, P9002, DOI 10.1074/jbc.M708369200; Ito H, 2014, PLANT CELL PHYSIOL, V55, P593, DOI 10.1093/pcp/pct203; Kunkel A, 1998, EUR J BIOCHEM, V252, P467, DOI 10.1046/j.1432-1327.1998.2520467.x; Kunugi M, 2013, J BIOL CHEM, V288, P19330, DOI 10.1074/jbc.M113.462663; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Liu ZF, 2011, J BACTERIOL, V193, P4996, DOI 10.1128/JB.05520-11; Meguro M, 2011, PLANT CELL, V23, P3442, DOI 10.1105/tpc.111.089714; Migliore A, 2014, CHEM REV, V114, P3381, DOI 10.1021/cr4006654; Mills DJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00218; Mochizuki N, 2010, TRENDS PLANT SCI, V15, P488, DOI 10.1016/j.tplants.2010.05.012; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Peters JW, 2015, BBA-MOL CELL RES, V1853, P1350, DOI 10.1016/j.bbamcr.2014.11.021; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Pryor KD, 1997, PROTEIN EXPRES PURIF, V10, P309, DOI 10.1006/prep.1997.0759; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rudiger W, 2002, PHOTOSYNTH RES, V74, P187, DOI 10.1023/A:1020959610952; Sakuraba Y, 2013, BIOCHEM BIOPH RES CO, V430, P32, DOI 10.1016/j.bbrc.2012.11.050; Sakuraba Y, 2012, PLANT CELL, V24, P507, DOI 10.1105/tpc.111.089474; Saunders AH, 2013, BIOCHEMISTRY-US, V52, P8442, DOI 10.1021/bi401172b; Shimoda Y, 2012, PLANT J, V72, P501, DOI 10.1111/j.1365-313X.2012.05095.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tanaka R, 2011, BBA-BIOENERGETICS, V1807, P968, DOI 10.1016/j.bbabio.2011.01.002; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103; Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vitt S, 2014, J MOL BIOL, V426, P2813, DOI 10.1016/j.jmb.2014.05.024; Weinberg DR, 2012, CHEM REV, V112, P4016, DOI 10.1021/cr200177j	54	16	16	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13349	13359		10.1074/jbc.M116.720342	http://dx.doi.org/10.1074/jbc.M116.720342			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27072131	hybrid, Green Published			2022-12-28	WOS:000379770500036
J	Dasgupta, T; Antony, J; Braithwaite, AW; Horsfield, JA				Dasgupta, Tanushree; Antony, Jisha; Braithwaite, Antony W.; Horsfield, Julia A.			HDAC8 Inhibition Blocks SMC3 Deacetylation and Delays Cell Cycle Progression without Affecting Cohesin-dependent Transcription in MCF7 Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-LANGE-SYNDROME; GENE-EXPRESSION; MUTATIONS; ACETYLATION; COMPLEX; CORNELIA; ESTABLISHMENT; RESISTANCE; UNDERLIE; PATHWAYS	Cohesin, a multi-subunit protein complex involved in chromosome organization, is frequently mutated or aberrantly expressed in cancer. Multiple functions of cohesin, including cell division and gene expression, highlight its potential as a novel therapeutic target. The SMC3 subunit of cohesin is acetylated (ac) during S phase to establish cohesion between replicated chromosomes. Following anaphase, ac-SMC3 is deacetylated by HDAC8. Reversal of SMC3 acetylation is imperative for recycling cohesin so that it can be reloaded in interphase for both non-mitotic and mitotic functions. We blocked deacetylation of ac-SMC3 using an HDAC8-specific inhibitor PCI-34051 in MCF7 breast cancer cells, and examined the effects on transcription of cohesin-dependent genes that respond to estrogen. HDAC8 inhibition led to accumulation of ac-SMC3 as expected, but surprisingly, had no influence on the transcription of estrogen-responsive genes that are altered by siRNA targeting of RAD21 or SMC3. Knockdown of RAD21 altered estrogen receptor alpha (ER) recruitment at SOX4 and IL20, and affected transcription of these genes, while HDAC8 inhibition did not. Rather, inhibition of HDAC8 delayed cell cycle progression, suppressed proliferation and induced apoptosis in a concentration-dependent manner. We conclude that HDAC8 inhibition does not change the estrogen-specific transcriptional role of cohesin in MCF7 cells, but instead, compromises cell cycle progression and cell survival. Our results argue that candidate inhibitors of cohesin function may differ in their effects depending on the cellular genotype and should be thoroughly tested for predicted effects on cohesin's mechanistic roles.	[Dasgupta, Tanushree; Antony, Jisha; Braithwaite, Antony W.; Horsfield, Julia A.] Univ Otago, Dunedin Sch Med, Dept Pathol, POB 913, Dunedin 9016, New Zealand; [Braithwaite, Antony W.; Horsfield, Julia A.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand	University of Otago; University of Auckland	Horsfield, JA (corresponding author), Univ Otago, Dunedin Sch Med, Dept Pathol, POB 913, Dunedin 9016, New Zealand.	julia.horsfield@otago.ac.nz	Horsfield, Julia A/B-5091-2012	Horsfield, Julia A/0000-0002-9536-7790	Genesis Oncology Trust; Cancer Society of New Zealand [11-18]; Health Research Council of NZ (HRC) [10-873, 15-229]; HRC [13-61, 14-219, 15-500]	Genesis Oncology Trust; Cancer Society of New Zealand; Health Research Council of NZ (HRC); HRC	This work was supported by Genesis Oncology Trust, Cancer Society of New Zealand (11-18), and Health Research Council of NZ (HRC) (10-873, 15-229) grants (to J. A. H.), along with HRC Grants 13-61, 14-219, and 15-500) (to A. W. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Antony J., 2014, BIOCHIM BIOPHYS ACTA, V24; Atienza JM, 2005, MOL CANCER THER, V4, P361; Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Borges V, 2010, MOL CELL, V39, P677, DOI 10.1016/j.molcel.2010.08.009; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Ha SD, 2014, J IMMUNOL, V193, P1333, DOI 10.4049/jimmunol.1400420; Horsfield Julia A., 2012, Frontiers in Genetics, V3, P171, DOI 10.3389/fgene.2012.00171; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kaiser FJ, 2014, HUM MOL GENET, V23, P2888, DOI 10.1093/hmg/ddu002; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Leeke B, 2014, EXP HEMATOL ONCOL, V3, DOI 10.1186/2162-3619-3-13; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Lopez G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133302; Losada A, 2014, NAT REV CANCER, V14, P389, DOI 10.1038/nrc3743; Mannini L, 2013, HUM MUTAT, V34, P1589, DOI 10.1002/humu.22430; Marsman J, 2014, BBA-GENE REGUL MECH, V1839, P50, DOI 10.1016/j.bbagrm.2013.11.007; Mazumdar C, 2015, CELL STEM CELL, V17, P1, DOI 10.1016/j.stem.2015.09.017; McEwan MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049160; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Mullenders J, 2015, J EXP MED, V212, P1833, DOI 10.1084/jem.20151323; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Olson DE, 2014, ACS CHEM BIOL, V9, P2210, DOI 10.1021/cb500492r; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Qi J, 2015, CELL STEM CELL, V17, P597, DOI 10.1016/j.stem.2015.08.004; Remeseiro S, 2013, DEVELOPMENT, V140, P3715, DOI 10.1242/dev.090605; Remeseiro S, 2013, CURR OPIN CELL BIOL, V25, P63, DOI 10.1016/j.ceb.2012.10.013; Rhodes JM, 2011, MOL CANCER RES, V9, P1587, DOI 10.1158/1541-7786.MCR-11-0382; Rhodes JM, 2010, DEV BIOL, V344, P637, DOI 10.1016/j.ydbio.2010.05.493; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Scholz C, 2015, NAT BIOTECHNOL, V33, P415, DOI 10.1038/nbt.3130; Schuster K, 2015, HUM MOL GENET, V24, P7005, DOI 10.1093/hmg/ddv402; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Sleiman SF, 2014, J NEUROSCI, V34, P14328, DOI 10.1523/JNEUROSCI.1010-14.2014; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Solomon DA, 2014, BMB REP, V47, P299, DOI 10.5483/BMBRep.2014.47.6.092; Thol F, 2014, BLOOD, V123, P914, DOI 10.1182/blood-2013-07-518746; Thota S, 2014, BLOOD, V124, P1790, DOI 10.1182/blood-2014-04-567057; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Viny AD, 2015, J EXP MED, V212, P1819, DOI 10.1084/jem.20151317; Wang C, 2014, AM J NUCL MED MOLEC, V4, P29; Xiong B, 2010, CURR BIOL, V20, P1660, DOI 10.1016/j.cub.2010.08.019; Xu HL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2814; Yuan B, 2015, J CLIN INVEST, V125, P636, DOI 10.1172/JCI77435; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	47	35	36	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12761	12770		10.1074/jbc.M115.704627	http://dx.doi.org/10.1074/jbc.M115.704627			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27072133	Green Published, hybrid			2022-12-28	WOS:000378119900028
J	Shao, Q; Lindstrom, K; Shi, RY; Kelly, J; Schroeder, A; Juusola, J; Levine, KL; Esseltine, JL; Penuela, S; Jackson, MF; Laird, DW				Shao, Qing; Lindstrom, Kristin; Shi, Ruoyang; Kelly, John; Schroeder, Audrey; Juusola, Jane; Levine, Kara L.; Esseltine, Jessica L.; Penuela, Silvia; Jackson, Michael F.; Laird, Dale W.			A Germline Variant in the PANX1 Gene Has Reduced Channel Function and Is Associated with Multisystem Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANNEXIN 1 CHANNELS; GAP-JUNCTION HEMICHANNELS; ATP RELEASE; INTERLEUKIN-1-BETA RELEASE; CONNEXIN HEMICHANNELS; HEARING-LOSS; ACTIVATION; PERMEABILITY; TRAFFICKING; MEMBRANE	Pannexin1 (PANX1) is probably best understood as an ATP release channel involved in paracrine signaling. Given its ubiquitous expression, PANX1 pathogenic variants would be expected to lead to disorders involving multiple organ systems. Using whole exome sequencing, we discovered the first patient with a homozygous PANX1 variant (c.650G -> A) resulting in an arginine to histidine substitution at position 217 (p.Arg217His). The 17-year-old female has intellectual disability, sensorineural hearing loss requiring bilateral cochlear implants, skeletal defects, including kyphoscoliosis, and primary ovarian failure. Her consanguineous parents are each heterozygous for this variant but are not affected by the multiorgan syndromes noted in the proband. Expression of the p.Arg217His mutant in HeLa, N2A, HEK293T, and Ad293 cells revealed normal PANX1 glycosylation and cell surface trafficking. Dye uptake, ATP release, and electrophysiological measurements revealed p.Arg217His to be a loss-of-function variant. Co-expression of the mutant with wild-type PANX1 suggested the mutant was not dominant-negative to PANX1 channel function. Collectively, we demonstrate a PANX1 missense change associated with human disease in the first report of a "PANX1-related disorder."	[Shao, Qing; Kelly, John; Esseltine, Jessica L.; Penuela, Silvia; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada; [Lindstrom, Kristin] Phoenix Childrens Hosp, Div Genet & Metab, Phoenix, AZ 85016 USA; [Shi, Ruoyang; Jackson, Michael F.] Univ Manitoba, Dept Pharmacol & Therapeut, Winnipeg, MB R3E 0Z3, Canada; [Shi, Ruoyang; Jackson, Michael F.] Kleysen Inst Adv Med, Hlth Sci Ctr, Winnipeg, MB R3E 0Z3, Canada; [Schroeder, Audrey] Univ Rochester, Med Ctr, Div Genet, Rochester, NY 14642 USA; [Juusola, Jane; Levine, Kara L.] GeneDx, Gaithersburg, MD 20877 USA	Western University (University of Western Ontario); Phoenix Children's Hospital; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Rochester	Laird, DW (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada.	dale.laird@schulich.uwo.ca	Esseltine, Jessica/F-5178-2017; Laird, Dale W/AAL-2407-2020; Penuela, Silvia/A-6961-2010	Esseltine, Jessica/0000-0002-0770-2334; Laird, Dale W/0000-0002-4568-3285; Penuela, Silvia/0000-0003-4829-5517; Kelly, John Joseph/0000-0002-3626-8629	Canadian Institutes of Health Research [130530, 125901]; Research Manitoba	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Research Manitoba	This work was supported in part by Canadian Institutes of Health Research Grants 130530 (to D. W. L. and S. P.) and 125901 (to M. F. J.). The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a postdoctoral fellowship from Research Manitoba.	Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; Bao BA, 2012, J BIOL CHEM, V287, P8407, DOI 10.1074/jbc.M111.306522; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Bargiotas P, 2011, P NATL ACAD SCI USA, V108, P20772, DOI 10.1073/pnas.1018262108; Benfenati V, 2009, CHANNELS, V3, P323, DOI 10.4161/chan.3.5.9568; Billaud M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005824; Boassa D, 2008, CELL COMMUN ADHES, V15, P119, DOI 10.1080/15419060802013885; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bond SR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00058; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bunse S, 2011, J MEMBRANE BIOL, V244, P21, DOI 10.1007/s00232-011-9393-3; Carlen PL, 2012, BRAIN RES, V1487, P54, DOI 10.1016/j.brainres.2012.06.059; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen F, 2015, INVEST OPHTH VIS SCI, V56, P544, DOI 10.1167/iovs.14-15204; Chen J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10762; Dahl G, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0191; Dubyak GR, 2009, AM J PHYSIOL-CELL PH, V296, pC235, DOI 10.1152/ajpcell.00639.2008; Gauthier J, 2011, HUM GENET, V130, P563, DOI 10.1007/s00439-011-0975-z; Gehi R, 2011, J BIOL CHEM, V286, P27639, DOI 10.1074/jbc.M111.260711; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Hansen DB, 2014, J BIOL CHEM, V289, P26058, DOI 10.1074/jbc.M114.582155; Jung SJ, 2015, FEBS LETT, V589, P822, DOI 10.1016/j.febslet.2015.02.015; Kalcheva N, 2007, P NATL ACAD SCI USA, V104, P20512, DOI 10.1073/pnas.0705472105; Kurtenbach S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00263; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Laird DW, 2014, FEBS LETT, V588, P1339, DOI 10.1016/j.febslet.2013.12.022; Lohman AW, 2014, FEBS LETT, V588, P1379, DOI 10.1016/j.febslet.2014.02.004; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; Molica F, 2015, THROMB HAEMOSTASIS, V114, P325, DOI 10.1160/TH14-11-0981; Moon PM, 2015, J MOL MED, V93, P845, DOI 10.1007/s00109-015-1311-1; Mylvaganam S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00172; Orellana JA, 2011, J NEUROCHEM, V118, P826, DOI 10.1111/j.1471-4159.2011.07210.x; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2008, CELL COMMUN ADHES, V15, P133, DOI 10.1080/15419060802014115; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2014, BIOCHEM J, V461, P371, DOI 10.1042/BJ20140447; Penuela S, 2014, J INVEST DERMATOL, V134, P2026, DOI 10.1038/jid.2014.86; Penuela S, 2014, FEBS LETT, V588, P1411, DOI 10.1016/j.febslet.2014.01.028; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Penuela S, 2012, J BIOL CHEM, V287, P29184, DOI 10.1074/jbc.M112.377176; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Prochnow N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051767; Romanov RA, 2012, J CELL SCI, V125, P5514, DOI 10.1242/jcs.111062; Rudenko G, 2001, TRENDS BIOCHEM SCI, V26, P363, DOI 10.1016/S0968-0004(01)01832-1; Saez JC, 2014, FEBS LETT, V588, P1205, DOI 10.1016/j.febslet.2014.03.004; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Sarrouilhe D, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00078; Scemes E, 2012, NEUROCHEM RES, V37, P2310, DOI 10.1007/s11064-012-0759-4; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Seror C, 2011, J EXP MED, V208, P1823, DOI 10.1084/jem.20101805; Sheckler LR, 2006, J BIOL CHEM, V281, P22896, DOI 10.1074/jbc.M603464200; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Stewart MKG, 2013, BIOCHEM J, V449, P401, DOI 10.1042/BJ20121070; Tanaka AJ, 2015, AM J HUM GENET, V97, P457, DOI 10.1016/j.ajhg.2015.07.014; Tanaka H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019411; Tang WX, 2008, NEUROREPORT, V19, P1253, DOI 10.1097/WNR.0b013e32830891f5; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Thompson RJ, 2015, J PHYSIOL-LONDON, V593, P3463, DOI 10.1113/jphysiol.2014.282426; Turmel P, 2011, MOL REPROD DEV, V78, P124, DOI 10.1002/mrd.21280; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Wang J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005392; Wang XH, 2009, J COMP NEUROL, V512, P336, DOI 10.1002/cne.21898; Wicki-Stordeur LE, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-11; Zadeh AD, 2009, J PHYSIOL-LONDON, V587, P4565, DOI 10.1113/jphysiol.2009.178442; Zhao HB, 2015, BIOCHEM BIOPH RES CO, V463, P143, DOI 10.1016/j.bbrc.2015.05.049	71	47	49	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12432	12443		10.1074/jbc.M116.717934	http://dx.doi.org/10.1074/jbc.M116.717934			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129271	Green Published, hybrid			2022-12-28	WOS:000378119900001
J	Zhao, D; Ma, G; Zhang, XL; He, Y; Li, M; Han, XY; Fu, LY; Dong, XY; Nagy, T; Zhao, Q; Fu, L; Dong, JT				Zhao, Dan; Ma, Gui; Zhang, Xiaolin; He, Yuan; Li, Mei; Han, Xueying; Fu, Liya; Dong, Xue-Yuan; Nagy, Tamas; Zhao, Qiang; Fu, Li; Dong, Jin-Tang			Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN GENE PROMOTER; BREAST-CANCER; GLAND DEVELOPMENT; EPITHELIAL-CELLS; HOMEOBOX GENES; RECEPTOR GENE; GROWTH-HORMONE; MESSENGER-RNA; UP-REGULATION; FACTOR ATBF1	The zinc finger homeobox 3 (ZFHX3, also named ATBF1 for AT motif binding factor 1) is a transcription factor that suppresses prostatic carcinogenesis and induces neuronal differentiation. It also interacts with estrogen receptor alpha to inhibit cell proliferation and regulate pubertal mammary gland development in mice. In the present study, we examined whether and how Zfhx3 regulates lactogenic differentiation in mouse mammary glands. At different stages of mammary gland development, Zfhx3 protein was expressed at varying levels, with the highest level at lactation. In the HC11 mouse mammary epithelial cell line, an in vitro model of lactogenesis, knockdown of Zfhx3 attenuated prolactin-induced beta-casein expression and morphological changes, indicators of lactogenic differentiation. In mouse mammary tissue, knock-out of Zfhx3 interrupted lactogenesis, resulting in underdeveloped glands with much smaller and fewer alveoli, reduced beta-casein expression, accumulation of large cytoplasmic lipid droplets in luminal cells after parturition, and failure in lactation. Mechanistically, Zfhx3 maintained the expression of Prlr (prolactin receptor) and Prlr-Jak2-Stat5 signaling activity, whereas knockdown and knock-out of Zfhx3 in HC11 cells and mammary tissues, respectively, decreased Prlr expression, Stat5 phosphorylation, and the expression of Prlr-Jak2-Stat5 target genes. These findings indicate that Zfhx3 plays an essential role in proper lactogenic development in mammary glands, at least in part by maintaining Prlr expression and Prlr-Jak2-Stat5 signaling activity.	[Zhao, Dan; Ma, Gui; Zhang, Xiaolin; He, Yuan; Han, Xueying; Fu, Liya; Zhao, Qiang; Dong, Jin-Tang] Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Tianjin 300071, Peoples R China; [Li, Mei] Ningbo Inst Med Sci, Ningbo 315020, Zhejiang, Peoples R China; [Dong, Xue-Yuan; Dong, Jin-Tang] Emory Univ, Winship Canc Inst, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Nagy, Tamas] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Fu, Li] Tianjin Med Univ, Canc Hosp, Tianjin 300060, Peoples R China	Nankai University; Emory University; University System of Georgia; University of Georgia; Tianjin Medical University	Dong, JT (corresponding author), Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Tianjin 300071, Peoples R China.; Dong, JT (corresponding author), Emory Univ, Winship Canc Inst, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.	j.dong@emory.edu	Zhao, Dan/Y-8065-2019	Zhao, Dan/0000-0002-5120-6725; Dong, Jin-Tang/0000-0003-2349-5782	National Natural Science Foundation of China [81472464]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 81472464 from the National Natural Science Foundation of China. The authors declare that they have no conflicts of interest with the contents of this article.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Berry FB, 2001, J BIOL CHEM, V276, P25057, DOI 10.1074/jbc.M010378200; Brisken C, 2002, J MAMMARY GLAND BIOL, V7, P39, DOI 10.1023/A:1015718406329; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Brisken C, 2006, J MAMMARY GLAND BIOL, V11, P239, DOI 10.1007/s10911-006-9026-0; Brooks CL, 2012, ENDOCR REV, V33, P504, DOI 10.1210/er.2011-1040; Casey TM, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.116137; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakrabarti R, 2012, STEM CELLS, V30, P1496, DOI 10.1002/stem.1112; Chen HX, 2003, J MAMMARY GLAND BIOL, V8, P159, DOI 10.1023/A:1025996707117; Choi YS, 2009, DEV BIOL, V329, P227, DOI 10.1016/j.ydbio.2009.02.032; Dammeier J, 1998, J BIOL CHEM, V273, P18185, DOI 10.1074/jbc.273.29.18185; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; Dong XY, 2011, J BIOL CHEM, V286, P13879, DOI 10.1074/jbc.M110.187849; Dong XY, 2010, J BIOL CHEM, V285, P32801, DOI 10.1074/jbc.M110.128330; DOPPLER W, 1989, P NATL ACAD SCI USA, V86, P104, DOI 10.1073/pnas.86.1.104; Duverger O, 2008, J CELL PHYSIOL, V216, P337, DOI 10.1002/jcp.21491; Feng F.-Y., 2011, ACTA AGR BOREALI SIN, V5; Galsgaard ED, 1999, J BIOL CHEM, V274, P18686, DOI 10.1074/jbc.274.26.18686; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hachim IY, 2016, APPL IMMUNOHISTO M M, V24, P238, DOI 10.1097/PAI.0000000000000178; Harris J, 2006, MOL ENDOCRINOL, V20, P1177, DOI 10.1210/me.2005-0473; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hesling C, 2013, DEVELOPMENT, V140, P167, DOI 10.1242/dev.085068; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Horseman ND, 1999, J MAMMARY GLAND BIOL, V4, P79, DOI 10.1023/A:1018708704335; Hu ZZ, 2002, ENDOCRINOLOGY, V143, P2139, DOI 10.1210/en.143.6.2139; Hynes NE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003186; Hynes NE, 1997, J MAMMARY GLAND BIOL, V2, P19, DOI 10.1023/A:1026317428542; Jung CG, 2005, DEVELOPMENT, V132, P5137, DOI 10.1242/dev.02098; Kataoka H, 2000, BIOCHEM BIOPH RES CO, V267, P91, DOI 10.1006/bbrc.1999.1911; Kavarthapu R, 2014, ONCOTARGET, V5, P9079, DOI 10.18632/oncotarget.2376; Kelly PA, 2002, MOL CELL ENDOCRINOL, V197, P127, DOI 10.1016/S0303-7207(02)00286-1; Kim NS, 2011, MOL CELL BIOL, V31, P4775, DOI 10.1128/MCB.05646-11; Kim NS, 2006, MOL CELL BIOL, V26, P1002, DOI 10.1128/MCB.26.3.1002-1013.2006; Kmiec M, 2006, J APPL GENET, V47, P139, DOI 10.1007/BF03194613; Lewis MT, 2000, BREAST CANCER RES, V2, P158, DOI 10.1186/bcr49; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051283; Li M, 2013, BIOCHEM BIOPH RES CO, V430, P358, DOI 10.1016/j.bbrc.2012.11.009; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; May M, 2016, EXP MOL PATHOL, V100, P39, DOI 10.1016/j.yexmp.2015.11.003; MEIER VS, 1994, MOL CELL BIOL, V14, P128, DOI 10.1128/MCB.14.1.128; Metz RP, 2006, DEV DYNAM, V235, P263, DOI 10.1002/dvdy.20605; MIURA Y, 1995, J BIOL CHEM, V270, P26840, DOI 10.1074/jbc.270.45.26840; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; Mori S, 2000, EMBO J, V19, P5772, DOI 10.1093/emboj/19.21.5772; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; Morrison B., 2009, JOVE-J VIS EXP, pe1265; Morrison BL, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-35; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Nouhi Z, 2006, CANCER RES, V66, P1824, DOI 10.1158/0008-5472.CAN-05-2292; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Pal R, 2009, BLOOD, V114, P3890, DOI 10.1182/blood-2009-01-201111; Parsons MJ, 2015, CELL, V162, P607, DOI 10.1016/j.cell.2015.06.060; Paten AM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1947-9; Peck AR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3328; Peck AR, 2011, J CLIN ONCOL, V29, P2448, DOI 10.1200/JCO.2010.30.3552; Peirce SK, 2001, J ENDOCRINOL, V171, pR1, DOI 10.1677/joe.0.171R001; Roylance R, 2006, ONCOGENE, V25, P6544, DOI 10.1038/sj.onc.1209659; Schennink A, 2015, J MOL ENDOCRINOL, V54, P1, DOI 10.1530/JME-14-0212; Silva CM, 2007, MOL ENDOCRINOL, V21, P1499, DOI 10.1210/me.2007-0109; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stute P, 2012, BREAST CANCER RES TR, V133, P617, DOI 10.1007/s10549-011-1811-9; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528; Sun XD, 2015, J GENET GENOMICS, V42, P373, DOI 10.1016/j.jgg.2015.06.004; Sun XD, 2014, NEOPLASIA, V16, P377, DOI 10.1016/j.neo.2014.05.001; Sun XD, 2012, GENESIS, V50, P819, DOI 10.1002/dvg.22041; Tabata H, 2012, J MOL ENDOCRINOL, V48, P169, DOI 10.1530/JME-11-0122; Tempfli K, 2011, ACTA VET HUNG, V59, P269, DOI 10.1556/AVet.2011.012; Wang XingPing, 2008, Agricultural Sciences in China, V7, P1374, DOI 10.1016/S1671-2927(08)60187-X; Watson C J, 1996, Rev Reprod, V1, P1; Welch RP, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku463; Yamashita H, 2006, ENDOCR-RELAT CANCER, V13, P885, DOI 10.1677/erc.1.01095; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034; YASUDA H, 1994, MOL CELL BIOL, V14, P1395, DOI 10.1128/MCB.14.2.1395; Zhang ZH, 2005, CLIN CANCER RES, V11, P193; Zhou J, 2005, EMBO J, V24, P635, DOI 10.1038/sj.emboj.7600538	82	17	19	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12809	12820		10.1074/jbc.M116.719377	http://dx.doi.org/10.1074/jbc.M116.719377			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129249	Green Published, hybrid			2022-12-28	WOS:000378119900032
J	Hashimoto, Y; Toyama, Y; Kusakari, S; Nawa, M; Matsuoka, M				Hashimoto, Yuichi; Toyama, Yuka; Kusakari, Shinya; Nawa, Mikiro; Matsuoka, Masaaki			An Alzheimer Disease-linked Rare Mutation Potentiates Netrin Receptor Uncoordinated-5C-induced Signaling That Merges with Amyloid beta Precursor Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CELL-DEATH; HEREDITARY CEREBRAL-HEMORRHAGE; N-TERMINAL KINASE; SKIN PROTEIN; DAP-KINASE; NADPH-OXIDASE; DUTCH TYPE; HUMANIN; ACTIVATION; APOPTOSIS	A missense mutation (T835M) in the uncoordinated-5C (UNC5C) netrin receptor gene increases the risk of late-onset Alzheimer disease (AD) and also the vulnerability of neurons harboring the mutation to various insults. The molecular mechanisms underlying T835M-UNC5C-induced death remain to be elucidated. In this study, we show that overexpression of wildtype UNC5C causes low-grade death, which is intensified by an AD-linked mutation T835M. An AD-linked survival factor, calmodulin-like skin protein (CLSP), and a natural ligand of UNC5C, netrin1, inhibit this death. T835M-UNC5C-induced neuronal cell death is mediated by an intracellular death-signaling cascade, consisting of death-associated protein kinase 1/protein kinase D/apoptosis signal-regulating kinase 1 (ASK1)/JNK/NADPH oxidase/caspases, which merges at ASK1 with a death-signaling cascade, mediated by amyloid beta precursor protein (APP). Notably, netrin1 also binds to APP and partially inhibits the death-signaling cascade, induced by APP. These results may provide new insight into the amyloid beta-independent pathomechanism of AD.	[Hashimoto, Yuichi; Toyama, Yuka; Kusakari, Shinya; Nawa, Mikiro; Matsuoka, Masaaki] Tokyo Med Univ, Dept Pharmacol, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan; [Matsuoka, Masaaki] Tokyo Med Univ, Dept Dermatol Neurosci, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan	Tokyo Medical University; Tokyo Medical University	Matsuoka, M (corresponding author), Tokyo Med Univ, Dept Pharmacol & Dermatol Neurosci, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	sakimatu@tokyo-med.ac.jp	Hashimoto, Yuichi/N-1508-2015	Hashimoto, Yuichi/0000-0001-5863-3618	Japan Society for the Promotion of Science [15H04689, 25460343]; Naito Foundation Natural Science Scholarship; Akaeda Medical Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation Natural Science Scholarship; Akaeda Medical Research Foundation	This work was supported in part by Grant-in-aid for Scientific Research (B) 15H04689 ( to M. M.) and Grant-in-aid for Scientific Research (C) 25460343 ( to Y. H.) from the Japan Society for the Promotion of Science, by a Naito Foundation Natural Science Scholarship ( to M. M.), and by a research grant from Akaeda Medical Research Foundation to ( to M. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ansari MA, 2011, FREE RADICAL BIO MED, V51, P171, DOI 10.1016/j.freeradbiomed.2011.03.025; Arakawa H, 2004, NAT REV CANCER, V4, P978, DOI 10.1038/nrc1504; Barbero-Camps E, 2013, HUM MOL GENET, V22, P3460, DOI 10.1093/hmg/ddt201; BODMER S, 1990, BIOCHEM BIOPH RES CO, V171, P890, DOI 10.1016/0006-291X(90)91229-L; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Dennis J, 2013, ANN NEUROL, V74, P328, DOI 10.1002/ana.24001; Eisenberg-Lerner A, 2007, CELL DEATH DIFFER, V14, P1908, DOI 10.1038/sj.cdd.4402212; Fujita Y, 2014, APOPTOSIS, V19, P339, DOI 10.1007/s10495-013-0917-4; Guenebeaud C, 2010, MOL CELL, V40, P863, DOI 10.1016/j.molcel.2010.11.021; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hashimoto Y, 2005, MOL CELL BIOL, V25, P9304, DOI 10.1128/MCB.25.21.9304-9317.2005; Hashimoto Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.80; Hashimoto Y, 2014, J NEUROCHEM, V130, P291, DOI 10.1111/jnc.12717; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Hayashi M, 2014, NEUROREPORT, V25, P725, DOI 10.1097/WNR.0b013e328362d9fe; Hernandes MS, 2012, CURR NEUROPHARMACOL, V10, P321, DOI 10.2174/157015912804143540; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kim BM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.216; Larrieu-Lahargue F, 2012, TRENDS CARDIOVAS MED, V22, P44, DOI 10.1016/j.tcm.2012.06.010; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Llambi F, 2005, EMBO J, V24, P1192, DOI 10.1038/sj.emboj.7600584; Lourenco FC, 2009, CELL DEATH DIFFER, V16, P655, DOI 10.1038/cdd.2008.191; Matsuoka M, 2015, MOL NEUROBIOL, V51, P1232, DOI 10.1007/s12035-014-8799-1; Matsuoka M, 2010, MOL NEUROBIOL, V41, P22, DOI 10.1007/s12035-009-8090-z; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mehan S, 2011, J MOL NEUROSCI, V43, P376, DOI 10.1007/s12031-010-9454-6; Moore SW, 2007, ADV EXP MED BIOL, V621, P17, DOI 10.1007/978-0-387-76715-4_2; PLATIKA D, 1985, P NATL ACAD SCI USA, V82, P3499, DOI 10.1073/pnas.82.10.3499; Rohn TT, 2010, APOPTOSIS, V15, P1403, DOI 10.1007/s10495-010-0463-2; Savage MJ, 2002, J NEUROSCI, V22, P3376; Selkoe DJ, 2013, CELL, V154, P468, DOI 10.1016/j.cell.2013.07.003; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Shiloh R, 2014, APOPTOSIS, V19, P286, DOI 10.1007/s10495-013-0924-5; Tachi N, 2012, BIOCHEM J, V442, P413, DOI 10.1042/BJ20100993; Takeshita Y, 2013, J BIOL CHEM, V288, P24691, DOI 10.1074/jbc.M113.469692; Tayeb HO, 2013, EXPERT OPIN BIOL TH, V13, P1075, DOI 10.1517/14712598.2013.789856; WATTENDORFF AR, 1995, J NEUROL NEUROSUR PS, V58, P699, DOI 10.1136/jnnp.58.6.699; Wetzel-Smith MK, 2014, NAT MED, V20, P1452, DOI 10.1038/nm.3736; Williams ME, 2003, J BIOL CHEM, V278, P17483, DOI 10.1074/jbc.M300415200; Yamatsuji T, 1996, SCIENCE, V272, P1349, DOI 10.1126/science.272.5266.1349; Zhou Q, 2015, ANN NEUROL, V77, P637, DOI 10.1002/ana.24361	42	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12282	12293		10.1074/jbc.M115.698092	http://dx.doi.org/10.1074/jbc.M115.698092			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27068745	Green Published, hybrid			2022-12-28	WOS:000378092800028
J	Shcherbatko, A; Foletti, D; Poulsen, K; Strop, P; Zhu, GY; Hasa-Moreno, A; Witt, JM; Loo, C; Krimm, S; Pios, A; Yu, J; Brown, C; Lee, JK; Stroud, R; Rajpal, A; Shelton, D				Shcherbatko, Anatoly; Foletti, Davide; Poulsen, Kris; Strop, Pavel; Zhu, Guoyun; Hasa-Moreno, Adela; Witt, Jody Melton; Loo, Carole; Krimm, Stellanie; Pios, Ariel; Yu, Jessica; Brown, Colleen; Lee, John K.; Stroud, Robert; Rajpal, Arvind; Shelton, David			Modulation of P2X3 and P2X2/3 Receptors by Monoclonal Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; IONOTROPIC ATP RECEPTORS; RAT SENSORY NEURONS; P2X(3) RECEPTOR; PHARMACOLOGICAL-PROPERTIES; RHEUMATOID-ARTHRITIS; INFLAMMATORY PAIN; ION CHANNELS; ANTAGONIST; SUBUNIT	Purinergic homomeric P2X3 and heteromeric P2X2/3 receptors are ligand-gated cation channels activated by ATP. Both receptors are predominantly expressed in nociceptive sensory neurons, and an increase in extracellular ATP concentration under pathological conditions, such as tissue damage or visceral distension, induces channel opening, membrane depolarization, and initiation of pain signaling. Hence, these receptors are considered important therapeutic targets for pain management, and development of selective antagonists is currently progressing. To advance the search for novel analgesics, we have generated a panel of monoclonal antibodies directed against human P2X3 (hP2X3). We have found that these antibodies produce distinct functional effects, depending on the homomeric or heteromeric composition of the target, its kinetic state, and the duration of antibody exposure. The most potent antibody, 12D4, showed an estimated IC50 of 16 nM on hP2X3 after short term exposure (up to 18 min), binding to the inactivated state of the channel to inhibit activity. By contrast, with the same short term application, 12D4 potentiated the slow inactivating current mediated by the heteromeric hP2X2/3 channel. Extending the duration of exposure to similar to 20 h resulted in a profound inhibition of both homomeric hP2X3 and heteromeric hP2X2/3 receptors, an effect mediated by efficient antibody-induced internalization of the channel from the plasma membrane. The therapeutic potential of mAb12D4 was assessed in the formalin, complete Freund's adjuvant, and visceral pain models. The efficacy of 12D4 in the visceral hypersensitivity model indicates that antibodies against P2X3 may have therapeutic potential in visceral pain indications.	[Shcherbatko, Anatoly; Foletti, Davide; Poulsen, Kris; Strop, Pavel; Zhu, Guoyun; Hasa-Moreno, Adela; Witt, Jody Melton; Loo, Carole; Krimm, Stellanie; Pios, Ariel; Yu, Jessica; Brown, Colleen; Rajpal, Arvind; Shelton, David] Pfizer Inc, Rinat Labs, 230 E Grand Ave, San Francisco, CA 94080 USA; [Lee, John K.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Stroud, Robert] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Pfizer; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco	Shcherbatko, A (corresponding author), Pfizer Inc, Rinat Labs, 230 E Grand Ave, San Francisco, CA 94080 USA.	anatoly.shcherbatko@pfizer.com						Abdulqawi R, 2015, LANCET, V385, P1198, DOI 10.1016/S0140-6736(14)61255-1; Baqi Y, 2011, J MED CHEM, V54, P817, DOI 10.1021/jm1012193; Barclay J, 2002, J NEUROSCI, V22, P8139; Brass D, 2012, PURINERG SIGNAL, V8, pS61, DOI 10.1007/s11302-011-9278-z; Buell G, 1998, BLOOD, V92, P3521, DOI 10.1182/blood.V92.10.3521.422k50_3521_3528; Burgard EC, 1999, J NEUROPHYSIOL, V82, P1590, DOI 10.1152/jn.1999.82.3.1590; Burnstock G, 2011, ADV PHARMACOL, V61, P333, DOI 10.1016/B978-0-12-385526-8.00011-4; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Burnstock G, 2014, EXP PHYSIOL, V99, P16, DOI 10.1113/expphysiol.2013.071951; Burnstock G, 2013, EUR J PHARMACOL, V716, P24, DOI 10.1016/j.ejphar.2013.01.078; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Chen XQ, 2014, J MOL CELL BIOL, V6, P140, DOI 10.1093/jmcb/mju011; Collo G, 1996, J NEUROSCI, V16, P2495; De Roo M, 2003, J PHYSIOL-LONDON, V552, P59, DOI 10.1113/jphysiol.2003.046078; De Roo M, 2010, NEUROPHARMACOLOGY, V58, P569, DOI 10.1016/j.neuropharm.2009.12.002; Evans RJ, 1996, SEMIN NEUROSCI, V8, P217, DOI 10.1006/smns.1996.0028; Fabbretti E, 2006, J NEUROSCI, V26, P6163, DOI 10.1523/JNEUROSCI.0647-06.2006; Ford AP, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00267; Ford AP, 2012, PURINERG SIGNAL, V8, pS3, DOI 10.1007/s11302-011-9271-6; GarciaGuzman M, 1997, MOL BRAIN RES, V47, P59, DOI 10.1016/S0169-328X(97)00036-3; Gever JR, 2010, BRIT J PHARMACOL, V160, P1387, DOI 10.1111/j.1476-5381.2010.00796.x; Golay J, 2012, ARCH BIOCHEM BIOPHYS, V526, P146, DOI 10.1016/j.abb.2012.02.011; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Goswami S, 2013, ANTIBODIES, V2, P452, DOI 10.3390/antib2030452; Grishin EV, 2010, ANN NEUROL, V67, P680, DOI 10.1002/ana.21949; Grubb BD, 1999, EUR J NEUROSCI, V11, P149, DOI 10.1046/j.1460-9568.1999.00426.x; Gum RJ, 2012, PURINERG SIGNAL, V8, pS41, DOI 10.1007/s11302-011-9272-5; Gunosewoyo H, 2010, EXPERT OPIN THER PAT, V20, P625, DOI 10.1517/13543771003702424; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Jarvis MF, 2002, P NATL ACAD SCI USA, V99, P17179, DOI 10.1073/pnas.252537299; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jiang LH, 2003, J NEUROSCI, V23, P8903; Kaan TKY, 2010, BRAIN, V133, P2549, DOI 10.1093/brain/awq194; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Keystone EC, 2012, ANN RHEUM DIS, V71, P1630, DOI 10.1136/annrheumdis-2011-143578; Kobayashi K, 2005, J COMP NEUROL, V481, P377, DOI 10.1002/cne.20393; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Lu Shing-Hwa, 2007, J Chin Med Assoc, V70, P439, DOI 10.1016/S1726-4901(08)70035-2; McGaraughty S, 2003, BRIT J PHARMACOL, V140, P1381, DOI 10.1038/sj.bjp.0705574; North RA, 1996, SEMIN NEUROSCI, V8, P187; Ohashi K, 2008, PHARMACOLOGY, V81, P144, DOI 10.1159/000110737; Paukert M, 2001, J BIOL CHEM, V276, P21077, DOI 10.1074/jbc.M101465200; Petruska JC, 2000, NEUROREPORT, V11, P3589, DOI 10.1097/00001756-200011090-00037; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Pratt EB, 2005, J NEUROSCI, V25, P7359, DOI 10.1523/JNEUROSCI.5189-04.2005; Rae MG, 1998, BRIT J PHARMACOL, V124, P176, DOI 10.1038/sj.bjp.0701803; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Robinson LE, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00233; Shields SD, 2010, PAIN, V151, P422, DOI 10.1016/j.pain.2010.08.001; Stock TC, 2012, J RHEUMATOL, V39, P720, DOI 10.3899/jrheum.110874; Ueno S, 1999, BRIT J PHARMACOL, V126, P429, DOI 10.1038/sj.bjp.0702319; Vacca F, 2009, J NEUROCHEM, V109, P1031, DOI 10.1111/j.1471-4159.2009.06029.x; Wesselmann U, 1998, NEUROSCI LETT, V246, P73, DOI 10.1016/S0304-3940(98)00234-1; Wirkner K, 2007, MOL NEUROBIOL, V36, P165, DOI 10.1007/s12035-007-0033-y; Ye Y, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-62	56	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12254	12270		10.1074/jbc.M116.722330	http://dx.doi.org/10.1074/jbc.M116.722330			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27129281	Green Published, hybrid			2022-12-28	WOS:000378092800026
J	Wu, Y; Lan, C; Ren, DR; Chen, GY				Wu, Yin; Lan, Chao; Ren, Dongren; Chen, Guo-Yun			Induction of Siglec-1 by Endotoxin Tolerance Suppresses the Innate Immune Response by Promoting TGF-beta 1 Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; SYK TYROSINE KINASE; REGULATORY T-CELLS; DENDRITIC CELLS; ADAPTIVE IMMUNITY; UBIQUITIN LIGASES; MARGINAL ZONE; UP-REGULATION; HUMAN SEPSIS; CBL-FAMILY	Sepsis is one of the leading causes of death worldwide. Although the prevailing theory for the sepsis syndrome is a condition of uncontrolled inflammation in response to infection, sepsis is increasingly being recognized as an immunosuppressive state known as endotoxin tolerance. We found sialylation of cell surface was significantly increased on LPS-induced tolerant cells; knockdown of Neu1 in macrophage cell line RAW 264.7 cells resulted in enhanced LPS-induced tolerance, whereas overexpression of Neu1 or treatment with sialidase abrogated LPS-induced tolerance, as defined by measuring TNF-alpha levels in the culture supernatants. Wealso found that the expression of Siglec-1 (a member of sialic acid-binding Ig (I)like lectin family members, the predominant sialic acid-binding proteins on cell surface) was specifically up-regulated in endotoxin tolerant cells and the induction of Siglec-1 suppresses the innate immune response by promoting TGF-beta 1 production. The enhanced TGF-beta 1 production by Siglec-1 was significantly attenuated by spleen tyrosine kinase (Syk) inhibitor. Knockdown of siglec-1 inRAW264.7 cells resulted in inhibiting the production of TGF-beta 1 by ubiquitin-dependent degradation of Syk. Mechanistically, Siglec-1 associates with adaptor protein DNAX-activation protein of 12k Da(DAP12) and transduces a signal to Syk to control the production of TGF-beta 1 in endotoxin tolerance. Thus, Siglec-1 plays an important role in the development of endotoxin tolerance and targeted manipulation of this process could lead to a new therapeutic opportunity for patients with sepsis.	[Wu, Yin; Lan, Chao; Ren, Dongren; Chen, Guo-Yun] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Childrens Fdn Res Inst, Memphis, TN 38103 USA	University of Tennessee System; University of Tennessee Health Science Center	Chen, GY (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Childrens Fdn Res Inst, Memphis, TN 38103 USA.	Gchen14@uthsc.edu			National Institutes of Health [AI105727]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Grant AI105727 from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beutler B, 2004, IMMUNITY, V21, P134, DOI 10.1016/j.immuni.2004.07.014; Bokers S, 2014, J IMMUNOL, V192, P2994, DOI 10.4049/jimmunol.1303367; Brennan PJ, 2006, INT IMMUNOL, V18, P627, DOI 10.1093/intimm/dxh344; Changsirivathanathamrong D, 2011, CRIT CARE MED, V39, P2678, DOI 10.1097/CCM.0b013e31822827f2; Chen GY, 2014, ELIFE, V3, DOI 10.7554/eLife.04066; Chen GY, 2014, GLYCOBIOLOGY, V24, P800, DOI 10.1093/glycob/cwu068; Chen GY, 2011, NAT BIOTECHNOL, V29, P428, DOI 10.1038/nbt.1846; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Crocker PR, 2002, CURR OPIN STRUC BIOL, V12, P609, DOI 10.1016/S0959-440X(02)00375-5; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; Crocker PR, 2001, TRENDS IMMUNOL, V22, P337, DOI 10.1016/S1471-4906(01)01930-5; Draisma A, 2009, CRIT CARE MED, V37, P1261, DOI 10.1097/CCM.0b013e31819c3c67; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; FINK MP, 1990, J SURG RES, V49, P186, DOI 10.1016/0022-4804(90)90260-9; Geahlen RL, 2014, TRENDS PHARMACOL SCI, V35, P414, DOI 10.1016/j.tips.2014.05.007; Glavey SV, 2014, BLOOD, V124, P1765, DOI 10.1182/blood-2014-03-560862; Hall Margaret Jean, 2011, NCHS Data Brief, P1; Heikema AP, 2010, INFECT IMMUN, V78, P3237, DOI 10.1128/IAI.01273-09; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Jenner J, 2006, EXP HEMATOL, V34, P1212, DOI 10.1016/j.exphem.2006.04.016; Jia Y, 2015, J ALLERGY CLIN IMMUN, V135, P799, DOI 10.1016/j.jaci.2015.01.004; Jones C, 2003, MOL MICROBIOL, V49, P1213, DOI 10.1046/j.1365-2958.2003.03634.x; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Martinez-Pomares L, 2012, TRENDS IMMUNOL, V33, P66, DOI 10.1016/j.it.2011.11.001; McGaha TL, 2011, BLOOD, V117, P5403, DOI 10.1182/blood-2010-11-320028; Meesmann HM, 2010, J CELL SCI, V123, P3347, DOI 10.1242/jcs.066696; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; Monteiro VG, 2005, PARASITOL RES, V97, P380, DOI 10.1007/s00436-005-1460-1; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Nahid MA, 2011, CELL MOL IMMUNOL, V8, P388, DOI 10.1038/cmi.2011.26; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; PILATTE Y, 1990, AM J MED, V88, P486, DOI 10.1016/0002-9343(90)90427-F; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; RANDOW F, 1995, J EXP MED, V181, P1887, DOI 10.1084/jem.181.5.1887; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; ROGENTINE GN, 1974, J IMMUNOL, V113, P848; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Sundar KM, 2013, INDIAN J CRIT CARE M, V17, P162, DOI 10.4103/0972-5229.117054; Takamiya R, 2013, GLYCOBIOLOGY, V23, P178, DOI 10.1093/glycob/cws139; Tateno H, 2007, MOL CELL BIOL, V27, P5699, DOI 10.1128/MCB.00383-07; VAITH P, 1978, Z IMMUNITATSFORSCH, V154, P1; Vanderheijden N, 2003, J VIROL, V77, P8207, DOI 10.1128/JVI.77.15.8207-8215.2003; Volk HD, 1996, INTENS CARE MED, V22, pS474, DOI 10.1007/BF01743727; von Gunten S, 2007, J ALLERGY CLIN IMMUN, V119, P1005, DOI 10.1016/j.jaci.2007.01.023; Wang TS, 2008, J MOL MED, V86, P495, DOI 10.1007/s00109-007-0300-4; West MA, 2008, J TRAUMA, V65, P893, DOI 10.1097/TA.0b013e3181877fde; Wood KA, 2004, PHARMACOECONOMICS, V22, P895, DOI 10.2165/00019053-200422140-00001; Wu C, 2009, J IMMUNOL, V182, P6508, DOI 10.4049/jimmunol.0804247; Yang WS, 2012, EXP CELL RES, V318, P1867, DOI 10.1016/j.yexcr.2012.05.016; Yankee TM, 1999, J IMMUNOL, V163, P5827; Yu XW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5136; Zheng QL, 2015, CELL RES, V25, P1121, DOI 10.1038/cr.2015.108	59	27	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12370	12382		10.1074/jbc.M116.721258	http://dx.doi.org/10.1074/jbc.M116.721258			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27129263	Green Published, hybrid			2022-12-28	WOS:000378092800035
J	Choi, SY; Park, SK; Yoo, HW; Pi, JH; Kang, CJ				Choi, Seung-Young; Park, Sung-Kyun; Yoo, Han-Woong; Pi, Joo-Hyun; Kang, Chang-Joong			Charged Amino Acid-rich Leucine Zipper-1 (Crlz-1) as a Target of Wnt Signaling Pathway Controls Pre -B Cell Proliferation by Affecting Runx/CBFj3-targeted VpreB and lambda 5 Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; ENHANCER ACTIVITY; DIFFERENTIATION; SITES; INHIBITION; ACTIVATION; EXPRESSION; MECHANISM; PROMOTER; RECEPTOR	The proliferation of pre-B cells is known to further increase the clonal diversity of B cells at the stage of pre-B cells by allowing the same rearranged heavy chains to combine with differently rearranged light chains in a subsequent developmental stage, Crlz-1 (charged amino acid -rich leucine zipper-1) was found to control this proliferation of pre-B cells by working as a Wnt (wingless -related mouse mammary tumor virus integration site) target gene in these cells. Mechanistically, Crlz-1 protein functioned by mobilizing cytoplasmic CBF13 (core binding factor (1) into the nucleus to allow Runx (runt -related transcription factor)/CBF/3 heterodimerization. Runx/CBF13 then turned on its target genes such as EBF (early B cell factor), VpreB, and A5 and thereby pre -B cell receptor signaling, leading to the expression of cyclins D2 and D3. Actually, the proliferative function of Crlz-1 was demonstrated by not only Crlz-1 or beta-catenin knockdown but also Crlz-1 overexpression. Furthermore, the mechanistic view that the proliferative function of Crlz-1 is caused by relaying Wnt/(3-catenin to pre-B cell receptor signaling pathways through the regulation of Runx/CBIT heterodimerization was also verified by employing niclosamide, XAV939, and Lid as Wnt inhibitors and activator, respectively.	[Choi, Seung-Young; Park, Sung-Kyun; Yoo, Han-Woong; Pi, Joo-Hyun; Kang, Chang-Joong] Kyung Hee Univ, Dept Genet Engn, Coll Life Sci, 1 Seocheon, Yongin 17104, Gyeonggi Do, South Korea	Kyung Hee University	Kang, CJ (corresponding author), Kyung Hee Univ, Dept Genet Engn, Coll Life Sci, 1 Seocheon, Yongin 17104, Gyeonggi Do, South Korea.	cjkang@khu.ac.kr	Kang, ChangJoong/AAG-1171-2021	Kang, Chang Joong/0000-0002-2696-4508	National Research Foundation of Korea [NRF-2013R1A1A2006609]; BK21-plus Program of the Ministry of Education of Korea	National Research Foundation of Korea(National Research Foundation of Korea); BK21-plus Program of the Ministry of Education of Korea	This work was supported by Grant NRF-2013R1A1A2006609 from the National Research Foundation of Korea and also in part by the BK21-plus Program of the Ministry of Education of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Bandapalli OR, 2009, J PATHOL, V218, P370, DOI 10.1002/path.2539; Chen MY, 2009, BIOCHEMISTRY-US, V48, P10267, DOI 10.1021/bi9009677; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; Huang H, 2012, GENE DEV, V26, P1587, DOI 10.1101/gad.192054.112; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kuo YH, 2008, BLOOD, V111, P1543, DOI 10.1182/blood-2007-07-104422; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Lim JH, 2006, J IMMUNOL, V177, P5420, DOI 10.4049/jimmunol.177.8.5420; Lim JH, 2013, J HISTOCHEM CYTOCHEM, V61, P522, DOI 10.1369/0022155413486159; Lim JH, 2009, J MOL BIOL, V390, P339, DOI 10.1016/j.jmb.2009.05.040; Martensson A, 2001, EUR J IMMUNOL, V31, P3165, DOI 10.1002/1521-4141(200111)31:11<3165::AID-IMMU3165>3.0.CO;2-N; Martensson IL, 2010, FEBS LETT, V584, P2572, DOI 10.1016/j.febslet.2010.04.057; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Neel BG, 2012, GENE DEV, V26, P1520, DOI 10.1101/gad.198051.112; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; Park SK, 2011, MOL CELLS, V32, P67, DOI 10.1007/s10059-011-1031-5; Park SK, 2009, BBA-GENE REGUL MECH, V1789, P702, DOI 10.1016/j.bbagrm.2009.08.011; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Sakuma T, 2001, MECH DEVELOP, V104, P151, DOI 10.1016/S0925-4773(01)00366-5; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wang JB, 2004, CURR OPIN GENET DEV, V14, P533, DOI 10.1016/j.gde.2004.07.013	26	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15008	15019		10.1074/jbc.M115.712901	http://dx.doi.org/10.1074/jbc.M115.712901			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226553	Green Published, hybrid			2022-12-28	WOS:000380583200013
J	Mohl, BP; Roy, P				Mohl, Bjorn-Patrick; Roy, Polly			Cellular Casein Kinase 2 and Protein Phosphatase 2A Modulate Replication Site Assembly of Bluetongue Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphorylation; protein phosphatase 2 (PP2A); viral protein; viral replication; virus assembly; bluetongue virus; CK2; VIBs; virus inclusion bodies	SINGLE-STRANDED RNA; NONSTRUCTURAL PROTEIN-2; INCLUSION-BODIES; PHOSPHORYLATION; PHOSPHOPROTEIN; INHIBITOR; RELEASE; GROWTH; CELLS; NS2	A number of cytoplasmic replicating viruses produce cytoplasmic inclusion bodies or protein aggregates; however, a hallmark of viruses of the Reoviridae family is that they utilize these sites for purposes of replication and capsid assembly, functioning as viral assembly factories. Here we have used bluetongue virus (BTV) as a model system for this broad family of important viruses to understand the mechanisms regulating inclusion body assembly. Newly synthesized viral proteins interact with sequestered viral RNA molecules prior to capsid assembly and double-stranded RNA synthesis within viral inclusion bodies (VIBs). VIBs are predominantly comprised of a BTV-encoded non-structural protein 2 (NS2). Previous in vitro studies indicated that casein kinase 2 (CK2) mediated the phosphorylation of NS2, which regulated the propensity of NS2 to form larger aggregates. Using targeted pharmacological reagents, specific mutation in the viral genome by reverse genetics and confocal microscopy, here we demonstrate that CK2 activity is important for BTV replication. Furthermore, we show that a novel host cell factor, protein phosphatase 2A, is involved in NS2 dephosphorylation and that, together with CK2, it regulates VIB morphology and virus replication. Thus, these two host enzymes influence the dynamic nature of VIB assembly/disassembly, and these concerted activities may be relevant to the assembly and the release of these cores from VIBs.	[Mohl, Bjorn-Patrick; Roy, Polly] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Roy, P (corresponding author), London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1E 7HT, England.	polly.roy@lshtm.ac.uk		Roy, Polly/0000-0001-6535-6911	Wellcome Trust [100218/Z/12/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by Wellcome Trust Senior Investigator Award 100218/Z/12/Z (to P. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Bauman AL, 2002, NAT CELL BIOL, V4, pE203, DOI 10.1038/ncb0802-e203; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Brautigan DL, 2013, FEBS J, V280, P324, DOI 10.1111/j.1742-4658.2012.08609.x; Butan C, 2004, J BIOL CHEM, V279, P37613, DOI 10.1074/jbc.M400502200; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; Das SC, 2004, J VIROL, V78, P6420, DOI 10.1128/JVI.78.12.6420-6430.2004; Eichwald C, 2002, J VIROL, V76, P3461, DOI 10.1128/JVI.76.7.3461-3470.2002; Hemonnot B, 2004, J BIOL CHEM, V279, P32426, DOI 10.1074/jbc.M313137200; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; HUISMANS H, 1987, J VIROL, V61, P3589, DOI 10.1128/JVI.61.11.3589-3595.1987; Hunter T, 2012, PHILOS T R SOC B, V367, P2513, DOI 10.1098/rstb.2012.0013; HYATT AD, 1989, VIROLOGY, V173, P21, DOI 10.1016/0042-6822(89)90218-3; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kar AK, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-4; Law LMJ, 2003, J VIROL, V77, P1764, DOI 10.1128/JVI.77.3.1764-1771.2003; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matsuo E, 2013, J VIROL, V87, P882, DOI 10.1128/JVI.02363-12; Mayer-Jaekel Regina E., 1994, Trends in Cell Biology, V4, P287, DOI 10.1016/0962-8924(94)90219-4; Modrof J, 2005, J VIROL, V79, P10023, DOI 10.1128/JVI.79.15.10023-10031.2005; Modrof J, 2002, J BIOL CHEM, V277, P33099, DOI 10.1074/jbc.M203775200; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Ross-Thriepland D, 2015, J VIROL, V89, P3123, DOI 10.1128/JVI.02995-14; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Strack S., 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/398751; Taraporewala ZF, 2001, VIROLOGY, V280, P221, DOI 10.1006/viro.2000.0764; THOMAS CP, 1990, J GEN VIROL, V71, P2073, DOI 10.1099/0022-1317-71-9-2073; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203	29	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14566	14574		10.1074/jbc.M116.714766	http://dx.doi.org/10.1074/jbc.M116.714766			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226558	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000380366700013
J	Kunishima, M; Yamauchi, Y; Mizutani, M; Kuse, M; Takikawa, H; Sugimoto, Y				Kunishima, Mikiko; Yamauchi, Yasuo; Mizutani, Masaharu; Kuse, Masaki; Takikawa, Hirosato; Sugimoto, Yukihiro			Identification of (Z)-3:(E)-2-Hexenal Isomerases Essential to the Production of the Leaf Aldehyde in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; enzyme purification; lipid peroxidation; plant biochemistry; polyunsaturated fatty acid (PUFA)	SWISS-MODEL; LIPOXYGENASE PATHWAY; BIOSYNTHETIC-PATHWAY; TOMATO; VOLATILES; ACID; ALCOHOL; AROMA; ENVIRONMENT; COMPONENTS	The green odor of plants is characterized by green leaf volatiles (GLVs) composed of C6 compounds. GLVs are biosynthesized from polyunsaturated fatty acids in thylakoid membranes by a series of enzymes. A representative member of GLVs (E)-2-hexenal, known as the leaf aldehyde, has been assumed to be produced by isomerization from (Z)-3-hexenal in the biosynthesis pathway; however, the enzyme has not yet been identified. In this study, we purified the (Z)-3:(E)-2-hexenal isomerase (HI) from paprika fruits and showed that various plant species have homologous HIs. Purified HI is a homotrimeric protein of 110 kDa composed of 35-kDa subunits and shows high activity at acidic and neutral pH values. Phylogenetic analysis showed that HIs belong to the cupin superfamily, and at least three catalytic amino acids (His, Lys, Tyr) are conserved in HIs of various plant species. Enzymatic isomerization of (Z)-3-hexenal in the presence of deuterium oxide resulted in the introduction of deuterium at the C4 position of (E)-2-hexenal, and a suicide substrate 3-hexyn-1-al inhibited HI irreversibly, suggesting that the catalytic mode of HI is a keto-enol tautomerism reaction mode mediated by a catalytic His residue. The gene expression of HIs in Solanaceae plants was enhanced in specific developmental stages and by wounding treatment. Transgenic tomato plants overexpressing paprika HI accumulated (E)-2-hexenal in contrast to wild-type tomato plants mainly accumulating (Z)-3-hexenal, suggesting that HI plays a key role in the production of (E)-2-hexenal in planta.	[Kunishima, Mikiko; Yamauchi, Yasuo; Mizutani, Masaharu; Kuse, Masaki; Takikawa, Hirosato; Sugimoto, Yukihiro] Kobe Univ, Grad Sch Agr Sci, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan	Kobe University	Yamauchi, Y (corresponding author), Kobe Univ, Grad Sch Agr Sci, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	yamauchi@kobe-u.ac.jp		Mizutani, Masaharu/0000-0002-4321-0644	University of Tsukuba, Gene Research Center, through the National Bio-Resource Project (NBRP) of the Japan Agency for Research and Development (AMED), Japan [TOMJPF00001]	University of Tsukuba, Gene Research Center, through the National Bio-Resource Project (NBRP) of the Japan Agency for Research and Development (AMED), Japan(Japan Agency for Medical Research and Development (AMED))	Tomato seeds (Micro-Tom, TOMJPF00001) were provided by University of Tsukuba, Gene Research Center, through the National Bio-Resource Project (NBRP) of the Japan Agency for Research and Development (AMED), Japan.	Alonso A, 2009, FOOD SCI TECHNOL INT, V15, P47, DOI 10.1177/1082013208102385; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bate NJ, 1998, PHYSIOL PLANTARUM, V104, P97, DOI 10.1034/j.1399-3054.1998.1040113.x; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bloch K., 1971, ENZYMES, V5, P441; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen GP, 2004, PLANT PHYSIOL, V136, P2641, DOI 10.1104/pp.104.041608; CROFT KPC, 1993, PLANT PHYSIOL, V101, P13, DOI 10.1104/pp.101.1.13; Curtins T, 1912, LIEBIGS ANN CHEM, V390, P89; D'Auria JC, 2007, PLANT J, V49, P194, DOI 10.1111/j.1365-313X.2006.02946.x; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; ENDO K, 1970, J BIOL CHEM, V245, P4293; Fall R, 1999, J GEOPHYS RES-ATMOS, V104, P15963, DOI 10.1029/1999JD900144; GALLIARD T, 1976, BIOCHIM BIOPHYS ACTA, V441, P181, DOI 10.1016/0005-2760(76)90161-2; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HATANAKA A, 1987, CHEM PHYS LIPIDS, V44, P341, DOI 10.1016/0009-3084(87)90057-0; HATANAKA A, 1975, PHYTOCHEMISTRY, V14, P2589, DOI 10.1016/0031-9422(75)85230-7; Howe GA, 2000, PLANT PHYSIOL, V123, P711, DOI 10.1104/pp.123.2.711; Kishimoto K, 2006, PLANT SCI, V170, P715, DOI 10.1016/j.plantsci.2005.11.002; Kishimoto K, 2005, PLANT CELL PHYSIOL, V46, P1093, DOI 10.1093/pcp/pci122; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Lewinsohn E, 2001, PLANT PHYSIOL, V127, P1256, DOI 10.1104/pp.127.3.1256; LUNING PA, 1995, J AGR FOOD CHEM, V43, P1493, DOI 10.1021/jf00054a015; Mano J, 2002, PLANT CELL PHYSIOL, V43, P1445, DOI 10.1093/pcp/pcf187; Mathieu S, 2009, J EXP BOT, V60, P325, DOI 10.1093/jxb/ern294; Matsui K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036433; Myung K, 2006, J AGR FOOD CHEM, V54, P1442, DOI 10.1021/jf052068+; Niinemets U, 2010, TRENDS PLANT SCI, V15, P145, DOI 10.1016/j.tplants.2009.11.008; Noordermeer MA, 1999, FEBS LETT, V443, P201, DOI 10.1016/S0014-5793(98)01706-2; PHILLIPS DR, 1979, PHYTOCHEMISTRY, V18, P401, DOI 10.1016/S0031-9422(00)81874-9; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Scala A, 2013, INT J MOL SCI, V14, P17781, DOI 10.3390/ijms140917781; Speirs J, 1998, PLANT PHYSIOL, V117, P1047, DOI 10.1104/pp.117.3.1047; Sun HJ, 2006, PLANT CELL PHYSIOL, V47, P426, DOI 10.1093/pcp/pci251; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tandon KS, 2000, POSTHARVEST BIOL TEC, V20, P261, DOI 10.1016/S0925-5214(00)00143-5; Vancanneyt G, 2001, P NATL ACAD SCI USA, V98, P8139, DOI 10.1073/pnas.141079498; Wang CL, 2001, PHYTOCHEMISTRY, V58, P227, DOI 10.1016/S0031-9422(01)00233-3; Wavrin L, 2002, SYNTHESIS-STUTTGART, P326; Yamauchi Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08030; Yamauchi Y, 2012, FEBS LETT, V586, P1208, DOI 10.1016/j.febslet.2012.03.013; Yamauchi Y, 2011, J BIOL CHEM, V286, P6999, DOI 10.1074/jbc.M110.202226	45	40	41	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14023	14033		10.1074/jbc.M116.726687	http://dx.doi.org/10.1074/jbc.M116.726687			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129773	hybrid, Green Published			2022-12-28	WOS:000379975100011
J	Lewis, BA; Burlingame, AL; Myers, SA				Lewis, Brian A.; Burlingame, Alma L.; Myers, Samuel A.			Human RNA Polymerase II Promoter Recruitment in Vitro Is Regulated by O-Linked N-Acetylglucosaminyltransferase (OGT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); RNA polymerase II; transcription	TERMINAL DOMAIN; GLCNAC; TRANSCRIPTION; PHOSPHORYLATION; METABOLISM; PROTEIN	Although the O-linked N-acetylglucosamine (O-GlcNAc) modification of the RNA polymerase II C-terminal domain was described 20 years ago, the function of this RNA polymerase II (pol II) species is not known. We show here that an O-GlcNAcylated pol II species (pol II) exists on promoters in vitro. Inhibition of O-GlcNAc-transferase activity and O-GlcNAcylation prevents pol II entry into the promoter, and O-GlcNAc removal from pol II is an ATP-dependent step during initiation. These data indicate that O-GlcNAc-transferase activity is essential for RNA pol II promoter recruitment and that pol II goes through a cycling of O-GlcNAcylation at the promoter. Mass spectrometry shows that serine residues 2 and 5 of the pol II C-terminal domain are O-GlcNAcylated, suggesting an overlap with the transcription factor IIH (TFIIH)-dependent serine 5 phosphorylation events during initiation and P-TEFb (positive transcriptional elongation factor b) events during elongation. These data provide unexpected and important insights into the role of a previously ill-defined species of RNA polymerase II in regulating transcription.	[Lewis, Brian A.] NCI, Transcript Regulat & Biochem Unit, Metab Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Burlingame, Alma L.; Myers, Samuel A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco	Lewis, BA (corresponding author), NCI, Transcript Regulat & Biochem Unit, Metab Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	lewisbri@mail.nih.gov		Lewis, Brian/0000-0002-8321-0665	NCI Intramural Program; Biomedical Technology Research Centers Program of the National Institutes of Health NIGMS; National Institutes of Health NIGMS [8P41GM103481]; NATIONAL CANCER INSTITUTE [ZIABC011223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER	NCI Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biomedical Technology Research Centers Program of the National Institutes of Health NIGMS; National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NCI Intramural Program (to B. A. L.) and by the Biomedical Technology Research Centers Program of the National Institutes of Health NIGMS, National Institutes of Health NIGMS Grant 8P41GM103481, and Howard Hughes Medical Institute (to S. A. M. and A. L. B.). The authors have no conflicts of interest to declare. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamson TE, 2003, METHOD ENZYMOL, V371, P264; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Cheng B, 2009, METHODS, V48, P346, DOI 10.1016/j.ymeth.2009.02.026; CHESNUT JD, 1992, J BIOL CHEM, V267, P10500; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hsu JY, 2008, GENE DEV, V22, P2353, DOI 10.1101/gad.1681808; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Lewis BA, 2013, BBA-GENE REGUL MECH, V1829, P1202, DOI 10.1016/j.bbagrm.2013.09.003; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Ma ZY, 2013, AMINO ACIDS, V45, P719, DOI 10.1007/s00726-013-1543-8; Macauley MS, 2010, BBA-GEN SUBJECTS, V1800, P107, DOI 10.1016/j.bbagen.2009.07.028; Myers SA, 2013, PROTEOMICS, V13, P982, DOI 10.1002/pmic.201200332; Qian H, 2007, ANNU REV PHYS CHEM, V58, P113, DOI 10.1146/annurev.physchem.58.032806.104550; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; REASON A J, 1991, Glycobiology, V1, P387, DOI 10.1093/glycob/1.4.387; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736	23	30	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14056	14061		10.1074/jbc.M115.684365	http://dx.doi.org/10.1074/jbc.M115.684365			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129214	Green Published, hybrid			2022-12-28	WOS:000379975100014
J	Bedard, LG; Dronamraju, R; Kerschner, JL; Hunter, GO; Axley, ED; Boyd, AK; Strahl, BD; Mosley, AL				Bedard, Lynn Glowczewski; Dronamraju, Raghuvar; Kerschner, Jenny L.; Hunter, Gerald O.; Axley, Elizabeth DeVlieger; Boyd, Asha K.; Strahl, Brian D.; Mosley, Amber L.			Quantitative Analysis of Dynamic Protein Interactions during Transcription Reveals a Role for Casein Kinase II in Polymerase-associated Factor (PAF) Complex Phosphorylation and Regulation of Histone H2B Monoubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; histone modification; phosphorylation; transcription; ubiquitylation (ubiquitination); FACT; PAF-C; SILAC; casein kinase II; quantitative proteomics	MASS SPECTROMETRY DATA; SACCHAROMYCES-CEREVISIAE; AFFINITY PURIFICATION; ELONGATION-FACTORS; IN-VIVO; YEAST; CK2; CHROMATIN; UBIQUITINATION; H3	Using affinity purification MS approaches, we have identified a novel role for casein kinase II (CKII) in the modification of the polymerase associated factor complex (PAF-C). Our data indicate that the facilitates chromatin transcription complex (FACT) interacts with CKII and may facilitate PAF complex phosphorylation. Posttranslational modification analysis of affinity-isolated PAF-C shows extensive CKII phosphorylation of all five subunits of PAF-C, although CKII subunits were not detected as interacting partners. Consistent with this, recombinant CKII or FACT-associated CKII isolated from cells can phosphorylate PAF-C in vitro, whereas no intrinsic kinase activity was detected in PAF-C samples. Significantly, PAF-C purifications combined with stable isotope labeling in cells (SILAC) quantitation for PAF-C phosphorylation from wild-type and CKII temperature-sensitive strains (cka1 cka2-8) showed that PAF-C phosphorylation at consensus CKII sites is significantly reduced in cka1 cka2-8 strains. Consistent with a role of CKII in FACT and PAF-C function, we show that decreased CKII function in vivo results in decreased levels of histone H2B lysine 123 monoubiquitylation, a modification dependent on FACT and PAF-C. Taken together, our results define a coordinated role of CKII and FACT in the regulation of RNA polymerase II transcription through chromatin via phosphorylation of PAF-C.	[Bedard, Lynn Glowczewski; Boyd, Asha K.] Depauw Univ, Dept Biol, Greencastle, IN 46135 USA; [Bedard, Lynn Glowczewski; Hunter, Gerald O.; Axley, Elizabeth DeVlieger; Boyd, Asha K.; Mosley, Amber L.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA; [Mosley, Amber L.] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Dronamraju, Raghuvar; Kerschner, Jenny L.; Strahl, Brian D.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Kerschner, Jenny L.; Strahl, Brian D.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Strahl, Brian D.] Univ N Carolina, Sch Med, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA	DePauw University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Mosley, AL (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	almosley@iu.edu	, PEP-MX Core/AGV-4051-2022; Strahl, Brian D/C-7601-2012	Strahl, Brian D/0000-0002-4947-6259	National Institutes of Health [R01 GM099714, R01 GM110058]; Indiana University School of Medicine; DePauw University; University of North Carolina Lineberger Comprehensive Cancer Center Basic Mechanisms of Viral and Chemical Carcinogenesis Training Grant [5 T32 CA009156]; summer undergraduate program for prospective physician scientists at the Indiana University School of Medicine; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM116352, R01GM110058, R01GM099714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University School of Medicine; DePauw University; University of North Carolina Lineberger Comprehensive Cancer Center Basic Mechanisms of Viral and Chemical Carcinogenesis Training Grant; summer undergraduate program for prospective physician scientists at the Indiana University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM099714 (to A.L.M.) and R01 GM110058 (to B.D.S.) and a biomedical research grant from the Indiana University School of Medicine. Summer support for part of the work on this project was provided by the DePauw University Student Faculty Summer Research Fund and Professional Development Fund (to L. G. B. and A. K. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a postdoctoral fellowship awarded by University of North Carolina Lineberger Comprehensive Cancer Center Basic Mechanisms of Viral and Chemical Carcinogenesis Training Grant 5 T32 CA009156.; Supported by the summer undergraduate program for prospective physician scientists at the Indiana University School of Medicine.	Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; Blatch GL, 1997, GENE, V194, P277, DOI 10.1016/S0378-1119(97)00206-0; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Choi H., 2012, CURR PROTOC BIOINFOR; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Costa PJ, 2000, GENETICS, V156, P535; Cucinotta CE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005420; Daniels DL, 2012, J PROTEOME RES, V11, P564, DOI 10.1021/pr200459c; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Dronamraju R, 2014, NUCLEIC ACIDS RES, V42, P870, DOI 10.1093/nar/gkt1003; Filhol O, 2015, CELL MOL LIFE SCI, V72, P3305, DOI 10.1007/s00018-015-1929-8; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; HANNA DE, 1995, J BIOL CHEM, V270, P25905, DOI 10.1074/jbc.270.43.25905; Hockman DJ, 1996, MOL CELL BIOL, V16, P892; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kemble DJ, 2013, J BIOL CHEM, V288, P10188, DOI 10.1074/jbc.C113.451369; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Kwon Y, 2013, SCIENCE, V342, P737, DOI 10.1126/science.1243971; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; McCullough L, 2013, GENETICS, V195, P101, DOI 10.1534/genetics.113.153080; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Miteva YV, 2013, ANAL CHEM, V85, P749, DOI 10.1021/ac3033257; Mosley AL, 2013, MOL CELL PROTEOMICS, V12, P1530, DOI 10.1074/mcp.M112.024034; Mosley AL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000687; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Peng YT, 2011, MOL BIOL CELL, V22, P2680, DOI 10.1091/mbc.E10-11-0915; Piazza F, 2012, LEUKEMIA, V26, P1174, DOI 10.1038/leu.2011.385; Piazza F, 2013, LEUKEMIA RES, V37, P221, DOI 10.1016/j.leukres.2012.10.016; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Riles L, 2004, YEAST, V21, P241, DOI 10.1002/yea.1068; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Ruan WJ, 2011, J BIOL CHEM, V286, P18701, DOI 10.1074/jbc.M111.222273; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Shi XM, 1997, MOL CELL BIOL, V17, P1160, DOI 10.1128/MCB.17.3.1160; Smith-Kinnaman WR, 2014, MOL BIOSYST, V10, P1730, DOI 10.1039/c4mb00109e; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; Thornton JL, 2014, GENE DEV, V28, P115, DOI 10.1101/gad.232215.113; Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011; Trembley JH, 2003, J BIOL CHEM, V278, P2265, DOI 10.1074/jbc.M207518200; Tripodi F, 2013, EUKARYOT CELL, V12, P1271, DOI 10.1128/EC.00117-13; Venerando A, 2014, BIOCHEM J, V460, P141, DOI 10.1042/BJ20140178; Wozniak GG, 2014, BBA-GENE REGUL MECH, V1839, P1353, DOI 10.1016/j.bbagrm.2014.03.002; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	60	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13410	13420		10.1074/jbc.M116.727735	http://dx.doi.org/10.1074/jbc.M116.727735			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27143358	Green Published, hybrid			2022-12-28	WOS:000379771100001
J	Morozov, YI; Temiakov, D				Morozov, Yaroslav I.; Temiakov, Dmitry			Human Mitochondrial Transcription Initiation Complexes Have Similar Topology on the Light and Heavy Strand Promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondrial DNA (mtDNA); promoter; protein cross-linking; RNA polymerase; transcription; transcription factor; LSP; TFAM; TFB2M; mtRNAP	RNA-POLYMERASE; REGULATORY ELEMENTS; DNA	Transcription is a highly regulated process in all domains of life. In human mitochondria, transcription of the circular genome involves only two promoters, called light strand promoter (LSP) and heavy strand promoter (HSP), located in the opposite DNA strands. Initiation of transcription occurs upon sequential assembly of an initiation complex that includes mitochondrial RNA polymerase (mtRNAP) and the initiation factors mitochondrial transcription factor A (TFAM) and TFB2M. It has been recently suggested that the transcription initiation factor TFAM binds to HSP and LSP in opposite directions, implying that the mechanisms of transcription initiation are drastically dissimilar at these promoters. In contrast, we found that binding of TFAM to HSP and the subsequent recruitment of mtRNAP results in a pre-initiation complex that is remarkably similar in topology and properties to that formed at the LSP promoter. Our data suggest that assembly of the pre-initiation complexes on LSP and HSP brings these transcription units in close proximity, providing an opportunity for regulatory proteins to simultaneously control transcription initiation in both mtDNA strands.	[Morozov, Yaroslav I.; Temiakov, Dmitry] Rowan Univ, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine	Temiakov, D (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA.	d.temiakov@rowan.edu			National Institutes of Health [RO1GM104231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant RO1GM104231 (to D. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; FISHER RP, 1987, CELL, V50, P247, DOI 10.1016/0092-8674(87)90220-0; Hallberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001; Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918; Morozov YI, 2015, NUCLEIC ACIDS RES, V43, P3726, DOI 10.1093/nar/gkv235; Morozov YI, 2014, NUCLEIC ACIDS RES, V42, P3884, DOI 10.1093/nar/gkt1356; Ngo HB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4077; Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159; Posse V, 2014, NUCLEIC ACIDS RES, V42, P3638, DOI 10.1093/nar/gkt1397; Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; TOPPER JN, 1989, MOL CELL BIOL, V9, P1200, DOI 10.1128/MCB.9.3.1200; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955	14	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13432	13435		10.1074/jbc.C116.727966	http://dx.doi.org/10.1074/jbc.C116.727966			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27226527	Green Published, hybrid			2022-12-28	WOS:000379771100003
J	Stolle, P; Hou, B; Bruser, T				Stolle, Patrick; Hou, Bo; Brueser, Thomas			The Tat Substrate CueO Is Transported in an Incomplete Folding State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper; metalloprotein; protein folding; protein translocation; stress response; Tat system	MULTICOPPER OXIDASE CUEO; ESCHERICHIA-COLI K-12; NITRITE REDUCTASE; ALCALIGENES-XYLOSOXIDANS; COPPER HOMEOSTASIS; CUPROUS OXIDASE; PROTEIN EXPORT; EXPRESSION; CLONING; PATHWAY	In Escherichia coli, cytoplasmic copper ions are toxic to cells even at the lowest concentrations. As a defense strategy, the cuprous oxidase CueO is secreted into the periplasm to oxidize the more membrane-permeable and toxic Cu(I) before it can enter the cytoplasm. CueO itself is a multicopper oxidase that requires copper for activity. Because it is transported by the twin-arginine translocation (Tat) pathway, which transports folded proteins, a requirement for cofactor assembly before translocation has been discussed. Here we show that CueO is transported as an apo-protein. Periplasmic CueO was readily activated by the addition of copper ions in vitro or under copper stress conditions in vivo. Cytoplasmic CueO did not contain copper, even under copper stress conditions. In vitro Tat transport proved that the cofactor assembly was not required for functional Tat transport of CueO. Due to the post-translocational activation of CueO, this enzyme contributes to copper resistance not only by its cuprous oxidase activity but also by chelation of copper ions before they can enter the cytoplasm. Apo-CueO was indistinguishable from holo-CueO in terms of secondary structural elements. Importantly, the binding of copper to apo-CueO greatly stabilized the protein, indicating a transformation from an open or flexible domain arrangement with accessible copper sites to a closed structure with deeply buried copper ions. CueO is thus the first example for a natural Tat substrate of such incomplete folding state. The Tat system may need to transport flexibly folded proteins in any case when cofactor assembly or quaternary structure formation occurs after transport.	[Stolle, Patrick; Hou, Bo; Brueser, Thomas] Leibniz Univ Hannover, Inst Microbiol, Herrenhauser Str 2, D-30419 Hannover, Germany	Leibniz University Hannover	Bruser, T (corresponding author), Leibniz Univ Hannover, Inst Microbiol, Herrenhauser Str 2, D-30419 Hannover, Germany.	brueser@ifmb.uni-hannover.de		Stolle, Patrick/0000-0001-5825-4079; Bruser, Thomas/0000-0002-5889-8306				Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Berthelmann F, 2008, J BIOL CHEM, V283, P25281, DOI 10.1074/jbc.M707757200; Bruser T, 2003, EUR J BIOCHEM, V270, P1211, DOI 10.1046/j.1432-1033.2003.03481.x; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Chen JY, 1996, BIOCHEM BIOPH RES CO, V219, P423, DOI 10.1006/bbrc.1996.0249; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Djoko KY, 2010, J AM CHEM SOC, V132, P2005, DOI 10.1021/ja9091903; Eser M, 2003, P NATL ACAD SCI USA, V100, P13231, DOI 10.1073/pnas.2234410100; Fan EG, 2010, BIOCHEM BIOPH RES CO, V398, P438, DOI 10.1016/j.bbrc.2010.06.095; Galli I, 2004, J BIOL INORG CHEM, V9, P90, DOI 10.1007/s00775-003-0501-4; Genest O, 2008, J BIOL CHEM, V283, P21433, DOI 10.1074/jbc.M802954200; Gort AS, 1999, MOL MICROBIOL, V32, P179, DOI 10.1046/j.1365-2958.1999.01343.x; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; Graubner W, 2007, J BIOL CHEM, V282, P7116, DOI 10.1074/jbc.M608235200; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HANLON SP, 1995, FEMS MICROBIOL LETT, V133, P271, DOI 10.1111/j.1574-6968.1995.tb07896.x; Hou Bo, 2011, Biomol Concepts, V2, P507, DOI 10.1515/BMC.2011.040; HOWES BD, 1994, BIOCHEMISTRY-US, V33, P3171, DOI 10.1021/bi00177a005; Kaluarachchi H, 2010, NAT PROD REP, V27, P681, DOI 10.1039/b906688h; Kittleson JT, 2006, BIOCHEMISTRY-US, V45, P11096, DOI 10.1021/bi0612622; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li X, 2007, BIOCHEM BIOPH RES CO, V354, P21, DOI 10.1016/j.bbrc.2006.12.116; Lindenstrauss U, 2009, FEMS MICROBIOL LETT, V295, P135, DOI 10.1111/j.1574-6968.2009.01600.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Moser Michael, 2007, V390, P63; MULLER M, 1984, P NATL ACAD SCI-BIOL, V81, P7421, DOI 10.1073/pnas.81.23.7421; NISHIYAMA M, 1993, J GEN MICROBIOL, V139, P725, DOI 10.1099/00221287-139-4-725; Prudencio M, 1999, J BACTERIOL, V181, P2323; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Rapisarda VA, 2002, ARCH BIOCHEM BIOPHYS, V405, P87, DOI 10.1016/S0003-9861(02)00277-1; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Richter S, 2007, J BIOL CHEM, V282, P33257, DOI 10.1074/jbc.M703303200; Roberts SA, 2003, J BIOL CHEM, V278, P31958, DOI 10.1074/jbc.M302963200; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Sakurai T, 2007, CHEM REC, V7, P220, DOI 10.1002/tcr.20125; Sedlak E, 2008, P NATL ACAD SCI USA, V105, P19258, DOI 10.1073/pnas.0806431105; Sevcenco AM, 2009, J BIOL INORG CHEM, V14, P631, DOI 10.1007/s00775-009-0477-9; Singh SK, 2004, J BACTERIOL, V186, P7815, DOI 10.1128/JB.186.22.7815-7817.2004; Stoyanov JV, 2001, MOL MICROBIOL, V39, P502, DOI 10.1046/j.1365-2958.2001.02264.x; Tree JJ, 2005, BIOCHEM BIOPH RES CO, V328, P1205, DOI 10.1016/j.bbrc.2005.01.084; Tsai TY, 1998, J BIOL CHEM, V273, P19243, DOI 10.1074/jbc.273.30.19243; Watmough NJ, 1998, J BIOENERG BIOMEMBR, V30, P55, DOI 10.1023/A:1020507511285; Wilms B, 2001, BIOTECHNOL BIOENG, V73, P95, DOI 10.1002/bit.1041; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Zumft WG, 2005, J MOL MICROB BIOTECH, V10, P154, DOI 10.1159/000091562	50	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13520	13528		10.1074/jbc.M116.729103	http://dx.doi.org/10.1074/jbc.M116.729103			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129241	Green Published, hybrid			2022-12-28	WOS:000379771100010
J	Celik, H; Bulut, G; Han, J; Graham, GT; Minas, TZ; Conn, EJ; Hong, SH; Pauly, GT; Hayran, M; Li, X; Ozdemirli, M; Ayhan, A; Rudek, MA; Toretsky, JA; Uren, A				Celik, Haydar; Bulut, Gulay; Han, Jenny; Graham, Garrett T.; Minas, Tsion Z.; Conn, Erin J.; Hong, Sung-Hyeok; Pauly, Gary T.; Hayran, Mutlu; Li, Xin; Ozdemirli, Metin; Ayhan, Ayse; Rudek, Michelle A.; Toretsky, Jeffrey A.; Uren, Aykut			Ezrin Inhibition Up-regulates Stress Response Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTATIC PHENOTYPE; ERM PROTEINS; MURINE MODEL; LINKER EZRIN; OSTEOSARCOMA; GROWTH; MTOR; PHOSPHORYLATION; METABOLISM; INITIATION	Ezrin is a member of the ERM (ezrin/radixin/moesin) family of proteins that links cortical cytoskeleton to the plasma membrane. High expression of ezrin correlates with poor prognosis and metastasis in osteosarcoma. In this study, to uncover specific cellular responses evoked by ezrin inhibition that can be used as a specific pharmacodynamic marker(s), we profiled global gene expression in osteosarcoma cells after treatment with small molecule ezrin inhibitors, NSC305787 and NSC668394. We identified and validated several up-regulated integrated stress response genes including PTGS2, ATF3, DDIT3, DDIT4, TRIB3, and ATF4 as novel ezrin-regulated transcripts. Analysis of transcriptional response in skin and peripheral blood mononuclear cells from NSC305787-treated mice compared with a control group revealed that, among those genes, the stress gene DDIT4/REDD1 may be used as a surrogate pharmacodynamic marker of ezrin inhibitor compound activity. In addition, we validated the anti-metastatic effects of NSC305787 in reducing the incidence of lung metastasis in a genetically engineered mouse model of osteosarcoma and evaluated the pharmacokinetics of NSC305787 and NSC668394 in mice. In conclusion, our findings suggest that cytoplasmic ezrin, previously considered a dormant and inactive protein, has important functions in regulating gene expression that may result in down-regulation of stress response genes.	[Celik, Haydar; Bulut, Gulay; Han, Jenny; Graham, Garrett T.; Minas, Tsion Z.; Conn, Erin J.; Hong, Sung-Hyeok; Toretsky, Jeffrey A.; Uren, Aykut] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Ozdemirli, Metin] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA; [Bulut, Gulay] Bahcesehir Univ, Fac Engn & Nat Sci, Dept Mol Biol & Genet, TR-34349 Istanbul, Turkey; [Pauly, Gary T.] NCI, Biol Chem Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Hayran, Mutlu] Hacettepe Univ, Inst Canc, Dept Prevent Oncol, TR-06800 Ankara, Turkey; [Li, Xin] Georgetown Univ, Dept Biostat Bioinformat & Biomath, Washington, DC 20057 USA; [Ayhan, Ayse] Seirei Mikatahara Hosp, Dept Pathol, Hamamatsu, Shizuoka, Japan; [Ayhan, Ayse] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka, Japan; [Ayhan, Ayse] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21218 USA; [Rudek, Michelle A.] Johns Hopkins Univ, Sch Med, Div Clin Pharmacol, Dept Oncol, Baltimore, MD 21218 USA; [Rudek, Michelle A.] Johns Hopkins Univ, Sch Med, Div Clin Pharmacol, Dept Med, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA	Georgetown University; Georgetown University; Bahcesehir University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hacettepe University; Georgetown University; Hamamatsu University School of Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Uren, A (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, Dept Biochem & Mol & Cellular Biol,NRB, 3970 Reservoir Rd NW,Rm E312, Washington, DC 20057 USA.	au26@georgetown.edu	AYHAN, Ayse/H-3331-2012; AYHAN, Ayse/AAP-2948-2021	AYHAN, Ayse/0000-0003-0136-4271; AYHAN, Ayse/0000-0003-0136-4271; Pauly, Gary/0000-0002-3481-7129; Celik, Haydar/0000-0003-4314-8438; Graham, Garrett/0000-0002-1097-0962	National Cancer Institute [P30CA51008]; NATIONAL CANCER INSTITUTE [P30CA006973, P30CA051008] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026824] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the Animal Models Shared Resource, Histopathology & Tissue Shared Resource and the Genomics & Epigenomics Shared Resource at the Lombardi Comprehensive Cancer Center (Georgetown University), which are supported by a grant P30CA51008 from the National Cancer Institute. We thank Dr. Chand Khanna from National Cancer Institute (NCI/NIH, Bethesda, MD) for providing human MG63.3 osteosarcoma and mouse K7M2 osteosarcoma cell lines. We thank Dr. Douglas H. Thamm (Colorado State University, Fort Collins, CO) for providing MCKOS, SKKOS and CSKOS canine osteosarcoma cell lines. We thank Dr. Stuart H. Orkin and Dr. Katherine A. Janeway (Harvard Medical School, Boston, MA) for providing mice to generate the Osx-Cre <SUP>+</SUP> p53<SUP>fl/f</SUP>lpRB<SUP>fl/fl</SUP> transgenic mouse model of osteosarcoma and helpful discussion. We thank the Brandon Carrington Lee Foundation and Children's Cancer Foundation for continuous support of our research program.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Brambilla D, 2009, INT J CANCER, V125, P2239, DOI 10.1002/ijc.24734; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Briggs JW, 2012, NEOPLASIA, V14, P297, DOI 10.1593/neo.11518; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Bulut G, 2012, ONCOGENE, V31, P269, DOI 10.1038/onc.2011.245; Celik H, 2015, MOL CANCER THER, V14, P2497, DOI 10.1158/1535-7163.MCT-15-0511; Celik H, 2015, MOL CELL BIOL, V35, P3145, DOI 10.1128/MCB.00332-15; Chen QY, 2013, MOL CELL BIOCHEM, V377, P207, DOI 10.1007/s11010-013-1586-x; Daw NC, 2015, BRIT J CANCER, V112, P278, DOI 10.1038/bjc.2014.585; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Ellisen LW, 2005, CELL CYCLE, V4, P1500, DOI 10.4161/cc.4.11.2139; Federici C, 2009, INT J CANCER, V124, P2804, DOI 10.1002/ijc.24255; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; Geiger KD, 2000, AM J PATHOL, V157, P1785, DOI 10.1016/S0002-9440(10)64816-X; Gill J, 2013, PHARMACOL THERAPEUT, V137, P89, DOI 10.1016/j.pharmthera.2012.09.003; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Iiizumi M, 2008, BBA-REV CANCER, V1786, P87, DOI 10.1016/j.bbcan.2008.07.002; Isakoff MS, 2015, J CLIN ONCOL, V33, P3029, DOI 10.1200/JCO.2014.59.4895; Kansara M, 2014, NAT REV CANCER, V14, P722, DOI 10.1038/nrc3838; Khanna C, 2000, CLIN EXP METASTAS, V18, P261, DOI 10.1023/A:1006767007547; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Khanna C, 2001, CANCER RES, V61, P3750; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; Kobel M, 2006, MODERN PATHOL, V19, P581, DOI 10.1038/modpathol.3800567; Leiphrakpam PD, 2014, CELL SIGNAL, V26, P868, DOI 10.1016/j.cellsig.2014.01.014; Li JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep17903; Li QC, 2012, TUMOR BIOL, V33, P1493, DOI 10.1007/s13277-012-0400-9; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; McClatchey AI, 2014, J CELL SCI, V127, P3199, DOI 10.1242/jcs.098343; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ren L, 2015, ONCOTARGET, V6, P29469, DOI 10.18632/oncotarget.5177; Ren L, 2014, ADV EXP MED BIOL, V804, P181, DOI 10.1007/978-3-319-04843-7_10; Ren L, 2012, CANCER RES, V72, P1001, DOI 10.1158/0008-5472.CAN-11-0210; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Wan XL, 2005, CANCER RES, V65, P2406, DOI 10.1158/0008-5472.CAN-04-3135; Weng WH, 2005, CLIN CANCER RES, V11, P6198, DOI 10.1158/1078-0432.CCR-05-0548; Wu BL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/651954; Xie JJ, 2009, INT J CANCER, V124, P2549, DOI 10.1002/ijc.24216; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966	48	31	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13257	13270		10.1074/jbc.M116.718189	http://dx.doi.org/10.1074/jbc.M116.718189			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27137931	Green Published, hybrid			2022-12-28	WOS:000379770500030
J	Lucena, MC; Carvalho-Cruz, P; Donadio, JL; Oliveira, IA; de Queiroz, RM; Marinho-Carvalho, MM; Sola-Penna, M; de Paula, IF; Gondim, KC; McComb, ME; Costello, CE; Whelan, SA; Todeschini, AR; Dias, WB				Lucena, Miguel C.; Carvalho-Cruz, Patricia; Donadio, Joana L.; Oliveira, Isadora A.; de Queiroz, Rafaela M.; Marinho-Carvalho, Monica M.; Sola-Penna, Mauro; de Paula, Iron F.; Gondim, Katia C.; McComb, Mark E.; Costello, Catherine E.; Whelan, Stephen A.; Todeschini, Adriane R.; Dias, Wagner B.			Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINE; O-GLCNAC TRANSFERASE; PROSTATE-CANCER CELLS; TUMOR PROGRESSION; BREAST-CANCER; CROSS-TALK; METABOLISM; GLYCANS; GLCNACYLATION; METASTASIS	Deregulated cellular metabolism is a hallmark of tumors. Cancer cells increase glucose and glutamine flux to provide energy needs and macromolecular synthesis demands. Several studies have been focused on the importance of glycolysis and pentose phosphate pathway. However, a neglected but very important branch of glucose metabolism is the hexosamine biosynthesis pathway (HBP). The HBP is a branch of the glucose metabolic pathway that consumes similar to 2-5% of the total glucose, generating UDP-GlcNAc as the end product. UDP-GlcNAc is the donor substrate used in multiple glycosylation reactions. Thus, HBP links the altered metabolism with aberrant glycosylation providing a mechanism for cancer cells to sense and respond to microenvironment changes. Here, we investigate the changes of glucose metabolism during epithelial mesenchymal transition (EMT) and the role of O-GlcNAcylation in this process. We show that A549 cells increase glucose uptake during EMT, but instead of increasing the glycolysis and pentose phosphate pathway, the glucose is shunted through the HBP. The activation of HBP induces an aberrant cell surface glycosylation and O-GlcNAcylation. The cell surface glycans display an increase of sialylation alpha 2-6, poly-LacNAc, and fucosylation, all known epitopes found in different tumor models. In addition, modulation of O-GlcNAc levels was demonstrated to be important during the EMT process. Taken together, our results indicate that EMT is an applicable model to study metabolic and glycophenotype changes during carcinogenesis, suggesting that cell glycosylation senses metabolic changes and modulates cell plasticity.	[Lucena, Miguel C.; Carvalho-Cruz, Patricia; Donadio, Joana L.; Oliveira, Isadora A.; de Queiroz, Rafaela M.; Todeschini, Adriane R.; Dias, Wagner B.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, Brazil; [Marinho-Carvalho, Monica M.; Sola-Penna, Mauro] Univ Fed Rio de Janeiro, Fac Farm, BR-21949900 Rio De Janeiro, Brazil; [de Paula, Iron F.; Gondim, Katia C.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, BR-21949900 Rio De Janeiro, Brazil; [McComb, Mark E.; Costello, Catherine E.; Whelan, Stephen A.] Boston Univ, Sch Med, Cardiovasc Prote Ctr, Dept Biochem, Boston, MA 02118 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Boston University	Dias, WB (corresponding author), Univ Fed Rio de Janeiro, Ilha Fundao, Inst Biofis Carlos Chagas Filho, Bloco D Sala 03 CCS, BR-21949900 Rio de Janeiro, Brazil.	diaswb@biof.ufrj.br	Dias, Wagner/B-1401-2016; de Carvalho, Mônica Mesquita Marinho/ABC-7373-2020; Sola-Penna, Mauro/E-8221-2011; Gondim, Katia C./AAN-4059-2020; Todeschini, Adriane Regina/ABC-9165-2020; Todeschini, Adriane/AAG-8128-2020	Sola-Penna, Mauro/0000-0001-9796-6829; Todeschini, Adriane Regina/0000-0002-6049-2751; Oliveira, Isadora/0000-0003-0269-1450; Costello, Catherine/0000-0003-1594-5122; /0000-0002-4249-485X; Dias, Wagner/0000-0002-8378-8846; Whelan, Stephen A/0000-0002-5439-6501; Muniz de Queiroz, Rafaela/0000-0001-5962-9071	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco, and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. The authors declare that they have no conflicts of interest with the contents of this article.	Alisson-Silva F, 2014, GLYCOBIOLOGY, V24, P458, DOI 10.1093/glycob/cwu012; Alisson-Silva F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060471; Amoedo ND, 2013, BIOSCIENCE REP, V33, P865, DOI 10.1042/BSR20130066; BAUMANN H, 1979, CANCER RES, V39, P2637; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Cazet A, 2010, CARBOHYD RES, V345, P1377, DOI 10.1016/j.carres.2010.01.024; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; de Queirozl RM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00132; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Ding MX, 2012, ASIAN PAC J CANCER P, V13, P5653, DOI 10.7314/APJCP.2012.13.11.5653; Fardini Y, 2013, FRONT ENDOCRINOL, V4, DOI 10.3389/fendo.2013.00099; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Freire-De-Lima L, 2011, P NATL ACAD SCI USA, V108, P17690, DOI 10.1073/pnas.1115191108; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Garcia AD, 2013, RAPID COMMUN MASS SP, V27, P1794, DOI 10.1002/rcm.6631; Guan F, 2009, P NATL ACAD SCI USA, V106, P7461, DOI 10.1073/pnas.0902368106; Guo JM, 2004, ONCOLOGY-BASEL, V67, P271, DOI 10.1159/000081328; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; HAMILTON SD, 1984, CLIN CHEM, V30, P226; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hauselmann I, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00028; Hedou J, 2009, PROTEOMICS, V9, P2139, DOI 10.1002/pmic.200800617; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Ito N, 1996, HISTOL HISTOPATHOL, V11, P203; Jin FZ, 2013, EXP CELL RES, V319, P1482, DOI 10.1016/j.yexcr.2013.03.013; Kang JG, 2009, J BIOL CHEM, V284, P34777, DOI 10.1074/jbc.M109.026351; Kee HJ, 2014, BMB REP, V47, P158, DOI 10.5483/BMBRep.2014.47.3.273; Krishnan V, 2005, CLIN EXP METASTAS, V22, P11, DOI 10.1007/s10585-005-2036-2; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Liu J, 2011, MOL MED REP, V4, P1299, DOI 10.3892/mmr.2011.569; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Lynch TP, 2011, CELL CYCLE, V10, P1712, DOI 10.4161/cc.10.11.15561; Ma ZY, 2014, J BIOL CHEM, V289, P34457, DOI 10.1074/jbc.R114.577718; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Masoudi-Nejad A, 2015, SEMIN CANCER BIOL, V30, P21, DOI 10.1016/j.semcancer.2014.01.007; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Okamoto T, 2013, MOL MED REP, V7, P359, DOI 10.3892/mmr.2012.1189; Onitsuka K, 2003, CANCER SCI, V94, P32, DOI 10.1111/j.1349-7006.2003.tb01348.x; Park SY, 2010, EMBO J, V29, P3787, DOI 10.1038/emboj.2010.254; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Pousset D, 1997, CANCER RES, V57, P4249; Ramirez-Correa GA, 2008, CIRC RES, V103, P1354, DOI 10.1161/CIRCRESAHA.108.184978; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Shan CL, 2014, MOL CELL, V55, P552, DOI 10.1016/j.molcel.2014.06.020; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Sola-Penna M, 2002, J BIOCHEM BIOPH METH, V50, P129, DOI 10.1016/S0165-022X(01)00180-4; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Todeschini AR, 2007, J BIOL CHEM, V282, P8123, DOI 10.1074/jbc.M611407200; Vasconcelos-dos-Santos A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00138; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Ye F, 2004, J BIOCHEM BIOPH METH, V59, P201, DOI 10.1016/j.jbbm.2003.02.001; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yoshioka K, 1996, APPL MICROBIOL BIOT, V46, P400; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zancan P, 2005, MOL GENET METAB, V86, P401, DOI 10.1016/j.ymgme.2005.06.011; Zhu AP, 2010, ANAL BIOCHEM, V396, P146, DOI 10.1016/j.ab.2009.09.017	65	68	71	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					12917	12929		10.1074/jbc.M116.729236	http://dx.doi.org/10.1074/jbc.M116.729236			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129262	hybrid, Green Published			2022-12-28	WOS:000379770500003
J	Diehl, C; Akke, M; Bekker-Jensen, S; Mailand, N; Streicher, W; Wikstrom, M				Diehl, Carl; Akke, Mikael; Bekker-Jensen, Simon; Mailand, Niels; Streicher, Werner; Wikstrom, Mats			Structural Analysis of a Complex between Small Ubiquitin-like Modifier 1 (SUMO1) and the ZZ Domain of CREB-binding Protein (CBP/p300) Reveals a New Interaction Surface on SUMO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL-EXCHANGE; DIPOLAR COUPLINGS; NMR; RESONANCES; SEQUENCE; PHOSPHORYLATION; CONJUGATION; SUMOYLATION; RESTRAINTS; DYNAMICS	We have recently discovered that the ZZ zinc finger domain represents a novel small ubiquitin-like modifier (SUMO) binding motif. In this study we identify the binding epitopes in the ZZ domain of CBP (CREB-binding protein) and SUMO1 using NMR spectroscopy. The binding site on SUMO1 represents a unique epitope for SUMO interaction spatially opposite to that observed for canonical SUMO interaction motifs (SIMs). HADDOCK docking simulations using chemical shift perturbations and residual dipolar couplings was employed to obtain a structural model for the ZZ domain-SUMO1 complex. Isothermal titration calorimetry experiments support this model by showing that the mutation of key residues in the binding site abolishes binding and that SUMO1 can simultaneously and noncooperatively bind both the ZZ domain and a canonical SIM motif. The binding dynamics of SUMO1 was further characterized using N-15 Carr-Purcell-Meiboom-Gill (CPMG) relaxation dispersions, which define the off rates for the ZZ domain and SIM motif and show that the dynamic binding process has different characteristics for the two cases. Furthermore, in the absence of bound ligands SUMO1 transiently samples a high energy conformation, which might be involved in ligand binding.	[Diehl, Carl; Bekker-Jensen, Simon; Mailand, Niels; Streicher, Werner; Wikstrom, Mats] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Diehl, Carl] SAR Biostruct, SE-22363 Lund, Sweden; [Akke, Mikael] Lund Univ, Ctr Mol Prot Sci, Dept Biophys Chem, SE-22100 Lund, Sweden; [Streicher, Werner] Novozymes AS, DK-2880 Bagsvaerd, Denmark; [Wikstrom, Mats] Amgen Inc, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA	University of Copenhagen; Lund University; Novozymes; Amgen	Wikstrom, M (corresponding author), Amgen Inc, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	mats.wikstrom@amgen.com		Akke, Mikael/0000-0002-2395-825X; Streicher, Werner/0000-0002-2425-5839	Novo Nordisk Foundation [NNF14CC0001]; European Commission [Bio-NMR 261863]; MAX laboratory, Lund, Sweden [20130289]; Novo Nordisk Foundation Center for Protein Research [PI Niels Mailand] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Commission(European CommissionEuropean Commission Joint Research Centre); MAX laboratory, Lund, Sweden; Novo Nordisk Foundation Center for Protein Research	This work was supported by Novo Nordisk Foundation Grant NNF14CC0001, the European Commission under the Seventh Framework Program (FP7) contract Bio-NMR 261863 providing access to the Swedish NMR Centre, Gothenburg, Sweden, and the MAX laboratory, Lund, Sweden, enabling access to the MAX laboratory (ID 20130289). The authors declare that they have no conflicts of interest with the contents of this article.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Becker J, 2013, NAT STRUCT MOL BIOL, V20, P525, DOI 10.1038/nsmb.2526; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cappadocia L, 2015, STRUCTURE, V23, P126, DOI 10.1016/j.str.2014.10.015; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P8172, DOI 10.1021/bi00487a027; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Danielsen JR, 2012, J CELL BIOL, V197, P179, DOI 10.1083/jcb.201106152; DAVIS DG, 1994, J MAGN RESON SER B, V104, P266, DOI 10.1006/jmrb.1994.1084; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Legge GB, 2004, J MOL BIOL, V343, P1081, DOI 10.1016/j.jmb.2004.08.087; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Meiler J, 2000, J BIOMOL NMR, V16, P245, DOI 10.1023/A:1008378624590; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P11, DOI 10.1016/0968-0004(96)80878-4; PRESS WH, 1986, NUMERICAL RECIPES AR; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Weininger U, 2014, BIOCHEMISTRY-US, V53, P4519, DOI 10.1021/bi500462k; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Yip GNB, 2004, J MAGN RESON, V171, P25, DOI 10.1016/j.jmr.2004.06.021; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	47	17	18	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12658	12672		10.1074/jbc.M115.711325	http://dx.doi.org/10.1074/jbc.M115.711325			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129204	Green Published, hybrid			2022-12-28	WOS:000378119900021
J	Merino-Gracia, J; Costas-Insua, C; Canales, MA; Rodriguez-Crespo, I				Merino-Gracia, Javier; Costas-Insua, Carlos; Angeles Canales, Maria; Rodriguez-Crespo, Ignacio			Insights into the C-terminal Peptide Binding Specificity of the PDZ Domain of Neuronal Nitric-oxide Synthase CHARACTERIZATION OF THE INTERACTION WITH THE TIGHT JUNCTION PROTEIN CLAUDIN-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTSYNAPTIC DENSITY; RECEPTOR INTERACTION; STRUCTURAL BASIS; TIGHT JUNCTIONS; PROTEIN; NNOS; RECOGNITION; COMPLEX; INHIBITORS; SEQUENCES	Neuronal nitric-oxide synthase, unlike its endothelial and inducible counterparts, displays a PDZ (PSD-95/Dlg/ZO-1) domain located at its N terminus involved in subcellular targeting. The C termini of various cellular proteins insert within the binding groove of this PDZ domain and determine the subcellular distribution of neuronal NOS (nNOS). The molecular mechanisms underlying these interactions are poorly understood because the PDZ domain of nNOS can apparently exhibit class I, class II, and class III binding specificity. In addition, it has been recently suggested that the PDZ domain of nNOS binds with very low affinity to the C termini of target proteins, and a necessary simultaneous lateral interaction must take place for binding to occur. We describe herein that the PDZ domain of nNOS can behave as a bona fide class III PDZ domain and bind to C-terminal sequences with acidic residues at the P-2 position with low micromolar binding constants. Binding to C-terminal sequences with a hydrophobic residue at the P-2 position plus an acidic residue at the P-3 position (class II) can also occur, although interactions involving residues extending up to the P-7 position mediate this type of binding. This promiscuous behavior also extends to its association to class I sequences, which must display a Glu residue at P-3 and a Thr residue at P-2. By means of site-directed mutagenesis and NMR spectroscopy, we have been able to identify the residues involved in each specific type of binding and rationalize the mechanisms used to recognize binding partners. Finally, we have analyzed the high affinity association of the PDZ domain of nNOS to claudin-3 and claudin-14, two tight junction tetraspan membrane proteins that are essential components of the paracellular barrier.	[Merino-Gracia, Javier; Costas-Insua, Carlos; Rodriguez-Crespo, Ignacio] Univ Complutense Madrid, Fac Ciencias Quim, Dept Bioquim & Biol Mol, E-28040 Madrid, Spain; [Angeles Canales, Maria] Univ Complutense Madrid, Fac Ciencias Quim, Dept Quim Organ, E-28040 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Rodriguez-Crespo, I (corresponding author), Univ Complutense Madrid, Fac Quim, Dept Bioquim & Biol Mol, Ciudad Univ, E-28040 Madrid, Spain.	nacho@bbm1.ucm.es	Canales, Angeles/K-7499-2015; Rodriguez-Crespo, J. Ignacio/M-1966-2018	Canales, Angeles/0000-0003-0542-3080; Rodriguez-Crespo, J. Ignacio/0000-0002-2582-129X; Merino Gracia, Javier/0000-0003-3397-8171	Spanish "Ministerio de Ciencia e Innovacion" [BFU2012-37934]	Spanish "Ministerio de Ciencia e Innovacion"(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by Spanish "Ministerio de Ciencia e Innovacion" Grant BFU2012-37934. The authors declare that they have no conflicts of interest with the contents of this article.	Aicart-Ramos C, 2014, J CELL SCI, V127, P3360, DOI 10.1242/jcs.148601; Angulo I, 2011, GLYCOBIOLOGY, V21, P1349, DOI 10.1093/glycob/cwr074; ASANO K, 1994, P NATL ACAD SCI USA, V91, P10089, DOI 10.1073/pnas.91.21.10089; Bach A, 2008, J MED CHEM, V51, P6450, DOI 10.1021/jm800836w; Bach A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12157; Bach A, 2009, ANGEW CHEM INT EDIT, V48, P9685, DOI 10.1002/anie.200904741; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Courtney MJ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00252; Erlendsson S, 2014, J BIOL CHEM, V289, P25327, DOI 10.1074/jbc.M114.548743; Ernst A, 2014, J MOL BIOL, V426, P3509, DOI 10.1016/j.jmb.2014.08.012; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Firestein BL, 1999, J BIOL CHEM, V274, P10545, DOI 10.1074/jbc.274.15.10545; Garcia-Mayoral MF, 2011, FEBS LETT, V585, P53, DOI 10.1016/j.febslet.2010.11.027; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Garcia-Mayoral MF, 2010, FEBS J, V277, P2340, DOI 10.1111/j.1742-4658.2010.07649.x; Gerber NC, 1997, J BIOL CHEM, V272, P6285, DOI 10.1074/jbc.272.10.6285; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Jackson CL, 2015, NITRIC OXIDE-BIOL CH, V44, P3, DOI 10.1016/j.niox.2014.11.003; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Koval M, 2013, ANNU REV PHYSIOL, V75, P551, DOI 10.1146/annurev-physiol-030212-183809; Lai Y, 2013, P NATL ACAD SCI USA, V110, P525, DOI 10.1073/pnas.1211431109; Lemaire JF, 2006, FEBS LETT, V580, P6948, DOI 10.1016/j.febslet.2006.11.061; Li LL, 2015, J NEUROSCI, V35, P7349, DOI 10.1523/JNEUROSCI.0037-15.2015; Li LL, 2013, J NEUROSCI, V33, P8185, DOI 10.1523/JNEUROSCI.4578-12.2013; Liu J, 2016, MOL NEUROBIOL, V53, P5935, DOI 10.1007/s12035-015-9504-8; Mandal PK, 2002, MONATSH CHEM, V133, P205, DOI 10.1007/s706-002-8252-5; Merino-Gracia J, 2015, FEBS J, V282, P3945, DOI 10.1111/febs.13388; Mitchell LA, 2011, AM J PHYSIOL-LUNG C, V301, pL40, DOI 10.1152/ajplung.00299.2010; Molina-Jijon E, 2014, FREE RADICAL BIO MED, V72, P162, DOI 10.1016/j.freeradbiomed.2014.03.040; Navarro-Lerida I, 2006, J CELL SCI, V119, P1558, DOI 10.1242/jcs.02878; Navarro-Lerida I, 2004, J BIOL CHEM, V279, P55682, DOI 10.1074/jbc.M406621200; Navarro-Lerida I, 2007, MOL BIOL CELL, V18, P2768, DOI 10.1091/mbc.E06-12-1102; Nomme J, 2015, J BIOL CHEM, V290, P16595, DOI 10.1074/jbc.M115.646695; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Ort T, 2000, EUR J CELL BIOL, V79, P621, DOI 10.1078/0171-9335-00095; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Persichini T, 2005, NEUROSCI LETT, V384, P254, DOI 10.1016/j.neulet.2005.04.085; Riefler GM, 2001, J BIOL CHEM, V276, P48262, DOI 10.1074/jbc.M106503200; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rodriguez-Crespo I, 1998, ARCH BIOCHEM BIOPHYS, V359, P297, DOI 10.1006/abbi.1998.0928; Saitoh F, 2004, J BIOL CHEM, V279, P29461, DOI 10.1074/jbc.M401471200; Sanchez-Ruiloba L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095191; Schepens J, 1997, FEBS LETT, V409, P53, DOI 10.1016/S0014-5793(97)00481-X; Schuh K, 2001, J CELL BIOL, V155, P201, DOI 10.1083/jcb.200104131; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Sulka B, 2009, J BIOL CHEM, V284, P10659, DOI 10.1074/jbc.M807643200; Tochio H, 2000, J MOL BIOL, V303, P359, DOI 10.1006/jmbi.2000.4148; Tochio H, 1999, NAT STRUCT BIOL, V6, P417; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Twiss F, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.27425; Van Itallie CM, 2012, J CELL SCI, V125, P4902, DOI 10.1242/jcs.111237; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783	64	20	22	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11581	11595		10.1074/jbc.M116.724427	http://dx.doi.org/10.1074/jbc.M116.724427			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27030110	hybrid, Green Published			2022-12-28	WOS:000377264800011
J	Baranovskiy, AG; Babayeva, ND; Zhang, YB; Gu, JY; Suwa, Y; Pavlov, YI; Tahirov, TH				Baranovskiy, Andrey G.; Babayeva, Nigar D.; Zhang, Yinbo; Gu, Jianyou; Suwa, Yoshiaki; Pavlov, Youri I.; Tahirov, Tahir H.			Mechanism of Concerted RNA-DNA Primer Synthesis by the Human Primosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE ALPHA-PRIMASE; C-TERMINAL DOMAIN; STRUCTURAL BASIS; POL ALPHA; EUKARYOTIC REPLISOME; CRYSTAL-STRUCTURE; P58 SUBUNIT; TRANSCRIPTION INITIATION; CATALYTIC SUBUNIT; REPLICATION	The human primosome, a 340-kilodalton complex of primase and DNA polymerase alpha (Pol alpha), synthesizes chimeric RNA-DNA primers to be extended by replicative DNA polymerases delta and epsilon. The intricate mechanism of concerted primer synthesis by two catalytic centers was an enigma for over three decades. Here we report the crystal structures of two key complexes, the human primosome and the C-terminal domain of the primase large subunit (p58(C)) with bound DNA/RNA duplex. These structures, along with analysis of primase/polymerase activities, provide a plausible mechanism for all transactions of the primosome including initiation, elongation, accurate counting of RNA primer length, primer transfer to Pol alpha, and concerted autoregulation of alternate activation/inhibition of the catalytic centers. Our findings reveal a central role of p58(C) in the coordinated actions of two catalytic domains in the primosome and ultimately could impact the design of anticancer drugs.	[Baranovskiy, Andrey G.; Babayeva, Nigar D.; Zhang, Yinbo; Gu, Jianyou; Suwa, Yoshiaki; Pavlov, Youri I.; Tahirov, Tahir H.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Zhang, Yinbo; Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Gu, Jianyou] Zhejiang Prov Hosp Tradit Chinese Med, Inst Hematol, Hangzhou 310006, Zhejiang, Peoples R China; [Suwa, Yoshiaki] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biomed Chem, Sanda, Hyogo 6691337, Japan	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Zhejiang Chinese Medical University; Kwansei Gakuin University	Tahirov, TH (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ttahirov@unmc.edu	Pavlov, Youri/T-7532-2017	Pavlov, Youri/0000-0003-1179-5796; Gu, Jianyou/0000-0003-0285-8919; Tahirov, Tahir/0000-0002-1238-0069	NIGMS National Institutes of Health [P41 GM103403]; National Institutes of Health-ORIP HEI Grant [S10 RR029205]; U.S. DOE [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM101167] Funding Source: NIH RePORTER	NIGMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health-ORIP HEI Grant; U.S. DOE(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Temiakov (Rowan University) for kindly providing the expression vector for T7 RNA polymerase and A. Rizzino, D. Price, and K. Jordan for critical reading and editing of this manuscript. This work is also based upon research conducted at the APS on the NECAT beamlines, which are supported by NIGMS National Institutes of Health Grant P41 GM103403. The Pilatus 6M detector on 24-ID-C beamline is funded by National Institutes of Health-ORIP HEI Grant S10 RR029205. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract DE-AC02-06CH11357.	Agarkar VB, 2011, CELL CYCLE, V10, P926, DOI 10.4161/cc.10.6.15010; Arezi B, 1999, BIOCHEMISTRY-US, V38, P12899, DOI 10.1021/bi9908991; Baranovskiy AG, 2008, CELL CYCLE, V7, P3026, DOI 10.4161/cc.7.19.6720; Baranovskiy AG, 2016, J BIOL CHEM, V291, P4793, DOI 10.1074/jbc.M115.704064; Baranovskiy AG, 2015, J BIOL CHEM, V290, P5635, DOI 10.1074/jbc.M114.624742; Baranovskiy AG, 2014, NUCLEIC ACIDS RES, V42, P14013, DOI 10.1093/nar/gku1209; Baranovskiy AG, 2014, ACTA CRYSTALLOGR F, V70, P206, DOI 10.1107/S2053230X13034432; Basu RS, 2014, J BIOL CHEM, V289, P24549, DOI 10.1074/jbc.M114.584037; Beck K, 2010, NUCLEIC ACIDS RES, V38, P6707, DOI 10.1093/nar/gkq447; Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Copeland WC, 1997, PROTEIN EXPRES PURIF, V9, P1, DOI 10.1006/prep.1996.0665; COPELAND WC, 1995, J BIOL CHEM, V270, P3905, DOI 10.1074/jbc.270.8.3905; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; Corn JE, 2005, MOL CELL, V20, P391, DOI 10.1016/j.molcel.2005.09.004; DeLano W.L, PYMOL MOL GRAPHICS S; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Geibel S, 2009, P NATL ACAD SCI USA, V106, P7810, DOI 10.1073/pnas.0902910106; Huang H, 2010, J BIOL CHEM, V285, P33475, DOI 10.1074/jbc.M110.156240; Jozwiakowski SK, 2015, P NATL ACAD SCI USA, V112, pE633, DOI 10.1073/pnas.1412982112; Kato M, 2004, J BIOL CHEM, V279, P30554, DOI 10.1074/jbc.M403485200; Kilkenny ML, 2012, J BIOL CHEM, V287, P23740, DOI 10.1074/jbc.M112.368951; Kilkenny ML, 2013, P NATL ACAD SCI USA, V110, P15961, DOI 10.1073/pnas.1311185110; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; KUCHTA RD, 1990, J BIOL CHEM, V265, P16158; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Liu X, 2011, SCIENCE, V333, P633, DOI 10.1126/science.1206629; Matsui E, 2003, BIOCHEMISTRY-US, V42, P14968, DOI 10.1021/bi035556o; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Muzi-Falconi Marco, 2003, ScientificWorldJournal, V3, P21; Nunez-Ramirez R, 2011, NUCLEIC ACIDS RES, V39, P8187, DOI 10.1093/nar/gkr534; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavlov YI, 2006, CURR BIOL, V16, P202, DOI 10.1016/j.cub.2005.12.002; Pavlov YI, 2006, INT REV CYTOL, V255, P41, DOI 10.1016/S0074-7696(06)55002-8; Pellegrini Luca, 2012, Subcell Biochem, V62, P157, DOI 10.1007/978-94-007-4572-8_9; Perera RL, 2013, ELIFE, V2, DOI 10.7554/eLife.00482; Reijns MAM, 2015, NATURE, V518, P502, DOI 10.1038/nature14183; Sauguet L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010083; SHEAFF RJ, 1994, BIOCHEMISTRY-US, V33, P2247, DOI 10.1021/bi00174a035; SHEAFF RJ, 1993, BIOCHEMISTRY-US, V32, P3027, DOI 10.1021/bi00063a014; Simon AC, 2014, NATURE, V510, P293, DOI 10.1038/nature13234; Sun JC, 2015, NAT STRUCT MOL BIOL, V22, P976, DOI 10.1038/nsmb.3113; Suwa Y, 2015, J BIOL CHEM, V290, P14328, DOI 10.1074/jbc.M115.649954; Urban M, 2010, BIOCHEMISTRY-US, V49, P727, DOI 10.1021/bi9019516; Vaithiyalingam S, 2014, J MOL BIOL, V426, P558, DOI 10.1016/j.jmb.2013.11.007; Vaithiyalingam S, 2010, P NATL ACAD SCI USA, V107, P13684, DOI 10.1073/pnas.1002009107; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Xie P, 2011, EUR BIOPHYS J BIOPHY, V40, P1157, DOI 10.1007/s00249-011-0746-8; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b; Zhang YB, 2014, J BIOL CHEM, V289, P22021, DOI 10.1074/jbc.M114.570333; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786; Zhou B, 2012, J BIOL CHEM, V287, P26854, DOI 10.1074/jbc.M112.363655	58	59	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10006	10020		10.1074/jbc.M116.717405	http://dx.doi.org/10.1074/jbc.M116.717405			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26975377	Green Published, hybrid			2022-12-28	WOS:000375602800014
J	Deredge, D; Li, JW; Johnson, KA; Wintrode, PL				Deredge, Daniel; Li, Jiawen; Johnson, Kenneth A.; Wintrode, Patrick L.			Hydrogen/Deuterium Exchange Kinetics Demonstrate Long Range Allosteric Effects of Thumb Site 2 Inhibitors of Hepatitis C Viral RNA-dependent RNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; VIRUS NS5B POLYMERASE; NONNUCLEOSIDE INHIBITORS; CRYSTAL-STRUCTURE; HYDROGEN-EXCHANGE; MECHANISM; BINDING; INITIATION; DYNAMICS; PROTEIN	New nonnucleoside analogs are being developed as part of a multi-drug regimen to treat hepatitis C viral infections. Particularly promising are inhibitors that bind to the surface of the thumb domain of the viral RNA-dependent RNA polymerase (NS5B). Numerous crystal structures have been solved showing small molecule non-nucleoside inhibitors bound to the hepatitis C viral polymerase, but these structures alone do not define the mechanism of inhibition. Our prior kinetic analysis showed that nonnucleoside inhibitors binding to thumb site-2 (NNI2) do not block initiation or elongation of RNA synthesis; rather, they block the transition from the initiation to elongation, which is thought to proceed with significant structural rearrangement of the enzyme-RNA complex. Here we have mapped the effect of three NNI2 inhibitors on the conformational dynamics of the enzyme using hydrogen/deuterium exchange kinetics. All three inhibitors rigidify an extensive allosteric network extending > 40 angstrom from the binding site, thus providing a structural rationale for the observed disruption of the transition from distributive initiation to processive elongation. The two more potent inhibitors also suppress slow cooperative unfolding in the fingers extension-thumb interface and primer grip, which may contribute their stronger inhibition. These results establish that NNI2 inhibitors act through long range allosteric effects, reveal important conformational changes underlying normal polymerase function, and point the way to the design of more effective allosteric inhibitors that exploit this new information.	[Deredge, Daniel; Wintrode, Patrick L.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 North Pine St, Baltimore, MD 21201 USA; [Li, Jiawen; Johnson, Kenneth A.] Univ Texas Austin, Inst Cell & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA	University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas Austin	Wintrode, PL (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 North Pine St, Baltimore, MD 21201 USA.; Johnson, KA (corresponding author), Univ Texas Austin, Inst Cell & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu; pwintrod@rx.umaryland.edu			National Institutes of Health [1R01AI110577]; University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center [SOP1841-IQB2014]; Welch Foundation [F-1604]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01AI110577 (NIAID; to K. A. J.). This work was also supported by the University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center (SOP1841-IQB2014) and by the Welch Foundation (F-1604; to K. A. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210; Boyce SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084808; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Caillet-Saguy C, 2011, J MOL BIOL, V414, P370, DOI 10.1016/j.jmb.2011.10.001; Canales E, 2012, BIOORG MED CHEM LETT, V22, P4288, DOI 10.1016/j.bmcl.2012.05.025; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Cherry AL, 2015, J VIROL, V89, P2052, DOI 10.1128/JVI.01106-14; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Davis BC, 2013, PROTEINS, V81, P40, DOI 10.1002/prot.24154; Engen JR, 1997, BIOCHEMISTRY-US, V36, P14384, DOI 10.1021/bi971635m; Guttman M, 2013, J AM SOC MASS SPECTR, V24, P1906, DOI 10.1007/s13361-013-0727-5; Hang JQ, 2009, J BIOL CHEM, V284, P15517, DOI 10.1074/jbc.M808889200; Harrus D, 2010, J BIOL CHEM, V285, P32906, DOI 10.1074/jbc.M110.151316; Hawse WF, 2012, J IMMUNOL, V188, P5819, DOI 10.4049/jimmunol.1200952; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Jin ZN, 2012, J BIOL CHEM, V287, P10674, DOI 10.1074/jbc.M111.325530; Lazerwith SE, 2014, J MED CHEM, V57, P1893, DOI 10.1021/jm401420j; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Li H, 2009, J MED CHEM, V52, P1255, DOI 10.1021/jm8014537; Li J., 2016, J BIOL CHEM, V291; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Morgan Christopher R, 2009, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1706s58; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Muir AJ, 2015, CLIN GASTROENTEROL H, V13, P2166, DOI 10.1016/j.cgh.2015.07.015; Persson F, 2015, P NATL ACAD SCI USA, V112, P10383, DOI 10.1073/pnas.1506079112; Rand KD, 2006, J BIOL CHEM, V281, P23018, DOI 10.1074/jbc.M602968200; Rigat K, 2010, ANTIVIR RES, V88, P197, DOI 10.1016/j.antiviral.2010.08.014; Seckler JM, 2011, BIOPHYS J, V100, P144, DOI 10.1016/j.bpj.2010.11.004; Seckler JM, 2009, BIOCHEMISTRY-US, V48, P7646, DOI 10.1021/bi900790x; Shi ZS, 2006, CURR OPIN STRUC BIOL, V16, P686, DOI 10.1016/j.sbi.2006.10.011; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Wales TE, 2015, BIOCHEMISTRY-US, V54, P6382, DOI 10.1021/acs.biochem.5b00875; West GM, 2011, STRUCTURE, V19, P1424, DOI 10.1016/j.str.2011.08.001; Winquist J, 2013, ANTIVIR RES, V97, P356, DOI 10.1016/j.antiviral.2012.12.027; Xue WW, 2014, ANTIVIR RES, V104, P40, DOI 10.1016/j.antiviral.2014.01.006; Zhang J, 2010, STRUCTURE, V18, P1332, DOI 10.1016/j.str.2010.07.007	38	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10078	10088		10.1074/jbc.M115.708370	http://dx.doi.org/10.1074/jbc.M115.708370			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	27006396	hybrid, Green Published			2022-12-28	WOS:000375602800020
J	Wu, XB; Kim, H; Seravalli, J; Barycki, JJ; Hart, PJ; Gohara, DW; Di Cera, E; Jung, WH; Kosman, DJ; Lee, J				Wu, Xiaobin; Kim, Heejeong; Seravalli, Javier; Barycki, Joseph J.; Hart, P. John; Gohara, David W.; Di Cera, Enrico; Jung, Won Hee; Kosman, Daniel J.; Lee, Jaekwon			Potassium and the K+/H+ Exchanger Kha1p Promote Binding of Copper to ApoFet3p Multi-copper Ferroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTICOPPER OXIDASE FET3P; UNFOLDED PROTEIN RESPONSE; VACUOLAR H+-ATPASE; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; CHLORIDE CHANNELS; GENE DELETION; DNA-BINDING; YEAST; IRON	Acquisition and distribution of metal ions support a number of biological processes. Here we show that respiratory growth of and iron acquisition by the yeast Saccharomyces cerevisiae relies on potassium (K+) compartmentalization to the trans-Golgi network via Kha1p, a K+/H+ exchanger. K+ in the trans-Golgi network facilitates binding of copper to the Fet3p multi-copper ferroxidase. The effect of K+ is not dependent on stable binding with Fet3p or alteration of the characteristics of the secretory pathway. The data suggest that K+ acts as a chemical factor in Fet3p maturation, a role similar to that of cations in folding of nucleic acids. Up-regulation of KHA1 gene in response to iron limitation via iron-specific transcription factors indicates that K+ compartmentalization is linked to cellular iron homeostasis. Our study reveals a novel functional role of K+ in the binding of copper to apoFet3p and identifies a K+/H+ exchanger at the secretory pathway as a new molecular factor associated with iron uptake in yeast.	[Wu, Xiaobin; Kim, Heejeong; Seravalli, Javier; Barycki, Joseph J.; Lee, Jaekwon] Univ Nebraska Lincoln, Dept Biochem, Lincoln, NE 68588 USA; [Wu, Xiaobin; Kim, Heejeong; Seravalli, Javier; Barycki, Joseph J.; Lee, Jaekwon] Univ Nebraska Lincoln, Redox Biol Ctr, Lincoln, NE 68588 USA; [Wu, Xiaobin] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai 200234, Peoples R China; [Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Gohara, David W.; Di Cera, Enrico] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Jung, Won Hee] Chung Ang Univ, Dept Syst Biotechnol, Anseong 456756, South Korea; [Kosman, Daniel J.] Univ Buffalo, Dept Biochem, Buffalo, NY 14214 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Shanghai Normal University; University of Texas System; University of Texas Health San Antonio; Saint Louis University; Chung Ang University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Lee, J (corresponding author), Univ Nebraska Lincoln, Dept Biochem, Lincoln, NE 68588 USA.; Lee, J (corresponding author), Univ Nebraska Lincoln, Redox Biol Ctr, Lincoln, NE 68588 USA.	jlee7@unl.edu		Gohara, David/0000-0001-8799-9125	National Institutes of Health [DK79209, HL49413, HL73813, HL112303, P30GM103335]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning [A-600115007202]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL049413, R01HL049413, R01HL073813, U54HL112303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK79209 (to J. L.), HL49413, HL73813, and HL112303 (to E. D. C.), and P30GM103335 (to the Nebraska Redox Biology Center). This work was also supported by the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (A-600115007202; to X. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Askwith CC, 1998, J BIOL CHEM, V273, P22415, DOI 10.1074/jbc.273.35.22415; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Braun NA, 2010, J CELL SCI, V123, P2342, DOI 10.1242/jcs.068403; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chen SJ, 2008, ANNU REV BIOPHYS, V37, P197, DOI 10.1146/annurev.biophys.37.032807.125957; Collins JF, 2010, NUTR REV, V68, P133, DOI 10.1111/j.1753-4887.2010.00271.x; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Cyert MS, 2013, GENETICS, V193, P677, DOI 10.1534/genetics.112.147207; Davis-Kaplan SR, 2004, J BIOL CHEM, V279, P4322, DOI 10.1074/jbc.M310680200; Davis-Kaplan SR, 1998, P NATL ACAD SCI USA, V95, P13641, DOI 10.1073/pnas.95.23.13641; deSilva D, 1997, J BIOL CHEM, V272, P14208, DOI 10.1074/jbc.272.22.14208; Diab HI, 2013, J BIOL CHEM, V288, P11366, DOI 10.1074/jbc.M112.419259; Flis K, 2005, BIOCHEM J, V390, P655, DOI 10.1042/BJ20050480; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gaxiola RA, 1998, P NATL ACAD SCI USA, V95, P4046, DOI 10.1073/pnas.95.7.4046; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Gupta A, 2009, FUTURE MED CHEM, V1, P1125, DOI 10.4155/FMC.09.84; Hassett RF, 1998, J BIOL CHEM, V273, P23274, DOI 10.1074/jbc.273.36.23274; Hoshida H, 2005, BIOSCI BIOTECH BIOCH, V69, P1090, DOI 10.1271/bbb.69.1090; Jensen LT, 1998, J BIOL CHEM, V273, P23805, DOI 10.1074/jbc.273.37.23805; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kim H, 2013, MOL ASPECTS MED, V34, P561, DOI 10.1016/j.mam.2012.07.011; Kim HJ, 2012, BBA-MOL CELL RES, V1823, P1604, DOI 10.1016/j.bbamcr.2012.04.008; Kosman DJ, 2010, J BIOL INORG CHEM, V15, P15, DOI 10.1007/s00775-009-0590-9; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lin SH, 2007, CURR MED CHEM, V14, P1551, DOI 10.2174/092986707780831050; Lipfert J, 2014, ANNU REV BIOCHEM, V83, P813, DOI 10.1146/annurev-biochem-060409-092720; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LYNCH SM, 1995, J BIOL CHEM, V270, P5158, DOI 10.1074/jbc.270.10.5158; Madsen E, 2007, ANNU REV NEUROSCI, V30, P317, DOI 10.1146/annurev.neuro.30.051606.094232; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NAYAL M, 1994, P NATL ACAD SCI USA, V91, P817, DOI 10.1073/pnas.91.2.817; Numata M, 2001, J BIOL CHEM, V276, P17387, DOI 10.1074/jbc.M101319200; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramirez J, 1998, J BACTERIOL, V180, P5860; Resch CT, 2011, BIOCHEM CELL BIOL, V89, P130, DOI [10.1139/O10-149, 10.1139/o10-149]; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Rose M. D., 1990, METHODS YEAST GENETI, P155; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Sato M, 2004, MOL BIOL CELL, V15, P1417, DOI 10.1091/mbc.E03-10-0765; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sedlak E, 2008, P NATL ACAD SCI USA, V105, P19258, DOI 10.1073/pnas.0806431105; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Supanchart C, 2008, ARCH BIOCHEM BIOPHYS, V473, P161, DOI 10.1016/j.abb.2008.03.029; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Theil EC, 2011, J NUTR, V141, p724S, DOI 10.3945/jn.110.127639; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wang T, 2004, GASTROENTEROLOGY, V126, P1157, DOI 10.1053/j.gastro.2004.01.015; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wong GCL, 2010, ANNU REV PHYS CHEM, V61, P171, DOI 10.1146/annurev.physchem.58.032806.104436; Wu XB, 2009, J BIOL CHEM, V284, P4112, DOI 10.1074/jbc.M807909200; Xu WJ, 2013, CELL METAB, V17, P319, DOI 10.1016/j.cmet.2013.02.004; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Youn JH, 2009, ANNU REV PHYSIOL, V71, P381, DOI 10.1146/annurev.physiol.010908.163241	62	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9796	9806		10.1074/jbc.M115.700500	http://dx.doi.org/10.1074/jbc.M115.700500			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26966178	Green Published, hybrid			2022-12-28	WOS:000375602300036
J	Sanfelice, D; Sanz-Hernandez, M; de Simone, A; Bullard, B; Pastore, A				Sanfelice, Domenico; Sanz-Hernandez, Maximo; de Simone, Alfonso; Bullard, Belinda; Pastore, Annalisa			Toward Understanding the Molecular Bases of Stretch Activation A STRUCTURAL COMPARISON OF THE TWO TROPONIN C ISOFORMS OF LETHOCERUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSECT FLIGHT-MUSCLE; LETHOCERUS TROPONIN-C; NMR-SPECTROSCOPY; STRIATED-MUSCLE; POTENTIAL FUNCTIONS; STRUCTURAL-CHANGES; CA2+ REGULATION; CHEMICAL-SHIFT; THIN-FILAMENTS; LIQUID WATER	Muscles are usually activated by calcium binding to the calcium sensory protein troponin-C, which is one of the three components of the troponin complex. However, in cardiac and insect flight muscle activation is also produced by mechanical stress. Little is known about the molecular bases of this calcium-independent activation. In Lethocerus, a giant water bug often used as a model system because of its large muscle fibers, there are two troponin-C isoforms, called F1 and F2, that have distinct roles in activating the muscle. It has been suggested that this can be explained either by differences in structural features or by differences in the interactions with other proteins. Here we have compared the structural and dynamic properties of the two proteins and shown how they differ. We have also mapped the interactions of the F2 isoform with peptides spanning the sequence of its natural partner, troponin-I. Our data have allowed us to build a model of the troponin complex and may eventually help in understanding the specialized function of the F1 and F2 isoforms and the molecular mechanism of stretch activation.	[Sanfelice, Domenico; Pastore, Annalisa] Kings Coll London, Wohl Inst, Dept Clin & Basic Neurosci, London SE5 3RT, England; [Sanz-Hernandez, Maximo; de Simone, Alfonso] Imperial Coll, Dept Life Sci, London SW7 2AZ, England; [Bullard, Belinda] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Pastore, Annalisa] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy	University of London; King's College London; Imperial College London; University of York - UK; University of Pavia	Pastore, A (corresponding author), Kings Coll London, Psychol & Neurosci, Div Neurosci, Maurice Wohl Clin Neurosci Inst, 5 Cutcombe Rd, London SE5 9RX, England.	annalisa.1.pastore@kcl.ac.uk	Sanfelice, domenico/E-8083-2018	Sanfelice, domenico/0000-0002-8908-0347; Sanz-Hernandez, Maximo/0000-0001-8522-8730	BBSRC; EPSRC; British Heart Foundation grants; Biotechnology and Biological Sciences Research Council [BB/M006824/1, BB/M00676X/1] Funding Source: researchfish; British Heart Foundation [PG/14/93/31237] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1579441] Funding Source: researchfish; Medical Research Council [MC_U117533887] Funding Source: researchfish; The Francis Crick Institute [10029] Funding Source: researchfish; BBSRC [BB/M006824/1, BB/M00676X/1] Funding Source: UKRI; MRC [MC_U117533887] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); British Heart Foundation grants; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by BBSRC, EPSRC, and British Heart Foundation grants. The authors declare that they have no conflicts of interest with the contents of this article.	Agianian B, 2004, EMBO J, V23, P772, DOI 10.1038/sj.emboj.7600097; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; Blumenschein TMA, 2006, BIOPHYS J, V90, P2436, DOI 10.1529/biophysj.105.076216; BOYD J, 1990, CHEM PHYS LETT, V175, P477, DOI 10.1016/0009-2614(90)85567-V; Bullard B, 2011, J MUSCLE RES CELL M, V32, P303, DOI 10.1007/s10974-011-9278-1; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Nicola GF, 2010, BIOCHEMISTRY-US, V49, P1719, DOI 10.1021/bi902094w; De Nicola G, 2007, STRUCTURE, V15, P813, DOI 10.1016/j.str.2007.05.007; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dickinson MH, 1997, BIOPHYS J, V73, P3122, DOI 10.1016/S0006-3495(97)78338-3; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Fukuda N, 2005, J GEN PHYSIOL, V125, P257, DOI 10.1085/jgp.200409177; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Gordon S, 2006, P NATL ACAD SCI USA, V103, P4311, DOI 10.1073/pnas.0510109103; GRANZIER HLM, 1993, BIOPHYS J, V65, P2141, DOI 10.1016/S0006-3495(93)81262-1; GREASER ML, 1971, J BIOL CHEM, V246, P4226; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hoffman RMB, 2006, J MOL BIOL, V361, P625, DOI 10.1016/j.jmb.2006.06.031; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Iwamoto H, 2010, BIOPHYS J, V99, P184, DOI 10.1016/j.bpj.2010.04.009; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Krzic U, 2010, J MOL BIOL, V397, P110, DOI 10.1016/j.jmb.2010.01.039; Linari M, 2004, BIOPHYS J, V87, P1101, DOI 10.1529/biophysj.103.037374; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; LINSE S, 1994, BIOCHEMISTRY-US, V33, P12478, DOI 10.1021/bi00207a015; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; MAK AS, 1981, BIOCHEM BIOPH RES CO, V101, P208, DOI 10.1016/S0006-291X(81)80032-0; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Martin SR, 2011, BIOCHEMISTRY-US, V50, P1839, DOI 10.1021/bi102076s; Perz-Edwards RJ, 2011, P NATL ACAD SCI USA, V108, P120, DOI 10.1073/pnas.1014599107; POTTER JD, 1995, J BIOL CHEM, V270, P2557, DOI 10.1074/jbc.270.6.2557; PRINGLE JWS, 1949, J PHYSIOL-LONDON, V108, P226, DOI 10.1113/jphysiol.1949.sp004326; PRINGLE JWS, 1981, J EXP BIOL, V94, P1; PRINGLE JWS, 1978, PROC R SOC SER B-BIO, V201, P107, DOI 10.1098/rspb.1978.0035; Steiger G., 1977, INSECT FLIGHT MUSCLE; Sun YB, 2006, P NATL ACAD SCI USA, V103, P17771, DOI 10.1073/pnas.0605430103; Sun YB, 2009, J PHYSIOL-LONDON, V587, P155, DOI 10.1113/jphysiol.2008.164707; SYME DA, 1995, J EXP BIOL, V198, P2221; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; THORSON J, 1983, J PHYSIOL-LONDON, V343, P59, DOI 10.1113/jphysiol.1983.sp014881; TOHTONG R, 1995, NATURE, V374, P650, DOI 10.1038/374650a0; Tress ML, 2003, J MOL BIOL, V330, P705, DOI 10.1016/S0022-2836(03)00622-3; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Wang Q, 2011, BIOPHYS J, V101, P2207, DOI 10.1016/j.bpj.2011.09.034; WRAY JS, 1979, NATURE, V280, P325, DOI 10.1038/280325a0; Wu SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012643	54	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16090	16099		10.1074/jbc.M116.726646	http://dx.doi.org/10.1074/jbc.M116.726646			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226601	Green Published, hybrid			2022-12-28	WOS:000380585400015
J	Lin, S; Yuan, ZF; Han, YM; Marchione, DM; Garcia, BA				Lin, Shu; Yuan, Zuo-Fei; Han, Yumiao; Marchione, Dylan M.; Garcia, Benjamin A.			Preferential Phosphorylation on Old Histones during Early Mitosis in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CHROMOSOME CONDENSATION; H3 LYSINE-56 ACETYLATION; DROSOPHILA MALE GERMLINE; AURORA-B; IN-VIVO; POSTTRANSLATIONAL MODIFICATION; MASS-SPECTROMETRY; DNA-REPLICATION; GENE-EXPRESSION; METHYLATION	How histone post-translational modifications (PTMs) are inherited through the cell cycle remains poorly understood. Canonical histones are made in the S phase of the cell cycle. Combining mass spectrometry-based technologies and stable isotope labeling by amino acids in cell culture, we question the distribution of multiple histone PTMs on old versus new his tones in synchronized human cells. We show that histone PTMs can be grouped into three categories according to their distributions. Most lysine mono-methylation and acetylation PTMs are either symmetrically distributed on old and new histones or are enriched on new histones. In contrast, most di- and tri-methylation PTMs are enriched on old histones, suggesting that the inheritance of different PTMs is regulated distinctly. Intriguingly, old and new histones are distinct in their phosphorylation status during early mitosis in the following three human cell types: HeLa, 293T, and human foreskin fibroblast cells. The mitotic hallmark H3SlOph is predominantly associated with old H3 at early mitosis and becomes symmetric with the progression of mitosis. This same distribution was observed with other mitotic phosphorylation marks, including H3T3/T6ph, H3.1/ 2S28ph, and H1.4S26ph but not S28/S3lph on the H3 variant H3.3. Although H3SlOph often associates with the neighboring Lys -9 di- or tri-methylations, they are not required for the asymmetric distribution of Ser-10 phosphorylation on the same H3 tail. Inhibition of the kinase Aurora B does not change the distribution despite significant reduction of H3Sl0ph levels. However, K9me2 abundance on the new H3 is significantly reduced after Aurora B inhibition, suggesting a cross-talk between H3SlOph and H3K9me2.	[Lin, Shu; Yuan, Zuo-Fei; Han, Yumiao; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Epigenet Program, Philadelphia, PA 19104 USA; [Marchione, Dylan M.] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lin, Shu] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Dartmouth College	Garcia, BA (corresponding author), Univ Penn, Dept Biochem & Biophys, Epigenet Program, Philadelphia, PA 19104 USA.	bgarci@mail.med.upenn.edu	Yuan, Zuofei/O-3209-2017	Yuan, Zuofei/0000-0003-1252-6766; Marchione, Dylan/0000-0001-6941-0604	National Science Foundation CAREER award; National Institutes of Health [GM110174, AI118891]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110174] Funding Source: NIH RePORTER	National Science Foundation CAREER award(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Science Foundation CAREER award and National Institutes of Health Grants GM110174 and AI118891 (to B. A. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Alabert C, 2015, GENE DEV, V29, P585, DOI 10.1101/gad.256354.114; Annunziato AT, 2015, GENES-BASEL, V6, P353, DOI 10.3390/genes6020353; Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Cerutti H, 2009, EPIGENETICS-US, V4, P71, DOI 10.4161/epi.4.2.7781; Chadee DN, 1999, J BIOL CHEM, V274, P24914, DOI 10.1074/jbc.274.35.24914; Demidov D, 2009, PLANT J, V59, P221, DOI 10.1111/j.1365-313X.2009.03861.x; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; Duan Q, 2008, J BIOL CHEM, V283, P33585, DOI 10.1074/jbc.M803312200; Evertts AG, 2013, J BIOL CHEM, V288, P12142, DOI 10.1074/jbc.M112.428318; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; Gaydos LJ, 2014, SCIENCE, V345, P1515, DOI 10.1126/science.1255023; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Hake SB, 2005, P NATL ACAD SCI USA, V102, P6344, DOI 10.1073/pnas.0502413102; Hammond SL, 2014, CELL CYCLE, V13, P440, DOI 10.4161/cc.27269; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HEINTZ N, 1991, BIOCHIM BIOPHYS ACTA, V1088, P327, DOI 10.1016/0167-4781(91)90122-3; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hergeth SP, 2011, J CELL SCI, V124, P1623, DOI 10.1242/jcs.084947; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Huang C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003558; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Jorgensen S, 2013, NUCLEIC ACIDS RES, V41, P2797, DOI 10.1093/nar/gkt012; Kang B, 2011, GENE DEV, V25, P1359, DOI 10.1101/gad.2055511; Kettenbach AN, 2011, ANAL CHEM, V83, P7635, DOI 10.1021/ac201894j; Kim W, 2014, CELL CYCLE, V13, P726, DOI 10.4161/cc.28104; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li QR, 2009, J PROTEOME RES, V8, P5375, DOI 10.1021/pr900659n; Lin S, 2014, MOL CELL PROTEOMICS, V13, P2450, DOI 10.1074/mcp.O113.036459; Lin S, 2012, METHOD ENZYMOL, V512, P3, DOI 10.1016/B978-0-12-391940-3.00001-9; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Oki Masaya, 2007, Subcell Biochem, V41, P319; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Perez-Cadahia B, 2010, CURR OPIN DRUG DISC, V13, P613; Perez-Cadahia B, 2009, BIOCHEM CELL BIOL, V87, P695, DOI 10.1139/O09-053; Petruk S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3841; Petruk S, 2012, CELL, V150, P922, DOI 10.1016/j.cell.2012.06.046; Polioudaki H, 2004, FEBS LETT, V560, P39, DOI 10.1016/S0014-5793(04)00060-2; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Sarg B, 2006, J BIOL CHEM, V281, P6573, DOI 10.1074/jbc.M508957200; Sawicka A, 2012, BIOCHIMIE, V94, P2193, DOI 10.1016/j.biochi.2012.04.018; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Tran V, 2012, SCIENCE, V338, P679, DOI 10.1126/science.1226028; Wang FW, 2011, CURR BIOL, V21, P1061, DOI 10.1016/j.cub.2011.05.016; WU RS, 1982, CELL, V31, P367, DOI 10.1016/0092-8674(82)90130-1; Xie J, 2015, CELL, V163, P920, DOI 10.1016/j.cell.2015.10.002; Xu M, 2012, EMBO REP, V13, P60, DOI 10.1038/embor.2011.206; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994; Yuan ZF, 2015, MOL CELL PROTEOMICS, V14, P1696, DOI 10.1074/mcp.M114.046011; Zee BM, 2012, MOL CELL BIOL, V32, P2503, DOI 10.1128/MCB.06673-11; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784; Zhang Q, 2011, ONCOGENE, V30, P3943, DOI 10.1038/onc.2011.105	72	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15342	15357		10.1074/jbc.M116.726067	http://dx.doi.org/10.1074/jbc.M116.726067			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226594	Green Published, hybrid			2022-12-28	WOS:000380583200039
J	Lee, S; Kim, E; Jhun, H; Hong, J; Kwak, A; Jo, S; Bae, S; Lee, J; Kim, B; Lee, J; Youn, S; Kim, S; Kim, M; Kim, H; Lee, Y; Choi, DK; Kim, YS; Kim, S				Lee, Siyoung; Kim, Eunsom; Jhun, Hyunjhung; Hong, Jaewoo; Kwak, Areum; Jo, Seunghyun; Bae, Suyoung; Lee, Jongho; Kim, Busun; Lee, Jungmin; Youn, Sulah; Kim, Somi; Kim, Miyeon; Kim, Hyunwoo; Lee, Youngmin; Choi, Dong-Ki; Kim, Yong-Sung; Kim, Soohyun			Proinsulin Shares a Motif with Interleukin-1 (IL-1) and Induces Inflammatory Cytokine via Interleukin-1 Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; insulin; interleukin 1 (IL-1); protein motif; toll; interleukin-1 receptor (TIR)*	CELL-MEDIATED-IMMUNITY; DEPENDENT DIABETES-MELLITUS; TUMOR-NECROSIS-FACTOR; INSULIN; INFECTION; FAMILY; LYMPHOCYTES; ANTAGONIST; EXPRESSION; IL-1-ALPHA	Although it has been established that diabetes increases susceptibility to infections, the role of insulin (INS) in the immune response is unknown. Here, we investigated the immunological function of INS. Proinsulin dimer (pINSd) was a potent immune stimulus that induced inflammatory cytokines, but mature INS was unable to induce an immune response. An affinity-purified rabbit polyclonal antibody raised against mature IL-1 recognized IL-1 and pINS but failed to detect mature INS and IL-1. Analysis of the pINS sequence revealed the existence of an INS/IL-1 motif in the C-peptide of pINS. Surprisingly, the INS/IL-1 motif was recognized by monoclonal antibody raised against IL-1. Deleting the INS/IL-1 motif in pINSd and IL-1 changed their activities. To investigate the pINSd receptor, the reconstitution of IL-1 receptor 1 (IL-1R1) in Wish cells restored pINSd activity that was reversed by an IL-1R antagonist. These data suggested that pINSd needs IL-1R1 for inflammatory cytokine induction. Mouse embryo fibroblast cells of IL-1R1-deficient mice further confirmed that pINSd promotes immune responses through IL-1R1.	[Lee, Siyoung; Kim, Eunsom; Jhun, Hyunjhung; Hong, Jaewoo; Kwak, Areum; Jo, Seunghyun; Bae, Suyoung; Lee, Jongho; Kim, Busun; Lee, Jungmin; Youn, Sulah; Kim, Soohyun] Konkuk Univ, Dept Biomed Sci & Technol, Lab Cytokine Immunol, 120 Neungdong Ro, Seoul 05029, South Korea; [Jhun, Hyunjhung; Hong, Jaewoo; Kwak, Areum; Jo, Seunghyun; Kim, Soohyun] Konkuk Univ, Coll Vet Med, 120 Neungdong Ro, Seoul 05029, South Korea; [Kim, Somi; Kim, Miyeon; Kim, Hyunwoo] Jeju Natl Univ, Dept Internal Med, Div Nephrol, Jeju Si 63243, Jeju Do, South Korea; [Lee, Youngmin] Inje Univ, Pusan Paik Hosp, Dept Med, Coll Med, Busan 47392, South Korea; [Choi, Dong-Ki; Kim, Yong-Sung] Ajou Univ, Dept Mol Sci & Technol, Suwon 16499, South Korea	Konkuk University; Konkuk University; Jeju National University; Inje University; Ajou University	Kim, S (corresponding author), Konkuk Univ, Dept Biomed Sci & Technol, Lab Cytokine Immunol, 120 Neungdong Ro, Seoul 05029, South Korea.	soohyun@konkuk.ac.kr		Hong, Jaewoo/0000-0003-3456-3672; Kim, Yong-Sung/0000-0003-2673-1509	National Research Foundation of Korea [NRF-2015R1A2A2A01003472, NRF-2014M3A6A4075058, NRF-2015R1A2A1A15051472]; Konkuk University	National Research Foundation of Korea(National Research Foundation of Korea); Konkuk University	This work was supported by National Research Foundation of Korea Grants NRF-2015R1A2A2A01003472, -2014M3A6A4075058, and -2015R1A2A1A15051472, and this paper resulted from the Konkuk University research support program. The authors declare that they have no conflicts of interest with the contents of this article.	Banting FG, 1923, BRIT MED J, V1923, P8, DOI 10.1136/bmj.1.3236.8; Bersudsky M, 2014, GUT, V63, P598, DOI 10.1136/gutjnl-2012-303329; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; CASEY JI, 1977, J INFECT DIS, V136, P495, DOI 10.1093/infdis/136.4.495; CORDELL B, 1979, CELL, V18, P533, DOI 10.1016/0092-8674(79)90070-9; CRIADO E, 1992, SURG GYNECOL OBSTET, V175, P135; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; ELIASHIV A, 1978, ARCH SURG-CHICAGO, V113, P1180; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gasbarrini A, 1998, EUR J GASTROEN HEPAT, V10, P469, DOI 10.1097/00042737-199806000-00006; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; HOEPELMAN IM, 1994, INT J ANTIMICROB AG, V4, P113, DOI 10.1016/0924-8579(94)90043-4; Hong J, 2011, J BIOL CHEM, V286, P20078, DOI 10.1074/jbc.M111.219089; IMANI F, 1993, J EXP MED, V178, P2165, DOI 10.1084/jem.178.6.2165; Kewcharoenwong C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03363; Kim B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00391; Kim SHM, 2001, P NATL ACAD SCI USA, V98, P3304, DOI 10.1073/pnas.051634098; KITABCHI AE, 1977, METABOLISM, V26, P547, DOI 10.1016/0026-0495(77)90099-3; Knobler H, 2000, MAYO CLIN PROC, V75, P355, DOI 10.4065/75.4.355; Kumar S, 2003, AM J PATHOL, V163, P2531, DOI 10.1016/S0002-9440(10)63608-5; LAMEY PJ, 1988, J ORAL PATHOL MED, V17, P354, DOI 10.1111/j.1600-0714.1988.tb01549.x; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Macleod JJR, 1922, BRIT MED J, V1922, P833, DOI 10.1136/bmj.2.3227.833; MOORADIAN AD, 1991, DIABETES CARE, V14, P63, DOI 10.2337/diacare.14.1.63; Moran A, 2013, LANCET, V381, P1905, DOI 10.1016/S0140-6736(13)60023-9; MOROHOSHI M, 1995, ANN NY ACAD SCI, V748, P562; MOUTSCHEN MP, 1992, DIABETES METAB, V18, P187; Myliwska J., 1998, HORM METAB RES, V30, P158; OHNO Y, 1993, J CLIN ENDOCR METAB, V77, P1072, DOI 10.1210/jc.77.4.1072; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; PLOUFFE JF, 1978, INFECT IMMUN, V21, P425, DOI 10.1128/IAI.21.2.425-429.1978; POZZILLI P, 1984, BIOMED BIOCHIM ACTA, V43, P621; ROBERTSO.HD, 1974, SURGERY, V75, P123; SANGER F, 1951, BIOCHEM J, V49, P463, DOI 10.1042/bj0490463; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648; VLASSARA H, 1988, SCIENCE, V240, P1546, DOI 10.1126/science.3259727; Watkins RA, 2016, TRANSL RES, V168, P96, DOI 10.1016/j.trsl.2015.08.010; WILLIAMS DC, 1982, SCIENCE, V215, P687, DOI 10.1126/science.7036343; Zozulinska D, 1999, DIABETOLOGIA, V42, P117	41	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14620	14627		10.1074/jbc.M116.731026	http://dx.doi.org/10.1074/jbc.M116.731026			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226621	Green Published, hybrid			2022-12-28	WOS:000380366700018
J	Zhou, Q; Hu, HQ; Li, ZY				Zhou, Qing; Hu, Huiqing; Li, Ziyin			An EF-hand-containing Protein in Trypanosoma brucei Regulates Cytokinesis Initiation by Maintaining the Stability of the Cytokinesis Initiation Factor CIF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cell cycle; cytokinesis; microbiology; Trypanosoma brucei; aurora B kinase; polo-like kinase; backup cytokinesis	FLAGELLUM ATTACHMENT ZONE; POLO-LIKE KINASE; CELL-DIVISION; INDUCIBLE EXPRESSION; HELA-CELLS; MORPHOGENESIS; CALMODULIN; COMPLEX; CYCLE; INTERDEPENDENCE	Trypanosoma brucei undergoes cytokinesis uni-directionally from the anterior tip of the new flagellum attachment zone (FAZ) toward the posterior end of the cell. We recently delineated a novel signaling pathway composed of polo-like kinase, cytokinesis initiation factor 1 (CIF1), and aurora B kinase that acts in concert at the new FAZ tip to regulate cytokinesis initiation. To identify new cytokinesis regulators, we carried out proximity-dependent biotin identification and identified many CIF1 binding partners and near neighbors. Here we report a novel CIF1-binding protein, named CIF2, and its mechanistic role in cytokinesis initiation. CIF2 interacts with CIF1 in vivo and co-localizes with CIF1 at the new FAZ tip during early cell cycle stages. RNAi of CIF2 inhibited the normal, anterior-to-posterior cytokinesis but activated an alternative, posterior-to-anterior cytokinesis. CIF2 depletion destabilized CIF1 and disrupted the localization of polo-like kinase and aurora B kinase to the new FAZ tip, thus revealing the mechanistic role of CIF2 in cytokinesis initiation. Surprisingly, overexpression of CIF2 also inhibited the normal, anterior-to-posterior cytokinesis and triggered the alternative, posterior-to-anterior cytokinesis, suggesting a tight control of CIF2 protein abundance. These results identified a new regulator in the cytokinesis regulatory pathway and reiterated that a backup cytokinesis pathway is activated by inhibiting the normal cytokinesis pathway.	[Zhou, Qing; Hu, Huiqing; Li, Ziyin] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Li, ZY (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	Ziyin.Li@uth.tmc.edu	Zhou, Qing/A-8296-2019; Zhou, Qing/I-6223-2019	Zhou, Qing/0000-0003-2096-1960; Zhou, Qing/0000-0003-2096-1960; Li, Ziyin/0000-0002-3960-9716	National Institutes of Health [R01 AI101437]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 AI101437 (to Z. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badjatia N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005498; Briggs LJ, 2004, J CELL SCI, V117, P1641, DOI 10.1242/jcs.00995; Carmena M, 2008, BIOCHEM SOC T, V36, P367, DOI 10.1042/BST0360367; Choudhary A, 2013, P NATL ACAD SCI USA, V110, P13026, DOI 10.1073/pnas.1308203110; de Graffenried CL, 2008, J CELL BIOL, V181, P431, DOI 10.1083/jcb.200708082; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Gonda K, 1999, J CELL SCI, V112, P3619; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; Hu HQ, 2015, J BIOL CHEM, V290, P30453, DOI 10.1074/jbc.M115.694109; Hu HQ, 2015, J BIOL CHEM, V290, P25012, DOI 10.1074/jbc.M115.674796; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; Li CJ, 1999, J CELL SCI, V112, P1567; Li Z, 2010, EUKARYOT CELL, V9, P705, DOI 10.1128/EC.00330-09; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Li ZY, 2012, EUKARYOT CELL, V11, P1180, DOI 10.1128/EC.00145-12; Li ZY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000575; LIU TY, 1992, MOL BIOL CELL, V3, P1403, DOI 10.1091/mbc.3.12.1403; McAllaster MR, 2015, MOL BIOL CELL, V26, P3013, DOI 10.1091/mbc.E15-04-0219; Mierzwa B, 2014, DEV CELL, V31, P525, DOI 10.1016/j.devcel.2014.11.006; Mittal S, 2015, J BIOSCIENCES, V40, P863, DOI 10.1007/s12038-015-9570-0; Morriswood B, 2013, EUKARYOT CELL, V12, P356, DOI 10.1128/EC.00326-12; Nusco GA, 2006, BIOCHEM BIOPH RES CO, V348, P109, DOI 10.1016/j.bbrc.2006.07.023; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Schmidt O, 2012, CURR BIOL, V22, pR116, DOI 10.1016/j.cub.2012.01.028; Sunter JD, 2016, TRENDS PARASITOL, V32, P309, DOI 10.1016/j.pt.2015.12.010; Sunter JD, 2015, J CELL SCI, V128, P1580, DOI 10.1242/jcs.166447; Thakur J, 2012, PLOS GENET, V8, P466, DOI 10.1371/journal.pgen.1002661; Tsang WY, 2006, MOL BIOL CELL, V17, P3423, DOI 10.1091/mbc.E06-04-0371; Tu XM, 2006, J BIOL CHEM, V281, P9677, DOI 10.1074/jbc.M511504200; Vaughan S, 2008, BIOCHEM SOC T, V36, P421, DOI 10.1042/BST0360421; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Watanabe R, 2014, CANCER RES, V74, P2465, DOI 10.1158/0008-5472.CAN-13-3608; Webb SE, 2008, PHILOS T R SOC B, V363, P1363, DOI 10.1098/rstb.2007.2253; Wei Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5060; Wei Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073869; Wheeler RJ, 2013, MOL MICROBIOL, V90, P1339, DOI 10.1111/mmi.12436; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wong R, 2005, CURR BIOL, V15, P1401, DOI 10.1016/j.cub.2005.06.060; Yu YY, 2005, CELL RES, V15, P548, DOI 10.1038/sj.cr.7290324; Yu YY, 2004, INT J BIOCHEM CELL B, V36, P1562, DOI 10.1016/j.biocel.2003.12.016; Zhou Q, 2016, P NATL ACAD SCI USA, V113, P3287, DOI 10.1073/pnas.1601596113; Zhou Q, 2015, MOL MICROBIOL, V98, P667, DOI 10.1111/mmi.13149; Zhou Q, 2015, J CELL SCI, V128, P2361, DOI 10.1242/jcs.168377; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676	50	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14395	14409		10.1074/jbc.M116.726133	http://dx.doi.org/10.1074/jbc.M116.726133			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226595	hybrid, Green Published			2022-12-28	WOS:000380366700001
J	Hildebrandt, ER; Arachea, BT; Wiener, MC; Schmidt, WK				Hildebrandt, Emily R.; Arachea, Buenafe T.; Wiener, Michael C.; Schmidt, Walter K.			Ste24p Mediates Proteolysis of Both Isoprenylated and Non-prenylated Oligopeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; membrane enzyme; metalloprotease; peptidase; protein isoprenylation	INSULIN-DEGRADING ENZYME; RAS-CONVERTING-ENZYME; BETA-STRAND MIMETICS; A-FACTOR PRECURSOR; SACCHAROMYCES-CEREVISIAE; CAAX PROTEASES; IN-VITRO; YEAST; PROTEIN; MEMBRANE	Rce1p and Ste24p are integral membrane proteins involved in the proteolytic maturation of isoprenylated proteins. Extensive published evidence indicates that Rce1p requires the isoprenyl moiety as an important substrate determinant. By contrast, we report that Ste24p can cleave both isoprenylated and non-prenylated substrates in vitro, indicating that the isoprenyl moiety is not required for substrate recognition. Steady-state enzyme kinetics are significantly different for prenylated versus non-prenylated substrates, strongly suggestive of a role for substrate-membrane interaction in protease function. Mass spectroscopy analyses identify a cleavage preference at bonds where P1 is aliphatic in both isoprenylated and non-prenylated substrates, although this is not necessarily predictive. The identified cleavage sites are not at a fixed distance position relative to the C terminus. In this study, the substrates cleaved by Ste24p are based on known isoprenylated proteins (i.e. K-Ras4b and the yeast a-factor mating pheromone) and non-prenylated biological peptides (A and insulin chains) that are known substrates of the M16A family of soluble zinc-dependent metalloproteases. These results establish that the substrate profile of Ste24p is broader than anticipated, being more similar to that of the M16A protease family than that of the Rce1p CAAX protease with which it has been functionally associated.	[Hildebrandt, Emily R.; Schmidt, Walter K.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Arachea, Buenafe T.; Wiener, Michael C.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University System of Georgia; University of Georgia; University of Virginia	Schmidt, WK (corresponding author), A416 Life Sci Bldg,120 Green St, Athens, GA 30602 USA.	wschmidt@bmb.uga.edu			National Institutes of Health [GM108612]; University of Georgia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108612, R01GM117148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM108612 (to M. C. W.) and University of Georgia institutional funds (to W. K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADAMES N, 1995, SCIENCE, V270, P464, DOI 10.1126/science.270.5235.464; Adolphsen K, 2012, G3-GENES GENOM GENET, V2, P629, DOI 10.1534/g3.112.002188; Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Alper BJ, 2009, YEAST, V26, P595, DOI 10.1002/yea.1709; Alper BJ, 2009, J NEUROSCI METH, V178, P40, DOI 10.1016/j.jneumeth.2008.11.010; ANDEREGG RJ, 1988, J BIOL CHEM, V263, P18236; Ast T, 2016, CELL, V164, P103, DOI 10.1016/j.cell.2015.11.053; Barrowman J, 2012, HUM MOL GENET, V21, P4084, DOI 10.1093/hmg/dds233; Barrowman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032120; Bergo MO, 2002, MOL CELL BIOL, V22, P171, DOI 10.1128/MCB.22.1.171-181.2002; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Boyartchuk VL, 1998, GENETICS, V150, P95; Chen P, 1997, MOL BIOL CELL, V8, P1273, DOI 10.1091/mbc.8.7.1273; Chen P, 1997, J CELL BIOL, V136, P251, DOI 10.1083/jcb.136.2.251; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; FujimuraKamada K, 1997, J CELL BIOL, V136, P271, DOI 10.1083/jcb.136.2.271; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guo Q, 2010, J MOL BIOL, V395, P430, DOI 10.1016/j.jmb.2009.10.072; Hanker AB, 2010, ONCOGENE, V29, P380, DOI 10.1038/onc.2009.336; Hildebrandt ER, 2013, BIOCHEMISTRY-US, V52, P6601, DOI 10.1021/bi400647c; Hollander I, 2000, ANAL BIOCHEM, V286, P129, DOI 10.1006/abio.2000.4795; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Keil B., 1905, SPECIFICITY PROTEOLY, V40, P155; Krishnankutty RK, 2009, YEAST, V26, P451, DOI 10.1002/yea.1678; Kukday SS, 2012, J BIOMOL SCREEN, V17, P1348, DOI 10.1177/1087057112451921; Kurochkin IV, 1998, FEBS LETT, V427, P153, DOI 10.1016/S0014-5793(98)00422-0; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; Lazure C, 1998, J BIOL CHEM, V273, P8572, DOI 10.1074/jbc.273.15.8572; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leung GK, 2001, J BIOL CHEM, V276, P29051, DOI 10.1074/jbc.M102908200; Loughlin WA, 2004, CHEM REV, V104, P6085, DOI 10.1021/cr040648k; Loughlin WA, 2010, CHEM REV, V110, pPR32, DOI 10.1021/cr900395y; Manandhar SP, 2007, J BIOMOL SCREEN, V12, P983, DOI 10.1177/1087057107307226; Manolaridis I, 2013, NATURE, V504, P301, DOI 10.1038/nature12754; McLure JA, 2000, BRIT J CLIN PHARMACO, V49, P453, DOI 10.1046/j.1365-2125.2000.00193.x; Mokry DZ, 2009, EUKARYOT CELL, V8, P1891, DOI 10.1128/EC.00169-09; Mukherjee A, 2000, J NEUROSCI, V20, P8745; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Otto JC, 1999, J BIOL CHEM, V274, P8379, DOI 10.1074/jbc.274.13.8379; Plummer LJ, 2006, J BIOL CHEM, V281, P4596, DOI 10.1074/jbc.M506284200; Porter SB, 2007, BBA-MOL CELL RES, V1773, P853, DOI 10.1016/j.bbamcr.2007.03.004; Pryor EE, 2013, SCIENCE, V339, P1600, DOI 10.1126/science.1232048; Quigley A, 2013, SCIENCE, V339, P1604, DOI 10.1126/science.1231513; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; Ricardo S, 2009, SCIENCE, V323, P943, DOI 10.1126/science.1166239; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Sakoh M, 2005, J BIOL CHEM, V280, P33305, DOI 10.1074/jbc.M506180200; Schmidt WK, 1998, P NATL ACAD SCI USA, V95, P11175, DOI 10.1073/pnas.95.19.11175; Schmidt WK, 2000, J BIOL CHEM, V275, P6227, DOI 10.1074/jbc.275.9.6227; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; SIKORSKI RS, 1989, GENETICS, V122, P19; Silvius JR, 2002, J MEMBRANE BIOL, V190, P83, DOI 10.1007/s00232-002-1026-4; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Tam A, 2001, J BIOL CHEM, V276, P46798, DOI 10.1074/jbc.M106150200; Tam A, 1998, J CELL BIOL, V142, P635, DOI 10.1083/jcb.142.3.635; Tipper DJ, 2002, MOL BIOL CELL, V13, P1158, DOI 10.1091/mbc.01-10-0488; Trueblood CE, 2000, MOL CELL BIOL, V20, P4381, DOI 10.1128/MCB.20.12.4381-4392.2000; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200	67	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14185	14198		10.1074/jbc.M116.718197	http://dx.doi.org/10.1074/jbc.M116.718197			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129777	Green Published, hybrid			2022-12-28	WOS:000379975100025
J	Hong, ZB; De Meulemeester, L; Jacobi, A; Pedersen, JS; Morth, JP; Andreasen, PA; Jensen, JK				Hong, Zebin; De Meulemeester, Laura; Jacobi, Annemarie; Pedersen, Jan Skov; Morth, J. Preben; Andreasen, Peter A.; Jensen, Jan K.			Crystal Structure of a Two-domain Fragment of Hepatocyte Growth Factor Activator Inhibitor-1: FUNCTIONAL INTERACTIONS BETWEEN THE KUNITZ-TYPE INHIBITOR DOMAIN-1 AND THE NEIGHBORING POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface protein; inhibition mechanism; protease inhibitor; protein-protein interaction; tertiary structure; multidomain protein	SERINE-PROTEASE INHIBITOR; MATRIPTASE; SCATTERING; HAI-1; SPECIFICITY; ICHTHYOSIS; SUBSTRATE; INSIGHTS; CLEAVAGE; COMPLEX	Hepatocyte growth factor activator inhibitor-1 (HAI-1) is a type I transmembrane protein and inhibitor of several serine proteases, including hepatocyte growth factor activator and matriptase. The protein is essential for development as knock-out mice die in utero due to placental defects caused by misregulated extracellular proteolysis. HAI-1 contains two Kunitz-type inhibitor domains (Kunitz), which are generally thought of as a functionally self-contained protease inhibitor unit. This is not the case for HAI-1, where our results reveal how interdomain interactions have evolved to stimulate the inhibitory activity of an integrated Kunitz. Here we present an x-ray crystal structure of an HAI-1 fragment covering the internal domain and Kunitz-1. The structure reveals not only that the previously uncharacterized internal domain is a member of the polycystic kidney disease domain family but also how the two domains engage in interdomain interactions. Supported by solution small angle x-ray scattering and a combination of site-directed mutagenesis and functional assays, we show that interdomain interactions not only stabilize the fold of the internal domain but also stimulate the inhibitory activity of Kunitz-1. By completing our structural characterization of the previously unknown N-terminal region of HAI-1, we provide new insight into the interplay between tertiary structure and the inhibitory activity of a multidomain protease inhibitor. We propose a previously unseen mechanism by which the association of an auxiliary domain stimulates the inhibitory activity of a Kunitz-type inhibitor (i.e. the first structure of an intramolecular interaction between a Kunitz and another domain).	[Hong, Zebin; De Meulemeester, Laura; Jacobi, Annemarie; Andreasen, Peter A.; Jensen, Jan K.] Aarhus Univ, Dept Mol Biol & Genet, Danish Chinese Ctr Proteases & Canc, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark; [Pedersen, Jan Skov] Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark; [Pedersen, Jan Skov] Aarhus Univ, iNANO Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark; [Morth, J. Preben] Univ Oslo, NCMM, NO-0316 Oslo, Norway	Aarhus University; Aarhus University; Aarhus University; University of Oslo	Jensen, JK (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Danish Chinese Ctr Proteases & Canc, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	jkj@mbg.au.dk	Pedersen, Jan Skov/A-8346-2008; Morth, Jens Preben/AAP-7834-2021; Morth, Jens Preben/G-4450-2013	Pedersen, Jan Skov/0000-0002-7768-0206; Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192	Danish Cancer Society	Danish Cancer Society(Danish Cancer Society)	This work was supported by the Danish Cancer Society. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bathige SDNK, 2015, FISH SHELLFISH IMMUN, V46, P285, DOI 10.1016/j.fsi.2015.07.004; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; Copeland R. A., 2000, ENZYMES PRACTICAL IN; Denda K, 2002, J BIOL CHEM, V277, P14053, DOI 10.1074/jbc.M112263200; Domoto T, 2012, CANCER SCI, V103, P448, DOI 10.1111/j.1349-7006.2011.02162.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Fan B, 2007, DEV BIOL, V303, P222, DOI 10.1016/j.ydbio.2006.11.005; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; Hashimoto T, 2010, FEBS J, V277, P4888, DOI 10.1111/j.1742-4658.2010.07894.x; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hong ZB, 2015, BIOCHEM J, V466, P299, DOI 10.1042/BJ20141236; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kataoka H, 2000, J BIOL CHEM, V275, P40453, DOI 10.1074/jbc.M006412200; Kato M, 2012, J BIOCHEM, V151, P179, DOI 10.1093/jb/mvr131; Kawaguchi M, 2011, AM J PATHOL, V179, P1815, DOI 10.1016/j.ajpath.2011.06.038; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Kojima K, 2008, J BIOL CHEM, V283, P2478, DOI 10.1074/jbc.M709073200; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2009, FUTURE ONCOL, V5, P97, DOI 10.2217/14796694.5.1.97; Ma L, 2009, J BIOL CHEM, V284, P32942, DOI 10.1074/jbc.M109.021832; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087675; Nagaike K, 2008, AM J PATHOL, V173, P1464, DOI 10.2353/ajpath.2008.071142; Orikoshi H, 2005, J APPL MICROBIOL, V99, P551, DOI 10.1111/j.1365-2672.2005.02630.x; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; PEDERSEN JS, 1994, EUR BIOPHYS J BIOPHY, V22, P379, DOI 10.1007/BF00180159; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; PRICE NC, 1985, BIOCHEM EDUC, V13, P81, DOI 10.1016/0307-4412(85)90016-0; Ranasinghe S, 2013, DEV COMP IMMUNOL, V39, P219, DOI 10.1016/j.dci.2012.10.005; Retailleau K, 2014, J PHYSIOL-LONDON, V592, P2453, DOI 10.1113/jphysiol.2014.271346; Rezaie AR, 2005, THROMB HAEMOSTASIS, V93, P1047, DOI 10.1160/TH04-11-0730; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; Shimomura T, 1999, J BIOCHEM-TOKYO, V126, P821, DOI 10.1093/oxfordjournals.jbchem.a022522; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; Tanaka H, 2005, MOL CELL BIOL, V25, P5687, DOI 10.1128/MCB.25.13.5687-5698.2005; Viswanathan M., 2009, CURR ENZYME INHIBIT, V5, P87; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhao BY, 2013, J BIOL CHEM, V288, P11155, DOI 10.1074/jbc.M113.454611	54	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14340	14355		10.1074/jbc.M115.707240	http://dx.doi.org/10.1074/jbc.M115.707240			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27189939	Green Published, hybrid			2022-12-28	WOS:000379975100036
J	Wang, WJ; Yan, RY; Nocek, BP; Vuong, TV; Di Leo, R; Xu, XH; Cui, H; Gatenholm, P; Toriz, G; Tenkanen, M; Savchenko, A; Master, ER				Wang, Weijun; Yan, Ruoyu; Nocek, Boguslaw P.; Vuong, Thu V.; Di Leo, Rosa; Xu, Xiaohui; Cui, Hong; Gatenholm, Paul; Toriz, Guillermo; Tenkanen, Maija; Savchenko, Alexei; Master, Emma R.			Biochemical and Structural Characterization of a Five-domain GH115-Glucuronidase from the Marine Bacterium Saccharophagus degradans 2-40(T)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate; crystal structure; enzyme catalysis; enzyme structure; protein domain; GH115-glucuronidase; carbohydrate degradation; catalytic apparatus; enzyme domain composition	PLANT-CELL WALL; THERMOTOGA-MARITIMA MSB8; ALPHA-GLUCURONIDASE; DENSITY MODIFICATION; FAMILY GH115; SCHIZOPHYLLUM-COMMUNE; INVERTING CHARACTER; CRYSTAL-STRUCTURES; XYLAN; POLYSACCHARIDES	Glucuronic acid (GlcAp) and/or methylglucuronic acid (MeGlcAp) decorate the major forms of xylan in hardwood and coniferous softwoods as well as many cereal grains. Accordingly, the complete utilization of glucuronoxylans or conversion to sugar precursors requires the action of main chain xylanases as well as -glucuronidases that release the - (12)-linked (Me)GlcAp side groups. Herein, a family GH115 enzymefrom the marine bacterium Saccharophagus degradans 2-40(T), SdeAgu115A, demonstrated activity toward glucuronoxylan and oligomers thereof with preference toward MeGlcAp linked to internal xylopyranosyl residues. Unique biochemical characteristics of NaCl activation were also observed. The crystal structure of SdeAgu115A revealed a five-domain architecture, with an additional insertion C+ domain that had significant impact on the domain arrangement of SdeAgu115A monomer and its dimerization. The participation of domain C+ in substrate binding was supported by reduced substrate inhibition upon introducing W773A, W689A, and F696A substitutions within this domain. In addition to Asp-335, the catalytic essentiality of Glu-216 was revealed by site-specific mutagenesis. A primary sequence analysis suggested that the SdeAgu115A architecture is shared by more than half of GH115 members, thus defining a distinct archetype for GH115 enzymes.	[Wang, Weijun; Yan, Ruoyu; Vuong, Thu V.; Di Leo, Rosa; Xu, Xiaohui; Cui, Hong; Savchenko, Alexei; Master, Emma R.] Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada; [Nocek, Boguslaw P.] Argonne Natl Lab, Struct Biol Ctr, Biosci Div, 9700 S Cass Ave, Argonne, IL 60439 USA; [Gatenholm, Paul; Toriz, Guillermo] Chalmers, Dept Chem & Chem Engn, Wallenberg Wood Sci Ctr, Kemivagen 4, S-41296 Gothenburg, Sweden; [Gatenholm, Paul; Toriz, Guillermo] Chalmers, Biopolymer Technol, Kemivagen 4, S-41296 Gothenburg, Sweden; [Toriz, Guillermo] Univ Guadalajara, Dept Wood Cellulose & Paper Res, Guadalajara 44100, Mexico; [Tenkanen, Maija] Univ Helsinki, Dept Food & Environm Sci, POB 27, FIN-00014 Helsinki, Finland	University of Toronto; United States Department of Energy (DOE); Argonne National Laboratory; Chalmers University of Technology; Chalmers University of Technology; Universidad de Guadalajara; University of Helsinki	Savchenko, A; Master, ER (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada.	alexei.savchenko@utoronto.ca; emma.master@utoronto.ca	Master, Emma/O-3554-2014; Toriz, Guillermo/Q-6876-2019; Toriz, Guillermo/GRE-6547-2022	Toriz, Guillermo/0000-0002-8154-8590; Tenkanen, Maija/0000-0003-2883-2717; wang, weijun/0000-0001-9283-5619	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	We thank G. Brown and Professor A. Yakunin (University of Toronto) for technical support and Dr. Masoud Vedadi and Dr. Guillermo Senisterra (Structural Genomics Consortium, Toronto, Canada) for circular dichroism spectra acquisition. We also thank K. Parikka for preparing figures of xylan structures. Structural results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne National Laboratory is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research, under contract DE-AC02-06CH11357.	Aalbers F, 2015, J MOL BIOL, V427, P3935, DOI 10.1016/j.jmb.2015.07.006; ANDRYKOVITCH G, 1988, APPL ENVIRON MICROB, V54, P1061, DOI 10.1128/AEM.54.4.1061-1062.1988; Biely P, 2000, BBA-GEN SUBJECTS, V1474, P360, DOI 10.1016/S0304-4165(00)00029-5; Bosmans TJ, 2014, BIOMACROMOLECULES, V15, P924, DOI 10.1021/bm4017868; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRONNENMEIER K, 1995, MICROBIOL-SGM, V141, P2033, DOI 10.1099/13500872-141-9-2033; Busse-Wicher M, 2014, PLANT J, V79, P492, DOI 10.1111/tpj.12575; Chong SL, 2011, APPL MICROBIOL BIOT, V90, P1323, DOI 10.1007/s00253-011-3157-y; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Copeland RA, 2000, ENZYMES PRACTICAL IN, P109; COUGHLAN MP, 1993, BIOTECHNOL APPL BIOC, V17, P259; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Cowtan K, 2001, ACTA CRYSTALLOGR D, V57, P1435, DOI 10.1107/S0907444901010812; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; de Vries RP, 2000, CARBOHYD RES, V327, P401, DOI 10.1016/S0008-6215(00)00066-5; DERUITER GA, 1992, ANAL BIOCHEM, V207, P176, DOI 10.1016/0003-2697(92)90520-H; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Eidam O, 2008, FEBS LETT, V582, P651, DOI 10.1016/j.febslet.2008.01.030; Ekborg NA, 2006, APPL ENVIRON MICROB, V72, P3396, DOI 10.1128/AEM.72.5.3396-3405.2006; Escalante A, 2012, CARBOHYD POLYM, V87, P2381, DOI 10.1016/j.carbpol.2011.11.003; Freelove Alexander C. J., 2001, Journal of Biological Chemistry, V276, P43010, DOI 10.1074/jbc.M107143200; Fujimoto Z, 2011, ACTA CRYSTALLOGR F, V67, P68, DOI 10.1107/S1744309110043721; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Golan G, 2004, J BIOL CHEM, V279, P3014, DOI 10.1074/jbc.M310098200; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hutcheson SW, 2011, MAR DRUGS, V9, P645, DOI 10.3390/md9040645; Ito T, 2013, J BIOL CHEM, V288, P11795, DOI 10.1074/jbc.M112.420109; Knight SD, 2002, ACTA CRYSTALLOGR D, V58, P1016, DOI 10.1107/S0907444902005954; Kolenova K, 2010, FEBS LETT, V584, P4063, DOI 10.1016/j.febslet.2010.08.031; KORMELINK FJM, 1993, APPL MICROBIOL BIOT, V38, P688, DOI 10.1007/BF00182811; Koutaniemi S, 2012, PLANTA, V236, P739, DOI 10.1007/s00425-012-1653-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lemak S, 2012, BIOCHEM J, V445, P193, DOI 10.1042/BJ20112113; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Mello LV, 2010, FEBS LETT, V584, P2421, DOI 10.1016/j.febslet.2010.04.045; Mikkonen KS, 2012, TRENDS FOOD SCI TECH, V28, P90, DOI 10.1016/j.tifs.2012.06.012; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nocek B, 2008, PROTEINS, V70, P273, DOI 10.1002/prot.21276; Nurizzo D, 2002, STRUCTURE, V10, P547, DOI 10.1016/S0969-2126(02)00742-6; Pathak S, 2008, CHEM BIOL, V15, P799, DOI 10.1016/j.chembiol.2008.06.010; Rogowski A, 2014, J BIOL CHEM, V289, P53, DOI 10.1074/jbc.M113.525295; Rosa L, 2013, FUNGAL BIOL-UK, V117, P380, DOI 10.1016/j.funbio.2013.04.002; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Ryabova O, 2009, FEBS LETT, V583, P1457, DOI 10.1016/j.febslet.2009.03.057; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Sedlmeyer FB, 2011, FOOD HYDROCOLLOID, V25, P1891, DOI 10.1016/j.foodhyd.2011.04.005; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Suresh C, 2003, BIOSCI BIOTECH BIOCH, V67, P2359, DOI 10.1271/bbb.67.2359; Suresh C, 2002, FEBS LETT, V517, P159, DOI 10.1016/S0014-5793(02)02611-X; Taylor LE, 2006, J BACTERIOL, V188, P3849, DOI 10.1128/JB.01348-05; Teleman A, 2000, CARBOHYD RES, V329, P807, DOI 10.1016/S0008-6215(00)00249-4; Tenkanen M, 2000, J BIOTECHNOL, V78, P149, DOI 10.1016/S0168-1656(99)00240-0; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Timell T. E., 1967, Wood Science and Technology, V1, P45, DOI 10.1007/BF00592255; Uchimura K, 2010, MAR BIOTECHNOL, V12, P526, DOI 10.1007/s10126-009-9237-7; Vuong TV, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-148; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087	65	11	11	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14120	14133		10.1074/jbc.M115.702944	http://dx.doi.org/10.1074/jbc.M115.702944			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129264	Green Published, hybrid			2022-12-28	WOS:000379975100020
J	Watson, JR; Fox, HM; Nietlispach, D; Gallop, JL; Owen, D; Mott, HR				Watson, Joanna R.; Fox, Helen M.; Nietlispach, Daniel; Gallop, Jennifer L.; Owen, Darerca; Mott, Helen R.			Investigation of the Interaction between Cdc42 and Its Effector TOCA1: HANDOVER OF Cdc42 TO THE ACTIN REGULATOR N-WASP IS FACILITATED BY DIFFERENTIAL BINDING AFFINITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; CDC42; endocytosis; nuclear magnetic resonance (NMR); protein-protein interaction; BAR domain; CIP4; FBP17; TOCA1; WASP	ALDRICH-SYNDROME PROTEIN; GTPASE-BINDING; SIGNAL INTEGRATION; STRUCTURAL BASIS; STRESS FIBERS; BAR-DOMAIN; WEB SERVER; COMPLEX; RHO; POLYMERIZATION	Transducer of Cdc42-dependent actin assembly protein 1 (TOCA1) is an effector of the Rho family small G protein Cdc42. It contains a membrane-deforming F-BAR domain as well as a Src homology 3 (SH3) domain and a G protein-binding homology region 1 (HR1) domain. TOCA1 binding to Cdc42 leads to actin rearrangements, which are thought to be involved in processes such as endocytosis, filopodia formation, and cell migration. We have solved the structure of the HR1 domain of TOCA1, providing the first structural data for this protein. We have found that the TOCA1 HR1, like the closely related CIP4 HR1, has interesting structural features that are not observed in other HR1 domains. We have also investigated the binding of the TOCA HR1 domain to Cdc42 and the potential ternary complex between Cdc42 and the G protein-binding regions of TOCA1 and a member of the Wiskott-Aldrich syndrome protein family, N-WASP. TOCA1 binds Cdc42 with micromolar affinity, in contrast to the nanomolar affinity of the N-WASP G protein-binding region for Cdc42. NMR experiments show that the Cdc42-binding domain from N-WASP is able to displace TOCA1 HR1 from Cdc42, whereas the N-WASP domain but not the TOCA1 HR1 domain inhibits actin polymerization. This suggests that TOCA1 binding to Cdc42 is an early step in the Cdc42-dependent pathways that govern actin dynamics, and the differential binding affinities of the effectors facilitate a handover from TOCA1 to N-WASP, which can then drive recruitment of the actin-modifying machinery.	[Watson, Joanna R.; Fox, Helen M.; Nietlispach, Daniel; Gallop, Jennifer L.; Owen, Darerca; Mott, Helen R.] Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England; [Fox, Helen M.; Gallop, Jennifer L.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Owen, D; Mott, HR (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	do202@cam.ac.uk; hrm28@cam.ac.uk	Mott, Helen/AAV-3873-2020	Mott, Helen/0000-0002-7890-7097; Watson, Joanna/0000-0002-0606-3200; Nietlispach, Daniel/0000-0003-4364-9291; Fox, Helen Mary/0000-0002-6907-2278; Gallop, Jennifer Louise/0000-0002-9978-1382	Herchel Smith studentship; Wellcome Trust Ph.D. Studentship [WT099740Z12Z]; Wellcome Trust Research Career Development Fellowship [WT095829AIA]; European Research Council Starting Grant [281971]; Gurdon Institute by Wellcome Trust [092096]; CRUK [C6946/A14492]	Herchel Smith studentship; Wellcome Trust Ph.D. Studentship(Wellcome Trust); Wellcome Trust Research Career Development Fellowship(Wellcome Trust); European Research Council Starting Grant(European Research Council (ERC)); Gurdon Institute by Wellcome Trust; CRUK(Cancer Research UK)	Supported by a Herchel Smith studentship.; Supported by Wellcome Trust Ph.D. Studentship WT099740Z12Z.; Supported by Wellcome Trust Research Career Development Fellowship WT095829AIA, European Research Council Starting Grant 281971, and Gurdon Institute funding provided by Wellcome Trust Grant 092096 and CRUK Grant C6946/A14492.	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; Bai ZY, 2015, P NATL ACAD SCI USA, V112, pE1443, DOI 10.1073/pnas.1418651112; Bailey LK, 2009, J BIOL CHEM, V284, P992, DOI 10.1074/jbc.M806167200; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bu WY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012153; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chander H, 2013, ONCOGENE, V32, P3080, DOI 10.1038/onc.2012.317; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Elliot-Smith AE, 2005, BIOCHEMISTRY-US, V44, P12373, DOI 10.1021/bi0506021; Elliot-Smith AE, 2007, BIOCHEMISTRY-US, V46, P14087, DOI 10.1021/bi701539x; Fenwick RB, 2010, STRUCTURE, V18, P985, DOI 10.1016/j.str.2010.05.013; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; Gallop JL, 2013, P NATL ACAD SCI USA, V110, P7193, DOI 10.1073/pnas.1305286110; Giuliani C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000675; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Hu JH, 2011, J BIOL CHEM, V286, P2261, DOI 10.1074/jbc.M110.157974; Hubbard S. J., 1993, NACCESS; Hutchinson CL, 2013, BIOCHEMISTRY-US, V52, P7999, DOI 10.1021/bi401216w; Hutchinson CL, 2011, BIOCHEMISTRY-US, V50, P2860, DOI 10.1021/bi200039u; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kobashigawa Y, 2009, J BIOMOL NMR, V44, P113, DOI 10.1007/s10858-009-9317-z; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Lee K, 2010, SCIENCE, V329, P1341, DOI 10.1126/science.1191710; Leung DW, 2005, P NATL ACAD SCI USA, V102, P5685, DOI 10.1073/pnas.0406472102; Ma L, 1998, J CELL BIOL, V140, P1125; Ma L, 1998, P NATL ACAD SCI USA, V95, P15362, DOI 10.1073/pnas.95.26.15362; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; Machesky LM, 1996, TRENDS CELL BIOL, V6, P304, DOI 10.1016/0962-8924(96)10026-X; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Miki H, 1998, BIOCHEM BIOPH RES CO, V243, P73, DOI 10.1006/bbrc.1997.8064; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miyamoto K, 2011, GENE DEV, V25, P946, DOI 10.1101/gad.615211; Modha R, 2008, J BIOL CHEM, V283, P1492, DOI 10.1074/jbc.M706760200; Mott HR, 2015, CRIT REV BIOCHEM MOL, V50, P85, DOI 10.3109/10409238.2014.999191; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Nakamura K, 2012, J BIOL CHEM, V287, P25478, DOI 10.1074/jbc.M112.365783; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Owen D, 2008, J BIOL CHEM, V283, P1692, DOI 10.1074/jbc.M707257200; Ozbabacan SEA, 2011, PROTEIN ENG DES SEL, V24, P635, DOI 10.1093/protein/gzr025; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 1996, CURR BIOL, V6, P1256, DOI 10.1016/S0960-9822(02)70711-2; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Van Itallie CM, 2015, MOL BIOL CELL, V26, P2769, DOI 10.1091/mbc.E15-04-0232; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walrant A, 2015, METHOD CELL BIOL, V128, P125, DOI 10.1016/bs.mcb.2015.01.020; Wang J, 2006, PLOS COMPUT BIOL, V2, P842, DOI 10.1371/journal.pcbi.0020078; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Watson JR, 2016, BIOMOL NMR ASSIGN, V10, P407, DOI 10.1007/s12104-016-9677-8; Wu M, 2013, P NATL ACAD SCI USA, V110, P1339, DOI 10.1073/pnas.1221538110	80	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13875	13890		10.1074/jbc.M116.724294	http://dx.doi.org/10.1074/jbc.M116.724294			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129201	Green Published, hybrid			2022-12-28	WOS:000379771100041
J	Wynn, ML; Yates, JA; Evans, CR; Van Wassenhove, LD; Wu, ZF; Bridges, S; Bao, LW; Fournier, C; Ashrafzadeh, S; Merrins, MJ; Satin, LS; Schnell, S; Burant, CF; Merajver, SD				Wynn, Michelle L.; Yates, Joel A.; Evans, Charles R.; Van Wassenhove, Lauren D.; Wu, Zhi Fen; Bridges, Sydney; Bao, Liwei; Fournier, Chelsea; Ashrafzadeh, Sepideh; Merrins, Matthew J.; Satin, Leslie S.; Schnell, Santiago; Burant, Charles F.; Merajver, Sofia D.			RhoC GTPase Is a Potent Regulator of Glutamine Metabolism and N-Acetylaspartate Production in Inflammatory Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; glutamine; hypoxia-inducible factor (HIF); Rho (Rho GTPase); tumor metabolism; N-acetylaspartate	KINASE TYPE M2; PYRUVATE-KINASE; LUNG-CANCER; E-CADHERIN; IN-VIVO; GROWTH; OVEREXPRESSION; HYPOXIA; PROTEIN; CARBOXYLATION	Inflammatory breast cancer (IBC) is an extremely lethal cancer that rapidly metastasizes. Although the molecular attributes of IBC have been described, little is known about the underlying metabolic features of the disease. Using a variety of metabolic assays, including C-13 tracer experiments, we found that SUM149 cells, the primary in vitro model of IBC, exhibit metabolic abnormalities that distinguish them from other breast cancer cells, including elevated levels of N-acetylaspartate, a metabolite primarily associated with neuronal disorders and gliomas. Here we provide the first evidence of N-acetylaspartate in breast cancer. We also report that the oncogene RhoC, a driver of metastatic potential, modulates glutamine and N-acetylaspartate metabolism in IBC cells in vitro, revealing a novel role for RhoC as a regulator of tumor cell metabolism that extends beyond its well known role in cytoskeletal rearrangement.	[Wynn, Michelle L.; Yates, Joel A.; Evans, Charles R.; Wu, Zhi Fen; Bridges, Sydney; Bao, Liwei; Fournier, Chelsea; Ashrafzadeh, Sepideh; Burant, Charles F.; Merajver, Sofia D.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wynn, Michelle L.; Schnell, Santiago] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Satin, Leslie S.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Van Wassenhove, Lauren D.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Merrins, Matthew J.] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; [Merrins, Matthew J.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Merajver, SD (corresponding author), Univ Michigan, Dept Internal Med, Ctr Canc 7217, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	smerajve@umich.edu	Burant, Charles/GPC-5690-2022; Schnell, Santiago/B-8682-2008	Burant, Charles/0000-0001-9189-5003; Schnell, Santiago/0000-0002-9477-3914; Merrins, Matthew J./0000-0003-1599-9227; Van Wassenhove, Lauren/0000-0002-6130-4580; Yates, Joel/0000-0002-1462-8494; Evans, Charles/0000-0001-6698-5330	National Institutes of Health [U24 DK097153]; NATIONAL CANCER INSTITUTE [T32CA140044, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK046409, U24DK097153, K25DK092558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work utilized core services of the Michigan Regional Comprehensive Metabolomics Resource Core, supported by National Institutes of Health Grant U24 DK097153. We thank Firas Midani for help with natural abundance correction algorithms and Mariana Rodriguez Ortiz for help with figure preparation.	Chen YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep09980; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Chu K, 2013, ONCOTARGET, V4, P446, DOI 10.18632/oncotarget.872; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321; EAGLE H, 1955, SCIENCE, V122, P501, DOI 10.1126/science.122.3168.501; Evans CR, 2014, J PROTEOME RES, V13, P640, DOI 10.1021/pr4007624; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Ferreira LMR, 2010, EXP MOL PATHOL, V89, P372, DOI 10.1016/j.yexmp.2010.08.006; Fong MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019963; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Griner EM, 2015, MOL CANCER RES, V13, P483, DOI 10.1158/1541-7786.MCR-14-0420; Hascalik S, 2006, INT J GYNECOL CANCER, V16, P423, DOI 10.1111/j.1525-1438.2006.00200.x; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Holleran AL, 1995, MOL CELL BIOCHEM, V152, P95, DOI 10.1007/BF01076071; Howlader N, 2015, SEER CANC STAT REV 1; Ikoma T, 2004, CLIN CANCER RES, V10, P1192, DOI 10.1158/1078-0432.CCR-03-0275; Kleer CG, 2005, BREAST CANCER RES TR, V93, P101, DOI 10.1007/s10549-005-4170-6; Kolwijck E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010293; Levine PH, 2012, CLIN BREAST CANCER, V12, P232, DOI 10.1016/j.clbc.2012.04.005; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Lou TF, 2016, CANCER PREV RES, V9, P43, DOI 10.1158/1940-6207.CAPR-14-0287; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; MEHTA V, 1995, MOL BRAIN RES, V31, P151, DOI 10.1016/0169-328X(95)00044-S; Merrins MJ, 2013, J BIOL CHEM, V288, P33312, DOI 10.1074/jbc.M113.508127; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Noguchi Y, 2009, J BIOL CHEM, V284, P33425, DOI 10.1074/jbc.M109.049478; Poore B, 2015, GLUTAMINE CLIN NUTR, P77; Rocheleau JV, 2004, J BIOL CHEM, V279, P31780, DOI 10.1074/jbc.M314005200; Rosenthal DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040979; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; SAUER LA, 1983, CANCER RES, V43, P3497; Silvera D, 2009, CELL CYCLE, V8, P3091, DOI 10.4161/cc.8.19.9637; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Tong ZY, 2004, MAGN RESON IMAGING, V22, P1017, DOI 10.1016/j.mri.2004.02.007; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; van Golen KL, 2000, CANCER RES, V60, P5832; van Golen KL, 2000, NEOPLASIA, V2, P418, DOI 10.1038/sj.neo.7900115; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vaupel P, 2012, INT J BIOCHEM CELL B, V44, P1477, DOI 10.1016/j.biocel.2012.05.019; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wecsler JS, 2015, BREAST CANCER RES TR, V151, P113, DOI 10.1007/s10549-015-3367-6; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Woodward WA, 2009, SEMIN RADIAT ONCOL, V19, P256, DOI 10.1016/j.semradonc.2009.05.008; Yalcinkaya C, 2005, NEUROPEDIATRICS, V36, P336, DOI 10.1055/s-2005-872878; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zand B, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv426	51	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13715	13729		10.1074/jbc.M115.703959	http://dx.doi.org/10.1074/jbc.M115.703959			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129239	Green Published, hybrid			2022-12-28	WOS:000379771100026
J	Ghosh, S; Taylor, A; Chin, M; Huang, HR; Conery, AR; Mertz, JA; Salmeron, A; Dakle, PJ; Mele, D; Cote, A; Jayaram, H; Setser, JW; Poy, F; Hatzivassiliou, G; DeAlmeida-Nagata, D; Sandy, P; Hatton, C; Romero, FA; Chiang, E; Reimer, T; Crawford, T; Pardo, E; Watson, VG; Tsui, V; Cochran, AG; Zawadzke, L; Harmange, JC; Audia, JE; Bryant, BM; Cummings, RT; Magnuson, SR; Grogan, JL; Bellon, SF; Albrecht, BK; Sims, RJ; Lora, JM				Ghosh, Srimoyee; Taylor, Alexander; Chin, Melissa; Huang, Hon-Ren; Conery, Andrew R.; Mertz, Jennifer A.; Salmeron, Andres; Dakle, Pranal J.; Mele, Deanna; Cote, Alexandre; Jayaram, Hari; Setser, Jeremy W.; Poy, Florence; Hatzivassiliou, Georgia; DeAlmeida-Nagata, Denise; Sandy, Peter; Hatton, Charlie; Romero, F. Anthony; Chiang, Eugene; Reimer, Thornik; Crawford, Terry; Pardo, Eneida; Watson, Venita G.; Tsui, Vickie; Cochran, Andrea G.; Zawadzke, Laura; Harmange, Jean-Christophe; Audia, James E.; Bryant, Barbara M.; Cummings, Richard T.; Magnuson, Steven R.; Grogan, Jane L.; Bellon, Steve F.; Albrecht, Brian K.; Sims, Robert J., III; Lora, Jose M.			Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-IMMUNOTHERAPY; IMMUNE-RESPONSES; BREAST-CANCER; P300; CHROMATIN; FOXP3; ACETYLTRANSFERASES; LYMPHOCYTES; ACTIVATION; CBP/P300	Covalent modification of histones is a fundamental mechanism of regulated gene expression in eukaryotes, and interpretation of histone modifications is an essential feature of epigenetic control. Bromodomains are specialized binding modules that interact with acetylated histones, linking chromatin recognition to gene transcription. Because of their ability to function in a domain-specific fashion, selective disruption of bromodomain: acetylated histone interactions with chemical probes serves as a powerful means for understanding biological processes regulated by these chromatin adaptors. Here we describe the discovery and characterization of potent and selective small molecule inhibitors for the bromodomains of CREBBP/EP300 that engage their target in cellular assays. We use these tools to demonstrate a critical role for CREBBP/EP300 bromodomains in regulatory T cell biology. Because regulatory T cell recruitment to tumors is a major mechanism of immune evasion by cancer cells, our data highlight the importance of CREBBP/EP300 bromodomain inhibition as a novel, small molecule-based approach for cancer immunotherapy.	[Ghosh, Srimoyee; Taylor, Alexander; Chin, Melissa; Huang, Hon-Ren; Conery, Andrew R.; Mertz, Jennifer A.; Salmeron, Andres; Dakle, Pranal J.; Mele, Deanna; Cote, Alexandre; Jayaram, Hari; Setser, Jeremy W.; Poy, Florence; Sandy, Peter; Hatton, Charlie; Pardo, Eneida; Watson, Venita G.; Zawadzke, Laura; Harmange, Jean-Christophe; Audia, James E.; Bryant, Barbara M.; Cummings, Richard T.; Bellon, Steve F.; Albrecht, Brian K.; Sims, Robert J., III; Lora, Jose M.] Constellat Pharmaceut Inc, 215 First St, Cambridge, MA 02142 USA; [Hatzivassiliou, Georgia; DeAlmeida-Nagata, Denise; Romero, F. Anthony; Chiang, Eugene; Reimer, Thornik; Crawford, Terry; Tsui, Vickie; Cochran, Andrea G.; Magnuson, Steven R.; Grogan, Jane L.] Genentech Inc, San Francisco, CA 94080 USA; [Chin, Melissa] Editas Med Inc, Cambridge, MA USA; [Huang, Hon-Ren] Intellia Therapeut, Cambridge, MA USA; [Salmeron, Andres] Potenza Therapeut, Cambridge, MA USA; [Dakle, Pranal J.; Mele, Deanna] AstraZeneca, Waltham, MA USA; [Sandy, Peter] Evelo Therapeut, Cambridge, MA USA; [Zawadzke, Laura] EMD Serono, Billerica, MA USA; [Harmange, Jean-Christophe] Third Rock Ventures, Boston, MA USA	Roche Holding; Genentech; AstraZeneca	Sims, RJ; Lora, JM (corresponding author), Constellat Pharmaceut Inc, 215 First St, Cambridge, MA 02142 USA.	robert.sims@constellationpharma.com; jose.lora@constellationpharma.com	Romero, F. Anthony/S-8530-2018	Romero, F. Anthony/0000-0001-7917-1459; CONERY, ANDREW/0000-0003-3638-7633; Bryant, Barbara/0000-0003-2707-1186; Cochran, Andrea/0000-0001-6469-795X; Hatton, Charlie/0000-0001-9903-4291				Anderson AC, 2014, CANCER IMMUNOL RES, V2, P393, DOI 10.1158/2326-6066.CIR-14-0039; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Cai GF, 2009, IMMUNOL REV, V229, P244, DOI 10.1111/j.1600-065X.2009.00783.x; Chen JH, 2011, EPIGENETICS-US, V6, P957, DOI 10.4161/epi.6.8.16065; Chen JH, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12224; Ciceri P, 2014, NAT CHEM BIOL, V10, P305, DOI 10.1038/nchembio.1471; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Conery AR, 2016, ELIFE, V5, DOI [10.7554/eLife.10483, 10.7554/eLife.19432]; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Goodman RH, 2000, GENE DEV, V14, P1553; Hammitzsch A, 2015, P NATL ACAD SCI USA, V112, P10768, DOI 10.1073/pnas.1501956112; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Huang H.-R., 2014, Patent No. [WO2014144303A1, 2014144303]; Jain N, 2010, P NATL ACAD SCI USA, V107, P1524, DOI 10.1073/pnas.0910341107; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Josling GA, 2012, GENES-BASEL, V3, P320, DOI 10.3390/genes3020320; Kono K, 2006, CANCER IMMUNOL IMMUN, V55, P1064, DOI 10.1007/s00262-005-0092-8; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Liu YJ, 2014, MOL CELL BIOL, V34, P3993, DOI 10.1128/MCB.00919-14; Liu YJ, 2013, NAT MED, V19, P1173, DOI 10.1038/nm.3286; Manning ET, 2001, MOL CELL BIOL, V21, P3876, DOI 10.1128/MCB.21.12.3876-3887.2001; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Muller S, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001992; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Picaud S., 2015, CANC RES, V75, P5106; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Rothbart SB, 2012, SCI REP-UK, V2, DOI 10.1038/srep00489; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Savage PA, 2013, TRENDS IMMUNOL, V34, P33, DOI 10.1016/j.it.2012.08.005; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Taylor A. M., 2016, ACS MED CHE IN PRESS; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; West NR, 2013, BRIT J CANCER, V108, P155, DOI 10.1038/bjc.2012.524; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	46	45	48	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13014	13027		10.1074/jbc.M115.708560	http://dx.doi.org/10.1074/jbc.M115.708560			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27056325	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000379770500011
J	Kim, Y; Joachimiak, G; Bigelow, L; Babnigg, G; Joachimiak, A				Kim, Youngchang; Joachimiak, Grazyna; Bigelow, Lance; Babnigg, Gyorgy; Joachimiak, Andrzej			How Aromatic Compounds Block DNA Binding of HcaR Catabolite Regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-HYDROXYBENZOATE HYDROXYLASE GENE; CRYSTAL-STRUCTURE REVEALS; TRANSCRIPTIONAL REGULATOR; MARR FAMILY; HIGH-THROUGHPUT; ESCHERICHIA-COLI; NUCLEIC-ACIDS; PROTEIN; MECHANISM; REPRESSOR	Bacterial catabolism of aromatic compounds from various sources including phenylpropanoids and flavonoids that are abundant in soil plays an important role in the recycling of carbon in the ecosystem. We have determined the crystal structures of apo-HcaR from Acinetobacter sp. ADP1, a MarR/SlyA transcription factor, in complexes with hydroxycinnamates and a specific DNA operator. The protein regulates the expression of the hca catabolic operon in Acinetobacter and related bacterial strains, allowing utilization of hydroxycinnamates as sole sources of carbon. HcaR binds multiple ligands, and as a result the transcription of genes encoding several catabolic enzymes is increased. The 1.9-2.4 angstrom resolution structures presented here explain how HcaR recognizes four ligands (ferulate, 3,4-dihydroxybenzoate, p-coumarate, and vanillin) using the same binding site. The ligand promiscuity appears to be an adaptation to match a broad specificity of hydroxycinnamate catabolic enzymes while responding to toxic thioester intermediates. Structures of apo-HcaR and in complex with a specific DNA hca operator when combined with binding studies of hydroxycinnamates show how aromatic ligands render HcaR unproductive in recognizing a specific DNA target. The current study contributes to a better understanding of the hca catabolic operon regulation mechanism by the transcription factor HcaR.	[Kim, Youngchang; Joachimiak, Grazyna; Bigelow, Lance; Babnigg, Gyorgy; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, 9700 S Cass Ave, Argonne, IL 60439 USA; [Kim, Youngchang; Babnigg, Gyorgy; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Biosci, 9700 S Cass Ave, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Joachimiak, A (corresponding author), Argonne Natl Lab, Struct Biol Ctr, Biosci, 9700 S Cass Ave, Argonne, IL 60439 USA.	andrzejj@anl.gov		Kim, Youngchang/0000-0002-1610-4889; Joachimiak, Andrzej/0000-0003-2535-6209	National Institute of Health [GM115586, GM094585]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, R24GM115586] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health Grants GM115586 and GM094585 and by United States Department of Energy, Office of Biological and Environmental Research, Contract DE-AC02-06CH11357. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Bordelon T, 2006, J MOL BIOL, V360, P168, DOI 10.1016/j.jmb.2006.05.005; Brugarolas P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388611; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; Chang YM, 2014, NUCLEIC ACIDS RES, V42, P5314, DOI 10.1093/nar/gku128; Chang YM, 2010, P NATL ACAD SCI USA, V107, P8617, DOI 10.1073/pnas.0913302107; Copley SD, 2015, TRENDS BIOCHEM SCI, V40, P72, DOI 10.1016/j.tibs.2014.12.004; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dal S, 2005, APPL ENVIRON MICROB, V71, P1025, DOI 10.1128/AEM.71.2.1025-1034.2005; Davis JR, 2010, APPL MICROBIOL BIOT, V86, P921, DOI 10.1007/s00253-009-2358-0; Di Fiore A, 2009, J MOL BIOL, V388, P559, DOI 10.1016/j.jmb.2009.03.030; Dolan KT, 2011, J BIOL CHEM, V286, P22178, DOI 10.1074/jbc.M111.245258; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fiorentino G, 2007, J BACTERIOL, V189, P7351, DOI 10.1128/JB.00885-07; Fischer R, 2008, MICROBIOL-SGM, V154, P3095, DOI 10.1099/mic.0.2008/016907-0; Guerra AJ, 2011, J AM CHEM SOC, V133, P19614, DOI 10.1021/ja2080532; Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185; Hirakawa H, 2012, J BACTERIOL, V194, P1960, DOI 10.1128/JB.06817-11; Hiromoto T, 2006, J MOL BIOL, V364, P863, DOI 10.1016/j.jmb.2006.08.098; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; JOACHIMIAK A, 1991, METHOD ENZYMOL, V208, P82; Kim Youngchang, 2004, Journal of Structural and Functional Genomics, V5, P111, DOI 10.1023/B:JSFG.0000029206.07778.fc; Kim Y, 2011, METHODS, V55, P12, DOI 10.1016/j.ymeth.2011.07.010; Kumaraswami M, 2009, NUCLEIC ACIDS RES, V37, P1211, DOI 10.1093/nar/gkn1046; Kumarevel T, 2009, NUCLEIC ACIDS RES, V37, P4723, DOI 10.1093/nar/gkp496; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Lintner NG, 2011, J MOL BIOL, V405, P939, DOI 10.1016/j.jmb.2010.11.019; Manso I, 2009, J BIOL CHEM, V284, P21218, DOI 10.1074/jbc.M109.008243; Michalska K, 2012, J MOL BIOL, V423, P555, DOI 10.1016/j.jmb.2012.08.017; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Oh SY, 2007, J BACTERIOL, V189, P6284, DOI 10.1128/JB.00632-07; OTWINOWSKI Z, 1991, DARESBURY STUDY WEEK, P80; Parke D, 2003, APPL ENVIRON MICROB, V69, P5398, DOI 10.1128/AEM.69.9.5398-5409.2003; Perera IC, 2011, PROTEIN SCI, V20, P621, DOI 10.1002/pro.588; Providenti MA, 2001, APPL ENVIRON MICROB, V67, P3530, DOI 10.1128/AEM.67.8.3530-3541.2001; Reyes-Caballero H, 2010, J MOL BIOL, V403, P197, DOI 10.1016/j.jmb.2010.08.030; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Saridakis V, 2008, J MOL BIOL, V377, P655, DOI 10.1016/j.jmb.2008.01.001; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schumacher MA, 2002, MOL MICROBIOL, V45, P885, DOI 10.1046/j.1365-2958.2002.03039.x; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Spory A, 2002, J BACTERIOL, V184, P3549, DOI 10.1128/JB.184.13.3549-3559.2002; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P1174, DOI 10.1107/S0907444903009922; Turlin E, 2005, RES MICROBIOL, V156, P312, DOI 10.1016/j.resmic.2004.10.012; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wilkinson SP, 2005, J MOL BIOL, V350, P617, DOI 10.1016/j.jmb.2005.05.027; Yoshida M, 2007, BIOCHEM BIOPH RES CO, V362, P275, DOI 10.1016/j.bbrc.2007.07.190	57	14	15	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13243	13256		10.1074/jbc.M115.712067	http://dx.doi.org/10.1074/jbc.M115.712067			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129205	hybrid, Green Published			2022-12-28	WOS:000379770500029
J	Valentini, M; Filloux, A				Valentini, Martina; Filloux, Alain			Biofilms and Cyclic di-GMP (c-di-GMP) Signaling: Lessons from Pseudomonas aeruginosa and Other Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RESPONSIVE TRANSCRIPTION FACTOR; RADIAL CAPILLARY ACTION; CYSTIC-FIBROSIS; POSTTRANSLATIONAL REGULATION; EXOPOLYSACCHARIDE PRODUCTION; ANTIMICROBIAL RESISTANCE; ALGINATE BIOSYNTHESIS; DIGUANYLATE CYCLASES; STRUCTURAL INSIGHTS; BINDING-PROTEINS	The cyclic di-GMP (c-di-GMP) second messenger represents a signaling system that regulates many bacterial behaviors and is of key importance for driving the lifestyle switch between motile loner cells and biofilm formers. This review provides an up-to-date compendium of c-di-GMP pathways connected to biofilm formation, biofilm-associated motilities, and other functionalities in the ubiquitous and opportunistic human pathogen Pseudomonas aeruginosa. This bacterium is frequently adopted as a model organism to study bacterial biofilm formation. Importantly, its versatility and adaptation capabilities are linked with a broad range of complex regulatory networks, including a large set of genes involved in c-di-GMP biosynthesis, degradation, and transmission.	[Valentini, Martina; Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, MRC Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Imperial College London	Valentini, M; Filloux, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, MRC Ctr Mol Microbiol & Infect, London SW7 2AZ, England.	m.valentini@imperial.ac.uk; a.filloux@imperial.ac.uk	Valentini, Martina/AAC-6009-2022	Valentini, Martina/0000-0002-1948-8339; Filloux, Alain/0000-0003-1307-0289	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L007959/1]; Imperial College Antimicrobial Research Collaborative (ARC) Early Career Research Fellowship; Biotechnology and Biological Sciences Research Council [BB/L007959/1] Funding Source: researchfish; BBSRC [BB/L007959/1] Funding Source: UKRI; MRC [MR/J006874/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Imperial College Antimicrobial Research Collaborative (ARC) Early Career Research Fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/L007959/1 (to A. F.). This work was also supported by an Imperial College Antimicrobial Research Collaborative (ARC) Early Career Research Fellowship (to M. V.). This is the third article in the Thematic Minireview series "Biofilms." The authors declare that they have no conflicts of interest with the contents of this article.	Almblad H, 2015, J BACTERIOL, V197, P2190, DOI 10.1128/JB.00193-15; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; An SW, 2010, APPL ENVIRON MICROB, V76, P8160, DOI 10.1128/AEM.01233-10; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Baraquet C, 2013, P NATL ACAD SCI USA, V110, P18478, DOI 10.1073/pnas.1318972110; Baraquet C, 2012, NUCLEIC ACIDS RES, V40, P7207, DOI 10.1093/nar/gks384; Barclay ML, 1996, J ANTIMICROB CHEMOTH, V37, P1155, DOI 10.1093/jac/37.6.1155; Bernier SP, 2011, RES MICROBIOL, V162, P680, DOI 10.1016/j.resmic.2011.04.014; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Boles BR, 2002, J BACTERIOL, V184, P5946, DOI 10.1128/JB.184.21.5946-5954.2002; Chambers JR, 2014, MOL MICROBIOL, V92, P471, DOI 10.1111/mmi.12562; Chen MW, 2012, J BACTERIOL, V194, P4837, DOI 10.1128/JB.00560-12; Chou SH, 2016, J BACTERIOL, V198, P32, DOI 10.1128/JB.00333-15; Christen M, 2010, SCIENCE, V328, P1295, DOI 10.1126/science.1188658; Christensen LD, 2013, INFECT IMMUN, V81, P2705, DOI 10.1128/IAI.00332-13; Chua SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5462; Cohen D, 2015, P NATL ACAD SCI USA, V112, P11359, DOI 10.1073/pnas.1421450112; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; De N, 2010, METHOD ENZYMOL, V471, P161, DOI 10.1016/S0076-6879(10)71010-7; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Duvel J, 2016, J BACTERIOL, V198, P138, DOI 10.1128/JB.00377-15; Duvel J, 2012, J MICROBIOL METH, V88, P229, DOI 10.1016/j.mimet.2011.11.015; Feirer N, 2015, MBIO, V6, DOI 10.1128/mBio.00156-15; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Grantcharova N, 2010, J BACTERIOL, V192, P456, DOI 10.1128/JB.01826-08; Gupta K, 2014, MOL MICROBIOL, V92, P488, DOI 10.1111/mmi.12587; Gupta K, 2013, J BACTERIOL, V195, P4975, DOI 10.1128/JB.00732-13; Gupta KR, 2015, APPL ENVIRON MICROB, V81, P2571, DOI 10.1128/AEM.03999-14; Guvener ZT, 2007, MOL MICROBIOL, V66, P1459, DOI 10.1111/j.1365-2958.2007.06008.x; Guzzo CR, 2013, J MOL BIOL, V425, P2174, DOI 10.1016/j.jmb.2013.03.021; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Haussler S, 1999, CLIN INFECT DIS, V29, P621, DOI 10.1086/598644; Hay ID, 2009, APPL ENVIRON MICROB, V75, P1110, DOI 10.1128/AEM.02416-08; Hengge R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3149pe44; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Huangyutitham V, 2013, MBIO, V4, DOI 10.1128/mBio.00242-13; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Klebensberger J, 2009, ENVIRON MICROBIOL, V11, P3073, DOI 10.1111/j.1462-2920.2009.02012.x; Kulasekara BR, 2013, ELIFE, V2, DOI 10.7554/eLife.01402; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Laventie BJ, 2015, JOVE-J VIS EXP, DOI 10.3791/51404; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Li SS, 2015, SCI REP-UK, V5, DOI 10.1038/srep16915; Li Y, 2013, J BACTERIOL, V195, P3531, DOI 10.1128/JB.01156-12; Li Z, 2012, J BIOL CHEM, V287, P30191, DOI 10.1074/jbc.M112.378273; Liao J, 2013, J BACTERIOL, V195, P3352, DOI 10.1128/JB.00318-13; Liao JL, 2012, J BACTERIOL, V194, P4823, DOI 10.1128/JB.00765-12; Lieberman OJ, 2014, ACS CHEM BIOL, V9, P183, DOI 10.1021/cb400485k; Luo Y, 2015, MBIO, V6, DOI 10.1128/mBio.02456-14; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Malone JG, 2007, MICROBIOL-SGM, V153, P980, DOI 10.1099/mic.0.2006/002824-0; Malone JG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002760; Malone JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000804; Marvig RL, 2015, NAT GENET, V47, P57, DOI 10.1038/ng.3148; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Merritt JH, 2010, MBIO, V1, DOI 10.1128/mBio.00183-10; Mikkelsen H, 2011, ENVIRON MICROBIOL, V13, P1666, DOI 10.1111/j.1462-2920.2011.02495.x; Moscoso JA, 2014, J BACTERIOL, V196, P4081, DOI 10.1128/JB.01850-14; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Nesper J, 2012, J PROTEOMICS, V75, P4874, DOI 10.1016/j.jprot.2012.05.033; Newell PD, 2011, J BACTERIOL, V193, P4685, DOI 10.1128/JB.05483-11; Nicastro GG, 2014, ENVIRON MICROBIOL, V16, P1321, DOI 10.1111/1462-2920.12422; NICKEL JC, 1985, ANTIMICROB AGENTS CH, V27, P619, DOI 10.1128/AAC.27.4.619; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Oglesby LL, 2008, MICROBIOL-SGM, V154, P1605, DOI 10.1099/mic.0.2007/015305-0; Orr MW, 2015, P NATL ACAD SCI USA, V112, pE5048, DOI 10.1073/pnas.1507245112; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Petrova OE, 2014, J BACTERIOL, V196, P2827, DOI 10.1128/JB.01628-14; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rinaldo S, 2015, J BACTERIOL, V197, P1525, DOI 10.1128/JB.02606-14; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Roy AB, 2014, MOL MICROBIOL, V94, P771, DOI 10.1111/mmi.12802; Roy AB, 2012, J BACTERIOL, V194, P2904, DOI 10.1128/JB.05346-11; Ryan RP, 2009, ENVIRON MICROBIOL, V11, P1126, DOI 10.1111/j.1462-2920.2008.01842.x; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Seshasayee ASN, 2010, NUCLEIC ACIDS RES, V38, P5970, DOI 10.1093/nar/gkq382; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Stelitano V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074920; Su TT, 2015, J STRUCT BIOL, V192, P1, DOI 10.1016/j.jsb.2015.09.002; Tarutina M, 2006, J BIOL CHEM, V281, P34751, DOI 10.1074/jbc.M604819200; Tchigvintsev A, 2010, J MOL BIOL, V402, P524, DOI 10.1016/j.jmb.2010.07.050; Trampari E, 2015, J BIOL CHEM, V290, P24470, DOI 10.1074/jbc.M115.661439; Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483; Whitney JC, 2015, J BIOL CHEM, V290, P12451, DOI 10.1074/jbc.M115.645051; Whitney JC, 2012, J BIOL CHEM, V287, P23582, DOI 10.1074/jbc.M112.375378; Wolfgang MC, 2003, DEV CELL, V4, P253, DOI 10.1016/S1534-5807(03)00019-4	100	286	296	16	164	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12547	12555		10.1074/jbc.R115.711507	http://dx.doi.org/10.1074/jbc.R115.711507			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129226	Green Published, hybrid			2022-12-28	WOS:000378119900010
J	Schulman, JJ; Wright, FA; Han, XB; Zluhan, EJ; Szczesniak, LM; Wojcikiewicz, RJH				Schulman, Jacqualyn J.; Wright, Forrest A.; Han, Xiaobing; Zluhan, Eric J.; Szczesniak, Laura M.; Wojcikiewicz, Richard J. H.			The Stability and Expression Level of Bok Are Governed by Binding to Inositol 1,4,5-Trisphosphate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY-MEMBER BOK; ENDOPLASMIC-RETICULUM STRESS; BCL-2 PROTEIN FAMILY; UBIQUITIN LIGASE; GENE-EXPRESSION; BH4 DOMAIN; CELL-DEATH; APOPTOSIS; MEMBRANE; DEGRADATION	Bok is a member of the Bcl-2 protein family that governs the intrinsic apoptosis pathway, although the role that Bok plays in this pathway is unclear. We have shown previously in cultured cell lines that Bok interacts strongly with inositol 1,4,5-trisphosphate receptors (IP(3)Rs), suggesting that it may contribute to the structural integrity or stability of IP3R tetramers. Here we report that Bok is similarly IP3R-assocated in mouse tissues, that essentially all cellular Bok is IP3R bound, that it is the helical nature of the Bok BH4 domain, rather than specific amino acids, that mediates binding to IP(3)Rs, that Bok is dramatically stabilized by binding to IP(3)Rs, that unbound Bok is ubiquitinated and degraded by the proteasome, and that binding to IP(3)Rs limits the pro-apoptotic effect of overexpressed Bok. Agents that stimulate IP3R activity, apoptosis, phosphorylation, and endoplasmic reticulum stress did not trigger the dissociation of mature Bok from IP(3)Rs or Bok degradation, indicating that the role of proteasome-mediated Bok degradation is to destroy newly synthesized Bok that is not IP3R associated. The existence of this unexpected proteolytic mechanism that is geared toward restricting Bok to that which is bound to IP(3)Rs, implies that unbound Bok is deleterious to cell viability and helps explain the current uncertainty regarding the cellular role of Bok.	[Schulman, Jacqualyn J.; Wright, Forrest A.; Han, Xiaobing; Zluhan, Eric J.; Szczesniak, Laura M.; Wojcikiewicz, Richard J. H.] SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wojcikiewicz, RJH (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	wojcikir@upstate.edu		Szczesniak, Laura/0000-0001-5321-9821; Schulman, Jacqualyn/0000-0001-6659-3388	National Institutes of Health [DK049194]; Carol M. Baldwin Breast Cancer Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049194, R29DK049194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carol M. Baldwin Breast Cancer Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK049194 and the Carol M. Baldwin Breast Cancer Research Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors-and does not necessarily represent the official views of the National Institutes of Health.	Bultynck G, 2004, BIOCHEM J, V381, P87, DOI 10.1042/BJ20040072; Carpio MA, 2016, P NATL ACAD SCI USA, V113, pE494, DOI 10.1073/pnas.1521979113; Carpio MA, 2015, P NATL ACAD SCI USA, V112, P7201, DOI 10.1073/pnas.1421063112; Carroll RG, 2014, CELL REP, V9, P1538, DOI 10.1016/j.celrep.2014.10.046; Chen HC, 2015, NAT CELL BIOL, V17, P1270, DOI 10.1038/ncb3236; Chi XK, 2014, BBA-MOL CELL RES, V1843, P2100, DOI 10.1016/j.bbamcr.2014.06.002; Distelhorst CW, 2011, CELL CALCIUM, V50, P234, DOI 10.1016/j.ceca.2011.05.011; Echeverry N, 2013, CELL DEATH DIFFER, V20, P785, DOI 10.1038/cdd.2013.10; Fernandez-Marrero Y, 2016, P NATL ACAD SCI USA, V113, pE492, DOI 10.1073/pnas.1516347113; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Inohara N, 1998, J BIOL CHEM, V273, P8705, DOI 10.1074/jbc.273.15.8705; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Kawahara H, 2013, J BIOCHEM, V153, P147, DOI 10.1093/jb/mvs149; Ke F, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.304; Ke F, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.176; Ke F, 2012, CELL DEATH DIFFER, V19, P915, DOI 10.1038/cdd.2011.210; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kleiger G, 2014, TRENDS CELL BIOL, V24, P352, DOI 10.1016/j.tcb.2013.12.003; Kochetov AV, 2008, BIOESSAYS, V30, P683, DOI 10.1002/bies.20771; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Lavik AR, 2015, ONCOTARGET, V6, P27388, DOI 10.18632/oncotarget.4489; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Lein ES, 2005, J COMP NEUROL, V485, P1, DOI 10.1002/cne.20426; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JP, 2011, J BIOL CHEM, V286, P24426, DOI 10.1074/jbc.M111.251983; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Miller RL, 2013, AM J PHYSIOL-RENAL, V304, pF177, DOI 10.1152/ajprenal.00431.2012; Moldoveanu T, 2014, TRENDS BIOCHEM SCI, V39, P101, DOI 10.1016/j.tibs.2013.12.006; Monaco G, 2012, CELL DEATH DIFFER, V19, P295, DOI 10.1038/cdd.2011.97; Monaco G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073386; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pearce MMP, 2007, J BIOL CHEM, V282, P20104, DOI 10.1074/jbc.M701862200; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; Rooswinkel RW, 2014, BLOOD, V123, P2806, DOI 10.1182/blood-2013-08-519470; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schulman JJ, 2013, J BIOL CHEM, V288, P25340, DOI 10.1074/jbc.M113.496570; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Wang L., 2015, J PHYSL IN PRESS; Wang P, 2013, CELL SIGNAL, V25, P2320, DOI 10.1016/j.cellsig.2013.07.016; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wilfling F, 2012, CELL DEATH DIFFER, V19, P1328, DOI 10.1038/cdd.2012.9; Wojcikiewicz RJH, 2009, CELL CALCIUM, V46, P147, DOI 10.1016/j.ceca.2009.05.002; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wright FA, 2015, J BIOL CHEM, V290, P13948, DOI 10.1074/jbc.M115.655043; Yang J, 2016, P NATL ACAD SCI USA, V113, pE1953, DOI 10.1073/pnas.1517935113; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005	52	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11820	11828		10.1074/jbc.M115.711242	http://dx.doi.org/10.1074/jbc.M115.711242			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27053113	hybrid, Green Published			2022-12-28	WOS:000377264800031
J	Stodola, JL; Stith, CM; Burgers, PM				Stodola, Joseph L.; Stith, Carrie M.; Burgers, Peter M.			Proficient Replication of the Yeast Genome by a Viral DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OKAZAKI FRAGMENT MATURATION; THYMINE-THYMINE DIMER; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; ACCESSORY SUBUNITS; STRUCTURAL BASIS; POL-ZETA; TRANSLESION SYNTHESIS; PROCESSIVITY FACTOR; URACIL RECOGNITION	DNA replication in eukaryotic cells requires minimally three B-family DNA polymerases: Pol alpha, Pol beta, and Pol epsilon. Pol delta replicates and matures Okazaki fragments on the lagging strand of the replication fork. Saccharomyces cerevisiae Pol delta is a three-subunit enzyme (Pol3-Pol31-Pol32). A small C-terminal domain of the catalytic subunit Pol3 carries both iron-sulfur cluster and zinc-binding motifs, which mediate interactions with Pol31, and processive replication with the replication clamp proliferating cell nuclear antigen (PCNA), respectively. We show that the entire N-terminal domain of Pol3, containing polymerase and proofreading activities, could be effectively replaced by those from bacteriophage RB69, and could carry out chromosomal DNA replication in yeast with remarkable high fidelity, provided that adaptive mutations in the replication clamp PCNA were introduced. This result is consistent with the model that all essential interactions for DNA replication in yeast are mediated through the small C-terminal domain of Pol3. The chimeric polymerase carries out processive replication with PCNA in vitro; however, in yeast, it requires an increased involvement of the mutagenic translesion DNA polymerase zeta during DNA replication.	[Stodola, Joseph L.; Stith, Carrie M.; Burgers, Peter M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Burgers, PM (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	burgers@biochem.wustl.edu	Burgers, Peter M/AAW-6621-2021		National Institutes of Health [GM032431]; U.S.-Israel Binational Science Foundation [2013358]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grants GM032431 from the National Institutes of Health (to P. M. B.) and 2013358 from the U.S.-Israel Binational Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya N, 2011, P NATL ACAD SCI USA, V108, P17927, DOI 10.1073/pnas.1109981108; Aksenova A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001209; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Baranovskiy AG, 2008, CELL CYCLE, V7, P3026, DOI 10.4161/cc.7.19.6720; Baranovskiy AG, 2016, J BIOL CHEM, V291, P10006, DOI 10.1074/jbc.M116.717405; Baranovskiy AG, 2012, J BIOL CHEM, V287, P17281, DOI 10.1074/jbc.M112.351122; Bebenek A, 2001, J BIOL CHEM, V276, P10387, DOI 10.1074/jbc.M007707200; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Burgers PMJ, 2016, MOL CELL, V61, P492, DOI 10.1016/j.molcel.2016.01.017; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Burgers PMJ, 2001, J BIOL CHEM, V276, P43487, DOI 10.1074/jbc.R100056200; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; Daigaku Y, 2015, NAT STRUCT MOL BIOL, V22, P192, DOI 10.1038/nsmb.2962; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Dressman HK, 1997, P NATL ACAD SCI USA, V94, P8042, DOI 10.1073/pnas.94.15.8042; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Fortune JM, 2005, J BIOL CHEM, V280, P29980, DOI 10.1074/jbc.M505236200; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Garbacz M, 2015, DNA REPAIR, V29, P23, DOI 10.1016/j.dnarep.2015.02.007; Garcia JS, 2004, NUCLEIC ACIDS RES, V32, P3005, DOI 10.1093/nar/gkh623; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Hanna M, 2007, MUTAT RES-FUND MOL M, V625, P164, DOI 10.1016/j.mrfmmm.2007.06.008; Haracska L, 2003, MOL CELL BIOL, V23, P1453, DOI 10.1128/MCB.23.4.1453-1459.2003; Hedglin M, 2016, P NATL ACAD SCI USA, V113, pE1777, DOI 10.1073/pnas.1523653113; Hopfner KP, 1999, P NATL ACAD SCI USA, V96, P3600, DOI 10.1073/pnas.96.7.3600; Huang ME, 2002, GENETICS, V160, P1409; Johansson E, 2004, J BIOL CHEM, V279, P22204, DOI 10.1074/jbc.M402652200; Johansson E, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012799; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 2015, MOL CELL, V59, P163, DOI 10.1016/j.molcel.2015.05.038; Johnson RE, 2012, P NATL ACAD SCI USA, V109, P12455, DOI 10.1073/pnas.1206052109; Karam JD, 2000, PROG NUCLEIC ACID RE, V64, P65, DOI 10.1016/S0079-6603(00)64002-3; Kilkenny ML, 2012, J BIOL CHEM, V287, P23740, DOI 10.1074/jbc.M112.368951; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; Kreuzer KN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-358; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lee YS, 2014, P NATL ACAD SCI USA, V111, P2954, DOI 10.1073/pnas.1324001111; Liu L, 2000, J BIOL CHEM, V275, P18739, DOI 10.1074/jbc.M001217200; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Makiniemi M, 1999, TRENDS BIOCHEM SCI, V24, P14, DOI 10.1016/S0968-0004(98)01327-9; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Miyabe I, 2015, NAT STRUCT MOL BIOL, V22, P932, DOI 10.1038/nsmb.3100; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; MORRISON A, 1989, J BACTERIOL, V171, P5659, DOI 10.1128/jb.171.10.5659-5667.1989; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Noble E, 2015, VIRUSES-BASEL, V7, P3186, DOI 10.3390/v7062766; Northam MR, 2006, EMBO J, V25, P4316, DOI 10.1038/sj.emboj.7601320; Northam MR, 2014, NUCLEIC ACIDS RES, V42, P290, DOI 10.1093/nar/gkt830; Northam MR, 2010, GENETICS, V184, P27, DOI 10.1534/genetics.109.107482; Pavlov YI, 2001, GENETICS, V159, P47; Reynolds N, 1998, CURR GENET, V34, P250, DOI 10.1007/s002940050394; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; SIMON M, 1991, EMBO J, V10, P2165, DOI 10.1002/j.1460-2075.1991.tb07751.x; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; Stodola JL, 2016, NAT STRUCT MOL BIOL, V23, P402, DOI 10.1038/nsmb.3207; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; TAN CK, 1986, J BIOL CHEM, V261, P2310; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Wardle J, 2008, NUCLEIC ACIDS RES, V36, P705, DOI 10.1093/nar/gkm1023; Wojtaszek J, 2012, J BIOL CHEM, V287, P33836, DOI 10.1074/jbc.M112.394841; Zhong XJ, 2006, NUCLEIC ACIDS RES, V34, P4731, DOI 10.1093/nar/gkl465	70	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11698	11705		10.1074/jbc.M116.728741	http://dx.doi.org/10.1074/jbc.M116.728741			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27072134	Green Published, hybrid			2022-12-28	WOS:000377264800020
J	McGarvey, JC; Xiao, KH; Bowman, SL; Mamonova, T; Zhang, QM; Bisello, A; Sneddon, WB; Ardura, JA; Jean-Alphonse, F; Vilardaga, JP; Puthenveedu, MA; Friedman, PA				McGarvey, Jennifer C.; Xiao, Kunhong; Bowman, Shanna L.; Mamonova, Tatyana; Zhang, Qiangmin; Bisello, Alessandro; Sneddon, W. Bruce; Ardura, Juan A.; Jean-Alphonse, Frederic; Vilardaga, Jean-Pierre; Puthenveedu, Manojkumar A.; Friedman, Peter A.			Actin-Sorting Nexin 27 (SNX27)-Retromer Complex Mediates Rapid Parathyroid Hormone Receptor Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; G protein-coupled receptor (GPCR); parathyroid hormone; receptor recycling; sorting nexin (SNX)	PROTEIN-COUPLED RECEPTOR; ETHYLMALEIMIDE-SENSITIVE FACTOR; PDZ-DOMAIN; MOLECULAR-DYNAMICS; RETROMER COMPLEX; TRAFFICKING; MEMBRANE; BINDING; INTERNALIZATION; PTH	The G protein-coupled parathyroid hormone receptor (PTHR) regulates mineral-ion homeostasis and bone remodeling. Upon parathyroid hormone (PTH) stimulation, the PTHR internalizes into early endosomes and subsequently traffics to the retromer complex, a sorting platform on early endosomes that promotes recycling of surface receptors. The C terminus of the PTHR contains a type I PDZ ligand that binds PDZ domain-containing proteins. Mass spectrometry identified sorting nexin 27 (SNX27) in isolated endosomes as a PTHR binding partner. PTH treatment enriched endosomal PTHR. SNX27 contains a PDZ domain and serves as a cargo selector for the retromer complex. VPS26, VPS29, and VPS35 retromer subunits were isolated with PTHR in endosomes from cells stimulated with PTH. Molecular dynamics and protein binding studies establish that PTHR and SNX27 interactions depend on the PDZ recognition motif in PTHR and the PDZ domain of SNX27. Depletion of either SNX27 or VPS35 or actin depolymerization decreased the rate of PTHR recycling following agonist stimulation. Mutating the PDZ ligand of PTHR abolished the interaction with SNX27 but did not affect the overall rate of recycling, suggesting that PTHR may directly engage the retromer complex. Coimmunoprecipitation and overlay experiments show that both intact and mutated PTHR bind retromer through the VPS26 protomer and sequentially assemble a ternary complex with PTHR and SNX27. SNX27-independent recycling may involve N-ethylmaleimide-sensitive factor, which binds both PDZ intact and mutant PTHRs. We conclude that PTHR recycles rapidly through at least two pathways, one involving the ASRT complex of actin, SNX27, and retromer and another possibly involving N-ethylmaleimide-sensitive factor.	[McGarvey, Jennifer C.; Xiao, Kunhong; Mamonova, Tatyana; Zhang, Qiangmin; Bisello, Alessandro; Sneddon, W. Bruce; Ardura, Juan A.; Jean-Alphonse, Frederic; Vilardaga, Jean-Pierre; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15261 USA; [Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA; [Bowman, Shanna L.; Puthenveedu, Manojkumar A.] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Ardura, Juan A.] San Pablo CEU Univ, Sch Med, Madrid 28668, Spain	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; San Pablo CEU University	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, E1356 Thomas E Starzl Biomed Sci Tower,200 Lothro, Pittsburgh, PA 15261 USA.	paf10@pitt.edu	Ardura, Juan Antonio/F-3378-2017; Puthenveedu, Manojkumar A/A-3795-2016; Xiao, Kunhong/AAG-4275-2020	Ardura, Juan Antonio/0000-0002-2827-3364; Xiao, Kunhong/0000-0002-1069-1226; McGarvey, Jennifer/0000-0001-8782-267X; Vilardaga, Jean-Pierre/0000-0002-1217-1435; JEAN-ALPHONSE, Frederic/0000-0002-7380-5825	National Institutes of Health [DK069998, DK054171, DK105811, DK087688, GM117425, DK102495]; National Science Foundation [1517776]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105811, R01DK102495, R01DK069998, R01DK087688, R01DK054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK069998, DK054171, and DK105811 (to P. A. F.); DK087688 and GM117425 (to M. A. P.); and DK102495 (to J. P. V.). This work was also supported by National Science Foundation Grant 1517776 (to M. A. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso V, 2013, MOL ENDOCRINOL, V27, P558, DOI 10.1210/me.2012-1404; Alonso V, 2011, J BONE MINER RES, V26, P2923, DOI 10.1002/jbmr.494; Ardura JA, 2011, J BIOL CHEM, V286, P35020, DOI 10.1074/jbc.M111.264978; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Balana B, 2011, P NATL ACAD SCI USA, V108, P5831, DOI 10.1073/pnas.1018645108; Bauch C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088529; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bowman SL, 2015, METHOD CELL BIOL, V130, P333, DOI 10.1016/bs.mcb.2015.05.007; Bowman SL, 2015, CELL REP, V10, P1925, DOI 10.1016/j.celrep.2015.02.045; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Case D, 2006, AMBER 9; Case D. A., 2021, AMBER 2022; Chan ASM, 2016, MOL BIOL CELL, V27, P1367, DOI 10.1091/mbc.E15-12-0851; Chaudhary S, 2012, NAT PROTOC, V7, P453, DOI 10.1038/nprot.2011.453; Chauvin S, 2002, MOL ENDOCRINOL, V16, P2720, DOI 10.1210/me.2002-0049; Cheloha RW, 2015, NAT REV ENDOCRINOL, V11, P712, DOI 10.1038/nrendo.2015.139; Cong M, 2001, J BIOL CHEM, V276, P45145, DOI 10.1074/jbc.M106087200; Conway RR, 2001, J CELL PHYSIOL, V189, P341, DOI 10.1002/jcp.10028; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Feinstein TN, 2013, J BIOL CHEM, V288, P27849, DOI 10.1074/jbc.M112.445098; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Ferrari SL, 1999, J BIOL CHEM, V274, P29968, DOI 10.1074/jbc.274.42.29968; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Gallon M, 2014, P NATL ACAD SCI USA, V111, pE3604, DOI 10.1073/pnas.1410552111; Garrido JL, 2009, MOL ENDOCRINOL, V23, P2048, DOI 10.1210/me.2008-0436; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Ghai R, 2013, P NATL ACAD SCI USA, V110, pE643, DOI 10.1073/pnas.1216229110; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Gidon A, 2014, NAT CHEM BIOL, V10, P707, DOI [10.1038/NCHEMBIO.1589, 10.1038/nchembio.1589]; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Harbour ME, 2010, J CELL SCI, V123, P3703, DOI 10.1242/jcs.071472; Helfer E, 2013, BIOL CELL, V105, P191, DOI 10.1111/boc.201200038; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; HUANG ZM, 1995, J BIOL CHEM, V270, P151, DOI 10.1074/jbc.270.1.151; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kahsai AW, 2014, NAT PROTOC, V9, P1301, DOI 10.1038/nprot.2014.075; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Lee S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10939; Lin TB, 2015, J NEUROSCI, V35, P14943, DOI 10.1523/JNEUROSCI.2587-15.2015; Linardopoulou EV, 2007, PLOS GENET, V3, P2477, DOI 10.1371/journal.pgen.0030237; Mahon MJ, 2009, MOL ENDOCRINOL, V23, P1691, DOI 10.1210/me.2009-0164; Mayle KM, 2012, BBA-GEN SUBJECTS, V1820, P264, DOI 10.1016/j.bbagen.2011.09.009; Miesenbock Gero, 2012, Cold Spring Harb Protoc, V2012, P213, DOI 10.1101/pdb.ip067827; Nakagawa T, 2013, J MEMBRANE BIOL, V246, P571, DOI 10.1007/s00232-013-9571-6; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Peng Y, 2014, PROTEOM CLIN APPL, V8, P554, DOI 10.1002/prca.201400043; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Ryu JK, 2015, SCIENCE, V347, P1485, DOI 10.1126/science.aaa5267; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Sneddon WB, 2004, ENDOCRINOLOGY, V145, P2815, DOI 10.1210/en.2003-1185; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Srivastava A, 2015, TRENDS ENDOCRIN MET, V26, P628, DOI 10.1016/j.tem.2015.09.001; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Syme CA, 2005, J BIOL CHEM, V280, P11281, DOI 10.1074/jbc.M413393200; Tawfeek HAW, 2004, AM J PHYSIOL-ENDOC M, V286, pE704, DOI 10.1152/ajpendo.00404.2003; Tawfeek HAW, 2002, MOL ENDOCRINOL, V16, P1, DOI 10.1210/me.16.1.1; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Valdes JL, 2011, J BIOL CHEM, V286, P39403, DOI 10.1074/jbc.M111.260802; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; van Weering JRT, 2014, SEMIN CELL DEV BIOL, V31, P40, DOI 10.1016/j.semcdb.2014.03.015; Vilardaga JP, 2014, NAT CHEM BIOL, V10, P700, DOI [10.1038/NCHEMBIO.1611, 10.1038/nchembio.1611]; Vilardaga JP, 2011, CELL MOL LIFE SCI, V68, P1, DOI 10.1007/s00018-010-0465-9; Vilardaga JP, 2002, J BIOL CHEM, V277, P8121, DOI 10.1074/jbc.M110433200; Vistein R, 2013, P NATL ACAD SCI USA, V110, P15289, DOI 10.1073/pnas.1306340110; Walther C, 2013, PROG MOL BIOL TRANSL, V118, P93, DOI 10.1016/B978-0-12-394440-5.00004-8; Wang B, 2008, MOL BIOL CELL, V19, P1637, DOI 10.1091/mbc.E07-11-1114; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang YY, 2007, MOL PHARMACOL, V72, P429, DOI 10.1124/mol.107.037747; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Zimmerman SP, 2013, BIOCHEM J, V455, P95, DOI 10.1042/BJ20121755	90	48	48	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					10986	11002		10.1074/jbc.M115.697045	http://dx.doi.org/10.1074/jbc.M115.697045			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27008860	Green Published, hybrid			2022-12-28	WOS:000377042100004
J	Esquivel, RN; Schulze, S; Xu, R; Hippler, M; Pohlschroder, M				Esquivel, Rianne N.; Schulze, Stefan; Xu, Rachel; Hippler, Michael; Pohlschroder, Mechthild			Identification of Haloferax volcanii Pilin N-Glycans with Diverse Roles in Pilus Biosynthesis, Adhesion, and Microcolony Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-LAYER GLYCOPROTEIN; METHANOCOCCUS-MARIPALUDIS; GLYCOSYLATION PATHWAY; PROTEIN GLYCOSYLATION; LINKED GLYCOSYLATION; MASS-SPECTROMETRY; GENETIC-ANALYSIS; ARCHAEA; MOTILITY; FLAGELLA	N-Glycosylation is a post-translational modification common to all three domains of life. In many archaea, the oligosacharyl-transferase (AglB)-dependent N-glycosylation of flagellins is required for flagella assembly. However, whether N-glycosylation is required for the assembly and/or function of the structurally related archaeal type IV pili is unknown. Here, we show that of six Haloferax volcanii adhesion pilins, PilA1 and PilA2, the most abundant pilins in pili of wild-type and Delta aglB strains, are modified under planktonic conditions in an AglB-dependent manner by the same pentasaccharide detected on H. volcanii flagellins. However, unlike wild-type cells, which have surfaces decorated with discrete pili and form a dispersed layer of cells on a plastic surface, Delta aglB cells have thick pili bundles and form microcolonies. Moreover, expressing PilA1, PilA2, or PilA6 in Delta pilA[1-6]Delta aglB stimulates microcolony formation compared with their expression in Delta pilA[1-6]. Conversely, expressing PilA3 or PilA4 in Delta pilA[1-6] cells results in strong surface adhesion, but not microcolony formation, and neither pilin stimulates surface adhesion in Delta pilA[1-6]Delta aglB cells. Although PilA4 assembles into pili in the Delta pilA[1-6]Delta aglB cells, these pili are, unlike wild-type pili, curled, perhaps rendering them non-functional. To our knowledge, this is the first demonstration of a differential effect of glycosylation on pilus assembly and function of paralogous pilins. The growth of wild-type cells in low salt media, a condition that decreases AglB glycosylation, also stimulates microcolony formation and inhibits motility, supporting our hypothesis that N-glycosylation plays an important role in regulating the transition between planktonic to sessile cell states as a response to stress.	[Esquivel, Rianne N.; Xu, Rachel; Pohlschroder, Mechthild] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Schulze, Stefan; Hippler, Michael] Univ Munster, Inst Plant Biol & Biotechnol, D-48143 Munster, Germany	University of Pennsylvania; University of Munster	Pohlschroder, M (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	pohlschr@sas.upenn.edu	Schulze, Stefan/T-7360-2019; Pohlschroder, Mechy/P-3206-2019	Schulze, Stefan/0000-0002-4771-7987; Michael, Hippler/0000-0001-9670-6101	National Institutes of Health Cell and Molecular Biology [TM32 GM-07229]; National Aeronautics and Space Administration [NNX10AR84G]; National Science Foundation [MCB-1413158]; Deutsche Forschungsgemeinschaft	National Institutes of Health Cell and Molecular Biology; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by the National Institutes of Health Cell and Molecular Biology Training Grant TM32 GM-07229.r Supported by National Aeronautics and Space Administration Grant NNX10AR84G and National Science Foundation Grant MCB-1413158.r Supported by Deutsche Forschungsgemeinschaft.	Abu-Qarn M, 2008, J BACTERIOL, V190, P3140, DOI 10.1128/JB.00056-08; Abu-Qarn M, 2007, J MOL BIOL, V374, P1224, DOI 10.1016/j.jmb.2007.10.042; Abu-Qarn M, 2006, MOL MICROBIOL, V61, P511, DOI 10.1111/j.1365-2958.2006.05252.x; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2003, BIOCHEM SOC T, V31, P706, DOI 10.1042/BST0310706; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; BLATTNER FR, 1977, SCIENCE, V196, P161, DOI 10.1126/science.847462; BLYN LB, 1990, EMBO J, V9, P4045, DOI 10.1002/j.1460-2075.1990.tb07626.x; Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359; Chaban B, 2006, MOL MICROBIOL, V61, P259, DOI 10.1111/j.1365-2958.2006.05226.x; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Esquivel RN, 2014, MOL MICROBIOL, V93, P494, DOI 10.1111/mmi.12673; Esquivel RN, 2013, J BACTERIOL, V195, P3808, DOI 10.1128/JB.00572-13; FEDOROV OV, 1994, CAN J MICROBIOL, V40, P45, DOI 10.1139/m94-007; Guan ZQ, 2012, ENVIRON MICROBIOL, V14, P743, DOI 10.1111/j.1462-2920.2011.02625.x; Guan ZQ, 2010, MOL MICROBIOL, V78, P1294, DOI 10.1111/j.1365-2958.2010.07405.x; Hammelmann M, 2008, J MICROBIOL METH, V75, P201, DOI 10.1016/j.mimet.2008.05.029; Jarrell KF, 2014, MICROBIOL MOL BIOL R, V78, P304, DOI 10.1128/MMBR.00052-13; Jarrell KF, 2012, TRENDS MICROBIOL, V20, P307, DOI 10.1016/j.tim.2012.04.007; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kaminski L, 2013, MBIO, V4, DOI 10.1128/mBio.00716-13; Kaminski L, 2010, J BACTERIOL, V192, P5572, DOI 10.1128/JB.00705-10; Kandiba L., 2016, GLYCOBIOLOGY, DOI [10.1093/glycob/cww014, DOI 10.1093/GLYCOBLCWW014]; Kelly J, 2009, CARBOHYD RES, V344, P648, DOI 10.1016/j.carres.2009.01.006; Magidovich H, 2010, MOL MICROBIOL, V76, P190, DOI 10.1111/j.1365-2958.2010.07090.x; Marshall R D, 1974, Biochem Soc Symp, P17; Mathieu-Rivet E, 2013, MOL CELL PROTEOMICS, V12, P3160, DOI 10.1074/mcp.M113.028191; Meyer BH, 2014, MICROBIOLOGYOPEN, V3, P531, DOI 10.1002/mbo3.185; Ng SYM, 2011, J BACTERIOL, V193, P804, DOI 10.1128/JB.00822-10; Nothaft H, 2013, J BIOL CHEM, V288, P6912, DOI 10.1074/jbc.R112.417857; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Pohlschroder M, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.00190, 10.3389/fmicb.2015.01515]; SOJAR HT, 1987, ARCH BIOCHEM BIOPHYS, V259, P52, DOI 10.1016/0003-9861(87)90469-3; Specht M, 2011, BIOINFORMATICS, V27, P1183, DOI 10.1093/bioinformatics/btr081; Tripepi M, 2013, MICROBIOL-SGM, V159, P2249, DOI 10.1099/mic.0.069617-0; Tripepi M, 2012, J BACTERIOL, V194, P4876, DOI 10.1128/JB.00731-12; Tripepi M, 2010, J BACTERIOL, V192, P3093, DOI 10.1128/JB.00133-10; VanDyke DJ, 2009, MOL MICROBIOL, V72, P633, DOI 10.1111/j.1365-2958.2009.06671.x; Voisin S, 2005, J BIOL CHEM, V280, P16586, DOI 10.1074/jbc.M500329200; Wang GH, 2006, J PROTEOME RES, V5, P1214, DOI 10.1021/pr050406g; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yurist-Doutsch S, 2008, MOL MICROBIOL, V69, P1234, DOI 10.1111/j.1365-2958.2008.06352.x; Yurist-Doutsch S, 2010, MOL MICROBIOL, V75, P1047, DOI 10.1111/j.1365-2958.2009.07045.x	46	35	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10602	10614		10.1074/jbc.M115.693556	http://dx.doi.org/10.1074/jbc.M115.693556			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26966177	Green Published, hybrid			2022-12-28	WOS:000377042600014
J	Radchenko, M; Nie, RX; Lu, M				Radchenko, Martha; Nie, Rongxin; Lu, Min			Disulfide Cross-linking of a Multidrug and Toxic Compound Extrusion Transporter Impacts Multidrug Efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE TRANSPORTER; STRUCTURAL BASIS; MATE; PROXIMITY; ANTIPORTER; MECHANISM; FAMILY; LOOPS; NORM	Multidrug and toxic compound extrusion (MATE) transporters contribute to multidrug resistance by extruding different drugs across cell membranes. The MATE transporters alternate between their extracellular and intracellular facing conformations to propel drug export, but how these structural changes occur is unclear. Here we combine site-specific cross-linking and functional studies to probe the movement of transmembrane helices in NorM from Neiserria gonorrheae (NorM-NG), a MATE transporter with known extracellular facing structure. We generated an active, cysteine-less NorM-NG and conducted pairwise cysteine mutagenesis on this variant. We found that copper phenanthroline catalyzed disulfide bond formation within five cysteine pairs and increased the electrophoretic mobility of the corresponding mutants. Furthermore, copper phenanthroline abolished the activity of the five paired cysteine mutants, suggesting that these substituted amino acids come in spatial proximity during transport, and the proximity changes are functionally indispensable. Our data also implied that the substrate-binding transmembrane helices move up to 10 angstrom in NorM-NG during transport and afforded distance restraints for modeling the intracellular facing transporter, thereby casting new light on the underlying mechanism.	[Radchenko, Martha; Nie, Rongxin; Lu, Min] Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, 3333 Green Bay Rd, N Chicago, IL 60064 USA	Rosalind Franklin University Medical & Science	Lu, M (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	min.lu@rosalindfranklin.edu	NIE, RONGXIN/ABI-3206-2020		National Institutes of Health [R01-GM094195]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01-GM094195 (to M. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Gudlur A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6164; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kubo Y, 2000, J BIOL CHEM, V275, P5270, DOI 10.1074/jbc.275.8.5270; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Lu M, 2016, CHANNELS, V10, P88, DOI 10.1080/19336950.2015.1106654; Lu M, 2013, NAT STRUCT MOL BIOL, V20, P1310, DOI 10.1038/nsmb.2687; Lu M, 2013, P NATL ACAD SCI USA, V110, P2099, DOI 10.1073/pnas.1219901110; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Radchenko M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8995; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Steed PR, 2013, BIOCHEMISTRY-US, V52, P5790, DOI 10.1021/bi4008935; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Tao Z, 2009, J BIOL CHEM, V284, P33807, DOI 10.1074/jbc.M109.071977; Valdes R, 2012, J BIOL CHEM, V287, P44036, DOI 10.1074/jbc.M112.414433	23	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9818	9826		10.1074/jbc.M116.715227	http://dx.doi.org/10.1074/jbc.M116.715227			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26975373	Green Published, hybrid			2022-12-28	WOS:000375602300038
J	Martin-Clemente, B; Alvarez-Castelao, B; Mayo, I; Sierra, AB; Diaz, V; Milan, M; Farinas, I; Gomez-Isla, T; Ferrer, I; Castano, JG				Martin-Clemente, Begona; Alvarez-Castelao, Beatriz; Mayo, Isabel; Sierra, Ana Belen; Diaz, Virginia; Milan, Miguel; Farinas, Isabel; Gomez-Isla, Teresa; Ferrer, Isidro; Castano, Jose G.			alpha-Synuclein expression levels do not significantly affect proteasome function and expression in mice and stably transfected PC12 cell lines (vol 279, pg 52984, 2004)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Mayo, Isabel Cantón/AAB-2429-2019; Alvarez-castelao, Beatriz/ABG-8826-2021; Farinas, Isabel/L-7118-2014	Mayo, Isabel Cantón/0000-0002-9757-8233; Farinas, Isabel/0000-0003-2903-4960				Martin-Clemente B, 2004, J BIOL CHEM, V279, P52984, DOI 10.1074/jbc.M409028200	1	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8986	8986		10.1074/jbc.A116.409028	http://dx.doi.org/10.1074/jbc.A116.409028			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	27129195	Green Published, hybrid			2022-12-28	WOS:000374849000013
J	Nishito, Y; Tsuji, N; Fujishiro, H; Takeda, T; Yamazaki, T; Teranishi, F; Okazaki, F; Matsunaga, A; Tuschl, K; Rao, R; Kono, S; Miyajima, H; Narita, H; Himeno, S; Kambe, T				Nishito, Yukina; Tsuji, Natsuko; Fujishiro, Hitomi; Takeda, Taka-aki; Yamazaki, Tomohiro; Teranishi, Fumie; Okazaki, Fumiko; Matsunaga, Ayu; Tuschl, Karin; Rao, Rajini; Kono, Satoshi; Miyajima, Hiroaki; Narita, Hiroshi; Himeno, Seiichiro; Kambe, Taiho			Direct Comparison of Manganese Detoxification/Efflux Proteins and Molecular Characterization of ZnT10 Protein as a Manganese Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						manganese; metal homeostasis; substrate specificity; transporter; zinc; ATP13A family protein; SPCA1; efflux; ferroportin	DIFFUSION FACILITATOR FAMILY; P-TYPE ATPASE; SECRETORY PATHWAY; ZINC TRANSPORTERS; SACCHAROMYCES-CEREVISIAE; VERTEBRATE CELLS; NEURODEGENERATIVE DISEASES; INTRACELLULAR TRAFFICKING; ALKALINE-PHOSPHATASES; ALPHA-SYNUCLEIN	Manganese homeostasis involves coordinated regulation of specific proteins involved in manganese influx and efflux. However, the proteins that are involved in detoxification/efflux have not been completely resolved nor has the basis by which they select their metal substrate. Here, we compared six proteins, which were reported to be involved in manganese detoxification/efflux, by evaluating their ability to reduce manganese toxicity in chicken DT40 cells, finding that human ZnT10 (hZnT10) was the most significant contributor. A domain swapping and substitution analysis between hZnT10 and the zinc-specific transporter hZnT1 showed that residue Asn(43), which corresponds to the His residue constituting the potential intramembranous zinc coordination site in other ZnT transporters, is necessary to impart hZnT10's unique manganese mobilization activity; residues Cys(52) and Leu(242) in transmembrane domains II and V play a subtler role in controlling the metal specificity of hZnT10. Interestingly, the His Asn reversion mutant in hZnT1 conferred manganese transport activity and loss of zinc transport activity. These results provide important information about manganese detoxification/efflux mechanisms in vertebrate cells as well as the molecular characterization of hZnT10 as a manganese transporter.	[Nishito, Yukina; Tsuji, Natsuko; Takeda, Taka-aki; Yamazaki, Tomohiro; Teranishi, Fumie; Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan; [Fujishiro, Hitomi; Himeno, Seiichiro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima 7708514, Japan; [Okazaki, Fumiko; Matsunaga, Ayu; Narita, Hiroshi] Kyoto Womens Univ, Dept Food Sci, Kyoto 6058501, Japan; [Tuschl, Karin] UCL, Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 1EH, England; [Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Kono, Satoshi; Miyajima, Hiroaki] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka 4313192, Japan; [Yamazaki, Tomohiro] Hokkaido Univ, Inst Med Genet, Sapporo, Hokkaido 0600815, Japan; [Okazaki, Fumiko] Ryukoku Univ, Fac Agr, Otsu, Shiga 5202194, Japan	Kyoto University; Tokushima Bunri University; Kyoto Womens University; University of London; University College London; Johns Hopkins University; Hamamatsu University School of Medicine; Hokkaido University; Ryukoku University	Kambe, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan.	kambe1@kais.kyoto-u.ac.jp	Himeno, Seiichiro/AAW-3421-2020	Himeno, Seiichiro/0000-0002-0773-2373; Kambe, Taiho/0000-0001-9757-063X; Tuschl, Karin/0000-0001-8599-8516	Japan Society for the Promotion of Science (KAKENHI) [21780309, 26660086, 15H04501]; Fuji Foundation for Protein Research; Salt Science Research Foundation; Kato Memorial Bioscience Foundation; Sasakawa Scientific Research Grant from the Japan Science Society; Mochida Memorial Foundation for Medical and Pharmaceutical Research; National Institute for Health Research [ACF-2009-18-025] Funding Source: researchfish; Action Medical Research [1999] Funding Source: researchfish; Grants-in-Aid for Scientific Research [15K08054] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Fuji Foundation for Protein Research(Fuji Foundation for Protein Research); Salt Science Research Foundation; Kato Memorial Bioscience Foundation; Sasakawa Scientific Research Grant from the Japan Science Society; Mochida Memorial Foundation for Medical and Pharmaceutical Research; National Institute for Health Research(National Institute for Health Research (NIHR)); Action Medical Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Young Scientists (B), Challenging Exploratory Research and Scientific Research (B), from the Japan Society for the Promotion of Science (KAKENHI) Grants 21780309, 26660086, and 15H04501, the Fuji Foundation for Protein Research, the Salt Science Research Foundation, the Kato Memorial Bioscience Foundation, the Sasakawa Scientific Research Grant from the Japan Science Society, and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Aronchik I, 2003, J INVEST DERMATOL, V121, P681, DOI 10.1046/j.1523-1747.2003.12472.x; Aschner Judy L., 2005, Molecular Aspects of Medicine, V26, P353, DOI 10.1016/j.mam.2005.07.003; Aschner M, 2009, NEUROMOL MED, V11, P252, DOI 10.1007/s12017-009-8083-0; Au C, 2008, NEUROTOXICOLOGY, V29, P569, DOI 10.1016/j.neuro.2008.04.022; Blindauer CA, 2010, METALLOMICS, V2, P510, DOI 10.1039/c004880a; Bosomworth HJ, 2012, METALLOMICS, V4, P771, DOI 10.1039/c2mt20088k; Bowman AB, 2011, J TRACE ELEM MED BIO, V25, P191, DOI 10.1016/j.jtemb.2011.08.144; Chen P, 2015, J NEUROCHEM, V134, P601, DOI 10.1111/jnc.13170; Chesi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034178; Coudray N, 2013, P NATL ACAD SCI USA, V110, P2140, DOI 10.1073/pnas.1215455110; Culotta VC, 2005, EUKARYOT CELL, V4, P1159, DOI 10.1128/EC.4.7.1159-1165.2005; Delhaize E, 2003, PLANT CELL, V15, P1131, DOI 10.1105/tpc.009134; Fujimoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077445; Fujishiro H, 2013, METALLOMICS, V5, P437, DOI 10.1039/c3mt00003f; Fujishiro H, 2012, METALLOMICS, V4, P700, DOI 10.1039/c2mt20024d; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Gupta S, 2014, NATURE, V512, P101, DOI 10.1038/nature13382; Gustin JL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-76; Hashimoto A, 2015, BIOCHEM J, V472, P183, DOI 10.1042/BJ20150862; Hoch E, 2012, P NATL ACAD SCI USA, V109, P7202, DOI 10.1073/pnas.1200362109; Hozumi I, 2011, J NEUROL SCI, V303, P95, DOI 10.1016/j.jns.2011.01.003; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Itsumura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064045; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kambe Taiho, 2006, Genomics Proteomics & Bioinformatics, V4, P1, DOI 10.1016/S1672-0229(06)60010-7; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kambe T, 2014, METHOD ENZYMOL, V534, P77, DOI 10.1016/B978-0-12-397926-1.00005-6; Kambe T, 2012, CURR TOP MEMBR, V69, P199, DOI 10.1016/B978-0-12-394390-3.00008-2; Kawachi M, 2008, J BIOL CHEM, V283, P8374, DOI 10.1074/jbc.M707646200; Kono S, 2010, BBA-MOL BASIS DIS, V1802, P968, DOI 10.1016/j.bbadis.2010.07.011; Lapinskas PJ, 1996, MOL MICROBIOL, V21, P519, DOI 10.1111/j.1365-2958.1996.tb02561.x; Leitch S, 2011, BIOMETALS, V24, P159, DOI 10.1007/s10534-010-9384-3; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Lin SJ, 1996, MOL CELL BIOL, V16, P6303; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Lucchini RG, 2009, NEUROMOL MED, V11, P311, DOI 10.1007/s12017-009-8108-8; Madejczyk MS, 2012, BBA-BIOMEMBRANES, V1818, P651, DOI 10.1016/j.bbamem.2011.12.002; Matsuura W, 2009, BIOSCI BIOTECH BIOCH, V73, P1142, DOI 10.1271/bbb.80910; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Ng E, 2015, HUM MOL GENET, V24, P4739, DOI 10.1093/hmg/ddv190; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Park JS, 2014, HUM MOL GENET, V23, P2802, DOI 10.1093/hmg/ddt623; Patrushev N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033211; Pedas P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113759; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Reddi AR, 2009, CHEM REV, V109, P4722, DOI 10.1021/cr900031u; Seve M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-32; Shusterman E, 2014, METALLOMICS, V6, P1656, DOI 10.1039/c4mt00108g; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Tan JQ, 2011, J BIOL CHEM, V286, P29654, DOI 10.1074/jbc.M111.233874; Ton VK, 2002, J BIOL CHEM, V277, P6422, DOI 10.1074/jbc.M110612200; Tsunemi T, 2014, HUM MOL GENET, V23, P2791, DOI 10.1093/hmg/ddt572; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Wei Y, 2000, J BIOL CHEM, V275, P23927, DOI 10.1074/jbc.M002618200; Wood RJ, 2009, NUTR REV, V67, P416, DOI 10.1111/j.1753-4887.2009.00214.x; Yin ZB, 2010, J NEUROCHEM, V112, P1190, DOI 10.1111/j.1471-4159.2009.06534.x; Zhao YT, 2016, TRAFFIC, V17, P267, DOI 10.1111/tra.12371	65	58	60	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14773	14787		10.1074/jbc.M116.728014	http://dx.doi.org/10.1074/jbc.M116.728014			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226609	Green Published, hybrid			2022-12-28	WOS:000380366700029
J	Crosnier, C; Iqbal, Z; Knuepfer, E; Maciuca, S; Perrin, AJ; Kamuyu, G; Goulding, D; Bustamante, LY; Miles, A; Moore, SC; Dougan, G; Holder, AA; Kwiatkowski, DP; Rayner, JC; Pleass, RJ; Wright, GJ				Crosnier, Cecile; Iqbal, Zamin; Knuepfer, Ellen; Maciuca, Sorina; Perrin, Abigail J.; Kamuyu, Gathoni; Goulding, David; Bustamante, Leyla Y.; Miles, Alistair; Moore, Shona C.; Dougan, Gordon; Holder, Anthony A.; Kwiatkowski, Dominic P.; Rayner, Julian C.; Pleass, Richard J.; Wright, Gavin J.			Binding of Plasmodium falciparum Merozoite Surface Proteins DBLMSP and DBLMSP2 to Human Immunoglobulin M Is Conserved among Broadly Diverged Sequence Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						genetic polymorphism; host-pathogen interaction; parasite; plasmodium; protein-protein interaction; immunoglobulin M (IgM); merozoite	HUMAN-IGM; INFECTED ERYTHROCYTES; MALARIA; INVASION; ANTIBODIES; DOMAINS; ANTIGEN; SELECTION; RECEPTOR; IDENTIFICATION	Diversity at pathogen genetic loci can be driven by host adaptive immune selection pressure and may reveal proteins important for parasite biology. Population-based genome sequencing of Plasmodium falciparum, the parasite responsible for the most severe form of malaria, has highlighted two related polymorphic genes called dblmsp and dblmsp2, which encode Duffy binding-like (DBL) domain-containing proteins located on the merozoite surface but whose function remains unknown. Using recombinant proteins and transgenic parasites, we show that DBLMSP and DBLMSP2 directly and avidly bind human IgM via their DBL domains. We used whole genome sequence data from over 400 African and Asian P. falciparum isolates to show that dblmsp and dblmsp2 exhibit extreme protein polymorphism in their DBL domain, with multiple variants of two major allelic classes present in every population tested. Despite this variability, the IgM binding function was retained across diverse sequence representatives. Although this interaction did not seem to have an effect on the ability of the parasite to invade red blood cells, binding of DBLMSP and DBLMSP2 to IgM inhibited the overall immunoreactivity of these proteins to IgG from patients who had been exposed to the parasite. This suggests that IgM binding might mask these proteins from the host humoral immune system.	[Crosnier, Cecile; Perrin, Abigail J.; Wright, Gavin J.] Wellcome Trust Sanger Inst, Cell Surface Signalling Lab, Cambridge CB10 1SA, England; [Crosnier, Cecile; Perrin, Abigail J.; Kamuyu, Gathoni; Bustamante, Leyla Y.; Miles, Alistair; Kwiatkowski, Dominic P.; Rayner, Julian C.; Wright, Gavin J.] Wellcome Trust Sanger Inst, Malaria Programme, Cambridge CB10 1SA, England; [Goulding, David; Dougan, Gordon] Wellcome Trust Sanger Inst, Microbial Pathogenesis Lab, Cambridge CB10 1SA, England; [Iqbal, Zamin; Maciuca, Sorina; Miles, Alistair; Kwiatkowski, Dominic P.] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Knuepfer, Ellen; Holder, Anthony A.] Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England; [Moore, Shona C.; Pleass, Richard J.] Univ Liverpool Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England; [Moore, Shona C.] Univ Warwick, Warwick Syst Biol Ctr, Senate House, Coventry CV4 7AL, W Midlands, England	Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; Francis Crick Institute; Liverpool School of Tropical Medicine; University of Warwick	Wright, GJ (corresponding author), Wellcome Trust Sanger Inst, Cell Surface Signalling Lab, Cambridge CB10 1SA, England.	gw2@sanger.ac.uk	Holder, Anthony A/A-7554-2013; Moore, Shona C/AAY-5049-2021; Pleass, Richard/N-7831-2019	Holder, Anthony A/0000-0002-8490-6058; Moore, Shona C/0000-0001-8610-2806; Pleass, Richard/0000-0001-7438-8296; Miles, Alistair/0000-0001-9018-4680; Iqbal, Zamin/0000-0001-8466-7547; Kwiatkowski, Dominic/0000-0002-5023-0176; Knuepfer, Ellen/0000-0002-6090-1877; Perrin, Abigail/0000-0001-6682-4297; Wright, Gavin/0000-0003-0537-0863; Rayner, Julian/0000-0002-9835-1014	Wellcome Trust [098051]; Sir Henry Dale Fellowship - Wellcome Trust [102541/Z/13/Z]; Sir Henry Dale Fellowship - Royal Society [102541/Z/13/Z]; European Community [242095]; Engineering and Physical Sciences Research Council [987447] Funding Source: researchfish; Medical Research Council [MR/M006212/1, MC_PC_12017] Funding Source: researchfish; The Francis Crick Institute [10097] Funding Source: researchfish; MRC [MC_PC_12017, MR/M006212/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Sir Henry Dale Fellowship - Royal Society; European Community(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 098051 (to C.C., L. Y. B., A. J. P., D. G., G. D., D. P. K., J. C. R., and G. J. W.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Sir Henry Dale Fellowship 102541/Z/13/Z jointly awarded by the Wellcome Trust and the Royal Society.; Supported by European Community's Seventh Framework Programme FP7/2007-2013 under Grant 242095.	Akhouri RR, 2016, CELL REP, V14, P723, DOI 10.1016/j.celrep.2015.12.067; Amambua-Ngwa A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002992; [Anonymous], CELLS LAB MANUAL SUB; Barfod L, 2011, P NATL ACAD SCI USA, V108, P12485, DOI 10.1073/pnas.1103708108; Bartholdson SJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003031; Braathen R, 2002, J BIOL CHEM, V277, P42755, DOI 10.1074/jbc.M205502200; BROWN MH, 1994, PROTEIN ENG, V7, P515, DOI 10.1093/protein/7.4.515; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Collins C, 2002, EUR J IMMUNOL, V32, P1802, DOI 10.1002/1521-4141(200206)32:6<1802::AID-IMMU1802>3.0.CO;2-C; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Crosnier C, 2013, MOL CELL PROTEOMICS, V12, P3976, DOI 10.1074/mcp.O113.028357; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Crosnier C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-76; Czajkowsky DM, 2010, J IMMUNOL, V184, P4597, DOI 10.4049/jimmunol.1000203; Douglas AD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1615; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Gerold P, 1996, MOL BIOCHEM PARASIT, V75, P131, DOI 10.1016/0166-6851(95)02518-9; Ghumra A, 2008, J IMMUNOL, V181, P1988, DOI 10.4049/jimmunol.181.3.1988; Gondeau C, 2009, MOL BIOCHEM PARASIT, V165, P153, DOI 10.1016/j.molbiopara.2009.01.015; Hodder AN, 2012, J BIOL CHEM, V287, P32922, DOI 10.1074/jbc.M112.350504; Iqbal Z, 2013, BIOINFORMATICS, V29, P275, DOI 10.1093/bioinformatics/bts673; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Jeppesen A, 2015, INFECT IMMUN, V83, P3972, DOI 10.1128/IAI.00337-15; Kerr JS, 2012, JOVE-J VIS EXP, DOI 10.3791/3881; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Lin CS, 2016, J BIOL CHEM, V291, P7703, DOI 10.1074/jbc.M115.698282; Lin CS, 2014, J BIOL CHEM, V289, P25655, DOI 10.1074/jbc.M114.586495; LING IT, 1994, PARASITE IMMUNOL, V16, P63, DOI 10.1111/j.1365-3024.1994.tb00324.x; MACKENZIE MR, 1971, J IMMUNOL, V106, P65; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; MCCOLL DJ, 1994, MOL BIOCHEM PARASIT, V68, P53, DOI 10.1016/0166-6851(94)00149-9; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mobegi VA, 2014, MOL BIOL EVOL, V31, P1490, DOI 10.1093/molbev/msu106; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Ochola LI, 2010, MOL BIOL EVOL, V27, P2344, DOI 10.1093/molbev/msq119; Okenu DMN, 2000, MOL BIOCHEM PARASIT, V109, P185, DOI 10.1016/S0166-6851(00)00245-0; ORLANDI PA, 1992, J CELL BIOL, V116, P901, DOI 10.1083/jcb.116.4.901; Patel SD, 2013, J INFECT DIS, V208, P1679, DOI 10.1093/infdis/jit385; Pleass RJ, 2016, TRENDS PARASITOL, V32, P108, DOI 10.1016/j.pt.2015.09.007; Rasti N, 2006, P NATL ACAD SCI USA, V103, P13795, DOI 10.1073/pnas.0601519103; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Rowe JA, 2002, AM J TROP MED HYG, V66, P692, DOI 10.4269/ajtmh.2002.66.692; RUDICH SM, 1987, MOL IMMUNOL, V24, P809, DOI 10.1016/0161-5890(87)90183-0; Sakamoto H, 2012, VACCINE, V30, P1972, DOI 10.1016/j.vaccine.2012.01.010; Scholander C, 1996, NAT MED, V2, P204, DOI 10.1038/nm0296-204; Segurel L, 2012, P NATL ACAD SCI USA, V109, P18493, DOI 10.1073/pnas.1210603109; Semblat JP, 2006, MOL BIOCHEM PARASIT, V146, P192, DOI 10.1016/j.molbiopara.2005.12.007; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Singh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005410; Sorensen V, 2000, INT IMMUNOL, V12, P19, DOI 10.1093/intimm/12.1.19; Stevenson L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005022; Sun Y, 2012, ANAL BIOCHEM, V424, P45, DOI 10.1016/j.ab.2012.01.034; TAYLOR TE, 1992, CLIN EXP IMMUNOL, V90, P357, DOI 10.1111/j.1365-2249.1992.tb05851.x; Tetteh KKA, 2013, INFECT IMMUN, V81, P3835, DOI 10.1128/IAI.00301-13; Tetteh KKA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005568; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tran TM, 2014, J INFECT DIS, V209, P789, DOI 10.1093/infdis/jit553; Weedall GD, 2010, TRENDS PARASITOL, V26, P363, DOI 10.1016/j.pt.2010.04.002; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Wickramarachchi T, 2009, INT J PARASITOL, V39, P763, DOI 10.1016/j.ijpara.2008.12.004	63	16	16	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14285	14299		10.1074/jbc.M116.722074	http://dx.doi.org/10.1074/jbc.M116.722074			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226583	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-28	WOS:000379975100032
J	Johansson, E; Hansen, JL; Hansen, AMK; Shaw, AC; Becker, P; Schaffer, L; Reedtz-Runge, S				Johansson, Eva; Hansen, Jakob Lerche; Hansen, Ann Maria Kruse; Shaw, Allan Christian; Becker, Peter; Schaffer, Lauge; Reedtz-Runge, Steffen			Type II Turn of Receptor-bound Salmon Calcitonin Revealed by X-ray Crystallography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; G protein-coupled receptor (GPCR); peptide conformation; peptide hormone; peptide interaction; amylin; calcitonin	CORTICOTROPIN-RELEASING-FACTOR; CLASS-B GPCR; CRYSTAL-STRUCTURE; AMYLIN RECEPTOR; MOLECULAR RECOGNITION; EXTRACELLULAR DOMAIN; 2-DIMENSIONAL NMR; STRUCTURAL BASIS; AMINO-TERMINUS; PROTEIN	Calcitonin is a peptide hormone consisting of 32 amino acid residues and the calcitonin receptor is a Class B G protein-coupled receptor (GPCR). The crystal structure of the human calcitonin receptor ectodomain (CTR ECD) in complex with a truncated analogue of salmon calcitonin ([BrPhe(22)]sCT(8-32)) has been determined to 2.1- resolution. Parallel analysis of a series of peptide ligands showed that the rank order of binding of the CTR ECD is identical to the rank order of binding of the full-length CTR, confirming the structural integrity and relevance of the isolated CTR ECD. The structure of the CTR ECD is similar to other Class B GPCRs and the ligand binding site is similar to the binding site of the homologous receptors for the calcitonin gene-related peptide (CGRP) and adrenomedulin (AM) recently published (Booe, J. M., Walker, C. S., Barwell, J., Kuteyi, G., Simms, J., Jamaluddin, M. A., Warner, M. L., Bill, R. M., Harris, P. W., Brimble, M. A., Poyner, D. R., Hay, D. L., and Pioszak, A. A. (2015) Mol. Cell 58, 1040-1052). Interestingly the receptor-bound structure of the ligand [BrPhe(22)]sCT(8-32) differs from the receptor-bound structure of the homologous ligands CGRP and AM. They all adopt an extended conformation followed by a C-terminal turn, however, [BrPhe(22)]sCT(8-32) adopts a type II turn (Gly(28)-Thr(31)), whereas CGRP and AM adopt type I turns. Our results suggest that a type II turn is the preferred conformation of calcitonin, whereas a type I turn is the preferred conformation of peptides that require RAMPs; CGRP, AM, and amylin. In addition the structure provides a detailed molecular explanation and hypothesis regarding ligand binding properties of CTR and the amylin receptors.	[Johansson, Eva; Hansen, Jakob Lerche; Hansen, Ann Maria Kruse; Shaw, Allan Christian; Becker, Peter; Schaffer, Lauge; Reedtz-Runge, Steffen] Novo Nordisk AS, Novo Nordisk Pk, DK-2760 Malov, Denmark; [Becker, Peter] Glycom Denmark AS, Diplomvej 378, DK-2800 Lyngby, Denmark	Novo Nordisk	Johansson, E (corresponding author), Novo Nordisk AS, Novo Nordisk Pk, DK-2760 Malov, Denmark.	evjh@novonordisk.com	Johansson, Eva/AAB-9003-2021	Johansson, Eva/0000-0001-9330-5169				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreotti G, 2006, J BIOL CHEM, V281, P24193, DOI 10.1074/jbc.M603528200; Biedermannova L, 2008, PHYS CHEM CHEM PHYS, V10, P6350, DOI 10.1039/b805087b; Booe JM, 2015, MOL CELL, V58, P1040, DOI 10.1016/j.molcel.2015.04.018; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; COPP DH, 1962, ENDOCRINOLOGY, V70, P638, DOI 10.1210/endo-70-5-638; Dong MQ, 2004, J BIOL CHEM, V279, P31177, DOI 10.1074/jbc.M404113200; Dong MQ, 2004, J BIOL CHEM, V279, P1167, DOI 10.1074/jbc.M305719200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Findlay DM, 2004, GROWTH FACTORS, V22, P217, DOI 10.1080/08977190410001728033; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Lee SM, 2016, J BIOL CHEM, V291, P8686, DOI 10.1074/jbc.M115.713628; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEADOWS RP, 1991, BIOCHEMISTRY-US, V30, P1247, DOI 10.1021/bi00219a012; MEYER JP, 1991, BIOPOLYMERS, V31, P233, DOI 10.1002/bip.360310210; MOTTA A, 1991, BIOCHEMISTRY-US, V30, P10444, DOI 10.1021/bi00107a012; Muff R, 1999, ENDOCRINOLOGY, V140, P2924, DOI 10.1210/en.140.6.2924; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Pham V, 2005, J BIOL CHEM, V280, P28610, DOI 10.1074/jbc.M503272200; Pham V, 2004, J BIOL CHEM, V279, P6720, DOI 10.1074/jbc.M307214200; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Pioszak AA, 2009, J BIOL CHEM, V284, P28382, DOI 10.1074/jbc.M109.022905; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Runge S, 2007, BIOCHEMISTRY-US, V46, P5830, DOI 10.1021/bi062309m; Sexton PM, 2006, ANN NY ACAD SCI, V1070, P90, DOI 10.1196/annals.1317.076; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; Tilakaratne N, 2000, J PHARMACOL EXP THER, V294, P61; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	37	28	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13689	13698		10.1074/jbc.M116.726034	http://dx.doi.org/10.1074/jbc.M116.726034			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27189946	hybrid, Green Published			2022-12-28	WOS:000379771100024
J	Soysa, HSM; Suginta, W				Soysa, H. Sasimali M.; Suginta, Wipa			Identification and Functional Characterization of a Novel OprD-like Chitin Uptake Channel in Non-chitinolytic Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate metabolism; chitin; Escherichia coli (E. coli); ion channel; sugar transport; chitin uptake channel; non-chitinolytic bacteria; single channel recordings	ACETYLGLUCOSAMINE UTILIZATION PATHWAY; N-N'-DIACETYLCHITOBIOSE; ESCHERICHIA-COLI; VIBRIO-HARVEYI; MARINE-BACTERIA; BURKHOLDERIA-PSEUDOMALLEI; SUGAR TRANSLOCATION; MOLECULAR-CLONING; STRUCTURAL BASIS; MALTOPORIN	Chitoporin from the chitinolytic marine Vibrio has been characterized as a trimeric OmpC-like channel responsible for effective chitin uptake. In this study we describe the identification and characterization of a novel OprD-like chitoporin (so-called EcChiP) from Escherichia coli. The gene was identified, cloned, and functionally expressed in the Omp-deficient E. coli BL21 (Omp8) Rosetta strain. On size exclusion chromatography, EcChiP had an apparent native molecular mass of 50 kDa, as predicted by amino acid sequencing and mass analysis, confirming that the protein is a monomer. Black lipid membrane reconstitution demonstrated that EcChiP could readily form stable, monomeric channels in artificial phospholipid membranes, with an average single channel conductance of 0.55 +/- 0.01 nanosiemens and a slight preference for cations. Single EcChiP channels showed strong specificity, interacting with long chain chitooligosaccharides but not with maltooligosaccharides. Liposome swelling assays indicated the bulk permeation of neutral monosaccharides and showed the size exclusion limit of EcChiP to be approximate to 200-300 Da for small permeants that pass through by general diffusion while allowing long chain chitooligosaccharides to pass through by a facilitated diffusion process. Taking E. coli as a model, we offer the first evidence that non-chitinolytic bacteria can activate a quiescent ChiP gene to express a functional chitoporin, enabling them to take up chitooligosaccharides for metabolism as an immediate source of energy.	[Soysa, H. Sasimali M.; Suginta, Wipa] Suranaree Univ Technol, Biochem Electrochem Res Unit, Nakhon Ratchasima 30000, Thailand; [Soysa, H. Sasimali M.; Suginta, Wipa] Suranaree Univ Technol, Inst Sci, Sch Chem, Nakhon Ratchasima 30000, Thailand; [Suginta, Wipa] Suranaree Univ Technol, Ctr Excellence Adv Funct Mat, Nakhon Ratchasima 30000, Thailand	Suranaree University of Technology; Suranaree University of Technology; Suranaree University of Technology	Suginta, W (corresponding author), Suranaree Univ Technol, Biochem Electrochem Res Unit, Nakhon Ratchasima 30000, Thailand.; Suginta, W (corresponding author), Suranaree Univ Technol, Inst Sci, Sch Chem, Nakhon Ratchasima 30000, Thailand.; Suginta, W (corresponding author), Suranaree Univ Technol, Ctr Excellence Adv Funct Mat, Nakhon Ratchasima 30000, Thailand.	wipa@sut.ac.th		M. Soysa, H. Sasimali/0000-0003-3244-8670	Suranaree University of Technology; Office of the Higher Education Commission under the National Research University project of Thailand; Suranaree University of Technology through a SUT-OGRG grant; Thailand Research Fund; Suranaree University of Technology through Basic Research Grant [BRG578001]; Suranaree University of Technology [SUT1-102-57-36-18, SUT1-102-59-12-17]	Suranaree University of Technology; Office of the Higher Education Commission under the National Research University project of Thailand; Suranaree University of Technology through a SUT-OGRG grant; Thailand Research Fund(Thailand Research Fund (TRF)); Suranaree University of Technology through Basic Research Grant; Suranaree University of Technology	This work was supported by Suranaree University of Technology and the Office of the Higher Education Commission under the National Research University project of Thailand. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Suranaree University of Technology through a SUT-OGRG grant.; Supported by the Thailand Research Fund and Suranaree University of Technology through Basic Research Grant BRG578001 and Suranaree University of Technology Grants SUT1-102-57-36-18 and SUT1-102-59-12-17. To whom correspondence should be addressed. E-mail: wipa@sut.ac.th.	Aunkham A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095918; BASSLER BL, 1991, J BIOL CHEM, V266, P24268; BASSLER BL, 1991, J BIOL CHEM, V266, P24276; BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137; Bezrukov SM, 2000, FEBS LETT, V476, P224, DOI 10.1016/S0014-5793(00)01753-1; Bhamidimarri SP, 2016, BIOPHYS J, V110, P600, DOI 10.1016/j.bpj.2015.12.027; Biswas S, 2007, NAT STRUCT MOL BIOL, V14, P1108, DOI 10.1038/nsmb1304; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Boulanger A, 2010, J BACTERIOL, V192, P1487, DOI 10.1128/JB.01418-09; Chumjan W, 2015, J BIOL CHEM, V290, P19184, DOI 10.1074/jbc.M115.660530; Conlan S, 2000, BIOCHEMISTRY-US, V39, P11845, DOI 10.1021/bi001065h; Danelon C, 2003, J BIOL CHEM, V278, P35542, DOI 10.1074/jbc.M305434200; Dumas F, 2000, J BIOL CHEM, V275, P19747, DOI 10.1074/jbc.M000268200; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Forst D, 1998, NAT STRUCT BIOL, V5, P37, DOI 10.1038/nsb0198-37; Francetic O, 2000, MOL MICROBIOL, V35, P1506, DOI 10.1046/j.1365-2958.2000.01817.x; Francetic O, 2000, EMBO J, V19, P6697, DOI 10.1093/emboj/19.24.6697; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; Keyhani NO, 2000, J BIOL CHEM, V275, P33102, DOI 10.1074/jbc.M001045200; Keyhani NO, 2000, J BIOL CHEM, V275, P33091, DOI 10.1074/jbc.M001044200; Keyhani NO, 2000, J BIOL CHEM, V275, P33084, DOI 10.1074/jbc.M001043200; Keyhani NO, 2000, J BIOL CHEM, V275, P33068, DOI 10.1074/jbc.M001041200; Kim BH, 2008, BACTERIAL PHYSIOLOGY AND METABOLISM, P1; Kullman L, 2002, BIOPHYS J, V82, P803, DOI 10.1016/S0006-3495(02)75442-8; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; Meekrathok P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149228; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Park JK, 2000, J BIOL CHEM, V275, P33077, DOI 10.1074/jbc.M001042200; PERI KG, 1990, BIOCHEM CELL BIOL, V68, P123, DOI 10.1139/o90-017; Plumbridge J, 2014, MOL MICROBIOL, V92, P648, DOI 10.1111/mmi.12573; Pruzzo C, 2008, ENVIRON MICROBIOL, V10, P1400, DOI 10.1111/j.1462-2920.2007.01559.x; Ranquin A, 2004, RES MICROBIOL, V155, P611, DOI 10.1016/j.resmic.2004.05.007; Rasmussen AA, 2009, MOL MICROBIOL, V72, P566, DOI 10.1111/j.1365-2958.2009.06688.x; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saint N, 1996, J BIOL CHEM, V271, P20676, DOI 10.1074/jbc.271.34.20676; SARAVOLAC EG, 1991, J BACTERIOL, V173, P4970, DOI 10.1128/jb.173.16.4970-4976.1991; Schwarz G, 2003, BIOPHYS J, V84, P2990, DOI 10.1016/S0006-3495(03)70025-3; Siritapetawee J, 2004, BIOCHEM J, V384, P609, DOI 10.1042/BJ20041102; Siritapetawee J, 2004, BIOCHEM J, V377, P579, DOI 10.1042/BJ20031118; Sritho N, 2012, APPL BIOCHEM BIOTECH, V166, P1192, DOI 10.1007/s12010-011-9504-8; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; Suginta W, 2013, J BIOL CHEM, V288, P11038, DOI 10.1074/jbc.M113.454108; Suginta W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055126; Suginta W, 2012, BIOSCI BIOTECH BIOCH, V76, P2275, DOI 10.1271/bbb.120559; Suginta W, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-40; Takanao S, 2014, BIOSCI BIOTECH BIOCH, V78, P524, DOI 10.1080/09168451.2014.882755; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; van den Berg B, 2012, J BIOL CHEM, V287, P41044, DOI 10.1074/jbc.M112.408518; Van Gelder P, 2000, EUR J BIOCHEM, V267, P79, DOI 10.1046/j.1432-1327.2000.00960.x; Verma SC, 2012, J BACTERIOL, V194, P4959, DOI 10.1128/JB.00533-12; Vogel J, 2006, CURR OPIN MICROBIOL, V9, P605, DOI 10.1016/j.mib.2006.10.006; Wang YF, 1997, J MOL BIOL, V272, P56, DOI 10.1006/jmbi.1997.1224; Yang C, 2006, J BIOL CHEM, V281, P29872, DOI 10.1074/jbc.M605052200; YOSHIMURA F, 1985, ANTIMICROB AGENTS CH, V27, P84, DOI 10.1128/AAC.27.1.84; YU C, 1991, J BIOL CHEM, V266, P24260; Zobell CE, 1938, J BACTERIOL, V35, P275, DOI 10.1128/JB.35.3.275-287.1938	58	8	8	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13622	13633		10.1074/jbc.M116.728881	http://dx.doi.org/10.1074/jbc.M116.728881			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27226611	hybrid, Green Published			2022-12-28	WOS:000379771100019
J	Jalloul, AH; Rogasevskaia, TP; Szerencsei, RT; Schnetkamp, PPM				Jalloul, Ali H.; Rogasevskaia, Tatiana P.; Szerencsei, Robert T.; Schnetkamp, Paul P. M.			A Functional Study of Mutations in K+-dependent Na+-Ca2+ Exchangers Associated with Amelogenesis Imperfecta and Non-syndromic Oculocutaneous Albinism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NCKX2 NA+/CA2+-K+ EXCHANGER; SKIN PIGMENTATION; SODIUM/CALCIUM EXCHANGER; GENE FAMILY; RETINAL ROD; AMELOBLASTS; TRANSPORT; SLC24A5; IDENTIFICATION; STOICHIOMETRY	K+-dependent Na+/Ca2+ exchangers belong to the solute carrier 24 (SLC24A1-5) gene family of membrane transporters. Five different gene products (NCKX1-5) have been identified in humans, which play key roles in biological processes including vision, olfaction, and skin pigmentation. NCKXs are bi-directional membrane transporters that transport 1 Ca2+ + K+ ions in exchange for 4 Na+ ions. Recent studies have linked mutations in the SLC24A4 (NCKX4) and SLC24A5 (NCKX5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous albinism (OCA6), respectively. Here, we introduced mutations found in patients with AI and OCA6 into human SLC24A4 (NCKX4) cDNA leading to single residue substitutions in the mutant NCKX4 proteins. We measured NCKX-mediated Ca2+ transport activity of WT and mutant NCKX4 proteins expressed in HEK293 cells. Three mutant NCKX4 cDNAs represent mutations found in the SCL24A4 gene and three represent mutations found in the SCL24A5 gene involving residues conserved between NCKX4 and NCKX5. Five mutant proteins had no observable NCKX activity, whereas one mutation resulted in a 78% reduction in transport activity. Total protein expression and trafficking to the plasma membrane (the latter with one exception) were not affected in the HEK293 cell expression system. We also analyzed two mutations in a Drosophila NCKX gene that have been reported to result in an increased susceptibility for seizures, and found that both resulted in mutant proteins with significantly reduced but observable NCKX activity. The data presented here support the genetic analyses that mutations in SLC24A4 and SLC24A5 are responsible for the phenotypic defects observed in human patients.	[Jalloul, Ali H.; Rogasevskaia, Tatiana P.; Szerencsei, Robert T.; Schnetkamp, Paul P. M.] Univ Calgary, Dept Physiol & Pharmacol, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada	University of Calgary	Schnetkamp, PPM (corresponding author), 3230 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	pschnetk@ucalgary.ca			Canadian Institutes for Health Research [MOP-81327]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research operating Grant MOP-81327. The authors declare that they have no competing financial interests.	Altimimi HF, 2007, J BIOL CHEM, V282, P3720, DOI 10.1074/jbc.M609285200; Altimimi HF, 2010, J BIOL CHEM, V285, P15245, DOI 10.1074/jbc.M109.090738; Bertolotti A, 2016, PIGM CELL MELANOMA R, V29, P104, DOI 10.1111/pcmr.12425; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Dong H, 2001, J BIOL CHEM, V276, P25919, DOI 10.1074/jbc.M103401200; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Herzog CR, 2015, OR SURG OR MED OR PA, V119, pE77, DOI 10.1016/j.oooo.2014.09.003; Hu P, 2012, CELLS TISSUES ORGANS, V196, P501, DOI 10.1159/000337493; HUBBARD MJ, 1995, EUR J BIOCHEM, V230, P68, DOI 10.1111/j.1432-1033.1995.0068i.x; Hubbard MJ, 2000, CRIT REV ORAL BIOL M, V11, P437, DOI 10.1177/10454411000110040401; Jalloul AH, 2016, CELL CALCIUM, V59, P1, DOI 10.1016/j.ceca.2015.11.001; Kang K, 2003, BIOCHEMISTRY-US, V42, P9438, DOI 10.1021/bi0342261; Kang K, 2003, BIOCHEMISTRY-US, V42, P4593, DOI 10.1021/bi027276z; Kang KJ, 2005, J BIOL CHEM, V280, P6823, DOI 10.1074/jbc.M407933200; Kinjo TG, 2003, BIOCHEMISTRY-US, V42, P2485, DOI 10.1021/bi0270788; Lacruz RS, 2013, J DENT RES, V92, P122, DOI 10.1177/0022034512470954; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Li XF, 2002, J BIOL CHEM, V277, P48410, DOI 10.1074/jbc.M210011200; Li XF, 2014, J BIOL CHEM, V289, P25445, DOI 10.1074/jbc.M114.564450; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Melom JE, 2013, J NEUROSCI, V33, P1169, DOI 10.1523/JNEUROSCI.3920-12.2013; Morice-Picard F, 2014, J INVEST DERMATOL, V134, P568, DOI 10.1038/jid.2013.360; Okumura R, 2010, J PHARMACOL SCI, V112, P223, DOI 10.1254/jphs.09267FP; Parry DA, 2013, AM J HUM GENET, V92, P307, DOI 10.1016/j.ajhg.2013.01.003; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Pospiech E, 2011, J HUM GENET, V56, P447, DOI 10.1038/jhg.2011.38; Schnetkamp PPM, 2014, CURR TOP MEMBR, V73, P263, DOI 10.1016/B978-0-12-800223-0.00007-4; Schnetkamp PPM, 2013, MOL ASPECTS MED, V34, P455, DOI 10.1016/j.mam.2012.07.008; SCHNETKAMP PPM, 1989, AM J PHYSIOL, V257, pC153, DOI 10.1152/ajpcell.1989.257.1.C153; Seymen F, 2014, J DENT RES, V93, P366, DOI 10.1177/0022034514523786; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Stephan AB, 2012, NAT NEUROSCI, V15, P131, DOI 10.1038/nn.2943; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Szerencsei RT, 2013, CHANNELS, V7, P109, DOI 10.4161/chan.23898; Szerencsei RT, 2001, BIOCHEMISTRY-US, V40, P6009, DOI 10.1021/bi0102353; Wang S, 2014, J DENT RES, V93, P94, DOI 10.1177/0022034514527971; Winkfein RJ, 2004, CELL CALCIUM, V36, P147, DOI 10.1016/j.ceca.2004.01.021; Winkfein RJ, 2003, BIOCHEMISTRY-US, V42, P543, DOI 10.1021/bi026982x	40	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13113	13123		10.1074/jbc.M116.728824	http://dx.doi.org/10.1074/jbc.M116.728824			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129268	Green Published, hybrid			2022-12-28	WOS:000379770500019
J	Zhang, YX; Lee, KM; Kinch, LN; Clark, L; Grishin, NV; Rosenbaum, DM; Brown, MS; Goldstein, JL; Radhakrishnan, A				Zhang, Yinxin; Lee, Kwang Min; Kinch, Lisa N.; Clark, Lindsay; Grishin, Nick V.; Rosenbaum, Daniel M.; Brown, Michael S.; Goldstein, Joseph L.; Radhakrishnan, Arun			Direct Demonstration That Loop1 of Scap Binds to Loop7 A CRUCIAL EVENT IN CHOLESTEROL HOMEOSTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEAVAGE-ACTIVATING PROTEIN; STEROL-REGULATED TRANSPORT; ENDOPLASMIC-RETICULUM; SENSING DOMAIN; COPII PROTEINS; SREBPS; GOLGI; INSIG; IDENTIFICATION; METABOLISM	Cholesterol homeostasis is mediated by Scap, a polytopic endoplasmic reticulum (ER) protein that transports sterol regulatory element-binding proteins from the ER to Golgi, where they are processed to forms that activate cholesterol synthesis. Scap has eight transmembrane helices and two large luminal loops, designated Loop1 and Loop7. We earlier provided indirect evidence that Loop1 binds to Loop7, allowing Scap to bind COPII proteins for transport in coated vesicles. When ER cholesterol rises, it binds to Loop1. We hypothesized that this causes dissociation from Loop7, abrogating COPII binding. Here we demonstrate direct binding of the two loops when expressed as isolated fragments or as a fusion protein. Expressed alone, Loop1 remained intracellular and membrane-bound. When Loop7 was co-expressed, it bound to Loop1, and the soluble complex was secreted. A Loop1-Loop7 fusion protein was also secreted, and the two loops remained bound when the linker between them was cleaved by a protease. Point mutations that disrupt the Loop1-Loop7 interaction prevented secretion of the Loop1-Loop7 fusion protein. These data provide direct documentation of intramolecular Loop1-Loop7 binding, a central event in cholesterol homeostasis.	[Zhang, Yinxin; Lee, Kwang Min; Brown, Michael S.; Goldstein, Joseph L.; Radhakrishnan, Arun] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Clark, Lindsay; Grishin, Nick V.; Rosenbaum, Daniel M.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Grishin, Nick V.; Rosenbaum, Daniel M.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Grishin, Nick V.; Radhakrishnan, Arun] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Zhang, Yinxin] Rockefeller Univ, Mol Genet Lab, New York, NY 10065 USA; [Zhang, Yinxin] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Lee, Kwang Min] Korea Food Res Inst, Songnam 13539, Gyeonggi Do, South Korea	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Korea Food Research Institute (KFRI)	Brown, MS; Goldstein, JL; Radhakrishnan, A (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	mike.brown@utsouthwestern.edu; joe.goldstein@utsouthwestern.edu; arun.radhakrishnan@utsouthwestern.edu	Radhakrishnan, Arun/Q-7437-2019; Zhang, Yinxin/I-9996-2019	Radhakrishnan, Arun/0000-0002-7266-7336; Zhang, Yinxin/0000-0001-5909-3676; Kinch, Lisa/0000-0003-3041-2615	National Institutes of Health [GM HL20948, GM094575, R01GM113050]; Robert A. Welch Foundation [I-1793, I-1505, I-1770]; American Heart Association [12SDG12040267, 16PRE27200004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575, R01GM113050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM HL20948 (to J. L. G. and M. S. B.), GM094575 (to N. V. G.), and R01GM113050 (to D. M. R.); Robert A. Welch Foundation Grants I-1793 (to A. R.), I-1505 (to N. V. G.), and I-1770 (to D. M. R.); and American Heart Association Grants 12SDG12040267 (to A. R.) and 16PRE27200004 (to L. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; KOVANEN PT, 1981, P NATL ACAD SCI-BIOL, V78, P1396, DOI 10.1073/pnas.78.3.1396; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Zhang YX, 2013, J BIOL CHEM, V288, P14059, DOI 10.1074/jbc.M113.469528	16	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12888	12896		10.1074/jbc.M116.729798	http://dx.doi.org/10.1074/jbc.M116.729798			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27068746	hybrid, Green Published			2022-12-28	WOS:000378119900039
J	Chowdhury, NP; Klomann, K; Seubert, A; Buckel, W				Chowdhury, Nilanjan Pal; Klomann, Katharina; Seubert, Andreas; Buckel, Wolfgang			Reduction of Flavodoxin by Electron Bifurcation and Sodium Ion-dependent Reoxidation by NAD(+) Catalyzed by Ferredoxin-NAD(+) Reductase (Rnf)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTACONYL-COA DECARBOXYLASE; TRANSFERRING FLAVOPROTEIN; 2-HYDROXYGLUTARYL-COA DEHYDRATASE; ACETOBACTERIUM-WOODII; NADH; DEHYDROGENASE; COMPLEX; NA+; PURIFICATION; HYDROGENASE	Electron-transferring flavoprotein (Etf) and butyryl-CoA dehydrogenase (Bcd) from Acidaminococcus fermentans catalyze the endergonic reduction of ferredoxin by NADH, which is also driven by the concomitant reduction of crotonyl-CoA by NADH, a process called electron bifurcation. Here we show that recombinant flavodoxin from A. fermentans produced in Escherichia coli can replace ferredoxin with almost equal efficiency. After complete reduction of the yellow quinone to the blue semiquinone, a second 1.4 times faster electron transfer affords the colorless hydroquinone. Mediated by a hydrogenase, protons reoxidize the fully reduced flavodoxin or ferredoxin to the semi-reduced species. In this hydrogen-generating system, both electron carriers act catalytically with apparent K-m = 0.26 mu M ferredoxin or 0.42 mu M flavodoxin. Membrane preparations of A. fermentans contain a highly active ferredoxin/flavodoxin-NAD(+) reductase (Rnf) that catalyzes the irreversible reduction of flavodoxin by NADH to the blue semiquinone. Using flavodoxin hydroquinone or reduced ferredoxin obtained by electron bifurcation, Rnf can be measured in the forward direction, whereby one NADH is recycled, resulting in the simple equation: crotonyl-CoA + NADH + H+ = butyryl-CoA + NAD(+) with K-m = 1.4 mu M ferredoxin or 2.0 mu M flavodoxin. This reaction requires Na+ (K-m = 0.12 mM) or Li+ (K-m = 0.25 mM) for activity, indicating that Rnf acts as a Na+ pump. The redox potential of the quinone/semiquinone couple of flavodoxin (Fld) is much higher than that of the semiquinone/hydroquinone couple. With free riboflavin, the opposite is the case. Based on this behavior, we refine our previous mechanism of electron bifurcation.	[Chowdhury, Nilanjan Pal; Klomann, Katharina; Buckel, Wolfgang] Univ Marburg, Fachbereich Biol, Lab Mikrobiol, Karl von Frisch Str 8, D-35032 Marburg, Germany; [Chowdhury, Nilanjan Pal; Klomann, Katharina; Buckel, Wolfgang] Univ Marburg, Synmikro, D-35032 Marburg, Germany; [Seubert, Andreas] Univ Marburg, Fachbereich Chem, Hans Meerwein Str, D-35032 Marburg, Germany; [Chowdhury, Nilanjan Pal; Buckel, Wolfgang] Max Planck Inst Terr Mikrobiol, Karl Von Frisch Str, D-35043 Marburg, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Max Planck Society	Buckel, W (corresponding author), Univ Marburg, Fachbereich Biol, Lab Mikrobiol, Karl von Frisch Str 8, D-35032 Marburg, Germany.	buckel@staff.uni-marburg.de	Chowdhury, Nilanjan Pal/AAE-5125-2021	Pal Chowdhury, Nilanjan/0000-0002-7645-3706	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported in part by a grant from the German Research Foundation (DFG). The authors declare that they have no conflicts of interest with the contents of this article.	ANDERSON RF, 1983, BIOCHIM BIOPHYS ACTA, V722, P158, DOI 10.1016/0005-2728(83)90169-X; Bertsch J, 2013, J BIOL CHEM, V288, P11304, DOI 10.1074/jbc.M112.444919; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Bienenstock J, 2015, NUTR REV, V73, P28, DOI 10.1093/nutrit/nuv019; Boiangiu CD, 2005, J MOL MICROB BIOTECH, V10, P105, DOI 10.1159/000091558; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brock M, 2004, EUR J BIOCHEM, V271, P3227, DOI 10.1111/j.1432-1033.2004.04255.x; BUCKEL W, 1986, METHOD ENZYMOL, V125, P547; BUCKEL W, 1982, FEBS LETT, V148, P35, DOI 10.1016/0014-5793(82)81237-4; Buckel W, 2001, BBA-BIOENERGETICS, V1505, P15, DOI 10.1016/S0005-2728(00)00273-5; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Buckel W, 2012, BBA-PROTEINS PROTEOM, V1824, P1278, DOI 10.1016/j.bbapap.2011.11.009; Campbell C, 2015, INT J SYST EVOL MICR, V65, P3203, DOI 10.1099/ijs.0.000347; Chang YJ, 2010, STAND GENOMIC SCI, V3, P1, DOI 10.4056/sigs.1002553; Chowdhury N.R., 2014, THESIS; Chowdhury NP, 2015, FEBS J, V282, P3149, DOI 10.1111/febs.13308; Chowdhury NP, 2014, J BIOL CHEM, V289, P5145, DOI 10.1074/jbc.M113.521013; Chung WSF, 2016, BMC BIOL, V14, DOI 10.1186/s12915-015-0224-3; CORNFORTH JW, 1959, J LIPID RES, V1, P3; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; DIMROTH P, 1986, EUR J BIOCHEM, V156, P157, DOI 10.1111/j.1432-1033.1986.tb09561.x; FILLAT MF, 1991, BIOCHEM J, V280, P187, DOI 10.1042/bj2800187; Hans M, 2002, BIOCHEMISTRY-US, V41, P5873, DOI 10.1021/bi020033m; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Hess V, 2013, J BIOL CHEM, V288, P31496, DOI 10.1074/jbc.M113.510255; Hess V, 2013, APPL ENVIRON MICROB, V79, P1942, DOI 10.1128/AEM.03604-12; Imkamp F, 2007, J BACTERIOL, V189, P8145, DOI 10.1128/JB.01017-07; Jayamani E., 2011, THESIS; Kaster AK, 2011, P NATL ACAD SCI USA, V108, P2981, DOI 10.1073/pnas.1016761108; Kim J, 2008, NATURE, V452, P239, DOI 10.1038/nature06637; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; Mayhew S. G., 1992, CHEM BIOCH FLAVOENZY, V3, P389; NAKOS G, 1971, BIOCHIM BIOPHYS ACTA, V227, P576, DOI 10.1016/0005-2744(71)90008-8; Nitschke W, 2012, BIOESSAYS, V34, P106, DOI 10.1002/bies.201100134; Osyczka A, 2005, TRENDS BIOCHEM SCI, V30, P176, DOI 10.1016/j.tibs.2005.02.001; Parthasarathy A, 2011, BIOCHEMISTRY-US, V50, P3540, DOI 10.1021/bi1020056; Sato K, 2013, J BIOCHEM, V153, P565, DOI 10.1093/jb/mvt026; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schuchmann K, 2012, J BIOL CHEM, V287, P31165, DOI 10.1074/jbc.M112.395038; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Steuber J, 2014, NATURE, V516, P62, DOI 10.1038/nature14003; Talfournier F, 2001, J BIOL CHEM, V276, P20190, DOI 10.1074/jbc.M010853200; Thamer W, 2003, ARCH MICROBIOL, V179, P197, DOI 10.1007/s00203-003-0517-8; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; Vital M, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-8; Wang SN, 2013, APPL ENVIRON MICROB, V79, P6176, DOI 10.1128/AEM.02015-13; Wang SN, 2013, J BACTERIOL, V195, P1267, DOI 10.1128/JB.02158-12; Wang SN, 2010, J BACTERIOL, V192, P5115, DOI 10.1128/JB.00612-10; ZEHNDER AJB, 1976, SCIENCE, V194, P1165, DOI 10.1126/science.793008; ZIEGENHORN J, 1976, CLIN CHEM, V22, P151	53	37	38	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					11993	12002		10.1074/jbc.M116.726299	http://dx.doi.org/10.1074/jbc.M116.726299			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27048649	Green Published, hybrid			2022-12-28	WOS:000378092800004
J	Soderberg, C; Gillam, ME; Ahlgren, EC; Hunter, GA; Gakh, O; Isaya, G; Ferreira, GC; Al-Karadaghi, S				Soderberg, Christopher; Gillam, Mallory E.; Ahlgren, Eva-Christina; Hunter, Gregory A.; Gakh, Oleksandr; Isaya, Grazia; Ferreira, Gloria C.; Al-Karadaghi, Salam			The Structure of the Complex between Yeast Frataxin and Ferrochelatase CHARACTERIZATION AND PRE-STEADY STATE REACTION OF FERROUS IRON DELIVERY AND HEME SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR CLUSTER BIOSYNTHESIS; FRIEDREICH ATAXIA; BACTERIAL FRATAXIN; BINDING-PROPERTIES; REACTION-MECHANISM; METAL-BINDING; PROTEIN; METABOLISM; MITOFERRIN; SITES	Frataxin is a mitochondrial iron-binding protein involved in iron storage, detoxification, and delivery for iron sulfur-cluster assembly and heme biosynthesis. The ability of frataxin from different organisms to populate multiple oligomeric states in the presence of metal ions, e.g. Fe2+ and Co2+, led to the suggestion that different oligomers contribute to the functions of frataxin. Here we report on the complex between yeast frataxin and ferrochelatase, the terminal enzyme of heme biosynthesis. Protein-protein docking and cross-linking in combination with mass spectroscopic analysis and single-particle reconstruction from negatively stained electron microscopic images were used to verify the Yfh1-ferrochelatase interactions. The model of the complex indicates that at the 2: 1 Fe2+-to-protein ratio, when Yfh1 populates a trimeric state, there are two interaction interfaces between frataxin and the ferrochelatase dimer. Each interaction site involves one ferrochelatase monomer and one frataxin trimer, with conserved polar and charged amino acids of the two proteins positioned at hydrogen-bonding distances from each other. One of the subunits of the Yfh1 trimer interacts extensively with one subunit of the ferrochelatase dimer, contributing to the stability of the complex, whereas another trimer subunit is positioned for Fe2+ delivery. Single-turnover stopped-flow kinetics experiments demonstrate that increased rates of heme production result from monomers, dimers, and trimers, indicating that these forms are most efficient in delivering Fe2+ to ferrochelatase and sustaining porphyrin metalation. Furthermore, they support the proposal that frataxin-mediated delivery of this potentially toxic substrate overcomes formation of reactive oxygen species.	[Soderberg, Christopher; Ahlgren, Eva-Christina; Al-Karadaghi, Salam] Lund Univ, Dept Chem, Ctr Mol Prot Sci, SE-22100 Lund, Sweden; [Gillam, Mallory E.; Hunter, Gregory A.; Ferreira, Gloria C.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Ferreira, Gloria C.] Univ S Florida, Dept Chem, Tampa, FL 33612 USA; [Gakh, Oleksandr; Isaya, Grazia] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Gakh, Oleksandr; Isaya, Grazia] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Soderberg, Christopher; Gillam, Mallory E.; Ferreira, Gloria C.] Lund Univ, MAX IV Lab, SE-22100 Lund, Sweden	Lund University; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Mayo Clinic; Mayo Clinic; Lund University	Al-Karadaghi, S (corresponding author), Lund Univ, Dept Chem, Ctr Mol Prot Sci, SE-22100 Lund, Sweden.; Ferreira, GC (corresponding author), Univ S Florida, Dept Mol Med, Morsani Coll Med, MDC 7, Tampa, FL 33612 USA.	gferreir@health.usf.edu; salam.al-karadaghi@biochemistry.lu.se	Ferreira, Gloria C/A-4709-2012	Ferreira, Gloria C/0000-0001-9279-2217	National Institutes of Health [GM080270, AG15709-19]; Swedish Research Council (Vetenskapsradet); American Heart Association, Greater SE Affiliate [10GRNT4300073, 13GRNT16970019]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); American Heart Association, Greater SE Affiliate(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080270 (to G. C. F.). This work was also supported by a grant from the Swedish Research Council (Vetenskapsradet) (to S. A.-K.) and the American Heart Association, Greater SE Affiliate, Grants 10GRNT4300073 and 13GRNT16970019 (to G. C. F.) and in part by National Institutes of Health Grant AG15709-19 (to G. I.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrahao A, 2015, NEUROGENETICS, V16, P151, DOI 10.1007/s10048-015-0439-z; Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Al-Karadaghi S, 2006, TRENDS BIOCHEM SCI, V31, P135, DOI 10.1016/j.tibs.2006.01.001; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Bencze KZ, 2007, CHEM COMMUN, P1798, DOI 10.1039/b703195e; Blow DM, 2002, ACTA CRYSTALLOGR D, V58, P792, DOI 10.1107/S0907444902003931; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Chen W, 2010, BLOOD, V116, P628, DOI 10.1182/blood-2009-12-259614; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; FERREIRA GC, 1994, J BIOL CHEM, V269, P4396; Ferreira GC, 2011, HANDB PORPHYR SCI, V15, P49; Fodje MN, 2002, PROTEIN ENG, V15, P353, DOI 10.1093/protein/15.5.353; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gakh O, 2002, BIOCHEMISTRY-US, V41, P6798, DOI 10.1021/bi025566+; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Hadzhieva M, 2014, NEUROPATH APPL NEURO, V40, P240, DOI 10.1111/nan.12096; Hales KG, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-79; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; HEMPSTEAD PD, 1994, FEBS LETT, V350, P258, DOI 10.1016/0014-5793(94)00781-0; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Hunter GA, 2008, J BIOL CHEM, V283, P23685, DOI 10.1074/jbc.M803372200; Isaya G, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00029; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lecerof D, 2003, J BIOL INORG CHEM, V8, P452, DOI 10.1007/s00775-002-0436-1; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Maliandi MV, 2011, FEBS J, V278, P470, DOI 10.1111/j.1742-4658.2010.07968.x; Metzendorf C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-68; Mielcarek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122538; Nair M, 2004, STRUCTURE, V12, P2037, DOI 10.1016/j.str.2004.08.012; Nichol H, 2003, BIOCHEMISTRY-US, V42, P5971, DOI 10.1021/bi027021l; O'Neill HA, 2005, J MOL BIOL, V345, P433, DOI 10.1016/j.jmb.2004.10.074; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Park S, 2002, J BIOL CHEM, V277, P38589, DOI 10.1074/jbc.M206711200; Pastore A, 2013, J NEUROCHEM, V126, P43, DOI 10.1111/jnc.12220; Pastore C, 2007, FEBS J, V274, P4199, DOI 10.1111/j.1742-4658.2007.05946.x; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rawat S, 2011, CHEM-EUR J, V17, P746, DOI 10.1002/chem.201002143; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Richardson DR, 2010, J MOL MED, V88, P323, DOI 10.1007/s00109-009-0565-x; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Schagerlof U, 2008, BIOCHEMISTRY-US, V47, P4948, DOI 10.1021/bi800052m; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Segel I. H., 1993, ENZYME KINETICS BEHA, P18; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shen Y, 2005, CHEM-EUR J, V11, P1549, DOI 10.1002/chem.200400298; Soderberg CAG, 2013, J BIOL CHEM, V288, P8156, DOI 10.1074/jbc.M112.442285; Soderberg CAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038927; Soderberg CAG, 2011, J MOL BIOL, V414, P783, DOI 10.1016/j.jmb.2011.10.034; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Vaubel RA, 2013, MOL CELL NEUROSCI, V55, P50, DOI 10.1016/j.mcn.2012.08.003; Welch KD, 2002, ARCH BIOCHEM BIOPHYS, V397, P360, DOI 10.1006/abbi.2001.2694; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200	68	17	17	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11887	11898		10.1074/jbc.M115.701128	http://dx.doi.org/10.1074/jbc.M115.701128			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27026703	Green Published, hybrid			2022-12-28	WOS:000377264800037
J	Bokori-Brown, M; Petrov, PG; Khafaji, MA; Mughal, MK; Naylor, CE; Shore, AC; Gooding, KM; Casanova, F; Mitchell, TJ; Titball, RW; Winlove, CP				Bokori-Brown, Monika; Petrov, Peter G.; Khafaji, Mawya A.; Mughal, Muhammad K.; Naylor, Claire E.; Shore, Angela C.; Gooding, Kim M.; Casanova, Francesco; Mitchell, Tim J.; Titball, Richard W.; Winlove, C. Peter			Red Blood Cell Susceptibility to Pneumolysin CORRELATION WITH MEMBRANE BIOCHEMICAL AND PHYSICAL PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSINS; SPHINGOMYELIN-SPECIFIC TOXIN; STREPTOCOCCUS-PNEUMONIAE; PERFRINGOLYSIN-O; ERYTHROCYTE DEFORMABILITY; SENESCENT ERYTHROCYTES; LIPID-PEROXIDATION; DISTRIBUTION WIDTH; CRYSTAL-STRUCTURE; OXIDATIVE STRESS	This study investigated the effect of the biochemical and biophysical properties of the plasma membrane as well as membrane morphology on the susceptibility of human red blood cells to the cholesterol-dependent cytolysin pneumolysin, a key virulence factor of Streptococcus pneumoniae, using single cell studies. We show a correlation between the physical properties of the membrane (bending rigidity and surface and dipole electrostatic potentials) and the susceptibility of red blood cells to pneumolysin-induced hemolysis. We demonstrate that biochemical modifications of the membrane induced by oxidative stress, lipid scrambling, and artificial cell aging modulate the cell response to the toxin. We provide evidence that the diversity of response to pneumolysin in diabetic red blood cells correlates with levels of glycated hemoglobin and that the mechanical properties of the red blood cell plasma membrane are altered in diabetes. Finally, we show that diabetic red blood cells are more resistant to pneumolysin and the related toxin perfringolysin O relative to healthy red blood cells. Taken together, these studies indicate that the diversity of cell response to pneumolysin within a population of human red blood cells is influenced by the biophysical and biochemical status of the plasma membrane and the chemical and/or oxidative stress pre-history of the cell.	[Bokori-Brown, Monika; Titball, Richard W.] Univ Exeter, Sch Biosci, Coll Life & Environm Sci, Geoffrey Pope Bldg,Stocker Rd, Exeter EX4 4QD, Devon, England; [Petrov, Peter G.; Khafaji, Mawya A.; Winlove, C. Peter] Univ Exeter, Sch Phys, Coll Engn Math & Phys Sci, Exeter EX4 4QL, Devon, England; [Khafaji, Mawya A.; Mitchell, Tim J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England; [Shore, Angela C.; Gooding, Kim M.; Casanova, Francesco] Univ Exeter, Sch Med, Dept Diabet & Vasc Med, Barrack Rd, Exeter EX2 5AX, Devon, England; [Shore, Angela C.; Gooding, Kim M.; Casanova, Francesco] Royal Devon & Exeter Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res Exeter Clin Res Facil, Exeter EX2 5DW, Devon, England; [Naylor, Claire E.] Birkbeck Coll, Dept Biol Sci, Malet St, London WC1E 7HX, England; [Khafaji, Mawya A.] King Abdulaziz Univ, Sch Med, Dept Radiol, POB 80215, Jeddah 21589, Saudi Arabia	University of Exeter; University of Exeter; University of Birmingham; University of Exeter; University of London; Birkbeck University London; King Abdulaziz University	Bokori-Brown, M (corresponding author), Univ Exeter, Sch Biosci, Coll Life & Environm Sci, Geoffrey Pope Bldg,Stocker Rd, Exeter EX4 4QD, Devon, England.	m.bokori-brown@exeter.ac.uk	Bokori-Brown, Monika/Y-2302-2019; Mughal, M. Kashif/O-1018-2019; khafaji, mawya/AAK-1221-2020	Mughal, M. Kashif/0000-0002-1321-0619; Casanova, Francesco/0000-0003-0275-4765; Shore, Angela/0000-0003-3039-308X; Mitchell, Timothy/0000-0002-8309-5556	Defence Science and Technology Laboratory, Porton Down, UK [DSTLx1000075949]	Defence Science and Technology Laboratory, Porton Down, UK	This work was supported by the Defence Science and Technology Laboratory Grant DSTLx1000075949, Porton Down, UK. The views expressed are those of the author(s) and not necessarily those of the National Health Service, the National Institute for Health Research (NIHR), or the Department of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Amer J, 2006, BBA-GEN SUBJECTS, V1760, P793, DOI 10.1016/j.bbagen.2006.01.012; Arese P, 2005, CELL PHYSIOL BIOCHEM, V16, P133, DOI 10.1159/000089839; Asawakarn T, 2001, J BIOL CHEM, V276, P38457, DOI 10.1074/jbc.M103269200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrera FN, 2012, P NATL ACAD SCI USA, V109, P14422, DOI 10.1073/pnas.1212665109; BECHINGER B, 1991, BIOCHEMISTRY-US, V30, P3923, DOI 10.1021/bi00230a017; Beisswenger P, 2003, DIABETES METAB, V29, pS95; BERRY AM, 1995, INFECT IMMUN, V63, P1969, DOI 10.1128/IAI.63.5.1969-1974.1995; Bokori-Brown M, 2013, PROTEIN SCI, V22, P650, DOI 10.1002/pro.2250; Bratosin D, 1998, BIOCHIMIE, V80, P173, DOI 10.1016/S0300-9084(98)80024-2; BROCKMAN H, 1994, CHEM PHYS LIPIDS, V73, P57, DOI 10.1016/0009-3084(94)90174-0; Buys AV, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-25; Callan-Jones A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004648; Celedon G, 2008, TOXICON, V51, P1383, DOI 10.1016/j.toxicon.2008.03.006; CHIEN S, 1978, BIOPHYS J, V24, P463, DOI 10.1016/S0006-3495(78)85395-8; Ciccoli L, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/432616; Cladera J, 1998, BIOPHYS J, V74, P2434, DOI 10.1016/S0006-3495(98)77951-2; Cladera J, 2001, EMBO J, V20, P19, DOI 10.1093/emboj/20.1.19; Cluitmans JCA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/764268; Davis S, 2015, J LIPID RES, V56, P1543, DOI 10.1194/jlr.M059519; deJong K, 1997, BIOCHEMISTRY-US, V36, P6768, DOI 10.1021/bi962973a; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deuticke B., 2003, RED CELL MEMBRANE TR, P27; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Duggan J, 2008, EUR BIOPHYS J BIOPHY, V37, P1279, DOI 10.1007/s00249-008-0349-1; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; EVANS E, 1987, J PHYS CHEM-US, V91, P4219, DOI 10.1021/j100300a003; EVANS T C, 1991, Journal of Emergency Medicine, V9, P71, DOI 10.1016/0736-4679(91)90592-4; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; Faure P, 1999, DIABETES, V48, P353, DOI 10.2337/diabetes.48.2.353; Feldman Charles, 2014, F1000Prime Rep, V6, P82, DOI 10.12703/P6-82; Fitchen N, 2003, MOL IMMUNOL, V40, P407, DOI 10.1016/S0161-5890(03)00153-6; Flanagan JJ, 2009, BIOCHEMISTRY-US, V48, P3977, DOI 10.1021/bi9002309; Foller M, 2008, IUBMB LIFE, V60, P661, DOI 10.1002/iub.106; FORTIER N, 1988, BLOOD, V71, P1427; Fortin CF, 2006, J LEUKOCYTE BIOL, V79, P1061, DOI 10.1189/jlb.0805481; Gallo A, 2005, DIABETES, V54, P1123, DOI 10.2337/diabetes.54.4.1123; GAWRISCH K, 1992, BIOPHYS J, V61, P1213, DOI 10.1016/S0006-3495(92)81931-8; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Gifford SC, 2006, BRIT J HAEMATOL, V135, P395, DOI 10.1111/j.1365-2141.2006.06279.x; Giovannetti A, 2012, CELL PHYSIOL BIOCHEM, V30, P418, DOI 10.1159/000339035; Gologan P., 2013, THESIS U EXETER EXET; Gurbuz N, 2004, CLIN HEMORHEOL MICRO, V31, P235; Hale JP, 2011, BIOPHYS J, V101, P1921, DOI 10.1016/j.bpj.2011.08.053; Hale JP, 2009, SOFT MATTER, V5, P3603, DOI 10.1039/b910422d; Hamilton NM, 2012, J MED CHEM, V55, P4431, DOI 10.1021/jm300317k; Harris FM, 2001, J BIOL CHEM, V276, P22722, DOI 10.1074/jbc.M010879200; Harvey RM, 2011, INFECT IMMUN, V79, P4122, DOI 10.1128/IAI.05418-11; HEBBEL RP, 1990, BLOOD, V76, P1015; Henriksen J, 2004, EUR BIOPHYS J BIOPHY, V33, P732, DOI 10.1007/s00249-004-0420-5; HENSELEIT U, 1990, BIOCHIM BIOPHYS ACTA, V1029, P127, DOI 10.1016/0005-2736(90)90445-T; Hess JR, 2009, TRANSFUSION, V49, P2599, DOI 10.1111/j.1537-2995.2009.02275.x; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Jewell SA, 2013, BBA-BIOMEMBRANES, V1828, P1250, DOI 10.1016/j.bbamem.2012.12.019; JOHNSON GJ, 1979, NEW ENGL J MED, V301, P522, DOI 10.1056/NEJM197909063011004; JOHNSON RM, 1994, BLOOD, V83, P1117; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; KANTOR L, 1994, GERONTOLOGY, V40, P1; Kantor L, 1998, GERONTOLOGY, V44, P26, DOI 10.1159/000021979; Kaul K, 2013, ADV EXP MED BIOL, V771, P1; Kempe DS, 2007, J MOL MED-JMM, V85, P269, DOI 10.1007/s00109-006-0123-8; Kennedy AL, 1997, METABOLISM, V46, P14, DOI 10.1016/S0026-0495(97)90311-5; Kirkham LAS, 2006, INFECT IMMUN, V74, P586, DOI 10.1128/IAI.74.1.586-593.2006; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; Lawrence SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14352; Lim H. W., 2008, REB BLOOD CELL SHAPE, V4, DOI [10.1002/9783527623372.ch2a, DOI 10.1002/9783527623372.CH2A]; Lim JE, 2013, BIOCHEM BIOPH RES CO, V430, P659, DOI 10.1016/j.bbrc.2012.11.095; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; LITTLE C, 1980, BIOCHEM J, V188, P39, DOI 10.1042/bj1880039; LOW PS, 1985, SCIENCE, V227, P531, DOI 10.1126/science.2578228; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Marshall JE, 2015, SCI REP-UK, V5, DOI 10.1038/srep13293; Massey JB, 2006, BIOCHEMISTRY-US, V45, P10747, DOI 10.1021/bi060540u; MCPHERSON RA, 1992, BIOCHEMISTRY-US, V31, P512, DOI 10.1021/bi00117a030; Meleard P, 1997, BIOPHYS J, V72, P2616, DOI 10.1016/S0006-3495(97)78905-7; Mishra R, 2015, CLIN HEMORHEOL MICRO, V59, P287, DOI 10.3233/CH-131726; Mitchell Tim J, 2014, Subcell Biochem, V80, P145, DOI 10.1007/978-94-017-8881-6_8; MITCHELL TJ, 1991, MOL MICROBIOL, V5, P1883, DOI 10.1111/j.1365-2958.1991.tb00812.x; MOKKEN FC, 1992, ANN HEMATOL, V64, P113, DOI 10.1007/BF01697397; Montagnana M, 2012, CLIN CHEM LAB MED, V50, P635, DOI [10.1515/CCLM.2011.831, 10.1515/cclm.2011.831]; Mughal M. K., 2014, THESIS U GLASGOW GLA; Niki E, 2005, BIOCHEM BIOPH RES CO, V338, P668, DOI 10.1016/j.bbrc.2005.08.072; O'Callaghan RJ, 2007, INVEST OPHTH VIS SCI, V48, P5125, DOI 10.1167/iovs.07-0320; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Ortqvist A, 2005, SEMIN RESP CRIT CARE, V26, P563, DOI 10.1055/s-2005-925523; Pan JJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.198103; Pretorius E, 2014, AGING-US, V6, P788, DOI 10.18632/aging.100695; Rahbar S, 2000, CLIN CHIM ACTA, V301, P65, DOI 10.1016/S0009-8981(00)00327-2; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; Rasband W. S, 2015, IMAGEJ; ROONEY M, 1986, CHEM PHYS LIPIDS, V41, P81, DOI 10.1016/0009-3084(86)90126-X; Rossjohn J, 1998, J MOL BIOL, V284, P449, DOI 10.1006/jmbi.1998.2167; ROTHMAN JE, 1977, SCIENCE, V195, P743, DOI 10.1126/science.402030; SAITO M, 1982, MECH AGEING DEV, V20, P53, DOI 10.1016/0047-6374(82)90074-4; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shewell LK, 2014, P NATL ACAD SCI USA, V111, pE5312, DOI 10.1073/pnas.1412703111; SHIGA T, 1990, CRIT REV ONCOL HEMAT, V10, P9, DOI 10.1016/1040-8428(90)90020-S; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; SHUKLA SD, 1978, BIOCHIM BIOPHYS ACTA, V512, P341, DOI 10.1016/0005-2736(78)90258-4; Siegl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076715; SNYDER LM, 1985, J CLIN INVEST, V76, P1971, DOI 10.1172/JCI112196; Soler-Jover A, 2004, J HISTOCHEM CYTOCHEM, V52, P931, DOI 10.1369/jhc.4A6254.2004; Solovyova AS, 2004, BIOPHYS J, V87, P540, DOI 10.1529/biophysj.104.039974; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; SONG JB, 1993, BIOPHYS J, V64, P1967, DOI 10.1016/S0006-3495(93)81566-2; Starke-Peterkovic T, 2006, BIOPHYS J, V90, P4060, DOI 10.1529/biophysj.105.074666; Taylor SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061300; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Tomaiuolo G, 2012, CYTOM PART A, V81A, P1040, DOI 10.1002/cyto.a.22215; Turchetti V, 1997, CLIN HEMORHEOL MICRO, V17, P209; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Tweten RK, 2001, CURR TOP MICROBIOL, V257, P15; Tziakas D, 2012, CLIN HEMORHEOL MICRO, V51, P243, DOI 10.3233/CH-2012-1530; Tziakas DN, 2007, J AM COLL CARDIOL, V49, P2081, DOI 10.1016/j.jacc.2006.08.069; VANDENBERG JJM, 1992, FREE RADICAL BIO MED, V12, P487, DOI 10.1016/0891-5849(92)90102-M; Wade KR, 2015, P NATL ACAD SCI USA, V112, P2204, DOI 10.1073/pnas.1423754112; Waheed AA, 2001, P NATL ACAD SCI USA, V98, P4926, DOI 10.1073/pnas.091090798; WALL J, 1995, MOL MEMBR BIOL, V12, P183, DOI 10.3109/09687689509027506; Watanabe I, 2006, J MED MICROBIOL, V55, P505, DOI 10.1099/jmm.0.46333-0; WAUGH R, 1979, BIOPHYS J, V26, P115, DOI 10.1016/S0006-3495(79)85239-X; WAUGH RE, 1992, BLOOD, V79, P1351; Wippel C, 2011, J INFECT DIS, V204, P930, DOI 10.1093/infdis/jir434; Yamaji-Hasegawa A, 2003, J BIOL CHEM, V278, P22762, DOI 10.1074/jbc.M213209200; Yasin Z, 2003, BLOOD, V102, P365, DOI 10.1182/blood-2002-11-3416; Ye Z, 2011, AM J CARDIOL, V107, P1241, DOI 10.1016/j.amjcard.2010.12.023; Yilmaz N, 2013, BIOPHYS J, V105, P1397, DOI 10.1016/j.bpj.2013.07.052	127	15	16	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10210	10227		10.1074/jbc.M115.691899	http://dx.doi.org/10.1074/jbc.M115.691899			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26984406	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000375602800030
J	Liu, K; Li, FZ; Han, HC; Chen, Y; Mao, ZB; Luo, JY; Zhao, YM; Zheng, B; Gu, W; Zhao, WH				Liu, Kun; Li, Fanzhou; Han, Haichao; Chen, Yue; Mao, Zebin; Luo, Jianyuan; Zhao, Yingming; Zheng, Bin; Gu, Wei; Zhao, Wenhui			Parkin Regulates the Activity of Pyruvate Kinase M2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; GLUCOSE-METABOLISM; CANCER METABOLISM; PROMOTES; UBIQUITIN; ISOFORM; PKM2; P53; MONOUBIQUITINATION; PHOSPHORYLATION	Parkin, a ubiquitin E3 ligase, is mutated in most cases of autosomal recessive early onset Parkinson disease. It was discovered that Parkin is also mutated in glioblastoma and other human malignancies and that it inhibits tumor cell growth. Here, we identified pyruvate kinase M2 (PKM2) as a unique substrate for parkin through biochemical purification. We found that parkin interacts with PKM2 both in vitro and in vivo, and this interaction dramatically increases during glucose starvation. Ubiquitylation of PKM2 by parkin does not affect its stability but decreases its enzymatic activity. Parkin regulates the glycolysis pathway and affects the cell metabolism. Our studies revealed the novel important roles of parkin in tumor cell metabolism and provided new insight for therapy of Parkinson disease.	[Zhao, Wenhui] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China; [Zhao, Wenhui] Beijing Key Lab Prot Posttranslat Modificat & Cel, Beijing 100191, Peoples R China; [Chen, Yue; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Luo, Jianyuan] Peking Univ, Hlth Sci Ctr, Dept Genet, Beijing 100191, Peoples R China; [Zheng, Bin] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Gu, Wei] Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Gu, Wei] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA	Peking University; University of Chicago; Peking University; Harvard University; Massachusetts General Hospital; Columbia University; Columbia University	Zhao, WH (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China.; Zhao, WH (corresponding author), Beijing Key Lab Prot Posttranslat Modificat & Cel, Beijing 100191, Peoples R China.	zhao6025729@bjmu.edu.cn	Li, Fangzhou/R-8789-2019; Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914; Zheng, Bin/0000-0002-0998-7177; ZHAO, WENHUI/0000-0002-7703-7106	Peking University Health Science Center [BMU20140379]; NATIONAL CANCER INSTITUTE [R01CA166717] Funding Source: NIH RePORTER	Peking University Health Science Center(Peking University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Peking University Health Science Center Initial Aid Grant BMU20140379. To whom correspondence should be addressed. Tel.: 86-010-82805552; Fax: 86-010-82802416; E-mail: zhao6025729@bjmu.edu.cn.	Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; Bettaieb A, 2013, J BIOL CHEM, V288, P17360, DOI 10.1074/jbc.M112.441469; Brooks CL, 2004, CELL CYCLE, V3, P436; Cesari R, 2003, P NATL ACAD SCI USA, V100, P5956, DOI 10.1073/pnas.0931262100; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Fujiwara M, 2008, ONCOGENE, V27, P6002, DOI 10.1038/onc.2008.199; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Keller KE, 2012, SCIENCE, V338, P1069, DOI 10.1126/science.1224409; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kumar A, 2015, EMBO J, V34, P2506, DOI 10.15252/embj.201592337; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2013, MOL CELL, V52, P340, DOI 10.1016/j.molcel.2013.09.004; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; McDonnell SRP, 2013, BLOOD, V122, P958, DOI 10.1182/blood-2013-01-482026; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Sauve V, 2015, EMBO J, V34, P2492, DOI 10.15252/embj.201592237; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	51	61	65	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10307	10317		10.1074/jbc.M115.703066	http://dx.doi.org/10.1074/jbc.M115.703066			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26975375	Green Published, hybrid			2022-12-28	WOS:000375602800037
J	Jules, J; Chen, W; Feng, X; Li, YP				Jules, Joel; Chen, Wei; Feng, Xu; Li, Yi-Ping			CCAAT/Enhancer-binding Protein alpha (C/EBP alpha) Is Important for Osteoclast Differentiation and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; COLONY-STIMULATING FACTOR; RANK CYTOPLASMIC MOTIF; RECEPTOR ACTIVATOR; BONE-RESORPTION; EXTRACELLULAR ACIDIFICATION; SKELETAL DEVELOPMENT; CELL-PROLIFERATION; CATHEPSIN-K; TNF FAMILY	CCAAT/enhancer-binding protein (C/EBP alpha) can appoint mouse bone marrow (MBM) cells to the osteoclast (OC) lineage for osteoclastogenesis. However, whether C/EBP alpha is also involved in OC differentiation and activity is unknown. Here we demonstrated that C/EBP alpha overexpression in MBM cells can promote OC differentiation and strongly induce the expression of theOCgenes encoding the nuclear factor of activated T-cells, c1 (NFATc1), cathepsin K (Cstk), and tartrate-resistant acid phosphatase 5 (TRAP) with receptor activator of NF-kappa B ligand-evoked OC lineage priming. Furthermore, while investigating the specific stage of OC differentiation that is regulated by C/EBP alpha, our gene overexpression studies revealed that, although C/EBP alpha plays a stronger role in the early stage of OC differentiation, it is also involved in the later stage. Accordingly, C/EBP alpha knockdown drastically inhibits osteoclastogenesis and markedly abrogates the expression of NFATc1, Cstk, and TRAP during OC differentiation. Consistently, C/EBP alpha silencing revealed that, although lack of C/EBP alpha affects all stages of OC differentiation, it has more impact on the early stage. Importantly, we showed that ectopic expression of rat C/EBP alpha restores osteoclastogenesis in C/EBP alpha-depleted MBM cells. Furthermore, our subsequent functional assays showed that C/EBP alpha exhibits a dispensable role on actin ring formation by mature OCs but is critically involved in bone resorption by stimulating extracellular acidification and regulating cell survival. We revealed that C/EBP alpha is important for receptor activator of NF-kappa B ligand-induced Akt activation, which is crucial for OC survival. Collectively, these results indicate that C/EBP alpha functions throughout osteoclastogenesis as well as in OC function. This study provides additional understanding of the roles of C/EBP alpha in OC biology.	[Jules, Joel; Chen, Wei; Feng, Xu] Univ Alabama Birmingham, Dept Pathol, SHEL 810,1825 Univ Blvd, Birmingham, AL 35294 USA; [Li, Yi-Ping] Univ Alabama Birmingham, Dept Pathol, 1825 Univ Blvd,Shelby Bldg 810, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Chen, W (corresponding author), Univ Alabama Birmingham, Dept Pathol, SHEL 810,1825 Univ Blvd, Birmingham, AL 35294 USA.; Li, YP (corresponding author), Univ Alabama Birmingham, Dept Pathol, 1825 Univ Blvd,Shelby Bldg 810, Birmingham, AL 35294 USA.	wechen@uab.edu; ypli@uab.edu			National Institutes of Health [R01-AR-044741, R01DE023813, AR-055307]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046031, R01AR044741, R01AR055307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants R01-AR-044741, R01DE023813, and AR-055307 (to Y. P. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Boyce BF, 2015, ENDOCRINOL METAB, V30, P35, DOI 10.3803/EnM.2015.30.1.35; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cappellen D, 2002, J BIOL CHEM, V277, P21971, DOI 10.1074/jbc.M200434200; Chen W, 2007, HUM MOL GENET, V16, P410, DOI 10.1093/hmg/ddl474; Chen W, 2014, P NATL ACAD SCI USA, V111, P8482, DOI 10.1073/pnas.1310617111; Chen W, 2013, P NATL ACAD SCI USA, V110, P7294, DOI 10.1073/pnas.1211383110; Cicek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017522; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; Gao B, 2013, J DENT RES, V92, P180, DOI 10.1177/0022034512468757; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Horowitz MC, 2001, CYTOKINE GROWTH F R, V12, P9, DOI 10.1016/S1359-6101(00)00030-7; Hu JP, 2008, EUR J PHARMACOL, V580, P70, DOI 10.1016/j.ejphar.2007.11.013; Jules J, 2015, J BIOL CHEM, V290, P23738, DOI 10.1074/jbc.M115.667535; Jules J, 2012, J BIOL CHEM, V287, P15728, DOI 10.1074/jbc.M111.296228; Jules J, 2010, J BIOL CHEM, V285, P37427, DOI 10.1074/jbc.M110.149484; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kwak HB, 2008, MOL CELLS, V26, P436; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Li YP, 1996, BIOCHEM BIOPH RES CO, V218, P813, DOI 10.1006/bbrc.1996.0145; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; LI YP, 1995, J BONE MINER RES, V10, P1197; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; Liu W, 2005, J BIOL CHEM, V280, P43064, DOI 10.1074/jbc.M509006200; Mueller BU, 2006, CURR OPIN HEMATOL, V13, P7, DOI 10.1097/01.moh.0000190110.08156.96; Murakami T, 1998, BIOCHEM BIOPH RES CO, V252, P747, DOI 10.1006/bbrc.1998.9723; NERLOV C, 1995, EMBO J, V14, P4318, DOI 10.1002/j.1460-2075.1995.tb00106.x; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Porse BT, 2005, J EXP MED, V202, P85, DOI 10.1084/jem.20050067; Qu XH, 2014, BIOCHEM BIOPH RES CO, V443, P658, DOI 10.1016/j.bbrc.2013.12.029; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Reckzeh K, 2010, INT J HEMATOL, V91, P557, DOI 10.1007/s12185-010-0573-1; Roe JS, 2014, J EXP MED, V211, P1, DOI 10.1084/jem.20132530; Sakoda Tsuyoshi, 2007, Exp Clin Cardiol, V12, P133; Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766; Taguchi Y, 2009, GENES CELLS, V14, P1331, DOI 10.1111/j.1365-2443.2009.01351.x; Tai TW, 2014, BONE, V67, P166, DOI 10.1016/j.bone.2014.07.003; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; TAMURA T, 1993, J BONE MINER RES, V8, P953; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tu QS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.152405; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Xu DR, 2006, J BIOL CHEM, V281, P4678, DOI 10.1074/jbc.M510383200; Yang DQ, 2012, J BONE MINER RES, V27, P1695, DOI 10.1002/jbmr.1623; Yang S, 2013, BONE RES, V1, P260, DOI 10.4248/BR201303005; Yang SY, 2007, GENE DEV, V21, P1803, DOI 10.1101/gad.1544107; Ye M, 2013, NAT CELL BIOL, V15, P385, DOI 10.1038/ncb2698; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhao QX, 2007, FRONT BIOSCI-LANDMRK, V12, P2519, DOI 10.2741/2252	59	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16390	16403		10.1074/jbc.M115.674598	http://dx.doi.org/10.1074/jbc.M115.674598			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27129246	Green Published, hybrid			2022-12-28	WOS:000380585400041
J	Pinto, BI; Garcia, IE; Pupo, A; Retamal, MA; Martinez, AD; Latorre, R; Gonzalez, C				Pinto, Bernardo I.; Garcia, Isaac E.; Pupo, Amaury; Retamal, Mauricio A.; Martinez, Agustin D.; Latorre, Ramon; Gonzalez, Carlos			Charged Residues at the First Transmembrane Region Contribute to the Voltage Dependence of the Slow Gate of Connexins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP JUNCTIONAL COMMUNICATION; CONFORMATIONAL-CHANGES; POTASSIUM CHANNEL; MOLECULAR-BASIS; HEMICHANNELS; CLONING; DOMAIN; MOUSE; PORE; SELECTIVITY	Connexins (Cxs) are a family of membrane-spanning proteins that form gap junction channels and hemichannels. Connexin-based channels exhibit two distinct voltage-dependent gating mechanisms termed slow and fast gating. Residues located at the C terminus of the first transmembrane segment (TM-1) are important structural components of the slow gate. Here, we determined the role of the charged residues at the end of TM-1 in voltage sensing in Cx26, Cx46, and Cx50. Conductance/voltage curves obtained from tail currents together with kinetics analysis reveal that the fast and slow gates of Cx26 involves the movement of two and four charges across the electric field, respectively. Primary sequence alignment of different Cxs shows the presence of well conserved glutamate residues in the C terminus of TM-1; only Cx26 contains a lysine in that position (lysine 41). Neutralization of lysine 41 in Cx26 increases the voltage dependence of the slow gate. Swapping of lysine 41 with glutamate 42 maintains the voltage dependence. In Cx46, neutralization of negative charges or addition of a positive charge in the Cx26 equivalent region reduced the slow gate voltage dependence. In Cx50, the addition of a glutamate in the same region decreased the voltage dependence, and the neutralization of a negative charge increased it. These results indicate that the charges at the end of TM-1 are part of the slow gate voltage sensor in Cxs. The fact that Cx42, which has no charge in this region, still presents voltage-dependent slow gating suggests that charges still unidentified also contribute to the slow gate voltage sensitivity.	[Pinto, Bernardo I.; Garcia, Isaac E.; Pupo, Amaury; Martinez, Agustin D.; Latorre, Ramon; Gonzalez, Carlos] Univ Valparaiso, Ctr Interdisciplinario Neurociencias Valparaiso, Valparaiso 2360102, Chile; [Retamal, Mauricio A.] Clin Alemana Univ Desarrollo, Fac Med, Ctr Fisiol Celular & Integrat, Santiago 7710162, Chile	Universidad de Valparaiso; Universidad del Desarrollo	Latorre, R; Gonzalez, C (corresponding author), Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencias Valparaiso, Ave Gran Bretana 1111, Valparaiso, Chile.	ramon.latorre@uv.cl; carlos.gonzalezl@uv.cl	Retamal, Mauricio/AAS-3621-2020; Gonzalez, Carlos/V-7628-2019	Pupo, Amaury/0000-0001-9162-9952; Retamal, Mauricio A./0000-0003-2562-6686	FONDECYT [1110430, 1150273, 1160261, 3150634, 1130855, 1160227]; ANILLO Grant [ACT1104]; CONICYT; CONICYT-PCHA/Magister Fellowships; Millennium Scientific Initiative of the Chilean Ministry of Economy, Development, and Tourism [P029-022-F]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ANILLO Grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); CONICYT-PCHA/Magister Fellowships; Millennium Scientific Initiative of the Chilean Ministry of Economy, Development, and Tourism	This work was supported by FONDECYT Grants 1110430 and 1150273 (to R. L.), 1160261 (to C. G.), 3150634 (to I. E. G.), 1130855 (to A. M.), and 1160227 (to M. A. R.), ANILLO Grant ACT1104 (to C. G., A. M., and M. A. R.), CONICYT Doctoral Fellowship (to A. P.), and CONICYT-PCHA/Magister/2014 Fellowships (to B. I. P.). The Centro Interdisciplinario de Neurociencia de Valparaiso is a Millennium Institute supported by the Millennium Scientific Initiative of the Chilean Ministry of Economy, Development, and Tourism Grant P029-022-F. The authors declare that they have no conflicts of interest with the contents of this article.	Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; Bairoch A, 1996, NUCLEIC ACIDS RES, V24, P21, DOI 10.1093/nar/24.1.21; Barrio L. C., 1995, P391; BARRIO LC, 1991, P NATL ACAD SCI USA, V88, P8410, DOI 10.1073/pnas.88.19.8410; Beahm DL, 2002, BIOPHYS J, V82, P2016, DOI 10.1016/S0006-3495(02)75550-1; BEZANILLA F, 1994, ANNU REV BIOPH BIOM, V23, P819, DOI 10.1146/annurev.bb.23.060194.004131; Blanchet J, 2007, BIOPHYS J, V92, P3513, DOI 10.1529/biophysj.106.090464; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P319, DOI 10.1038/nsmb1070; De Santiago-Castillo JA, 2010, CHANNELS, V4, P422, DOI 10.4161/chan.4.5.13404; Deng YQ, 2006, HEARING RES, V220, P87, DOI 10.1016/j.heares.2006.07.004; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EBIHARA L, 1993, J GEN PHYSIOL, V102, P59, DOI 10.1085/jgp.102.1.59; Garcia IE, 2015, J INVEST DERMATOL, V135, P1338, DOI 10.1038/jid.2015.20; Gonzalez C, 2013, J GEN PHYSIOL, V141, P275, DOI 10.1085/jgp.201210857; Gonzalez D, 2007, PROG BIOPHYS MOL BIO, V94, P66, DOI 10.1016/j.pbiomolbio.2007.03.007; Gonzalez D, 2006, FASEB J, V20, P2329, DOI 10.1096/fj.06-5828com; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; HARRIS AL, 1981, J GEN PHYSIOL, V77, P95, DOI 10.1085/jgp.77.1.95; JIANG JX, 1994, MOL BIOL CELL, V5, P363, DOI 10.1091/mbc.5.3.363; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kronengold J, 2012, J MEMBRANE BIOL, V245, P453, DOI 10.1007/s00232-012-9457-z; Kwon T, 2013, J GEN PHYSIOL, V141, P243, DOI 10.1085/jgp.201210839; Kwon T, 2011, J GEN PHYSIOL, V138, P475, DOI 10.1085/jgp.201110679; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Lopez W, 2013, J GEN PHYSIOL, V142, P23, DOI 10.1085/jgp.201210893; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; McLachlan E, 2003, J NEUROSCI RES, V73, P753, DOI 10.1002/jnr.10712; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Palacios-Prado N, 2009, P NATL ACAD SCI USA, V106, P14855, DOI 10.1073/pnas.0901923106; Purnick PEM, 2000, BIOPHYS J, V79, P2403, DOI 10.1016/S0006-3495(00)76485-X; Retamal MA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00080; Richard G, 1998, HUM GENET, V103, P393, DOI 10.1007/s004390050839; Rouan F, 2001, J CELL SCI, V114, P2105; RUBIN JB, 1992, BIOPHYS J, V62, P183, DOI 10.1016/S0006-3495(92)81804-0; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sarkar D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/673895; Sohl G, 2003, CELL COMMUN ADHES, V10, P173, DOI 10.1080/15419060390262877; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; Tang QX, 2009, J GEN PHYSIOL, V133, P555, DOI 10.1085/jgp.200910207; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Tong JJ, 2006, BIOPHYS J, V91, P2142, DOI 10.1529/biophysj.106.082859; Trexler EB, 1996, P NATL ACAD SCI USA, V93, P5836, DOI 10.1073/pnas.93.12.5836; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Verselis VK, 2008, J GEN PHYSIOL, V132, P315, DOI 10.1085/jgp.200810029; Verselis VK, 2009, J BIOL CHEM, V284, P4484, DOI 10.1074/jbc.M807430200; WHITE TW, 1992, MOL BIOL CELL, V3, P711, DOI 10.1091/mbc.3.7.711; WILLECKE K, 1991, J CELL BIOL, V114, P1049, DOI 10.1083/jcb.114.5.1049; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	54	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15740	15752		10.1074/jbc.M115.709402	http://dx.doi.org/10.1074/jbc.M115.709402			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27143357	Green Published, hybrid			2022-12-28	WOS:000380584200027
J	De Tavernier, E; Detalle, L; Morizzo, E; Roobrouck, A; De Taeye, S; Rieger, M; Verhaeghe, T; Correia, A; Van Hegelsom, R; Figueirido, R; Noens, J; Steffensen, S; Stohr, T; Van de Velde, W; Depla, E; Dombrecht, B				De Tavernier, Evelyn; Detalle, Laurent; Morizzo, Erika; Roobrouck, Annelies; De Taeye, Severine; Rieger, Melanie; Verhaeghe, Tom; Correia, Andreia; Van Hegelsom, Rob; Figueirido, Rita; Noens, Jeroen; Steffensen, Soren; Stohr, Thomas; Van de Velde, Willem; Depla, Erik; Dombrecht, Bruno			High Throughput Combinatorial Formatting of PcrV Nanobodies for Efficient Potency Improvement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; III SECRETION; V-ANTIGEN; MURINE MODEL; INFECTION; PROTEIN; TRANSLOCATION; IMMUNIZATION; MACROPHAGES	Improving potencies through concomitant blockage of multiple epitopes and avid binding by fusing multiple (different) monovalent Nanobody building blocks via linker sequences into one multivalent polypeptide chain is an elegant alternative to affinity maturation. We explored a large and random formatting library of bivalent (combinations of two identical) and biparatopic (combinations of two different) Nanobodies for functional blockade of Pseudonionas aeruginosa PcrV. PcrV is an essential part of the P. aeruginosa type III secretion system (T3SS), and its oligomeric nature allows for multiple complex binding and blocking options. The library screening yielded a large number of promising biparatopic lead candidates, revealing significant (and non-trivial) preferences in terms of Nanobody building block and epitope bin combinations and orientations. Excellent potencies were confirmed upon further characterization in two different P. aeruginosa T3SS- mediated cytotoxicity assays. Three biparatopic Nanobodies were evaluated in a lethal mouse P. aeruginosa challenge pneumonia model, conferring 100% survival upon prophylactic administration and reducing lung P. aeruginosa burden by up to 2 logs. At very low doses, they protected the mice from P. aeruginosa infection -related changes in lung histology, myeloperoxidase production, and lung weight. Importantly, the most potent Nanobody still conferred protection after therapeutic administration up to 24 h post -infection. The concept of screening such formatting libraries for potency improvement is applicable to other targets and biological therapeutic platforms.	[De Tavernier, Evelyn; Detalle, Laurent; Morizzo, Erika; Roobrouck, Annelies; De Taeye, Severine; Rieger, Melanie; Verhaeghe, Tom; Correia, Andreia; Van Hegelsom, Rob; Figueirido, Rita; Noens, Jeroen; Steffensen, Soren; Stohr, Thomas; Van de Velde, Willem; Depla, Erik; Dombrecht, Bruno] Ablynx NV, Technol Pk 21, B-9052 Ghent, Belgium; [Rieger, Melanie] Univ Hosp Munster, Inst Expt Musculoskeletal Med, Domagkstrasse 3, D-48149 Munster, Germany; [Figueirido, Rita] Immunocore Ltd, 90 Pk Dr,Milton Pk, Abingdon OX14 RY, Oxon, England; [Stohr, Thomas] A2M Pharma GmbH, Alfred Nobel Str 10, D-40789 Monheim, Germany; [Depla, Erik] VIB Discovery Sci, Gaston Geenslaan 1, B-3001 Leuven, Belgium	University of Munster; Flanders Institute for Biotechnology (VIB)	Dombrecht, B (corresponding author), Ablynx NV, Technol Pk 21, B-9052 Ghent, Belgium.	bruno.dombrecht@ablynx.com		Detalle, Laurent/0000-0001-8481-7736	Ablynx N.V.	Ablynx N.V.	This work was supported by Ablynx N.V. All authors are or have been Ablynx employees.	[Anonymous], 2010, Drug Discov Today Technol, V7, pe95, DOI 10.1016/j.ddtec.2010.03.002; Audia JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081792; Baer M, 2009, INFECT IMMUN, V77, P1083, DOI 10.1128/IAI.00815-08; Bradley ME, 2015, MOL PHARMACOL, V87, P251, DOI 10.1124/mol.114.094821; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Caroline G, 2008, J BIOL CHEM, V283, P23940, DOI 10.1074/jbc.M803146200; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Dacheux D, 2000, INFECT IMMUN, V68, P2916, DOI 10.1128/IAI.68.5.2916-2924.2000; Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; Derewenda U, 2004, STRUCTURE, V12, P301, DOI 10.1016/j.str.2004.01.010; DiGiandomenico A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009655; Firth AE, 2005, BIOINFORMATICS, V21, P3314, DOI 10.1093/bioinformatics/bti516; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Holder IA, 2001, INFECT IMMUN, V69, P5908, DOI 10.1128/IAI.69.9.5908-5910.2001; Huet HA, 2014, MABS-AUSTIN, V6, P1560, DOI 10.4161/19420862.2014.975099; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; Jahnichen S, 2010, P NATL ACAD SCI USA, V107, P20565, DOI 10.1073/pnas.1012865107; Kim J, 2005, MICROBIOL-SGM, V151, P3575, DOI 10.1099/mic.0.28277-0; Lee PC, 2010, MOL MICROBIOL, V75, P924, DOI 10.1111/j.1365-2958.2009.07027.x; Lunelli M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002163; Maussang D, 2013, J BIOL CHEM, V288, P29562, DOI 10.1074/jbc.M113.498436; Moriyama K, 2009, MICROBIOL IMMUNOL, V53, P587, DOI 10.1111/j.1348-0421.2009.00165.x; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Ohgita T, 2013, FASEB J, V27, P2862, DOI 10.1096/fj.13-229054; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001; Roovers RC, 2007, CANCER IMMUNOL IMMUN, V56, P303, DOI 10.1007/s00262-006-0180-4; Roovers RC, 2011, INT J CANCER, V129, P2013, DOI 10.1002/ijc.26145; Sato H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00142; Sawa T, 1999, NAT MED, V5, P392, DOI 10.1038/7391; Sawa T, 2014, MICROBIOL IMMUNOL, V58, P267, DOI 10.1111/1348-0421.12147; Secher T, 2011, J ANTIMICROB CHEMOTH, V66, P1100, DOI 10.1093/jac/dkr038; Shime N, 2001, J IMMUNOL, V167, P5880, DOI 10.4049/jimmunol.167.10.5880; Stryjewski ME, 2003, P C C I D, V7, P1; Sundin C, 2004, MICROB PATHOGENESIS, V37, P313, DOI 10.1016/j.micpath.2004.10.005; Terryn S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109367; Warrener P, 2014, ANTIMICROB AGENTS CH, V58, P4384, DOI 10.1128/AAC.02643-14	39	13	15	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15243	15255		10.1074/jbc.M115.684241	http://dx.doi.org/10.1074/jbc.M115.684241			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226529	Green Published, hybrid			2022-12-28	WOS:000380583200031
J	Chen, XC; Stauffer, S; Chen, YH; Dong, JX				Chen, Xingcheng; Stauffer, Seth; Chen, Yuanhong; Dong, Jixin			Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; cyclin-dependent kinase (CDK); Hippo pathway; mitosis; phosphorylation; signal transduction	ORGAN SIZE CONTROL; LIM PROTEIN AJUBA; HIPPO PATHWAY; YAP; KINASE; AURORA; KIBRA; PHOSPHATASE; TAZ; ACTIVATION	Recent studies identified the adaptor protein Ajuba as a positive regulator of Yes-associated protein (YAP) oncogenic activity through inhibiting large tumor suppressor (Lats1/2) core kinases of the Hippo pathway, a signaling pathway that plays important roles in cancer. In this study, we define a novel mechanism for phospho-regulation of Ajuba in mitosis and its biological significance in cancer. We found that Ajuba is phosphorylated in vitro and in vivo by cyclin-dependent kinase 1 (CDK1) at Ser(119) and Ser(175) during the G2/M phase of the cell cycle. Mitotic phosphorylation of Ajuba controls the expression of multiple cell cycle regulators; however, it does not affect Hippo signaling activity, nor does it induce epithelial-mesenchymal transition. We further showed that mitotic phosphorylation of Ajuba is sufficient to promote cell proliferation and anchorage-independent growth in vitro and tumorigenesis in vivo. Collectively, our discoveries reveal a previously unrecognized mechanism for Ajuba regulation in mitosis and its role in tumorigenesis.	[Chen, Xingcheng; Stauffer, Seth; Chen, Yuanhong; Dong, Jixin] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Chen, Xingcheng; Stauffer, Seth] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Dong, JX (corresponding author), 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	dongj@unmc.edu	Chen, Xingcheng/AAL-3210-2020		National Institutes of Health [P30 GM106397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397, R01GM109066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	All fluorescence images were acquired by Zeiss LSM 710 confocal microscope at the Advanced Microscopy Core at the University of Nebraska Medical Center. The core is supported in part by Grant P30 GM106397 from the National Institutes of Health. We also thank Dr. Joyce Solheim for critical reading and comments on the manuscript.	Abe Y, 2006, FEBS LETT, V580, P782, DOI 10.1016/j.febslet.2005.12.096; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; BRATTAIN MG, 1984, CANCER METAST REV, V3, P177, DOI 10.1007/BF00048384; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Ferrand A, 2009, BIOL CELL, V101, P221, DOI 10.1042/BC20080060; Gaedcke J, 2010, GENE CHROMOSOME CANC, V49, P1024, DOI 10.1002/gcc.20811; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Gunn-Moore FJ, 2005, FEBS LETT, V579, P5089, DOI 10.1016/j.febslet.2005.07.097; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hong Y, 2010, CLIN EXP METASTAS, V27, P83, DOI 10.1007/s10585-010-9305-4; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Ji M, 2012, BIOCHEM J, V447, P93, DOI 10.1042/BJ20120751; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Kisseleva M, 2005, MOL CELL BIOL, V25, P3956, DOI 10.1128/MCB.25.10.3956-3966.2005; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Liang XH, 2014, CANCER SCI, V105, P660, DOI 10.1111/cas.12404; Ma B, 2015, NAT CELL BIOL, V17, P95, DOI 10.1038/ncb3073; Mardin BR, 2010, NAT CELL BIOL, V12, P1166, DOI 10.1038/ncb2120; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Nigg Erich A., 1993, Trends in Cell Biology, V3, P296, DOI 10.1016/0962-8924(93)90011-O; Nishio M, 2012, J CLIN INVEST, V122, P4505, DOI 10.1172/JCI63735; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; Schimizzi GV, 2015, CURR BIOL, V25, pR445, DOI 10.1016/j.cub.2015.02.034; Sharp TV, 2008, P NATL ACAD SCI USA, V105, P19932, DOI 10.1073/pnas.0805003105; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Tanaka I, 2015, ONCOGENE, V34, P73, DOI 10.1038/onc.2013.528; Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113; Xiao L, 2011, J BIOL CHEM, V286, P36304, DOI 10.1074/jbc.M111.246850; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; Yabuta N, 2007, J BIOL CHEM, V282, P19259, DOI 10.1074/jbc.M608562200; Yang SP, 2015, J BIOL CHEM, V290, P6191, DOI 10.1074/jbc.M114.624411; Yang SP, 2014, CELL SIGNAL, V26, P343, DOI 10.1016/j.cellsig.2013.11.012; Yang SP, 2013, CANCER RES, V73, P6722, DOI 10.1158/0008-5472.CAN-13-2049; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhang L, 2015, ONCOTARGET, V6, P31399, DOI 10.18632/oncotarget.5189; Zhang L, 2012, J BIOL CHEM, V287, P34069, DOI 10.1074/jbc.M112.385518; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303	52	34	34	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14761	14772		10.1074/jbc.M116.722751	http://dx.doi.org/10.1074/jbc.M116.722751			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226586	hybrid, Green Published			2022-12-28	WOS:000380366700028
J	Rahman, KS; Chowdhury, EU; Sachse, K; Kaltenboeck, B				Rahman, Kh. Shamsur; Chowdhury, Erfan Ullah; Sachse, Konrad; Kaltenboeck, Bernhard			Inadequate Reference Datasets Biased toward Short Non-epitopes Confound B-cell Epitope Prediction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; antigen; bioinformatics; epitope mapping; immunogenicity; protein motif; protein-protein interaction	OUTER-MEMBRANE PROTEIN; INTRINSICALLY UNSTRUCTURED PROTEINS; CHLAMYDIA-TRACHOMATIS SEROVAR; AMINO-ACID RESIDUES; ANTIGENIC DETERMINANTS; SECONDARY-STRUCTURE; SOLVENT ACCESSIBILITY; DISORDERED REGIONS; WEB-SERVER; ANTIBODY	X-ray crystallography has shown that an antibody paratope typically binds 15-22 amino acids (aa) of an epitope, of which 2-5 randomly distributed amino acids contribute most of the binding energy. In contrast, researchers typically choose for B-cell epitope mapping short peptide antigens in antibody binding assays. Furthermore, short 6-11-aa epitopes, and in particular non-epitopes, are over-represented in published B-cell epitope datasets that are commonly used for development of B-cell epitope prediction approaches from protein antigen sequences. We hypothesized that such suboptimal length peptides result in weak antibody binding and cause false-negative results. We tested the influence of peptide antigen length on antibody binding by analyzing data on more than 900 peptides used for B-cell epitope mapping of immunodominant proteins of Chlamydia spp. We demonstrate that short 7-12-aa peptides of B-cell epitopes bind antibodies poorly; thus, epitope mapping with short peptide antigens falsely classifies many B-cell epitopes as non-epitopes. We also show in published datasets of confirmed epitopes and non-epitopes a direct correlation between length of peptide antigens and antibody binding. Elimination of short, 11-aa epitope/non-epitope sequences improved datasets for evaluation of in silico B-cell epitope prediction. Achieving up to 86% accuracy, protein disorder tendency is the best indicator of B-cell epitope regions for chlamydial and published datasets. For B-cell epitope prediction, the most effective approach is plotting disorder of protein sequences with the IUPred-L scale, followed by antibody reactivity testing of 16-30-aa peptides from peak regions. This strategy overcomes the well known inaccuracy of in silico B-cell epitope prediction from primary protein sequences.	[Rahman, Kh. Shamsur; Chowdhury, Erfan Ullah; Kaltenboeck, Bernhard] Auburn Univ, Dept Pathobiol, Auburn, AL 36849 USA; [Sachse, Konrad] Fed Inst Anim Hlth, D-07743 Jena, Germany	Auburn University System; Auburn University	Kaltenboeck, B (corresponding author), Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA.	kaltebe@auburn.edu	Rahman, Kh Shamsur/M-2419-2019; Sachse, Konrad/GWC-4999-2022	Rahman, Kh Shamsur/0000-0001-7243-8501; Sachse, Konrad/0000-0003-1230-1786	Molecular Diagnostics Laboratory at the Department of Pathobiology, College of Veterinary Medicine at Auburn University	Molecular Diagnostics Laboratory at the Department of Pathobiology, College of Veterinary Medicine at Auburn University	This work was supported by the Molecular Diagnostics Laboratory at the Department of Pathobiology, College of Veterinary Medicine at Auburn University. The authors declare that they have no conflicts of interest with the contents of this article.	Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; Batteiger BE, 1996, INFECT IMMUN, V64, P542, DOI 10.1128/IAI.64.2.542-547.1996; BHASKARAN R, 1988, INT J PEPT PROT RES, V32, P241; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; BRACK C, 1978, CELL, V15, P1, DOI 10.1016/0092-8674(78)90078-8; Canaves JM, 2004, J MOL BIOL, V344, P977, DOI 10.1016/j.jmb.2004.09.076; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Cilia E, 2014, NUCLEIC ACIDS RES, V42, pW264, DOI 10.1093/nar/gku270; CONLAN JW, 1988, MOL MICROBIOL, V2, P673, DOI 10.1111/j.1365-2958.1988.tb00076.x; DELEAGE G, 1987, PROTEIN ENG, V1, P289, DOI 10.1093/protein/1.4.289; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; El-Manzalawy Yasser, 2010, Immunome Res, V6 Suppl 2, pS2, DOI 10.1186/1745-7580-6-S2-S2; El-Manzalawy Yasser, 2008, Comput Syst Bioinformatics Conf, V7, P121, DOI 10.1142/9781848162648_0011; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Faraggi E, 2009, STRUCTURE, V17, P1515, DOI 10.1016/j.str.2009.09.006; Faraggi E, 2009, PROTEINS, V74, P847, DOI 10.1002/prot.22193; Galzitskaya OV, 2006, BIOINFORMATICS, V22, P2948, DOI 10.1093/bioinformatics/btl504; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Greenbaum JA, 2007, J MOL RECOGNIT, V20, P75, DOI 10.1002/jmr.815; GUY HR, 1985, BIOPHYS J, V47, P61, DOI 10.1016/S0006-3495(85)83877-7; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Huntley MA, 2002, PROTEINS, V48, P134, DOI 10.1002/prot.10150; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Joo K, 2012, PROTEINS, V80, P1791, DOI 10.1002/prot.24074; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Kringelum JV, 2013, MOL IMMUNOL, V53, P24, DOI 10.1016/j.molimm.2012.06.001; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Kulkarni-Kale U, 2005, NUCLEIC ACIDS RES, V33, pW168, DOI 10.1093/nar/gki460; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Le Gall T, 2007, J BIOMOL STRUCT DYN, V24, P325; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu ZR, 2014, PROTEIN SCI, V23, P539, DOI 10.1002/pro.2443; Magnan CN, 2014, BIOINFORMATICS, V30, P2592, DOI 10.1093/bioinformatics/btu352; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mirabello C, 2013, BIOINFORMATICS, V29, P2056, DOI 10.1093/bioinformatics/btt344; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Mizianty MJ, 2010, BIOINFORMATICS, V26, pi489, DOI 10.1093/bioinformatics/btq373; MULLER S, 1986, MOL IMMUNOL, V23, P593, DOI 10.1016/0161-5890(86)90095-7; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; Ofran Y, 2008, J IMMUNOL, V181, P6230, DOI 10.4049/jimmunol.181.9.6230; Oldfield CJ, 2005, PROTEINS, V59, P444, DOI 10.1002/prot.20446; PAL S, 1993, J GEN MICROBIOL, V139, P1565, DOI 10.1099/00221287-139-7-1565; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Ponomarenko JV, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-64; Ponomarenko JV, 2009, STRUCTURAL BIOINFORM, V2, P849; Price WN, 2009, NAT BIOTECHNOL, V27, P51, DOI 10.1038/nbt.1514; Rahman KS, 2015, CLIN VACCINE IMMUNOL, V22, P539, DOI 10.1128/CVI.00102-15; Rapberger R, 2007, J MOL RECOGNIT, V20, P113, DOI 10.1002/jmr.819; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287; Saha S, 2004, LECT NOTES COMPUT SC, V3239, P197; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062216; Sivalingam GN, 2012, MOL IMMUNOL, V51, P304, DOI 10.1016/j.molimm.2012.03.030; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Sun J., 2011, MATH PROBL ENG, P1, DOI DOI 10.1155/2011/469031; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; TAINER JA, 1984, NATURE, V312, P127, DOI 10.1038/312127a0; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Van Regenmortel MHV, 2009, METHODS MOL BIOL, V524, P3, DOI 10.1007/978-1-59745-450-6_1; VILLENEUVE A, 1994, MICROBIOL-UK, V140, P2481, DOI 10.1099/13500872-140-9-2481; Wang J, 2010, J IMMUNOL, V185, P1670, DOI 10.4049/jimmunol.1001240; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; ZHONG GM, 1990, INFECT IMMUN, V58, P1450, DOI 10.1128/IAI.58.5.1450-1455.1990	87	25	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14585	14599		10.1074/jbc.M116.729020	http://dx.doi.org/10.1074/jbc.M116.729020			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27189949	Green Published, hybrid			2022-12-28	WOS:000380366700015
J	Sundararaman, A; Amirtham, U; Rangarajan, A				Sundararaman, Ananthalakshmy; Amirtham, Usha; Rangarajan, Annapoorni			Calcium-Oxidant Signaling Network Regulates AMP-activated Protein Kinase (AMPK) Activation upon Matrix Deprivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); anoikis; calcium; cancer biology; reactive oxygen species (ROS); matrix deprivation	OXIDATIVE STRESS; CELL-SURVIVAL; EXTRACELLULAR-MATRIX; MITOCHONDRIAL ROS; BREAST-CANCER; MEDIATED ACTIVATION; ANOIKIS RESISTANCE; ENDOTHELIAL-CELLS; NUCLEAR CALCIUM; ENERGY STRESS	The AMP-activated protein kinase (AMPK) has recently been implicated in anoikis resistance. However, the molecular mechanisms that activate AMPK upon matrix detachment remain unexplored. In this study, we show that AMPK activation is a rapid and sustained phenomenon upon matrix deprivation, whereas re-attachment to the matrix leads to its dephosphorylation and inactivation. Because matrix detachment leads to loss of integrin signaling, we investigated whether integrin signaling negatively regulates AMPK activation. However, modulation of focal adhesion kinase or Src, the major downstream components of integrin signaling, failed to cause a corresponding change in AMPK signaling. Further investigations revealed that the upstream AMPK kinases liver kinase B1 (LKB1) and Ca2+/calmodulin-dependent protein kinase kinase (CaMKK) contribute to AMPK activation upon detachment. In LKB1-deficient cells, we found AMPK activation to be predominantly dependent on CaMKK. We observed no change in ATP levels under detached conditions at early time points suggesting that rapid AMPK activation upon detachment was not triggered by energy stress. We demonstrate that matrix deprivation leads to a spike in intracellular calcium as well as oxidant signaling, and both these intracellular messengers contribute to rapid AMPK activation upon detachment. We further show that endoplasmic reticulum calcium release-induced store-operated calcium entry contributes to intracellular calcium increase, leading to reactive oxygen species production, and AMPK activation. We additionally show that the LKB1/CaMKK-AMPK axis and intracellular calcium levels play a critical role in anchorage-independent cancer sphere formation. Thus, the Ca2+/reactive oxygen species-triggered LKB1/CaMKK-AMPK signaling cascade may provide a quick, adaptable switch to promote survival of metastasizing cancer cells.	[Sundararaman, Ananthalakshmy; Rangarajan, Annapoorni] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Amirtham, Usha] Kidwai Mem Inst Oncol, Dept Pathol, Bangalore 560030, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Kidwai Memorial Institute of Oncology	Rangarajan, A (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	anu@mrdg.iisc.ernet.in		Sundararaman, Ananthalakshmy/0000-0002-5661-4656	Department of Science and Technology (DST)-Fund for Improvement of Science & Technology infrastructure in universities & higher educational institutions (FIST); University Grants Commission (UGC), Govt. of India	Department of Science and Technology (DST)-Fund for Improvement of Science & Technology infrastructure in universities & higher educational institutions (FIST); University Grants Commission (UGC), Govt. of India(University Grants Commission, India)	We acknowledge Dr. Oliver Griesbeck and Dr. Lewis C. Cantley for TN-XXL and AMPK AR FRET constructs, respectively, and Dr. Graham Hardie for AMPK antibody used in kinase assays. We also acknowledge Nehanjali Dwivedi and Rachana Sathyendran for Western blotting; Manipa Saha and C. R. Madhwesh for help with in vitro kinase assay and immunocytochemistry, respectively; and members of the A. R. laboratory for their critical inputs during the course of the study and for help with manuscript preparation. We also thank Dr. Rekha V. Kumar and R. Anisha from Kidwai Memorial Institute of Oncology for help with immunohistochemistry. We acknowledge Drs. N. V. Joshi, Kumar Somasundaram, Deepak Saini, and Ramray Bhat for their input in the study and statistical analysis of the data. We acknowledge the flow cytometry facility at IISc. Support from Department of Science and Technology (DST)-Fund for Improvement of Science & Technology infrastructure in universities & higher educational institutions (FIST), and University Grants Commission (UGC), Govt. of India, to the Department of MRDG are also acknowledged.	Alexander A, 2011, FEBS LETT, V585, P952, DOI 10.1016/j.febslet.2011.03.010; Aoshiba K, 2001, AM J PHYSIOL-LUNG C, V281, pL556; Auciello FR, 2014, FEBS LETT, V588, P3361, DOI 10.1016/j.febslet.2014.07.025; Avivar-Valderas A, 2011, MOL CELL BIOL, V31, P3616, DOI 10.1128/MCB.05164-11; Baron V, 2000, J BIOL CHEM, V275, P39318, DOI 10.1074/jbc.M003618200; Birnbaum MJ, 2005, MOL CELL, V19, P289, DOI 10.1016/j.molcel.2005.07.012; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Bouchard V, 2007, J CELL PHYSIOL, V212, P717, DOI 10.1002/jcp.21096; Bouchekioua-Bouzaghou K, 2014, INT J CANCER, V135, P1307, DOI 10.1002/ijc.28781; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; DAVIES SP, 1990, EUR J BIOCHEM, V187, P183, DOI 10.1111/j.1432-1033.1990.tb15293.x; Davis FM, 2014, ONCOGENE, V33, P2307, DOI 10.1038/onc.2013.187; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Ellerstrom C, 2007, STEM CELLS, V25, P1690, DOI 10.1634/stemcells.2006-0607; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Fenton H, 2006, APPL IMMUNOHISTO M M, V14, P146, DOI 10.1097/01.pai.0000176157.07908.20; Frigo DE, 2011, CANCER RES, V71, P528, DOI 10.1158/0008-5472.CAN-10-2581; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gusarova GA, 2011, MOL CELL BIOL, V31, P3546, DOI 10.1128/MCB.05114-11; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hart PC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7053; Hindupur SK, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0420-z; Howe AK, 2001, J BIOL CHEM, V276, P14541, DOI 10.1074/jbc.C000797200; Itano N, 2003, P NATL ACAD SCI USA, V100, P5181, DOI 10.1073/pnas.0531397100; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Karacosta LG, 2012, J BIOL CHEM, V287, P24832, DOI 10.1074/jbc.M112.370783; LEBEL CP, 1992, TOXICOL APPL PHARM, V112, P161, DOI 10.1016/0041-008X(92)90292-Z; Lee SW, 2015, MOL CELL, V57, P1022, DOI 10.1016/j.molcel.2015.01.015; Lewis RS, 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A003970; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luo LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123927; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MALGAROLI A, 1987, J CELL BIOL, V105, P2145, DOI 10.1083/jcb.105.5.2145; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mittal S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-128; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Mungai PT, 2011, MOL CELL BIOL, V31, P3531, DOI 10.1128/MCB.05124-11; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Ng TL, 2012, CELL DEATH DIFFER, V19, P501, DOI 10.1038/cdd.2011.119; Ogata M, 1999, J BIOL CHEM, V274, P20717, DOI 10.1074/jbc.274.29.20717; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Peart T, 2015, ONCOTARGET, V6, P22424, DOI 10.18632/oncotarget.4211; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Pusl T, 2002, J BIOL CHEM, V277, P27517, DOI 10.1074/jbc.M203002200; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shen Z, 2002, CLIN CANCER RES, V8, P2085; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Sjaastad MD, 1996, MOL BIOL CELL, V7, P1025, DOI 10.1091/mbc.7.7.1025; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Smyth JT, 2007, J CELL SCI, V120, P3762, DOI 10.1242/jcs.015735; Song P, 2008, J BIOL CHEM, V283, P12446, DOI 10.1074/jbc.M708208200; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Tsou L, 2011, CELL METAB, V13, P476, DOI 10.1016/j.cmet.2011.03.006; Voss M, 2011, CELL SIGNAL, V23, P114, DOI 10.1016/j.cellsig.2010.08.010; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Xu SH, 2014, DEV CELL, V31, P48, DOI 10.1016/j.devcel.2014.08.002; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Zagorska A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000616; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111	76	47	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14410	14429		10.1074/jbc.M116.731257	http://dx.doi.org/10.1074/jbc.M116.731257			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226623	Green Published, hybrid			2022-12-28	WOS:000380366700002
J	Zwick, M; Esposito, C; Hellstern, M; Seelig, A				Zwick, Matthias; Esposito, Cinzia; Hellstern, Manuel; Seelig, Anna			How Phosphorylation and ATPase Activity Regulate Anion Flux though the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; biosensor; cyclic AMP (cAMP); cystic fibrosis transmembrane conductance regulator (CFTR); protein kinase A (PKA)	PROTEIN-KINASE-A; NUCLEOTIDE-BINDING DOMAINS; MULTIDRUG ABC TRANSPORTER; P-GLYCOPROTEIN ACTIVATION; CHLORIDE-CHANNEL; R-DOMAIN; CL-CHANNEL; STAPHYLOCOCCUS-AUREUS; LIVING CELLS; FORSKOLIN INHIBITION	The cystic fibrosis transmembrane conductance regulator (CFTR, ABCC7), mutations of which cause cystic fibrosis, belongs to the ATP-binding cassette (ABC) transporter family and works as a channel for small anions, such as chloride and bicarbonate. Anion channel activity is known to depend on phosphorylation by cAMP-dependent protein kinase A (PKA) and CFTR-ATPase activity. Whereas anion channel activity has been extensively investigated, phosphorylation and CFTR-ATPase activity are still poorly understood. Here, we show that the two processes can be measured in a label-free and non-invasive manner in real time in live cells, stably transfected with CFTR. This study reveals three key findings. (i) The major contribution (90%) to the total CFTR-related ATP hydrolysis rate is due to phosphorylation by PKA and the minor contribution (10%) to CFTR-ATPase activity. (ii) The mutant CFTR-E1371S that is still conductive, but defective in ATP hydrolysis, is not phosphorylated, suggesting that phosphorylation requires a functional nucleotide binding domain and occurs in the post-hydrolysis transition state. (iii) CFTR-ATPase activity is inversely related to CFTR anion flux. The present data are consistent with a model in which CFTR is in a closed conformation with two ATPs bound. The open conformation is induced by ATP hydrolysis and corresponds to the post-hydrolysis transition state that is stabilized by phosphorylation and binding of chloride channel potentiators.	[Zwick, Matthias; Esposito, Cinzia; Hellstern, Manuel; Seelig, Anna] Univ Basel, Biozentrum, Biophys Chem, Klingelbergstr 50-70, CH-4056 Basel, Switzerland	University of Basel	Seelig, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	anna.seelig@unibas.ch			Swiss National Science Foundation [3100A-107793]; Werner Siemens-Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Werner Siemens-Foundation	This work was supported in part by the Swiss National Science Foundation Grant 3100A-107793. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Werner Siemens-Foundation Ph.D. fellowship within the program "Opportunities for Excellence."	Aanismaa P, 2007, BIOCHEMISTRY-US, V46, P3394, DOI 10.1021/bi0619526; Ai T, 2004, MOL PHARMACOL, V65, P1415, DOI 10.1124/mol.65.6.1415; Al-Nakkash L, 1999, PFLUG ARCH EUR J PHY, V437, P553, DOI 10.1007/s004240050817; Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; Aleksandrov AA, 1998, FEBS LETT, V431, P97, DOI 10.1016/S0014-5793(98)00713-3; Aleksandrov AA, 2002, FEBS LETT, V518, P183, DOI 10.1016/S0014-5793(02)02698-4; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Ataullakhanov FI, 2002, BIOSCIENCE REP, V22, P501, DOI 10.1023/A:1022069718709; Baldursson O, 2000, AM J PHYSIOL-LUNG C, V279, pL835, DOI 10.1152/ajplung.2000.279.5.L835; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; BAUKROWITZ T, 1994, NEURON, V12, P473, DOI 10.1016/0896-6273(94)90206-2; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Beck A, 2013, BIOCHEMISTRY-US, V52, P3297, DOI 10.1021/bi400203d; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Bozoky Z, 2013, FEBS J, V280, P4407, DOI 10.1111/febs.12422; CHANG XB, 1993, J BIOL CHEM, V268, P11304; Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Csanady L, 2005, J GEN PHYSIOL, V125, P171, DOI 10.1085/jgp.200409076; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; Csanady L, 2013, J GEN PHYSIOL, V142, P61, DOI 10.1085/jgp.201210954; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Cui GY, 2012, PFLUG ARCH EUR J PHY, V463, P405, DOI 10.1007/s00424-011-1035-1; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; Egido E, 2015, MOL PHARMACEUT, V12, P4026, DOI 10.1021/acs.molpharmaceut.5b00463; Ernst R, 2010, FEBS J, V277, P540, DOI 10.1111/j.1742-4658.2009.07485.x; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Gadsby DC, 1999, ADV SEC MESS PHOSPH, V33, P79; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+; Gatlik-Landwojtowicz E, 2004, BIOCHEMISTRY-US, V43, P14840, DOI 10.1021/bi048761s; GEISBUHLER TP, 1987, PFLUG ARCH EUR J PHY, V409, P158, DOI 10.1007/BF00584765; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; Guarino RD, 2004, BIOTECHNOL BIOENG, V86, P775, DOI 10.1002/bit.20072; GUNDERSON KL, 1994, J BIOL CHEM, V269, P19349; Hafner F, 2000, BIOSENS BIOELECTRON, V15, P149, DOI 10.1016/S0956-5663(00)00069-5; Hegedus T, 2009, BBA-BIOMEMBRANES, V1788, P1341, DOI 10.1016/j.bbamem.2009.03.015; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hughes LK, 2008, MOL MEMBR BIOL, V25, P528, DOI 10.1080/09687680802487967; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Ketchum CJ, 2004, BIOCHEMISTRY-US, V43, P1045, DOI 10.1021/bi035382a; Klein I, 1999, BBA-BIOMEMBRANES, V1461, P237, DOI 10.1016/S0005-2736(99)00161-3; Kogan Ilana, 2004, J Cyst Fibros, V3 Suppl 2, P133, DOI 10.1016/j.jcf.2004.05.028; Kopeikin Z, 2010, J GEN PHYSIOL, V136, P659, DOI 10.1085/jgp.201010518; Landwojtowicz E, 2002, BIOCHEMISTRY-US, V41, P8050, DOI 10.1021/bi025720s; Laohapitakworn S, 2011, AM J PHYSIOL-CELL PH, V301, pC137, DOI 10.1152/ajpcell.00001.2011; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Li-Blatter XC, 2012, BIOPHYS J, V102, P1383, DOI 10.1016/j.bpj.2012.02.018; Li-Blatter X, 2009, BBA-BIOMEMBRANES, V1788, P2335, DOI 10.1016/j.bbamem.2009.07.010; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Linsdell Paul, 2014, World J Biol Chem, V5, P26, DOI 10.4331/wjbc.v5.i1.26; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P169, DOI 10.1016/S0925-4439(97)00027-6; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4; Luckie DB, 2001, J MEMBRANE BIOL, V179, P275, DOI 10.1007/s002320010052; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Mathews CJ, 1998, J PHYSIOL-LONDON, V508, P365, DOI 10.1111/j.1469-7793.1998.365bq.x; MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199; Moran O, 2005, FEBS LETT, V579, P3979, DOI 10.1016/j.febslet.2005.06.026; Moran O, 2010, J THEOR BIOL, V262, P73, DOI 10.1016/j.jtbi.2009.08.032; Moran O, 2008, J CYST FIBROS, V7, P483, DOI 10.1016/j.jcf.2008.05.003; Muallem D, 2009, PHILOS T R SOC B, V364, P247, DOI 10.1098/rstb.2008.0191; OWICKI JC, 1990, P NATL ACAD SCI USA, V87, P4007, DOI 10.1073/pnas.87.10.4007; Park JB, 1999, BIOCHEM BIOPH RES CO, V260, P568, DOI 10.1006/bbrc.1999.0890; Pereira MMC, 2007, BIOCHEM J, V405, P181, DOI 10.1042/BJ20061879; Qin L, 2008, BIOCHEMISTRY-US, V47, P13952, DOI 10.1021/bi801532g; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rosenberg MF, 2011, J BIOL CHEM, V286, P42647, DOI 10.1074/jbc.M111.292268; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SCHULTZ BD, 1995, J GEN PHYSIOL, V105, P329, DOI 10.1085/jgp.105.3.329; Seelig A, 2007, J MOL NEUROSCI, V33, P32, DOI 10.1007/s12031-007-0055-y; SERGEANT S, 1985, J BIOL CHEM, V260, P4677; Sheppard DN, 1997, J PHYSIOL-LONDON, V503, P333, DOI 10.1111/j.1469-7793.1997.333bh.x; Szollosi A, 2011, J GEN PHYSIOL, V137, P549, DOI 10.1085/jgp.201110608; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; Takahashi M, 2013, J BIOL CHEM, V288, P27712, DOI 10.1074/jbc.M113.466904; Tang L, 2009, J CYST FIBROS, V8, P115, DOI 10.1016/j.jcf.2008.10.004; Thedinga E, 2007, TOXICOL APPL PHARM, V220, P33, DOI 10.1016/j.taap.2006.12.027; VANVALEN F, 1988, BONE, V9, P89, DOI 10.1016/8756-3282(88)90108-1; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Vera JC, 1996, J BIOL CHEM, V271, P8719, DOI 10.1074/jbc.271.15.8719; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang F, 1998, J GEN PHYSIOL, V111, P477, DOI 10.1085/jgp.111.3.477; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; Wang WY, 2012, J BIOL CHEM, V287, P10156, DOI 10.1074/jbc.M112.342972; Wielinga PR, 2003, J BIOL CHEM, V278, P17664, DOI 10.1074/jbc.M212723200; Winter MC, 1997, NATURE, V389, P294, DOI 10.1038/38514; Wu DZ, 2008, J PHARMACOL EXP THER, V325, P256, DOI 10.1124/jpet.107.131961; Xu Y, 2014, THESIS; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327	97	6	6	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14483	14498		10.1074/jbc.M116.721415	http://dx.doi.org/10.1074/jbc.M116.721415			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226582	Green Published, hybrid			2022-12-28	WOS:000380366700007
J	Wen, Y; Kim, IH; Kim, KS				Wen, Yancheng; Kim, In Hwang; Kim, Kun-Soo			Iron- and Quorum-sensing Signals Converge on Small Quorum-regulatory RNAs for Coordinated Regulation of Virulence Factors in Vibrio vulnificus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial signal transduction; host-pathogen interaction; iron; quorum sensing; small interfering RNA (siRNA); virulence factor; Fur; Qrrs; Vibrio vulnificus; smcR	GRAM-NEGATIVE BACTERIA; METALLOPROTEASE VVPE; ESCHERICHIA-COLI; GLOBAL REGULATOR; BOUND IRON; LUXR GENE; IN-VIVO; HARVEYI; EXPRESSION; CHOLERAE	Vibrio vulnificus is a marine bacterium that causes human infections resulting in high mortality. This pathogen harbors five quorum-regulatory RNAs (Qrr1-5) that affect the expression of pathogenicity genes by modulating the expression of the master regulator SmcR. The qrr genes are activated by phosphorylated LuxO to different degrees; qrr2 is strongly activated; qrr3 and qrr5 are moderately activated, and qrr1 and qrr4 are marginally activated and are the only two that do not respond to cell density-dependent regulation. Qrrs function redundantly to inhibit SmcR at low cell density and fully repress when all five are activated. In this study, we found that iron inhibits qrr expression in three distinct ways. First, the iron-ferric uptake regulator (Fur) complex directly binds to qrr promoter regions, inhibiting LuxO activation by competing with LuxO for cis-acting DNA elements. Second, qrr transcription is repressed by iron independently of Fur. Third, LuxO expression is repressed by iron independently of Fur. We also found that, under iron-limiting conditions, the five Qrrs functioned additively, not redundantly, to repress SmcR, suggesting that cells lacking iron enter a high cell density mode earlier and could thereby modulate expression of virulence factors sooner. This study suggests that iron and quorum sensing, along with their cognate regulatory circuits, are linked together in the coordinated expression of virulence factors.	[Wen, Yancheng; Kim, In Hwang; Kim, Kun-Soo] Sogang Univ, Dept Life Sci, 35 Baekbeom Ro, Seoul 121742, South Korea; [Kim, Kun-Soo] Sogang Univ, Interdisciplinary Program Integrated Biotechnol, 35 Baekbeom Ro, Seoul 121742, South Korea	Sogang University; Sogang University	Kim, KS (corresponding author), Sogang Univ, Dept Life Sci, 35 Baekbeom Ro, Seoul 121742, South Korea.	kskim@sogang.ac.kr		KIM, KUN-SOO/0000-0002-5433-4175	National Research Foundation from Korean Government [NRF-2011-0018115, NRF-2015M3C9A2054020]	National Research Foundation from Korean Government	This work was supported by the National Research Foundation Grants NRF-2011-0018115 and NRF-2015M3C9A2054020 from the Korean Government. The authors declare that they have no conflict of interest with the contents of this article.	BAGG A, 1987, BIOCHEMISTRY-US, V26, P5471, DOI 10.1021/bi00391a039; BASSLER BL, 1994, MOL MICROBIOL, V12, P403, DOI 10.1111/j.1365-2958.1994.tb01029.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Feng LH, 2015, CELL, V160, P228, DOI 10.1016/j.cell.2014.11.051; Freeman JA, 1999, J BACTERIOL, V181, P899, DOI 10.1128/JB.181.3.899-906.1999; Freeman JA, 1999, MOL MICROBIOL, V31, P665, DOI 10.1046/j.1365-2958.1999.01208.x; GRAY LD, 1989, TOXICON, V27, P459, DOI 10.1016/0041-0101(89)90208-0; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; HANTKE K, 1981, MOL GEN GENET, V182, P288, DOI 10.1007/BF00269672; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Jeong HS, 2003, J BIOL CHEM, V278, P45072, DOI 10.1074/jbc.M308184200; Jeong HS, 2001, J BIOL CHEM, V276, P13875, DOI 10.1074/jbc.M010567200; Jobling MG, 1997, MOL MICROBIOL, V26, P1023, DOI 10.1046/j.1365-2958.1997.6402011.x; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim CM, 2007, FEMS MICROBIOL LETT, V269, P170, DOI 10.1111/j.1574-6968.2006.00622.x; Kim CM, 2006, BIOL PHARM BULL, V29, P911, DOI 10.1248/bpb.29.911; Kim IH, 2015, J BIOL CHEM, V290, P18708, DOI 10.1074/jbc.M115.656306; Kim IH, 2013, INFECT IMMUN, V81, P2888, DOI 10.1128/IAI.00375-13; Kim SY, 2003, MOL MICROBIOL, V48, P1647, DOI 10.1046/j.1365-2958.2003.03536.x; KOTHARY MH, 1987, J GEN MICROBIOL, V133, P1783; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kumamoto Kenneth S., 1998, Journal of Emergency Medicine, V16, P61, DOI 10.1016/S0736-4679(97)00230-8; Lee BC, 2008, MICROBES INFECT, V10, P1504, DOI 10.1016/j.micinf.2008.09.006; Lee HJ, 2003, J BACTERIOL, V185, P5891, DOI 10.1128/JB.185.19.5891-5896.2003; Lee HS, 2015, J MICROBIOL BIOTECHN, V25, P1380, DOI 10.4014/jmb.1503.03031; Lee HJ, 2013, MOL MICROBIOL, V88, P813, DOI 10.1111/mmi.12224; Lee JH, 2007, J MICROBIOL BIOTECHN, V17, P325; Lee MA, 2015, J MICROBIOL BIOTECHN, V25, P302, DOI 10.4014/jmb.1501.01007; Lee SE, 2004, BIOCHEM BIOPH RES CO, V324, P86, DOI 10.1016/j.bbrc.2004.09.020; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Lilley BN, 2000, MOL MICROBIOL, V36, P940, DOI 10.1046/j.1365-2958.2000.01913.x; Lim JG, 2014, J MICROBIOL, V52, P413, DOI 10.1007/s12275-014-3592-4; Lim JG, 2014, INFECT IMMUN, V82, P569, DOI 10.1128/IAI.01141-13; Lin W, 2005, J BACTERIOL, V187, P3013, DOI 10.1128/JB.187.9.3013-3019.2005; Litwin CM, 1996, INFECT IMMUN, V64, P2834, DOI 10.1128/IAI.64.7.2834-2838.1996; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATHER MW, 1995, GENE, V156, P85, DOI 10.1016/0378-1119(95)00074-G; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Milton DL, 2006, INT J MED MICROBIOL, V296, P61, DOI 10.1016/j.ijmm.2006.01.044; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Miyashiro T, 2010, MOL MICROBIOL, V77, P1556, DOI 10.1111/j.1365-2958.2010.07309.x; MORRIS JG, 1987, FEMS MICROBIOL LETT, V40, P55; Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200; Okujo N, 1996, MICROBIOL IMMUNOL, V40, P595, DOI 10.1111/j.1348-0421.1996.tb01114.x; Park JH, 2011, J BACTERIOL, V193, P2062, DOI 10.1128/JB.00110-11; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Roh JB, 2006, J BIOL CHEM, V281, P34775, DOI 10.1074/jbc.M607844200; Rutherford ST, 2011, GENE DEV, V25, P397, DOI 10.1101/gad.2015011; Sambrook J., 2001, MOL CLONING LAB MANU; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Shao CP, 2011, J BACTERIOL, V193, P2557, DOI 10.1128/JB.01259-10; Shao Y, 2014, MOL MICROBIOL, V92, P921, DOI 10.1111/mmi.12599; Shao Y, 2013, EMBO J, V32, P2158, DOI 10.1038/emboj.2013.155; Shao Y, 2012, MOL MICROBIOL, V83, P599, DOI 10.1111/j.1365-2958.2011.07959.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SIMPSON LM, 1983, INFECT IMMUN, V41, P644, DOI 10.1128/IAI.41.2.644-649.1983; Storz G, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P157; Svenningsen SL, 2008, GENE DEV, V22, P226, DOI 10.1101/gad.1629908; Svenningsen SL, 2009, EMBO J, V28, P429, DOI 10.1038/emboj.2008.300; SWARTZMAN E, 1992, J BACTERIOL, V174, P7490, DOI 10.1128/jb.174.22.7490-7493.1992; TESTA J, 1984, INFECT IMMUN, V45, P458, DOI 10.1128/IAI.45.2.458-463.1984; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Tu KC, 2007, GENE DEV, V21, P221, DOI 10.1101/gad.1502407; Tu KC, 2010, MOL CELL, V37, P567, DOI 10.1016/j.molcel.2010.01.022; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Webster ACD, 2000, INFECT IMMUN, V68, P526, DOI 10.1128/IAI.68.2.526-534.2000; Wen Y, 2012, J BIOL CHEM, V287, P26727, DOI 10.1074/jbc.M112.374165; WRIGHT AC, 1990, INFECT IMMUN, V58, P1769, DOI 10.1128/IAI.58.6.1769-1773.1990; WRIGHT AC, 1981, INFECT IMMUN, V34, P503, DOI 10.1128/IAI.34.2.503-507.1981; Wyman C, 1997, SCIENCE, V275, P1658, DOI 10.1126/science.275.5306.1658	74	14	15	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14213	14230		10.1074/jbc.M116.714063	http://dx.doi.org/10.1074/jbc.M116.714063			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27151217	hybrid, Green Published			2022-12-28	WOS:000379975100027
J	Sun, J; Mao, LQ; Polonsky, KS; Ren, DC				Sun, Juan; Mao, Li-qun; Polonsky, Kenneth S.; Ren, De-cheng			Pancreatic beta-Cell Death due to Pdx-1 Deficiency Requires Multi-BH Domain Protein Bax but Not Bak	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; Bax; beta cell (-cell); cell death; diabetes	BH3-ONLY PROTEINS; APOPTOSIS; PUMA; BIM; ACTIVATION; SURVIVAL; ISLETS	Diabetes develops in Pdx1-haploinsufficient mice due to an increase in -cell death leading to reduced -cell mass and decreased insulin secretion. Knockdown of Pdx1 gene expression in mouse MIN6 insulinoma cells induced apoptotic cell death with an increase in Bax activation and knockdown of Bax reduced apoptotic -cell death. In Pdx1 haploinsufficient mice, Bax ablation in -cells increased -cell mass, decreased the number of TUNEL positive cells and improved glucose tolerance after glucose challenge. These changes were not observed with Bak ablation in Pdx1-haploinsufficient mice. These results suggest that Bax mediates -cell apoptosis in Pdx1-deficient diabetes.	[Sun, Juan; Polonsky, Kenneth S.; Ren, De-cheng] Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 1027, Chicago, IL 60637 USA; [Mao, Li-qun] Rosalind Franklin Univ Med & Sci, Dept Microbiol & Immunol, N Chicago, IL 60064 USA	University of Chicago; Rosalind Franklin University Medical & Science	Polonsky, KS; Ren, DC (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 1027, Chicago, IL 60637 USA.	polonsky@bsd.uchicago.edu; decheng@uchicago.edu			National Institutes of Health [R01 DK031842, P30-DK020595]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031842, P30DK020595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health Grants R01 DK031842 (to K. S. P.) and P30-DK020595 (The University of Chicago and Diabetes Research and Training Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Boyd Vinc, 2008, Curr Trends Biotechnol Pharm, V2, P66; Fujimoto K, 2010, P NATL ACAD SCI USA, V107, P10214, DOI 10.1073/pnas.0914209107; Fujimoto K, 2009, J BIOL CHEM, V284, P27664, DOI 10.1074/jbc.M109.041616; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Jayaraman S, 2005, J IMMUNOL METHODS, V306, P68, DOI 10.1016/j.jim.2005.07.024; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Lindenboim L, 2005, CELL DEATH DIFFER, V12, P713, DOI 10.1038/sj.cdd.4401638; McKenzie MD, 2010, DIABETES, V59, P644, DOI 10.2337/db09-1151; Mondal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034277; Ren DC, 2014, DIABETES, V63, P2744, DOI 10.2337/db13-1513; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Wali JA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.88; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	19	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13529	13534		10.1074/jbc.M115.705293	http://dx.doi.org/10.1074/jbc.M115.705293			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27137932	hybrid, Green Published			2022-12-28	WOS:000379771100011
J	Blevitt, JM; Hack, MD; Herman, K; Chang, L; Keith, JM; Mirzadegan, T; Rao, NL; Lebsack, AD; Milla, ME				Blevitt, Jonathan M.; Hack, Michael D.; Herman, Krystal; Chang, Leon; Keith, John M.; Mirzadegan, Tara; Rao, Navin L.; Lebsack, Alec D.; Milla, Marcos E.			A Single Amino Acid Difference between Mouse and Human 5-Lipoxygenase Activating Protein (FLAP) Explains the Speciation and Differential Pharmacology of Novel FLAP Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOTRIENE BIOSYNTHESIS INHIBITOR; PROSTAGLANDIN-E SYNTHASE-1; INFLAMMATORY DISEASES; ASTHMATIC SUBJECTS; POLYPHARMACOLOGY; EXPRESSION; MODULATORS; MK-0591; CLONING; MODELS	5-Lipoxygenase activating protein (FLAP) plays a critical role in the metabolism of arachidonic acid to leukotriene A(4), the precursor to the potent pro-inflammatory mediators leukotriene B-4 and leukotriene C-4. Studies with small molecule inhibitors of FLAP have led to the discovery of a drug binding pocket on the protein surface, and several pharmaceutical companies have developed compounds and performed clinical trials. Crystallographic studies and mutational analyses have contributed to a general understanding of compound binding modes. During our own efforts, we identified two unique chemical series. One series demonstrated strong inhibition of human FLAP but differential pharmacology across species and was completely inactive in assays with mouse or rat FLAP. The other series was active across rodent FLAP, as well as human and dog FLAP. Comparison of rodent and human FLAP amino acid sequences together with an analysis of a published crystal structure led to the identification of amino acid residue 24 in the floor of the putative binding pocket as a likely candidate for the observed speciation. On that basis, we tested compounds for binding to human G24A and mouse A24G FLAP mutant variants and compared the data to that generated for wild type human and mouse FLAP. These studies confirmed that a single amino acid mutation was sufficient to reverse the speciation observed in wild type FLAP. In addition, a PK/PD method was established in canines to enable preclinical profiling of mouse-inactive compounds.	[Chang, Leon; Keith, John M.; Rao, Navin L.; Lebsack, Alec D.] Janssen Res & Dev, Dept Immunol, San Diego, CA 92121 USA; [Blevitt, Jonathan M.; Hack, Michael D.; Herman, Krystal; Mirzadegan, Tara; Milla, Marcos E.] Janssen Res & Dev, Dept Discovery Sci, San Diego, CA 92121 USA		Milla, ME (corresponding author), Adapt Biotechnol, San Diego, CA 92121 USA.	mmilla@adaptivebiotech.com						Bacani G M, 2014, PCT Int. Appl, Patent No. [WO2014121055, 2014121055, WO 2014121055]; BRIDEAU C, 1992, CAN J PHYSIOL PHARM, V70, P799, DOI 10.1139/y92-107; Chai W., 2014, U.S. Patent, Patent No. 20140275029; Chai W., 2014, U.S. Patent, Patent No. 20140275028; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dahlen B, 1997, THORAX, V52, P342, DOI 10.1136/thx.52.4.342; DIAMANT Z, 1995, J ALLERGY CLIN IMMUN, V95, P42, DOI 10.1016/S0091-6749(95)70151-6; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Fitzgerald A. E., 2014, [No title captured], Patent No. [WO2014121040 A1, 2014121040]; HAEGGSTROM JZ, 1993, J LIPID MEDIATOR, V6, P1; LAM BK, 1994, P NATL ACAD SCI USA, V91, P7663, DOI 10.1073/pnas.91.16.7663; Lemurell M, 2015, J MED CHEM, V58, P897, DOI 10.1021/jm501531v; Lewis David F. V., 2009, Drug Metabolism and Drug Interactions, V24, P229, DOI 10.1515/DMDI.2009.24.2-4.229; LIN JH, 1995, DRUG METAB DISPOS, V23, P1008; Lorrain DS, 2010, EUR J PHARMACOL, V640, P211, DOI 10.1016/j.ejphar.2010.05.003; MANCINI JA, 1992, MOL PHARMACOL, V41, P267; Miller D. K., 2004, P INFL RES ASS 12 IN; Pawelzik SC, 2010, J BIOL CHEM, V285, P29254, DOI 10.1074/jbc.M110.114454; ROUZER CA, 1990, J BIOL CHEM, V265, P1436; Sampson AP, 2009, CURR OPIN INVEST DR, V10, P1163; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Singh D, 2013, INT J GEN MED, V6, P897, DOI 10.2147/IJGM.S51364; Song J, 2016, J BIOMOL SCREEN, V21, P127, DOI 10.1177/1087057115607815; Song J, 2015, J LIPID RES, V56, P1492, DOI 10.1194/jlr.M058677; Tichenor MS, 2015, J MED CHEM, V58, P7119, DOI 10.1021/acs.jmedchem.5b00516; VICKERS PJ, 1992, MOL PHARMACOL, V42, P1014; VICKERS PJ, 1995, J LIPID MEDIAT CELL, V12, P185, DOI 10.1016/0929-7855(95)00018-L; WELSCH DJ, 1994, P NATL ACAD SCI USA, V91, P9745, DOI 10.1073/pnas.91.21.9745; Xu DG, 2008, J PHARMACOL EXP THER, V326, P754, DOI 10.1124/jpet.108.138776	31	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12724	12731		10.1074/jbc.M116.725325	http://dx.doi.org/10.1074/jbc.M116.725325			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129215	hybrid, Green Published			2022-12-28	WOS:000378119900025
J	Misu, A; Yamanaka, H; Aramaki, T; Kondo, S; Skerrett, M; Iovine, MK; Watanabe, M				Misu, Akihiro; Yamanaka, Hiroaki; Aramaki, Toshihiro; Kondo, Shigeru; Skerrett, Martha; Iovine, M. Kathryn; Watanabe, Masakatsu			Two Different Functions of Connexin43 Confer Two Different Bone Phenotypes in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONS; OSTEOBLAST; DISEASE; GROWTH; FIN; PROSTAGLANDIN; COMMUNICATION; MORPHOGENESIS; EXPRESSION; OSTEOCYTES	Fish remain nearly the same shape as they grow, but there are two different modes of bone growth. Bones in the tail fin (fin ray segments) are added distally at the tips of the fins and do not elongate once produced. On the other hand, vertebrae enlarge in proportion to body growth. To elucidate how bone growth is controlled, we investigated a zebrafish mutant, steopsel (stp(tl28d)). Vertebrae of stp(tl28d/+) fish look normal in larvae (similar to 30 days) but are distinctly shorter (59-81%) than vertebrae of wild type fish in adults. In contrast, the lengths of fin rays are only slightly shorter (similar to 95%) than those of the wild type in both larvae and adults. Positional cloning revealed that stp encodes Connexin43 (Cx43), a connexin that functions as a gap junction and hemichannel. Interestingly, cx43 was also identified as the gene causing the short-of-fin (sof) phenotype, in which the fin ray segments are shorter but the vertebrae are normal. To identify the cause of this difference between the alleles, we expressed Cx43 exogenously in Xenopus oocytes and performed electrophysiological analysis of the mutant proteins. Gap junction coupling induced by Cx43(stp) or Cx43(sof) was reduced compared with Cx43-WT. On the other hand, only Cx43(stp) induced abnormally high (50x wild type) transmembrane currents through hemichannels. Our results suggest that Cx43 plays critical and diverse roles in zebrafish bone growth.	[Misu, Akihiro; Yamanaka, Hiroaki; Aramaki, Toshihiro; Kondo, Shigeru; Watanabe, Masakatsu] Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan; [Kondo, Shigeru] Japan Sci & Technol Agcy, CREST, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan; [Skerrett, Martha] Buffalo State Coll, Dept Biol, Buffalo, NY 14222 USA; [Iovine, M. Kathryn] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	Osaka University; Japan Science & Technology Agency (JST); State University of New York (SUNY) System; Buffalo State College; Lehigh University	Watanabe, M (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	watanabe-m@fbs.osaka-u.ac.jp	WATANABE, Masakatsu/V-9082-2019	WATANABE, Masakatsu/0000-0002-5744-197X; Kondo, Shigeru/0000-0003-0192-5526	Ministry of Education, Culture, Sports, Science, and Technology in Japan KAKENHI Grant [22127003]; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency; Japanese Society for the Promotion of Science KAKENHI Grant [26291049]; Grants-in-Aid for Scientific Research [26291049] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology in Japan KAKENHI Grant; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japanese Society for the Promotion of Science KAKENHI Grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology in Japan KAKENHI Grant 22127003 (to S. K.); by the Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (to S. K.); and by Japanese Society for the Promotion of Science KAKENHI Grant 26291049 (to M. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Abascal F, 2013, BBA-BIOMEMBRANES, V1828, P4, DOI 10.1016/j.bbamem.2012.02.007; Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Bai DL, 2016, SEMIN CELL DEV BIOL, V50, P74, DOI 10.1016/j.semcdb.2015.11.015; Becker DL, 2016, SEMIN CELL DEV BIOL, V50, P49, DOI 10.1016/j.semcdb.2015.12.009; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Caetano-Lopes J, 2007, ACTA REUMATOL PORT, V32, P103; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Clement A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000136; Cooper KL, 2013, NATURE, V495, P375, DOI 10.1038/nature11940; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Duplomb L, 2007, STEM CELLS, V25, P544, DOI 10.1634/stemcells.2006-0395; Eastman SD, 2006, GENOMICS, V87, P265, DOI 10.1016/j.ygeno.2005.10.005; Furutani K, 2009, MOL PHARMACOL, V75, P1287, DOI 10.1124/mol.108.052936; Gluhak-Heinrich J, 2003, J BONE MINER RES, V18, P807, DOI 10.1359/jbmr.2003.18.5.807; Gray RS, 2014, DEV BIOL, V386, P72, DOI 10.1016/j.ydbio.2013.11.028; Haffter P, 1996, DEV GENES EVOL, V206, P260, DOI 10.1007/s004270050051; Haffter P, 1996, DEVELOPMENT, V123, P1; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hoptak-Solga AD, 2008, DEV BIOL, V317, P541, DOI 10.1016/j.ydbio.2008.02.051; Hoptak-Solga AD, 2007, FEBS LETT, V581, P3297, DOI 10.1016/j.febslet.2007.06.030; Huycke TR, 2012, DEVELOPMENT, V139, P2371, DOI 10.1242/dev.079806; Iovine MK, 2005, DEV BIOL, V278, P208, DOI 10.1016/j.ydbio.2004.11.005; Iovine MK, 2000, GENETICS, V155, P1321; Kimmel CB, 2001, DEV BIOL, V233, P239, DOI 10.1006/dbio.2001.0201; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Laird DW, 2014, FEBS LETT, V588, P1339, DOI 10.1016/j.febslet.2013.12.022; Merrifield PA, 2016, SEMIN CELL DEV BIOL, V50, P67, DOI 10.1016/j.semcdb.2015.12.001; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Perathoner S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004080; Piotrowski T, 1996, DEVELOPMENT, V123, P345; Pizzuti Antonio, 2004, Hum Mutat, V23, P286, DOI 10.1002/humu.9220; Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037; Schilling TF, 1996, DEVELOPMENT, V122, P1417; Schoenebeck JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002849; Sims K, 2009, DEV BIOL, V327, P410, DOI 10.1016/j.ydbio.2008.12.027; Suda K, 2004, J IMMUNOL, V172, P2504, DOI 10.4049/jimmunol.172.4.2504; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244	39	15	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12601	12611		10.1074/jbc.M116.720110	http://dx.doi.org/10.1074/jbc.M116.720110			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129238	hybrid, Green Published			2022-12-28	WOS:000378119900017
J	Donaubauer, EM; Hunzicker-Dunn, ME				Donaubauer, Elyse M.; Hunzicker-Dunn, Mary E.			Extracellular Signal-regulated Kinase (ERK)-dependent Phosphorylation of Y-Box-binding Protein 1 (YB-1) Enhances Gene Expression in Granulosa Cells in Response to Follicle-stimulating Hormone (FSH)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; RIBOSOMAL S6 KINASE; HISTONE H3 PHOSPHORYLATION; STEROIDOGENIC FACTOR-I; OVARIAN-CANCER CELLS; GLOBIN MESSENGER-RNA; COLD SHOCK DOMAIN; BREAST-CANCER; CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE; BETA-CATENIN	Within the ovarian follicle, immature oocytes are surrounded and supported by granulosa cells (GCs). Stimulation of GCs by FSH leads to their proliferation and differentiation, events that are necessary for fertility. FSH activates multiple signaling pathways to regulate genes necessary for follicular maturation. Herein, we investigated the role of Y-box-binding protein-1 (YB-1) within GCs. YB-1 is a nucleic acid binding protein that regulates transcription and translation. Our results show that FSH promotes an increase in the phosphorylation of YB-1 on Ser(102) within 15 min that is maintained at significantly increased levels until similar to 8 h post treatment. FSH-stimulated phosphorylation of YB-1(Ser(102)) is prevented by pretreatment of GCs with the PKA-selective inhibitor PKA inhibitor (PKI), the MEK inhibitor PD98059, or the ribosomal S6 kinase-2 (RSK-2) inhibitor BI-D1870. Thus, phosphorylation of YB-1 on Ser(102) is PKA-, ERK-, and RSK-2-dependent. However, pretreatment of GCs with the protein phosphatase 1 (PP1) inhibitor tautomycin increased phosphorylation of YB-1(Ser(102)) in the absence of FSH; FSH did not further increase YB-1(Ser(102)) phosphorylation. This result suggests that the major effect of RSK-2 is to inhibit PP1 rather than to directly phosphorylate YB-1 on Ser(102). YB-1 coimmunoprecipitated with PP1 beta catalytic subunit and RSK-2. Transduction of GCs with the dephospho-adenoviral-YB-1(S102A) mutant prevented the induction by FSH of Egfr, Cyp19a1, Inha, Lhcgr, Cyp11a1, Hsd17b1, and Pappa mRNAs and estradiol-17 beta production. Collectively, our results reveal that phosphorylation of YB-1 on Ser(102) via the ERK/RSK-2 signaling pathway is necessary for FSH-mediated expression of target genes required for maturation of follicles to a preovulatory phenotype.	[Donaubauer, Elyse M.; Hunzicker-Dunn, Mary E.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Hunzicker-Dunn, ME (corresponding author), Washington State Univ, Biotechnol Life Sci Bldg,Rm 202, Pullman, WA 99164 USA.	mehd@vetmed.wsu.edu			National Institutes of Health Grant [P50HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD028934, R01HD062053, R01HD065859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083864] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core, supported by National Institutes of Health Grant P50HD28934, for estradiol-17 beta RIAs. We thank Dr. Wenlong Bai, University of South Florida, Tampa, FL, for kindly providing the full-length human Egfr promoter-luciferase construct. We also thank Dr. John H. Nilson, Dr. Maria Herndon, and Nate Law for many helpful discussions.	Alam H, 2004, J BIOL CHEM, V279, P19431, DOI 10.1074/jbc.M401235200; Alam H, 2009, ENDOCRINOLOGY, V150, P915, DOI 10.1210/en.2008-0850; Andric N, 2006, MOL ENDOCRINOL, V20, P3308, DOI 10.1210/me.2006-0241; Bader AG, 2005, MOL CELL BIOL, V25, P2095, DOI 10.1128/MCB.25.6.2095-2106.2005; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Basaki Y, 2007, ONCOGENE, V26, P2736, DOI 10.1038/sj.onc.1210084; Bennett J, 2012, ENDOCRINOLOGY, V153, P2474, DOI 10.1210/en.2011-1969; BLOBEL G, 1972, BIOCHEM BIOPH RES CO, V47, P88, DOI 10.1016/S0006-291X(72)80014-7; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; BOUVET P, 1995, J BIOL CHEM, V270, P28297; Carlone DL, 1997, MOL ENDOCRINOL, V11, P292, DOI 10.1210/me.11.3.292; CARR DW, 1993, J BIOL CHEM, V268, P20729; Chatfield K, 2004, BIOCHEM BIOPH RES CO, V323, P1313, DOI 10.1016/j.bbrc.2004.09.003; Chen MJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18319; Chen SY, 1999, ENDOCRINOLOGY, V140, P2100, DOI 10.1210/en.140.5.2100; Coles LS, 2005, FEBS LETT, V579, P5372, DOI 10.1016/j.febslet.2005.08.075; Cottom J, 2003, J BIOL CHEM, V278, P7167, DOI 10.1074/jbc.M203901200; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Das S, 1996, ENDOCRINOLOGY, V137, P967, DOI 10.1210/en.137.3.967; DeManno DA, 1999, MOL ENDOCRINOL, V13, P91, DOI 10.1210/me.13.1.91; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; El-Hayek S, 2014, P NATL ACAD SCI USA, V111, P16778, DOI 10.1073/pnas.1414648111; El-Hefnawy T, 2001, ENDOCRINOLOGY, V142, P4357, DOI 10.1210/en.142.10.4357; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; ERICKSON GF, 1978, ENDOCRINOLOGY, V102, P1275, DOI 10.1210/endo-102-4-1275; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Finkbeiner MR, 2009, ONCOGENE, V28, P1421, DOI 10.1038/onc.2008.485; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Fukada T, 2003, EMBO J, V22, P479, DOI 10.1093/emboj/cdg067; GAY V L, 1970, Federation Proceedings, V29, P1880; Gessner C, 2004, EUR RESPIR J, V23, P14, DOI 10.1183/09031936.03.00033203; Gonzalez-Robayna IJ, 2000, MOL ENDOCRINOL, V14, P1283, DOI 10.1210/me.14.8.1283; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Hakkarainen J, 2015, FASEB J, V29, P3806, DOI 10.1096/fj.14-269035; Hsieh M, 2007, MOL CELL BIOL, V27, P1914, DOI 10.1128/MCB.01919-06; Hsieh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021574; HSUEH AJW, 1984, ENDOCR REV, V5, P76, DOI 10.1210/edrv-5-1-76; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Hunzicker-Dunn M., 2015, KNOBIL NEILLS PHYSL, V1, P1, DOI [10.1016/B978-012515400-0/50019-1, DOI 10.1016/B978-012515400-0/50019-1, 10.1016/b978-0-12-397175-3.00020-x]; Hunzicker-Dunn ME, 2012, P NATL ACAD SCI USA, V109, pE2979, DOI 10.1073/pnas.1205661109; HUNZICKERDUNN M, 1981, J BIOL CHEM, V256, P2185; Ito M, 2000, MOL ENDOCRINOL, V14, P66, DOI 10.1210/me.14.1.66; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; KEMP BE, 1988, METHOD ENZYMOL, V159, P173; Law NC, 2016, J BIOL CHEM, V291, P4547, DOI 10.1074/jbc.M115.698761; Law NC, 2013, MOL ENDOCRINOL, V27, P1295, DOI 10.1210/me.2013-1025; Liu XF, 2013, FEBS LETT, V587, P3995, DOI 10.1016/j.febslet.2013.10.036; Liu ZL, 2009, MOL ENDOCRINOL, V23, P649, DOI 10.1210/me.2008-0412; Miro F, 1996, ENDOCRINOLOGY, V137, P464, DOI 10.1210/en.137.2.464; MOREL C, 1971, FEBS LETT, V18, P84, DOI 10.1016/0014-5793(71)80413-1; Mukherjee A, 1996, ENDOCRINOLOGY, V137, P3234, DOI 10.1210/en.137.8.3234; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; Nyegaard M, 2010, BIOL REPROD, V82, P1129, DOI 10.1095/biolreprod.109.079517; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Otsuka F, 2002, P NATL ACAD SCI USA, V99, P8060, DOI 10.1073/pnas.122066899; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; PEI L, 1991, MOL ENDOCRINOL, V5, P521, DOI 10.1210/mend-5-4-521; Reipas KM, 2013, ONCOTARGET, V4, P329, DOI 10.18632/oncotarget.834; RICHARDS JS, 1995, RECENT PROG HORM RES, V50, P223; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Salvador LM, 2001, J BIOL CHEM, V276, P40146, DOI 10.1074/jbc.M106710200; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shen Z, 2011, MOL CELL ENDOCRINOL, V338, P58, DOI 10.1016/j.mce.2011.02.023; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; Stratford AL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1767; Stratford AL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2202; Sunters A, 2010, J BIOL CHEM, V285, P8743, DOI 10.1074/jbc.M109.027086; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; TAFURI SR, 1992, NEW BIOL, V4, P349; To K, 2007, MOL PHARMACOL, V72, P641, DOI 10.1124/mol.107.036111; Tremblay JJ, 2001, ENDOCRINOLOGY, V142, P977, DOI 10.1210/en.142.3.977; Tremblay JJ, 2003, J STEROID BIOCHEM, V85, P291, DOI 10.1016/S0960-0760(03)00211-5; TSAIMORRIS CH, 1995, J BIOL CHEM, V270, P7487, DOI 10.1074/jbc.270.13.7487; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Weck J, 2006, MOL ENDOCRINOL, V20, P1090, DOI 10.1210/me.2005-0199; Wu Joyce, 2007, Transl Oncogenomics, V2, P49; Wu J, 2006, CANCER RES, V66, P4872, DOI 10.1158/0008-5472.CAN-05-3561; Zeleznik AJ, 2003, ENDOCRINOLOGY, V144, P3985, DOI 10.1210/en.2003-0293; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172	84	29	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12145	12160		10.1074/jbc.M115.705368	http://dx.doi.org/10.1074/jbc.M115.705368			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27080258	Green Published, hybrid			2022-12-28	WOS:000378092800017
J	Tesikova, M; Dezitter, X; Nenseth, HZ; Klokk, TI; Mueller, F; Hager, GL; Saatcioglu, F				Tesikova, Martina; Dezitter, Xavier; Nenseth, Hatice Z.; Klokk, Tove I.; Mueller, Florian; Hager, Gordon L.; Saatcioglu, Fahri			Divergent Binding and Transactivation by Two Related Steroid Receptors at the Same Response Element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-SPECIFIC DYNAMICS; TUMOR VIRUS PROMOTER; RNA-POLYMERASE-II; ANDROGEN RECEPTOR; GLUCOCORTICOID-RECEPTOR; LIVING CELLS; HISTONE DEACETYLASES; GENE-EXPRESSION; PROSTATE-CANCER; TRANSCRIPTION	Transcription factor (TF) recruitment to chromatin is central to activation of transcription. TF-chromatin interactions are highly dynamic, which are evaluated by recovery half time (t(1/2)) in seconds, determined by fluorescence recovery experiments in living cells, and chromatin immunoprecipitation (ChIP) analysis, measured in minutes. These two states are related: the larger the t(1/2), the longer the ChIP occupancy resulting in increased transcription. Here we present data showing that this relationship does not always hold. We found that histone deacetylase inhibitors (HDACis) significantly increased t(1/2) of green fluorescent protein (GFP) fused androgen receptor (AR) on a tandem array of positive hormone response elements (HREs) in chromatin. This resulted in increased ChIP signal of GFP-AR. Unexpectedly, however, transcription was inhibited. In contrast, the GFP-fused glucocorticoid receptor (GR), acting through the same HREs, displayed a profile consistent with current models. We provide evidence that these differences are mediated, at least in part, by HDACs. Our results provide insight into TF action in living cells and show that very closely related TFs may trigger significantly divergent outcomes at the same REs.	[Tesikova, Martina; Dezitter, Xavier; Nenseth, Hatice Z.; Klokk, Tove I.; Saatcioglu, Fahri] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Mueller, Florian] Inst Pasteur, Computat Imaging & Modeling Unit, F-75015 Paris, France; [Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA; [Saatcioglu, Fahri] Oslo Univ Hosp, Inst Canc Genet & Informat, Div Canc & Surg, N-0310 Oslo, Norway; [Dezitter, Xavier] Univ Lille Nord France, UDSL, ICPAL, Plateforme Binding, F-59000 Lille, France; [Klokk, Tove I.] Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, Ctr Canc Biomed, N-0310 Oslo, Norway	University of Oslo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oslo; Universite de Lille - ISITE; Universite de Lille; University of Oslo	Saatcioglu, F (corresponding author), Univ Oslo, Dept Biosci, N-0316 Oslo, Norway.; Saatcioglu, F (corresponding author), Oslo Univ Hosp, Inst Canc Genet & Informat, Div Canc & Surg, N-0310 Oslo, Norway.	fahris@ibv.uio.no	Dezitter, Xavier/H-6923-2018; Mueller, Florian/C-9075-2012	Dezitter, Xavier/0000-0001-6932-6947; Mueller, Florian/0000-0002-9622-4396; Saatcioglu, Fahri/0000-0002-5366-4391; Nenseth, Hatice Zeynep/0000-0002-8385-3476	Norwegian Research Council [191733]; Norwegian Cancer Society [PR-2006-0335]; NATIONAL CANCER INSTITUTE [ZIABC005450] Funding Source: NIH RePORTER	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Norwegian Research Council (191733, to F. S.) and Norwegian Cancer Society (PR-2006-0335, to F. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; BRESNICK EH, 1990, P NATL ACAD SCI USA, V87, P3977, DOI 10.1073/pnas.87.10.3977; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Coffey K, 2013, NUCLEIC ACIDS RES, V41, P4433, DOI 10.1093/nar/gkt106; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Elbi C, 2004, P NATL ACAD SCI USA, V101, P2876, DOI 10.1073/pnas.0400116101; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Faus H, 2008, J CELL BIOCHEM, V104, P511, DOI 10.1002/jcb.21640; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gaughan L, 2011, NUCLEIC ACIDS RES, V39, P1266, DOI 10.1093/nar/gkq861; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; Korkmaz CG, 2004, J ENDOCRINOL, V182, P377, DOI 10.1677/joe.0.1820377; Lavery DN, 2011, J BIOL CHEM, V286, P17796, DOI 10.1074/jbc.M110.198655; LEFEBVRE P, 1991, MOL CELL BIOL, V11, P2529, DOI 10.1128/MCB.11.5.2529; List HJ, 1999, EXP CELL RES, V252, P471, DOI 10.1006/excr.1999.4638; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nenseth HZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105204; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Qiu Y, 2011, J BIOL CHEM, V286, P7641, DOI 10.1074/jbc.M110.185488; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Seo WY, 2013, NUCLEIC ACIDS RES, V41, P8526, DOI 10.1093/nar/gkt644; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; Smith CL, 2008, BIOESSAYS, V30, P15, DOI 10.1002/bies.20687; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Walker D, 1999, METHODS, V19, P386, DOI 10.1006/meth.1999.0874; Welsbie DS, 2009, CANCER RES, V69, P958, DOI 10.1158/0008-5472.CAN-08-2216; Yang Y, 2011, ONCOGENE, V30, P2207, DOI 10.1038/onc.2010.600	36	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11899	11910		10.1074/jbc.M115.684480	http://dx.doi.org/10.1074/jbc.M115.684480			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27056330	Green Published, hybrid			2022-12-28	WOS:000377264800038
J	Zhang, F; Yu, JW; Yang, T; Xu, D; Chi, ZX; Xia, YH; Xu, ZH				Zhang, Feng; Yu, Jingwen; Yang, Tao; Xu, Dan; Chi, Zhixia; Xia, Yanheng; Xu, Zhiheng			A Novel c-Jun N-terminal Kinase (JNK) Signaling Complex Involved in Neuronal Migration during Brain Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING CEREBRAL-CORTEX; DEVELOPING NEOCORTEX; CELL-MIGRATION; IN-VIVO; KAPPA-B; PROTEIN; ACTIVATION; PATHWAYS; WDR62; POSH	Disturbance of neuronal migration may cause various neurological disorders. Both the transforming growth factor-beta (TGF-beta) signaling and microcephaly-associated protein WDR62 are important for neuronal migration during brain development; however, the underlying molecular mechanisms involved remain unclear. We show here that knock-out or knockdown of Tak1 (TGF beta-activated kinase 1) and Jnk2 (c-Jun N-terminal kinase 2) perturbs neuronal migration during cortical development and that the migration defects incurred by knock-out and/or knockdown of T beta r2 (type II TGF-beta receptor) or Tak1 can be partially rescued by expression of TAK1 and JNK2, respectively. Furthermore, TAK1 forms a protein complex with RAC1 and two scaffold proteins of the JNK pathway, the microcephaly-associated protein WDR62 and the RAC1-interacting protein POSH (plenty of Src homology). Components of the complex coordinate with each other in the regulation of TAK1 as well as JNK activities. We suggest that unique JNK protein complexes are involved in the diversified biological and pathological functions during brain development and pathogenesis of diseases.	[Zhang, Feng; Yu, Jingwen; Yang, Tao; Xu, Dan; Chi, Zhixia; Xia, Yanheng; Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China; [Xu, Zhiheng] Tongji Univ, Sch Med, Shanghai East Hosp, Translat Med Ctr Stem Cell Therapy, Shanghai 200120, Peoples R China; [Zhang, Feng; Xia, Yanheng] Univ Chinese Acad Sci, Beijing 100101, Peoples R China; [Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Tongji University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, ZH (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.	zhxu@genetics.ac.cn	Yang, T/AFR-6763-2022	Xu, Zhiheng/0000-0002-4809-2851; Zhang, Feng/0000-0003-2887-8184	National Natural Science Foundation (China) [31430037, 31271156, 31270826, 31470845]; "973" program of the Ministry of Science and Technology (China) [2014CB942801, 2012CB517904, 2013DFA31990, 2012YQ03026006]	National Natural Science Foundation (China)(National Natural Science Foundation of China (NSFC)); "973" program of the Ministry of Science and Technology (China)	This work was supported by National Natural Science Foundation (China) Grants 31430037/31271156/31270826/31470845 and the "973" program of the Ministry of Science and Technology (China) Grants 2014CB942801/2012CB517904/2013DFA31990/2012YQ03026006). The authors declare that they have no conflicts of interest with the contents of this article.	Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Chen L, 2007, J NEUROSCI, V27, P3884, DOI 10.1523/JNEUROSCI.3509-06.2007; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Govek EE, 2011, DEV NEUROBIOL, V71, P528, DOI 10.1002/dneu.20850; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hirai S, 2006, J NEUROSCI, V26, P11992, DOI 10.1523/JNEUROSCI.2272-06.2006; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kawauchi T, 2008, DEV NEUROSCI-BASEL, V30, P36, DOI 10.1159/000109850; Konno D, 2005, J BIOL CHEM, V280, P5082, DOI 10.1074/jbc.M408251200; Kriegstein AR, 2005, EPILEPSIA, V46, P15, DOI 10.1111/j.1528-1167.2005.00304.x; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kukekov NV, 2006, J BIOL CHEM, V281, P15517, DOI 10.1074/jbc.M601056200; Mao RF, 2011, CELL SIGNAL, V23, P222, DOI 10.1016/j.cellsig.2010.09.006; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; Sarkisian MR, 2006, NEURON, V52, P789, DOI 10.1016/j.neuron.2006.10.024; Tan X, 2013, WIRES DEV BIOL, V2, P443, DOI 10.1002/wdev.88; Tapon N, 1998, EMBO J, V17, P1395, DOI 10.1093/emboj/17.5.1395; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Wang X, 2007, MOL CELL BIOL, V27, P7935, DOI 10.1128/MCB.00226-07; Westerlund N, 2011, NAT NEUROSCI, V14, P305, DOI 10.1038/nn.2755; Xu D, 2014, CELL REP, V6, P104, DOI 10.1016/j.celrep.2013.12.016; Xu ZH, 2005, MOL CELL BIOL, V25, P9949, DOI 10.1128/MCB.25.22.9949-9959.2005; Xu ZH, 2003, EMBO J, V22, P252, DOI 10.1093/emboj/cdg021; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001; Yamasaki T, 2011, J NEUROSCI, V31, P16872, DOI 10.1523/JNEUROSCI.1111-11.2011; Yang T, 2012, CELL REP, V2, P640, DOI 10.1016/j.celrep.2012.08.007; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yu JW, 2014, J MOL CELL BIOL, V6, P349, DOI 10.1093/jmcb/mju030; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683; Zhang F., 2014, INT J DISTRIB SENS N, V2014, P1, DOI DOI 10.3969/J.ISSN.1000-2324.2014.02.01	36	27	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11466	11475		10.1074/jbc.M116.716811	http://dx.doi.org/10.1074/jbc.M116.716811			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27026702	Green Published, hybrid			2022-12-28	WOS:000377264800001
J	Yang, Q; Wang, LX				Yang, Qiang; Wang, Lai-Xi			Mammalian-1,6-Fucosyltransferase (FUT8) Is the Sole Enzyme Responsible for the N-Acetylglucosaminyltransferase I-independent Core Fucosylation of High-mannose N-Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						erythropoietin; fucosyltransferase; glycoprotein; glycoprotein biosynthesis; glycosylation	PERFORMANCE LIQUID-CHROMATOGRAPHY; CHEMOENZYMATIC SYNTHESIS; GLYCOPROTEIN-SYNTHESIS; HEPATOMA-CELLS; RAT-LIVER; L-FUCOSE; OLIGOSACCHARIDES; GLYCOSYLATION; TRANSFERASE; ERYTHROPOIETIN	Understanding the biosynthetic pathway of protein glycosylation in various expression cell lines is important for controlling and modulating the glycosylation profiles of recombinant glycoproteins. We found that expression of erythropoietin (EPO) in a HEK293S N-acetylglucosaminyltransferase I (GnT I)(-/-) cell line resulted in production of the Man(5)GlcNAc(2) glycoforms, in which more than 50% were core-fucosylated, implicating a clear GnT I-independent core fucosylation pathway. Expression of GM-CSF and the ectodomain of FcIIIA receptor led to approximate to 30% and 3% core fucosylation, suggesting that the level of core fucosylation also depends on the nature of the recombinant proteins. To elucidate the GnT I-independent core fucosylation pathway, we generated a stable HEK293S GnT I-/- cell line with either knockdown or overexpression of FUT8 by a highly efficient lentivirus-mediated gene transfer approach. We found that the EPO produced from the FUT8 knockdown cell line was the pure Man(5)GlcNAc(2) glycoform, whereas that produced from the FUT8-overexpressing cell line was found to be fully core-fucosylated oligomannose glycan (Man(5)GlcNAc(2)Fuc). These results provide direct evidence that FUT8, the mammalian 1,6-fucosyltransferase, is the sole enzyme responsible for the GnT I-independent core fucosylation pathway. The production of the homogeneous core-fucosylated Man(5)GlcNAc(2) glycoform of EPO in the FUT8-overexpressed HEK293S GnT I-/- cell line represents the first example of production of fully core-fucosylated high-mannose glycoforms.	[Yang, Qiang; Wang, Lai-Xi] Univ Maryland, Dept Chem & Biochem, 8051 Regents Dr,3500 Chem Bldg, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Wang, LX (corresponding author), Univ Maryland, Dept Chem & Biochem, 8051 Regents Dr,3500 Chem Bldg, College Pk, MD 20742 USA.	wang518@umd.edu	wang, xl/Y-8251-2019; wang, xiao/HGB-7081-2022; Wang, Lai-Xi/E-8790-2019; Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022; Wang, Lai-Xi/E-8755-2019	wang, xiao/0000-0002-4088-3341; Wang, Lai-Xi/0000-0003-4293-5819; Wang, Xin/0000-0002-4457-7376; 	National Institutes of Health [R01 GM080374]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM080374. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Crispin M, 2006, GLYCOBIOLOGY, V16, P748, DOI 10.1093/glycob/cwj119; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; DELORME E, 1992, BIOCHEMISTRY-US, V31, P9871, DOI 10.1021/bi00156a003; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Endo T, 1996, EUR J BIOCHEM, V236, P579, DOI 10.1111/j.1432-1033.1996.t01-1-00579.x; Faid V, 2006, GLYCOBIOLOGY, V16, P440, DOI 10.1093/glycob/cwj081; Hacker DL, 2013, PROTEIN EXPRES PURIF, V92, P67, DOI 10.1016/j.pep.2013.09.001; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HOWARD DR, 1982, J BIOL CHEM, V257, P861; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Juliant S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110422; Kamoda S, 2005, J PROTEOME RES, V4, P146, DOI 10.1021/pr049825o; Kittur FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076468; Li L, 2015, CHEM SCI, V6, P5652, DOI 10.1039/c5sc02025e; LIN AI, 1994, GLYCOBIOLOGY, V4, P895, DOI 10.1093/glycob/4.6.895; LONGMORE GD, 1982, CARBOHYD RES, V100, P365, DOI 10.1016/S0008-6215(00)81049-6; Miyoshi E, 1999, CANCER RES, V59, P2237; Oberbek A, 2011, BIOTECHNOL BIOENG, V108, P600, DOI 10.1002/bit.22968; Ohta M, 2001, J CHROMATOGR A, V910, P1, DOI 10.1016/S0021-9673(00)01116-X; Osumi D, 2009, CANCER SCI, V100, P888, DOI 10.1111/j.1349-7006.2009.01125.x; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rodriguez-Diaz J, 2011, APPL ENVIRON MICROB, V77, P703, DOI 10.1128/AEM.01906-10; SCHACHTER H, 1983, CAN J BIOCHEM CELL B, V61, P1049, DOI 10.1139/o83-134; SHAO MC, 1994, CARBOHYD RES, V251, P163, DOI 10.1016/0008-6215(94)84283-3; TAKAHASHI T, 1983, J BIOL CHEM, V258, P2819; VOYNOW JA, 1991, J BIOL CHEM, V266, P21572; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang LX, 2014, CHEM BIOL, V21, P51, DOI 10.1016/j.chembiol.2014.01.001; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; WILSON JR, 1976, BIOCHEM BIOPH RES CO, V72, P909, DOI 10.1016/S0006-291X(76)80218-5	32	33	34	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11064	11071		10.1074/jbc.M116.720789	http://dx.doi.org/10.1074/jbc.M116.720789			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27008861	Green Published, hybrid			2022-12-28	WOS:000377042100010
J	Zou, HY; Wu, Y; Brew, K				Zou, Haiyin; Wu, Ying; Brew, Keith			Thermodynamic Basis of Selectivity in the Interactions of Tissue Inhibitors of Metalloproteinases N-domains with Matrix Metalloproteinases-1,-3, and-14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calorimetry; conformational change; enzyme inhibitor; matrix metalloproteinase (MMP); protein dynamic; protein engineering; protein-protein interaction; thermodynamics; tissue inhibitor of metalloproteinase (TIMP); zinc	CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; TERMINAL DOMAIN; HEAT-CAPACITY; BINDING; TIMP-1; ENTROPY; SITE; FLEXIBILITY; COMPLEX	The four tissue inhibitors of metalloproteinases (TIMPs) are potent inhibitors of the many matrixins (MMPs), except that TIMP1 weakly inhibits some MMPs, including MMP14. The broad-spectrum inhibition of MMPs by TIMPs and their N-domains (NTIMPs) is consistent with the previous isothermal titration calorimetric finding that their interactions are entropy-driven but differ in contributions from solvent and conformational entropy (S-solv, S-conf), estimated using heat capacity changes (C-p). Selective engineered NTIMPs have potential applications for treating MMP-related diseases, including cancer and cardiomyopathy. Here we report isothermal titration calorimetric studies of the effects of selectivity-modifying mutations in NTIMP1 and NTIMP2 on the thermodynamics of their interactions with MMP1, MMP3, and MMP14. The weak inhibition of MMP14 by NTIMP1 reflects a large conformational entropy penalty for binding. The T98L mutation, peripheral to the NTIMP1 reactive site, enhances binding by increasing S-solv but also reduces S-conf. However, the same mutation increases NTIMP1 binding to MMP3 in an interaction that has an unusual positive C-p. This indicates a decrease in solvent entropy compensated by increased conformational entropy, possibly reflecting interactions involving alternative conformers. The NTIMP2 mutant, S2D/S4A is a selective MMP1 inhibitor through electrostatic effects of a unique MMP-1 arginine. Asp-2 increases reactive site polarity, reducing C-p, but increases conformational entropy to maintain strong binding to MMP1. There is a strong negative correlation between S-solv and S-conf for all characterized interactions, but the data for each MMP have characteristic ranges, reflecting intrinsic differences in the structures and dynamics of their free and inhibitor-bound forms.	[Zou, Haiyin; Wu, Ying; Brew, Keith] Florida Atlantic Univ, Dept Biomed Sci, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA; [Wu, Ying] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Wu, Ying] Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA	State University System of Florida; Florida Atlantic University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brew, K (corresponding author), Florida Atlantic Univ, Dept Biomed Sci, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA.	kbrew@fau.edu	Brew, Keith/W-1643-2019	Brew, Keith/0000-0003-1306-1032	National Institutes of Health [RO1 AR40994]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant RO1 AR40994. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arumugam S, 2003, J MOL BIOL, V327, P719, DOI 10.1016/S0022-2836(03)00180-3; Arumugam S, 1998, BIOCHEMISTRY-US, V37, P9650, DOI 10.1021/bi980128h; Bahudhanapati H, 2011, J BIOL CHEM, V286, P31761, DOI 10.1074/jbc.M111.253328; Baker BM, 1998, METHOD ENZYMOL, V295, P294; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Batra J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075836; Batra J, 2012, J BIOL CHEM, V287, P15935, DOI 10.1074/jbc.M112.341156; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Chang CEA, 2008, P NATL ACAD SCI USA, V105, P7456, DOI 10.1073/pnas.0800452105; Chen LY, 1999, J MOL BIOL, V293, P545, DOI 10.1006/jmbi.1999.3147; EFTINK MR, 1983, BIOCHEMISTRY-US, V22, P3884, DOI 10.1021/bi00285a025; Erijman A, 2011, BIOCHEMISTRY-US, V50, P602, DOI 10.1021/bi101563v; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Grossman M, 2010, BIOCHEMISTRY-US, V49, P6184, DOI 10.1021/bi902141x; Grunberg R, 2006, STRUCTURE, V14, P683, DOI 10.1016/j.str.2006.01.014; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; Higashi S, 1999, J BIOL CHEM, V274, P10497, DOI 10.1074/jbc.274.15.10497; Huang W, 1996, FEBS LETT, V384, P155, DOI 10.1016/0014-5793(96)00304-3; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Kumar S, 2000, PROTEIN SCI, V9, P10; Lee MH, 2004, J BIOL CHEM, V279, P17562, DOI 10.1074/jbc.M312589200; Liang XY, 2010, BIOPHYS J, V99, P273, DOI 10.1016/j.bpj.2010.04.002; Lim NH, 2010, BIOCHEM J, V431, P113, DOI 10.1042/BJ20100725; Maskos K, 2007, J MOL BIOL, V366, P1222, DOI 10.1016/j.jmb.2006.11.072; Meng Q, 1999, J BIOL CHEM, V274, P10184, DOI 10.1074/jbc.274.15.10184; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Negi SS, 2007, BIOINFORMATICS, V23, P3397, DOI 10.1093/bioinformatics/btm474; Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043; Palde PB, 2015, P NATL ACAD SCI USA, V112, P7960, DOI 10.1073/pnas.1504376112; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Van Doren SR, 2008, BIOPOLYMERS, V89, P960, DOI 10.1002/bip.21043; Velazquez Campoy A., 2005, BIOPHYS CHEM, V115, P115, DOI DOI 10.1016/J.BPC.2004.12.015; Wei S, 2005, J BIOL CHEM, V280, P32877, DOI 10.1074/jbc.C500220200; Wei S, 2003, J BIOL CHEM, V278, P9831, DOI 10.1074/jbc.M211793200; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; Williamson RA, 1999, J BIOL CHEM, V274, P37226, DOI 10.1074/jbc.274.52.37226; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088; Wu B, 2000, J MOL BIOL, V295, P257, DOI 10.1006/jmbi.1999.3362; Wu Y, 2011, J BIOL CHEM, V286, P16891, DOI 10.1074/jbc.M111.222307	45	7	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11348	11358		10.1074/jbc.M116.720250	http://dx.doi.org/10.1074/jbc.M116.720250			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27033700	hybrid, Green Published			2022-12-28	WOS:000377042100033
J	Babinsky, VN; Hannan, FM; Gorvin, CM; Howles, SA; Nesbit, MA; Rust, N; Hanyaloglu, AC; Hu, JX; Spiegel, AM; Thakker, RV				Babinsky, Valerie N.; Hannan, Fadil M.; Gorvin, Caroline M.; Howles, Sarah A.; Nesbit, M. Andrew; Rust, Nigel; Hanyaloglu, Aylin C.; Hu, Jianxin; Spiegel, Allen M.; Thakker, Rajesh V.			Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein alpha-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; ACTIVATING MUTATIONS; MUTANT RECEPTORS; CINACALCET; DOMAIN; CELLS; HYPOPARATHYROIDISM; IDENTIFICATION; TRANSDUCTION; KIDNEY	Germline loss- and gain-of-function mutations of G-protein alpha-11 (G alpha(11)), which couples the calcium-sensing receptor (CaSR) to intracellular calcium (Ca-i(2+)) signaling, lead to familial hypocalciuric hypercalcemia type 2 (FHH2) and autosomal dominant hypocalcemia type 2 (ADH2), respectively, whereas somatic Gall mutations mediate uveal melanoma development by constitutively up-regulating MAPK signaling. Cinacalcet and NPS-2143 are allosteric CaSR activators and inactivators, respectively, that ameliorate signaling disturbances associated with CaSR mutations, but their potential to modulate abnormalities of the downstream Gall protein is unknown. This study investigated whether cinacalcet and NPS-2143 may rectify Ca-i(2+) alterations associated with FHH2- and ADH2-causing Got, mutations, and evaluated the influence of germline gain of-function Gall mutations on MAPK signaling by measuring ERK phosphorylation, and assessed the effect of NPS-2143 on a uveal melanoma Gall mutant. WT and mutant G alpha(11) proteins causing FHH2, ADH2 or uveal melanoma were transfected in CaSR-expressing HEK293 cells, and Ca-i(2+) and ERK phosphorylation responses measured by flow-cytometry and Alphascreen immunoassay following exposure to extracellular Ca2+ (Ca-0(2+)) and allosteric modulators. Cinacalcet and NPS-2143 rectified the Ca-i(2+) responses of FHH2- and ADH2-associated G alpha(11) loss and gain-of-function mutations, respectively. ADH2-causing	[Babinsky, Valerie N.; Hannan, Fadil M.; Gorvin, Caroline M.; Howles, Sarah A.; Nesbit, M. Andrew; Thakker, Rajesh V.] Univ Oxford, Radcliffe Dept Med, S Parks Rd, Oxford OX3 7LJ, England; [Hannan, Fadil M.] Univ Liverpool, Dept Musculoskeletal Biol, Liverpool L69 3GA, Merseyside, England; [Nesbit, M. Andrew] Univ Ulster, Biomed Sci Res Inst, Coleraine BT52 1SA, Londonderry, North Ireland; [Rust, Nigel] Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England; [Hanyaloglu, Aylin C.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Inst Reprod Biol & Dev, London W12 0NN, England; [Hu, Jianxin] NIDDK, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Spiegel, Allen M.] Albert Einstein Coll Med, Bronx, NY 10461 USA	University of Oxford; University of Liverpool; Ulster University; University of Oxford; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Yeshiva University; Albert Einstein College of Medicine	Thakker, RV (corresponding author), Churchill Hosp, Acad Endocrine Unit, Radcliffe Dept Med, OCDEM, Oxford OX3 7LJ, England.	rajesh.thakker@ndm.ox.ac.uk	Gorvin, Caroline/T-2406-2019	Gorvin, Caroline/0000-0002-1361-9174; Thakker, Rajesh/0000-0002-1438-3220; Hannan, Fadil/0000-0002-2975-5170; /0000-0003-4206-737X; Howles, Sarah/0000-0001-6342-0895	United Kingdom Medical Research Council (MRC) [G9825289, G1000467]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme; European Commission [FP7-264663]; Medical Research Council [G1000467, MR/K006312/1, G9825289] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10091, CL-2015-13-005] Funding Source: researchfish; Wellcome Trust [106995/Z/15/Z] Funding Source: researchfish; MRC [MR/K006312/1, G1000467, G9825289] Funding Source: UKRI	United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the United Kingdom Medical Research Council (MRC) Programme Grants G9825289 and G1000467 (to M. A. N., F. M. H., C. M. G., and R. V. T), and National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme (to M. A. N. and R. V. T.); European Commission Seventh Framework Programme (FP7-264663) (to V. N. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or NIHR (UK).	Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Breitwieser GE, 2001, AM J PHYSIOL-CELL PH, V280, pC1412, DOI 10.1152/ajpcell.2001.280.6.C1412; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Davey AE, 2012, ENDOCRINOLOGY, V153, P1232, DOI 10.1210/en.2011-1426; Dong BZ, 2015, J BONE MINER RES, V30, P1980, DOI 10.1002/jbmr.2551; Fang Y, 1999, METHOD ENZYMOL, V302, P207, DOI 10.1016/S0076-6879(99)02020-0; Festen-Spanjer B, 2008, CLIN ENDOCRINOL, V68, P324, DOI 10.1111/j.1365-2265.2007.03027.x; Gannon AW, 2014, J CLIN ENDOCR METAB, V99, P7, DOI 10.1210/jc.2013-2834; Gowen M, 2000, J CLIN INVEST, V105, P1595, DOI 10.1172/JCI9038; Hannan FM, 2015, HUM MOL GENET, V24, P5079, DOI 10.1093/hmg/ddv226; Hannan FM, 2015, ENDOCRINOLOGY, V156, P3114, DOI 10.1210/en.2015-1269; Hannan FM, 2013, BEST PRACT RES CL EN, V27, P359, DOI 10.1016/j.beem.2013.04.007; Hannan FM, 2012, HUM MOL GENET, V21, P2768, DOI 10.1093/hmg/dds105; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hu JX, 2005, J BIOL CHEM, V280, P5113, DOI 10.1074/jbc.M413403200; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Leach K, 2013, ENDOCRINOLOGY, V154, P1105, DOI 10.1210/en.2012-1887; Leach K, 2012, ENDOCRINOLOGY, V153, P4304, DOI 10.1210/en.2012-1449; Letz S, 2010, J CLIN ENDOCR METAB, V95, pE229, DOI 10.1210/jc.2010-0651; Li D, 2014, J CLIN ENDOCR METAB, V99, pE1774, DOI 10.1210/jc.2014-1029; Mannstadt M, 2013, NEW ENGL J MED, V368, P2532, DOI 10.1056/NEJMc1300278; Miedlich SU, 2004, J BIOL CHEM, V279, P7254, DOI 10.1074/jbc.M307191200; Nemeth EF, 2004, J PHARMACOL EXP THER, V308, P627, DOI 10.1124/jpet.103.057273; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; Nesbit MA, 2013, NAT GENET, V45, P93, DOI 10.1038/ng.2492; Newey PJ, 2013, NEW ENGL J MED, V369, P2012, DOI 10.1056/NEJMoa1307557; Pearce SHS, 1996, J CLIN INVEST, V98, P1860, DOI 10.1172/JCI118987; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; Radhika V, 2001, ONCOGENE, V20, P1607, DOI 10.1038/sj.onc.1204274; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Riccardi D, 2010, AM J PHYSIOL-RENAL, V298, pF485, DOI 10.1152/ajprenal.00608.2009; Rus R, 2008, J CLIN ENDOCR METAB, V93, P4797, DOI 10.1210/jc.2008-1076; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; WU DQ, 1992, J BIOL CHEM, V267, P1811	35	27	29	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10876	10885		10.1074/jbc.M115.696401	http://dx.doi.org/10.1074/jbc.M115.696401			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26994139	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000377042600037
J	Cuevas-Velazquez, CL; Saab-Rincon, G; Reyes, JL; Covarrubias, AA				Cuevas-Velazquez, Cesar L.; Saab-Rincon, Gloria; Luis Reyes, Jose; Covarrubias, Alejandra A.			The Unstructured N-terminal Region of Arabidopsis Group 4 Late Embryogenesis Abundant (LEA) Proteins Is Required for Folding and for Chaperone-like Activity under Water Deficit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY DISORDERED PROTEINS; IN-VITRO; SECONDARY STRUCTURE; CIRCULAR-DICHROISM; FORMING PROPERTIES; ESCHERICHIA-COLI; EXCLUDED-VOLUME; BINDING; PEPTIDES; THALIANA	Late embryogenesis abundant (LEA) proteins are a conserved group of proteins widely distributed in the plant kingdom that participate in the tolerance to water deficit of different plant species. In silico analyses indicate that most LEA proteins are structurally disordered. The structural plasticity of these proteins opens the question of whether water deficit modulates their conformation and whether these possible changes are related to their function. In this work, we characterized the secondary structure of Arabidopsis group 4 LEA proteins. We found that they are disordered in aqueous solution, with high intrinsic potential to fold into alpha-helix. We demonstrate that complete dehydration is not required for these proteins to sample ordered structures because milder water deficit and macromolecular crowding induce high alpha-helix levels in vitro, suggesting that prevalent conditions under water deficit modulate their conformation. We also show that the N-terminal region, conserved across all group 4 LEA proteins, is necessary and sufficient for conformational transitions and that their protective function is confined to this region, suggesting that folding into alpha-helix is required for chaperone-like activity under water limitation. We propose that these proteins can exist as different conformers, favoring functional diversity, a moonlighting property arising from their structural dynamics.	[Cuevas-Velazquez, Cesar L.; Luis Reyes, Jose; Covarrubias, Alejandra A.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Biol Mol Plantas, Cuernavaca 62250, Morelos, Mexico; [Saab-Rincon, Gloria] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62250, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Covarrubias, AA (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Biol Mol Plantas, Cuernavaca 62250, Morelos, Mexico.	crobles@ibt.unam.mx	Saab-RIncon, Gloria/AFO-4892-2022	Saab-RIncon, Gloria/0000-0002-5251-1000; Cuevas-Velazquez, Cesar/0000-0002-6629-6444	Direccion General de Apoyo al Personal Academico/Programa de Apoyo a Proyectos de Investigation e Innovation Tecnologica PAPIIT, Universidad Nacional Autonoma de Mexico [IN208212]; Consejo Nacional de Ciencia y Tecnologia [132258, 221448]; Consejo Nacional de Ciencia y Tecnologia doctoral fellowship	Direccion General de Apoyo al Personal Academico/Programa de Apoyo a Proyectos de Investigation e Innovation Tecnologica PAPIIT, Universidad Nacional Autonoma de Mexico; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia doctoral fellowship	This work was partially supported by Grants IN208212 from the Direccion General de Apoyo al Personal Academico/Programa de Apoyo a Proyectos de Investigation e Innovation Tecnologica PAPIIT, Universidad Nacional Autonoma de Mexico and Grants 132258 and 221448 from the Consejo Nacional de Ciencia y Tecnologia. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Consejo Nacional de Ciencia y Tecnologia doctoral fellowship.	Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Borcherds W, 2014, NAT CHEM BIOL, V10, P1000, DOI 10.1038/nchembio.1668; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Campos F, 2006, BIOCHEM BIOPH RES CO, V342, P406, DOI 10.1016/j.bbrc.2006.01.151; Campos F, 2011, PROTEIN EXPRES PURIF, V80, P47, DOI 10.1016/j.pep.2011.06.007; Cheng JL, 2005, DATA MIN KNOWL DISC, V11, P213, DOI 10.1007/s10618-005-0001-y; Cino EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049876; Cuevas-Velazquez CL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00583; Dang NX, 2014, PLANTA, V240, P325, DOI 10.1007/s00425-014-2089-z; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Garay-Arroyo A, 2000, J BIOL CHEM, V275, P5668, DOI 10.1074/jbc.275.8.5668; Goyal K, 2003, J BIOL CHEM, V278, P12977, DOI 10.1074/jbc.M212007200; Haaning S, 2008, J BIOL CHEM, V283, P31142, DOI 10.1074/jbc.M805024200; Hughes S, 2011, PROTEIN SCI, V20, P42, DOI 10.1002/pro.534; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Hundertmark M, 2012, BIOCHEM BIOPH RES CO, V417, P122, DOI 10.1016/j.bbrc.2011.11.067; Hundertmark M, 2011, BBA-BIOMEMBRANES, V1808, P446, DOI 10.1016/j.bbamem.2010.09.010; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Lee SH, 2012, CURR PROTEIN PEPT SC, V13, P34, DOI 10.2174/138920312799277974; Liu GB, 2011, PLANT CELL PHYSIOL, V52, P994, DOI 10.1093/pcp/pcr052; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; MCCUBBIN WD, 1985, CAN J BIOCHEM CELL B, V63, P803, DOI 10.1139/o85-102; Minton AP, 1997, CURR OPIN BIOTECH, V8, P65, DOI 10.1016/S0958-1669(97)80159-0; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Mouillon JM, 2006, PLANT PHYSIOL, V141, P638, DOI 10.1104/pp.106.079848; Mouillon JM, 2008, PLANT PHYSIOL, V148, P1925, DOI 10.1104/pp.108.124099; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Olvera-Carrillo Y, 2011, PLANT SIGNAL BEHAV, V6, P586, DOI 10.4161/psb.6.4.15042; Olvera-Carrillo Y, 2010, PLANT PHYSIOL, V154, P373, DOI 10.1104/pp.110.158964; Popova AV, 2011, BBA-BIOMEMBRANES, V1808, P1879, DOI 10.1016/j.bbamem.2011.03.009; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Reichmann D, 2012, CELL, V148, P947, DOI 10.1016/j.cell.2012.01.045; Reyes JL, 2005, PLANT CELL ENVIRON, V28, P709, DOI 10.1111/j.1365-3040.2005.01317.x; Reyes JL, 2008, PLANT CELL ENVIRON, V31, P1781, DOI 10.1111/j.1365-3040.2008.01879.x; Rivera-Najera LY, 2014, J BIOL CHEM, V289, P31995, DOI 10.1074/jbc.M114.583369; Rogers JM, 2014, J AM CHEM SOC, V136, P5197, DOI 10.1021/ja4125065; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shih MD, 2012, PLANT SCI, V196, P152, DOI 10.1016/j.plantsci.2012.07.012; Shih MD, 2010, PLANT CELL PHYSIOL, V51, P395, DOI 10.1093/pcp/pcq005; Shimizu T, 2010, BIOCHEMISTRY-US, V49, P1093, DOI 10.1021/bi901745f; Soulages JL, 2002, PLANT PHYSIOL, V128, P822, DOI 10.1104/pp.010521; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Sun XL, 2013, PLANT CELL, V25, P38, DOI 10.1105/tpc.112.106062; Szasz C, 2011, BIOCHEMISTRY-US, V50, P5834, DOI [10.1021/bi200365J, 10.1021/bi200365j]; Tapley TL, 2009, P NATL ACAD SCI USA, V106, P5557, DOI 10.1073/pnas.0811811106; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Tompa P, 2010, BIOCHEM CELL BIOL, V88, P167, DOI [10.1139/O09-163, 10.1139/o09-163]; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	60	46	50	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10893	10903		10.1074/jbc.M116.720318	http://dx.doi.org/10.1074/jbc.M116.720318			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27006402	Green Published, hybrid			2022-12-28	WOS:000377042600039
J	Ruszkowski, M; Dauter, Z				Ruszkowski, Milosz; Dauter, Zbigniew			Structural Studies of Medicago truncatula Histidinol Phosphate Phosphatase from Inositol Monophosphatase Superfamily Reveal Details of Penultimate Step of Histidine Biosynthesis in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE TARGET; MOLECULAR-CLONING; ESCHERICHIA-COLI; LITHIUM; MYOINOSITOL; PATHWAY; MECHANISM; BINDING; DEHYDROGENASE; PROTEINS	The penultimate enzyme in the histidine biosynthetic pathway catalyzes dephosphorylation of L-histidinol 1-phosphate (HOLP) into L-histidinol. The recently discovered in Arabidopsis thaliana plant-type histidinol phosphate phosphatase (HPP) shares no homology with the two other HPP superfamilies known previously in prokaryotes and resembles myo-inositol monophosphatases (IMPases). In this work, identification of an HPP enzyme from a model legume, Medicago truncatula (MtHPP) was based on the highest sequence identity to A. thaliana enzyme. Biochemical assays confirmed that MtHPP was able to cleave inorganic phosphate from HOLP but not from D-myo-inositol-1-phosphate, the main substrate of IMPases. Dimers of MtHPP, determined by size exclusion chromatography, in the presence of CO2 or formaldehyde form mutual, methylene-bridged cross-links between Lys(158) and Cys(245) residues. Four high resolution crystal structures, namely complexes with HOLP (substrate), L-histidinol (product), and PO43- (by-product) as well as the structure showing the cross-linking between two MtHPP molecules, provide detailed structural information on the enzyme. Based on the crystal structures, the enzymatic reaction mechanism of IMPases is accustomed to fit the data for MtHPP. The enzymatic reaction, which requires Mg2+ cations, is catalyzed mainly by amino acid residues from the N-terminal domain. The C-terminal domain, sharing little identity with IMPases, is responsible for the substrate specificity (i.e. allows the enzyme to distinguish between HOLP and D-myo-inositol-1-phosphate). Structural features, mainly the presence of a conserved Asp(246), allow MtHPP to bind HOLP specifically.	[Ruszkowski, Milosz; Dauter, Zbigniew] NCI, Synchrotron Radiat Res Sect, MCL, NIH, Argonne, IL 60439 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ruszkowski, M (corresponding author), NCI, Synchrotron Radiat Res Sect, MCL, S Cass Ave 9700,Bldg 202,Rm Q-141, Argonne, IL 60439 USA.	mruszkowski@anl.gov		Ruszkowski, Milosz/0000-0002-4415-3100	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [ZIABC010378] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge Dr. Joanna Banasiak for assistance with identification of the MTHPP gene. We are also thankful to Dr. Jerry Alexandratos, who performed LC-MS studies at the Biophysics Resource in the Structural Biophysics Laboratory, National Cancer Institute at Frederick. Diffraction data were collected at the (i) SER-CAT beamline 22-ID at the Advanced Photon Source, Argonne National Laboratory, supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract W-31-109-Eng-38 and (ii) Structural Biology Center at the Advanced Photon Source, operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Alifano P, 1996, MICROBIOL REV, V60, P44, DOI 10.1128/MMBR.60.1.44-69.1996; Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; BAKER GR, 1991, BIOORG MED CHEM LETT, V1, P193, DOI 10.1016/S0960-894X(00)80250-4; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BONE R, 1992, P NATL ACAD SCI USA, V89, P10031, DOI 10.1073/pnas.89.21.10031; BONE R, 1994, BIOCHEMISTRY-US, V33, P9460, DOI 10.1021/bi00198a011; BONE R, 1994, BIOCHEMISTRY-US, V33, P9468, DOI 10.1021/bi00198a012; Brilli M, 2004, J MOL EVOL, V58, P225, DOI 10.1007/s00239-003-2547-x; BUCHWALD SL, 1984, J AM CHEM SOC, V106, P4916, DOI 10.1021/ja00329a048; COLE AG, 1994, J CHEM SOC CHEM COMM, P1139, DOI 10.1039/c39940001139; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Eicher T., 2013, CHEM HETEROCYCLES ST; El Malki F, 1998, PLANT MOL BIOL, V37, P1013, DOI 10.1023/A:1006007125448; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fauroux CMJ, 1999, J AM CHEM SOC, V121, P8385, DOI 10.1021/ja991939r; Fujimori K, 1998, MOL GEN GENET, V259, P216, DOI 10.1007/s004380050807; Fujimori K, 1998, PLANT PHYSIOL, V118, P275, DOI 10.1104/pp.118.1.275; Fujimori K, 1998, FEBS LETT, V428, P229, DOI 10.1016/S0014-5793(98)00535-3; Ghodge SV, 2013, BIOCHEMISTRY-US, V52, P1101, DOI 10.1021/bi301496p; Gill R, 2005, ACTA CRYSTALLOGR D, V61, P545, DOI 10.1107/S0907444905004038; GREASLEY PJ, 1994, EUR J BIOCHEM, V222, P453, DOI 10.1111/j.1432-1033.1994.tb18885.x; GREASLEY PJ, 1993, FEBS LETT, V331, P114, DOI 10.1016/0014-5793(93)80308-H; HALLCHER LM, 1980, J BIOL CHEM, V255, P896; HAUSER M, 1995, PLANT PHYSIOL, V108, P1059, DOI 10.1104/pp.108.3.1059; HELDT HW, 1973, BIOCHIM BIOPHYS ACTA, V314, P224, DOI 10.1016/0005-2728(73)90137-0; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Hwang HJ, 2014, BIOCHEM BIOPH RES CO, V445, P78, DOI 10.1016/j.bbrc.2014.01.152; Ingle RA, 2005, PLANT CELL, V17, P2089, DOI 10.1105/tpc.104.030577; Ingle Robert A, 2011, Arabidopsis Book, V9, pe0141, DOI 10.1199/tab.0141; Ishijima S, 2003, ARCH BIOCHEM BIOPHYS, V412, P126, DOI 10.1016/S0003-9861(03)00038-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim Y, 2011, METHODS, V55, P12, DOI 10.1016/j.ymeth.2011.07.010; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Koslowsky S, 2008, PLANT BIOTECHNOL J, V6, P281, DOI 10.1111/j.1467-7652.2007.00314.x; Kowiel M, 2014, ACTA CRYSTALLOGR D, V70, P3290, DOI 10.1107/S1399004714024572; Kramer U, 1996, NATURE, V379, P635, DOI 10.1038/379635a0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lahiri SD, 2003, SCIENCE, V299, P2067, DOI 10.1126/science.1082710; LANG PF, 2010, J CHEM SOC DA, V39, P7786, DOI DOI 10.1039/C0DT00401D; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Le Coq D, 1999, J BACTERIOL, V181, P3277, DOI 10.1128/JB.181.10.3277-3280.1999; Lee HS, 2008, J BACTERIOL, V190, P2629, DOI 10.1128/JB.01722-07; LEECH AP, 1993, EUR J BIOCHEM, V212, P693, DOI 10.1111/j.1432-1033.1993.tb17707.x; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Marineo S, 2008, CURR MICROBIOL, V56, P6, DOI 10.1007/s00284-007-9014-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Miller DJ, 2000, CHEMBIOCHEM, V1, P262, DOI 10.1002/1439-7633(20001117)1:4<262::AID-CBIC262>3.0.CO;2-#; Mormann S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-205; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NAGAI A, 1991, ARCH BIOCHEM BIOPHYS, V284, P127, DOI 10.1016/0003-9861(91)90274-M; NAGAI A, 1991, P NATL ACAD SCI USA, V88, P4133, DOI 10.1073/pnas.88.10.4133; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nourbakhsh A, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00725; PENNY DE, 1983, J CHEM SOC FARAD T 1, V79, P2103, DOI 10.1039/f19837902103; Petersen LN, 2010, PLANT PHYSIOL, V152, P1186, DOI 10.1104/pp.109.150805; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POLLACK SJ, 1993, EUR J BIOCHEM, V217, P281, DOI 10.1111/j.1432-1033.1993.tb18244.x; POLLACK SJ, 1994, P NATL ACAD SCI USA, V91, P5766, DOI 10.1073/pnas.91.13.5766; Rangarajan ES, 2006, J BIOL CHEM, V281, P37930, DOI 10.1074/jbc.M604916200; Rees JD, 2009, PLANT BIOTECHNOL J, V7, P499, DOI 10.1111/j.1467-7652.2009.00419.x; Ruszkowski M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00869; Saudek V, 1996, EUR J BIOCHEM, V240, P288, DOI 10.1111/j.1432-1033.1996.0288h.x; Seligmann H, 2003, J MOL EVOL, V56, P151, DOI 10.1007/s00239-002-2388-z; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Stepansky A, 2006, AMINO ACIDS, V30, P121, DOI 10.1007/s00726-005-0246-1; Swire J, 2007, J MOL EVOL, V64, P558, DOI 10.1007/s00239-006-0206-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-312; Thaller MC, 1998, PROTEIN SCI, V7, P1647, DOI 10.1002/pro.5560070722; Torabinejad J, 2009, PLANT PHYSIOL, V150, P951, DOI 10.1104/pp.108.135129; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; WIATER A, 1971, ACTA BIOCHIM POL, V18, P299; Wilkie J, 1996, J CHEM SOC PERK T 2, P783, DOI 10.1039/p29960000783; WILKIE J, 1995, J CHEM SOC PERK T 1, P2709, DOI 10.1039/p19950002709; WLODEK L, 1988, ACTA BIOCHIM POL, V35, P307; WONG YS, 1981, PHYTOCHEMISTRY, V20, P1831, DOI 10.1016/0031-9422(81)84014-9; YOUNG VR, 1994, J NUTR, V124, pS1517, DOI 10.1093/jn/124.suppl_8.1517S	85	14	14	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9960	9973		10.1074/jbc.M115.708727	http://dx.doi.org/10.1074/jbc.M115.708727			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26994138	Green Published, hybrid			2022-12-28	WOS:000375602800011
J	[Anonymous]				[Anonymous]			Probing Beneath the Surface: Discovering O-GlcNAc on Intracellular Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material																			0	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6607	6608		10.1074/jbc.O116.000001	http://dx.doi.org/10.1074/jbc.O116.000001			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26993850	hybrid, Green Published			2022-12-28	WOS:000372894200045
J	Liu, CJ; Li, YN; Xing, Y; Cao, BJ; Yang, F; Yang, TX; Ai, ZL; Wei, YY; Jiang, JH				Liu, Chanjuan; Li, Yinan; Xing, Yang; Cao, Benjin; Yang, Fan; Yang, Tianxiao; Ai, Zhilong; Wei, Yuanyan; Jiang, Jianhai			The Interaction between Cancer Stem Cell Marker CD133 and Src Protein Promotes Focal Adhesion Kinase (FAK) Phosphorylation and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE; HEMATOPOIETIC STEM; FAMILY KINASES; ACTIVATION; EXPRESSION; IDENTIFICATION; METASTASIS; CONTRIBUTES; INHIBITION	CD133, a widely known cancer stem cell marker, has been proved to promote tumor metastasis. However, the mechanism by which CD133 regulates metastasis remains largely unknown. Here, we report that CD133 knockdown inhibits cancer cell migration, and CD133 overexpression promotes cell migration. CD133 expression is beneficial to activate the Src-focal adhesion kinase (FAK) signaling pathway. Further studies show that CD133 could interact with Src, and the region between amino acids 845 and 857 in the CD133 C-terminal domain is indispensable for its interaction with Src. The interaction activates Src to phosphorylate its substrate FAK and to promote cell migration. Likewise, a Src binding-deficient CD133 mutant loses the abilities to increase Src and FAK phosphorylation and to promote cell migration. Inhibition of Src activity by PP2, a known Src activity inhibitor, could block the activation of FAK phosphorylation and cell migration induced by CD133. In summary, our data suggest that activation of FAK by the interaction between CD133 and Src promotes cell migration, providing clues to understand the migratory mechanism of CD133(+) tumor cells.	[Liu, Chanjuan; Li, Yinan; Xing, Yang; Cao, Benjin; Yang, Fan; Yang, Tianxiao; Wei, Yuanyan; Jiang, Jianhai] Fudan Univ, Dept Biochem & Mol Biol, Key Lab Glycoconjugates Res, Shanghai Med Coll,Minist Publ Hlth, Shanghai 200032, Peoples R China; [Ai, Zhilong] Fudan Univ, Zhongshan Hosp, Div Gen Surg, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Wei, YY; Jiang, JH (corresponding author), Fudan Univ, Dept Biochem & Mol Biol, Key Lab Glycoconjugates Res, Shanghai Med Coll,Minist Publ Hlth, Shanghai 200032, Peoples R China.; Ai, ZL (corresponding author), Fudan Univ, Zhongshan Hosp, Div Gen Surg, Shanghai 200032, Peoples R China.	ai.zhilong@zs-hospital.sh.cn; yywei@fudan.edu.cn; jianhaijiang@fudan.edu.cn	Ai, Zhi-Long/AAB-1758-2021		Program for National Natural Scientific Foundation of China [81272435, 81472724, 31370807]; National Basic Research Program of China [2013CB910503]	Program for National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by Program for National Natural Scientific Foundation of China Grants 81272435, 81472724, and 31370807 and National Basic Research Program of China Grant 2013CB910503. The authors declare that they have no financial and personal relationships with other people or organizations that could inappropriately influence (bias) the work in this study.	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; Adini A, 2013, ANGIOGENESIS, V16, P405, DOI 10.1007/s10456-012-9323-8; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Boivin D, 2009, BIOCHEMISTRY-US, V48, P3998, DOI 10.1021/bi900159d; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Canis M, 2013, TUMOR BIOL, V34, P437, DOI 10.1007/s13277-012-0568-z; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen JS, 2010, CLIN EXP METASTAS, V27, P71, DOI 10.1007/s10585-010-9306-3; Chen KL, 2011, CLIN EXP METASTAS, V28, P751, DOI 10.1007/s10585-011-9407-7; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Choi CW, 2015, EXP DERMATOL, V24, P361, DOI 10.1111/exd.12676; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Deramaudt TB, 2011, MOL BIOL CELL, V22, P964, DOI 10.1091/mbc.E10-08-0725; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Eyler CE, 2008, STEM CELLS, V26, P3027, DOI 10.1634/stemcells.2007-1073; Futschik M, 2002, GENOME LETT, V1, P26; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Han XS, 2014, INT J ONCOL, V45, P302, DOI 10.3892/ijo.2014.2432; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hou Y, 2012, CELL RES, V22, P259, DOI 10.1038/cr.2011.139; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Kim HI, 2015, ONCOTARGET, V6, P42905, DOI 10.18632/oncotarget.5466; Kohga K, 2010, J HEPATOL, V52, P872, DOI 10.1016/j.jhep.2009.12.030; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Maeda S, 2008, BRIT J CANCER, V98, P1389, DOI 10.1038/sj.bjc.6604307; Mak AB, 2012, CELL REP, V2, P951, DOI 10.1016/j.celrep.2012.09.016; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Nagelkerke A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3373; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Olempska M, 2007, HEPATOB PANCREAT DIS, V6, P92; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Shang N, 2015, HEPATOLOGY, V61, P214, DOI 10.1002/hep.27402; Singh SK, 2003, CANCER RES, V63, P5821; Song YJ, 2013, CANCER LETT, V339, P70, DOI 10.1016/j.canlet.2013.07.021; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Tai YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16408; Thiyagarajan V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141285; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Wu YJ, 2009, STEM CELLS DEV, V18, P1127, DOI 10.1089/scd.2008.0338; Yan MX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061056; Ye Q, 2013, J MOL BIOL, V425, P755, DOI 10.1016/j.jmb.2012.11.035; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zhang SS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-85	60	42	44	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15540	15550		10.1074/jbc.M115.712976	http://dx.doi.org/10.1074/jbc.M115.712976			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226554	Green Published, hybrid			2022-12-28	WOS:000380584200011
J	Smith, N; Adle, DJ; Zhao, MY; Qin, XJ; Kim, H; Lee, J				Smith, Nathan; Adle, David J.; Zhao, Miaoyun; Qin, Xiaojuan; Kim, Heejeong; Lee, Jaekwon			Endoplasmic Reticulum-associated Degradation of Pcal p, a Polytopic Protein, via Interaction with the Proteasome at the Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; UBIQUITIN LIGASE HUL5; SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; RETRO-TRANSLOCATION; MISFOLDED PROTEINS; LUMINAL PROTEIN; WASTE-DISPOSAL; AAA-ATPASE; RAT-LIVER	Endoplasmic reticulum-associated degradation (ERAD) plays a critical role in the destruction of terminally misfolded proteins at the secretory pathway. The system also regulates expression levels of several proteins such as Pcalp, a cadmium exporter in yeast. To gain better insight into the mechanisms underlying ERAD of Pcalp and other polytopic proteins by the proteasome in the cytosol, our study determined the roles for the molecular factors of ERAD in dislodging Pcalp from the endoplasmic reticulum (ER). Inactivation of the 20S proteasome leads to accumulation of ubiquitinated Pcalp in the ER membrane, suggesting a role for the proteasome in extraction of Pcalp from the ER. Pcalp formed a complex with the proteasome at the membrane in a Doal0p E3 ligase-dependent manner. Cdc48p is required for recruiting the proteasome to Pcalp. Although the Ufd2p E4 ubiquitin chain extension enzyme is involved in efficient degradation of Pcalp, Ufd2p-deficient cells did not affect the formation of a complex between Pcalp and the proteasome. Two other polytopic membrane proteins undergoing ERAD, Steh*p and Hmg2p, also displayed the same outcomes observed for Pcalp. However, poly-ubiquitinated Cpyl*p, a luminal ERAD substrate, was detected in the cytosol independent of proteolytic activities of the proteasome. These results indicate that extraction and degradation of polytopic membrane proteins at the ER is a coupled event. This mechanism would relieve the cost of exposed hydrophobic domains in the cytosol during ERAD.	[Smith, Nathan; Adle, David J.; Zhao, Miaoyun; Qin, Xiaojuan; Kim, Heejeong; Lee, Jaekwon] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Smith, Nathan; Adle, David J.; Zhao, Miaoyun; Qin, Xiaojuan; Kim, Heejeong; Lee, Jaekwon] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Qin, Xiaojuan] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai 200234, Peoples R China	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Shanghai Normal University	Lee, J (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.; Lee, J (corresponding author), Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA.	jlee7@unl.edu			National Institutes of Health [ES016337, P30GM103335]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants ES016337 (to J. L.) and P30GM103335 (to the Nebraska Redox Biology Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adle DJ, 2008, J BIOL CHEM, V283, P31460, DOI 10.1074/jbc.M806054200; Adle DJ, 2009, P NATL ACAD SCI USA, V106, P10189, DOI 10.1073/pnas.0812114106; Ausubel FM, 1987, CURR PROTOC MOL BIOL; Aviram S, 2010, MOL CELL BIOL, V30, P985, DOI 10.1128/MCB.00909-09; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Bogyo M, 1997, P NATL ACAD SCI USA, V94, P6629, DOI 10.1073/pnas.94.13.6629; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Chen L, 2011, J BIOL CHEM, V286, P3104, DOI 10.1074/jbc.M110.135863; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Fang NN, 2012, PRION, V6, P240, DOI 10.4161/pri.19929; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Finley D, 1998, TRENDS BIOCHEM SCI, V23, P244, DOI 10.1016/S0968-0004(98)01222-5; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Huyer G, 2004, MOL BIOL CELL, V15, P908, DOI 10.1091/mbc.E03-07-0546; Ikeda Y, 2009, J BIOL CHEM, V284, P34889, DOI 10.1074/jbc.M109.044875; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kohlmann S, 2008, J BIOL CHEM, V283, P16374, DOI 10.1074/jbc.M801702200; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; Liu C, 2010, J BIOL CHEM, V285, P10265, DOI 10.1074/jbc.M110.110551; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mehnert M, 2010, BIOESSAYS, V32, P905, DOI 10.1002/bies.201000046; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Oberdorf J, 2006, J CELL SCI, V119, P303, DOI 10.1242/jcs.02732; Overton MC, 2002, J BIOL CHEM, V277, P41463, DOI 10.1074/jbc.M205368200; Palmer A, 1996, BIOCHEM J, V316, P401, DOI 10.1042/bj3160401; PETERS JM, 1994, J BIOL CHEM, V269, P7709; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Plemper RK, 1999, J CELL SCI, V112, P4123; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; RIVETT AJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1165, DOI 10.1177/40.8.1619280; Rivett AJ, 1998, CURR OPIN IMMUNOL, V10, P110, DOI 10.1016/S0952-7915(98)80040-X; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Tandy S, 2000, J BIOL CHEM, V275, P1023, DOI 10.1074/jbc.275.2.1023; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wolf DH, 2005, CURR TOP MICROBIOL, V300, P41; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	73	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15082	15092		10.1074/jbc.M116.726265	http://dx.doi.org/10.1074/jbc.M116.726265			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226596	Green Published, hybrid			2022-12-28	WOS:000380583200019
J	Caria, S; Marshall, B; Burton, RL; Campbell, S; Pantaki-Eimany, D; Hawkins, CJ; Barry, M; Kvansakul, M				Caria, Sofia; Marshall, Bevan; Burton, Robyn-Lee; Campbell, Stephanie; Pantaki-Eimany, Delara; Hawkins, Christine J.; Barry, Michele; Kvansakul, Marc			The N Terminus of the Vaccinia Virus Protein F1L Is an Intrinsically Unstructured Region That Is Not Involved in Apoptosis Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; B-cell lymphoma 2 (Bcl-2) family; poxvirus; protein structure; small angle x-ray scattering (SAXS); caspases; vaccinia virus	PROGRAMMED CELL-DEATH; ANGLE SCATTERING DATA; EPSTEIN-BARR-VIRUS; BCL-2 HOMOLOG; PROSURVIVAL BCL-2; MACROMOLECULAR COMPLEXES; MEDIATED INHIBITION; PROMOTES VIRULENCE; BH3-ONLY PROTEINS; FAMILY-MEMBERS	Subversion of host cell apoptotic responses is a prominent feature of viral immune evasion strategies to prevent premature clearance of infected cells. Numerous poxviruses encode structural and functional homologs of the Bcl-2 family of proteins, and vaccinia virus harbors antiapoptotic F1L that potently inhibits the mitochondrial apoptotic checkpoint. Recently F1L has been assigned a caspase-9 inhibitory function attributed to an N-terminal helical region of F1L spanning residues 1-15 (1) preceding the domain-swapped Bcl-2-like domains. Using a reconstituted caspase inhibition assay in yeast we found that unlike AcP35, a well characterized caspase-9 inhibitor from the insect virus Autographa californica multiple nucleopolyhedrovirus, F1L does not prevent caspase-9-mediated yeast cell death. Furthermore, we found that deletion of the F1L N-terminal region does not impede F1L antiapoptotic activity in the context of a viral infection. Solution analysis of the F1L N-terminal regions using small angle x-ray scattering indicates that the region of F1L spanning residues 1-50 located N-terminally from the Bcl-2 fold is an intrinsically unstructured region. We conclude that the N terminus of F1L is not involved in apoptosis inhibition and may act as a regulatory element in other signaling pathways in a manner reminiscent of other unstructured regulatory elements commonly found in mammalian prosurvival Bcl-2 members including Bcl-x(L) and Mcl-1.	[Caria, Sofia; Marshall, Bevan; Pantaki-Eimany, Delara; Hawkins, Christine J.; Kvansakul, Marc] La Trobe Univ, Dept Biochem & Genet, La Trobe Inst Mol Sci, Bundoora, Vic 3086, Australia; [Burton, Robyn-Lee; Campbell, Stephanie; Barry, Michele] Univ Alberta, Dept Med Microbiol & Immunol, Li Ka Shing Inst Virol, Edmonton, AB T6G 2S2, Canada	La Trobe University; University of Alberta	Kvansakul, M (corresponding author), La Trobe Univ, Dept Biochem & Genet, La Trobe Inst Mol Sci, Bundoora, Vic 3086, Australia.; Barry, M (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Li Ka Shing Inst Virol, Edmonton, AB T6G 2S2, Canada.	micheleb@ualberta.ca; m.kvansakul@latrobe.edu.au	Marshall, Bevan/N-2821-2018; Kvansakul, Marc/AAF-2453-2019; Hawkins, Christine/B-8769-2011	Marshall, Bevan/0000-0002-2882-6459; Kvansakul, Marc/0000-0003-2639-2498; Hawkins, Christine/0000-0001-8120-1071; Caria, Sofia/0000-0001-7289-2093	Australian Research Council [FT130101349]; National Health and Medical Research Council [APP1007918]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in whole or part by Australian Research Council Grant FT130101349 and National Health and Medical Research Council Project Grant APP1007918. The authors declare that they have no conflicts of interest with the contents of this article.	Aoyagi M, 2007, PROTEIN SCI, V16, P118, DOI 10.1110/ps.062454707; Banadyga L, 2007, J VIROL, V81, P11032, DOI 10.1128/JVI.00734-07; Banadyga L, 2011, J VIROL, V85, P1922, DOI 10.1128/JVI.01959-10; Banadyga L, 2009, J VIROL, V83, P7085, DOI 10.1128/JVI.00437-09; Bartlett N, 2002, J GEN VIROL, V83, P1965, DOI 10.1099/0022-1317-83-8-1965; Beaumont TE, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.143; Brand IL, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.127; Brand IL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039248; Burton DR, 2015, ACTA CRYSTALLOGR D, V71, P1593, DOI 10.1107/S1399004715009402; Campbell S, 2014, J VIROL, V88, P8667, DOI 10.1128/JVI.01092-14; Campbell S, 2010, J BIOL CHEM, V285, P4695, DOI 10.1074/jbc.M109.053769; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHY, 1997, P NATL ACAD SCI USA, V94, P690, DOI 10.1073/pnas.94.2.690; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; de Motes CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002430; Douglas AE, 2007, PROTEIN SCI, V16, P695, DOI 10.1110/ps.062720107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer SF, 2006, CELL DEATH DIFFER, V13, P109, DOI 10.1038/sj.cdd.4401718; Fleming P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003192; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gerlic M, 2013, P NATL ACAD SCI USA, V110, P7808, DOI 10.1073/pnas.1215995110; Giam M, 2008, ONCOGENE, V27, pS128, DOI 10.1038/onc.2009.50; Goldmacher VS, 1999, P NATL ACAD SCI USA, V96, P12536, DOI 10.1073/pnas.96.22.12536; GRAHAM KA, 1992, VIROLOGY, V191, P112, DOI 10.1016/0042-6822(92)90172-L; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hawkins CJ, 1999, P NATL ACAD SCI USA, V96, P2885, DOI 10.1073/pnas.96.6.2885; Hawkins CJ, 2001, APOPTOSIS, V6, P331, DOI 10.1023/A:1011329917895; Huang QL, 2003, J MOL BIOL, V332, P1123, DOI 10.1016/j.jmb.2003.08.007; Huang QL, 2002, P NATL ACAD SCI USA, V99, P3428, DOI 10.1073/pnas.062525799; Jabbour AM, 2006, J CELL SCI, V119, P2572, DOI 10.1242/jcs.02985; Jurak I, 2008, J VIROL, V82, P4812, DOI 10.1128/JVI.02570-07; Jurgensmeier JM, 1997, MOL BIOL CELL, V8, P325; Kirby NM, 2014, CURR OPIN STRUC BIOL, V28, P41, DOI 10.1016/j.sbi.2014.07.007; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Konarev PV, 2001, J APPL CRYSTALLOGR, V34, P527, DOI 10.1107/S0021889801006100; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Kvansakul M, 2007, MOL CELL, V25, P933, DOI 10.1016/j.molcel.2007.02.004; Kvansakul M, 2015, APOPTOSIS, V20, P136, DOI 10.1007/s10495-014-1051-7; Kvansakul M, 2014, METHOD ENZYMOL, V544, P49, DOI 10.1016/B978-0-12-417158-9.00003-0; Kvansakul M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001236; Leshchiner ES, 2013, P NATL ACAD SCI USA, V110, pE986, DOI 10.1073/pnas.1214313110; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Manzur M, 2009, CELL DEATH DIFFER, V16, P312, DOI 10.1038/cdd.2008.152; MARCHINI A, 1991, J VIROL, V65, P5991, DOI 10.1128/JVI.65.11.5991-6000.1991; Marshall B, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.52; Mehta N, 2015, VIROLOGY, V475, P74, DOI 10.1016/j.virol.2014.10.023; Nava VE, 1997, J VIROL, V71, P4118, DOI 10.1128/JVI.71.5.4118-4122.1997; Okamoto T, 2012, J VIROL, V86, P11501, DOI 10.1128/JVI.01115-12; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Postigo A, 2006, CELL DEATH DIFFER, V13, P1651, DOI 10.1038/sj.cdd.4401853; Rautureau GJP, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.178; Rautureau GJP, 2010, PROTEINS, V78, P2181, DOI 10.1002/prot.22728; Rautureau GJP, 2010, INT J MOL SCI, V11, P1808, DOI 10.3390/ijms11041808; Reubold TF, 2012, CELL SIGNAL, V24, P1420, DOI 10.1016/j.cellsig.2012.03.007; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Stewart TL, 2005, J VIROL, V79, P1084, DOI 10.1128/JVI.79.2.1084-1098.2005; Taylor JM, 2006, J BIOL CHEM, V281, P39728, DOI 10.1074/jbc.M607465200; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Wasilenko ST, 2003, P NATL ACAD SCI USA, V100, P14345, DOI 10.1073/pnas.2235583100; Wasilenko ST, 2005, J VIROL, V79, P14031, DOI 10.1128/JVI.79.22.14031-14043.2005; WHITE E, 1992, MOL CELL BIOL, V12, P2570, DOI 10.1128/MCB.12.6.2570; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu E, 2011, J BIOL CHEM, V286, P30748, DOI 10.1074/jbc.M111.280149; Yuan SJ, 2010, STRUCTURE, V18, P571, DOI 10.1016/j.str.2010.04.001; Zhai DY, 2010, J BIOL CHEM, V285, P5569, DOI 10.1074/jbc.M109.078113	72	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14600	14608		10.1074/jbc.M116.726851	http://dx.doi.org/10.1074/jbc.M116.726851			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27151220	Green Published, hybrid			2022-12-28	WOS:000380366700016
J	Elimam, H; Papillon, J; Kaufman, DR; Guillemette, J; Aoudjit, L; Gross, RW; Takano, T; Cybulsky, AV				Elimam, Hanan; Papillon, Joan; Kaufman, Daniel R.; Guillemette, Julie; Aoudjit, Lamine; Gross, Richard W.; Takano, Tomoko; Cybulsky, Andrey V.			Genetic Ablation of Calcium-independent Phospholipase A(2) Induces Glomerular Injury in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; mitochondria; Phospholipase A; podocyte; proteinuria; cell injury; glomerulonephritis	ENDOPLASMIC-RETICULUM STRESS; PROTEINURIC KIDNEY-DISEASE; MITOCHONDRIAL DYSFUNCTION; MEMBRANOUS NEPHROPATHY; PODOCYTE INJURY; CELL BIOLOGY; COMPLEMENT; AUTOPHAGY; GLOMERULOSCLEROSIS; PATHOPHYSIOLOGY	Glomerular visceral epithelial cells (podocytes) play a critical role in the maintenance of glomerular permselectivity. Podocyte injury, manifesting as proteinuria, is the cause of many glomerular diseases. We reported previously that calcium-independent phospholipase A(2) (iPLA(2)) is cytoprotective against complement-mediated glomerular epithelial cell injury. Studies in iPLA(2) KO mice have demonstrated an important role for iPLA(2) in mitochondrial lipid turnover, membrane structure, and metabolism. The aim of the present study was to employ iPLA(2) KO mice to better understand the role of iPLA(2) in normal glomerular and podocyte function as well as in glomerular injury. We show that deletion of iPLA(2) did not cause detectable albuminuria; however, it resulted in mitochondrial structural abnormalities and enhanced autophagy in podocytes as well as loss of podocytes in aging KO mice. Moreover, after induction of anti-glomerular basement membrane nephritis in young mice, iPLA(2) KO mice exhibited significantly increased levels of albuminuria, podocyte injury, and loss of podocytes compared with wild type. Thus, iPLA(2) has a protective functional role in the normal glomerulus and in glomerulonephritis. Understanding the role of iPLA(2) in glomerular pathophysiology provides opportunities for the development of novel therapeutic approaches to glomerular injury and proteinuria.	[Elimam, Hanan; Papillon, Joan; Kaufman, Daniel R.; Guillemette, Julie; Aoudjit, Lamine; Takano, Tomoko; Cybulsky, Andrey V.] McGill Univ, Ctr Hlth, Res Inst, Dept Med, Montreal, PQ H4A 3J1, Canada; [Gross, Richard W.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Elimam, Hanan] Misr Int Univ, Dept Biochem, Km 28,Cairo Ismailia Rd, Cairo, Egypt	McGill University; Washington University (WUSTL); Egyptian Knowledge Bank (EKB); Misr International University; Misr University for Science & Technology	Takano, T; Cybulsky, AV (corresponding author), Res Inst EM13244, Div Nephrol, 1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada.	tomoko.takano@mcgill.ca; andrey.cybulsky@mcgill.ca	Cybulsky, Andrey V./AAG-8238-2020; Elimam, Hanan/H-5858-2017	Cybulsky, Andrey V./0000-0003-4348-2348; Elimam, Hanan/0000-0003-2585-9957	Canadian Institutes of Health Research [MOP-53264, MOP-133492, MOP-125988, MOP-53335]; National Institutes of Health [RO1 HL118639]; Catherine McLaughlin Hakim Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118639] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Catherine McLaughlin Hakim Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Canadian Institutes of Health Research Grants MOP-53264, MOP-133492, MOP-125988, and MOP-53335; National Institutes of Health Grant RO1 HL118639; and the Catherine McLaughlin Hakim Chair (to A. V. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bechtel W, 2013, J AM SOC NEPHROL, V24, P727, DOI 10.1681/ASN.2012070700; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Casalena G, 2014, AM J PHYSIOL-RENAL, V306, pF1372, DOI 10.1152/ajprenal.00608.2013; Chiang CK, 2010, NAT REV NEPHROL, V6, P539, DOI 10.1038/nrneph.2010.103; Cohen D, 2008, AM J PHYSIOL-RENAL, V294, pF469, DOI 10.1152/ajprenal.00372.2007; COUSER WG, 1985, KIDNEY INT, V28, P879, DOI 10.1038/ki.1985.214; Cybulsky AV, 2013, KIDNEY INT, V84, P25, DOI 10.1038/ki.2012.390; Cybulsky AV, 2011, CONTRIB NEPHROL, V169, P107, DOI 10.1159/000313948; Cybulsky AV, 2010, KIDNEY INT, V77, P187, DOI 10.1038/ki.2009.389; D'Agati VD, 2008, KIDNEY INT, V73, P399, DOI 10.1038/sj.ki.5002655; Drozdova T, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.86; Elimam H, 2015, J BIOL CHEM, V290, P3009, DOI 10.1074/jbc.M114.592261; Elimam H, 2013, J BIOL CHEM, V288, P3871, DOI 10.1074/jbc.M112.396614; Gomes LC, 2013, BBA-MOL CELL RES, V1833, P205, DOI 10.1016/j.bbamcr.2012.02.012; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Huber TB, 2012, AUTOPHAGY, V8, P1009, DOI 10.4161/auto.19821; Inagi R, 2014, NAT REV NEPHROL, V10, P369, DOI 10.1038/nrneph.2014.67; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Kinsey GR, 2008, J LIPID RES, V49, P1477, DOI 10.1194/jlr.M800030-JLR200; Kreidberg JA, 2003, J AM SOC NEPHROL, V14, P806, DOI 10.1097/01.ASN.0000054887.42550.14; Lin F, 2002, LAB INVEST, V82, P563, DOI 10.1038/labinvest.3780451; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mancuso DJ, 2010, J BIOL CHEM, V285, P36495, DOI 10.1074/jbc.M110.115766; Mancuso DJ, 2009, J BIOL CHEM, V284, P35632, DOI 10.1074/jbc.M109.055194; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moon SH, 2012, J BIOL CHEM, V287, P29837, DOI 10.1074/jbc.M112.373654; Muller-Deile J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00209; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Nezvitsky L, 2014, AM J PHYSIOL-RENAL, V307, pF634, DOI 10.1152/ajprenal.00191.2014; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Periyasamy-Thandavan S, 2009, AM J PHYSIOL-RENAL, V297, pF244, DOI 10.1152/ajprenal.00033.2009; Petermann AT, 2004, NEPHRON EXP NEPHROL, V98, pE114, DOI 10.1159/000081555; Petermann AT, 2003, KIDNEY INT, V64, P1222, DOI 10.1046/j.1523-1755.2003.00217.x; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Ramanadham S, 2015, J LIPID RES, V56, P1643, DOI 10.1194/jlr.R058701; SALANT DJ, 1988, METHOD ENZYMOL, V162, P421; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Takano T, 2013, SEMIN NEPHROL, V33, P586, DOI 10.1016/j.semnephrol.2013.08.009; Tanaka H, 2000, BIOCHEM BIOPH RES CO, V272, P320, DOI 10.1006/bbrc.2000.2776; van den Berg JG, 2004, KIDNEY INT, V66, P1901, DOI 10.1111/j.1523-1755.2004.00964.x; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Yoda E, 2010, J LIPID RES, V51, P3003, DOI 10.1194/jlr.M008060	47	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14468	14482		10.1074/jbc.M115.696781	http://dx.doi.org/10.1074/jbc.M115.696781			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226532	hybrid, Green Published			2022-12-28	WOS:000380366700006
J	Blanchetot, C; De Jonge, N; Desmyter, A; Ongenae, N; Hofman, E; Klarenbeek, A; Sadi, A; Hultberg, A; Kretz-Rommel, A; Spinelli, S; Loris, R; Cambillau, C; de Haard, H				Blanchetot, Christophe; De Jonge, Natalie; Desmyter, Aline; Ongenae, Nico; Hofman, Erik; Klarenbeek, Alex; Sadi, Ava; Hultberg, Anna; Kretz-Rommel, Anke; Spinelli, Silvia; Loris, Remy; Cambillau, Christian; de Haard, Hans			Structural Mimicry of Receptor Interaction by Antagonistic Interleukin-6 (IL-6) Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; crystal structure; immunology; interleukin 6 (IL-6); structure-function; high affinity	CRYSTAL-STRUCTURE; SOLUBLE RECEPTORS; MOLECULAR-CLONING; T-CELL; NEUTRALIZATION; TOCILIZUMAB; EXPRESSION; ARTHRITIS; BIOLOGY; EPITOPE	Interleukin 6 plays a key role in mediating inflammatory reactions in autoimmune diseases and cancer, where it is also involved in metastasis and tissue invasion. Neutralizing antibodies against IL-6 and its receptor have been approved for therapeutic intervention or are in advanced stages of clinical development. Here we describe the crystal structures of the complexes of IL-6 with two Fabs derived from conventional camelid antibodies that antagonize the interaction between the cytokine and its receptor. The x-ray structures of these complexes provide insights into the mechanism of neutralization by the two antibodies and explain the very high potency of one of the antibodies. It effectively competes for binding to the cytokine with IL-6 receptor (IL-6R) by using side chains of two CDR residues filling the site I cavities of IL-6, thus mimicking the interactions of Phe(229) and Phe(279) of IL-6R. In the first antibody, a HCDR3 tryptophan binds similarly to hot spot residue Phe(279). Mutation of this HCDR3 Trp residue into any other residue except Tyr or Phe significantly weakens binding of the antibody to IL-6, as was also observed for IL-6R mutants of Phe(279). In the second antibody, the side chain of HCDR3 valine ties into site I like IL-6R Phe(279), whereas a LCDR1 tyrosine side chain occupies a second cavity within site I and mimics the interactions of IL-6R Phe(229).	[Blanchetot, Christophe; De Jonge, Natalie; Ongenae, Nico; Hofman, Erik; Klarenbeek, Alex; Sadi, Ava; Hultberg, Anna; de Haard, Hans] Argenx, B-9052 Zwijnaarde, Belgium; [Desmyter, Aline; Spinelli, Silvia; Cambillau, Christian] CNRS, UMR 6098, Architecture & Fonct Macromol Biol, F-13284 Marseille, France; [Desmyter, Aline; Spinelli, Silvia; Cambillau, Christian] Univ Marseille, F-13284 Marseille, France; [Kretz-Rommel, Anke] Bird Rock Bio, La Jolla, CA 92037 USA; [Loris, Remy] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Loris, Remy] Inst Biotechnol, Struct Biol Res Ctr, B-1050 Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Vrije Universiteit Brussel	de Haard, H (corresponding author), Argenx BVBA, Ind Pk Zwijnaarde 7, B-9052 Zwijnaarde, Belgium.	hdehaard@argenx.com	Loris, Remy/GPG-0894-2022	Loris, Remy/0000-0002-8862-3338; Blanchetot, christophe/0000-0001-9152-9978	Agentschap voor Innovatie door Wetenschap en Technologie [IWT090297]	Agentschap voor Innovatie door Wetenschap en Technologie	This work was supported by Agentschap voor Innovatie door Wetenschap en Technologie Grant IWT090297. C. B., N. D. J., E. H., N. O., A. K.-R., A. H., and H. d. H. are employees of argenx. A. K.-R. is an employee of Bird Rock Bio.	Akira S, 1997, INT J BIOCHEM CELL B, V29, P1401, DOI 10.1016/S1357-2725(97)00063-0; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; BRAKENHOFF JPJ, 1990, J IMMUNOL, V145, P561; Briso EM, 2008, J IMMUNOL, V180, P7102, DOI 10.4049/jimmunol.180.11.7102; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Drucker C, 2010, J AUTOIMMUN, V34, P29, DOI 10.1016/j.jaut.2009.08.003; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Grutter C, 2008, P NATL ACAD SCI USA, V105, P20251, DOI 10.1073/pnas.0807200106; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hirano T, 1998, Int Rev Immunol, V16, P249; HORIUCHI S, 1994, EUR J IMMUNOL, V24, P1945, DOI 10.1002/eji.1830240837; Ito H, 2004, GASTROENTEROLOGY, V126, P989, DOI 10.1053/j.gastro.2004.01.012; Jones SA, 2002, BBA-MOL CELL RES, V1592, P251, DOI 10.1016/S0167-4889(02)00319-1; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalai M, 1997, BLOOD, V89, P1319, DOI 10.1182/blood.V89.4.1319; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; Klarenbeek A, 2016, PROTEIN ENG DES SEL, V29, P123, DOI 10.1093/protein/gzw003; Kremer JM, 2011, ARTHRITIS RHEUM-US, V63, P609, DOI 10.1002/art.30158; MULLBERG J, 1994, J IMMUNOL, V152, P4958; Ogata A, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/946048; OHNO S, 1985, P NATL ACAD SCI USA, V82, P2945, DOI 10.1073/pnas.82.9.2945; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Shaw S, 2014, MABS-AUSTIN, V6, P773, DOI 10.4161/mabs.28612; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Sulzenbacher G, 2002, ACTA CRYSTALLOGR D, V58, P2109, DOI 10.1107/S0907444902013938; Tanaka T, 2011, FEBS LETT, V585, P3699, DOI 10.1016/j.febslet.2011.03.023; Tanaka Y, 2014, ANN RHEUM DIS, V73, P1595, DOI 10.1136/annrheumdis-2013-205002; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; VANSNICK J, 1987, J EXP MED, V165, P641, DOI 10.1084/jem.165.3.641; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	38	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13846	13854		10.1074/jbc.M115.695528	http://dx.doi.org/10.1074/jbc.M115.695528			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129274	hybrid, Green Published			2022-12-28	WOS:000379771100038
J	Kim, SH; Kaschula, CH; Priedigkeit, N; Lee, AV; Singh, SV				Kim, Su-Hyeong; Kaschula, Catherine H.; Priedigkeit, Nolan; Lee, Adrian V.; Singh, Shivendra V.			Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; cancer stem cells; chemoprevention; FOXO; natural product	TRANSCRIPTION FACTOR; PREVENTION; CHEMOPREVENTION; IDENTIFICATION; ISOTHIOCYANATE; APOPTOSIS; TUMORS; AJOENE; RISK	Diallyl trisulfide (DATS), a metabolic byproduct of garlic, is known to inhibit the growth of breast cancer cells in vitro and in vivo. This study demonstrates that DATS targets breast cancer stem cells (bCSC). Exposure of MCF-7 and SUM159 human breast cancer cells to pharmacological concentrations of DATS (2.5 and 5 m) resulted in dose-dependent inhibition of bCSC, as evidenced by a mammosphere assay and flow cytometric analysis of aldehyde dehydrogenase 1 (ALDH1) activity and the CD44(high)/CD24(low)/epithelial specific antigen-positive fraction. DATS-mediated inhibition of bCSC was associated with a decrease in the protein level of FoxQ1. Overexpression of FoxQ1 in MCF-7 and SUM159 cells increased ALDH1 activity and the CD49f(+)/CD24(-) fraction. Inhibition of ALDH1 activity and/or mammosphere formation upon DATS treatment was significantly attenuated by overexpression of FoxQ1. In agreement with these results, stable knockdown of FoxQ1 using small hairpin RNA augmented bCSC inhibition by DATS. Expression profiling for cancer stem cell-related genes suggested that FoxQ1 may negatively regulate the expression of Dachshund homolog 1 (DACH1), whose expression is lost in invasive breast cancer. Chromatin immunoprecipitation confirmed recruitment of FoxQ1 at the DACH1 promoter. Moreover, inducible expression of DACH1 augmented DATS-mediated inhibition of bCSC. Expression of FoxQ1 protein was significantly higher in triple-negative breast cancer cases compared with normal mammary tissues. Moreover, an inverse association was observed between FoxQ1 and DACH1 gene expression in breast cancer cell lines and tumors. DATS administration inhibited ALDH1 activity in vivo in SUM159 xenografts. These results indicate that FoxQ1 is a novel target of bCSC inhibition by DATS.	[Kim, Su-Hyeong; Priedigkeit, Nolan; Lee, Adrian V.; Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Kim, Su-Hyeong; Priedigkeit, Nolan; Lee, Adrian V.; Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA 15213 USA; [Kaschula, Catherine H.] Univ Cape Town, Dept Chem, ZA-7701 Cape Town, South Africa	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Cape Town	Singh, SV (corresponding author), Hillman Canc Ctr 2 32A, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.	singhs@upmc.edu		Priedigkeit, Nolan/0000-0001-8330-5210; Lee, Adrian/0000-0001-9917-514X	Cancer Center Support Grant, National Cancer Institute [P30 CA047904]; NATIONAL CANCER INSTITUTE [R01CA142604, P30CA047904] Funding Source: NIH RePORTER	Cancer Center Support Grant, National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research project used the Flow Cytometry Facility, Cell and Tissue Imaging Facility, and Animal Facility supported in part by the Cancer Center Support Grant P30 CA047904, National Cancer Institute.	Agarwal KC, 1996, MED RES REV, V16, P111, DOI 10.1002/(SICI)1098-1128(199601)16:1&lt;111::AID-MED4&gt;3.0.CO;2-5; Antony ML, 2011, INDIAN J EXP BIOL, V49, P805; Bauer D, 2014, ANTICANCER RES, V34, P2763; Bieller A, 2001, DNA CELL BIOL, V20, P555, DOI 10.1089/104454901317094963; BLOCK E, 1985, SCI AM, V252, P114, DOI 10.1038/scientificamerican0385-114; BLOCK E, 1984, J AM CHEM SOC, V106, P8295, DOI 10.1021/ja00338a049; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Challier B, 1998, EUR J EPIDEMIOL, V14, P737, DOI 10.1023/A:1007512825851; Chandra-Kuntal K, 2013, BREAST CANCER RES TR, V138, P69, DOI 10.1007/s10549-013-2440-2; Christensen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060051; Daemen A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r110; DORANT E, 1995, BREAST CANCER RES TR, V33, P163, DOI 10.1007/BF00682723; Ebrahimi M, 2013, CELL J, V15, P65; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Gao M, 2014, AM J PATHOL, V184, P133, DOI 10.1016/j.ajpath.2013.09.024; Gao M, 2012, INT J MOL SCI, V13, P13881, DOI 10.3390/ijms131113881; Gendoo DMA, 2016, BIOINFORMATICS, V32, P1097, DOI 10.1093/bioinformatics/btv693; Goss PE, 2011, NEW ENGL J MED, V364, P2381, DOI 10.1056/NEJMoa1103507; Gued LR, 2003, ONCOL REP, V10, P739; Hahm ER, 2014, BREAST CANCER RES TR, V144, P47, DOI 10.1007/s10549-014-2841-x; Hahm ER, 2013, JNCI-J NATL CANCER I, V105, P1111, DOI 10.1093/jnci/djt153; Herman-Antosiewicz A, 2007, ACTA PHARMACOL SIN, V28, P1355, DOI 10.1111/j.1745-7254.2007.00682.x; Jo MJ, 2010, CANCER RES, V70, P8948, DOI 10.1158/0008-5472.CAN-10-1936; Kaschula CH, 2012, EUR J MED CHEM, V50, P236, DOI 10.1016/j.ejmech.2012.01.058; Kim SH, 2013, CANCER PREV RES, V6, P782, DOI 10.1158/1940-6207.CAPR-13-0100; LEVI F, 1993, NUTR CANCER, V19, P327, DOI 10.1080/01635589309514263; Li H, 2004, CHINESE MED J-PEKING, V117, P1155; LIU JZ, 1992, CARCINOGENESIS, V13, P1847, DOI 10.1093/carcin/13.10.1847; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Milner JA, 2006, J NUTR, V136, p827S, DOI 10.1093/jn/136.3.727S; Modem Suhasini, 2012, Genes Cancer, V3, P177, DOI 10.1177/1947601912458581; Na HK, 2012, BIOCHEM PHARMACOL, V84, P1241, DOI 10.1016/j.bcp.2012.08.024; Naznin MT, 2008, FOOD CHEM, V106, P1113, DOI 10.1016/j.foodchem.2007.07.041; Nkrumah-Elie YM, 2012, FOOD CHEM TOXICOL, V50, P2524, DOI 10.1016/j.fct.2012.04.010; O'Brien Ciara S., 2011, Hormones & Cancer, V2, P91, DOI 10.1007/s12672-011-0066-6; Patro R., 2015, 021592 BIORXIV; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Rivlin R. S., 2001, Journal of Nutrition, V131, P951; Schaffer EM, 1996, CANCER LETT, V102, P199, DOI 10.1016/0304-3835(96)04160-2; Shah M, 2012, BREAST CANCER-TARGET, V4, P155, DOI 10.2147/BCTT.S26434; Sun X, 2006, YAKUGAKU ZASSHI, V126, P521, DOI 10.1248/yakushi.126.521; Sun Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-137; Velasco-Velazquez MA, 2012, INT J BIOCHEM CELL B, V44, P573, DOI 10.1016/j.biocel.2011.12.020; Wilks C, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau093; Wu KM, 2014, CANCER RES, V74, P829, DOI 10.1158/0008-5472.CAN-13-2466; Wu KM, 2011, J BIOL CHEM, V286, P2132, DOI 10.1074/jbc.M110.148395; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; YU TH, 1989, J AGR FOOD CHEM, V37, P725, DOI 10.1021/jf00087a032; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825; Zhang YS, 2012, J BIOL CHEM, V287, P41514, DOI 10.1074/jbc.M112.404871; [No title captured]	53	50	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13495	13508		10.1074/jbc.M116.715219	http://dx.doi.org/10.1074/jbc.M116.715219			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129776	Green Published, hybrid			2022-12-28	WOS:000379771100008
J	Shi, ZX; Zhang, J; Chen, SQ; Li, YX; Lei, XP; Qiao, HM; Zhu, QW; Hu, BY; Zhou, Q; Jiao, JW				Shi, Zixiao; Zhang, Juan; Chen, Shuangquan; Li, Yanxin; Lei, Xuepei; Qiao, Huimin; Zhu, Qianwen; Hu, Baoyang; Zhou, Qi; Jiao, Jianwei			Conversion of Fibroblasts to Parvalbumin Neurons by One Transcription Factor, Ascl1, and the Chemical Compound Forskolin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast; immunochemistry; infection; neuron; small molecule	DOPAMINERGIC-NEURONS; FUNCTIONAL-NEURONS; MOUSE FIBROBLASTS; SMALL MOLECULES; STEM-CELLS; GENERATION; INTERNEURONS; INDUCTION; OCT4; GENE	Abnormalities in parvalbumin (PV)-expressing interneurons cause neurodevelopmental disorders such as epilepsy, autism, and schizophrenia. Unlike other types of neurons that can be efficiently differentiated from pluripotent stem cells, PV neurons were minimally generated using a conventional differentiation strategy. In this study we developed an adenovirus-based transdifferentiation strategy that incorporates an additional chemical compound for the efficient generation of induced PV (iPV) neurons. The chemical compound forskolin combined with Ascl1 induced approximate to 80% of mouse fibroblasts to iPV neurons. The iPV neurons generated by this procedure matured 5-7 days post infection and were characterized by electrophysiological properties and known neuronal markers, such as PV and GABA. Our studies, therefore, identified an efficient approach for generating PV neurons.	[Shi, Zixiao; Zhang, Juan; Chen, Shuangquan; Li, Yanxin; Lei, Xuepei; Qiao, Huimin; Hu, Baoyang; Zhou, Qi; Jiao, Jianwei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cells & Reprod Biol, Beijing 100101, Peoples R China; [Shi, Zixiao; Zhang, Juan; Chen, Shuangquan; Li, Yanxin; Lei, Xuepei; Qiao, Huimin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhu, Qianwen] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Jiao, JW (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cells & Reprod Biol, Beijing 100101, Peoples R China.	jwjiao@ioz.ac.cn	Zhang, Juan/GRX-2638-2022; Jiao, Jianwei/I-1452-2013; Jiao, Jianwei/AAA-7902-2020; Hu, Baoyang/R-8374-2016	Jiao, Jianwei/0000-0002-7893-0721; Jiao, Jianwei/0000-0002-7893-0721; Hu, Baoyang/0000-0003-3993-4014	National Basic Research Program of China [2015CB964501, 2014CB964903]; National Science Foundation of China [31371477]; Strategic Priority Stem Cell Program [XDA01020301]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Stem Cell Program	This work was supported by the National Basic Research Program of China (2015CB964501 and 2014CB964903), the National Science Foundation of China (31371477), and the Strategic Priority Stem Cell Program (XDA01020301). The authors declare that they have no conflicts of interest with the contents of this article.	Ango F, 2008, PLOS BIOL, V6, P739, DOI 10.1371/journal.pbio.0060103; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020; Chow A, 1999, J NEUROSCI, V19, P9332; Georgiev D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043904; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Lau S, 2014, CELL REP, V9, P1673, DOI 10.1016/j.celrep.2014.11.017; Li X, 2015, CELL STEM CELL, V17, P195, DOI 10.1016/j.stem.2015.06.003; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Meng FX, 2012, CELL RES, V22, P436, DOI 10.1038/cr.2011.185; Meyer-Lindenberg A, 2010, NATURE, V468, P194, DOI 10.1038/nature09569; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Popowski M, 2014, STEM CELL REP, V2, P26, DOI 10.1016/j.stemcr.2013.12.002; Shi ZX, 2014, J BIOL CHEM, V289, P6415, DOI 10.1074/jbc.M113.515601; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Zhu SY, 2011, ANNU REV BIOMED ENG, V13, P73, DOI 10.1146/annurev-bioeng-071910-124715	25	18	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13560	13570		10.1074/jbc.M115.709808	http://dx.doi.org/10.1074/jbc.M115.709808			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27137935	hybrid, Green Published			2022-12-28	WOS:000379771100014
J	Pandyarajan, V; Phillips, NB; Rege, N; Lawrence, MC; Whittaker, J; Weiss, MA				Pandyarajan, Vijay; Phillips, Nelson B.; Rege, Nischay; Lawrence, Michael C.; Whittaker, Jonathan; Weiss, Michael A.			Contribution of Tyr(B26) to the Function and Stability of Insulin STRUCTURE-ACTIVITY RELATIONSHIPS AT A CONSERVED HORMONE-RECEPTOR INTERFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; GROWTH-FACTOR-I; 1ST 3 DOMAINS; NEGATIVE COOPERATIVITY; BIOLOGICAL-ACTIVITY; CRYSTAL-STRUCTURE; BINDING; PROTEIN; CONFORMATION; ANALOGS	Crystallographic studies of insulin bound to receptor domains have defined the primary hormone-receptor interface. We investigated the role of Tyr(B26), a conserved aromatic residue at this interface. To probe the evolutionary basis for such conservation, we constructed 18 variants at B26. Surprisingly, non-aromatic polar or charged side chains (such as Glu, Ser, or ornithine (Orn)) conferred high activity, whereas the weakest-binding analogs contained Val, Ile, and Leu substitutions. Modeling of variant complexes suggested that the B26 side chains pack within a shallow depression at the solvent-exposed periphery of the interface. This interface would disfavor large aliphatic side chains. The analogs with highest activity exhibited reduced thermodynamic stability and heightened susceptibility to fibrillation. Perturbed self-assembly was also demonstrated in studies of the charged variants (Orn and Glu); indeed, the Glu(B26) analog exhibited aberrant aggregation in either the presence or absence of zinc ions. Thus, although Tyr(B26) is part of insulin's receptor-binding surface, our results suggest that its conservation has been enjoined by the aromatic ring's contributions to native stability and self-assembly. We envisage that such classical structural relationships reflect the implicit threat of toxic misfolding (rather than hormonal function at the receptor level) as a general evolutionary determinant of extant protein sequences.	[Pandyarajan, Vijay; Phillips, Nelson B.; Rege, Nischay; Whittaker, Jonathan; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Lawrence, Michael C.] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia; [Lawrence, Michael C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Walter & Eliza Hall Institute; University of Melbourne	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem Med & Biomed Engn, Cleveland, OH 44016 USA.	michael.weiss@case.edu	Lawrence, Michael C/A-5357-2009	Pandyarajan, Vijay/0000-0002-8835-5601; Lawrence, Michael/0000-0003-1999-0801	National Institutes of Health [R01 DK040949, DK079233]; Australian National Health and Medical Research Council (NHMRC) [1005896, 1058233]; Hazel and Pip Appel Fund; Sanofi (Germany); Case Western Reserve University Medical Scientist Training Program by National Institutes of Health (NIH) [T32 GM007250]; individual NIH Fellowship from the NIDDK [F30 DK094685-04]; American Diabetes Association; National Health and Medical Research Council [361646]; Victorian State Government Operational Infrastructure Support Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949, F30DK112644, R01DK079233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Hazel and Pip Appel Fund; Sanofi (Germany)(Sanofi-Aventis); Case Western Reserve University Medical Scientist Training Program by National Institutes of Health (NIH); individual NIH Fellowship from the NIDDK; American Diabetes Association(American Diabetes Association); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01 DK040949 and DK079233 (NIDDK; to M. A. W.). This work was also supported by Australian National Health and Medical Research Council (NHMRC) Project Grants 1005896 and 1058233 and the Hazel and Pip Appel Fund (to M. C. L.). M. A. W. has equity in Thermalin Diabetes, LLC (Cleveland, OH), where he serves as Chief Scientific Officer. He has also been a consultant to Merck Research Laboratories and DEKA Research and Development Corp. N. B. P. and J. W. are consultants to Thermalin Diabetes, LLC. Part of M. C. L.'s research was funded by Sanofi (Germany). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by a predoctoral fellowship of the Case Western Reserve University Medical Scientist Training Program supported by National Institutes of Health (NIH) Grant T32 GM007250 and individual NIH Fellowship F30 DK094685-04 from the NIDDK.r Supported in part by the American Diabetes Association.r Recipient of National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme Grant 361646 and Victorian State Government Operational Infrastructure Support Grant (to the Walter and Eliza Hall Institute).	Attri AK, 2010, BIOPHYS CHEM, V148, P28, DOI 10.1016/j.bpc.2010.02.002; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Barany G., 1980, PEPTIDES, P273; Birnbaum DT, 1997, PHARMACEUT RES, V14, P25, DOI 10.1023/A:1012095115151; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Brange J., 1987, GALENICS OF INSULIN, P17; Brange J., 2000, PHARM FORMULATION DE, P89; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; Cabail MZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7406; Campbell RK, 1996, ANN PHARMACOTHER, V30, P1263, DOI 10.1177/106002809603001111; Chen H, 2000, PROTEIN ENG, V13, P779, DOI 10.1093/protein/13.11.779; CISZAK E, 1994, BIOCHEMISTRY-US, V33, P1512, DOI 10.1021/bi00172a030; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; Conlon JM, 2001, PEPTIDES, V22, P1183, DOI 10.1016/S0196-9781(01)00423-5; COSMATOS A, 1979, INT J PEPT PROT RES, V14, P457; Croll TI, 2016, STRUCTURE, V24, P469, DOI 10.1016/j.str.2015.12.014; De Meyts P, 2002, INSULIN & RELATED PROTEINS - STRUCTURE TO FUNCTION AND PHARMACOLOGY, P131; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; FISCHER WH, 1985, BIOL CHEM H-S, V366, P521, DOI 10.1515/bchm3.1985.366.1.521; Garg SK, 2005, EXPERT OPIN PHARMACO, V6, P643, DOI 10.1517/14656566.6.4.643; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; Goldman-Levine JD, 2005, ANN PHARMACOTHER, V39, P502, DOI 10.1345/aph.1E334; HELLMAN U, 1990, BIOCHEM BIOPH RES CO, V169, P571, DOI 10.1016/0006-291X(90)90369-X; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; HU SQ, 1993, J PROTEIN CHEM, V12, P741, DOI 10.1007/BF01024932; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Hua Qing-Xin, 2011, Front Endocrinol (Lausanne), V2, P48, DOI 10.3389/fendo.2011.00048; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; HUA QX, 1993, BIOCHEMISTRY-US, V32, P1433, DOI 10.1021/bi00057a006; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; INOUYE K, 1981, BIOPOLYMERS, V20, P1845, DOI 10.1002/bip.1981.360200909; IZUMIYA N, 1959, J BIOCHEM-TOKYO, V46, P1347, DOI 10.1093/oxfordjournals.jbchem.a126931; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; JORGENSEN AMM, 1992, J MOL BIOL, V227, P1146, DOI 10.1016/0022-2836(92)90527-Q; Keating GM, 2013, DRUGS, V73, P575, DOI 10.1007/s40265-013-0051-1; KOBAYASHI M, 1982, BIOCHEM J, V206, P597, DOI 10.1042/bj2060597; KOBAYASHI M, 1986, BIOCHEM BIOPH RES CO, V137, P250, DOI 10.1016/0006-291X(86)91203-9; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; KUBIAK T, 1986, INT J PEPT PROT RES, V27, P514; KUROSE T, 1994, J BIOL CHEM, V269, P29190; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; NISHI M, 1990, MOL ENDOCRINOL, V4, P1192, DOI 10.1210/mend-4-8-1192; Pace CN, 2000, PROTEINS, P1; Pandyarajan V, 2014, J BIOL CHEM, V289, P34709, DOI 10.1074/jbc.M114.608562; Papaioannou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144058; POCKER Y, 1980, BIOCHEMISTRY-US, V19, P5043, DOI 10.1021/bi00563a017; RINDERKNECHT E, 1978, FEBS LETT, V89, P283, DOI 10.1016/0014-5793(78)80237-3; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; ROY M, 1989, J BIOL CHEM, V264, P19081; SHOELSON SE, 1993, J BIOL CHEM, V268, P4085; Smith GD, 1996, PROTEIN SCI, V5, P1502, DOI 10.1002/pro.5560050806; Smith GD, 2000, ACTA CRYSTALLOGR D, V56, P1541, DOI 10.1107/S0907444900012749; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Vikova J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19431; Ward CW, 2013, BIOESSAYS, V35, P945, DOI 10.1002/bies.201300065; Weiss MA, 2002, INSULIN & RELATED PROTEINS - STRUCTURE TO FUNCTION AND PHARMACOLOGY, P103, DOI 10.1007/0-306-47582-0_9; Weiss MA, 2013, FEBS LETT, V587, P1942, DOI 10.1016/j.febslet.2013.04.044; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Yang YW, 2010, J BIOL CHEM, V285, P10806, DOI 10.1074/jbc.M109.067850; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w; Zakova L, 2014, ACTA CRYSTALLOGR D, V70, P2765, DOI 10.1107/S1399004714017775; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033	82	20	19	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					12978	12990		10.1074/jbc.M115.708347	http://dx.doi.org/10.1074/jbc.M115.708347			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129279	hybrid, Green Published			2022-12-28	WOS:000379770500008
J	Allewell, NM				Allewell, Norma M.			Introduction to Biofilms Thematic Minireview Series	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The biofilms that many bacteria and fungi produce enable them to form communities, adhere tightly to surfaces, evade host immunity, and resist antibiotics. Pathogenic microorganisms that form biofilms are very difficult to eradicate and thus are a frequent source of life-threatening, hospital-acquired infections. This series of five minireviews from the Journal of Biological Chemistry provides a broad overview of our current understanding of biofilms and the challenges that remain. The structure, biosynthesis, and biological function of the biofilms produced by pathogenic fungi are the subject of the first article, by Sheppard and Howell. Gunn, Bakaletz, and Wozniak focus on the biochemistry and structure of bacterial biofilms, how these structures enable bacteria to evade host immunity, and current and developing strategies for overcoming this resistance. The third and fourth articles present two of the best understood cell signaling pathways involved in biofilm formation. Valentini and Filloux focus on cyclic di-GMP, while Kavanaugh and Horswill discuss the quorum-sensing (agr) system and the relationship between quorum sensing and biofilm formation. Mechanisms of antibiotic resistance, particularly the role of efflux pumps and the development of persister cells, are the topics of the final article by Van Acker and Coenye. The advances described in this series guarantee that ongoing interdisciplinary and international efforts will lead to new insights into the basic biology of biofilm formation, as well as new strategies for therapeutic interventions.	[Allewell, Norma M.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Allewell, NM (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	allewell@umd.edu						Gunn JS, 2016, J BIOL CHEM, V291, P12538, DOI 10.1074/jbc.R115.707547; Kavanaugh JS, 2016, J BIOL CHEM, V291, P12556, DOI 10.1074/jbc.R116.722710; Sheppard DC, 2016, J BIOL CHEM, V291, P12529, DOI 10.1074/jbc.R116.720995; Valentini M, 2016, J BIOL CHEM, V291, P12547, DOI 10.1074/jbc.R115.711507; Van Acker H, 2016, J BIOL CHEM, V291, P12565, DOI 10.1074/jbc.R115.707257	5	12	12	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12527	+		10.1074/jbc.R116.734103	http://dx.doi.org/10.1074/jbc.R116.734103			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129220	Green Published, hybrid			2022-12-28	WOS:000378119900007
J	Sheppard, DC; Howell, PL				Sheppard, Donald C.; Howell, P. Lynne			Biofilm Exopolysaccharides of Pathogenic Fungi: Lessons from Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDA-ALBICANS BIOFILMS; IN-VITRO ACTIVITY; STREPTOCOCCUS-THERMOPHILUS SFI6; PSEUDOMONAS-AERUGINOSA BIOFILM; AMYLOID-FORMING SEQUENCES; YEAST-CELL WALL; C-DI-GMP; ASPERGILLUS-FUMIGATUS; EXTRACELLULAR DNA; BETA-(1->3)GLUCAN SYNTHETASE	Exopolysaccharides play an important structural and functional role in the development and maintenance of microbial biofilms. Although the majority of research to date has focused on the exopolysaccharide systems of biofilm-forming bacteria, recent studies have demonstrated that medically relevant fungi such as Candida albicans and Aspergillus fumigatus also form biofilms during infection. These fungal biofilms share many similarities with those of bacteria, including the presence of secreted exopolysaccharides as core components of the extracellular matrix. This review will highlight our current understanding of fungal biofilm exopolysaccharides, as well as the parallels that can be drawn with those of their bacterial counterparts.	[Sheppard, Donald C.] McGill Univ, Ctr Hlth, Res Inst, Dept Med, Montreal, PQ H4A 3J1, Canada; [Sheppard, Donald C.] McGill Univ, Ctr Hlth, Res Inst, Dept Microbiol & Immunol, Montreal, PQ H4A 3J1, Canada; [Sheppard, Donald C.] McGill Univ, Ctr Hlth, Res Inst, Infect Dis & Immun Global Hlth Program, Montreal, PQ H4A 3J1, Canada; [Howell, P. Lynne] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 0A4, Canada; [Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	McGill University; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Sheppard, DC (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Dept Med, Montreal, PQ H4A 3J1, Canada.; Sheppard, DC (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Dept Microbiol & Immunol, Montreal, PQ H4A 3J1, Canada.; Sheppard, DC (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Infect Dis & Immun Global Hlth Program, Montreal, PQ H4A 3J1, Canada.	don.sheppard@mcgill.ca; howell@sickkids.ca	Sheppard, Donald/B-4637-2008	Sheppard, Donald/0000-0001-8877-880X	Canada Institute of Health Research [81361, 123306, 13337, 43998]; Cystic Fibrosis Canada [3019]; Chercheur-Boursier Award from the Fonds de Recherche Quebec Sante (FRQS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI119116] Funding Source: NIH RePORTER	Canada Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; Chercheur-Boursier Award from the Fonds de Recherche Quebec Sante (FRQS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Canada Institute of Health Research Grants 81361 (to P. L. H. and D. C. S.), 123306 (to D. C. S.), and 13337 and 43998 (to P. L. H.) and by Cystic Fibrosis Canada Grant 3019 (to P. L. H. and D. C. S.). This work is also supported by a Chercheur-Boursier Award from the Fonds de Recherche Quebec Sante (FRQS) (to D. C. S.). This is the first article in the Thematic Minireview series "Biofilms." The authors declare that they have no conflicts of interest with the contents of this article.	Al Abdallah Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049959; Alem MAS, 2006, EUKARYOT CELL, V5, P1770, DOI 10.1128/EC.00219-06; Bachmann SP, 2002, ANTIMICROB AGENTS CH, V46, P3591, DOI 10.1128/AAC.46.11.3591-3596.2002; Bamford NC, 2015, J BIOL CHEM, V290, P27438, DOI 10.1074/jbc.M115.679050; Beauvais A, 2005, APPL ENVIRON MICROB, V71, P1531, DOI 10.1128/AEM.71.3.1531-1538.2005; Beauvais A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003716; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Colvin KM, 2013, J BACTERIOL, V195, P2329, DOI 10.1128/JB.02150-12; Colvin KM, 2012, ENVIRON MICROBIOL, V14, P1913, DOI 10.1111/j.1462-2920.2011.02657.x; Dongari-Bagtzoglou A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007967; Douglas CM, 1997, ANTIMICROB AGENTS CH, V41, P2471, DOI 10.1128/AAC.41.11.2471; Fontaine T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002372; Fontaine T, 2010, FUNGAL GENET BIOL, V47, P707, DOI 10.1016/j.fgb.2010.04.006; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Fu Y, 2002, MOL MICROBIOL, V44, P61, DOI 10.1046/j.1365-2958.2002.02873.x; Garcia MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017632; Gravelat FN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003575; Gravelat FN, 2010, CELL MICROBIOL, V12, P473, DOI 10.1111/j.1462-5822.2009.01408.x; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Jain S, 2005, INFECT IMMUN, V73, P6429, DOI 10.1128/IAI.73.10.6429-6436.2005; Jennings LK, 2015, P NATL ACAD SCI USA, V112, P11353, DOI 10.1073/pnas.1503058112; Kawano S, 2002, J BIOSCI BIOENG, V94, P275, DOI 10.1263/jbb.94.275; Koseoglu VK, 2015, MOL MICROBIOL, V96, P728, DOI 10.1111/mmi.12966; Kondoh O, 1997, J BACTERIOL, V179, P7734, DOI 10.1128/jb.179.24.7734-7741.1997; Koo HM, 1998, BIOSCI BIOTECH BIOCH, V62, P2257, DOI 10.1271/bbb.62.2257; Lamarre C, 2009, CELL MICROBIOL, V11, P1612, DOI 10.1111/j.1462-5822.2009.01352.x; Lazzell AL, 2009, J ANTIMICROB CHEMOTH, V64, P567, DOI 10.1093/jac/dkp242; Lee MJ, 2016, MBIO, V7, DOI 10.1128/mBio.00252-16; Lee MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005187; Lee MJ, 2014, J BIOL CHEM, V289, P1243, DOI 10.1074/jbc.M113.522516; Li F, 2007, EUKARYOT CELL, V6, P931, DOI 10.1128/EC.00049-07; Lin CJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005205; Little DJ, 2015, J BIOL CHEM, V290, P22827, DOI 10.1074/jbc.M115.672469; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Loussert C, 2010, CELL MICROBIOL, V12, P405, DOI 10.1111/j.1462-5822.2009.01409.x; Martins M, 2012, MYCOSES, V55, P80, DOI 10.1111/j.1439-0507.2011.02047.x; Martins M, 2010, MYCOPATHOLOGIA, V169, P323, DOI 10.1007/s11046-009-9264-y; Maubon D, 2006, FUNGAL GENET BIOL, V43, P366, DOI 10.1016/j.fgb.2006.01.006; Mazur P, 1996, J BIOL CHEM, V271, P14604, DOI 10.1074/jbc.271.24.14604; Mio T, 1997, J BACTERIOL, V179, P4096, DOI 10.1128/jb.179.13.4096-4105.1997; Mishra M, 2012, CELL MICROBIOL, V14, P95, DOI 10.1111/j.1462-5822.2011.01704.x; Mitchell KF, 2013, ANTIMICROB AGENTS CH, V57, P1918, DOI 10.1128/AAC.02378-12; Mitchell KF, 2015, P NATL ACAD SCI USA, V112, P4092, DOI 10.1073/pnas.1421437112; Mowat E, 2007, J MED MICROBIOL, V56, P1205, DOI 10.1099/jmm.0.47247-0; Nakai T, 2013, J BACTERIOL, V195, P958, DOI 10.1128/JB.01473-12; Nett J, 2007, ANTIMICROB AGENTS CH, V51, P510, DOI 10.1128/AAC.01056-06; Nett JE, 2010, J INFECT DIS, V202, P171, DOI 10.1086/651200; NICHOLS WW, 1988, ANTIMICROB AGENTS CH, V32, P518, DOI 10.1128/AAC.32.4.518; Nobile CJ, 2008, CURR BIOL, V18, P1017, DOI 10.1016/j.cub.2008.06.034; Nobile CJ, 2006, CELL MICROBIOL, V8, P1382, DOI 10.1111/j.1462-5822.2006.00761.x; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; ORLEAN PAB, 1982, EUR J BIOCHEM, V127, P397, DOI 10.1111/j.1432-1033.1982.tb06885.x; Otoo HN, 2008, EUKARYOT CELL, V7, P776, DOI 10.1128/EC.00309-07; Bom VLP, 2015, EUKARYOT CELL, V14, P728, DOI 10.1128/EC.00008-15; Rajendran R, 2013, EUKARYOT CELL, V12, P420, DOI 10.1128/EC.00287-12; Ramage G, 2009, CRIT REV MICROBIOL, V35, P340, DOI 10.3109/10408410903241436; Ramsook CB, 2010, EUKARYOT CELL, V9, P393, DOI 10.1128/EC.00068-09; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Sadovskaya I, 2010, GLYCOBIOLOGY, V20, P895, DOI 10.1093/glycob/cwq047; SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995; SHEMATEK EM, 1980, J BIOL CHEM, V255, P895; SHEMATEK EM, 1980, J BIOL CHEM, V255, P888; Sheppard DC, 2004, J BIOL CHEM, V279, P30480, DOI 10.1074/jbc.M401929200; Stingele F, 1996, J BACTERIOL, V178, P1680, DOI 10.1128/jb.178.6.1680-1690.1996; Stingele F, 1999, MOL MICROBIOL, V32, P1287, DOI 10.1046/j.1365-2958.1999.01441.x; Taff HT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002848; TCHEKMEDYIAN NS, 1986, AM J MED SCI, V291, P419, DOI 10.1097/00000441-198606000-00009; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001; Whitney JC, 2012, J BIOL CHEM, V287, P23582, DOI 10.1074/jbc.M112.375378; Winkelstroter LK, 2015, MOL MICROBIOL, V96, P42, DOI 10.1111/mmi.12919; Xie ZH, 2012, J INFECT DIS, V206, P1936, DOI 10.1093/infdis/jis607; Zarnowski R, 2014, MBIO, V5, DOI 10.1128/mBio.01333-14; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	78	62	67	5	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12529	12537		10.1074/jbc.R116.720995	http://dx.doi.org/10.1074/jbc.R116.720995			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129222	Green Published, hybrid			2022-12-28	WOS:000378119900008
J	Ledoux, S; Guthrie, C				Ledoux, Sarah; Guthrie, Christine			Retinitis Pigmentosa Mutations in Bad Response to Refrigeration 2 (Brr2) Impair ATPase and Helicase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							U4/U6.U5 TRI-SNRNP; STRUCTURAL BASIS; DNA-BINDING; SPLICEOSOME; DOMAIN; PROTEIN; PRP8; ARCHITECTURE; HYDROLYSIS; ACTIVATION	Brr2 is an RNA-dependent ATPase required to unwind the U4/U6 snRNA duplex during spliceosome assembly. Mutations within the ratchet helix of the Brr2 RNA binding channel result in a form of degenerative human blindness known as retinitis pigmentosa (RP). The biochemical consequences of these mutations on Brr2's RNA binding, helicase, and ATPase activity have not yet been characterized. Therefore, we identified the largest construct of Brr2 that is soluble in vitro, which truncates the first 247 amino acids of the N terminus (Delta 247-Brr2), to characterize the effects of the RP mutations on Brr2 activity. The Delta 247-Brr2 RP mutants exhibit a gradient of severity of weakened RNA binding, reduced helicase activity, and reduced ATPase activity compared with wild type Delta 247-Brr2. The globular C-terminal Jab1/Mpn1-like domain of Prp8 increases the ability of Delta 247-Brr2 to bind the U4/U6 snRNA duplex at high pH and increases Delta 247-Brr2's RNA-dependent ATPase activity and the extent of RNA unwinding. However, this domain of Prp8 does not differentially affect the Delta 247-Brr2 RP mutants compared with the wild type Delta 247-Brr2. When stimulated by Prp8, wild type Delta 247-Brr2 is able to unwind long stable duplexes in vitro, and even the RP mutants capable of binding RNA with tight affinity are incapable of fully unwinding short duplex RNAs. Our data suggest that the RP mutations within the ratchet helix impair Brr2 translocation through RNA helices.	[Ledoux, Sarah; Guthrie, Christine] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Guthrie, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	christineguthrie@gmail.com			National Institutes of Health [GM021119-39]; American Cancer Society [118703-PF-10-061-01-RMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021119, R01GM021119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM021119-39 ( to C. G.) and American Cancer Society Postdoctoral Fellowship 118703-PF-10-061-01-RMC ( to S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Absmeier E, 2015, GENE DEV, V29, P2576, DOI 10.1101/gad.271528.115; Absmeier E, 2015, ACTA CRYSTALLOGR D, V71, P762, DOI 10.1107/S1399004715001005; Agafonov DE, 2016, SCIENCE, V351, P1416, DOI 10.1126/science.aad2085; Bellare P, 2008, NAT STRUCT MOL BIOL, V15, P444, DOI 10.1038/nsmb.1401; Benaglio P, 2011, HUM MUTAT, V32, pE2246, DOI 10.1002/humu.21485; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Hahn D, 2012, GENE DEV, V26, P2408, DOI 10.1101/gad.199307.112; Johnson SJ, 2013, RNA BIOL, V10, P33, DOI 10.4161/rna.22101; Kim DH, 1999, RNA, V5, P959, DOI 10.1017/S135583829999012X; Korneta I, 2012, NUCLEIC ACIDS RES, V40, P7046, DOI 10.1093/nar/gks347; Li ND, 2010, INVEST OPHTH VIS SCI, V51, P1036, DOI 10.1167/iovs.09-3725; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Mozaffari-Jovin S, 2014, RNA BIOL, V11, P298, DOI 10.4161/rna.28353; Mozaffari-Jovin S, 2013, SCIENCE, V341, P80, DOI 10.1126/science.1237515; Mozaffari-Jovin S, 2012, GENE DEV, V26, P2422, DOI 10.1101/gad.200949.112; Pena V, 2007, MOL CELL, V25, P615, DOI 10.1016/j.molcel.2007.01.023; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Richards JD, 2008, J BIOL CHEM, V283, P5118, DOI 10.1074/jbc.M707548200; Santos KF, 2012, P NATL ACAD SCI USA, V109, P17418, DOI 10.1073/pnas.1208098109; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; Taylor LL, 2014, NUCLEIC ACIDS RES, V42, P13861, DOI 10.1093/nar/gku1208; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Nguyen THD, 2013, STRUCTURE, V21, P910, DOI 10.1016/j.str.2013.04.017; Ventura GT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115941; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wan RX, 2016, SCIENCE, V351, P466, DOI 10.1126/science.aad6466; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Woodman IL, 2007, J MOL BIOL, V374, P1139, DOI 10.1016/j.jmb.2007.10.004; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Zhang LD, 2015, NUCLEIC ACIDS RES, V43, P3286, DOI 10.1093/nar/gkv062; Zhang LD, 2009, NAT STRUCT MOL BIOL, V16, P731, DOI 10.1038/nsmb.1625; Zhao C, 2006, HUM GENET, V119, P617, DOI 10.1007/s00439-006-0168-3; Zhao C, 2009, AM J HUM GENET, V85, P617, DOI 10.1016/j.ajhg.2009.09.020	36	9	10	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					11954	11965		10.1074/jbc.M115.710848	http://dx.doi.org/10.1074/jbc.M115.710848			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27072132	Green Published, hybrid			2022-12-28	WOS:000378092800001
J	Nakamura, Y; Morrow, DH; Modgil, A; Huyghe, D; Deeb, TZ; Lumb, MJ; Davies, PA; Moss, SJ				Nakamura, Yasuko; Morrow, Danielle H.; Modgil, Amit; Huyghe, Deborah; Deeb, Tarek Z.; Lumb, Michael J.; Davies, Paul A.; Moss, Stephen J.			Proteomic Characterization of Inhibitory Synapses Using a Novel pHluorin-tagged gamma-Aminobutyric Acid Receptor, Type A (GABA(A)), alpha 2 Subunit Knock-in Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; DIRECT BINDING; BETA 2; SUBTYPES; GEPHYRIN; PHOSPHORYLATION; TRAFFICKING; DYNAMICS; BENZODIAZEPINES; SCHIZOPHRENIA	Theaccumulation of gamma-aminobutyric acid receptors(GABA(A)Rs) at the appropriate postsynaptic sites is critical for determining the efficacy of fast inhibitory neurotransmission. Although we know that the majority of synaptic GABA(A)R subtypes are assembled from alpha 1-3, beta, and gamma 2 subunits, our understanding of how neurons facilitate their targeting to and stabilization at inhibitory synapses is rudimentary. To address these issues, we have created knock-in mice in which the pH-sensitive green fluorescent protein (GFP) and the Myc epitope were introduced to the extracellular domain of the mature receptor alpha 2 subunit (pH alpha 2). Using immunoaffinity purification and mass spectroscopy, we identified a stable complex of 174 proteins that were associated with pH alpha 2, including other GABA(A)R subunits, and previously identified receptor-associated proteins such as gephyrin and collybistin. 149 of these proteins were novel GABA(A)R binding partners and included G-protein-coupled receptors and ion channel subunits, proteins that regulate trafficking and degradation, regulators of protein phosphorylation, GTPases, and a number of proteins that regulate their activity. Notably, members of the postsynaptic density family of proteins that are critical components of excitatory synapses were not associated with GABA(A)Rs. Crucially, we demonstrated for a subset of these novel proteins (including cullin1, ephexin, potassium channel tetramerization domain containing protein 12, mitofusin2, metabotropic glutamate receptor 5, p21-activated kinase 7, and Ras-related protein 5A) bind directly to the intracellular domains of GABA(A)Rs, validating our proteomic analysis. Thus, our experiments illustrate the complexity of the GABA(A)R proteome and enhance our understanding of the mechanisms neurons use to construct inhibitory synapses.	[Nakamura, Yasuko; Morrow, Danielle H.; Modgil, Amit; Huyghe, Deborah; Deeb, Tarek Z.; Davies, Paul A.; Moss, Stephen J.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Lumb, Michael J.; Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, Mortimer St, London WC1E 6BT, England	Tufts University; University of London; University College London	Moss, SJ (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.; Moss, SJ (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Mortimer St, London WC1E 6BT, England.	Stephen.Moss@Tufts.edu	Nakamura, Yasuko/O-5551-2016; Davies, Paul A/P-4595-2017	Nakamura, Yasuko/0000-0002-0660-4126; Davies, Paul A/0000-0002-3973-3143	National Institutes of Health from NINDS [NS051195, NS056359, NS081735, R21NS080064, NS087662]; National Institute of Mental Health [MH097446]; Department of Defense Grant [AR140209]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH106954, R01MH097446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056359, R01NS081986, R21NS080064, R01NS051195, R01NS087662] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Defense Grant(United States Department of Defense); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS051195, NS056359, NS081735, R21NS080064, and NS087662 from NINDS ( to S. J. M.), National Institute of Mental Health Grant MH097446 ( to P. A. D. and S. J. M.), and Department of Defense Grant AR140209 ( to P. A. D. and S. J. M.). S. J. M. serves as a consultant for AstraZeneca and SAGE Therapeutics relationships that are regulated by Tufts University and do not impact this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramian AM, 2010, J BIOL CHEM, V285, P41795, DOI 10.1074/jbc.M110.149229; Balasubramanian S, 2004, J BIOL CHEM, V279, P18840, DOI 10.1074/jbc.M313470200; Benke D, 2004, J BIOL CHEM, V279, P43654, DOI 10.1074/jbc.M407154200; Besheer J, 2005, NEUROPSYCHOPHARMACOL, V30, P747, DOI 10.1038/sj.npp.1300616; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brandon NJ, 2003, MOL CELL NEUROSCI, V22, P87, DOI 10.1016/S1044-7431(02)00017-9; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Charych EI, 2009, NEUROPHARMACOLOGY, V57, P481, DOI 10.1016/j.neuropharm.2009.07.027; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1996, P NATL ACAD SCI USA, V93, P9899, DOI 10.1073/pnas.93.18.9899; del Rio JC, 2001, J NEUROCHEM, V79, P183; DUGGAN MJ, 1991, J BIOL CHEM, V266, P24778; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Gorrie GH, 1997, J NEUROSCI, V17, P6587; Heller EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039572; Hortnagl H, 2013, NEUROSCIENCE, V236, P345, DOI 10.1016/j.neuroscience.2013.01.008; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jacob TC, 2012, P NATL ACAD SCI USA, V109, P18595, DOI 10.1073/pnas.1204994109; Ju YH, 2009, J NEUROSCI RES, V87, P1737, DOI 10.1002/jnr.21991; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; McDonald BJ, 1997, NEUROPHARMACOLOGY, V36, P1377, DOI 10.1016/S0028-3908(97)00111-1; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Patel B, 2014, BRIT J PHARMACOL, V171, P985, DOI 10.1111/bph.12514; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; POLLARD S, 1995, J BIOL CHEM, V270, P21285, DOI 10.1074/jbc.270.36.21285; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Rudolph U, 2014, ANNU REV PHARMACOL, V54, P483, DOI 10.1146/annurev-pharmtox-011613-135947; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Shi Lei, 2010, Commun Integr Biol, V3, P622, DOI 10.4161/cib.3.6.13481; Shi L, 2010, NEURON, V65, P204, DOI 10.1016/j.neuron.2010.01.012; Sieghart W, 2015, ADV PHARMACOL, V72, P53, DOI 10.1016/bs.apha.2014.10.002; Smith KR, 2014, CELL REP, V9, P298, DOI 10.1016/j.celrep.2014.08.061; Smith KR, 2012, J NEUROSCI, V32, P2485, DOI 10.1523/JNEUROSCI.1622-11.2011; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stuppia G, 2015, J NEUROL SCI, V356, P7, DOI 10.1016/j.jns.2015.05.033; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173	53	40	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12394	12407		10.1074/jbc.M116.724443	http://dx.doi.org/10.1074/jbc.M116.724443			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27044742	hybrid, Green Published			2022-12-28	WOS:000378092800037
J	Huang, K; Zhang, JJ; O'Neill, KL; Gurumurthy, CB; Quadros, RM; Tu, YP; Luo, X				Huang, Kai; Zhang, Jingjing; O'Neill, Katelyn L.; Gurumurthy, Channabasavaiah B.; Quadros, Rolen M.; Tu, Yaping; Luo, Xu			Cleavage by Caspase 8 and Mitochondrial Membrane Association Activate the BH3-only Protein Bid during TRAIL-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; CELL-DEATH; BCL-2 FAMILY; PROMOTES APOPTOSIS; BAX; RECEPTORS; PATHWAYS; PERMEABILIZATION; MODULATION; AGONISTS	The BH3-only protein Bid is known as a critical mediator of the mitochondrial pathway of apoptosis following death receptor activation. However, since full-length Bid possesses potent apoptotic activity, the role of a caspase-mediated Bid cleavage is not established in vivo. In addition, due to the fact that multiple caspases cleave Bid at the same site in vitro, the identity of the Bid-cleaving caspase during death receptor signaling remains uncertain. Moreover, as Bid maintains its overall structure following its cleavage by caspase 8, it remains unclear how Bid is activated upon cleavage. Here, Bid-deficient (Bid KO) colon cancer cells were generated by gene editing, and were reconstituted with wild-type or mutants of Bid. While the loss of Bid blocked apoptosis following treatment by TNF-related apoptosis inducing ligand (TRAIL), this blockade was relieved by re-introduction of the wild-type Bid. In contrast, the caspase-resistant mutant Bid(D60E) and a BH3 defective mutant Bid(G94E) failed to restore TRAIL-induced apoptosis. By generating Bid/Bax/Bak-deficient (TKO) cells, we demonstrated that Bid is primarily cleaved by caspase 8, not by effector caspases, to give rise to truncated Bid (tBid) upon TRAIL treatment. Importantly, despite the presence of an intact BH3 domain, a tBid mutant lacking the mitochondrial targeting helices (alpha 6 and alpha 7) showed diminished apoptotic activity. Together, these results for the first time establish that cleavage by caspase 8 and the subsequent association with the outer mitochondrial membrane are two critical events that activate Bid during death receptor-mediated apoptosis.	[Huang, Kai; Zhang, Jingjing; O'Neill, Katelyn L.; Luo, Xu] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Gurumurthy, Channabasavaiah B.; Quadros, Rolen M.] Univ Nebraska Med Ctr, Munroe Meyer Inst Genet & Rehabil, Dept Dev Neurosci, Omaha, NE 68198 USA; [Gurumurthy, Channabasavaiah B.] Univ Nebraska Med Ctr, Mouse Genome Engn Core Facil, Vice Chancellor Res Off, Omaha, NE 68198 USA; [Tu, Yaping] Creighton Univ, Sch Med, Dept Pharmacol, Omaha, NE 68178 USA; [Zhang, Jingjing] Cent S Univ, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Creighton University; Central South University	Luo, X (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	xuluo@unmc.edu	Gurumurthy, Channabasavaiah B/H-8268-2016; Gurumurthy, Channabasavaiah B/E-7205-2011	Gurumurthy, Channabasavaiah B/0000-0002-8022-4033; 	Nebraska Center for Cellular Signaling; NIGMS, National Institutes of Health [P30 GM106397]; National Institutes of Health [1R21CA193271]; NATIONAL CANCER INSTITUTE [R21CA193271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397] Funding Source: NIH RePORTER	Nebraska Center for Cellular Signaling; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Nebraska Center for Cellular Signaling, which is funded by an Institutional Development Award (IDeA) from NIGMS, National Institutes of Health under Grant P30 GM106397, and by National Institutes of Health Grant 1R21CA193271 (to Y. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Gao ZH, 2005, J BIOL CHEM, V280, P38271, DOI 10.1074/jbc.M506488200; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Lopez H, 2010, J BIOL CHEM, V285, P15016, DOI 10.1074/jbc.M109.086231; Luo X, 1996, MOL CELL BIOL, V16, P1367; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Reiners JJ, 2002, CELL DEATH DIFFER, V9, P934, DOI 10.1038/sj.cdd.4401048; Sarig R, 2003, J BIOL CHEM, V278, P10707, DOI 10.1074/jbc.M210296200; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Stegh AH, 2002, J BIOL CHEM, V277, P4351, DOI 10.1074/jbc.M108947200; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Sutton VR, 2000, J EXP MED, V192, P1403, DOI 10.1084/jem.192.10.1403; Valentijn AJ, 2004, J BIOL CHEM, V279, P32848, DOI 10.1074/jbc.M313375200; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang L, 2011, CELL DEATH DIFFER, V18, P864, DOI 10.1038/cdd.2010.152	47	71	74	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11843	11851		10.1074/jbc.M115.711051	http://dx.doi.org/10.1074/jbc.M115.711051			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27053107	Green Published, hybrid			2022-12-28	WOS:000377264800033
J	Lyons, B; Ravulapalli, R; Lanoue, J; Lugo, MR; Dutta, D; Carlin, S; Merrill, AR				Lyons, Bronwyn; Ravulapalli, Ravikiran; Lanoue, Jason; Lugo, Miguel R.; Dutta, Debajyoti; Carlin, Stephanie; Merrill, A. Rod			Scabin, a Novel DNA-acting ADP-ribosyltransferase from Streptomyces scabies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial toxin; bioinformatics; crystallography; DNA binding protein; enzyme kinetics; fluorescence; molecular modeling	APOPTOSIS-INDUCING PROTEIN; IOTA-TOXIN; RIBOSYLATION; MECHANISM; INHIBITORS; BOTULINUM; INSIGHTS; ENZYME; DOMAIN	A bioinformatics strategy was used to identify Scabin, a novel DNA-targeting enzyme from the plant pathogen 87.22 strain of Streptomyces scabies. Scabin shares nearly 40% sequence identity with the Pierisin family of mono-ADP-ribosyltransferase toxins. Scabin was purified to homogeneity as a 22-kDa single-domain enzyme and was shown to possess high NAD(+)-glycohydrolase (K-m(NAD) = 68 +/- 3 m; k(cat) = 94 +/- 2 min(-1)) activity with an RSQXE motif; it was also shown to target deoxyguanosine and showed sigmoidal enzyme kinetics (K-0.5(deoxyguanosine) = 302 +/- 12 m; k(cat) = 14 min(-1)). Mass spectrometry analysis revealed that Scabin labels the exocyclic amino group on guanine bases in either single-stranded or double-stranded DNA. Several small molecule inhibitors were identified, and the most potent compounds were found to inhibit the enzyme activity with K-i values ranging from 3 to 24 m. PJ34, a well known inhibitor of poly-ADP-ribosyltransferases, was shown to be the most potent inhibitor of Scabin. Scabin was crystallized, representing the first structure of a DNA-targeting mono-ADP-ribosyltransferase enzyme; the structures of the apo-form (1.45 ) and with two inhibitors (P6-E, 1.4 ; PJ34, 1.6 ) were solved. These x-ray structures are also the first high resolution structures of the Pierisin subgroup of the mono-ADP-ribosyltransferase toxin family. A model of Scabin with its DNA substrate is also proposed.	[Lyons, Bronwyn; Ravulapalli, Ravikiran; Lanoue, Jason; Lugo, Miguel R.; Carlin, Stephanie; Merrill, A. Rod] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Dutta, Debajyoti] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2R3, Canada	University of Guelph; University of Alberta	Merrill, AR (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rmerrill@uoguelph.ca	Lanoue, Jason/AAF-3363-2020; Merrill, Rod/M-8313-2014; Dutta, Debajyoti/AGT-3216-2022; Dutta, Debajyoti/E-2798-2018	Dutta, Debajyoti/0000-0003-0403-2192; Dutta, Debajyoti/0000-0003-0403-2192; Lanoue, Jason/0000-0002-8935-5718	Canadian Institutes of Health Research [MOP-106661]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (Grant MOP-106661 to A. R. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKTORIES K, 1988, EUR J BIOCHEM, V172, P445, DOI 10.1111/j.1432-1033.1988.tb13908.x; Armstrong S, 2001, ANAL BIOCHEM, V292, P26, DOI 10.1006/abio.2001.5052; BARBIERI JT, 1989, INFECT IMMUN, V57, P3549, DOI 10.1128/IAI.57.11.3549-3554.1989; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fieldhouse RJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001029; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Goyer C, 1997, PLANT DIS, V81, P901, DOI 10.1094/PDIS.1997.81.8.901; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Healey A, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-21; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Jorgensen R, 2008, J BIOL CHEM, V283, P10671, DOI 10.1074/jbc.M710008200; Joshi MV, 2010, MOL MICROBIOL, V77, P252, DOI 10.1111/j.1365-2958.2010.07206.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krska D, 2015, J BIOL CHEM, V290, P1639, DOI 10.1074/jbc.M114.589846; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lerat S, 2009, MOL PLANT PATHOL, V10, P579, DOI [10.1111/J.1364-3703.2009.00561.X, 10.1111/j.1364-3703.2009.00561.x]; Lesnick ML, 2001, MOL MICROBIOL, V39, P1464, DOI 10.1046/j.1365-2958.2001.02360.x; Lugo M. R., 2016, J BIOMOL STRUCT DYN, V26, P1; Lugo MR, 2015, J BIOMOL STRUCT DYN, V33, P2452, DOI 10.1080/07391102.2014.1000972; Lugo MR, 2015, J MOL RECOGNIT, V28, P539, DOI 10.1002/jmr.2469; Masignani V, 2004, INT J MED MICROBIOL, V293, P471, DOI 10.1078/1438-4221-00296; Nakano T, 2015, CURR TOP MICROBIOL, V384, P127, DOI 10.1007/82_2014_416; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Parikh SL, 2004, BIOCHEMISTRY-US, V43, P1204, DOI 10.1021/bi035907z; Ravulapalli R, 2015, BIOCHEMISTRY-US, V54, P5920, DOI 10.1021/acs.biochem.5b00921; Reinert DJ, 2006, J MOL BIOL, V357, P1226, DOI 10.1016/j.jmb.2006.01.025; Sakurai J, 2003, ADV ENZYME REGUL, V43, P361, DOI 10.1016/S0065-2571(02)00044-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Takamura-Enya T, 2001, P NATL ACAD SCI USA, V98, P12414, DOI 10.1073/pnas.221444598; Tsurumura T, 2013, P NATL ACAD SCI USA, V110, P4267, DOI 10.1073/pnas.1217227110; Turgeon Z, 2011, ANTIMICROB AGENTS CH, V55, P983, DOI 10.1128/AAC.01164-10; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Visschedyk D, 2012, J BIOL CHEM, V287, P41089, DOI 10.1074/jbc.M112.412809; Visschedyk DD, 2010, J BIOL CHEM, V285, P13525, DOI 10.1074/jbc.M109.077339; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; Watanabe M, 1999, P NATL ACAD SCI USA, V96, P10608, DOI 10.1073/pnas.96.19.10608; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007; Yates SP, 2005, BIOCHEM J, V385, P667, DOI 10.1042/BJ20041480	45	36	37	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11198	11215		10.1074/jbc.M115.707653	http://dx.doi.org/10.1074/jbc.M115.707653			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27002155	hybrid, Green Published			2022-12-28	WOS:000377042100022
J	Prinz, F; Puetter, V; Holton, SJ; Andres, D; Stegmann, CM; Kwiatkowski, D; Prechtl, S; Petersen, K; Beckmann, G; Kreft, B; Mumberg, D; Fernandez-Montalvan, A				Prinz, Florian; Puetter, Vera; Holton, Simon J.; Andres, Dorothee; Stegmann, Christian M.; Kwiatkowski, Dennis; Prechtl, Stefan; Petersen, Kirstin; Beckmann, Georg; Kreft, Bertolt; Mumberg, Dominik; Fernandez-Montalvan, Amaury			Functional and Structural Characterization of Bub3 center dot BubR1 Interactions Required for Spindle Assembly Checkpoint Signaling in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kinetics; mitosis; protein-protein interaction; structure-function; thermodynamics; Bub3; BubR1; WD40; spindle assembly checkpoint	PROTEIN-PROTEIN INTERACTIONS; AGING-ASSOCIATED PHENOTYPES; BREAST-CANCER CELLS; MITOTIC CHECKPOINT; CHROMOSOME MISSEGREGATION; WDR5-MLL INTERACTION; SMALL MOLECULES; HIGH-AFFINITY; BUB3; MICE	The spindle assembly checkpoint (SAC) is an essential safeguarding mechanism devised to ensure equal chromosome distribution in daughter cells upon mitosis. The proteins Bub3 and BubR1 are key components of the mitotic checkpoint complex, an essential part of the molecular machinery on which the SAC relies. In the present work we have performed a detailed functional and biochemical characterization of the interaction between human Bub3 and BubR1 in cells and in vitro. Our results demonstrate that genetic knockdown of Bub3 abrogates the SAC, promotes apoptosis, and inhibits the proliferation of human cancer cells. We also show that the integrity of the human mitotic checkpoint complex depends on the specific recognition between BubR1 and Bub3, for which the BubR1 Gle2 binding sequence motif is essential. This 1:1 binding event is high affinity, enthalpy-driven and with slow dissociation kinetics. The affinity, kinetics, and thermodynamic parameters of the interaction are differentially modulated by small regions in the N and C termini of the Gle2 binding domain sequence, suggesting the existence of hotspots for this protein-protein interaction. Furthermore, we show that specific disruption of endogenous BubR1Bub3 complexes in human cancer cells phenocopies the effects observed in gene targeting experiments. Our work enhances the current understanding of key members of the SAC and paves the road for the pursuit of novel targeted cancer therapies based on SAC inhibition.	[Puetter, Vera; Holton, Simon J.; Andres, Dorothee; Stegmann, Christian M.; Kwiatkowski, Dennis; Prechtl, Stefan; Fernandez-Montalvan, Amaury] Bayer Pharma AG, Global Drug Discovery, Lead Discovery, D-13353 Berlin, Germany; [Beckmann, Georg] Bayer Pharma AG, Global Drug Discovery, Target Discovery, D-13353 Berlin, Germany; [Prinz, Florian; Petersen, Kirstin; Kreft, Bertolt; Mumberg, Dominik] Bayer Pharma AG, Global Drug Discovery, TRG Discovery, D-13353 Berlin, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals	Fernandez-Montalvan, A (corresponding author), Bayer Pharma AG, Global Drug Discovery, Lead Discovery, D-13353 Berlin, Germany.; Prinz, F (corresponding author), Bayer Pharma AG, Global Drug Discovery, TRG Discovery, D-13353 Berlin, Germany.	florian.prinz@bayer.com; amaury.fernandez@bayer.com		Fernandez-Montalvan, Amaury/0000-0001-9156-0000; Kwiatkowski, Dennis/0000-0002-8235-9716				Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Baker DJ, 2006, J CELL BIOL, V172, P529, DOI 10.1083/jcb.200507081; Bolshan Y, 2013, ACS MED CHEM LETT, V4, P353, DOI 10.1021/ml300467n; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Chari A, 2015, NAT METHODS, V12, P859, DOI [10.1038/NMETH.3493, 10.1038/nmeth.3493]; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Daniel J, 2011, P NATL ACAD SCI USA, V108, P5384, DOI 10.1073/pnas.1007645108; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Grebien F, 2015, NAT CHEM BIOL, V11, P571, DOI [10.1038/nchembio.1859, 10.1038/NCHEMBIO.1859]; Hahn M, 2001, J MOL BIOL, V314, P293, DOI 10.1006/jmbi.2001.5135; Han JS, 2014, P NATL ACAD SCI USA, V111, pE4185, DOI 10.1073/pnas.1416277111; Harris L, 2005, EXP CELL RES, V308, P85, DOI 10.1016/j.yexcr.2005.03.036; Hutsell SQ, 2010, METHODS MOL BIOL, V627, P75, DOI 10.1007/978-1-60761-670-2_4; Jemaa M, 2013, CELL DEATH DIFFER, V20, P1532, DOI 10.1038/cdd.2013.105; Jemaa M, 2012, EMBO MOL MED, V4, P500, DOI 10.1002/emmm.201200228; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Kalitsis P, 2005, GENE CHROMOSOME CANC, V44, P29, DOI 10.1002/gcc.20215; Karatas H, 2013, J AM CHEM SOC, V135, P669, DOI 10.1021/ja306028q; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Krenn V, 2012, J CELL BIOL, V196, P451, DOI 10.1083/jcb.201110013; Larsen NA, 2004, J MOL BIOL, V344, P885, DOI 10.1016/j.jmb.2004.09.094; Larsen NA, 2007, P NATL ACAD SCI USA, V104, P1201, DOI 10.1073/pnas.0610358104; Layton CJ, 2011, PROTEIN SCI, V20, P1439, DOI 10.1002/pro.674; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logarinho E, 2008, CELL CYCLE, V7, P1763, DOI 10.4161/cc.7.12.6180; London N, 2013, CURR OPIN CHEM BIOL, V17, P952, DOI 10.1016/j.cbpa.2013.10.011; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Myszka DG, 1998, BIOPHYS J, V75, P583, DOI 10.1016/S0006-3495(98)77549-6; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; O'Brien R, 2000, PROTEIN SCI, V9, P570; Overlack K, 2015, ELIFE, V4, DOI 10.7554/eLife.05269; Primorac I, 2013, ELIFE, V2, DOI 10.7554/eLife.01030; Rich RL, 2000, CURR OPIN BIOTECH, V11, P54, DOI 10.1016/S0958-1669(99)00054-3; Sackton KL, 2014, NATURE, V514, P646, DOI 10.1038/nature13660; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Senisterra G, 2013, BIOCHEM J, V449, P151, DOI 10.1042/BJ20121280; Shepperd LA, 2012, CURR BIOL, V22, P891, DOI 10.1016/j.cub.2012.03.051; Slee RB, 2014, MOL CANCER THER, V13, P307, DOI 10.1158/1535-7163.MCT-13-0324; Stolt PC, 2004, BIOCHEMISTRY-US, V43, P10979, DOI 10.1021/bi049092l; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tange Y, 2008, GENETICS, V179, P785, DOI 10.1534/genetics.107.081695; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Verdine GL, 2012, METHOD ENZYMOL, V503, P3, DOI 10.1016/B978-0-12-396962-0.00001-X; Wang XS, 2001, J BIOL CHEM, V276, P26559, DOI 10.1074/jbc.M101083200; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wilson DK, 2005, J BIOL CHEM, V280, P13944, DOI 10.1074/jbc.M412919200; Windecker H, 2009, EMBO REP, V10, P1022, DOI 10.1038/embor.2009.183; Yamagishi Y, 2012, NAT CELL BIOL, V14, P746, DOI 10.1038/ncb2515; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903	59	7	7	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11252	11267		10.1074/jbc.M115.702142	http://dx.doi.org/10.1074/jbc.M115.702142			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27030009	Green Published, hybrid			2022-12-28	WOS:000377042100026
J	Sparks, AE; Chen, C; Breslin, MB; Lan, MS				Sparks, Avis E.; Chen, Chiachen; Breslin, Mary B.; Lan, Michael S.			Functional Domains of Autoimmune Regulator (AIRE) Modulate INS-VNTR Transcription in Human Thymic Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; insulin; protein domain; transcription; type 1 diabetes; AIRE; VNTR; insulin autoimmunity; thymus	CANDIDIASIS-ECTODERMAL DYSTROPHY; CENTRAL TOLERANCE; INSULIN-TREATMENT; GENE-EXPRESSION; BINDING PROTEIN; HISTONE H3K4; PHD FINGER; MUTATIONS; AUTOANTIBODIES; INHERITANCE	INS-VNTR (insulin-variable number of tandem repeats) and AIRE (autoimmune regulator) have been associated with the modulation of insulin gene expression in thymus, which is essential to induce either insulin tolerance or the development of insulin autoimmunity and type 1 diabetes. We sought to analyze whether each functional domain of AIRE is critical for the activation of INS-VNTR in human thymic epithelial cells. Twelve missense or nonsense mutations in AIRE and two chimeric AIRE constructs were generated. A luciferase reporter assay and a pulldown assay using biotinylated INS-class I VNTR probe were performed to examine the transactivation and binding activities of WT, mutant, and chimeric AIREs on the INS-VNTR promoter. Confocal microscopy analysis was performed for WT or mutant AIRE cellular localization. We found that all of the AIRE mutations resulted in loss of transcriptional activation of INS-VNTR except mutant P252L. Using WT/mutant AIRE heterozygous forms to modulate the INS-VNTR target revealed five mutations (R257X, G228W, C311fsX376, L397fsX478, and R433fsX502) that functioned in a dominant negative fashion. The LXXLL-3 motif is identified for the first time to be essential for DNA binding to INS-VNTR, whereas the intact PHD1, PHD2, LXXLL-3, and LXXLL-4 motifs were important for successful transcriptional activation. AIRE nuclear localization in the human thymic epithelial cell line was disrupted by mutations in the homogenously staining region domain and the R257X mutation in the PHD1 domain. This study supports the notion that AIRE mutation could specifically affect human insulin gene expression in thymic epithelial cells through INS-VNTR and subsequently induce either insulin tolerance or autoimmunity.	[Sparks, Avis E.; Chen, Chiachen; Breslin, Mary B.; Lan, Michael S.] Childrens Hosp, Res Inst Children, 200 Henry Clay Ave, New Orleans, LA 70118 USA; [Lan, Michael S.] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70112 USA; [Lan, Michael S.] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA 70112 USA	Children's Hospital of New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Lan, MS (corresponding author), Childrens Hosp, Res Inst Children, 200 Henry Clay Ave, New Orleans, LA 70118 USA.	mlan@chnola-research.org	Lan, Michael/CAF-1839-2022		American Diabetes Association [ADA-1-13-BS-101]; Research Institute for Children, Children's Hospital, New Orleans, LA	American Diabetes Association(American Diabetes Association); Research Institute for Children, Children's Hospital, New Orleans, LA	This work was supported by American Diabetes Association Research Grant ADA-1-13-BS-101 (to M. S. L.) and in part by the Research Institute for Children, Children's Hospital, New Orleans, LA. Part of the data was presented as a poster in the 74th Scientific Sessions of the American Diabetes Association annual meeting, June 13-17, 2014 in San Francisco. The authors declare that they have no conflicts of interest with the contents of this article.	AHONEN P, 1985, CLIN GENET, V27, P535, DOI 10.1111/j.1399-0004.1985.tb02037.x; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Awata T, 2007, J CLIN ENDOCR METAB, V92, P1791, DOI 10.1210/jc.2006-2242; Bjorses P, 2000, AM J HUM GENET, V66, P378, DOI 10.1086/302765; Bottomley MJ, 2005, J BIOL CHEM, V280, P11505, DOI 10.1074/jbc.M413959200; Cai CQ, 2011, DIABETES, V60, P336, DOI 10.2337/db10-0255; Cetani F, 2001, J CLIN ENDOCR METAB, V86, P4747, DOI 10.1210/jc.86.10.4747; Cihakova D, 2001, HUM MUTAT, V18, P225, DOI 10.1002/humu.1178; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Fan Y, 2009, EMBO J, V28, P2812, DOI 10.1038/emboj.2009.212; Ferguson BJ, 2008, J BIOL CHEM, V283, P1723, DOI 10.1074/jbc.M707211200; FERNANDEZ E, 1994, BLOOD, V83, P3245; Finnish-German A.C., 1997, NAT GENET, V17, P399, DOI DOI 10.1038/NG1297-399; Giraud M, 2007, NATURE, V448, P934, DOI 10.1038/nature06066; Halonen M, 2004, HUM MUTAT, V23, P245, DOI 10.1002/humu.20003; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Heino M, 1999, HUM MUTAT, V13, P69, DOI 10.1002/(SICI)1098-1004(1999)13:1<69::AID-HUMU8>3.0.CO;2-6; Heino M, 2001, HUM MUTAT, V18, P205, DOI 10.1002/humu.1176; Ilmarinen T, 2005, HUM MUTAT, V26, P322, DOI 10.1002/humu.20224; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; KUGLIN B, 1988, DIABETES, V37, P130, DOI 10.2337/diabetes.37.1.130; Kumar PG, 2001, J BIOL CHEM, V276, P41357, DOI 10.1074/jbc.M104898200; Kyewski B, 2010, CELL, V140, P24, DOI 10.1016/j.cell.2009.12.036; Liiv I, 2008, BBA-MOL CELL RES, V1783, P74, DOI 10.1016/j.bbamcr.2007.09.003; Meloni A, 2005, Hum Mutat, V25, P319, DOI 10.1002/humu.9309; Meloni A, 2008, MOL IMMUNOL, V45, P805, DOI 10.1016/j.molimm.2007.06.156; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Oftedal BE, 2015, IMMUNITY, V42, P1185, DOI 10.1016/j.immuni.2015.04.021; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Pitkanen J, 2001, J BIOL CHEM, V276, P19597, DOI 10.1074/jbc.M008322200; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Plevin MJ, 2005, TRENDS BIOCHEM SCI, V30, P66, DOI 10.1016/j.tibs.2004.12.001; Su MA, 2008, J CLIN INVEST, V118, P1712, DOI 10.1172/JCI34523; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; Wang CY, 1998, HUM GENET, V103, P681, DOI 10.1007/s004390050891; Ward L, 1999, J CLIN ENDOCR METAB, V84, P844, DOI 10.1210/jc.84.3.844; Zumer K, 2012, MOL CELL BIOL, V32, P1354, DOI 10.1128/MCB.06359-11	40	12	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11313	11322		10.1074/jbc.M116.722488	http://dx.doi.org/10.1074/jbc.M116.722488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27048654	hybrid, Green Published			2022-12-28	WOS:000377042100030
J	Zorzini, V; Mernik, A; Lah, J; Sterckx, YGJ; De Jonge, N; Garcia-Pino, A; De Greve, H; Versees, W; Loris, R				Zorzini, Valentina; Mernik, Andrej; Lah, Jurij; Sterckx, Yann G. J.; De Jonge, Natalie; Garcia-Pino, Abel; De Greve, Henri; Versees, Wim; Loris, Remy			Substrate Recognition and Activity Regulation of the Escherichia coli mRNA Endonuclease MazF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; ribonuclease; stress response; structure-function; substrate specificity; persistence; toxin-antitoxin	TOXIN-ANTITOXIN MODULES; PERSISTER CELLS; SELECTIVE TRANSLATION; FUNCTIONAL-ANALYSIS; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; CLEAVAGE; INTERFERASE; PROTEIN; MECHANISMS	Escherichia coli MazF (EcMazF) is the archetype of a large family of ribonucleases involved in bacterial stress response. The crystal structure of EcMazF in complex with a 7-nucleotide substrate mimic explains the relaxed substrate specificity of the E. coli enzyme relative to its Bacillus subtilis counterpart and provides a framework for rationalizing specificity in this enzyme family. In contrast to a conserved mode of substrate recognition and a conserved active site, regulation of enzymatic activity by the antitoxin EcMazE diverges from its B. subtilis homolog. Central in this regulation is an EcMazE-induced double conformational change as follows: a rearrangement of a crucial active site loop and a relative rotation of the two monomers in the EcMazF dimer. Both are induced by the C-terminal residues Asp-78-Trp-82 of EcMazE, which are also responsible for strong negative cooperativity in EcMazE-EcMazF binding. This situation shows unexpected parallels to the regulation of the F-plasmid CcdB activity by CcdA and further supports a common ancestor despite the different activities of the MazF and CcdB toxins. In addition, we pinpoint the origin of the lack of activity of the E24A point mutant of EcMazF in its inability to support the substrate binding-competent conformation of EcMazF.	[Zorzini, Valentina; Sterckx, Yann G. J.; De Jonge, Natalie; Garcia-Pino, Abel; De Greve, Henri; Versees, Wim; Loris, Remy] Vrije Univ Brussel, Dept Biotechnol, Struct Biol Brussels, Pl Laan 2, B-1050 Brussels, Belgium; [Zorzini, Valentina; Sterckx, Yann G. J.; De Jonge, Natalie; De Greve, Henri; Versees, Wim; Loris, Remy] VIB, Struct Biol Res Ctr, Pl Laan 2, B-1050 Brussels, Belgium; [Mernik, Andrej; Lah, Jurij] Univ Ljubljana, Fac Chem & Chem Technol, Vecna Pot 113, Ljubljana 1000, Slovenia; [Garcia-Pino, Abel] Univ Libre Bruxelles, Biol Struct & Biophys, Rue Prof Jeener & Brachet 12, B-6041 Gosselies, Belgium; [Zorzini, Valentina] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, B-3000 Leuven, Belgium; [De Jonge, Natalie] arGEN X, Technol Pk 30, B-9052 Zwijnaarde, Belgium	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); University of Ljubljana; Universite Libre de Bruxelles; KU Leuven	Loris, R (corresponding author), Vrije Univ Brussel, Dept Biotechnol, Struct Biol Brussels, Pl Laan 2, B-1050 Brussels, Belgium.; Loris, R (corresponding author), VIB, Struct Biol Res Ctr, Pl Laan 2, B-1050 Brussels, Belgium.	reloris@vub.ac.be	Loris, Remy/GPG-0894-2022; Sterckx, Yann G.-J./F-2269-2017; Versées, Wim/H-5518-2015	Sterckx, Yann G.-J./0000-0002-7420-0983; Versees, Wim/0000-0002-4695-696X; Zorzini, Valentina/0000-0002-8727-309X; Loris, Remy/0000-0002-8862-3338	ESRF, Grenoble, France [BM29]; SOLEIL, Gif-sur-Yvette, France [PROXIMA-1, PROXIMA-2a]	ESRF, Grenoble, France; SOLEIL, Gif-sur-Yvette, France	We thank the beamline scientists from BM29 (ESRF, Grenoble, France) and PROXIMA-1 and PROXIMA-2a (SOLEIL, Gif-sur-Yvette, France) for their support.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agarwal S, 2010, J BIOL CHEM, V285, P7254, DOI 10.1074/jbc.M109.073387; Amato SM, 2013, MOL CELL, V50, P475, DOI 10.1016/j.molcel.2013.04.002; Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; Belitsky M, 2011, MOL CELL, V41, P625, DOI 10.1016/j.molcel.2011.02.023; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen-Dalsgaard M, 2008, NUCLEIC ACIDS RES, V36, P6472, DOI 10.1093/nar/gkn667; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; D'Alessio G., 1997, RIBONUCLEASES STRUCT; Dao-Thi MH, 2005, J MOL BIOL, V348, P1091, DOI 10.1016/j.jmb.2005.03.049; De Jonge N, 2010, J BIOL CHEM, V285, P5606, DOI 10.1074/jbc.M109.068429; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; Dunican BF, 2015, BIOCHEMISTRY-US, V54, P7048, DOI 10.1021/acs.biochem.5b00866; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Germain E, 2015, P NATL ACAD SCI USA, V112, P5171, DOI 10.1073/pnas.1423536112; Hargreaves D, 2002, STRUCTURE, V10, P1425, DOI 10.1016/S0969-2126(02)00856-0; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kamphuis MB, 2007, PROTEINS, V67, P219, DOI 10.1002/prot.21254; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Li GY, 2006, J MOL BIOL, V357, P139, DOI 10.1016/j.jmb.2005.12.035; Loris R, 1999, J MOL BIOL, V285, P1667, DOI 10.1006/jmbi.1998.2395; Loris R, 2014, CHEM REV, V114, P6933, DOI 10.1021/cr400656f; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moll I, 2012, TRENDS BIOCHEM SCI, V37, P493, DOI 10.1016/j.tibs.2012.07.007; Munoz-Gomez AJ, 2004, FEBS LETT, V567, P316, DOI 10.1016/j.febslet.2004.05.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pankhurst KL, 2006, J BIOL CHEM, V281, P20589, DOI 10.1074/jbc.M603077200; Park JH, 2011, FEBS LETT, V585, P2526, DOI 10.1016/j.febslet.2011.07.008; Rothenbacher FP, 2012, J BACTERIOL, V194, P3464, DOI 10.1128/JB.00217-12; Schifano JM, 2013, P NATL ACAD SCI USA, V110, P8501, DOI 10.1073/pnas.1222031110; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Simanshu DK, 2013, MOL CELL, V52, P447, DOI 10.1016/j.molcel.2013.09.006; Sterckx YGJ, 2015, PROTEIN EXPRES PURIF, V108, P30, DOI 10.1016/j.pep.2015.01.001; Steyaert J, 1997, EUR J BIOCHEM, V247, P1, DOI 10.1111/j.1432-1033.1997.t01-1-00001.x; Tripathi A, 2014, J BIOL CHEM, V289, P4191, DOI 10.1074/jbc.M113.510511; Verstraeten N, 2015, MOL CELL, V59, P9, DOI 10.1016/j.molcel.2015.05.011; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; Zorzini V, 2014, NUCLEIC ACIDS RES, V42, P6709, DOI 10.1093/nar/gku266	49	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					10950	10960		10.1074/jbc.M116.715912	http://dx.doi.org/10.1074/jbc.M116.715912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27026704	hybrid, Green Published			2022-12-28	WOS:000377042100001
J	Leung, A; Trac, C; Du, J; Natarajan, R; Schones, DE				Leung, Amy; Trac, Candi; Du, Juan; Natarajan, Rama; Schones, Dustin E.			Persistent Chromatin Modifications Induced by High Fat Diet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM PERSISTENCE; REGULATORY ELEMENTS; FOLLOW-UP; EPIGENETICS; OBESITY; MECHANISMS; ALIGNMENT; PATTERNS; REVEALS; LIVERS	Obesity is a highly heritable complex disease that results from the interaction of multiple genetic and environmental factors. Formerly obese individuals are susceptible to metabolic disorders later in life, even after lifestyle changes are made to mitigate the obese state. This is reminiscent of the metabolic memory phenomenon originally observed for persistent complications in diabetic patients, despite subsequent glycemic control. Epigenetic modifications represent a potential mediator of this observed memory. We previously demonstrated that a high fat diet leads to changes in chromatin accessibility in the mouse liver. The regions of greatest chromatin changes in accessibility are largely strain-dependent, indicating a genetic component in diet-induced chromatin alterations. We have now examined the persistence of diet-induced chromatin accessibility changes upon diet reversal in two strains of mice. We find that a substantial fraction of loci that undergo chromatin accessibility changes with a high fat diet remains in the remodeled state after diet reversal in C57BL/6J mice. In contrast, the vast majority of diet-induced chromatin accessibility changes in A/J mice are transient. Our data also indicate that the persistent chromatin accessibility changes observed in C57BL/6J mice are associated with specific transcription factors and histone post-translational modifications. The persistent loci identified here are likely to be contributing to the overall phenotype and are attractive targets for therapeutic intervention.	[Leung, Amy; Trac, Candi; Du, Juan; Natarajan, Rama; Schones, Dustin E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet Complicat & Metab, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Du, Juan; Natarajan, Rama; Schones, Dustin E.] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope	Schones, DE (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet Complicat & Metab, 1500 E Duarte Rd, Duarte, CA 91010 USA.	dschones@coh.org		Leung, Amy/0000-0002-5175-430X	National Institutes of Health [K22HL101950, T32DK007571-24, 1K01DK104993, R01HL106089, RO1DK065073]; Schaeffer Endowment funds; National Institutes of Health under NO [P30CA33572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K22HL101950, R01HL106089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065073, K01DK104993, T32DK007571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Schaeffer Endowment funds; National Institutes of Health under NO; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants K22HL101950 (to D. E. S.), T32DK007571-24 (to A. L.), 1K01DK104993 (to A. L), and R01HL106089 and RO1DK065073 and Schaeffer Endowment funds (to R. N.). Research reported in this publication included work performed in the Pathology and Integrative Genomics Cores of the City of Hope supported by National Institutes of Health under NO Award P30CA33572. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Cooper ME, 2010, CIRC RES, V107, P1403, DOI 10.1161/CIRCRESAHA.110.223552; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fradin D, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/647514; Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Guo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005370; Guo YR, 2013, MOL CELL PROTEOMICS, V12, P3744, DOI 10.1074/mcp.M113.027441; Hicks SC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0679-0; Hill-Baskin AE, 2009, HUM MOL GENET, V18, P2975, DOI 10.1093/hmg/ddp236; Hoek-van den Hil EF, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0469-z; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jayaraman S, 2011, EPIGENOMICS-UK, V3, P639, DOI [10.2217/EPI.11.78, 10.2217/epi.11.78]; Keating ST, 2015, CIRC RES, V116, P715, DOI 10.1161/CIRCRESAHA.116.303936; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KRAMER FM, 1989, INT J OBESITY, V13, P123; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leung A, 2014, J BIOL CHEM, V289, P23557, DOI 10.1074/jbc.M114.581439; Leung A, 2013, CIRC RES, V113, P266, DOI 10.1161/CIRCRESAHA.112.300849; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Littlejohns B, 2014, CELL PHYSIOL BIOCHEM, V34, P1090, DOI 10.1159/000366323; Littlejohns B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100579; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Meng ZX, 2015, CELL REP, V13, P1658, DOI 10.1016/j.celrep.2015.10.033; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Podrini C, 2015, FASEB J, V29, P1676, DOI 10.1096/fj.14-262717; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Rosenbaum M, 2008, AM J CLIN NUTR, V88, P906, DOI 10.1093/ajcn/88.4.906; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schones DE, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-23; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sookoian S, 2015, WORLD J GASTROENTERO, V21, P711, DOI 10.3748/wjg.v21.i3.711; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Takamura T, 2008, OBESITY, V16, P2601, DOI 10.1038/oby.2008.419; Tsompana M, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-33; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992	48	46	47	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10446	10455		10.1074/jbc.M115.711028	http://dx.doi.org/10.1074/jbc.M115.711028			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27006400	hybrid, Green Published			2022-12-28	WOS:000377042600002
J	Tavares, CDJ; Sharabi, K; Dominy, JE; Lee, Y; Isasa, M; Orozco, JM; Jedrychowski, MP; Kamenecka, TM; Griffin, PR; Gygi, SP; Puigserver, P				Tavares, Clint D. J.; Sharabi, Kfir; Dominy, John E.; Lee, Yoonjin; Isasa, Marta; Orozco, Jose M.; Jedrychowski, Mark P.; Kamenecka, Theodore M.; Griffin, Patrick R.; Gygi, Steven P.; Puigserver, Pere			The Methionine Transamination Pathway Controls Hepatic Glucose Metabolism through Regulation of the GCN5 Acetyltransferase and the PGC-1 alpha Transcriptional Coactivator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-METABOLISM; HISTONE ACETYLTRANSFERASE; PROTEIN; RESTRICTION; GLUCONEOGENESIS; HOMOCYSTEINE; HOMEOSTASIS; EXPRESSION; REPRESSION; MECHANISM	Methionine is an essential sulfur amino acid that is engaged in key cellular functions such as protein synthesis and is a precursor for critical metabolites involved in maintaining cellular homeostasis. In mammals, in response to nutrient conditions, the liver plays a significant role in regulating methionine concentrations by altering its flux through the transmethylation, transsulfuration, and transamination metabolic pathways. A comprehensive understanding of how hepatic methionine metabolism intersects with other regulatory nutrient signaling and transcriptional events is, however, lacking. Here, we show that methionine and derived-sulfur metabolites in the transamination pathway activate the GCN5 acetyltransferase promoting acetylation of the transcriptional coactivator PGC-1 alpha to control hepatic gluconeogenesis. Methionine was the only essential amino acid that rapidly induced PGC-1 alpha acetylation through activating the GCN5 acetyltransferase. Experiments employing metabolic pathway intermediates revealed that methionine transamination, and not the transmethylation or transsulfuration pathways, contributed to methionine-induced PC4C-1 alpha acetylation. Moreover, aminooxyacetic acid, a transaminase inhibitor, was able to potently suppress PGC-1 alpha acetylation stimulated by methionine, which was accompanied by predicted alterations in PGC-1 alpha-mediated gluconeogenic gene expression and glucose production in primary murine hepatocytes. Methionine administration in mice likewise induced hepatic PGC-1 alpha acetylation, suppressed the gluconeogenic gene program, and lowered glycemia, indicating that a similar phenomenon occurs in vivo. These results highlight a communication between methionine metabolism and PGC-1 alpha-mediated hepatic gluconeogenesis, suggesting that influencing methionine metabolic flux has the potential to be therapeutically exploited for diabetes treatment.	[Tavares, Clint D. J.; Sharabi, Kfir; Dominy, John E.; Lee, Yoonjin; Orozco, Jose M.; Puigserver, Pere] Dana Farber Canc Inst, Dept Canc Biol, 450 Brookline Ave,CLSB 11144, Boston, MA 02115 USA; [Tavares, Clint D. J.; Sharabi, Kfir; Dominy, John E.; Lee, Yoonjin; Isasa, Marta; Orozco, Jose M.; Jedrychowski, Mark P.; Gygi, Steven P.; Puigserver, Pere] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Kamenecka, Theodore M.; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Scripps Research Institute	Puigserver, P (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave,CLSB 11144, Boston, MA 02215 USA.	pere_puigserver@dfci.harvard.edu			National Institutes of Health [RO11069966, R24DK080261-06]; American Diabetes Association [1-16-PDF-111]; American Heart Association [15POST22880002]; National Research Service Award Kirschstein fellowship from the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); National Research Service Award Kirschstein fellowship from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO11069966 (NIDDK; to P. P.) and R24DK080261-06 (NIDDK; to P. P. and P. R. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by a mentor-based American Diabetes Association postdoctoral fellowship and also by a postdoctoral fellowship from the American Diabetes Association (Grant 1-16-PDF-111).r Supported by a postdoctoral fellowship from the American Heart Association (15POST22880002).r Supported by a National Research Service Award Kirschstein fellowship from the National Institutes of Health.	Ables GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051357; Barlev NA, 1998, MOL CELL BIOL, V18, P1349, DOI 10.1128/MCB.18.3.1349; BENEVENGA NJ, 1974, J AGR FOOD CHEM, V22, P2, DOI 10.1021/jf60191a036; BLOM HJ, 1989, CLIN SCI, V76, P43, DOI 10.1042/cs0760043; Cahill G F Jr, 1970, N Engl J Med, V282, P668, DOI 10.1056/NEJM197003052821026; CHERRINGTON A D, 1987, Diabetes Metabolism Reviews, V3, P307; Dever JT, 2008, J PHARMACOL EXP THER, V326, P809, DOI 10.1124/jpet.108.141044; Dever TE, 1999, TRENDS BIOCHEM SCI, V24, P398, DOI 10.1016/S0968-0004(99)01457-7; Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; FINKELSTEIN JD, 1986, J BIOL CHEM, V261, P1582; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; Fukagawa NK, 2000, AM J CLIN NUTR, V72, P22; Gallinetti J, 2013, BIOCHEM J, V449, P1, DOI 10.1042/BJ20121098; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145, DOI 10.1002/j.1460-2075.1992.tb05507.x; Gietzen DW, 2006, TRENDS NEUROSCI, V29, P91, DOI 10.1016/j.tins.2005.12.007; GRIFFITH OW, 1987, METHOD ENZYMOL, V143, P366; HARPER AE, 1970, PHYSIOL REV, V50, P428, DOI 10.1152/physrev.1970.50.3.428; Hasek BE, 2010, AM J PHYSIOL-REG I, V299, pR728, DOI 10.1152/ajpregu.00837.2009; Korendyaseva TK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000076; Lee BC, 2016, ANN NY ACAD SCI, V1363, P116, DOI 10.1111/nyas.12973; Lee YJ, 2014, NATURE, V510, P547, DOI 10.1038/nature13267; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Lin WC, 2008, DEV DYNAM, V237, P928, DOI 10.1002/dvdy.21479; Livesey G, 1980, BIOCHEM SOC T, V8, P540, DOI 10.1042/bst0080540; MARCHESINI G, 1992, HEPATOLOGY, V16, P149; MITCHELL AD, 1978, J NUTR, V108, P67, DOI 10.1093/jn/108.1.67; Patten IS, 2012, TRENDS ENDOCRIN MET, V23, P90, DOI 10.1016/j.tem.2011.09.007; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Riss A, 2015, J BIOL CHEM, V290, P28997, DOI 10.1074/jbc.M115.668533; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; SCISLOWSKI PWD, 1993, MOL CELL BIOCHEM, V129, P39, DOI 10.1007/BF00926574; SCISLOWSKI PWD, 1989, ARCH BIOCHEM BIOPHYS, V273, P602, DOI 10.1016/0003-9861(89)90521-3; STEELE RD, 1978, J BIOL CHEM, V253, P7844; Sternglanz R, 1999, P NATL ACAD SCI USA, V96, P8807, DOI 10.1073/pnas.96.16.8807; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Stone KP, 2014, DIABETES, V63, P3721, DOI 10.2337/db14-0464; Toue S, 2006, J NUTR, V136, p1716S, DOI 10.1093/jn/136.6.1716S; Wang L, 2014, EPIGENOMICS-UK, V6, P329, DOI [10.2217/EPI.14.22, 10.2217/epi.14.22]; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; Xu JY, 2014, J BIOL CHEM, V289, P27034, DOI 10.1074/jbc.M114.579078; Yamada H, 2012, FREE RADICAL BIO MED, V52, P1716, DOI 10.1016/j.freeradbiomed.2012.02.033; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	46	21	22	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10635	10645		10.1074/jbc.M115.706200	http://dx.doi.org/10.1074/jbc.M115.706200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27022023	Green Published, hybrid			2022-12-28	WOS:000377042600017
J	Zhou, BY; Ritt, DA; Morrison, DK; Der, CJ; Cox, AD				Zhou, Bingying; Ritt, Daniel A.; Morrison, Deborah K.; Der, Channing J.; Cox, Adrienne D.			Protein Kinase CK2 Maintains Extracellular Signal-regulated Kinase (ERK) Activity in a CK2 Kinase-independent Manner to Promote Resistance to Inhibitors of RAF and MEK but Not ERK in BRAF Mutant Melanoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug resistance; dual specificity phosphoprotein phosphatase; extracellular signal-regulated kinase (ERK); melanoma; Ras protein; CK2; kinase suppressor of RAS 1 (KSR1)	PANCREATIC-CANCER; ACTIVATION; CK2-ALPHA; CELLS; PHOSPHORYLATES; CARCINOMA; SURVIVAL; LEUKEMIA; COMPLEX	The protein kinase casein kinase 2 (CK2) is a pleiotropic and constitutively active kinase that plays crucial roles in cellular proliferation and survival. Overexpression of CK2, particularly the catalytic subunit (CK2, CSNK2A1), has been implicated in a wide variety of cancers and is associated with poorer survival and resistance to both conventional and targeted anticancer therapies. Here, we found that CK2 protein is elevated in melanoma cell lines compared with normal human melanocytes. We then tested the involvement of CK2 in drug resistance to Food and Drug Administration-approved single agent targeted therapies for melanoma. In BRAF mutant melanoma cells, ectopic CK2 decreased sensitivity to vemurafenib (BRAF inhibitor), dabrafenib (BRAF inhibitor), and trametinib (MEK inhibitor) by a mechanism distinct from that of mutant NRAS. Conversely, knockdown of CK2 sensitized cells to inhibitor treatment. CK2-mediated RAF-MEK kinase inhibitor resistance was tightly linked to its maintenance of ERK phosphorylation. We found that CK2 post-translationally regulates the ERK-specific phosphatase dual specificity phosphatase 6 (DUSP6) in a kinase dependent-manner, decreasing its abundance. However, we unexpectedly showed, by using a kinase-inactive mutant of CK2, that RAF-MEK inhibitor resistance did not rely on CK2 kinase catalytic function, and both wild-type and kinase-inactive CK2 maintained ERK phosphorylation upon inhibition of BRAF or MEK. That both wild-type and kinase-inactive CK2 bound equally well to the RAF-MEK-ERK scaffold kinase suppressor of Ras 1 (KSR1) suggested that CK2 increases KSR facilitation of ERK phosphorylation. Accordingly, CK2 did not cause resistance to direct inhibition of ERK by the ERK1/2-selective inhibitor SCH772984. Our findings support a kinase-independent scaffolding function of CK2 that promotes resistance to RAF- and MEK-targeted therapies.	[Zhou, Bingying; Der, Channing J.; Cox, Adrienne D.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Der, Channing J.; Cox, Adrienne D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Cox, Adrienne D.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Ritt, Daniel A.; Morrison, Deborah K.] NCI, Lab Cell & Dev Signaling, Ctr Canc Res, NIH, Frederick, MD 21702 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cox, AD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	adrienne_cox@med.unc.edu		Der, Channing/0000-0002-7751-2747; Cox, Adrienne D./0000-0002-4901-2454	National Institutes of Health [CA042978, CA179193, CA199235]; NCI [ZIA BC 010329]; Pancreatic Cancer Action Network-American Association for Cancer Research; NATIONAL CANCER INSTITUTE [U01CA199235, ZIABC010329, R21CA179193, ZIABC011107, R01CA042978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pancreatic Cancer Action Network-American Association for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA042978, CA179193, and CA199235 (to A. D. C. and C. J. D.) and ZIA BC 010329 from the NCI (to D. K. M. and D. A. R.) and by the Pancreatic Cancer Action Network-American Association for Cancer Research (to A. D. C. and C. J. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bae JS, 2015, INT J CANCER, V136, P797, DOI 10.1002/ijc.29043; Borgo C, 2013, MOL ONCOL, V7, P1103, DOI 10.1016/j.molonc.2013.08.006; Casar B, 2008, MOL CELL, V31, P708, DOI 10.1016/j.molcel.2008.07.024; Castelli M, 2004, J BIOL CHEM, V279, P44731, DOI 10.1074/jbc.M407669200; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; Di Maira G, 2007, ONCOGENE, V26, P6915, DOI 10.1038/sj.onc.1210495; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giusiano S, 2011, EUR J CANCER, V47, P792, DOI 10.1016/j.ejca.2010.11.028; Gyenis L, 2011, J PROTEOME RES, V10, P4887, DOI 10.1021/pr2008994; Hanif IM, 2010, INT J BIOCHEM CELL B, V42, P1602, DOI 10.1016/j.biocel.2010.06.010; Hayes TK, 2016, CANCER CELL, V29, P75, DOI 10.1016/j.ccell.2015.11.011; Heriche JK, 1998, ONCOGENE, V17, P13, DOI 10.1038/sj.onc.1201900; Herrero A, 2015, CANCER CELL, V28, P170, DOI 10.1016/j.ccell.2015.07.001; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Jovanovic B, 2008, J INVEST DERMATOL, V128, P2696, DOI 10.1038/jid.2008.134; Kreutzer JN, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-440; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Martins LR, 2010, BLOOD, V116, P2724, DOI 10.1182/blood-2010-04-277947; Menzies AM, 2014, LANCET ONCOL, V15, pE371, DOI 10.1016/S1470-2045(14)70072-5; Mitev Vanio, 1994, Journal of Dermatological Science, V8, P45, DOI 10.1016/0923-1811(94)90320-4; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Muda M, 1996, J BIOL CHEM, V271, P4319; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ortega CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115609; Parker R, 2014, MOL CANCER THER, V13, P1894, DOI 10.1158/1535-7163.MCT-13-0938; Piazza FA, 2006, BLOOD, V108, P1698, DOI 10.1182/blood-2005-11-013672; Pinna LA, 2009, CELL MOL LIFE SCI, V66, P1797, DOI 10.1007/s00018-009-9148-9; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Plotnikov A, 2011, MOL CELL BIOL, V31, P3515, DOI 10.1128/MCB.05424-11; Ritt DA, 2007, CURR BIOL, V17, P179, DOI 10.1016/j.cub.2006.11.061; Shields JM, 2007, CANCER RES, V67, P1502, DOI 10.1158/0008-5472.CAN-06-3311; Solit DB, 2014, CANCER DISCOV, V4, P27, DOI 10.1158/2159-8290.CD-13-0961; Spagnolo F, 2014, ONCOTARGET, V5, P10206, DOI 10.18632/oncotarget.2602; Sullivan RJ, 2013, EUR J CANCER, V49, P1297, DOI 10.1016/j.ejca.2012.11.019; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Zhang HX, 2015, ONCOTARGET, V6, P34800, DOI 10.18632/oncotarget.5470; Zhang WJ, 2015, CURR OPIN PHARMACOL, V23, P68, DOI 10.1016/j.coph.2015.05.015	40	24	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17804	17815		10.1074/jbc.M115.712885	http://dx.doi.org/10.1074/jbc.M115.712885			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27226552	Green Published, hybrid			2022-12-28	WOS:000383241300027
J	Haeseleer, F; Williams, B; Lee, A				Haeseleer, Francoise; Williams, Brittany; Lee, Amy			Characterization of C-terminal Splice Variants of CaV1.4 Ca2+Channels in Human Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATIONARY NIGHT BLINDNESS; CALCIUM-DEPENDENT INACTIVATION; PHOTORECEPTOR RIBBON SYNAPSES; OUTER PLEXIFORM LAYER; AUDITORY HAIR-CELLS; GATED CA2+ CHANNELS; CA(V)1.3 CHANNELS; MOUSE RETINA; CACNA1F GENE; CA2+-DEPENDENT INACTIVATION	Voltage-gated Ca(2+) channels (Cav) undergo extensive alternative splicing that greatly enhances their functional diversity in excitable cells. Here, we characterized novel splice variants of the cytoplasmic C-terminal domain of Cav1.4 Ca(2+) channels that regulate neurotransmitter release in photoreceptors in the retina. These variants lack a portion of exon 45 and/or the entire exon 47 (Cav1.4 Delta ex p45, Cav1.4 Delta ex 47, Cav1.4 Delta ex p45,47) and are expressed in the retina of primates but not mice. Although the electrophysiological properties of Cav1.4 Delta ex p45 are similar to those of full-length channels (Cav1.4FL), skipping of exon 47 dramatically alters Cav1.4 function. Deletion of exon 47 removes part of a C-terminal automodulatory domain (CTM) previously shown to suppress Ca(2+)-dependent inactivation (CDI) and to cause a positive shift in the voltage dependence of channel activation. Exon 47 is crucial for these effects of the CTM because variants lacking this exon show intense CDI and activate at more hyperpolarized voltages than Cav1.4FL The robust CDI of Cav1.4 Delta ex 47 is suppressed by CaBP4, a regulator of Cav1.4 channels in photoreceptors. Although CaBP4 enhances activation of Cav1.4FL, Cav1.4 Delta ex 47 shows similar voltage-dependent activation in the presence and absence of CaBP4. We conclude that exon 47 encodes structural determinants that regulate CDI and voltage-dependent activation of Cav1.4, and is necessary for modulation of channel activation by CaBP4	[Haeseleer, Francoise] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Williams, Brittany; Lee, Amy] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Lee, Amy] Univ Iowa, Dept Otolaryngol Head Neck Surg, Iowa City, IA 52242 USA; [Lee, Amy] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Williams, Brittany] Univ Iowa, Interdisciplinary Grad Program Neurosci, Iowa City, IA 52242 USA	University of Washington; University of Washington Seattle; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Lee, A (corresponding author), Dept Mol Physiol & Biophys Otolaryngol Head Neck, 169 Newton Rd,PBDB 5318, Iowa City, IA 52242 USA.	amy-lee@uiowa.edu		Lee, Amy/0000-0001-8021-0443; williams, brittany/0000-0002-6597-619X	National Institutes of Health [EY020850, NS084190, DC009433]; Carver Research Program of Excellence Award; NATIONAL EYE INSTITUTE [R01EY020850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009433, R55DC009433] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Research Program of Excellence Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health Grants EY020850 (to F. H.), NS084190 and DC009433 (to A. L.), and a Carver Research Program of Excellence Award (to A. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Ball SL, 2011, BRAIN RES, V1412, P1, DOI 10.1016/j.brainres.2011.07.033; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Berntson A, 2004, VISUAL NEUROSCI, V21, P693, DOI 10.1017/S0952523804215048; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Calin-Jageman I, 2007, J NEUROSCI, V27, P1374, DOI 10.1523/JNEUROSCI.5191-06.2007; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Christel C, 2012, BBA-GEN SUBJECTS, V1820, P1243, DOI 10.1016/j.bbagen.2011.12.012; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; Cui GY, 2007, J PHYSIOL-LONDON, V585, P791, DOI 10.1113/jphysiol.2007.142307; Doering CJ, 2007, CHANNELS, V1; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Findeisen F, 2013, J MOL BIOL, V425, P3217, DOI 10.1016/j.jmb.2013.06.024; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Griessmeier K, 2009, J BIOL CHEM, V284, P29809, DOI 10.1074/jbc.M109.048082; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Hardie J, 2016, CHANNELS, V10, P33, DOI 10.1080/19336950.2015.1051273; Hauke J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076414; Hoda JC, 2006, J NEUROCHEM, V96, P1648, DOI 10.1111/j.1471-4159.2006.03678.x; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Jalkanen R, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040741; Jalkanen R, 2007, INVEST OPHTH VIS SCI, V48, P2498, DOI 10.1167/iovs.06-1103; Katiyar R, 2015, INVEST OPHTH VIS SCI, V56, P2312, DOI 10.1167/iovs.15-16654; Koschak A, 2003, J NEUROSCI, V23, P6041, DOI 10.1523/JNEUROSCI.23-14-06041.2003; KOSTYUK PG, 1982, J MEMBRANE BIOL, V70, P171, DOI 10.1007/BF01870560; Lee A, 2015, J BIOL CHEM, V290, P1505, DOI 10.1074/jbc.M114.607465; Lee A, 2014, J NEUROSCI, V34, P15159, DOI 10.1523/JNEUROSCI.3275-14.2014; Lieb A, 2014, BIOPHYS J, V106, P1467, DOI 10.1016/j.bpj.2014.02.017; Lipscombe D, 2013, TRENDS NEUROSCI, V36, P598, DOI 10.1016/j.tins.2013.06.008; Liu XD, 2010, NATURE, V463, P968, DOI 10.1038/nature08766; Liu XN, 2013, CHANNELS, V7, P514, DOI 10.4161/chan.26376; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Oz S, 2013, J BIOL CHEM, V288, P12680, DOI 10.1074/jbc.M113.460949; Raven MA, 2008, J COMP NEUROL, V506, P745, DOI 10.1002/cne.21526; Regus-Leidig H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086769; Scharinger A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00309; Shaltiel L, 2012, J BIOL CHEM, V287, P36312, DOI 10.1074/jbc.M112.392811; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Specht D, 2009, INVEST OPHTH VIS SCI, V50, P505, DOI 10.1167/iovs.08-2758; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Tan BZ, 2011, J BIOL CHEM, V286, P42725, DOI 10.1074/jbc.M111.265207; Tan GMY, 2012, J BIOL CHEM, V287, P832, DOI 10.1074/jbc.M111.268722; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; Witkovsky P, 1997, J NEUROSCI, V17, P7297; Wycisk KA, 2006, INVEST OPHTH VIS SCI, V47, P3523, DOI 10.1167/iovs.06-0271; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Yang PS, 2014, NAT CHEM BIOL, V10, P231, DOI [10.1038/NCHEMBIO.1436, 10.1038/nchembio.1436]; Zhou H, 2004, J NEUROSCI, V24, P4698, DOI 10.1523/JNEUROSCI.5523-03.2004	56	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15663	15673		10.1074/jbc.M116.731737	http://dx.doi.org/10.1074/jbc.M116.731737			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226626	Green Published, hybrid			2022-12-28	WOS:000380584200021
J	Heidrich, J; Wulf, V; Hennig, R; Saur, M; Markl, J; Sonnichsen, C; Schneider, D				Heidrich, Jennifer; Wulf, Verena; Hennig, Raoul; Saur, Michael; Markl, Juergen; Soennichsen, Carsten; Schneider, Dirk			Organization into Higher Ordered Ring Structures Counteracts Membrane Binding of IM30, a Protein Associated with Inner Membranes in Chloroplasts and Cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGE-SHOCK-PROTEIN; SP PCC 6803; THYLAKOID MEMBRANE; ESCHERICHIA-COLI; PLASMONIC NANOPARTICLES; VIPP1; SYNECHOCYSTIS; PSPA; DOMAIN; NANOSENSORS	The IM30 (inner membrane-associated protein of 30 kDa), also known as the Vippl (vesicle-inducing protein in plastids 1), has a crucial role in thylakoid membrane biogenesis and maintenance. Recent results suggest that the protein binds peripherally to membranes containing negatively charged lipids. However, although IM30 monomers interact and assemble into large oligomeric ring complexes with different numbers of monomers, it is still an open question whether ring formation is crucial for membrane interaction. Here we show that binding of IM30 rings to negatively charged phosphatidylglycerol membrane surfaces results in a higher ordered membrane state, both in the head group and in the inner core region of the lipid bilayer. Furthermore, by using gold nanorods covered with phosphatidylglycerol layers and single particle spectroscopy, we show that not only IM30 rings but also lower oligomeric IM30 structures interact with membranes, although with higher affinity. Thus, ring formation is not crucial for, and even counteracts, membrane interaction of IM30.	[Heidrich, Jennifer; Hennig, Raoul; Schneider, Dirk] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Johann Joachim Becher Weg 30, D-55128 Mainz, Germany; [Wulf, Verena; Soennichsen, Carsten] Johannes Gutenberg Univ Mainz, Inst Phys Chem, D-55128 Mainz, Germany; [Saur, Michael; Markl, Juergen] Johannes Gutenberg Univ Mainz, Inst Zool, D-55128 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Schneider, D (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Johann Joachim Becher Weg 30, D-55128 Mainz, Germany.	Dirk.Schneider@uni-mainz.de	Sönnichsen, Carsten/A-5682-2009; Wulf, Verena/AFU-0261-2022	Sönnichsen, Carsten/0000-0003-1824-7696; Saur, Michael/0000-0002-6612-6656	Max Planck Graduate Center at the Max Planck Institutes; University of Mainz	Max Planck Graduate Center at the Max Planck Institutes; University of Mainz	This work was supported by the Max Planck Graduate Center at the Max Planck Institutes and the University of Mainz. The authors declare that they have no conflicts of interest with the contents of this article.	Adamczyk Z, 1996, J CHEM PHYS, V105, P5562, DOI 10.1063/1.472409; Ahijado-Guzman R, 2014, NANO LETT, V14, P5528, DOI 10.1021/nl501865p; Ament I, 2012, NANO LETT, V12, P1092, DOI 10.1021/nl204496g; Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Aseeva E, 2004, J BIOL CHEM, V279, P35535, DOI 10.1074/jbc.M401750200; Aseeva E, 2007, PLANT PHYSIOL BIOCH, V45, P119, DOI 10.1016/j.plaphy.2007.01.005; BARBER J, 1986, PHOTOSYNTH RES, V9, P239, DOI 10.1007/BF00029747; BISWAL B, 1989, BIOCHEM PHYSIOL PFL, V184, P213, DOI 10.1016/S0015-3796(89)80005-8; BRISSETTE JL, 1990, P NATL ACAD SCI USA, V87, P862, DOI 10.1073/pnas.87.3.862; Bultema Jelle B, 2010, Commun Integr Biol, V3, P162; DeLisa MP, 2004, J BACTERIOL, V186, P366, DOI 10.1128/JB.186.2.366-373.2004; Fuhrmann E, 2009, MOL BIOL CELL, V20, P4620, DOI 10.1091/mbc.E09-04-0319; Fuhrmann E, 2009, PLANT PHYSIOL, V149, P735, DOI 10.1104/pp.108.132373; Hankamer BD, 2004, J BIOL CHEM, V279, P8862, DOI 10.1074/jbc.M307889200; HARRIS JR, 1994, MICRON, V25, P5; Hennig R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8018; Kobayashi R, 2007, MOL MICROBIOL, V66, P100, DOI 10.1111/j.1365-2958.2007.05893.x; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; Lamy-Freund MT, 2003, CHEM PHYS LIPIDS, V122, P19, DOI 10.1016/S0009-3084(02)00175-5; LI HM, 1994, PLANT MOL BIOL, V25, P619, DOI 10.1007/BF00029601; Liu CM, 2007, PLANT J, V50, P265, DOI 10.1111/j.1365-313X.2007.03047.x; MURATA N, 1992, PLANT CELL PHYSIOL, V33, P933; MURATA N, 1989, J BIOENERG BIOMEMBR, V21, P61, DOI 10.1007/BF00762212; Olson J, 2015, CHEM SOC REV, V44, P40, DOI 10.1039/c4cs00131a; Osadnik H, 2015, MOL MICROBIOL, V98, P743, DOI 10.1111/mmi.13154; Otters S, 2013, PLANTA, V237, P529, DOI 10.1007/s00425-012-1772-1; Raschke G, 2003, NANO LETT, V3, P935, DOI 10.1021/nl034223+; Rast A, 2015, BBA-BIOENERGETICS, V1847, P821, DOI 10.1016/j.bbabio.2015.01.007; Rosman C, 2013, NANO LETT, V13, P3243, DOI 10.1021/nl401354f; Sanchez SA, 2012, P NATL ACAD SCI USA, V109, P7314, DOI 10.1073/pnas.1118288109; Srivastava R, 2005, PROTEOMICS, V5, P4905, DOI 10.1002/pmic.200500111; Suzuki I, 2001, MOL MICROBIOL, V40, P235, DOI 10.1046/j.1365-2958.2001.02379.x; vanderHeide UA, 1996, CHEM PHYS LETT, V253, P118, DOI 10.1016/0009-2614(96)00212-6; Vothknecht UC, 2012, J EXP BOT, V63, P1699, DOI 10.1093/jxb/err357; Westphal S, 2001, FEBS LETT, V506, P257, DOI 10.1016/S0014-5793(01)02931-3; Westphal S, 2001, P NATL ACAD SCI USA, V98, P4243, DOI 10.1073/pnas.061501198; Zhang L, 2013, BBA-GEN SUBJECTS, V1830, P2150, DOI 10.1016/j.bbagen.2012.09.016	37	22	22	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14954	14962		10.1074/jbc.M116.722686	http://dx.doi.org/10.1074/jbc.M116.722686			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226585	hybrid, Green Published			2022-12-28	WOS:000380583200008
J	Kromann-Hansen, T; Oldenburg, E; Yung, KWY; Ghassabeh, GH; Muyldermans, S; Declerck, PJ; Huang, MD; Andreasen, PA; Ngo, JCK				Kromann-Hansen, Tobias; Oldenburg, Emil; Yung, Kristen Wing Yu; Ghassabeh, Gholamreza H.; Muyldermans, Serge; Declerck, Paul J.; Huang, Mingdong; Andreasen, Peter A.; Ngo, Jacky Chi Ki			A Camelid-derived Antibody Fragment Targeting the Active Site of a Serine Protease Balances between Inhibitor and Substrate Behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR; UROKINASE INHIBITOR; PLASMA KALLIKREIN; STRUCTURAL BASIS; TRYPSIN; MECHANISM; BINDING; CHYMOTRYPSIN; SPECIFICITY; AFFINITY	A peptide segment that binds the active site of a serine protease in a substrate-like manner may behave like an inhibitor or a substrate. However, there is sparse information on which factors determine the behavior a particular peptide segment will exhibit. Here, we describe the first x-ray crystal structure of a nanobody in complex with a serine protease. The nanobody displays a new type of interaction between an antibody and a serine protease as it inserts its complementary determining region-H3 loop into the active site of the protease in a substrate-like manner. The unique binding mechanism causes the nanobody to behave as a strong inhibitor as well as a poor substrate. Intriguingly, its substrate behavior is incomplete, as 30-40% of the nanobody remainedintactandinhibitoryafterprolongedincubationwiththe protease. Biochemical analysis reveals that an intra-loop interaction network within the complementary determining region-H3 of the nanobody balances its inhibitor versus substrate behavior. Collectively, our results unveil molecular factors, which may be a general mechanism to determine the substrate versus inhibitor behavior of other protease inhibitors.	[Kromann-Hansen, Tobias; Oldenburg, Emil; Andreasen, Peter A.] Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark; [Yung, Kristen Wing Yu; Ngo, Jacky Chi Ki] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Ghassabeh, Gholamreza H.; Muyldermans, Serge] Vrije Univ Brussels, Lab Cellular & Mol Immunol, B-1050 Brussels, Belgium; [Ghassabeh, Gholamreza H.] Flanders Inst Biotechnol, Nanobody Serv Facil, B-1050 Brussels, Belgium; [Declerck, Paul J.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Therapeut & Diagnost Antibodies, B-3000 Leuven, Belgium; [Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China	Aarhus University; Chinese University of Hong Kong; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); KU Leuven; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS	Kromann-Hansen, T (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	tobiaskh@mbg.au.dk	Declerck, Paul J/A-2330-2017; Huang, Mingdong/J-4278-2017; Muyldermans, Serge/AAC-7374-2019; Ngo, Jacky C/O-8093-2017	Declerck, Paul J/0000-0003-1259-9105; Huang, Mingdong/0000-0003-0085-9141; Muyldermans, Serge/0000-0002-3678-3575; Ngo, Jacky C/0000-0002-6004-7041; Yung, Kristen Wing Yu/0000-0001-7389-3012	Danish National Research Foundation [26-331-6]; Natural Science Foundation of China [31161130356, 31170707, 31370737]; Lundbeck Foundation [R83-A7826]; Cancer Research Foundation of 1989; Research Grants Council of Hong Kong SAR [GRF 473310, CUHK1/CRF/13G]; CUHK One-off Funding for Joint Lab Project [3132980]; Graduate School of Science and Technology, Aarhus University; Carlsberg Foundation [CF15-0814]	Danish National Research Foundation(Danmarks Grundforskningsfond); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Lundbeck Foundation(Lundbeckfonden); Cancer Research Foundation of 1989; Research Grants Council of Hong Kong SAR(Hong Kong Research Grants Council); CUHK One-off Funding for Joint Lab Project; Graduate School of Science and Technology, Aarhus University; Carlsberg Foundation(Carlsberg Foundation)	This work was supported in part by Danish National Research Foundation Grant 26-331-6 (to P. A. A.), Natural Science Foundation of China Grants 31161130356, 31170707, and 31370737 (to M. H.), Lundbeck Foundation Grant R83-A7826 (to P. A. A.), The Cancer Research Foundation of 1989 (to P. A. A.), Research Grants Council of Hong Kong SAR Grants GRF 473310 and CUHK1/CRF/13G, and CUHK One-off Funding for Joint Lab Project Number 3132980 (to J. C. K. N.) the Graduate School of Science and Technology, Aarhus University (to T. K. H.), Carlsberg Foundation Grant CF15-0814 (to T. K. H.). The authors declare that they have no conflicts of interest with the content of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Cohen I, 2016, BIOCHEM J, V473, P1329, DOI 10.1042/BJ20151410; Cudic M, 2009, CURR PROTEIN PEPT SC, V10, P297, DOI 10.2174/138920309788922207; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; de Veer SJ, 2015, BIOCHEM J, V469, P243, DOI 10.1042/BJ20150412; DeLano W.L, PYMOL MOL GRAPHICS S; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farady CJ, 2008, J MOL BIOL, V380, P351, DOI 10.1016/j.jmb.2008.05.009; Farady CJ, 2010, CHEMBIOCHEM, V11, P2341, DOI 10.1002/cbic.201000442; Felizmenio-Quimio ME, 2001, J BIOL CHEM, V276, P22875, DOI 10.1074/jbc.M101666200; FINKENSTADT WR, 1967, J BIOL CHEM, V242, P771; FINKENSTADT WR, 1965, J BIOL CHEM, V240, pP962; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hendrickx MLV, 2011, J THROMB HAEMOST, V9, P2268, DOI 10.1111/j.1538-7836.2011.04495.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kenniston JA, 2014, J BIOL CHEM, V289, P23596, DOI 10.1074/jbc.M114.569061; Kromann-Hansen T, 2013, BIOCHEMISTRY-US, V52, P7114, DOI 10.1021/bi400491k; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LONGSTAFF C, 1990, BIOCHEMISTRY-US, V29, P7339, DOI 10.1021/bi00483a025; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petersen HH, 2001, EUR J BIOCHEM, V268, P4430, DOI 10.1046/j.1432-1327.2001.02365.x; PETERSEN LC, 1985, BIOCHEM J, V225, P149, DOI 10.1042/bj2250149; Puente X O, 2008, THE CANC DEGRADOME, P3; Quimbar P, 2013, J BIOL CHEM, V288, P13885, DOI 10.1074/jbc.M113.460030; Radisky ES, 2005, BIOCHEMISTRY-US, V44, P6823, DOI 10.1021/bi047301w; Radisky ES, 2004, BIOCHEMISTRY-US, V43, P13648, DOI 10.1021/bi048797k; Radisky ES, 2003, BIOCHEMISTRY-US, V42, P6484, DOI 10.1021/bi034275d; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schneider EL, 2012, J MOL BIOL, V415, P699, DOI 10.1016/j.jmb.2011.11.036; Stoop AA, 2003, NAT BIOTECHNOL, V21, P1063, DOI 10.1038/nbt860; Swedberg JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019302; Tarr AW, 2013, HEPATOLOGY, V58, P932, DOI 10.1002/hep.26430; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Vincke Cecile, 2012, Methods Mol Biol, V907, P145, DOI 10.1007/978-1-61779-974-7_8; Wu Y, 2007, P NATL ACAD SCI USA, V104, P19784, DOI 10.1073/pnas.0708251104; Xu P, 2015, J MED CHEM, V58, P8868, DOI 10.1021/acs.jmedchem.5b01128; Zakharova E, 2008, J MOL BIOL, V382, P998, DOI 10.1016/j.jmb.2008.07.063; Zhao BY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115872; Zhao GX, 2007, J STRUCT BIOL, V160, P1, DOI 10.1016/j.jsb.2007.06.003	52	29	30	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15156	15168		10.1074/jbc.M116.732503	http://dx.doi.org/10.1074/jbc.M116.732503			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226628	Green Published, hybrid			2022-12-28	WOS:000380583200025
J	Hindman, R; Gollnick, P				Hindman, Ryan; Gollnick, Paul			Nucleoside Triphosphate Phosphohydrolase I (NPH I) Functions as a 5 to 3 Translocase in Transcription Termination of Vaccinia Early Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; transcription; transcription termination; viral polymerase; viral transcription	DNA-DEPENDENT ATPASE; REPAIR COUPLING FACTOR; VIRUS CAPPING ENZYME; SINGLE-STRANDED-DNA; RNA-POLYMERASE; ESCHERICHIA-COLI; FACTOR-RHO; RELEASE FACTOR; NASCENT RNA; PROTEIN DISPLACEMENT	Vaccinia virus early genes are transcribed immediately upon infection. Nucleoside triphosphate phosphohydrolase I (NPH I) is an essential component of the early gene transcription complex. NPH I hydrolyzes ATP to release transcripts during transcription termination. The ATPase activity of NPH I requires single-stranded (ss) DNA as a cofactor; however, the source of this cofactor within the transcription complex is not known. Based on available structures of transcription complexes it has been hypothesized that the ssDNA cofactor is obtained from the unpaired non-template strand within the transcription bubble. In vitro transcription on templates that lack portions of the non-template strand within the transcription bubble showed that the upstream portion of the transcription bubble is required for efficient NPH I-mediated transcript release. Complementarity between the template and non-template strands in this region is also required for NPH I-mediated transcript release. This observation complicates locating the source of the ssDNA cofactor within the transcription complex because removal of the non-template strand also disrupts transcription bubble reannealing. Prior studies have shown that ssRNA binds to NPH I, but it does not activate ATPase activity. Chimeric transcription templates with RNA in the non-template strand confirm that the source of the ssDNA cofactor for NPH I is the upstream portion of the non-template strand in the transcription bubble. Consistent with this conclusion we also show that isolated NPH I acts as a 5 to 3 translocase on single-stranded DNA.	[Hindman, Ryan; Gollnick, Paul] Univ Buffalo, Dept Biol Sci, Hochstetter Hall, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Gollnick, P (corresponding author), Univ Buffalo, Dept Biol Sci, Hochstetter Hall, Buffalo, NY USA.	gollnick@buffalo.edu			National Science Foundation [MCB 1019969]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB 1019969. The authors have no conflicts of interest with the contents of this article.	AHN BY, 1992, P NATL ACAD SCI USA, V89, P3536, DOI 10.1073/pnas.89.8.3536; AHN BY, 1994, J BIOL CHEM, V269, P7552; Barnes CO, 2015, MOL CELL, V59, P258, DOI 10.1016/j.molcel.2015.06.034; BAYLISS CD, 1995, J BIOL CHEM, V270, P1550, DOI 10.1074/jbc.270.4.1550; Black EP, 1998, VIROLOGY, V245, P313, DOI 10.1006/viro.1998.9166; Boudvillain M, 2010, METHODS MOL BIOL, V587, P137, DOI 10.1007/978-1-60327-355-8_10; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; Broyles SS, 2003, J GEN VIROL, V84, P2293, DOI 10.1099/vir.0.18942-0; BROYLES SS, 1987, J VIROL, V61, P1738, DOI 10.1128/JVI.61.5.1738-1742.1987; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Chi W, 2014, PLANT CELL, V26, P4918, DOI 10.1105/tpc.114.132118; Christen LA, 1999, BIOCHEMISTRY-US, V38, P8072, DOI 10.1021/bi9903749; Christen LA, 2008, VIROLOGY, V376, P225, DOI 10.1016/j.virol.2008.03.031; Christen LM, 1998, VIROLOGY, V245, P360, DOI 10.1006/viro.1998.9177; Condit RC, 1996, VIROLOGY, V220, P10, DOI 10.1006/viro.1996.0280; Deng L, 1996, J BIOL CHEM, V271, P29386, DOI 10.1074/jbc.271.46.29386; Deng L, 1998, GENE DEV, V12, P538, DOI 10.1101/gad.12.4.538; Deng L, 1996, J BIOL CHEM, V271, P19556, DOI 10.1074/jbc.271.32.19556; DIAZGUERRA M, 1993, J VIROL, V67, P7561, DOI 10.1128/JVI.67.12.7561-7572.1993; Fan L, 2015, PROG BIOPHYS MOL BIO, V117, P174, DOI 10.1016/j.pbiomolbio.2014.12.005; Finkel JS, 2010, GENETICS, V184, P107, DOI 10.1534/genetics.109.110031; Gajewski S, 2011, J MOL BIOL, V405, P65, DOI 10.1016/j.jmb.2010.10.004; GEISELMANN J, 1993, P NATL ACAD SCI USA, V90, P7754, DOI 10.1073/pnas.90.16.7754; Graham JE, 2004, NUCLEIC ACIDS RES, V32, P3093, DOI 10.1093/nar/gkh630; HAGLER J, 1992, P NATL ACAD SCI USA, V89, P10099, DOI 10.1073/pnas.89.21.10099; HOWARD BH, 1976, J BIOL CHEM, V251, P2520; Kawaoka J, 2004, NAT STRUCT MOL BIOL, V11, P526, DOI 10.1038/nsmb771; KOONIN EV, 1992, J GEN VIROL, V73, P989, DOI 10.1099/0022-1317-73-4-989; Lackner CA, 2000, J BIOL CHEM, V275, P1485, DOI 10.1074/jbc.275.2.1485; LUO Y, 1993, J BIOL CHEM, V268, P21253; LUO Y, 1995, J VIROL, V69, P3852, DOI 10.1128/JVI.69.6.3852-3856.1995; Mackeldanz P, 2013, BIOCHIMIE, V95, P817, DOI 10.1016/j.biochi.2012.11.014; Martins A, 1999, J VIROL, V73, P1302, DOI 10.1128/JVI.73.2.1302-1308.1999; Matlock DL, 2010, BIOCHEMISTRY-US, V49, P2097, DOI 10.1021/bi901977k; MILLIGAN JF, 1989, BIOCHEMISTRY-US, V28, P2849, DOI 10.1021/bi00433a016; MITRA SK, 1969, EUR J BIOCHEM, V9, P79, DOI 10.1111/j.1432-1033.1969.tb00578.x; Mohamed MR, 2003, J BIOL CHEM, V278, P11794, DOI 10.1074/jbc.M213263200; Morris PD, 2001, METHODS, V23, P149, DOI 10.1006/meth.2000.1116; Moss B, 2007, FIELDS VIROLOGY; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Piacente S, 2008, VIROLOGY, V376, P211, DOI 10.1016/j.virol.2008.03.011; Piacente SC, 2003, VIROLOGY, V310, P109, DOI 10.1016/S0042-6822(03)00092-8; Porrua O, 2013, NAT STRUCT MOL BIOL, V20, P884, DOI 10.1038/nsmb.2592; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Roberts J, 2004, CURR OPIN MICROBIOL, V7, P120, DOI 10.1016/j.mib.2004.02.014; ROHRMANN G, 1986, CELL, V46, P1029, DOI 10.1016/0092-8674(86)90702-6; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Santangelo TJ, 2004, MOL CELL, V14, P117, DOI 10.1016/S1097-2765(04)00154-6; Schwartz A, 2007, J BIOL CHEM, V282, P31469, DOI 10.1074/jbc.M706935200; Shatzer AN, 2008, VIROLOGY, V375, P236, DOI 10.1016/j.virol.2008.01.028; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; SIMPSON DA, 1995, J VIROL, V69, P6131, DOI 10.1128/JVI.69.10.6131-6139.1995; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Tate J, 2015, VIROLOGY, V485, P179, DOI 10.1016/j.virol.2015.05.008; Tate J, 2011, J BIOL CHEM, V286, P44764, DOI 10.1074/jbc.M111.263822; Xiang Y, 1998, J VIROL, V72, P7012, DOI 10.1128/JVI.72.9.7012-7023.1998; Xie Z, 1997, J BIOL CHEM, V272, P31902, DOI 10.1074/jbc.272.50.31902; Xie Z, 1996, J BIOL CHEM, V271, P11043, DOI 10.1074/jbc.271.19.11043; Zuo YH, 2015, MOL CELL, V58, P534, DOI 10.1016/j.molcel.2015.03.010	62	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14826	14838		10.1074/jbc.M116.730135	http://dx.doi.org/10.1074/jbc.M116.730135			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27189950	Green Published, hybrid			2022-12-28	WOS:000380366700034
J	Chen, Z; Dempsey, DR; Thomas, SN; Hayward, D; Bolduc, DM; Cole, PA				Chen, Zan; Dempsey, Daniel R.; Thomas, Stefani N.; Hayward, Dawn; Bolduc, David M.; Cole, Philip A.			Molecular Features of Phosphatase and Tensin Homolog (PTEN) Regulation by C-terminal Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatase; phosphatase and tensin homolog (PTEN); phosphorylation; post-translational modification (PTM); protein conformation; pten	TUMOR-SUPPRESSOR PTEN; MEMBRANE ASSOCIATION; STABILITY; CANCER; GENE; TAIL	PTEN is a tumor suppressor that functions to negatively regulate the PI3K/AKT pathway as the lipid phosphatase for phosphatidylinositol 3,4,5-triphosphate. Phosphorylation of a cluster of Ser/Thr residues (amino acids 380-385) on the C-terminal tail serves to alter the conformational state of PTEN from an open active state to a closed inhibited state, resulting in a reduction of plasma membrane localization and inhibition of enzyme activity. The relative contribution of each phosphorylation site to PTEN autoinhibition and the structural basis for the conformational closure is still unclear. To further the structural understanding of PTEN regulation by C-terminal tail phosphorylation, we used protein semisynthesis to insert stoichiometric and site-specific phospho-Ser/Thr(s) in the C-terminal tail of PTEN. Additionally, we employed photo-cross-linking to map the intramolecular PTEN interactions of the phospho-tail. Systematic evaluation of the PTEN C-tail phospho-cluster showed autoinhibition, and conformational closure was influenced by the aggregate effect of multiple phospho-sites rather than dominated by a single phosphorylation site. Moreover, photo-cross-linking suggested a direct interaction between the PTEN C-tail and a segment in the N-terminal region of the catalytic domain. Mutagenesis experiments provided additional insights into how the PTEN phospho-tail interacts with both the C2 and catalytic domains.	[Chen, Zan; Dempsey, Daniel R.; Thomas, Stefani N.; Hayward, Dawn; Bolduc, David M.; Cole, Philip A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, 316 Hunterian,725 N Wolfe St, Baltimore, MD 21205 USA	Johns Hopkins University	Cole, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, 316 Hunterian,725 N Wolfe St, Baltimore, MD 21205 USA.	pcole@jhmi.edu	Thomas, Stefani/AAF-4212-2021; Chen, Zan/D-3531-2019	Thomas, Stefani/0000-0003-1679-5453; Chen, Zan/0000-0001-9925-872X	National Institutes of Health [CA74305]; NATIONAL CANCER INSTITUTE [R01CA074305, R29CA074305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM120855] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant CA74305. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Bolduc D, 2013, ELIFE, V2, DOI 10.7554/eLife.00691; Chen Z, 2015, CURR OPIN CHEM BIOL, V28, P115, DOI 10.1016/j.cbpa.2015.07.001; Forne I, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012088; Nguyen HN, 2014, P NATL ACAD SCI USA, V111, pE2684, DOI 10.1073/pnas.1409433111; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Masson GR, 2016, BIOCHEM J, V473, P135, DOI 10.1042/BJ20150931; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mueller-Planitz F, 2015, BIOINFORMATICS, V31, P2043, DOI 10.1093/bioinformatics/btv083; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Odriozola L, 2007, J BIOL CHEM, V282, P23306, DOI 10.1074/jbc.M611240200; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Salvesen HB, 2001, INT J CANCER, V91, P22, DOI 10.1002/1097-0215(20010101)91:1<22::AID-IJC1002>3.0.CO;2-S; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang Q, 2010, J MOL GRAPH MODEL, V29, P102, DOI 10.1016/j.jmgm.2010.05.004; Wang X, 2008, ONCOGENE, V27, P5454, DOI 10.1038/onc.2008.242; Wang XJ, 2008, CELL RES, V18, P807, DOI 10.1038/cr.2008.83; Wei Y, 2015, J BIOL CHEM, V290, P1592, DOI 10.1074/jbc.M114.588590; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907	24	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14160	14169		10.1074/jbc.M116.728980	http://dx.doi.org/10.1074/jbc.M116.728980			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226612	hybrid, Green Published			2022-12-28	WOS:000379975100023
J	Kim, SM; Kim, JW; Kwak, TH; Park, SW; Kim, KP; Park, H; Lim, KT; Kang, K; Kim, J; Yang, JH; Han, H; Lee, I; Hyun, JK; Bae, YM; Scholer, HR; Lee, HT; Han, DW				Kim, Sung Min; Kim, Jong-Wan; Kwak, Tae Hwan; Park, Sang Woong; Kim, Kee-Pyo; Park, Hyunji; Lim, Kyung Tae; Kang, Kyuree; Kim, Jonghun; Yang, Ji Hun; Han, Heonjong; Lee, Insuk; Hyun, Jung Keun; Bae, Young Min; Schoeler, Hans R.; Lee, Hoon Taek; Han, Dong Wook			Generation of Integration-free Induced Neural Stem Cells from Mouse Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cell therapy; neural stem cell (NSC); regenerative medicine; reprogramming	DIRECT CONVERSION; GENE-THERAPY; CARDIOMYOCYTES; INDUCTION; NEURONS; MODEL; CNS	The viral vector-mediated overexpression of the defined transcription factors, Brn4/Pou3f4, Sox2, Klf4, and c-Myc (BSKM), could induce the direct conversion of somatic fibroblasts into induced neural stem cells (iNSCs). However, viral vectors may be randomly integrated into the host genome thereby increasing the risk for undesired genotoxicity, mutagenesis, and tumor formation. Here we describe the generation of integration-free iNSCs from mouse fibroblasts by non-viral episomal vectors containing BSKM. The episomal vector-derived iNSCs (e-iNSCs) closely resemble control NSCs, and iNSCs generated by retrovirus (r-iNSCs) in morphology, gene expression profile, epigenetic status, and self-renewal capacity. The e-iNSCs are functionally mature, as they could differentiate into all the neuronal cell types both in vitro and in vivo. Our study provides a novel concept for generating functional iNSCs using a non-viral, non-integrating, plasmid-based system that could facilitate their biomedical applicability.	[Kim, Sung Min; Kwak, Tae Hwan; Lim, Kyung Tae; Kang, Kyuree; Kim, Jonghun; Han, Dong Wook] Konkuk Univ, Dept Stem Cell Biol, Sch Med, 1 Hwayang Dong, Seoul 05029, South Korea; [Kim, Sung Min; Lee, Hoon Taek] Konkuk Univ, Dept Anim Biotechnol, 1 Hwayang Dong, Seoul 05029, South Korea; [Park, Sang Woong; Park, Hyunji; Bae, Young Min] Konkuk Univ, Sch Med, Dept Physiol, Chungju 27478, Chungbuk, South Korea; [Kim, Jong-Wan; Hyun, Jung Keun] Dankook Univ, Dept Nanobiomed Sci, Grad Sch, Cheonan 31116, South Korea; [Kim, Kee-Pyo; Yang, Ji Hun; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, Germany; [Han, Heonjong; Lee, Insuk] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 04056, South Korea; [Schoeler, Hans R.] Univ Munster, Fac Med, Domagkstr 3, D-48149 Munster, Germany; [Han, Dong Wook] Konkuk Univ, Inst Biomed Sci & Technol, KU Open Innovat Ctr, 1 Hwayang Dong, Seoul 05029, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University; Konkuk University Medical Center; Dankook University; Max Planck Society; Yonsei University; University of Munster; Konkuk University	Han, DW (corresponding author), Konkuk Univ, Dept Stem Cell Biol, Sch Med, 1 Hwayang Dong, Seoul 05029, South Korea.	dwhan@konkuk.ac.kr	Lim, Kyungtae/GYU-3532-2022; , HS/AAB-4434-2019; Hyun, Jung Keun/ABB-2173-2020	Lim, Kyungtae/0000-0001-6044-2191; , HS/0000-0003-2643-5136; Hyun, Jung Keun/0000-0001-9254-4424; Bae, Young Min/0000-0002-0635-0787; Kim, Jonghun/0000-0002-9154-5529; Kim, Sungmin/0000-0002-3249-9075	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0013885]; Korea Health Technology R&D Project, Ministry of Health Welfare [A120392]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Korea Health Technology R&D Project, Ministry of Health Welfare	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), supported by Ministry of Education, Science and Technology Grant 2011-0013885, and Korea Health Technology R&D Project, Ministry of Health & Welfare Grant A120392. The authors declare that they have no conflicts of interest with the contents of this article.	Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Buganim Y, 2012, CELL STEM CELL, V11, P373, DOI 10.1016/j.stem.2012.07.019; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Cassady JP, 2014, STEM CELL REP, V3, P948, DOI 10.1016/j.stemcr.2014.10.001; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ginsberg M, 2012, CELL, V151, P559, DOI 10.1016/j.cell.2012.09.032; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Han DW, 2009, STEM CELLS, V27, P1088, DOI 10.1002/stem.43; Hemmer K, 2014, STEM CELL REP, V3, P423, DOI 10.1016/j.stemcr.2014.06.017; Hong JY, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.588871; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jakel RJ, 2004, NAT REV GENET, V5, P136, DOI 10.1038/nrg1268; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kim SM, 2016, STEM CELL RES, V16, P460, DOI 10.1016/j.scr.2016.02.025; Kim SM, 2014, NAT PROTOC, V9, P871, DOI 10.1038/nprot.2014.056; Lee JH, 2015, CELL REP, V11, P1367, DOI 10.1016/j.celrep.2015.04.056; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Lu JF, 2013, CELL REP, V3, P1580, DOI 10.1016/j.celrep.2013.04.004; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Schlaeger TM, 2015, NAT BIOTECHNOL, V33, P58, DOI 10.1038/nbt.3070; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Van Craenenbroeck K, 2000, EUR J BIOCHEM, V267, P5665, DOI 10.1046/j.1432-1327.2000.01645.x; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang LH, 2013, NAT METHODS, V10, P84, DOI [10.1038/NMETH.2283, 10.1038/nmeth.2283]; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Xu XH, 2011, CNS DRUGS, V25, P555, DOI 10.2165/11587830-000000000-00000; Xuan AG, 2009, NEUROSCI LETT, V450, P167, DOI 10.1016/j.neulet.2008.12.001; Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	44	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14199	14212		10.1074/jbc.M115.713578	http://dx.doi.org/10.1074/jbc.M115.713578			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27189941	Green Published, hybrid			2022-12-28	WOS:000379975100026
J	Rivera-de-Torre, E; Garcia-Linares, S; Alegre-Cebollada, J; Lacadena, J; Gavilanes, JG; Martinez-del-Pozo, A				Rivera-de-Torre, Esperanza; Garcia-Linares, Sara; Alegre-Cebollada, Jorge; Lacadena, Javier; Gavilanes, Jose G.; Martinez-del-Pozo, Alvaro			Synergistic Action of Actinoporin Isoforms from the Same Sea Anemone Species Assembled into Functionally Active Heteropores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						erythrocyte; ion channel; lipid-protein interaction; oligomerization; protein cross-linking; toxin; equinatoxin; lysis; pore-forming-toxin; sticholysin	PORE-FORMING PROTEINS; CYTOLYSIN EQUINATOXIN-II; WATER-MEMBRANE INTERFACE; STICHOLYSIN-II; STICHODACTYLA-HELIANTHUS; LIPID-MEMBRANES; ACTINIA-EQUINA; MODEL MEMBRANES; RADIANTHUS-MACRODACTYLUS; 3-DIMENSIONAL STRUCTURE	Among the toxic polypeptides secreted in the venom of sea anemones, actinoporins are the pore-forming toxins whose toxic activity relies on the formation of oligomeric pores within biological membranes. Intriguingly, actinoporins appear as multigene families that give rise to many protein isoforms in the same individual displaying high sequence identities but large functional differences. However, the evolutionary advantage of producing such similar isotoxins is not fully understood. Here, using sticholysins I and II (StnI and StnII) from the sea anemone Stichodactyla helianthus, it is shown that actinoporin isoforms can potentiate each other's activity. Through hemolysis and calcein releasing assays, it is revealed that mixtures of StnI and StnII are more lytic than equivalent preparations of the corresponding isolated isoforms. It is then proposed that this synergy is due to the assembly of heteropores because (i) StnI and StnII can be chemically cross-linked at the membrane and (ii) the affinity of sticholysin mixtures for the membrane is increased with respect to any of them acting in isolation, as revealed by isothermal titration calorimetry experiments. These results help us understand the multigene nature of actinoporins and may be extended to other families of toxins that require oligomerization to exert toxicity.	[Rivera-de-Torre, Esperanza; Garcia-Linares, Sara; Lacadena, Javier; Gavilanes, Jose G.; Martinez-del-Pozo, Alvaro] Univ Complutense, Dept Bioquim & Biol Mol 1, Fac Quim & Biol, E-28040 Madrid, Spain; [Alegre-Cebollada, Jorge] Ctr Nacl Invest Cardiovasc Carlos III, Madrid 28029, Spain	Complutense University of Madrid; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Gavilanes, JG; Martinez-del-Pozo, A (corresponding author), Univ Complutense, Dept Bioquim & Biol Mol 1, Fac Quim & Biol, E-28040 Madrid, Spain.	ppgf@bbm1.ucm.es; alvaromp@quim.ucm.es	Martinez-del-Pozo, Alvaro/L-8556-2014; de Torre, Esperanza Rivera/I-3832-2016; Alegre-Cebollada, Jorge/I-4301-2014; Linares, Sara García/I-4290-2016	Martinez-del-Pozo, Alvaro/0000-0003-0043-5939; de Torre, Esperanza Rivera/0000-0002-0272-6150; Alegre-Cebollada, Jorge/0000-0003-0542-0170; Linares, Sara García/0000-0003-4983-5730	Spanish Ministerio de Ciencia e Innovacion [BFU2012-32404]; Formacion de Personal Universitario fellowship; Universidad Complutense de Madrid collaboration fellowship; Ramon y Cajal Award [RYC-2014-16604]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Formacion de Personal Universitario fellowship; Universidad Complutense de Madrid collaboration fellowship; Ramon y Cajal Award(Spanish Government)	This work was supported by Grant BFU2012-32404 from the Spanish Ministerio de Ciencia e Innovacion (to A. M. P.), a Formacion de Personal Universitario fellowship (to S. G. L.), a Universidad Complutense de Madrid collaboration fellowship (to E. R. T.), and Ramon y Cajal Award RYC-2014-16604) (to J. A. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Alegre-Cebollada J, 2007, CURR PROTEIN PEPT SC, V8, P558, DOI 10.2174/138920307783018686; Alegre-Cebollada J, 2006, FEBS J, V273, P863, DOI 10.1111/j.1742-4658.2006.05122.x; Alegre-Cebollada J, 2004, FEBS LETT, V575, P14, DOI 10.1016/j.febslet.2004.08.031; Alegre-Cebollada J, 2008, J MOL BIOL, V382, P920, DOI 10.1016/j.jmb.2008.07.053; Alegre-Cebollada J, 2007, BIOPHYS J, V93, P3191, DOI 10.1529/biophysj.106.102566; Alegre-Cebollada J, 2007, J BIOTECHNOL, V127, P211, DOI 10.1016/j.jbiotec.2006.07.006; Alm I, 2015, BBA-BIOMEMBRANES, V1848, P925, DOI 10.1016/j.bbamem.2014.12.017; Alvarez C, 2009, TOXICON, V54, P1135, DOI 10.1016/j.toxicon.2009.02.022; Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Anderluh G, 1999, TOXICON, V37, P1391, DOI 10.1016/S0041-0101(99)00082-3; Anderluh G, 1999, EUR J BIOCHEM, V263, P128, DOI 10.1046/j.1432-1327.1999.00477.x; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; Athanasiadis A, 2001, STRUCTURE, V9, P341, DOI 10.1016/S0969-2126(01)00592-5; Baker MAB, 2014, CHEMBIOCHEM, V15, P2139, DOI 10.1002/cbic.201300799; Bakrac B, 2010, ADV EXP MED BIOL, V677, P106; Barlic A, 2004, J BIOL CHEM, V279, P34209, DOI 10.1074/jbc.M313817200; BARTLETT GR, 1959, J BIOL CHEM, V234, P469; Bellomio A, 2009, TOXICON, V54, P869, DOI 10.1016/j.toxicon.2009.06.022; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Bischofberger M, 2012, CELL HOST MICROBE, V12, P266, DOI 10.1016/j.chom.2012.08.005; Brinkman DL, 2014, J BIOL CHEM, V289, P4798, DOI 10.1074/jbc.M113.534149; Caaveiro JMM, 2001, BIOPHYS J, V80, P1343, DOI 10.1016/S0006-3495(01)76107-3; Castrillo I, 2010, PROTEINS, V78, P1959, DOI 10.1002/prot.22712; Cosentino K, 2016, BBA-BIOMEMBRANES, V1858, P457, DOI 10.1016/j.bbamem.2015.09.013; De los Rios V, 1998, EUR J BIOCHEM, V252, P284, DOI 10.1046/j.1432-1327.1998.2520284.x; de los Rios V, 2000, PROTEIN EXPRES PURIF, V18, P71, DOI 10.1006/prep.1999.1174; de los Rios V, 1999, FEBS LETT, V455, P27, DOI 10.1016/S0014-5793(99)00846-7; del Monte-Martinez A, 2014, PROTEIN EXPRES PURIF, V95, P57, DOI 10.1016/j.pep.2013.11.016; Dewson G, 2016, EMBO J, V35, P371, DOI 10.15252/embj.201593723; Garcia-Linares S, 2015, MAR DRUGS, V13, P1647, DOI 10.3390/md13041647; Garcia-Linares S, 2014, FEBS J, V281, P1465, DOI 10.1111/febs.12717; Garcia-Linares S, 2013, ARCH BIOCHEM BIOPHYS, V532, P39, DOI 10.1016/j.abb.2013.01.005; Garcia-Ortega L, 2011, BBA-BIOMEMBRANES, V1808, P2275, DOI 10.1016/j.bbamem.2011.05.012; Gilbert RJC, 2014, TRENDS BIOCHEM SCI, V39, P510, DOI 10.1016/j.tibs.2014.09.002; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Gouaux E, 1997, CURR OPIN STRUC BIOL, V7, P566, DOI 10.1016/S0959-440X(97)80123-6; Hinds MG, 2002, J MOL BIOL, V315, P1219, DOI 10.1006/jmbi.2001.5321; Hu B, 2011, INT J BIOL SCI, V7, P729, DOI 10.7150/ijbs.7.729; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; Kristan KC, 2009, TOXICON, V54, P1125, DOI 10.1016/j.toxicon.2009.02.026; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leichenko EV, 2014, ACTA NATURAE, V6, P89, DOI 10.32607/20758251-2014-6-4-89-98; MACEK P, 1994, TOXICOLOGY, V87, P205, DOI 10.1016/0300-483X(94)90252-6; MACEK P, 1992, FEMS MICROBIOL IMMUN, V105, P121, DOI 10.1016/0378-1097(92)90082-Y; Mancheno JM, 2003, STRUCTURE, V11, P1319, DOI 10.1016/j.str.2003.09.019; Marchioretto M, 2013, BIOPHYS CHEM, V182, P64, DOI 10.1016/j.bpc.2013.06.015; Martin-Benito J, 2000, BIOPHYS J, V78, P3186, DOI 10.1016/S0006-3495(00)76855-X; Martinez D, 2002, TOXICON, V40, P1219, DOI 10.1016/S0041-0101(02)00101-0; Martinez D, 2001, TOXICON, V39, P1547, DOI 10.1016/S0041-0101(01)00127-1; Martinez D, 2007, TOXICON, V49, P68, DOI 10.1016/j.toxicon.2006.09.019; Martinez-Ruiz A, 2001, METHODS ENZYMOL, V341, P335, DOI 10.1016/S0076-6879(01)41162-1; Maula T, 2013, BBA-BIOMEMBRANES, V1828, P1390, DOI 10.1016/j.bbamem.2013.01.018; Mechaly AE, 2011, STRUCTURE, V19, P181, DOI 10.1016/j.str.2010.11.013; Menestrina G, 1999, BIOCHEM BIOPH RES CO, V254, P174, DOI 10.1006/bbrc.1998.9898; Monastyrnaya M, 2010, TOXICON, V56, P1299, DOI 10.1016/j.toxicon.2010.07.011; Monastyrnaya MM, 2002, TOXICON, V40, P1197, DOI 10.1016/S0041-0101(02)00139-3; Morante K, 2015, FEBS LETT, V589, P1840, DOI 10.1016/j.febslet.2015.06.012; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; Onaderra M, 1998, MOL MEMBR BIOL, V15, P141, DOI 10.3109/09687689809074525; Pardo-Cea MA, 2011, FEBS J, V278, P2080, DOI 10.1111/j.1742-4658.2011.08123.x; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Pazos IF, 2003, TOXICON, V42, P571, DOI 10.1016/S0041-0101(03)00227-7; Pedrera L, 2015, LANGMUIR, V31, P9911, DOI 10.1021/acs.langmuir.5b01687; Rojko N, 2014, BIOPHYS J, V106, P1630, DOI 10.1016/j.bpj.2013.11.4507; Rojko N, 2016, BBA-BIOMEMBRANES, V1858, P446, DOI 10.1016/j.bbamem.2015.09.007; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; Ros U, 2015, BIOCHIMIE, V116, P70, DOI 10.1016/j.biochi.2015.06.024; Ros U, 2015, J MEMBRANE BIOL, V248, P545, DOI 10.1007/s00232-015-9820-y; Ros U, 2011, J BIOSCIENCES, V36, P781, DOI 10.1007/s12038-011-9156-4; SHIN ML, 1979, BIOCHIM BIOPHYS ACTA, V555, P79, DOI 10.1016/0005-2736(79)90073-7; Subburaj Y, 2015, J BIOL CHEM, V290, P4856, DOI 10.1074/jbc.M114.600676; Tanaka K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7337; Tejuca M, 1996, BIOCHEMISTRY-US, V35, P14947, DOI 10.1021/bi960787z; TURK T, 1991, J TOXICOL-TOXIN REV, V10, P223, DOI 10.3109/15569549109053857; Uechi G, 2010, TOXICON, V56, P1470, DOI 10.1016/j.toxicon.2010.09.002; Valcarcel CA, 2001, BIOPHYS J, V80, P2761, DOI 10.1016/S0006-3495(01)76244-3; Valle A, 2015, TOXICON, V103, P176, DOI 10.1016/j.toxicon.2015.06.028; Wacklin HP, 2016, BBA-BIOMEMBRANES, V1858, P640, DOI 10.1016/j.bbamem.2015.12.019; Wang YW, 2008, TOXICON, V51, P1374, DOI 10.1016/j.toxicon.2008.03.005; Wong ESW, 2012, GENE, V496, P1, DOI 10.1016/j.gene.2012.01.009	80	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14109	14119		10.1074/jbc.M115.710491	http://dx.doi.org/10.1074/jbc.M115.710491			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129251	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000379975100019
J	Damerow, M; Graalfs, F; Guther, MLS; Mehlert, A; Izquierdo, L; Ferguson, MAJ				Damerow, Manuela; Graalfs, Frauke; Guether, M. Lucia S.; Mehlert, Angela; Izquierdo, Luis; Ferguson, Michael A. J.			A Gene of the 3-Glycosyltransferase Family Encodes N-Acetylglucosaminyltransferase II Function in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; glycosyltransferase; parasite; post-translational modification (PTM); Trypanosoma brucei; N-acetylglucosamine	VARIANT SURFACE GLYCOPROTEIN; ASPARAGINE-LINKED OLIGOSACCHARIDES; ANTIGENIC VARIATION; AFRICAN TRYPANOSOMES; GALACTOSE METABOLISM; MEMBRANE ANCHOR; BINDING PROTEIN; GLYCOSYLATION; IDENTIFICATION; GLYCAN	The bloodstream form of the human pathogen Trypanosoma brucei expresses oligomannose, paucimannose, and complex N-linked glycans, including some exceptionally large poly-N-acetyllactosamine-containing structures. Despite the presence of complex N-glycans in this organism, no homologues of the canonical N-acetylglucosaminyltransferase I or II genes can be found in the T. brucei genome. These genes encode the activities that initiate the elaboration of the Man1-3 and Man1-6 arms, respectively, of the conserved trimannosyl-N-acetylchitobiosyl core of N-linked glycans. Previously, we identified a highly divergent T. brucei N-acetylglucosaminyltransferase I (TbGnTI) among a set of putative T. brucei glycosyltransferase genes belonging to the 3-glycosyltransferase superfamily (Damerow, M., Rodrigues, J. A., Wu, D., Guther, M. L., Mehlert, A., and Ferguson, M. A. (2014) J. Biol. Chem. 289, 9328-9339). Here, we demonstrate that TbGT15, another member of the same 3-glycosyltransferase family, encodes an equally divergent N-acetylglucosaminyltransferase II (TbGnTII) activity. In contrast to multicellular organisms, where GnTII activity is essential, TbGnTII null mutants of T. brucei grow in culture and are still infectious to animals. Characterization of the large poly-N-acetyllactosamine containing N-glycans of the TbGnTII null mutants by methylation linkage analysis suggests that, in wild-type parasites, the Man1-6 arm of the conserved trimannosyl core may carry predominantly linear poly-N-acetyllactosamine chains, whereas the Man1-3 arm may carry predominantly branched poly-N-acetyllactosamine chains. These results provide further detail on the structure and biosynthesis of complex N-glycans in an important human pathogen and provide a second example of the adaptation by trypanosomes of 3-glycosyltransferase family members to catalyze 1-2 glycosidic linkages.	[Damerow, Manuela; Graalfs, Frauke; Guether, M. Lucia S.; Mehlert, Angela; Izquierdo, Luis; Ferguson, Michael A. J.] Univ Dundee, Sch Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; [Izquierdo, Luis] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, E-08036 Barcelona, Spain	University of Dundee; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona	Ferguson, MAJ (corresponding author), Univ Dundee, Sch Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland.	m.a.j.ferguson@dundee.ac.uk	Izquierdo, Luis/L-9291-2015	Izquierdo, Luis/0000-0002-3704-9874; Ferguson, Michael/0000-0003-1321-8714	Wellcome Trust [097945]	Wellcome Trust(Wellcome TrustEuropean Commission)	Mass spectrometry was performed in the Fingerprint Proteomics Facility that is supported by Wellcome Trust Award 097945. We thank Dr. Liaqat Ali for help with LC-MS.	Acosta-Serrano A, 2004, EUKARYOT CELL, V3, P255, DOI 10.1128/EC.3.2.255-263.2004; Alexander DL, 2002, J CELL SCI, V115, P3253; Atrih A, 2005, J BIOL CHEM, V280, P865, DOI 10.1074/jbc.M411061200; BENDIAK B, 1987, J BIOL CHEM, V262, P5784; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Cross GAM, 1996, BIOESSAYS, V18, P283, DOI 10.1002/bies.950180406; CROSS GAM, 1984, J CELL BIOCHEM, V24, P79, DOI 10.1002/jcb.240240107; Damerow M, 2014, J BIOL CHEM, V289, P9328, DOI 10.1074/jbc.M114.555029; Ferguson M. A. J., 1992, LIPID MODIFICATION P, P191; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4963; FERGUSON MAJ, 1994, GLYCOBIOLOGY PRACTIC, P349; Geisler C, 2012, J BIOL CHEM, V287, P7084, DOI 10.1074/jbc.M111.296814; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Guther MLS, 2001, EMBO J, V20, P4923, DOI 10.1093/emboj/20.17.4923; Horn D, 2014, MOL BIOCHEM PARASIT, V195, P123, DOI 10.1016/j.molbiopara.2014.05.001; Izquierdo L, 2009, MOL MICROBIOL, V71, P478, DOI 10.1111/j.1365-2958.2008.06542.x; Izquierdo L, 2015, GLYCOBIOLOGY, V25, P438, DOI 10.1093/glycob/cwu131; Izquierdo L, 2012, GLYCOBIOLOGY, V22, P696, DOI 10.1093/glycob/cws003; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; JAEKEN J, 1994, ARCH DIS CHILD, V71, P123, DOI 10.1136/adc.71.2.123; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Manthri S, 2008, GLYCOBIOLOGY, V18, P367, DOI 10.1093/glycob/cwn014; Marino K, 2011, EUKARYOT CELL, V10, P985, DOI 10.1128/EC.05025-11; Mehlert A, 2002, GLYCOBIOLOGY, V12, P607, DOI 10.1093/glycob/cwf079; Mehlert A, 1998, MOL BIOCHEM PARASIT, V91, P145, DOI 10.1016/S0166-6851(97)00187-4; Mehlert A, 1998, J MOL BIOL, V277, P379, DOI 10.1006/jmbi.1997.1600; Mehlert A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002618; Mehlert A, 2010, MOL BIOCHEM PARASIT, V174, P74, DOI 10.1016/j.molbiopara.2010.06.007; Milne KG, 2001, MOL BIOCHEM PARASIT, V112, P301, DOI 10.1016/S0166-6851(00)00369-8; Nakanishi M, 2014, PARASITOL INT, V63, P513, DOI 10.1016/j.parint.2014.01.007; Narimatsu H, 2006, CURR OPIN STRUC BIOL, V16, P567, DOI 10.1016/j.sbi.2006.09.001; Pays E, 2004, CURR OPIN MICROBIOL, V7, P369, DOI 10.1016/j.mib.2004.05.001; Roper JR, 2005, J BIOL CHEM, V280, P19728, DOI 10.1074/jbc.M502370200; Roper JR, 2002, P NATL ACAD SCI USA, V99, P5884, DOI 10.1073/pnas.092669999; Schachter H, 1999, BBA-MOL BASIS DIS, V1455, P179, DOI 10.1016/S0925-4439(99)00054-X; Schachter H, 2010, SEMIN CELL DEV BIOL, V21, P609, DOI 10.1016/j.semcdb.2010.02.010; Sevova ES, 2009, MOL BIOL CELL, V20, P4739, DOI 10.1091/mbc.E09-07-0542; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; STEVERDING D, 1995, J CELL BIOL, V131, P1173, DOI 10.1083/jcb.131.5.1173; Steverding Dietmar, 2000, Parasitology International, V48, P191, DOI 10.1016/S1383-5769(99)00018-5; Stokes MJ, 2008, J BIOL CHEM, V283, P16147, DOI 10.1074/jbc.M709581200; Sutterwala SS, 2008, MOL MICROBIOL, V70, P281, DOI 10.1111/j.1365-2958.2008.06393.x; Urbaniak MD, 2006, EUKARYOT CELL, V5, P1906, DOI 10.1128/EC.00156-06; Urbaniak MD, 2013, J PROTEOME RES, V12, P2233, DOI 10.1021/pr400086y; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; Wang Y, 2001, GLYCOBIOLOGY, V11, P1051, DOI 10.1093/glycob/11.12.1051; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; ZAMZE SE, 1991, J BIOL CHEM, V266, P20244; ZAMZE SE, 1990, EUR J BIOCHEM, V187, P657, DOI 10.1111/j.1432-1033.1990.tb15350.x; ZIEGELBAUER K, 1992, J BIOL CHEM, V267, P10791	52	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13834	13845		10.1074/jbc.M116.733246	http://dx.doi.org/10.1074/jbc.M116.733246			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27189951	Green Published, hybrid			2022-12-28	WOS:000379771100037
J	Sabourin, J; Bartoli, F; Antigny, F; Gomez, AM; Benitah, JP				Sabourin, Jessica; Bartoli, Fiona; Antigny, Fabrice; Gomez, Ana Maria; Benitah, Jean-Pierre			Transient Receptor Potential Canonical (TRPC)/Orai1-dependent Store-operated Ca2+ Channels NEW TARGETS OF ALDOSTERONE IN CARDIOMYOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STROMAL INTERACTION MOLECULE-1; PATHOLOGICAL CARDIAC-HYPERTROPHY; SMOOTH-MUSCLE-CELLS; TRPC CHANNELS; MINERALOCORTICOID RECEPTOR; HEART-FAILURE; MYOCARDIAL-INFARCTION; VENTRICULAR MYOCYTES; RYANODINE RECEPTOR; CALCIUM-CHANNELS	Store-operated Ca2+ entry (SOCE) has emerged as an important mechanism in cardiac pathology. However, the signals that up-regulate SOCE in the heart remain unexplored. Clinical trials have emphasized the beneficial role of mineralocorticoid receptor (MR) signaling blockade in heart failure and associated arrhythmias. Accumulated evidence suggests that the mineralocorticoid hormone aldosterone, through activation of its receptor, MR, might be a key regulator of Ca2+ influx in cardiomyocytes. We thus assessed whether and how SOCE involving transient receptor potential canonical (TRPC) and Orai1 channels are regulated by aldosterone/MR in neonatal rat ventricular cardiomyocytes. Molecular screening using qRT-PCR and Western blotting demonstrated that aldosterone treatment for 24 h specifically increased the mRNA and/or protein levels of Orai1, TRPC1, -C4, -C5, and stromal interaction molecule 1 through MR activation. These effects were correlated with a specific enhancement of SOCE activities sensitive to store-operated channel inhibitors (SKF-96365 and BTP2) and to a potent Orai1 blocker (S66) and were prevented by TRPC1, -C4, and Orai1 dominant negative mutants or TRPC5 siRNA. A mechanistic approach showed that up-regulation of serum-and glucocorticoid-regulated kinase 1 mRNA expression by aldosterone is involved in enhanced SOCE. Functionally, 24-h aldosterone-enhanced SOCE is associated with increased diastolic [Ca2+](i), which is blunted by store-operated channel inhibitors. Our study provides the first evidence that aldosterone promotes TRPC1-, -C4-, -C5-, and Orai1-mediated SOCE in cardiomyocytes through an MR and serum-and glucocorticoid-regulated kinase 1 pathway.	[Sabourin, Jessica; Bartoli, Fiona; Gomez, Ana Maria; Benitah, Jean-Pierre] Univ Paris Saclay, Univ Paris 11, INSERM, UMR S1180, F-92296 Chatenay Malabry, France; [Antigny, Fabrice] Univ Paris Saclay, Univ Paris 11, INSERM, UMR S999,Ctr Chirurg Marie Lannelongue, F-92350 Le Plessis Robinson, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Sabourin, J (corresponding author), Univ Paris Saclay, Univ Paris 11, INSERM, UMR S1180, F-92296 Chatenay Malabry, France.	jessica.sabourin@u-psud.fr	Antigny, Fabrice/Q-3999-2018; Gomez, Ana M./B-5376-2013; Benitah, Jean-Pierre/L-6060-2018	Antigny, Fabrice/0000-0002-9515-6571; Gomez, Ana M./0000-0003-0009-2884; Benitah, Jean-Pierre/0000-0002-9866-9081; Bartoli, Fiona/0000-0001-9487-9551; Sabourin, Jessica/0000-0002-2980-8455	European Section of Aldosterone Council France; University of Paris Sud; Agence Nationale de la Recherche [ANR-13-BSV1-0023-01, ANR-15-CE14-0005]; Cardiovasculaire-Obesite-Rein-Diabete (CORDDIM) (Region Ile de France)	European Section of Aldosterone Council France; University of Paris Sud; Agence Nationale de la Recherche(French National Research Agency (ANR)); Cardiovasculaire-Obesite-Rein-Diabete (CORDDIM) (Region Ile de France)(Region Ile-de-France)	This work was supported by European Section of Aldosterone Council France, Attractivity Grant 2014 from University of Paris Sud, Agence Nationale de la Recherche Grants ANR-13-BSV1-0023-01 and ANR-15-CE14-0005, and Cardiovasculaire-Obesite-Rein-Diabete (CORDDIM) (Region Ile de France). The authors declare that they have no conflicts of interest with the contents of this article.	Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Aoyama T, 2005, CIRCULATION, V111, P1652, DOI 10.1161/01.CIR.0000160352.58142.06; Bae YM, 2007, J HYPERTENS, V25, P809, DOI 10.1097/HJH.0b013e3280148312; Benard L, 2016, CIRCULATION, V133, P1458, DOI 10.1161/CIRCULATIONAHA.115.020678; Benitah JP, 2001, J PHYSIOL-LONDON, V537, P151, DOI 10.1111/j.1469-7793.2001.0151k.x; Benitah JP, 1999, CIRC RES, V85, P1139; Berna-Erro A, 2012, ADV EXP MED BIOL, V740, P349, DOI 10.1007/978-94-007-2888-2_15; Borst O, 2012, BLOOD, V119, P251, DOI 10.1182/blood-2011-06-359976; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Cheng KT, 2013, CURR TOP MEMBR, V71, P149, DOI 10.1016/B978-0-12-407870-3.00007-X; Cioffi DL, 2012, CIRC RES, V110, P1435, DOI 10.1161/CIRCRESAHA.112.269506; Collins HE, 2013, AM J PHYSIOL-HEART C, V305, pH446, DOI 10.1152/ajpheart.00104.2013; Correll RN, 2015, J MOL CELL CARDIOL, V87, P38, DOI 10.1016/j.yjmcc.2015.07.032; Das S, 2012, CIRCULATION, V126, P2208, DOI 10.1161/CIRCULATIONAHA.112.115592; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Doleschal B, 2015, CARDIOVASC RES, V106, P163, DOI 10.1093/cvr/cvv022; Dominguez-Rodriguez A, 2015, J MOL CELL CARDIOL, V87, P74, DOI 10.1016/j.yjmcc.2015.07.002; Ferron L, 2011, CARDIOVASC RES, V90, P105, DOI 10.1093/cvr/cvq379; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Gomez AM, 2013, CURR VASC PHARMACOL, V11, P497, DOI 10.2174/1570161111311040013; Gomez AM, 2009, CIRCULATION, V119, P2179, DOI 10.1161/CIRCULATIONAHA.108.805804; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; He BJ, 2011, NAT MED, V17, P1610, DOI 10.1038/nm.2506; Hirose M, 2011, CIRC J, V75, P2333, DOI 10.1253/circj.CJ-10-1213; Hu GQ, 2009, MOL ENDOCRINOL, V23, P689, DOI 10.1210/me.2008-0350; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Huang JB, 2006, AM J PHYSIOL-CELL PH, V290, pC1572, DOI 10.1152/ajpcell.00226.2005; Hulot JS, 2011, CIRCULATION, V124, P796, DOI 10.1161/CIRCULATIONAHA.111.031229; Imai S, 2003, LIFE SCI, V72, P2199, DOI 10.1016/S0024-3205(03)00092-4; Kim MS, 2009, J BIOL CHEM, V284, P9733, DOI 10.1074/jbc.M808097200; Kojima A, 2012, BRIT J ANAESTH, V109, P352, DOI 10.1093/bja/aes212; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Lang F, 2013, THROMB HAEMOSTASIS, V110, P925, DOI 10.1160/TH13-02-0176; Lee KP, 2014, J BIOL CHEM, V289, P6372, DOI 10.1074/jbc.M113.546556; Li J, 2011, BRIT J PHARMACOL, V164, P382, DOI 10.1111/j.1476-5381.2011.01368.x; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Londono JEC, 2015, EUR HEART J, V36, P2257, DOI 10.1093/eurheartj/ehv250; Luo X, 2012, J MOL CELL CARDIOL, V52, P136, DOI 10.1016/j.yjmcc.2011.11.003; Ma HT, 2008, J IMMUNOL, V180, P2233, DOI 10.4049/jimmunol.180.4.2233; Makarewich CA, 2014, CIRC RES, V115, P567, DOI 10.1161/CIRCRESAHA.115.303831; Messaoudi S, 2013, HYPERTENSION, V61, P361, DOI 10.1161/HYPERTENSIONAHA.112.198986; Messaoudi S, 2012, MOL CELL ENDOCRINOL, V350, P266, DOI 10.1016/j.mce.2011.06.038; Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com; Nilius B, 2014, PHARMACOL REV, V66, P676, DOI 10.1124/pr.113.008268; Ohba T, 2007, J MOL CELL CARDIOL, V42, P498, DOI 10.1016/j.yjmcc.2006.10.020; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Ouvrard-Pascaud A, 2005, CIRCULATION, V111, P3025, DOI 10.1161/CIRCULATIONAHA.104.503706; Perrier E, 2004, CIRCULATION, V110, P776, DOI 10.1161/01.CIR.0000138973.55605.38; Perrier R, 2005, J PHYSIOL-LONDON, V569, P153, DOI 10.1113/jphysiol.2005.092692; Poteser M, 2008, FEBS LETT, V582, P2696, DOI 10.1016/j.febslet.2008.06.049; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Sabourin J, 2012, J BIOL CHEM, V287, P26688, DOI 10.1074/jbc.M112.378588; Sabourin J, 2011, CARDIOVASC RES, V92, P226, DOI 10.1093/cvr/cvr167; Satoh S, 2007, MOL CELL BIOCHEM, V294, P205, DOI 10.1007/s11010-006-9261-0; Shigaev A, 2000, AM J PHYSIOL-RENAL, V278, pF613, DOI 10.1152/ajprenal.2000.278.4.F613; Sundivakkam PC, 2012, MOL PHARMACOL, V81, P510, DOI 10.1124/mol.111.074658; Takeda Y, 2002, CIRCULATION, V105, P677, DOI 10.1161/hc0602.104675; Taruno A, 2008, AM J PHYSIOL-RENAL, V294, pF177, DOI 10.1152/ajprenal.00250.2007; Thompson JL, 2013, CURR TOP MEMBR, V71, P125, DOI 10.1016/B978-0-12-407870-3.00006-8; Touchberry CD, 2011, BIOCHEM BIOPH RES CO, V416, P45, DOI 10.1016/j.bbrc.2011.10.133; Uehara A, 2002, CELL CALCIUM, V31, P89, DOI 10.1054/ceca.2001.0257; Volkers M, 2012, J CELL SCI, V125, P287, DOI 10.1242/jcs.090464; Voelkers M, 2010, J MOL CELL CARDIOL, V48, P1329, DOI 10.1016/j.yjmcc.2010.01.020; Wang PP, 2012, EUR J PHARMACOL, V681, P60, DOI 10.1016/j.ejphar.2012.01.045; Watanabe H, 2009, CIRC J, V73, P419, DOI 10.1253/circj.CJ-08-1153; Wolkowicz PE, 2011, EUR J PHARMACOL, V668, P208, DOI 10.1016/j.ejphar.2011.06.025; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zhang BB, 2016, BIOCHEM BIOPH RES CO, V470, P384, DOI 10.1016/j.bbrc.2016.01.034; Zhang YH, 2013, PFLUG ARCH EUR J PHY, V465, P1439, DOI 10.1007/s00424-013-1291-3; Zhou R, 2011, CELL PHYSIOL BIOCHEM, V27, P299, DOI 10.1159/000327956	75	52	54	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13394	13409		10.1074/jbc.M115.693911	http://dx.doi.org/10.1074/jbc.M115.693911			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129253	Green Published, hybrid			2022-12-28	WOS:000379770500039
J	Chaplin, AK; Wilson, MT; Hough, MA; Svistunenko, DA; Hemsworth, GR; Walton, PH; Vijgenboom, E; Worrall, JAR				Chaplin, Amanda K.; Wilson, Michael T.; Hough, Michael A.; Svistunenko, Dimitri A.; Hemsworth, Glyn R.; Walton, Paul H.; Vijgenboom, Erik; Worrall, Jonathan A. R.			Heterogeneity in the Histidine-brace Copper Coordination Sphere in Auxiliary Activity Family 10 (AA10) Lytic Polysaccharide Monooxygenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-LIVIDANS; CELLULOSE DEGRADATION; CELLOBIOSE DEHYDROGENASE; STRUCTURAL BASIS; PROTEIN; BIOMASS; INSIGHTS; CLEAVAGE; CHITIN; MORPHOGENESIS	Copper-dependent lytic polysaccharide monooxygenases (LPMOs) are enzymes that oxidatively deconstruct polysaccharides. The active site copper in LPMOs is coordinated by a histidine-brace. This utilizes the amino group and side chain of the N-terminal His residue with the side chain of a second His residue to create a T-shaped arrangement of nitrogen ligands. We report a structural, kinetic, and thermodynamic appraisal of copper binding to the histidine-brace in an auxiliary activity family 10 (AA10) LPMO from Streptomyces lividans (SliLPMO10E). Unexpectedly, we discovered the existence of two apo-SliLPMO10E species in solution that can each bind copper at a single site with distinct kinetic and thermodynamic (exothermic and endothermic) properties. The experimental EPR spectrum of copper-bound SliLPMO10E requires the simulation of two different line shapes, implying two different copper-bound species, indicative of three and two nitrogen ligands coordinating the copper. Amino group coordination was probed through the creation of an N-terminal extension variant (SliLPMO10E-Ext). The kinetics and thermodynamics of copper binding to SliLPMO10E-Ext are in accord with copper binding to one of the apo-forms in the wild-type protein, suggesting that amino group coordination is absent in the two-nitrogen coordinate form of SliLPMO10E. Copper binding to SliLPMO10B was also investigated, and again it revealed the presence of two apo-forms with kinetics and stoichiometry of copper binding identical to that of SliLPMO10E. Our findings highlight that heterogeneity exists in the active site copper coordination sphere of LPMOs that may have implications for the mechanism of loading copper in the cell.	[Chaplin, Amanda K.; Wilson, Michael T.; Hough, Michael A.; Svistunenko, Dimitri A.; Worrall, Jonathan A. R.] Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Hemsworth, Glyn R.; Walton, Paul H.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Vijgenboom, Erik] Leiden Univ, Sylvius Lab, Inst Biol, Mol Biotechnol, POB 9505, NL-2300 RA Leiden, Netherlands	University of Essex; University of York - UK; Leiden University; Leiden University - Excl LUMC	Worrall, JAR (corresponding author), Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	jworrall@essex.ac.uk	Hemsworth, Glyn/AAS-5473-2021	Hemsworth, Glyn/0000-0002-8226-1380; Walton, Paul/0000-0002-1152-1480; Svistunenko, Dimitri/0000-0001-8060-2738; Chaplin, Amanda/0000-0002-9606-8346; Vijgenboom, Erik/0000-0002-5059-069X; Hough, Michael/0000-0001-7377-6713	University of Essex Silberrad Ph.D. scholarship	University of Essex Silberrad Ph.D. scholarship	Recipient of a University of Essex Silberrad Ph.D. scholarship.	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Anne J, 2012, J BIOTECHNOL, V158, P159, DOI 10.1016/j.jbiotec.2011.06.028; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Beeson WT, 2015, ANNU REV BIOCHEM, V84, P923, DOI 10.1146/annurev-biochem-060614-034439; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Blundell KLIM, 2014, BIOCHEM J, V459, P525, DOI 10.1042/BJ20140017; Blundell KLIM, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120163; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chaplin AK, 2015, BIOCHEM J, V469, P433, DOI 10.1042/BJ20150190; CRAWFORD DL, 1978, APPL ENVIRON MICROB, V35, P1041, DOI 10.1128/AEM.35.6.1041-1045.1978; Cruz-Morales P, 2013, GENOME BIOL EVOL, V5, P1165, DOI 10.1093/gbe/evt082; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dwarakanath S, 2012, J BIOL CHEM, V287, P17833, DOI 10.1074/jbc.M112.352740; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Forsberg Z, 2014, BIOCHEMISTRY-US, V53, P1647, DOI 10.1021/bi5000433; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Frandsen KEH, 2016, NAT CHEM BIOL, V12, P298, DOI [10.1038/NCHEMBIO.2029, 10.1038/nchembio.2029]; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2015, TRENDS BIOTECHNOL, V33, P747, DOI 10.1016/j.tibtech.2015.09.006; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Hemsworth GR, 2013, J AM CHEM SOC, V135, P6069, DOI 10.1021/ja402106e; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim S, 2014, P NATL ACAD SCI USA, V111, P149, DOI 10.1073/pnas.1316609111; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Liman R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054112; Lo Leggio L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6961; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MCCARTHY AJ, 1992, GENE, V115, P189, DOI 10.1016/0378-1119(92)90558-7; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0376-y; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakagawa YS, 2015, FEBS J, V282, P1065, DOI 10.1111/febs.13203; Nielsen J, 1996, TRENDS BIOTECHNOL, V14, P438, DOI 10.1016/0167-7799(96)10055-X; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; Petrus MLC, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150149; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Romling U, 2002, RES MICROBIOL, V153, P205, DOI 10.1016/S0923-2508(02)01316-5; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; Svistunenko DA, 2004, BIOPHYS J, V87, P582, DOI 10.1529/biophysj.104.041046; Takasuka TE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01030; Tan TC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8542; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2012, J MOL BIOL, V416, P239, DOI 10.1016/j.jmb.2011.12.033; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; van Dissel D, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0224-6; van Dissel D, 2014, ADV APPL MICROBIOL, V89, P1, DOI 10.1016/B978-0-12-800259-9.00001-9; van Veluw GJ, 2012, APPL MICROBIOL BIOT, V96, P1301, DOI 10.1007/s00253-012-4490-5; Vrancken K, 2009, FUTURE MICROBIOL, V4, P181, DOI 10.2217/17460913.4.2.181; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Westereng B, 2015, SCI REP-UK, V5, DOI 10.1038/srep18561; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wong E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002373; Xu HB, 2008, J BACTERIOL, V190, P4971, DOI 10.1128/JB.01849-07	62	33	33	1	64	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12838	12850		10.1074/jbc.M116.722447	http://dx.doi.org/10.1074/jbc.M116.722447			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129229	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000378119900034
J	Kadiyala, V; Sasse, SK; Altonsy, MO; Berman, R; Chu, HW; Phang, TL; Gerber, AN				Kadiyala, Vineela; Sasse, Sarah K.; Altonsy, Mohammed O.; Berman, Reena; Chu, Hong W.; Phang, Tzu L.; Gerber, Anthony N.			Cistrome-based Cooperation between Airway Epithelial Glucocorticoid Receptor and NF-kappa B Orchestrates Anti-inflammatory Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NEGATIVE REGULATOR; CHROMATIN ACCESSIBILITY; TRANSCRIPTION FACTORS; GENE-TRANSCRIPTION; INNATE IMMUNITY; BINDING-SITES; TARGET GENES; MAST-CELLS; CHIP-SEQ	Antagonism of pro-inflammatory transcription factors by monomeric glucocorticoid receptor (GR) has long been viewed as central to glucocorticoid (GC) efficacy. However, the mechanisms and targets through which GCs exert therapeutic effects in diseases such as asthma remain incompletely understood. We previously defined a surprising cooperative interaction between GR and NF-kappa B that enhanced expression of A20 (TNFAIP3), a potent inhibitor of NF-kappa B. Here we extend this observation to establish that A20 is required for maximal cytokine repression by GCs. To ascertain the global extent of GR and NF-kappa B cooperation, we determined genome-wide occupancy of GR, the p65 subunit of NF-kappa B, and RNA polymerase II in airway epithelial cells treated with dexamethasone, TNF, or both using chromatin immunoprecipitation followed by deep sequencing. We found that GR recruits p65 to dimeric GR binding sites across the genome and discovered additional regulatory elements in which GR-p65 cooperation augments gene expression. GR targets regulated by this mechanism include key anti-inflammatory and injury response genes such as SERPINA1, which encodes alpha 1 antitrypsin, and FOXP4, an inhibitor of mucus production. Although dexamethasone treatment reduced RNA polymerase II occupancy of TNF targets such as IL8 and TNFAIP2, we were unable to correlate specific binding sequences for GR or occupancy patterns with repressive effects on transcription. Our results suggest that cooperative anti-inflammatory gene regulation by GR and p65 contributes to GC efficacy, whereas tethering interactions between GR and p65 are not universally required for GC-based gene repression.	[Kadiyala, Vineela; Sasse, Sarah K.; Altonsy, Mohammed O.; Berman, Reena; Chu, Hong W.; Gerber, Anthony N.] Natl Jewish Hlth, Dept Med, Rm K621,1400 Jackson St, Denver, CO 80206 USA; [Altonsy, Mohammed O.] Sohag Univ, Dept Zool, Sohag 825224, Egypt; [Phang, Tzu L.; Gerber, Anthony N.] Univ Colorado, Dept Med, Denver, CO 80045 USA	National Jewish Health; Egyptian Knowledge Bank (EKB); Sohag University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Gerber, AN (corresponding author), Natl Jewish Hlth, Dept Med, Rm K621,1400 Jackson St, Denver, CO 80206 USA.	gerbera@njhealth.org			National Institutes of Health [P30-CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109557] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Katrina Diener for expert technical assistance and Robert Newton for critical review of the manuscript. ChIP sequencing was performed at the University of Colorado Cancer Center, which is supported by National Institutes of Health Grant P30-CA046934 (NCI).	Allen MA, 2014, ELIFE, V3, DOI 10.7554/eLife.02200; Altonsy MO, 2014, J BIOL CHEM, V289, P8231, DOI 10.1074/jbc.M113.545178; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Azofeifa JG, 2017, IEEE ACM T COMPUT BI, V14, P1070, DOI 10.1109/TCBB.2016.2520919; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman R, 2014, J CLIN CELL IMMUNOL, V5, P257; Bhakta Nirav R, 2013, Clin Transl Allergy, V3, P24, DOI 10.1186/2045-7022-3-24; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bouazza B, 2014, AM J RESP CELL MOL, V50, P301, DOI 10.1165/rcmb.2012-0522OC; Bradding P, 2016, CLIN EXP ALLERGY, V46, P194, DOI 10.1111/cea.12675; Chang I, 2013, J CLIN INVEST, V123, P2643, DOI 10.1172/JCI66735; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Deregowski V, 2002, BIOCHEM PHARMACOL, V64, P873, DOI 10.1016/S0006-2952(02)01151-6; Edwards MR, 2006, AM J RESP CELL MOL, V34, P616, DOI 10.1165/rcmb.2005-0385OC; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Gerber AN, 2015, ADV EXP MED BIOL, V872, P279, DOI 10.1007/978-1-4939-2895-8_12; Gertz J, 2013, MOL CELL, V52, P25, DOI 10.1016/j.molcel.2013.08.037; Gong DP, 2013, J IMMUNOL, V191, P4514, DOI 10.4049/jimmunol.1202603; Hallstrand TS, 2014, CLIN IMMUNOL, V151, P1, DOI 10.1016/j.clim.2013.12.003; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hiemstra PS, 2015, EUR RESPIR J, V45, P1150, DOI 10.1183/09031936.00141514; Holden NS, 2014, J PHARMACOL EXP THER, V348, P12, DOI 10.1124/jpet.113.204586; Horvath AJ, 2005, J BIOL CHEM, V280, P43168, DOI 10.1074/jbc.M505598200; Hosakote YM, 2011, AM J RESP CRIT CARE, V183, P1550, DOI 10.1164/rccm.201010-1755OC; Hu AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060452; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kadiyala V, 2016, ANN AM THORAC SOC, V13, pS103, DOI 10.1513/AnnalsATS.201508-534MG; Kelly MM, 2012, BRIT J PHARMACOL, V165, P1737, DOI 10.1111/j.1476-5381.2011.01620.x; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; Kraft M, 2003, CHEST, V124, P42, DOI 10.1378/chest.124.1.42; Lambert WM, 2013, MOL CELL BIOL, V33, P3700, DOI 10.1128/MCB.00150-13; Langlais D, 2012, MOL CELL, V47, P38, DOI 10.1016/j.molcel.2012.04.021; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lannan EA, 2012, ENDOCRINOLOGY, V153, P3701, DOI 10.1210/en.2012-1020; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Li SR, 2012, DEVELOPMENT, V139, P2500, DOI 10.1242/dev.079699; Liang K, 2012, BIOINFORMATICS, V28, P121, DOI 10.1093/bioinformatics/btr605; Lim HW, 2015, GENOME RES, V25, P836, DOI 10.1101/gr.188581.114; Liu T, 2014, METHODS MOL BIOL, V1150, P81, DOI 10.1007/978-1-4939-0512-6_4; Lu XQ, 2008, BLOOD, V112, P4098, DOI 10.1182/blood-2008-03-148726; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; MacIntyre NR, 2006, RESP CARE, V51, P289; Martinez FD, 2013, LANCET, V382, P1360, DOI 10.1016/S0140-6736(13)61536-6; McMaster A, 2008, NAT CLIN PRACT ENDOC, V4, P91, DOI 10.1038/ncpendmet0745; Meijsing SH, 2015, ADV EXP MED BIOL, V872, P59, DOI 10.1007/978-1-4939-2895-8_3; Miyata M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7062; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002; Pelaia G, 2015, EXPERT OPIN PHARMACO, V16, P2009, DOI 10.1517/14656566.2015.1070826; Raney BJ, 2014, BIOINFORMATICS, V30, P1003, DOI 10.1093/bioinformatics/btt637; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Reddy TE, 2012, MOL CELL BIOL, V32, P3756, DOI 10.1128/MCB.00062-12; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Roesler WJ, 1998, MOL CELL BIOCHEM, V178, P1, DOI 10.1023/A:1006886421795; Sacta MA, 2016, ANNU REV PHYSIOL, V78, P155, DOI 10.1146/annurev-physiol-021115-105323; Sasse SK, 2015, J BIOL CHEM, V290, P19756, DOI 10.1074/jbc.M115.668558; Sasse SK, 2013, MOL CELL BIOL, V33, P2104, DOI 10.1128/MCB.01474-12; Schaecke H, 2007, MOL CELL ENDOCRINOL, V275, P109, DOI 10.1016/j.mce.2007.05.014; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Shipp LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013754; Siedlinski M, 2009, EUR RESPIR J, V33, P986, DOI 10.1183/09031936.00171507; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Stafford JM, 2001, J BIOL CHEM, V276, P3811, DOI 10.1074/jbc.M009389200; Starick SR, 2015, GENOME RES, V25, P825, DOI 10.1101/gr.185157.114; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Suzuki S, 2006, FEBS LETT, V580, P3257, DOI 10.1016/j.febslet.2006.04.086; Thun GA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003585; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Vandevyver S, 2013, ENDOCRINOLOGY, V154, P993, DOI 10.1210/en.2012-2045; Vandevyver S, 2012, J CLIN INVEST, V122, P2130, DOI 10.1172/JCI60006; Vettorazzi S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8796; Walsh GM, 2003, J ENDOCRINOL, V178, P37, DOI 10.1677/joe.0.1780037; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Wu Q, 2013, VIROLOGY, V446, P199, DOI 10.1016/j.virol.2013.08.005; Wu Q, 2012, J ALLERGY CLIN IMMUN, V129, P825, DOI 10.1016/j.jaci.2011.10.043; Wu Q, 2009, EXPERT REV CLIN IMMU, V5, P97, DOI 10.1586/1744666X.5.1.97; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang N, 2007, J IMMUNOL, V179, P578, DOI 10.4049/jimmunol.179.1.578	81	28	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12673	12687		10.1074/jbc.M116.721217	http://dx.doi.org/10.1074/jbc.M116.721217			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27076634	Green Published, hybrid			2022-12-28	WOS:000378119900022
J	Kumar, AS; Jagadeeshan, S; Subramanian, A; Chidambaram, SB; Surabhi, RP; Singhal, M; Bhoopalan, H; Sekar, S; Pitani, RS; Duvuru, P; Venkatraman, G; Rayala, SK				Kumar, Arathy S.; Jagadeeshan, Sankar; Subramanian, Anirudh; Chidambaram, Saravana Babu; Surabhi, Rohan Prasad; Singhal, Mahak; Bhoopalan, Hemadev; Sekar, Sathiya; Pitani, Ravi Shankar; Duvuru, Prathiba; Venkatraman, Ganesh; Rayala, Suresh K.			Molecular Mechanism of Regulation of MTA1 Expression by Granulocyte Colony-stimulating Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-HYDROXYLASE GENE; PARKINSONS-DISEASE; C-FOS; G-CSF; FACTOR PROTECTS; TRANSCRIPTION; RECEPTOR; MODEL; MICE; INDUCTION	Parkinson disease (PD) is a neurodegenerative disorder with loss of dopaminergic neurons of the brain, which results in insufficient synthesis and action of dopamine. Metastasis-associated protein 1 (MTA1) is an upstream modulator of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis, and hence MTA1 plays a significant role in PD pathogenesis. To impart functional and clinical significance to MTA1, we analyzed MTA1 and TH levels in the substantia nigra region of a large cohort of human brain tissue samples by Western blotting, quantitative PCR, and immunohistochemistry. Our results showed that MTA1 and TH levels were significantly down-regulated in PD samples as compared with normal brain tissue. Correspondingly, immunohistochemistry analysis for MTA1 in substantia nigra sections revealed that 74.1% of the samples had a staining intensity of <6 in the PD samples as compared with controls, 25.9%, with an odds ratio of 8.54. Because of the clinical importance of MTA1 established in PD, we looked at agents to modulate MTA1 expression in neuronal cells, and granulocyte colony-stimulating factor (G-CSF) was chosen, due to its clinically proven neurogenic effects. Treatment of the human neuronal cell line KELLY and acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model with G-CSF showed significant induction of MTA1 and TH with rescue of phenotype in the mouse model. Interestingly, the observed induction of TH was compromised on silencing of MTA1. The underlying molecular mechanism of MTA1 induction by G-CSF was proved to be through induction of c-Fos and its recruitment to the MTA1 promoter.	[Kumar, Arathy S.; Jagadeeshan, Sankar; Subramanian, Anirudh; Singhal, Mahak; Rayala, Suresh K.] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Chidambaram, Saravana Babu; Sekar, Sathiya] Sri Ramachandra Univ, Ctr Toxicol & Dev Res CEFT, Madras 600116, Tamil Nadu, India; [Surabhi, Rohan Prasad; Bhoopalan, Hemadev; Venkatraman, Ganesh] Sri Ramachandra Univ, Dept Human Genet, Madras 600116, Tamil Nadu, India; [Pitani, Ravi Shankar] Sri Ramachandra Univ, Dept Community Med, Madras 600116, Tamil Nadu, India; [Duvuru, Prathiba] Sri Ramachandra Univ, Dept Pathol, Madras 600116, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Sri Ramachandra Institute of Higher Education & Research; Sri Ramachandra Institute of Higher Education & Research; Sri Ramachandra Institute of Higher Education & Research; Sri Ramachandra Institute of Higher Education & Research	Rayala, SK (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.; Venkatraman, G (corresponding author), Sri Ramachandra Univ, Madras 600116, Tamil Nadu, India.	ganeshv@sriramachandra.edu.in; rayala@iitm.ac.in	JAGADEESHAN, SANKAR/S-8384-2019; Chidambaram, Saravana babu/V-2319-2019; Sekar, Sathiya/AAN-7175-2020; Venkatraman, Ganesh/AAB-1467-2020; Singhal, Mahak/V-4017-2019	JAGADEESHAN, SANKAR/0000-0002-3778-8757; Venkatraman, Ganesh/0000-0003-0179-9785; Singhal, Mahak/0000-0002-7303-9585; Rayala, Suresh/0000-0003-4394-4450; Muralikrishnan, Anirudh Subramanian/0000-0001-7102-9968	Department of Biotechnology from the Government of India [BT/PR14372/Med/30/529/2010]; IIT MADRAS, India	Department of Biotechnology from the Government of India; IIT MADRAS, India	This work was supported by Department of Biotechnology Grant BT/PR14372/Med/30/529/2010 from the Government of India and IIT MADRAS, India. The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 1996, GUID CAR US LAB AN, P45; Bademci G, 2012, CNS NEUROL DISORD-DR, V11, P469, DOI 10.2174/187152712800792866; Cao XQ, 2006, J NEUROCHEM, V99, P861, DOI 10.1111/j.1471-4159.2006.04125.x; Charafe-Jaufrret E, 2004, J PATHOL, V202, P265, DOI 10.1002/path.1515; COLOTTA F, 1987, J EXP MED, V165, P1224, DOI 10.1084/jem.165.4.1224; Deshpande RV, 1998, MOL CELL BIOCHEM, V178, P47, DOI 10.1023/A:1006894329316; Duarte RF, 2000, BLOOD, V96, P3422; Fernagut PO, 2002, J NEUROSCI METH, V113, P123, DOI 10.1016/S0165-0270(01)00485-X; Feve AP, 2012, CNS NEUROL DISORD-DR, V11, P450; Frank T, 2012, BRAIN, V135, P1914, DOI 10.1093/brain/aws054; Hu N, 2015, J BIOL CHEM, V290, P24561, DOI 10.1074/jbc.M115.668871; Huang HY, 2007, NEUROBIOL AGING, V28, P1258, DOI 10.1016/j.neurobiolaging.2006.05.037; Ishikawa S, 2010, J BIOL CHEM, V285, P39718, DOI 10.1074/jbc.M110.137034; Jeong H, 2006, NEUROSCI LETT, V396, P57, DOI 10.1016/j.neulet.2005.11.011; Khaleque M, 2008, ONCOGENE, V27, P1886, DOI 10.1038/sj.onc.1210834; Khan MS, 2012, CNS NEUROL DISORD-DR, V11, P369; Kingwell Katie, 2011, Nat Rev Neurol, V7, P241, DOI 10.1038/nrneurol.2011.48; Lu LL, 2012, INT J BIOCHEM CELL B, V44, P65, DOI 10.1016/j.biocel.2011.09.007; Ma H., 2008, NAT SCI, V6, P66; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; McCollum M, 2010, MOL NEUROBIOL, V41, P410, DOI 10.1007/s12035-010-8118-4; Messmer K, 2007, INT J DEV NEUROSCI, V25, P29, DOI 10.1016/j.ijdevneu.2006.11.003; Meuer K, 2006, J NEUROCHEM, V97, P675, DOI 10.1111/j.1471-4159.2006.03727.x; Michael J. Z., 1996, 5 GENERATION PROGR, P1781; Mullin S, 2015, BRIT MED BULL, V114, P39, DOI 10.1093/bmb/ldv022; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pezzoli G, 2010, CLIN NEUROL NEUROSUR, V112, P65, DOI 10.1016/j.clineuro.2009.08.023; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; Reddy SDN, 2011, P NATL ACAD SCI USA, V108, P4200, DOI 10.1073/pnas.1101193108; Romano G, 2007, J CELL PHYSIOL, V211, P431, DOI 10.1002/jcp.20949; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Schumm S, 2012, J NEUROCHEM, V122, P1032, DOI 10.1111/j.1471-4159.2012.07837.x; Sen N, 2014, CANCER METAST REV, V33, P869, DOI 10.1007/s10555-014-9514-4; Solaroglu I, 2006, STROKE, V37, P1123, DOI 10.1161/01.STR.0000208205.26253.96; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Solaroglu I, 2007, FRONT BIOSCI-LANDMRK, V12, P712, DOI 10.2741/2095; Solaroglu I, 2009, NEUROL RES, V31, P167, DOI 10.1179/174313209X393582; Sun BY, 2003, J NEUROCHEM, V85, P1421, DOI 10.1046/j.1471-4159.2003.01789.x; Sun BY, 2002, J NEUROCHEM, V80, P295, DOI 10.1046/j.0022-3042.2001.00692.x; Tabrez S, 2012, CNS NEUROL DISORD-DR, V11, P395, DOI 10.2174/187152712800792785; Trinh J, 2013, NAT REV NEUROL, V9, P445, DOI 10.1038/nrneurol.2013.132; Huynh T, 2011, NAT REV DRUG DISCOV, V10, P571, DOI 10.1038/nrd3515; Wang WJ, 2012, NEUROSCI LETT, V524, P10, DOI 10.1016/j.neulet.2012.06.063; Zhu YZ, 2012, CNS NEUROL DISORD-DR, V11, P350, DOI 10.2174/187152712800792901	44	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12310	12321		10.1074/jbc.M115.707224	http://dx.doi.org/10.1074/jbc.M115.707224			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27044752	hybrid, Green Published			2022-12-28	WOS:000378092800030
J	Smith, N; Wei, WZ; Zhao, MY; Qin, XJ; Seravalli, J; Kim, H; Lee, J				Smith, Nathan; Wei, Wenzhong; Zhao, Miaoyun; Qin, Xiaojuan; Seravalli, Javier; Kim, Heejeong; Lee, Jaekwon			Cadmium and Secondary Structure-dependent Function of a Degron in the Pca1p Cadmium Exporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; PROTEIN-QUALITY CONTROL; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRANSPORTING P-1B-TYPE ATPASE; UBIQUITIN-PROTEASOME PATHWAY; ER-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONES; CHEMICAL CHAPERONES; ALZHEIMERS-DISEASE	Protein turnover is a critical cellular process regulating biochemical pathways and destroying terminally misfolded or damaged proteins. Pca1p, a cadmium exporter in the yeast Saccharomyces cerevisiae, is rapidly degraded by the endoplasmic reticulum-associated degradation (ERAD) system via a cis-acting degron that exists at the 250-350 amino acid region of Pca1p and is transferable to other proteins to serve as a degradation signal. Cadmium stabilizes Pca1p in a manner dependent on the degron. This suggested that cadmium-mediated masking of the degron impedes its interaction with the molecular factors involved in the ERAD. The characteristics and mechanisms of action of the degron in Pca1p and most of those in other proteins however remain to be determined. The results presented here indicate that specific cysteine residues in a degron of Pca1p sense cadmium. An unbiased approach selecting non-functional degrons indicated a critical role of hydrophobic amino acids in the degron for its function. A secondary structure modeling predicted the formation of an amphipathic helix. Site-directed mutagenesis confirmed the functional significance of the hydrophobic patch. Last, hydrophobic amino acids in the degron- and cadmium-binding region affected the interaction of Pca1p with the Ssa1p molecular chaperone, which is involved in ERAD. These results reveal the mechanism of action of the degron, which might be useful for the identification and characterization of other degrons.	[Smith, Nathan; Wei, Wenzhong; Zhao, Miaoyun; Qin, Xiaojuan; Seravalli, Javier; Kim, Heejeong; Lee, Jaekwon] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Smith, Nathan; Wei, Wenzhong; Zhao, Miaoyun; Qin, Xiaojuan; Seravalli, Javier; Kim, Heejeong; Lee, Jaekwon] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Qin, Xiaojuan] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai 200234, Peoples R China	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Shanghai Normal University	Lee, J (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.; Lee, J (corresponding author), Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA.	jlee7@unl.edu			National Institutes of Health [ES16337, P30GM103335]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants ES16337 ( to J. L.) and P30GM103335 ( to the Nebraska Redox Biology Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adle DJ, 2008, J BIOL CHEM, V283, P31460, DOI 10.1074/jbc.M806054200; Adle DJ, 2007, J BIOL CHEM, V282, P947, DOI 10.1074/jbc.M609535200; Adle DJ, 2009, P NATL ACAD SCI USA, V106, P10189, DOI 10.1073/pnas.0812114106; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ansari N, 2013, CURR DRUG TARGETS, V14, P114, DOI 10.2174/138945013804806532; Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Ausubel FM, 1987, CURR PROTOC MOL BIOL; Babst M, 2014, J CELL BIOL, V205, P11, DOI 10.1083/jcb.201310113; Becker J, 1996, MOL CELL BIOL, V16, P4378; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Epping EA, 2002, J BIOL CHEM, V277, P34860, DOI 10.1074/jbc.M202987200; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Fukutomi T, 2014, MOL CELL BIOL, V34, P832, DOI 10.1128/MCB.01191-13; FURST P, 1988, CELL, V55, P705, DOI 10.1016/0092-8674(88)90229-2; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1; Gilon T, 2000, MOL CELL BIOL, V20, P7214, DOI 10.1128/MCB.20.19.7214-7219.2000; Guerriero CJ, 2013, J BIOL CHEM, V288, P18506, DOI 10.1074/jbc.M113.475905; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; He L, 2009, TOXICOL APPL PHARM, V238, P250, DOI 10.1016/j.taap.2009.02.017; Heo DH, 2012, BIOTECHNOL LETT, V34, P303, DOI 10.1007/s10529-011-0763-9; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hochstrasser M, 1996, CELL, V84, P813, DOI 10.1016/S0092-8674(00)81058-2; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kanarek N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000166; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; Marques C, 2004, FASEB J, V18, P1424, DOI 10.1096/fj.04-1743fje; McCullum EO, 2010, METHODS MOL BIOL, V634, P103, DOI 10.1007/978-1-60761-652-8_7; Meplan C, 1999, J BIOL CHEM, V274, P31663, DOI 10.1074/jbc.274.44.31663; Mercado G, 2013, TRENDS MOL MED, V19, P165, DOI 10.1016/j.molmed.2012.12.005; Mollereau B, 2014, J CELL COMMUN SIGNAL, V8, P311, DOI 10.1007/s12079-014-0251-9; MORIUCHI H, 1995, P NATL ACAD SCI USA, V92, P9333, DOI 10.1073/pnas.92.20.9333; Moulis JM, 2010, BIOMETALS, V23, P877, DOI 10.1007/s10534-010-9336-y; Moxley MA, 2014, J BIOL CHEM, V289, P3639, DOI 10.1074/jbc.M113.523704; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Pariyarath R, 2001, J BIOL CHEM, V276, P541, DOI 10.1074/jbc.M007944200; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Sharma D, 2011, P NATL ACAD SCI USA, V108, P13665, DOI 10.1073/pnas.1107421108; Shearer AG, 2004, J BIOL CHEM, V279, P188, DOI 10.1074/jbc.M307734200; Singh MV, 2002, ANAL BIOCHEM, V307, P13, DOI 10.1016/S0003-2697(02)00018-0; Smith AT, 2014, J BIOL INORG CHEM, V19, P947, DOI 10.1007/s00775-014-1129-2; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Smith N., 2013, ENCY INORGANIC BIOIN, P1; Summers DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052099; Tateishi Y, 2004, EMBO J, V23, P4813, DOI 10.1038/sj.emboj.7600472; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Viana RJS, 2012, MOL NEUROBIOL, V46, P522, DOI 10.1007/s12035-012-8301-x; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wei WZ, 2014, ANTIOXID REDOX SIGN, V21, P1475, DOI 10.1089/ars.2013.5436; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	72	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12420	12431		10.1074/jbc.M116.724930	http://dx.doi.org/10.1074/jbc.M116.724930			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27059957	Green Published, hybrid			2022-12-28	WOS:000378092800039
J	Anderson, KW; Mast, N; Hudgens, JW; Lin, JB; Turko, IV; Pikuleva, IA				Anderson, Kyle W.; Mast, Natalia; Hudgens, Jeffrey W.; Lin, Joseph B.; Turko, Illarion V.; Pikuleva, Irina A.			Mapping of the Allosteric Site in Cholesterol Hydroxylase CYP46A1 for Efavirenz, a Drug That Stimulates Enzyme Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME P450 OXIDOREDUCTASE; MASS-SPECTROMETRY; DIRECTED EVOLUTION; HYDROGEN-EXCHANGE; STRUCTURAL BASIS; HUMAN BRAIN; 46A1; TURNOVER; BINDING; MICE	Cytochrome P450 46A1 (CYP46A1) is a microsomal enzyme and cholesterol 24-hydroxylase that controls cholesterol elimination from the brain. This P450 is also a potential target for Alzheimer disease because it can be activated pharmacologically by some marketed drugs, as exemplified by efavirenz, the anti-HIV medication. Previously, we suggested that pharmaceuticals activate CYP46A1 allosterically through binding to a site on the cytosolic protein surface, which is different from the enzyme active site facing the membrane. Here we identified this allosteric site for efavirenz on CYP46A1 by using a combination of hydrogen-deuterium exchange coupled to MS, computational modeling, site-directed mutagenesis, and analysis of the CYP46A1 crystal structure. We also mapped the binding region for the CYP46A1 redox partner oxidoreductase and found that the allosteric and redox partner binding sites share a common border. On the basis of the data obtained, we propose the mechanism of CYP46A1 allostery and the pathway for the signal transmission from the P450 allosteric site to the active site.	[Anderson, Kyle W.; Hudgens, Jeffrey W.; Turko, Illarion V.] NIST, Biomol Measurement Div, Gaithersburg, MD 20899 USA; [Anderson, Kyle W.; Hudgens, Jeffrey W.; Turko, Illarion V.] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Mast, Natalia; Lin, Joseph B.; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 2085 Adelbert Rd, Cleveland, OH 44106 USA	National Institute of Standards & Technology (NIST) - USA; Case Western Reserve University	Pikuleva, IA (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 2085 Adelbert Rd, Cleveland, OH 44106 USA.	iap8@case.edu		Pikuleva, Irina/0000-0001-9742-6232; Hudgens, Jeffrey/0000-0003-2805-1048; Lin, Joseph/0000-0001-6667-9018; Anderson, Kyle/0000-0002-2808-3026	Public Health Service Grant [GM062882]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882] Funding Source: NIH RePORTER	Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Public Health Service Grant GM062882 (to I. A. P). The authors declare that they have no conflicts of interest with the contents of this article. Certain commercial materials, instruments, and equipment are identified in this manuscript in order to specify the experimental procedure as completely as possible. In no case does such identification imply a recommendation or endorsement by the National Institute of Standards and Technology nor does it imply that the materials, instruments, or equipment identified are necessarily the best available for the purpose.	Bjorkhem I, 1998, J LIPID RES, V39, P1594; Bryleva EY, 2010, P NATL ACAD SCI USA, V107, P3081, DOI 10.1073/pnas.0913828107; Chali F, 2015, EUR J NEUROSCI, V41, P1345, DOI 10.1111/ejn.12911; Chalmers MJ, 2011, INT J MASS SPECTROM, V302, P59, DOI 10.1016/j.ijms.2010.08.002; Decloedt EH, 2015, CLIN PHARMACOKINET, V54, P581, DOI 10.1007/s40262-015-0257-3; Djelti F, 2015, BRAIN, V138, P2383, DOI 10.1093/brain/awv166; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; Konermann L, 2014, ANALYST, V139, P6078, DOI 10.1039/c4an01307g; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; Kumar S, 2005, J BIOL CHEM, V280, P19569, DOI 10.1074/jbc.M500158200; Kumar S, 2005, BIOCHEM BIOPH RES CO, V338, P456, DOI 10.1016/j.bbrc.2005.08.080; LAMBETH JD, 1980, J BIOL CHEM, V255, P138; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Maioli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068534; Mast N, 2004, ARCH BIOCHEM BIOPHYS, V428, P99, DOI 10.1016/j.abb.2004.05.012; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Mast N, 2014, J BIOL CHEM, V289, P3529, DOI 10.1074/jbc.M113.532846; Mast N, 2013, MOL PHARMACOL, V84, P86, DOI 10.1124/mol.113.085902; Mast N, 2013, J BIOL CHEM, V288, P4613, DOI 10.1074/jbc.M112.438754; Mast N, 2012, MOL PHARMACOL, V82, P824, DOI 10.1124/mol.112.080424; Mast N, 2010, J BIOL CHEM, V285, P31783, DOI 10.1074/jbc.M110.143313; Mast N, 2009, ARCH BIOCHEM BIOPHYS, V483, P81, DOI 10.1016/j.abb.2009.01.002; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Poulos T. L., 2005, CYTOCHROME P450 STRU, P87; Shafaati M, 2010, J LIPID RES, V51, P318, DOI 10.1194/jlr.M900174-JLR200; Shinkyo R, 2011, J BIOL CHEM, V286, P4632, DOI 10.1074/jbc.M110.193409; Sun MY, 2016, NEUROSCIENTIST, V22, P132, DOI 10.1177/1073858414568122; White MA, 2008, ACTA CRYSTALLOGR D, V64, P487, DOI 10.1107/S0907444908004046; Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	35	32	34	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11876	11886		10.1074/jbc.M116.723577	http://dx.doi.org/10.1074/jbc.M116.723577			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27056331	Green Published, hybrid			2022-12-28	WOS:000377264800036
J	Dries, DR; Zhu, Y; Brooks, MM; Forero, DA; Adachi, M; Cenik, B; West, JM; Han, YH; Yu, C; Arbella, J; Nordin, A; Adolfsson, R; Del-Favero, J; Lu, QR; Callaerts, P; Birnbaum, SG; Yu, G				Dries, Daniel R.; Zhu, Yi; Brooks, Mieu M.; Forero, Diego A.; Adachi, Megumi; Cenik, Basar; West, James M.; Han, Yu-Hong; Yu, Cong; Arbella, Jennifer; Nordin, Annelie; Adolfsson, Rolf; Del-Favero, Jurgen; Lu, Q. Richard; Callaerts, Patrick; Birnbaum, Shari G.; Yu, Gang			Loss of Nicastrin from Oligodendrocytes Results in Hypomyelination and Schizophrenia with Compulsive Behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE; ALZHEIMERS-DISEASE; WHITE-MATTER; MICE; DISORDERS; MATURATION; RECEPTOR; GENE; ASSOCIATION; MOUSE	The biological underpinnings and the pathological lesions of psychiatric disorders are centuries-old questions that have yet to be understood. Recent studies suggest that schizophrenia and related disorders likely have their origins in perturbed neurodevelopment and can result from a large number of common genetic variants or multiple, individually rare genetic alterations. It is thus conceivable that key neurodevelopmental pathways underline the various genetic changes and the still unknown pathological lesions in schizophrenia. Here, we report that mice defective of the nicastrin subunit of gamma-secretase in oligodendrocytes have hypomyelination in the central nervous system. These mice have altered dopamine signaling and display profound abnormal phenotypes reminiscent of schizophrenia. In addition, we identify an association of the nicastrin gene with a human schizophrenia cohort. These observations implicate gamma-secretase and its mediated neurodevelopmental pathways in schizophrenia and provide support for the "myelination hypothesis" of the disease. Moreover, by showing that schizophrenia and obsessive-compulsive symptoms could be modeled in animals wherein a single genetic factor is altered, our work provides a biological basis that schizophrenia with obsessive-compulsive disorder is a distinct subtype of schizophrenia.	[Dries, Daniel R.; Zhu, Yi; Brooks, Mieu M.; Cenik, Basar; West, James M.; Han, Yu-Hong; Yu, Cong; Yu, Gang] Univ Texas SW Med Ctr Dallas, Dept Neurosci, 6000 Harry Hines Blvd, Dallas, TX 75390 USA; [Adachi, Megumi; Birnbaum, Shari G.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Dries, Daniel R.; Arbella, Jennifer] Juniata Coll, Dept Chem, Huntingdon, PA 16652 USA; [Forero, Diego A.] Univ Antonio Narino, Sch Med, Biomed Sci Res Grp, Lab NeuroPsychiat Genet, Bogota 3794, Colombia; [Nordin, Annelie; Adolfsson, Rolf] Umea Univ, Dept Clin Sci, Div Psychiat, SE-90187 Umea, Sweden; [Del-Favero, Jurgen] Univ Antwerp, VIB Dept Mol Genet, Appl Mol Genom Unit, B-2610 Antwerp, Belgium; [Lu, Q. Richard] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Callaerts, Patrick] Katholieke Univ Leuven, VIB Ctr Biol Dis, Ctr Human Genet, Lab Behav & Dev Genet, B-3000 Leuven, Belgium	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Universidad Antonio Narino; Umea University; Flanders Institute for Biotechnology (VIB); University of Antwerp; Cincinnati Children's Hospital Medical Center; Flanders Institute for Biotechnology (VIB); KU Leuven	Yu, G (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	gang.yu@utsouthwestern.edu	Forero, Diego A./O-9981-2019; Callaerts, Patrick/I-8118-2013; Forero, Diego/GPX-2849-2022; Adachi, Megumi/M-7746-2017	Forero, Diego A./0000-0001-9175-3363; Forero, Diego/0000-0001-9175-3363; Adachi, Megumi/0000-0003-3404-6640; Callaerts, Patrick/0000-0003-4530-4561; Adolfsson, Rolf/0000-0001-9785-8473; /0000-0002-8114-7615	National Institute of Neurological Disorders and Stroke [R01 NS079796]; National Institute on Aging [F32 AG031625]; Hartwell Foundation; Fund for Scientific Research Flanders; Industrial Research Fund; University of Antwerp, Belgium; Swedish Medical Research Council [K2001-21X-10412-09A]; County Council of Vasterbotten and Norrbotten, Sweden; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072427, R37NS096359, R01NS075243, R01NS079796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG031625] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Hartwell Foundation; Fund for Scientific Research Flanders(FWO); Industrial Research Fund; University of Antwerp, Belgium; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); County Council of Vasterbotten and Norrbotten, Sweden; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute of Neurological Disorders and Stroke Grant R01 NS079796, by the National Institute on Aging Grant F32 AG031625), by the Hartwell Foundation, by the Fund for Scientific Research Flanders, by the Industrial Research Fund, by the Special Research Fund of the University of Antwerp, Belgium, by Swedish Medical Research Council Grant K2001-21X-10412-09A, and the County Council of Vasterbotten and Norrbotten, Sweden. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BERRIOS GE, 1989, COMPR PSYCHIAT, V30, P283, DOI 10.1016/0010-440X(89)90052-7; Blobel CR, 2009, EXP CELL RES, V315, P671, DOI 10.1016/j.yexcr.2008.10.011; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bottas A, 2005, J PSYCHIATR NEUROSCI, V30, P187; Buckley PF, 2009, SCHIZOPHRENIA BULL, V35, P383, DOI 10.1093/schbul/sbn135; Casey BJ, 2013, ANNU REV MED, V64, P427, DOI 10.1146/annurev-med-052611-130408; Coolen MW, 2005, NEURON, V45, P497, DOI 10.1016/j.neuron.2004.12.054; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Dejaegere T, 2008, P NATL ACAD SCI USA, V105, P9775, DOI 10.1073/pnas.0800507105; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Greer JM, 2002, NEURON, V33, P23, DOI 10.1016/S0896-6273(01)00564-5; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; Kuroda K, 2011, HUM MOL GENET, V20, P4666, DOI 10.1093/hmg/ddr400; Lai C, 2004, BIOCHEM BIOPH RES CO, V314, P535, DOI 10.1016/j.bbrc.2003.12.131; Meier IB, 2012, J INT NEUROPSYCH SOC, V18, P414, DOI 10.1017/S1355617712000227; Mi S, 2011, NAT MED, V17, P816, DOI 10.1038/nm.2373; Murray PS, 2012, NEUROBIOL AGING, V33, P2807, DOI 10.1016/j.neurobiolaging.2012.02.015; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romberg C, 2013, BRAIN RES BULL, V92, P49, DOI 10.1016/j.brainresbull.2012.02.007; Roy K, 2007, P NATL ACAD SCI USA, V104, P8131, DOI 10.1073/pnas.0702157104; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Simon VM, 2000, EUR NEUROPSYCHOPHARM, V10, P159, DOI 10.1016/S0924-977X(00)00070-5; Spalletta G, 2012, J ALZHEIMERS DIS, V29, P761, DOI 10.3233/JAD-2012-111886; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Tabuchi K, 2009, J NEUROSCI, V29, P7290, DOI 10.1523/JNEUROSCI.1320-09.2009; Takahashi N, 2011, PROG NEUROBIOL, V93, P13, DOI 10.1016/j.pneurobio.2010.09.004; Venken T, 2007, HUM MUTAT, V28, P1156, DOI 10.1002/humu.20582; Wang BX, 2010, SCIENCE, V330, P1065, DOI 10.1126/science.1196284; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Young-Pearse TL, 2010, J NEUROSCI, V30, P10431, DOI 10.1523/JNEUROSCI.1445-10.2010; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	48	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11647	11656		10.1074/jbc.M116.715078	http://dx.doi.org/10.1074/jbc.M116.715078			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27008863	Green Published, hybrid			2022-12-28	WOS:000377264800016
J	Yuan, Q; Dohrmann, PR; Sutton, MD; McHenry, CS				Yuan, Quan; Dohrmann, Paul R.; Sutton, Mark D.; McHenry, Charles S.			DNA Polymerase III, but Not Polymerase IV, Must Be Bound to a tau-Containing DnaX Complex to Enable Exchange into Replication Forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SLIDING-CLAMP; TRANSLESION SYNTHESIS; PROCESSIVITY CLAMP; ALPHA-SUBUNIT; HOLOENZYME; PURIFICATION; BINDING; PROTEINS; DOMAIN	Examples of dynamic polymerase exchange have been previously characterized in model systems provided by coliphages T4 and T7. Using a dominant negative D403E polymerase (Pol) III alpha that can form initiation complexes and sequester primer termini but not elongate, we investigated the possibility of exchange at the Escherichia coli replication fork on a rolling circle template. Unlike other systems, addition of polymerase alone did not lead to exchange. Only when D403E Pol III was bound to a tau-containing DnaX complex did exchange occur. In contrast, addition of Pol IV led to rapid exchange in the absence of bound DnaX complex. Examination of Pol III* with varying composition of tau or the alternative shorter dnaX translation product gamma showed that tau-, tau(2)-, or tau(3)-DnaX complexes supported equivalent levels of synthesis, identical Okazaki fragment size, and gaps between fragments, possessed the ability to challenge pre-established replication forks, and displayed equivalent susceptibility to challenge by exogenous D403E Pol III*. These findings reveal that redundant interactions at the replication fork must stabilize complexes containing only one tau. Previously, it was thought that at least two tau s in the trimeric DnaX complex were required to couple the leading and lagging strand polymerases at the replication fork. Possible mechanisms of exchange are discussed.	[Yuan, Quan; Dohrmann, Paul R.; McHenry, Charles S.] Univ Colorado, Dept Chem & Biochem, 3415 Colorado Ave, Boulder, CO 80303 USA; [Sutton, Mark D.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept of Biochem, Buffalo, NY 14214 USA	University of Colorado System; University of Colorado Boulder; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	McHenry, CS (corresponding author), Univ Colorado, Dept Chem & Biochem, 3415 Colorado Ave, Boulder, CO 80303 USA.	charles.mchenry@colorado.edu	yuan, quan/GZM-5597-2022		National Science Foundation [MCB-1329285]; Public Health Service Award from the NIGMS/National Institutes of Health [R01 GM066094]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066094] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1329285] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Public Health Service Award from the NIGMS/National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Award MCB-1329285 (to C. S. M.) and a Public Health Service Award R01 GM066094 from the NIGMS/National Institutes of Health (to M. D. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This is the last original research paper based on work initiated in the McHenry laboratory during our 40 years of investigating mechanisms of DNA replication. It is particularly fitting that the first paper from our laboratory (1) was also published in this Journal.	Burnouf DY, 2004, J MOL BIOL, V335, P1187, DOI 10.1016/j.jmb.2003.11.049; CARTER JR, 1993, NUCLEIC ACIDS RES, V21, P3281, DOI 10.1093/nar/21.14.3281; Clover BP, 2001, CELL, V105, P925, DOI 10.1016/S0092-8674(01)00400-7; Dohrmann PR, 2016, NUCLEIC ACIDS RES, V44, P1285, DOI 10.1093/nar/gkv1510; Dohrmann PR, 2011, J MOL BIOL, V414, P15, DOI 10.1016/j.jmb.2011.09.039; Downey CD, 2011, J MOL BIOL, V412, P340, DOI 10.1016/j.jmb.2011.07.051; Downey CD, 2010, MOL CELL, V37, P481, DOI 10.1016/j.molcel.2010.01.013; Eckstein F., 1995, NUCLEIC ACIDS MOL BI, P115; Fernandez-Leiro R, 2015, ELIFE, V4, DOI 10.7554/eLife.11134; Furukohri A, 2008, J BIOL CHEM, V283, P11260, DOI 10.1074/jbc.M709689200; Gabbai CB, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.613257; Gao DX, 2001, J BIOL CHEM, V276, P4441, DOI 10.1074/jbc.M009830200; Georgescu RE, 2012, NAT STRUCT MOL BIOL, V19, P113, DOI 10.1038/nsmb.2179; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; Heltzel JMH, 2012, J BACTERIOL, V194, P3589, DOI 10.1128/JB.00520-12; Heltzel JMH, 2009, P NATL ACAD SCI USA, V106, P12664, DOI 10.1073/pnas.0903460106; Ikeda M, 2014, NUCLEIC ACIDS RES, V42, P8461, DOI 10.1093/nar/gku547; Indiani C, 2005, MOL CELL, V19, P805, DOI 10.1016/j.molcel.2005.08.011; Jergic S, 2013, EMBO J, V32, P1322, DOI 10.1038/emboj.2012.347; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; Johnson DE, 2007, P NATL ACAD SCI USA, V104, P5312, DOI 10.1073/pnas.0701062104; KABOORD BF, 1995, CURR BIOL, V5, P149, DOI 10.1016/S0960-9822(95)00036-4; Kath JE, 2016, NUCLEIC ACIDS RES, V44, P1681, DOI 10.1093/nar/gkv1375; Kath JE, 2014, P NATL ACAD SCI USA, V111, P7647, DOI 10.1073/pnas.1321076111; Kim DR, 1996, J BIOL CHEM, V271, P20681, DOI 10.1074/jbc.271.34.20681; Kim DR, 1996, J BIOL CHEM, V271, P20690, DOI 10.1074/jbc.271.34.20690; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Lia G, 2012, SCIENCE, V335, P328, DOI 10.1126/science.1210400; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; Marians KJ, 1995, METHOD ENZYMOL, V262, P507; Maul RW, 2007, MOL MICROBIOL, V65, P811, DOI 10.1111/j.1365-2958.2007.05828.x; McHenry C. S., 1988, DNA REPLICATION MUTA, P14; McHenry C. S., 2015, MOL LIFE SCI ENCY RE; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; MCHENRY CS, 1979, J BIOL CHEM, V254, P1748; Postow L, 1999, BIOESSAYS, V21, P805, DOI 10.1002/(SICI)1521-1878(199910)21:10<805::AID-BIES1>3.0.CO;2-7; Pritchard AE, 1999, J MOL BIOL, V285, P1067, DOI 10.1006/jmbi.1998.2352; Scotland MK, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005507; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P170, DOI 10.1038/nsmb.1381; Tanner NA, 2011, EMBO J, V30, P1830, DOI 10.1038/emboj.2011.84; Wieczorek A, 2006, J BIOL CHEM, V281, P12561, DOI 10.1074/jbc.M513844200; Wieczorek A, 2010, J BIOL CHEM, V285, P29049, DOI 10.1074/jbc.C110.165076; Yang JS, 2004, P NATL ACAD SCI USA, V101, P8289, DOI 10.1073/pnas.0402625101; Yuan Q, 2014, NUCLEIC ACIDS RES, V42, P1747, DOI 10.1093/nar/gkt1098; Yuan Q, 2009, J BIOL CHEM, V284, P31672, DOI 10.1074/jbc.M109.050740	47	13	13	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11727	11735		10.1074/jbc.M116.725358	http://dx.doi.org/10.1074/jbc.M116.725358			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27056333	Green Published, hybrid			2022-12-28	WOS:000377264800023
J	Guerrera, D; Shah, J; Vasileva, E; Sluysmans, S; Mean, I; Jond, L; Poser, I; Mann, M; Hyman, AA; Citi, S				Guerrera, Diego; Shah, Jimit; Vasileva, Ekaterina; Sluysmans, Sophie; Mean, Isabelle; Jond, Lionel; Poser, Ina; Mann, Matthias; Hyman, Anthony A.; Citi, Sandra			PLEKHA7 Recruits PDZD11 to Adherens Junctions to Stabilize Nectins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adherens junction; cadherin; epithelium; kidney; PDZ domain; PLEKHA7; nectin	GENOME-WIDE ASSOCIATION; ANGLE-CLOSURE GLAUCOMA; CELL-CELL ADHESION; EPITHELIAL-CELLS; TIGHT-JUNCTION; BLOOD-PRESSURE; CONTAINING PROTEIN; DOMAIN PROTEIN; CINGULIN; CADHERIN	PLEKHA7 is a junctional protein implicated in stabilization of the cadherin protein complex, hypertension, cardiac contractility, glaucoma, microRNA processing, and susceptibility to bacterial toxins. To gain insight into the molecular basis for the functions of PLEKHA7, we looked for new PLEKHA7 interactors. Here, we report the identification of PDZ domain-containing protein 11 (PDZD11) as a new interactor of PLEKHA7 by yeast two-hybrid screening and by mass spectrometry analysis of PLEKHA7 immunoprecipitates. We show that PDZD11 (17 kDa) is expressed in epithelial and endothelial cells, where it forms a complex with PLEKHA7, as determined by co-immunoprecipitation analysis. The N-terminal Trp-Trp (WW) domain of PLEKHA7 interacts directly with the N-terminal 44 amino acids of PDZD11, as shown by GST-pulldown assays. Immunofluorescence analysis shows that PDZD11 is localized at adherens junctions in a PLEKHA7-dependent manner, because its junctional localization is abolished by knock-out of PLEKHA7, and is rescued by re-expression of exogenous PLEKHA7. The junctional recruitment of nectin-1 and nectin-3 and their protein levels are decreased via proteasome-mediated degradation in epithelial cells where either PDZD11 or PLEKHA7 have been knocked-out. PDZD11 forms a complex with nectin-1 and nectin-3, and its PDZ domain interacts directly with the PDZ-binding motif of nectin-1. PDZD11 is required for the efficient assembly of apical junctions of epithelial cells at early time points in the calcium-switch model. These results show that the PLEKHA7-PDZD11 complex stabilizes nectins to promote efficient early junction assembly and uncover a new molecular mechanism through which PLEKHA7 recruits PDZ-binding membrane proteins to epithelial adherens junctions.	[Guerrera, Diego; Shah, Jimit; Vasileva, Ekaterina; Sluysmans, Sophie; Mean, Isabelle; Jond, Lionel; Citi, Sandra] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Guerrera, Diego; Shah, Jimit; Vasileva, Ekaterina; Sluysmans, Sophie; Mean, Isabelle; Jond, Lionel; Citi, Sandra] Univ Geneva, Inst Genet & Genom Geneva iGE3, CH-1211 Geneva 4, Switzerland; [Poser, Ina; Hyman, Anthony A.] Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; [Mann, Matthias] Max Planck Inst Biochem, D-82152 Martinsried, Germany	University of Geneva; University of Geneva; Max Planck Society; Max Planck Society	Citi, S (corresponding author), Dept Cell Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	sandra.citi@unige.ch	Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017	Hyman, Anthony A/0000-0003-3664-154X; Citi, Sandra/0000-0002-6537-4818; Guerrera, Diego/0000-0002-5323-4447	Swiss National Fund [31003A103637, 31003A116763]; Swiss Cancer League [KFS-2813-08-2011]	Swiss National Fund(Swiss National Science Foundation (SNSF)); Swiss Cancer League	This work was supported in part by Swiss National Fund Grants 31003A103637 and 31003A116763 and the Swiss Cancer League Grant KFS-2813-08-2011 (to S. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi M, 2009, MOL CELL BIOL, V29, P2372, DOI 10.1128/MCB.01505-08; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Asakura T, 1999, GENES CELLS, V4, P573, DOI 10.1046/j.1365-2443.1999.00283.x; Cardellini P, 1996, DEV DYNAM, V207, P104, DOI 10.1002/(SICI)1097-0177(199609)207:1<104::AID-AJA10>3.0.CO;2-0; Chen YH, 2014, INVEST OPHTH VIS SCI, V55, P3797, DOI 10.1167/iovs.14-14370; Citi S, 2001, CELL CELL INTERACTIO, P153; Citi S, 2012, ANN NY ACAD SCI, V1257, P125, DOI 10.1111/j.1749-6632.2012.06506.x; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; Dudak A, 2011, EUR J CELL BIOL, V90, P365, DOI 10.1016/j.ejcb.2011.01.004; Endres BT, 2014, P NATL ACAD SCI USA, V111, P12817, DOI 10.1073/pnas.1410745111; Fukuhara A, 2002, GENES CELLS, V7, P1059, DOI 10.1046/j.1365-2443.2002.00578.x; Goellner GM, 2003, ANN NY ACAD SCI, V986, P461, DOI 10.1111/j.1749-6632.2003.tb07230.x; Guillemot L, 2014, MOL BIOL CELL, V25, P1995, DOI 10.1091/mbc.E13-11-0680; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Hong KW, 2010, J HUM GENET, V55, P336, DOI 10.1038/jhg.2010.31; Hoshino T, 2004, MOL BIOL CELL, V15, P1077, DOI 10.1091/mbc.E03-05-0321; Hubner NC, 2011, METHODS, V53, P453, DOI 10.1016/j.ymeth.2010.12.016; Ishiuchi T, 2012, GENES CELLS, V17, P387, DOI 10.1111/j.1365-2443.2012.01593.x; Kourtidis A, 2015, NAT CELL BIOL, V17, P1145, DOI 10.1038/ncb3227; Kurita S, 2013, J BIOL CHEM, V288, P29356, DOI 10.1074/jbc.M113.453464; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lin YH, 2011, ATHEROSCLEROSIS, V219, P709, DOI 10.1016/j.atherosclerosis.2011.09.006; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; Mandai K, 2015, CURR TOP DEV BIOL, V112, P197, DOI 10.1016/bs.ctdb.2014.11.019; MARTINEZPALOMO A, 1980, J CELL BIOL, V87, P736, DOI 10.1083/jcb.87.3.736; McCrea PD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002923; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Miyahara M, 2000, J BIOL CHEM, V275, P613, DOI 10.1074/jbc.275.1.613; Nabokina SM, 2011, AM J PHYSIOL-GASTR L, V300, pG561, DOI 10.1152/ajpgi.00530.2010; Paschoud S, 2008, MOL MEMBR BIOL, V25, P1, DOI 10.1080/09687680701474009; Paschoud S, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28755; Paschoud S, 2011, MOL MEMBR BIOL, V28, P123, DOI 10.3109/09687688.2010.538937; Popov LM, 2015, P NATL ACAD SCI USA, V112, P14337, DOI 10.1073/pnas.1510265112; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Pulimeno P, 2011, J BIOL CHEM, V286, P16743, DOI 10.1074/jbc.M111.230862; Pulimeno P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012207; Reymond N, 2005, FEBS LETT, V579, P2243, DOI 10.1016/j.febslet.2005.03.010; Rikitake Y, 2012, J CELL SCI, V125, P3713, DOI 10.1242/jcs.099572; Shah J, 2016, INT J BIOCHEM CELL B, V75, P112, DOI 10.1016/j.biocel.2016.04.001; Spadaro D, 2014, J BIOL CHEM, V289, P22500, DOI 10.1074/jbc.M114.556449; Stephenson SEM, 2005, J BIOL CHEM, V280, P33270, DOI 10.1074/jbc.M505889200; Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takeichi M, 2014, NAT REV MOL CELL BIO, V15, P397, DOI 10.1038/nrm3802; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; Wythe JD, 2011, DIS MODEL MECH, V4, P607, DOI 10.1242/dmm.002204; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783; Zhang JX, 2012, J BIOL CHEM, V287, P11132, DOI 10.1074/jbc.M111.321216	50	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11016	11029		10.1074/jbc.M115.712935	http://dx.doi.org/10.1074/jbc.M115.712935			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27044745	hybrid, Green Published			2022-12-28	WOS:000377042100006
J	Rodriguez, Y; Hinz, JM; Laughery, MF; Wyrick, JJ; Smerdon, MJ				Rodriguez, Yesenia; Hinz, John M.; Laughery, Marian F.; Wyrick, John J.; Smerdon, Michael J.			Site-specific Acetylation of Histone H3 Decreases Polymerase Activity on Nucleosome Core Particles in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						base excision repair (BER); DNA damage; DNA polymerase; histone acetylation; nucleosome; DNA glycosylase	BASE EXCISION-REPAIR; DNA-DAMAGE RESPONSE; LYSINE 56; H3K56 ACETYLATION; APE1 ENDONUCLEASE; GENOME STABILITY; MAMMALIAN-CELLS; CHROMATIN; ACCESSIBILITY; GENE	Histone posttranslational modifications have been associated with changes in chromatin structure necessary for transcription, replication, and DNA repair. Acetylation is one of the most studied and best characterized histone posttranslational modifications, but it is not known if histone acetylation modulates base excision repair of DNA lesions in chromatin. To address this question, we generated nucleosome core particles (NCPs) containing site-specifically acetylated H3K14 or H3K56 and measured repair of uracil and single-nucleotide gaps. We find that H3K56Ac and H3K14Ac do not significantly contribute to removal of uracils by uracil DNA glycosylase regardless of the translational or rotational position of the lesions within NCPs. In repair of single-nucleotide gaps, however, the presence of H3K56Ac or H3K14Ac in NCPs decreases the gap-filling activity of DNA polymerase near the dyad center, with H3K14Ac exhibiting stronger inhibition. To a lesser extent, H3K56Ac induces a similar effect near the DNA ends. Moreover, using restriction enzyme accessibility, we detect no changes in NCP structure or dynamics between H3K14Ac-NCPs and WT-NCPs containing single-nucleotide gaps. Thus, acetylation at H3K56 and H3K14 in nucleosomes may promote alternative gap-filling pathways by inhibiting DNA polymerase activity.	[Rodriguez, Yesenia; Hinz, John M.; Laughery, Marian F.; Wyrick, John J.; Smerdon, Michael J.] Washington State Univ, Sch Mol Biosci, Biochem & Biophys, Pullman, WA 99164 USA; [Rodriguez, Yesenia] NIEHS, Genorne Integr & Struct Biol Lab, NIH, POB 12233,Mail Drop F3-01, Res Triangle Pk, NC 27709 USA	Washington State University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Smerdon, MJ (corresponding author), Washington State Univ, Sch Mol Biosci, Life Sci & Biotechnol Bldg, Pullman, WA 99164 USA.	smerdon@wsu.edu			National Institutes of Health [ES020955, ES002614, ES004106, T32GM008336]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004106, R37ES002614, R01ES002614, R21ES020955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants ES020955 (to J M. H.), ES002614 and ES004106 (NIEHS; to M. J. S.), and Training Grant T32GM008336 (NIGMS; to Y. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson JD, 2000, J MOL BIOL, V296, P979, DOI 10.1006/jmbi.2000.3531; Baute J, 2008, CRIT REV BIOCHEM MOL, V43, P239, DOI 10.1080/10409230802309905 ; Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100; Cole HA, 2010, J BIOL CHEM, V285, P2876, DOI 10.1074/jbc.M109.073544; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Donigan KA, 2012, J BIOL CHEM, V287, P23830, DOI 10.1074/jbc.M111.324947; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Duan MR, 2010, J BIOL CHEM, V285, P26295, DOI 10.1074/jbc.M110.140087; Fernandez AG, 2007, J MOL BIOL, V371, P649, DOI 10.1016/j.jmb.2007.05.090; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; Garcia-Diaz M, 2007, CRIT REV PLANT SCI, V26, P105, DOI 10.1080/07352680701252817; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hinz JM, 2014, MUTAT RES-FUND MOL M, V766, P19, DOI 10.1016/j.mrfmmm.2014.05.008; Hinz JM, 2010, P NATL ACAD SCI USA, V107, P4646, DOI 10.1073/pnas.0914443107; Hodges AJ, 2015, GENETICS, V200, P795, DOI 10.1534/genetics.115.175885; Hwang BJ, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0041-9; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kasten M, 2004, EMBO J, V23, P1348, DOI 10.1038/sj.emboj.7600143; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Liu XQ, 2000, J BIOL CHEM, V275, P23729, DOI 10.1074/jbc.M002206200; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luebben WR, 2010, P NATL ACAD SCI USA, V107, P19254, DOI 10.1073/pnas.1009650107; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Mann DB, 1997, P NATL ACAD SCI USA, V94, P2215, DOI 10.1073/pnas.94.6.2215; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Menoni H, 2007, MOL CELL BIOL, V27, P5949, DOI 10.1128/MCB.00376-07; Miller KM, 2006, CELL CYCLE, V5, P2561, DOI 10.4161/cc.5.22.3501; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Mutskov V, 1998, MOL CELL BIOL, V18, P6293, DOI 10.1128/MCB.18.11.6293; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; North JA, 2012, NUCLEIC ACIDS RES, V40, P10215, DOI 10.1093/nar/gks747; Odell ID, 2011, MOL CELL BIOL, V31, P4623, DOI 10.1128/MCB.05715-11; Ozdemir A, 2006, CELL CYCLE, V5, P2602, DOI 10.4161/cc.5.22.3473; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Prasad A, 2007, MOL CELL BIOL, V27, P8442, DOI 10.1128/MCB.00791-07; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Rodriguez Y, 2013, J BIOL CHEM, V288, P13863, DOI 10.1074/jbc.M112.441444; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Shimko JC, 2011, J MOL BIOL, V408, P187, DOI 10.1016/j.jmb.2011.01.003; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; Stoilov L, 2000, INT J RADIAT BIOL, V76, P1485, DOI 10.1080/09553000050176243; Swygert SG, 2014, BBA-GENE REGUL MECH, V1839, P728, DOI 10.1016/j.bbagrm.2014.02.013; Tims HS, 2007, METHODS, V41, P296, DOI 10.1016/j.ymeth.2007.01.001; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; TULLIUS TD, 1991, FREE RADICAL RES COM, V12-3, P521; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; Varga-Weisz P, 2001, ONCOGENE, V20, P3076, DOI 10.1038/sj.onc.1204332; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Vempati RK, 2010, J BIOL CHEM, V285, P28553, DOI 10.1074/jbc.M110.149393; Wang Y, 2012, J BIOL CHEM, V287, P4386, DOI 10.1074/jbc.M111.329417; Widlund HR, 1997, J MOL BIOL, V267, P807, DOI 10.1006/jmbi.1997.0916; Wurtele H, 2012, MOL CELL BIOL, V32, P154, DOI 10.1128/MCB.05415-11; Xu Z, 2015, CELL CYCLE, V14, P269, DOI 10.4161/15384101.2014.980641; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	61	21	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11434	11445		10.1074/jbc.M116.725788	http://dx.doi.org/10.1074/jbc.M116.725788			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27033702	Green Published, hybrid			2022-12-28	WOS:000377042100040
J	He, L; Chang, E; Peng, J; An, H; McMillin, SM; Radovick, S; Stratakis, CA; Wondisford, FE				He, Ling; Chang, Evan; Peng, Jinghua; An, Hongying; McMillin, Sara M.; Radovick, Sally; Stratakis, Constantine A.; Wondisford, Fredric E.			Activation of the cAMP-PKA pathway Antagonizes Metformin Suppression of Hepatic Glucose Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; GENETIC-VARIATION; COACTIVATOR P300; AMPK ACTIVATION; GLUCAGON; ALPHA; PHOSPHORYLATION; HYPERGLYCEMIA; HYPERGLUCAGONEMIA; GLUCONEOGENESIS	Metformin is the most commonly prescribed oral anti-diabetic agent worldwide. Surprisingly, about 35% of diabetic patients either lack or have a delayed response to metformin treatment, and many patients become less responsive to metformin over time. It remains unknown how metformin resistance or insensitivity occurs. Recently, we found that therapeutic metformin concentrations suppressed glucose production in primary hepatocytes through AMPK; activation of the cAMP-PKA pathway negatively regulates AMPK activity by phosphorylating AMPK alpha subunit at Ser-485, which in turn reduces AMPK activity. In this study, we find that metformin failed to suppress glucose production in primary hepatocytes with constitutively activated PKA and did not improve hyperglycemia in mice with hyperglucagonemia. Expression of the AMPK alpha 1(S485A) mutant, which is unable to be phosphorylated by PKA, increased both AMPK alpha activation and the suppression of glucose production in primary hepatocytes treated with metformin. Intriguingly, salicylate/aspirin prevents the phosphorylation of AMPK alpha at Ser-485, blocks cAMP-PKA negative regulation of AMPK, and improves metformin resistance. We propose that aspirin/salicylate may augment metformin's hepatic action to suppress glucose production.	[He, Ling; Chang, Evan; Peng, Jinghua; An, Hongying] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Metab, Baltimore, MD 21287 USA; [McMillin, Sara M.; Wondisford, Fredric E.] Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08901 USA; [Radovick, Sally] Rutgers Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08901 USA; [Stratakis, Constantine A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Endocrinol & Genet, Bethesda, MD 20892 USA	Johns Hopkins University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	He, L (corresponding author), Div Metab, 600 N Wolfe St,CMSC10-113, Baltimore, MD 21287 USA.	heling@jhmi.edu	Stratakis, Constantine/AAP-4745-2020		National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health [R00DK085142, R01DK107641, R01DK063349]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK085142, R01DK063349, R01DK107641] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health: R00DK085142 (to L. H.), R01DK107641 (to L. H.), and R01DK063349 (to F. E. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An HY, 2016, J ENDOCRINOL, V228, pR97, DOI 10.1530/JOE-15-0447; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; BARON AD, 1987, DIABETES, V36, P274, DOI 10.2337/diabetes.36.3.274; Burcelin R, 1996, DIABETES METAB, V22, P373; Cao J, 2014, J BIOL CHEM, V289, P20435, DOI 10.1074/jbc.M114.567271; CONSOLI A, 1992, DIABETES CARE, V15, P430, DOI 10.2337/diacare.15.3.430; Cook MN, 2007, DIABETIC MED, V24, P350, DOI 10.1111/j.1464-5491.2007.02078.x; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Ford RJ, 2015, BIOCHEM J, V468, P125, DOI 10.1042/BJ20150125; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; He L, 2014, J ENDOCRINOL, V221, P363, DOI 10.1530/JOE-14-0084; He L, 2012, J BIOL CHEM, V287, P32069, DOI 10.1074/jbc.M112.385864; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; HERMANN LS, 1990, DIABETES CARE, V13, P37, DOI 10.2337/diacare.13.3.37; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kirschner LS, 2005, CANCER RES, V65, P4506, DOI 10.1158/0008-5472.CAN-05-0580; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Meng SM, 2015, J BIOL CHEM, V290, P3793, DOI 10.1074/jbc.M114.604421; MILLER JD, 1983, DIABETES, V32, P439, DOI 10.2337/diabetes.32.5.439; Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155; Pawlyk AC, 2014, DIABETES, V63, P2590, DOI 10.2337/db13-1367; REAVEN GM, 1987, J CLIN ENDOCR METAB, V64, P106, DOI 10.1210/jcem-64-1-106; Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Song WJ, 2011, CELL METAB, V13, P308, DOI 10.1016/j.cmet.2011.02.002; UNGER RH, 1970, J CLIN INVEST, V49, P837, DOI 10.1172/JCI106297; UNGER RH, 1985, DIABETOLOGIA, V28, P574, DOI 10.1007/BF00281991; Webb GC, 2002, DIABETES, V51, P398, DOI 10.2337/diabetes.51.2.398; Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI200114178; Wondisford AR, 2014, J BIOL CHEM, V289, P4326, DOI 10.1074/jbc.M113.540500; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	35	26	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10562	10570		10.1074/jbc.M116.719666	http://dx.doi.org/10.1074/jbc.M116.719666			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27002150	Green Published, hybrid			2022-12-28	WOS:000377042600011
J	Kostantin, E; Hardy, S; Valinsky, WC; Kompatscher, A; de Baaij, JHF; Zolotarov, Y; Landry, M; Uetani, N; Martinez-Cruz, LA; Hoenderop, JGJ; Shrier, A; Tremblay, ML				Kostantin, Elie; Hardy, Serge; Valinsky, William C.; Kompatscher, Andreas; de Baaij, Jeroen H. F.; Zolotarov, Yevgen; Landry, Melissa; Uetani, Noriko; Alfonso Martinez-Cruz, Luis; Hoenderop, Joost G. J.; Shrier, Alvin; Tremblay, Michel L.			Inhibition of PRL-2.CNNM3 Protein Complex Formation Decreases Breast Cancer Proliferation and Tumor Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORAGE-INDEPENDENT GROWTH; CYCLIN M2 CNNM2; MAGNESIUM TRANSPORTER; MOLECULAR-MECHANISMS; REGENERATING LIVER; CELL-MIGRATION; CBS DOMAINS; PHOSPHATASE; METASTASIS; PRL-3	The oncogenic phosphatase of regenerating liver 2 (PRL-2) has been shown to regulate intracellular magnesium levels by forming a complex through an extended amino acid loop present in the Bateman module of the CNNM3 magnesium transporter. Here we identified highly conserved residues located on this amino acid loop critical for the binding with PRL-2. A single point mutation (D426A) of one of those critical amino acids was found to completely disrupt PRL-2.human Cyclin M 3 (CNNM3) complex formation. Whole-cell voltage clamping revealed that expression of CNNM3 influenced the surface current, whereas overexpression of the binding mutant had no effect, indicating that the binding of PRL-2 to CNNM3 is important for the activity of the complex. Interestingly, overexpression of the CNNM3 D426A-binding mutant in cancer cells decreased their ability to proliferate under magnesium-deprived situations and under anchorage independent growth conditions, demonstrating a PRL2.CNNM3 complex-dependent oncogenic advantage in a more stringent environment. We further confirmed the importance of this complex in vivo using an orthotopic xenograft breast cancer model. Finally, because molecular modeling showed that the Asp-426 side chain in CNNM3 buries into the catalytic cavity of PRL-2, we showed that a PRI, inhibitor could abrogate complex formation, resulting in a decrease in proliferation of human breast cancer cells. In summary, we provide evidence that this fundamental regulatory aspect of PRL-2 in cancer cells could potentially lead to broadly applicable and innovative therapeutic avenues.	[Kostantin, Elie; Hardy, Serge; Zolotarov, Yevgen; Landry, Melissa; Uetani, Noriko; Tremblay, Michel L.] Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Kostantin, Elie; Zolotarov, Yevgen; Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ H3A 0G4, Canada; [Valinsky, William C.; Shrier, Alvin] McGill Univ, Dept Physiol, Montreal, PQ H3A 0G4, Canada; [Kompatscher, Andreas; de Baaij, Jeroen H. F.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, NL-6500 HB Nijmegen, Netherlands; [Alfonso Martinez-Cruz, Luis] Ctr Cooperat Res Biosci CIC BioGUNE, Struct Biol Unit, Technol Pk Bizkaia, Derio 48160, Bizkaia, Spain	McGill University; McGill University; Radboud University Nijmegen; CIC bioGUNE	Tremblay, ML (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, 1160 Pine Ave W, Montreal, PQ H3A 1A3, Canada.	michel.tremblay@mcgill.ca	de Baaij, Jeroen/P-5704-2015; Zolotarov, Yevgen/AAK-6125-2021; Hoenderop, Joost G.J./H-8047-2014	de Baaij, Jeroen/0000-0003-2372-8486; Zolotarov, Yevgen/0000-0001-5445-1219; Hoenderop, Joost G.J./0000-0002-1816-8544; Valinsky, Corey/0000-0001-7736-9146	Canadian Institutes of Health Research [CIHR MOP 142497]; Merck, Sharp AMP; Dohme Corp./McGill Faculty of Medicine [PT 66481]; Quebec Breast Cancer Foundation; Canadian Breast Cancer Research Alliance [020303]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Merck, Sharp AMP; Dohme Corp./McGill Faculty of Medicine; Quebec Breast Cancer Foundation; Canadian Breast Cancer Research Alliance	This work was supported by an operating grant from the Canadian Institutes of Health Research (The PRL-CNNM-Magnesium Cascade, a New Paradigm in Oncogenesis: CIHR MOP 142497). This work was also supported by a Merck, Sharp & Dohme Corp./McGill Faculty of Medicine Grant for Translational Research Program: Characterization of the PTP4A2/CNNM3 Complex as a Novel Target for Cancer Therapy (Grant PT 66481) and by the Quebec Breast Cancer Foundation and the Canadian Breast Cancer Research Alliance (Grant 020303). The authors declare that they have no conflicts of interest with the contents of this article.	Ackerman D, 2014, TRENDS CELL BIOL, V24, P472, DOI 10.1016/j.tcb.2014.06.001; Al-Aidaroos AQO, 2010, J CELL BIOCHEM, V111, P1087, DOI 10.1002/jcb.22913; Corral-Rodriguez MA, 2014, BIOCHEM J, V464, P23, DOI 10.1042/BJ20140409; Arjona FJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004267; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; Castiglioni S, 2011, MAGNESIUM RES, V24, pS92, DOI 10.1684/mrh.2011.0285; Daouti S, 2008, CANCER RES, V68, P1162, DOI 10.1158/0008-5472.CAN-07-2349; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; de Baaij JHF, 2012, J BIOL CHEM, V287, P13644, DOI 10.1074/jbc.M112.342204; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estevez R, 2004, J PHYSIOL-LONDON, V557, P363, DOI 10.1113/jphysiol.2003.058453; Funato Y, 2014, J CLIN INVEST, V124, P5398, DOI 10.1172/JCI76614; Gavenonis J, 2014, NAT CHEM BIOL, V10, P716, DOI [10.1038/NCHEMBIO.1580, 10.1038/nchembio.1580]; Gomez-Garcia I, 2012, ACTA CRYSTALLOGR F, V68, P1198, DOI 10.1107/S1744309112035348; Gopinath P, 2015, P NATL ACAD SCI USA, V112, P12011, DOI 10.1073/pnas.1516239112; Guzinska-Ustymowicz K, 2011, ANTI-CANCER AGENT ME, V11, P99, DOI 10.2174/187152011794941145; Hardy S, 2015, ONCOGENE, V34, P986, DOI 10.1038/onc.2014.33; Hardy S, 2010, CANCER RES, V70, P8959, DOI 10.1158/0008-5472.CAN-10-2041; HERSCHMAN HR, 1987, CARCINOGENESIS, V8, P993, DOI 10.1093/carcin/8.7.993; Hirata Y, 2014, J BIOL CHEM, V289, P14731, DOI 10.1074/jbc.M114.551176; Hoeger B, 2014, EUR J MED CHEM, V88, P89, DOI 10.1016/j.ejmech.2014.08.060; Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163; Jeong DG, 2005, J MOL BIOL, V345, P401, DOI 10.1016/j.jmb.2004.10.061; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kobayashi M, 2014, STEM CELLS, V32, P1956, DOI 10.1002/stem.1672; Labbe DP, 2012, PROG MOL BIOL TRANSL, V106, P253, DOI 10.1016/B978-0-12-396456-4.00009-2; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; McParland V, 2011, BIOCHEMISTRY-US, V50, P7579, DOI 10.1021/bi201095z; Meng XJ, 2013, CANCER LETT, V333, P96, DOI 10.1016/j.canlet.2013.01.031; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; Middelbeek J, 2012, CANCER RES, V72, P4250, DOI 10.1158/0008-5472.CAN-11-3863; Nelson CA, 1996, J IMMUNOL, V157, P755; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; Rao VR, 2015, CANCERS, V7, P849, DOI 10.3390/cancers7020813; Rios P, 2013, FEBS J, V280, P505, DOI 10.1111/j.1742-4658.2012.08565.x; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Stuiver M, 2011, AM J HUM GENET, V88, P333, DOI 10.1016/j.ajhg.2011.02.005; Tan ZJ, 2011, METAL IONS LIFE SCI, V9, P101, DOI 10.1039/978184973251200101; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Wang CY, 2003, GENE, V306, P37, DOI 10.1016/S0378-1119(02)01210-6; Wang Y, 2012, ONCOGENE, V31, P818, DOI 10.1038/onc.2011.281; Wolf FI, 2012, CLIN SCI, V123, P417, DOI 10.1042/CS20120086; Wolf FI, 2004, FRONT BIOSCI-LANDMRK, V9, P2056, DOI 10.2741/1389; Ye Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep17046; Zhao N, 2011, PROTEIN SCI, V20, P1275, DOI 10.1002/pro.655; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	50	32	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10716	10725		10.1074/jbc.M115.705863	http://dx.doi.org/10.1074/jbc.M115.705863			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26969161	hybrid, Green Published			2022-12-28	WOS:000377042600023
J	Hsieh, LS; Su, WM; Han, GS; Carman, GM				Hsieh, Lu-Sheng; Su, Wen-Min; Han, Gil-Soo; Carman, George M.			Phosphorylation of Yeast Pah1 Phosphatidate Phosphatase by Casein Kinase II Regulates Its Function in Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL-ELECTROPHORESIS; NUCLEAR-MEMBRANE GROWTH; PATCH PROTEIN APP1P; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; GLOBAL ANALYSIS; BETA-SUBUNIT; SIGNAL-TRANSDUCTION; MEDIATED REGULATION; ORTHOLOGUE PAH1P	Pah1 phosphatidate phosphatase in Saccharomyces cerevisiae catalyzes the penultimate step in the synthesis of triacylglycerol (i.e. the production of diacylglycerol by dephosphorylation of phosphatidate). The enzyme playing a major role in lipid metabolism is subject to phosphorylation (e.g. by Pho85-Pho80, Cdc28-cyclin B, and protein kinases A and C) and dephosphorylation (e.g. by Nem1-Spo7) that regulate its cellular location, catalytic activity, and stability/degradation. In this work, we show that Pah1 is a substrate for casein kinase II (CKII); its phosphorylation was time-and dose-dependent and was dependent on the concentrations of Pah1 (K-m = 0.23 mu M) and ATP (K-m = 5.5 mu M). By mass spectrometry, truncation analysis, site-directed mutagenesis, phosphopeptide mapping, and phosphoamino acid analysis, we identified that >90% of its phosphorylation occurs on Thr-170, Ser-250, Ser-313, Ser-705, Ser-814, and Ser-818. The CKII-phosphorylated Pah1 was a substrate for the Nem1-Spo7 protein phosphatase and was degraded by the 20S proteasome. The prephosphorylation of Pah1 by protein kinase A or protein kinase C reduced its subsequent phosphorylation by CKII. The prephosphorylation of Pah1 by CKII reduced its subsequent phosphorylation by protein kinase A but not by protein kinase C. The expression of Pah1 with combined mutations of S705D and 7A, which mimic its phosphorylation by CKII and lack of phosphorylation by Pho85-Pho80, caused an increase in triacylglycerol content and lipid droplet number in cells expressing the Nem1-Spo7 phosphatase complex.	Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu	Lu-Sheng, Hsieh/AAZ-9188-2020	Lu-Sheng, Hsieh/0000-0001-7555-759X; Su, Wen-Min/0000-0002-1861-6335	National Institutes of Health [NS046593]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge Symeon Siniossoglou for supplying the pah1 Delta and pah1 Delta nem1 Delta mutants used in this study. The mass spectrometry data were obtained from an instrument purchased in part by National Institutes of Health Grant NS046593 for the support of the Rutgers Mass Spectrometry Center for Integrative Neuroscience Research.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Barbosa AD, 2015, MOL BIOL CELL, V26, P3641, DOI 10.1091/mbc.E15-03-0173; BIDWAI AP, 1995, J BIOL CHEM, V270, P10395, DOI 10.1074/jbc.270.18.10395; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Brindley DN, 1996, CHEM PHYS LIPIDS, V80, P45, DOI 10.1016/0009-3084(96)02545-5; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Chae M, 2013, J BIOL CHEM, V288, P6427, DOI 10.1074/jbc.M112.449629; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Chang YF, 2006, J BIOL CHEM, V281, P4754, DOI 10.1074/jbc.M513064200; CHENWU JLP, 1988, MOL CELL BIOL, V8, P4981, DOI 10.1128/MCB.8.11.4981; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; De Virgilio C, 2012, FEMS MICROBIOL REV, V36, P306, DOI 10.1111/j.1574-6976.2011.00287.x; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fei WH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002201; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P1698, DOI 10.1021/bi00536a035; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leggett David S., 2005, V301, P57; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIN YP, 1989, J BIOL CHEM, V264, P8641; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Lussier M, 1997, GENETICS, V147, P435; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; MARIN O, 1986, EUR J BIOCHEM, V160, P239, DOI 10.1111/j.1432-1033.1986.tb09962.x; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; PADMANABHA R, 1987, J BIOL CHEM, V262, P1829; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Poole A, 2005, MOL CELL BIOCHEM, V274, P163, DOI 10.1007/s11010-005-2945-z; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; REED JC, 1994, J BIOL CHEM, V269, P18192; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Rose MD., 1990, METHODS YEAST GENETI; Ruiz C, 1999, YEAST, V15, P1001; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; Siniossoglou S, 2009, TRAFFIC, V10, P1181, DOI 10.1111/j.1600-0854.2009.00923.x; SMITH SW, 1957, J BIOL CHEM, V228, P915; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Su WM, 2014, J BIOL CHEM, V289, P34699, DOI 10.1074/jbc.M114.614883; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; WHITE MJ, 1991, J BIOL CHEM, V266, P863; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983	108	27	29	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9974	9990		10.1074/jbc.M116.726588	http://dx.doi.org/10.1074/jbc.M116.726588			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	27044741	Green Published, hybrid			2022-12-28	WOS:000375602800012
J	Giddens, JP; Lomino, JV; Amin, MN; Wang, LX				Giddens, John P.; Lomino, Joseph V.; Amin, Mohammed N.; Wang, Lai-Xi			Endo-F3 Glycosynthase Mutants Enable Chemoenzymatic Synthesis of Core-fucosylated Triantennary Complex Type Glycopeptides and Glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; ASPARAGINE-LINKED OLIGOSACCHARIDES; ANION-EXCHANGE CHROMATOGRAPHY; FLAVOBACTERIUM-MENINGOSEPTICUM; TRANSGLYCOSYLATION ACTIVITY; BISECTING GLCNAC; GLYCOSYLATION; GLYCANS; SEPARATION; BINDING	Chemoenzymatic synthesis is emerging as a promising approach to the synthesis of homogeneous glycopeptides and glycoproteins highly demanded for functional glycomics studies, but its generality relies on the availability of a range of enzymes with high catalytic efficiency and well defined substrate specificity. We describe in this paper the discovery of glycosynthase mutants derived from Elizabethkingia meningoseptica endoglycosidase F3 (Endo-F3) of the GH18 family, which are devoid of the inherent hydrolytic activity but are able to take glycan oxazolines for transglycosylation. Notably, the Endo-F3 D165A and D165Q mutants demonstrated high acceptor substrate specificity toward alpha 1,6-fucosyl-GlcNAc-Asn or alpha 1, 6-fucosyl-GlcNAc-polypeptide in transglycosylation, enabling a highly convergent synthesis of core-fucosylated, complex CD52 glycopeptide antigen. The Endo-F3 mutants were able to use both bi- and triantennary glycan oxazolines as substrates for transglycosylation, in contrast to previously reported endogly-cosidases derived from Endo-S, Endo-M, Endo-D, and Endo-A mutants that could not recognize triantennary N-glycans. Using rituximab as a model system, we have further demonstrated that the Endo-F3 mutants are highly efficient for glycosylation remodeling of monoclonal antibodies to produce homogeneous intact antibody glycoforms. Interestingly, the new triantennary glycan glycoform of antibody showed much higher affinity for galectin-3 than that of the commercial antibody. The Endo-F3 mutants represent the first endoglycosidase-based glycosynthases capable of transferring triantennary complex N-glycans, which would be very useful for glycoprotein synthesis and glycosylation remodeling of antibodies.	[Giddens, John P.; Lomino, Joseph V.; Amin, Mohammed N.; Wang, Lai-Xi] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Giddens, John P.; Amin, Mohammed N.; Wang, Lai-Xi] Univ Maryland, Dept Chem & Biochem, 8051 Regents Dr,3500 Chem Bldg, College Pk, MD 20742 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park	Wang, LX (corresponding author), Univ Maryland, Dept Chem & Biochem, 8051 Regents Dr,3500 Chem Bldg, College Pk, MD 20742 USA.	wang518@umd.edu	wang, xl/Y-8251-2019; Wang, Lai-Xi/E-8790-2019; Wang, Xin/GYU-1129-2022; Wang, Lai-Xi/E-8755-2019; wang, xiao/HGB-7081-2022; Wang, Xin/AAN-8435-2021	Wang, Lai-Xi/0000-0003-4293-5819; wang, xiao/0000-0002-4088-3341; Wang, Xin/0000-0002-4457-7376; Giddens, John/0000-0001-8123-8704	National Institutes of Health [R01 GM080374]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 GM080374 (to L. X. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amin MN, 2013, NAT CHEM BIOL, V9, P521, DOI 10.1038/nchembio.1288; Amin MN, 2011, J AM CHEM SOC, V133, P14404, DOI 10.1021/ja204831z; Andre S, 2007, BIOCHEMISTRY-US, V46, P6984, DOI 10.1021/bi7000467; Andre S, 2009, BIOL CHEM, V390, P557, DOI 10.1515/BC.2009.072; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Barrabes S, 2007, GLYCOBIOLOGY, V17, P388, DOI 10.1093/glycob/cwm002; BENDIAK B, 1989, BIOCHEMISTRY-US, V28, P6491, DOI 10.1021/bi00441a050; Buskas T, 2006, GLYCOBIOLOGY, V16, p113R, DOI 10.1093/glycob/cwj125; Castilho A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054836; Castilho A, 2012, BIOTECHNOL J, V7, DOI 10.1002/biot.201200032; Chalker JM, 2011, ACCOUNTS CHEM RES, V44, P730, DOI 10.1021/ar200056q; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Dwek RA, 2002, NAT REV DRUG DISCOV, V1, P65, DOI 10.1038/nrd708; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Eller S, 2007, ANGEW CHEM INT EDIT, V46, P4173, DOI 10.1002/anie.200604788; Fan SQ, 2012, J BIOL CHEM, V287, P11272, DOI 10.1074/jbc.M112.340497; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Funasaka T, 2014, GLYCOBIOLOGY, V24, P886, DOI 10.1093/glycob/cwu086; Gaidzik N, 2013, CHEM SOC REV, V42, P4421, DOI 10.1039/c3cs35470a; Gamblin DP, 2009, CHEM REV, V109, P131, DOI 10.1021/cr078291i; GREEN ED, 1988, J BIOL CHEM, V263, P18253; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hamilton SR, 2007, CURR OPIN BIOTECH, V18, P387, DOI 10.1016/j.copbio.2007.09.001; Hang HC, 2001, ACCOUNTS CHEM RES, V34, P727, DOI 10.1021/ar9901570; HARDY MR, 1988, P NATL ACAD SCI USA, V85, P3289, DOI 10.1073/pnas.85.10.3289; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hojo H, 2012, J ORG CHEM, V77, P9437, DOI 10.1021/jo3010155; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Huang W, 2011, CHEMBIOCHEM, V12, P932, DOI 10.1002/cbic.201000763; Huang W, 2010, ORG BIOMOL CHEM, V8, P5224, DOI 10.1039/c0ob00341g; Huang W, 2010, CHEMBIOCHEM, V11, P1350, DOI 10.1002/cbic.201000242; Huang W, 2009, J AM CHEM SOC, V131, P2214, DOI 10.1021/ja8074677; Jacobs PP, 2009, NAT PROTOC, V4, P58, DOI 10.1038/nprot.2008.213; Jefferis R, 2005, BIOTECHNOL PROGR, V21, P11, DOI 10.1021/bp040016j; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Jenkins N, 1996, NAT BIOTECHNOL, V14, P975, DOI 10.1038/nbt0896-975; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Kim KK, 2005, INT J SYST EVOL MICR, V55, P1287, DOI 10.1099/ijs.0.63541-0; Kurogochi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132848; Li L, 2015, CHEM SCI, V6, P5652, DOI 10.1039/c5sc02025e; Lin CW, 2015, P NATL ACAD SCI USA, V112, P10611, DOI 10.1073/pnas.1513456112; Lomino JV, 2011, J BACTERIOL, V193, P2089, DOI 10.1128/JB.01231-10; MOSESSON MW, 1966, BIOCHEMISTRY-US, V5, P2829, DOI 10.1021/bi00873a008; Noguchi M, 2009, J ORG CHEM, V74, P2210, DOI 10.1021/jo8024708; Plummer TH, 1996, ANAL BIOCHEM, V235, P98; Raju TS, 2000, GLYCOBIOLOGY, V10, P477, DOI 10.1093/glycob/10.5.477; Rich JR, 2009, NAT CHEM BIOL, V5, P206, DOI 10.1038/nchembio.148; Rose RJ, 2013, MABS-AUSTIN, V5, P219, DOI 10.4161/mabs.23532; Sato H, 2008, CARBOHYD RES, V343, P1333, DOI 10.1016/j.carres.2008.03.008; Schmaltz RM, 2011, CHEM REV, V111, P4259, DOI 10.1021/cr200113w; Shen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008119; SPIRO RG, 1960, J BIOL CHEM, V235, P2860; STANLEY P, 1992, GLYCOBIOLOGY, V2, P99, DOI 10.1093/glycob/2.2.99; Sun B, 2008, CHEM-EUR J, V14, P7072, DOI 10.1002/chem.200800757; Takahashi M, 2009, CARBOHYD RES, V344, P1387, DOI 10.1016/j.carres.2009.04.031; Taniguchi N, 2015, ADV CANCER RES, V126, P11, DOI 10.1016/bs.acr.2014.11.001; Tarentino A, 1999, GLYCOBIOLOGY, V9, pIII; TARENTINO AL, 1995, GLYCOBIOLOGY, V5, P599, DOI 10.1093/glycob/5.6.599; TARENTINO AL, 1993, J BIOL CHEM, V268, P9702; TOWNSEND RR, 1989, ANAL BIOCHEM, V182, P1; TRIMBLE RB, 1991, J BIOL CHEM, V266, P1646; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Umekawa M, 2010, BBA-GEN SUBJECTS, V1800, P1203, DOI 10.1016/j.bbagen.2010.07.003; Umekawa M, 2010, J BIOL CHEM, V285, P511, DOI 10.1074/jbc.M109.059832; Unverzagt C, 2002, J MED CHEM, V45, P478, DOI 10.1021/jm0110237; Unverzagt C, 1994, Bioorg Med Chem, V2, P1189, DOI 10.1016/S0968-0896(00)82070-2; Unverzagt C, 2013, CHEM SOC REV, V42, P4408, DOI 10.1039/c3cs35485g; Verostek MF, 2000, ANAL BIOCHEM, V278, P111, DOI 10.1006/abio.1999.4433; Waddling CA, 2000, BIOCHEMISTRY-US, V39, P7878, DOI 10.1021/bi0001731; Walczak MA, 2012, J AM CHEM SOC, V134, P16430, DOI 10.1021/ja307628w; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang H, 2013, BIOORGAN MED CHEM, V21, P2037, DOI 10.1016/j.bmc.2013.01.028; Wang LX, 2008, CARBOHYD RES, V343, P1509, DOI 10.1016/j.carres.2008.03.025; Wang LX, 2014, CHEM BIOL, V21, P51, DOI 10.1016/j.chembiol.2014.01.001; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; Wang P, 2009, J AM CHEM SOC, V131, P16669, DOI 10.1021/ja907136d; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Yuan Y, 2010, BIOPOLYMERS, V94, P373, DOI 10.1002/bip.21374	79	65	69	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9356	9370		10.1074/jbc.M116.721597	http://dx.doi.org/10.1074/jbc.M116.721597			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26966183	hybrid, Green Published			2022-12-28	WOS:000374849000043
J	Kavi, H; Emelyanov, AV; Fyodorov, DV; Skoultchi, AI				Kavi, Harsh; Emelyanov, Alexander V.; Fyodorov, Dmitry V.; Skoultchi, Arthur I.			Independent Biological and Biochemical Functions for Individual Structural Domains of Drosophila Linker Histone H1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; CHROMATIN IN-VIVO; HETEROCHROMATIN FORMATION; GLOBULAR DOMAIN; NUCLEOSOME; BINDING; SU(VAR)3-9; PROTEIN; HP1; PHOSPHORYLATION	Linker histone H1 is among the most abundant components of chromatin. H1 has profound effects on chromosome architecture. H1 also helps to tether DNA-and histone-modifying enzymes to chromatin. Metazoan linker histones have a conserved tripartite structure comprising N-terminal, globular, and long, unstructured C-terminal domains. Here we utilize truncated Drosophila H1 polypeptides in vitro and H1 mutant transgenes in vivo to interrogate the roles of these domains in multiple biochemical and biological activities of H1. We demonstrate that the globular domain and the proximal part of the C-terminal domain are essential for H1 deposition into chromosomes and for the stability of H1-chromatin binding. The two domains are also essential for fly viability and the establishment of a normal polytene chromosome structure. Additionally, through interaction with the heterochromatin-specific histone H3 Lys-9 methyltransferase Su(var)3-9, the H1 C-terminal domain makes important contributions to formation and H3K9 methylation of heterochromatin as well as silencing of transposons in heterochromatin. Surprisingly, the N-terminal domain does not appear to be required for any of these functions. However, it is involved in the formation of a single chromocenter in polytene chromosomes. In summary, we have discovered that linker histone H1, similar to core histones, exerts its multiple biological functions through independent, biochemically separable activities of its individual structural domains.	[Fyodorov, Dmitry V.] Albert Einstein Coll Med, Dept Cell Biol, Chanin 414,1300 Morris Pk Ave, Bronx, NY 10461 USA; [Kavi, Harsh] North Shore Univ Hosp, Long Isl Jewish Med Ctr, Manhasset, NY 11030 USA	Yeshiva University; Albert Einstein College of Medicine; Northwell Health; North Shore University Hospital	Fyodorov, DV (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Chanin 414,1300 Morris Pk Ave, Bronx, NY 10461 USA.; Skoultchi, AI (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Chanin 402,1300 Morris Pk Ave, Bronx, NY 10461 USA.	dmitry.fyodorov@einstein.yu.edu; arthur.skoultchi@einstein.yu.edu			National Institutes of Health [GM074233, GM093190, GM116143]; NCI (National Institutes of Health) Cancer Center [CA013330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074233, R01GM093190, R01GM116143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI (National Institutes of Health) Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM074233 (to D. V. F.) and GM093190 and GM116143 (to A. I. S.) and NCI (National Institutes of Health) Cancer Center Support Grant CA013330 (to the Albert Einstein College of Medicine). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALLAN J, 1986, J MOL BIOL, V187, P591, DOI 10.1016/0022-2836(86)90337-2; Bierhoff H, 2014, EPIGENETICS-US, V9, P53, DOI 10.4161/epi.26485; Bonet-Costa C, 2012, J PROTEOMICS, V75, P4124, DOI 10.1016/j.jprot.2012.05.034; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Brown DT, 2001, GENOME BIOL, V2; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Caterino TL, 2011, BIOCHEM CELL BIOL, V89, P35, DOI 10.1139/O10-024; CERF C, 1993, BIOCHEMISTRY-US, V32, P11345, DOI 10.1021/bi00093a011; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Emelyanov AV, 2014, GENE DEV, V28, P2027, DOI 10.1101/gad.248583.114; Emelyanov AV, 2010, J BIOL CHEM, V285, P15027, DOI 10.1074/jbc.M109.064790; Eskeland R, 2004, BIOCHEMISTRY-US, V43, P3740, DOI 10.1021/bi035964s; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fish MP, 2007, NAT PROTOC, V2, P2325, DOI 10.1038/nprot.2007.328; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Hendzel MJ, 2004, J BIOL CHEM, V279, P20028, DOI 10.1074/jbc.M400070200; Kim K, 2008, J BIOL CHEM, V283, P9113, DOI 10.1074/jbc.M708205200; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Lu X, 2004, J BIOL CHEM, V279, P8701, DOI 10.1074/jbc.M311348200; Lu XW, 2013, SCIENCE, V340, P78, DOI 10.1126/science.1234654; Lu XW, 2009, GENE DEV, V23, P452, DOI 10.1101/gad.1749309; Lu X, 2009, BIOCHEMISTRY-US, V48, P164, DOI 10.1021/bi801636y; McBryant SJ, 2010, CELL RES, V20, P519, DOI 10.1038/cr.2010.35; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Patterton HG, 1998, J BIOL CHEM, V273, P7268, DOI 10.1074/jbc.273.13.7268; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Syed SH, 2010, P NATL ACAD SCI USA, V107, P9620, DOI 10.1073/pnas.1000309107; Thomas JO, 1999, CURR OPIN CELL BIOL, V11, P312, DOI 10.1016/S0955-0674(99)80042-8; van Holde KE., 1989, SPRINGER SERIES MOL; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Widlak P, 2005, BIOCHEMISTRY-US, V44, P7871, DOI 10.1021/bi050100n; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Wolffe A., 1998, CHROMATIN STRUCTURE; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Xu N, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-16; Yang SM, 2013, P NATL ACAD SCI USA, V110, P1708, DOI 10.1073/pnas.1213266110; ZHANG P, 1995, GENETICS, V139, P659; Zhou BR, 2013, P NATL ACAD SCI USA, V110, P19390, DOI 10.1073/pnas.1314905110	44	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15143	15155		10.1074/jbc.M116.730705	http://dx.doi.org/10.1074/jbc.M116.730705			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226620	hybrid, Green Published			2022-12-28	WOS:000380583200024
J	Nocadello, S; Minasov, G; Shuvalova, LS; Dubrovska, I; Sabini, E; Anderson, WF				Nocadello, Salvatore; Minasov, George; Shuvalova, Ludmilla S.; Dubrovska, Ievgeniia; Sabini, Elisabetta; Anderson, Wayne F.			Crystal Structures of the SpoIID Lytic Transglycosylases Essential for Bacterial Sporulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGG-WHITE LYSOZYME; CELL-WALL; X-RAY; BACILLUS-SUBTILIS; CATALYTIC DOMAIN; BACTERIOPHAGE-T4 LYSOZYME; PROTEIN; PURIFICATION; DEGRADATION; ENGULFMENT	Bacterial spores are the most resistant form of life known on Earth and represent a serious problem for (i) bioterrorism attack, (ii) horizontal transmission of microbial pathogens in the community, and (iii) persistence in patients and in a nosocomial environment. Stage II sporulation protein D (Spoilt)) is a lytic transglycosylase (LT) essential for sporulation. The LT superfamily is a potential drug target because it is active in essential bacterial processes involving the peptidoglycan, which is unique to bacteria. However, the absence of structural information for the sporulation-specific LT enzymes has hindered mechanistic understanding of SpoIID. Here, we report the first crystal structures with and without ligands of the SpoIID family from two community relevant spore-forming pathogens, Bacillus anthracis and Clostridium difficile. The structures allow us to visualize the overall architecture, characterize the substrate recognition model, identify critical residues, and provide the structural basis for catalysis by this new family of enzymes.	[Nocadello, Salvatore; Minasov, George; Shuvalova, Ludmilla S.; Dubrovska, Ievgeniia; Sabini, Elisabetta; Anderson, Wayne F.] Northwestern Univ, Ctr Struct Genom Infect Dis, Dept Biochem & Mol Genet, Feinberg Sch Med, Morton 7-601,303 E Chicago Ave, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Anderson, WF (corresponding author), Northwestern Univ, Ctr Struct Genom Infect Dis, Dept Biochem & Mol Genet, Feinberg Sch Med, Morton 7-601,303 E Chicago Ave, Chicago, IL 60611 USA.	wf-anderson@northwestern.edu		Minasov, George/0000-0001-5460-3462	United States Department of Energy [DE-AC02-06CH11357]	United States Department of Energy(United States Department of Energy (DOE))	X-ray data collection was done at the LS-CAT beamlines 21ID-G (3ROH) and 21ID-F (4Q7G) at the Advanced Photon Source Science User Facility operated for the United States Department of Energy (DOE), supported by the United States Department of Energy under Contract Number DE-AC02-06CH11357.	Abanes-De Mello A, 2002, GENE DEV, V16, P3253, DOI 10.1101/gad.1039902; Anderson W. F., 2009, Infectious Disorders - Drug Targets, V9, P507; ANDERSON WF, 1981, J MOL BIOL, V147, P523, DOI 10.1016/0022-2836(81)90398-3; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Chastanet A, 2007, MOL MICROBIOL, V64, P139, DOI 10.1111/j.1365-2958.2007.05652.x; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Gutierrez J, 2010, J BACTERIOL, V192, P3174, DOI 10.1128/JB.00127-10; HADFIELD AT, 1994, J MOL BIOL, V243, P856, DOI 10.1006/jmbi.1994.1688; HARZ H, 1990, ANAL BIOCHEM, V190, P120, DOI 10.1016/0003-2697(90)90144-X; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; JACOBS C, 1994, EMBO J, V13, P4684, DOI 10.1002/j.1460-2075.1994.tb06792.x; Jing X, 2012, PROTEINS, V80, P2469, DOI 10.1002/prot.24140; Kim Y, 2008, ADV PROTEIN CHEM, V75, P85, DOI 10.1016/S0065-3233(07)75003-9; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YF, 2012, J BACTERIOL, V194, P4537, DOI 10.1128/JB.00877-12; Lin YJ, 2012, BIOINFORMATICS, V28, P1172, DOI 10.1093/bioinformatics/bts095; MATTHEWS BW, 1981, J MOL BIOL, V147, P545, DOI 10.1016/0022-2836(81)90399-5; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Morlot C, 2010, GENE DEV, V24, P411, DOI 10.1101/gad.1878110; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THUNNISSEN AMWH, 1995, PROTEINS, V22, P245, DOI 10.1002/prot.340220305; THUNNISSEN AMWH, 1994, NATURE, V367, P750, DOI 10.1038/367750a0; THUNNISSEN AMWH, 1995, BIOCHEMISTRY-US, V34, P12729, DOI 10.1021/bi00039a032; WEAVER LH, 1995, J MOL BIOL, V245, P54, DOI 10.1016/S0022-2836(95)80038-7; Wu N, 2000, ACTA CRYSTALLOGR D, V56, P912, DOI 10.1107/S090744490000576X; ZHOU RQ, 1988, ANAL BIOCHEM, V171, P141, DOI 10.1016/0003-2697(88)90134-0	35	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14915	14926		10.1074/jbc.M116.729749	http://dx.doi.org/10.1074/jbc.M116.729749			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226615	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000380583200005
J	Song, L; Chen, J; Peng, GD; Tang, K; Jing, NH				Song, Lu; Chen, Jun; Peng, Guangdun; Tang, Ke; Jing, Naihe			Dynamic Heterogeneity of Brachyury in Mouse Epiblast Stem Cells Mediates Distinct Response to Extrinsic Bone Morphogenetic Protein (BMP) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; EARLY EMBRYONIC-DEVELOPMENT; PRIMITIVE-STREAK; MESODERM FORMATION; FATE DECISIONS; ID PROTEINS; INDUCTION; GENE; PLURIPOTENCY; EXPRESSION	Mouse pluripotent cells, such as embryonic stem cells (ESCs) and epiblast stem cells (EpiSCs), provide excellent in vitro systems to study imperative pre- and postimplantation events of in vivo mammalian development. It is known that mouse ESCs are dynamic heterogeneous populations. However, it remains largely unclear whether and how EpiSCs possess heterogeneity and plasticity similar to that of ESCs. Here, we show that EpiSCs are discriminated by the expression of a specific marker '1' (Brachyury) into two populations. The T -positive (T+) and the T-negative (T-) populations can be interconverted within the same culture condition. In addition, the two populations display distinct responses to bone morphogenetic protein (BMP) signaling and different developmental potentials. The T- EpiSCs are preferentially differentiated into ectoderm lineages, whereas EpiSCs have a biased potential for mesendoderm fates. Mechanistic studies reveal that T+ EpiSCs have an earlier and faster response to BMP4 stimulation than T- EpiSCs. Idl mediates the commitment of T- EpiSCs to epidermal lineage during BMP4 treatment. On the other hand, Snail modulates the conversion of T+ EpiSCs to mesendoderm fates with the presence of BMP4. Furthermore, T expression is essential for epithelialmesenchymal transition during EpiSCs differentiation. Our findings suggest that the dynamic heterogeneity of the T+ /T-subpopulation primes EpiSCs toward particular cell lineages, providing important insights into the dynamic development of the early mouse embryo.	[Song, Lu; Chen, Jun; Peng, Guangdun; Jing, Naihe] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Tang, Ke] Nanchang Univ, Inst Life Sci, Nanchang 330031, Jiangxi, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanchang University	Jing, NH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China.	njing@sibcb.ac.cn	Peng, Guangdun/AAH-9044-2019	Peng, Guangdun/0000-0002-8586-0637	Chinese Academy of Sciences [XDA01010201]; National Key Basic Research and Development Program of China [2014CB964804, 2015CB964500]; National Natural Science Foundation of China [31430058, 31571513, 91519314, 31501173]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the "Strategic Priority Research Program" of the Chinese Academy of Sciences, Grant XDA01010201; National Key Basic Research and Development Program of China Grants 2014CB964804 and 2015CB964500; and National Natural Science Foundation of China Grants 31430058, 31571513, 91519314, and 31501173. The authors declare that they have no conflicts of interest with the contents of this article.	Nieto MA, 2009, INT J DEV BIOL, V53, P1541, DOI 10.1387/ijdb.072410mn; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Bernemann C, 2011, STEM CELLS, V29, P1496, DOI 10.1002/stem.709; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Coppe JP, 2003, EXP CELL RES, V285, P131, DOI 10.1016/S0014-4827(03)00014-4; Di-Gregorio A, 2007, DEVELOPMENT, V134, P3359, DOI 10.1242/dev.005967; Edwards YH, 1996, GENOME RES, V6, P226, DOI 10.1101/gr.6.3.226; Faial T, 2015, DEVELOPMENT, V142, P2121, DOI 10.1242/dev.117838; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Fernando RI, 2010, J CLIN INVEST, V120, P533, DOI 10.1172/JCI38379; Furusawa T, 2004, BIOL REPROD, V70, P1452, DOI 10.1095/biolreprod.103.024190; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Gundry RL, 2011, PROTEOMICS, V11, P3947, DOI 10.1002/pmic.201100100; Hamilton DH, 2012, SEMIN ONCOL, V39, P358, DOI 10.1053/j.seminoncol.2012.02.005; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Imajyo I, 2012, INT J ONCOL, V41, P1985, DOI 10.3892/ijo.2012.1673; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; Kojima Y, 2014, CELL STEM CELL, V14, P107, DOI 10.1016/j.stem.2013.09.014; Li LY, 2015, J MOL CELL BIOL, V7, P455, DOI 10.1093/jmcb/mjv030; Li LY, 2011, GENES-BASEL, V2, P298, DOI 10.3390/genes2020298; Li LY, 2013, DEVELOPMENT, V140, P4533, DOI 10.1242/dev.092866; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Naber HPH, 2013, BIOCHEM BIOPH RES CO, V435, P58, DOI 10.1016/j.bbrc.2013.04.037; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pillai S, 2011, MOL CELL BIOL, V31, P3052, DOI 10.1128/MCB.01311-10; Rivera-Perez JA, 2005, DEV BIOL, V288, P363, DOI 10.1016/j.ydbio.2005.09.012; Rossant J, 2004, DEV CELL, V7, P155, DOI 10.1016/j.devcel.2004.07.012; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Sheng NY, 2010, P NATL ACAD SCI USA, V107, P18886, DOI 10.1073/pnas.1009244107; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Sun SR, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0076-4; Takaoka K, 2012, DEVELOPMENT, V139, P3, DOI 10.1242/dev.060095; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tam PPL, 2006, CURR OPIN GENET DEV, V16, P419, DOI 10.1016/j.gde.2006.06.008; Tan FZ, 2015, J BIOL CHEM, V290, P4500, DOI 10.1074/jbc.M114.609016; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Torres-Padilla ME, 2014, DEVELOPMENT, V141, P2173, DOI 10.1242/dev.102624; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trevino AE, 2014, METHOD ENZYMOL, V546, P161, DOI 10.1016/B978-0-12-801185-0.00008-8; Tsakiridis A, 2014, DEVELOPMENT, V141, P1209, DOI 10.1242/dev.101014; Turner DA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0063-7; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Wade M, 2015, J BIOMOL SCREEN, V20, P1027, DOI 10.1177/1087057115587916; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Williams M, 2012, DEV DYNAM, V241, P270, DOI 10.1002/dvdy.23711; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wu YD, 2010, CELL ADHES MIGR, V4, P199, DOI 10.4161/cam.4.2.10943; Wu YX, 2015, CELL RES, V25, P67, DOI 10.1038/cr.2014.160; Yamamoto Y, 2004, NATURWISSENSCHAFTEN, V91, P519, DOI 10.1007/s00114-004-0575-z; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494; Zhu QQ, 2014, ELIFE, V3, DOI 10.7554/eLife.02224	70	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15212	15225		10.1074/jbc.M115.705418	http://dx.doi.org/10.1074/jbc.M115.705418			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226536	Green Published, hybrid			2022-12-28	WOS:000380583200029
J	dela Sena, C; Sun, J; Narayanasamy, S; Riedl, KM; Yuan, Y; Curley, RW; Schwartz, SJ; Harrison, EH				dela Sena, Carlo; Sun, Jian; Narayanasamy, Sureshbabu; Riedl, Kenneth M.; Yuan, Yan; Curley, Robert W., Jr.; Schwartz, Steven J.; Harrison, Earl H.			Substrate Specificity of Purified Recombinant Chicken -Carotene 9,10-Oxygenase (BCO2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carotenoid; dioxygenase; enzyme; enzyme purification; lipid metabolism; recombinant protein expression; retinoid	ACYCLO-RETINOIC ACID; BETA-CAROTENE; IN-VITRO; PIGMENT EPITHELIUM; CANCER CELLS; VISUAL CYCLE; RPE65; METABOLISM; ISOMEROHYDROLASE; CLEAVAGE	Provitamin A carotenoids are oxidatively cleaved by -carotene 15,15-dioxygenase (BCO1) at the central 15-15 double bond to form retinal (vitamin A aldehyde). Another carotenoid oxygenase, -carotene 9,10-oxygenase (BCO2) catalyzes the oxidative cleavage of carotenoids at the 9-10 bond to yield an ionone and an apo-10-carotenoid. Previously published substrate specificity studies of BCO2 were conducted using crude lysates from bacteria or insect cells expressing recombinant BCO2. Our attempts to obtain active recombinant human BCO2 expressed in Escherichia coli were unsuccessful. We have expressed recombinant chicken BCO2 in the strain E. coli BL21-Gold (DE3) and purified the enzyme by cobalt ion affinity chromatography. Like BCO1, purified recombinant chicken BCO2 catalyzes the oxidative cleavage of the provitamin A carotenoids -carotene, -carotene, and -cryptoxanthin. Its catalytic activity with -carotene as substrate is at least 10-fold lower than that of BCO1. In further contrast to BCO1, purified recombinant chicken BCO2 also catalyzes the oxidative cleavage of 9-cis--carotene and the non-provitamin A carotenoids zeaxanthin and lutein, and is inactive with all-trans-lycopene and -apocarotenoids. Apo-10-carotenoids were detected as enzymatic products by HPLC, and the identities were confirmed by LC-MS. Small amounts of 3-hydroxy--apo-8-carotenal were also consistently detected in BCO2--cryptoxanthin reaction mixtures. With the exception of this activity with -cryptoxanthin, BCO2 cleaves specifically at the 9-10 bond to produce apo-10-carotenoids. BCO2 has been shown to function in preventing the excessive accumulation of carotenoids, and its broad substrate specificity is consistent with this.	[dela Sena, Carlo; Sun, Jian; Narayanasamy, Sureshbabu; Yuan, Yan; Harrison, Earl H.] Ohio State Univ, Dept Human Nutr, Columbus, OH 43210 USA; [dela Sena, Carlo; Curley, Robert W., Jr.; Harrison, Earl H.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Riedl, Kenneth M.; Schwartz, Steven J.] Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA; [Curley, Robert W., Jr.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Harrison, EH (corresponding author), Ohio State Univ, 314 Campbell Hall,1787 Neil Ave, Columbus, OH 43210 USA.	harrison.304@osu.edu	riedl, ken/G-8621-2014; Riedl, Ken/K-1881-2019; Harrison, Earl H/AAN-5378-2021; NARAYANASAMY, SURESHBABU/AAN-6604-2021	riedl, ken/0000-0002-9020-3471; Narayanasamy, Sureshbabu/0000-0002-5846-3230	National Institutes of Health [R01-HL49879]; Ohio Agricultural Research Development Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Agricultural Research Development Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01-HL49879 and a grant from the Ohio Agricultural Research Development Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amengual J, 2013, J BIOL CHEM, V288, P34081, DOI 10.1074/jbc.M113.501049; Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906; Babino D, 2015, J BIOL CHEM, V290, P24844, DOI 10.1074/jbc.M115.668822; Ben-Dor A, 2001, ARCH BIOCHEM BIOPHYS, V391, P295, DOI 10.1006/abbi.2001.2412; Britton G., 1995, SPECTROSCOPY-US, V1B, P13; dela Sena C, 2013, J BIOL CHEM, V288, P37094, DOI 10.1074/jbc.M113.507160; Eroglu A, 2013, J LIPID RES, V54, P1719, DOI 10.1194/jlr.R039537; Eroglu A, 2012, J BIOL CHEM, V287, P15886, DOI 10.1074/jbc.M111.325142; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Grolier P, 1997, ARCH BIOCHEM BIOPHYS, V348, P233, DOI 10.1006/abbi.1997.0388; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kim YS, 2011, BIOTECHNOL LETT, V33, P1195, DOI 10.1007/s10529-011-0556-1; Kim YS, 2009, BIOTECHNOL LETT, V31, P403, DOI 10.1007/s10529-008-9873-4; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Kotake-Nara E, 2002, ANTICANCER RES, V22, P689; KRINSKY NI, 1990, J NUTR, V120, P1654, DOI 10.1093/jn/120.12.1654; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li BX, 2014, P NATL ACAD SCI USA, V111, P10173, DOI 10.1073/pnas.1402526111; Lindqvist A, 2005, J HISTOCHEM CYTOCHEM, V53, P1403, DOI 10.1369/jhc.5A6705.2005; Lobo GP, 2010, J BIOL CHEM, V285, P27891, DOI 10.1074/jbc.M110.132571; Lyubarsky AL, 2005, BIOCHEMISTRY-US, V44, P9880, DOI 10.1021/bi0505363; Mein JR, 2011, ARCH BIOCHEM BIOPHYS, V506, P109, DOI 10.1016/j.abb.2010.11.005; Messing SAJ, 2010, PLANT CELL, V22, P2970, DOI 10.1105/tpc.110.074815; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Nikolaeva O, 2009, FEBS J, V276, P3020, DOI 10.1111/j.1742-4658.2009.07021.x; Palczewski G, 2014, FASEB J, V28, P4457, DOI 10.1096/fj.14-252411; Poliakov E, 2005, J BIOL CHEM, V280, P29217, DOI 10.1074/jbc.M500409200; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Richelle M, 2010, BRIT J NUTR, V103, P1800, DOI 10.1017/S0007114510000103; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Stahl W, 2000, ARCH BIOCHEM BIOPHYS, V373, P271, DOI 10.1006/abbi.1999.1510; Sui XW, 2013, ARCH BIOCHEM BIOPHYS, V539, P203, DOI 10.1016/j.abb.2013.06.012; Toomey MB, 2007, INVEST OPHTH VIS SCI, V48, P3976, DOI 10.1167/iovs.07-0208; Walter MH, 2010, PLANTA, V232, P1, DOI 10.1007/s00425-010-1156-3; Wang XD, 2009, CAROTENOIDS SER, V5, P383, DOI 10.1007/978-3-7643-7501-0_18	38	54	54	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14609	14619		10.1074/jbc.M116.723684	http://dx.doi.org/10.1074/jbc.M116.723684			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27143479	Green Published, hybrid			2022-12-28	WOS:000380366700017
J	Holmes, B; Lee, J; Landon, KA; Benavides-Serrato, A; Bashir, T; Jung, ME; Lichtenstein, A; Gera, J				Holmes, Brent; Lee, Jihye; Landon, Kenna A.; Benavides-Serrato, Angelica; Bashir, Tariq; Jung, Michael E.; Lichtenstein, Alan; Gera, Joseph			Mechanistic Target of Rapamycin (mTOR) Inhibition Synergizes with Reduced Internal Ribosome Entry Site (IRES)-mediated Translation of Cyclin D1 and c-MYC mRNAs to Treat Glioblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclin D1; glioblastoma; heterogeneous nuclear ribonucleoprotein (hnRNP); mechanistic target of rapamycin (mTOR); Myc (c-Myc); translation; IRES; ITAF; mRNA translation	NUCLEAR RIBONUCLEOPROTEIN A1; TRANS-ACTING FACTOR; HNRNP A1; MAMMALIAN TARGET; GROWTH; INITIATION; IMPORT	Our previous work has demonstrated an intrinsic mRNA-specific protein synthesis salvage pathway operative in glioblastoma (GBM) tumor cells that is resistant to mechanistic target of rapamycin (mTOR) inhibitors. The activation of this internal ribosome entry site (IRES)-dependent mRNA translation initiation pathway results in continued translation of critical transcripts involved in cell cycle progression in the face of global eIF-4E-mediated translation inhibition. Recently we identified compound 11 (C11), a small molecule capable of inhibiting c-MYC IRES translation as a consequence of blocking the interaction of a requisite c-MYC IRES trans-acting factor, heterogeneous nuclear ribonucleoprotein A1, with its IRES. Here we demonstrate that C11 also blocks cyclin D1 IRES-dependent initiation and demonstrates synergistic anti-GBM properties when combined with the mechanistic target of rapamycin kinase inhibitor PP242. The structure-activity relationship of C11 was investigated and resulted in the identification of IRES-J007, which displayed improved IRES-dependent initiation blockade and synergistic anti-GBM effects with PP242. Mechanistic studies with C11 and IRES-J007 revealed binding of the inhibitors within the UP1 fragment of heterogeneous nuclear ribonucleoprotein A1, and docking analysis suggested a small pocket within close proximity to RRM2 as the potential binding site. We further demonstrate that co-therapy with IRES-J007 and PP242 significantly reduces tumor growth of GBM xenografts in mice and that combined inhibitor treatments markedly reduce the mRNA translational state of cyclin D1 and c-MYC transcripts in these tumors. These data support the combined use of IRES-J007 and PP242 to achieve synergistic antitumor responses in GBM.	[Holmes, Brent; Lichtenstein, Alan; Gera, Joseph] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90048 USA; [Jung, Michael E.; Lichtenstein, Alan; Gera, Joseph] Univ Calif Los Angeles, Jonnson Comprehens Canc Ctr, Los Angeles, CA 90048 USA; [Jung, Michael E.; Gera, Joseph] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90048 USA; [Lee, Jihye; Jung, Michael E.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90048 USA; [Holmes, Brent; Landon, Kenna A.; Benavides-Serrato, Angelica; Bashir, Tariq; Lichtenstein, Alan; Gera, Joseph] Greater Los Angeles Vet Affairs Healthcare Syst, Dept Res & Dev, Los Angeles, CA 91343 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Gera, J (corresponding author), 16111 Plummer St 151,Bldg 1,Rm C111A, Los Angeles, CA 91343 USA.	jgera@mednet.ucla.edu		Gera, Joseph/0000-0002-2908-6894; Holmes, Brent/0000-0002-2768-2991	National Institutes of Health [R01CA168700]; Department of Veterans Affairs MERIT Grant [I01BX002665]; NATIONAL CANCER INSTITUTE [R01CA168700] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs MERIT Grant(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grant R01CA168700 and by Department of Veterans Affairs MERIT Grant I01BX002665. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Babic I, 2013, CELL METAB, V17, P1000, DOI 10.1016/j.cmet.2013.04.013; Benavides-Serrato Angelica, 2014, Genes Cancer, V5, P393; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Chang SM, 2005, INVEST NEW DRUG, V23, P357, DOI 10.1007/s10637-005-1444-0; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cloninger C, 2011, MOL CANCER THER, V10, P2244, DOI 10.1158/1535-7163.MCT-11-0478; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324; Culjkovic B, 2005, J CELL BIOL, V169, P245, DOI 10.1083/jcb.200501019; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Fan QW, 2011, CURR TOP MICROBIOL, V347, P279, DOI 10.1007/82_2010_67; Fridell RA, 1997, J CELL SCI, V110, P1325; Gini B, 2013, CLIN CANCER RES, V19, P5722, DOI 10.1158/1078-0432.CCR-13-0527; Iwanami A, 2013, P NATL ACAD SCI USA, V110, P4339, DOI 10.1073/pnas.1217602110; Jean-Philippe J, 2013, INT J MOL SCI, V14, P18999, DOI 10.3390/ijms140918999; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; Kanoh N, 2005, ANGEW CHEM INT EDIT, V44, P3559, DOI 10.1002/anie.200462370; Ko CC, 2014, J BIOL CHEM, V289, P22078, DOI 10.1074/jbc.M114.553248; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lewis SM, 2008, ONCOGENE, V27, P1033, DOI 10.1038/sj.onc.1210777; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Martin J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.205096; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Morgan CE, 2015, J MOL BIOL, V427, P3241, DOI 10.1016/j.jmb.2015.05.009; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; Shi Y, 2016, ONCOGENE, V35, P1015, DOI 10.1038/onc.2015.156; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; Thompson SR, 2012, WIRES RNA, V3, P697, DOI 10.1002/wrna.1129; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wu Si-Han, 2014, Cancer Biology Medicine, V11, P255, DOI 10.7497/j.issn.2095-3941.2014.04.004	39	35	37	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14146	14159		10.1074/jbc.M116.726927	http://dx.doi.org/10.1074/jbc.M116.726927			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226604	hybrid, Green Published			2022-12-28	WOS:000379975100022
J	Hwang, S; Hartman, IZ; Calhoun, LN; Garland, K; Young, GA; Mitsche, MA; McDonald, J; Xu, F; Engelking, L; DeBose-Boyd, RA				Hwang, Seonghwan; Hartman, Isamu Z.; Calhoun, Leona N.; Garland, Kristina; Young, Gennipher A.; Mitsche, Matthew A.; McDonald, Jeffrey; Xu, Fang; Engelking, Luke; DeBose-Boyd, Russell A.			Contribution of Accelerated Degradation to Feedback Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Cholesterol Metabolism in the Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol metabolism; endoplasmic reticulum (ER); endoplasmic-reticulum-associated protein degradation (ERAD); isoprenoid; lipid metabolism	HMG-COA REDUCTASE; FATTY-ACID SYNTHESIS; ENDOPLASMIC-RETICULUM; TRANSGENIC MICE; ENZYME DEGRADATION; UBIQUITIN LIGASE; INSIG PROTEINS; MESSENGER-RNA; RAT-LIVER; STEROLS	Accumulation of sterols in endoplasmic reticulum membranes stimulates the ubiquitination of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), which catalyzes a rate-limiting step in synthesis of cholesterol. This ubiquitination marks HMGCR for proteasome-mediated degradation and constitutes one of several mechanisms for feedback control of cholesterol synthesis. Mechanisms for sterol-accelerated ubiquitination and degradation of HMGCR have been elucidated through the study of cultured mammalian cells. However, the extent to which these reactions modulate HMGCR and contribute to control of cholesterol metabolism in whole animals is unknown. Here, we examine transgenic mice expressing in the liver the membrane domain of HMGCR (HMGCR (TM1-8)), a region necessary and sufficient for sterol-accelerated degradation, and knock-in mice in which endogenous HMGCR harbors mutations that prevent sterol-induced ubiquitination. Characterization of transgenic mice revealed that HMGCR (TM1-8) is appropriately regulated in the liver of mice fed a high cholesterol diet or chow diet supplemented with the HMGCR inhibitor lovastatin. Ubiquitination-resistant HMGCR protein accumulates in the liver and other tissues disproportionately to its mRNA, indicating that sterol-accelerated degradation significantly contributes to feedback regulation of HMGCR in vivo. Results of these studies demonstrate that HMGCR is subjected to sterol-accelerated degradation in the liver through mechanisms similar to those established in cultured cells. Moreover, these studies designate sterol-accelerated degradation of HMGCR as a potential therapeutic target for prevention of atherosclerosis and associated cardiovascular disease.	[Hwang, Seonghwan; Hartman, Isamu Z.; Calhoun, Leona N.; Garland, Kristina; Young, Gennipher A.; Mitsche, Matthew A.; McDonald, Jeffrey; Xu, Fang; Engelking, Luke; DeBose-Boyd, Russell A.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	DeBose-Boyd, RA (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Russell.DeBose-Boyd@utsouthwestern.edu		Engelking, Luke/0000-0002-1355-4964	National Institutes of Health [HL20948]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK102652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant HL20948 and an Early Career Scientist Award from the Howard Hughes Medical Institute (to R. D. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BROWN MS, 1980, J LIPID RES, V21, P505; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Doolman R, 2004, J BIOL CHEM, V279, P38184, DOI 10.1074/jbc.M405935200; EDWARDS PA, 1972, J BIOL CHEM, V247, P1520; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Engelking LJ, 2006, J CLIN INVEST, V116, P2356, DOI 10.1172/JCI28988; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Jo Y, 2011, J BIOL CHEM, V286, P15022, DOI 10.1074/jbc.M110.211326; Keller RK, 1996, ARCH BIOCHEM BIOPHYS, V328, P324, DOI 10.1006/abbi.1996.0180; KITA T, 1980, J CLIN INVEST, V66, P1094, DOI 10.1172/JCI109938; LISCUM L, 1985, J BIOL CHEM, V260, P522; Liu TF, 2012, CELL METAB, V16, P213, DOI 10.1016/j.cmet.2012.06.014; McDonald JG, 2012, J LIPID RES, V53, P1399, DOI 10.1194/jlr.D022285; McFarlane MR, 2014, J BIOL CHEM, V289, P2148, DOI 10.1074/jbc.M113.524041; Mitsche MA, 2015, ELIFE, V4, DOI 10.7554/eLife.07999; Morris LL, 2014, J BIOL CHEM, V289, P19053, DOI 10.1074/jbc.M114.576652; Ness GC, 2005, FEBS LETT, V579, P3126, DOI 10.1016/j.febslet.2005.05.001; REIHNER E, 1990, NEW ENGL J MED, V323, P224, DOI 10.1056/NEJM199007263230403; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Sharpe LJ, 2013, J BIOL CHEM, V288, P18707, DOI 10.1074/jbc.R113.479808; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3	35	27	27	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13479	13494		10.1074/jbc.M116.728469	http://dx.doi.org/10.1074/jbc.M116.728469			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129778	hybrid, Green Published			2022-12-28	WOS:000379771100007
J	Stegmayr, J; Lepur, A; Kahl-Knutson, B; Aguilar-Moncayo, M; Klyosov, AA; Field, RA; Oredsson, S; Nilsson, UJ; Leffler, H				Stegmayr, John; Lepur, Adriana; Kahl-Knutson, Barbro; Aguilar-Moncayo, Matilde; Klyosov, Anatole A.; Field, Robert A.; Oredsson, Stina; Nilsson, Ulf J.; Leffler, Hakon			Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODIFIED CITRUS PECTIN; PROSTATE-CANCER CELLS; L-PHENYLALANINE 2-NAPHTHYLAMIDE; RECEPTOR GALECTIN-8; MELANOMA-CELLS; HUMAN BREAST; POLYSACCHARIDES; RECOGNITION; METASTASIS; APOPTOSIS	Some complex plant-derived polysaccharides, such as modified citrus pectins and galactomannans, have been shown to have promising anti-inflammatory and anti-cancer effects. Most reports propose or claim that these effects are due to interaction of the polysaccharides with galectins because the polysaccharides contain galactose-containing side chains that might bind this class of lectin. However, their direct binding to and/or inhibition of the evolutionarily conserved galactoside-binding site of galectins has not been demonstrated. Using a well established fluorescence anisotropy assay, we tested the direct interaction of several such polysaccharides with physiological concentrations of a panel of galectins. The bioactive pectic samples tested were very poor inhibitors of the canonical galactoside-binding site for the tested galectins, with IC50 values >10 mg/ml for a few or in most cases no inhibitory activity at all. The galactomannan Davanat (R) was more active, albeit not a strong inhibitor (IC50 values ranging from 3 to 20 mg/ml depending on the galectin). Pure synthetic oligosaccharide fragments found in the side chains and backbone of pectins and galactomannans were additionally tested. The most commonly found galactan configuration in pectins had no inhibition of the galectins tested. Galactosylated tri- and pentamannosides, representing the structure of Davanat (R), had an inhibitory effect of galectins comparable with that of free galactose. Further evaluation using cell-based assays, indirectly linked to galectin-3 inhibition, showed no inhibition of galectin-3 by the polysaccharides. These data suggest that the physiological effects of these plant polysaccharides are not due to inhibition of the canonical galectin carbohydrate-binding site.	[Stegmayr, John; Lepur, Adriana; Kahl-Knutson, Barbro; Leffler, Hakon] Lund Univ, Dept Lab Med, Sect MIG Microbiol, Immunol,Glycobiol, S-22100 Lund, Sweden; [Stegmayr, John; Oredsson, Stina] Lund Univ, Dept Biol, Lund, Sweden; [Nilsson, Ulf J.] Lund Univ, Dept Chem, Ctr Anal & Synth, Lund, Sweden; [Aguilar-Moncayo, Matilde; Field, Robert A.] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Klyosov, Anatole A.] Galectin Therapeut, Newton, MA 02459 USA; [Lepur, Adriana] Ruoer Boskovic Inst, Div Mol Med, Zagreb, Croatia	Lund University; Lund University; Lund University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Stegmayr, J; Leffler, H (corresponding author), BMC C12,Klinikgatan 18, SE-22184 Lund, Sweden.	john.stegmayr@med.lu.se; hakon.leffler@med.lu.se	Leffler, Hakon/A-2416-2019; Nilsson, Ulf J./L-3219-2014	Nilsson, Ulf J./0000-0001-5815-9522; Stegmayr, John/0000-0002-8167-9259; Leffler, Hakon/0000-0003-4482-8945; Field, Rob/0000-0001-8574-0275	European Community [HEALTH-F2-2011-256986, 043682]; Swedish Research Council [621-2009-5656, 621-2003-4265]; Knut and Alice Wallenberg Foundation, Sweden; United Kingdom Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant on Understanding and Exploiting Metabolism [BB/J004561/1]; John Innes Foundation; BBSRC [BBS/E/J/000C0618, BBS/E/J/000CA469] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0618, BBS/E/J/000CA469] Funding Source: researchfish	European Community(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation, Sweden(Knut & Alice Wallenberg Foundation); United Kingdom Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant on Understanding and Exploiting Metabolism(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Community Seventh Framework Programme (FP7-2007-2013) under Grant HEALTH-F2-2011-256986 (PANACREAS) (to J. S.), FP6 Project "EuroPharm" Grant 043682 (to A. L.), Swedish Research Council Grant 621-2009-5656 (to H. L.) and 621-2003-4265 (to U. J. N.), Knut and Alice Wallenberg Foundation, Sweden (to H. L., U. J. N., and J. S.), United Kingdom Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant on Understanding and Exploiting Metabolism BB/J004561/1, and the John Innes Foundation (to M. A. and R. A. F.). A. A. K. is a shareholder in Galectin Therapeutics Inc., the company that owns the intellectual property for Davanat (R). U. J. N. and H. L. are shareholders in Galecto Biotech AB, a company that develops galectin inhibitors (e.g. 33DFTG).	Aits S, 2015, AUTOPHAGY, V11, P1408, DOI 10.1080/15548627.2015.1063871; BERG TO, 1994, BIOCHEM J, V300, P229, DOI 10.1042/bj3000229; Bian CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025007; Bohne A, 1999, BIOINFORMATICS, V15, P767, DOI 10.1093/bioinformatics/15.9.767; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; BUTLER WT, 1963, J IMMUNOL, V90, P663; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Chauhan D, 2005, CANCER RES, V65, P8350, DOI 10.1158/0008-5472.CAN-05-0163; Clark MC, 2012, BLOOD, V120, P4635, DOI 10.1182/blood-2012-06-438234; Cumpstey I, 2005, ORG BIOMOL CHEM, V3, P1922, DOI 10.1039/b502354h; Dabelic S, 2012, IN VITRO CELL DEV-AN, V48, P518, DOI 10.1007/s11626-012-9540-x; Demotte N, 2010, CANCER RES, V70, P7476, DOI 10.1158/0008-5472.CAN-10-0761; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; Dings RPM, 2013, J PHARMACOL EXP THER, V344, P589, DOI 10.1124/jpet.112.199646; Dings RPM, 2012, J MED CHEM, V55, P5121, DOI 10.1021/jm300014q; Gao XG, 2013, J BIOL CHEM, V288, P33953, DOI 10.1074/jbc.M113.482315; Gao XG, 2012, GLYCOCONJUGATE J, V29, P159, DOI 10.1007/s10719-012-9382-5; Glinskii OV, 2005, NEOPLASIA, V7, P522, DOI 10.1593/neo.04646; Glinsky VV, 2009, CARBOHYD RES, V344, P1788, DOI 10.1016/j.carres.2008.08.038; Gunning AP, 2009, FASEB J, V23, P415, DOI 10.1096/fj.08-106617; Hayashi A, 2000, Altern Med Rev, V5, P546; HO MK, 1982, J IMMUNOL, V128, P1221; INOHARA H, 1994, GLYCOCONJUGATE J, V11, P527, DOI 10.1007/BF00731303; Jackson CL, 2007, GLYCOBIOLOGY, V17, P805, DOI 10.1093/glycob/cwm054; JADOT M, 1984, BIOCHEM J, V219, P965, DOI 10.1042/bj2190965; Jiang JH, 2013, INTEGR CANCER THER, V12, P145, DOI 10.1177/1534735412442369; John CM, 2003, CLIN CANCER RES, V9, P2374; Johnson KD, 2007, NEOPLASIA, V9, P662, DOI 10.1593/neo.07433; Kim BW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2606; Klyosov AA, 2003, PRECLINICA, V1, P175; Klyosov AA, 2006, ACS SYM SER, V932, P67; Kolatsi-Joannou M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018683; LAPIERRE Y, 1990, TRANSFUSION, V30, P109, DOI 10.1046/j.1537-2995.1990.30290162894.x; Leclere L, 2016, CARBOHYD POLYM, V137, P39, DOI 10.1016/j.carbpol.2015.10.055; Leclere L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115831; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Lepur A, 2012, J BIOL CHEM, V287, P21751, DOI 10.1074/jbc.C112.358002; Li L, 2015, CELL BIOL INT, V39, P531, DOI 10.1002/cbin.10424; Li S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003730; Ma ZC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148792; MacKinnon AC, 2013, GLYCOBIOLOGY, V23, P654, DOI 10.1093/glycob/cwt006; MacKinnon AC, 2012, AM J RESP CRIT CARE, V185, P537, DOI 10.1164/rccm.201106-0965OC; Mandal S, 2016, CAN J CHEM, V94, P936, DOI 10.1139/cjc-2015-0598; Martinez-Martinez E, 2016, INT J OBESITY, V40, P1034, DOI 10.1038/ijo.2016.19; Martinez-Martinez E, 2015, HYPERTENSION, V66, P961, DOI 10.1161/HYPERTENSIONAHA.115.06032; Maxwell EG, 2012, TRENDS FOOD SCI TECH, V24, P64, DOI 10.1016/j.tifs.2011.11.002; Miller MC, 2016, GLYCOBIOLOGY, V26, P88, DOI 10.1093/glycob/cwv073; Miller MC, 2012, GLYCOBIOLOGY, V22, P543, DOI 10.1093/glycob/cwr173; Miller MC, 2009, GLYCOBIOLOGY, V19, P1034, DOI 10.1093/glycob/cwp084; Miller MC, 2009, CARBOHYD RES, V344, P1205, DOI 10.1016/j.carres.2009.04.010; Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Nishi N, 2008, GLYCOBIOLOGY, V18, P1065, DOI 10.1093/glycob/cwn089; NOWAK TP, 1976, BIOCHEM BIOPH RES CO, V68, P650, DOI 10.1016/0006-291X(76)91195-5; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIENTA KJ, 1995, J NATL CANCER I, V87, P348, DOI 10.1093/jnci/87.5.348; PLATT D, 1992, J NATL CANCER I, V84, P438, DOI 10.1093/jnci/84.6.438; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Salomonsson E, 2011, J BIOL CHEM, V286, P13801, DOI 10.1074/jbc.C111.229096; Salomonsson E, 2010, BIOCHEMISTRY-US, V49, P9518, DOI 10.1021/bi1009584; Salomonsson E, 2010, J BIOL CHEM, V285, P35079, DOI 10.1074/jbc.M109.098160; Sathisha UV, 2007, GLYCOCONJUGATE J, V24, P497, DOI 10.1007/s10719-007-9042-3; SATO S, 1994, J BIOL CHEM, V269, P4424; Schneider D, 2010, EUR J CELL BIOL, V89, P788, DOI 10.1016/j.ejcb.2010.07.001; Sorme P, 2004, ANAL BIOCHEM, V334, P36, DOI 10.1016/j.ab.2004.06.042; SPRINGER TA, 1981, J BIOL CHEM, V256, P3833; Stowell SR, 2009, J BIOL CHEM, V284, P4989, DOI 10.1074/jbc.M808925200; Streetly MJ, 2010, BLOOD, V115, P3939, DOI 10.1182/blood-2009-10-251660; THIBAULT JF, 1993, CARBOHYD RES, V238, P271, DOI 10.1016/0008-6215(93)87019-O; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Vayssade M, 2010, PHYTOTHER RES, V24, P982, DOI 10.1002/ptr.3040; Yamamoto-Sugitani M, 2011, P NATL ACAD SCI USA, V108, P17468, DOI 10.1073/pnas.1111138108; Yan J, 2010, INTEGR CANCER THER, V9, P197, DOI 10.1177/1534735410369672	76	38	39	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13318	13334		10.1074/jbc.M116.721464	http://dx.doi.org/10.1074/jbc.M116.721464			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129206	Green Published, hybrid			2022-12-28	WOS:000379770500034
J	Jing, YP; Wang, D; Han, XL; Dong, DJ; Wang, JX; Zhao, XF				Jing, Yu-Pu; Wang, Di; Han, Xiao-Lin; Dong, Du-Juan; Wang, Jin-Xing; Zhao, Xiao-Fan			The Steroid Hormone 20-Hydroxyecdysone Enhances Gene Transcription through the cAMP Response Element-binding Protein (CREB) Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ECDYSONE RECEPTOR; COUPLED RECEPTOR; KINASE-A; DROSOPHILA-MELANOGASTER; PKA PHOSPHORYLATION; CATALYTIC SUBUNIT; NONGENOMIC ACTION; CELL-MEMBRANE; MANDUCA-SEXTA; BOMBYX-MORI	Animal steroid hormones regulate gene transcription through genomic pathways by binding to nuclear receptors. These steroid hormones also rapidly increase intracellular calcium and cyclic adenosine monophosphate (cAMP) levels and activate the protein kinase C (PKC) and protein kinase A (PKA) nongenomic pathways. However, the function and mechanism of the nongenomic pathways of the steroid hormones are unclear, and the relationship between the PKC and PKA pathways is also unclear. We propose that the steroid hormone 20-hydroxyecdysone (20E) activates the PKA pathway to enhance 20E-induced gene transcription in the lepidopteran insect Helicoverpa armigera. The expression of the catalytic subunit 1 of PKA (PKAC1) increased during metamorphosis, and PKAC1 knockdown blocked pupation and repressed 20E-responsive gene expression. 20E regulated PKAC1 phosphorylation at threonine 200 and nuclear translocation through an ecdysone-responsive G-protein-coupled receptor 2. PKAC1 induced cAMP response element-binding protein (CREB) phosphorylation at serine 143, which bound to the cAMP response element on DNA to enhance 20E-responsive gene transcription. Through ecdysone-responsive G-protein-coupled receptor 2, 20E increased cAMP levels, which induced CREB PKA phosphorylation and 20E-responsive gene expression. This study demonstrates that the PKA/CREB pathway tightly and critically regulates 20E-induced gene transcription as well as its relationship with the 20E-induced PKC pathway.	[Jing, Yu-Pu; Wang, Di; Han, Xiao-Lin; Dong, Du-Juan; Wang, Jin-Xing; Zhao, Xiao-Fan] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Peoples R China	Shandong University	Zhao, XF (corresponding author), Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Peoples R China.	xfzhao@sdu.edu.cn	Zhao, Xiao-Fan/AGW-9886-2022; Wang, Jin-Xing/AAU-1514-2021; Jing, Yu-Pu/AAE-3531-2022	Wang, Jin-Xing/0000-0003-0283-3930; Dong, Dujuan/0000-0003-3416-5017; Zhao, Xiao-Fan/0000-0003-1809-4730	National Natural Science Foundation of China [31230067]; National Basic Research Program of China 973 Program [2012CB114101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grant 31230067 and National Basic Research Program of China 973 Program Grant 2012CB114101. The authors declare that they have no conflicts of interest with the contents of this article.	ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUTTERWORTH JF, 1993, ANESTHESIOLOGY, V79, P88, DOI 10.1097/00000542-199307000-00014; Cai MJ, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-9; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Chen DS, 1999, MOL CELL BIOL, V19, P1002; Cheng XD, 1998, P NATL ACAD SCI USA, V95, P9849, DOI 10.1073/pnas.95.17.9849; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Chung WC, 2005, J PHARMACOL EXP THER, V313, P191, DOI 10.1124/jpet.104.078311; Clouse S, 2001, CURR BIOL, V11, pR904, DOI 10.1016/S0960-9822(01)00549-8; Cruz J, 2007, MECH DEVELOP, V124, P180, DOI 10.1016/j.mod.2006.12.003; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dittmer NT, 2003, MOL CELL ENDOCRINOL, V210, P39, DOI 10.1016/j.mce.2003.08.010; EcklyMichel AE, 1997, EUR J PHARMACOL, V324, P85, DOI 10.1016/S0014-2999(97)00149-0; Edwards HV, 2012, BIOCHEM J, V446, P437, DOI 10.1042/BJ20120570; Edwards HV, 2012, SEMIN CELL DEV BIOL, V23, P181, DOI 10.1016/j.semcdb.2011.09.005; Edwards HV, 2012, BIOCHEM SOC T, V40, P210, DOI 10.1042/BST20110673; Elmogy M, 2004, EUR J BIOCHEM, V271, P3171, DOI 10.1111/j.1432-1033.2004.04249.x; Elmogy M, 2006, ZOOL SCI, V23, P715, DOI 10.2108/zsj.23.715; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; GELLER RG, 1972, CIRC RES, V31, P857, DOI 10.1161/01.RES.31.6.857; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; HAROOTUNIAN AT, 1993, MOL BIOL CELL, V4, P993, DOI 10.1091/mbc.4.10.993; HORNER MA, 1995, DEV BIOL, V168, P490, DOI 10.1006/dbio.1995.1097; Iga M, 2007, MOL CELL ENDOCRINOL, V263, P18, DOI 10.1016/j.mce.2006.08.005; Impey S, 2001, Sci STKE, V2001, ppe1; Ishimoto H, 2009, P NATL ACAD SCI USA, V106, P6381, DOI 10.1073/pnas.0810213106; Jian D, 2011, STEROIDS, V76, P1297, DOI 10.1016/j.steroids.2011.06.008; Jing YP, 2015, J BIOL CHEM, V290, P8469, DOI 10.1074/jbc.M114.622696; Kim CH, 2015, DNA CELL BIOL, V34, P379, DOI 10.1089/dna.2015.2857; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Koga T, 2014, AUTOIMMUNITY, V47, P445, DOI 10.3109/08916934.2014.915954; Kraft R, 2006, J NEUROSCI, V26, P8734, DOI 10.1523/JNEUROSCI.2106-06.2006; Lam G, 1999, DEV BIOL, V212, P204, DOI 10.1006/dbio.1999.9343; Lan Q, 1999, MOL CELL BIOL, V19, P4897; Lan Q, 1997, INSECT MOL BIOL, V6, P3, DOI 10.1046/j.1365-2583.1997.00151.x; Liu W, 2014, J BIOL CHEM, V289, P13026, DOI 10.1074/jbc.M113.547018; Liu W, 2014, ENDOCRINOLOGY, V155, P1738, DOI 10.1210/en.2013-2020; Liu W, 2013, BBA-GEN SUBJECTS, V1830, P5184, DOI 10.1016/j.bbagen.2013.06.037; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mane-Padros D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045019; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; MOORADIAN AD, 1987, ENDOCR REV, V8, P1, DOI 10.1210/edrv-8-1-1; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Nahar J, 2015, ENDOCRINOLOGY, V156, P2831, DOI 10.1210/en.2015-1273; Norman AW, 2004, NAT REV DRUG DISCOV, V3, P27, DOI 10.1038/nrd1283; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Ren J, 2014, J STEROID BIOCHEM, V144, P313, DOI 10.1016/j.jsbmb.2014.08.006; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Sanden C, 2011, MOL PHARMACOL, V79, P400, DOI 10.1124/mol.110.069500; Shao HL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003127; SMALLRIDGE RC, 1992, ENDOCRINOLOGY, V131, P1883, DOI 10.1210/en.131.4.1883; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Thummel CS, 2002, GENE DEV, V16, P3113, DOI 10.1101/gad.1042102; Toi M, 2014, BREAST CANCER-TOKYO, V21, P20, DOI 10.1007/s12282-012-0344-3; Wang D, 2015, SCI REP-UK, V5, DOI 10.1038/srep08675; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zhang Li-li, 2015, Beijing Da Xue Xue Bao Yi Xue Ban, V47, P489; Zhao XF, 1998, INSECT BIOCHEM MOLEC, V28, P259, DOI 10.1016/S0965-1748(98)00015-0	74	23	24	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12771	12785		10.1074/jbc.M115.706028	http://dx.doi.org/10.1074/jbc.M115.706028			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129227	Green Published, hybrid			2022-12-28	WOS:000378119900029
J	Watanabe, Y; Papoutsoglou, P; Maturi, V; Tsubakihara, Y; Hottiger, MO; Heldin, CH; Moustakas, A				Watanabe, Yukihide; Papoutsoglou, Panagiotis; Maturi, Varun; Tsubakihara, Yutaro; Hottiger, Michael O.; Heldin, Carl-Henrik; Moustakas, Aristidis			Regulation of Bone Morphogenetic Protein Signaling by ADP-ribosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTORS; BREAST-CANCER; CELL-LINES; POLY(ADP-RIBOSE); PARP-1; TRANSCRIPTION; TRANSDUCTION; EXPRESSION; PROGRESS; PATHWAY	We previously established a mechanism of negative regulation of transforming growth factor beta signaling mediated by the nuclear ADP-ribosylating enzyme poly-(ADP-ribose) polymerase 1 (PARP1) and the deribosylating enzyme poly-(ADP-ribose) glycohydrolase (PARG), which dynamically regulate ADP-ribosylation of Smad3 and Smad4, two central signaling proteins of the pathway. Here we demonstrate that the bone morphogenetic protein (BMP) pathway can also be regulated by the opposing actions of PARP1 and PARG. PARG positively contributes to BMP signaling and forms physical complexes with Smad5 and Smad4. The positive role PARG plays during BMP signaling can be neutralized by PARP1, as demonstrated by experiments where PARG and PARP1 are simultaneously silenced. In contrast to PARG, ectopic expression of PARP1 suppresses BMP signaling, whereas silencing of endogenous PARP1 enhances signaling and BMP-induced differentiation. The two major Smad proteins of the BMP pathway, Smad1 and Smad5, interact with PARP1 and can be ADP-ribosylated in vitro, whereas PARG causes deribosylation. The overall outcome of this mode of regulation of BMP signal transduction provides a fine-tuning mechanism based on the two major enzymes that control cellular ADP-ribosylation.	[Watanabe, Yukihide; Papoutsoglou, Panagiotis; Maturi, Varun; Tsubakihara, Yutaro; Heldin, Carl-Henrik; Moustakas, Aristidis] Uppsala Univ, Sci Life Lab, Ludwig Canc Res, SE-75124 Uppsala, Sweden; [Hottiger, Michael O.] Univ Zurich, Dept Mol Mech Dis, CH-8057 Zurich, Switzerland; [Moustakas, Aristidis] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Watanabe, Yukihide] Univ Tsukuba, Fac Med, Dept Expt Pathol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan	Uppsala University; University of Zurich; Uppsala University; University of Tsukuba	Moustakas, A (corresponding author), Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Ludwig Canc Res,Biomed Ctr, Box 582, SE-75123 Uppsala, Sweden.	aris.moustakas@imbim.uu.se	Hottiger, Michael O./J-7747-2013; Maturi, Varun/K-1837-2019; Papoutsoglou, Panagiotis/AAF-8898-2019	Hottiger, Michael O./0000-0002-7323-2270; Maturi, Varun/0000-0003-1177-0839; Papoutsoglou, Panagiotis/0000-0003-2115-3500	Ludwig Cancer Research; Swedish Research Council [K2010-67X-14936-07-3, K2013-66X-14936-10-5]; Bodossaki Foundation, Greece	Ludwig Cancer Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Bodossaki Foundation, Greece	This work was supported by Ludwig Cancer Research grants (to A. M. and C.-H. H.), Swedish Research Council Grants K2010-67X-14936-07-3 and K2013-66X-14936-10-5 (to A. M.), and funds from the Bodossaki Foundation, Greece (to P. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Dahl M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103651; Gagne JP, 2006, CURR OPIN CELL BIOL, V18, P145, DOI 10.1016/j.ceb.2006.02.013; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hottiger MO, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001645; Huang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027123; Itoh S, 2011, GROWTH FACTORS, V29, P163, DOI 10.3109/08977194.2011.614236; Karaulanov E, 2004, EMBO J, V23, P844, DOI 10.1038/sj.emboj.7600101; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Ku MC, 2003, BIOCHEM BIOPH RES CO, V311, P702, DOI 10.1016/j.bbrc.2003.10.053; Liu L, 2014, MOL CANCER RES, V12, P1597, DOI 10.1158/1541-7786.MCR-14-0201; Lonn P, 2010, MOL CELL, V40, P521, DOI 10.1016/j.molcel.2010.10.029; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meyer-Ficca ML, 2004, EXP CELL RES, V297, P521, DOI 10.1016/j.yexcr.2004.03.050; Miwa M, 2007, CANCER SCI, V98, P1528, DOI 10.1111/j.1349-7006.2007.00567.x; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Moren A, 2003, J BIOL CHEM, V278, P33571, DOI 10.1074/jbc.M300159200; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Pu H, 2014, CARCINOGENESIS, V35, P2592, DOI 10.1093/carcin/bgu183; Rosenthal F, 2013, NAT STRUCT MOL BIOL, V20, P502, DOI 10.1038/nsmb.2521; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sterling JA, 2006, ANTICANCER RES, V26, P1893; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Zhang P, 2013, BLOOD, V122, P2224, DOI 10.1182/blood-2013-05-503250	34	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12706	12723		10.1074/jbc.M116.729699	http://dx.doi.org/10.1074/jbc.M116.729699			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129221	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000378119900024
J	Dey, A; Shree, S; Pandey, SK; Tripathi, RP; Ramachandran, R				Dey, Abhishek; Shree, Sonal; Pandey, Sarvesh Kumar; Tripathi, Rama Pati; Ramachandran, Ravishankar			Crystal Structure of Mycobacterium tuberculosis H37Rv AldR (Rv2779c), a Regulator of the ald Gene DNA BINDING AND IDENTIFICATION OF SMALL MOLECULE INHIBITORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENCODING ALANINE DEHYDROGENASE; MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; LRP/ASNC FAMILY; STRUCTURE VALIDATION; EFFECTOR-BINDING; PROTEIN; FL11; LRP; RECOGNITION	Here we report the crystal structure of M. tuberculosis AldR (Rv2779c) showing that the N-terminal DNA-binding domains are swapped, forming a dimer, and four dimers are assembled into an octamer through crystal symmetry. The C-terminal domain is involved in oligomeric interactions that stabilize the oligomer, and it contains the effector-binding sites. The latter sites are 30-60% larger compared with homologs like MtbFFRP (Rv3291c) and can consequently accommodate larger molecules. MtbAldR binds to the region upstream to the ald gene that is highly up-regulated in nutrient-starved tuberculosis models and codes for L-alanine dehydrogenase (MtbAld; Rv2780). Further, the MtbAldR-DNA complex is inhibited upon binding of Ala, Tyr, Trp and Asp to the protein. Studies involving a ligand-binding site G131T mutant show that the mutant forms a DNA complex that cannot be inhibited by adding the amino acids. Comparative studies suggest that binding of the amino acids changes the relative spatial disposition of the DNA-binding domains and thereby disrupt the protein-DNA complex. Finally, we identified small molecules, including a tetrahydroquinoline carbonitrile derivative (S010-0261), that inhibit the MtbAldR-DNA complex. The latter molecules represent the very first inhibitors of a feast/famine regulatory protein from any source and set the stage for exploring MtbAldR as a potential anti-tuberculosis target.	[Dey, Abhishek; Shree, Sonal; Ramachandran, Ravishankar] Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India; [Pandey, Sarvesh Kumar; Tripathi, Rama Pati] Cent Drug Res Inst, CSIR, Med & Proc Chem Div, Sitapur Rd, Lucknow 226031, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Ramachandran, R (corresponding author), Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.	r_ravishankar@cdri.res.in	Shree, Sonal/AAE-9442-2020; Dey, Abhishek/AAA-4517-2022	Shree, Sonal/0000-0002-5665-8157; Dey, Abhishek/0000-0002-3899-1124	Council of Scientific and Industrial Research (CSIR), India [BSC0104, BSC0121]; Indian Council of Medical Research; University Grants Commission; CSIR	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); University Grants Commission(University Grants Commission, India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by Council of Scientific and Industrial Research (CSIR), India, vide Grants BSC0104 (SPLenDID) and BSC0121 (GENESIS). This paper bears the CDRI communication number 9203. The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a fellowship from the Indian Council of Medical Research.r Recipient of a fellowship from the University Grants Commission.r Recipient of a fellowship from CSIR.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Beloin C, 2003, J BIOL CHEM, V278, P5333, DOI 10.1074/jbc.M207489200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CALVO JM, 1994, MICROBIOL REV, V58, P466, DOI 10.1128/MMBR.58.3.466-490.1994; de los Rios S, 2007, J MOL BIOL, V366, P1589, DOI 10.1016/j.jmb.2006.12.032; Deng WY, 2011, J CELL BIOCHEM, V112, P2655, DOI 10.1002/jcb.23193; Dey A, 2014, ACTA CRYSTALLOGR F, V70, P97, DOI 10.1107/S2053230X13033128; Ducati RG, 2007, CURR DRUG TARGETS, V8, P423, DOI 10.2174/138945007780059004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giffin MM, 2012, J BACTERIOL, V194, P1045, DOI 10.1128/JB.05914-11; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Hasan S, 2006, PLOS COMPUT BIOL, V2, P539, DOI 10.1371/journal.pcbi.0020061; Jeong JA, 2015, J BACTERIOL, V197, P3142, DOI 10.1128/JB.00453-15; Jeong JA, 2013, J BACTERIOL, V195, P3610, DOI 10.1128/JB.00482-13; Kumarevel T, 2008, NUCLEIC ACIDS RES, V36, P4808, DOI 10.1093/nar/gkn456; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NEWMAN EB, 1992, CELL, V68, P617, DOI 10.1016/0092-8674(92)90135-Y; Parish T, 2002, MICROBIOL-SGM, V148, P3069, DOI 10.1099/00221287-148-10-3069; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Schwaiger R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-40; Shrivastava T, 2007, NUCLEIC ACIDS RES, V35, P7324, DOI 10.1093/nar/gkm850; Shrivastava T, 2009, J MOL BIOL, V392, P1007, DOI 10.1016/j.jmb.2009.07.084; Singh P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026629; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Tani TH, 2002, P NATL ACAD SCI USA, V99, P13471, DOI 10.1073/pnas.212510999; Thaw P, 2006, NUCLEIC ACIDS RES, V34, P1439, DOI 10.1093/nar/gkl009; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tripathi SM, 2008, PROTEINS, V72, P1089, DOI 10.1002/prot.22101; Tripathi SM, 2006, J MOL BIOL, V362, P877, DOI 10.1016/j.jmb.2006.08.019; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamada M, 2009, PROTEINS, V74, P520, DOI 10.1002/prot.22269; Yokoyama K, 2006, FEMS MICROBIOL REV, V30, P89, DOI 10.1111/j.1574-6976.2005.00005.x; Yokoyama K, 2007, STRUCTURE, V15, P1542, DOI 10.1016/j.str.2007.10.015; Yokoyama K, 2009, NUCLEIC ACIDS RES, V37, P4407, DOI 10.1093/nar/gkp378	37	13	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					11967	11980		10.1074/jbc.M115.700484	http://dx.doi.org/10.1074/jbc.M115.700484			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27006398	Green Published, hybrid			2022-12-28	WOS:000378092800002
J	Katamune, C; Koyanagi, S; Shiromizu, S; Matsunaga, N; Shimba, S; Shibata, S; Ohdo, S				Katamune, Chiharu; Koyanagi, Satoru; Shiromizu, Shoya; Matsunaga, Naoya; Shimba, Shigeki; Shibata, Shigenobu; Ohdo, Shigehiro			Different Roles of Negative and Positive Components of the Circadian Clock in Oncogene-induced Neoplastic Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-T-ANTIGEN; TUMOR SUPPRESSION; TRANSCRIPTION; MOUSE; SENESCENCE; EXPRESSION; INK4A/ARF; LIGHT; ATF4	In mammals, circadian rhythms in physiological function are generated by a molecular oscillator driven by transcriptional-translational feedback loop consisting of negative and positive regulators. Disruption of this circadian clock machinery is thought to increase the risk of cancer development, but the potential contributions of each component of circadian clock to oncogenesis have been little explored. Here we reported that negative and positive transcriptional regulators of circadian feedback loop had different roles in oncogene-induced neoplastic transformation. Mouse embryonic fibroblasts prepared from animals deficient in negative circadian clock regulators, Period2 (Per2) or Cryptochrome1/2 (Cry1/2), were prone to transformation induced by co-expression of H-ras(V12) and SV40 large T antigen (SV40LT). In contrast, mouse embryonic fibroblasts prepared from mice deficient in positive circadian clock regulators, Bmal1 or Clock, showed resistance to oncogene-induced transformation. In Per2 mutant and Cry1/2-null cells, the introduction of oncogenes induced expression of ATF4, a potent repressor of cell senescence-associated proteins p16INK4a and p19ARF. Elevated levels of ATF4 were sufficient to suppress expression of these proteins and drive oncogenic transformation. Conversely, in Bmal1-null and Clock mutant cells, the expression of ATF4 was not induced by oncogene introduction, which allowed constitutive expression of p16INK4a and p19ARF triggering cellular senescence. Although genetic ablation of either negative or positive transcriptional regulators of the circadian clock leads to disrupted rhythms in physiological functions, our findings define their different contributions to neoplastic cellular transformation.	[Katamune, Chiharu; Shiromizu, Shoya; Matsunaga, Naoya; Ohdo, Shigehiro] Kyushu Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Fukuoka 8128582, Japan; [Koyanagi, Satoru] Kyushu Univ, Fac Pharmaceut Sci, Dept Glocal Healthcare Sci, Fukuoka 8128582, Japan; [Shimba, Shigeki] Nihon Univ, Sch Pharm, Dept Hlth Sci, Funabashi, Chiba 2748555, Japan; [Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Tokyo 1620056, Japan	Kyushu University; Kyushu University; Nihon University; Waseda University	Ohdo, S (corresponding author), Kyushu Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ohdo@phar.kyushu-u.ac.jp	Koyanagi, Satoru/AAE-6843-2020	Koyanagi, Satoru/0000-0003-4849-2377; matsunaga2, naoya2/0000-0001-6226-8473	Japan Society for the Promotion of Science (JSPS) KAKENHI [FCG6670317, 25253038]; Mandom International Research Grants on Alternative to Animal Experiments; Grants-in-Aid for Scientific Research [26670317] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mandom International Research Grants on Alternative to Animal Experiments; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part of Japan Society for the Promotion of Science (JSPS) KAKENHI Grants FCG6670317 (to S. K.) and 25253038 (to S. O.) and the Mandom International Research Grants on Alternative to Animal Experiments. The authors declare that they have no conflicts of interest with the contents of this article.	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Dibner C, 2015, J INTERN MED, V277, P513, DOI 10.1111/joim.12347; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Filipski E, 2005, JNCI-J NATL CANCER I, V97, P507, DOI 10.1093/jnci/dji083; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Grechez-Cassiau A, 2008, J BIOL CHEM, V283, P4535, DOI 10.1074/jbc.M705576200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horiguchi M, 2012, CANCER RES, V72, P395, DOI 10.1158/0008-5472.CAN-11-1891; Jozefczuk J, 2012, JOVE-J VIS EXP, DOI 10.3791/3854; Kakumoto K, 2006, P NATL ACAD SCI USA, V103, P5490, DOI 10.1073/pnas.0601222103; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kloog I, 2009, CHRONOBIOL INT, V26, P108, DOI 10.1080/07420520802694020; Koyanagi S, 2011, J BIOL CHEM, V286, P32416, DOI 10.1074/jbc.M111.258970; Lahti TA, 2008, INT J CANCER, V123, P2148, DOI 10.1002/ijc.23566; Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010995; Masri S, 2015, CURR OPIN ONCOL, V27, P50, DOI 10.1097/CCO.0000000000000153; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; ZALVIDE J, 1995, MOL CELL BIOL, V15, P5800; ZHU JY, 1991, J VIROL, V65, P6872, DOI 10.1128/JVI.65.12.6872-6880.1991	32	12	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10541	10550		10.1074/jbc.M115.706481	http://dx.doi.org/10.1074/jbc.M115.706481			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26961881	Green Published, hybrid			2022-12-28	WOS:000377042600009
J	Wolf, J; Waetzig, GH; Chalaris, A; Reinheimer, TM; Wege, HN; Rose-John, S; Garbers, C				Wolf, Janina; Waetzig, Georg H.; Chalaris, Athena; Reinheimer, Torsten M.; Wege, Henning; Rose-John, Stefan; Garbers, Christoph			Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO-INFLAMMATORY ACTIVITIES; LEUKEMIA INHIBITORY FACTOR; CORONARY-HEART-DISEASE; IL-6 RECEPTOR; EXPRESSION; RESPONSES; COMPLEX; ADAM17; CELLS; MEMBRANE	Soluble forms of the IL-6 receptor (sIL-6R) bind to the cytokine IL-6 with similar affinity as the membrane-bound IL-6R. IL-6.sIL-6R complexes initiate IL-6 trans-signaling via activation of the ubiquitously expressed membrane-bound beta-receptor glycoprotein 130 (gp130). Inhibition of IL-6 trans-signaling has been shown to be favorable in numerous inflammatory diseases. Furthermore, different soluble forms of gp130 (sgp130) exist that, together with the sIL-6R, are thought to form a buffer for IL-6 in the blood. However, a functional role for the different sgp130 forms has not been described to date. Here we demonstrate that the metalloproteases ADAM10 and ADAM17 can produce sgp130 by ectodomain shedding of gp130, even though this mechanism only accounts for a minor proportion of sgp130 in the circulation. We further show that full-length sgp130 and the shorter forms sgp130-rheumatoid arthritis-associated peptide (RAPS) and sgp130-E10 are differentially expressed in a cell type-specific manner. Remarkably, full-length sgp130 is expressed by monocytes, but this expression is completely lost during differentiation into macrophages in vitro. Using genetically engineered murine pre-B cells that secrete different forms of sgp130, we found that these secreted sgp130 proteins are able to prevent trans-signaling-driven cell proliferation of the secreting cells, whereas conditioned supernatant from these cells failed to block IL-6 trans-signaling in other cells. Thus, our data suggest that the different sgp130 forms are released from cells into their immediate surroundings and appear to form cell-associated gradients to modulate their own susceptibility for IL-6 trans-signaling.	[Wolf, Janina; Chalaris, Athena; Rose-John, Stefan; Garbers, Christoph] Univ Kiel, Inst Biochem, Rudolf Hoeber Str 1, D-24098 Kiel, Germany; [Waetzig, Georg H.] CONARIS Res Inst AG, D-24118 Kiel, Germany; [Reinheimer, Torsten M.] Ferring Pharmaceut AS, Nonclin Dev, DK-2300 Copenhagen, Denmark; [Wege, Henning] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med, D-20246 Hamburg, Germany	University of Kiel; Ferring Pharmaceuticals; University of Hamburg; University Medical Center Hamburg-Eppendorf	Garbers, C (corresponding author), Univ Kiel, Inst Biochem, Rudolf Hoeber Str 1, D-24098 Kiel, Germany.	cgarbers@biochem.uni-kiel.de	Rose-John, Stefan/A-7998-2010; Garbers, Christoph/D-9932-2015; Waetzig, Georg/AAV-7486-2021	Rose-John, Stefan/0000-0002-7519-3279; Garbers, Christoph/0000-0003-4939-6950; 	Deutsche Forschungsgemeinschaft (DFG) [SFB877]; Federal Ministry of Education and Research (BMBF, E:Bio-Modul II InTraSig project B); Cluster of Excellence "Inflammation at Interfaces"; Ferring Pharmaceuticals A/S (Copenhagen, Denmark)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF, E:Bio-Modul II InTraSig project B)(Federal Ministry of Education & Research (BMBF)); Cluster of Excellence "Inflammation at Interfaces"; Ferring Pharmaceuticals A/S (Copenhagen, Denmark)	This work was funded by grants from the Deutsche Forschungsgemeinschaft (DFG) (SFB877 projects A1 (to A. C. and S. R. J.) and A10 (to C. G.)), from the Federal Ministry of Education and Research (BMBF, E:Bio-Modul II InTraSig project B) and by the Cluster of Excellence "Inflammation at Interfaces." G. H. W. is employed by CONARIS Research Institute AG (a company commercially developing sgp130Fc proteins), S. R. J. is a shareholder of CONARIS, and both are inventors of patents owned by CONARIS. T. M. R. is employed at Ferring Pharmaceuticals A/S.r Supported by a grant from Ferring Pharmaceuticals A/S (Copenhagen, Denmark).	Baran P, 2013, J BIOL CHEM, V288, P14756, DOI 10.1074/jbc.M113.466169; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Diamant M, 1997, FEBS LETT, V412, P379, DOI 10.1016/S0014-5793(97)00750-3; Dietrich C, 2014, J IMMUNOL, V192, P5382, DOI 10.4049/jimmunol.1303435; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Garbers C, 2015, CURR OPIN IMMUNOL, V34, P75, DOI 10.1016/j.coi.2015.02.008; Garbers C, 2014, BBA-MOL BASIS DIS, V1842, P1485, DOI 10.1016/j.bbadis.2014.05.018; Garbers C, 2013, BIOL CHEM, V394, P1145, DOI 10.1515/hsz-2013-0166; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; GEARING DP, 1994, P NATL ACAD SCI USA, V91, P1119, DOI 10.1073/pnas.91.3.1119; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Jones SA, 1998, EUR J IMMUNOL, V28, P3514, DOI 10.1002/(SICI)1521-4141(199811)28:11<3514::AID-IMMU3514>3.3.CO;2-K; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; MACKIEWICZ A, 1992, J IMMUNOL, V149, P2021; MULLBERG J, 1994, J IMMUNOL, V152, P4958; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; MULLBERG J, 1993, FEBS LETT, V332, P174, DOI 10.1016/0014-5793(93)80507-Q; NARAZAKI M, 1993, BLOOD, V82, P1120, DOI 10.1182/blood.V82.4.1120.bloodjournal8241120; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Scheller J, 2014, SEMIN IMMUNOL, V26, P2, DOI 10.1016/j.smim.2013.11.002; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; SHARKEY AM, 1995, BIOL REPROD, V53, P974, DOI 10.1095/biolreprod53.4.974; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sommer J, 2014, J BIOL CHEM, V289, P22140, DOI 10.1074/jbc.M114.560938; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Tanaka M, 2000, J CLIN INVEST, V106, P137, DOI 10.1172/JCI7479; Tenhumberg S, 2006, BIOCHEM BIOPH RES CO, V346, P649, DOI 10.1016/j.bbrc.2006.05.173; Waetzig GH, 2012, EXPERT OPIN THER TAR, V16, P225, DOI 10.1517/14728222.2012.660307; Wauman J, 2011, J CELL SCI, V124, P921, DOI 10.1242/jcs.078055; Wege H, 2003, GASTROENTEROLOGY, V124, P432, DOI 10.1053/gast.2003.50064; Wolf J, 2016, BIOCHEM BIOPH RES CO, V470, P870, DOI 10.1016/j.bbrc.2016.01.127; Wolf J, 2014, CYTOKINE, V70, P11, DOI 10.1016/j.cyto.2014.05.024; Zhang JG, 1998, J BIOL CHEM, V273, P10798, DOI 10.1074/jbc.273.17.10798	41	60	60	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16186	16196		10.1074/jbc.M116.718551	http://dx.doi.org/10.1074/jbc.M116.718551			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226573	Green Published, hybrid			2022-12-28	WOS:000380585400023
J	Chen, S; Lee, B; Lee, AYF; Modzelewski, AJ; He, L				Chen, Sean; Lee, Benjamin; Lee, Angus Yiu-Fai; Modzelewski, Andrew J.; He, Lin			Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene knockout; genetics; mouse; ribonuclear protein (RNP); tyrosinase; CRISPR; Cas9; Genome Editing; Electroporation; RNP	ZINC-FINGER NUCLEASES; EMBRYONIC STEM-CELLS; HOMOLOGOUS RECOMBINATION; GENE KNOCKOUT; SGRNA DESIGN; MICE; RNA; DNA; CAS9; GENERATION	The CRISPR/Cas9 system has been employed to efficiently edit the genomes of diverse model organisms. CRISPR-mediated mouse genome editing is typically accomplished by microinjection of Cas9 DNA/RNA and single guide RNA (sgRNA) into zygotes to generate modified animals in one step. However, microinjection is a technically demanding, labor-intensive, and costly procedure with poor embryo viability. Here, we describe a simple and economic electroporation-based strategy to deliver Cas9/sgRNA ribonucleoproteins into mouse zygotes with 100% efficiency for in vivo genome editing. Our methodology, designated as CRISPR RNP Electroporation of Zygotes (CRISPR-EZ), enables highly efficient and high-throughput genome editing in vivo, with a significant improvement in embryo viability compared with microinjection. Using CRISPR-EZ, we generated a variety of editing schemes in mouse embryos, including indel (insertion/deletion) mutations, point mutations, large deletions, and small insertions. In a proof-of-principle experiment, we used CRISPR-EZ to target the tyrosinase (Tyr) gene, achieving 88% bi-allelic editing and 42% homology-directed repair-mediated precise sequence modification in live mice. Taken together, CRISPR-EZ is simple, economic, high throughput, and highly efficient with the potential to replace microinjection for in vivo genome editing in mice and possibly in other mammals.	[Chen, Sean; Lee, Benjamin; Lee, Angus Yiu-Fai; Modzelewski, Andrew J.; He, Lin] Univ Calif Berkeley, MCB Dept, Div Cellular & Dev Biol, Berkeley, CA 94705 USA	University of California System; University of California Berkeley	He, L (corresponding author), Univ Calif Berkeley, MCB Dept, Div Cellular & Dev Biol, Berkeley, CA 94705 USA.	lhe@berkeley.edu	Modzelewski, Andrew J/GXG-0370-2022	Lee, Benjamin/0000-0003-2532-1882	National Institutes of Health from NCI [R01 CA139067]; NIGMS [RO1 1R01GM114414]; California Institute for Regenerative Medicine; National Institutes of Health [1F32CA192636]; NATIONAL CANCER INSTITUTE [F32CA192636, R01CA139067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114414] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 CA139067 from NCI and Grant RO1 1R01GM114414 from NIGMS (to L. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a California Institute for Regenerative Medicine predoctoral fellowship.; Supported by National Institutes of Health Postdoctoral Fellowship 1F32CA192636. To whom correspondence may be addressed. E-mail: modzelewski.andrew@berkeley.edu.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Basrur V, 2003, J PROTEOME RES, V2, P69, DOI 10.1021/pr025562r; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Hashimoto M., 2015, SCI REPORTS, V5, P5, DOI DOI 10.1038/SREP11315; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Mizuno S, 2014, MAMM GENOME, V25, P327, DOI 10.1007/s00335-014-9524-0; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Paterson EK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143702; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Qin WN, 2015, GENETICS, V200, P423, DOI 10.1534/genetics.115.176594; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Takahashi G, 2015, SCI REP-UK, V5, DOI 10.1038/srep11406; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wang BM, 2015, BIOTECHNIQUES, V59, P201, DOI 10.2144/000114339; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang WB, 2016, J GENET GENOMICS, V43, P319, DOI 10.1016/j.jgg.2016.02.004; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhu W, 2016, VIRUS RES, V217, P125, DOI 10.1016/j.virusres.2016.04.003; ZIJLSTRA M, 1989, NATURE, V342, P435, DOI 10.1038/342435a0	49	163	168	2	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14457	14467		10.1074/jbc.M116.733154	http://dx.doi.org/10.1074/jbc.M116.733154			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27151215	Green Published, hybrid			2022-12-28	WOS:000380366700005
J	Kundu, P; Biswas, R; Mukherjee, S; Reinhard, L; Dutta, A; Mueller-Dieckmann, J; Weiss, MS; Pal, NK; Das, AK				Kundu, Prasun; Biswas, Rupam; Mukherjee, Somnath; Reinhard, Linda; Dutta, Anirudha; Mueller-Dieckmann, Jochen; Weiss, Manfred S.; Pal, Nishit Kumar; Das, Amit Kumar			Structure-based Epitope Mapping of Mycobacterium tuberculosis Secretary Antigen MTC28	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antigen; crystal structure; epitope mapping; high-performance liquid chromatography (HPLC); Mycobacterium tuberculosis	PHOTOSYSTEM-II; BORRELIA-BURGDORFERI; PSBP PROTEIN; ARABIDOPSIS-THALIANA; ANTIBODY-RESPONSES; CRYSTAL-STRUCTURE; HIGH-THROUGHPUT; LYME-DISEASE; PROLINE; DETERMINANTS	Secretary proteins of Mycobacterium tuberculosis are key players of the mycobacterial infection pathway. MTC28 is a 28-kDa proline-rich secretary antigen of Mycobacterium tuberculosis and is only conserved in pathogenic strains of mycobacteria. Here we report the crystal structure of MTC28 at 2.8- and 2.15-angstrom resolutions for the structure-based epitope design. MTC28 shares a mog1p-fold consisting of seven antiparallel strands stacked between helices. Five probable epitopes have been located on a solvent-accessible flexible region by computational analysis of the structure of MTC28. Simultaneously, the protein is digested with trypsin and the resulting fragments are purified by HPLC. Such 10 purified peptide fragments are screened against sera from patients infected with pulmonary tuberculosis (PTB). Two of these 10 fragments, namely (127)ALDITLPMPPR(137) and (138)WTQVPDPNVPDAFVVIADR(156),are found to be major immunogenic epitopes that are localized on the outer surface of the protein molecule and are part of a single continuous epitope that have been predicted in silico. Mutagenesis and antibody inhibition studies are in accordance with the results obtained from epitope mapping.	[Kundu, Prasun; Biswas, Rupam; Mukherjee, Somnath; Dutta, Anirudha; Das, Amit Kumar] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India; [Reinhard, Linda] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Reinhard, Linda] DESY, Ctr Struct Syst Biol, Rontgen Angstrom Cluster, Karolinska Inst Outstn, D-22607 Hamburg, Germany; [Reinhard, Linda] European Mol Biol Lab, Hamburg Unit, D-22603 Hamburg, Germany; [Mueller-Dieckmann, Jochen] Univ Hamburg, Abt Mikrobiol & Biotechnol, Biozentrum Klein Flottbek, Ohnhorststr 18, D-22609 Hamburg, Germany; [Weiss, Manfred S.] Helmholtz Zentrum Berlin Mat & Energie, Macromol Crystallog HZB MX, D-12489 Berlin, Germany; [Pal, Nishit Kumar] Nil Ratan Sirkar Med Coll & Hosp, 138 AJC Bose Rd, Kolkata 700014, W Bengal, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; Karolinska Institutet; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); European Molecular Biology Laboratory (EMBL); University of Hamburg; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Das, AK (corresponding author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.	amitk@hijli.iitkgp.ernet.in		Biswas, Rupam/0000-0001-7732-0115; Weiss, Manfred S/0000-0002-2362-7047	DBT, Government of India	DBT, Government of India(Department of Biotechnology (DBT) India)	We acknowledge Debabrata Dutta for his kind assistance in data processing and Dr. Shiv Sekhar Chatterjee for the collection of human blood samples in NRS, Kolkata. The genomic DNA of H37Rv was a kind gift from Professor Harald G. Wiker, University of Bergen, Norway. The x-ray facility was funded by DBT, Government of India. Diffraction data were collected using the in-house facility at CRF and the ESRF synchrotron (Grenoble, France).	ADZHUBEI AA, 1993, J MOL BIOL, V229, P472, DOI 10.1006/jmbi.1993.1047; Arnaboldi PM, 2013, CLIN VACCINE IMMUNOL, V20, P474, DOI 10.1128/CVI.00608-12; Bachler BC, 2013, J VIROL, V87, P4403, DOI 10.1128/JVI.02888-12; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao P, 2015, MOL PLANT, V8, P664, DOI 10.1016/j.molp.2015.01.002; Chen JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034627; Coleman AS, 2011, CLIN VACCINE IMMUNOL, V18, P406, DOI 10.1128/CVI.00461-10; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; de Sanctis D, 2012, J SYNCHROTRON RADIAT, V19, P455, DOI 10.1107/S0909049512009715; Dormitzer PR, 2012, NAT REV MICROBIOL, V10, P807, DOI 10.1038/nrmicro2893; Dormitzer PR, 2008, TRENDS BIOTECHNOL, V26, P659, DOI 10.1016/j.tibtech.2008.08.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Firbas C, 2010, VACCINE, V28, P2397, DOI 10.1016/j.vaccine.2009.12.072; GHANOTAKIS DF, 1984, FEBS LETT, V170, P169, DOI 10.1016/0014-5793(84)81393-9; Gourlay LJ, 2013, CHEM BIOL, V20, P1147, DOI 10.1016/j.chembiol.2013.07.010; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kohler SD, 2010, PROTEIN SCI, V19, P625, DOI 10.1002/pro.345; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lassaux P, 2013, STRUCTURE, V21, P167, DOI 10.1016/j.str.2012.10.005; LAUNOIS P, 1994, INFECT IMMUN, V62, P3679, DOI 10.1128/IAI.62.9.3679-3687.1994; Lawrenz MB, 1999, J CLIN MICROBIOL, V37, P3997, DOI 10.1128/JCM.37.12.3997-4004.1999; Li WD, 2014, VACCINES-BASEL, V2, P515, DOI 10.3390/vaccines2030515; Liang FT, 1999, J IMMUNOL, V163, P5566; Lyashchenko K, 1998, INFECT IMMUN, V66, P3606, DOI 10.1128/IAI.66.8.3606-3610.1998; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Manca C, 1997, INFECT IMMUN, V65, P4951, DOI 10.1128/IAI.65.12.4951-4957.1997; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michoux F, 2010, BIOCHEMISTRY-US, V49, P7411, DOI 10.1021/bi1011145; Mueller-Dieckmann J, 2006, ACTA CRYSTALLOGR D, V62, P1446, DOI 10.1107/S0907444906038121; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGAI S, 1991, INFECT IMMUN, V59, P372, DOI 10.1128/IAI.59.1.372-382.1991; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; Oki M, 1998, P NATL ACAD SCI USA, V95, P15388, DOI 10.1073/pnas.95.26.15388; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Reinhard L, 2013, ACTA CRYSTALLOGR F, V69, P209, DOI 10.1107/S1744309112051858; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shui GH, 2012, EMBO MOL MED, V4, P27, DOI 10.1002/emmm.201100185; Signorino G, 2014, CLIN VACCINE IMMUNOL, V21, P704, DOI 10.1128/CVI.00792-13; Skjot RLV, 2002, INFECT IMMUN, V70, P5446, DOI 10.1128/IAI.70.10.5446-5453.2002; Skwarczynski M, 2016, CHEM SCI, V7, P842, DOI 10.1039/c5sc03892h; Stewart M, 2000, J MOL BIOL, V299, P213, DOI 10.1006/jmbi.2000.3733; Toes REM, 1996, J IMMUNOL, V156, P3911; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Wu XQ, 2010, CLIN CHIM ACTA, V411, P1520, DOI 10.1016/j.cca.2010.06.014; Wu XQ, 2010, CLIN VACCINE IMMUNOL, V17, P372, DOI [10.1128/CVI.00287-09, 10.3785/j.issn.1006-754X.2010.05.011]; Yi XP, 2007, J BIOL CHEM, V282, P24833, DOI 10.1074/jbc.M705011200; Yi XP, 2009, FEBS LETT, V583, P2142, DOI 10.1016/j.febslet.2009.05.048; Young D, 1991, Bull Int Union Tuberc Lung Dis, V66, P47	63	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					13943	13954		10.1074/jbc.M116.726422	http://dx.doi.org/10.1074/jbc.M116.726422			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27189947	hybrid, Green Published			2022-12-28	WOS:000379975100004
J	Shi, SJ; Luke, CJ; Miedel, MT; Silverman, GA; Kleyman, TR				Shi, Shujie; Luke, Cliff J.; Miedel, Mark T.; Silverman, Gary A.; Kleyman, Thomas R.			Activation of the Caenorhabditis elegans Degenerin Channel by Shear Stress Requires the MEC-10 Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acid-sensing ion channel (ASIC); Caenorhabditis elegans (C; elegans); electrophysiology; epithelial sodium channel (ENaC); mechanotransduction; shear stress	EPITHELIAL SODIUM-CHANNEL; TOUCH RECEPTOR NEURONS; NA+ CHANNEL; ION-CHANNEL; ALPHA-SUBUNIT; C-ELEGANS; DEG/ENAC CHANNEL; PROTEIN; MECHANOTRANSDUCTION; DOMAIN	Mechanotransduction in Caenorhabditis elegans touch receptor neurons is mediated by an ion channel formed by MEC-4, MEC-10, and accessory proteins. To define the role of these subunits in the channel's response to mechanical force, we expressed degenerin channels comprising MEC-4 and MEC-10 in Xenopus oocytes and examined their response to laminar shear stress (LSS). Shear stress evoked a rapid increase in whole cell currents in oocytes expressing degenerin channels as well as channels with a MEC-4 degenerin mutation (MEC-4d), suggesting that C. elegans degenerin channels are sensitive to LSS. MEC-10 is required for a robust LSS response as the response was largely blunted in oocytes expressing homomeric MEC-4 or MEC-4d channels. We examined a series of MEC-10/MEC-4 chimeras to identify specific domains (amino terminus, first transmembrane domain, and extracellular domain) and sites (residues 130-132 and 134-137) within MEC-10 that are required for a robust response to shear stress. In addition, the LSS response was largely abolished by MEC-10 mutations encoded by a touch-insensitive mec-10 allele, providing a correlation between the channel's responses to two different mechanical forces. Our findings suggest that MEC-10 has an important role in the channel's response to mechanical forces.	[Shi, Shujie; Kleyman, Thomas R.] Univ Pittsburgh, Dept Med, 930 Scaife Hall, Pittsburgh, PA 15261 USA; [Luke, Cliff J.; Miedel, Mark T.; Silverman, Gary A.] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15261 USA; [Silverman, Gary A.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Silverman, Gary A.] Washington Univ, Dept Pediat, St Louis, MO 63110 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL)	Kleyman, TR (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Sch Med, A919 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu	Silverman, Gary/AAJ-1269-2020	Miedel, Mark/0000-0002-0132-6032	National Institutes of Health [DK103834, DK051391, DK096990, DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051391, R37DK051391, P01DK096990, P30DK079307, K01DK103834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK103834 (to S. S.), DK051391 (to T. R. K.), DK096990 (to G. A. S.), and DK079307 (to T. R. K.). The authors declare no conflict interests. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abi-Antoun T, 2011, AM J PHYSIOL-RENAL, V300, pF1089, DOI 10.1152/ajprenal.00610.2010; Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Althaus M, 2007, FASEB J, V21, P2389, DOI 10.1096/fj.06-7694com; Arnadottir J, 2011, J NEUROSCI, V31, P12695, DOI 10.1523/JNEUROSCI.4580-10.2011; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Bianchi L, 2004, NAT NEUROSCI, V7, P1337, DOI 10.1038/nn1347; Brown AL, 2008, J GEN PHYSIOL, V131, P605, DOI 10.1085/jgp.200709910; Brown AL, 2007, J GEN PHYSIOL, V129, P161, DOI 10.1085/jgp.200609672; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Carattino MD, 2007, AM J PHYSIOL-RENAL, V293, pF316, DOI 10.1152/ajprenal.00455.2006; Carattino MD, 2005, J BIOL CHEM, V280, P4393, DOI 10.1074/jbc.M413123200; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Chalfie Martin, 2014, WormBook, DOI 10.1895/wormbook.1.172.1; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Chatzigeorgiou M, 2010, J NEUROPHYSIOL, V104, P3334, DOI 10.1152/jn.00330.2010; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Chen YS, 2016, MOL BIOL CELL, V27, P1272, DOI 10.1091/mbc.E15-08-0561; Chen YS, 2015, P NATL ACAD SCI USA, V112, P11690, DOI 10.1073/pnas.1515968112; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Eastwood AL, 2015, P NATL ACAD SCI USA, V112, pE6955, DOI 10.1073/pnas.1514138112; Eastwood AL, 2012, PHYSIOLOGY, V27, P282, DOI 10.1152/physiol.00006.2012; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Gu GQ, 1996, P NATL ACAD SCI USA, V93, P6577, DOI 10.1073/pnas.93.13.6577; Guo DQ, 2016, J CELL SCI, V129, P290, DOI 10.1242/jcs.168831; Hoger JH, 2002, P NATL ACAD SCI USA, V99, P7780, DOI 10.1073/pnas.102184999; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2005, J BIOL CHEM, V280, P26206, DOI 10.1074/jbc.M503500200; Kashlan OB, 2012, EXP CELL RES, V318, P1011, DOI 10.1016/j.yexcr.2012.02.024; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; Lapatsina L, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120096; Levy E, 2007, AM J PHYSIOL-GASTR L, V293, pG1252, DOI 10.1152/ajpgi.00369.2007; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; MITANI S, 1993, DEVELOPMENT, V119, P773; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Price MP, 2004, J BIOL CHEM, V279, P53886, DOI 10.1074/jbc.M407708200; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Shi Shujie, 2013, Curr Mol Pharmacol, V6, P28; Shi SJ, 2012, J BIOL CHEM, V287, P15439, DOI 10.1074/jbc.M112.346551; Shi SJ, 2011, J BIOL CHEM, V286, P14753, DOI 10.1074/jbc.M110.191734; Syntichaki P, 2004, PHYSIOL REV, V84, P1097, DOI 10.1152/physrev.00043.2003; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	53	9	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14012	14022		10.1074/jbc.M116.718031	http://dx.doi.org/10.1074/jbc.M116.718031			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27189943	hybrid, Green Published			2022-12-28	WOS:000379975100010
J	Vemu, A; Atherton, J; Spector, JO; Szyk, A; Moores, CA; Roll-Mecak, A				Vemu, Annapurna; Atherton, Joseph; Spector, Jeffrey O.; Szyk, Agnieszka; Moores, Carolyn A.; Roll-Mecak, Antonina			Structure and Dynamics of Single-isoform Recombinant Neuronal Human Tubulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE PLUS-END; ALPHA-BETA-TUBULIN; IN-VITRO; ELECTRON CRYOMICROSCOPY; GTP HYDROLYSIS; RESOLUTION; INSTABILITY; MICROSCOPY; RECONSTRUCTIONS; ISOTYPES	Microtubules are polymers that cycle stochastically between polymerization and depolymerization, i.e. they exhibit "dynamic instability." This behavior is crucial for cell division, motility, and differentiation. Although studies in the last decade have made fundamental breakthroughs in our understanding of how cellular effectors modulate microtubule dynamics, analysis of the relationship between tubulin sequence, structure, and dynamics has been held back by a lack of dynamics measurements with and structural characterization of homogeneous isotypically pure engineered tubulin. Here, we report for the first time the cryo-EM structure and in vitro dynamics parameters of recombinant isotypically pure human tubulin. alpha 1A/beta III is a purely neuronal tubulin isoform. The 4.2-angstrom structure of post-translationally unmodified human alpha 1A/beta III microtubules shows overall similarity to that of heterogeneous brain microtubules, but it is distinguished by subtle differences at polymerization interfaces, which are hot spots for sequence divergence between tubulin isoforms. In vitro dynamics assays show that, like mosaic brain microtubules, recombinant homogeneous microtubules undergo dynamic instability, but they polymerize slower and have fewer catastrophes. Interestingly, we find that epitaxial growth of alpha 1A/beta III microtubules from heterogeneous brain seeds is inefficient but can be fully rescued by incorporating as little as 5% of brain tubulin into the homogeneous alpha 1A/beta III lattice. Our study establishes a system to examine the structure and dynamics of mammalian microtubules with well defined tubulin species and is a first and necessary step toward uncovering how tubulin genetic and chemical diversity is exploited to modulate intrinsic microtubule dynamics.	[Vemu, Annapurna; Spector, Jeffrey O.; Szyk, Agnieszka; Roll-Mecak, Antonina] NINDS, Cell Biol & Biophys Unit, Bethesda, MD 20892 USA; [Roll-Mecak, Antonina] NHLBI, Ctr Biophys, NIH, Bethesda, MD 20892 USA; [Atherton, Joseph; Moores, Carolyn A.] Univ London, Inst Struct & Mol Biol, Dept Biol Sci, Birkbeck Coll, London WC1E, England	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of London	Moores, CA (corresponding author), Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England.; Roll-Mecak, A (corresponding author), NIH, Cell Biol & Biophys Unit, Porter Neurosci Res Ctr, Bldg 35,Rm 3B-203,35 Convent Dr,MSC 3700, Bethesda, MD 20892 USA.	c.moores@mail.cryst.bbk.ac.uk; Antonina@mail.nih.gov		Roll-Mecak, Antonina/0000-0003-2621-7307	Medical Research Council, United Kingdom; NINDS; NHLBI, National Institutes of Health; Medical Research Council [MR/J000973/1] Funding Source: researchfish; MRC [MR/J000973/1] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003164, ZIANS003122] Funding Source: NIH RePORTER	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Medical Research Council, United Kingdom (to J. A. and C. A. M.), and by the Intramural Programs of the NINDS and the NHLBI, National Institutes of Health (to A. V., J. O. S., A. S. and A. R.-M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrishami V, 2015, J STRUCT BIOL, V189, P163, DOI 10.1016/j.jsb.2015.02.001; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Atherton J, 2014, ELIFE, V3, DOI 10.7554/eLife.03680; BANERJEE A, 1988, J BIOL CHEM, V263, P3029; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; BURGOYNE RD, 1988, EMBO J, V7, P2311, DOI 10.1002/j.1460-2075.1988.tb03074.x; Cardone G, 2013, J STRUCT BIOL, V184, P226, DOI 10.1016/j.jsb.2013.08.002; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gardner MK, 2011, CELL, V146, P582, DOI 10.1016/j.cell.2011.06.053; Garnham CP, 2015, CELL, V161, P1112, DOI 10.1016/j.cell.2015.04.003; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Miller KE, 1996, J CELL BIOL, V133, P1355, DOI 10.1083/jcb.133.6.1355; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Minoura I, 2013, FEBS LETT, V587, P3450, DOI 10.1016/j.febslet.2013.08.032; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Newton CN, 2002, J BIOL CHEM, V277, P42456, DOI 10.1074/jbc.M207134200; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; PANDA D, 1994, P NATL ACAD SCI USA, V91, P11358, DOI 10.1073/pnas.91.24.11358; Pecqueur L, 2012, P NATL ACAD SCI USA, V109, P12011, DOI 10.1073/pnas.1204129109; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; Podolski M, 2014, J BIOL CHEM, V289, P28087, DOI 10.1074/jbc.M114.584300; Roll-Mecak A, 2015, SEMIN CELL DEV BIOL, V37, P11, DOI 10.1016/j.semcdb.2014.09.026; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Sousa D, 2007, J STRUCT BIOL, V157, P201, DOI 10.1016/j.jsb.2006.08.003; SULLIVAN KF, 1986, P NATL ACAD SCI USA, V83, P4327, DOI 10.1073/pnas.83.12.4327; Szyk A, 2014, CELL, V157, P1405, DOI 10.1016/j.cell.2014.03.061; TOSO RJ, 1993, BIOCHEMISTRY-US, V32, P1285, DOI 10.1021/bi00056a013; TRINCZEK B, 1993, MOL BIOL CELL, V4, P323, DOI 10.1091/mbc.4.3.323; VALE RD, 1994, J BIOL CHEM, V269, P23769; Valenstein ML, 2016, CELL, V164, P911, DOI 10.1016/j.cell.2016.01.019; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; WEISENBERG RC, 1972, SCIENCE, V177, P1104, DOI 10.1126/science.177.4054.1104; Yu I, 2015, J BIOL CHEM, V290, P17163, DOI 10.1074/jbc.R115.637447; Zambito AM, 2002, BBA-PROTEINS PROTEOM, V1601, P200, DOI 10.1016/S1570-9639(02)00472-7; Zhang R, 2015, CELL, V162, P849, DOI 10.1016/j.cell.2015.07.012; Ziolkowska NE, 2013, METHODS MOL BIOL, V1046, P323, DOI 10.1007/978-1-62703-538-5_19	51	77	78	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					12907	12915		10.1074/jbc.C116.731133	http://dx.doi.org/10.1074/jbc.C116.731133			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129203	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000379770500002
J	Wakita, M; Edamatsu, H; Li, MZ; Emi, A; Kitazawa, S; Kataoka, T				Wakita, Masahiro; Edamatsu, Hironori; Li, Mingzhen; Emi, Aki; Kitazawa, Sohei; Kataoka, Tohru			Phospholipase C epsilon Activates Nuclear Factor-kappa B Signaling by Causing Cytoplasmic Localization of Ribosomal S6 Kinase and Facilitating Its Phosphorylation of Inhibitor kappa B in Colon Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; INDUCED INTERLEUKIN-8 PRODUCTION; PROTEIN-KINASE; CRUCIAL ROLE; NEUTROPHIL INFILTRATION; LYSOPHOSPHATIDIC ACID; MAINTENANCE THERAPY; CHEMOKINE RECEPTORS; SKIN INFLAMMATION; PLC-EPSILON	Phospholipase C epsilon (PLC epsilon), an effector of Ras and Rap small GTPases, plays a crucial role in inflammation by augmenting proinflammatory cytokine expression. This proinflammatory function of PLC epsilon is implicated in its facilitative role in tumor promotion and progression during skin and colorectal carcinogenesis, although their direct link remains to be established. Moreover, the molecular mechanism underlying these functions of PLC epsilon remains unknown except that PKD works downstream of PLC epsilon. Here we show by employing the colitis-induced colorectal carcinogenesis model, where Apc(Min/+) mice are administered with dextran sulfate sodium, that PLC epsilon knock-out alleviates the colitis and suppresses the following tumorigenesis concomitant with marked attenuation of proinflammatory cytokine expression. In human colon epithelial Caco2 cells, TNF-alpha induces sustained expression of proinflammatory molecules and sustained activation of nuclear factor-kappa B (NF-kappa B) and PKD, the late phases of which are suppressed by not only siRNA-mediated PLC epsilon knockdown but also treatment with a lysophosphatidic acid (LPA) receptor antagonist. Also, LPA stimulation induces these events in an early time course, suggesting that LPA mediates TNF-alpha signaling in an autocrine manner. Moreover, PLC epsilon knockdown results in inhibition of phosphorylation of I kappa B by ribosomal S6 kinase (RSK) but not by I kappa B kinases. Subcellular fractionation suggests that enhanced phosphorylation of a scaffolding protein, PEA15 (phosphoprotein enriched in astrocytes 15), downstream of the PLC epsilon-PKD axis causes sustained cytoplasmic localization of phosphorylated RSK, thereby facilitating I kappa B phosphorylation in the cytoplasm. These results suggest the crucial role of the TNF-alpha-LPA-LPA receptor-PLC epsilon-PKD-PEA15-RSK-I kappa B-NF-kappa B pathway in facilitating inflammation and inflammation-associated carcinogenesis in the colon.	[Wakita, Masahiro; Edamatsu, Hironori; Li, Mingzhen; Emi, Aki; Kataoka, Tohru] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan; [Kitazawa, Sohei] Ehime Univ, Grad Sch Med, Dept Mol Pathol, Toon, Ehime 7910295, Japan; [Li, Mingzhen] Beijing Ctr Phys & Chem Anal, Beijing 100089, Peoples R China	Kobe University; Ehime University	Kataoka, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kataoka@people.kobe-u.ac.jp	Kitazawa, Sohei/E-5602-2010	Kitazawa, Sohei/0000-0002-7466-7356; Edamatsu, Hironori/0000-0002-1335-4217	JSPS KAKENHI [23390071, 24590379]; Global COE Program [A08]; Project for Development of Innovative Research on Cancer Therapeutics from MEXT; Grants-in-Aid for Scientific Research [26670176] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project for Development of Innovative Research on Cancer Therapeutics from MEXT; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grants 23390071 and 24590379 and in part by Global COE Program A08 and the Project for Development of Innovative Research on Cancer Therapeutics from MEXT. The authors declare that they have no conflicts of interest with the contents of this article.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Ajuebor MN, 2002, IMMUNOLOGY, V105, P137, DOI 10.1046/j.1365-2567.2002.01309.x; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Banno T, 2005, J BIOL CHEM, V280, P18973, DOI 10.1074/jbc.M411758200; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Chiu TT, 2007, AM J PHYSIOL-CELL PH, V292, pC767, DOI 10.1152/ajpcell.00308.2006; Cicalese L, 1996, TRANSPLANTATION, V62, P161, DOI 10.1097/00007890-199607270-00003; Cooper HS, 2001, GASTROENTEROLOGY, V121, P1407, DOI 10.1053/gast.2001.29609; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Dudhgaonkar S. P., 2007, Inflammopharmacology, V15, P188, DOI 10.1007/s10787-007-1603-3; Dusaban SS, 2015, J BIOL CHEM, V290, P26776, DOI 10.1074/jbc.M115.676098; Dusaban SS, 2013, P NATL ACAD SCI USA, V110, P3609, DOI 10.1073/pnas.1217355110; Farooq SM, 2009, J PHARMACOL EXP THER, V329, P123, DOI 10.1124/jpet.108.145862; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Hains MD, 2006, MOL PHARMACOL, V69, P2068, DOI 10.1124/mol.105.017921; Harada Y, 2011, BIOCHEM BIOPH RES CO, V414, P106, DOI 10.1016/j.bbrc.2011.09.032; Hu LZ, 2010, J IMMUNOL, V184, P993, DOI 10.4049/jimmunol.0901816; Ikuta S, 2008, CANCER RES, V68, P64, DOI 10.1158/0008-5472.CAN-07-3245; Ishikawa TO, 2011, CARCINOGENESIS, V32, P417, DOI 10.1093/carcin/bgq268; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kojouharoff G, 1997, CLIN EXP IMMUNOL, V107, P353, DOI 10.1111/j.1365-2249.1997.291-ce1184.x; Kucharzik T, 2005, GUT, V54, P1565, DOI 10.1136/gut.2004.061168; Li MZ, 2009, CARCINOGENESIS, V30, P1424, DOI 10.1093/carcin/bgp125; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Nagano T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108373; Noguchi M, 1998, GUT, V43, P203, DOI 10.1136/gut.43.2.203; Oka M, 2011, LAB INVEST, V91, P711, DOI 10.1038/labinvest.2011.10; Osawa Y, 2001, J IMMUNOL, V167, P173, DOI 10.4049/jimmunol.167.1.173; Pasparakis M, 2012, IMMUNOL REV, V246, P346, DOI 10.1111/j.1600-065X.2012.01109.x; Peng C, 2010, FASEB J, V24, P3490, DOI 10.1096/fj.09-151290; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Platt AM, 2010, J IMMUNOL, V184, P6843, DOI 10.4049/jimmunol.0903987; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Schouten GJ, 1997, EMBO J, V16, P3133, DOI 10.1093/emboj/16.11.3133; Seifert JP, 2004, J BIOL CHEM, V279, P47992, DOI 10.1074/jbc.M407111200; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Tadano M, 2005, MOL CELL BIOL, V25, P2191, DOI 10.1128/MCB.25.6.2191-2199.2005; Takenaka N, 2011, EUR J IMMUNOL, V41, P202, DOI 10.1002/eji.201040675; Taylor JA, 1999, J MOL BIOL, V290, P839, DOI 10.1006/jmbi.1999.2912; Vaidyanathan H, 2003, J BIOL CHEM, V278, P32367, DOI 10.1074/jbc.M303988200; Vaidyanathan H, 2007, P NATL ACAD SCI USA, V104, P19837, DOI 10.1073/pnas.0704514104; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wu DM, 2003, EUR J NEUROSCI, V17, P1571, DOI 10.1046/j.1460-9568.2003.02591.x; Wu JM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-71; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yamaguchi T, 2011, INT J ONCOL, V39, P23, DOI 10.3892/ijo.2011.1015; Zhang LH, 2013, CELL, V153, P216, DOI 10.1016/j.cell.2013.02.047; Zhang LY, 2005, J NUTR, V135, P1752, DOI 10.1093/jn/135.7.1752	62	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12586	12600		10.1074/jbc.M116.717561	http://dx.doi.org/10.1074/jbc.M116.717561			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27053111	Green Published, hybrid			2022-12-28	WOS:000378119900016
J	Brozzi, F; Gerlo, S; Grieco, FA; Juusola, M; Balhuizen, A; Lievens, S; Gysemans, C; Bugliani, M; Mathieu, C; Marchetti, P; Tavernier, J; Eizirik, DL				Brozzi, Flora; Gerlo, Sarah; Grieco, Fabio Arturo; Juusola, Matilda; Balhuizen, Alexander; Lievens, Sam; Gysemans, Conny; Bugliani, Marco; Mathieu, Chantal; Marchetti, Piero; Tavernier, Jan; Eizirik, Decio L.			Ubiquitin D Regulates IRE1 alpha/c-Jun N-terminal Kinase (JNK) Protein-dependent Apoptosis in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; MAJOR HISTOCOMPATIBILITY COMPLEX; NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; INTERFERON-GAMMA; SIGNAL-TRANSDUCTION; DIABETES-MELLITUS; GENE-EXPRESSION; CANDIDATE GENE; CYTOKINES	Pro-inflammatory cytokines contribute to pancreatic beta cell apoptosis in type 1 diabetes at least in part by inducing endoplasmic reticulum (ER) stress and the consequent unfolded protein response (UPR). It remains to be determined what causes the transition from "physiological" to "apoptotic" UPR, but accumulating evidence indicates that signaling by the ER transmembrane protein IRE1 alpha is critical for this transition. IRE1 alpha activation is regulated by both intra-ER and cytosolic cues. We evaluated the role for the presently discovered cytokine-induced and IRE1 alpha-interacting protein ubiquitin D (UBD) on the regulation of IRE1 alpha and its downstream targets. UBD was identified by use of a MAPPIT (mammalian protein-protein interaction trap)-based IRE1 alpha interactome screen followed by comparison against functional genomic analysis of human and rodent beta cells exposed to pro-inflammatory cytokines. Knockdown ofUBDin human and rodent beta cells and detailed signal transduction studies indicated that UBD modulates cytokine-induced UPR/IRE1 alpha activation and apoptosis. UBD expression is induced by the pro-inflammatory cytokines interleukin (IL)-1 beta and interferon (IFN)-gamma in rat and human pancreatic beta cells, and it is also up-regulated in beta cells of inflamed islets from non-obese diabetic mice. UBD interacts with IRE1 alpha in human and rodent beta cells, modulating IRE1 alpha-dependent activation of JNK and cytokine-induced apoptosis. Our data suggest that UBD provides a negative feedback on cytokine-induced activation of the IRE1 alpha/JNK pro-apoptotic pathway in cytokine-exposed beta cells.	[Brozzi, Flora; Grieco, Fabio Arturo; Juusola, Matilda; Balhuizen, Alexander; Eizirik, Decio L.] Univ Libre Bruxelles, Fac Med, Ctr Diabet Res, B-1070 Brussels, Belgium; [Gerlo, Sarah; Lievens, Sam; Tavernier, Jan; Eizirik, Decio L.] Flanders Interuniv Inst Biotechnol VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Gerlo, Sarah; Lievens, Sam; Tavernier, Jan] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Gysemans, Conny; Mathieu, Chantal] KULeuven, Lab Clin & Expt Endocrinol, B-3000 Leuven, Belgium; [Bugliani, Marco; Marchetti, Piero] Univ Pisa, Islet Cell Lab, Dept Clin & Expt Med, I-56126 Pisa, Italy	Universite Libre de Bruxelles; Flanders Institute for Biotechnology (VIB); Ghent University; KU Leuven; University of Pisa	Eizirik, DL (corresponding author), Univ Libre Bruxelles, Ctr Diabet Res, Route Lennik 808 CP618, B-1070 Brussels, Belgium.	deizirik@ulb.ac.be	mathieu, chantal/ABD-5505-2021; Tavernier, Jan/AAG-3636-2019; Bugliani, Marco/I-3168-2019; Juusola, Matilda/W-4754-2018	mathieu, chantal/0000-0002-4055-5233; Bugliani, Marco/0000-0002-1744-1561; Juusola, Matilda/0000-0002-2834-3211; gysemans, conny/0000-0003-3559-6089; Balhuizen, Alexander/0000-0001-7581-121X	Juvenile Diabetes Research Foundation International Grant [17-2013-515]; NIDDK, Human Islet Research, National Institutes of Health Network Consortium [1UC4DK104166-01]; Fund for Scientific Research Flanders (FWO) [1522313N]; European Union; Actions de Recherche Concertee de la Communaute Francaise; Fonds National de la Recherche Scientifique, Belgium; Ghent University GROUP-ID Multidisciplinary Research Platform; Katholieke Universiteit Leuven; Seventh Framework Program of the European Union NAIMIT; Innovative Medicines Initiative 2 Joint Undertaking [115797]; Union's Horizon research and innovation program; EFPIA; JDRF; The Leona M. and Harry B. Helmsley Charitable Trust; ERC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104166] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation International Grant(Juvenile Diabetes Research Foundation); NIDDK, Human Islet Research, National Institutes of Health Network Consortium; Fund for Scientific Research Flanders (FWO)(FWO); European Union(European Commission); Actions de Recherche Concertee de la Communaute Francaise; Fonds National de la Recherche Scientifique, Belgium(Fonds de la Recherche Scientifique - FNRS); Ghent University GROUP-ID Multidisciplinary Research Platform; Katholieke Universiteit Leuven(KU Leuven); Seventh Framework Program of the European Union NAIMIT; Innovative Medicines Initiative 2 Joint Undertaking; Union's Horizon research and innovation program; EFPIA; JDRF(Juvenile Diabetes Research Foundation); The Leona M. and Harry B. Helmsley Charitable Trust; ERC(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the Juvenile Diabetes Research Foundation International Grant 17-2013-515 and NIDDK, Human Islet Research, National Institutes of Health Network Consortium Grant 1UC4DK104166-01 (to D. L. E.), the Fund for Scientific Research Flanders (FWO Grant 1522313N), European Union (Seventh Framework Projects of the European Union. NAIMIT and BetaBat), Actions de Recherche Concertee de la Communaute Francaise, and the Fonds National de la Recherche Scientifique, Belgium (to D. L. E.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the Ghent University GROUP-ID Multidisciplinary Research Platform.r Supported by the Katholieke Universiteit Leuven and the Seventh Framework Program of the European Union NAIMIT.r Supported by the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement 115797 (INNODIA). This Joint Undertaking receives support from the Union's Horizon 2020 research and innovation program and "EFPIA," "JDRF," and "The Leona M. and Harry B. Helmsley Charitable Trust."r Recipient of an ERC advanced grant.	Aichem A, 2012, J CELL SCI, V125, P4576, DOI 10.1242/jcs.107789; Aly TA, 2008, DIABETES, V57, P770, DOI 10.2337/db07-0900; Ammendrup A, 2000, DIABETES, V49, P1468, DOI 10.2337/diabetes.49.9.1468; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Baschal EE, 2011, J DIABETES, V3, P238, DOI 10.1111/j.1753-0407.2011.00131.x; Blankenhorn EP, 2009, DIABETES, V58, P2930, DOI 10.2337/db09-0387; Bonny C, 2000, J BIOL CHEM, V275, P16466, DOI 10.1074/jbc.M908297199; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Brozzi F, 2014, J BIOL CHEM, V289, P20677, DOI 10.1074/jbc.M114.568808; Buerger S, 2015, J IMMUNOL, V195, P4106, DOI 10.4049/jimmunol.1500592; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cardozo AK, 2001, DIABETES, V50, P909, DOI 10.2337/diabetes.50.5.909; Chen MC, 2001, DIABETOLOGIA, V44, P325, DOI 10.1007/s001250051622; Cort L, 2014, GENES IMMUN, V15, P168, DOI 10.1038/gene.2013.72; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Ebstein F, 2009, INT J BIOCHEM CELL B, V41, P1205, DOI 10.1016/j.biocel.2008.10.023; Eizirik DL, 2013, DIABETOLOGIA, V56, P234, DOI 10.1007/s00125-012-2762-3; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Eizirik DL, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3110pe7; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1994, P NATL ACAD SCI USA, V91, P9253, DOI 10.1073/pnas.91.20.9253; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Gong PF, 2010, J AM SOC NEPHROL, V21, P316, DOI 10.1681/ASN.2009050479; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Lievens S, 2012, METHODS MOL BIOL, V812, P283, DOI 10.1007/978-1-61779-455-1_17; Lievens S, 2009, J PROTEOME RES, V8, P877, DOI 10.1021/pr8005167; Lisak RP, 2011, J NEUROIMMUNOL, V238, P19, DOI 10.1016/j.jneuroim.2011.06.010; Liu YC, 1999, P NATL ACAD SCI USA, V96, P4313, DOI 10.1073/pnas.96.8.4313; Lukasiak S, 2008, ONCOGENE, V27, P6068, DOI 10.1038/onc.2008.201; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Marroqui L, 2015, EBIOMEDICINE, V2, P378, DOI 10.1016/j.ebiom.2015.03.012; Marroqui L, 2014, DIABETES, V63, P2516, DOI 10.2337/db13-1443; Miani M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.236; Miani M, 2012, ENDOCRINOLOGY, V153, P3017, DOI 10.1210/en.2011-2090; Moore F, 2012, METHODS MOL BIOL, V820, P179, DOI 10.1007/978-1-61779-439-1_11; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Ortis F, 2006, MOL ENDOCRINOL, V20, P1867, DOI 10.1210/me.2005-0268; Ortis F, 2010, DIABETES, V59, P358, DOI 10.2337/db09-1159; Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Raasi S, 1999, EUR J IMMUNOL, V29, P4030, DOI 10.1002/(SICI)1521-4141(199912)29:12<4030::AID-IMMU4030>3.0.CO;2-Y; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schmidtke G, 2014, BBA-MOL CELL RES, V1843, P97, DOI 10.1016/j.bbamcr.2013.01.009; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Yu X, 2012, DIGEST DIS SCI, V57, P2347, DOI 10.1007/s10620-012-2189-1	61	36	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12040	12056		10.1074/jbc.M115.704619	http://dx.doi.org/10.1074/jbc.M115.704619			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27044747	Green Published, hybrid			2022-12-28	WOS:000378092800009
J	Cifelli, JL; Dozier, L; Chung, TS; Patrick, GN; Yang, J				Cifelli, Jessica L.; Dozier, Lara; Chung, Tim S.; Patrick, Gentry N.; Yang, Jerry			Benzothiazole Amphiphiles Promote the Formation of Dendritic Spines in Primary Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; PATHOLOGY; ANILINE; ACTIN; PLASTICITY; DISORDERS; SYNAPSES; DENSITY; SCHIZOPHRENIA	The majority of excitatory synapses in the brain exist on dendritic spines. Accordingly, the regulation of dendritic spine density in the hippocampus is thought to play a central role in learning and memory. The development of novel methods to control spine density could, therefore, have important implications for treatment of a host of neurodegenerative and developmental cognitive disorders. Herein, we report the design and evaluation of a new class of benzothiazole amphiphiles that exhibit a dose-dependent response leading to an increase in dendritic spine density in primary hippocampal neurons. Cell exposure studies reveal that the increase in spine density can persist for days in the presence of these compounds, but returns to normal spine density levels within 24 h when the compounds are removed, demonstrating the capability to reversibly control spinogenic activity. Time-lapse imaging of dissociated hippocampal neuronal cultures shows that these compounds promote a net increase in spine density through the formation of new spines. Biochemical studies support that promotion of spine formation by these compounds is accompanied by Ras activation. These spinogenic molecules were also capable of inhibiting a suspected mechanism for dendritic spine loss induced by Alzheimer-related aggregated amyloid-beta peptides in primary neurons. Evaluation of this new group of spinogenic agents reveals that they also exhibit relatively low toxicity at concentrations displaying activity. Collectively, these results suggest that small molecules that promote spine formation could be potentially useful for ameliorating cognitive deficiencies associated with spine loss in neurodegenerative diseases such as Alzheimer disease, and may also find use as general cognitive enhancers.	[Cifelli, Jessica L.; Chung, Tim S.; Yang, Jerry] Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Dozier, Lara; Patrick, Gentry N.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Yang, J (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jerryyang@ucsd.edu			UCSD Alzheimer's Disease Research Center (National Institutes of Health) [3P50 AG005131]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	UCSD Alzheimer's Disease Research Center (National Institutes of Health); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the UCSD Alzheimer's Disease Research Center (National Institutes of Health Grant 3P50 AG005131). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Cartier AE, 2009, J NEUROSCI, V29, P7857, DOI 10.1523/JNEUROSCI.1817-09.2009; Chittiboyina AG, 2006, J MED CHEM, V49, P4072, DOI 10.1021/jm0510880; Dennis J, 2013, ANN NEUROL, V74, P328, DOI 10.1002/ana.24001; Djakovic SN, 2009, J BIOL CHEM, V284, P26655, DOI 10.1074/jbc.M109.021956; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Finkelstein H, 1910, BER DTSCH CHEM GES, V43, P1528, DOI 10.1002/cber.19100430257; Furuta T, 2001, J HISTOCHEM CYTOCHEM, V49, P1497, DOI 10.1177/002215540104901203; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; HUANG CH, 1969, BIOCHEMISTRY-US, V8, P344, DOI 10.1021/bi00829a048; Inbar P, 2006, CHEMBIOCHEM, V7, P1563, DOI 10.1002/cbic.200600119; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Kolomeets NS, 2005, SYNAPSE, V57, P47, DOI 10.1002/syn.20153; Kramer JA, 2007, NAT REV DRUG DISCOV, V6, P636, DOI 10.1038/nrd2378; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Lai KO, 2013, BBA-MOL BASIS DIS, V1832, P2257, DOI 10.1016/j.bbadis.2013.08.012; Lee NJ, 2016, BBA-MOL BASIS DIS, V1862, P284, DOI 10.1016/j.bbadis.2015.12.007; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; Megill A, 2013, J NEUROSCI, V33, P9306, DOI 10.1523/JNEUROSCI.1615-12.2013; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Namboodiri VV, 2002, ORG LETT, V4, P3161, DOI 10.1021/ol026608p; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Park N, 2012, EUR J ORG CHEM, V2012, P1984, DOI 10.1002/ejoc.201101773; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Prangkio P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047261; Prangkio P, 2011, BBA-BIOMEMBRANES, V1808, P2877, DOI 10.1016/j.bbamem.2011.08.024; Ranu BC, 2006, EUR J ORG CHEM, V2006, P3767, DOI 10.1002/ejoc.200600335; Rodrigues EM, 2016, J NEUROSCI, V36, P1590, DOI 10.1523/JNEUROSCI.2964-15.2016; Schaumann E., 2007, SULFUR MEDIATED REAR; Schulz-Schaeffer WJ, 2010, ACTA NEUROPATHOL, V120, P131, DOI 10.1007/s00401-010-0711-0; Scudder SL, 2014, J NEUROSCI, V34, P16637, DOI 10.1523/JNEUROSCI.2452-14.2014; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; Song JM, 2014, EXP NEUROL, V252, P105, DOI 10.1016/j.expneurol.2013.11.023; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Yang J, 2002, J ORG CHEM, V67, P5057, DOI 10.1021/jo020174u; Zhao XB, 2010, ACS CHEM NEUROSCI, V1, P655, DOI 10.1021/cn100067e	48	8	9	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					11981	11992		10.1074/jbc.M115.701482	http://dx.doi.org/10.1074/jbc.M115.701482			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27022020	Green Published, hybrid			2022-12-28	WOS:000378092800003
J	Defenouillere, Q; Zhang, E; Namane, A; Mouaikel, J; Jacquier, A; Fromont-Racine, M				Defenouillere, Quentin; Zhang, Elodie; Namane, Abdelkader; Mouaikel, John; Jacquier, Alain; Fromont-Racine, Micheline			Rqc1 and Ltn1 Prevent C-terminal Alanine-Threonine Tail (CAT-tail)-induced Protein Aggregation by Efficient Recruitment of Cdc48 on Stalled 60S Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL COMPLEX; MESSENGER-RNA SURVEILLANCE; TRANSCRIPTION FACTOR; MISFOLDED PROTEINS; TRANSLATION; RIBOSOME; DEGRADATION; PROTEASOME; YEAST; DISSOCIATION	Protein homeostasis is maintained by quality control mechanisms that detect and eliminate deficient translation products. Cytosolic defective proteins can arise from translation of aberrant mRNAs lacking a termination codon (NonStop) or containing a sequence that blocks translation elongation (No-Go), which results in translational arrest. Stalled ribosomes are dissociated, aberrant mRNAs are degraded by the cytoplasmic exosome, and the nascent peptides remaining in stalled 60S exit tunnels are detected by the ribosome-bound quality control complex (RQC) composed of Ltn1, Rqc1, Rqc2, and Cdc48. Whereas Ltn1 polyubiquitylates these nascent peptides, Rqc2 directs the addition of C-terminal alanine-threonine tails (CAT-tails), and a Cdc48 hexamer is recruited to extract the nascent peptides, which are addressed to the proteasome for degradation. Although the functions of most RQC components have been described, the role of Rqc1 in this quality control process remains undetermined. In this article we show that the absence of Rqc1 or Ltn1 results in the aggregation of aberrant proteins, a phenomenon that requires CAT-tail addition to the nascent peptides by Rqc2. Our results suggest that aberrant CAT-tailed protein aggregation results from a defect in Cdc48 recruitment to stalled 60S particles, a process that requires both Rqc1 and Ltn1. These protein aggregates contain Ltn1-dependent polyubiquitin chains and are degraded by the proteasome. Finally, aggregate characterization by proteomics revealed that they contain specific chaperones including Sis1, Sgt2, Ssa1/2, and Hsp82, suggesting that these protein aggregates may be addressed to aggresome-like structures when the RQC complex fails to deliver aberrant nascent peptides to the proteasome for degradation.	[Defenouillere, Quentin; Zhang, Elodie; Namane, Abdelkader; Mouaikel, John; Jacquier, Alain; Fromont-Racine, Micheline] Inst Pasteur, CNRS, UMR 3525, Genet Interact Macromol, F-75724 Paris, France; [Defenouillere, Quentin; Zhang, Elodie] Univ Paris 06, Sorbonne Univ, Complex Vivant, F-75252 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Fromont-Racine, M (corresponding author), Inst Pasteur, 25-28 Rue Dr Roux, F-75724 Paris, France.	mfromont@pasteur.fr	Namane, Abdelkader/O-1857-2013	Namane, Abdelkader/0000-0001-7180-7619; Fromont-Racine, Micheline/0000-0001-9906-0334; Defenouillere, Quentin/0000-0003-2255-4859; JACQUIER, ALAIN/0000-0001-5707-9184	Agence Nationale de la Recherche [ANR-2011-BSV6-011-02, ANR-14-CE-10-0014-01]; Institut Pasteur; CNRS; Ministere de l'Enseignement Superieur et de la Recherche; Association pour la Recherche contre le Cancer	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by Agence Nationale de la Recherche Grants ANR-2011-BSV6-011-02 and ANR-14-CE-10-0014-01 and funds from the Institut Pasteur and the CNRS. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by fellowships from the Ministere de l'Enseignement Superieur et de la Recherche and from the Association pour la Recherche contre le Cancer.	Albrecht AN, 2004, HUM MOL GENET, V13, P2351, DOI 10.1093/hmg/ddh277; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Brandman O, 2016, NAT STRUCT MOL BIOL, V23, P7, DOI 10.1038/nsmb.3147; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Defenouillere Q, 2013, P NATL ACAD SCI USA, V110, P5046, DOI 10.1073/pnas.1221724110; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Fujii K, 2012, EMBO J, V31, P2579, DOI 10.1038/emboj.2012.85; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; LaRiviere FJ, 2006, MOL CELL, V24, P619, DOI 10.1016/j.molcel.2006.10.008; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Lyumkis D, 2014, P NATL ACAD SCI USA, V111, P15981, DOI 10.1073/pnas.1413882111; Miller SBM, 2015, EMBO J, V34, P778, DOI 10.15252/embj.201489524; Morano KA, 1999, MOL CELL BIOL, V19, P402; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rott R, 2008, J BIOL CHEM, V283, P3316, DOI 10.1074/jbc.M704809200; Shao SC, 2015, MOL CELL, V57, P433, DOI 10.1016/j.molcel.2014.12.015; Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shoemaker CJ, 2011, P NATL ACAD SCI USA, V108, pE1392, DOI 10.1073/pnas.1113956108; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614	33	54	56	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12245	12253		10.1074/jbc.M116.722264	http://dx.doi.org/10.1074/jbc.M116.722264			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27129255	Green Published, hybrid			2022-12-28	WOS:000378092800025
J	Pasi, S; Kant, R; Surolia, A				Pasi, Shweta; Kant, Ravi; Surolia, Avadhesha			Toll/Interleukin-1 Receptor Domain Derived from TcpC (TIR-TcpC) Ameliorates Experimental Autoimmune Arthritis by Down-modulating Th17 Cell Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-INDUCED ARTHRITIS; EARLY RHEUMATOID-ARTHRITIS; SYNOVIAL TISSUE; DENDRITIC CELLS; PROINFLAMMATORY CYTOKINES; CARTILAGE DESTRUCTION; INTERFERON-GAMMA; II COLLAGEN; T-CELLS; MYD88	Evasion through immunomodulation is one of the several strategies adopted by pathogens to prolong their survival within the host. One such pathogen, Escherichia coli CFT073, utilizes an immunomodulatory protein, TcpC, to combat the host's innate immune defense. TcpC abrogates the function of MyD88 in macrophages, thus perturbing all the signaling processes that involve this adaptor protein. Although central to various signaling pathways initiated by IL-1, IL-18, and toll-like receptors, the precise contribution of MyD88 to the development of autoimmunity, particularly rheumatoid arthritis, still needs extensive exploration. Herein, by using the toll/interleukin-1 receptor (TIR) domain homologous C-terminal motif of TcpC, i.e. TIR-TcpC, we found MyD88 to be critical for the induction and progression of rheumatoid arthritis through its pivotal role in the development of Th17 cells, the subset of CD4(+) T-cells widely implicated in various autoimmune disorders. The TIR-TcpC mediated inhibition of signaling through MyD88, and subsequent amelioration of experimental autoimmune arthritis was observed to be an outcome of perturbations in the NF kappa B-ROR gamma t (RAR-related orphan receptor gamma t) axis.	Natl Inst Immunol, Mol Sci Lab, New Delhi 110067, India; [Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Science (IISC) - Bangalore	Surolia, A (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	surolia@mbu.iisc.ernet.in			Council of Scientific and Industrial Research (CSIR), India; CSIR	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Council of Scientific and Industrial Research (CSIR), India ( to A. S.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by CSIR research fellowships.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Aliahmadi E, 2009, EUR J IMMUNOL, V39, P1221, DOI 10.1002/eji.200838742; Bingham CO, 2002, J RHEUMATOL, V29, P3; Braddock M, 2004, EXPERT OPIN BIOL TH, V4, P847, DOI 10.1517/14712598.4.6.847; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.3.CO;2-U; Chang J, 2013, P NATL ACAD SCI USA, V110, P2270, DOI 10.1073/pnas.1206048110; Choy E, 2012, CURR MED RES OPIN, V28, P1733, DOI 10.1185/03007995.2012.731388; Chu CQ, 2007, ARTHRITIS RHEUM, V56, P1145, DOI 10.1002/art.22453; Chu CQ, 2003, ANN RHEUM DIS, V62, P983, DOI 10.1136/ard.62.10.983; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; EASTGATE JA, 1988, LANCET, V2, P706; Eriksson U, 2003, J EXP MED, V197, P323, DOI 10.1084/jem.20021788; Hardiman G, 1996, ONCOGENE, V13, P2467; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; HULTMARK D, 1994, BIOCHEM BIOPH RES CO, V199, P144, DOI 10.1006/bbrc.1994.1206; Inglis JJ, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2319; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Joosten LAB, 1996, ARTHRITIS RHEUM, V39, P797, DOI 10.1002/art.1780390513; KAHLE P, 1992, ANN RHEUM DIS, V51, P731, DOI 10.1136/ard.51.6.731; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; LORD KA, 1990, ONCOGENE, V5, P1095; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Luft T, 2002, J IMMUNOL, V168, P713, DOI 10.4049/jimmunol.168.2.713; ManourySchwartz B, 1997, J IMMUNOL, V158, P5501; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pasi S, 2015, BIOMATERIALS, V42, P121, DOI 10.1016/j.biomaterials.2014.11.041; Pierer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023539; Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Roelofs MF, 2006, J IMMUNOL, V176, P7021, DOI 10.4049/jimmunol.176.11.7021; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Saal JG, 1999, ARTHRITIS RHEUM-US, V42, P1485, DOI 10.1002/1529-0131(199907)42:7<1485::AID-ANR24>3.0.CO;2-7; SAAL JG, 1992, RHEUMATOL INT, V12, P147, DOI 10.1007/BF00274934; Sacre SM, 2007, AM J PATHOL, V170, P518, DOI 10.2353/ajpath.2007.060657; Sarkar S, 2010, CLIN EXP IMMUNOL, V159, P225, DOI 10.1111/j.1365-2249.2009.04016.x; Sarkar S, 2010, RHEUM DIS CLIN N AM, V36, P345, DOI 10.1016/j.rdc.2010.02.006; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Schenten D, 2014, IMMUNITY, V40, P78, DOI 10.1016/j.immuni.2013.10.023; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Snyder GA, 2013, P NATL ACAD SCI USA, V110, P6985, DOI 10.1073/pnas.1215770110; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; van den Berg WB, 1999, ANN RHEUM DIS, V58, P40; van der Heijden IM, 2000, ARTHRITIS RHEUM-US, V43, P593, DOI 10.1002/1529-0131(200003)43:3<593::AID-ANR16>3.0.CO;2-1; van Hamburg JP, 2011, ARTHRITIS RHEUM-US, V63, P73, DOI 10.1002/art.30093; WALLE TK, 1990, SCAND J IMMUNOL, V31, P535, DOI 10.1111/j.1365-3083.1990.tb02802.x; Warner N, 2013, J IMMUNOL, V190, P3, DOI 10.4049/jimmunol.1203103; Yadav M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001120; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	54	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12358	12369		10.1074/jbc.M116.722801	http://dx.doi.org/10.1074/jbc.M116.722801			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27022030	Green Published, hybrid			2022-12-28	WOS:000378092800034
J	Ahmed, UK; Maller, NC; Iqbal, AJ; Al-Riyami, L; Harnett, W; Raynes, JG				Ahmed, Umul Kulthum; Maller, N. Claire; Iqbal, Asif J.; Al-Riyami, Lamyaa; Harnett, William; Raynes, John G.			The Carbohydrate-linked Phosphorylcholine of the Parasitic Nematode Product ES-62 Modulates Complement Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; N-GLYCANS; IN-VIVO; LYMPHATIC FILARIASIS; SECRETED PRODUCT; LECTIN PATHWAY; GLOBULAR HEAD; BRUGIA-MALAYI; PHOSPHOCHOLINE; GLYCOPROTEIN	Parasitic nematodes manufacture various carbohydrate-linked phosphorylcholine (PCh)-containing molecules, including ES-62, a protein with an N-linked glycan terminally substituted with PCh. The PCh component is biologically important because it is required for immunomodulatory effects. We showed that most ES-62 was bound to a single protein, C-reactive protein (CRP), in normal human serum, displaying a calcium-dependent, high-avidity interaction and ability to form large complexes. Unexpectedly, CRP binding to ES-62 failed to efficiently activate complement as far as the C3 convertase stage in comparison with PCh-BSA and PCh-containing Streptococcus pneumoniae cell wall polysaccharide. C1q capture assays demonstrated an ES-62-CRP-C1q interaction in serum. The three ligands all activated C1 and generated C4b to similar extents. However, a C2a active site was not generated following ES-62 binding to CRP, demonstrating that C2 cleavage was far less efficient for ES-62-containing complexes. Weproposed that failure of C2 cleavage was due to the flexible nature of carbohydrate-bound PCh and that reduced proximity of the C1 complex was the reason that C2 was poorly cleaved. This was confirmed using synthetic analogues that were similar to ES-62 only in respect of having a flexible PCh. Furthermore, ES-62 was shown to deplete early complement components, such as the rate-limiting C4, following CRP interaction and thereby inhibit classical pathway activation. Thus, flexible PCh-glycan represents a novel mechanism for subversion of complement activation. These data illustrate the importance of the rate-limiting C4/C2 stage of complement activation and reveal a new addition to the repertoire of ES-62 immunomodulatory mechanisms with possible therapeutic applications.	[Ahmed, Umul Kulthum; Maller, N. Claire; Iqbal, Asif J.; Raynes, John G.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, Keppel St, London WC1E 7HT, England; [Al-Riyami, Lamyaa; Harnett, William] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland	University of London; London School of Hygiene & Tropical Medicine; University of Strathclyde	Raynes, JG (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, Keppel St, London WC1E 7HT, England.	john.raynes@lshtm.ac.uk	Raynes, John G/G-7932-2011	Raynes, John G/0000-0002-8536-1328; Harnett, William/0000-0001-9545-9401; Iqbal, Asif/0000-0002-3224-3651	Medical Research Council (MRC); Wellcome Trust	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by a Medical Research Council (MRC) studentship.; Supported by the Wellcome Trust.	Azzimonti F, 2003, J CHROMATOGR B, V784, P33, DOI 10.1016/S1570-0232(02)00749-3; Biro A, 2007, IMMUNOLOGY, V121, P40, DOI 10.1111/j.1365-2567.2007.02535.x; Bodman-Smith KB, 2002, IMMUNOLOGY, V107, P252, DOI 10.1046/j.1365-2567.2002.01481.x; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; Clarke EV, 2014, J LEUKOCYTE BIOL, V96, P745, DOI 10.1189/jlb.3MR0214-109R; Culley FJ, 1996, J IMMUNOL, V156, P4691; Culley FJ, 2000, GLYCOBIOLOGY, V10, P59, DOI 10.1093/glycob/10.1.59; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Goodridge HS, 2001, J IMMUNOL, V167, P940, DOI 10.4049/jimmunol.167.2.940; Haapasalo K, 2009, INFECT IMMUN, V77, P3886, DOI 10.1128/IAI.01583-08; Hammond DJ, 2010, J BIOL CHEM, V285, P36235, DOI 10.1074/jbc.M110.142026; Harnett MM, 2008, ANN RHEUM DIS, V67, P518, DOI 10.1136/ard.2007.073502; Harnett MM, 2010, CLIN EXP IMMUNOL, V159, P256, DOI 10.1111/j.1365-2249.2009.04064.x; Harnett W, 1999, MOL BIOCHEM PARASIT, V104, P11, DOI 10.1016/S0166-6851(99)00113-9; HARNETT W, 1993, J IMMUNOL, V151, P4829; Harnett W, 1999, IMMUNOL TODAY, V20, P125, DOI 10.1016/S0167-5699(98)01419-4; Haslam SM, 1999, J BIOL CHEM, V274, P20953, DOI 10.1074/jbc.274.30.20953; Hebecker M, 2010, MOL IMMUNOL, V47, P1347, DOI 10.1016/j.molimm.2009.12.005; Hewitson JR, 2008, MOL BIOCHEM PARASIT, V160, P8, DOI 10.1016/j.molbiopara.2008.02.007; Holm L, 2012, IMMUNOBIOLOGY, V217, P256, DOI 10.1016/j.imbio.2011.07.021; Kojouharova M, 2010, MOL IMMUNOL, V47, P2154, DOI 10.1016/j.molimm.2010.05.011; Kouser L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00317; LAL RB, 1989, T ROY SOC TROP MED H, V83, P652, DOI 10.1016/0035-9203(89)90387-8; LAL RB, 1991, J CLIN IMMUNOL, V11, P46, DOI 10.1007/BF00918794; LAL RB, 1987, J IMMUNOL, V138, P3454; LOVELESS RW, 1992, EMBO J, V11, P813, DOI 10.1002/j.1460-2075.1992.tb05118.x; MAIZELS RM, 1987, PARASITE IMMUNOL, V9, P49, DOI 10.1111/j.1365-3024.1987.tb00488.x; McGrath FDG, 2006, J IMMUNOL, V176, P2950, DOI 10.4049/jimmunol.176.5.2950; McInnes IB, 2003, J IMMUNOL, V171, P2127, DOI 10.4049/jimmunol.171.4.2127; MOLD C, 1981, J EXP MED, V154, P1703, DOI 10.1084/jem.154.5.1703; NIELSEN HE, 1992, APMIS, V100, P1053, DOI 10.1111/j.1699-0463.1992.tb04040.x; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; Paschinger K, 2012, INT J PARASITOL, V42, P279, DOI 10.1016/j.ijpara.2012.01.002; Paschinger K, 2012, GLYCOBIOLOGY, V22, P300, DOI 10.1093/glycob/cwr149; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Poltl G, 2007, FEBS J, V274, P714, DOI 10.1111/j.1742-4658.2006.05615.x; RAO UR, 1987, IMMUNOL CELL BIOL, V65, P365, DOI 10.1038/icb.1987.41; Rawal N, 2008, J BIOL CHEM, V283, P7853, DOI 10.1074/jbc.M707591200; Simons JP, 2014, IMMUNOLOGY, V142, P414, DOI 10.1111/imm.12266; Singh SK, 2012, J BIOL CHEM, V287, P3550, DOI 10.1074/jbc.M111.310011; SUGANE K, 1983, PARASITE IMMUNOL, V5, P385, DOI 10.1111/j.1365-3024.1983.tb00754.x; SUGANE K, 1983, IMMUNOLOGY, V50, P113; Taylor K, 1997, PARASITOLOGY, V115, P297, DOI 10.1017/S0031182097001418; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Vassal-Stermann E, 2014, J IMMUNOL, V193, P5699, DOI 10.4049/jimmunol.1400127; VOLANAKI.JE, 1971, P SOC EXP BIOL MED, V136, P612; Wallis R, 2007, J BIOL CHEM, V282, P7844, DOI 10.1074/jbc.M606326200; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Weinhold B, 1997, BIOCHEM J, V325, P617, DOI 10.1042/bj3250617; Wilson EH, 2003, IMMUNOLOGY, V109, P238, DOI 10.1046/j.1365-2567.2003.01661.x; Wuhrer M, 2000, BIOCHEM J, V348, P417, DOI 10.1042/0264-6021:3480417; YOUNG NM, 1978, J IMMUNOL, V121, P1893	53	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11939	11953		10.1074/jbc.M115.702746	http://dx.doi.org/10.1074/jbc.M115.702746			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27044740	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000377264800041
J	Rasheedi, S; Shun, MC; Serrao, E; Sowd, GA; Qian, J; Hao, CL; Dasgupta, T; Engelman, AN; Skowronski, J				Rasheedi, Sheeba; Shun, Ming-Chieh; Serrao, Erik; Sowd, Gregory A.; Qian, Juan; Hao, Caili; Dasgupta, Twishasri; Engelman, Alan N.; Skowronski, Jacek			The Cleavage and Polyadenylation Specificity Factor 6 (CPSF6) Subunit of the Capsid-recruited Pre-messenger RNA Cleavage Factor I (CFIm) Complex Mediates HIV-1 Integration into Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MESSENGER-RNA; STRUCTURAL BASIS; DNA INTEGRATION; NUCLEAR IMPORT; SPLICING FACTORS; SR PROTEINS; 3 END; LEDGF/P75; INFECTION	HIV-1 favors integration into active genes and gene-enriched regions of host cell chromosomes, thus maximizing the probability of provirus expression immediately after integration. This requires cleavage and polyadenylation specificity factor 6 (CPSF6), a cellular protein involved in pre-mRNA 3' end processing that binds HIV-1 capsid and connects HIV-1 preintegration complexes to intranuclear trafficking pathways that link integration to transcriptionally active chromatin. CPSF6 together with CPSF5 and CPSF7 are known subunits of the cleavage factor I (CFIm) 3' end processing complex; however, CPSF6 could participate in additional protein complexes. The molecular mechanisms underpinning the role of CPSF6 in HIV-1 infection remain to be defined. Here, we show that a majority of cellular CPSF6 is incorporated into the CFIm complex. HIV-1 capsid recruits CFIm in a CPSF6-dependent manner, which suggests that the CFIm-complex mediates the known effects of CPSF6 in HIV-1 infection. To dissect the roles of CPSF6 and other CFIm complex subunits in HIV-1 infection, we analyzed virologic and integration site targeting properties of a CPSF6 variant with mutations that prevent its incorporation into CFIm. We show, somewhat surprisingly, that CPSF6 incorporation into CFIm is not required for its ability to direct preferential HIV-1 integration into genes. The CPSF5 and CPSF7 subunits appear to have only a minor, if any, role in this process even though they appear to facilitate CPSF6 binding to capsid. Thus, CPSF6 alone controls the key molecular interactions that specify HIV-1 preintegration complex trafficking to active chromatin.	[Rasheedi, Sheeba; Shun, Ming-Chieh; Qian, Juan; Hao, Caili; Dasgupta, Twishasri; Skowronski, Jacek] Case Western Reserve Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Serrao, Erik; Sowd, Gregory A.; Engelman, Alan N.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02215 USA	Case Western Reserve University; Harvard University; Dana-Farber Cancer Institute	Skowronski, J (corresponding author), Case Western Reserve Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	jacek.skowronski@case.edu			National Institutes of Health [P50 GM082251]; National Institutes of Health Center for AIDS Research [P30 AI036219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007245, P30AI036219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Center for AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P50 GM082251 (to A. N. E. and J. S.). Shared resources at Case Western Reserve University are supported by National Institutes of Health Center for AIDS Research Grant P30 AI036219. The authors declare that they have no conflicts of interest with the contents of this article.	Ambrose Z, 2012, J VIROL, V86, P4708, DOI 10.1128/JVI.05887-11; Bhattacharya A, 2014, P NATL ACAD SCI USA, V111, P18625, DOI 10.1073/pnas.1419945112; Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Chin CR, 2015, CELL REP, V13, P1717, DOI 10.1016/j.celrep.2015.10.036; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; De Iaco A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-20; Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200; Di Nunzio F, 2013, VIROLOGY, V440, P8, DOI 10.1016/j.virol.2013.02.008; Ferris AL, 2010, P NATL ACAD SCI USA, V107, P3135, DOI 10.1073/pnas.0914142107; Fricke T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-46; Gres AT, 2015, SCIENCE, V349, P99, DOI 10.1126/science.aaa5936; Gruber AR, 2012, RNA BIOL, V9, P1405, DOI 10.4161/rna.22570; Hori T, 2013, J VIROL, V87, P7726, DOI 10.1128/JVI.00124-13; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Hulme AE, 2011, P NATL ACAD SCI USA, V108, P9975, DOI 10.1073/pnas.1014522108; Katahira J, 2013, NUCLEIC ACIDS RES, V41, P7060, DOI 10.1093/nar/gkt414; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Koh Y, 2013, J VIROL, V87, P648, DOI 10.1128/JVI.01148-12; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Lee K, 2012, J VIROL, V86, P3851, DOI 10.1128/JVI.06607-11; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Maertens GN, 2014, P NATL ACAD SCI USA, V111, P2728, DOI 10.1073/pnas.1320755111; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Martin G, 2010, RNA, V16, P1646, DOI 10.1261/rna.2164210; Matreyek KA, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0090-z; Matreyek KA, 2011, J VIROL, V85, P7818, DOI 10.1128/JVI.00325-11; Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Pornillos O, 2010, J MOL BIOL, V401, P985, DOI 10.1016/j.jmb.2010.06.042; Price AJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004459; Price AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002896; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruegsegger U, 1996, J BIOL CHEM, V271, P6107; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Schrijvers R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002558; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2008, J VIROL, V82, P11555, DOI 10.1128/JVI.01561-08; Singh PK, 2015, GENE DEV, V29, P2287, DOI 10.1101/gad.267609.115; Sowd GA, 2016, P NATL ACAD SCI USA, V113, pE1054, DOI 10.1073/pnas.1524213113; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Yang Q, 2011, STRUCTURE, V19, P368, DOI 10.1016/j.str.2010.12.021; Yang Q, 2010, P NATL ACAD SCI USA, V107, P10062, DOI 10.1073/pnas.1000848107; Zhang RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015620	53	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11809	11819		10.1074/jbc.M116.721647	http://dx.doi.org/10.1074/jbc.M116.721647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	26994143	Green Published, hybrid			2022-12-28	WOS:000377264800030
J	Zhong, MM; Zhao, XW; Li, JM; Yuan, WJ; Yan, GH; Tong, MM; Guo, SG; Zhu, YC; Jiang, Y; Liu, YJ; Jiang, Y				Zhong, Mingming; Zhao, Xuwen; Li, Jinmei; Yuan, Wenjie; Yan, Gonghong; Tong, Mingming; Guo, Shuguang; Zhu, Yichao; Jiang, Yong; Liu, Yongjian; Jiang, Yu			Tumor Suppressor Folliculin Regulates mTORC1 through Primary Cilia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOGG-DUBE-SYNDROME; POLYCYSTIC KIDNEYS; SENSORY ORGANELLE; SIGNALING CENTER; CELLS ANTENNA; GENE-PRODUCT; ACTIVATION; PATHWAY; DISEASE; PROTEIN	Folliculin (FLCN) is the tumor suppressor associated with Birt-Hogg-Dube (BHD) syndrome that predisposes patients to incident of hamartomas and cysts in multiple organs. Its inactivation causes deregulation in the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway. However, the underlying mechanism is poorly defined. In this study, we show that FLCN is a ciliary protein that functions through primary cilia to regulate mTORC1. In response to flow stress, FLCN associates with LKB1 and recruits the kinase to primary cilia for activation of AMPK resided at basal bodies, which causes mTORC1 down-regulation. In cells depleted of FLCN, LKB1 fails to accumulate in primary cilia and AMPK at the basal bodies remains inactive, thus nullifying the inhibitory effect of flow stress on mTORC1 activity. Our results demonstrate that FLCN is part of a flow sensory mechanism that regulates mTORC1 through primary cilia.	[Zhong, Mingming; Zhao, Xuwen; Li, Jinmei; Jiang, Yong] Southern Med Univ, Minist Educ China, State Key Lab Organ Failure Res,Dept Pathophysiol, Key Lab Transcript & Prote,Guangdong Prov Key Lab, Guangzhou 510515, Guangdong, Peoples R China; [Zhong, Mingming; Zhao, Xuwen; Li, Jinmei; Yuan, Wenjie; Yan, Gonghong; Tong, Mingming; Guo, Shuguang; Jiang, Yu] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Zhu, Yichao; Liu, Yongjian] Nanjing Med Univ, Dept Physiol, Nanjing 211166, Jiangsu, Peoples R China	Ministry of Education, China; Southern Medical University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nanjing Medical University	Jiang, Y (corresponding author), Southern Med Univ, Minist Educ China, State Key Lab Organ Failure Res,Dept Pathophysiol, Key Lab Transcript & Prote,Guangdong Prov Key Lab, Guangzhou 510515, Guangdong, Peoples R China.; Jiang, Y (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA.	jiang48321@163.com; yuj5@pitt.edu	Liu, Yongjian/J-7852-2018		National Institutes of Health [CA169186]; National Natural Science Foundation of China [81272269, 81372030]; NATIONAL CANCER INSTITUTE [R21CA169186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA169186 (to Yu J.) and National Natural Science Foundation of China Grants 81272269 (to Yu J.) and 81372030 (to Yong J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Baba M, 2012, BLOOD, V120, P1254, DOI 10.1182/blood-2012-02-410407; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Chen JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003581; Dere R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009239; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hartman TR, 2009, HUM MOL GENET, V18, P151, DOI 10.1093/hmg/ddn325; Hasumi H, 2015, P NATL ACAD SCI USA, V112, pE1624, DOI 10.1073/pnas.1419502112; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Huber TB, 2011, KIDNEY INT, V79, P502, DOI 10.1038/ki.2010.457; Hudon V, 2010, J MED GENET, V47, P182, DOI 10.1136/jmg.2009.072009; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kim S, 2013, CURR OPIN CELL BIOL, V25, P506, DOI 10.1016/j.ceb.2013.04.011; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Luijten MNH, 2013, HUM MOL GENET, V22, P4383, DOI 10.1093/hmg/ddt288; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Pan JM, 2013, CELL MOL LIFE SCI, V70, P1849, DOI 10.1007/s00018-012-1052-z; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schmidt LS, 2013, FAM CANCER, V12, P357, DOI 10.1007/s10689-012-9574-y; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Takagi Y, 2008, ONCOGENE, V27, P5339, DOI 10.1038/onc.2008.261; Verhey KJ, 2011, BIOCHEM SOC T, V39, P1120, DOI 10.1042/BST0391120; Yan M, 2014, J CLIN INVEST, V124, P2640, DOI 10.1172/JCI71749; Yang Y, 2008, CANCER GENET CYTOGEN, V180, P100, DOI 10.1016/j.cancergencyto.2007.10.010	35	23	23	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11689	11697		10.1074/jbc.M116.719997	http://dx.doi.org/10.1074/jbc.M116.719997			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27072130	Green Published, hybrid			2022-12-28	WOS:000377264800019
J	Lu, L; Lin, CD; Yan, ZJ; Wang, S; Zhang, YH; Wang, SH; Wang, JL; Liu, C; Chen, JF				Lu, Ling; Lin, ChangDong; Yan, ZhanJun; Wang, Shu; Zhang, YouHua; Wang, ShiHui; Wang, JunLei; Liu, Cui; Chen, JianFeng			Kindlin-3 Is Essential for the Resting alpha 4 beta 1 Integrin-mediated Firm Cell Adhesion under Shear Flow Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOCYTE ADHESION; DEFICIENCY-III; OUTSIDE-IN; T-CELLS; COACTIVATOR KINDLIN-3; DIVALENT-CATIONS; STRUCTURAL BASIS; ACTIVATION; AFFINITY; BINDING	Integrin-mediated rolling and firm cell adhesion are two critical steps in leukocyte trafficking. Integrin alpha 4 beta 1 mediates a mixture of rolling and firm cell adhesion on vascular cell adhesion molecule-1 (VCAM-1) when in its resting state but only supports firm cell adhesion upon activation. The transition from rolling to firm cell adhesion is controlled by integrin activation. Kindlin-3 has been shown to bind to integrin tails and trigger integrin activation via inside-out signaling. However, the role of kindlin-3 in regulating resting alpha 4 beta 1-mediated cell adhesion is not well characterized. Herein we demonstrate that kindlin-3 was required for the resting alpha 4 beta 1-mediated firm cell adhesion but not rolling adhesion. Knockdown of kindlin-3 significantly decreased the binding of kindlin-3 to beta 1 and down regulated the binding affinity of the resting alpha 4 beta 1 to soluble VCAM-1. Notably, it converted the resting alpha 4 beta 1-mediated firm cell adhesion to rolling adhesion on VCAM-1 substrates, increased cell rolling velocity, and impaired the stability of cell adhesion. By contrast, firm cell adhesion mediated by Mn2+ activated alpha 4 beta 1 was barely affected by knockdown of kindlin-3. Structurally, lack of kindlin-3 led to a more bent conformation of the resting alpha 4 beta 1. Thus, kindlin-3 plays an important role in maintaining a proper conformation of the resting alpha 4 beta 1 to mediate both rolling and firm cell adhesion. Defective kindlin-3 binding to the resting alpha 4 beta 1 leads to a transition from firm to rolling cell adhesion on VCAM-1, implying its potential role in regulating the transition between integrin-mediated rolling and firm cell adhesion.	[Lu, Ling; Lin, ChangDong; Wang, Shu; Zhang, YouHua; Wang, ShiHui; Wang, JunLei; Liu, Cui; Chen, JianFeng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol,CAS Ctr Excellence Mol Ce, Shanghai 200031, Peoples R China; [Yan, ZhanJun] Soochow Univ, Affiliated Hosp 2, Suzhou 215004, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Soochow University - China	Chen, JF (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	jfchen@sibcb.ac.cn		Lin, ChangDong/0000-0002-6766-3699	National Basic Research Program of China [2014CB541905]; National Natural Science Foundation of China [31525016, 31190061, 31271487]; Personalized Medicines Molecular Signature-based Drug Discovery and Development; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12000000]; Chinese Academy of Sciences/State Administration of Foreign Experts Affairs International Partnership Program for Creative Research Teams; Science and Technology Commission of Shanghai Municipality [11JC1414200]; Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Personalized Medicines Molecular Signature-based Drug Discovery and Development; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences/State Administration of Foreign Experts Affairs International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program	This work was supported by National Basic Research Program of China Grant 2014CB541905; National Natural Science Foundation of China Grants 31525016, 31190061, and 31271487; Personalized Medicines Molecular Signature-based Drug Discovery and Development; Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA12000000; the Chinese Academy of Sciences/State Administration of Foreign Experts Affairs International Partnership Program for Creative Research Teams; Science and Technology Commission of Shanghai Municipality Grant 11JC1414200; and the Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program. The authors declare that they have no conflicts of interest with the contents of this article.	Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Askari JA, 2010, J CELL BIOL, V188, P891, DOI 10.1083/jcb.200907174; Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chen C, 1999, J IMMUNOL, V162, P1084; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen J, 2006, P NATL ACAD SCI USA, V103, P13062, DOI 10.1073/pnas.0605666103; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Chigaev A, 2003, J BIOL CHEM, V278, P38174, DOI 10.1074/jbc.M210472200; Cohen SJ, 2013, BLOOD, V122, P2609, DOI 10.1182/blood-2013-04-495036; de Chateau M, 2001, BIOCHEMISTRY-US, V40, P13972, DOI 10.1021/bi011582f; Dixit N, 2012, J IMMUNOL, V189, P5954, DOI 10.4049/jimmunol.1201638; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Hyduk SJ, 2011, J IMMUNOL, V187, P4360, DOI 10.4049/jimmunol.1003725; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kahner BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034056; Karakose E, 2010, J CELL SCI, V123, P2353, DOI 10.1242/jcs.064600; KASSNER PD, 1993, J EXP MED, V178, P649, DOI 10.1084/jem.178.2.649; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Lefort CT, 2012, BLOOD, V119, P4275, DOI 10.1182/blood-2011-08-373118; Leitinger B, 2000, BBA-MOL CELL RES, V1498, P91, DOI 10.1016/S0167-4889(00)00086-0; Liao ZJ, 2015, BLOOD, V125, P1995, DOI 10.1182/blood-2014-09-603035; Lim YC, 2000, MICROCIRCULATION, V7, P201, DOI 10.1038/sj.mn.7300103; Liu SC, 2000, J CELL SCI, V113, P3563; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Manevich-Mendelson E, 2009, BLOOD, V114, P2344, DOI 10.1182/blood-2009-04-218636; McDowall A, 2010, BLOOD, V115, P4834, DOI 10.1182/blood-2009-08-238709; Meller J, 2012, J THROMB HAEMOST, V10, P1397, DOI 10.1111/j.1538-7836.2012.04768.x; Moretti F, 2010, EUR J CELL BIOL, V89, P51; Moretti FA, 2013, P NATL ACAD SCI USA, V110, P17005, DOI 10.1073/pnas.1316032110; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Pan YP, 2010, P NATL ACAD SCI USA, V107, P21388, DOI 10.1073/pnas.1015487107; Rose DM, 2000, BLOOD, V95, P602, DOI 10.1182/blood.V95.2.602; Salas A, 2002, J BIOL CHEM, V277, P50255, DOI 10.1074/jbc.M209822200; Shimaoka M, 2004, CURR TOP MED CHEM, V4, P1485, DOI 10.2174/1568026043387575; Sun H, 2014, DEV CELL, V30, P61, DOI 10.1016/j.devcel.2014.05.002; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TAKADA Y, 1993, J BIOL CHEM, V268, P17597; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Theodosiou M, 2016, ELIFE, V5, DOI 10.7554/eLife.10130; Tidswell M, 1997, J IMMUNOL, V159, P1497; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Ye F, 2013, CURR BIOL, V23, P2288, DOI 10.1016/j.cub.2013.09.050; Ye F, 2011, CURR OPIN HEMATOL, V18, P356, DOI 10.1097/MOH.0b013e3283497f09; Yue J, 2013, J BIOL CHEM, V288, P14228, DOI 10.1074/jbc.M113.462630; Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702	60	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10363	10371		10.1074/jbc.M116.717694	http://dx.doi.org/10.1074/jbc.M116.717694			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26994136	Green Published, hybrid			2022-12-28	WOS:000375602800041
J	Liu, Y; Rodrigues, JPGLM; Bonvin, AMJJ; Zaal, EA; Berkers, CR; Heger, M; Gawarecka, K; Swiezewska, E; Breukink, E; Egmond, MR				Liu, Yao; Rodrigues, Joao P. G. L. M.; Bonvin, Alexandre M. J. J.; Zaal, Esther A.; Berkers, Celia R.; Heger, Michal; Gawarecka, Katarzyna; Swiezewska, Ewa; Breukink, Eefjan; Egmond, Maarten R.			New Insight into the Catalytic Mechanism of Bacterial MraY from Enzyme Kinetics and Docking Studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLMURAMYL-PENTAPEPTIDE-TRANSLOCASE; 1ST MEMBRANE STEP; LYSIS PROTEIN-E; PEPTIDOGLYCAN SYNTHESIS; ESCHERICHIA-COLI; INHIBITION; SITE; PREDICTION; IDENTIFICATION; PURIFICATION	Phospho-MurNAc-pentapeptide translocase (MraY) catalyzes the synthesis of Lipid I, a bacterial peptidoglycan precursor. As such, MraY is essential for bacterial survival and therefore is an ideal target for developing novel antibiotics. However, the understanding of its catalytic mechanism, despite the recently determined crystal structure, remains limited. In the present study, the kinetic properties of Bacillus subtilis MraY (BsMraY) were investigated by fluorescence enhancement using dansylated UDP-MurNAc-pentapeptide and heptaprenyl phosphate (C35-P, short chain homolog of undecaprenyl phosphate, the endogenous substrate of MraY) as second substrate. Varying the concentrations of both of these substrates and fitting the kinetics data to two-substrate models showed that the concomitant binding of both UDP-MurNAc-pentapeptide-DNS and C35-P to the enzyme is required before the release of the two products, Lipid I and UMP. We built a model of BsMraY and performed docking studies with the substrate C35-P to further deepen our understanding of how MraY accommodates this lipid substrate. Based on these modeling studies, a novel catalytic role was put forward for a fully conserved histidine residue in MraY (His -289 in BsMraY), which has been experimentally confirmed to be essential for MraY activity. Using the current model of BsMraY, we propose that a small conformational change is necessary to relocate the His -289 residue, such that the translocase reaction can proceed via a nucleophilic attack of the phosphate moiety of C35 -P on bound UDP-MurNAc-pentapeptide.	[Liu, Yao; Breukink, Eefjan; Egmond, Maarten R.] Univ Utrecht, Inst Biomembranes, Dept Membrane Biochem & Biophys, NL-3584 CH Utrecht, Netherlands; [Rodrigues, Joao P. G. L. M.; Bonvin, Alexandre M. J. J.] Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Computat Struct Biol, NL-3584 CH Utrecht, Netherlands; [Zaal, Esther A.; Berkers, Celia R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Biomol Mass Spectrometry & Prote, NL-3584 CH Utrecht, Netherlands; [Heger, Michal] Univ Amsterdam, Acad Med Ctr, Dept Expt Surg, NL-1105 AZ Amsterdam, Netherlands; [Gawarecka, Katarzyna; Swiezewska, Ewa] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	Utrecht University; Utrecht University; Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Breukink, E (corresponding author), Univ Utrecht, Inst Biomembranes, Membrane Biochem & Biophys, NL-3584 CH Utrecht, Netherlands.	E.J.Breukink@uu.nl	RODRIGUES, JOÃO/AAC-6993-2019; Bonvin, Alexandre M.J.J./A-5420-2009; Breukink, Eefjan/I-3039-2016; Rodrigues, João/GVU-7735-2022; Rodrigues, João/J-6579-2013; Gawarecka, Katarzyna/N-6184-2014	Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Breukink, Eefjan/0000-0002-7311-0660; Rodrigues, João/0000-0001-9796-3193; Swiezewska, Ewa/0000-0002-3439-8948; Berkers, Celia/0000-0003-0746-8565	Netherlands Organization for Scientific Research (NWO) [205.100.008]; VENI grant from the NWO [722.013.009]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); VENI grant from the NWO	Supported by ZonMW Grant 205.100.008 from the Netherlands Organization for Scientific Research (NWO).r Supported by a VENI grant (project 722.013.009) from the NWO.	Al-Dabbagh B, 2008, J BACTERIOL, V190, P7141, DOI 10.1128/JB.00676-08; Al-Dabbagh B, 2008, BIOCHEMISTRY-US, V47, P8919, DOI 10.1021/bi8006274; Allner O, 2012, J CHEM THEORY COMPUT, V8, P1493, DOI 10.1021/ct3000734; Bouhss A, 2004, J BIOL CHEM, V279, P29974, DOI 10.1074/jbc.M314165200; Bouhss A, 1999, MOL MICROBIOL, V34, P576, DOI 10.1046/j.1365-2958.1999.01623.x; Boyle DS, 1998, J BACTERIOL, V180, P6429; Brandish PE, 1996, J BIOL CHEM, V271, P7609, DOI 10.1074/jbc.271.13.7609; Brandish PE, 1996, ANTIMICROB AGENTS CH, V40, P1640, DOI 10.1128/AAC.40.7.1640; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chang HY, 2014, J BIOL CHEM, V289, P18719, DOI 10.1074/jbc.M114.575076; Chung BC, 2013, SCIENCE, V341, P1012, DOI 10.1126/science.1236501; DANILOV LL, 1989, CHEM PHYS LIPIDS, V51, P191, DOI 10.1016/0009-3084(89)90006-6; deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HEYDANEK MG, 1969, BIOCHEMISTRY-US, V8, P1214, DOI 10.1021/bi00831a056; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Huang LY, 2014, ANGEW CHEM INT EDIT, V53, P8060, DOI 10.1002/anie.201402313; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Lloyd AJ, 2004, J BACTERIOL, V186, P1747, DOI 10.1128/JB.186.6.1747-1757.2004; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Ma Y, 2011, J BIOL CHEM, V286, P38844, DOI 10.1074/jbc.M111.301085; Mendel S, 2006, MICROBIOL-SGM, V152, P2959, DOI 10.1099/mic.0.28776-0; Mihalyi A., 2014, THESIS; Mihalyi A, 2014, BIOORGAN MED CHEM, V22, P4566, DOI 10.1016/j.bmc.2014.07.035; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Murakami R, 2009, J ANTIBIOT, V62, P153, DOI 10.1038/ja.2009.4; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-37; PLESS DD, 1973, J BIOL CHEM, V248, P1568; Rodolis MT, 2014, CHEMBIOCHEM, V15, P1300, DOI 10.1002/cbic.201402064; Rodrigues JPGLM, 2012, PROTEINS, V80, P1810, DOI 10.1002/prot.24078; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Stachyra T, 2004, ANTIMICROB AGENTS CH, V48, P897, DOI 10.1128/AAC.48.3.897-902.2004; Swiezewska Ewa, 1994, Acta Biochimica Polonica, V41, P221; Tanaka S, 2012, MOL MICROBIOL, V85, P975, DOI 10.1111/j.1365-2958.2012.08153.x; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Winn M, 2010, NAT PROD REP, V27, P279, DOI 10.1039/b816215h; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zheng Y, 2008, GENETICS, V180, P1459, DOI 10.1534/genetics.108.093443	44	10	10	0	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15057	15068		10.1074/jbc.M116.717884	http://dx.doi.org/10.1074/jbc.M116.717884			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226570	Green Published, hybrid			2022-12-28	WOS:000380583200017
J	Towner, LD; Wheat, RA; Hughes, TR; Morgan, BP				Towner, Laurence D.; Wheat, Richard A.; Hughes, Timothy R.; Morgan, B. Paul			Complement Membrane Attack and Tumorigenesis A SYSTEMS BIOLOGY APPROACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; GLOMERULAR MESANGIAL CELLS; NF-KAPPA-B; MATRIX METALLOPROTEINASES; GENE-EXPRESSION; REGULATORY PROTEINS; PROMOTER ACTIVITY; CANCER CELLS; FACTOR-ALPHA; TUMOR-CELLS	Tumor development driven by inflammation is now an established phenomenon, but the role that complement plays remains uncertain. Recent evidence has suggested that various components of the complement (C) cascade may influence tumor development in disparate ways; however, little attention has been paid to that of the membrane attack complex (MAC). This is despite abundant evidence documenting the effects of this complex on cell behavior, including cell activation, protection from/induction of apoptosis, release of inflammatory cytokines, growth factors, and ECM components and regulators, and the triggering of the NLRP3 inflammasome. Here we present a novel approach to this issue by using global gene expression studies in conjunction with a systems biology analysis. Using network analysis of MAC -responsive expression changes, we demonstrate a cluster of co-regulated genes known to have impact in the extracellular space and on the supporting stroma and with well characterized tumor -promoting roles. Network analysis highlighted the central role for EGE receptor activation in mediating the observed responses to MAC exposure. Overall, the study sheds light on the mechanisms by which sublytic MAC causes tumor cell responses and exposes a gene expression signature that implicates MAC as a driver of tumor progression. These findings have implications for understanding of the roles of complement and the MAC in tumor development and progression, which in turn will inform future therapeutic strategies in cancer.	[Towner, Laurence D.; Wheat, Richard A.; Hughes, Timothy R.; Morgan, B. Paul] Cardiff Univ, Complement Biol Grp, Div Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Towner, Laurence D.] Thomson Reuters IP & Sci, London EC1N 8JS, England	Cardiff University; Clarivate	Morgan, BP (corresponding author), Cardiff Univ, Sch Med, Div Infect & Immun, Syst Immun URI, Henry Wellcome Bldg,Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	MorganBP@cardiff.ac.uk			Cardiff University School of Medicine	Cardiff University School of Medicine	This work was supported by a Cardiff University School of Medicine Ph.D. studentship (to L. D. T.). The authors declare that they have no conflicts of interest relevant to the contents of this article.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Ahmad R, 2007, CELL SIGNAL, V19, P2549, DOI 10.1016/j.cellsig.2007.08.013; Badea TD, 2003, J NEUROIMMUNOL, V142, P58, DOI 10.1016/S0165-5728(03)00261-3; Beadling C, 1999, J IMMUNOL, V162, P2677; BENZAQUEN LR, 1994, J EXP MED, V179, P985, DOI 10.1084/jem.179.3.985; Bessarabova M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S13; Bjorge L, 2005, BRIT J CANCER, V92, P895, DOI 10.1038/sj.bjc.6602334; Bolitho C, 2010, ENDOCR-RELAT CANCER, V17, P929, DOI 10.1677/ERC-10-0107; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carpenter G, 1999, J CELL BIOL, V146, P697, DOI 10.1083/jcb.146.4.697; Castillo J, 2006, CANCER RES, V66, P6129, DOI 10.1158/0008-5472.CAN-06-0404; Chintakuntlawar AV, 2009, J INTERF CYTOK RES, V29, P657, DOI 10.1089/jir.2009.0006; Cole DS, 2003, CLIN SCI, V104, P455, DOI 10.1042/CS20020362; Corrales L, 2012, J IMMUNOL, V189, P4674, DOI 10.4049/jimmunol.1201654; Cybulsky AV, 1999, AM J PATHOL, V155, P1701, DOI 10.1016/S0002-9440(10)65485-5; D'Antonio A, 2002, INT J ONCOL, V21, P941; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; Fang F, 2011, AM J PATHOL, V179, P537, DOI 10.1016/j.ajpath.2011.05.007; Fang F, 2011, AM J PATHOL, V178, P2077, DOI 10.1016/j.ajpath.2011.01.035; Fishelson Z, 2003, MOL IMMUNOL, V40, P109, DOI 10.1016/S0161-5890(03)00112-3; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; Fosbrink M, 2006, J BIOL CHEM, V281, P19009, DOI 10.1074/jbc.M602055200; Gunn L, 2012, J IMMUNOL, V189, P2985, DOI 10.4049/jimmunol.1200846; HALPERIN JA, 1993, J CLIN INVEST, V91, P1974, DOI 10.1172/JCI116418; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HANSCH GM, 1987, INT ARCH ALLER A IMM, V82, P317, DOI 10.1159/000234216; Hepburn NJ, 2007, J BIOL CHEM, V282, P8292, DOI 10.1074/jbc.M609858200; Hila S, 2001, GLIA, V36, P58, DOI 10.1002/glia.1095; Huang MY, 2010, ONCOL REP, V24, P1241, DOI 10.3892/or_00000978; James AB, 2005, J NEUROCHEM, V95, P796, DOI 10.1111/j.1471-4159.2005.03400.x; JOHNSON GR, 1992, J CELL BIOL, V118, P741, DOI 10.1083/jcb.118.3.741; JOHNSON GR, 1993, J BIOL CHEM, V268, P2924; KILGORE KS, 1995, J IMMUNOL, V155, P1434; Kudo Y, 2012, J BIOL CHEM, V287, P38716, DOI 10.1074/jbc.M112.373159; Kumbrink J, 2010, J CELL BIOCHEM, V111, P207, DOI 10.1002/jcb.22690; LEJEUNE S, 1993, CANCER RES, V53, P3597; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Liu LS, 2012, J BIOL CHEM, V287, P16410, DOI 10.1074/jbc.M111.319566; LO TN, 1979, CANCER RES, V39, P3156; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Lucas SD, 1996, HUM PATHOL, V27, P1329, DOI 10.1016/S0046-8177(96)90346-9; Lueck K, 2011, EYE, V25, P1074, DOI 10.1038/eye.2011.109; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Markiewski MM, 2009, CANCER RES, V69, P6367, DOI 10.1158/0008-5472.CAN-09-1918; Markiewski MM, 2009, TRENDS IMMUNOL, V30, P286, DOI 10.1016/j.it.2009.04.002; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; MORGAN BP, 1989, BIOCHEM J, V264, P1; Morgia G, 2005, UROL RES, V33, P44, DOI 10.1007/s00240-004-0440-8; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; NICULESCU F, 1994, J BIOL CHEM, V269, P4417; NICULESCU F, 1992, AM J PATHOL, V140, P1039; Nunn MA, 2005, J IMMUNOL, V174, P2084, DOI 10.4049/jimmunol.174.4.2084; O'Barr SA, 2001, J IMMUNOL, V166, P4154, DOI 10.4049/jimmunol.166.6.4154; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Pio R, 2014, ADV EXP MED BIOL, V772, P229, DOI 10.1007/978-1-4614-5915-6_11; Pio R, 2013, SEMIN IMMUNOL, V25, P54, DOI 10.1016/j.smim.2013.04.001; Rubie C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-178; Rus HG, 1996, J IMMUNOL, V156, P4892; Rutkowski MJ, 2010, MOL CANCER RES, V8, P1453, DOI 10.1158/1541-7786.MCR-10-0225; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Taylor RP, 2014, METHODS, V65, P18, DOI 10.1016/j.ymeth.2013.07.027; Triantafilou K, 2013, J CELL SCI, V126, P2903, DOI 10.1242/jcs.124388; Viedt C, 2000, FASEB J, V14, P2370; WAGNER C, 1994, EXP NEPHROL, V2, P51; Wai PY, 2005, CARCINOGENESIS, V26, P741, DOI 10.1093/carcin/bgi027; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang Q, 2011, NAT MED, V17, P1674, DOI 10.1038/nm.2543; YAMAKAWA M, 1994, CANCER, V73, P2808, DOI 10.1002/1097-0142(19940601)73:11<2808::AID-CNCR2820731125>3.0.CO;2-P; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Yee J, 1997, KIDNEY INT, V52, P120, DOI 10.1038/ki.1997.311; Ytting H, 2004, SCAND J GASTROENTERO, V39, P674, DOI 10.1080/00365520410005603; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338	77	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14927	14938		10.1074/jbc.M115.708446	http://dx.doi.org/10.1074/jbc.M115.708446			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226542	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000380583200006
J	Tian, XF; Irannejad, R; Bowman, SL; Du, Y; Puthenveedu, MA; von Zastrow, M; Benovic, JL				Tian, Xufan; Irannejad, Roshanak; Bowman, Shanna L.; Du, Yang; Puthenveedu, Manojkumar A.; von Zastrow, Mark; Benovic, Jeffrey L.			The -Arrestin ARRDC3 Regulates the Endosomal Residence Time and Intracellular Signaling of the (2)-Adrenergic Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arrestin; cell signaling; G protein-coupled receptor (GPCR); receptor recycling; trafficking; arrestin domain-containing protein 3; 2 adrenergic receptor; endosomal signaling	DOMAIN-CONTAINING PROTEINS; BETA(2)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; BETA-ARRESTINS; ENDOCYTIC PATHWAY; PDZ-DOMAIN; E3 LIGASE; TRAFFICKING; MEMBRANE; UBIQUITINATION	Arrestin domain-containing protein 3 (ARRDC3) is a member of the mammalian -arrestin family, which is predicted to share similar tertiary structure with visual-/-arrestins and also contains C-terminal PPXY motifs that mediate interaction with E3 ubiquitin ligases. Recently, ARRDC3 has been proposed to play a role in regulating the trafficking of G protein-coupled receptors, although mechanistic insight into this process is lacking. Here, we focused on characterizing the role of ARRDC3 in regulating the trafficking of the (2)-adrenergic receptor ((2)AR). We find that ARRDC3 primarily localizes to EEA1-positive early endosomes and directly interacts with the (2)AR in a ligand-independent manner. Although ARRDC3 has no effect on (2)AR endocytosis or degradation, it negatively regulates (2)AR entry into SNX27-occupied endosomal tubules. This results in delayed recycling of the receptor and a concomitant increase in (2)AR-dependent endosomal signaling. Thus, ARRDC3 functions as a switch to modulate the endosomal residence time and subsequent intracellular signaling of the (2)AR.	[Tian, Xufan; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Irannejad, Roshanak; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Bowman, Shanna L.; Puthenveedu, Manojkumar A.] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Puthenveedu, Manojkumar A.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Jefferson University; University of California System; University of California San Francisco; Carnegie Mellon University; Stanford University	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	jeffrey.benovic@jefferson.edu	Puthenveedu, Manojkumar A/A-3795-2016		Sidney Kimmel Cancer Center Bioimaging Facility; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL122508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047417, R01GM068857, R01GM117425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154, R21DA036086, R01DA010711, R01DA012864] Funding Source: NIH RePORTER	Sidney Kimmel Cancer Center Bioimaging Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Drs. B.T. Lobingier, M. Bouvier, and A. Marchese and the Sidney Kimmel Cancer Center Bioimaging Facility for reagents, technical advice, training, and support.	Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Aubry L, 2013, PROG MOL BIOL TRANSL, V118, P21, DOI 10.1016/B978-0-12-394440-5.00002-4; Aubry L, 2009, CURR GENOMICS, V10, P133, DOI 10.2174/138920209787847014; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Dores MR, 2015, MOL BIOL CELL, V26, P4660, DOI 10.1091/mbc.E15-05-0284; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Gallon M, 2014, P NATL ACAD SCI USA, V111, pE3604, DOI 10.1073/pnas.1410552111; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hamdan FF, 2006, CURR PROTOC NEUROSCI, V5, P523, DOI DOI 10.1002/0471142301.NS0523S34; Han SO, 2013, EMBO REP, V14, P164, DOI 10.1038/embor.2012.187; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hislop JN, 2011, METHODS MOL BIOL, V746, P425, DOI 10.1007/978-1-61779-126-0_25; Irannejad R, 2014, CURR OPIN CELL BIOL, V27, P109, DOI 10.1016/j.ceb.2013.10.003; Irannejad R, 2014, METHOD ENZYMOL, V535, P403, DOI 10.1016/B978-0-12-397925-4.00023-7; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jean-Charles PY, 2016, J CELL PHYSIOL, V231, P2071, DOI 10.1002/jcp.25317; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; Kang DS, 2013, METHOD ENZYMOL, V521, P91, DOI 10.1016/B978-0-12-391862-8.00005-3; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Oka S, 2006, ENDOCRINOLOGY, V147, P733, DOI 10.1210/en.2005-0679; Patwari P, 2011, CELL METAB, V14, P671, DOI 10.1016/j.cmet.2011.08.011; Puca L, 2013, J CELL SCI, V126, P4457, DOI 10.1242/jcs.130500; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Qi SQ, 2014, PROTEIN SCI, V23, P1708, DOI 10.1002/pro.2549; Qi SQ, 2014, J BIOL CHEM, V289, P4743, DOI 10.1074/jbc.M113.527473; Raiborg C, 2006, J CELL SCI, V119, P2414, DOI 10.1242/jcs.02978; Rauch S, 2011, J VIROL, V85, P3546, DOI 10.1128/JVI.02045-10; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Shea FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050557; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Werthmann RC, 2012, FASEB J, V26, P2043, DOI 10.1096/fj.11-195248; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801	44	43	43	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14510	14525		10.1074/jbc.M116.716589	http://dx.doi.org/10.1074/jbc.M116.716589			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226565	Green Published, hybrid			2022-12-28	WOS:000380366700009
J	Rorsman, C; Tsioumpekou, M; Heldin, CH; Lennartsson, J				Rorsman, Charlotte; Tsioumpekou, Maria; Heldin, Carl-Henrik; Lennartsson, Johan			The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor beta (PDGFR beta) Internalization and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; EGF RECEPTOR; DOWN-REGULATION; BINDING DOMAIN; IN-VIVO; PROTEIN; DEGRADATION; ENDOCYTOSIS; PHOSPHORYLATION; FAMILY	Protein ubiquitination controls protein stability and subcellular localization of tyrosine kinase receptors, hence affecting signaling both quantitatively and qualitatively. In this report, we demonstrate that, after ligand stimulation, the PDGF beta receptor (PDGFR beta) becomes ubiquitinated in a manner requiring both the c-Cbl and Cbl-b ubiquitin ligases. Simultaneous depletion of c-Cbl and Cbl-b resulted in reduced ligand-induced PDGFR beta clearance from the cell surface because of reduced endocytosis of the receptor. Cbl-b formed a complex with c-Cbl, as well as with the PDGFR beta, in response to PDGF-BB stimulation. We were unable to find a direct interaction between the receptor and c-Cbl, raising the possibility that Cbl-b is necessary for c-Cbl to interact with PDGFR beta. Phosphorylated Tyr-1021 in PDGFR beta was the primary interaction site for Cbl-b, with some contribution from Tyr-1009. Depletion of c-Cbl and Cbl-b led to an increased ligand-induced tyrosine phosphorylation of the receptor. Several tyrosine residues with elevated phosphorylation (i.e. Tyr-579, Tyr-581, Tyr-1009, and Tyr-1021) have previously been shown to interact with Src kinases and PLC gamma. Indeed, in cells depleted of c-Cbl and Cbl-b, both Src and PLC gamma phosphorylation were enhanced, whereas activation of other pathways, such as Erk1/2 MAP kinase and Akt, were not affected. In addition, Stat3 phosphorylation, which has been connected to Src activity, was also elevated in cells lacking c-Cbl and Cbl-b. Functionally, we found that cells depleted of c-Cbl and Cbl-b were more prone to migrate toward PDGF-BB, whereas no reproducible effect on cell proliferation could be observed. In conclusion, internalization as well as signaling via PDGFR beta are controlled by ubiquitination.	[Rorsman, Charlotte; Tsioumpekou, Maria; Heldin, Carl-Henrik; Lennartsson, Johan] Uppsala Univ, Sci Life Lab, Ludwig Inst Canc Res, S-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University	Lennartsson, J (corresponding author), Biomed Ctr, Ludwig Inst Canc Res, Box 595, S-75124 Uppsala, Sweden.	Johan.Lennartsson@LICR.uu.se			Swedish Cancer Society [140332]; Ludwig Institute for Cancer Research	Swedish Cancer Society(Swedish Cancer Society); Ludwig Institute for Cancer Research	This work was supported by Swedish Cancer Society Grant 140332 and the Ludwig Institute for Cancer Research. The authors declare that they have no conflicts of interest with the contents of this article.	Bonita DP, 1997, MOL CELL BIOL, V17, P4597, DOI 10.1128/MCB.17.8.4597; Bornfeldt KE, 1995, ANN NY ACAD SCI, V766, P416, DOI 10.1111/j.1749-6632.1995.tb26691.x; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; GALISTEO ML, 1995, J BIOL CHEM, V270, P20242, DOI 10.1074/jbc.270.35.20242; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; HELDIN CH, 1982, J BIOL CHEM, V257, P4216; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kales SC, 2010, CANCER RES, V70, P4789, DOI 10.1158/0008-5472.CAN-10-0610; Lennartsson J, 2013, J BIOL CHEM, V288, P15736, DOI 10.1074/jbc.M113.476424; Mao YF, 2011, J BIOL CHEM, V286, P41852, DOI 10.1074/jbc.M111.288514; Miyake S, 1999, J BIOL CHEM, V274, P16619, DOI 10.1074/jbc.274.23.16619; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; MORI S, 1993, EMBO J, V12, P2257, DOI 10.1002/j.1460-2075.1993.tb05879.x; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Reddi AL, 2007, J BIOL CHEM, V282, P29336, DOI 10.1074/jbc.M701797200; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; VALIUS M, 1993, MOL CELL BIOL, V13, P133, DOI 10.1128/MCB.13.1.133; Wang YZ, 2000, ONCOGENE, V19, P2075, DOI 10.1038/sj.onc.1203548	26	18	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11608	11618		10.1074/jbc.M115.705814	http://dx.doi.org/10.1074/jbc.M115.705814			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27048651	Green Published, hybrid			2022-12-28	WOS:000377264800013
J	Solopova, A; Formosa-Dague, C; Courtin, P; Furlan, S; Veiga, P; Pechoux, C; Armalyte, J; Sadauskas, M; Kok, J; Hols, P; Dufrene, YF; Kuipers, OP; Chapot-Chartier, MP; Kulakauskas, S				Solopova, Ana; Formosa-Dague, Cecile; Courtin, Pascal; Furlan, Sylviane; Veiga, Patrick; Pechoux, Christine; Armalyte, Julija; Sadauskas, Mikas; Kok, Jan; Hols, Pascal; Dufrene, Yves F.; Kuipers, Oscar P.; Chapot-Chartier, Marie-Pierre; Kulakauskas, Saulius			Regulation of Cell Wall Plasticity by Nucleotide Metabolism in Lactococcus lactis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aspartate (aspartic acid); bacteria; cell wall; nucleoside; nucleotide metabolism; peptidoglycan	PEPTIDOGLYCAN; ACID; SYSTEM; DNA; IDENTIFICATION; EXPRESSION; BACTERIA; PLASMID; GROWTH; MURAMIDASE	To ensure optimal cell growth and separation and to adapt to environmental parameters, bacteria have to maintain a balance between cell wall (CW) rigidity and flexibility. This can be achieved by a concerted action of peptidoglycan (PG) hydrolases and PG-synthesizing/modifying enzymes. In a search for new regulatory mechanisms responsible for the maintenance of this equilibrium in Lactococcus lactis, we isolated mutants that are resistant to the PG hydrolase lysozyme. We found that 14% of the causative mutations were mapped in the guaA gene, the product of which is involved in purine metabolism. Genetic and transcriptional analyses combined with PG structure determination of the guaA mutant enabled us to reveal the pivotal role of the pyrB gene in the regulation of CW rigidity. Our results indicate that conversion of l-aspartate (l-Asp) to N-carbamoyl-l-aspartate by PyrB may reduce the amount of l-Asp available for PG synthesis and thus cause the appearance of Asp/Asn-less stem peptides in PG. Such stem peptides do not form PG cross-bridges, resulting in a decrease in PG cross-linking and, consequently, reduced PG thickness and rigidity. We hypothesize that the concurrent utilization of l-Asp for pyrimidine and PG synthesis may be part of the regulatory scheme, ensuring CW flexibility during exponential growth and rigidity in stationary phase. The fact that l-Asp availability is dependent on nucleotide metabolism, which is tightly regulated in accordance with the growth rate, provides L. lactis cells the means to ensure optimal CW plasticity without the need to control the expression of PG synthesis genes.	[Solopova, Ana; Kok, Jan; Kuipers, Oscar P.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, Nijenborgh 7, NL-9747 AG Groningen, Netherlands; [Formosa-Dague, Cecile; Hols, Pascal; Dufrene, Yves F.] Catholic Univ Louvain, Inst Life Sci, Croix Sud 4-5,Bte L7-07-06, B-1348 Louvain, Belgium; [Courtin, Pascal; Furlan, Sylviane; Veiga, Patrick; Armalyte, Julija; Sadauskas, Mikas; Chapot-Chartier, Marie-Pierre; Kulakauskas, Saulius] Univ Paris Saclay, AgroParisTech, Inst Natl Rech Agron, Micalis Inst, F-78350 Jouy En Josas, France; [Pechoux, Christine] Univ Paris Saclay, AgroParisTech, Inst Natl Rech Agron, Genet Anim & Biol Integrat, F-78350 Jouy En Josas, France; [Formosa-Dague, Cecile; Hols, Pascal; Dufrene, Yves F.] FNRS, Brussels, Belgium; [Veiga, Patrick] Danone Nutr Res, RD 128,Ave Vauve, F-91767 Palaiseau, France; [Armalyte, Julija] Vilnius State Univ, Fac Nat Sci, Dept Biochem & Mol Biol, MK Ciurlionio 21, LT-03101 Vilnius, Lithuania; [Sadauskas, Mikas] Vilnius State Univ, Fac Nat Sci, Dept Microbiol & Biotechnol, Ciurlionio 21-27, LT-03101 Vilnius, Lithuania	University of Groningen; Universite Catholique Louvain; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Fonds de la Recherche Scientifique - FNRS; Danone Nutricia; Vilnius University; Vilnius University	Kulakauskas, S (corresponding author), Univ Paris Saclay, AgroParisTech, Inst Natl Rech Agron, Micalis Inst, F-78350 Jouy En Josas, France.	Saulius.Kulakauskas@jouy.inra.fr	Kok, Jan/C-9972-2012; Armalyte, Julija/L-5149-2019; Sadauskas, Mikas/ABC-2607-2020; Veiga, Patrick/A-9862-2011; Kuipers, Oscar/B-6752-2009	Armalyte, Julija/0000-0003-0986-9805; Veiga, Patrick/0000-0001-6318-8547; Kuipers, Oscar/0000-0001-5596-7735; Formosa-Dague, Cecile/0000-0002-8627-3784; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519; Dufrene, Yves/0000-0002-7289-4248; Sadauskas, Mikas/0000-0001-9072-6523	Region Ile-de-France; National Foundation for Scientific Research (FNRS); Research Department of the Communaute francaise de Belgique (Concerted Research Action); Region Ile-de-France (Domaine d'Interet Majeur Malinf)	Region Ile-de-France(Region Ile-de-France); National Foundation for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Research Department of the Communaute francaise de Belgique (Concerted Research Action); Region Ile-de-France (Domaine d'Interet Majeur Malinf)(Region Ile-de-France)	This work was supported in part by the Institut National de la Recherche Agronomique and the Region Ile-de-France (to P. C., S. F., P. V., J. A., M. S., M.-P.C.-C., and S. K.) and the National Foundation for Scientific Research (FNRS) and the Research Department of the Communaute francaise de Belgique (Concerted Research Action) (to C. F.-D., Y. F. D., and P. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a fellowship from the Region Ile-de-France (Domaine d'Interet Majeur Malinf). Present address: Dept. of Biochemistry and Molecular Biology, Faculty of Natural Sciences, Vilnius University, M. K. Ciurlionio 21, LT-03101 Vilnius, Lithuania.	Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Brouwer R. W. W., 2014, THESIS U GRONINGEN N; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Buckley ND, 1999, APPL ENVIRON MICROB, V65, P3800; BUIST G, 1995, J BACTERIOL, V177, P1554, DOI 10.1128/jb.177.6.1554-1563.1995; Cava F, 2014, CURR OPIN MICROBIOL, V18, P46, DOI 10.1016/j.mib.2014.01.004; Chapot-Chartier MP, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S9; Chapot-Chartier MP, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P383, DOI 10.1007/978-3-642-05062-6_13; Chopinet L, 2013, MICRON, V48, P26, DOI 10.1016/j.micron.2013.02.003; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; CRUZRODZ AL, 1990, MOL GEN GENET, V224, P152, DOI 10.1007/BF00259462; Daveran-Mingot ML, 1998, J BACTERIOL, V180, P4834, DOI 10.1128/JB.180.18.4834-4842.1998; de Jong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053085; Dufrene YF, 2014, MBIO, V5, DOI 10.1128/mBio.01363-14; Duwat P, 1997, J BACTERIOL, V179, P4473, DOI 10.1128/jb.179.14.4473-4479.1997; Formosa C, 2015, NAT PROTOC, V10, P199, DOI 10.1038/nprot.2015.004; GASSON MJ, 1983, J BACTERIOL, V154, P1; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Hauryliuk V, 2015, NAT REV MICROBIOL, V13, P298, DOI 10.1038/nrmicro3448; Ibrahim HR, 2001, J BIOL CHEM, V276, P43767, DOI 10.1074/jbc.M106317200; JENSEN PR, 1993, APPL ENVIRON MICROB, V59, P4363, DOI 10.1128/AEM.59.12.4363-4366.1993; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Kilstrup M, 2005, FEMS MICROBIOL REV, V29, P555, DOI 10.1016/j.femsre.2005.04.006; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Lee TK, 2013, CURR OPIN MICROBIOL, V16, P760, DOI 10.1016/j.mib.2013.08.005; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; Leloup L, 1997, APPL ENVIRON MICROB, V63, P2117, DOI 10.1128/AEM.63.6.2117-2123.1997; Loskill P, 2014, BIOPHYS J, V107, P1082, DOI 10.1016/j.bpj.2014.07.029; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Martinez B, 2007, MOL MICROBIOL, V64, P473, DOI 10.1111/j.1365-2958.2007.05668.x; Martinussen J, 2001, J BACTERIOL, V183, P2785, DOI 10.1128/JB.183.9.2785-2794.2001; MARTINUSSEN J, 1994, J BACTERIOL, V176, P1514, DOI 10.1128/jb.176.5.1514-1516.1994; Matsuhashi M., 1994, BACTERIAL CELL WALL, P55; Mercier C, 2000, FEMS MICROBIOL LETT, V187, P47, DOI 10.1111/j.1574-6968.2000.tb09135.x; Mercier C, 2002, MOL MICROBIOL, V46, P235, DOI 10.1046/j.1365-2958.2002.03160.x; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Moynihan PJ, 2011, INT J BIOCHEM CELL B, V43, P1655, DOI 10.1016/j.biocel.2011.08.007; Pinho MG, 2013, NAT REV MICROBIOL, V11, P601, DOI 10.1038/nrmicro3088; Pinto J., 2015, THESIS U GRONINGEN N; Rallu F, 2000, MOL MICROBIOL, V35, P517, DOI 10.1046/j.1365-2958.2000.01711.x; Rallu F, 1996, ANTON LEEUW INT J G, V70, P243, DOI 10.1007/BF00395935; Regulski K, 2013, J BIOL CHEM, V288, P20416, DOI 10.1074/jbc.M112.446344; Regulski K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032301; Reichmann NT, 2013, MICROBIOL-SGM, V159, P1868, DOI 10.1099/mic.0.069898-0; Renye JA, 2010, J APPL MICROBIOL, V108, P2142, DOI 10.1111/j.1365-2672.2009.04615.x; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Shepherd J, 2013, FEBS LETT, V587, P2895, DOI 10.1016/j.febslet.2013.07.036; Singh SK, 2012, MOL MICROBIOL, V86, P1036, DOI 10.1111/mmi.12058; Steen A, 2005, J BACTERIOL, V187, P114, DOI 10.1128/JB.187.1.114-124.2005; Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x; Turner RD, 2014, MOL MICROBIOL, V91, P862, DOI 10.1111/mmi.12513; van Heijenoort J, 2007, MICROBIOL MOL BIOL R, V71, P620, DOI 10.1128/MMBR.00016-07; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Veiga P, 2006, MOL MICROBIOL, V62, P1713, DOI 10.1111/j.1365-2958.2006.05474.x; Veiga P, 2009, J BACTERIOL, V191, P3752, DOI 10.1128/JB.00126-09; Vollmer W, 2004, J BACTERIOL, V186, P5978, DOI 10.1128/jb.186.18.5978-5987.2004; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Vollmer W, 2012, MOL MICROBIOL, V86, P1031, DOI 10.1111/mmi.12059; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wheeler R, 2015, MBIO, V6, DOI 10.1128/mBio.00660-15; Wilson DN, 2007, CRIT REV BIOCHEM MOL, V42, P187, DOI 10.1080/10409230701360843; Zomer AL, 2007, J BACTERIOL, V189, P1366, DOI 10.1128/JB.01013-06	69	12	12	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11323	11336		10.1074/jbc.M116.714303	http://dx.doi.org/10.1074/jbc.M116.714303			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27022026	Green Published, hybrid			2022-12-28	WOS:000377042100031
J	Happonen, KE; Tran, S; Morgelin, M; Prince, R; Calzavarini, S; Angelillo-Scherrer, A; Dahlback, B				Happonen, Kaisa E.; Sinh Tran; Morgelin, Matthias; Prince, Raja; Calzavarini, Sara; Angelillo-Scherrer, Anne; Dahlback, Bjorn			The Gas6-Axl Protein Interaction Mediates Endothelial Uptake of Platelet Microparticles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE RECEPTOR; APOPTOTIC CELLS; DENDRITIC CELLS; TAM RECEPTOR; ACTIVATED PLATELETS; AXL; MER; PHAGOCYTOSIS; CLEARANCE; GROWTH	Upon activation, platelets release plasma membrane-derived microparticles (PMPs) exposing phosphatidylserine on their surface. The functions and clearance mechanism of these microparticles are incompletely understood. As they are pro-coagulant and potentially pro-inflammatory, rapid clearance from the circulation is essential for prevention of thrombotic diseases. The tyrosine kinase receptors Tyro3, Axl, and Mer (TAMs) and their ligands protein S and Gas6 are involved in the uptake of phosphatidylserine-exposing apoptotic cells in macrophages and dendritic cells. Both TAMs and their ligands are expressed in the vasculature, the functional significance of which is poorly understood. In this study, we investigated how vascular TAMs and their ligands may mediate endothelial uptake of PMPs. PMPs, generated from purified human platelets, were isolated by ultracentrifugation and labeled with biotin or PKH67. The uptake of labeled microparticles in the presence of protein S and Gas6 in human aortic endothelial cells and human umbilical vein endothelial cells was monitored by flow cytometry, Western blotting, and confocal/electron microscopy. We found that both endothelial cell types can phagocytose PMPs, and by using TAM-blocking antibodies or siRNA knockdown of individual TAMs, we show that the uptake is mediated by endothelial Axl and Gas6. As circulatingPMPlevels were not altered in Gas6(-/-) mice compared with Gas6(+/+) mice, we hypothesize that the Gas6-mediated uptake is not a means to clear the bulk of circulating PMPs but may serve to locally phagocytose PMPs generated at sites of platelet activation and as a way to effect endothelial responses.	[Happonen, Kaisa E.; Sinh Tran; Dahlback, Bjorn] Lund Univ, Dept Translat Med, Div Clin Chem, Inga Marie Nilssons Gata 53, SE-20502 Malmo, Sweden; [Morgelin, Matthias] Lund Univ, Dept Clin Sci, Div Infect Med, SE-22185 Lund, Sweden; [Prince, Raja; Calzavarini, Sara; Angelillo-Scherrer, Anne] Univ Hosp Bern, Univ Clin Hematol, CH-3010 Bern, Switzerland; [Prince, Raja; Calzavarini, Sara; Angelillo-Scherrer, Anne] Univ Hosp Bern, Cent Hematol Lab, CH-3010 Bern, Switzerland; [Prince, Raja; Calzavarini, Sara; Angelillo-Scherrer, Anne] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland	Lund University; Lund University; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Happonen, KE (corresponding author), Lund Univ, Dept Translat Med Clin Chem, Wallenberg Lab, Inga Marie Nilssons Gata 53, SE-20502 Malmo, Sweden.	kaisa.happonen@med.lu.se	Calzavarini, Sara/AAU-9368-2020	Calzavarini, Sara/0000-0002-7494-2995; Dahlback, Bjorn/0000-0003-1546-0328; Happonen, Kaisa/0000-0002-8346-6302; Angelillo-Scherrer, Anne/0000-0003-2872-4863	Swedish Research Council; Heart-Lung Foundation; Soderberg's Foundation; Skane University Hospital Research Funds; Foundation of Greta; Foundation of Johan Kock; Royal Physiographic Society in Lund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Heart-Lung Foundation(Swedish Heart-Lung Foundation); Soderberg's Foundation; Skane University Hospital Research Funds; Foundation of Greta; Foundation of Johan Kock; Royal Physiographic Society in Lund	This work was supported by grants from Swedish Research Council (to B. D.), the Heart-Lung Foundation (to B. D.), the Soderberg's Foundation (to B. D.), Skane University Hospital Research Funds (to B. D.) and grants from the Foundations of Greta and Johan Kock (to K. E. H.), Alfred Osterlund (to K. E. H.), Tore Nilsson (to K. E. H.), Prof. Nanna Svartz (to K. E. H.), Apotekare Hedberg (to K. E. H.), and the Royal Physiographic Society in Lund (to K. E. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aatonen MT, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24692; Abdel-Monem H, 2010, THROMB HAEMOSTASIS, V104, P335, DOI 10.1160/TH09-12-0849; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Arraud N, 2014, J THROMB HAEMOST, V12, P614, DOI 10.1111/jth.12554; Barry OP, 1998, J CLIN INVEST, V102, P136, DOI 10.1172/JCI2592; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Bertin FR, 2015, J THROMB HAEMOST, V13, P2260, DOI 10.1111/jth.13156; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Cosemans JMEM, 2010, J THROMB HAEMOST, V8, P1797, DOI 10.1111/j.1538-7836.2010.03935.x; DAHLBACK B, 1983, BIOCHEM J, V209, P837, DOI 10.1042/bj2090837; DAHLBACK B, 1992, BIOCHEMISTRY-US, V31, P12769, DOI 10.1021/bi00166a009; DAHLBACK B, 1990, J BIOL CHEM, V265, P8127; Dasgupta SK, 2009, BLOOD, V113, P1332, DOI 10.1182/blood-2008-07-167148; Dasgupta SK, 2012, CIRCULATION, V125, P1664, DOI 10.1161/CIRCULATIONAHA.111.068833; Dransfield I, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.18; Duchez AC, 2015, P NATL ACAD SCI USA, V112, pE3564, DOI 10.1073/pnas.1507905112; Ekman C, 2010, J THROMB HAEMOST, V8, P838, DOI 10.1111/j.1538-7836.2010.03752.x; Faille D, 2012, J CELL MOL MED, V16, P1731, DOI 10.1111/j.1582-4934.2011.01434.x; Fens MHAM, 2008, BLOOD, V111, P4542, DOI 10.1182/blood-2007-06-094763; Flaumenhaft R, 2009, BLOOD, V113, P1112, DOI 10.1182/blood-2008-06-163832; Fraineau S, 2012, BLOOD, V120, P5073, DOI 10.1182/blood-2012-05-429183; Gallicchio M, 2005, BLOOD, V105, P1970, DOI 10.1182/blood-2004-04-1469; Gould WR, 2005, J THROMB HAEMOST, V3, P733, DOI 10.1111/j.1538-7836.2005.01186.x; Grommes C, 2008, J NEUROIMMUNE PHARM, V3, P130, DOI 10.1007/s11481-007-9090-2; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hasanbasic I, 2004, AM J PHYSIOL-HEART C, V287, pH1207, DOI 10.1152/ajpheart.00020.2004; Healy AM, 2001, AM J PHYSIOL-LUNG C, V280, pL1273, DOI 10.1152/ajplung.2001.280.6.L1273; Horstman LL, 1999, CRIT REV ONCOL HEMAT, V30, P111, DOI 10.1016/S1040-8428(98)00044-4; Italiano JE, 2010, CURR OPIN HEMATOL, V17, P578, DOI 10.1097/MOH.0b013e32833e77ee; Koshiar RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104200; Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801; Laurance S, 2014, J THROMB HAEMOST, V12, P395, DOI 10.1111/jth.12481; Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; LUNDBLAD RL, 1975, BIOCHEM BIOPH RES CO, V66, P482, DOI 10.1016/0006-291X(75)90536-7; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Mause SF, 2005, ARTERIOSCL THROM VAS, V25, P1512, DOI 10.1161/01.ATV.0000170133.43608.37; Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974; NAKANO T, 1995, J BIOL CHEM, V270, P5702, DOI 10.1074/jbc.270.11.5702; Nomura S, 2001, ATHEROSCLEROSIS, V158, P277, DOI 10.1016/S0021-9150(01)00433-6; Piccin A, 2007, BLOOD REV, V21, P157, DOI 10.1016/j.blre.2006.09.001; Rand ML, 2006, J THROMB HAEMOST, V4, P1621, DOI 10.1111/j.1538-7836.2006.02011.x; Rank A, 2011, PLATELETS, V22, P111, DOI 10.3109/09537104.2010.520373; Robins RS, 2013, BLOOD, V121, P692, DOI 10.1182/blood-2012-05-433730; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Ruan GX, 2012, EMBO J, V31, P1692, DOI 10.1038/emboj.2012.21; Sadallah S, 2014, THROMB HAEMOSTASIS, V112, P1219, DOI 10.1160/TH14-03-0281; Sadallah S, 2011, J IMMUNOL, V186, P6543, DOI 10.4049/jimmunol.1002788; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313; Somajo S, 2014, THROMB RES, V134, P144, DOI 10.1016/j.thromres.2014.04.031; Stenhoff J, 2004, BIOCHEM BIOPH RES CO, V319, P871, DOI 10.1016/j.bbrc.2004.05.070; Subramanian M, 2014, J CLIN INVEST, V124, P1296, DOI 10.1172/JCI72051; Tsou WI, 2014, J BIOL CHEM, V289, P25750, DOI 10.1074/jbc.M114.569020; Vollrath D, 2001, P NATL ACAD SCI USA, V98, P12584, DOI 10.1073/pnas.221364198; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Xiong W, 2008, REPRODUCTION, V135, P77, DOI 10.1530/REP-07-0287; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386	64	37	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10586	10601		10.1074/jbc.M115.699058	http://dx.doi.org/10.1074/jbc.M115.699058			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27006397	Green Published, hybrid			2022-12-28	WOS:000377042600013
J	Sakakini, N; Turchi, L; Bergon, A; Holota, H; Rekim, S; Lopez, F; Paquis, P; Almairac, F; Fontaine, D; Baeza-Kallee, N; Van Obberghen-Schilling, E; Junier, MP; Chneiweiss, H; Figarella-Branger, D; Burel-Vandenbos, F; Imbert, J; Virolle, T				Sakakini, Nathalie; Turchi, Laurent; Bergon, Aurelie; Holota, Helene; Rekim, Samah; Lopez, Fabrice; Paquis, Philipe; Almairac, Fabien; Fontaine, Denys; Baeza-Kallee, Nathalie; Van Obberghen-Schilling, Ellen; Junier, Marie-Pierre; Chneiweiss, Herve; Figarella-Branger, Dominique; Burel-Vandenbos, Fanny; Imbert, Jean; Virolle, Thierry			A Positive Feed-forward Loop Associating EGR1 and PDGFA Promotes Proliferation and Self-renewal in Glioblastoma Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FINGER TRANSCRIPTION FACTOR; GLIOMA-INITIATING CELLS; PROSTATE-CANCER CELLS; MALIGNANT GLIOMA; TUMOR-GROWTH; IN-VIVO; EXPRESSION; INHIBITION; DEATH; P53	Glioblastomas are the most common primary brain tumors, highly vascularized, infiltrating, and resistant to current therapies. This cancer leads to a fatal outcome in less than 18 months. The aggressive behavior of glioblastomas, including resistance to current treatments and tumor recurrence, has been attributed to glioma stemlike/progenitor cells. The transcription factor EGR1 (early growth response 1), a member of a zinc finger transcription factor family, has been described as tumor suppressor in gliomas when ectopically overexpressed. Although EGR1 expression in human glioblastomas has been associated with patient survival, its precise location in tumor territories as well as its contribution to glioblastoma progression remain elusive. In the present study, we show that EGR1-expressing cells are more frequent in high grade gliomas where the nuclear expression of EGR1 is restricted to proliferating/progenitor cells. We show in primary cultures of glioma stemlike cells that EGR1 contributes to stemness marker expression and proliferation by orchestrating a PDGFA-dependent growth-stimulatory loop. In addition, we demonstrate that EGR1 acts as a positive regulator of several important genes, including SHH, GLI1, GLI2, and PDGFA, previously linked to the maintenance and proliferation of glioma stemlike cells.	[Sakakini, Nathalie; Turchi, Laurent; Rekim, Samah; Paquis, Philipe; Almairac, Fabien; Van Obberghen-Schilling, Ellen; Burel-Vandenbos, Fanny; Virolle, Thierry] Univ Nice Sophia Antipolis, CNRS, INSERM, iBV, F-06108 Nice, France; [Sakakini, Nathalie; Bergon, Aurelie; Holota, Helene; Lopez, Fabrice; Imbert, Jean] INSERM, TGML TAGC, U1090, F-13009 Marseille, France; [Sakakini, Nathalie; Bergon, Aurelie; Holota, Helene; Lopez, Fabrice; Imbert, Jean] Aix Marseille Univ, TGML TAGC, UMR S 1090, F-13009 Marseille, France; [Burel-Vandenbos, Fanny] CHU Nice, Hop Pasteur, Serv Anatomopathol, F-06107 Nice, France; [Paquis, Philipe; Almairac, Fabien; Fontaine, Denys] CHU Nice, Hop Pasteur, Serv Neurchirurg, F-06107 Nice, France; [Baeza-Kallee, Nathalie; Figarella-Branger, Dominique] Aix Marseille Univ, Fac Med Timone, F-13284 Marseille, France; [Baeza-Kallee, Nathalie; Figarella-Branger, Dominique] INSERM UMR 911, CRO2, F-13284 Marseille, France; [Figarella-Branger, Dominique] CHU Timone, Dept Pathol, F-13385 Marseille 5, France; [Junier, Marie-Pierre; Chneiweiss, Herve] CNRS, Team Glial Plast, Neurosci Paris Seine IBPS UMR8246, 7 Quai St Bernard, F-75005 Paris, France; [Junier, Marie-Pierre; Chneiweiss, Herve] INSERM U1130, Team Glial Plast, Neurosci Paris Seine IBPS, 7 Quai St Bernard, F-75005 Paris, France; [Junier, Marie-Pierre; Chneiweiss, Herve] Univ Paris 06, Team Glial Plast, Neurosci Paris Seine IBPS, UMCR18, 7 Quai St Bernard, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; CHU Nice; CHU Nice; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Imbert, J (corresponding author), INSERM U1090, TAGC, Parc Sci Luminy,Case 928,163 Ave de Luminy, F-13288 Marseille 09, France.; Virolle, T (corresponding author), Univ Nice Sophia Antipolis, UFR Sci, iBV, Batiment Sci Nat,Parc Valrose,28 Ave Valrose, F-06108 Nice 2, France.	jean.imbert@inserm.fr; virolle@unice.fr	Van Obberghen-Schilling, Ellen/Q-4372-2019; Lopez, Fabrice/M-5021-2016; herve, chneiweiss/Q-6818-2019; Inserm U1090, TAGC/ABE-9980-2021; Virolle, Thierry/E-5838-2016; Imbert, Jean/G-3248-2013; Imbert, Jean/AAG-1165-2020; Van Obberghen-Schilling, Ellen/O-1581-2016; Bergon, Aurélie/M-4977-2016	Van Obberghen-Schilling, Ellen/0000-0003-2961-0059; Lopez, Fabrice/0000-0002-2401-0292; herve, chneiweiss/0000-0001-7675-5061; Imbert, Jean/0000-0002-0478-9593; Imbert, Jean/0000-0002-0478-9593; Van Obberghen-Schilling, Ellen/0000-0003-2961-0059; Bergon, Aurélie/0000-0003-1518-4562; Turchi, Laurent/0000-0003-2020-5831; Fontaine, Denys/0000-0001-5012-6769	INSERM; GIS IBiSA; Aix-Marseille-Universite;  [ANR-10-INBS-0009-10]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); GIS IBiSA; Aix-Marseille-Universite; 	We thank A. Borderie, S. Bestree, C. Hagnere, and F. Frassinetti for technical assistance and C Colin for statistical analyses. High throughput sequencing was performed at the TGML Platform, supported by grants from INSERM, GIS IBiSA, Aix-Marseille-Universite, and ANR-10-INBS-0009-10.	Baron V, 2003, ONCOGENE, V22, P4194, DOI 10.1038/sj.onc.1206560; Ben-Chetrit N, 2013, CELL ADHES MIGR, V7, P33, DOI 10.4161/cam.22263; Calogero A, 2004, CANCER CELL INT, V4, DOI 10.1186/1475-2867-4-1; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Choi BH, 2008, CANCER RES, V68, P1369, DOI 10.1158/0008-5472.CAN-07-5222; Cibelli G, 2002, J NEUROSCI RES, V67, P450, DOI 10.1002/jnr.10141; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Eid MA, 1998, CANCER RES, V58, P2461; Fareh M, 2012, CELL DEATH DIFFER, V19, P232, DOI 10.1038/cdd.2011.89; Gregg Jennifer, 2011, Genes Cancer, V2, P900, DOI 10.1177/1947601911431885; Huang RP, 1997, INT J CANCER, V72, P102, DOI 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L; KHACHIGIAN LM, 1995, J BIOL CHEM, V270, P27679, DOI 10.1074/jbc.270.46.27679; Kim Jin Wook, 2014, Genes Cancer, V5, P165; LEVIN WJ, 1995, ONCOGENE, V11, P1261; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mehta S, 2011, CANCER CELL, V19, P359, DOI 10.1016/j.ccr.2011.01.035; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Mitchell A, 2004, NUCLEIC ACIDS RES, V32, P3065, DOI 10.1093/nar/gkh626; Mittelbronn M, 2009, BRAIN PATHOL, V19, P195, DOI 10.1111/j.1750-3639.2008.00175.x; Nair P, 1997, J BIOL CHEM, V272, P20131, DOI 10.1074/jbc.272.32.20131; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Pagel JI, 2011, INDIAN J BIOCHEM BIO, V48, P226; Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; RUPPRECHT HD, 1993, AM J PHYSIOL, V265, pF351, DOI 10.1152/ajprenal.1993.265.3.F351; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seto M, 2009, MOL CARCINOGEN, V48, P703, DOI 10.1002/mc.20516; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Thomas-Chollier M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1104; Thomas-Chollier M, 2011, NAT PROTOC, V6, P1860, DOI 10.1038/nprot.2011.409; Thyss R, 2005, EMBO J, V24, P128, DOI 10.1038/sj.emboj.7600501; Turchi L, 2013, STEM CELLS, V31, P1252, DOI 10.1002/stem.1373; Virolle T, 2003, J BIOL CHEM, V278, P11802, DOI 10.1074/jbc.M210279200; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang W, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/867517; Worden B, 2005, CANCER RES, V65, P7071, DOI 10.1158/0008-5472.CAN-04-0989; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137	41	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10684	10699		10.1074/jbc.M116.720698	http://dx.doi.org/10.1074/jbc.M116.720698			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27002148	Green Published, hybrid			2022-12-28	WOS:000377042600021
J	Rebbeck, RT; Nitu, FR; Rohde, D; Most, P; Bers, DM; Thomas, DD; Cornea, RL				Rebbeck, Robyn T.; Nitu, Florentin R.; Rohde, David; Most, Patrick; Bers, Donald M.; Thomas, David D.; Cornea, Razvan L.			S100A1 Protein Does Not Compete with Calmodulin for Ryanodine Receptor Binding but Structurally Alters the Ryanodine Receptor center dot Calmodulin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM CA2+ RELEASE; TIME-RESOLVED FRET; HEART-FAILURE; SKELETAL; SITE; INHIBITION; MODULATION; ACTIVATION; LOCATIONS; INCREASES	S100A1 has been suggested as a therapeutic agent to enhance myocyte Ca2+ cycling in heart failure, but its molecular mode of action is poorly understood. Using FRET, we tested the hypothesis that S100A1 directly competes with calmodulin (CaM) for binding to intact, functional ryanodine receptors type I (RyR1) and II (RyR2) from skeletal and cardiac muscle, respectively. Our FRET readout provides an index of acceptor-labeled CaM binding near donor-labeled FKBP (FK506-binding protein 12.6) on the cytoplasmic domain of RyR in isolated sarcoplasmic reticulum vesicles. S100A1 (0.01-400 mu M) partially inhibited FRET (i.e. CaM binding), with K-i > 10 mu M, for both RyR1 and RyR2. The high [S100A1] required for partial effects on FRET indicates a lack of competition by S100A1 on CaM/RyR binding under normal physiological conditions. High-resolution analysis of time-resolved FRET detects two structural states of RyR-bound CaM, which respond to [Ca2+] and are isoform-specific. The distribution of these structural states was perturbed only by high micromolar [S100A1], which promoted a shift of bound CaM to a lower FRET orientation (without altering the amount of CaM bound to RyR). Thus, high micromolar S100A1 does alter the CaM/RyR interaction, without involving competition. Nevertheless, submicromolar S100A1 can alter RyR function, an effect that is influenced by both [Ca2+] and [CaM]. We conclude that CaM and S100A1 can concurrently bind to and functionally modulate RyR1 and RyR2, but this does not involve direct competition at the RyR CaM binding site.	[Rebbeck, Robyn T.; Nitu, Florentin R.; Thomas, David D.; Cornea, Razvan L.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, 321 Church St, Minneapolis, MN 55455 USA; [Rohde, David; Most, Patrick] Heidelberg Univ, Dept Internal Med 3, Ctr Mol & Translat Cardiol, INF 410, D-69120 Heidelberg, Germany; [Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	University of Minnesota System; University of Minnesota Twin Cities; Ruprecht Karls University Heidelberg; University of California System; University of California Davis	Cornea, RL (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 321 Church St, Minneapolis, MN 55455 USA.	corne002@umn.edu		Cornea, Razvan/0000-0001-5739-0992; Nitu, Florentin/0000-0001-9768-6333; Thomas, David D./0000-0002-8822-2040	National Institutes of Health [R01HL092097, R01GM027906, T32HL069764]; American Heart Association [14POST20310024, 15GRNT25610022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092097, R01HL030077, T32HL069764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG026160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants R01HL092097 (to R. L. C. and D. M. B.), R01GM027906 (to D. D. T.), and T32HL069764 (to F. R. N.) and American Heart Association Grants 14POST20310024 (to R. T. R.) and 15GRNT25610022 (to R. L. C.). P. M. holds patents on the therapeutic use of S100A1 in cardiovascular diseases. P. M. is a shareholder of UniQure N.K. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; Bers DM, 2011, AM J PHYSIOL-CELL PH, V300, pC974, DOI 10.1152/ajpcell.00051.2011; Bolewska K, 1997, ACTA BIOCHIM POL, V44, P275; Brinks H, 2011, J AM COLL CARDIOL, V58, P966, DOI 10.1016/j.jacc.2011.03.054; BURATTI R, 1995, BIOCHEM BIOPH RES CO, V213, P1082, DOI 10.1006/bbrc.1995.2238; Cornea RL, 2010, J BIOL CHEM, V285, P19219, DOI 10.1074/jbc.M109.066944; Cornea RL, 2009, P NATL ACAD SCI USA, V106, P6128, DOI 10.1073/pnas.0813010106; Dong XQ, 2014, BIOCHEM BIOPH RES CO, V449, P196, DOI 10.1016/j.bbrc.2014.04.166; Ehlermann P, 2000, J CHROMATOGR B, V737, P39, DOI 10.1016/S0378-4347(99)00366-7; Fruen BR, 2000, AM J PHYSIOL-CELL PH, V279, pC724, DOI 10.1152/ajpcell.2000.279.3.C724; Fruen BR, 2005, BIOCHEMISTRY-US, V44, P278, DOI 10.1021/bi048246u; Fruen BR, 2003, BIOCHEMISTRY-US, V42, P2740, DOI 10.1021/bi0267689; Goch G, 2005, FEBS J, V272, P2557, DOI 10.1111/j.1742-4658.2005.04680.x; Gruber SJ, 2014, J BIOMOL SCREEN, V19, P215, DOI 10.1177/1087057113510740; Guhathakurta P, 2015, P NATL ACAD SCI USA, V112, P4660, DOI 10.1073/pnas.1420101112; Guo T, 2011, BIOPHYS J, V101, P2170, DOI 10.1016/j.bpj.2011.09.030; Huang XJ, 2012, J BIOL CHEM, V287, P30328, DOI 10.1074/jbc.M112.383109; Kettlewell S, 2005, J MOL CELL CARDIOL, V39, P900, DOI 10.1016/j.yjmcc.2005.06.018; Maier LS, 2006, J MOL CELL CARDIOL, V41, P451, DOI 10.1016/j.yjmcc.2006.04.020; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Most P, 2004, J CLIN INVEST, V114, P1550, DOI 10.1172/JCI200421454; Most P, 2003, J BIOL CHEM, V278, P26356, DOI 10.1074/jbc.M303338200; Most P, 2006, CIRCULATION, V114, P1258, DOI 10.1161/CIRCULATIONAHA.106.622415; Oda T, 2015, J MOL CELL CARDIOL, V85, P240, DOI 10.1016/j.yjmcc.2015.06.009; PEDROCCHI M, 1993, BIOCHEM BIOPH RES CO, V197, P529, DOI 10.1006/bbrc.1993.2511; Pleger ST, 2006, EUR J MED RES, V11, P418; Pleger ST, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002097; Prosser BL, 2008, J BIOL CHEM, V283, P5046, DOI 10.1074/jbc.M709231200; Remppis A, 2002, BASIC RES CARDIOL S1, V97, P56; Ritterhoff J, 2015, MOL THER, V23, P1320, DOI 10.1038/mt.2015.93; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; Svensson B, 2014, BIOPHYS J, V107, P2037, DOI 10.1016/j.bpj.2014.09.029; Treves S, 1997, BIOCHEMISTRY-US, V36, P11496, DOI 10.1021/bi970160w; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; Volkers M, 2007, CELL CALCIUM, V41, P135, DOI 10.1016/j.ceca.2006.06.001; Wright NT, 2008, J BIOL CHEM, V283, P26676, DOI 10.1074/jbc.M804432200; Xu L, 2004, BIOPHYS J, V86, P797, DOI 10.1016/S0006-3495(04)74155-7; Yamaguchi N, 2013, AM J PHYSIOL-HEART C, V305, pH86, DOI 10.1152/ajpheart.00144.2013; Yamaguchi N, 2011, AM J PHYSIOL-CELL PH, V300, pC998, DOI 10.1152/ajpcell.00370.2010; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Zhukova L, 2004, BBA-MOL CELL RES, V1742, P191, DOI 10.1016/j.bbamcr.2004.10.002	42	18	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15896	15907		10.1074/jbc.M115.713107	http://dx.doi.org/10.1074/jbc.M115.713107			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226555	hybrid, Green Published			2022-12-28	WOS:000380584200040
J	Sato, W; Hitaoka, S; Inoue, K; Imai, M; Saio, T; Uchida, T; Shinzawa-Itoh, K; Yoshikawa, S; Yoshizawa, K; Ishimori, K				Sato, Wataru; Hitaoka, Seiji; Inoue, Kaoru; Imai, Mizue; Saio, Tomohide; Uchida, Takeshi; Shinzawa-Itoh, Kyoko; Yoshikawa, Shinya; Yoshizawa, Kazunari; Ishimori, Koichiro			Energetic Mechanism of Cytochrome c-Cytochrome c Oxidase Electron Transfer Complex Formation under Turnover Conditions Revealed by Mutational Effects and Docking Simulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN DOCKING; PARACOCCUS-DENITRIFICANS; SHAPE COMPLEMENTARITY; FERROCYTOCHROME-C; FREE-ENERGIES; BINDING SITE; ELECTROSTATICS; MOLECULES; OXIDATION; DYNAMICS	Based on the mutational effects on the steady-state kinetics of the electron transfer reaction and our NMR analysis of the interaction site (Sakamoto, K., Kamiya, M., Imai, M., Shinzawa-Itoh, K., Uchida, T., Kawano, K., Yoshikawa, S., and Ishimori, K. (2011) Proc. Natl. Acad. Sci. U.S.A. 108, 1227112276), we determined the structure of the electron transfer complex between cytochrome c (Cyt c) and cytochrome c oxidase (CcO) under turnover conditions and energetically characterized the interactions essential for complex formation. The complex structures predicted by the protein docking simulation were computationally selected and validated by the experimental kinetic data for mutant Cyt c in the electron transfer reaction to CcO. The interaction analysis using the selected Cyt c-CcO complex structure revealed the electrostatic and hydrophobic contributions of each amino acid residue to the free energy required for complex formation. Several charged residues showed large unfavorable (desolvation) electrostatic interactions that were almost cancelled out by large favorable (Columbic) electrostatic interactions but resulted in the destabilization of the complex. The residual destabilizing free energy is compensated by the van der Waals interactions mediated by hydrophobic amino acid residues to give the stabilized complex. Thus, hydrophobic interactions are the primary factors that promote complex formation between Cyt c and CcO under turnover conditions, whereas the change in the electrostatic destabilization free energy provides the variance of the binding free energy in the mutants. The distribution of favorable and unfavorable electrostatic interactions in the interaction site determines the orientation of the binding of Cyt c on CcO.	[Sato, Wataru; Imai, Mizue; Saio, Tomohide; Uchida, Takeshi; Ishimori, Koichiro] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido 0608628, Japan; [Hitaoka, Seiji; Yoshizawa, Kazunari] Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 8190315, Japan; [Inoue, Kaoru] Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600810, Japan; [Saio, Tomohide; Uchida, Takeshi; Ishimori, Koichiro] Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido 0600810, Japan; [Shinzawa-Itoh, Kyoko; Yoshikawa, Shinya] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Kamigori, Hyogo 6781297, Japan	Hokkaido University; Kyushu University; Hokkaido University; Hokkaido University; University of Hyogo	Ishimori, K (corresponding author), Hokkaido Univ, Fac Sci, Dept Chem, Kita Ku, Kita 10,Nishi 8, Sapporo, Hokkaido 0600810, Japan.	koichiro@sci.hokudai.ac.jp	Ishimori, Koichiro/S-1247-2016; Uchida, Takeshi/A-6455-2017; Ishimori, Koichiro/AAQ-4434-2021	Ishimori, Koichiro/0000-0002-5868-0462; Uchida, Takeshi/0000-0001-9270-8329; Ishimori, Koichiro/0000-0002-5868-0462; Saio, Tomohide/0000-0003-3639-7399	Japan Society for the Promotion of Science [25288072, 25109501, 26234567, 24109014, 15K13710]; Global Center of Excellence Program; Targeted Protein Research Program; CREST from Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT; Grants-in-Aid for Scientific Research [26291033] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Protein Research Program; CREST from Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid 25288072 and 25109501 (to K. I.), 26234567 (to S. Y.), and 24109014 and 15K13710 (to K. Y.) from the Japan Society for the Promotion of Science, the Global Center of Excellence Program, the Targeted Protein Research Program, CREST from Ministry of Education, Culture, Sports, Science and Technology (MEXT), and MEXT Projects of "Integrated Research on Chemical Synthesis" and "Elements Strategy Initiative to Form Core Research Center." The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 1984, THESIS U CALIFORNIA; Autenrieth F, 2004, J COMPUT CHEM, V25, P1613, DOI 10.1002/jcc.20079; Banci L, 1999, J BIOL INORG CHEM, V4, P21, DOI 10.1007/s007750050285; Banci L, 1997, BIOCHEMISTRY-US, V36, P9867, DOI 10.1021/bi970724w; Basdevant N, 2006, J AM CHEM SOC, V128, P12766, DOI 10.1021/ja060830y; BISSON R, 1980, BIOCHEMISTRY-US, V19, P4173, DOI 10.1021/bi00559a006; BRUNORI M, 1981, FEBS LETT, V126, P195, DOI 10.1016/0014-5793(81)80240-2; BRUNORI M, 1995, BIOCHIMIE, V77, P668, DOI 10.1016/0300-9084(96)88182-X; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Drosou V, 2002, EUR J BIOCHEM, V269, P2980, DOI 10.1046/j.1432-1033.2002.02979.x; FERGUSONMILLER S, 1978, J BIOL CHEM, V253, P149; Flock D, 2002, PROTEINS, V47, P75, DOI 10.1002/prot.10066; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Hitaoka S, 2013, J PESTIC SCI, V38, P60, DOI 10.1584/jpestics.D12-082; Hitaoka S, 2011, J CHEM INF MODEL, V51, P2706, DOI 10.1021/ci2002395; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Imai M, 2016, BIOCHEM BIOPH RES CO, V469, P978, DOI 10.1016/j.bbrc.2015.12.079; Jeng WY, 2002, J BIOENERG BIOMEMBR, V34, P423, DOI 10.1023/A:1022561924392; Kaila VRI, 2010, CHEM REV, V110, P7062, DOI 10.1021/cr1002003; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li L, 2003, PROTEINS, V53, P693, DOI 10.1002/prot.10460; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MALMSTROM BG, 1979, BIOCHIM BIOPHYS ACTA, V549, P281; MARGOLIASH E., 1966, ADVANCE PROTEIN CHEM, V21, P113, DOI 10.1016/S0065-3233(08)60128-X; MICHEL B, 1989, BIOCHEMISTRY-US, V28, P244, DOI 10.1021/bi00427a034; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; MINNAERT K, 1961, BIOCHIM BIOPHYS ACTA, V50, P23, DOI 10.1016/0006-3002(61)91055-1; Moore, 1987, CYTOCHROMES C BIOL A, P1, DOI 10.1007/978-3-642-72698-9_1; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Muramoto K, 2010, P NATL ACAD SCI USA, V107, P7740, DOI 10.1073/pnas.0910410107; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PAPA S, 1982, J BIOENERG BIOMEMBR, V14, P69, DOI 10.1007/BF00745021; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Rajagopal BS, 2013, BIOCHEM J, V456, P441, DOI 10.1042/BJ20130758; Roberts VA, 1999, J BIOL CHEM, V274, P38051, DOI 10.1074/jbc.274.53.38051; Sakamoto K, 2011, P NATL ACAD SCI USA, V108, P12271, DOI 10.1073/pnas.1108320108; Sakamoto K, 2010, BIOCHEM BIOPH RES CO, V398, P231, DOI 10.1016/j.bbrc.2010.06.065; Seifert A, 2006, PROTEINS, V64, P147, DOI 10.1002/prot.20951; Sheinerman FB, 2002, J MOL BIOL, V318, P161, DOI 10.1016/S0022-2836(02)00030-X; SPECK SH, 1984, P NATL ACAD SCI-BIOL, V81, P347, DOI 10.1073/pnas.81.2.347; TAKANO T, 1973, J BIOL CHEM, V248, P5234; Tashiro M, 2005, J PHYS CHEM B, V109, P1015, DOI 10.1021/jp0462456; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Volkov AN, 2015, ACCOUNTS CHEM RES, V48, P3036, DOI 10.1021/acs.accounts.5b00343; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; WILSON MT, 1994, J BIOL CHEM, V269, P24114; Witt H, 1998, J BIOL CHEM, V273, P5132, DOI 10.1074/jbc.273.9.5132; Witt H, 1998, EUR J BIOCHEM, V251, P367, DOI 10.1046/j.1432-1327.1998.2510367.x; Yoshida T, 2012, J PHYS CHEM B, V116, P10283, DOI 10.1021/jp305476x; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Yoshikawa S, 2006, BBA-BIOENERGETICS, V1757, P395, DOI 10.1016/j.bbabio.2006.04.028; Yoshikawa S, 2015, CHEM REV, V115, P1936, DOI 10.1021/cr500266a	60	12	12	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15320	15331		10.1074/jbc.M115.708065	http://dx.doi.org/10.1074/jbc.M115.708065			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226541	Green Published, hybrid			2022-12-28	WOS:000380583200037
J	Boateng, LR; Bennin, D; De Oliveira, S; Huttenlocher, A				Boateng, Lindsy R.; Bennin, David; De Oliveira, Sofia; Huttenlocher, Anna			Mammalian Actin-binding Protein-1/Hip-55 Interacts with FHL2 and Negatively Regulates Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; cell invasion; cell migration; focal adhesion; Rho (Rho GTPase); FHL2; mAbp1	CLATHRIN-COATED PITS; BREAST-CANCER CELLS; ONLY PROTEIN FHL2; TRANSCRIPTIONAL COACTIVATOR FHL2; TRANS-GOLGI NETWORK; BETA-CATENIN; ALPHA-SUBUNIT; TUMOR-CELLS; RECEPTOR; ACTIVATION	Mammalian actin-binding protein-1 (mAbp1) is an adaptor protein that binds actin and modulates scission during endocytosis. Recent studies suggest that mAbp1 impairs cell invasion; however, the mechanism for the inhibitory effects of mAbp1 remain unclear. We performed a yeast two-hybrid screen and identified the adaptor protein, FHL2, as a novel binding partner that interacts with the N-terminal actin depolymerizing factor homology domain (ADFH) domain of mAbp1. Here we report that depletion of mAbp1 or ectopic expression of the ADFH domain of mAbp1 increased Rho GTPase signaling and breast cancer cell invasion. Moreover, cell invasion induced by the ADFH domain of mAbp1 required the expression of FHL2. Taken together, our findings show that mAbp1 and FHL2 are novel binding partners that differentially regulate Rho GTPase signaling and MTLn3 breast cancer cell invasion.	[Boateng, Lindsy R.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Bennin, David; De Oliveira, Sofia; Huttenlocher, Anna] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Bennin, David; De Oliveira, Sofia; Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Huttenlocher, A (corresponding author), Dept Med Microbiol & Immunol, 1550 Linden Dr,4225 Microbial Sci Bldg,Rm 4205, Madison, WI 53706 USA.	huttenlocher@wisc.edu	de Oliveira, Sofia/AAV-4304-2020	de Oliveira, Sofia/0000-0003-0893-111X	National Institutes of Health [T32 CA009135, R01 CA085862]; NATIONAL CANCER INSTITUTE [R01CA085862, T32CA009135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 CA009135 (NCI Cancer Biology; to L. B.) and R01 CA085862 (NCI; to A. H.). The authors declare no competing or financial interests. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blau N, 2000, HUM MUTAT, V16, P54, DOI 10.1002/1098-1004(200007)16:1<54::AID-HUMU10>3.0.CO;2-C; Boateng LR, 2012, J CELL SCI, V125, P1329, DOI 10.1242/jcs.096529; Borczuk AC, 2004, AM J RESP CRIT CARE, V170, P167, DOI 10.1164/rccm.200401-066OC; Brun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055034; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Carragher NO, 2006, ONCOGENE, V25, P5726, DOI 10.1038/sj.onc.1209582; Chan KK, 1998, GENE, V210, P345, DOI 10.1016/S0378-1119(97)00644-6; Chung SY, 2012, ONCOTARGET, V3, P1629; Coghill ID, 2003, J BIOL CHEM, V278, P24139, DOI 10.1074/jbc.M213259200; Connert S, 2006, EMBO J, V25, P1611, DOI 10.1038/sj.emboj.7601053; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Cortesio CL, 2010, MOL BIOL CELL, V21, P186, DOI 10.1091/mbc.E09-02-0106; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Dergai O, 2010, BIOCHEM BIOPH RES CO, V402, P408, DOI 10.1016/j.bbrc.2010.10.045; Gabriel B, 2006, J SOC GYNECOL INVEST, V13, P69, DOI 10.1016/j.jsgi.2005.10.001; Gabriel B, 2004, ANTICANCER RES, V24, P921; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; He KM, 2015, FASEB J, V29, P2495, DOI 10.1096/fj.14-264259; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Jang HS, 2010, NEUROCHEM RES, V35, P1796, DOI 10.1007/s11064-010-0246-8; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kessels MM, 2000, MOL BIOL CELL, V11, P393, DOI 10.1091/mbc.11.1.393; Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351; KIM YO, 1995, BIOCHEM J, V308, P63, DOI 10.1042/bj3080063; Kinoshita M, 2005, INT J UROL, V12, P390, DOI 10.1111/j.1442-2042.2005.01093.x; Kobayashi S, 2004, ENDOCR RES, V30, P617, DOI 10.1081/ERC-200043789; Labalette C, 2004, MOL CELL BIOL, V24, P10689, DOI 10.1128/MCB.24.24.10689-10702.2004; Lange S, 2002, J CELL SCI, V115, P4925, DOI 10.1242/jcs.00181; Li M, 2008, GLIA, V56, P1328, DOI 10.1002/glia.20701; Liu JL, 2009, MOL BIOL CELL, V20, P3763, DOI 10.1091/mbc.E08-09-0967; Liu N, 2014, INT J MOL SCI, V15, P4903, DOI 10.3390/ijms15034903; Luke MR, 2003, J BIOL CHEM, V278, P4216, DOI 10.1074/jbc.M210387200; Malik N, 1996, J BIOL CHEM, V271, P22754, DOI 10.1074/jbc.271.37.22754; Malik N, 1998, MAMM GENOME, V9, P136, DOI 10.1007/s003359900704; Mamoune A, 2003, CANCER RES, V63, P4632; Martin B, 2002, J CELL BIOL, V159, P113, DOI 10.1083/jcb.200202075; Martin BT, 2007, CELL CYCLE, V6, P1779, DOI 10.4161/cc.6.14.4448; Morgan MJ, 1996, BIOCHEM BIOPH RES CO, V225, P632, DOI 10.1006/bbrc.1996.1222; Morlon A, 2003, P NATL ACAD SCI USA, V100, P3977, DOI 10.1073/pnas.0735923100; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; O'Connor RJ, 2001, ONCOGENE, V20, P1882, DOI 10.1038/sj.onc.1204278; Ozaki K, 2004, NATURE, V429, P72, DOI 10.1038/nature02502; RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Samson T, 2004, J BIOL CHEM, V279, P28641, DOI 10.1074/jbc.M312894200; Sturm A, 2004, J IMMUNOL, V173, P3825, DOI 10.4049/jimmunol.173.6.3825; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; THONY B, 1992, BIOCHEM BIOPH RES CO, V189, P1437, DOI 10.1016/0006-291X(92)90235-D; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200; Westphal P, 2015, AM J CLIN PATHOL, V143, P248, DOI 10.1309/AJCPXEC6CIT2TXAF; Wixler V, 2000, J BIOL CHEM, V275, P33669, DOI 10.1074/jbc.M002519200; Wixler V, 2007, J CELL BIOL, V177, P163, DOI 10.1083/jcb.200606043; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Xiong ZH, 2010, IUBMB LIFE, V62, P669, DOI 10.1002/iub.367; Xu WD, 2006, J BIOL CHEM, V281, P11826, DOI 10.1074/jbc.M510141200; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yan JH, 2003, FEBS LETT, V553, P183, DOI 10.1016/S0014-5793(03)00978-5; Yoshioka K, 1999, CANCER RES, V59, P2004; Zhang WJ, 2011, EUR J CANCER, V47, P121, DOI 10.1016/j.ejca.2010.07.045; Zhang WJ, 2010, CARCINOGENESIS, V31, P1220, DOI 10.1093/carcin/bgq094; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111	63	10	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					13987	13998		10.1074/jbc.M116.725739	http://dx.doi.org/10.1074/jbc.M116.725739			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129278	Green Published, hybrid			2022-12-28	WOS:000379975100008
J	Oldemeyer, S; Franz, S; Wenzel, S; Essen, LO; Mittag, M; Kottke, T				Oldemeyer, Sabine; Franz, Sophie; Wenzel, Sandra; Essen, Lars-Oliver; Mittag, Maria; Kottke, Tilman			Essential Role of an Unusually Long-lived Tyrosyl Radical in the Response to Red Light of the Animal-like Cryptochrome aCRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						algae; biophysics; cryptochrome; flavoprotein; infrared spectroscopy (IR spectroscopy); photoreceptor; ultraviolet-visible spectroscopy (UV-Vis spectroscopy)	RIBONUCLEOTIDE REDUCTASE; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; 6-4 PHOTOLYASE; HYDROGEN-BOND; FLAVIN COFACTOR; DNA PHOTOLYASE; BLUE; PHOTOACTIVATION; MECHANISM	Cryptochromes constitute a group of flavin-binding blue light receptors in bacteria, fungi, plants, and insects. Recently, the response of cryptochromes to light was extended to nearly the entire visible spectral region on the basis of the activity of the animal-like cryptochrome aCRY in the green alga Chlamydomonas reinhardtii. This finding was explained by the absorption of red light by the flavin neutral radical as the dark state of the receptor, which then forms the anionic fully reduced state. In this study, time-resolved UV-visible spectroscopy on the full-length aCRY revealed an unusually long-lived tyrosyl radical with a lifetime of 2.6 s, which is present already 1 s after red light illumination of the flavin radical. Mutational studies disclosed the tyrosine 373 close to the surface to form the long-lived radical and to be essential for photoreduction. This residue is conserved exclusively in the sequences of other putative aCRY proteins distinguishing them from conventional (6-4) photolyases. Size exclusion chromatography showed the full-length aCRY to be a dimer in the dark at 0.5 mm injected concentration with the C-terminal extension as the dimerization site. Upon illumination, partial oligomerization was observed via disulfide bridge formation at cysteine 482 in close proximity to tyrosine 373. The lack of any light response in the C-terminal extension as evidenced by FTIR spectroscopy differentiates aCRY from plant and Drosophila cryptochromes. These findings imply that aCRY might have evolved a different signaling mechanism via a light-triggered redox cascade culminating in photooxidation of a yet unknown substrate or binding partner.	[Oldemeyer, Sabine; Kottke, Tilman] Univ Bielefeld, Phys & Biophys Chem, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany; [Franz, Sophie; Essen, Lars-Oliver] Univ Marburg, Dept Chem, Struct Biochem, Hans Meerwein Str 4, D-35039 Marburg, Germany; [Wenzel, Sandra; Mittag, Maria] Univ Jena, Inst Gen Bot & Plant Physiol, Planetarium 1, D-07743 Jena, Germany	University of Bielefeld; Philipps University Marburg; Friedrich Schiller University of Jena	Kottke, T (corresponding author), Univ Bielefeld, Phys & Biophys Chem, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany.	tilman.kottke@uni-bielefeld.de	Essen, Lars-Oliver/L-3862-2016; Kottke, Tilman/B-7102-2011	Essen, Lars-Oliver/0000-0003-4272-4026; Kottke, Tilman/0000-0001-8080-9579	Deutsche Forschungsgemeinschaft [KO3580/1-2, MI373/12-1, MI373/12-2, ES152/12]; Heisenberg Fellowship [KO3580/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heisenberg Fellowship(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft within the framework of Research Group 1261 (Grants KO3580/1-2, MI373/12-1, MI373/12-2, and ES152/12) and by a Heisenberg Fellowship (KO3580/4-1). The authors declare that they have no conflicts of interest with the contents of this article.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aubert C, 1999, P NATL ACAD SCI USA, V96, P5423, DOI 10.1073/pnas.96.10.5423; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Beel B, 2012, PLANT CELL, V24, P2992, DOI 10.1105/tpc.112.098947; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Biskup T, 2009, ANGEW CHEM INT EDIT, V48, P404, DOI 10.1002/anie.200803102; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Brazard J, 2010, J AM CHEM SOC, V132, P4935, DOI 10.1021/ja1002372; Campbell KA, 1997, J AM CHEM SOC, V119, P4787, DOI 10.1021/ja9706155; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Gauden M, 2006, P NATL ACAD SCI USA, V103, P10895, DOI 10.1073/pnas.0600720103; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Geisselbrecht Y, 2012, EMBO REP, V13, P223, DOI 10.1038/embor.2012.2; Giovani B, 2003, NAT STRUCT BIOL, V10, P489, DOI 10.1038/nsb933; Glover SD, 2014, J AM CHEM SOC, V136, P14039, DOI 10.1021/ja503348d; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Hoganson CW, 2004, BBA-BIOENERGETICS, V1655, P116, DOI 10.1016/j.bbabio.2003.10.017; Immeln D, 2007, J BIOL CHEM, V282, P21720, DOI 10.1074/jbc.M700849200; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; Kondoh M, 2011, J MOL BIOL, V413, P128, DOI 10.1016/j.jmb.2011.08.031; Langenbacher T, 2009, J AM CHEM SOC, V131, P14274, DOI 10.1021/ja901628y; Lendzian F, 2005, BBA-BIOENERGETICS, V1707, P67, DOI 10.1016/j.bbabio.2004.02.011; Lokhandwala J, 2015, STRUCTURE, V23, P116, DOI 10.1016/j.str.2014.10.020; Losi A, 2012, ANNU REV PLANT BIOL, V63, P49, DOI 10.1146/annurev-arplant-042811-105538; Minnihan EC, 2013, ACCOUNTS CHEM RES, V46, P2524, DOI 10.1021/ar4000407; Muller P, 2015, CHEM COMMUN, V51, P15502, DOI 10.1039/c5cc06276d; Muller P, 2011, J BIOL CHEM, V286, P21033, DOI 10.1074/jbc.M111.228940; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; Partch CL, 2005, BIOCHEMISTRY-US, V44, P3795, DOI 10.1021/bi047545g; Paulus B, 2015, FEBS J, V282, P3175, DOI 10.1111/febs.13299; Pokorny R, 2008, P NATL ACAD SCI USA, V105, P21023, DOI 10.1073/pnas.0805830106; Proshlyakov DA, 2004, BBA-BIOENERGETICS, V1655, P282, DOI 10.1016/j.bbabio.2003.10.014; Pujols-Ayala I, 2004, BBA-BIOENERGETICS, V1655, P205, DOI 10.1016/j.bbabio.2003.07.010; RUPERT CS, 1960, J GEN PHYSIOL, V43, P573, DOI 10.1085/jgp.43.3.573; Saito K, 2013, P NATL ACAD SCI USA, V110, P7690, DOI 10.1073/pnas.1300817110; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; SOLAR S, 1991, J PHYS CHEM-US, V95, P3639, DOI 10.1021/j100162a038; Spexard M, 2014, BIOCHEMISTRY-US, V53, P1041, DOI 10.1021/bi401599z; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THELANDER M, 1985, J BIOL CHEM, V260, P2737; Thoing C, 2015, J AM CHEM SOC, V137, P5990, DOI 10.1021/jacs.5b01404; TODO T, 1993, NATURE, V361, P371, DOI 10.1038/361371a0; Vaidya AT, 2013, P NATL ACAD SCI USA, V110, P20455, DOI 10.1073/pnas.1313336110; van Dam PJ, 1998, J AM CHEM SOC, V120, P5080, DOI 10.1021/ja9737127; Weber S, 2002, P NATL ACAD SCI USA, V99, P1319, DOI 10.1073/pnas.032469399; Yamada D, 2012, BIOCHEMISTRY-US, V51, P5774, DOI 10.1021/bi300530x; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Zhang F, 2013, P NATL ACAD SCI USA, V110, P7217, DOI 10.1073/pnas.1302377110	51	40	41	1	32	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14062	14071		10.1074/jbc.M116.726976	http://dx.doi.org/10.1074/jbc.M116.726976			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27189948	hybrid, Green Published			2022-12-28	WOS:000379975100015
J	Salabei, JK; Lorkiewicz, PK; Mehra, P; Gibb, AA; Haberzettl, P; Hong, KU; Wei, XL; Zhang, X; Li, QH; Wysoczynski, M; Bolli, R; Bhatnagar, A; Hill, BG				Salabei, Joshua K.; Lorkiewicz, Pawel K.; Mehra, Parul; Gibb, Andrew A.; Haberzettl, Petra; Hong, Kyung U.; Wei, Xiaoli; Zhang, Xiang; Li, Qianhong; Wysoczynski, Marcin; Bolli, Roberto; Bhatnagar, Aruni; Hill, Bradford G.			Type 2 Diabetes Dysregulates Glucose Metabolism in Cardiac Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell therapy; diabetes; glycolysis; heart failure; metabolomics; mitochondria; cell therapy; glycolysis; isotope; stable isotope	PENTOSE-PHOSPHATE PATHWAY; SITE-DIRECTED MUTAGENESIS; SMALL-MOLECULE INHIBITION; PLURIPOTENT STEM-CELLS; ISCHEMIC CARDIOMYOPATHY; BONE-MARROW; HEART-FAILURE; MYOCARDIAL-INFARCTION; 6-PHOSPHOFRUCTO-2-KINASE FRUCTOSE-2,6-BISPHOSPHATASE; FRUCTOSE 2,6-BISPHOSPHATE	Type 2 diabetes is associated with increased mortality and progression to heart failure. Recent studies suggest that diabetes also impairs reparative responses after cell therapy. In this study, we examined potential mechanisms by which diabetes affects cardiac progenitor cells (CPCs). CPCs isolated from the diabetic heart showed diminished proliferation, a propensity for cell death, and a pro-adipogenic phenotype. The diabetic CPCs were insulin-resistant, and they showed higher energetic reliance on glycolysis, which was associated with up-regulation of the pro-glycolytic enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3). In WT CPCs, expression of a mutant form of PFKFB, which mimics PFKFB3 activity and increases glycolytic rate, was sufficient to phenocopy the mitochondrial and proliferative deficiencies found in diabetic cells. Consistent with activation of phosphofructokinase in diabetic cells, stable isotope carbon tracing in diabetic CPCs showed dysregulation of the pentose phosphate and glycero(phospho)lipid synthesis pathways. We describe diabetes-induced dysregulation of carbon partitioning using stable isotope metabolomics-based coupling quotients, which relate relative flux values between metabolic pathways. These findings suggest that diabetes causes an imbalance in glucose carbon allocation by uncoupling biosynthetic pathway activity, which could diminish the efficacy of CPCs for myocardial repair.	[Salabei, Joshua K.; Lorkiewicz, Pawel K.; Mehra, Parul; Gibb, Andrew A.; Haberzettl, Petra; Hong, Kyung U.; Li, Qianhong; Wysoczynski, Marcin; Bolli, Roberto; Bhatnagar, Aruni; Hill, Bradford G.] Univ Louisville, Inst Mol Cardiol, Louisville, KY 40202 USA; [Salabei, Joshua K.; Lorkiewicz, Pawel K.; Mehra, Parul; Gibb, Andrew A.; Haberzettl, Petra; Hong, Kyung U.; Wysoczynski, Marcin; Bolli, Roberto; Bhatnagar, Aruni; Hill, Bradford G.] Univ Louisville, Diabet & Obes Ctr, Louisville, KY 40202 USA; [Bhatnagar, Aruni; Hill, Bradford G.] Univ Louisville, Dept Biochem & Mol Genet, Louisville, KY 40202 USA; [Gibb, Andrew A.; Bolli, Roberto; Bhatnagar, Aruni; Hill, Bradford G.] Univ Louisville, Dept Physiol, Louisville, KY 40202 USA; [Wei, Xiaoli; Zhang, Xiang] Univ Louisville, Dept Chem, Louisville, KY 40202 USA; [Zhang, Xiang] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA; [Wei, Xiaoli; Zhang, Xiang] Univ Louisville, Ctr Regulatory & Environm Analyt Metabol, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville	Hill, BG (corresponding author), Univ Louisville, Diabet & Obes Ctr, Inst Mol Cardiol, Dept Med, 580 S Preston St,Rm 321E, Louisville, KY 40202 USA.	bradford.hill@louisville.edu	Hong, Kyung Uk/G-7145-2011; Li, Qianhong/AAJ-7643-2020; Hill, Bradford/I-4154-2013	Hong, Kyung Uk/0000-0001-6700-9470; Hill, Bradford/0000-0001-5332-8286; Gibb, Andrew/0000-0003-2770-430X	National Institutes of Health [GM103492, HL55477, HL78825, HL113530, HL122580]; American Diabetes Association Pathway to Stop Diabetes Grant [1-16-JDF-041]; Seahorse Bioscience; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL113530, P01HL078825, R56HL122580, R01HL130174, R01HL055477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Pathway to Stop Diabetes Grant; Seahorse Bioscience; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM103492 (to A. B.), HL55477 (to A. B.), HL78825 (to R. B.), HL113530 (to R. B.), and HL122580 (to B. G. H.) and the American Diabetes Association Pathway to Stop Diabetes Grant 1-16-JDF-041 (to B. G. H.). Seahorse Bioscience provided travel awards to J. K. S. and B. G. H. for presenting data at scientific meetings but did not contribute to the work described in this manuscript.	Agoston C, 2004, AM J CARDIOL, V94, P1003, DOI 10.1016/j.amjcard.2004.06.054; Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105; Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; Albiero M, 2014, DIABETES, V63, P1353, DOI 10.2337/db13-0894; ARGAUD D, 1995, J BIOL CHEM, V270, P24229, DOI 10.1074/jbc.270.41.24229; ASHCROFT SJ, 1972, BIOCHEM J, V126, P525, DOI 10.1042/bj1260525; Atsumi T, 2005, DIABETES, V54, P3349, DOI 10.2337/diabetes.54.12.3349; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; BLACKMORE PF, 1982, FEBS LETT, V142, P255, DOI 10.1016/0014-5793(82)80147-6; Boada J, 2000, FEBS LETT, V480, P261, DOI 10.1016/S0014-5793(00)01950-5; Bolli R, 2013, CIRCULATION, V128, P122, DOI 10.1161/CIRCULATIONAHA.112.001075; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Chan HHL, 2012, J CARDIOVASC TRANSL, V5, P678, DOI 10.1007/s12265-012-9389-0; Cheng K, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001260; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Chesney J, 2013, CURR PHARM BIOTECHNO, V14, P251, DOI 10.2174/1389201011314030002; Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Clem BF, 2013, MOL CANCER THER, V12, P1461, DOI 10.1158/1535-7163.MCT-13-0097; Cordero-Espinoza L, 2013, J BIOL CHEM, V288, P36020, DOI 10.1074/jbc.M113.510289; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; Cummins TD, 2014, AM J PHYSIOL-ENDOC M, V307, pE262, DOI 10.1152/ajpendo.00271.2013; Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102; De Saedeleer CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046571; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Duran J, 2009, FEBS J, V276, P4555, DOI 10.1111/j.1742-4658.2009.07161.x; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Fischer KM, 2009, CIRCULATION, V120, P2077, DOI 10.1161/CIRCULATIONAHA.109.884403; Fransioli J, 2008, STEM CELLS, V26, P1315, DOI 10.1634/stemcells.2007-0751; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Huang HY, 2013, STEM CELL RES, V10, P278, DOI 10.1016/j.scr.2012.12.005; Huang HY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002691; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Hubbard SR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008946; Huo YQ, 2010, J BIOL CHEM, V285, P3713, DOI 10.1074/jbc.M109.058446; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Katare R, 2013, CARDIOVASC RES, V97, P55, DOI 10.1093/cvr/cvs291; Kim YB, 2002, J BIOL CHEM, V277, P32915, DOI 10.1074/jbc.M204710200; KURLAND IJ, 1992, J BIOL CHEM, V267, P4416; Lane AN, 2009, ANAL CHIM ACTA, V651, P201, DOI 10.1016/j.aca.2009.08.032; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Lehninger A. L., 2000, LEHNINGER PRINCIPLES, P527; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Lombardi R, 2011, PEDIATR CARDIOL, V32, P360, DOI 10.1007/s00246-011-9890-2; Lombardi R, 2009, CIRC RES, V104, P1076, DOI 10.1161/CIRCRESAHA.109.196899; Lorkiewicz P, 2012, METABOLOMICS, V8, P930, DOI 10.1007/s11306-011-0388-y; Lorkiewicz P, 2009, J MASS SPECTROM, V44, P137, DOI 10.1002/jms.1483; Mohsin S, 2012, J AM COLL CARDIOL, V60, P1278, DOI 10.1016/j.jacc.2012.04.047; Molgat ASD, 2014, CIRCULATION, V130, pS70, DOI 10.1161/CIRCULATIONAHA.113.007908; Mookerjee SA, 2015, BBA-BIOENERGETICS, V1847, P171, DOI 10.1016/j.bbabio.2014.10.005; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; Noor E, 2010, MOL CELL, V39, P809, DOI 10.1016/j.molcel.2010.08.031; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P2517, DOI 10.1001/jama.289.19.2517; Rota M, 2006, CIRC RES, V99, P42, DOI 10.1161/01.RES.0000231289.63468.08; Ruan GX, 2013, J BIOL CHEM, V288, P21161, DOI 10.1074/jbc.M113.474619; Saito H, 2012, AM J PHYSIOL-CELL PH, V302, pC892, DOI 10.1152/ajpcell.00380.2011; Sakakibara R, 1997, J BIOCHEM-TOKYO, V122, P122; Salabei JK, 2015, STEM CELLS, V33, P2613, DOI 10.1002/stem.2047; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Singh H, 2005, J CARD FAIL, V11, P23, DOI 10.1016/j.cardfail.2004.04.002; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; TAULER A, 1990, J BIOL CHEM, V265, P15617; Telang S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-95; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Teusink B, 1998, TRENDS BIOCHEM SCI, V23, P162, DOI 10.1016/S0968-0004(98)01205-5; Trefely S, 2015, J BIOL CHEM, V290, P25834, DOI 10.1074/jbc.M115.658815; Vacanti NM, 2013, BBA-GEN SUBJECTS, V1830, P2361, DOI 10.1016/j.bbagen.2012.08.007; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; van Heerden JH, 2014, SCIENCE, V343, P987, DOI 10.1126/science.1245114; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wang QW, 2008, AM J PHYSIOL-HEART C, V294, pH2889, DOI 10.1152/ajpheart.91501.2007; Welt FGP, 2013, CIRC-HEART FAIL, V6, P99, DOI 10.1161/CIRCHEARTFAILURE.112.972273; Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Wu CD, 2004, ENDOCRINOLOGY, V145, P650, DOI 10.1210/en.2003-1290; Yalcin A, 2009, J BIOL CHEM, V284, P24223, DOI 10.1074/jbc.M109.016816; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Yamamoto T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4480; Yan JL, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002238; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Yiu KH, 2014, ARTERIOSCL THROM VAS, V34, P1136, DOI 10.1161/ATVBAHA.114.302192; Zafir A, 2013, STEM CELLS, V31, P765, DOI 10.1002/stem.1325; Zakharova L, 2014, J HEART LUNG TRANSPL, V33, P644, DOI 10.1016/j.healun.2014.03.006; Zdychova J, 2005, PHYSIOL RES, V54, P1, DOI 10.33549/physiolres.930582; Zhang LX, 2014, AM J PHYSIOL-CELL PH, V307, pC358, DOI 10.1152/ajpcell.00187.2013	94	36	41	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13634	13648		10.1074/jbc.M116.722496	http://dx.doi.org/10.1074/jbc.M116.722496			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27151219	Green Published, hybrid			2022-12-28	WOS:000379771100020
J	Martinez, NA; Ayala, AM; Martinez, M; Martinez-Rivera, FJ; Miranda, JD; Silva, WI				Martinez, Namyr A.; Ayala, Alondra M.; Martinez, Magdiel; Martinez-Rivera, Freddyson J.; Miranda, Jorge D.; Silva, Walter I.			Caveolin-1 Regulates the P2Y(2) Receptor Signaling in Human 1321N1 Astrocytoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; LIPID RAFTS; SCAFFOLDING DOMAIN; CORTICAL-NEURONS; KINASE-ACTIVITY; UP-REGULATION; P2 RECEPTORS; PROTEIN; EXPRESSION; ACTIVATION	Damage to the CNS can cause a differential spatio-temporal release of multiple factors, such as nucleotides, ATP and UTP. The latter interact with neuronal and glial nucleotide receptors. The P2Y(2) nucleotide receptor (P2Y(2)R) has gained prominence as a modulator of gliotic responses after CNS injury. Still, the molecular mechanisms underlying these responses in glia are not fully understood. Membrane-raft microdomains, such as caveolae, and their constituent caveolins, modulate receptor signaling in astrocytes; yet, their role in P2Y(2)R signaling has not been adequately explored. Hence, this study evaluated the role of caveolin-1 (Cav-1) in modulating P2Y(2)R subcellular distribution and signaling in human 1321N1 astrocytoma cells. Recombinant hP2Y(2)R expressed in 1321N1 cells and Cav-1 were found to co-fractionate in light-density membrane-raft fractions, co-localize via confocal microscopy, and co-immunoprecipitate. Raft localization was dependent on ATP stimulation and Cav-1 expression. This hP2Y(2)R/Cav-1 distribution and interaction was confirmed with various cell model systems differing in the expression of both P2Y(2)R and Cav-1, and shRNA knockdown of Cav-1 expression. Furthermore, shRNA knockdown of Cav-1 expression decreased nucleotide-induced increases in the intracellular Ca2+ concentration in 1321N1 and C6 glioma cells without altering TRAP-6 and carbachol Ca2+ responses. In addition, Cav-1 shRNA knockdown also decreased AKT phosphorylation and altered the kinetics of ERK1/2 activation in 1321N1 cells. Our findings strongly suggest that P2Y(2)R interaction with Cav-1 in membrane-raft caveolae of 1321N1 cells modulates receptor coupling to its downstream signaling machinery. Thus, P2Y(2)R/Cav-1 interactions represent a novel target for controlling P2Y(2)R function after CNS injury.	[Martinez, Namyr A.; Martinez, Magdiel; Miranda, Jorge D.; Silva, Walter I.] Univ Puerto Rico, Sch Med, Dept Physiol & Biophys, Med Sci Campus, San Juan, PR 00936 USA; [Ayala, Alondra M.] Univ Puerto Rico, Sch Med, Dept Psychiat, Med Sci Campus, San Juan, PR 00936 USA; [Martinez-Rivera, Freddyson J.] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, Med Sci Campus, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Silva, WI (corresponding author), POB 365067, San Juan, PR 00936 USA.	walter.silva@upr.edu			NCRR at the UPR-MSC [G12RR003051]; NCRR at the Universidad Central del Caribe [G12RR03035];  [ISI0 RR-13705-01];  [DBI-0923132]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051, G12RR003035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838, P20GM103642] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	NCRR at the UPR-MSC; NCRR at the Universidad Central del Caribe; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank Dr. G. A. Weisman for kindly providing the WT 1321N1, pLXSN 1321N1, and hHAP2Y<INF>2</INF>R 1321N1 astrocytoma cells; Dr. Jeffrey E. Pessin for kindly providing the Myc-tagged human caveolin-1 pcDNA3.1 expression vector; Dr. Priscila Sanabria (Universidad Central del Caribe, PR) for support with the calcium flux and confocal microscopy imaging studies. We also thank Monica Quinones for support in some of the experiments. Some of the experiments were performed at the RCMI Facilities of the University of Puerto Rico, MSC, and Universidad Central del Caribe. Shared instrumentation was supported by NCRR Grants G12RR003051 and G12RR03035, at the UPR-MSC and Universidad Central del Caribe, respectively. The Confocal Microscopy Facility at UPR-RP was supported by Grants ISI0 RR-13705-01 and DBI-0923132. Some experiments were performed at the Molecular Sciences Research Building of the University of Puerto Rico.	Abbracchio Maria P, 2006, Purinergic Signal, V2, P595, DOI 10.1007/s11302-006-9016-0; Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Ando K, 2010, J PHARMACOL EXP THER, V334, P809, DOI 10.1124/jpet.110.167528; Arthur DB, 2007, J NEUROCHEM, V100, P1257, DOI 10.1111/j.1471-4159.2006.04305.x; Arthur DB, 2005, P NATL ACAD SCI USA, V102, P19138, DOI 10.1073/pnas.0505913102; Arthur DB, 2006, J NEUROSCI, V26, P3798, DOI 10.1523/JNEUROSCI.5338-05.2006; Bhatnagar A, 2004, J BIOL CHEM, V279, P34614, DOI 10.1074/jbc.M404673200; Bittar E., 2005, CAVEOLAE LIPID RAFTS; Burgos M, 2007, J NEUROCHEM, V103, P1785, DOI 10.1111/j.1471-4159.2007.04872.x; Camden JM, 2005, J BIOL CHEM, V280, P18696, DOI 10.1074/jbc.M500219200; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Choi RCY, 2013, MOL PHARMACOL, V84, P50, DOI 10.1124/mol.112.084160; Chorna NE, 2004, J NEUROCHEM, V91, P119, DOI 10.1111/j.1471-4159.2004.02699.x; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; Cordes N, 2007, ONCOGENE, V26, P6851, DOI 10.1038/sj.onc.1210498; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; D' Ambrosi N, 2013, CURR MED CHEM, V20, P56; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Ding L, 2011, J BIOL CHEM, V286, P27027, DOI 10.1074/jbc.M111.235176; Dohlman HG, 2015, J BIOL CHEM, V290, P19469, DOI 10.1074/jbc.R115.675728; Duncan GW, 2011, CLIN GERIATR MED, V27, P629, DOI 10.1016/j.cger.2011.07.008; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; ERB L, 1995, J BIOL CHEM, V270, P4185, DOI 10.1074/jbc.270.9.4185; Flores RV, 2005, MOL CELL BIOCHEM, V280, P35, DOI 10.1007/s11010-005-8050-5; Fridolfsson HN, 2014, FASEB J, V28, P3823, DOI 10.1096/fj.14-252320; FUKURODA T, 1994, J APPL PHYSIOL, V76, P1976, DOI 10.1152/jappl.1994.76.5.1976; Gangadharan V, 2015, AM J PHYSIOL-CELL PH, V308, pC41, DOI 10.1152/ajpcell.00037.2014; Gentry PR, 2015, J BIOL CHEM, V290, P19478, DOI 10.1074/jbc.R115.662759; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Head BP, 2008, FASEB J, V22, P828, DOI 10.1096/fj.07-9299com; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffmann C, 2008, J BIOL CHEM, V283, P30933, DOI 10.1074/jbc.M801472200; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Kong MMC, 2007, MOL PHARMACOL, V72, P1157, DOI 10.1124/mol.107.034769; Kong Q, 2009, J NEUROCHEM, V109, P1300, DOI 10.1111/j.1471-4159.2009.06048.x; Kubale V, 2007, CELL TISSUE RES, V330, P231, DOI 10.1007/s00441-007-0462-y; Lazarowski ER, 1997, J BIOL CHEM, V272, P24348, DOI 10.1074/jbc.272.39.24348; Li HJ, 2011, MOL CELL ENDOCRINOL, V338, P28, DOI 10.1016/j.mce.2011.02.014; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Luttikhuizen DT, 2004, CELL TISSUE RES, V317, P289, DOI 10.1007/s00441-004-0939-x; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Meyer C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.204; Morris GE, 2012, AM J PHYSIOL-CELL PH, V302, pC723, DOI [10.1152/ajpcell.00202.2011, 10.1152/ajpcell.00202.2011.]; Moskvina E, 2003, J NEUROSCI, V23, P7479; Neary JT, 2009, TRENDS NEUROSCI, V32, P189, DOI 10.1016/j.tins.2009.01.002; Nguyen T, 1995, J BIOL CHEM, V270, P30845, DOI 10.1074/jbc.270.52.30845; Norambuena A, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.081166; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Ostrom RS, 2002, MOL PHARMACOL, V61, P473, DOI 10.1124/mol.61.3.473; Otero M, 2000, MOL CELL BIOCHEM, V205, P115, DOI 10.1023/A:1007018001735; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Patel HH, 2009, ANTIOXID REDOX SIGN, V11, P1357, DOI [10.1089/ars.2008.2365, 10.1089/ARS.2008.2365]; Peterson TS, 2013, J NEUROCHEM, V125, P885, DOI 10.1111/jnc.12252; Peterson TS, 2010, MOL NEUROBIOL, V41, P356, DOI 10.1007/s12035-010-8115-7; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Rimmerman N, 2012, BRIT J PHARMACOL, V165, P2436, DOI 10.1111/j.1476-5381.2011.01380.x; Rodriguez-Zayas AE, 2010, INT J DEV NEUROSCI, V28, P413, DOI 10.1016/j.ijdevneu.2010.07.001; Salgado IK, 2012, CELL MOL NEUROBIOL, V32, P409, DOI 10.1007/s10571-011-9771-5; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schroeder F, 2005, ADV MOL CEL, V36, P3, DOI 10.1016/S1569-6603(05)36001-6; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shigematsu S, 2003, J BIOL CHEM, V278, P10683, DOI 10.1074/jbc.M208563200; Silva WI, 2007, J NEUROCHEM, V103, P101, DOI 10.1111/j.1471-4159.2007.04712.x; Silva WI, 2005, INT J DEV NEUROSCI, V23, P599, DOI 10.1016/j.ijdevneu.2005.07.007; Silva WI, 1999, INT J DEV NEUROSCI, V17, P705, DOI 10.1016/S0736-5748(99)00040-4; Singh SP, 1998, NEUROREPORT, V9, P115, DOI 10.1097/00001756-199801050-00023; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Spisni E, 2005, BIOCHEM BIOPH RES CO, V338, P1383, DOI 10.1016/j.bbrc.2005.10.099; Sromek SM, 1998, MOL PHARMACOL, V54, P485, DOI 10.1124/mol.54.3.485; Miras-Portugal MT, 2015, COMPUT STRUCT BIOTEC, V13, P176, DOI 10.1016/j.csbj.2015.02.005; Tran MD, 2011, NEUROSCI LETT, V492, P155, DOI 10.1016/j.neulet.2011.01.078; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951; Tulapurkar ME, 2005, CELL MOL LIFE SCI, V62, P1388, DOI 10.1007/s00018-005-5052-0; Vohringer C, 2001, DRUG DEVELOP RES, V53, P172, DOI 10.1002/ddr.1185; Wang LB, 2003, J LIPID RES, V44, P807, DOI 10.1194/jlr.M200449-JLR200; Weisman GA, 2012, MOL NEUROBIOL, V46, P96, DOI 10.1007/s12035-012-8263-z; Weisman GA, 2012, PURINERG SIGNAL, V8, P559, DOI 10.1007/s11302-012-9307-6; Wypych D, 2012, ACTA BIOCHIM POL, V59, P711; Wypych D, 2013, ADV EXP MED BIOL, V986, P31, DOI 10.1007/978-94-007-4719-7_3; Xu WP, 2003, CANCER RES, V63, P7777; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Zhu XD, 2011, J BIOL CHEM, V286, P8231, DOI 10.1074/jbc.M110.145888; Zinchuk V, 2011, NAT PROTOC, V6, P1554, DOI 10.1038/nprot.2011.384	91	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12208	12222		10.1074/jbc.M116.730226	http://dx.doi.org/10.1074/jbc.M116.730226			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27129210	hybrid, Green Published			2022-12-28	WOS:000378092800022
J	Sato, S; Jung, HM; Nakagawa, T; Pawlosky, R; Takeshima, T; Lee, WR; Sakiyama, H; Laxman, S; Wynn, RM; Tu, BP; MacMillan, JB; De Brabander, JK; Veech, RL; Uyeda, K				Sato, Shogo; Jung, Hunmin; Nakagawa, Tsutomu; Pawlosky, Robert; Takeshima, Tomomi; Lee, Wan-Ru; Sakiyama, Haruhiko; Laxman, Sunil; Wynn, R. Max; Tu, Benjamin P.; MacMillan, John B.; De Brabander, Jef K.; Veech, Richard L.; Uyeda, Kosaku			Metabolite Regulation of Nuclear Localization of Carbohydrate-response Element-binding Protein (ChREBP) ROLE OF AMP AS AN ALLOSTERIC INHIBITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-HYDROXYBUTYRATE; TRANSCRIPTION FACTOR; FATTY-ACID; FREE MG2+; GLUCOSE; PHOSPHORYLATION; LIPOGENESIS; DEFICIENCY; MECHANISM; MODEL	The carbohydrate-response element-binding protein (ChREBP) is a glucose-responsive transcription factor that plays an essential role in converting excess carbohydrate to fat storage in the liver. In response to glucose levels, ChREBP is regulated by nuclear/cytosol trafficking via interaction with 14-3-3 proteins, CRM-1 (exportin-1 or XPO-1), or importins. Nuclear localization of ChREBP was rapidly inhibited when incubated in branched-chain alpha-ketoacids, saturated and unsaturated fatty acids, or 5-aminoimidazole-4-carboxamide ribonucleotide. Here, we discovered that protein-free extracts of high fat-fed livers contained, in addition to ketone bodies, a new metabolite, identified as AMP, which specifically activates the interaction between ChREBP and 14-3-3. The crystal structure showed that AMP binds directly to the N terminus of ChREBP-alpha 2 helix. Our results suggest that AMP inhibits the nuclear localization of ChREBP through an allosteric activation of ChREBP/14-3-3 interactions and not by activation of AMPK. AMP and ketone bodies together can therefore inhibit lipogenesis by restricting localization of ChREBP to the cytoplasm during periods of ketosis.	[Sakiyama, Haruhiko; Laxman, Sunil; Wynn, R. Max; Tu, Benjamin P.; MacMillan, John B.; De Brabander, Jef K.; Uyeda, Kosaku] Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Pawlosky, Robert; Veech, Richard L.] NIAAA, Bethesda, MD 20892 USA; [Uyeda, Kosaku] Dallas Vet Affairs Med Ctr, Dallas, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Uyeda, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Uyeda, K (corresponding author), Vet Affairs Med Ctr, 4500 S Lancaster Rd, Dallas, TX USA.	kuyeda@utsouthwestern.edu	Jung, Hunmin/ABD-2108-2020; Laxman, Sunil/F-9886-2018	Laxman, Sunil/0000-0002-0861-5080; Wynn, Richard/0000-0002-1879-2136; Sato, Shogo/0000-0002-2874-7072; Jung, Hunmin/0000-0002-8171-0412; MacMillan, John/0000-0003-1430-1077	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000110] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [16K01820] Funding Source: KAKEN	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr. Hong Zhang, the Biochemistry and Biophysics Department, University of Texas Southwestern Medical Center for use of the crystallization chamber, and Dr. Jay Horton, Internal Medicine, University of Texas Southwestern Medical Center, for acetylCoA carboxylase. We also thank Dr Martin Kemper, the National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, for assistance in calculation of phosphorylation potentials. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by University of Chicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ge Q, 2012, J BIOL CHEM, V287, P41914, DOI 10.1074/jbc.M112.418855; Ge Q, 2011, J BIOL CHEM, V286, P28119, DOI 10.1074/jbc.M111.237016; Gohda T, 2001, CLIN NEPHROL, V56, P475; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; GUYNN RW, 1973, J BIOL CHEM, V248, P6966; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; Hunter RW, 2014, CHEM BIOL, V21, P866, DOI 10.1016/j.chembiol.2014.05.014; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nakagawa T, 2013, J BIOL CHEM, V288, P28358, DOI 10.1074/jbc.M113.498550; NEWTON RP, 1984, BIOCHEM J, V221, P665, DOI 10.1042/bj2210665; Sakiyama H, 2010, BIOCHEM BIOPH RES CO, V402, P784, DOI 10.1016/j.bbrc.2010.10.113; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Srivastava S, 2012, J NEUROCHEM, V123, P668, DOI 10.1111/jnc.12026; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; VEECH RL, 1979, J BIOL CHEM, V254, P6538; VELOSO D, 1973, J BIOL CHEM, V248, P4811; Wong RHF, 2010, CURR OPIN PHARMACOL, V10, P684, DOI 10.1016/j.coph.2010.08.004; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804	32	43	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10515	10527		10.1074/jbc.M115.708982	http://dx.doi.org/10.1074/jbc.M115.708982			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26984404	hybrid, Green Published			2022-12-28	WOS:000377042600007
J	Becker, A; Zhang, P; Allmann, L; Meilinger, D; Bertulat, B; Eck, D; Hofstaetter, M; Bartolomei, G; Hottiger, MO; Schreiber, V; Leonhardt, H; Cardoso, MC				Becker, Annette; Zhang, Peng; Allmann, Lena; Meilinger, Daniela; Bertulat, Bianca; Eck, Daniel; Hofstaetter, Maria; Bartolomei, Giody; Hottiger, Michael O.; Schreiber, Valerie; Leonhardt, Heinrich; Cardoso, M. Cristina			Poly(ADP-ribosyl)ation of methyl CpG binding protein 2 regulates chromatin structure (vol 291, pg 4873, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Hottiger, Michael O./J-7747-2013; Schreiber, Valérie/M-5007-2016	Hottiger, Michael O./0000-0002-7323-2270; Schreiber, Valérie/0000-0003-0507-639X				Becker A, 2016, J BIOL CHEM, V291, P4873, DOI 10.1074/jbc.M115.698357	1	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9382	9382		10.1074/jbc.A115.698357	http://dx.doi.org/10.1074/jbc.A115.698357			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	27129196	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000374849000045
